data_2l8b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l8b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 . . . . . 0 N--CA 1.503 2.206 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.87 -43.15 99.43 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.537 -1.352 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 70.8 m -62.78 -44.2 96.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.673 -0.642 . . . . 0.0 110.312 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.439 ' HA ' ' CD2' ' A' ' 395' ' ' LEU . 69.1 t -65.84 -36.32 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.634 -0.666 . . . . 0.0 110.836 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.73 -44.2 97.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 111.568 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.0 91.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.492 -0.755 . . . . 0.0 112.124 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 392' ' ' VAL . 1.8 pp -71.88 -28.51 63.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.179 -0.951 . . . . 0.0 112.256 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.9 t -63.09 -43.9 97.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.701 -1.249 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -64.98 -42.97 94.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.731 -0.606 . . . . 0.0 111.59 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -63.28 -40.05 96.31 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.417 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.402 ' CD1' HD12 ' A' ' 395' ' ' LEU . 82.3 mt -63.52 -42.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.3 mtp -63.54 -32.0 73.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.165 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -57.87 -32.34 67.59 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.423 ' CG ' ' NH1' ' A' ' 415' ' ' ARG . 7.7 mp0 -93.09 -15.91 25.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.998 -1.064 . . . . 0.0 109.603 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -64.75 -36.35 84.03 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.24 18.43 17.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.785 . . . . 0.0 109.596 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.9 p -35.54 142.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.609 0 CA-C-O 121.354 0.597 . . . . 0.0 111.686 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 9.4 t -74.27 72.98 1.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.707 -0.621 . . . . 0.0 109.782 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 412' ' ' SER . 11.2 p -104.39 132.03 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.918 . . . . 0.0 111.52 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -93.33 142.05 24.76 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.46 -28.35 54.01 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.085 1.045 . . . . 0.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.22 -23.94 62.73 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.569 -0.707 . . . . 0.0 110.482 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 57.21 0.51 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' SER . . . . . 0.438 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 35.5 t -59.01 126.48 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 111.499 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.77 113.12 53.09 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.921 -0.487 . . . . 0.0 110.446 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.26 142.72 50.95 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.102 1.054 . . . . 0.0 109.423 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.423 ' NH1' ' CG ' ' A' ' 402' ' ' GLN . 83.2 mtp180 -159.38 63.11 0.39 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 109.534 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 74.1 p -66.83 -35.7 80.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.938 -1.101 . . . . 0.0 108.741 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -69.56 -10.45 58.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 111.2 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.13 -44.63 97.16 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -93.94 -2.42 53.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.13 -1.218 . . . . 0.0 109.805 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.3 t -80.61 -36.81 32.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -79.06 -46.03 18.94 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.388 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.14 -49.67 76.32 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.89 0.852 . . . . 0.0 110.781 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.415 ' CG1' HD21 ' A' ' 426' ' ' LEU . 55.9 t -72.16 -40.49 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.767 -0.583 . . . . 0.0 112.297 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 66.8 p -59.39 -39.13 82.36 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.889 -1.132 . . . . 0.0 110.835 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . 0.4 ' HA ' ' OE1' ' A' ' 428' ' ' GLN . 97.3 t -61.51 -42.49 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.71 -0.619 . . . . 0.0 109.67 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.3 OUTLIER -58.62 -32.73 69.3 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.444 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.72 73.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.607 -1.308 . . . . 0.0 109.32 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 425' ' ' VAL . 82.7 mt-30 -62.62 -31.22 72.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 426' ' ' LEU . 90.2 m-20 -62.89 -90.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.4 ' HB3' ' CD ' ' A' ' 431' ' ' PRO . 1.4 tpp180 -171.92 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.346 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 430' ' ' ARG . 48.4 Cg_endo -69.68 105.73 1.52 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.039 1.02 . . . . 0.0 110.482 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 531' ' ' GLN . 0.4 OUTLIER -85.15 100.93 12.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.782 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.741 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 20.9 tp -165.04 96.94 0.72 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.756 -1.215 . . . . 0.0 111.821 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -144.07 177.02 8.87 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.769 0.795 . . . . 0.0 111.89 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 435' ' ' ILE . 44.4 pt -116.7 139.29 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 44.1 t -144.33 145.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.4 m -129.96 139.04 51.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.51 -0.744 . . . . 0.0 109.551 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.36 149.76 19.41 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -103.96 -49.64 3.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.751 -0.852 . . . . 0.0 109.262 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -146.75 153.86 25.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 93.09 106.62 1.76 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -46.99 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -1.009 . . . . 0.0 110.675 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.79 84.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 112.01 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.29 -29.25 64.54 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 120.729 -1.232 . . . . 0.0 110.514 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -38.89 89.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.509 -0.995 . . . . 0.0 110.804 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -64.91 -41.74 95.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.015 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.77 -27.79 63.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.301 -0.874 . . . . 0.0 110.498 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -62.89 -56.13 20.03 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.334 -0.854 . . . . 0.0 111.219 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.34 -32.04 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.508 -1.37 . . . . 0.0 108.932 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.425 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.03 -26.34 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.59 -32.7 71.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.06 -37.32 87.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.43 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 59.4 t -60.6 -27.05 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.78 -0.575 . . . . 0.0 109.812 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.59 -37.1 82.09 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.9 ttp -58.38 -29.46 66.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.652 0.739 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.77 31.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 0.0 109.555 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.41 -43.17 98.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -71.59 -27.43 63.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.732 -0.605 . . . . 0.0 110.478 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -82.65 6.44 17.81 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.493 -0.755 . . . . 0.0 111.282 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.63 28.42 72.24 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.867 -1.146 . . . . 0.0 110.628 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -134.6 129.07 34.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.052 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.408 ' HB2' HD11 ' A' ' 487' ' ' ILE . 75.8 mm-40 -85.26 167.54 15.55 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 23.5 m -145.31 149.25 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.86 . . . . 0.0 110.293 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -97.52 126.11 42.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.427 HG22 ' CG2' ' A' ' 453' ' ' VAL . 1.9 pt -134.07 139.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.458 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.31 126.08 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.347 -0.846 . . . . 0.0 110.688 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 508' ' ' ASP . . . -84.28 -177.92 6.78 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.542 -0.723 . . . . 0.0 109.934 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -58.0 -162.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.213 0.53 . . . . 0.0 110.043 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.28 -16.86 6.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -0.969 . . . . 0.0 110.556 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -72.04 -11.07 60.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.374 -0.829 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -56.05 -34.0 65.51 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.13 -0.981 . . . . 0.0 111.903 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 39.0 t -55.66 -45.87 77.63 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.153 -0.967 . . . . 0.0 110.426 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -64.94 -37.91 89.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -32.47 70.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.92 -0.487 . . . . 0.0 110.506 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -59.65 -42.18 92.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.964 -1.085 . . . . 0.0 108.817 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.7 mtt -65.46 -35.65 81.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -102.92 -148.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 51.04 45.18 28.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.955 -1.091 . . . . 0.0 111.604 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -95.42 12.01 30.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.28 -0.887 . . . . 0.0 110.903 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -84.01 -1.68 55.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 111.131 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.976 -1.078 . . . . 0.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.66 30.03 6.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.553 -1.342 . . . . 0.0 111.785 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 37.3 m -60.91 -28.21 68.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.935 -1.103 . . . . 0.0 110.251 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 161.81 46.84 0.02 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -130.54 40.82 3.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.57 -0.959 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.36 -81.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 503' ' ' SER . 0.0 OUTLIER -175.63 -60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.41 -1.431 . . . . 0.0 112.547 173.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.469 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.5 t -101.82 12.83 36.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.467 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -87.28 66.38 3.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.484 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.8 ttm180 -143.39 -63.42 0.4 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.32 -1.106 . . . . 0.0 108.885 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -101.86 -36.04 8.8 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.979 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 497' ' ' MET . 11.4 tt0 -61.24 -29.96 70.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.644 -0.66 . . . . 0.0 111.492 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.467 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 5.9 mt -93.57 -29.91 15.25 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.513 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -38.21 7.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -6.39 12.13 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 100.47 -19.34 53.05 Favored Glycine 0 N--CA 1.504 3.204 0 CA-C-N 120.641 1.564 . . . . 0.0 112.274 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 10.9 mtp -69.29 175.1 4.13 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.982 -1.305 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.57 150.04 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.493 -0.754 . . . . 0.0 111.138 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.484 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -113.71 150.03 33.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.718 -0.614 . . . . 0.0 109.72 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.9 t -55.32 107.19 0.8 Allowed Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.474 -0.766 . . . . 0.0 110.573 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.408 ' HG2' ' CB ' ' A' ' 528' ' ' HIS . 40.0 Cg_endo -67.76 114.28 3.28 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.173 1.091 . . . . 0.0 110.316 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -166.11 26.19 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.436 ' HB2' HG21 ' A' ' 487' ' ' ILE . 22.9 t -96.0 -179.62 4.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.297 -1.119 . . . . 0.0 111.628 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 87.5 m -124.14 131.88 53.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.415 ' CG1' ' CD1' ' A' ' 522' ' ' LEU . 62.9 t -121.5 135.78 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.901 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 506' ' ' ILE . 26.0 pt -135.99 118.86 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.421 HG12 ' CG2' ' A' ' 534' ' ' ILE . 4.9 p -115.51 104.29 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 111.451 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 467' ' ' ALA . 9.9 p-10 -86.73 121.39 29.16 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 468' ' ' ALA . 1.9 pm0 -156.47 129.2 7.76 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -176.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . 0.4 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -77.56 -44.87 11.82 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -77.19 148.04 36.11 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -99.51 -12.19 20.38 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 121.907 -0.495 . . . . 0.0 111.645 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -34.98 79.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.8 m -69.68 -37.71 76.77 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.578 0.704 . . . . 0.0 110.577 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.14 -42.79 99.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.736 -0.602 . . . . 0.0 111.209 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.37 -43.3 86.3 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 518' ' ' THR . 18.9 pt-20 -68.29 -42.13 79.93 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.858 -1.151 . . . . 0.0 110.51 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.401 ' N ' ' HG3' ' A' ' 517' ' ' GLU . 52.1 m -61.55 -40.14 93.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -39.8 91.12 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 75.6 p -60.09 -57.08 14.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.049 -1.032 . . . . 0.0 110.672 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.43 -41.12 98.47 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.149 -0.969 . . . . 0.0 110.721 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.415 ' CD1' ' CG1' ' A' ' 505' ' ' VAL . 5.1 tt -57.66 -30.39 65.39 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.627 -0.671 . . . . 0.0 110.727 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.12 -47.44 68.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.488 -0.758 . . . . 0.0 111.421 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -60.63 -50.02 72.19 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.18 83.32 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.662 -0.905 . . . . 0.0 111.687 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.7 -25.12 66.17 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.273 -0.892 . . . . 0.0 110.964 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -53.47 -40.38 65.24 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.204 -0.935 . . . . 0.0 108.73 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.408 ' CB ' ' HG2' ' A' ' 501' ' ' PRO . 1.5 t-80 -93.02 -135.35 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -88.87 78.95 7.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.602 -1.311 . . . . 0.0 112.402 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -140.21 168.68 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.114 -0.991 . . . . 0.0 108.62 178.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -164.0 162.97 23.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.602 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.6 t -113.44 110.69 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.709 0.766 . . . . 0.0 112.071 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.89 117.63 34.64 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.421 ' CG2' HG12 ' A' ' 507' ' ' VAL . 11.7 pt -135.69 160.75 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 117.533 -1.667 . . . . 0.0 111.921 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 47.0 p -125.55 -168.45 1.84 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -159.35 168.83 25.39 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' SER . . . . . 0.4 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.9 17.98 2.31 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.583 178.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.95 11.49 3.36 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -95.59 0.85 53.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.04 -1.271 . . . . 0.0 111.305 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -53.69 -26.72 24.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.031 -1.043 . . . . 0.0 111.22 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 56.8 m -107.08 -36.81 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.417 -0.802 . . . . 0.0 109.89 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -134.42 107.46 0.66 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 15.1 t -97.74 -43.26 7.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -1.004 . . . . 0.0 111.629 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.65 -35.02 90.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 34.5 m -62.0 -32.24 72.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -1.079 . . . . 0.0 110.173 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.06 79.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.86 -0.525 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.1 mp -61.76 -43.72 98.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.0 -34.0 76.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 108.741 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -52.77 -52.5 56.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 32.0 ttp -58.31 -42.96 87.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.325 -0.86 . . . . 0.0 109.866 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.6 -32.16 72.27 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.738 -0.601 . . . . 0.0 111.233 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.52 -12.72 61.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.589 -0.694 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.83 6.85 1.04 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.321 -0.862 . . . . 0.0 113.013 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.3 -15.76 42.48 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.522 -1.361 . . . . 0.0 110.933 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.291 -1.123 . . . . 0.0 109.863 -179.258 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.293 0.568 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.54 -38.49 89.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.69 -0.632 . . . . 0.0 110.976 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.0 m -62.51 -47.41 84.05 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.389 -0.819 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.15 -36.47 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.481 -0.762 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.36 82.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.237 -0.914 . . . . 0.0 109.655 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.55 -34.19 77.66 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.664 0.745 . . . . 0.0 108.999 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.6 OUTLIER -60.67 -39.45 88.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.98 -0.45 . . . . 0.0 110.659 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.9 m -64.6 -36.95 85.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.479 -0.763 . . . . 0.0 111.029 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -64.51 -46.63 82.09 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.288 -0.882 . . . . 0.0 111.997 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -70.06 -41.22 74.46 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.24 -0.913 . . . . 0.0 111.703 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -40.6 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 109.675 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 18.3 mtp -63.01 -31.97 73.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.617 -0.677 . . . . 0.0 110.114 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -60.74 -32.93 72.2 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.041 -1.037 . . . . 0.0 109.517 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -90.44 -14.93 31.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.797 -1.189 . . . . 0.0 109.385 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -65.48 -35.94 82.38 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -115.63 18.6 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 9.9 p -39.07 148.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-O 121.677 0.751 . . . . 0.0 112.228 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 19.3 m -84.35 77.53 9.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.8 p -97.21 131.48 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.343 -0.848 . . . . 0.0 112.355 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -96.62 145.04 28.89 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.89 -21.57 57.19 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.066 1.035 . . . . 0.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.62 -36.29 66.81 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.83 0.824 . . . . 0.0 110.42 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 67.61 0.51 Allowed 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 14.3 m -62.67 135.27 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.818 0.818 . . . . 0.0 111.091 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.436 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 8.6 p -81.51 149.19 64.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.3 Cg_endo -58.47 136.67 75.83 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.018 1.009 . . . . 0.0 110.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.403 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 80.5 mtt85 -96.3 -8.94 31.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.664 -0.648 . . . . 0.0 112.662 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.0 t -99.34 19.09 16.14 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.95 -1.094 . . . . 0.0 109.175 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -106.17 -36.97 6.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -68.82 -38.62 85.51 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 415' ' ' ARG . 3.8 m-85 -94.9 -8.05 38.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.774 -1.427 . . . . 0.0 110.42 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -40.54 65.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.873 -1.142 . . . . 0.0 108.529 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -76.11 -44.47 38.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.898 -0.501 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -66.96 -48.59 68.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 111.445 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 72.2 t -67.87 -42.96 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.598 -0.689 . . . . 0.0 111.441 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.6 t -59.09 -42.61 90.86 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.812 -1.18 . . . . 0.0 111.309 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.8 -46.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.193 -0.942 . . . . 0.0 110.886 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 395' ' ' LEU . 0.7 OUTLIER -56.87 -37.24 71.06 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.243 -0.91 . . . . 0.0 112.28 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.43 -36.87 79.69 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.896 -1.128 . . . . 0.0 108.937 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -59.82 -30.49 68.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.26 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.494 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.44 -55.88 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.603 -1.31 . . . . 0.0 109.416 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 49.2 Cg_endo -73.4 106.44 2.18 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.0 m -85.17 97.82 10.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.878 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 18.1 tp -150.01 134.02 17.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -174.4 175.35 2.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.905 -1.122 . . . . 0.0 110.894 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 20.1 pt -134.09 121.05 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.403 0.62 . . . . 0.0 110.072 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 62.7 t -120.61 134.76 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.227 -0.92 . . . . 0.0 109.257 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 11.8 p -118.24 123.6 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.85 -1.156 . . . . 0.0 111.809 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 -178.14 34.18 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -171.41 39.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.991 . . . . 0.0 109.599 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -155.04 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -118.35 134.49 10.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -98.78 -16.08 19.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.689 -0.889 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.35 77.78 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.48 -0.763 . . . . 0.0 111.824 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -78.66 -35.05 33.27 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.42 -35.44 79.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.963 . . . . 0.0 109.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -60.49 -46.75 88.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.835 -0.541 . . . . 0.0 110.364 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.99 -29.37 69.19 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.169 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 57.7 ttt85 -62.06 -46.01 91.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 450' ' ' ALA . 5.3 p -58.81 -30.63 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.801 -1.187 . . . . 0.0 109.03 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.42 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -62.93 -26.49 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 79.3 mm-40 -60.77 -35.63 76.91 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.92 -1.113 . . . . 0.0 108.412 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.38 -37.9 87.52 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.897 . . . . 0.0 108.673 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 66.8 t -57.97 -28.9 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.588 -0.695 . . . . 0.0 109.976 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 65.8 mtt -65.76 -39.5 91.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.383 -0.823 . . . . 0.0 108.814 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 63.0 ttp -61.66 -21.49 64.46 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.608 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.19 32.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 0.0 109.891 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -67.08 -40.77 87.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 109.324 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.21 -34.19 75.8 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.604 0.716 . . . . 0.0 109.1 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -76.78 1.53 17.03 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.65 27.39 72.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -128.74 118.62 23.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -1.038 . . . . 0.0 110.402 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 0.5 OUTLIER -76.22 164.58 25.93 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 34.3 m -136.88 157.53 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.272 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.423 ' HA ' ' CD2' ' A' ' 486' ' ' LEU . 59.2 tt0 -105.7 111.81 24.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 465' ' ' ILE . 1.2 pt -122.32 129.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.41 HG21 ' CZ ' ' A' ' 471' ' ' ARG . 5.3 mp -119.36 111.99 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 112.169 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.436 ' HB2' ' CD ' ' A' ' 446' ' ' ARG . . . -57.43 164.12 2.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.294 -0.878 . . . . 0.0 109.806 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.78 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.898 -0.501 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -57.84 -12.25 2.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.117 -0.989 . . . . 0.0 111.2 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -88.82 6.08 40.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.145 -0.972 . . . . 0.0 111.164 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . 0.41 ' CZ ' HG21 ' A' ' 466' ' ' ILE . 53.6 ttp180 -57.9 -25.28 60.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.067 . . . . 0.0 111.037 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 7.7 t -59.02 -47.62 84.56 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.219 -0.925 . . . . 0.0 111.218 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.07 -35.82 82.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 33.0 ttp -66.28 -32.0 73.15 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.52 -37.3 83.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.31 -0.869 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 45.0 mtt -60.5 -36.4 78.24 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -121.08 -143.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 47.96 88.24 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.98 -1.075 . . . . 0.0 111.456 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -129.03 20.93 5.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 110.081 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -110.17 -0.72 17.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 111.377 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -135.25 -13.36 2.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.886 -1.134 . . . . 0.0 112.723 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.95 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.967 -1.083 . . . . 0.0 111.004 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.6 m -75.11 -18.26 60.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.64 47.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 20.1 pt-20 -139.9 74.8 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.669 -0.901 . . . . 0.0 111.051 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 487' ' ' ILE . 67.3 mt -94.85 -81.02 0.4 Allowed 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.443 ' CG2' ' HB3' ' A' ' 503' ' ' SER . 0.4 OUTLIER 161.16 -34.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.75 0 C-N-CA 123.552 0.741 . . . . 0.0 110.435 173.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.492 ' HA ' ' CD2' ' A' ' 499' ' ' PHE . 7.0 p -102.14 12.7 36.36 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -153.36 95.78 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.433 ' N ' ' CD2' ' A' ' 493' ' ' LEU . 72.2 ttt180 -145.81 -72.21 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 495' ' ' GLU . 74.1 mtt-85 -90.13 -16.55 29.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.962 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -56.95 4.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.71 -1.244 . . . . 0.0 109.95 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 494' ' ' LEU . 1.1 pt? -58.92 -28.08 65.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.724 -0.61 . . . . 0.0 111.07 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.443 ' N ' ' HG ' ' A' ' 493' ' ' LEU . 1.0 OUTLIER -104.81 -46.37 4.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 111.938 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 491' ' ' ARG . 51.0 mt-10 -104.25 -7.93 19.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 112.5 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.87 -3.5 87.04 Favored Glycine 0 N--CA 1.508 3.438 0 O-C-N 120.581 -1.324 . . . . 0.0 110.051 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.427 ' HB2' ' CB ' ' A' ' 491' ' ' ARG . 93.7 mmm -64.8 -177.25 0.32 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -1.075 . . . . 0.0 112.721 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.64 169.46 8.8 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.744 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.492 ' CD2' ' HA ' ' A' ' 488' ' ' THR . 1.2 p90 -142.33 150.09 40.31 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.564 -0.71 . . . . 0.0 110.443 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 30.8 m -61.77 109.25 2.06 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -84.91 113.35 1.55 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.362 1.191 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 168.85 31.83 0.02 OUTLIER Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.584 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.443 ' HB3' ' CG2' ' A' ' 487' ' ' ILE . 4.5 p -96.35 -175.4 3.34 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.418 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 25.1 m -110.03 122.75 48.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 522' ' ' LEU . 46.4 t -115.64 129.58 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.731 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 465' ' ' ILE . 15.2 pt -124.6 119.31 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.441 HG13 ' CG2' ' A' ' 534' ' ' ILE . 3.6 p -107.34 110.76 32.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.807 -1.183 . . . . 0.0 109.96 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 468' ' ' ALA . 21.4 m-20 -82.71 105.7 13.95 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 0.4 OUTLIER -109.21 178.37 4.47 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.08 0.943 . . . . 0.0 112.714 -175.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -167.36 -91.24 0.08 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -38.89 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.603 -0.299 . . . . 0.0 111.566 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -179.02 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.39 -1.444 . . . . 0.0 110.883 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.87 -30.77 71.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.573 -0.704 . . . . 0.0 109.935 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 6.0 p -69.17 -38.79 78.9 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.761 -0.587 . . . . 0.0 111.749 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 13.6 tp -64.26 -45.45 88.04 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.396 -0.815 . . . . 0.0 112.106 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -65.11 -45.48 84.98 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.73 -42.62 95.08 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.288 -0.882 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 74.4 m -58.54 -46.93 85.78 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.834 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.95 -36.91 85.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.246 -0.908 . . . . 0.0 111.008 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.5 m -58.07 -41.31 83.14 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.165 -0.959 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.38 -37.84 63.32 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.59 0.71 . . . . 0.0 109.498 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 505' ' ' VAL . 2.0 tp -63.65 -22.23 66.79 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -46.43 -52.78 12.37 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.5 -0.75 . . . . 0.0 112.005 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.74 -50.54 53.17 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.401 ' CB ' HG23 ' A' ' 488' ' ' THR . . . -58.26 -44.12 88.24 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.667 -0.902 . . . . 0.0 111.858 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.35 -25.41 67.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 0.0 111.246 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -55.41 -26.2 40.3 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.091 -1.005 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.469 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.9 m80 -110.88 -130.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.607 -0.683 . . . . 0.0 109.913 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -88.49 78.05 7.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.557 -1.339 . . . . 0.0 112.614 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 0.9 OUTLIER -134.34 158.4 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 109.152 178.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -150.82 157.99 43.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.739 -0.601 . . . . 0.0 109.726 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 69.1 t -110.78 96.81 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.192 -0.943 . . . . 0.0 113.468 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.9 114.19 25.88 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.441 ' CG2' HG13 ' A' ' 507' ' ' VAL . 4.9 pt -130.04 136.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.401 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 18.5 p -96.68 176.25 6.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 1.8 p30 -158.59 168.16 27.66 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.948 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.7 t -140.61 59.36 1.55 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -37.28 158.95 0.01 OUTLIER Glycine 0 N--CA 1.507 3.382 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.999 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.78 -87.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.166 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -108.77 -81.23 0.57 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.775 -1.203 . . . . 0.0 112.805 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 t -139.75 -30.16 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.675 0.75 . . . . 0.0 109.511 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -98.89 50.97 1.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.0 t -76.34 3.27 11.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 122.128 -0.631 . . . . 0.0 111.731 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -50.2 -26.68 9.53 Favored Glycine 0 N--CA 1.502 3.088 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.0 m -70.61 -20.85 62.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.995 -1.297 . . . . 0.0 109.047 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.33 75.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.83 -42.65 97.57 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.393 -0.817 . . . . 0.0 109.928 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.07 -34.51 75.02 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.09 39.11 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' MET . . . . . 0.405 ' N ' HD22 ' A' ' 515' ' ' LEU . 1.4 tmt? -57.49 -47.11 82.8 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.5 -33.42 71.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.677 -0.64 . . . . 0.0 111.496 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -63.96 -18.89 64.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.295 -0.878 . . . . 0.0 110.064 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.99 0.07 6.61 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.36 -0.838 . . . . 0.0 112.379 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 111.7 -12.4 27.6 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.816 -1.177 . . . . 0.0 111.52 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 68.8 t . . . . . 0 N--CA 1.496 1.867 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 -179.864 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.629 0.728 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.13 -37.3 86.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.503 -0.748 . . . . 0.0 110.882 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 49.0 m -60.02 -44.23 94.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.587 -0.696 . . . . 0.0 111.189 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 77.2 t -77.21 -29.56 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 111.063 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -65.51 -47.8 74.75 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.12 . . . . 0.0 111.166 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.26 88.76 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.876 0.846 . . . . 0.0 110.331 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 399' ' ' ILE . 8.3 tt -61.88 -38.83 89.75 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.207 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.2 m -61.15 -36.72 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.063 -0.398 . . . . 0.0 110.77 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -60.76 -44.07 97.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 110.734 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . 0.425 ' O ' ' CE1' ' A' ' 419' ' ' TYR . 39.1 t70 -65.58 -44.39 86.81 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 0.0 111.962 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 395' ' ' LEU . 0.9 OUTLIER -63.3 -42.17 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 121.106 -0.996 . . . . 0.0 108.983 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 2.9 ttt -61.96 -26.72 68.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.727 -0.608 . . . . 0.0 109.578 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -62.27 -31.13 71.67 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.413 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 27.4 tp60 -89.75 -11.69 41.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 0.0 109.83 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.51 -39.92 88.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 -116.57 17.8 15.23 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.788 -1.195 . . . . 0.0 109.721 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.4 p -56.87 118.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.612 -0.68 . . . . 0.0 110.001 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -54.58 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.083 -1.011 . . . . 0.0 109.559 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.02 130.9 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.899 -0.501 . . . . 0.0 110.132 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.12 131.78 34.1 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.475 -0.765 . . . . 0.0 109.878 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 -24.03 43.88 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.164 1.086 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.36 -37.4 80.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.941 0.877 . . . . 0.0 110.181 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 67.6 1.03 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.8 p -49.8 155.3 0.88 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.108 0.956 . . . . 0.0 112.088 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.45 143.65 27.02 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 131.26 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 N-CA-C 109.104 -1.152 . . . . 0.0 109.104 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -109.51 -19.06 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.516 -0.74 . . . . 0.0 112.502 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 420' ' ' SER . 9.8 t -101.86 14.95 30.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -75.55 -77.86 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.689 -0.632 . . . . 0.0 111.607 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -89.0 -0.72 80.65 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.782 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' A' ' 398' ' ' ASP . 80.2 m-85 -107.98 -26.39 10.71 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.775 2.288 . . . . 0.0 108.763 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 416' ' ' THR . 4.9 t -71.19 -38.78 72.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 175.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 -38.8 92.19 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.22 78.74 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.748 0.785 . . . . 0.0 109.327 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 75.9 t -66.85 -44.42 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.7 p -61.02 -37.82 83.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.642 -1.286 . . . . 0.0 111.529 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.25 -46.47 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -55.3 -32.78 62.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 0.0 111.686 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.16 78.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.806 -1.184 . . . . 0.0 108.877 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.49 -30.57 65.21 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.68 -89.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.442 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -174.67 -54.33 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.617 -1.302 . . . . 0.0 108.93 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.9 Cg_endo -70.81 98.71 0.8 Allowed 'Trans proline' 0 N--CA 1.487 1.135 0 N-CA-C 109.179 -1.123 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 531' ' ' GLN . 0.4 OUTLIER -84.34 102.09 12.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.804 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.91 98.1 1.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.35 -0.844 . . . . 0.0 111.928 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.92 168.32 19.99 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.48 -0.763 . . . . 0.0 111.82 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.27 129.92 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.747 -0.596 . . . . 0.0 111.385 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.02 155.44 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.312 -0.868 . . . . 0.0 110.083 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.7 t -133.09 138.9 46.87 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.427 -0.796 . . . . 0.0 111.024 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -101.41 -171.34 28.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -153.18 26.15 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.732 -0.863 . . . . 0.0 109.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.9 10.33 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.56 55.35 15.22 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.42 -9.08 59.58 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -57.69 -45.96 84.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.134 -0.979 . . . . 0.0 111.723 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -83.05 -28.55 36.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.74 -40.43 88.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.952 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -65.97 -39.27 90.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.51 -0.744 . . . . 0.0 109.66 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -67.66 -29.5 68.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.141 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 49.7 ttt85 -64.21 -47.0 81.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 450' ' ' ALA . 9.5 p -56.5 -30.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.554 -1.341 . . . . 0.0 109.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.498 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 95.3 mt-10 -62.76 -33.68 75.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.734 -1.229 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.02 -34.54 78.67 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 59.3 t -60.47 -31.75 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 96.3 mmm -65.14 -40.1 93.95 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.3 ttp -59.63 -22.45 61.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.603 -0.686 . . . . 0.0 110.318 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -81.93 -22.79 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -65.37 -43.09 91.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.429 -0.794 . . . . 0.0 109.655 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.19 -28.93 63.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -76.03 -2.92 33.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.699 -0.626 . . . . 0.0 111.388 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.58 19.99 72.46 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -136.72 151.18 48.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -1.064 . . . . 0.0 110.406 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.421 ' HB2' HD11 ' A' ' 487' ' ' ILE . 92.3 mt-10 -102.07 178.84 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.44 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 19.4 m -141.9 158.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.778 -1.201 . . . . 0.0 111.578 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -102.1 119.33 38.62 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.77 130.97 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.232 -0.918 . . . . 0.0 111.081 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.408 ' CD1' HG23 ' A' ' 518' ' ' THR . 91.1 mt -129.11 123.56 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.852 -0.53 . . . . 0.0 110.277 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.66 165.71 24.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.1 -161.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.571 -0.706 . . . . 0.0 110.528 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.53 -20.52 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -74.57 -2.86 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.395 -0.815 . . . . 0.0 110.752 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.19 -26.06 26.15 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.108 -0.995 . . . . 0.0 110.46 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.2 p -65.41 -46.81 78.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.392 -0.818 . . . . 0.0 109.966 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.77 -49.25 69.03 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.373 -0.829 . . . . 0.0 110.329 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 6.4 ttt -58.57 -30.61 67.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 110.403 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -58.75 -33.37 70.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 47.3 ttp -58.47 -39.08 78.95 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.315 0.579 . . . . 0.0 110.295 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -125.14 -157.36 0.78 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.835 -0.541 . . . . 0.0 109.663 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 45.82 61.44 2.65 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.443 -0.786 . . . . 0.0 112.167 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -98.05 9.03 43.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.586 -0.696 . . . . 0.0 109.795 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -93.04 -0.59 57.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.16 3.38 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 112.454 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.5 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.872 -1.142 . . . . 0.0 111.815 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.9 p -93.76 48.24 1.27 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.132 -0.98 . . . . 0.0 108.926 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.82 26.66 28.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -118.52 47.58 1.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.495 -1.003 . . . . 0.0 108.814 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.11 -82.77 0.39 Allowed 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.644 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.443 HG13 ' CB ' ' A' ' 503' ' ' SER . 38.0 mm -142.71 -90.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.076 -1.015 . . . . 0.0 108.99 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.447 ' OG1' ' CD2' ' A' ' 499' ' ' PHE . 0.0 OUTLIER -102.09 11.85 37.73 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.653 -0.654 . . . . 0.0 110.263 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.78 77.62 2.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.492 ' CG ' ' H ' ' A' ' 491' ' ' ARG . 0.2 OUTLIER -144.47 -86.11 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.492 ' H ' ' CG ' ' A' ' 490' ' ' ARG . 77.9 mtt85 -112.14 -17.16 12.87 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.443 -0.785 . . . . 0.0 109.227 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 497' ' ' MET . 8.0 mp0 -49.64 -36.1 23.51 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.61 -1.306 . . . . 0.0 111.226 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.84 -66.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.16 -0.962 . . . . 0.0 108.465 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.11 -28.99 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.408 0.623 . . . . 0.0 110.377 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 80.0 mm-40 -84.51 -3.16 58.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.0 111.585 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 69.91 48.87 38.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 94.4 mtp -123.01 -177.39 3.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -1.001 . . . . 0.0 111.127 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.48 170.63 7.96 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.649 -0.657 . . . . 0.0 110.325 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.447 ' CD2' ' OG1' ' A' ' 488' ' ' THR . 4.6 m-85 -109.21 125.64 52.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.257 -0.902 . . . . 0.0 108.612 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.7 t -68.02 150.89 97.58 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.613 -0.679 . . . . 0.0 110.852 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.415 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 42.5 Cg_endo -71.6 123.7 9.67 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.611 1.322 . . . . 0.0 111.049 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 161.64 -2.06 0.07 OUTLIER Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.72 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.443 ' CB ' HG13 ' A' ' 487' ' ' ILE . 8.6 m -82.81 153.21 25.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.343 . . . . 0.0 113.502 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 50.7 m -118.58 91.88 3.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.404 ' CG2' HD22 ' A' ' 522' ' ' LEU . 18.3 t -87.85 135.8 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 506' ' ' ILE . 18.2 pt -136.55 122.43 28.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 507' ' ' VAL . 8.5 p -123.67 111.98 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.669 -1.269 . . . . 0.0 112.787 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -86.59 123.04 31.34 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -160.52 129.23 4.76 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 117.488 -1.685 . . . . 0.0 115.434 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -85.3 -43.02 6.76 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.61 151.54 45.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -98.83 -11.68 21.55 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.24 -40.46 90.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 13.5 t -67.71 -39.95 84.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.819 -0.551 . . . . 0.0 111.201 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.67 -44.76 95.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.595 -0.691 . . . . 0.0 111.235 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -71.36 -46.57 60.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.294 -0.878 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.03 -44.08 85.7 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.408 HG23 ' CD1' ' A' ' 466' ' ' ILE . 83.1 m -56.84 -43.4 81.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.309 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -34.42 58.94 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.33 0.586 . . . . 0.0 109.882 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 27.0 m -62.35 -41.48 98.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.508 -0.745 . . . . 0.0 109.513 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -40.52 97.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.738 0.78 . . . . 0.0 108.928 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.404 HD22 ' CG2' ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.33 -21.34 63.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.923 -0.485 . . . . 0.0 110.851 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -46.09 -64.55 0.72 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.622 -0.673 . . . . 0.0 112.453 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.03 -52.47 49.79 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 120.577 -1.327 . . . . 0.0 110.737 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.24 68.18 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.258 -1.142 . . . . 0.0 111.006 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.487 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -65.87 -20.66 66.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -37.9 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 0.7 OUTLIER -145.44 -79.25 0.18 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.267 -1.521 . . . . 0.0 113.751 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.407 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 82.5 m-20 -90.65 72.63 6.76 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.712 -1.243 . . . . 0.0 114.087 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.487 ' CB ' ' HA ' ' A' ' 526' ' ' ALA . 9.6 p -130.16 150.63 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.738 -1.226 . . . . 0.0 112.572 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 87.8 mm-40 -144.02 149.86 37.34 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 5.2 t -112.33 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.761 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -103.08 116.67 32.96 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . . . . . . . . . 9.8 pt -136.0 150.7 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.747 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.3 p -118.13 -163.99 0.98 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.54 163.15 40.36 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.607 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.8 p -128.7 22.25 5.9 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.875 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -174.0 43.85 0.14 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.35 -0.41 56.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.881 -0.776 . . . . 0.0 111.732 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -55.68 -42.71 75.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.995 -1.066 . . . . 0.0 110.851 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 m -116.76 156.38 27.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.591 -0.693 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.53 34.38 55.22 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.9 t -62.62 -43.36 98.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.42 -1.047 . . . . 0.0 110.61 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.53 87.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.9 m -63.98 -39.45 94.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.846 -0.797 . . . . 0.0 111.007 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.09 82.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.01 -42.26 99.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.657 -0.652 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 63.8 tpp -63.59 -34.58 78.14 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.5 -0.75 . . . . 0.0 109.515 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.89 50.26 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 39.0 ttp -58.57 -44.86 89.88 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.317 -0.864 . . . . 0.0 109.914 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . 0.434 ' HA ' ' CG2' ' A' ' 555' ' ' VAL . 75.8 mmtt -60.28 -32.04 70.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.643 -0.66 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.81 -16.6 63.83 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.337 -0.852 . . . . 0.0 110.607 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.38 2.85 2.65 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 138.73 -16.66 3.29 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.21 -1.472 . . . . 0.0 111.817 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 551' ' ' LYS . 35.2 m . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.996 -1.297 . . . . 0.0 110.262 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.66 -31.13 66.48 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.904 -1.123 . . . . 0.0 110.827 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 17.0 p -64.63 -40.64 95.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.816 -0.552 . . . . 0.0 111.915 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.59 -35.93 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 111.961 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.81 -46.99 82.66 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.71 -1.244 . . . . 0.0 110.63 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.35 75.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.436 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 1.3 tt -63.34 -39.03 93.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.825 -0.547 . . . . 0.0 110.52 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 59.3 m -61.23 -37.84 84.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.424 -0.797 . . . . 0.0 110.419 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -63.3 -44.69 94.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.325 -0.859 . . . . 0.0 111.663 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -67.66 -46.06 73.48 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.149 -0.969 . . . . 0.0 111.949 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 63.9 mt -65.44 -42.35 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.985 -1.072 . . . . 0.0 109.921 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 16.6 ttm -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.19 -25.66 65.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.52 -0.738 . . . . 0.0 109.381 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 0.0 OUTLIER -93.11 -15.64 25.83 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.867 -1.146 . . . . 0.0 109.025 175.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.3 -40.3 86.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.608 -0.683 . . . . 0.0 110.263 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -115.49 18.67 15.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.969 -1.082 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 407' ' ' VAL . 7.1 p -48.7 116.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.492 -0.755 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.8 p -50.49 89.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.786 -0.571 . . . . 0.0 111.016 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 405' ' ' VAL . 14.2 p -108.74 133.7 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -96.76 141.7 23.47 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 110.85 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.93 -24.35 39.83 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.143 1.075 . . . . 0.0 110.232 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -66.76 -32.32 73.53 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.782 0.801 . . . . 0.0 110.392 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 67.21 1.14 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 18.6 t -49.56 148.74 2.69 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.55 -0.718 . . . . 0.0 110.604 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.9 p -100.93 110.06 59.9 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.637 . . . . 0.0 110.855 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.81 121.37 5.44 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.004 1.002 . . . . 0.0 111.3 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -169.4 61.7 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.825 . . . . 0.0 110.181 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 417' ' ' ALA . 5.2 t -67.47 -31.36 71.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.323 -0.861 . . . . 0.0 108.799 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.425 ' N ' HG23 ' A' ' 416' ' ' THR . . . -64.55 -12.64 47.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 110.735 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.7 81.24 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.489 ' CD1' HG11 ' A' ' 436' ' ' VAL . 26.0 p90 -90.27 -0.42 57.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.93 -1.336 . . . . 0.0 110.161 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.8 m -76.07 -38.81 56.59 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.447 0.642 . . . . 0.0 109.962 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.49 -49.51 75.08 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.971 0.891 . . . . 0.0 111.068 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 97.4 t -68.41 -42.24 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.771 -0.581 . . . . 0.0 111.146 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 88.1 p -59.48 -33.05 70.83 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.007 . . . . 0.0 110.42 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.11 -46.03 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.7 -0.625 . . . . 0.0 111.026 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 423' ' ' VAL . 1.8 pp -64.13 -34.76 78.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.178 -0.951 . . . . 0.0 112.367 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.26 85.5 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.629 -1.294 . . . . 0.0 109.15 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -63.3 -32.3 73.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -66.33 -93.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.428 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -177.26 -53.79 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.369 -1.457 . . . . 0.0 109.433 177.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 41.1 Cg_endo -68.72 106.36 1.46 Allowed 'Trans proline' 0 N--CA 1.48 0.726 0 N-CA-C 108.204 -1.498 . . . . 0.0 108.204 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.446 ' HB3' ' N ' ' A' ' 532' ' ' VAL . 0.2 OUTLIER -92.36 103.56 15.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -164.07 89.81 0.57 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.938 -1.102 . . . . 0.0 109.27 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.436 ' HB2' ' CD2' ' A' ' 395' ' ' LEU . . . -137.4 170.0 16.83 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.785 0.802 . . . . 0.0 111.414 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.35 126.73 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 419' ' ' TYR . 22.4 t -130.04 160.4 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 110.729 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.5 t -133.58 138.79 46.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.434 -0.791 . . . . 0.0 110.685 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.02 166.51 23.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -116.89 -44.59 2.81 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.283 -1.128 . . . . 0.0 109.492 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.9 165.85 38.3 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.98 36.21 64.73 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -59.13 -22.34 60.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.79 -0.829 . . . . 0.0 112.001 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.56 90.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.82 -29.49 59.15 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -60.17 -41.3 92.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.597 -0.943 . . . . 0.0 109.957 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.0 mtm180 -64.01 -36.12 82.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.16 -30.13 68.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.415 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.62 -49.73 69.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 111.124 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -57.43 -32.58 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.003 -1.061 . . . . 0.0 110.138 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.67 -27.18 68.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 454' ' ' MET . 83.4 tt0 -66.55 -36.6 83.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 455' ' ' MET . 0.4 OUTLIER -62.56 -35.47 79.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.488 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 46.9 t -64.63 -28.2 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 95.0 mtp -68.26 -42.73 79.17 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.216 -0.928 . . . . 0.0 111.764 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 6.6 ptm -63.36 -21.58 66.36 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.51 -1.369 . . . . 0.0 109.245 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.43 48.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.456 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.16 -41.05 97.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.47 -22.53 62.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.799 -0.563 . . . . 0.0 110.497 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -75.28 -0.23 18.9 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.171 -0.956 . . . . 0.0 111.651 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 82.24 12.53 80.59 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 120.92 -1.112 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -139.54 151.84 46.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 110.653 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -92.85 179.28 5.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.587 -0.696 . . . . 0.0 109.205 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 14.7 m -141.85 153.23 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.779 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -98.52 118.31 34.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -122.72 128.82 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.42 -0.8 . . . . 0.0 109.467 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 465' ' ' ILE . 5.4 mp -121.39 115.92 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.972 -0.455 . . . . 0.0 110.224 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -71.05 161.41 31.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -57.36 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.121 -0.987 . . . . 0.0 110.298 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -48.43 -19.8 0.35 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.036 -1.04 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.22 -10.64 59.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -55.11 -25.51 31.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 111.827 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 77.9 p -59.06 -41.92 89.1 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.989 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -64.95 -41.54 95.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.566 -0.709 . . . . 0.0 109.541 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 38.7 ttm -58.0 -36.6 72.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.588 -0.695 . . . . 0.0 110.536 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -60.89 -40.62 93.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -0.82 . . . . 0.0 109.869 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 52.2 mtt -62.79 -40.05 96.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.622 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 65.0 pttt -117.52 -158.3 0.7 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.165 -0.959 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 94.8 mm-40 46.15 88.83 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.452 -0.78 . . . . 0.0 112.118 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -116.75 26.28 9.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -107.7 -9.82 15.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 111.449 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -11.39 3.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 111.909 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -173.58 55.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 5.7 t -62.27 -18.48 61.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.318 -0.864 . . . . 0.0 109.921 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 163.81 -21.08 0.15 Allowed Glycine 0 N--CA 1.501 2.986 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.51 71.31 3.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.029 -1.277 . . . . 0.0 110.014 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.421 ' O ' HD11 ' A' ' 487' ' ' ILE . 0.1 OUTLIER -86.77 -82.96 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.398 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 486' ' ' LEU . 34.5 mm -145.23 -86.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.147 . . . . 0.0 110.322 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 69.7 p -96.33 47.78 1.08 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.46 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -111.65 59.84 0.35 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.454 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 79.2 ttt180 -143.98 -61.44 0.39 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.438 -1.037 . . . . 0.0 108.908 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -110.71 -31.01 7.35 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.382 0.611 . . . . 0.0 110.558 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -35.92 82.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.306 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.46 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 7.1 mt -91.95 -26.46 18.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.332 -0.855 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 41.7 tp -104.55 -41.64 5.65 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.66 -8.68 18.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.972 -1.08 . . . . 0.0 113.733 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 86.6 -16.36 46.0 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.674 -1.267 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.83 -178.52 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.197 -1.178 . . . . 0.0 109.429 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.38 156.49 22.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.177 -0.952 . . . . 0.0 110.644 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.454 ' CE1' ' HB3' ' A' ' 490' ' ' ARG . 0.1 OUTLIER -113.66 149.06 35.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.855 -0.528 . . . . 0.0 109.726 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 4.9 t -47.09 104.67 0.42 Allowed Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.531 -0.731 . . . . 0.0 110.575 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.72 111.89 3.34 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.25 1.131 . . . . 0.0 110.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 174.42 34.64 0.04 OUTLIER Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 14.5 m -99.35 -177.21 3.52 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.331 1.063 . . . . 0.0 113.461 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 52.4 m -120.48 128.79 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 531' ' ' GLN . 37.4 t -116.45 131.79 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.911 0.863 . . . . 0.0 112.726 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.416 HG21 HG22 ' A' ' 449' ' ' VAL . 39.6 mt -129.71 113.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.947 -1.096 . . . . 0.0 108.121 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.413 HG13 ' CG2' ' A' ' 534' ' ' ILE . 10.6 p -114.93 105.21 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.883 -1.136 . . . . 0.0 111.9 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -85.48 124.17 31.75 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 468' ' ' ALA . 9.3 tp-100 -160.1 125.78 4.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -91.4 -31.82 9.28 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.15 -164.08 0.83 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.02 -5.67 3.09 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.89 -39.14 79.92 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.126 -0.984 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 1.9 m -87.29 -17.34 32.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.559 -0.713 . . . . 0.0 111.733 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.52 -41.8 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.43 -0.794 . . . . 0.0 109.871 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.54 -43.06 57.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.527 -0.733 . . . . 0.0 111.888 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.05 -44.55 97.22 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.971 -1.081 . . . . 0.0 110.954 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -60.16 -42.1 94.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 0.0 109.508 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -38.35 77.21 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.797 -0.564 . . . . 0.0 109.619 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.9 m -61.42 -36.33 80.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.303 -0.873 . . . . 0.0 108.993 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -38.29 81.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.8 -0.563 . . . . 0.0 109.984 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 526' ' ' ALA . 0.5 OUTLIER -67.68 -21.29 65.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.15 -0.969 . . . . 0.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -46.44 -63.33 1.03 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.37 -0.831 . . . . 0.0 111.198 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.74 79.36 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.75 37.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.75 -0.853 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.422 ' HA ' HG11 ' A' ' 530' ' ' VAL . . . -46.42 -25.41 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 112.767 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -59.02 -42.91 91.31 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.78 -35.74 0.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.286 -0.884 . . . . 0.0 110.856 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -79.77 103.14 9.47 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 526' ' ' ALA . 16.4 m -149.45 125.86 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.08 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.7 OUTLIER 176.23 100.2 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.446 ' N ' ' HB3' ' A' ' 432' ' ' SER . 95.5 t -107.47 109.86 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.629 1.204 . . . . 0.0 109.989 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . 0.306 4.3 tt -114.45 115.58 27.51 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 103.028 -2.952 . . . . 0.0 103.028 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.413 ' CG2' HG13 ' A' ' 507' ' ' VAL . 0.5 OUTLIER -134.48 129.65 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.841 -177.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.43 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 68.1 p -100.87 -163.58 1.03 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.6 165.62 36.02 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.21 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 4.4 p -132.94 16.14 4.23 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.38 42.96 0.31 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -96.5 -0.04 49.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.745 -0.856 . . . . 0.0 112.182 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -46.07 -32.06 2.65 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.161 -0.962 . . . . 0.0 111.496 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 t -131.49 162.59 29.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.463 -0.773 . . . . 0.0 109.377 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.69 31.71 58.0 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.8 t -61.91 -46.53 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.964 . . . . 0.0 110.758 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.3 -38.19 94.78 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 5.6 t -63.13 -33.73 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.816 -0.814 . . . . 0.0 109.686 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.11 80.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.598 -0.689 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.97 -41.02 97.67 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.461 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 87.7 mmm -65.51 -32.97 74.85 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.377 -0.827 . . . . 0.0 108.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -54.11 -54.76 35.04 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.597 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 65.9 ttp -59.11 -43.22 91.89 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.16 -0.962 . . . . 0.0 110.439 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.26 -32.36 73.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.424 -0.798 . . . . 0.0 112.133 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.1 -13.54 61.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.375 -0.828 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -72.8 6.91 2.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 112.664 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 140.7 -17.69 2.82 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.87 -1.157 . . . . 0.0 110.967 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 81.5 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.155 -1.203 . . . . 0.0 110.303 -179.407 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 120.557 0.218 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.31 -39.71 87.95 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.6 m -64.24 -42.57 96.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.477 -0.764 . . . . 0.0 109.946 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.79 -34.41 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.784 -0.572 . . . . 0.0 110.621 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -61.12 -48.09 83.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.296 -0.877 . . . . 0.0 111.349 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.89 78.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.45 -0.782 . . . . 0.0 110.458 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 399' ' ' ILE . 10.0 tt -61.86 -39.15 90.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.751 -0.593 . . . . 0.0 110.507 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 60.6 m -63.17 -40.35 97.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.747 -0.596 . . . . 0.0 111.49 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.42 -41.8 97.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.333 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.3 -42.39 93.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.618 -0.676 . . . . 0.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -63.08 -39.01 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 120.906 -1.121 . . . . 0.0 108.761 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.5 mtp -65.37 -28.47 69.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.37 -29.87 70.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.538 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 55.1 tt0 -92.8 -13.58 28.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.43 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -66.18 -36.91 84.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.651 -0.656 . . . . 0.0 109.458 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -116.81 18.85 14.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.791 -1.193 . . . . 0.0 109.919 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.8 p -61.81 118.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.493 -0.754 . . . . 0.0 110.007 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.2 m -53.91 105.08 0.12 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.53 132.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.612 -0.68 . . . . 0.0 109.548 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -91.95 140.68 24.83 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.552 -0.718 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.1 -23.37 33.88 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.264 1.139 . . . . 0.0 110.265 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -58.68 -43.0 89.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.322 -0.862 . . . . 0.0 109.395 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 67.38 0.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 91.4 p -52.66 117.4 2.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.241 -0.912 . . . . 0.0 111.525 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.447 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 8.7 p -62.58 149.94 87.4 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.447 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.6 Cg_endo -61.88 140.47 85.41 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.068 1.036 . . . . 0.0 110.095 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.435 ' NH2' ' HB2' ' A' ' 439' ' ' GLN . 42.2 mtm180 -106.44 -12.77 15.54 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.839 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 38.5 p -103.26 10.77 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.388 -1.445 . . . . 0.0 108.792 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.68 -87.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.47 78.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.652 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 419' ' ' TYR . 78.7 m-85 -108.32 -25.38 11.04 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 120.756 2.278 . . . . 0.0 109.184 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.7 t -72.94 -40.75 65.14 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -64.12 -35.87 82.16 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.13 84.71 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.338 0.589 . . . . 0.0 109.877 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.84 -45.6 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 0.0 111.03 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 85.9 p -60.08 -41.51 92.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.142 -0.974 . . . . 0.0 111.577 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.88 -47.02 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.404 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.55 -32.56 18.89 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.61 -0.682 . . . . 0.0 112.0 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.18 71.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 0.0 109.278 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.08 -29.46 69.76 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -64.73 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.65 -51.12 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.503 -1.373 . . . . 0.0 111.346 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 50.1 Cg_endo -86.31 110.11 0.98 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 O-C-N 122.698 0.841 . . . . 0.0 110.03 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.8 m -91.19 99.78 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 111.089 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.803 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 7.4 tp -156.79 90.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.619 -0.676 . . . . 0.0 111.017 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.43 166.58 23.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.772 -0.58 . . . . 0.0 110.979 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.17 125.36 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.631 -0.668 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.21 153.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.012 -1.055 . . . . 0.0 110.748 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.9 t -132.92 139.09 47.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.21 -0.931 . . . . 0.0 111.735 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.401 ' HA2' ' NH1' ' A' ' 415' ' ' ARG . . . -141.57 143.85 13.63 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . 0.435 ' HB2' ' NH2' ' A' ' 415' ' ' ARG . 27.1 mt-30 -143.29 55.25 1.36 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -1.066 . . . . 0.0 110.279 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 151.73 140.31 3.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.47 79.66 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.01 60.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.964 . . . . 0.0 112.014 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.35 89.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 110.883 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.79 -31.05 56.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.17 -40.39 86.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.699 -0.883 . . . . 0.0 111.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.405 ' O ' HG12 ' A' ' 449' ' ' VAL . 51.9 mtt-85 -64.14 -41.84 97.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -72.65 -29.51 63.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -61.25 -46.13 91.66 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.394 -0.816 . . . . 0.0 110.463 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -62.78 -31.22 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.317 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -58.81 -34.19 71.22 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.93 -30.18 70.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.2 -0.938 . . . . 0.0 108.619 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.06 -37.07 83.58 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.59 -29.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.87 -39.43 87.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -23.97 66.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.654 -0.654 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.08 -21.75 36.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -67.48 -41.56 84.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.852 -0.53 . . . . 0.0 110.297 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -71.77 -34.44 69.44 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.089 -1.007 . . . . 0.0 110.374 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -77.71 6.99 6.31 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.464 -0.773 . . . . 0.0 111.702 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.85 24.12 72.81 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.53 129.17 50.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.609 -0.936 . . . . 0.0 110.835 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -92.54 161.41 14.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 17.2 m -145.31 157.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.431 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 57.6 tt0 -103.13 124.68 49.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.795 -0.566 . . . . 0.0 109.726 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.414 ' HA ' ' CG1' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -129.09 132.17 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.048 . . . . 0.0 109.31 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.402 ' CG2' ' HD3' ' A' ' 471' ' ' ARG . 87.2 mt -125.11 121.4 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.062 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -79.75 163.0 24.82 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.69 -159.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.337 -0.852 . . . . 0.0 109.949 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.53 -16.08 0.33 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.643 -1.286 . . . . 0.0 111.021 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -72.16 -14.53 61.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.975 -1.078 . . . . 0.0 110.218 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . 0.402 ' HD3' ' CG2' ' A' ' 466' ' ' ILE . 49.1 ttp180 -57.47 -30.92 65.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.161 -0.962 . . . . 0.0 110.877 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 85.1 p -55.46 -44.3 76.27 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.343 -0.848 . . . . 0.0 109.66 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -65.03 -37.99 89.41 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -36.46 77.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.715 -0.616 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -59.23 -38.1 79.15 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.195 -0.941 . . . . 0.0 109.938 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 97.8 mtp -60.22 -38.09 82.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.88 -146.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.497 -0.752 . . . . 0.0 109.772 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 47.58 78.51 0.08 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.036 -1.04 . . . . 0.0 111.853 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -117.75 10.26 13.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -77.94 -4.48 47.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.971 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.4 17.63 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.224 -0.923 . . . . 0.0 113.278 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . 0.41 ' CD1' ' HG2' ' A' ' 481' ' ' ARG . 9.8 mp -125.44 4.86 7.64 Favored 'General case' 0 N--CA 1.508 2.438 0 CA-C-N 120.475 1.489 . . . . 0.0 112.279 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 10.3 m -74.55 35.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.385 -1.447 . . . . 0.0 112.512 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 109.08 9.78 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 120.669 -1.27 . . . . 0.0 110.088 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -87.82 11.7 14.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.135 -1.215 . . . . 0.0 110.385 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 464' ' ' GLN . 3.9 mm? -53.37 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -174.65 -69.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.87 . . . . 0.0 109.118 174.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.409 ' HB ' ' CB ' ' A' ' 499' ' ' PHE . 3.0 t -103.35 10.5 37.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.0 111.496 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -79.82 66.89 3.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 499' ' ' PHE . 66.4 ttt180 -142.78 -69.64 0.34 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.425 ' HG3' ' HG2' ' A' ' 490' ' ' ARG . 74.9 mtt180 -116.1 -19.8 10.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.248 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.1 -39.81 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 0.0 108.487 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 3.2 mt -92.51 -18.34 23.29 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.132 0.491 . . . . 0.0 110.966 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 52.5 tp -104.23 -46.84 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.417 -0.802 . . . . 0.0 112.548 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.47 -5.72 15.09 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.26 -0.9 . . . . 0.0 113.103 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 79.0 48.15 7.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.68 -179.44 3.7 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 122.118 -0.637 . . . . 0.0 109.626 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.18 149.54 35.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 0.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 490' ' ' ARG . 28.2 m-85 -131.22 149.21 52.67 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.776 0.798 . . . . 0.0 111.723 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 2.6 t -56.07 107.29 0.84 Allowed Pre-proline 0 N--CA 1.496 1.831 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.947 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 528' ' ' HIS . 52.5 Cg_endo -74.62 114.74 4.1 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.54 1.284 . . . . 0.0 109.435 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -174.35 30.85 0.09 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.417 ' CB ' ' CD1' ' A' ' 487' ' ' ILE . 86.0 p -92.7 173.25 7.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 112.44 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 26.5 m -119.81 99.55 6.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.36 134.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.819 0.819 . . . . 0.0 112.071 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 18.5 pt -130.1 149.54 33.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 534' ' ' ILE . 5.2 p -142.07 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.435 1.112 . . . . 0.0 110.785 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -83.91 108.94 17.21 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -133.9 114.97 13.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.76 -32.39 59.23 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -97.31 175.33 6.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.46 -7.76 13.42 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.81 -0.556 . . . . 0.0 111.027 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 514' ' ' SER . 4.3 pp -67.62 -37.95 83.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.212 -0.93 . . . . 0.0 111.254 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' SER . . . . . 0.4 ' N ' ' CD1' ' A' ' 513' ' ' LEU . 2.3 p -93.24 -14.77 26.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 0.0 111.199 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.08 -48.38 57.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.01 -1.056 . . . . 0.0 108.424 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.97 -42.44 89.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.001 -0.437 . . . . 0.0 111.667 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -57.9 -46.93 84.2 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.212 -0.93 . . . . 0.0 111.111 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.436 ' O ' HD21 ' A' ' 522' ' ' LEU . 98.6 m -62.31 -45.94 90.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.417 ' HG ' ' HG3' ' A' ' 550' ' ' MET . 0.0 OUTLIER -55.3 -28.56 54.36 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.632 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 m -64.15 -28.24 69.63 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 39.3 tp -80.93 -34.03 33.61 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.523 -0.736 . . . . 0.0 109.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 518' ' ' THR . 4.3 mm? -58.01 -31.86 67.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.8 -63.89 0.86 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.951 -0.468 . . . . 0.0 111.62 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.5 52.04 Favored Glycine 0 N--CA 1.499 2.886 0 O-C-N 120.867 -1.146 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.1 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.105 -1.232 . . . . 0.0 113.284 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.606 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -58.13 -26.2 62.37 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.083 -1.011 . . . . 0.0 112.128 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -54.89 -30.36 58.02 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 501' ' ' PRO . 7.0 t60 -106.65 -128.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.389 -0.82 . . . . 0.0 110.439 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.71 67.7 9.92 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.721 -1.237 . . . . 0.0 111.974 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.606 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 2.8 t -133.86 163.83 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.66 -1.275 . . . . 0.0 110.253 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 2.9 mm-40 -163.81 165.0 23.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 33.1 t -109.95 105.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.427 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.4 OUTLIER -103.75 115.07 29.81 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.412 HG23 HG11 ' A' ' 532' ' ' VAL . 7.1 pt -136.0 164.97 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 117.854 -1.538 . . . . 0.0 113.912 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 70.1 p -127.67 -168.3 1.87 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.97 169.08 25.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.85 17.18 2.31 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.784 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -155.27 33.55 0.65 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.04 -0.29 47.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.683 -0.893 . . . . 0.0 111.66 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -51.36 -43.88 61.95 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 77.2 p -119.59 161.12 21.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 57.93 29.06 61.53 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.0 t -59.85 -45.58 91.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.291 -1.123 . . . . 0.0 110.615 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.82 93.32 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 35.5 m -63.76 -35.72 81.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.033 -0.686 . . . . 0.0 110.788 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.15 80.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.509 -0.744 . . . . 0.0 110.355 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.02 -40.19 94.84 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 48.3 ttp -63.96 -30.35 71.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.49 -53.97 31.9 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' MET . . . . . 0.417 ' HG3' ' HG ' ' A' ' 519' ' ' LEU . 12.4 ttp -57.76 -42.96 85.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -0.837 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.18 -31.68 67.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.476 -0.765 . . . . 0.0 111.669 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -68.43 -31.87 71.51 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.304 -0.873 . . . . 0.0 109.95 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.81 21.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.945 -0.472 . . . . 0.0 111.465 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 107.43 25.61 5.97 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.657 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.561 -0.964 . . . . 0.0 109.961 179.179 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.29 -41.32 98.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.115 -0.991 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 61.4 m -59.81 -43.68 94.37 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.57 -0.706 . . . . 0.0 110.206 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 69.4 t -65.76 -35.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.302 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -61.93 -46.4 89.49 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.289 -0.882 . . . . 0.0 110.59 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.19 80.14 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.696 0.76 . . . . 0.0 109.161 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.477 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -61.96 -39.39 91.98 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 68.3 m -61.15 -36.43 79.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.072 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -63.87 -44.48 92.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.085 -1.009 . . . . 0.0 111.46 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.84 -46.09 76.18 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.182 -0.949 . . . . 0.0 111.861 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.84 -42.74 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.812 . . . . 0.0 109.99 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 40.4 mmm -62.22 -31.76 72.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.874 -0.516 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -58.53 -34.09 70.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.377 -0.827 . . . . 0.0 109.154 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.57 -14.64 32.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.22 -39.27 89.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -116.85 18.8 14.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.945 -1.097 . . . . 0.0 110.555 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.402 HG13 ' CZ ' ' A' ' 415' ' ' ARG . 3.5 p -51.34 117.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.538 -0.726 . . . . 0.0 109.177 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 25.4 m -52.17 98.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.499 0.666 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.42 133.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.755 -0.59 . . . . 0.0 109.906 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -92.19 140.28 24.43 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 111.185 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.91 -28.17 42.66 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.254 1.133 . . . . 0.0 110.22 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.9 -33.29 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.826 0.822 . . . . 0.0 109.861 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.17 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 118.53 5.24 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.746 . . . . 0.0 110.675 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 110.65 8.08 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.757 -0.589 . . . . 0.0 110.319 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.03 139.18 29.46 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 O-C-N 123.066 1.035 . . . . 0.0 110.31 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.402 ' CZ ' HG13 ' A' ' 405' ' ' VAL . 23.7 ptt85 -168.85 60.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.672 -0.642 . . . . 0.0 110.738 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 417' ' ' ALA . 9.7 t -65.48 -34.96 79.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 416' ' ' THR . . . -67.29 -7.05 21.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.689 -0.632 . . . . 0.0 110.953 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.75 -43.73 98.53 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 436' ' ' VAL . 1.1 m-85 -91.64 -3.36 56.44 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.857 -1.378 . . . . 0.0 108.938 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 33.8 p -77.96 -39.04 43.8 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.6 -43.55 31.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.471 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.16 -49.82 74.3 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.666 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.26 -41.42 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.922 -0.487 . . . . 0.0 111.861 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -58.92 -41.7 87.94 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.03 -1.044 . . . . 0.0 111.242 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.47 -45.42 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.3 OUTLIER -56.17 -35.71 67.52 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.54 -0.725 . . . . 0.0 111.993 -177.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.92 81.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.062 -1.024 . . . . 0.0 108.593 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.88 -30.59 71.6 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -63.68 -89.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.05 -60.66 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.449 -1.407 . . . . 0.0 109.565 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.56 113.28 3.58 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 N-CA-C 108.242 -1.484 . . . . 0.0 108.242 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 15.2 m -108.96 117.28 33.79 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.897 0.856 . . . . 0.0 112.039 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.42 ' O ' ' CG1' ' A' ' 392' ' ' VAL . 0.4 OUTLIER -173.22 97.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.87 172.54 12.7 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.203 -0.935 . . . . 0.0 112.462 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.81 136.95 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.381 0.61 . . . . 0.0 109.703 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 60.4 t -141.58 152.9 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 109.629 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.1 p -139.81 149.81 43.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.868 . . . . 0.0 110.752 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.63 159.94 21.76 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -149.23 22.96 0.94 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.93 . . . . 0.0 110.835 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -162.5 -118.13 0.45 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.89 131.33 11.78 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -103.47 -15.02 16.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.293 -1.122 . . . . 0.0 111.291 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -71.55 -43.94 65.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.42 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.08 -28.76 71.22 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -63.84 -40.55 96.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.638 -0.919 . . . . 0.0 109.98 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -64.31 -41.18 96.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.559 -0.713 . . . . 0.0 110.418 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.07 -29.28 66.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.087 -1.008 . . . . 0.0 110.222 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -62.92 -53.09 59.41 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 450' ' ' ALA . 13.6 p -57.77 -30.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.051 -1.031 . . . . 0.0 108.626 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.429 ' N ' HG12 ' A' ' 449' ' ' VAL . . . -64.11 -26.52 68.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.71 -35.33 80.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.866 -1.146 . . . . 0.0 108.292 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.93 -31.38 72.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.495 -0.753 . . . . 0.0 109.009 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 58.1 t -58.48 -38.36 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.248 -0.908 . . . . 0.0 108.948 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 48.0 mtt -63.49 -35.82 81.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.495 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -54.78 -26.24 33.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.366 -0.834 . . . . 0.0 109.587 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.84 32.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.667 -0.646 . . . . 0.0 110.497 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -62.02 -46.09 90.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.373 -0.829 . . . . 0.0 108.989 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.0 -31.82 70.93 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.56 -0.84 21.8 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.41 32.03 82.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -130.79 122.15 26.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.969 . . . . 0.0 110.868 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.71 162.78 28.93 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.45 168.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.999 -1.063 . . . . 0.0 111.588 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -120.45 115.78 24.16 Favored 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 465' ' ' ILE . 0.1 OUTLIER -131.11 138.83 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.508 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.91 125.39 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.716 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.4 164.76 25.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.7 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.693 -0.629 . . . . 0.0 109.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -46.55 -21.44 0.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.175 -0.953 . . . . 0.0 112.043 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -75.37 -7.62 54.51 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.406 -0.809 . . . . 0.0 112.397 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -57.5 -25.53 59.94 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.784 -1.198 . . . . 0.0 110.904 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.1 p -59.14 -41.98 89.57 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -62.44 -41.16 98.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.79 69.66 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.87 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -58.31 -39.75 80.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.081 . . . . 0.0 109.171 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 69.1 mtm -60.92 -39.33 89.0 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.793 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -122.97 -140.7 0.32 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.354 -0.841 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 48.52 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.791 -1.193 . . . . 0.0 112.53 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -136.81 28.53 2.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.29 -0.881 . . . . 0.0 109.671 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -108.99 -9.24 15.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -133.3 -10.45 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 112.418 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.92 61.99 0.06 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.751 -1.218 . . . . 0.0 113.062 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 44.2 t -89.36 48.63 1.64 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.746 -1.221 . . . . 0.0 110.575 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 100.03 2.5 55.98 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.986 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -91.05 43.31 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.122 1.461 . . . . 0.0 110.273 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.418 ' O ' ' CG1' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -58.73 -81.92 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -173.37 -73.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 487' ' ' ILE 0.251 70.5 p -103.31 25.47 9.52 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.82 94.81 0.53 Allowed Glycine 0 N--CA 1.496 2.639 0 O-C-N 121.549 -0.72 . . . . 0.0 111.835 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -144.35 -111.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 495' ' ' GLU . 28.4 mmt180 -103.2 -32.73 9.47 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.002 -1.061 . . . . 0.0 108.597 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -47.84 -22.45 0.56 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.04 -58.96 4.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.318 -0.864 . . . . 0.0 111.317 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.71 5.41 26.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.974 -1.079 . . . . 0.0 111.994 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 491' ' ' ARG . 59.0 mm-40 -84.66 -5.93 59.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.977 -1.077 . . . . 0.0 113.069 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 95.82 -11.95 67.65 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.715 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.44 -176.69 0.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.128 -1.219 . . . . 0.0 108.98 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.41 170.43 8.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.352 -0.842 . . . . 0.0 109.637 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -111.41 153.02 26.68 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 52.2 m -81.98 120.71 78.08 Favored Pre-proline 0 N--CA 1.484 1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.84 138.91 77.05 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.407 1.214 . . . . 0.0 111.291 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 149.6 -7.38 0.81 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.442 ' HA ' HD12 ' A' ' 487' ' ' ILE . 48.7 m -85.25 160.25 19.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.302 . . . . 0.0 112.209 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.4 m -106.0 163.27 12.89 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 59.7 t -151.14 121.7 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.878 -1.139 . . . . 0.0 111.312 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 6.2 pt -136.2 112.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.504 HG12 ' CG2' ' A' ' 534' ' ' ILE . 7.8 p -114.48 104.33 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.6 1.191 . . . . 0.0 113.06 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 124.96 31.59 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 126.69 4.75 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.95 -41.86 6.97 Favored Glycine 0 N--CA 1.505 3.258 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -72.04 142.55 49.27 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.68 -12.78 20.71 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.095 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.99 -33.64 76.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 36.3 t -81.14 -23.36 38.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.847 -0.533 . . . . 0.0 111.314 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.85 -47.34 75.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.177 -0.952 . . . . 0.0 110.417 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.673 -0.642 . . . . 0.0 111.586 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -58.81 -51.2 71.02 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.271 -0.893 . . . . 0.0 110.599 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 73.9 m -58.07 -41.07 82.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -38.09 80.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.041 -0.412 . . . . 0.0 111.853 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 47.0 p -64.71 -35.68 81.83 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.793 -1.192 . . . . 0.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -38.25 74.8 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.313 1.054 . . . . 0.0 108.19 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.98 -28.01 69.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.156 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -47.21 -63.12 1.12 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -51.4 58.76 Favored Glycine 0 N--CA 1.502 3.042 0 O-C-N 120.58 -1.325 . . . . 0.0 110.018 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -60.41 -30.22 69.47 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -1.036 . . . . 0.0 110.306 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -64.08 -20.61 66.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.757 -0.59 . . . . 0.0 112.315 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -37.76 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -147.69 -79.93 0.15 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 120.634 1.561 . . . . 0.0 114.304 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.412 ' HB2' ' N ' ' A' ' 502' ' ' GLY . 82.4 m-20 -86.26 60.59 6.32 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.9 p -117.91 133.49 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.858 -1.151 . . . . 0.0 113.362 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 94.3 mt-30 -122.42 129.12 51.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 70.7 t -115.09 117.95 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.123 0.964 . . . . 0.0 112.049 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.33 118.43 33.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.504 ' CG2' HG12 ' A' ' 507' ' ' VAL . 9.3 pt -128.77 134.8 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 118.254 -1.378 . . . . 0.0 110.858 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 55.3 p -112.87 -163.46 0.85 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.41 165.24 36.27 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.646 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' SER . . . . . 0.405 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 6.6 p -130.17 22.17 5.27 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.876 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -168.47 35.22 0.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -95.81 -0.63 50.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -47.53 -24.7 0.91 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.149 -0.969 . . . . 0.0 111.251 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 69.3 p -124.57 162.0 24.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 51.21 38.09 39.6 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.8 t -59.45 -45.39 91.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.665 -0.903 . . . . 0.0 110.508 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.15 94.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 33.1 m -61.55 -32.65 72.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.745 -0.856 . . . . 0.0 109.629 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.83 79.28 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -62.51 -40.02 95.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.765 . . . . 0.0 109.305 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.14 -31.53 72.03 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.2 28.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.935 -0.478 . . . . 0.0 109.828 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 79.6 mmm -57.98 -43.25 86.44 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.475 -0.766 . . . . 0.0 109.619 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.18 -31.61 70.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.756 -0.59 . . . . 0.0 110.958 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.82 -25.29 67.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.145 -0.972 . . . . 0.0 109.532 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.44 13.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.484 -0.76 . . . . 0.0 111.723 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 109.31 -14.74 33.15 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.295 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.5 2.059 0 CA-C-N 118.685 1.242 . . . . 0.0 110.13 -179.519 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.479 0.657 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.57 -37.2 86.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.7 m -61.92 -41.72 98.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.473 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.29 -34.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.162 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.71 -42.77 89.41 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.876 -1.14 . . . . 0.0 109.815 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.49 73.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.305 -0.872 . . . . 0.0 108.737 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.8 OUTLIER -60.51 -41.55 94.61 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.45 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 40.0 t -64.88 -39.28 93.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.432 -0.793 . . . . 0.0 111.403 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.57 -43.86 92.56 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.301 -0.874 . . . . 0.0 112.461 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -75.66 -45.72 35.47 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.823 -1.173 . . . . 0.0 112.115 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.87 -42.27 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.88 . . . . 0.0 109.995 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 35.6 mtp -60.77 -31.84 71.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.665 -0.647 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.57 -22.5 66.93 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.3 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.419 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 72.5 tp60 -92.65 -20.63 20.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.097 . . . . 0.0 108.98 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.02 -30.95 70.3 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -114.99 19.25 15.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.211 -0.931 . . . . 0.0 109.857 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 8.4 p -50.84 113.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.1 t -48.77 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.638 -0.664 . . . . 0.0 111.833 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.92 133.42 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.536 -0.728 . . . . 0.0 110.117 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -96.04 143.24 25.78 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.89 . . . . 0.0 110.044 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.85 -24.62 53.71 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.34 1.179 . . . . 0.0 110.385 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -61.28 -39.79 91.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 66.23 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 93.4 p -50.48 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.096 -1.003 . . . . 0.0 110.313 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.33 110.33 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.923 -0.485 . . . . 0.0 110.616 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.5 136.35 12.35 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 O-C-N 122.939 0.968 . . . . 0.0 110.531 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -153.67 70.14 0.83 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.503 -0.748 . . . . 0.0 110.766 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 46.3 p -65.21 -39.03 92.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -49.86 -25.2 2.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.682 -0.636 . . . . 0.0 111.383 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -50.77 -62.25 5.42 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.376 -0.827 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 436' ' ' VAL . 20.0 p90 -88.22 -2.7 58.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.791 -1.417 . . . . 0.0 111.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 51.6 p -72.19 -39.75 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.86 -45.66 27.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.978 -0.451 . . . . 0.0 110.571 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.9 79.69 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.439 -0.788 . . . . 0.0 111.099 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 89.3 t -68.48 -46.19 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.1 p -64.18 -33.04 74.87 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.665 -1.272 . . . . 0.0 111.039 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.65 -36.17 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.695 . . . . 0.0 111.506 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 1.6 pp -70.25 -33.89 72.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 111.586 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.56 78.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.909 -1.119 . . . . 0.0 109.647 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -65.54 -33.38 75.78 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -65.29 -95.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -169.85 -61.85 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.442 -1.411 . . . . 0.0 109.452 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.26 113.85 2.08 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 109.196 -1.117 . . . . 0.0 109.196 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.435 ' HB3' ' CA ' ' A' ' 531' ' ' GLN . 17.3 t -96.55 103.31 15.21 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.718 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.96 88.23 1.31 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 426' ' ' LEU . . . -118.04 156.43 28.6 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.025 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . 0.263 62.2 mt -122.61 127.3 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 45.2 t -141.42 153.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.954 -1.091 . . . . 0.0 111.196 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.3 p -136.26 143.06 44.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.72 129.6 9.95 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.52 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.23 -23.69 10.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.886 -0.773 . . . . 0.0 109.841 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.14 160.28 33.56 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.43 46.47 94.29 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.37 77.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 111.029 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.63 92.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.294 -0.879 . . . . 0.0 111.157 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.85 72.15 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.82 -41.06 90.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -1.014 . . . . 0.0 110.277 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -67.48 -38.5 84.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.364 -0.835 . . . . 0.0 110.996 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -71.64 -31.85 67.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.271 -0.893 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.74 -53.61 44.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.067 -1.021 . . . . 0.0 110.41 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.24 -30.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.038 -1.039 . . . . 0.0 109.218 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.37 -27.95 68.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.15 -34.95 79.6 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.34 -36.07 79.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 95.2 t -58.28 -29.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 91.7 mtp -67.2 -39.68 86.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -55.39 -27.89 50.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.306 -0.871 . . . . 0.0 109.893 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.72 40.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.8 -43.34 88.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 109.514 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -68.59 -30.43 69.17 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.458 0.647 . . . . 0.0 109.841 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -73.68 -1.09 17.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.655 -0.653 . . . . 0.0 111.641 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 79.86 18.56 72.36 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 120.876 -1.14 . . . . 0.0 110.612 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.81 149.94 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.347 -1.09 . . . . 0.0 111.093 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -94.96 -178.51 4.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.413 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 7.3 m -148.0 170.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.926 -1.109 . . . . 0.0 110.805 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -119.35 128.37 54.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 11.2 pt -134.55 141.53 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.251 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.405 ' CG2' ' HD3' ' A' ' 471' ' ' ARG . 85.8 mt -132.7 124.71 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.595 -0.691 . . . . 0.0 109.719 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -79.84 165.9 22.25 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.54 -159.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -49.08 -20.86 0.61 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.61 -1.307 . . . . 0.0 111.334 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.39 -8.98 58.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.456 -0.777 . . . . 0.0 111.353 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . 0.405 ' HD3' ' CG2' ' A' ' 466' ' ' ILE . 64.5 ttp85 -59.44 -23.11 62.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.909 -1.119 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 12.5 t -59.64 -44.13 93.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.391 -0.818 . . . . 0.0 109.527 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -60.89 -45.22 95.46 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.31 -36.0 72.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.637 -0.664 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -59.22 -40.31 85.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.157 -0.965 . . . . 0.0 111.331 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 7.5 ttm -61.59 -36.3 80.28 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.293 -0.879 . . . . 0.0 110.604 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.416 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 53.4 pttt -125.29 -146.84 0.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.797 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . 0.416 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 87.9 mm-40 51.59 71.71 0.43 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.091 -1.006 . . . . 0.0 112.41 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -112.17 18.57 18.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.29 -10.56 40.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.429 -0.795 . . . . 0.0 111.289 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 -0.95 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.955 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.31 62.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.64 -1.288 . . . . 0.0 111.415 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 36.6 m -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.888 -1.133 . . . . 0.0 110.318 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 153.19 55.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.8 pt-20 -158.0 92.47 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.2 1.0 . . . . 0.0 110.757 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 487' ' ' ILE . 61.8 mt -99.16 -82.13 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 486' ' ' LEU . 3.1 mp -150.15 -69.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.4 t -99.91 16.23 24.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.383 -0.823 . . . . 0.0 112.092 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.08 59.67 4.96 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 70.7 ttt180 -142.0 -54.83 0.45 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -1.142 . . . . 0.0 109.544 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.413 ' HD2' ' CE ' ' A' ' 497' ' ' MET . 28.3 mmt180 -104.12 -36.23 7.77 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.778 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.46 -41.0 96.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 493' ' ' LEU . 1.2 mt -70.19 -42.08 72.88 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.521 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.89 -42.94 5.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.64 -10.63 24.73 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.921 -1.111 . . . . 0.0 113.083 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 88.3 -21.69 23.57 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 120.68 -1.262 . . . . 0.0 110.909 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.413 ' CE ' ' HD2' ' A' ' 491' ' ' ARG . 78.6 mtm -66.14 176.23 1.81 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.138 -1.213 . . . . 0.0 110.188 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.27 152.03 28.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 111.056 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.436 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.1 OUTLIER -113.14 150.07 32.71 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.0 t -43.25 105.59 0.44 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.032 -0.418 . . . . 0.0 110.524 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.03 114.09 2.66 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.336 1.177 . . . . 0.0 111.572 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.66 34.91 0.18 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 13.1 p -93.61 167.62 11.56 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 112.827 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.2 m -119.52 159.58 24.05 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 73.7 t -143.57 130.78 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 118.527 -1.269 . . . . 0.0 113.026 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 4.7 pt -137.0 120.61 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.484 HG12 ' CG2' ' A' ' 534' ' ' ILE . 11.5 p -119.32 99.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.691 -1.256 . . . . 0.0 111.547 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.08 98.42 9.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -124.78 123.93 41.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . 0.414 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -75.19 -53.93 5.91 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -69.61 -161.52 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.95 -10.6 2.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.947 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.4 -28.02 68.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -0.981 . . . . 0.0 108.596 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 3.6 m -83.84 -19.86 34.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.663 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -48.93 70.07 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.412 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.01 -39.87 65.66 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.0 111.824 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.83 -47.22 86.07 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.586 -0.696 . . . . 0.0 111.572 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.7 m -60.96 -43.01 99.35 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.45 -35.65 68.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.873 -0.517 . . . . 0.0 110.717 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 97.6 m -64.35 -43.91 93.11 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 111.668 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.22 -42.01 93.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.265 -0.897 . . . . 0.0 108.944 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 505' ' ' VAL . 1.8 tp -62.78 -28.47 70.01 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.531 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -46.5 -65.46 0.55 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.413 -0.804 . . . . 0.0 113.166 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -67.88 -49.4 48.74 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.129 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.12 67.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.679 -0.895 . . . . 0.0 111.332 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.48 ' HA ' ' CG2' ' A' ' 530' ' ' VAL . . . -57.13 -24.19 52.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 112.619 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -41.94 -27.0 0.1 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.565 -0.709 . . . . 0.0 112.182 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -108.95 -118.99 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.208 -0.932 . . . . 0.0 112.584 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -89.23 90.25 8.27 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 120.355 -1.466 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -119.4 136.87 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 O-C-N 120.407 -1.433 . . . . 0.0 113.116 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.435 ' CA ' ' HB3' ' A' ' 432' ' ' SER . 9.9 mp0 -126.36 133.58 51.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 40.6 t -114.99 121.66 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 122.971 1.367 . . . . 0.0 111.648 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.8 OUTLIER -123.67 122.53 38.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.484 ' CG2' HG12 ' A' ' 507' ' ' VAL . 9.6 pt -133.09 133.24 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.826 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.433 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 55.8 p -106.47 -164.32 0.99 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.79 168.73 26.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' SER . . . . . 0.414 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -135.38 13.71 3.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.418 178.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -152.22 27.6 0.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -99.5 0.86 43.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -1.062 . . . . 0.0 112.272 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -59.62 -33.98 72.2 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.977 -1.077 . . . . 0.0 112.12 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 27.6 m -102.98 -58.06 1.94 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.072 -1.017 . . . . 0.0 110.819 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -100.34 94.43 1.32 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.8 t -95.31 -36.32 11.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -1.009 . . . . 0.0 110.48 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -60.26 -34.78 86.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.8 p -64.05 -34.3 77.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.942 . . . . 0.0 111.09 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.29 83.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.425 -0.797 . . . . 0.0 109.887 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.81 -40.14 96.45 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.471 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.0 mmm -68.18 -27.52 66.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.401 -0.812 . . . . 0.0 110.319 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -59.46 -55.41 35.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 51.8 ttm -58.89 -48.63 80.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.478 -0.764 . . . . 0.0 110.394 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -59.48 -32.57 70.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.644 -0.66 . . . . 0.0 111.781 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -66.45 -25.07 66.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.259 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.48 -1.04 9.62 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.334 -0.854 . . . . 0.0 111.192 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 116.16 -15.22 15.84 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.897 -1.127 . . . . 0.0 111.162 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.503 2.217 0 CA-C-N 118.942 1.371 . . . . 0.0 109.713 -179.853 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.775 0.321 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.42 -42.08 98.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.193 -0.942 . . . . 0.0 109.396 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.4 m -64.89 -42.88 94.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.878 -0.514 . . . . 0.0 110.712 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 99.9 t -66.45 -35.69 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.536 -0.728 . . . . 0.0 110.665 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -62.45 -45.29 93.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.277 -0.889 . . . . 0.0 109.802 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -71.56 -36.88 71.07 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.58 0.705 . . . . 0.0 110.149 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 426' ' ' LEU . 2.6 tm? -61.18 -38.75 87.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.964 -0.46 . . . . 0.0 110.016 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 42.7 t -63.72 -40.48 96.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.636 -0.665 . . . . 0.0 109.845 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.18 -42.75 99.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.543 -0.723 . . . . 0.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.79 -42.21 97.77 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.116 -0.99 . . . . 0.0 111.708 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.63 -41.21 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 0.0 110.431 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 47.1 mmm -58.25 -33.91 69.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.52 -33.39 75.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.563 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -92.4 -3.83 54.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.936 -1.102 . . . . 0.0 109.778 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 9.2 m120 -89.15 -26.99 21.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.488 -0.757 . . . . 0.0 109.033 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 19.14 15.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 108.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.61 107.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.2 m -49.73 101.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.316 -0.865 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.6 133.32 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.614 . . . . 0.0 110.113 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -92.04 140.17 24.6 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.593 -0.692 . . . . 0.0 109.871 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 -27.87 33.73 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.282 1.149 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -62.41 -29.91 70.83 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.364 -0.835 . . . . 0.0 110.0 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 59.11 0.68 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.3 t -60.03 122.28 13.94 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.934 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.9 p -74.54 120.61 82.33 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.723 -0.61 . . . . 0.0 110.378 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 47.5 Cg_endo -73.65 132.44 17.33 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 122.907 0.951 . . . . 0.0 110.008 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 414' ' ' PRO . 90.8 mtt180 -160.94 56.07 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.833 -0.542 . . . . 0.0 110.017 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 45.0 p -67.34 -34.38 77.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.73 -1.231 . . . . 0.0 108.417 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -71.12 -2.29 15.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.783 -0.573 . . . . 0.0 112.195 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.0 97.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -98.15 -4.06 36.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 110.12 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 8.1 t -73.91 -42.07 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -71.79 -40.82 68.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.34 98.73 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.72 0.771 . . . . 0.0 110.257 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.18 -42.17 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.637 -0.664 . . . . 0.0 111.641 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 90.6 p -58.84 -41.67 87.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 0.0 110.946 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.54 -43.39 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.337 -0.852 . . . . 0.0 110.899 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.432 ' HB3' ' HG ' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -62.64 -35.12 78.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.193 -0.942 . . . . 0.0 111.669 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.72 77.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.734 -1.229 . . . . 0.0 109.217 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.64 -30.11 70.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.8 -88.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.96 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 120.487 -1.383 . . . . 0.0 109.999 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.01 109.98 2.94 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 123.092 1.048 . . . . 0.0 109.724 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.4 m -83.81 98.66 9.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.35 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 10.8 tp -146.04 135.42 22.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -172.18 164.77 6.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 435' ' ' ILE . 19.5 pt -133.51 118.45 30.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.426 ' CG1' HG23 ' A' ' 535' ' ' THR . 0.6 OUTLIER -126.6 150.87 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.995 -1.066 . . . . 0.0 109.863 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 9.2 p -131.73 139.95 49.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.815 -0.553 . . . . 0.0 109.723 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.48 160.9 20.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.84 -19.2 11.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.656 -0.908 . . . . 0.0 110.306 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -174.93 168.15 40.63 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 57.48 82.73 0.05 OUTLIER Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -93.32 -18.49 22.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.502 -0.999 . . . . 0.0 111.444 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.88 -44.74 84.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.973 . . . . 0.0 109.516 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.03 -28.58 70.2 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -61.22 -41.12 96.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.645 -0.914 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 57.9 mtm-85 -61.31 -42.05 98.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.92 . . . . 0.0 110.304 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -72.27 -28.76 63.33 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.387 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -62.21 -50.6 71.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.917 -1.115 . . . . 0.0 110.995 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.16 -32.8 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.691 -1.255 . . . . 0.0 108.341 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.85 -27.53 69.4 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 454' ' ' MET . 80.4 tt0 -65.08 -33.57 76.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.43 -36.31 82.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 99.1 t -60.93 -27.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 59.4 mtt -66.13 -38.94 89.4 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -22.95 65.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.719 0.771 . . . . 0.0 109.18 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.09 -24.97 30.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -69.49 -40.48 77.02 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.947 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.37 -31.59 71.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.272 -0.892 . . . . 0.0 109.422 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -81.56 10.13 6.43 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.69 36.28 93.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -138.44 123.25 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.451 -1.029 . . . . 0.0 111.819 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.412 ' HB2' HD12 ' A' ' 487' ' ' ILE . 46.7 mp0 -85.29 166.47 16.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 34.0 m -138.14 157.8 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 111.99 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -96.44 111.51 23.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.23 131.9 70.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.845 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 467' ' ' ALA . 3.5 mp -102.08 170.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 508' ' ' ASP . . . -123.67 156.82 35.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.55 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.502 0.668 . . . . 0.0 109.964 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -54.43 -11.34 0.52 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.947 -1.096 . . . . 0.0 111.845 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -91.6 7.03 43.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.707 -1.246 . . . . 0.0 112.051 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -59.26 -34.45 72.27 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.856 -1.153 . . . . 0.0 111.526 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 3.7 t -57.21 -53.92 52.62 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.928 -1.108 . . . . 0.0 111.92 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -66.43 -37.92 86.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.895 -1.128 . . . . 0.0 109.457 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.68 -32.52 69.21 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.758 -0.589 . . . . 0.0 109.515 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -62.11 -37.8 86.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.766 -0.583 . . . . 0.0 109.673 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.58 -40.61 79.38 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.915 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.49 -152.71 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.588 -0.695 . . . . 0.0 109.147 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 50.34 81.33 0.06 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.863 -1.148 . . . . 0.0 111.623 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -122.03 27.47 8.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 110.09 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -113.42 -19.85 11.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -109.19 -14.44 14.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.693 -0.63 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.87 62.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.081 -1.012 . . . . 0.0 111.33 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 51.4 p -90.72 48.59 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.832 -1.168 . . . . 0.0 110.169 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.84 26.03 43.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.99 54.01 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -1.06 . . . . 0.0 109.1 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.21 -81.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.43 ' O ' ' CD2' ' A' ' 499' ' ' PHE . 0.0 OUTLIER 178.29 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.979 -1.076 . . . . 0.0 111.514 174.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.421 ' CG2' HG22 ' A' ' 487' ' ' ILE . 4.0 p -102.69 10.05 38.84 Favored 'General case' 0 C--N 1.3 -1.543 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.299 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.7 65.62 2.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.3 ttm180 -144.31 -68.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.94 -29.92 8.04 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.934 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -62.01 -45.54 93.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.58 -0.7 . . . . 0.0 111.285 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.01 -18.54 24.45 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.347 -0.846 . . . . 0.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -47.3 4.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.373 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -101.98 -8.32 21.61 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.78 -14.53 61.44 Favored Glycine 0 N--CA 1.503 3.131 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.588 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 63.1 mtt -67.97 -176.14 0.65 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.63 148.18 38.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.622 -0.674 . . . . 0.0 110.745 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.434 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.371 -0.831 . . . . 0.0 109.195 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.3 t -60.85 112.11 5.18 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.171 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.429 ' HG3' ' CG ' ' A' ' 528' ' ' HIS . 43.2 Cg_endo -72.29 113.74 3.79 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.402 1.212 . . . . 0.0 109.501 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -162.33 19.74 0.17 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.408 ' CB ' HD13 ' A' ' 487' ' ' ILE . 24.2 p -93.9 175.34 6.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.254 -1.145 . . . . 0.0 111.096 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 54.1 m -116.73 127.72 54.65 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.42 ' CG1' ' CD2' ' A' ' 522' ' ' LEU . 69.1 t -113.64 129.87 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.371 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.4 164.11 27.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.415 ' CG1' ' CG2' ' A' ' 534' ' ' ILE . 13.8 p -151.2 110.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.959 -1.088 . . . . 0.0 108.874 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . 0.449 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 53.8 t0 -84.25 104.96 14.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.369 1.08 . . . . 0.0 108.138 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -98.73 174.57 6.34 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.498 1.142 . . . . 0.0 113.285 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.33 -56.31 0.05 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -75.09 -156.39 0.05 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -125.83 -19.17 4.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 110.461 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 513' ' ' LEU . 4.4 mm? -70.41 -31.07 68.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.368 -0.833 . . . . 0.0 110.679 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 57.7 p -67.77 -40.55 84.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.784 -0.572 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.449 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 13.4 tp -64.59 -45.94 84.79 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 111.143 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.62 -43.35 80.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.418 -0.801 . . . . 0.0 113.064 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -65.76 -41.81 91.63 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.765 -1.209 . . . . 0.0 110.362 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.408 HG22 ' HB ' ' A' ' 507' ' ' VAL . 98.0 m -62.88 -42.48 99.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.006 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -39.42 88.05 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.691 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 81.3 p -65.27 -31.3 72.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.389 -0.819 . . . . 0.0 111.897 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 9.6 tt -81.9 -38.45 25.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.037 -1.04 . . . . 0.0 109.787 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.42 ' CD2' ' CG1' ' A' ' 505' ' ' VAL . 1.8 mt -64.11 -26.62 68.62 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.782 -0.574 . . . . 0.0 111.292 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -48.22 -51.21 26.39 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.275 -0.891 . . . . 0.0 111.586 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -71.41 -50.2 22.16 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.89 -38.43 86.25 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.473 -1.016 . . . . 0.0 113.001 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.9 -33.88 73.8 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.211 -0.931 . . . . 0.0 111.602 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -57.17 -28.82 63.13 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.962 -1.086 . . . . 0.0 108.11 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.429 ' CG ' ' HG3' ' A' ' 501' ' ' PRO . 80.0 m80 -93.99 -135.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -89.77 69.69 7.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.725 -1.234 . . . . 0.0 112.893 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 2.5 t -141.77 168.24 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.54 162.75 35.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.842 -0.536 . . . . 0.0 110.843 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 42.4 t -109.79 100.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.15 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.58 117.98 35.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.415 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 9.8 pt -127.51 155.58 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.323 -176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.426 HG23 ' CG1' ' A' ' 436' ' ' VAL . 36.7 p -128.39 -178.11 4.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 436' ' ' VAL . 61.8 m-20 -154.55 163.71 39.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.7 p -140.35 18.85 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.916 -0.49 . . . . 0.0 109.732 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.79 26.0 0.18 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.07 0.74 51.88 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.128 -1.219 . . . . 0.0 111.814 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -43.4 -42.04 4.48 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.224 -0.923 . . . . 0.0 111.366 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 65.5 p -106.19 163.48 12.77 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 50.11 36.79 28.98 Favored Glycine 0 N--CA 1.503 3.152 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.406 HG21 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -58.74 -43.66 90.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.52 -0.988 . . . . 0.0 111.107 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . 0.406 ' N ' HG21 ' A' ' 543' ' ' THR . . . -63.6 -38.4 96.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 43.1 m -65.32 -33.02 74.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -1.0 . . . . 0.0 111.364 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.5 87.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.731 . . . . 0.0 110.294 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.58 -42.66 99.17 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.501 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 8.4 tpp -61.85 -34.71 76.47 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.1 60.86 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.174 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 40.1 ttp -57.32 -45.66 84.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.344 -0.848 . . . . 0.0 110.177 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.7 -31.28 72.4 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.429 -0.794 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.88 -13.02 62.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.471 -0.768 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -78.87 9.77 3.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.432 -0.792 . . . . 0.0 112.709 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 123.84 -14.75 7.99 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 -179.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.243 0.544 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.35 -33.04 74.92 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.71 -0.619 . . . . 0.0 110.659 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 50.9 m -60.79 -36.7 79.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.325 -0.859 . . . . 0.0 109.736 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.0 t -65.48 -33.82 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.287 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.52 -48.24 79.82 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.241 -0.912 . . . . 0.0 110.914 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.13 77.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -0.791 . . . . 0.0 109.435 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 426' ' ' LEU . 0.9 OUTLIER -62.17 -39.66 93.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.951 -0.468 . . . . 0.0 111.504 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 55.8 p -65.71 -37.52 86.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -0.912 . . . . 0.0 110.325 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -65.07 -44.85 87.59 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.537 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.69 -43.3 80.44 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.131 -0.981 . . . . 0.0 111.331 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.453 HG21 HD11 ' A' ' 399' ' ' ILE . 96.7 mt -61.45 -42.28 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' MET . . . . . 0.407 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 19.5 mtp -62.67 -29.1 70.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.952 -0.467 . . . . 0.0 109.981 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -61.2 -29.67 69.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.85 -1.156 . . . . 0.0 109.541 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 99.3 mm-40 -89.33 -16.97 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 109.231 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 400' ' ' MET . 2.7 t-20 -66.4 -38.54 87.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.526 -0.733 . . . . 0.0 110.799 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -116.32 19.0 15.05 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 10.8 p -48.15 117.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.65 -0.657 . . . . 0.0 111.019 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.8 p -52.35 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.86 133.06 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.598 0.713 . . . . 0.0 110.663 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -90.8 135.1 29.3 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.33 -30.38 45.07 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.098 1.052 . . . . 0.0 110.542 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -59.65 -28.33 67.16 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.811 0.815 . . . . 0.0 109.822 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 56.2 0.76 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.9 m -54.17 117.78 3.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.67 0.748 . . . . 0.0 111.379 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.87 111.51 7.9 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.563 . . . . 0.0 110.869 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.31 138.13 24.39 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 122.999 1.0 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -161.25 70.68 0.37 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.829 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 57.9 p -67.75 -38.06 82.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.837 -1.165 . . . . 0.0 107.895 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 420' ' ' SER . . . -56.63 -23.95 44.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.871 -0.518 . . . . 0.0 111.177 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -47.99 -58.18 7.22 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -87.41 -1.99 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.967 -1.314 . . . . 0.0 110.847 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 10.9 t -71.03 -42.9 68.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.909 -1.12 . . . . 0.0 108.502 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -75.69 -44.63 41.19 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.811 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.407 ' O ' ' CG1' ' A' ' 425' ' ' VAL . . . -65.71 -48.02 73.41 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 436' ' ' VAL . 57.9 t -68.27 -44.41 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.334 -0.854 . . . . 0.0 111.45 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.6 m -61.73 -38.14 86.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 111.229 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 426' ' ' LEU . 12.4 p -65.03 -29.5 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 112.754 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 395' ' ' LEU . 2.2 pp -76.98 -32.2 57.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.398 -1.439 . . . . 0.0 110.575 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.39 84.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 108.837 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -59.27 -36.22 75.14 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -64.73 -88.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -175.13 -60.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.726 -1.233 . . . . 0.0 109.635 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.39 102.76 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 122.886 0.94 . . . . 0.0 111.397 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 531' ' ' GLN . 0.1 OUTLIER -82.51 99.99 9.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.85 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 11.0 tp -163.7 93.04 0.72 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.26 -0.9 . . . . 0.0 111.195 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -150.04 162.36 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.011 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.5 pp -113.96 128.55 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.094 0.473 . . . . 0.0 109.897 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 423' ' ' VAL . 78.3 t -132.18 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -0.877 . . . . 0.0 108.935 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 42.8 t -130.46 138.63 50.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.023 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -95.94 135.99 12.61 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.679 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -107.71 -14.27 14.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.959 -0.73 . . . . 0.0 110.255 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.57 170.6 42.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.19 44.94 97.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.92 89.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.332 -1.099 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.39 -44.7 93.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.627 -0.671 . . . . 0.0 110.55 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.87 -28.66 64.42 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.4 -41.88 98.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.909 . . . . 0.0 109.607 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -61.77 -45.01 95.75 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.375 -0.828 . . . . 0.0 110.047 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -63.45 -29.65 70.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.661 . . . . 0.0 109.42 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -67.52 -50.54 58.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.578 -0.701 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 450' ' ' ALA . 12.3 p -55.21 -31.74 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.528 -1.357 . . . . 0.0 110.423 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.475 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -64.36 -26.83 68.64 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -60.19 -35.13 74.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.94 -37.68 88.01 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.424 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 85.4 t -63.05 -27.06 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.013 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.6 mtp -66.28 -39.73 89.6 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.189 -0.944 . . . . 0.0 108.642 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.1 ttp -58.88 -25.8 63.67 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.64 -0.663 . . . . 0.0 109.442 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.63 -22.43 34.71 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.581 -0.7 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.88 -47.57 71.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.76 -28.47 65.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -79.5 5.2 13.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.58 -0.7 . . . . 0.0 110.756 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.45 34.45 89.97 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -130.75 127.14 38.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -1.01 . . . . 0.0 110.292 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -81.53 159.28 24.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 19.9 m -144.87 151.81 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.502 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 505' ' ' VAL . 57.9 tt0 -102.98 123.33 46.39 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.543 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -141.7 146.25 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 120.825 -1.172 . . . . 0.0 108.732 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 471' ' ' ARG . 83.6 mt -134.01 129.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -78.22 168.58 19.63 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.26 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.505 -0.747 . . . . 0.0 109.786 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -48.56 -22.74 0.8 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.915 -1.115 . . . . 0.0 111.903 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -73.23 -6.3 45.0 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.332 -0.855 . . . . 0.0 112.206 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 466' ' ' ILE . 34.7 ttt85 -60.16 -24.73 64.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.803 -1.186 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -61.45 -46.37 90.35 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.216 -0.928 . . . . 0.0 110.612 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -65.21 -41.3 94.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 53.2 ttm -60.39 -32.47 71.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.027 -0.421 . . . . 0.0 110.453 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -61.36 -37.69 84.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 80.5 mmm -59.76 -35.9 75.55 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.951 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.47 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 59.4 pttt -134.93 -141.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 109.801 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . 0.47 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 89.3 mm-40 47.06 90.46 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.969 -1.082 . . . . 0.0 113.034 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -94.55 -23.46 17.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 482' ' ' LEU . 98.0 mt-10 -70.44 -29.53 66.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.514 -0.741 . . . . 0.0 109.059 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' A' ' 450' ' ' ALA . 9.1 mpt_? -83.52 8.48 13.91 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.997 -0.44 . . . . 0.0 111.294 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 482' ' ' LEU . 3.2 mm? 53.87 28.26 8.22 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.986 -1.071 . . . . 0.0 110.802 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.28 50.24 0.06 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.493 -0.755 . . . . 0.0 112.417 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 159.61 42.04 0.02 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -179.62 89.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.597 -0.943 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 487' ' ' ILE . 47.1 mt -99.09 -81.28 0.45 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 486' ' ' LEU . 1.1 mp -158.98 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.487 -0.758 . . . . 0.0 109.448 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 1.8 p -102.86 14.31 32.26 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.496 -0.752 . . . . 0.0 111.411 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -79.55 56.92 4.48 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -143.06 -61.75 0.42 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.224 -1.162 . . . . 0.0 109.245 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -109.35 -31.29 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.298 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -64.08 -38.1 89.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.404 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 5.4 mt -91.16 -26.82 18.89 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 111.358 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.72 -44.36 4.67 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -102.4 -8.33 21.23 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.863 -1.148 . . . . 0.0 113.518 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.81 -21.49 33.11 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.732 -1.23 . . . . 0.0 111.276 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 38.0 mtm -64.09 -178.6 0.35 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -1.186 . . . . 0.0 109.348 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.04 154.16 28.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 111.347 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.82 148.98 39.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.937 -0.477 . . . . 0.0 109.864 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 79.1 m -44.06 101.52 0.26 Allowed Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 122.089 -0.382 . . . . 0.0 110.759 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 43.4 Cg_endo -68.34 113.75 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.681 1.358 . . . . 0.0 109.239 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . 0.473 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . 174.98 38.06 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 13.6 p -90.83 174.55 7.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.882 -0.776 . . . . 0.0 111.79 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.448 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 13.6 m -112.74 94.36 4.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 464' ' ' GLN . 59.4 t -85.64 131.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.225 1.012 . . . . 0.0 112.656 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 533' ' ' LEU 0.294 65.3 mt -137.77 96.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.487 HG11 ' CG2' ' A' ' 534' ' ' ILE . 3.9 p -104.19 107.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.978 1.371 . . . . 0.0 113.574 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.44 107.58 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.0 -1.062 . . . . 0.0 109.413 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -126.96 116.46 20.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -72.83 -40.61 52.06 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 175.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -86.71 147.22 25.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.11 -12.07 22.19 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.629 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.96 -38.81 92.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 109.526 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 72.1 p -86.82 -16.61 35.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.615 -0.678 . . . . 0.0 111.109 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.06 -47.69 49.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.165 -0.959 . . . . 0.0 109.905 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -69.85 -46.02 66.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.679 -0.638 . . . . 0.0 112.692 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.67 -41.59 98.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.965 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 29.9 m -56.86 -44.74 82.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.483 -0.76 . . . . 0.0 111.194 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.77 -28.22 68.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.7 m -61.1 -41.17 96.18 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.327 -0.858 . . . . 0.0 109.472 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.49 -41.09 93.64 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.438 ' CD1' ' CG1' ' A' ' 505' ' ' VAL . 1.4 tt -64.17 -22.95 67.13 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.845 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -48.06 -64.19 0.86 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.376 -0.828 . . . . 0.0 113.205 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.69 -50.54 60.84 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.771 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -62.35 -36.38 82.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.966 . . . . 0.0 111.77 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -64.99 -25.23 67.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.447 -0.783 . . . . 0.0 112.72 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -40.88 -27.82 0.06 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -107.28 -108.73 0.31 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.109 -0.994 . . . . 0.0 113.065 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.473 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.1 OUTLIER -89.51 81.47 6.53 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.553 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 531' ' ' GLN . 5.9 t -143.87 165.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.843 -1.161 . . . . 0.0 111.729 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 12.8 mm-40 -157.52 161.83 38.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.85 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 55.3 t -114.96 107.17 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.354 -0.841 . . . . 0.0 111.511 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 506' ' ' ILE . 5.5 tt -105.49 119.22 38.55 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.487 ' CG2' HG11 ' A' ' 507' ' ' VAL . 4.1 pt -139.94 153.08 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.296 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.6 p -143.11 114.62 8.01 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.95 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -77.08 175.56 9.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.681 1.229 . . . . 0.0 111.83 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' SER . . . . . 0.403 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.3 m -129.98 -10.3 4.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.105 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -122.67 34.78 3.65 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -98.29 0.84 46.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.862 -0.787 . . . . 0.0 111.999 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -49.36 -31.22 8.97 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.096 -1.003 . . . . 0.0 110.216 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 46.1 p -129.78 166.54 19.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.5 34.66 55.38 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.8 t -61.7 -45.8 92.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.496 -1.002 . . . . 0.0 111.802 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -63.23 -34.69 90.65 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 48.0 m -64.08 -37.86 88.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.71 -0.876 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -57.26 -37.25 72.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 110.023 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 10.9 mp -63.14 -39.94 96.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.658 -0.652 . . . . 0.0 110.102 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.68 -29.11 70.41 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.487 -0.758 . . . . 0.0 109.203 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -56.29 -52.6 63.9 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 56.0 ttm -55.61 -46.65 77.31 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.277 -0.889 . . . . 0.0 109.521 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . 0.463 ' HA ' HG22 ' A' ' 555' ' ' VAL . 97.5 mttt -57.6 -32.0 66.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.824 -0.548 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -68.46 -25.51 65.03 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.4 -0.813 . . . . 0.0 111.403 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.37 0.85 5.75 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.083 -1.011 . . . . 0.0 112.787 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.39 -15.25 9.28 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 120.787 -1.196 . . . . 0.0 110.832 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 551' ' ' LYS . 34.2 m . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.304 -1.115 . . . . 0.0 110.034 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.638 0.256 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.51 -42.56 99.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.235 -0.916 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.3 m -60.99 -42.12 97.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.715 -0.616 . . . . 0.0 110.082 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.23 -35.27 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.691 -0.631 . . . . 0.0 111.032 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -63.27 -47.1 83.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.043 0.925 . . . . 0.0 109.448 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.96 -38.86 90.1 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.719 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.8 m -68.32 -36.15 78.87 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -63.07 -45.28 92.91 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.261 -0.899 . . . . 0.0 111.129 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.13 -40.87 86.86 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.116 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.75 -42.58 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 110.031 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 0.9 OUTLIER -61.04 -31.57 71.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.77 -30.87 71.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.966 -1.084 . . . . 0.0 109.827 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.405 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 61.0 tp60 -89.39 -16.31 31.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 109.205 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 437' ' ' SER . 2.6 t-20 -66.11 -34.31 77.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.571 -0.706 . . . . 0.0 109.672 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -114.09 17.9 17.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 109.518 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 8.3 p -40.43 148.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.559 0.695 . . . . 0.0 112.243 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.401 ' N ' HG21 ' A' ' 405' ' ' VAL . 63.4 m -85.63 77.18 9.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.51 129.74 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 111.064 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -98.92 144.93 29.09 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.6 -19.09 42.56 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.199 1.105 . . . . 0.0 111.488 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.61 -33.22 71.21 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.09 64.03 0.45 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.5 m -61.3 131.28 49.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 110.979 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.435 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 7.8 p -78.68 148.66 73.33 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.5 Cg_endo -60.18 138.82 83.89 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.834 0.912 . . . . 0.0 110.622 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -101.05 -5.02 26.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 420' ' ' SER . 17.5 p -97.83 17.97 16.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.777 -1.202 . . . . 0.0 108.943 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.28 -32.56 7.73 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -69.47 -40.01 79.37 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -98.93 -10.95 22.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.74 -1.447 . . . . 0.0 111.215 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 416' ' ' THR . 58.2 p -74.17 -38.13 63.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.746 -1.221 . . . . 0.0 107.841 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.17 -48.35 24.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.31 73.41 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.527 -0.733 . . . . 0.0 111.727 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.407 ' HA ' HD21 ' A' ' 426' ' ' LEU . 58.0 t -66.94 -43.82 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.576 -0.703 . . . . 0.0 112.423 -177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -61.59 -42.19 98.51 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.856 -1.152 . . . . 0.0 111.147 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.7 -28.65 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.3 -0.875 . . . . 0.0 110.667 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -72.89 -32.12 65.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.446 -0.784 . . . . 0.0 111.558 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.35 76.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.904 -1.123 . . . . 0.0 109.389 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -61.93 -30.14 70.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.51 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.402 ' CB ' ' CD ' ' A' ' 431' ' ' PRO . 3.4 tpp85 -172.19 -61.21 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.694 -1.254 . . . . 0.0 109.256 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 531' ' ' GLN . 44.3 Cg_endo -71.35 110.91 2.97 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 O-C-N 123.086 1.045 . . . . 0.0 110.637 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 531' ' ' GLN . 6.7 t -88.46 98.06 11.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.69 -0.631 . . . . 0.0 110.45 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.821 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 19.7 tp -164.31 97.07 0.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.663 -1.273 . . . . 0.0 112.34 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -141.34 175.63 9.5 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.104 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 435' ' ' ILE . 46.4 pt -118.83 130.59 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.325 0.583 . . . . 0.0 110.4 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.88 136.02 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.921 -1.112 . . . . 0.0 109.611 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.411 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 73.9 m -121.56 125.69 47.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.345 -0.847 . . . . 0.0 110.996 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -103.2 -176.71 26.46 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -129.41 -41.17 1.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.616 -0.932 . . . . 0.0 109.838 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -159.88 167.0 35.23 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.7 64.06 2.97 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.6 -21.26 41.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.59 -0.947 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.22 97.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.462 -0.774 . . . . 0.0 111.171 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -66.1 -31.06 78.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.77 -30.41 71.41 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.603 -0.939 . . . . 0.0 109.807 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.404 ' HD2' ' HB3' ' A' ' 467' ' ' ALA . 2.8 mmt85 -63.97 -43.45 95.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.59 -0.694 . . . . 0.0 109.976 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.74 -33.85 64.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.335 -0.853 . . . . 0.0 110.783 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.24 -53.59 52.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.362 -0.836 . . . . 0.0 111.511 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.61 -33.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.757 -1.214 . . . . 0.0 108.883 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.62 68.07 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.42 -37.99 82.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.064 -1.022 . . . . 0.0 108.61 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 455' ' ' MET . 79.2 mt -63.12 -36.72 84.54 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.66 -27.44 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -0.825 . . . . 0.0 109.586 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 94.4 mtp -67.73 -40.95 84.17 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' MET . . . . . 0.417 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.1 OUTLIER -62.41 -20.74 64.79 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.235 -0.916 . . . . 0.0 109.93 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.23 -23.06 32.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.614 -0.679 . . . . 0.0 109.562 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -68.56 -40.19 80.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.676 . . . . 0.0 109.563 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.45 -32.21 68.06 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.408 -0.807 . . . . 0.0 109.661 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.68 3.1 12.38 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.753 -0.592 . . . . 0.0 111.725 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.44 71.8 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -125.37 122.42 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 109.868 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 98.1 mt-10 -84.85 168.18 15.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 34.4 m -143.62 149.08 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 111.22 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 505' ' ' VAL . 1.4 pt20 -99.08 121.66 41.28 Favored 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 176.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -123.5 129.72 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 471' ' ' ARG . 4.4 mp -117.76 112.99 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.404 ' HB3' ' HD2' ' A' ' 446' ' ' ARG . . . -65.23 -179.44 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.813 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.94 -161.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.16 -14.59 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.732 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.72 -3.07 45.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.122 -0.986 . . . . 0.0 111.967 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 466' ' ' ILE . 74.6 ttt-85 -57.04 -31.13 64.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.886 -1.133 . . . . 0.0 111.21 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.6 t -60.01 -44.44 94.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.855 . . . . 0.0 109.857 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.21 -36.01 82.86 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.1 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.864 -0.523 . . . . 0.0 109.936 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -61.47 -37.57 84.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.534 -0.729 . . . . 0.0 109.605 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 65.5 ttp -58.55 -38.11 77.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.919 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -124.89 -152.42 0.51 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 48.3 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.909 -1.12 . . . . 0.0 111.824 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -127.65 11.47 6.75 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.562 -0.712 . . . . 0.0 110.665 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -98.24 -14.51 20.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.546 -0.721 . . . . 0.0 110.267 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -108.67 -13.96 14.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.557 -0.715 . . . . 0.0 111.84 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.7 56.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.953 -1.092 . . . . 0.0 110.932 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 93.2 p -60.17 -23.67 64.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.017 -1.052 . . . . 0.0 110.181 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 151.22 55.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -132.4 48.87 2.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.821 -0.811 . . . . 0.0 110.407 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.61 -80.56 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.463 ' O ' ' CD2' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -178.96 -44.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.796 -1.19 . . . . 0.0 110.246 174.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.401 ' CG2' HG23 ' A' ' 487' ' ' ILE . 5.0 p -102.63 8.75 39.63 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.851 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.85 60.09 4.68 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.436 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 66.3 ttt180 -145.77 -45.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.906 -0.761 . . . . 0.0 109.542 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 36.7 mtt85 -120.86 -46.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.429 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.408 ' CG ' ' HA ' ' A' ' 498' ' ' ALA . 32.4 mt-30 -61.61 -50.32 73.04 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.092 -1.005 . . . . 0.0 111.452 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.08 -37.53 72.45 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.97 -0.457 . . . . 0.0 111.603 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.76 -38.07 6.82 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.13 -8.18 15.19 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.773 -1.205 . . . . 0.0 114.132 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 91.54 -21.34 36.1 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 120.766 -1.209 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.499 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 52.1 mmm -67.12 178.73 1.35 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.133 -1.216 . . . . 0.0 109.851 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 492' ' ' GLN . . . -114.31 148.83 36.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 112.23 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -115.95 148.92 39.55 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.559 0.695 . . . . 0.0 110.301 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 19.1 m -52.45 107.57 0.87 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.869 -0.52 . . . . 0.0 110.117 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.74 114.41 3.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.437 1.23 . . . . 0.0 109.556 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -171.95 27.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.406 ' CB ' HD12 ' A' ' 487' ' ' ILE . 60.2 p -94.3 177.97 5.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.634 -0.921 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 51.5 m -125.53 125.39 43.16 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 464' ' ' GLN . 8.5 p -109.32 131.01 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.949 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 2.4 pt -126.0 112.32 29.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.453 HG11 ' CG2' ' A' ' 534' ' ' ILE . 4.3 p -112.68 115.5 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 111.851 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.12 105.63 14.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 21.8 tm0? -94.12 174.12 7.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.7 0.762 . . . . 0.0 111.199 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.46 -74.66 0.04 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 105.364 -3.094 . . . . 0.0 105.364 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -54.49 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 5.3 mttt 179.07 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.625 0 O-C-N 120.695 -1.253 . . . . 0.0 110.57 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.0 -20.89 63.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.641 -0.662 . . . . 0.0 110.493 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 17.9 m -64.43 -42.12 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.358 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 7.6 tp -65.5 -44.17 87.88 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.23 0.538 . . . . 0.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.71 -43.89 83.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.457 -0.777 . . . . 0.0 112.348 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.85 -51.21 69.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.05 -1.031 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 30.6 m -59.1 -41.5 88.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -39.23 79.63 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.924 -0.485 . . . . 0.0 110.848 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.1 m -61.02 -37.14 81.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 0.0 110.167 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.09 -40.43 86.94 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' A' ' 505' ' ' VAL . 0.3 OUTLIER -64.66 -21.95 66.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.754 -0.591 . . . . 0.0 111.641 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -45.74 -62.66 1.21 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.592 -0.692 . . . . 0.0 111.951 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -84.68 -48.17 5.08 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.984 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.94 74.49 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -65.0 -25.69 67.97 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.786 -1.196 . . . . 0.0 112.325 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -42.46 -28.13 0.2 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.411 -0.806 . . . . 0.0 112.182 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.23 -137.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 111.177 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.415 ' O ' HG21 ' A' ' 530' ' ' VAL . 84.5 m-20 -72.43 73.97 1.02 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.9 -1.125 . . . . 0.0 112.129 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.446 ' CB ' ' HA ' ' A' ' 526' ' ' ALA . 41.2 t -137.73 164.52 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.42 -0.8 . . . . 0.0 110.668 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 432' ' ' SER . 1.5 mm-40 -160.59 162.21 32.77 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 8.5 t -114.65 111.62 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 120.947 -1.096 . . . . 0.0 113.794 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.2 tp -102.2 114.86 29.38 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.453 ' CG2' HG11 ' A' ' 507' ' ' VAL . 7.9 pt -133.33 161.46 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 C-N-CA 118.677 -1.209 . . . . 0.0 112.596 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 68.9 p -131.16 -171.56 2.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 24.0 t70 -151.12 157.58 42.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.83 20.87 2.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.387 -0.821 . . . . 0.0 110.794 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -153.75 -42.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -78.79 0.32 27.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.503 -0.998 . . . . 0.0 111.229 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -38.1 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.0 p -102.36 -25.14 13.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.962 -1.086 . . . . 0.0 110.623 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -127.51 55.57 0.75 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.9 t -75.17 -15.64 60.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.783 -0.833 . . . . 0.0 111.542 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.09 93.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 87.8 p -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -1.044 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.46 76.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 109.628 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.4 mp -61.71 -43.21 99.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.405 -0.809 . . . . 0.0 109.163 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.7 ttp -63.34 -35.14 79.39 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -52.0 -50.64 60.94 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 28.2 ttt -57.97 -46.1 85.67 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -60.9 -31.45 70.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.414 -0.804 . . . . 0.0 111.052 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.83 -20.86 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.389 -0.82 . . . . 0.0 110.071 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.82 3.3 6.8 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.426 -0.796 . . . . 0.0 112.64 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.63 -13.26 8.75 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.419 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.269 . . . . 0.0 109.911 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.439 0.638 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -40.26 96.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.979 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.9 t -60.63 -45.72 92.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.456 -0.777 . . . . 0.0 110.68 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.66 -28.48 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -64.51 -52.3 58.52 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.999 -1.063 . . . . 0.0 111.533 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.32 77.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.336 -0.853 . . . . 0.0 109.134 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' A' ' 399' ' ' ILE . 8.0 tt -61.27 -38.06 85.35 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 t -65.51 -43.65 89.41 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.118 -0.989 . . . . 0.0 111.781 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -64.07 -45.36 89.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.319 -0.863 . . . . 0.0 111.964 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -64.94 -44.86 88.06 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.29 -0.881 . . . . 0.0 111.283 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.4 HD12 ' CD2' ' A' ' 395' ' ' LEU . 71.4 mt -63.98 -41.83 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.34 -0.85 . . . . 0.0 110.519 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 5.6 tpp -60.62 -35.01 75.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.351 -0.843 . . . . 0.0 109.995 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.35 -31.03 70.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -87.45 -16.59 34.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.801 -1.187 . . . . 0.0 108.78 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.33 -31.98 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.722 -0.611 . . . . 0.0 110.273 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -113.67 17.84 17.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.418 HG12 ' CG2' ' A' ' 407' ' ' VAL . 7.6 p -52.46 108.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.59 -0.694 . . . . 0.0 109.729 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 64.9 p -50.03 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.462 -0.774 . . . . 0.0 111.37 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.418 ' CG2' HG12 ' A' ' 405' ' ' VAL . 58.6 t -107.24 133.02 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -94.32 142.21 24.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.572 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.22 -21.91 54.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.336 1.177 . . . . 0.0 110.318 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -60.46 -40.29 90.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 110.002 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 68.28 1.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.4 t -53.89 110.62 0.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.63 111.54 4.95 Favored Pre-proline 0 N--CA 1.492 1.653 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.813 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.8 133.32 21.66 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.096 1.051 . . . . 0.0 109.972 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.91 63.6 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.485 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 68.8 p -66.0 -33.16 75.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 108.762 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -63.59 -10.26 17.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.626 -0.671 . . . . 0.0 111.578 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.56 51.93 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.965 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.16 -2.04 55.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.61 -1.524 . . . . 0.0 110.133 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 4.8 m -82.48 -33.0 28.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 108.781 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -78.88 -44.42 22.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.666 . . . . 0.0 110.123 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 425' ' ' VAL . . . -64.94 -42.02 95.02 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.636 -0.665 . . . . 0.0 111.412 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.418 ' CG2' ' CG2' ' A' ' 436' ' ' VAL . 88.8 t -80.2 -44.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.773 -0.579 . . . . 0.0 112.258 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.1 m -60.28 -42.01 94.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.929 -1.107 . . . . 0.0 110.475 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 422' ' ' ALA . 13.5 p -64.22 -29.76 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.422 -0.799 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 434' ' ' ALA . 0.2 OUTLIER -68.32 -31.77 71.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.554 -0.716 . . . . 0.0 110.074 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.49 78.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.056 -1.028 . . . . 0.0 108.771 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.13 -28.87 63.09 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -67.46 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.464 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 6.0 tmm_? -173.04 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 120.726 -1.234 . . . . 0.0 110.397 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.3 Cg_endo -71.17 120.48 7.04 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 N-CA-C 110.182 -0.738 . . . . 0.0 110.182 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 2.0 t -94.91 99.96 11.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.779 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.8 tp -163.24 98.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.955 -1.091 . . . . 0.0 110.741 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 426' ' ' LEU . . . -140.48 177.14 8.22 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.504 0.669 . . . . 0.0 111.047 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.3 mt -117.43 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.819 -0.551 . . . . 0.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.418 ' CG2' ' CG2' ' A' ' 423' ' ' VAL . 67.1 t -133.47 140.05 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.47 -0.769 . . . . 0.0 110.473 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 19.1 m -132.25 142.87 49.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.711 -0.618 . . . . 0.0 109.586 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.01 162.95 22.08 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -120.43 -42.74 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.895 . . . . 0.0 109.308 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.83 63.82 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 173.62 86.2 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.23 -28.23 10.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.512 -0.993 . . . . 0.0 110.724 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.49 79.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.444 -0.785 . . . . 0.0 110.781 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -77.97 -30.74 50.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.12 -31.55 64.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.401 -1.058 . . . . 0.0 109.348 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.425 ' O ' HG11 ' A' ' 449' ' ' VAL . 61.2 ttp180 -62.9 -43.66 98.2 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.569 0.699 . . . . 0.0 110.152 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -80.0 -29.46 39.47 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -0.853 . . . . 0.0 110.619 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -62.62 -47.69 82.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 446' ' ' ARG . 12.0 p -60.32 -31.53 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.903 -1.123 . . . . 0.0 108.227 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.2 -28.45 69.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.806 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -63.14 -32.9 74.39 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.45 -33.05 74.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 60.6 t -59.98 -29.8 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 61.4 mtt -66.65 -36.07 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.23 -27.52 62.1 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.576 -0.702 . . . . 0.0 109.435 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.1 32.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.64 -0.663 . . . . 0.0 109.777 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -64.39 -44.64 90.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -71.46 -30.9 66.55 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.503 0.668 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -76.38 -2.16 30.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.676 -0.64 . . . . 0.0 110.981 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.44 25.68 74.83 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -133.38 120.78 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.501 -1.0 . . . . 0.0 110.552 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 487' ' ' ILE . 92.9 mt-10 -79.85 172.1 14.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 27.2 m -144.46 153.02 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.4 ' HA ' HD22 ' A' ' 486' ' ' LEU . 54.1 tt0 -97.82 120.2 37.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -131.34 135.06 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.044 -1.035 . . . . 0.0 110.321 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 518' ' ' THR . 93.2 mt -127.51 123.55 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -78.81 162.96 25.74 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -161.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.666 -0.646 . . . . 0.0 109.294 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -47.64 -19.03 0.17 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.783 -1.198 . . . . 0.0 111.69 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.31 -7.17 54.37 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -57.09 -24.9 57.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.035 -1.041 . . . . 0.0 111.276 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 40.4 t -58.44 -45.36 88.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.403 -0.811 . . . . 0.0 110.181 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.95 -40.67 96.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 108.623 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 7.6 ttm -57.25 -39.5 75.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.742 -0.599 . . . . 0.0 110.446 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -57.11 -35.43 69.43 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 53.5 tpp -59.67 -36.77 77.1 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.347 0.594 . . . . 0.0 110.04 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -134.76 -145.87 0.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.586 . . . . 0.0 110.403 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 51.11 40.95 26.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.749 -1.219 . . . . 0.0 111.498 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.33 10.85 18.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.0 110.313 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.74 -3.94 57.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 111.487 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.78 15.23 0.14 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.206 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 1.6 pp -169.45 38.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.716 -1.24 . . . . 0.0 111.888 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 90.8 p -87.78 50.4 1.99 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.32 24.77 28.01 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -125.49 57.64 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.517 -0.99 . . . . 0.0 108.982 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 487' ' ' ILE . 84.7 mt -97.49 -82.05 0.42 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.459 HD12 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER 175.77 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 174.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 499' ' ' PHE . 8.8 t -104.28 10.45 35.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.884 -0.51 . . . . 0.0 111.112 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -149.66 93.91 0.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.432 ' HG2' ' N ' ' A' ' 491' ' ' ARG . 34.9 ttm180 -139.82 -81.15 0.28 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.432 ' N ' ' HG2' ' A' ' 490' ' ' ARG . 8.7 ptm180 -134.18 -13.91 2.37 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.986 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 499' ' ' PHE . 8.2 mt-30 -61.42 -30.69 70.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.879 -1.138 . . . . 0.0 111.252 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.42 HD23 ' CZ ' ' A' ' 499' ' ' PHE . 36.0 mt -64.88 -57.64 8.29 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.36 -37.98 89.36 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.925 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.55 -7.63 58.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.766 -0.584 . . . . 0.0 112.541 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.34 60.19 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.457 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 96.2 mtp -122.7 -173.49 2.71 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.375 -1.074 . . . . 0.0 110.046 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -103.25 165.93 10.74 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.669 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 492' ' ' GLN . 65.2 m-85 -111.58 152.6 27.39 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.651 0.739 . . . . 0.0 112.284 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.5 m -69.86 112.2 11.55 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.27 115.69 2.3 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.284 1.149 . . . . 0.0 111.226 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.58 27.64 0.04 OUTLIER Glycine 0 N--CA 1.505 3.29 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.294 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.459 ' CB ' HD12 ' A' ' 487' ' ' ILE . 12.5 p -96.84 -177.39 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.959 -1.318 . . . . 0.0 111.877 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 79.4 m -118.51 112.36 19.82 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.03 137.2 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 119.661 -0.815 . . . . 0.0 112.564 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 4.0 pt -134.26 163.13 37.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 507' ' ' VAL . 10.1 p -159.95 106.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 122.873 1.32 . . . . 0.0 111.842 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.94 122.45 28.29 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.427 ' HG2' HG22 ' A' ' 507' ' ' VAL . 86.7 mm-40 -145.17 112.54 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.67 -34.36 56.78 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.45 147.16 23.59 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.32 -10.49 22.25 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.025 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.32 -34.63 78.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.429 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 71.6 m -87.75 -17.44 31.66 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.38 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 56.4 tp -67.62 -46.43 72.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 108.765 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -70.29 -40.46 74.27 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.76 -49.96 75.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.253 -0.905 . . . . 0.0 111.06 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.407 ' CG2' ' CD1' ' A' ' 466' ' ' ILE . 91.3 m -56.5 -39.99 74.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.34 -0.85 . . . . 0.0 109.834 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -38.91 68.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.593 -0.692 . . . . 0.0 110.123 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 99.4 m -62.45 -39.19 92.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.512 -0.742 . . . . 0.0 109.783 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.498 -0.751 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.26 -21.46 63.93 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.484 -0.76 . . . . 0.0 111.08 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -45.81 -65.33 0.56 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.76 -51.68 55.76 Favored Glycine 0 N--CA 1.503 3.15 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.521 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -59.03 -32.46 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.56 -0.965 . . . . 0.0 111.296 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.4 -22.47 66.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.151 -0.968 . . . . 0.0 112.437 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -39.18 -28.23 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -119.04 -110.98 0.34 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.142 -0.974 . . . . 0.0 111.828 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -90.8 93.12 9.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.381 -1.449 . . . . 0.0 113.578 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.5 t -141.19 166.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.859 -1.15 . . . . 0.0 111.498 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.453 ' HG2' ' N ' ' A' ' 432' ' ' SER . 1.1 tp-100 -164.68 163.25 21.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.9 t -114.64 107.39 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 1.6 tp -104.53 119.04 38.06 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.437 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 14.9 pt -140.5 161.03 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 117.613 -1.635 . . . . 0.0 112.96 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 81.7 p -121.74 -169.86 1.94 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -149.16 155.79 41.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.18 20.38 2.43 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.042 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.06 -46.21 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 2.44 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.888 . . . . 0.0 111.648 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -36.33 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 66.7 p -93.02 117.98 30.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.074 -1.016 . . . . 0.0 109.242 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 63.83 70.21 1.12 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 74.9 p -80.13 -3.17 47.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.752 -0.852 . . . . 0.0 111.981 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.65 -35.59 81.87 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 -32.54 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.827 -0.808 . . . . 0.0 110.279 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.19 80.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.658 . . . . 0.0 109.324 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.45 -43.28 99.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.796 -0.565 . . . . 0.0 110.639 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 93.4 mtp -65.2 -37.61 87.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -50.92 -51.46 51.82 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.099 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 38.0 ttp -58.29 -40.47 82.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.364 -0.835 . . . . 0.0 109.561 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.9 -32.17 72.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.0 110.368 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.4 -16.09 62.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 0.0 110.352 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -77.14 8.41 3.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.214 -0.929 . . . . 0.0 112.629 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 155.79 -16.74 0.47 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.79 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.495 1.814 0 CA-C-N 118.967 1.384 . . . . 0.0 109.273 179.75 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 121.3 0.571 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.48 -42.36 98.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.729 -0.607 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 33.9 p -64.36 -37.69 88.38 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.477 -0.764 . . . . 0.0 110.585 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 79.8 t -65.9 -35.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -62.75 -51.37 67.41 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.418 -0.801 . . . . 0.0 110.815 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.96 79.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.424 -0.798 . . . . 0.0 109.811 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.9 tt -62.18 -39.06 91.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.968 -0.458 . . . . 0.0 111.123 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.2 m -62.65 -37.47 86.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.43 -44.18 92.0 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.905 . . . . 0.0 112.249 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.95 -45.02 91.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.061 -1.024 . . . . 0.0 111.639 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.09 -40.84 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.724 -0.61 . . . . 0.0 109.965 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 30.9 mtp -63.73 -32.58 74.11 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.575 -0.703 . . . . 0.0 110.416 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.05 -32.24 70.72 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.106 -0.996 . . . . 0.0 110.143 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -91.17 -14.68 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.432 ' ND2' ' CB ' ' A' ' 437' ' ' SER . 2.2 t-20 -67.11 -36.98 83.1 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 0.0 109.5 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -115.33 20.38 14.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 12.5 p -37.34 146.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 122.149 -0.344 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 14.1 p -72.89 72.91 1.12 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.346 -0.846 . . . . 0.0 109.976 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -111.14 133.39 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.945 0.878 . . . . 0.0 112.819 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -92.37 145.76 31.23 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.698 -0.627 . . . . 0.0 109.848 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.96 -28.95 81.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 O-C-N 123.05 1.026 . . . . 0.0 109.825 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.57 -26.54 2.27 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.766 0.793 . . . . 0.0 111.168 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 67.21 0.75 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 82.4 p -51.07 109.86 0.37 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.522 -0.737 . . . . 0.0 110.585 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 413' ' ' VAL . 19.9 m -76.68 110.45 11.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.886 -0.509 . . . . 0.0 110.558 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.92 137.95 42.91 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 N-CA-C 109.663 -0.937 . . . . 0.0 109.663 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -147.73 83.53 1.53 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 113.704 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 420' ' ' SER . 33.0 p -100.09 26.85 6.03 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.021 -1.05 . . . . 0.0 108.481 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -110.06 -31.71 7.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.319 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -57.7 -50.59 64.14 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 436' ' ' VAL . 30.0 p90 -98.96 -11.77 21.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.814 -1.403 . . . . 0.0 111.975 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 416' ' ' THR . 6.2 t -65.92 -47.4 74.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.336 -1.477 . . . . 0.0 109.197 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -77.21 -45.36 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 110.63 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.14 77.82 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.597 -0.69 . . . . 0.0 111.475 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.85 -43.15 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.717 -0.614 . . . . 0.0 112.021 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.7 p -56.73 -39.96 74.85 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.113 -0.992 . . . . 0.0 111.225 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.99 -43.84 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.784 . . . . 0.0 109.834 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.2 OUTLIER -60.55 -34.14 73.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 112.045 -178.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -37.03 77.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.348 -1.47 . . . . 0.0 108.056 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.77 -29.63 70.26 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -179.44 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.344 -1.473 . . . . 0.0 108.969 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.7 99.14 0.72 Allowed 'Trans proline' 0 N--CA 1.484 0.913 0 N-CA-C 108.938 -1.216 . . . . 0.0 108.938 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.4 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 4.3 t -87.59 101.3 13.5 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.765 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -156.82 88.95 1.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 109.989 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.99 164.97 28.63 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.894 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.57 128.54 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.879 -0.513 . . . . 0.0 109.714 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.43 HG12 ' CG ' ' A' ' 419' ' ' TYR . 75.6 t -124.37 140.88 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.759 -0.588 . . . . 0.0 109.755 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.432 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 4.8 m -126.65 132.61 51.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 110.908 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.92 169.82 23.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -141.75 32.0 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.944 . . . . 0.0 109.626 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 138.08 168.73 11.4 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.84 92.55 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.85 88.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.906 . . . . 0.0 110.418 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.71 96.22 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.278 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.11 75.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.47 -38.82 81.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.981 . . . . 0.0 110.472 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 449' ' ' VAL . 90.3 mmt-85 -64.26 -40.22 95.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.368 -0.833 . . . . 0.0 110.138 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -70.81 -30.13 66.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.7 -46.68 78.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.372 -0.83 . . . . 0.0 111.575 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 446' ' ' ARG . 7.5 p -60.56 -32.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.774 -1.203 . . . . 0.0 108.974 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.82 -28.37 69.96 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.691 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.61 -37.58 82.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.08 -37.0 85.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 67.8 t -59.27 -26.66 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.679 -0.638 . . . . 0.0 109.314 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 17.0 mmt -67.66 -36.49 80.84 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 459' ' ' GLN . 14.8 tmm? -59.45 -29.05 67.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.834 -0.541 . . . . 0.0 110.233 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.04 -21.13 37.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.476 -0.765 . . . . 0.0 109.929 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -72.68 -25.33 61.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.651 -0.656 . . . . 0.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 455' ' ' MET . 96.9 mm-40 -77.27 2.41 15.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.338 -0.851 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.83 82.85 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 120.936 -1.103 . . . . 0.0 111.705 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -138.06 144.53 41.01 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 118.821 1.31 . . . . 0.0 111.428 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -89.44 175.3 7.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 16.6 m -138.74 162.38 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.855 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.78 115.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.2 120.55 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.788 -1.195 . . . . 0.0 112.116 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 94.9 mt -107.66 172.95 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.795 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -129.41 156.6 43.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.29 -159.75 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.673 -0.642 . . . . 0.0 109.424 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -46.84 -15.98 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.904 -1.122 . . . . 0.0 112.849 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -88.05 4.93 43.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.879 -1.138 . . . . 0.0 111.985 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -58.57 -37.61 76.14 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.066 -1.021 . . . . 0.0 111.14 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 53.5 m -56.11 -47.18 78.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.447 -0.783 . . . . 0.0 111.1 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -65.97 -37.71 86.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -0.829 . . . . 0.0 109.101 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -34.45 71.84 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.748 -0.595 . . . . 0.0 110.192 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -61.39 -39.84 92.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.0 109.593 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 59.6 ttp -62.01 -41.61 98.25 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -111.01 -150.1 0.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 109.052 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 48.26 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.021 -1.05 . . . . 0.0 112.302 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -132.91 21.48 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.605 . . . . 0.0 110.463 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 480' ' ' GLU . 47.7 tp10 -110.15 3.67 20.37 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.397 -0.814 . . . . 0.0 111.408 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.17 -24.31 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.905 -1.122 . . . . 0.0 112.421 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.21 69.64 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.106 -0.997 . . . . 0.0 110.81 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 24.7 t -90.38 51.15 1.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.58 16.82 23.37 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.081 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -126.16 59.9 1.32 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.177 -1.19 . . . . 0.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 84.7 mt -64.18 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.069 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 488' ' ' THR . 14.4 mm -155.15 -82.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.16 -0.962 . . . . 0.0 109.736 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.523 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.0 t -98.99 12.25 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.784 -0.572 . . . . 0.0 110.761 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -97.05 79.93 0.69 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.54 -67.99 0.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 495' ' ' GLU . 95.7 mtt-85 -96.75 -26.72 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.802 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -67.52 -44.34 78.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.933 -1.104 . . . . 0.0 110.524 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.46 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 2.6 mt -70.59 -37.84 73.96 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 -39.98 6.45 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 491' ' ' ARG . 89.7 mt-10 -102.14 -9.47 20.48 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.815 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 84.31 -9.18 64.9 Favored Glycine 0 N--CA 1.5 2.949 0 O-C-N 120.523 -1.36 . . . . 0.0 111.111 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.17 179.25 1.6 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.248 . . . . 0.0 112.11 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.55 153.77 25.77 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.523 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.4 155.04 25.95 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.191 0.996 . . . . 0.0 112.036 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 7.3 t -44.6 132.33 4.89 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.642 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.409 ' HB3' ' CA ' ' A' ' 528' ' ' HIS . 56.3 Cg_endo -85.51 112.94 1.35 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.596 1.314 . . . . 0.0 109.51 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.11 26.05 0.07 OUTLIER Glycine 0 N--CA 1.504 3.194 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.987 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.418 ' CB ' HG21 ' A' ' 487' ' ' ILE . 74.7 m -92.8 173.87 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -1.207 . . . . 0.0 111.022 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 91.6 m -115.66 127.71 55.37 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 531' ' ' GLN . 13.2 t -118.46 130.51 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.867 0.842 . . . . 0.0 111.125 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.6 123.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 534' ' ' ILE . 14.5 p -113.73 115.18 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.647 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 36.7 m-20 -84.34 108.48 17.2 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.894 -1.129 . . . . 0.0 108.418 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 0.5 OUTLIER -99.73 175.36 5.83 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 122.376 1.084 . . . . 0.0 112.969 -176.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.81 -55.85 0.05 OUTLIER Glycine 0 N--CA 1.503 3.102 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.19 -155.05 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.51 -17.86 2.54 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.046 -1.033 . . . . 0.0 111.019 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 57.5 tp -72.43 -25.05 61.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.278 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 75.2 m -65.58 -44.31 87.05 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 110.492 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 11.0 tp -64.46 -46.31 83.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.829 -0.544 . . . . 0.0 111.938 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.55 -43.81 79.8 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 0.0 112.084 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -62.5 -51.13 68.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.112 -0.992 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -59.81 -43.07 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.832 -0.542 . . . . 0.0 110.459 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -41.36 90.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.747 -0.596 . . . . 0.0 111.464 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 39.1 p -64.47 -33.27 75.49 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.053 -1.03 . . . . 0.0 109.832 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 60.8 tp -68.3 -40.44 81.75 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.694 0.759 . . . . 0.0 109.83 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -22.22 62.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -47.46 -60.17 2.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.393 -0.817 . . . . 0.0 111.895 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.88 -51.13 56.06 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -55.15 -29.83 58.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.684 -0.891 . . . . 0.0 110.414 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -47.96 -37.67 15.01 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -66.58 -42.51 86.89 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.409 ' CA ' ' HB3' ' A' ' 501' ' ' PRO . 32.2 m80 -94.62 -94.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.31 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -83.69 144.17 29.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.963 -1.085 . . . . 0.0 110.074 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 4.2 p -171.81 146.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.392 -1.323 . . . . 0.0 113.836 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.8 OUTLIER 171.86 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 76.5 t -110.44 104.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 120.742 -1.223 . . . . 0.0 113.258 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.26 116.17 31.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.435 ' CG2' HG13 ' A' ' 507' ' ' VAL . 5.7 pt -127.91 155.19 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.475 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 61.4 p -128.87 -172.69 2.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -149.4 156.04 41.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 110.563 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 85.3 p -145.32 23.26 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.663 . . . . 0.0 110.654 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -163.63 -41.6 0.02 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.63 0.4 38.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.979 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -40.58 -39.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.583 -0.698 . . . . 0.0 112.23 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 40.5 p -63.86 -91.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -70.25 79.53 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.4 t -87.06 -18.72 29.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.953 . . . . 0.0 111.611 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.22 -38.97 93.97 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 18.9 m -69.17 -24.93 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.515 -0.991 . . . . 0.0 109.792 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.53 77.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.76 -0.587 . . . . 0.0 109.865 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.298 -0.876 . . . . 0.0 108.877 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 56.8 ttm -64.55 -31.91 73.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.93 -50.39 61.23 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 90.0 mtp -58.43 -44.27 89.05 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.838 . . . . 0.0 110.339 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.44 -32.07 73.4 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.459 -0.776 . . . . 0.0 111.474 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.67 -15.86 62.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.66 3.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.266 -0.896 . . . . 0.0 112.725 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 147.65 -13.08 1.35 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.364 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.015 -1.285 . . . . 0.0 110.708 -179.449 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.505 2.309 0 CA-C-O 121.498 0.665 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -40.53 89.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 77.8 p -66.11 -41.44 90.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.442 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.31 -33.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.679 -0.638 . . . . 0.0 110.451 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -58.37 -48.99 78.83 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.421 -0.799 . . . . 0.0 111.402 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.68 -32.17 71.79 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.949 0.88 . . . . 0.0 109.856 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.409 ' CD2' HD13 ' A' ' 399' ' ' ILE . 2.2 tm? -61.8 -41.53 97.87 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.758 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.5 p -71.86 -34.68 69.43 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.193 -0.942 . . . . 0.0 112.641 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.0 -50.22 71.6 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.996 -1.065 . . . . 0.0 112.435 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.06 -43.14 71.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.263 -0.898 . . . . 0.0 112.014 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 399' ' ' ILE . 94.1 mt -61.41 -44.79 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.112 -0.992 . . . . 0.0 110.009 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 5.9 ttm -61.42 -31.55 71.49 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.617 -0.677 . . . . 0.0 110.758 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.26 -25.21 67.7 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.539 -0.726 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 419' ' ' TYR . 65.5 tp60 -99.79 -20.65 16.11 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.272 -0.893 . . . . 0.0 109.21 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 98.0 m-20 -82.7 -7.01 59.68 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -94.67 -56.47 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 402' ' ' GLN . 6.4 p -27.88 124.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.1 m -60.13 95.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 122.159 0.98 . . . . 0.0 109.979 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.415 ' CG2' ' CZ ' ' A' ' 415' ' ' ARG . 13.9 t -65.27 137.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.132 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.2 130.68 29.1 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.684 -0.635 . . . . 0.0 110.267 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.47 -20.79 41.27 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.117 1.061 . . . . 0.0 111.07 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.35 -32.6 71.78 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.787 0.803 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 69.88 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.0 m -49.69 142.3 8.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.791 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.86 143.88 27.17 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.38 136.63 56.1 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 N-CA-C 108.794 -1.272 . . . . 0.0 108.794 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.415 ' CZ ' ' CG2' ' A' ' 407' ' ' VAL . 98.1 mtt180 -123.18 -15.53 7.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.391 -0.818 . . . . 0.0 112.881 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.9 p -102.74 6.45 39.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.025 . . . . 0.0 109.014 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -78.51 -79.92 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.05 -1.031 . . . . 0.0 111.745 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -74.12 -4.75 68.95 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.623 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 402' ' ' GLN . 81.7 m-85 -107.07 -1.94 21.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.616 -1.52 . . . . 0.0 110.207 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -84.88 -33.71 22.74 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.63 -37.68 67.95 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.11 85.72 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.099 0.952 . . . . 0.0 110.301 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.71 -40.98 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.253 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -69.45 -36.61 76.79 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.028 -1.045 . . . . 0.0 111.71 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.27 -42.46 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.381 -0.825 . . . . 0.0 112.008 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.51 -31.08 71.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.25 69.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.955 . . . . 0.0 109.424 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.15 -32.53 74.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -61.24 -86.49 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.475 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -172.18 -57.46 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.773 -1.205 . . . . 0.0 109.529 177.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 55.2 Cg_endo -71.07 103.44 1.38 Allowed 'Trans proline' 0 N--CA 1.488 1.198 0 N-CA-C 109.688 -0.928 . . . . 0.0 109.688 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 t -85.34 98.72 10.71 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.963 0.887 . . . . 0.0 110.712 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.2 tp -146.51 136.61 23.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -169.96 163.21 9.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.823 -1.173 . . . . 0.0 110.923 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 22.1 mt -123.49 121.52 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.793 -0.567 . . . . 0.0 110.409 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 57.3 t -127.27 137.14 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.917 . . . . 0.0 109.137 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 4.1 p -131.83 139.24 48.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.98 -1.075 . . . . 0.0 111.536 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -148.88 168.06 29.37 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.67 70.01 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 110.48 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 133.24 148.97 6.02 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.68 32.31 81.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.68 -9.16 58.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.698 -0.884 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.07 94.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.136 -0.978 . . . . 0.0 110.834 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -79.21 -28.01 54.34 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.94 -41.01 90.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.539 -0.977 . . . . 0.0 109.55 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 467' ' ' ALA . 8.4 mmm180 -64.89 -40.15 94.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.876 -0.515 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -70.27 -31.63 69.09 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.074 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.99 -50.49 64.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.52 -0.738 . . . . 0.0 112.051 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.5 -33.57 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.272 . . . . 0.0 109.174 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.89 -27.3 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -61.33 -33.95 74.45 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 455' ' ' MET . 1.5 tp -63.56 -38.43 91.08 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 91.8 t -58.88 -25.85 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 90.0 mtp -66.2 -39.77 89.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.45 -0.781 . . . . 0.0 109.221 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.3 OUTLIER -60.06 -23.44 63.76 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.874 0.845 . . . . 0.0 109.089 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 455' ' ' MET . . . -83.77 -23.65 31.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.463 0.649 . . . . 0.0 109.878 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 23.9 tpt85 -67.0 -42.96 84.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -71.42 -27.9 63.61 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.726 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -74.89 0.02 17.02 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.617 -0.677 . . . . 0.0 111.725 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.36 76.43 Favored Glycine 0 N--CA 1.496 2.679 0 O-C-N 120.837 -1.164 . . . . 0.0 110.718 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 461' ' ' ARG . 16.8 ptp180 -129.87 136.27 49.34 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.215 -1.168 . . . . 0.0 110.953 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 99.2 mt-10 -91.84 161.53 14.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.222 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 29.1 m -136.77 153.22 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 111.271 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.447 ' O ' HG11 ' A' ' 505' ' ' VAL . 53.4 tt0 -100.72 116.41 32.56 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 465' ' ' ILE . 1.1 pt -130.29 135.11 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.065 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 87.5 mt -126.22 122.12 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.118 -0.989 . . . . 0.0 111.86 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.413 ' CB ' ' NE ' ' A' ' 446' ' ' ARG . . . -66.03 155.88 35.4 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.452 -0.78 . . . . 0.0 109.128 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.99 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.406 -0.809 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 511' ' ' GLU . 5.0 t0 -46.11 -22.68 0.24 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.23 -0.919 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -70.32 -4.65 23.11 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.446 -0.784 . . . . 0.0 110.892 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -53.77 -34.18 58.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.118 -0.989 . . . . 0.0 112.929 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 75.5 m -59.41 -45.23 92.08 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.137 -0.977 . . . . 0.0 110.074 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 476' ' ' MET . 51.4 tt0 -66.84 -39.35 87.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.7 -0.625 . . . . 0.0 109.932 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 15.8 mmt -60.39 -34.52 74.02 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -61.77 -36.23 80.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.28 -0.888 . . . . 0.0 108.621 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 473' ' ' GLN . 7.3 tpp -59.45 -41.94 90.82 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.568 0.699 . . . . 0.0 109.124 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -118.16 -146.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 46.06 88.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.216 -0.927 . . . . 0.0 111.627 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -131.79 22.55 4.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.735 -0.603 . . . . 0.0 110.139 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -115.77 -15.49 11.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.695 -0.628 . . . . 0.0 110.735 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -118.15 -7.0 10.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 113.175 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -171.54 54.45 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 120.751 -1.218 . . . . 0.0 112.296 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.0 p -64.67 -21.63 66.78 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.926 -1.109 . . . . 0.0 110.576 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 149.67 48.17 0.02 OUTLIER Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.93 59.17 1.74 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.788 -0.83 . . . . 0.0 109.774 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 464' ' ' GLN . 24.9 mt -80.17 -80.29 0.14 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER 177.27 -41.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 174.131 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.9 p -103.85 9.53 36.84 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.503 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -103.14 60.78 0.48 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 499' ' ' PHE . 54.7 ttm-85 -144.12 -50.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.956 . . . . 0.0 108.835 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 98.0 mtt180 -122.97 -29.86 3.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.976 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 497' ' ' MET . 9.8 mt-30 -65.2 -41.19 94.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -0.921 . . . . 0.0 110.534 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.58 -31.48 21.17 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.503 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.93 -43.57 5.49 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -100.13 -9.65 22.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.535 -1.353 . . . . 0.0 113.904 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.22 -18.83 46.57 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.676 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.411 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 98.3 mtp -66.36 -178.47 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -1.151 . . . . 0.0 109.935 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.23 145.7 41.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.734 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -114.35 149.32 36.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.664 -0.648 . . . . 0.0 110.645 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 94.6 m -50.54 103.71 0.38 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 0.0 109.811 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.498 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 44.3 Cg_endo -72.37 113.04 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.559 1.294 . . . . 0.0 108.928 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 529' ' ' ASN . . . 171.05 34.33 0.03 OUTLIER Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.431 ' HB3' HD12 ' A' ' 487' ' ' ILE . 22.8 p -92.91 179.04 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -1.061 . . . . 0.0 110.654 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.428 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 97.8 m -111.17 121.6 45.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.45 HG13 ' CD2' ' A' ' 522' ' ' LEU . 63.4 t -123.02 134.89 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.205 -0.934 . . . . 0.0 113.227 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 4.2 pt -131.99 120.29 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 507' ' ' VAL . 9.8 p -106.1 114.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.537 -1.352 . . . . 0.0 111.478 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 468' ' ' ALA . 12.0 m-20 -82.27 108.5 15.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.9 tm0? -106.83 175.15 5.6 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.349 1.071 . . . . 0.0 113.305 -175.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -170.58 -51.91 0.04 OUTLIER Glycine 0 N--CA 1.503 3.145 0 N-CA-C 103.401 -3.88 . . . . 0.0 103.401 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 469' ' ' ASP . 32.0 tp10 -82.17 162.94 22.26 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 173.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.69 -12.32 20.11 Favored 'General case' 0 C--N 1.274 -2.712 0 O-C-N 121.636 -0.665 . . . . 0.0 110.658 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 513' ' ' LEU . 4.5 mm? -67.44 -27.16 66.81 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.2 m -91.43 -13.06 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 111.225 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 20.5 tp -78.34 -46.84 19.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -80.61 -38.52 29.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.467 -0.77 . . . . 0.0 111.512 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.64 -44.39 96.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.9 -1.125 . . . . 0.0 109.702 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 85.8 m -62.2 -41.96 98.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 519' ' ' LEU . 0.8 OUTLIER -60.2 -31.76 70.45 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.762 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 21.4 m -64.65 -53.98 39.03 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.855 -1.153 . . . . 0.0 110.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.27 93.57 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.133 -0.979 . . . . 0.0 109.888 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.45 ' CD2' HG13 ' A' ' 505' ' ' VAL . 3.2 mt -65.34 -31.98 73.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.459 -0.776 . . . . 0.0 112.181 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.06 -45.9 68.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.017 -1.052 . . . . 0.0 110.325 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.33 62.13 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.52 82.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.508 -0.995 . . . . 0.0 112.375 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.433 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -26.38 68.22 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.956 -1.09 . . . . 0.0 110.872 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -53.72 -25.8 20.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.485 -0.759 . . . . 0.0 109.243 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.498 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.7 m80 -109.98 -130.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.423 ' HB2' ' CA ' ' A' ' 502' ' ' GLY . 98.1 m-20 -89.91 70.65 7.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.532 -1.355 . . . . 0.0 113.234 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -133.28 158.0 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -148.77 154.59 39.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.759 -0.588 . . . . 0.0 109.608 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 35.4 t -107.14 106.55 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.35 -0.844 . . . . 0.0 113.12 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 506' ' ' ILE . 5.2 tp -106.72 113.66 27.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.413 HG21 HG12 ' A' ' 532' ' ' VAL . 12.1 pt -125.56 130.4 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.028 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.486 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 62.5 p -96.8 179.03 5.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -154.82 161.0 41.64 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.589 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.59 14.58 2.74 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.464 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -146.95 20.19 1.6 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 56.4 tt0 -93.83 -0.95 55.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.301 -1.117 . . . . 0.0 111.038 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -55.86 -42.75 76.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.834 -1.166 . . . . 0.0 111.25 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.1 m -102.75 -58.25 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 111.169 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -90.98 85.83 1.31 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.424 ' HA ' ' HG3' ' A' ' 539' ' ' GLN . 14.9 t -98.56 -40.78 8.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.561 -0.964 . . . . 0.0 111.608 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.09 -41.39 97.13 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 4.5 t -68.54 -23.31 64.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.522 -0.987 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.52 94.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 108.642 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -65.36 -42.11 93.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.743 -0.598 . . . . 0.0 109.958 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.21 -29.67 68.88 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.657 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.71 79.93 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 24.9 ttm -56.78 -53.02 62.65 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.598 -0.689 . . . . 0.0 110.282 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.39 -31.88 69.64 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.639 -0.663 . . . . 0.0 110.986 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -61.48 -20.04 62.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.415 -0.803 . . . . 0.0 109.776 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -72.37 -1.17 14.54 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.191 -0.943 . . . . 0.0 111.868 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.04 -8.81 9.76 Favored Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.872 -1.143 . . . . 0.0 110.992 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.124 -1.221 . . . . 0.0 108.505 178.759 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.58 -30.11 70.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.358 -0.839 . . . . 0.0 110.724 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.6 m -60.98 -44.71 96.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.22 -33.77 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.437 -0.789 . . . . 0.0 109.949 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -59.39 -47.79 84.1 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.179 -0.95 . . . . 0.0 110.559 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.64 78.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' A' ' 434' ' ' ALA . 0.6 OUTLIER -62.14 -39.38 92.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.025 -0.422 . . . . 0.0 111.195 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.0 p -64.69 -34.49 78.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 110.748 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -65.15 -43.73 90.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.96 -44.77 75.98 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.328 -0.858 . . . . 0.0 112.235 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 399' ' ' ILE . 62.2 mt -64.27 -43.77 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 6.9 tpp -61.36 -29.28 69.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.315 0.578 . . . . 0.0 109.484 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.06 -29.17 70.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.449 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 6.4 mm-40 -90.9 -15.5 29.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.081 . . . . 0.0 109.419 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.5 -37.98 86.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.648 -0.657 . . . . 0.0 110.079 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -116.86 18.9 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.047 -1.033 . . . . 0.0 110.441 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.1 p -58.76 120.92 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.397 -0.814 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 3.8 t -56.94 104.22 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.645 0.736 . . . . 0.0 110.525 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.0 p -112.71 135.33 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 138.31 25.6 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.96 -27.94 36.1 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.12 1.063 . . . . 0.0 110.758 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -62.53 -31.36 72.12 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.91 0.862 . . . . 0.0 109.996 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.61 59.32 0.69 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 30.7 t -61.34 126.99 29.33 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.751 0.786 . . . . 0.0 111.313 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.18 146.14 84.13 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.01 121.24 8.24 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -95.05 14.17 22.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.462 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 419' ' ' TYR . 14.6 p -92.07 20.9 5.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.878 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.23 -29.18 9.48 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.0 -49.63 76.5 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.456 ' CD1' HG11 ' A' ' 436' ' ' VAL . 21.0 p90 -99.29 -11.91 20.83 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.055 1.428 . . . . 0.0 112.943 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.3 m -70.88 -42.14 70.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.264 -1.523 . . . . 0.0 108.203 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 425' ' ' VAL . 33.6 t70 -78.94 -44.58 22.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.907 -0.496 . . . . 0.0 110.758 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -64.74 -48.04 76.05 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.773 -0.579 . . . . 0.0 112.409 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.42 -42.33 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.319 -0.863 . . . . 0.0 111.469 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 81.2 p -60.68 -42.84 97.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.182 -0.949 . . . . 0.0 111.343 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 421' ' ' ASP . 32.8 m -68.7 -29.32 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.33 -0.856 . . . . 0.0 111.949 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.34 -33.18 64.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.283 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.27 -32.71 73.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.026 -1.046 . . . . 0.0 108.594 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.17 -33.98 77.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.38 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.44 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -177.06 -56.11 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.556 -1.34 . . . . 0.0 110.001 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.4 Cg_endo -68.59 107.93 1.74 Allowed 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 109.291 -1.08 . . . . 0.0 109.291 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 531' ' ' GLN . 1.5 m -100.41 109.21 21.36 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.89 0.852 . . . . 0.0 110.898 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -174.8 95.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' A' ' 395' ' ' LEU . . . -136.86 167.01 22.29 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.929 0.871 . . . . 0.0 112.372 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 435' ' ' ILE . 40.0 pt -116.3 127.66 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.467 0.651 . . . . 0.0 109.541 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 54.0 t -125.04 137.35 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.369 -0.832 . . . . 0.0 109.327 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 28.1 m -119.61 123.45 43.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.359 -0.838 . . . . 0.0 110.951 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.96 155.66 19.63 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.17 75.55 0.25 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.737 -0.861 . . . . 0.0 109.368 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 113.65 145.49 9.2 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.27 38.96 95.39 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.25 -30.0 69.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.6 -0.941 . . . . 0.0 110.737 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.29 93.88 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.416 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.55 -28.05 68.26 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.37 -46.5 88.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.49 -1.006 . . . . 0.0 110.757 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 13.0 mtm-85 -64.81 -40.76 95.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.557 -0.714 . . . . 0.0 111.189 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.22 -29.97 68.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.127 -0.983 . . . . 0.0 110.37 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -61.67 -51.5 68.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.329 -0.857 . . . . 0.0 110.449 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 2.4 p -58.0 -31.74 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.095 -1.003 . . . . 0.0 108.765 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.02 -27.34 69.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.24 -34.28 76.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.106 -0.996 . . . . 0.0 108.756 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.87 -34.41 77.88 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 85.7 t -59.3 -30.12 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.633 -0.667 . . . . 0.0 109.742 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 60.3 mtt -66.34 -39.28 89.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.001 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.4 ttp -58.86 -25.21 63.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.652 -0.655 . . . . 0.0 110.176 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.36 -22.68 32.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 110.058 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -64.52 -45.39 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.573 -0.704 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.05 -29.86 65.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -75.82 3.8 9.26 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 111.357 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.67 23.92 75.45 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -128.37 145.64 51.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.445 -1.032 . . . . 0.0 110.344 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.432 ' CB ' HD13 ' A' ' 487' ' ' ILE . 51.0 mp0 -99.09 169.79 9.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 35.5 m -141.27 150.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.086 -1.009 . . . . 0.0 111.212 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.402 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 41.4 tt0 -101.2 123.62 45.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.49 146.78 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.225 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 95.5 mt -132.99 124.61 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.437 -0.789 . . . . 0.0 110.674 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.8 161.94 28.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.16 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.534 -0.729 . . . . 0.0 109.863 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -49.42 -19.16 0.49 Allowed 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.665 -1.272 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -76.17 -5.67 47.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.213 -0.929 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -56.97 -23.44 45.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.033 -1.042 . . . . 0.0 111.027 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 11.6 t -60.6 -48.57 81.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.11 -46.36 84.57 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 30.1 tpp -53.57 -35.03 60.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.897 -0.502 . . . . 0.0 110.904 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -60.72 -38.7 85.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.439 -0.788 . . . . 0.0 109.962 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 10.6 tpt -61.79 -37.67 85.22 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.602 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -113.12 -144.47 0.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 55.54 50.73 13.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.829 -1.169 . . . . 0.0 111.398 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -100.6 23.57 10.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.27 -10.21 39.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 112.265 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . 0.417 ' N ' ' CD ' ' A' ' 481' ' ' ARG . 0.0 OUTLIER -173.2 24.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.944 -1.098 . . . . 0.0 112.746 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 3.8 pp -171.62 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.4 p -61.13 -21.44 63.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.112 -0.992 . . . . 0.0 110.804 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 164.0 53.24 0.02 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.6 66.14 0.75 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.661 -0.905 . . . . 0.0 109.77 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 486' ' ' LEU . 75.4 mt -77.2 -82.1 0.09 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.427 -0.795 . . . . 0.0 109.21 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 503' ' ' SER . 35.8 mm -152.64 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 109.255 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 499' ' ' PHE . 3.9 t -100.74 10.67 40.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.572 -0.705 . . . . 0.0 111.077 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.426 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -91.92 72.63 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.461 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 51.0 ttm-85 -142.92 -73.96 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -90.37 -26.81 19.74 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.255 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -62.67 -48.06 80.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 110.512 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.426 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 4.8 mt -71.64 -41.82 68.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.513 -0.742 . . . . 0.0 111.457 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 45.9 tp -102.66 -45.4 5.04 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -87.02 -5.02 59.21 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.076 -1.015 . . . . 0.0 112.492 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 62.41 47.22 91.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.02 -177.17 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.923 . . . . 0.0 109.411 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.87 48.62 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 109.12 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.461 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.3 OUTLIER -113.92 148.74 36.28 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.076 0.941 . . . . 0.0 111.453 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 8.2 t -48.68 121.43 9.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.586 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.84 114.36 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.384 1.202 . . . . 0.0 110.676 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -170.69 33.36 0.16 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.441 ' HB2' ' CG2' ' A' ' 487' ' ' ILE . 36.7 t -80.75 143.22 33.08 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 48.1 m -115.25 108.48 16.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 464' ' ' GLN . 41.4 t -113.09 141.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 506' ' ' ILE . 15.9 pt -136.46 103.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 175.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 507' ' ' VAL . 8.6 p -103.49 107.02 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.739 -1.225 . . . . 0.0 112.263 -176.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.18 107.95 17.49 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 6.5 tp-100 -131.0 115.18 16.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . 0.484 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -73.33 -64.73 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.85 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.85 -12.87 1.96 Allowed 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.629 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.74 -34.56 78.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.342 -0.849 . . . . 0.0 109.438 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 22.9 t -90.4 -14.52 32.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.697 -0.627 . . . . 0.0 111.236 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.45 -48.92 71.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.038 -1.039 . . . . 0.0 108.922 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.86 -41.7 74.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.968 -0.457 . . . . 0.0 110.865 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.92 -47.05 81.52 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 78.9 m -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.367 -0.833 . . . . 0.0 110.239 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -39.58 77.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.849 -0.532 . . . . 0.0 110.674 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 11.5 m -61.97 -39.63 92.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.384 -0.823 . . . . 0.0 110.301 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.34 -41.68 96.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.873 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.82 -22.4 65.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.748 -0.595 . . . . 0.0 110.458 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -47.24 -63.69 0.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.07 -51.71 50.85 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.708 -1.245 . . . . 0.0 110.46 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -29.34 65.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.908 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.475 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -59.99 -25.1 64.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.513 -0.742 . . . . 0.0 112.481 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -41.94 -27.74 0.13 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.542 -0.724 . . . . 0.0 111.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -108.22 -126.94 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.73 . . . . 0.0 111.047 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -89.86 96.87 10.88 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.622 -1.299 . . . . 0.0 114.49 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -113.17 131.08 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 O-C-N 120.893 -1.129 . . . . 0.0 111.462 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 432' ' ' SER . 86.8 mt-30 -120.27 126.85 51.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.08 123.51 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 122.581 1.181 . . . . 0.0 113.091 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 9.2 mp -119.57 119.3 33.4 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 534' ' ' ILE . 0.8 OUTLIER -132.78 129.01 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.658 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.544 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 30.2 p -101.58 -166.69 1.33 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 4.3 t0 -159.07 169.12 24.96 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' SER . . . . . 0.484 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -140.73 17.85 2.34 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.719 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.99 2.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 536' ' ' ASP . 83.9 mt-30 -96.75 1.19 50.58 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.507 -0.996 . . . . 0.0 111.947 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -53.45 -40.66 65.41 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.985 -1.072 . . . . 0.0 111.388 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.0 m -104.18 -45.18 4.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.162 -0.961 . . . . 0.0 111.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.85 67.27 0.34 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.0 t -65.39 -42.81 92.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.523 -0.987 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.71 -39.83 97.96 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 57.3 m -60.56 -33.94 73.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.589 -0.948 . . . . 0.0 109.997 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.2 82.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.14 -42.16 98.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.57 -0.706 . . . . 0.0 109.637 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 99.1 mtp -65.44 -31.84 73.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.705 -0.622 . . . . 0.0 109.832 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.44 -54.05 48.66 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.513 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.22 -44.14 95.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.306 -0.871 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.68 -31.57 72.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.359 -0.838 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -67.72 -15.59 63.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.089 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.59 6.73 4.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 112.098 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 151.15 -16.68 0.9 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.209 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.072 -1.252 . . . . 0.0 109.858 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.004 0.43 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.1 -46.62 86.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.518 -0.739 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.6 t -62.74 -44.03 97.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.787 -0.571 . . . . 0.0 110.303 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.16 -34.64 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.177 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.0 -42.07 98.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.526 -0.734 . . . . 0.0 111.658 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.33 59.6 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.002 -1.061 . . . . 0.0 112.388 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 399' ' ' ILE . 1.1 pp -69.62 -33.92 73.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.996 . . . . 0.0 111.057 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 70.3 m -55.55 -43.07 75.48 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.589 -0.694 . . . . 0.0 111.226 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -68.09 -41.19 82.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -0.817 . . . . 0.0 111.518 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -65.51 -40.41 92.97 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.187 -0.946 . . . . 0.0 112.59 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 395' ' ' LEU . 0.0 OUTLIER -66.66 -39.24 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 121.147 -0.971 . . . . 0.0 109.882 -178.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' MET . . . . . 0.417 ' CG ' HD11 ' A' ' 435' ' ' ILE . 8.7 mtp -64.42 -39.73 94.41 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.153 -0.967 . . . . 0.0 109.174 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.74 -29.83 70.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 419' ' ' TYR . 59.8 tp60 -90.47 -11.15 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.473 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.54 -38.91 77.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.806 -0.559 . . . . 0.0 110.291 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -117.8 19.26 13.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.066 . . . . 0.0 109.872 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.15 148.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 CA-C-O 121.176 0.513 . . . . 0.0 110.859 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.6 m -77.06 81.38 3.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.4 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.402 ' CG1' ' CB ' ' A' ' 412' ' ' SER . 48.4 t -105.58 130.26 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.944 0.878 . . . . 0.0 111.702 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -96.79 144.38 27.76 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.66 -23.44 56.54 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.143 1.075 . . . . 0.0 110.767 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.398 -0.814 . . . . 0.0 110.69 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 56.76 0.5 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' SER . . . . . 0.402 ' CB ' ' CG1' ' A' ' 407' ' ' VAL . 11.7 p -69.53 137.43 52.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.443 -0.786 . . . . 0.0 111.334 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.9 p -88.99 146.25 36.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.52 135.48 28.73 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.09 1.047 . . . . 0.0 111.276 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 417' ' ' ALA . 99.8 mtt180 -96.81 -87.84 0.3 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.714 -0.616 . . . . 0.0 109.515 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.0 t -29.8 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 415' ' ' ARG . . . -50.83 -69.99 0.1 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.302 -0.873 . . . . 0.0 111.46 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -77.36 -1.57 76.14 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.708 -1.245 . . . . 0.0 111.29 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 402' ' ' GLN . 76.6 m-85 -108.25 0.32 21.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.791 -1.417 . . . . 0.0 110.28 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.0 p -92.6 -33.72 14.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -73.74 -37.2 65.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.83 82.73 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.43 0.633 . . . . 0.0 110.038 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.442 ' HA ' ' CD2' ' A' ' 426' ' ' LEU . 77.0 t -67.74 -42.66 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.624 -0.672 . . . . 0.0 111.758 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.6 m -59.82 -43.29 94.61 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.975 -1.078 . . . . 0.0 112.352 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.91 -50.58 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.013 -1.055 . . . . 0.0 109.747 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -47.75 -31.57 4.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.641 -0.662 . . . . 0.0 111.688 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.74 -35.46 74.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 109.292 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.32 -31.03 72.07 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.549 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.35 -74.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.545 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER 178.89 -53.91 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.18 -0.95 . . . . 0.0 110.108 178.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.5 Cg_endo -79.84 116.23 3.43 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 1.8 m -105.67 100.39 9.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.355 -0.938 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.4 137.72 20.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -173.45 160.72 3.95 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 120.511 -1.368 . . . . 0.0 112.762 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 400' ' ' MET . 3.3 pt -122.32 117.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.4 ' CG2' ' CG2' ' A' ' 423' ' ' VAL . 70.4 t -122.11 137.77 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 110.749 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.9 t -121.74 129.83 52.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.017 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.75 147.9 18.76 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -146.11 80.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.587 -0.949 . . . . 0.0 109.645 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 121.83 110.48 2.11 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.09 85.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.03 -19.72 25.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.587 -0.949 . . . . 0.0 110.613 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.93 92.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 110.914 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.9 -30.58 70.13 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -62.6 -40.19 96.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.611 -0.935 . . . . 0.0 110.44 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.411 ' O ' HG11 ' A' ' 449' ' ' VAL . 8.4 mpt_? -64.37 -38.1 89.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -71.28 -30.15 65.92 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.3 -0.875 . . . . 0.0 109.996 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -64.81 -44.7 89.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.548 -0.72 . . . . 0.0 111.646 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 450' ' ' ALA . 10.5 p -64.72 -32.44 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -64.42 -31.07 72.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.21 -38.02 75.95 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.051 -1.03 . . . . 0.0 108.445 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.4 -31.09 72.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.14 -32.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 58.2 mtt -66.13 -40.13 90.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 56.4 ttp -58.99 -21.07 58.21 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.241 0.543 . . . . 0.0 110.101 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 463' ' ' VAL . . . -84.54 -22.64 30.05 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.37 -27.4 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -78.26 9.17 4.03 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.312 -0.868 . . . . 0.0 112.274 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.09 26.4 72.41 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.88 145.32 36.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 111.405 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -99.43 163.23 12.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 456' ' ' ALA . 33.7 m -132.21 158.77 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 118.924 -1.11 . . . . 0.0 112.268 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.99 107.13 17.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.429 HD13 ' CG2' ' A' ' 449' ' ' VAL . 0.5 OUTLIER -118.2 124.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.706 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.468 ' HB ' HG22 ' A' ' 507' ' ' VAL . 85.6 mt -122.03 115.37 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.862 -0.524 . . . . 0.0 110.916 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 508' ' ' ASP . . . -66.17 165.63 13.35 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.471 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.01 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -51.41 -19.07 1.21 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.956 -1.09 . . . . 0.0 111.129 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -78.98 -8.19 58.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -0.787 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . 0.403 ' HD2' ' CG2' ' A' ' 466' ' ' ILE . 79.8 ttt-85 -52.36 -24.85 8.35 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.99 -1.069 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -58.12 -42.88 86.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.806 . . . . 0.0 109.358 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -65.09 -38.83 91.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' MET . . . . . 0.416 ' CE ' ' HG2' ' A' ' 478' ' ' GLN . 28.2 ttt -62.0 -32.28 72.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.783 -0.573 . . . . 0.0 110.29 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -61.69 -40.04 93.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 110.083 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 73.4 mtm -62.51 -35.54 79.73 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 62.8 pttt -121.47 -148.06 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . 0.416 ' HG2' ' CE ' ' A' ' 474' ' ' MET . 1.0 OUTLIER 53.6 70.09 0.63 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.161 -0.962 . . . . 0.0 111.192 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -112.98 23.8 13.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.68 3.21 26.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.854 . . . . 0.0 111.06 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.13 -29.8 0.53 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.19 -0.944 . . . . 0.0 111.664 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.41 72.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.803 -1.186 . . . . 0.0 110.791 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.4 m -72.36 -18.42 61.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.464 -0.772 . . . . 0.0 110.121 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.43 46.68 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 485' ' ' GLU . 13.6 pt-20 -149.01 103.74 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.926 . . . . 0.0 110.572 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.531 ' O ' HG13 ' A' ' 487' ' ' ILE . 96.4 mt -98.46 -84.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.602 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 486' ' ' LEU . 3.3 mp -157.35 -65.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.08 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.469 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.6 t -99.9 11.12 40.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.45 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -92.91 77.22 1.17 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 54.5 ttt85 -145.17 -63.72 0.34 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 495' ' ' GLU . 92.7 mtt-85 -97.98 -31.32 12.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.421 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -64.53 -43.95 92.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.45 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 2.2 mt -69.09 -38.53 79.01 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.318 0.58 . . . . 0.0 110.822 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.87 -48.4 3.64 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 491' ' ' ARG . 94.8 mt-10 -90.0 -10.3 45.45 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.666 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 491' ' ' ARG . . . 83.0 -13.16 45.81 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.641 -1.287 . . . . 0.0 111.017 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 70.6 mmm -67.86 -179.67 1.23 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.095 -1.238 . . . . 0.0 111.01 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.96 153.62 28.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.64 -0.663 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.469 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.52 151.03 32.08 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.773 0.797 . . . . 0.0 110.354 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -55.72 150.42 26.86 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.83 -0.544 . . . . 0.0 111.839 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.66 115.74 4.35 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.653 1.344 . . . . 0.0 109.599 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -177.12 39.34 0.09 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.496 ' HA ' HG12 ' A' ' 487' ' ' ILE . 29.0 t -99.96 109.99 22.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.909 -0.76 . . . . 0.0 112.806 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.413 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 55.5 m -95.48 107.06 19.19 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 43.4 t -109.58 126.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.414 -174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 533' ' ' LEU . 38.6 pt -122.59 109.99 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 466' ' ' ILE . 13.9 p -108.03 112.95 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 43.6 t0 -84.04 110.39 18.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.6 tm0? -97.39 175.2 6.33 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.356 1.074 . . . . 0.0 113.757 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -169.69 -44.05 0.03 OUTLIER Glycine 0 N--CA 1.508 3.46 0 N-CA-C 105.91 -2.876 . . . . 0.0 105.91 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -99.54 -162.56 0.96 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -120.27 -1.67 10.22 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 111.222 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 513' ' ' LEU . 4.6 mm? -74.84 -27.4 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.751 . . . . 0.0 109.454 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 52.9 m -87.15 -17.09 33.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.66 -0.65 . . . . 0.0 112.008 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 31.7 tp -81.51 -52.59 7.07 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.847 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -71.43 -43.47 66.68 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.599 -0.688 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -40.0 95.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.027 -1.046 . . . . 0.0 111.143 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 70.6 m -61.26 -48.32 81.97 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.264 -0.975 . . . . 0.0 108.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 519' ' ' LEU . 0.1 OUTLIER -58.15 -32.34 68.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.301 0.572 . . . . 0.0 109.654 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.6 m -61.79 -41.58 97.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.826 -0.546 . . . . 0.0 109.876 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.55 -42.27 74.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 109.682 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 2.0 mt -59.6 -22.25 61.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.625 -0.672 . . . . 0.0 111.225 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.8 -57.4 4.92 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.672 -0.643 . . . . 0.0 112.235 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.59 50.03 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.009 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.36 64.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.882 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -56.48 -23.62 40.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.408 -0.808 . . . . 0.0 111.863 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.73 -36.61 37.28 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.125 -0.984 . . . . 0.0 110.919 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -132.88 -69.79 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.374 -0.829 . . . . 0.0 111.13 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.402 ' C ' ' CG2' ' A' ' 530' ' ' VAL . 31.0 m-80 -83.56 154.92 23.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.31 -0.868 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -179.59 153.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 CA-C-O 121.401 0.62 . . . . 0.0 109.939 177.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.45 ' CG ' ' HB2' ' A' ' 432' ' ' SER . 0.1 OUTLIER -174.75 95.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 41.7 t -104.69 107.16 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.41 ' HB2' ' CG2' ' A' ' 506' ' ' ILE . 7.4 mp -108.31 114.1 27.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . . . . . . . . . 8.2 pt -123.85 136.29 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.571 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 53.4 p -112.99 -169.63 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -157.87 166.14 33.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.032 -1.042 . . . . 0.0 110.85 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 2.9 p -146.83 21.94 1.26 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.81 -0.556 . . . . 0.0 109.912 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.39 -30.71 0.04 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -78.76 -0.13 29.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.086 -1.243 . . . . 0.0 111.142 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -38.88 -29.88 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -102.93 -29.44 11.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.43 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -120.22 59.08 0.55 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.5 t -64.57 -37.26 86.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.625 -0.927 . . . . 0.0 110.717 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -57.16 -43.8 93.35 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 93.9 p -63.56 -29.57 70.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.414 -1.051 . . . . 0.0 109.676 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.39 80.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.732 -0.605 . . . . 0.0 109.882 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.99 -41.14 97.72 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.5 mmm -64.74 -33.63 76.41 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -57.14 -53.57 56.58 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.105 0.479 . . . . 0.0 109.92 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 33.4 ttm -55.11 -47.19 75.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.427 -0.795 . . . . 0.0 110.332 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.606 -0.684 . . . . 0.0 111.401 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -66.38 -17.8 64.98 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 4.48 5.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.354 -0.841 . . . . 0.0 112.384 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 154.66 -17.54 0.57 Allowed Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.533 -1.318 . . . . 0.0 111.524 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.042 -1.269 . . . . 0.0 110.327 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 120.716 0.293 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 38.5 tp -59.4 -29.34 67.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 71.3 m -60.83 -44.99 96.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.571 -0.706 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.15 -34.18 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.704 . . . . 0.0 110.605 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -58.16 -52.5 65.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.421 -0.8 . . . . 0.0 111.576 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.54 78.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.386 -0.821 . . . . 0.0 109.954 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.409 ' CD2' HD13 ' A' ' 399' ' ' ILE . 3.2 tt -62.17 -38.52 89.39 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.588 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.1 m -71.55 -34.18 69.79 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.984 -1.072 . . . . 0.0 112.137 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.71 -45.23 87.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.104 -0.997 . . . . 0.0 112.335 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -70.39 -41.62 72.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.122 -0.986 . . . . 0.0 111.999 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.497 ' HA ' ' CD1' ' A' ' 419' ' ' TYR . 50.0 mt -63.73 -40.72 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.358 -0.839 . . . . 0.0 108.936 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 ttm -58.62 -34.88 71.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.705 -0.622 . . . . 0.0 109.486 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.41 -20.08 62.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.055 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.495 ' HG2' ' CD2' ' A' ' 419' ' ' TYR . 6.2 tp-100 -91.58 -20.26 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.938 -1.101 . . . . 0.0 108.995 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.66 -32.67 73.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -116.36 19.75 14.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.088 -1.008 . . . . 0.0 110.286 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 5.9 p -59.06 117.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.557 -0.714 . . . . 0.0 109.852 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.8 p -52.71 102.92 0.06 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.477 -0.764 . . . . 0.0 110.748 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.59 132.86 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.553 -0.717 . . . . 0.0 110.233 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -93.94 139.77 22.74 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.532 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.75 -25.28 53.77 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.219 1.115 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.15 -29.15 69.39 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.522 0.677 . . . . 0.0 111.133 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 58.65 0.57 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 80.4 p -50.31 111.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.667 0.746 . . . . 0.0 111.941 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.03 150.49 91.81 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.48 147.86 92.95 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.313 1.165 . . . . 0.0 110.567 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.42 ' HD3' ' HB3' ' A' ' 439' ' ' GLN . 82.2 mtp180 -128.49 -15.35 4.55 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.625 -0.672 . . . . 0.0 112.604 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 t -103.88 18.32 22.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 108.391 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -86.21 -76.46 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.703 -0.623 . . . . 0.0 112.208 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -75.73 -4.01 74.85 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.972 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 399' ' ' ILE . 96.8 m-85 -107.8 -13.88 14.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.293 1.546 . . . . 0.0 109.647 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -41.33 74.85 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -68.73 -36.69 78.74 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.01 81.27 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 122.038 0.923 . . . . 0.0 109.807 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 426' ' ' LEU . 79.4 t -69.07 -44.06 81.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -60.69 -38.92 86.57 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.879 -1.138 . . . . 0.0 111.287 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.19 -44.14 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -55.61 -32.61 63.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.651 -0.656 . . . . 0.0 111.74 -178.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.37 77.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.618 -1.301 . . . . 0.0 108.631 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.54 -30.1 71.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.78 -89.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -179.9 -58.58 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.506 -1.372 . . . . 0.0 109.017 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.61 99.78 0.65 Allowed 'Trans proline' 0 N--CA 1.485 1.004 0 N-CA-C 108.661 -1.323 . . . . 0.0 108.661 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.473 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 67.7 m -94.98 110.36 22.27 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.864 0.84 . . . . 0.0 111.872 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 1.3 tp -166.56 90.22 0.4 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -135.49 169.77 16.99 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.93 0.871 . . . . 0.0 112.439 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 435' ' ' ILE . 33.0 pt -127.22 130.21 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.425 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.66 97.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.864 -1.147 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 37.3 m -76.01 129.5 36.96 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.382 -0.824 . . . . 0.0 111.145 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -107.19 170.93 16.13 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . 0.42 ' HB3' ' HD3' ' A' ' 415' ' ' ARG . 67.6 tp60 -170.03 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.522 -0.987 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -64.12 -49.7 65.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -156.32 141.95 8.38 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -111.85 -26.09 9.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.972 . . . . 0.0 110.639 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.57 88.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.394 -0.816 . . . . 0.0 110.617 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.39 -29.36 64.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.51 -39.01 91.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.62 -0.929 . . . . 0.0 109.477 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -61.97 -46.52 88.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 111.391 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.11 -32.85 65.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.047 -1.033 . . . . 0.0 111.199 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 57.9 ttm-85 -61.8 -47.37 85.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 452' ' ' LEU . 3.7 p -57.44 -30.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.747 -1.221 . . . . 0.0 108.565 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.3 -26.42 68.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 80.8 mm-40 -63.87 -33.25 75.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.942 -1.099 . . . . 0.0 108.618 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 452' ' ' LEU . 4.0 mm? -63.17 -33.97 76.62 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 90.1 t -59.75 -30.56 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.617 . . . . 0.0 109.586 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.22 -35.25 79.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -60.72 -28.75 68.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 109.597 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.7 31.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.512 -0.742 . . . . 0.0 109.72 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -63.61 -43.82 95.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.12 -30.61 69.81 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -76.28 5.48 6.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.564 -0.71 . . . . 0.0 111.757 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.4 75.19 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -138.44 120.32 15.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.485 -1.009 . . . . 0.0 110.802 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.06 171.12 14.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 109.246 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 30.0 m -140.14 155.14 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 111.433 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.418 ' HA ' ' CD2' ' A' ' 486' ' ' LEU . 51.7 tt0 -101.52 117.65 35.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 465' ' ' ILE . 2.5 pt -128.38 136.15 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.809 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 466' ' ' ILE . 4.7 mp -125.42 117.38 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.092 -1.005 . . . . 0.0 111.279 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -65.79 161.17 21.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.734 -1.229 . . . . 0.0 109.016 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.74 -158.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 511' ' ' GLU . 28.8 p-10 -44.81 -21.58 0.06 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.818 -1.176 . . . . 0.0 112.411 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.2 -2.79 23.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.321 -0.862 . . . . 0.0 111.577 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.03 -41.33 82.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.94 -1.1 . . . . 0.0 111.735 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.1 m -55.82 -45.36 78.35 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.966 -1.084 . . . . 0.0 110.469 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.29 -37.16 86.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.491 -0.755 . . . . 0.0 108.972 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.2 ttp -60.52 -33.8 73.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.761 -0.587 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.83 -37.7 85.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.78 -40.85 94.12 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.248 -0.908 . . . . 0.0 109.722 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -121.93 -141.94 0.33 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 109.453 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 51.23 88.86 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.706 -1.246 . . . . 0.0 110.936 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -136.74 34.96 2.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.728 . . . . 0.0 109.157 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -128.52 -3.69 5.41 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.879 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -132.36 -13.28 3.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.97 -1.081 . . . . 0.0 112.443 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.59 71.83 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.893 -1.129 . . . . 0.0 111.169 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.7 p -92.41 50.04 1.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.43 36.16 7.11 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -122.27 47.25 1.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.622 -0.928 . . . . 0.0 110.104 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 464' ' ' GLN . 20.7 mt -75.44 -79.87 0.09 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.433 HG22 ' CG2' ' A' ' 488' ' ' THR . 0.1 OUTLIER 179.31 -42.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 110.342 174.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.433 ' CG2' HG22 ' A' ' 487' ' ' ILE . 3.2 p -103.85 8.94 37.05 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.564 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -97.95 60.29 0.99 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.376 -1.889 . . . . 0.0 108.376 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.412 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 67.6 ttt180 -142.42 -70.9 0.33 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -108.87 -21.0 12.86 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.872 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -65.42 -46.79 78.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.633 -0.667 . . . . 0.0 111.898 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.96 -56.72 2.98 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.0 111.075 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.17 -42.21 93.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.471 -0.768 . . . . 0.0 112.808 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -99.99 -3.32 32.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.944 -1.098 . . . . 0.0 113.142 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 65.05 47.82 77.81 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 44.3 mtt -119.75 -174.05 2.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.788 -0.831 . . . . 0.0 109.655 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.23 131.94 55.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.32 -0.863 . . . . 0.0 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.43 ' O ' ' HD3' ' A' ' 501' ' ' PRO . 0.3 OUTLIER -115.19 140.32 49.19 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 2.2 t -44.7 99.96 0.22 Allowed Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 122.212 -0.305 . . . . 0.0 111.597 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 499' ' ' PHE . 41.9 Cg_endo -67.92 113.95 3.19 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 107.996 -1.579 . . . . 0.0 107.996 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 179.52 32.25 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 40.0 t -93.13 176.29 6.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.066 . . . . 0.0 111.591 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.442 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 79.2 m -116.61 124.23 49.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.406 ' CG2' HD12 ' A' ' 522' ' ' LEU . 57.6 t -121.92 136.82 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 112.872 -175.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 2.0 pp -130.07 110.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.455 HG13 ' CG2' ' A' ' 534' ' ' ILE . 12.4 p -99.16 108.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.147 -1.596 . . . . 0.0 110.344 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 73.0 m-20 -82.78 108.25 16.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -97.8 174.66 6.49 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 122.743 1.259 . . . . 0.0 113.194 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.56 -64.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.822 0 N-CA-C 103.943 -3.663 . . . . 0.0 103.943 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 469' ' ' ASP . 32.3 tt0 -70.98 -142.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.02 -19.04 1.16 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.727 -1.233 . . . . 0.0 111.442 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.24 -21.92 62.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 77.3 p -72.05 -41.09 67.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.503 -0.748 . . . . 0.0 110.953 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 10.8 tp -65.39 -52.47 53.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.0 111.283 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . 0.412 ' HG3' ' CB ' ' A' ' 553' ' ' ALA . 25.9 ttmt -67.36 -46.88 72.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.501 -0.75 . . . . 0.0 111.571 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.39 -49.01 79.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.272 -0.892 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 81.7 m -58.54 -42.67 88.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.475 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -40.41 93.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.326 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 37.8 p -64.88 -39.94 94.33 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.056 -1.027 . . . . 0.0 111.195 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -41.77 87.21 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.202 1.001 . . . . 0.0 108.588 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.406 HD12 ' CG2' ' A' ' 505' ' ' VAL . 0.8 OUTLIER -65.36 -22.01 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.721 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -47.29 -62.82 1.25 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.318 -0.864 . . . . 0.0 112.992 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.79 61.71 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.313 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.43 71.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.657 -0.908 . . . . 0.0 111.805 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.455 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -72.19 -22.57 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 112.382 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -40.57 -27.47 0.05 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.428 -0.795 . . . . 0.0 112.385 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' A' ' 501' ' ' PRO . 49.7 t60 -114.23 -117.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 111.5 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.5 90.01 8.1 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.513 -1.367 . . . . 0.0 114.551 -177.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.455 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 7.6 p -127.79 149.52 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 109.967 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 86.5 mt-30 -126.04 132.31 52.0 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.994 -0.441 . . . . 0.0 110.07 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 87.3 t -109.33 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.49 1.138 . . . . 0.0 111.576 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.3 OUTLIER -117.14 119.77 36.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.455 ' CG2' HG13 ' A' ' 507' ' ' VAL . 4.5 pt -129.1 140.43 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.464 -1.294 . . . . 0.0 111.902 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.5 p -110.23 -174.23 2.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -154.98 161.51 41.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.027 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 68.2 p -140.36 18.11 2.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.012 -0.43 . . . . 0.0 109.907 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.07 0.23 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -98.62 0.91 45.74 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.393 -1.063 . . . . 0.0 110.764 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -40.21 54.96 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.117 -0.99 . . . . 0.0 112.271 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 8.6 p -96.39 -63.76 1.11 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.256 -0.903 . . . . 0.0 110.764 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -89.12 95.2 2.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 15.4 t -98.51 -41.39 7.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.687 -0.89 . . . . 0.0 110.191 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.46 93.86 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 46.5 t -63.91 -38.65 91.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.621 -0.929 . . . . 0.0 111.07 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.08 87.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.515 -0.74 . . . . 0.0 110.663 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.46 -40.66 97.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.487 -0.758 . . . . 0.0 109.867 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.01 -32.25 73.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.675 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.49 -53.03 61.45 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.925 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 36.6 ttm -58.06 -48.35 80.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.381 -0.824 . . . . 0.0 110.768 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.82 -31.53 68.55 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.329 -0.857 . . . . 0.0 111.286 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.84 -21.71 66.01 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.3 -0.875 . . . . 0.0 110.382 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.412 ' CB ' ' HG3' ' A' ' 516' ' ' LYS . . . -72.26 0.28 10.31 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.263 -0.898 . . . . 0.0 112.532 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 125.48 -14.97 7.23 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.83 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.239 . . . . 0.0 109.832 -179.889 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.765 0.793 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 67.6 tp -63.41 -40.67 97.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.622 -0.674 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.6 m -60.87 -44.79 96.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.557 -0.714 . . . . 0.0 110.625 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.75 -35.03 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.654 -0.653 . . . . 0.0 111.043 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -60.4 -49.13 78.8 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.992 -1.067 . . . . 0.0 111.272 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.19 80.15 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.134 -0.979 . . . . 0.0 109.613 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 434' ' ' ALA . 0.7 OUTLIER -59.39 -40.27 86.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.444 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 400' ' ' MET . 47.3 t -63.34 -42.5 98.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -59.22 -45.8 90.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.257 -0.902 . . . . 0.0 111.917 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -65.88 -41.34 91.7 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.152 -0.968 . . . . 0.0 111.089 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 435' ' ' ILE . 92.9 mt -62.31 -41.02 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 396' ' ' SER . 32.4 mmm -63.42 -34.97 78.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.487 -0.758 . . . . 0.0 110.845 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.19 -28.28 67.83 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.828 -1.17 . . . . 0.0 110.221 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -90.79 -20.03 22.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.805 -1.185 . . . . 0.0 108.498 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . 0.405 ' OD1' ' CB ' ' A' ' 437' ' ' SER . 39.6 t30 -64.46 -31.57 72.83 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -114.42 18.81 16.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 9.9 p -40.9 149.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 121.535 0.683 . . . . 0.0 112.149 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 23.3 p -87.43 72.86 9.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.61 131.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.363 -0.836 . . . . 0.0 112.219 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -96.89 144.1 27.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.635 . . . . 0.0 109.747 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.31 -20.82 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.405 1.213 . . . . 0.0 110.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -57.31 -40.87 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.85 0.833 . . . . 0.0 110.031 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 67.98 0.96 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 27.0 t -54.5 119.8 5.75 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 122.066 0.936 . . . . 0.0 112.048 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.428 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 7.3 p -71.06 147.65 93.84 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 35.3 Cg_endo -59.42 135.15 63.1 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.058 1.031 . . . . 0.0 110.765 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . 0.459 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 90.8 mtm-85 -103.51 -6.29 21.92 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.272 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 6.0 p -99.49 18.9 16.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.674 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.26 -35.01 6.93 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.67 94.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 415' ' ' ARG . 4.0 m-85 -93.86 -9.9 35.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.762 -1.434 . . . . 0.0 110.399 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -43.98 61.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.867 -1.145 . . . . 0.0 109.004 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.78 -45.72 57.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.727 -0.608 . . . . 0.0 110.307 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.48 -49.04 78.39 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.75 -0.594 . . . . 0.0 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 90.3 t -69.57 -43.43 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 0.0 112.575 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 79.5 p -62.26 -39.54 93.22 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.925 -1.109 . . . . 0.0 111.421 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 426' ' ' LEU . 12.1 p -67.69 -28.13 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.321 -0.862 . . . . 0.0 111.821 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.433 ' N ' HG11 ' A' ' 425' ' ' VAL . 0.4 OUTLIER -75.02 -31.22 61.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 111.151 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.14 74.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.963 . . . . 0.0 109.203 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.21 -29.88 70.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.97 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.556 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.36 -52.3 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.713 -1.242 . . . . 0.0 111.671 177.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.5 Cg_endo -77.7 112.7 3.36 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 O-C-N 122.568 0.773 . . . . 0.0 110.775 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 0.3 OUTLIER -87.12 99.66 12.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.631 -0.668 . . . . 0.0 109.245 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.5 tp -162.67 92.56 0.79 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.171 -0.956 . . . . 0.0 111.063 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 395' ' ' LEU . . . -139.83 170.56 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.542 0.687 . . . . 0.0 111.832 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.493 HD11 HG23 ' A' ' 435' ' ' ILE . 45.3 pt -121.84 141.52 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 109.414 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.427 HG12 ' CG ' ' A' ' 419' ' ' TYR . 57.3 t -141.92 148.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -0.805 . . . . 0.0 109.806 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' OD1' ' A' ' 403' ' ' ASN . 44.5 t -127.38 133.64 50.01 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.439 -0.788 . . . . 0.0 110.272 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -115.17 129.51 8.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -130.61 34.19 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.616 -0.932 . . . . 0.0 109.818 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -148.73 -137.45 2.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -67.29 120.87 14.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.68 -9.13 23.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.883 . . . . 0.0 111.734 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.72 90.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.49 -28.2 73.34 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.33 -38.36 87.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.755 -0.85 . . . . 0.0 110.199 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.416 ' CD ' ' CB ' ' A' ' 467' ' ' ALA . 0.1 OUTLIER -59.86 -50.15 74.9 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.438 -0.789 . . . . 0.0 110.281 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.36 -29.28 67.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -61.04 -54.97 38.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.772 -0.58 . . . . 0.0 112.01 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.68 -35.65 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.909 -1.119 . . . . 0.0 109.394 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.53 -26.89 68.91 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.444 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.41 -34.78 79.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.037 -1.04 . . . . 0.0 108.828 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.97 -35.57 81.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 88.6 t -58.42 -27.31 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.846 -0.534 . . . . 0.0 109.714 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.4 mtt -71.09 -34.92 71.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.29 -32.78 72.63 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.55 0.691 . . . . 0.0 109.604 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.63 -22.69 32.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.772 -0.58 . . . . 0.0 110.231 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -65.65 -42.74 91.06 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.259 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.59 -29.44 63.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.326 -0.859 . . . . 0.0 110.512 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.71 8.22 4.74 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 111.07 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.94 75.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.65 124.31 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -1.007 . . . . 0.0 110.527 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.96 166.53 18.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.186 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.411 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 33.4 m -141.11 156.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -102.6 120.05 39.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.09 128.51 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.192 -0.943 . . . . 0.0 111.104 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.5 121.2 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.416 ' CB ' ' CD ' ' A' ' 446' ' ' ARG . . . -81.25 165.04 21.82 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.277 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.66 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.423 0.63 . . . . 0.0 109.612 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -51.22 -12.63 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.736 -1.228 . . . . 0.0 112.639 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -81.99 -2.94 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.773 -1.204 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.945 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 35.4 t -63.38 -44.24 95.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -62.85 -41.61 99.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.659 -0.65 . . . . 0.0 110.139 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.0 mmt -67.76 -29.08 68.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.625 . . . . 0.0 110.706 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -59.99 -42.13 93.57 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.655 -1.278 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 mtm -67.19 -39.22 86.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 109.629 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -131.6 128.86 40.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.802 . . . . 0.0 110.632 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 55.32 92.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.189 -0.944 . . . . 0.0 112.255 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . 0.429 ' O ' ' HG ' ' A' ' 482' ' ' LEU . 75.7 m-20 -81.84 26.27 0.51 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.4 ' CB ' HD21 ' A' ' 482' ' ' LEU . 4.7 mp0 50.83 42.48 27.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.561 -1.337 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 57.09 21.92 6.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 479' ' ' ASP . 0.3 OUTLIER -124.42 20.03 8.81 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.54 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.0 p -47.21 -22.25 0.36 Allowed 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 168.98 78.92 0.04 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -175.01 41.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.711 -0.876 . . . . 0.0 109.677 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 487' ' ' ILE . 78.2 mt -75.3 -82.76 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.463 ' CD1' ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -162.15 -70.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.658 -1.276 . . . . 0.0 109.751 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 3.1 t -100.08 8.75 43.71 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.153 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.476 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -82.92 61.27 4.8 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.556 -2.217 . . . . 0.0 107.556 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -143.77 -68.51 0.33 Allowed 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.609 -0.936 . . . . 0.0 109.252 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -100.73 -31.06 11.38 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.487 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -62.02 -43.99 97.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.509 -0.744 . . . . 0.0 110.826 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.476 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 6.0 mt -72.42 -39.05 68.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.553 -0.717 . . . . 0.0 111.8 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 43.1 tp -106.11 -42.26 5.14 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -89.72 -4.06 57.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.892 -1.13 . . . . 0.0 113.254 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 66.13 47.16 75.04 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.3 mmm -120.01 177.29 5.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.944 -0.739 . . . . 0.0 111.128 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.38 134.51 54.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -114.75 149.32 37.07 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.871 0.843 . . . . 0.0 111.486 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -50.82 105.69 0.55 Allowed Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.48 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.402 ' HB2' ' CB ' ' A' ' 528' ' ' HIS . 53.3 Cg_endo -78.47 112.75 3.23 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.283 1.149 . . . . 0.0 109.21 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.23 0.19 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.463 ' CB ' ' CD1' ' A' ' 487' ' ' ILE . 92.0 p -95.8 175.47 6.5 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.451 1.119 . . . . 0.0 113.713 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.2 m -125.92 106.99 10.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 175.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.36 136.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.375 -0.828 . . . . 0.0 111.524 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 3.9 pt -141.0 110.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 507' ' ' VAL . 7.1 p -112.21 114.65 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.388 -1.445 . . . . 0.0 113.152 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -84.58 131.39 34.62 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.6 tp-100 -156.95 114.89 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.721 -1.592 . . . . 0.0 115.011 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . 0.429 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -76.93 -66.54 1.8 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 31.1 tt0 -58.65 172.12 0.55 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.26 -13.75 11.71 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.196 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.66 -36.78 83.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.236 -0.915 . . . . 0.0 109.632 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 4.7 m -83.09 -13.8 54.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.776 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 509' ' ' GLN . 33.0 tp -69.15 -44.62 71.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 108.812 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.9 -36.01 77.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.851 -0.531 . . . . 0.0 111.401 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -57.28 -50.27 73.43 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.807 -1.183 . . . . 0.0 110.465 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 522' ' ' LEU . 68.3 m -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.599 -0.688 . . . . 0.0 110.502 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -39.5 76.15 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.73 -0.606 . . . . 0.0 111.106 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.7 m -61.86 -39.65 92.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.389 -0.819 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.61 84.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.575 -0.703 . . . . 0.0 109.561 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 518' ' ' THR . 0.4 OUTLIER -61.11 -22.8 64.99 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.464 -0.772 . . . . 0.0 111.808 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -46.0 -60.84 2.03 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.233 -0.917 . . . . 0.0 112.174 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -74.02 -50.79 9.92 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.508 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.75 83.67 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.326 -1.103 . . . . 0.0 113.432 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.458 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -65.67 -23.82 66.87 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -44.67 -25.87 0.32 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.381 -0.825 . . . . 0.0 111.514 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.402 ' CB ' ' HB2' ' A' ' 501' ' ' PRO . 1.8 t-80 -98.06 -140.06 0.3 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.226 -0.921 . . . . 0.0 111.224 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.08 85.8 0.73 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.822 -1.174 . . . . 0.0 111.815 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.458 ' CB ' ' HA ' ' A' ' 526' ' ' ALA . 71.6 t -146.2 168.13 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.097 -1.002 . . . . 0.0 111.494 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 432' ' ' SER . 8.5 tp60 -162.31 164.53 27.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 3.6 t -115.45 115.39 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.435 -0.791 . . . . 0.0 112.163 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.9 tp -110.78 120.53 42.69 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.406 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 2.4 pt -139.95 146.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.079 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 65.1 p -105.48 -169.5 1.6 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -158.75 167.95 28.14 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.321 -0.862 . . . . 0.0 109.923 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' SER . . . . . 0.429 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.8 OUTLIER -133.03 -6.64 3.07 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.677 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -129.09 28.42 4.1 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . 0.424 ' CG ' ' HA ' ' A' ' 543' ' ' THR . 44.5 tt0 -98.67 -1.49 40.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.757 -0.849 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -56.32 -43.95 79.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.206 -0.934 . . . . 0.0 112.173 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 26.2 m -102.6 -56.89 2.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.913 -1.117 . . . . 0.0 110.94 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -88.51 59.0 4.1 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 539' ' ' GLN . 11.7 t -65.58 -44.38 86.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.983 . . . . 0.0 111.572 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.27 -40.26 98.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.5 m -62.9 -37.36 86.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.947 . . . . 0.0 111.53 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.6 72.07 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.088 -1.008 . . . . 0.0 109.73 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.85 -41.26 97.85 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.907 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.37 -30.12 70.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.188 -0.945 . . . . 0.0 109.017 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.92 41.33 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.298 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 57.8 ttm -55.65 -46.82 77.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . 0.419 ' HA ' ' CG1' ' A' ' 555' ' ' VAL . 86.4 mttt -61.17 -31.78 71.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.576 -0.703 . . . . 0.0 112.183 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.71 -16.58 62.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.353 -0.842 . . . . 0.0 111.226 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 5.49 4.24 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.171 -0.956 . . . . 0.0 113.059 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 118.35 -16.58 11.62 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 120.805 -1.184 . . . . 0.0 111.037 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 551' ' ' LYS . 10.3 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.199 -1.177 . . . . 0.0 110.764 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 . . . . . 0 N--CA 1.503 2.175 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.74 -36.64 81.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.261 -0.899 . . . . 0.0 110.617 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.1 t -62.79 -43.15 99.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.435 -0.791 . . . . 0.0 109.487 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 81.0 t -66.31 -36.08 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.982 -0.449 . . . . 0.0 110.76 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -60.75 -50.51 73.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.19 -0.944 . . . . 0.0 110.232 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.37 -33.02 72.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 7.6 tt -59.7 -39.7 85.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.81 -0.556 . . . . 0.0 110.621 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.1 p -68.6 -32.49 72.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.409 -0.807 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -64.34 -43.06 95.79 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.557 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -69.03 -40.31 78.7 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.0 112.719 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.07 -43.37 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 27.2 mtp -61.86 -22.66 65.71 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.26 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -63.26 -30.54 71.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.104 -0.997 . . . . 0.0 108.984 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -90.04 -14.21 34.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.192 -0.942 . . . . 0.0 109.457 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -66.39 -39.3 88.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.77 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -116.92 18.45 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.752 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 6.3 p -59.43 114.93 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.385 -0.822 . . . . 0.0 109.793 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.0 p -52.12 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.171 -0.956 . . . . 0.0 110.95 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.661 -0.65 . . . . 0.0 110.179 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.24 137.35 24.89 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 0.0 110.204 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.44 -29.3 45.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.165 1.087 . . . . 0.0 111.279 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.55 -25.59 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.119 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 60.54 0.5 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 m -58.91 115.79 3.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.495 0.664 . . . . 0.0 111.52 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.44 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 6.9 p -64.15 150.09 92.91 Favored Pre-proline 0 N--CA 1.501 2.095 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.6 Cg_endo -59.91 139.14 86.62 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 122.789 0.889 . . . . 0.0 110.228 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -116.38 -1.39 12.3 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.465 ' HA ' ' CE2' ' A' ' 419' ' ' TYR . 34.9 p -97.34 22.09 9.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.766 -1.209 . . . . 0.0 109.489 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -108.68 -31.58 7.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.37 -44.16 98.04 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 416' ' ' THR . 27.0 p90 -103.04 -10.81 18.61 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.418 . . . . 0.0 111.875 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.0 t -67.22 -43.03 83.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 108.083 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -79.36 -44.32 21.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.933 -0.479 . . . . 0.0 111.304 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -65.38 -46.33 80.54 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.629 -0.67 . . . . 0.0 112.417 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 88.8 t -70.37 -43.31 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.444 -0.785 . . . . 0.0 111.99 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -43.17 99.48 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.918 -1.114 . . . . 0.0 111.813 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.47 -29.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.204 -0.935 . . . . 0.0 111.495 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -71.57 -33.99 69.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 111.737 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.57 -33.26 70.91 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.59 -30.76 71.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -64.21 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.443 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.2 OUTLIER -177.32 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 110.399 177.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -72.48 101.5 1.27 Allowed 'Trans proline' 0 N--CA 1.485 0.99 0 N-CA-C 109.455 -1.017 . . . . 0.0 109.455 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 26.4 t -87.72 101.2 13.45 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.559 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.98 89.33 0.79 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 426' ' ' LEU . . . -131.68 164.84 25.05 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.882 0.848 . . . . 0.0 112.481 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.77 128.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 58.4 t -122.3 138.33 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.2 m -119.58 126.46 51.25 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 111.494 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -129.45 160.39 22.64 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -120.71 -30.63 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.896 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.1 173.45 31.27 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.17 29.73 70.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.89 -20.5 65.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 111.188 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.27 89.16 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.134 -0.979 . . . . 0.0 110.904 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.73 -37.12 57.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -62.17 -35.8 79.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.784 -0.833 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.416 ' O ' HG11 ' A' ' 449' ' ' VAL . 0.0 OUTLIER -61.52 -44.45 97.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.675 0.75 . . . . 0.0 109.724 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -68.84 -31.56 70.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.973 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -64.63 -45.04 88.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 111.713 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 450' ' ' ALA . 10.0 p -58.15 -31.21 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.613 -1.305 . . . . 0.0 108.9 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.97 -27.05 68.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -64.51 -36.02 82.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.873 -1.142 . . . . 0.0 108.503 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.38 -34.33 78.07 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 98.1 t -60.53 -30.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.3 mmm -68.33 -37.01 80.14 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.547 -0.72 . . . . 0.0 109.417 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -58.31 -28.82 65.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.767 -0.583 . . . . 0.0 109.976 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -85.03 -22.98 28.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -66.95 -44.6 80.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 110.413 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -74.42 -29.33 61.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.327 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.49 14.75 5.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.592 -0.692 . . . . 0.0 112.193 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.98 26.67 71.48 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.477 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -124.05 126.16 45.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.216 -1.167 . . . . 0.0 110.337 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -92.56 158.56 15.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.456 -0.777 . . . . 0.0 110.28 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.03 163.33 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.768 0.794 . . . . 0.0 111.516 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -113.75 121.56 44.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.03 123.47 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.26 1.028 . . . . 0.0 111.829 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 467' ' ' ALA . 4.5 mp -101.11 169.06 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 471' ' ' ARG . . . -130.83 156.47 44.96 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.84 -159.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.448 -0.783 . . . . 0.0 110.019 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -48.66 -15.25 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.991 -1.068 . . . . 0.0 111.823 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -87.54 5.47 39.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.003 -1.061 . . . . 0.0 111.007 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 467' ' ' ALA . 13.8 tpt180 -58.95 -36.94 75.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.298 -0.876 . . . . 0.0 111.447 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 21.9 t -59.7 -45.42 92.19 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.405 -0.809 . . . . 0.0 110.2 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.09 -41.0 95.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.361 -0.837 . . . . 0.0 110.396 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 18.5 ttm -62.84 -35.17 79.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 0.0 111.19 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -60.13 -39.26 85.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.346 -0.846 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.3 -40.23 93.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 63.1 pttt -109.18 -148.81 0.43 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.556 -0.715 . . . . 0.0 109.865 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 477' ' ' LYS . 23.7 tt0 50.46 80.6 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.195 -0.941 . . . . 0.0 110.957 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -123.73 34.75 5.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -125.9 4.81 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.494 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.22 -34.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 112.503 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.47 71.73 1.29 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.987 -1.071 . . . . 0.0 112.108 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 35.0 t -92.28 48.81 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.7 33.1 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -119.64 54.91 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.53 -0.982 . . . . 0.0 110.392 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.59 -84.22 0.45 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.488 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.97 -88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.257 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . 0.251 26.4 p -102.7 22.48 13.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 111.511 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -62.41 89.25 0.05 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -111.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -106.32 -21.97 12.95 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.616 -1.302 . . . . 0.0 109.416 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -47.96 -23.5 0.8 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.876 . . . . 0.0 111.629 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.51 -60.37 3.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 112.068 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 5.96 28.01 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.299 -1.501 . . . . 0.0 111.885 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -83.41 -6.07 59.35 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.035 -1.041 . . . . 0.0 112.702 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.84 -7.6 80.64 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.085 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.64 -176.23 0.61 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.176 -1.19 . . . . 0.0 109.493 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.56 167.52 10.53 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.01 150.91 29.94 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.4 t -82.5 138.99 44.29 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 139.05 52.85 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.283 1.149 . . . . 0.0 110.357 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.9 -9.09 0.98 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 10.9 t -77.41 139.03 39.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -1.154 . . . . 0.0 113.164 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 531' ' ' GLN . 80.6 m -111.13 124.28 51.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 50.4 t -116.34 125.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.61 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 533' ' ' LEU . 22.6 pt -121.57 120.27 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 534' ' ' ILE . 9.6 p -120.21 108.86 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.145 -0.972 . . . . 0.0 111.622 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -85.11 121.63 28.15 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.888 -1.132 . . . . 0.0 108.343 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.0 tp-100 -148.59 105.25 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . 0.488 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -69.42 -38.79 80.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 4.9 tt0 -79.43 -155.44 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 -7.01 0.56 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.625 -0.672 . . . . 0.0 110.974 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.28 -34.42 74.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.357 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' SER . . . . . 0.414 ' HB2' ' NE2' ' A' ' 509' ' ' GLN . 1.6 m -87.71 -22.19 24.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.333 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.4 tp -68.74 -46.33 69.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.15 -0.969 . . . . 0.0 109.606 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 553' ' ' ALA . 32.8 ttpt -69.09 -44.18 73.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.664 -0.648 . . . . 0.0 112.296 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -39.99 94.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.498 -1.376 . . . . 0.0 110.452 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 77.5 m -60.42 -44.2 95.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.113 -0.992 . . . . 0.0 109.347 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.404 ' CD1' ' HG3' ' A' ' 550' ' ' MET . 0.1 OUTLIER -55.85 -35.54 66.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.944 -0.473 . . . . 0.0 109.998 -179.226 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.5 m -59.05 -39.15 81.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.1 -40.86 78.1 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.492 0.663 . . . . 0.0 109.971 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.77 -22.79 67.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.456 -0.777 . . . . 0.0 111.146 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -47.93 -57.42 5.73 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.446 -0.784 . . . . 0.0 111.774 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.32 -50.84 61.08 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.18 -29.88 34.21 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.482 -1.011 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -57.96 -23.51 54.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.776 -0.577 . . . . 0.0 111.255 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -41.39 -43.89 2.67 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.598 -0.689 . . . . 0.0 112.319 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 -62.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.416 ' C ' ' CG2' ' A' ' 530' ' ' VAL . 4.3 t30 -80.77 156.09 26.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.392 -0.817 . . . . 0.0 110.468 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.416 ' CG2' ' C ' ' A' ' 529' ' ' ASN . 0.1 OUTLIER -174.34 151.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.988 0.899 . . . . 0.0 110.791 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.4 ' CB ' HG22 ' A' ' 504' ' ' THR . 0.0 OUTLIER -177.39 91.71 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 54.2 t -99.36 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.011 0.91 . . . . 0.0 111.3 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.77 113.41 26.63 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 176.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.502 ' CG2' HG13 ' A' ' 507' ' ' VAL . 0.6 OUTLIER -131.28 144.77 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.837 -177.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.539 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 69.9 p -105.6 -177.11 3.27 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -160.03 168.11 26.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.013 -1.055 . . . . 0.0 110.83 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' SER . . . . . 0.488 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -142.94 -4.89 0.91 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.328 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -103.98 5.64 46.58 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 543' ' ' THR . 97.0 mt-30 -82.42 -1.43 50.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -1.192 . . . . 0.0 111.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.59 -43.21 75.79 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 0.0 110.494 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 24.6 m -106.98 -45.02 4.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.56 70.41 0.3 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 539' ' ' GLN . 11.9 t -64.76 -43.97 91.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.58 -0.953 . . . . 0.0 111.402 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -64.16 -29.64 75.52 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.099 -1.001 . . . . 0.0 110.637 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t -65.16 -36.07 83.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.301 -1.117 . . . . 0.0 110.797 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.39 90.9 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.796 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 10.8 mp -62.63 -42.22 99.47 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.838 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.5 ttp -63.14 -35.76 81.36 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.275 -0.891 . . . . 0.0 108.705 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.98 -50.44 61.28 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' MET . . . . . 0.404 ' HG3' ' CD1' ' A' ' 519' ' ' LEU . 58.0 ttm -55.33 -49.15 72.93 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.795 -0.566 . . . . 0.0 110.395 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.58 -31.75 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.683 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.87 -17.09 64.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.843 . . . . 0.0 109.92 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 516' ' ' LYS . . . -68.88 1.05 3.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.343 -0.848 . . . . 0.0 113.122 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 137.04 -11.2 3.89 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.224 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.257 -1.143 . . . . 0.0 110.25 -179.643 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.34 -40.16 96.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.71 -0.619 . . . . 0.0 111.135 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.4 m -61.25 -46.42 90.45 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.699 -0.626 . . . . 0.0 111.561 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 67.7 t -66.29 -33.06 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 110.147 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -60.39 -48.75 80.4 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.937 -1.102 . . . . 0.0 109.848 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.824 . . . . 0.0 108.841 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.54 -41.11 93.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.513 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -36.38 82.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.25 -0.906 . . . . 0.0 110.453 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -66.07 -45.25 81.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.382 -0.823 . . . . 0.0 112.194 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.87 -43.5 75.24 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.109 -0.994 . . . . 0.0 111.879 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.69 -41.38 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.442 -0.786 . . . . 0.0 110.528 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 mtt -59.62 -33.22 71.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.736 -0.603 . . . . 0.0 110.445 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.31 -36.8 78.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.748 -0.595 . . . . 0.0 110.495 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 63.3 tp60 -92.75 -13.9 28.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.638 -1.289 . . . . 0.0 110.02 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.28 -32.31 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -115.3 18.6 16.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.371 -0.831 . . . . 0.0 109.72 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.8 p -41.87 149.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.257 0.551 . . . . 0.0 112.095 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 47.5 p -82.65 72.97 9.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.49 131.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.393 -0.817 . . . . 0.0 111.313 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -94.91 145.0 28.77 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.08 -23.41 60.82 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.093 1.049 . . . . 0.0 110.272 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -55.87 -24.43 37.0 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.617 0.722 . . . . 0.0 110.861 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.99 63.1 0.46 Allowed 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 59.5 p -50.25 107.12 0.14 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.25 -0.906 . . . . 0.0 111.177 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.65 153.62 77.51 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.58 122.17 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.254 -1.095 . . . . 0.0 109.254 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -96.62 -5.96 37.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 420' ' ' SER . 13.4 p -93.3 22.79 4.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.767 -1.208 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -105.0 -37.3 7.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.767 . . . . 0.0 109.044 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.48 -49.0 77.82 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.45 ' CD1' HG13 ' A' ' 436' ' ' VAL . 43.1 p90 -100.89 -8.89 22.11 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.503 1.652 . . . . 0.0 112.982 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 416' ' ' THR . 80.9 p -69.71 -36.59 76.05 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.574 -1.65 . . . . 0.0 107.05 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -78.64 -48.14 15.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.959 -0.463 . . . . 0.0 111.173 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.57 -48.7 78.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.429 -0.795 . . . . 0.0 111.251 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 426' ' ' LEU . 77.1 t -65.28 -46.05 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.611 . . . . 0.0 111.803 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.6 t -61.19 -45.9 92.71 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.976 -1.077 . . . . 0.0 112.64 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.53 -46.95 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.116 -0.99 . . . . 0.0 110.715 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -53.33 -33.97 55.62 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 111.821 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.54 75.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.872 -1.142 . . . . 0.0 109.045 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -60.83 -29.15 69.32 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -66.84 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.6 -55.76 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.589 -1.319 . . . . 0.0 109.839 178.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.0 Cg_endo -71.99 106.21 1.97 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 N-CA-C 106.744 -2.06 . . . . 0.0 106.744 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.494 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 0.2 OUTLIER -90.52 99.92 12.86 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.107 -177.298 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 2.9 mt -141.99 140.39 32.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -169.5 150.89 4.26 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.559 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 20.7 pt -119.43 120.97 65.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 419' ' ' TYR . 82.1 t -125.36 139.98 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.1 t -117.05 122.43 44.14 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 155.35 20.57 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -136.12 -36.21 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.574 -0.957 . . . . 0.0 111.439 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.13 155.51 26.18 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.15 62.23 4.85 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -86.54 -21.35 26.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.997 . . . . 0.0 110.537 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.83 84.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.393 -0.817 . . . . 0.0 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 -36.4 77.22 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.73 -35.77 75.23 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 109.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.447 ' HD3' ' CB ' ' A' ' 467' ' ' ALA . 16.0 tpt85 -62.97 -49.79 73.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.63 -0.669 . . . . 0.0 112.243 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -74.5 -31.13 62.07 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.963 -1.086 . . . . 0.0 111.108 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.73 -48.4 81.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.372 -0.83 . . . . 0.0 110.275 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.46 -31.34 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.737 -1.227 . . . . 0.0 108.655 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.14 -29.53 70.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.4 -32.38 73.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.112 -0.993 . . . . 0.0 108.358 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.35 -35.09 76.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.429 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 52.0 t -61.1 -26.5 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.6 tpp -66.66 -40.16 88.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.358 -0.839 . . . . 0.0 108.748 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -56.49 -27.09 56.21 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.95 -23.4 31.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.78 -34.24 71.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -82.22 10.21 7.28 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.608 -0.683 . . . . 0.0 112.077 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.44 29.83 71.49 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 19.8 tpp85 -126.02 126.98 45.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.95 . . . . 0.0 110.546 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 48.7 tp10 -95.94 160.22 14.57 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.429 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 19.1 m -142.27 161.36 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.777 -1.202 . . . . 0.0 112.493 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 58.7 tt0 -107.54 122.82 47.44 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -128.09 128.55 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.505 -0.747 . . . . 0.0 110.782 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 78.6 mt -126.89 122.16 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.607 -0.683 . . . . 0.0 110.016 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . 0.447 ' CB ' ' HD3' ' A' ' 446' ' ' ARG . . . -86.69 169.02 13.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.045 -1.035 . . . . 0.0 108.776 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 467' ' ' ALA . . . -57.28 -160.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.64 -15.95 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.661 -1.274 . . . . 0.0 113.412 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -76.35 -9.44 58.64 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.591 -1.318 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -57.35 -32.85 67.16 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.055 . . . . 0.0 111.093 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 26.2 t -62.16 -44.46 96.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.415 -0.803 . . . . 0.0 110.047 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.16 -41.53 94.58 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.428 -0.795 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.48 76.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.547 -0.721 . . . . 0.0 110.578 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.61 -39.13 87.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.181 -0.95 . . . . 0.0 109.376 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -39.72 95.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -100.07 -146.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.68 80.06 0.1 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.807 -1.183 . . . . 0.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.45 14.06 15.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.965 -0.459 . . . . 0.0 110.291 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -92.5 -2.32 56.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 111.686 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.66 33.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.058 -1.026 . . . . 0.0 110.823 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 1.4 tp -151.61 7.14 0.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.185 -1.006 . . . . 0.0 113.596 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.8 t -55.0 -25.22 28.44 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.474 -1.391 . . . . 0.0 110.445 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 160.46 41.65 0.02 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -130.86 30.65 4.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.663 -0.904 . . . . 0.0 109.314 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 464' ' ' GLN . 1.9 tp -60.33 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 487' ' ' ILE . 29.5 mm -153.23 -82.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 108.656 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.452 ' HA ' ' CD2' ' A' ' 499' ' ' PHE . 24.4 p -100.34 11.36 39.59 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.347 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -77.42 63.91 3.28 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -135.48 -70.96 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . 0.406 ' HD3' ' CE ' ' A' ' 497' ' ' MET . 87.2 mtt-85 -118.52 -8.23 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.848 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 499' ' ' PHE . 4.3 mp0 -73.45 -38.05 65.62 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . 0.416 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 2.8 mt -93.85 -21.44 19.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 25.8 tp -103.64 -31.3 9.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 491' ' ' ARG . 0.5 OUTLIER -131.47 -2.13 3.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.559 -1.338 . . . . 0.0 113.148 -177.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 78.77 49.26 6.62 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 118.646 -1.74 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' MET . . . . . 0.406 ' CE ' ' HD3' ' A' ' 491' ' ' ARG . 1.8 ttm -112.41 -177.38 3.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -118.82 137.34 53.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 492' ' ' GLN . 0.1 OUTLIER -114.4 150.02 35.29 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.314 -0.866 . . . . 0.0 111.902 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 8.7 t -64.0 115.32 18.25 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.963 -0.46 . . . . 0.0 109.842 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.44 ' CG ' ' CB ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -69.3 115.71 4.16 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.217 1.114 . . . . 0.0 110.282 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -157.75 19.69 0.37 Allowed Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.431 ' HB3' HD11 ' A' ' 487' ' ' ILE . 17.3 p -97.89 174.42 6.59 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.774 1.274 . . . . 0.0 113.751 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.411 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 10.1 m -122.5 103.53 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.44 134.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -134.39 121.49 36.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 507' ' ' VAL . 7.5 p -115.94 104.18 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.537 -1.352 . . . . 0.0 111.446 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.83 99.36 10.85 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 515' ' ' LEU . 94.4 mm-40 -111.62 103.9 12.24 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -175.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.5 62.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -98.9 163.16 12.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -100.33 -9.05 22.71 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.825 -0.547 . . . . 0.0 111.125 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -41.34 97.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.298 -0.876 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -6.13 48.34 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.589 -0.695 . . . . 0.0 111.276 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 509' ' ' GLN . 0.9 OUTLIER -69.78 -56.5 6.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 178.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.2 -40.68 64.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.473 -0.767 . . . . 0.0 111.468 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.009 -1.057 . . . . 0.0 110.605 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 98.6 m -60.07 -44.41 94.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.223 -0.923 . . . . 0.0 108.789 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -37.44 42.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -0.763 . . . . 0.0 110.434 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.3 m -64.77 -42.28 95.21 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.525 -0.734 . . . . 0.0 111.852 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -47.16 74.71 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.226 -0.922 . . . . 0.0 111.565 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 4.3 pp -78.2 -18.11 55.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.396 -0.815 . . . . 0.0 111.9 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -47.07 -46.1 22.24 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.405 -0.81 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.31 90.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.89 89.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.787 . . . . 0.0 111.668 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.427 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -62.04 -29.38 70.25 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.063 -1.023 . . . . 0.0 111.005 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -58.15 -27.39 63.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.044 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.44 ' CB ' ' CG ' ' A' ' 501' ' ' PRO . 65.4 m80 -108.9 -117.66 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.832 -0.542 . . . . 0.0 111.094 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.4 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 10.5 m120 -91.28 65.78 5.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.405 -1.434 . . . . 0.0 113.666 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -139.71 165.18 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.551 -1.343 . . . . 0.0 110.279 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.434 ' CB ' ' CB ' ' A' ' 432' ' ' SER . 15.1 mp0 -150.5 161.02 43.33 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.729 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 18.9 t -112.3 107.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.992 -1.068 . . . . 0.0 113.075 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 7.2 tp -110.67 117.48 33.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.404 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 10.7 pt -137.36 133.71 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 117.996 -1.481 . . . . 0.0 113.148 -175.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 82.4 p -99.02 -168.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -155.54 164.67 38.36 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.28 -18.81 0.71 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.551 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -111.77 -17.05 8.77 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.69 1.74 52.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.452 -1.028 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -32.32 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 78.3 p -101.05 115.16 29.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 69.8 59.8 5.35 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 58.7 p -68.46 -10.32 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.949 -0.736 . . . . 0.0 110.659 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.96 80.48 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 39.0 m -61.08 -29.85 69.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.974 . . . . 0.0 109.312 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.26 70.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.922 -0.486 . . . . 0.0 110.028 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.1 mp -61.8 -42.62 99.23 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 109.26 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 64.3 mtt -64.64 -34.31 77.98 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -48.92 -51.75 28.39 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 96.4 mmm -56.1 -42.57 76.98 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -57.56 -31.72 66.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.528 -0.732 . . . . 0.0 110.059 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -62.76 -30.0 71.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.34 -7.61 38.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.648 -0.658 . . . . 0.0 111.246 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.25 -5.16 38.41 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.515 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.501 2.125 0 CA-C-N 118.942 1.371 . . . . 0.0 111.117 -178.802 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.122 0.486 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -40.27 95.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.497 -0.752 . . . . 0.0 110.193 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 75.7 p -61.32 -40.79 95.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.664 -0.647 . . . . 0.0 110.946 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.8 t -71.3 -24.11 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.587 -0.696 . . . . 0.0 111.769 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.11 -52.92 52.58 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.945 -1.097 . . . . 0.0 111.178 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.94 78.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.438 -0.789 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . 0.431 ' O ' HG13 ' A' ' 399' ' ' ILE . 8.1 tt -62.18 -41.02 97.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.743 -0.598 . . . . 0.0 111.152 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 11.1 t -62.81 -40.26 96.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 0.0 111.309 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.76 -44.34 93.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.415 -0.803 . . . . 0.0 110.861 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -65.52 -38.1 88.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.359 -0.838 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 395' ' ' LEU . 0.5 OUTLIER -64.13 -40.85 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.241 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 56.6 mtp -63.39 -28.82 70.25 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.83 -26.83 66.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.255 -0.903 . . . . 0.0 108.799 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -90.44 -18.45 25.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 176.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -66.04 -38.48 88.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.688 -0.633 . . . . 0.0 110.397 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -116.5 18.67 15.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 8.2 p -60.39 118.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.506 -0.746 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 t -53.11 101.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.417 0.627 . . . . 0.0 111.536 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.21 134.62 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' HIS . . . . . 0.418 ' CB ' ' HE2' ' A' ' 411' ' ' LYS . 0.1 OUTLIER -91.09 141.53 26.5 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.438 -0.789 . . . . 0.0 109.8 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.53 -27.72 32.73 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.151 1.08 . . . . 0.0 110.138 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.86 -34.12 76.08 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.761 0.791 . . . . 0.0 109.668 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 408' ' ' HIS . 0.0 OUTLIER -138.82 58.66 1.64 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.7 t -50.68 98.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.116 -0.99 . . . . 0.0 111.81 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.437 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 7.6 p -58.61 148.44 66.53 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.93 -0.482 . . . . 0.0 109.713 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 38.4 Cg_endo -63.47 149.76 90.26 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.228 1.12 . . . . 0.0 109.682 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -136.3 -8.86 1.98 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.667 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 420' ' ' SER . 19.2 p -102.17 19.32 18.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -80.32 -77.01 0.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.612 -0.68 . . . . 0.0 111.854 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -84.36 -2.23 89.15 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.217 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 402' ' ' GLN . 85.3 m-85 -107.14 -20.89 13.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 120.573 2.187 . . . . 0.0 108.827 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 416' ' ' THR . 37.6 t -72.67 -40.61 66.14 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.66 -38.11 88.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.09 89.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.807 0.813 . . . . 0.0 109.297 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 63.5 t -66.39 -44.97 90.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -61.42 -35.58 77.96 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.964 -1.085 . . . . 0.0 111.257 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.27 -47.46 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.427 -0.795 . . . . 0.0 110.679 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 1.4 pp -57.56 -33.29 67.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.413 -0.804 . . . . 0.0 111.996 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.17 -36.96 80.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.716 -1.24 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -31.93 71.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -65.65 -90.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 8.3 tpp85 -178.54 -57.97 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.406 -1.434 . . . . 0.0 109.097 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.33 93.54 0.41 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.447 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 5.5 t -85.96 111.48 20.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.4 OUTLIER -163.97 89.12 0.55 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -139.15 168.31 20.13 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.686 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.82 130.93 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.617 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.38 150.83 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.91 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 13.8 m -123.05 127.46 48.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.315 -0.865 . . . . 0.0 110.663 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -122.49 160.3 16.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -148.85 -47.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.911 . . . . 0.0 109.562 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -101.46 142.44 15.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 73.87 89.16 0.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.7 -44.69 4.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.945 . . . . 0.0 110.804 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.27 97.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.784 . . . . 0.0 110.775 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.11 62.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.37 -41.76 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -1.027 . . . . 0.0 110.771 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -43.85 98.13 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -67.73 -29.13 68.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.199 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -61.61 -47.66 84.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.524 -0.735 . . . . 0.0 110.864 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 450' ' ' ALA . 7.1 p -59.66 -31.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.857 -1.152 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -64.0 -27.88 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.576 -0.849 . . . . 0.0 108.758 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.84 -34.06 77.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.149 -0.97 . . . . 0.0 108.448 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' LEU . . . . . 0.408 ' O ' ' CG ' ' A' ' 455' ' ' MET . 33.3 tp -62.62 -34.99 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.01 -25.81 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 79.9 mtp -69.81 -42.37 73.77 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.878 . . . . 0.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.0 OUTLIER -62.39 -20.8 64.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.121 -0.987 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.0 -22.69 36.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 0.0 109.745 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.26 -41.91 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.333 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.25 -26.74 63.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.486 -0.759 . . . . 0.0 109.51 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.1 2.86 16.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.0 111.707 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 83.95 4.27 88.68 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.033 -1.042 . . . . 0.0 111.878 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 132.2 33.78 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.993 1.397 . . . . 0.0 111.136 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -76.7 -174.38 2.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.61 -0.681 . . . . 0.0 110.036 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.95 144.77 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.44 114.56 27.14 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.437 HG22 HD13 ' A' ' 465' ' ' ILE 0.255 0.0 OUTLIER -127.3 129.13 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 111.431 -175.811 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 83.1 mt -124.71 120.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.834 -0.542 . . . . 0.0 110.545 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.45 24.95 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.34 -160.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.81 -0.556 . . . . 0.0 110.085 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -51.37 -17.08 0.66 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.76 -1.213 . . . . 0.0 111.082 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -73.44 -6.33 45.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.481 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -57.54 -31.62 66.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.3 m -59.08 -45.69 90.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.547 -0.721 . . . . 0.0 110.301 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.56 -40.43 95.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.494 -0.754 . . . . 0.0 109.056 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 92.7 mtp -62.37 -33.15 74.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.829 -0.544 . . . . 0.0 110.744 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -61.25 -38.98 88.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.949 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.5 ttp -59.18 -40.13 84.71 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.43 -0.794 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.417 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 62.6 pttt -119.58 -146.39 0.38 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' GLN . . . . . 0.417 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.3 mm-40 43.64 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.135 -0.978 . . . . 0.0 112.131 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -121.35 14.04 11.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.528 -0.732 . . . . 0.0 110.527 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -101.61 -10.12 20.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 111.659 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -132.15 0.41 3.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.109 -0.994 . . . . 0.0 112.939 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.32 44.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.656 -1.278 . . . . 0.0 112.873 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.7 t -89.34 48.76 1.65 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.654 -1.279 . . . . 0.0 110.47 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.06 58.24 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.8 44.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -1.15 . . . . 0.0 109.672 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' LEU . . . . . 0.404 ' O ' HG12 ' A' ' 487' ' ' ILE . 95.1 mt -59.03 -84.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.923 -1.11 . . . . 0.0 109.318 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.425 HG13 ' OG ' ' A' ' 503' ' ' SER . 22.8 mm -156.37 -82.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.83 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' THR . . . . . 0.447 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.5 t -98.37 11.57 37.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.791 -0.568 . . . . 0.0 110.472 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.96 74.65 2.29 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . 0.411 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 72.8 ttt-85 -144.83 -72.5 0.26 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -107.42 -22.73 12.46 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.565 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.02 -37.93 89.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.196 -0.94 . . . . 0.0 109.847 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.3 mt -89.32 -53.72 4.43 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.022 0.915 . . . . 0.0 108.647 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.39 -42.96 87.14 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.032 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -112.79 -8.81 13.72 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.16 -4.74 79.84 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.273 -1.517 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 94.6 mtp -68.52 -177.73 0.99 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.056 -1.261 . . . . 0.0 110.594 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.54 148.33 32.35 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.446 -0.784 . . . . 0.0 110.652 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.447 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.34 155.15 25.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.069 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 4.9 t -51.31 116.68 7.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.18 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 528' ' ' HIS . 48.3 Cg_endo -76.41 114.45 3.88 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.434 1.229 . . . . 0.0 110.41 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.2 28.62 0.03 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' SER . . . . . 0.425 ' OG ' HG13 ' A' ' 487' ' ' ILE . 47.1 t -92.01 169.24 10.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.363 -1.081 . . . . 0.0 111.833 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 52.6 m -110.88 117.86 34.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 531' ' ' GLN . 32.1 t -112.33 130.23 66.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.725 0.774 . . . . 0.0 110.008 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.416 ' CG1' HG12 ' A' ' 465' ' ' ILE . 14.6 pt -138.91 131.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.125 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.464 HG11 ' CG2' ' A' ' 534' ' ' ILE . 7.7 p -129.63 109.25 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.243 1.021 . . . . 0.0 111.245 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -85.47 110.16 18.98 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -126.19 106.91 9.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.61 58.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -85.97 149.15 25.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.0 -15.59 18.22 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.55 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.41 -31.41 65.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 5.0 m -83.45 -20.08 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.435 -0.791 . . . . 0.0 110.469 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.84 -43.99 86.86 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.5 -40.31 85.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.849 -0.532 . . . . 0.0 111.371 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.01 -51.72 68.12 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.065 -1.022 . . . . 0.0 110.719 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 92.2 m -59.34 -39.53 83.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 519' ' ' LEU . 0.8 OUTLIER -59.49 -38.52 81.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 122.092 -0.38 . . . . 0.0 111.279 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 69.5 p -64.11 -30.88 71.92 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.939 -1.1 . . . . 0.0 109.297 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 48.7 tp -70.02 -41.26 74.52 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.733 0.777 . . . . 0.0 109.331 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 -20.63 61.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.98 -0.45 . . . . 0.0 111.672 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -58.88 3.93 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.264 -0.897 . . . . 0.0 111.439 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.29 80.21 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.03 -30.37 66.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.877 -0.778 . . . . 0.0 110.575 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -52.24 -27.53 15.22 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.126 -0.984 . . . . 0.0 110.782 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -64.24 -36.79 85.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.633 -0.667 . . . . 0.0 109.27 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 501' ' ' PRO . 1.0 OUTLIER -132.2 -60.11 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.674 -0.641 . . . . 0.0 110.775 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -78.68 116.27 18.93 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 2.4 p -169.68 144.11 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 C-N-CA 117.262 -1.775 . . . . 0.0 115.462 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.527 ' O ' ' HB ' ' A' ' 505' ' ' VAL . 1.8 mt-30 175.9 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 80.3 t -115.0 114.73 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.501 0 O-C-N 120.525 -1.36 . . . . 0.0 113.853 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.3 OUTLIER -116.93 117.47 29.79 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 103.447 -2.798 . . . . 0.0 103.447 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' ILE . . . . . 0.464 ' CG2' HG11 ' A' ' 507' ' ' VAL . 6.2 pt -135.43 149.12 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.416 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 49.2 p -112.86 -168.07 1.27 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -158.69 168.14 27.66 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.733 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.32 17.68 1.71 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.214 0.53 . . . . 0.0 109.675 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -150.84 27.14 1.03 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.62 0.03 57.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.6 -0.941 . . . . 0.0 111.288 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -54.36 -43.66 71.51 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.869 -1.144 . . . . 0.0 110.048 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 73.3 p -113.88 155.38 25.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.13 43.76 83.64 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.8 t -63.22 -43.96 96.64 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.314 -1.11 . . . . 0.0 110.866 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.24 89.4 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 65.9 m -62.39 -36.41 82.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.9 -0.765 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.89 84.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.353 -0.842 . . . . 0.0 109.871 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.3 mp -62.94 -41.77 99.59 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.635 0.731 . . . . 0.0 109.074 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 97.4 mtp -62.69 -28.12 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.98 50.16 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 89.8 mmm -55.62 -46.15 77.43 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.28 -0.888 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.39 -30.88 71.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.708 -0.62 . . . . 0.0 111.424 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -67.19 -18.02 65.08 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.552 -0.717 . . . . 0.0 110.895 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.82 7.08 4.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.402 -0.811 . . . . 0.0 112.679 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.85 -12.69 9.29 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.094 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.057 -1.26 . . . . 0.0 109.826 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.166 0.508 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 15.2 m -82.02 150.66 27.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.807 -0.558 . . . . 0.0 110.26 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 78.35 23.49 65.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 41.3 pt -97.57 -4.34 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.485 -1.009 . . . . 0.0 111.311 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -62.71 -44.86 95.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.916 -1.115 . . . . 0.0 109.444 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.65 132.66 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.0 110.476 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 96.5 mt -113.15 -171.4 1.86 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.962 . . . . 0.0 110.312 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -60.49 -41.05 93.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 0.0 110.999 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -142.11 3.84 1.6 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.0 -1.063 . . . . 0.0 112.379 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.87 -43.15 99.43 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.537 -1.352 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 70.8 m -62.78 -44.2 96.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.673 -0.642 . . . . 0.0 110.312 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.439 ' HA ' ' CD2' ' A' ' 395' ' ' LEU . 69.1 t -65.84 -36.32 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.634 -0.666 . . . . 0.0 110.836 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.73 -44.2 97.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 111.568 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.0 91.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.492 -0.755 . . . . 0.0 112.124 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 392' ' ' VAL . 1.8 pp -71.88 -28.51 63.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.179 -0.951 . . . . 0.0 112.256 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.9 t -63.09 -43.9 97.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.701 -1.249 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -64.98 -42.97 94.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.731 -0.606 . . . . 0.0 111.59 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -63.28 -40.05 96.31 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.417 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.402 ' CD1' HD12 ' A' ' 395' ' ' LEU . 82.3 mt -63.52 -42.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.3 mtp -63.54 -32.0 73.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.165 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -57.87 -32.34 67.59 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.423 ' CG ' ' NH1' ' A' ' 415' ' ' ARG . 7.7 mp0 -93.09 -15.91 25.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.998 -1.064 . . . . 0.0 109.603 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -64.75 -36.35 84.03 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.24 18.43 17.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.785 . . . . 0.0 109.596 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.9 p -35.54 142.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.609 0 CA-C-O 121.354 0.597 . . . . 0.0 111.686 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 9.4 t -74.27 72.98 1.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.707 -0.621 . . . . 0.0 109.782 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 412' ' ' SER . 11.2 p -104.39 132.03 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.918 . . . . 0.0 111.52 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -93.33 142.05 24.76 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.46 -28.35 54.01 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.085 1.045 . . . . 0.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.22 -23.94 62.73 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.569 -0.707 . . . . 0.0 110.482 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 57.21 0.51 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' SER . . . . . 0.438 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 35.5 t -59.01 126.48 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 111.499 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.77 113.12 53.09 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.921 -0.487 . . . . 0.0 110.446 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.26 142.72 50.95 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.102 1.054 . . . . 0.0 109.423 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.423 ' NH1' ' CG ' ' A' ' 402' ' ' GLN . 83.2 mtp180 -159.38 63.11 0.39 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 109.534 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 74.1 p -66.83 -35.7 80.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.938 -1.101 . . . . 0.0 108.741 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -69.56 -10.45 58.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 111.2 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.13 -44.63 97.16 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -93.94 -2.42 53.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.13 -1.218 . . . . 0.0 109.805 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.3 t -80.61 -36.81 32.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -79.06 -46.03 18.94 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.388 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.14 -49.67 76.32 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.89 0.852 . . . . 0.0 110.781 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.415 ' CG1' HD21 ' A' ' 426' ' ' LEU . 55.9 t -72.16 -40.49 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.767 -0.583 . . . . 0.0 112.297 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 66.8 p -59.39 -39.13 82.36 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.889 -1.132 . . . . 0.0 110.835 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . 0.4 ' HA ' ' OE1' ' A' ' 428' ' ' GLN . 97.3 t -61.51 -42.49 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.71 -0.619 . . . . 0.0 109.67 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.3 OUTLIER -58.62 -32.73 69.3 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.444 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.72 73.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.607 -1.308 . . . . 0.0 109.32 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 425' ' ' VAL . 82.7 mt-30 -62.62 -31.22 72.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 426' ' ' LEU . 90.2 m-20 -62.89 -90.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.4 ' HB3' ' CD ' ' A' ' 431' ' ' PRO . 1.4 tpp180 -171.92 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.346 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 430' ' ' ARG . 48.4 Cg_endo -69.68 105.73 1.52 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.039 1.02 . . . . 0.0 110.482 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 531' ' ' GLN . 0.4 OUTLIER -85.15 100.93 12.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.782 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.741 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 20.9 tp -165.04 96.94 0.72 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.756 -1.215 . . . . 0.0 111.821 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -144.07 177.02 8.87 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.769 0.795 . . . . 0.0 111.89 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 435' ' ' ILE . 44.4 pt -116.7 139.29 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 44.1 t -144.33 145.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.4 m -129.96 139.04 51.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.51 -0.744 . . . . 0.0 109.551 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.36 149.76 19.41 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -103.96 -49.64 3.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.751 -0.852 . . . . 0.0 109.262 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -146.75 153.86 25.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 93.09 106.62 1.76 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -46.99 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -1.009 . . . . 0.0 110.675 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.79 84.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 112.01 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.29 -29.25 64.54 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 120.729 -1.232 . . . . 0.0 110.514 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -38.89 89.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.509 -0.995 . . . . 0.0 110.804 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -64.91 -41.74 95.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.015 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.77 -27.79 63.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.301 -0.874 . . . . 0.0 110.498 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -62.89 -56.13 20.03 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.334 -0.854 . . . . 0.0 111.219 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.34 -32.04 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.508 -1.37 . . . . 0.0 108.932 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.425 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.03 -26.34 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -60.59 -32.7 71.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.06 -37.32 87.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.43 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 59.4 t -60.6 -27.05 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.78 -0.575 . . . . 0.0 109.812 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.59 -37.1 82.09 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.9 ttp -58.38 -29.46 66.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.652 0.739 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.77 31.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 0.0 109.555 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.41 -43.17 98.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -71.59 -27.43 63.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.732 -0.605 . . . . 0.0 110.478 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -82.65 6.44 17.81 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.493 -0.755 . . . . 0.0 111.282 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.63 28.42 72.24 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.867 -1.146 . . . . 0.0 110.628 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -134.6 129.07 34.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.052 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.408 ' HB2' HD11 ' A' ' 487' ' ' ILE . 75.8 mm-40 -85.26 167.54 15.55 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 23.5 m -145.31 149.25 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.86 . . . . 0.0 110.293 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -97.52 126.11 42.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.427 HG22 ' CG2' ' A' ' 453' ' ' VAL . 1.9 pt -134.07 139.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.458 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.31 126.08 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.347 -0.846 . . . . 0.0 110.688 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.422 ' HA ' ' CG ' ' A' ' 508' ' ' ASP . . . -84.28 -177.92 6.78 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.542 -0.723 . . . . 0.0 109.934 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -58.0 -162.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.213 0.53 . . . . 0.0 110.043 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.28 -16.86 6.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -0.969 . . . . 0.0 110.556 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -72.04 -11.07 60.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.374 -0.829 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -56.05 -34.0 65.51 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.13 -0.981 . . . . 0.0 111.903 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 39.0 t -55.66 -45.87 77.63 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.153 -0.967 . . . . 0.0 110.426 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -64.94 -37.91 89.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -32.47 70.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.92 -0.487 . . . . 0.0 110.506 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -59.65 -42.18 92.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.964 -1.085 . . . . 0.0 108.817 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.7 mtt -65.46 -35.65 81.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -102.92 -148.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 51.04 45.18 28.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.955 -1.091 . . . . 0.0 111.604 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -95.42 12.01 30.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.28 -0.887 . . . . 0.0 110.903 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -84.01 -1.68 55.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 111.131 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.976 -1.078 . . . . 0.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.66 30.03 6.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.553 -1.342 . . . . 0.0 111.785 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 37.3 m -60.91 -28.21 68.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.935 -1.103 . . . . 0.0 110.251 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 161.81 46.84 0.02 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -130.54 40.82 3.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.57 -0.959 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.36 -81.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 503' ' ' SER . 0.0 OUTLIER -175.63 -60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.41 -1.431 . . . . 0.0 112.547 173.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.469 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.5 t -101.82 12.83 36.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.467 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -87.28 66.38 3.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.484 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.8 ttm180 -143.39 -63.42 0.4 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.32 -1.106 . . . . 0.0 108.885 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -101.86 -36.04 8.8 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.979 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 497' ' ' MET . 11.4 tt0 -61.24 -29.96 70.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.644 -0.66 . . . . 0.0 111.492 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.467 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 5.9 mt -93.57 -29.91 15.25 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.513 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -38.21 7.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -6.39 12.13 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 100.47 -19.34 53.05 Favored Glycine 0 N--CA 1.504 3.204 0 CA-C-N 120.641 1.564 . . . . 0.0 112.274 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 10.9 mtp -69.29 175.1 4.13 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.982 -1.305 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.57 150.04 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.493 -0.754 . . . . 0.0 111.138 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.484 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -113.71 150.03 33.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.718 -0.614 . . . . 0.0 109.72 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.9 t -55.32 107.19 0.8 Allowed Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.474 -0.766 . . . . 0.0 110.573 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.408 ' HG2' ' CB ' ' A' ' 528' ' ' HIS . 40.0 Cg_endo -67.76 114.28 3.28 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.173 1.091 . . . . 0.0 110.316 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -166.11 26.19 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.436 ' HB2' HG21 ' A' ' 487' ' ' ILE . 22.9 t -96.0 -179.62 4.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.297 -1.119 . . . . 0.0 111.628 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 87.5 m -124.14 131.88 53.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.415 ' CG1' ' CD1' ' A' ' 522' ' ' LEU . 62.9 t -121.5 135.78 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.901 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 506' ' ' ILE . 26.0 pt -135.99 118.86 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.421 HG12 ' CG2' ' A' ' 534' ' ' ILE . 4.9 p -115.51 104.29 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 111.451 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . 0.422 ' CG ' ' HA ' ' A' ' 467' ' ' ALA . 9.9 p-10 -86.73 121.39 29.16 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 468' ' ' ALA . 1.9 pm0 -156.47 129.2 7.76 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -176.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . 0.4 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -77.56 -44.87 11.82 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -77.19 148.04 36.11 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -99.51 -12.19 20.38 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 121.907 -0.495 . . . . 0.0 111.645 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -34.98 79.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.8 m -69.68 -37.71 76.77 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.578 0.704 . . . . 0.0 110.577 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.14 -42.79 99.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.736 -0.602 . . . . 0.0 111.209 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.37 -43.3 86.3 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 518' ' ' THR . 18.9 pt-20 -68.29 -42.13 79.93 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.858 -1.151 . . . . 0.0 110.51 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.401 ' N ' ' HG3' ' A' ' 517' ' ' GLU . 52.1 m -61.55 -40.14 93.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -39.8 91.12 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 75.6 p -60.09 -57.08 14.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.049 -1.032 . . . . 0.0 110.672 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.43 -41.12 98.47 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.149 -0.969 . . . . 0.0 110.721 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.415 ' CD1' ' CG1' ' A' ' 505' ' ' VAL . 5.1 tt -57.66 -30.39 65.39 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.627 -0.671 . . . . 0.0 110.727 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.12 -47.44 68.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.488 -0.758 . . . . 0.0 111.421 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -60.63 -50.02 72.19 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -64.42 -36.18 83.32 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.662 -0.905 . . . . 0.0 111.687 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.7 -25.12 66.17 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.273 -0.892 . . . . 0.0 110.964 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -53.47 -40.38 65.24 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.204 -0.935 . . . . 0.0 108.73 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.408 ' CB ' ' HG2' ' A' ' 501' ' ' PRO . 1.5 t-80 -93.02 -135.35 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -88.87 78.95 7.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.602 -1.311 . . . . 0.0 112.402 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -140.21 168.68 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.114 -0.991 . . . . 0.0 108.62 178.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -164.0 162.97 23.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.602 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.6 t -113.44 110.69 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.709 0.766 . . . . 0.0 112.071 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.89 117.63 34.64 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.421 ' CG2' HG12 ' A' ' 507' ' ' VAL . 11.7 pt -135.69 160.75 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 117.533 -1.667 . . . . 0.0 111.921 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 47.0 p -125.55 -168.45 1.84 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -159.35 168.83 25.39 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' SER . . . . . 0.4 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.9 17.98 2.31 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.583 178.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.95 11.49 3.36 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -95.59 0.85 53.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.04 -1.271 . . . . 0.0 111.305 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -53.69 -26.72 24.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.031 -1.043 . . . . 0.0 111.22 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 56.8 m -107.08 -36.81 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.417 -0.802 . . . . 0.0 109.89 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -134.42 107.46 0.66 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 15.1 t -97.74 -43.26 7.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -1.004 . . . . 0.0 111.629 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.65 -35.02 90.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 34.5 m -62.0 -32.24 72.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -1.079 . . . . 0.0 110.173 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.06 79.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.86 -0.525 . . . . 0.0 109.923 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.1 mp -61.76 -43.72 98.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.0 -34.0 76.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 108.741 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -52.77 -52.5 56.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 32.0 ttp -58.31 -42.96 87.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.325 -0.86 . . . . 0.0 109.866 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.6 -32.16 72.27 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.738 -0.601 . . . . 0.0 111.233 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.52 -12.72 61.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.589 -0.694 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.83 6.85 1.04 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.321 -0.862 . . . . 0.0 113.013 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.3 -15.76 42.48 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.522 -1.361 . . . . 0.0 110.933 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 13.6 p -66.99 121.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.291 -1.123 . . . . 0.0 109.863 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -157.11 113.6 2.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.844 -0.535 . . . . 0.0 109.899 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 6.2 t -92.76 113.41 25.68 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.55 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -87.5 -81.06 0.24 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -155.49 -64.4 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.487 -0.758 . . . . 0.0 110.379 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -87.01 -22.66 25.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -149.01 151.64 34.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -93.12 -138.67 8.88 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -96.05 24.18 31.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -64.42 -33.34 75.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -1.039 . . . . 0.0 110.257 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.19 -1.14 56.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.788 -0.57 . . . . 0.0 111.292 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -107.1 79.82 0.75 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.096 -1.002 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.94 -16.46 32.58 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.272 1.143 . . . . 0.0 111.649 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -157.52 22.42 0.29 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.169 -0.957 . . . . 0.0 111.271 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.641 179.818 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 120.874 0.368 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 93.6 p -62.88 -32.96 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 109.663 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 103.29 117.08 4.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 77.6 mt -95.27 117.59 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.539 -0.977 . . . . 0.0 109.666 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -68.82 -33.78 74.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.844 -0.535 . . . . 0.0 110.557 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.48 141.76 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.619 -0.676 . . . . 0.0 110.916 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.28 127.14 55.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.737 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -115.64 -168.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.5 -0.75 . . . . 0.0 110.076 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.51 87.86 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.565 -0.71 . . . . 0.0 110.162 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.54 -38.49 89.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.69 -0.632 . . . . 0.0 110.976 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.0 m -62.51 -47.41 84.05 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.389 -0.819 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.15 -36.47 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.481 -0.762 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.36 82.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.237 -0.914 . . . . 0.0 109.655 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.55 -34.19 77.66 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.664 0.745 . . . . 0.0 108.999 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.6 OUTLIER -60.67 -39.45 88.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.98 -0.45 . . . . 0.0 110.659 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.9 m -64.6 -36.95 85.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.479 -0.763 . . . . 0.0 111.029 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -64.51 -46.63 82.09 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.288 -0.882 . . . . 0.0 111.997 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -70.06 -41.22 74.46 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.24 -0.913 . . . . 0.0 111.703 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -40.6 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 109.675 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 18.3 mtp -63.01 -31.97 73.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.617 -0.677 . . . . 0.0 110.114 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -60.74 -32.93 72.2 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.041 -1.037 . . . . 0.0 109.517 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -90.44 -14.93 31.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.797 -1.189 . . . . 0.0 109.385 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -65.48 -35.94 82.38 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -115.63 18.6 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 9.9 p -39.07 148.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-O 121.677 0.751 . . . . 0.0 112.228 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 19.3 m -84.35 77.53 9.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.8 p -97.21 131.48 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.343 -0.848 . . . . 0.0 112.355 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -96.62 145.04 28.89 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.89 -21.57 57.19 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.066 1.035 . . . . 0.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.62 -36.29 66.81 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.83 0.824 . . . . 0.0 110.42 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 67.61 0.51 Allowed 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 14.3 m -62.67 135.27 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.818 0.818 . . . . 0.0 111.091 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.436 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 8.6 p -81.51 149.19 64.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.3 Cg_endo -58.47 136.67 75.83 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.018 1.009 . . . . 0.0 110.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.403 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 80.5 mtt85 -96.3 -8.94 31.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.664 -0.648 . . . . 0.0 112.662 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.0 t -99.34 19.09 16.14 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.95 -1.094 . . . . 0.0 109.175 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -106.17 -36.97 6.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -68.82 -38.62 85.51 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 415' ' ' ARG . 3.8 m-85 -94.9 -8.05 38.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.774 -1.427 . . . . 0.0 110.42 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -40.54 65.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.873 -1.142 . . . . 0.0 108.529 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -76.11 -44.47 38.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.898 -0.501 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -66.96 -48.59 68.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 111.445 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 72.2 t -67.87 -42.96 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.598 -0.689 . . . . 0.0 111.441 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.6 t -59.09 -42.61 90.86 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.812 -1.18 . . . . 0.0 111.309 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.8 -46.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.193 -0.942 . . . . 0.0 110.886 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 395' ' ' LEU . 0.7 OUTLIER -56.87 -37.24 71.06 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.243 -0.91 . . . . 0.0 112.28 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.43 -36.87 79.69 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.896 -1.128 . . . . 0.0 108.937 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -59.82 -30.49 68.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.26 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.494 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.44 -55.88 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.603 -1.31 . . . . 0.0 109.416 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 49.2 Cg_endo -73.4 106.44 2.18 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.0 m -85.17 97.82 10.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.878 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 18.1 tp -150.01 134.02 17.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -174.4 175.35 2.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.905 -1.122 . . . . 0.0 110.894 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 20.1 pt -134.09 121.05 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.403 0.62 . . . . 0.0 110.072 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 62.7 t -120.61 134.76 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.227 -0.92 . . . . 0.0 109.257 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 11.8 p -118.24 123.6 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.85 -1.156 . . . . 0.0 111.809 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 -178.14 34.18 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -171.41 39.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.991 . . . . 0.0 109.599 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -155.04 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -118.35 134.49 10.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -98.78 -16.08 19.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.689 -0.889 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.35 77.78 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.48 -0.763 . . . . 0.0 111.824 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -78.66 -35.05 33.27 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.42 -35.44 79.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.963 . . . . 0.0 109.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.436 ' CD ' ' HB2' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -60.49 -46.75 88.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.835 -0.541 . . . . 0.0 110.364 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.99 -29.37 69.19 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.169 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 57.7 ttt85 -62.06 -46.01 91.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 450' ' ' ALA . 5.3 p -58.81 -30.63 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.801 -1.187 . . . . 0.0 109.03 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.42 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -62.93 -26.49 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 79.3 mm-40 -60.77 -35.63 76.91 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.92 -1.113 . . . . 0.0 108.412 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.38 -37.9 87.52 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.897 . . . . 0.0 108.673 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 66.8 t -57.97 -28.9 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.588 -0.695 . . . . 0.0 109.976 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 65.8 mtt -65.76 -39.5 91.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.383 -0.823 . . . . 0.0 108.814 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 63.0 ttp -61.66 -21.49 64.46 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.608 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.19 32.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 0.0 109.891 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -67.08 -40.77 87.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 109.324 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.21 -34.19 75.8 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.604 0.716 . . . . 0.0 109.1 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -76.78 1.53 17.03 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.65 27.39 72.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -128.74 118.62 23.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -1.038 . . . . 0.0 110.402 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 0.5 OUTLIER -76.22 164.58 25.93 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 34.3 m -136.88 157.53 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.272 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.423 ' HA ' ' CD2' ' A' ' 486' ' ' LEU . 59.2 tt0 -105.7 111.81 24.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 465' ' ' ILE . 1.2 pt -122.32 129.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.41 HG21 ' CZ ' ' A' ' 471' ' ' ARG . 5.3 mp -119.36 111.99 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 112.169 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.436 ' HB2' ' CD ' ' A' ' 446' ' ' ARG . . . -57.43 164.12 2.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.294 -0.878 . . . . 0.0 109.806 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.78 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.898 -0.501 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -57.84 -12.25 2.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.117 -0.989 . . . . 0.0 111.2 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -88.82 6.08 40.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.145 -0.972 . . . . 0.0 111.164 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . 0.41 ' CZ ' HG21 ' A' ' 466' ' ' ILE . 53.6 ttp180 -57.9 -25.28 60.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.067 . . . . 0.0 111.037 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 7.7 t -59.02 -47.62 84.56 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.219 -0.925 . . . . 0.0 111.218 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.07 -35.82 82.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 33.0 ttp -66.28 -32.0 73.15 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.52 -37.3 83.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.31 -0.869 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 45.0 mtt -60.5 -36.4 78.24 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -121.08 -143.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 47.96 88.24 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.98 -1.075 . . . . 0.0 111.456 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -129.03 20.93 5.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 110.081 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -110.17 -0.72 17.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 111.377 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -135.25 -13.36 2.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.886 -1.134 . . . . 0.0 112.723 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.95 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.967 -1.083 . . . . 0.0 111.004 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.6 m -75.11 -18.26 60.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.64 47.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 20.1 pt-20 -139.9 74.8 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.669 -0.901 . . . . 0.0 111.051 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 487' ' ' ILE . 67.3 mt -94.85 -81.02 0.4 Allowed 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.443 ' CG2' ' HB3' ' A' ' 503' ' ' SER . 0.4 OUTLIER 161.16 -34.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.75 0 C-N-CA 123.552 0.741 . . . . 0.0 110.435 173.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.492 ' HA ' ' CD2' ' A' ' 499' ' ' PHE . 7.0 p -102.14 12.7 36.36 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -153.36 95.78 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.433 ' N ' ' CD2' ' A' ' 493' ' ' LEU . 72.2 ttt180 -145.81 -72.21 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 495' ' ' GLU . 74.1 mtt-85 -90.13 -16.55 29.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.962 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -56.95 4.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.71 -1.244 . . . . 0.0 109.95 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 494' ' ' LEU . 1.1 pt? -58.92 -28.08 65.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.724 -0.61 . . . . 0.0 111.07 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.443 ' N ' ' HG ' ' A' ' 493' ' ' LEU . 1.0 OUTLIER -104.81 -46.37 4.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 111.938 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 491' ' ' ARG . 51.0 mt-10 -104.25 -7.93 19.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 112.5 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.87 -3.5 87.04 Favored Glycine 0 N--CA 1.508 3.438 0 O-C-N 120.581 -1.324 . . . . 0.0 110.051 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.427 ' HB2' ' CB ' ' A' ' 491' ' ' ARG . 93.7 mmm -64.8 -177.25 0.32 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -1.075 . . . . 0.0 112.721 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.64 169.46 8.8 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.744 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.492 ' CD2' ' HA ' ' A' ' 488' ' ' THR . 1.2 p90 -142.33 150.09 40.31 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.564 -0.71 . . . . 0.0 110.443 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 30.8 m -61.77 109.25 2.06 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -84.91 113.35 1.55 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.362 1.191 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 168.85 31.83 0.02 OUTLIER Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.584 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.443 ' HB3' ' CG2' ' A' ' 487' ' ' ILE . 4.5 p -96.35 -175.4 3.34 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.418 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 25.1 m -110.03 122.75 48.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 522' ' ' LEU . 46.4 t -115.64 129.58 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.731 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 465' ' ' ILE . 15.2 pt -124.6 119.31 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.441 HG13 ' CG2' ' A' ' 534' ' ' ILE . 3.6 p -107.34 110.76 32.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.807 -1.183 . . . . 0.0 109.96 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 468' ' ' ALA . 21.4 m-20 -82.71 105.7 13.95 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 0.4 OUTLIER -109.21 178.37 4.47 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.08 0.943 . . . . 0.0 112.714 -175.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -167.36 -91.24 0.08 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -38.89 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.603 -0.299 . . . . 0.0 111.566 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -179.02 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.39 -1.444 . . . . 0.0 110.883 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.87 -30.77 71.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.573 -0.704 . . . . 0.0 109.935 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 6.0 p -69.17 -38.79 78.9 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.761 -0.587 . . . . 0.0 111.749 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 13.6 tp -64.26 -45.45 88.04 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.396 -0.815 . . . . 0.0 112.106 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -65.11 -45.48 84.98 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.73 -42.62 95.08 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.288 -0.882 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 74.4 m -58.54 -46.93 85.78 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.834 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 5.5 mt -62.95 -36.91 85.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.246 -0.908 . . . . 0.0 111.008 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.5 m -58.07 -41.31 83.14 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.165 -0.959 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.38 -37.84 63.32 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.59 0.71 . . . . 0.0 109.498 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 505' ' ' VAL . 2.0 tp -63.65 -22.23 66.79 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -46.43 -52.78 12.37 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.5 -0.75 . . . . 0.0 112.005 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.74 -50.54 53.17 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.401 ' CB ' HG23 ' A' ' 488' ' ' THR . . . -58.26 -44.12 88.24 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.667 -0.902 . . . . 0.0 111.858 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.35 -25.41 67.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 0.0 111.246 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -55.41 -26.2 40.3 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.091 -1.005 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.469 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.9 m80 -110.88 -130.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.607 -0.683 . . . . 0.0 109.913 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -88.49 78.05 7.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.557 -1.339 . . . . 0.0 112.614 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 0.9 OUTLIER -134.34 158.4 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 109.152 178.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -150.82 157.99 43.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.739 -0.601 . . . . 0.0 109.726 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 69.1 t -110.78 96.81 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.192 -0.943 . . . . 0.0 113.468 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.9 114.19 25.88 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.441 ' CG2' HG13 ' A' ' 507' ' ' VAL . 4.9 pt -130.04 136.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.401 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 18.5 p -96.68 176.25 6.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 1.8 p30 -158.59 168.16 27.66 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.948 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.7 t -140.61 59.36 1.55 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -37.28 158.95 0.01 OUTLIER Glycine 0 N--CA 1.507 3.382 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.999 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.78 -87.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.166 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -108.77 -81.23 0.57 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.775 -1.203 . . . . 0.0 112.805 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 t -139.75 -30.16 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.675 0.75 . . . . 0.0 109.511 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -98.89 50.97 1.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.0 t -76.34 3.27 11.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 122.128 -0.631 . . . . 0.0 111.731 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -50.2 -26.68 9.53 Favored Glycine 0 N--CA 1.502 3.088 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.0 m -70.61 -20.85 62.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.995 -1.297 . . . . 0.0 109.047 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.33 75.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.83 -42.65 97.57 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.393 -0.817 . . . . 0.0 109.928 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.07 -34.51 75.02 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.09 39.11 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' MET . . . . . 0.405 ' N ' HD22 ' A' ' 515' ' ' LEU . 1.4 tmt? -57.49 -47.11 82.8 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.5 -33.42 71.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.677 -0.64 . . . . 0.0 111.496 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -63.96 -18.89 64.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.295 -0.878 . . . . 0.0 110.064 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.99 0.07 6.61 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.36 -0.838 . . . . 0.0 112.379 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 111.7 -12.4 27.6 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.816 -1.177 . . . . 0.0 111.52 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 68.8 t -82.89 114.95 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -172.53 138.99 0.93 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.42 -0.8 . . . . 0.0 109.932 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 88.9 m -92.15 135.5 33.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -73.17 -79.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.13 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -157.81 -70.31 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.552 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -81.33 -23.14 37.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 0.0 111.113 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -158.85 148.37 19.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.332 -0.855 . . . . 0.0 110.815 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -106.79 149.12 16.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.54 90.16 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.09 -2.35 50.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.623 -0.928 . . . . 0.0 111.696 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -82.87 -0.77 49.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.083 -1.011 . . . . 0.0 110.85 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -103.94 81.75 0.51 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.64 -21.02 52.72 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.283 1.149 . . . . 0.0 111.033 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -160.72 -51.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.444 -0.785 . . . . 0.0 110.15 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.077 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.944 0.402 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.8 m -104.45 31.41 4.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.741 . . . . 0.0 109.646 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 101.62 111.1 3.41 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 85.1 mt -97.61 -14.8 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.574 -0.957 . . . . 0.0 110.224 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -64.88 -42.75 94.55 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.325 -0.86 . . . . 0.0 109.337 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 82.4 t -94.41 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.794 -0.566 . . . . 0.0 110.286 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 96.4 mt -79.5 97.16 6.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.523 -0.736 . . . . 0.0 109.955 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -99.75 118.37 36.1 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.503 -0.748 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -116.23 33.14 5.7 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.629 0.728 . . . . 0.0 109.402 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.13 -37.3 86.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.503 -0.748 . . . . 0.0 110.882 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 49.0 m -60.02 -44.23 94.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.587 -0.696 . . . . 0.0 111.189 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 77.2 t -77.21 -29.56 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 111.063 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -65.51 -47.8 74.75 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.12 . . . . 0.0 111.166 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.26 88.76 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.876 0.846 . . . . 0.0 110.331 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 399' ' ' ILE . 8.3 tt -61.88 -38.83 89.75 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.207 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.2 m -61.15 -36.72 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.063 -0.398 . . . . 0.0 110.77 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -60.76 -44.07 97.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 110.734 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.425 ' O ' ' CE1' ' A' ' 419' ' ' TYR . 39.1 t70 -65.58 -44.39 86.81 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 0.0 111.962 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 395' ' ' LEU . 0.9 OUTLIER -63.3 -42.17 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 121.106 -0.996 . . . . 0.0 108.983 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 2.9 ttt -61.96 -26.72 68.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.727 -0.608 . . . . 0.0 109.578 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -62.27 -31.13 71.67 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.413 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 27.4 tp60 -89.75 -11.69 41.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 0.0 109.83 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.51 -39.92 88.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 -116.57 17.8 15.23 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.788 -1.195 . . . . 0.0 109.721 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.4 p -56.87 118.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.612 -0.68 . . . . 0.0 110.001 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -54.58 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.083 -1.011 . . . . 0.0 109.559 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.02 130.9 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.899 -0.501 . . . . 0.0 110.132 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.12 131.78 34.1 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.475 -0.765 . . . . 0.0 109.878 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 -24.03 43.88 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.164 1.086 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.36 -37.4 80.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.941 0.877 . . . . 0.0 110.181 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 67.6 1.03 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.8 p -49.8 155.3 0.88 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.108 0.956 . . . . 0.0 112.088 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.45 143.65 27.02 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.77 131.26 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 N-CA-C 109.104 -1.152 . . . . 0.0 109.104 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -109.51 -19.06 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.516 -0.74 . . . . 0.0 112.502 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 420' ' ' SER . 9.8 t -101.86 14.95 30.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -75.55 -77.86 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.689 -0.632 . . . . 0.0 111.607 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -89.0 -0.72 80.65 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.782 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' A' ' 398' ' ' ASP . 80.2 m-85 -107.98 -26.39 10.71 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.775 2.288 . . . . 0.0 108.763 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 416' ' ' THR . 4.9 t -71.19 -38.78 72.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 175.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 -38.8 92.19 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -59.88 -37.22 78.74 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.748 0.785 . . . . 0.0 109.327 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 75.9 t -66.85 -44.42 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.7 p -61.02 -37.82 83.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.642 -1.286 . . . . 0.0 111.529 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.25 -46.47 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -55.3 -32.78 62.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 0.0 111.686 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.16 78.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.806 -1.184 . . . . 0.0 108.877 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.49 -30.57 65.21 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.68 -89.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.442 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -174.67 -54.33 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.617 -1.302 . . . . 0.0 108.93 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.9 Cg_endo -70.81 98.71 0.8 Allowed 'Trans proline' 0 N--CA 1.487 1.135 0 N-CA-C 109.179 -1.123 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 531' ' ' GLN . 0.4 OUTLIER -84.34 102.09 12.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.804 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.91 98.1 1.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.35 -0.844 . . . . 0.0 111.928 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.92 168.32 19.99 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.48 -0.763 . . . . 0.0 111.82 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.27 129.92 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.747 -0.596 . . . . 0.0 111.385 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.02 155.44 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.312 -0.868 . . . . 0.0 110.083 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.7 t -133.09 138.9 46.87 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.427 -0.796 . . . . 0.0 111.024 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -101.41 -171.34 28.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -153.18 26.15 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.732 -0.863 . . . . 0.0 109.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.9 10.33 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.56 55.35 15.22 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.42 -9.08 59.58 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -57.69 -45.96 84.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.134 -0.979 . . . . 0.0 111.723 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -83.05 -28.55 36.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.74 -40.43 88.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.952 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -65.97 -39.27 90.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.51 -0.744 . . . . 0.0 109.66 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -67.66 -29.5 68.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.141 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 49.7 ttt85 -64.21 -47.0 81.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 450' ' ' ALA . 9.5 p -56.5 -30.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.554 -1.341 . . . . 0.0 109.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.498 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 95.3 mt-10 -62.76 -33.68 75.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.734 -1.229 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.02 -34.54 78.67 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 59.3 t -60.47 -31.75 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 96.3 mmm -65.14 -40.1 93.95 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.3 ttp -59.63 -22.45 61.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.603 -0.686 . . . . 0.0 110.318 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -81.93 -22.79 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -65.37 -43.09 91.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.429 -0.794 . . . . 0.0 109.655 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.19 -28.93 63.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -76.03 -2.92 33.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.699 -0.626 . . . . 0.0 111.388 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.58 19.99 72.46 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -136.72 151.18 48.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -1.064 . . . . 0.0 110.406 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.421 ' HB2' HD11 ' A' ' 487' ' ' ILE . 92.3 mt-10 -102.07 178.84 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.44 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 19.4 m -141.9 158.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.778 -1.201 . . . . 0.0 111.578 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -102.1 119.33 38.62 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.77 130.97 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.232 -0.918 . . . . 0.0 111.081 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.408 ' CD1' HG23 ' A' ' 518' ' ' THR . 91.1 mt -129.11 123.56 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.852 -0.53 . . . . 0.0 110.277 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.66 165.71 24.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.1 -161.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.571 -0.706 . . . . 0.0 110.528 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.53 -20.52 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -74.57 -2.86 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.395 -0.815 . . . . 0.0 110.752 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.19 -26.06 26.15 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.108 -0.995 . . . . 0.0 110.46 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.2 p -65.41 -46.81 78.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.392 -0.818 . . . . 0.0 109.966 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.77 -49.25 69.03 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.373 -0.829 . . . . 0.0 110.329 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 6.4 ttt -58.57 -30.61 67.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 110.403 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -58.75 -33.37 70.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 47.3 ttp -58.47 -39.08 78.95 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.315 0.579 . . . . 0.0 110.295 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -125.14 -157.36 0.78 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.835 -0.541 . . . . 0.0 109.663 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 45.82 61.44 2.65 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.443 -0.786 . . . . 0.0 112.167 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -98.05 9.03 43.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.586 -0.696 . . . . 0.0 109.795 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -93.04 -0.59 57.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.16 3.38 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 112.454 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.5 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.872 -1.142 . . . . 0.0 111.815 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.9 p -93.76 48.24 1.27 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.132 -0.98 . . . . 0.0 108.926 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.82 26.66 28.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -118.52 47.58 1.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.495 -1.003 . . . . 0.0 108.814 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.11 -82.77 0.39 Allowed 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.644 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.443 HG13 ' CB ' ' A' ' 503' ' ' SER . 38.0 mm -142.71 -90.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.076 -1.015 . . . . 0.0 108.99 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.447 ' OG1' ' CD2' ' A' ' 499' ' ' PHE . 0.0 OUTLIER -102.09 11.85 37.73 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.653 -0.654 . . . . 0.0 110.263 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.78 77.62 2.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.492 ' CG ' ' H ' ' A' ' 491' ' ' ARG . 0.2 OUTLIER -144.47 -86.11 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.492 ' H ' ' CG ' ' A' ' 490' ' ' ARG . 77.9 mtt85 -112.14 -17.16 12.87 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.443 -0.785 . . . . 0.0 109.227 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 497' ' ' MET . 8.0 mp0 -49.64 -36.1 23.51 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.61 -1.306 . . . . 0.0 111.226 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.84 -66.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.16 -0.962 . . . . 0.0 108.465 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.11 -28.99 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.408 0.623 . . . . 0.0 110.377 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 80.0 mm-40 -84.51 -3.16 58.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.0 111.585 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 69.91 48.87 38.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 94.4 mtp -123.01 -177.39 3.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -1.001 . . . . 0.0 111.127 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.48 170.63 7.96 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.649 -0.657 . . . . 0.0 110.325 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.447 ' CD2' ' OG1' ' A' ' 488' ' ' THR . 4.6 m-85 -109.21 125.64 52.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.257 -0.902 . . . . 0.0 108.612 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.7 t -68.02 150.89 97.58 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.613 -0.679 . . . . 0.0 110.852 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.415 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 42.5 Cg_endo -71.6 123.7 9.67 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.611 1.322 . . . . 0.0 111.049 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 161.64 -2.06 0.07 OUTLIER Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.72 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.443 ' CB ' HG13 ' A' ' 487' ' ' ILE . 8.6 m -82.81 153.21 25.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.343 . . . . 0.0 113.502 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 50.7 m -118.58 91.88 3.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.404 ' CG2' HD22 ' A' ' 522' ' ' LEU . 18.3 t -87.85 135.8 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 506' ' ' ILE . 18.2 pt -136.55 122.43 28.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 507' ' ' VAL . 8.5 p -123.67 111.98 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.669 -1.269 . . . . 0.0 112.787 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -86.59 123.04 31.34 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -160.52 129.23 4.76 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 117.488 -1.685 . . . . 0.0 115.434 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -85.3 -43.02 6.76 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.61 151.54 45.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -98.83 -11.68 21.55 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.24 -40.46 90.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 13.5 t -67.71 -39.95 84.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.819 -0.551 . . . . 0.0 111.201 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.67 -44.76 95.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.595 -0.691 . . . . 0.0 111.235 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -71.36 -46.57 60.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.294 -0.878 . . . . 0.0 112.975 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.03 -44.08 85.7 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.408 HG23 ' CD1' ' A' ' 466' ' ' ILE . 83.1 m -56.84 -43.4 81.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.309 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -34.42 58.94 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.33 0.586 . . . . 0.0 109.882 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 27.0 m -62.35 -41.48 98.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.508 -0.745 . . . . 0.0 109.513 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -40.52 97.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.738 0.78 . . . . 0.0 108.928 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.404 HD22 ' CG2' ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.33 -21.34 63.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.923 -0.485 . . . . 0.0 110.851 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -46.09 -64.55 0.72 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.622 -0.673 . . . . 0.0 112.453 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.03 -52.47 49.79 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 120.577 -1.327 . . . . 0.0 110.737 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.24 68.18 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.258 -1.142 . . . . 0.0 111.006 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.487 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -65.87 -20.66 66.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -37.9 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 0.7 OUTLIER -145.44 -79.25 0.18 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.267 -1.521 . . . . 0.0 113.751 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.407 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 82.5 m-20 -90.65 72.63 6.76 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.712 -1.243 . . . . 0.0 114.087 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.487 ' CB ' ' HA ' ' A' ' 526' ' ' ALA . 9.6 p -130.16 150.63 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.738 -1.226 . . . . 0.0 112.572 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 87.8 mm-40 -144.02 149.86 37.34 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 5.2 t -112.33 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.761 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -103.08 116.67 32.96 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . . . . . . . . . 9.8 pt -136.0 150.7 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.747 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.3 p -118.13 -163.99 0.98 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.54 163.15 40.36 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.607 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.8 p -128.7 22.25 5.9 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.875 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -174.0 43.85 0.14 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.35 -0.41 56.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.881 -0.776 . . . . 0.0 111.732 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -55.68 -42.71 75.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.995 -1.066 . . . . 0.0 110.851 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 m -116.76 156.38 27.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.591 -0.693 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.53 34.38 55.22 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.9 t -62.62 -43.36 98.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.42 -1.047 . . . . 0.0 110.61 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.53 87.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.9 m -63.98 -39.45 94.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.846 -0.797 . . . . 0.0 111.007 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.09 82.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.01 -42.26 99.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.657 -0.652 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 63.8 tpp -63.59 -34.58 78.14 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.5 -0.75 . . . . 0.0 109.515 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.23 -53.89 50.26 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 39.0 ttp -58.57 -44.86 89.88 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.317 -0.864 . . . . 0.0 109.914 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . 0.434 ' HA ' ' CG2' ' A' ' 555' ' ' VAL . 75.8 mmtt -60.28 -32.04 70.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.643 -0.66 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.81 -16.6 63.83 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.337 -0.852 . . . . 0.0 110.607 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.38 2.85 2.65 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 138.73 -16.66 3.29 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.21 -1.472 . . . . 0.0 111.817 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 551' ' ' LYS . 35.2 m -102.01 120.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 120.996 -1.297 . . . . 0.0 110.262 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -169.71 133.29 1.25 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.757 -0.589 . . . . 0.0 109.974 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 46.4 m -98.84 126.86 44.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.41 -0.806 . . . . 0.0 109.364 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -76.92 -80.87 0.09 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.274 -0.891 . . . . 0.0 111.373 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -171.9 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.374 -0.829 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -86.27 -21.56 27.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 110.921 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -123.89 124.38 42.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -72.81 -128.32 0.11 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -70.12 96.47 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.65 -6.74 58.78 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.673 -0.898 . . . . 0.0 111.426 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -98.46 -21.77 16.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.137 -0.977 . . . . 0.0 110.688 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.46 120.36 42.89 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 110.43 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -9.69 22.41 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.22 1.116 . . . . 0.0 109.225 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -74.03 65.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.225 0 O-C-N 121.409 -0.807 . . . . 0.0 109.909 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.216 -179.761 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 67.2 m -58.93 -43.8 91.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.908 . . . . 0.0 110.701 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 135.13 -9.59 4.45 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.156 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 96.5 mt -88.49 126.04 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.126 -1.22 . . . . 0.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -120.42 165.73 14.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.432 -0.793 . . . . 0.0 110.377 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.11 142.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.788 . . . . 0.0 109.817 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.9 124.54 48.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.728 . . . . 0.0 109.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 431' ' ' PRO . 62.9 t0 -68.97 -52.21 31.4 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.421 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -139.39 3.02 2.1 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.437 -0.789 . . . . 0.0 111.419 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.66 -31.13 66.48 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.904 -1.123 . . . . 0.0 110.827 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 17.0 p -64.63 -40.64 95.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.816 -0.552 . . . . 0.0 111.915 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.59 -35.93 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 111.961 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.81 -46.99 82.66 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.71 -1.244 . . . . 0.0 110.63 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.35 75.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.436 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 1.3 tt -63.34 -39.03 93.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.825 -0.547 . . . . 0.0 110.52 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 59.3 m -61.23 -37.84 84.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.424 -0.797 . . . . 0.0 110.419 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -63.3 -44.69 94.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.325 -0.859 . . . . 0.0 111.663 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -67.66 -46.06 73.48 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.149 -0.969 . . . . 0.0 111.949 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 63.9 mt -65.44 -42.35 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.985 -1.072 . . . . 0.0 109.921 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 16.6 ttm -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.19 -25.66 65.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.52 -0.738 . . . . 0.0 109.381 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 0.0 OUTLIER -93.11 -15.64 25.83 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.867 -1.146 . . . . 0.0 109.025 175.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.3 -40.3 86.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.608 -0.683 . . . . 0.0 110.263 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -115.49 18.67 15.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.969 -1.082 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 407' ' ' VAL . 7.1 p -48.7 116.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.492 -0.755 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.8 p -50.49 89.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.786 -0.571 . . . . 0.0 111.016 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 405' ' ' VAL . 14.2 p -108.74 133.7 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -96.76 141.7 23.47 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 110.85 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.93 -24.35 39.83 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.143 1.075 . . . . 0.0 110.232 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -66.76 -32.32 73.53 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.782 0.801 . . . . 0.0 110.392 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 67.21 1.14 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 18.6 t -49.56 148.74 2.69 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.55 -0.718 . . . . 0.0 110.604 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.9 p -100.93 110.06 59.9 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.637 . . . . 0.0 110.855 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.81 121.37 5.44 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.004 1.002 . . . . 0.0 111.3 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -169.4 61.7 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.825 . . . . 0.0 110.181 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 417' ' ' ALA . 5.2 t -67.47 -31.36 71.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.323 -0.861 . . . . 0.0 108.799 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.425 ' N ' HG23 ' A' ' 416' ' ' THR . . . -64.55 -12.64 47.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 110.735 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.7 81.24 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.489 ' CD1' HG11 ' A' ' 436' ' ' VAL . 26.0 p90 -90.27 -0.42 57.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.93 -1.336 . . . . 0.0 110.161 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.8 m -76.07 -38.81 56.59 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.447 0.642 . . . . 0.0 109.962 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.49 -49.51 75.08 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.971 0.891 . . . . 0.0 111.068 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 97.4 t -68.41 -42.24 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.771 -0.581 . . . . 0.0 111.146 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 88.1 p -59.48 -33.05 70.83 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.007 . . . . 0.0 110.42 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.11 -46.03 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.7 -0.625 . . . . 0.0 111.026 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 423' ' ' VAL . 1.8 pp -64.13 -34.76 78.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.178 -0.951 . . . . 0.0 112.367 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.26 85.5 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.629 -1.294 . . . . 0.0 109.15 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -63.3 -32.3 73.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -66.33 -93.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.428 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -177.26 -53.79 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.369 -1.457 . . . . 0.0 109.433 177.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 41.1 Cg_endo -68.72 106.36 1.46 Allowed 'Trans proline' 0 N--CA 1.48 0.726 0 N-CA-C 108.204 -1.498 . . . . 0.0 108.204 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.446 ' HB3' ' N ' ' A' ' 532' ' ' VAL . 0.2 OUTLIER -92.36 103.56 15.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -164.07 89.81 0.57 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.938 -1.102 . . . . 0.0 109.27 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.436 ' HB2' ' CD2' ' A' ' 395' ' ' LEU . . . -137.4 170.0 16.83 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.785 0.802 . . . . 0.0 111.414 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.35 126.73 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 419' ' ' TYR . 22.4 t -130.04 160.4 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 110.729 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.5 t -133.58 138.79 46.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.434 -0.791 . . . . 0.0 110.685 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.02 166.51 23.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -116.89 -44.59 2.81 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.283 -1.128 . . . . 0.0 109.492 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.9 165.85 38.3 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.98 36.21 64.73 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -59.13 -22.34 60.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.79 -0.829 . . . . 0.0 112.001 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.56 90.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.82 -29.49 59.15 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -60.17 -41.3 92.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.597 -0.943 . . . . 0.0 109.957 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.0 mtm180 -64.01 -36.12 82.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.16 -30.13 68.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.415 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.62 -49.73 69.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 111.124 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -57.43 -32.58 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.003 -1.061 . . . . 0.0 110.138 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.67 -27.18 68.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 454' ' ' MET . 83.4 tt0 -66.55 -36.6 83.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 455' ' ' MET . 0.4 OUTLIER -62.56 -35.47 79.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.488 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 46.9 t -64.63 -28.2 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 95.0 mtp -68.26 -42.73 79.17 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.216 -0.928 . . . . 0.0 111.764 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 6.6 ptm -63.36 -21.58 66.36 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.51 -1.369 . . . . 0.0 109.245 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.43 48.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.456 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.16 -41.05 97.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.47 -22.53 62.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.799 -0.563 . . . . 0.0 110.497 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -75.28 -0.23 18.9 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.171 -0.956 . . . . 0.0 111.651 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 82.24 12.53 80.59 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 120.92 -1.112 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -139.54 151.84 46.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 110.653 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -92.85 179.28 5.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.587 -0.696 . . . . 0.0 109.205 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 14.7 m -141.85 153.23 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.779 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -98.52 118.31 34.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -122.72 128.82 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.42 -0.8 . . . . 0.0 109.467 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 465' ' ' ILE . 5.4 mp -121.39 115.92 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.972 -0.455 . . . . 0.0 110.224 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -71.05 161.41 31.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -57.36 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.121 -0.987 . . . . 0.0 110.298 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -48.43 -19.8 0.35 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.036 -1.04 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.22 -10.64 59.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -55.11 -25.51 31.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 111.827 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 77.9 p -59.06 -41.92 89.1 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.989 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -64.95 -41.54 95.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.566 -0.709 . . . . 0.0 109.541 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 38.7 ttm -58.0 -36.6 72.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.588 -0.695 . . . . 0.0 110.536 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -60.89 -40.62 93.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -0.82 . . . . 0.0 109.869 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 52.2 mtt -62.79 -40.05 96.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.622 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.401 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 65.0 pttt -117.52 -158.3 0.7 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.165 -0.959 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 94.8 mm-40 46.15 88.83 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.452 -0.78 . . . . 0.0 112.118 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -116.75 26.28 9.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -107.7 -9.82 15.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 111.449 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -11.39 3.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 111.909 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -173.58 55.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 5.7 t -62.27 -18.48 61.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.318 -0.864 . . . . 0.0 109.921 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 163.81 -21.08 0.15 Allowed Glycine 0 N--CA 1.501 2.986 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.51 71.31 3.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.029 -1.277 . . . . 0.0 110.014 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.421 ' O ' HD11 ' A' ' 487' ' ' ILE . 0.1 OUTLIER -86.77 -82.96 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.398 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.421 HD11 ' O ' ' A' ' 486' ' ' LEU . 34.5 mm -145.23 -86.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.147 . . . . 0.0 110.322 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 69.7 p -96.33 47.78 1.08 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.46 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -111.65 59.84 0.35 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.454 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 79.2 ttt180 -143.98 -61.44 0.39 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.438 -1.037 . . . . 0.0 108.908 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -110.71 -31.01 7.35 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.382 0.611 . . . . 0.0 110.558 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -35.92 82.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.306 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.46 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 7.1 mt -91.95 -26.46 18.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.332 -0.855 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 41.7 tp -104.55 -41.64 5.65 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.66 -8.68 18.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.972 -1.08 . . . . 0.0 113.733 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 86.6 -16.36 46.0 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.674 -1.267 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.83 -178.52 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.197 -1.178 . . . . 0.0 109.429 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.38 156.49 22.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.177 -0.952 . . . . 0.0 110.644 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.454 ' CE1' ' HB3' ' A' ' 490' ' ' ARG . 0.1 OUTLIER -113.66 149.06 35.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.855 -0.528 . . . . 0.0 109.726 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 4.9 t -47.09 104.67 0.42 Allowed Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.531 -0.731 . . . . 0.0 110.575 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.72 111.89 3.34 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.25 1.131 . . . . 0.0 110.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 174.42 34.64 0.04 OUTLIER Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 14.5 m -99.35 -177.21 3.52 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.331 1.063 . . . . 0.0 113.461 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.417 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 52.4 m -120.48 128.79 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 531' ' ' GLN . 37.4 t -116.45 131.79 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.911 0.863 . . . . 0.0 112.726 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.416 HG21 HG22 ' A' ' 449' ' ' VAL . 39.6 mt -129.71 113.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.947 -1.096 . . . . 0.0 108.121 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.413 HG13 ' CG2' ' A' ' 534' ' ' ILE . 10.6 p -114.93 105.21 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.883 -1.136 . . . . 0.0 111.9 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -85.48 124.17 31.75 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 468' ' ' ALA . 9.3 tp-100 -160.1 125.78 4.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -91.4 -31.82 9.28 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.15 -164.08 0.83 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.02 -5.67 3.09 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.89 -39.14 79.92 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.126 -0.984 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 1.9 m -87.29 -17.34 32.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.559 -0.713 . . . . 0.0 111.733 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.52 -41.8 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.43 -0.794 . . . . 0.0 109.871 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.54 -43.06 57.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.527 -0.733 . . . . 0.0 111.888 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.05 -44.55 97.22 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.971 -1.081 . . . . 0.0 110.954 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -60.16 -42.1 94.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 0.0 109.508 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -38.35 77.21 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.797 -0.564 . . . . 0.0 109.619 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.9 m -61.42 -36.33 80.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.303 -0.873 . . . . 0.0 108.993 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.36 -38.29 81.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.8 -0.563 . . . . 0.0 109.984 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 526' ' ' ALA . 0.5 OUTLIER -67.68 -21.29 65.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.15 -0.969 . . . . 0.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -46.44 -63.33 1.03 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.37 -0.831 . . . . 0.0 111.198 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.74 79.36 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.75 37.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.75 -0.853 . . . . 0.0 110.48 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.422 ' HA ' HG11 ' A' ' 530' ' ' VAL . . . -46.42 -25.41 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 112.767 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -59.02 -42.91 91.31 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.78 -35.74 0.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.286 -0.884 . . . . 0.0 110.856 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -79.77 103.14 9.47 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 526' ' ' ALA . 16.4 m -149.45 125.86 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.08 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.7 OUTLIER 176.23 100.2 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.446 ' N ' ' HB3' ' A' ' 432' ' ' SER . 95.5 t -107.47 109.86 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.629 1.204 . . . . 0.0 109.989 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . 0.306 4.3 tt -114.45 115.58 27.51 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 103.028 -2.952 . . . . 0.0 103.028 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.413 ' CG2' HG13 ' A' ' 507' ' ' VAL . 0.5 OUTLIER -134.48 129.65 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.841 -177.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.43 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 68.1 p -100.87 -163.58 1.03 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.6 165.62 36.02 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.21 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 4.4 p -132.94 16.14 4.23 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.38 42.96 0.31 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -96.5 -0.04 49.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.745 -0.856 . . . . 0.0 112.182 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -46.07 -32.06 2.65 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.161 -0.962 . . . . 0.0 111.496 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 t -131.49 162.59 29.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.463 -0.773 . . . . 0.0 109.377 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.69 31.71 58.0 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.8 t -61.91 -46.53 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.964 . . . . 0.0 110.758 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.3 -38.19 94.78 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 5.6 t -63.13 -33.73 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.816 -0.814 . . . . 0.0 109.686 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.11 80.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.598 -0.689 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.97 -41.02 97.67 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.461 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 87.7 mmm -65.51 -32.97 74.85 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.377 -0.827 . . . . 0.0 108.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -54.11 -54.76 35.04 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.597 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 65.9 ttp -59.11 -43.22 91.89 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.16 -0.962 . . . . 0.0 110.439 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.26 -32.36 73.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.424 -0.798 . . . . 0.0 112.133 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.1 -13.54 61.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.375 -0.828 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -72.8 6.91 2.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 112.664 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 140.7 -17.69 2.82 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.87 -1.157 . . . . 0.0 110.967 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 81.5 t -91.2 114.51 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.155 -1.203 . . . . 0.0 110.303 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -166.69 128.5 1.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.472 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 7.9 t -80.98 127.92 33.11 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.423 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.96 -91.55 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 0.0 111.06 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -158.74 -81.77 0.05 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.041 -1.037 . . . . 0.0 110.982 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -75.44 -22.61 57.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 111.064 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -132.14 158.05 42.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.289 -0.882 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 152.34 -149.96 21.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -97.35 26.22 23.83 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -95.14 -25.19 16.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.407 -1.055 . . . . 0.0 110.665 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.58 -5.1 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.348 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.72 71.79 2.58 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.067 -1.021 . . . . 0.0 109.875 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.95 -24.03 40.06 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.682 1.359 . . . . 0.0 111.34 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . 177.5 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.234 -0.916 . . . . 0.0 110.098 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.137 -179.433 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 71.2 m -59.15 -35.58 73.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.562 -0.711 . . . . 0.0 109.799 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.21 96.94 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 9.1 tp -93.41 133.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.475 -1.015 . . . . 0.0 110.613 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.94 165.4 18.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.706 -0.621 . . . . 0.0 110.392 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 70.9 t -107.21 126.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.644 -0.66 . . . . 0.0 109.311 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.76 128.43 45.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.652 -0.655 . . . . 0.0 109.813 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.31 12.83 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.076 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.57 -10.28 59.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.52 -0.738 . . . . 0.0 111.501 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.31 -39.71 87.95 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.6 m -64.24 -42.57 96.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.477 -0.764 . . . . 0.0 109.946 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.79 -34.41 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.784 -0.572 . . . . 0.0 110.621 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -61.12 -48.09 83.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.296 -0.877 . . . . 0.0 111.349 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.89 78.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.45 -0.782 . . . . 0.0 110.458 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 399' ' ' ILE . 10.0 tt -61.86 -39.15 90.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.751 -0.593 . . . . 0.0 110.507 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 60.6 m -63.17 -40.35 97.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.747 -0.596 . . . . 0.0 111.49 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.42 -41.8 97.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.333 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.3 -42.39 93.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.618 -0.676 . . . . 0.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -63.08 -39.01 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 120.906 -1.121 . . . . 0.0 108.761 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.5 mtp -65.37 -28.47 69.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.37 -29.87 70.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.538 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 55.1 tt0 -92.8 -13.58 28.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.43 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -66.18 -36.91 84.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.651 -0.656 . . . . 0.0 109.458 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -116.81 18.85 14.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.791 -1.193 . . . . 0.0 109.919 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.8 p -61.81 118.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.493 -0.754 . . . . 0.0 110.007 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.2 m -53.91 105.08 0.12 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.53 132.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.612 -0.68 . . . . 0.0 109.548 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -91.95 140.68 24.83 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.552 -0.718 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.1 -23.37 33.88 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.264 1.139 . . . . 0.0 110.265 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -58.68 -43.0 89.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.322 -0.862 . . . . 0.0 109.395 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 67.38 0.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 91.4 p -52.66 117.4 2.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.241 -0.912 . . . . 0.0 111.525 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.447 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 8.7 p -62.58 149.94 87.4 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.447 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.6 Cg_endo -61.88 140.47 85.41 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.068 1.036 . . . . 0.0 110.095 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.435 ' NH2' ' HB2' ' A' ' 439' ' ' GLN . 42.2 mtm180 -106.44 -12.77 15.54 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.839 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 38.5 p -103.26 10.77 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.388 -1.445 . . . . 0.0 108.792 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.68 -87.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.47 78.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.652 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 419' ' ' TYR . 78.7 m-85 -108.32 -25.38 11.04 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 120.756 2.278 . . . . 0.0 109.184 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.7 t -72.94 -40.75 65.14 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -64.12 -35.87 82.16 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.13 84.71 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.338 0.589 . . . . 0.0 109.877 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.84 -45.6 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 0.0 111.03 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 85.9 p -60.08 -41.51 92.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.142 -0.974 . . . . 0.0 111.577 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.88 -47.02 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.404 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.55 -32.56 18.89 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.61 -0.682 . . . . 0.0 112.0 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.18 71.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 0.0 109.278 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.08 -29.46 69.76 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -64.73 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.65 -51.12 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.503 -1.373 . . . . 0.0 111.346 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 50.1 Cg_endo -86.31 110.11 0.98 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 O-C-N 122.698 0.841 . . . . 0.0 110.03 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.8 m -91.19 99.78 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 111.089 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.803 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 7.4 tp -156.79 90.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.619 -0.676 . . . . 0.0 111.017 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.43 166.58 23.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.772 -0.58 . . . . 0.0 110.979 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.17 125.36 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.631 -0.668 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.21 153.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.012 -1.055 . . . . 0.0 110.748 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.9 t -132.92 139.09 47.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.21 -0.931 . . . . 0.0 111.735 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.401 ' HA2' ' NH1' ' A' ' 415' ' ' ARG . . . -141.57 143.85 13.63 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . 0.435 ' HB2' ' NH2' ' A' ' 415' ' ' ARG . 27.1 mt-30 -143.29 55.25 1.36 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -1.066 . . . . 0.0 110.279 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 151.73 140.31 3.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.47 79.66 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.01 60.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.964 . . . . 0.0 112.014 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.35 89.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 110.883 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.79 -31.05 56.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -67.17 -40.39 86.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.699 -0.883 . . . . 0.0 111.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.405 ' O ' HG12 ' A' ' 449' ' ' VAL . 51.9 mtt-85 -64.14 -41.84 97.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -72.65 -29.51 63.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -61.25 -46.13 91.66 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.394 -0.816 . . . . 0.0 110.463 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -62.78 -31.22 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.317 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -58.81 -34.19 71.22 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.93 -30.18 70.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.2 -0.938 . . . . 0.0 108.619 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.06 -37.07 83.58 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.59 -29.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.87 -39.43 87.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -23.97 66.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.654 -0.654 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.08 -21.75 36.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -67.48 -41.56 84.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.852 -0.53 . . . . 0.0 110.297 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -71.77 -34.44 69.44 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.089 -1.007 . . . . 0.0 110.374 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -77.71 6.99 6.31 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.464 -0.773 . . . . 0.0 111.702 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.85 24.12 72.81 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.53 129.17 50.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.609 -0.936 . . . . 0.0 110.835 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -92.54 161.41 14.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 17.2 m -145.31 157.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.431 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 57.6 tt0 -103.13 124.68 49.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.795 -0.566 . . . . 0.0 109.726 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.414 ' HA ' ' CG1' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -129.09 132.17 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.048 . . . . 0.0 109.31 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.402 ' CG2' ' HD3' ' A' ' 471' ' ' ARG . 87.2 mt -125.11 121.4 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.062 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -79.75 163.0 24.82 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.69 -159.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.337 -0.852 . . . . 0.0 109.949 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.53 -16.08 0.33 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.643 -1.286 . . . . 0.0 111.021 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -72.16 -14.53 61.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.975 -1.078 . . . . 0.0 110.218 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . 0.402 ' HD3' ' CG2' ' A' ' 466' ' ' ILE . 49.1 ttp180 -57.47 -30.92 65.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.161 -0.962 . . . . 0.0 110.877 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 85.1 p -55.46 -44.3 76.27 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.343 -0.848 . . . . 0.0 109.66 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -65.03 -37.99 89.41 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -36.46 77.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.715 -0.616 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -59.23 -38.1 79.15 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.195 -0.941 . . . . 0.0 109.938 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 97.8 mtp -60.22 -38.09 82.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.88 -146.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.497 -0.752 . . . . 0.0 109.772 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 47.58 78.51 0.08 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.036 -1.04 . . . . 0.0 111.853 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -117.75 10.26 13.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -77.94 -4.48 47.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.971 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.4 17.63 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.224 -0.923 . . . . 0.0 113.278 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.41 ' CD1' ' HG2' ' A' ' 481' ' ' ARG . 9.8 mp -125.44 4.86 7.64 Favored 'General case' 0 N--CA 1.508 2.438 0 CA-C-N 120.475 1.489 . . . . 0.0 112.279 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 10.3 m -74.55 35.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.385 -1.447 . . . . 0.0 112.512 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 109.08 9.78 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 120.669 -1.27 . . . . 0.0 110.088 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -87.82 11.7 14.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.135 -1.215 . . . . 0.0 110.385 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 464' ' ' GLN . 3.9 mm? -53.37 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -174.65 -69.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.87 . . . . 0.0 109.118 174.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.409 ' HB ' ' CB ' ' A' ' 499' ' ' PHE . 3.0 t -103.35 10.5 37.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.0 111.496 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -79.82 66.89 3.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 499' ' ' PHE . 66.4 ttt180 -142.78 -69.64 0.34 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.425 ' HG3' ' HG2' ' A' ' 490' ' ' ARG . 74.9 mtt180 -116.1 -19.8 10.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.248 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.1 -39.81 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 0.0 108.487 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 3.2 mt -92.51 -18.34 23.29 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.132 0.491 . . . . 0.0 110.966 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 52.5 tp -104.23 -46.84 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.417 -0.802 . . . . 0.0 112.548 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.47 -5.72 15.09 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.26 -0.9 . . . . 0.0 113.103 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 79.0 48.15 7.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.68 -179.44 3.7 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 122.118 -0.637 . . . . 0.0 109.626 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.18 149.54 35.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 0.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 490' ' ' ARG . 28.2 m-85 -131.22 149.21 52.67 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.776 0.798 . . . . 0.0 111.723 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 2.6 t -56.07 107.29 0.84 Allowed Pre-proline 0 N--CA 1.496 1.831 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.947 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 528' ' ' HIS . 52.5 Cg_endo -74.62 114.74 4.1 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.54 1.284 . . . . 0.0 109.435 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -174.35 30.85 0.09 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.417 ' CB ' ' CD1' ' A' ' 487' ' ' ILE . 86.0 p -92.7 173.25 7.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 112.44 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 26.5 m -119.81 99.55 6.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.36 134.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.819 0.819 . . . . 0.0 112.071 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 18.5 pt -130.1 149.54 33.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 534' ' ' ILE . 5.2 p -142.07 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.435 1.112 . . . . 0.0 110.785 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -83.91 108.94 17.21 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -133.9 114.97 13.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.76 -32.39 59.23 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -97.31 175.33 6.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.46 -7.76 13.42 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.81 -0.556 . . . . 0.0 111.027 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 514' ' ' SER . 4.3 pp -67.62 -37.95 83.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.212 -0.93 . . . . 0.0 111.254 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' SER . . . . . 0.4 ' N ' ' CD1' ' A' ' 513' ' ' LEU . 2.3 p -93.24 -14.77 26.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 0.0 111.199 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.08 -48.38 57.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.01 -1.056 . . . . 0.0 108.424 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.97 -42.44 89.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.001 -0.437 . . . . 0.0 111.667 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -57.9 -46.93 84.2 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.212 -0.93 . . . . 0.0 111.111 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.436 ' O ' HD21 ' A' ' 522' ' ' LEU . 98.6 m -62.31 -45.94 90.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.417 ' HG ' ' HG3' ' A' ' 550' ' ' MET . 0.0 OUTLIER -55.3 -28.56 54.36 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.632 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 m -64.15 -28.24 69.63 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 39.3 tp -80.93 -34.03 33.61 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.523 -0.736 . . . . 0.0 109.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 518' ' ' THR . 4.3 mm? -58.01 -31.86 67.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.8 -63.89 0.86 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.951 -0.468 . . . . 0.0 111.62 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.5 52.04 Favored Glycine 0 N--CA 1.499 2.886 0 O-C-N 120.867 -1.146 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.1 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.105 -1.232 . . . . 0.0 113.284 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.606 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -58.13 -26.2 62.37 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.083 -1.011 . . . . 0.0 112.128 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -54.89 -30.36 58.02 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 501' ' ' PRO . 7.0 t60 -106.65 -128.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.389 -0.82 . . . . 0.0 110.439 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.71 67.7 9.92 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.721 -1.237 . . . . 0.0 111.974 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.606 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 2.8 t -133.86 163.83 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.66 -1.275 . . . . 0.0 110.253 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 2.9 mm-40 -163.81 165.0 23.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 33.1 t -109.95 105.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.427 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.4 OUTLIER -103.75 115.07 29.81 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.412 HG23 HG11 ' A' ' 532' ' ' VAL . 7.1 pt -136.0 164.97 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 117.854 -1.538 . . . . 0.0 113.912 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 70.1 p -127.67 -168.3 1.87 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.97 169.08 25.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.85 17.18 2.31 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.784 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -155.27 33.55 0.65 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.04 -0.29 47.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.683 -0.893 . . . . 0.0 111.66 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -51.36 -43.88 61.95 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 77.2 p -119.59 161.12 21.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 57.93 29.06 61.53 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.0 t -59.85 -45.58 91.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.291 -1.123 . . . . 0.0 110.615 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.82 93.32 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 35.5 m -63.76 -35.72 81.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.033 -0.686 . . . . 0.0 110.788 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.15 80.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.509 -0.744 . . . . 0.0 110.355 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.02 -40.19 94.84 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 48.3 ttp -63.96 -30.35 71.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.49 -53.97 31.9 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' MET . . . . . 0.417 ' HG3' ' HG ' ' A' ' 519' ' ' LEU . 12.4 ttp -57.76 -42.96 85.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -0.837 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.18 -31.68 67.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.476 -0.765 . . . . 0.0 111.669 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -68.43 -31.87 71.51 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.304 -0.873 . . . . 0.0 109.95 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.81 21.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.945 -0.472 . . . . 0.0 111.465 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 107.43 25.61 5.97 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.657 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.92 110.76 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.561 -0.964 . . . . 0.0 109.961 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -170.96 133.09 0.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.519 -0.738 . . . . 0.0 110.822 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 8.9 t -116.76 122.28 44.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -72.87 -80.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.276 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 559' ' ' ARG . 8.7 tpm_? -135.13 -78.67 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.589 -0.694 . . . . 0.0 109.157 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.24 -23.39 16.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.535 -0.728 . . . . 0.0 110.113 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -147.82 129.61 15.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -112.98 35.68 4.47 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 77.62 16.48 80.14 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.49 -24.62 66.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -1.127 . . . . 0.0 110.146 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -88.12 -4.7 58.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.533 -0.73 . . . . 0.0 111.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . 0.531 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -168.3 54.88 0.27 Allowed Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.257 -0.902 . . . . 0.0 110.174 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 37.8 Cg_endo -87.71 -5.44 7.08 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 122.946 0.972 . . . . 0.0 110.636 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -94.16 -12.99 27.2 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.408 -0.808 . . . . 0.0 111.055 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.904 -1.045 . . . . 0.0 109.407 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.244 0.545 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 58.5 m -133.38 158.64 42.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.633 -0.667 . . . . 0.0 109.96 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 97.0 -21.8 44.24 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 92.8 mt -107.01 -21.81 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -1.029 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -114.18 51.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.03 133.92 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.38 0.609 . . . . 0.0 109.935 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 387' ' ' LEU . 4.5 mm? -98.21 4.14 48.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.451 -0.78 . . . . 0.0 111.384 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -60.31 -45.32 93.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.169 -0.957 . . . . 0.0 110.891 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -130.25 -3.91 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.293 -0.879 . . . . 0.0 111.999 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.29 -41.32 98.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.115 -0.991 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 61.4 m -59.81 -43.68 94.37 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.57 -0.706 . . . . 0.0 110.206 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 69.4 t -65.76 -35.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.302 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -61.93 -46.4 89.49 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.289 -0.882 . . . . 0.0 110.59 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.19 80.14 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.696 0.76 . . . . 0.0 109.161 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.477 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -61.96 -39.39 91.98 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 68.3 m -61.15 -36.43 79.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.072 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -63.87 -44.48 92.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.085 -1.009 . . . . 0.0 111.46 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.84 -46.09 76.18 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.182 -0.949 . . . . 0.0 111.861 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.84 -42.74 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.812 . . . . 0.0 109.99 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 40.4 mmm -62.22 -31.76 72.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.874 -0.516 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -58.53 -34.09 70.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.377 -0.827 . . . . 0.0 109.154 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -90.57 -14.64 32.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.22 -39.27 89.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -116.85 18.8 14.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.945 -1.097 . . . . 0.0 110.555 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.402 HG13 ' CZ ' ' A' ' 415' ' ' ARG . 3.5 p -51.34 117.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.538 -0.726 . . . . 0.0 109.177 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 25.4 m -52.17 98.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.499 0.666 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.42 133.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.755 -0.59 . . . . 0.0 109.906 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -92.19 140.28 24.43 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 111.185 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.91 -28.17 42.66 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.254 1.133 . . . . 0.0 110.22 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.9 -33.29 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.826 0.822 . . . . 0.0 109.861 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.17 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 118.53 5.24 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.746 . . . . 0.0 110.675 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 110.65 8.08 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.757 -0.589 . . . . 0.0 110.319 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.03 139.18 29.46 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 O-C-N 123.066 1.035 . . . . 0.0 110.31 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.402 ' CZ ' HG13 ' A' ' 405' ' ' VAL . 23.7 ptt85 -168.85 60.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.672 -0.642 . . . . 0.0 110.738 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 417' ' ' ALA . 9.7 t -65.48 -34.96 79.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 416' ' ' THR . . . -67.29 -7.05 21.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.689 -0.632 . . . . 0.0 110.953 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.75 -43.73 98.53 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 436' ' ' VAL . 1.1 m-85 -91.64 -3.36 56.44 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.857 -1.378 . . . . 0.0 108.938 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 33.8 p -77.96 -39.04 43.8 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -77.6 -43.55 31.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.471 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.16 -49.82 74.3 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.666 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.26 -41.42 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.922 -0.487 . . . . 0.0 111.861 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -58.92 -41.7 87.94 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.03 -1.044 . . . . 0.0 111.242 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 84.4 t -64.47 -45.42 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.3 OUTLIER -56.17 -35.71 67.52 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.54 -0.725 . . . . 0.0 111.993 -177.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.92 81.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.062 -1.024 . . . . 0.0 108.593 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.88 -30.59 71.6 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -63.68 -89.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.05 -60.66 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.449 -1.407 . . . . 0.0 109.565 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.56 113.28 3.58 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 N-CA-C 108.242 -1.484 . . . . 0.0 108.242 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 15.2 m -108.96 117.28 33.79 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.897 0.856 . . . . 0.0 112.039 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.42 ' O ' ' CG1' ' A' ' 392' ' ' VAL . 0.4 OUTLIER -173.22 97.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.87 172.54 12.7 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.203 -0.935 . . . . 0.0 112.462 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.81 136.95 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.381 0.61 . . . . 0.0 109.703 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 60.4 t -141.58 152.9 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 109.629 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.1 p -139.81 149.81 43.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.868 . . . . 0.0 110.752 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.63 159.94 21.76 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -149.23 22.96 0.94 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.93 . . . . 0.0 110.835 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -162.5 -118.13 0.45 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.89 131.33 11.78 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -103.47 -15.02 16.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.293 -1.122 . . . . 0.0 111.291 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -71.55 -43.94 65.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.42 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.08 -28.76 71.22 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -63.84 -40.55 96.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.638 -0.919 . . . . 0.0 109.98 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -64.31 -41.18 96.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.559 -0.713 . . . . 0.0 110.418 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.07 -29.28 66.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.087 -1.008 . . . . 0.0 110.222 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -62.92 -53.09 59.41 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 450' ' ' ALA . 13.6 p -57.77 -30.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.051 -1.031 . . . . 0.0 108.626 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.429 ' N ' HG12 ' A' ' 449' ' ' VAL . . . -64.11 -26.52 68.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.71 -35.33 80.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.866 -1.146 . . . . 0.0 108.292 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.93 -31.38 72.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.495 -0.753 . . . . 0.0 109.009 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 58.1 t -58.48 -38.36 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.248 -0.908 . . . . 0.0 108.948 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 48.0 mtt -63.49 -35.82 81.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.495 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -54.78 -26.24 33.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.366 -0.834 . . . . 0.0 109.587 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.51 -22.84 32.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.667 -0.646 . . . . 0.0 110.497 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -62.02 -46.09 90.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.373 -0.829 . . . . 0.0 108.989 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.0 -31.82 70.93 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.56 -0.84 21.8 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.41 32.03 82.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -130.79 122.15 26.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.969 . . . . 0.0 110.868 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.71 162.78 28.93 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.45 168.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.999 -1.063 . . . . 0.0 111.588 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -120.45 115.78 24.16 Favored 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 465' ' ' ILE . 0.1 OUTLIER -131.11 138.83 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.508 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.91 125.39 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.716 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.4 164.76 25.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.7 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.693 -0.629 . . . . 0.0 109.918 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -46.55 -21.44 0.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.175 -0.953 . . . . 0.0 112.043 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -75.37 -7.62 54.51 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.406 -0.809 . . . . 0.0 112.397 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -57.5 -25.53 59.94 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.784 -1.198 . . . . 0.0 110.904 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.1 p -59.14 -41.98 89.57 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -62.44 -41.16 98.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.79 69.66 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.87 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -58.31 -39.75 80.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.081 . . . . 0.0 109.171 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 69.1 mtm -60.92 -39.33 89.0 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.793 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -122.97 -140.7 0.32 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.354 -0.841 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 48.52 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.791 -1.193 . . . . 0.0 112.53 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -136.81 28.53 2.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.29 -0.881 . . . . 0.0 109.671 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -108.99 -9.24 15.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -133.3 -10.45 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 112.418 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.92 61.99 0.06 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.751 -1.218 . . . . 0.0 113.062 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 44.2 t -89.36 48.63 1.64 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.746 -1.221 . . . . 0.0 110.575 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 100.03 2.5 55.98 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.986 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -91.05 43.31 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.122 1.461 . . . . 0.0 110.273 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.418 ' O ' ' CG1' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -58.73 -81.92 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -173.37 -73.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 487' ' ' ILE 0.251 70.5 p -103.31 25.47 9.52 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.82 94.81 0.53 Allowed Glycine 0 N--CA 1.496 2.639 0 O-C-N 121.549 -0.72 . . . . 0.0 111.835 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -144.35 -111.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 495' ' ' GLU . 28.4 mmt180 -103.2 -32.73 9.47 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.002 -1.061 . . . . 0.0 108.597 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -47.84 -22.45 0.56 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.04 -58.96 4.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.318 -0.864 . . . . 0.0 111.317 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.71 5.41 26.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.974 -1.079 . . . . 0.0 111.994 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 491' ' ' ARG . 59.0 mm-40 -84.66 -5.93 59.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.977 -1.077 . . . . 0.0 113.069 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 95.82 -11.95 67.65 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.715 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.44 -176.69 0.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.128 -1.219 . . . . 0.0 108.98 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.41 170.43 8.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.352 -0.842 . . . . 0.0 109.637 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -111.41 153.02 26.68 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 52.2 m -81.98 120.71 78.08 Favored Pre-proline 0 N--CA 1.484 1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.84 138.91 77.05 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.407 1.214 . . . . 0.0 111.291 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 149.6 -7.38 0.81 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.442 ' HA ' HD12 ' A' ' 487' ' ' ILE . 48.7 m -85.25 160.25 19.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.302 . . . . 0.0 112.209 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.4 m -106.0 163.27 12.89 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 59.7 t -151.14 121.7 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.878 -1.139 . . . . 0.0 111.312 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 6.2 pt -136.2 112.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.504 HG12 ' CG2' ' A' ' 534' ' ' ILE . 7.8 p -114.48 104.33 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.6 1.191 . . . . 0.0 113.06 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 124.96 31.59 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 126.69 4.75 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.95 -41.86 6.97 Favored Glycine 0 N--CA 1.505 3.258 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -72.04 142.55 49.27 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.68 -12.78 20.71 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.095 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.99 -33.64 76.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 36.3 t -81.14 -23.36 38.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.847 -0.533 . . . . 0.0 111.314 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.85 -47.34 75.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.177 -0.952 . . . . 0.0 110.417 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.673 -0.642 . . . . 0.0 111.586 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -58.81 -51.2 71.02 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.271 -0.893 . . . . 0.0 110.599 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 73.9 m -58.07 -41.07 82.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -38.09 80.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.041 -0.412 . . . . 0.0 111.853 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 47.0 p -64.71 -35.68 81.83 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.793 -1.192 . . . . 0.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -38.25 74.8 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.313 1.054 . . . . 0.0 108.19 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.98 -28.01 69.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.156 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -47.21 -63.12 1.12 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -51.4 58.76 Favored Glycine 0 N--CA 1.502 3.042 0 O-C-N 120.58 -1.325 . . . . 0.0 110.018 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -60.41 -30.22 69.47 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -1.036 . . . . 0.0 110.306 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -64.08 -20.61 66.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.757 -0.59 . . . . 0.0 112.315 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -37.76 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -147.69 -79.93 0.15 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 120.634 1.561 . . . . 0.0 114.304 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.412 ' HB2' ' N ' ' A' ' 502' ' ' GLY . 82.4 m-20 -86.26 60.59 6.32 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.9 p -117.91 133.49 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.858 -1.151 . . . . 0.0 113.362 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 94.3 mt-30 -122.42 129.12 51.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 70.7 t -115.09 117.95 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.123 0.964 . . . . 0.0 112.049 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.33 118.43 33.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 174.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.504 ' CG2' HG12 ' A' ' 507' ' ' VAL . 9.3 pt -128.77 134.8 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 118.254 -1.378 . . . . 0.0 110.858 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 55.3 p -112.87 -163.46 0.85 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.41 165.24 36.27 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.646 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' SER . . . . . 0.405 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 6.6 p -130.17 22.17 5.27 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.876 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -168.47 35.22 0.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -95.81 -0.63 50.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -47.53 -24.7 0.91 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.149 -0.969 . . . . 0.0 111.251 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 69.3 p -124.57 162.0 24.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 51.21 38.09 39.6 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.8 t -59.45 -45.39 91.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.665 -0.903 . . . . 0.0 110.508 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.15 94.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 33.1 m -61.55 -32.65 72.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.745 -0.856 . . . . 0.0 109.629 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.83 79.28 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -62.51 -40.02 95.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.765 . . . . 0.0 109.305 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.14 -31.53 72.03 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.2 28.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.935 -0.478 . . . . 0.0 109.828 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 79.6 mmm -57.98 -43.25 86.44 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.475 -0.766 . . . . 0.0 109.619 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.18 -31.61 70.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.756 -0.59 . . . . 0.0 110.958 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.82 -25.29 67.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.145 -0.972 . . . . 0.0 109.532 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.94 0.44 13.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.484 -0.76 . . . . 0.0 111.723 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 109.31 -14.74 33.15 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.295 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.2 t -65.84 115.01 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.685 1.242 . . . . 0.0 110.13 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -164.39 137.13 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.803 -0.561 . . . . 0.0 110.124 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 9.9 t -98.64 143.76 28.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -74.86 -79.24 0.09 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.315 -0.866 . . . . 0.0 110.496 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -143.18 -79.97 0.21 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -91.25 -20.7 21.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -119.93 156.93 29.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.341 -0.849 . . . . 0.0 111.325 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -71.24 -128.22 0.07 OUTLIER Glycine 0 N--CA 1.485 1.949 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -96.08 44.05 2.07 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -96.15 -17.83 20.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.407 -1.054 . . . . 0.0 110.6 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -91.98 -3.92 55.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 110.685 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -119.0 83.32 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 111.327 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.16 -12.77 25.77 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.564 1.297 . . . . 0.0 109.999 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -107.36 69.85 0.77 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.287 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.105 -179.859 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.304 0.573 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 4.9 m -71.03 -14.53 62.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.702 -0.624 . . . . 0.0 110.462 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.25 11.99 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.883 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 36.1 pt -82.13 160.1 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.332 -1.099 . . . . 0.0 110.47 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -141.83 138.03 31.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.918 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.6 t -111.63 131.63 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.541 -0.724 . . . . 0.0 109.228 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.85 120.57 38.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.077 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -145.37 158.29 43.86 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 -86.37 57.19 4.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.719 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.57 -37.2 86.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.7 m -61.92 -41.72 98.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.473 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.29 -34.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.162 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.71 -42.77 89.41 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.876 -1.14 . . . . 0.0 109.815 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.49 73.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.305 -0.872 . . . . 0.0 108.737 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.8 OUTLIER -60.51 -41.55 94.61 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.45 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 40.0 t -64.88 -39.28 93.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.432 -0.793 . . . . 0.0 111.403 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.57 -43.86 92.56 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.301 -0.874 . . . . 0.0 112.461 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -75.66 -45.72 35.47 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.823 -1.173 . . . . 0.0 112.115 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.87 -42.27 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.88 . . . . 0.0 109.995 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 35.6 mtp -60.77 -31.84 71.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.665 -0.647 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.57 -22.5 66.93 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.3 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.419 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 72.5 tp60 -92.65 -20.63 20.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.097 . . . . 0.0 108.98 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.02 -30.95 70.3 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -114.99 19.25 15.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.211 -0.931 . . . . 0.0 109.857 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 8.4 p -50.84 113.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.1 t -48.77 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.638 -0.664 . . . . 0.0 111.833 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.92 133.42 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.536 -0.728 . . . . 0.0 110.117 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -96.04 143.24 25.78 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.89 . . . . 0.0 110.044 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.85 -24.62 53.71 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.34 1.179 . . . . 0.0 110.385 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -61.28 -39.79 91.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 66.23 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 93.4 p -50.48 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.096 -1.003 . . . . 0.0 110.313 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.33 110.33 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.923 -0.485 . . . . 0.0 110.616 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.5 136.35 12.35 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 O-C-N 122.939 0.968 . . . . 0.0 110.531 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -153.67 70.14 0.83 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.503 -0.748 . . . . 0.0 110.766 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 46.3 p -65.21 -39.03 92.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -49.86 -25.2 2.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.682 -0.636 . . . . 0.0 111.383 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -50.77 -62.25 5.42 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.376 -0.827 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 436' ' ' VAL . 20.0 p90 -88.22 -2.7 58.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.791 -1.417 . . . . 0.0 111.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 51.6 p -72.19 -39.75 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.86 -45.66 27.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.978 -0.451 . . . . 0.0 110.571 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.9 79.69 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.439 -0.788 . . . . 0.0 111.099 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 89.3 t -68.48 -46.19 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.1 p -64.18 -33.04 74.87 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.665 -1.272 . . . . 0.0 111.039 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.65 -36.17 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.695 . . . . 0.0 111.506 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 1.6 pp -70.25 -33.89 72.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 111.586 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.56 78.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.909 -1.119 . . . . 0.0 109.647 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -65.54 -33.38 75.78 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -65.29 -95.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -169.85 -61.85 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.442 -1.411 . . . . 0.0 109.452 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.26 113.85 2.08 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 109.196 -1.117 . . . . 0.0 109.196 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.435 ' HB3' ' CA ' ' A' ' 531' ' ' GLN . 17.3 t -96.55 103.31 15.21 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.718 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.96 88.23 1.31 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 426' ' ' LEU . . . -118.04 156.43 28.6 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.025 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . 0.263 62.2 mt -122.61 127.3 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 45.2 t -141.42 153.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.954 -1.091 . . . . 0.0 111.196 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.3 p -136.26 143.06 44.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.72 129.6 9.95 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.52 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.23 -23.69 10.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.886 -0.773 . . . . 0.0 109.841 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.14 160.28 33.56 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.43 46.47 94.29 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.37 77.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 111.029 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.63 92.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.294 -0.879 . . . . 0.0 111.157 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.85 72.15 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.82 -41.06 90.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -1.014 . . . . 0.0 110.277 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -67.48 -38.5 84.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.364 -0.835 . . . . 0.0 110.996 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -71.64 -31.85 67.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.271 -0.893 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.74 -53.61 44.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.067 -1.021 . . . . 0.0 110.41 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.24 -30.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.038 -1.039 . . . . 0.0 109.218 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.37 -27.95 68.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.15 -34.95 79.6 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.34 -36.07 79.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 95.2 t -58.28 -29.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 91.7 mtp -67.2 -39.68 86.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -55.39 -27.89 50.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.306 -0.871 . . . . 0.0 109.893 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.72 40.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.8 -43.34 88.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 109.514 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -68.59 -30.43 69.17 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.458 0.647 . . . . 0.0 109.841 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -73.68 -1.09 17.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.655 -0.653 . . . . 0.0 111.641 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 79.86 18.56 72.36 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 120.876 -1.14 . . . . 0.0 110.612 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.81 149.94 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.347 -1.09 . . . . 0.0 111.093 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -94.96 -178.51 4.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.413 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 7.3 m -148.0 170.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.926 -1.109 . . . . 0.0 110.805 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -119.35 128.37 54.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 11.2 pt -134.55 141.53 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.251 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.405 ' CG2' ' HD3' ' A' ' 471' ' ' ARG . 85.8 mt -132.7 124.71 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.595 -0.691 . . . . 0.0 109.719 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -79.84 165.9 22.25 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.54 -159.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -49.08 -20.86 0.61 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.61 -1.307 . . . . 0.0 111.334 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.39 -8.98 58.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.456 -0.777 . . . . 0.0 111.353 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . 0.405 ' HD3' ' CG2' ' A' ' 466' ' ' ILE . 64.5 ttp85 -59.44 -23.11 62.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.909 -1.119 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 12.5 t -59.64 -44.13 93.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.391 -0.818 . . . . 0.0 109.527 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -60.89 -45.22 95.46 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.31 -36.0 72.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.637 -0.664 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -59.22 -40.31 85.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.157 -0.965 . . . . 0.0 111.331 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 7.5 ttm -61.59 -36.3 80.28 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.293 -0.879 . . . . 0.0 110.604 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.416 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 53.4 pttt -125.29 -146.84 0.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.797 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . 0.416 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 87.9 mm-40 51.59 71.71 0.43 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.091 -1.006 . . . . 0.0 112.41 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -112.17 18.57 18.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.29 -10.56 40.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.429 -0.795 . . . . 0.0 111.289 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.8 -0.95 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.955 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.31 62.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.64 -1.288 . . . . 0.0 111.415 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 36.6 m -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.888 -1.133 . . . . 0.0 110.318 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 153.19 55.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.8 pt-20 -158.0 92.47 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.2 1.0 . . . . 0.0 110.757 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 487' ' ' ILE . 61.8 mt -99.16 -82.13 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 486' ' ' LEU . 3.1 mp -150.15 -69.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.4 t -99.91 16.23 24.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.383 -0.823 . . . . 0.0 112.092 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.08 59.67 4.96 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 70.7 ttt180 -142.0 -54.83 0.45 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -1.142 . . . . 0.0 109.544 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.413 ' HD2' ' CE ' ' A' ' 497' ' ' MET . 28.3 mmt180 -104.12 -36.23 7.77 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.778 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.46 -41.0 96.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 493' ' ' LEU . 1.2 mt -70.19 -42.08 72.88 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.521 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.89 -42.94 5.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.64 -10.63 24.73 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.921 -1.111 . . . . 0.0 113.083 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 88.3 -21.69 23.57 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 120.68 -1.262 . . . . 0.0 110.909 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.413 ' CE ' ' HD2' ' A' ' 491' ' ' ARG . 78.6 mtm -66.14 176.23 1.81 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.138 -1.213 . . . . 0.0 110.188 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.27 152.03 28.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 111.056 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.436 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.1 OUTLIER -113.14 150.07 32.71 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.0 t -43.25 105.59 0.44 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.032 -0.418 . . . . 0.0 110.524 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.03 114.09 2.66 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.336 1.177 . . . . 0.0 111.572 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.66 34.91 0.18 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 13.1 p -93.61 167.62 11.56 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 112.827 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.2 m -119.52 159.58 24.05 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 73.7 t -143.57 130.78 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 118.527 -1.269 . . . . 0.0 113.026 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 4.7 pt -137.0 120.61 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.484 HG12 ' CG2' ' A' ' 534' ' ' ILE . 11.5 p -119.32 99.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.691 -1.256 . . . . 0.0 111.547 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.08 98.42 9.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -124.78 123.93 41.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . 0.414 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -75.19 -53.93 5.91 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -69.61 -161.52 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.95 -10.6 2.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.947 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.4 -28.02 68.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -0.981 . . . . 0.0 108.596 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 3.6 m -83.84 -19.86 34.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.663 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -48.93 70.07 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.412 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.01 -39.87 65.66 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.0 111.824 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.83 -47.22 86.07 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.586 -0.696 . . . . 0.0 111.572 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.7 m -60.96 -43.01 99.35 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.45 -35.65 68.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.873 -0.517 . . . . 0.0 110.717 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 97.6 m -64.35 -43.91 93.11 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 111.668 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.22 -42.01 93.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.265 -0.897 . . . . 0.0 108.944 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 505' ' ' VAL . 1.8 tp -62.78 -28.47 70.01 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.531 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -46.5 -65.46 0.55 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.413 -0.804 . . . . 0.0 113.166 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -67.88 -49.4 48.74 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.129 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.12 67.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.679 -0.895 . . . . 0.0 111.332 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.48 ' HA ' ' CG2' ' A' ' 530' ' ' VAL . . . -57.13 -24.19 52.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 112.619 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -41.94 -27.0 0.1 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.565 -0.709 . . . . 0.0 112.182 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -108.95 -118.99 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.208 -0.932 . . . . 0.0 112.584 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -89.23 90.25 8.27 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 120.355 -1.466 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -119.4 136.87 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 O-C-N 120.407 -1.433 . . . . 0.0 113.116 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.435 ' CA ' ' HB3' ' A' ' 432' ' ' SER . 9.9 mp0 -126.36 133.58 51.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 40.6 t -114.99 121.66 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 122.971 1.367 . . . . 0.0 111.648 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.8 OUTLIER -123.67 122.53 38.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.484 ' CG2' HG12 ' A' ' 507' ' ' VAL . 9.6 pt -133.09 133.24 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.826 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.433 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 55.8 p -106.47 -164.32 0.99 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.79 168.73 26.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' SER . . . . . 0.414 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -135.38 13.71 3.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.418 178.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -152.22 27.6 0.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -99.5 0.86 43.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -1.062 . . . . 0.0 112.272 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -59.62 -33.98 72.2 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.977 -1.077 . . . . 0.0 112.12 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 27.6 m -102.98 -58.06 1.94 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.072 -1.017 . . . . 0.0 110.819 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -100.34 94.43 1.32 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.8 t -95.31 -36.32 11.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -1.009 . . . . 0.0 110.48 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -60.26 -34.78 86.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.8 p -64.05 -34.3 77.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.942 . . . . 0.0 111.09 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.29 83.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.425 -0.797 . . . . 0.0 109.887 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.81 -40.14 96.45 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.471 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.0 mmm -68.18 -27.52 66.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.401 -0.812 . . . . 0.0 110.319 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -59.46 -55.41 35.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 51.8 ttm -58.89 -48.63 80.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.478 -0.764 . . . . 0.0 110.394 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -59.48 -32.57 70.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.644 -0.66 . . . . 0.0 111.781 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -66.45 -25.07 66.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.259 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.48 -1.04 9.62 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.334 -0.854 . . . . 0.0 111.192 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 116.16 -15.22 15.84 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.897 -1.127 . . . . 0.0 111.162 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.82 102.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 118.942 1.371 . . . . 0.0 109.713 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -158.87 114.06 2.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.813 -0.555 . . . . 0.0 109.629 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 28.8 m -99.09 90.62 4.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.335 -0.853 . . . . 0.0 109.565 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -89.01 -89.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -169.8 -48.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.966 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -102.95 -24.25 13.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -140.16 157.38 45.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -0.814 . . . . 0.0 109.72 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 155.83 -112.81 0.54 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -86.12 -7.72 79.84 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -96.21 -10.53 27.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.304 -1.115 . . . . 0.0 110.755 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -93.06 -9.27 40.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.92 -1.112 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -105.01 89.56 3.03 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.54 -18.74 37.9 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.823 1.433 . . . . 0.0 111.206 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -166.18 113.99 0.91 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.453 -0.779 . . . . 0.0 110.326 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.01 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 36.4 t -62.92 -44.71 95.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.473 -0.767 . . . . 0.0 109.967 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 106.24 63.3 0.61 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 45.8 pt -108.61 25.59 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.622 -0.928 . . . . 0.0 110.132 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -90.84 36.09 0.9 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.36 148.88 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.708 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.08 162.11 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.656 -0.652 . . . . 0.0 110.236 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -87.71 12.64 12.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.39 17.03 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.997 . . . . 0.0 110.454 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.42 -42.08 98.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.193 -0.942 . . . . 0.0 109.396 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.4 m -64.89 -42.88 94.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.878 -0.514 . . . . 0.0 110.712 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 99.9 t -66.45 -35.69 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.536 -0.728 . . . . 0.0 110.665 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -62.45 -45.29 93.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.277 -0.889 . . . . 0.0 109.802 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -71.56 -36.88 71.07 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.58 0.705 . . . . 0.0 110.149 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 426' ' ' LEU . 2.6 tm? -61.18 -38.75 87.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.964 -0.46 . . . . 0.0 110.016 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 42.7 t -63.72 -40.48 96.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.636 -0.665 . . . . 0.0 109.845 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.18 -42.75 99.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.543 -0.723 . . . . 0.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.79 -42.21 97.77 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.116 -0.99 . . . . 0.0 111.708 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.63 -41.21 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 0.0 110.431 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 47.1 mmm -58.25 -33.91 69.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.52 -33.39 75.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.563 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -92.4 -3.83 54.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.936 -1.102 . . . . 0.0 109.778 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 9.2 m120 -89.15 -26.99 21.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.488 -0.757 . . . . 0.0 109.033 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 19.14 15.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 108.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.61 107.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.2 m -49.73 101.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.316 -0.865 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.6 133.32 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.614 . . . . 0.0 110.113 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -92.04 140.17 24.6 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.593 -0.692 . . . . 0.0 109.871 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 -27.87 33.73 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.282 1.149 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -62.41 -29.91 70.83 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.364 -0.835 . . . . 0.0 110.0 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 59.11 0.68 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.3 t -60.03 122.28 13.94 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.934 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.9 p -74.54 120.61 82.33 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.723 -0.61 . . . . 0.0 110.378 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 47.5 Cg_endo -73.65 132.44 17.33 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 122.907 0.951 . . . . 0.0 110.008 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 414' ' ' PRO . 90.8 mtt180 -160.94 56.07 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.833 -0.542 . . . . 0.0 110.017 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 45.0 p -67.34 -34.38 77.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.73 -1.231 . . . . 0.0 108.417 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -71.12 -2.29 15.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.783 -0.573 . . . . 0.0 112.195 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.0 97.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -98.15 -4.06 36.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 110.12 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 8.1 t -73.91 -42.07 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -71.79 -40.82 68.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.34 98.73 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.72 0.771 . . . . 0.0 110.257 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.18 -42.17 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.637 -0.664 . . . . 0.0 111.641 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 90.6 p -58.84 -41.67 87.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 0.0 110.946 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.54 -43.39 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.337 -0.852 . . . . 0.0 110.899 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.432 ' HB3' ' HG ' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -62.64 -35.12 78.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.193 -0.942 . . . . 0.0 111.669 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.72 77.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.734 -1.229 . . . . 0.0 109.217 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.64 -30.11 70.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.8 -88.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.96 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 120.487 -1.383 . . . . 0.0 109.999 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.01 109.98 2.94 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 123.092 1.048 . . . . 0.0 109.724 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.4 m -83.81 98.66 9.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.35 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 10.8 tp -146.04 135.42 22.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -172.18 164.77 6.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 435' ' ' ILE . 19.5 pt -133.51 118.45 30.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.426 ' CG1' HG23 ' A' ' 535' ' ' THR . 0.6 OUTLIER -126.6 150.87 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.995 -1.066 . . . . 0.0 109.863 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 9.2 p -131.73 139.95 49.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.815 -0.553 . . . . 0.0 109.723 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.48 160.9 20.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.84 -19.2 11.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.656 -0.908 . . . . 0.0 110.306 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -174.93 168.15 40.63 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 57.48 82.73 0.05 OUTLIER Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -93.32 -18.49 22.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.502 -0.999 . . . . 0.0 111.444 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.88 -44.74 84.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.973 . . . . 0.0 109.516 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.03 -28.58 70.2 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -61.22 -41.12 96.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.645 -0.914 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 57.9 mtm-85 -61.31 -42.05 98.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.92 . . . . 0.0 110.304 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -72.27 -28.76 63.33 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.387 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -62.21 -50.6 71.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.917 -1.115 . . . . 0.0 110.995 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.16 -32.8 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.691 -1.255 . . . . 0.0 108.341 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.85 -27.53 69.4 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 454' ' ' MET . 80.4 tt0 -65.08 -33.57 76.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.43 -36.31 82.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 99.1 t -60.93 -27.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 59.4 mtt -66.13 -38.94 89.4 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -22.95 65.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.719 0.771 . . . . 0.0 109.18 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.09 -24.97 30.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -69.49 -40.48 77.02 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.947 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.37 -31.59 71.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.272 -0.892 . . . . 0.0 109.422 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -81.56 10.13 6.43 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.69 36.28 93.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -138.44 123.25 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.451 -1.029 . . . . 0.0 111.819 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.412 ' HB2' HD12 ' A' ' 487' ' ' ILE . 46.7 mp0 -85.29 166.47 16.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 34.0 m -138.14 157.8 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 111.99 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -96.44 111.51 23.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.23 131.9 70.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.845 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 467' ' ' ALA . 3.5 mp -102.08 170.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 508' ' ' ASP . . . -123.67 156.82 35.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.55 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.502 0.668 . . . . 0.0 109.964 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -54.43 -11.34 0.52 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.947 -1.096 . . . . 0.0 111.845 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -91.6 7.03 43.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.707 -1.246 . . . . 0.0 112.051 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -59.26 -34.45 72.27 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.856 -1.153 . . . . 0.0 111.526 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 3.7 t -57.21 -53.92 52.62 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.928 -1.108 . . . . 0.0 111.92 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -66.43 -37.92 86.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.895 -1.128 . . . . 0.0 109.457 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.68 -32.52 69.21 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.758 -0.589 . . . . 0.0 109.515 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -62.11 -37.8 86.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.766 -0.583 . . . . 0.0 109.673 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.58 -40.61 79.38 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.915 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.49 -152.71 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.588 -0.695 . . . . 0.0 109.147 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 50.34 81.33 0.06 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.863 -1.148 . . . . 0.0 111.623 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -122.03 27.47 8.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 110.09 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -113.42 -19.85 11.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -109.19 -14.44 14.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.693 -0.63 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.87 62.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.081 -1.012 . . . . 0.0 111.33 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 51.4 p -90.72 48.59 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.832 -1.168 . . . . 0.0 110.169 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.84 26.03 43.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.99 54.01 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -1.06 . . . . 0.0 109.1 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.21 -81.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.43 ' O ' ' CD2' ' A' ' 499' ' ' PHE . 0.0 OUTLIER 178.29 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.979 -1.076 . . . . 0.0 111.514 174.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.421 ' CG2' HG22 ' A' ' 487' ' ' ILE . 4.0 p -102.69 10.05 38.84 Favored 'General case' 0 C--N 1.3 -1.543 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.299 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.7 65.62 2.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.3 ttm180 -144.31 -68.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.94 -29.92 8.04 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.934 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -62.01 -45.54 93.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.58 -0.7 . . . . 0.0 111.285 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.01 -18.54 24.45 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.347 -0.846 . . . . 0.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -47.3 4.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.373 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -101.98 -8.32 21.61 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.78 -14.53 61.44 Favored Glycine 0 N--CA 1.503 3.131 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.588 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 63.1 mtt -67.97 -176.14 0.65 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.63 148.18 38.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.622 -0.674 . . . . 0.0 110.745 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.434 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.371 -0.831 . . . . 0.0 109.195 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.3 t -60.85 112.11 5.18 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.171 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.429 ' HG3' ' CG ' ' A' ' 528' ' ' HIS . 43.2 Cg_endo -72.29 113.74 3.79 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.402 1.212 . . . . 0.0 109.501 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -162.33 19.74 0.17 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.408 ' CB ' HD13 ' A' ' 487' ' ' ILE . 24.2 p -93.9 175.34 6.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.254 -1.145 . . . . 0.0 111.096 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.404 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 54.1 m -116.73 127.72 54.65 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.42 ' CG1' ' CD2' ' A' ' 522' ' ' LEU . 69.1 t -113.64 129.87 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.371 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.4 164.11 27.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.415 ' CG1' ' CG2' ' A' ' 534' ' ' ILE . 13.8 p -151.2 110.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.959 -1.088 . . . . 0.0 108.874 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . 0.449 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 53.8 t0 -84.25 104.96 14.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.369 1.08 . . . . 0.0 108.138 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -98.73 174.57 6.34 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.498 1.142 . . . . 0.0 113.285 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.33 -56.31 0.05 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -75.09 -156.39 0.05 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -125.83 -19.17 4.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 110.461 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 513' ' ' LEU . 4.4 mm? -70.41 -31.07 68.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.368 -0.833 . . . . 0.0 110.679 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 57.7 p -67.77 -40.55 84.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.784 -0.572 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.449 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 13.4 tp -64.59 -45.94 84.79 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 111.143 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.62 -43.35 80.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.418 -0.801 . . . . 0.0 113.064 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -65.76 -41.81 91.63 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.765 -1.209 . . . . 0.0 110.362 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.408 HG22 ' HB ' ' A' ' 507' ' ' VAL . 98.0 m -62.88 -42.48 99.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.006 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -39.42 88.05 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.691 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 81.3 p -65.27 -31.3 72.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.389 -0.819 . . . . 0.0 111.897 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 9.6 tt -81.9 -38.45 25.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.037 -1.04 . . . . 0.0 109.787 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.42 ' CD2' ' CG1' ' A' ' 505' ' ' VAL . 1.8 mt -64.11 -26.62 68.62 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.782 -0.574 . . . . 0.0 111.292 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -48.22 -51.21 26.39 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.275 -0.891 . . . . 0.0 111.586 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -71.41 -50.2 22.16 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.89 -38.43 86.25 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.473 -1.016 . . . . 0.0 113.001 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.9 -33.88 73.8 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.211 -0.931 . . . . 0.0 111.602 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -57.17 -28.82 63.13 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.962 -1.086 . . . . 0.0 108.11 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.429 ' CG ' ' HG3' ' A' ' 501' ' ' PRO . 80.0 m80 -93.99 -135.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -89.77 69.69 7.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.725 -1.234 . . . . 0.0 112.893 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 2.5 t -141.77 168.24 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.54 162.75 35.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.842 -0.536 . . . . 0.0 110.843 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 42.4 t -109.79 100.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.15 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.58 117.98 35.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.415 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 9.8 pt -127.51 155.58 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.323 -176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.426 HG23 ' CG1' ' A' ' 436' ' ' VAL . 36.7 p -128.39 -178.11 4.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 436' ' ' VAL . 61.8 m-20 -154.55 163.71 39.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.7 p -140.35 18.85 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.916 -0.49 . . . . 0.0 109.732 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.79 26.0 0.18 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.07 0.74 51.88 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.128 -1.219 . . . . 0.0 111.814 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -43.4 -42.04 4.48 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.224 -0.923 . . . . 0.0 111.366 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 65.5 p -106.19 163.48 12.77 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 50.11 36.79 28.98 Favored Glycine 0 N--CA 1.503 3.152 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.406 HG21 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -58.74 -43.66 90.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.52 -0.988 . . . . 0.0 111.107 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.406 ' N ' HG21 ' A' ' 543' ' ' THR . . . -63.6 -38.4 96.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 43.1 m -65.32 -33.02 74.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -1.0 . . . . 0.0 111.364 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.5 87.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.731 . . . . 0.0 110.294 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.58 -42.66 99.17 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.501 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 8.4 tpp -61.85 -34.71 76.47 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.1 60.86 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.174 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 40.1 ttp -57.32 -45.66 84.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.344 -0.848 . . . . 0.0 110.177 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.7 -31.28 72.4 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.429 -0.794 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.88 -13.02 62.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.471 -0.768 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -78.87 9.77 3.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.432 -0.792 . . . . 0.0 112.709 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 123.84 -14.75 7.99 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.2 t -85.19 115.41 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -169.1 127.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.696 -0.627 . . . . 0.0 109.606 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 13.0 t -97.15 133.09 42.26 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -73.15 -79.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.704 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -139.58 -81.22 0.29 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.213 -0.929 . . . . 0.0 110.781 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -91.15 -21.86 20.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 110.563 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -149.71 122.03 8.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.345 -0.847 . . . . 0.0 110.347 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -86.14 -130.53 2.65 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -101.79 33.66 6.32 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -91.79 -12.99 32.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.69 -0.888 . . . . 0.0 111.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -83.07 -1.97 54.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.34 -0.85 . . . . 0.0 112.122 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -109.34 75.3 0.72 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.062 -1.024 . . . . 0.0 110.804 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.69 -26.56 32.98 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.291 1.153 . . . . 0.0 110.17 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -176.17 34.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.352 -0.842 . . . . 0.0 110.12 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.361 -179.864 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.226 0.536 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.79 22.7 1.77 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.458 -0.776 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -98.48 -45.94 2.24 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 77.3 mt -109.11 130.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.579 -0.953 . . . . 0.0 110.22 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -129.15 59.12 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.03 155.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.736 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 387' ' ' LEU . 4.4 mm? -82.41 137.12 34.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.105 -0.997 . . . . 0.0 109.711 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -95.79 9.43 40.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 111.196 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.98 -34.21 72.99 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.135 -0.978 . . . . 0.0 109.904 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.35 -33.04 74.92 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.71 -0.619 . . . . 0.0 110.659 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 50.9 m -60.79 -36.7 79.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.325 -0.859 . . . . 0.0 109.736 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.0 t -65.48 -33.82 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.287 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.52 -48.24 79.82 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.241 -0.912 . . . . 0.0 110.914 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.13 77.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -0.791 . . . . 0.0 109.435 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 426' ' ' LEU . 0.9 OUTLIER -62.17 -39.66 93.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.951 -0.468 . . . . 0.0 111.504 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 55.8 p -65.71 -37.52 86.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -0.912 . . . . 0.0 110.325 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -65.07 -44.85 87.59 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.537 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.69 -43.3 80.44 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.131 -0.981 . . . . 0.0 111.331 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.453 HG21 HD11 ' A' ' 399' ' ' ILE . 96.7 mt -61.45 -42.28 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' MET . . . . . 0.407 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 19.5 mtp -62.67 -29.1 70.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.952 -0.467 . . . . 0.0 109.981 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -61.2 -29.67 69.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.85 -1.156 . . . . 0.0 109.541 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 99.3 mm-40 -89.33 -16.97 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 109.231 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 400' ' ' MET . 2.7 t-20 -66.4 -38.54 87.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.526 -0.733 . . . . 0.0 110.799 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -116.32 19.0 15.05 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 10.8 p -48.15 117.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.65 -0.657 . . . . 0.0 111.019 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.8 p -52.35 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.86 133.06 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.598 0.713 . . . . 0.0 110.663 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -90.8 135.1 29.3 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.33 -30.38 45.07 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.098 1.052 . . . . 0.0 110.542 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -59.65 -28.33 67.16 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.811 0.815 . . . . 0.0 109.822 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 56.2 0.76 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.9 m -54.17 117.78 3.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.67 0.748 . . . . 0.0 111.379 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.87 111.51 7.9 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.563 . . . . 0.0 110.869 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.31 138.13 24.39 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 122.999 1.0 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -161.25 70.68 0.37 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.829 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 57.9 p -67.75 -38.06 82.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.837 -1.165 . . . . 0.0 107.895 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 420' ' ' SER . . . -56.63 -23.95 44.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.871 -0.518 . . . . 0.0 111.177 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -47.99 -58.18 7.22 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -87.41 -1.99 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.967 -1.314 . . . . 0.0 110.847 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 10.9 t -71.03 -42.9 68.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.909 -1.12 . . . . 0.0 108.502 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -75.69 -44.63 41.19 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.811 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.407 ' O ' ' CG1' ' A' ' 425' ' ' VAL . . . -65.71 -48.02 73.41 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 436' ' ' VAL . 57.9 t -68.27 -44.41 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.334 -0.854 . . . . 0.0 111.45 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.6 m -61.73 -38.14 86.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 111.229 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 426' ' ' LEU . 12.4 p -65.03 -29.5 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 112.754 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 395' ' ' LEU . 2.2 pp -76.98 -32.2 57.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.398 -1.439 . . . . 0.0 110.575 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.39 84.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 108.837 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -59.27 -36.22 75.14 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -64.73 -88.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -175.13 -60.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.726 -1.233 . . . . 0.0 109.635 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.39 102.76 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 122.886 0.94 . . . . 0.0 111.397 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 531' ' ' GLN . 0.1 OUTLIER -82.51 99.99 9.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.85 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 11.0 tp -163.7 93.04 0.72 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.26 -0.9 . . . . 0.0 111.195 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -150.04 162.36 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.011 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.5 pp -113.96 128.55 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.094 0.473 . . . . 0.0 109.897 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 423' ' ' VAL . 78.3 t -132.18 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -0.877 . . . . 0.0 108.935 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 42.8 t -130.46 138.63 50.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.023 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -95.94 135.99 12.61 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.679 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -107.71 -14.27 14.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.959 -0.73 . . . . 0.0 110.255 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.57 170.6 42.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.19 44.94 97.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.92 89.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.332 -1.099 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.39 -44.7 93.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.627 -0.671 . . . . 0.0 110.55 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.87 -28.66 64.42 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.4 -41.88 98.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.909 . . . . 0.0 109.607 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -61.77 -45.01 95.75 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.375 -0.828 . . . . 0.0 110.047 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -63.45 -29.65 70.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.661 . . . . 0.0 109.42 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -67.52 -50.54 58.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.578 -0.701 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 450' ' ' ALA . 12.3 p -55.21 -31.74 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.528 -1.357 . . . . 0.0 110.423 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.475 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -64.36 -26.83 68.64 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -60.19 -35.13 74.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.94 -37.68 88.01 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.424 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 85.4 t -63.05 -27.06 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.013 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.6 mtp -66.28 -39.73 89.6 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.189 -0.944 . . . . 0.0 108.642 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.1 ttp -58.88 -25.8 63.67 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.64 -0.663 . . . . 0.0 109.442 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.63 -22.43 34.71 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.581 -0.7 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.88 -47.57 71.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.76 -28.47 65.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -79.5 5.2 13.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.58 -0.7 . . . . 0.0 110.756 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.45 34.45 89.97 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -130.75 127.14 38.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -1.01 . . . . 0.0 110.292 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -81.53 159.28 24.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 19.9 m -144.87 151.81 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.502 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 505' ' ' VAL . 57.9 tt0 -102.98 123.33 46.39 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.543 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -141.7 146.25 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 120.825 -1.172 . . . . 0.0 108.732 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 471' ' ' ARG . 83.6 mt -134.01 129.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -78.22 168.58 19.63 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.26 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.505 -0.747 . . . . 0.0 109.786 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -48.56 -22.74 0.8 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.915 -1.115 . . . . 0.0 111.903 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -73.23 -6.3 45.0 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.332 -0.855 . . . . 0.0 112.206 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 466' ' ' ILE . 34.7 ttt85 -60.16 -24.73 64.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.803 -1.186 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -61.45 -46.37 90.35 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.216 -0.928 . . . . 0.0 110.612 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -65.21 -41.3 94.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 53.2 ttm -60.39 -32.47 71.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.027 -0.421 . . . . 0.0 110.453 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -61.36 -37.69 84.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 80.5 mmm -59.76 -35.9 75.55 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.951 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.47 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 59.4 pttt -134.93 -141.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 109.801 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . 0.47 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 89.3 mm-40 47.06 90.46 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.969 -1.082 . . . . 0.0 113.034 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -94.55 -23.46 17.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.411 ' O ' ' CD2' ' A' ' 482' ' ' LEU . 98.0 mt-10 -70.44 -29.53 66.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.514 -0.741 . . . . 0.0 109.059 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' A' ' 450' ' ' ALA . 9.1 mpt_? -83.52 8.48 13.91 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.997 -0.44 . . . . 0.0 111.294 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 482' ' ' LEU . 3.2 mm? 53.87 28.26 8.22 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.986 -1.071 . . . . 0.0 110.802 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.28 50.24 0.06 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.493 -0.755 . . . . 0.0 112.417 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 159.61 42.04 0.02 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -179.62 89.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.597 -0.943 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 487' ' ' ILE . 47.1 mt -99.09 -81.28 0.45 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 486' ' ' LEU . 1.1 mp -158.98 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.487 -0.758 . . . . 0.0 109.448 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 1.8 p -102.86 14.31 32.26 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.496 -0.752 . . . . 0.0 111.411 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -79.55 56.92 4.48 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -143.06 -61.75 0.42 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.224 -1.162 . . . . 0.0 109.245 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -109.35 -31.29 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.298 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -64.08 -38.1 89.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.404 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 5.4 mt -91.16 -26.82 18.89 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 111.358 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.72 -44.36 4.67 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -102.4 -8.33 21.23 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.863 -1.148 . . . . 0.0 113.518 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.81 -21.49 33.11 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.732 -1.23 . . . . 0.0 111.276 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 38.0 mtm -64.09 -178.6 0.35 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -1.186 . . . . 0.0 109.348 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.04 154.16 28.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 111.347 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.82 148.98 39.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.937 -0.477 . . . . 0.0 109.864 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 79.1 m -44.06 101.52 0.26 Allowed Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 122.089 -0.382 . . . . 0.0 110.759 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 43.4 Cg_endo -68.34 113.75 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.681 1.358 . . . . 0.0 109.239 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . 0.473 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . 174.98 38.06 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 13.6 p -90.83 174.55 7.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.882 -0.776 . . . . 0.0 111.79 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.448 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 13.6 m -112.74 94.36 4.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 464' ' ' GLN . 59.4 t -85.64 131.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.225 1.012 . . . . 0.0 112.656 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 533' ' ' LEU 0.294 65.3 mt -137.77 96.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.487 HG11 ' CG2' ' A' ' 534' ' ' ILE . 3.9 p -104.19 107.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.978 1.371 . . . . 0.0 113.574 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.44 107.58 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.0 -1.062 . . . . 0.0 109.413 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -126.96 116.46 20.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -72.83 -40.61 52.06 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 175.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -86.71 147.22 25.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.11 -12.07 22.19 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.629 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.96 -38.81 92.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 109.526 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 72.1 p -86.82 -16.61 35.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.615 -0.678 . . . . 0.0 111.109 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.06 -47.69 49.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.165 -0.959 . . . . 0.0 109.905 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -69.85 -46.02 66.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.679 -0.638 . . . . 0.0 112.692 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.67 -41.59 98.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.965 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 29.9 m -56.86 -44.74 82.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.483 -0.76 . . . . 0.0 111.194 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 43.3 mt -60.77 -28.22 68.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.7 m -61.1 -41.17 96.18 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.327 -0.858 . . . . 0.0 109.472 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 50.7 tp -65.49 -41.09 93.64 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.438 ' CD1' ' CG1' ' A' ' 505' ' ' VAL . 1.4 tt -64.17 -22.95 67.13 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.845 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -48.06 -64.19 0.86 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.376 -0.828 . . . . 0.0 113.205 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.69 -50.54 60.84 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.771 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -62.35 -36.38 82.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.966 . . . . 0.0 111.77 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -64.99 -25.23 67.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.447 -0.783 . . . . 0.0 112.72 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -40.88 -27.82 0.06 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -107.28 -108.73 0.31 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.109 -0.994 . . . . 0.0 113.065 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.473 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.1 OUTLIER -89.51 81.47 6.53 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.553 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 531' ' ' GLN . 5.9 t -143.87 165.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.843 -1.161 . . . . 0.0 111.729 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 12.8 mm-40 -157.52 161.83 38.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.85 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 55.3 t -114.96 107.17 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.354 -0.841 . . . . 0.0 111.511 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 506' ' ' ILE . 5.5 tt -105.49 119.22 38.55 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.487 ' CG2' HG11 ' A' ' 507' ' ' VAL . 4.1 pt -139.94 153.08 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.296 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.6 p -143.11 114.62 8.01 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.95 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -77.08 175.56 9.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.681 1.229 . . . . 0.0 111.83 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' SER . . . . . 0.403 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.3 m -129.98 -10.3 4.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.105 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -122.67 34.78 3.65 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -98.29 0.84 46.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.862 -0.787 . . . . 0.0 111.999 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -49.36 -31.22 8.97 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.096 -1.003 . . . . 0.0 110.216 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 46.1 p -129.78 166.54 19.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.5 34.66 55.38 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.8 t -61.7 -45.8 92.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.496 -1.002 . . . . 0.0 111.802 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -63.23 -34.69 90.65 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 48.0 m -64.08 -37.86 88.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.71 -0.876 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -57.26 -37.25 72.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 110.023 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 10.9 mp -63.14 -39.94 96.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.658 -0.652 . . . . 0.0 110.102 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.68 -29.11 70.41 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.487 -0.758 . . . . 0.0 109.203 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -56.29 -52.6 63.9 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 56.0 ttm -55.61 -46.65 77.31 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.277 -0.889 . . . . 0.0 109.521 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . 0.463 ' HA ' HG22 ' A' ' 555' ' ' VAL . 97.5 mttt -57.6 -32.0 66.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.824 -0.548 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -68.46 -25.51 65.03 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.4 -0.813 . . . . 0.0 111.403 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.37 0.85 5.75 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.083 -1.011 . . . . 0.0 112.787 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.39 -15.25 9.28 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 120.787 -1.196 . . . . 0.0 110.832 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 551' ' ' LYS . 34.2 m -86.83 109.72 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.304 -1.115 . . . . 0.0 110.034 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -171.05 140.63 1.56 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.244 -0.91 . . . . 0.0 110.002 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 57.4 m -95.54 134.71 38.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.413 -0.804 . . . . 0.0 109.168 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.14 -79.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 110.576 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -130.83 -78.88 0.53 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.411 -0.806 . . . . 0.0 111.281 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -93.1 -21.84 19.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.043 -1.035 . . . . 0.0 111.308 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -137.22 148.65 46.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -129.56 115.49 1.92 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 75.75 11.26 84.67 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -95.35 -11.69 27.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.186 -1.184 . . . . 0.0 111.121 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -82.18 -8.12 59.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.214 -0.928 . . . . 0.0 110.437 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.19 99.68 18.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 110.517 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.04 -17.59 36.2 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.281 1.148 . . . . 0.0 111.159 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -170.81 131.17 0.84 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.623 179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.277 0.561 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 1.5 m 52.73 -172.61 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.508 -0.745 . . . . 0.0 110.159 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.52 85.01 0.38 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 384' ' ' ILE . 47.4 pt -74.62 135.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.959 . . . . 0.0 110.304 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.83 -39.65 83.87 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.728 . . . . 0.0 110.697 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.23 124.43 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.332 -0.855 . . . . 0.0 110.384 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 64.8 mt -104.5 2.06 30.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.692 -0.63 . . . . 0.0 111.623 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.04 -69.5 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.015 -1.053 . . . . 0.0 110.728 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.05 14.1 1.31 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.277 -0.889 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.51 -42.56 99.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.235 -0.916 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.3 m -60.99 -42.12 97.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.715 -0.616 . . . . 0.0 110.082 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.23 -35.27 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.691 -0.631 . . . . 0.0 111.032 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -63.27 -47.1 83.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.043 0.925 . . . . 0.0 109.448 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.96 -38.86 90.1 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.719 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.8 m -68.32 -36.15 78.87 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -63.07 -45.28 92.91 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.261 -0.899 . . . . 0.0 111.129 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.13 -40.87 86.86 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.116 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.75 -42.58 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 110.031 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 0.9 OUTLIER -61.04 -31.57 71.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.77 -30.87 71.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.966 -1.084 . . . . 0.0 109.827 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.405 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 61.0 tp60 -89.39 -16.31 31.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 109.205 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 437' ' ' SER . 2.6 t-20 -66.11 -34.31 77.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.571 -0.706 . . . . 0.0 109.672 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -114.09 17.9 17.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 109.518 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 8.3 p -40.43 148.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.559 0.695 . . . . 0.0 112.243 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.401 ' N ' HG21 ' A' ' 405' ' ' VAL . 63.4 m -85.63 77.18 9.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.51 129.74 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 111.064 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -98.92 144.93 29.09 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.6 -19.09 42.56 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.199 1.105 . . . . 0.0 111.488 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.61 -33.22 71.21 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.09 64.03 0.45 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.5 m -61.3 131.28 49.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 110.979 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.435 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 7.8 p -78.68 148.66 73.33 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.5 Cg_endo -60.18 138.82 83.89 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.834 0.912 . . . . 0.0 110.622 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -101.05 -5.02 26.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 420' ' ' SER . 17.5 p -97.83 17.97 16.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.777 -1.202 . . . . 0.0 108.943 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.28 -32.56 7.73 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -69.47 -40.01 79.37 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -98.93 -10.95 22.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.74 -1.447 . . . . 0.0 111.215 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 416' ' ' THR . 58.2 p -74.17 -38.13 63.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.746 -1.221 . . . . 0.0 107.841 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.17 -48.35 24.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.31 73.41 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.527 -0.733 . . . . 0.0 111.727 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.407 ' HA ' HD21 ' A' ' 426' ' ' LEU . 58.0 t -66.94 -43.82 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.576 -0.703 . . . . 0.0 112.423 -177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -61.59 -42.19 98.51 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.856 -1.152 . . . . 0.0 111.147 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.7 -28.65 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.3 -0.875 . . . . 0.0 110.667 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -72.89 -32.12 65.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.446 -0.784 . . . . 0.0 111.558 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.35 76.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.904 -1.123 . . . . 0.0 109.389 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -61.93 -30.14 70.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.51 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.402 ' CB ' ' CD ' ' A' ' 431' ' ' PRO . 3.4 tpp85 -172.19 -61.21 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.694 -1.254 . . . . 0.0 109.256 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 531' ' ' GLN . 44.3 Cg_endo -71.35 110.91 2.97 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 O-C-N 123.086 1.045 . . . . 0.0 110.637 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 531' ' ' GLN . 6.7 t -88.46 98.06 11.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.69 -0.631 . . . . 0.0 110.45 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.821 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 19.7 tp -164.31 97.07 0.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.663 -1.273 . . . . 0.0 112.34 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -141.34 175.63 9.5 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.104 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 435' ' ' ILE . 46.4 pt -118.83 130.59 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.325 0.583 . . . . 0.0 110.4 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.88 136.02 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.921 -1.112 . . . . 0.0 109.611 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.411 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 73.9 m -121.56 125.69 47.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.345 -0.847 . . . . 0.0 110.996 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -103.2 -176.71 26.46 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -129.41 -41.17 1.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.616 -0.932 . . . . 0.0 109.838 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -159.88 167.0 35.23 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.7 64.06 2.97 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.6 -21.26 41.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.59 -0.947 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.22 97.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.462 -0.774 . . . . 0.0 111.171 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -66.1 -31.06 78.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.77 -30.41 71.41 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.603 -0.939 . . . . 0.0 109.807 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.404 ' HD2' ' HB3' ' A' ' 467' ' ' ALA . 2.8 mmt85 -63.97 -43.45 95.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.59 -0.694 . . . . 0.0 109.976 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.74 -33.85 64.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.335 -0.853 . . . . 0.0 110.783 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.24 -53.59 52.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.362 -0.836 . . . . 0.0 111.511 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.61 -33.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.757 -1.214 . . . . 0.0 108.883 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.62 68.07 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.42 -37.99 82.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.064 -1.022 . . . . 0.0 108.61 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 455' ' ' MET . 79.2 mt -63.12 -36.72 84.54 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.66 -27.44 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -0.825 . . . . 0.0 109.586 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 94.4 mtp -67.73 -40.95 84.17 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' MET . . . . . 0.417 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.1 OUTLIER -62.41 -20.74 64.79 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.235 -0.916 . . . . 0.0 109.93 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.23 -23.06 32.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.614 -0.679 . . . . 0.0 109.562 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -68.56 -40.19 80.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.676 . . . . 0.0 109.563 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.45 -32.21 68.06 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.408 -0.807 . . . . 0.0 109.661 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.68 3.1 12.38 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.753 -0.592 . . . . 0.0 111.725 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.44 71.8 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -125.37 122.42 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 109.868 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 98.1 mt-10 -84.85 168.18 15.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 34.4 m -143.62 149.08 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 111.22 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 505' ' ' VAL . 1.4 pt20 -99.08 121.66 41.28 Favored 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 176.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -123.5 129.72 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 471' ' ' ARG . 4.4 mp -117.76 112.99 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.404 ' HB3' ' HD2' ' A' ' 446' ' ' ARG . . . -65.23 -179.44 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.813 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.94 -161.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.16 -14.59 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.732 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.72 -3.07 45.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.122 -0.986 . . . . 0.0 111.967 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 466' ' ' ILE . 74.6 ttt-85 -57.04 -31.13 64.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.886 -1.133 . . . . 0.0 111.21 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.6 t -60.01 -44.44 94.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.855 . . . . 0.0 109.857 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.21 -36.01 82.86 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.1 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.864 -0.523 . . . . 0.0 109.936 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -61.47 -37.57 84.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.534 -0.729 . . . . 0.0 109.605 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 65.5 ttp -58.55 -38.11 77.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.919 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -124.89 -152.42 0.51 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 48.3 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.909 -1.12 . . . . 0.0 111.824 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -127.65 11.47 6.75 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.562 -0.712 . . . . 0.0 110.665 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -98.24 -14.51 20.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.546 -0.721 . . . . 0.0 110.267 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -108.67 -13.96 14.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.557 -0.715 . . . . 0.0 111.84 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.7 56.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.953 -1.092 . . . . 0.0 110.932 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 93.2 p -60.17 -23.67 64.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.017 -1.052 . . . . 0.0 110.181 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 151.22 55.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -132.4 48.87 2.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.821 -0.811 . . . . 0.0 110.407 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.61 -80.56 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.463 ' O ' ' CD2' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -178.96 -44.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.796 -1.19 . . . . 0.0 110.246 174.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.401 ' CG2' HG23 ' A' ' 487' ' ' ILE . 5.0 p -102.63 8.75 39.63 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.851 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.85 60.09 4.68 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.436 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 66.3 ttt180 -145.77 -45.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.906 -0.761 . . . . 0.0 109.542 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 36.7 mtt85 -120.86 -46.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.429 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.408 ' CG ' ' HA ' ' A' ' 498' ' ' ALA . 32.4 mt-30 -61.61 -50.32 73.04 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.092 -1.005 . . . . 0.0 111.452 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.08 -37.53 72.45 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.97 -0.457 . . . . 0.0 111.603 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.76 -38.07 6.82 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.13 -8.18 15.19 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.773 -1.205 . . . . 0.0 114.132 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 91.54 -21.34 36.1 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 120.766 -1.209 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.499 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 52.1 mmm -67.12 178.73 1.35 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.133 -1.216 . . . . 0.0 109.851 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 492' ' ' GLN . . . -114.31 148.83 36.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 112.23 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -115.95 148.92 39.55 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.559 0.695 . . . . 0.0 110.301 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 19.1 m -52.45 107.57 0.87 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.869 -0.52 . . . . 0.0 110.117 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.74 114.41 3.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.437 1.23 . . . . 0.0 109.556 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -171.95 27.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.406 ' CB ' HD12 ' A' ' 487' ' ' ILE . 60.2 p -94.3 177.97 5.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.634 -0.921 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.4 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 51.5 m -125.53 125.39 43.16 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 464' ' ' GLN . 8.5 p -109.32 131.01 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.949 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 2.4 pt -126.0 112.32 29.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.453 HG11 ' CG2' ' A' ' 534' ' ' ILE . 4.3 p -112.68 115.5 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 111.851 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.12 105.63 14.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 21.8 tm0? -94.12 174.12 7.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.7 0.762 . . . . 0.0 111.199 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.46 -74.66 0.04 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 105.364 -3.094 . . . . 0.0 105.364 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -54.49 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 5.3 mttt 179.07 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.625 0 O-C-N 120.695 -1.253 . . . . 0.0 110.57 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.0 -20.89 63.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.641 -0.662 . . . . 0.0 110.493 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 17.9 m -64.43 -42.12 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.358 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 7.6 tp -65.5 -44.17 87.88 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.23 0.538 . . . . 0.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.71 -43.89 83.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.457 -0.777 . . . . 0.0 112.348 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.85 -51.21 69.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.05 -1.031 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 30.6 m -59.1 -41.5 88.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -39.23 79.63 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.924 -0.485 . . . . 0.0 110.848 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.1 m -61.02 -37.14 81.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 0.0 110.167 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.09 -40.43 86.94 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' A' ' 505' ' ' VAL . 0.3 OUTLIER -64.66 -21.95 66.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.754 -0.591 . . . . 0.0 111.641 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -45.74 -62.66 1.21 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.592 -0.692 . . . . 0.0 111.951 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -84.68 -48.17 5.08 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.984 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.94 74.49 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -65.0 -25.69 67.97 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.786 -1.196 . . . . 0.0 112.325 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -42.46 -28.13 0.2 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.411 -0.806 . . . . 0.0 112.182 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.23 -137.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 111.177 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.415 ' O ' HG21 ' A' ' 530' ' ' VAL . 84.5 m-20 -72.43 73.97 1.02 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.9 -1.125 . . . . 0.0 112.129 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.446 ' CB ' ' HA ' ' A' ' 526' ' ' ALA . 41.2 t -137.73 164.52 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.42 -0.8 . . . . 0.0 110.668 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 432' ' ' SER . 1.5 mm-40 -160.59 162.21 32.77 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 8.5 t -114.65 111.62 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 120.947 -1.096 . . . . 0.0 113.794 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.2 tp -102.2 114.86 29.38 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.453 ' CG2' HG11 ' A' ' 507' ' ' VAL . 7.9 pt -133.33 161.46 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 C-N-CA 118.677 -1.209 . . . . 0.0 112.596 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 68.9 p -131.16 -171.56 2.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 24.0 t70 -151.12 157.58 42.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.83 20.87 2.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.387 -0.821 . . . . 0.0 110.794 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -153.75 -42.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -78.79 0.32 27.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.503 -0.998 . . . . 0.0 111.229 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -38.1 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.0 p -102.36 -25.14 13.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.962 -1.086 . . . . 0.0 110.623 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -127.51 55.57 0.75 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 8.9 t -75.17 -15.64 60.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.783 -0.833 . . . . 0.0 111.542 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.09 93.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 87.8 p -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -1.044 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.46 76.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 109.628 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.4 mp -61.71 -43.21 99.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.405 -0.809 . . . . 0.0 109.163 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.7 ttp -63.34 -35.14 79.39 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -52.0 -50.64 60.94 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 28.2 ttt -57.97 -46.1 85.67 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -60.9 -31.45 70.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.414 -0.804 . . . . 0.0 111.052 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.83 -20.86 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.389 -0.82 . . . . 0.0 110.071 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.82 3.3 6.8 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.426 -0.796 . . . . 0.0 112.64 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.63 -13.26 8.75 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.419 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.04 109.9 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.269 . . . . 0.0 109.911 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -170.89 147.81 2.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.566 -0.709 . . . . 0.0 110.268 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 94.2 m -92.6 120.76 33.36 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -89.56 -78.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.043 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -137.62 -78.63 0.38 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.339 -0.85 . . . . 0.0 110.126 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.35 -17.56 34.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.805 . . . . 0.0 110.842 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -116.24 141.69 47.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.069 -1.019 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 141.88 50.37 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 76.01 12.9 83.67 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.519 -0.989 . . . . 0.0 110.681 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -94.61 -8.78 37.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.229 -1.16 . . . . 0.0 110.72 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -92.59 -5.73 50.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -162.42 50.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.221 -0.924 . . . . 0.0 110.561 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 566' ' ' ARG . 47.4 Cg_endo -71.69 -15.85 30.18 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.372 1.196 . . . . 0.0 111.431 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -114.44 -23.64 9.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 110.983 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.425 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.103 0.478 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 78.2 p -61.27 -38.64 87.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.365 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 154.88 69.79 0.01 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.3 11.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.617 -0.931 . . . . 0.0 110.972 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -91.42 -4.14 55.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 0.0 111.248 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 14.8 p -107.41 129.55 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 0.0 109.872 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.45 146.61 46.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -78.92 91.1 4.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.363 -0.836 . . . . 0.0 110.744 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.88 54.76 1.82 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.74 . . . . 0.0 109.96 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -40.26 96.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.979 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.9 t -60.63 -45.72 92.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.456 -0.777 . . . . 0.0 110.68 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.66 -28.48 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -64.51 -52.3 58.52 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.999 -1.063 . . . . 0.0 111.533 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.32 77.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.336 -0.853 . . . . 0.0 109.134 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' A' ' 399' ' ' ILE . 8.0 tt -61.27 -38.06 85.35 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 t -65.51 -43.65 89.41 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.118 -0.989 . . . . 0.0 111.781 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -64.07 -45.36 89.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.319 -0.863 . . . . 0.0 111.964 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -64.94 -44.86 88.06 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.29 -0.881 . . . . 0.0 111.283 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.4 HD12 ' CD2' ' A' ' 395' ' ' LEU . 71.4 mt -63.98 -41.83 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.34 -0.85 . . . . 0.0 110.519 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 5.6 tpp -60.62 -35.01 75.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.351 -0.843 . . . . 0.0 109.995 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.35 -31.03 70.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -87.45 -16.59 34.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.801 -1.187 . . . . 0.0 108.78 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.33 -31.98 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.722 -0.611 . . . . 0.0 110.273 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -113.67 17.84 17.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.418 HG12 ' CG2' ' A' ' 407' ' ' VAL . 7.6 p -52.46 108.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.59 -0.694 . . . . 0.0 109.729 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 64.9 p -50.03 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.462 -0.774 . . . . 0.0 111.37 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.418 ' CG2' HG12 ' A' ' 405' ' ' VAL . 58.6 t -107.24 133.02 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -94.32 142.21 24.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.572 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.22 -21.91 54.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.336 1.177 . . . . 0.0 110.318 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -60.46 -40.29 90.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 110.002 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 68.28 1.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.4 t -53.89 110.62 0.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.63 111.54 4.95 Favored Pre-proline 0 N--CA 1.492 1.653 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.813 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.8 133.32 21.66 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.096 1.051 . . . . 0.0 109.972 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.91 63.6 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.485 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 68.8 p -66.0 -33.16 75.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 108.762 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -63.59 -10.26 17.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.626 -0.671 . . . . 0.0 111.578 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.56 51.93 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.965 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.16 -2.04 55.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.61 -1.524 . . . . 0.0 110.133 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 4.8 m -82.48 -33.0 28.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 108.781 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -78.88 -44.42 22.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.666 . . . . 0.0 110.123 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 425' ' ' VAL . . . -64.94 -42.02 95.02 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.636 -0.665 . . . . 0.0 111.412 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.418 ' CG2' ' CG2' ' A' ' 436' ' ' VAL . 88.8 t -80.2 -44.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.773 -0.579 . . . . 0.0 112.258 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.1 m -60.28 -42.01 94.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.929 -1.107 . . . . 0.0 110.475 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 422' ' ' ALA . 13.5 p -64.22 -29.76 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.422 -0.799 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 434' ' ' ALA . 0.2 OUTLIER -68.32 -31.77 71.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.554 -0.716 . . . . 0.0 110.074 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.49 78.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.056 -1.028 . . . . 0.0 108.771 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.13 -28.87 63.09 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -67.46 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.464 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 6.0 tmm_? -173.04 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 120.726 -1.234 . . . . 0.0 110.397 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.3 Cg_endo -71.17 120.48 7.04 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 N-CA-C 110.182 -0.738 . . . . 0.0 110.182 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 2.0 t -94.91 99.96 11.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.779 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.8 tp -163.24 98.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.955 -1.091 . . . . 0.0 110.741 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 426' ' ' LEU . . . -140.48 177.14 8.22 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.504 0.669 . . . . 0.0 111.047 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.3 mt -117.43 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.819 -0.551 . . . . 0.0 110.146 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.418 ' CG2' ' CG2' ' A' ' 423' ' ' VAL . 67.1 t -133.47 140.05 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.47 -0.769 . . . . 0.0 110.473 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 19.1 m -132.25 142.87 49.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.711 -0.618 . . . . 0.0 109.586 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.01 162.95 22.08 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -120.43 -42.74 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.895 . . . . 0.0 109.308 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.83 63.82 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 173.62 86.2 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.23 -28.23 10.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.512 -0.993 . . . . 0.0 110.724 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.49 79.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.444 -0.785 . . . . 0.0 110.781 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -77.97 -30.74 50.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.12 -31.55 64.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.401 -1.058 . . . . 0.0 109.348 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.425 ' O ' HG11 ' A' ' 449' ' ' VAL . 61.2 ttp180 -62.9 -43.66 98.2 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.569 0.699 . . . . 0.0 110.152 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -80.0 -29.46 39.47 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -0.853 . . . . 0.0 110.619 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -62.62 -47.69 82.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 446' ' ' ARG . 12.0 p -60.32 -31.53 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.903 -1.123 . . . . 0.0 108.227 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.2 -28.45 69.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.806 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -63.14 -32.9 74.39 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.45 -33.05 74.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 60.6 t -59.98 -29.8 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 61.4 mtt -66.65 -36.07 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.23 -27.52 62.1 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.576 -0.702 . . . . 0.0 109.435 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.27 -23.1 32.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.64 -0.663 . . . . 0.0 109.777 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -64.39 -44.64 90.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -71.46 -30.9 66.55 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.503 0.668 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -76.38 -2.16 30.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.676 -0.64 . . . . 0.0 110.981 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.44 25.68 74.83 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -133.38 120.78 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.501 -1.0 . . . . 0.0 110.552 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 487' ' ' ILE . 92.9 mt-10 -79.85 172.1 14.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 27.2 m -144.46 153.02 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.4 ' HA ' HD22 ' A' ' 486' ' ' LEU . 54.1 tt0 -97.82 120.2 37.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -131.34 135.06 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.044 -1.035 . . . . 0.0 110.321 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 518' ' ' THR . 93.2 mt -127.51 123.55 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -78.81 162.96 25.74 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -161.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.666 -0.646 . . . . 0.0 109.294 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -47.64 -19.03 0.17 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.783 -1.198 . . . . 0.0 111.69 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.31 -7.17 54.37 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -57.09 -24.9 57.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.035 -1.041 . . . . 0.0 111.276 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 40.4 t -58.44 -45.36 88.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.403 -0.811 . . . . 0.0 110.181 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.95 -40.67 96.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 108.623 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 7.6 ttm -57.25 -39.5 75.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.742 -0.599 . . . . 0.0 110.446 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -57.11 -35.43 69.43 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 53.5 tpp -59.67 -36.77 77.1 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.347 0.594 . . . . 0.0 110.04 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -134.76 -145.87 0.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.586 . . . . 0.0 110.403 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 51.11 40.95 26.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.749 -1.219 . . . . 0.0 111.498 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.33 10.85 18.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.0 110.313 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.74 -3.94 57.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 111.487 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.78 15.23 0.14 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.206 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 1.6 pp -169.45 38.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.716 -1.24 . . . . 0.0 111.888 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 90.8 p -87.78 50.4 1.99 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.32 24.77 28.01 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -125.49 57.64 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.517 -0.99 . . . . 0.0 108.982 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 487' ' ' ILE . 84.7 mt -97.49 -82.05 0.42 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.459 HD12 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER 175.77 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 174.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 499' ' ' PHE . 8.8 t -104.28 10.45 35.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.884 -0.51 . . . . 0.0 111.112 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -149.66 93.91 0.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.432 ' HG2' ' N ' ' A' ' 491' ' ' ARG . 34.9 ttm180 -139.82 -81.15 0.28 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.432 ' N ' ' HG2' ' A' ' 490' ' ' ARG . 8.7 ptm180 -134.18 -13.91 2.37 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.986 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 499' ' ' PHE . 8.2 mt-30 -61.42 -30.69 70.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.879 -1.138 . . . . 0.0 111.252 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.42 HD23 ' CZ ' ' A' ' 499' ' ' PHE . 36.0 mt -64.88 -57.64 8.29 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.36 -37.98 89.36 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.925 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.55 -7.63 58.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.766 -0.584 . . . . 0.0 112.541 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.34 60.19 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.457 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 96.2 mtp -122.7 -173.49 2.71 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.375 -1.074 . . . . 0.0 110.046 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -103.25 165.93 10.74 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.669 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 492' ' ' GLN . 65.2 m-85 -111.58 152.6 27.39 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.651 0.739 . . . . 0.0 112.284 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.5 m -69.86 112.2 11.55 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.27 115.69 2.3 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.284 1.149 . . . . 0.0 111.226 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.58 27.64 0.04 OUTLIER Glycine 0 N--CA 1.505 3.29 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.294 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.459 ' CB ' HD12 ' A' ' 487' ' ' ILE . 12.5 p -96.84 -177.39 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.959 -1.318 . . . . 0.0 111.877 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 79.4 m -118.51 112.36 19.82 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.03 137.2 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 119.661 -0.815 . . . . 0.0 112.564 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 4.0 pt -134.26 163.13 37.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 507' ' ' VAL . 10.1 p -159.95 106.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 122.873 1.32 . . . . 0.0 111.842 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.94 122.45 28.29 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.427 ' HG2' HG22 ' A' ' 507' ' ' VAL . 86.7 mm-40 -145.17 112.54 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.67 -34.36 56.78 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.45 147.16 23.59 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.32 -10.49 22.25 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.025 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.32 -34.63 78.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.429 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 71.6 m -87.75 -17.44 31.66 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.38 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 56.4 tp -67.62 -46.43 72.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 108.765 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -70.29 -40.46 74.27 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.76 -49.96 75.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.253 -0.905 . . . . 0.0 111.06 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.407 ' CG2' ' CD1' ' A' ' 466' ' ' ILE . 91.3 m -56.5 -39.99 74.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.34 -0.85 . . . . 0.0 109.834 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.89 -38.91 68.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.593 -0.692 . . . . 0.0 110.123 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 99.4 m -62.45 -39.19 92.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.512 -0.742 . . . . 0.0 109.783 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.498 -0.751 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.26 -21.46 63.93 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.484 -0.76 . . . . 0.0 111.08 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -45.81 -65.33 0.56 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.76 -51.68 55.76 Favored Glycine 0 N--CA 1.503 3.15 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.521 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -59.03 -32.46 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.56 -0.965 . . . . 0.0 111.296 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.4 -22.47 66.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.151 -0.968 . . . . 0.0 112.437 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -39.18 -28.23 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -119.04 -110.98 0.34 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.142 -0.974 . . . . 0.0 111.828 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -90.8 93.12 9.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.381 -1.449 . . . . 0.0 113.578 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.5 t -141.19 166.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.859 -1.15 . . . . 0.0 111.498 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.453 ' HG2' ' N ' ' A' ' 432' ' ' SER . 1.1 tp-100 -164.68 163.25 21.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.779 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.9 t -114.64 107.39 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 1.6 tp -104.53 119.04 38.06 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.437 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 14.9 pt -140.5 161.03 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 117.613 -1.635 . . . . 0.0 112.96 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 81.7 p -121.74 -169.86 1.94 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -149.16 155.79 41.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.18 20.38 2.43 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.042 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.06 -46.21 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 2.44 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.888 . . . . 0.0 111.648 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -36.33 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 66.7 p -93.02 117.98 30.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.074 -1.016 . . . . 0.0 109.242 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 63.83 70.21 1.12 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 74.9 p -80.13 -3.17 47.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.752 -0.852 . . . . 0.0 111.981 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.65 -35.59 81.87 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 -32.54 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.827 -0.808 . . . . 0.0 110.279 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.19 80.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.658 . . . . 0.0 109.324 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.45 -43.28 99.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.796 -0.565 . . . . 0.0 110.639 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 93.4 mtp -65.2 -37.61 87.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -50.92 -51.46 51.82 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.099 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 38.0 ttp -58.29 -40.47 82.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.364 -0.835 . . . . 0.0 109.561 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.9 -32.17 72.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.0 110.368 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.4 -16.09 62.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 0.0 110.352 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -77.14 8.41 3.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.214 -0.929 . . . . 0.0 112.629 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 155.79 -16.74 0.47 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.79 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 53.2 t -86.96 97.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 118.967 1.384 . . . . 0.0 109.273 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -154.86 129.94 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.897 -0.502 . . . . 0.0 109.873 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 75.3 m -103.27 122.39 44.68 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -73.92 -80.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.814 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -175.8 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.206 -0.934 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -88.39 -21.98 24.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.478 -0.764 . . . . 0.0 111.28 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -130.02 147.27 51.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 111.333 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -107.51 122.42 6.82 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 59.1 64.19 4.5 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.19 -5.23 55.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -1.012 . . . . 0.0 111.291 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -89.1 -1.19 57.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . 0.531 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -152.72 51.72 0.77 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.466 -0.771 . . . . 0.0 111.299 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 38.8 Cg_endo -85.49 -39.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 122.869 0.931 . . . . 0.0 111.098 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -165.43 30.05 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.253 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.065 179.879 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 120.922 0.392 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 6.1 t -60.07 -43.95 95.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.439 -0.788 . . . . 0.0 110.238 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -155.7 132.24 3.32 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 89.8 mt -102.97 -25.07 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.984 . . . . 0.0 110.787 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -89.59 11.99 18.01 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.213 -0.929 . . . . 0.0 111.208 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 11.0 p -111.14 132.0 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.364 -0.835 . . . . 0.0 110.763 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 387' ' ' LEU . 4.4 mm? -76.28 145.24 39.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.611 -0.68 . . . . 0.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -141.75 117.77 10.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.502 -0.749 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -111.1 30.78 6.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.609 -0.682 . . . . 0.0 109.836 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.48 -42.36 98.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.729 -0.607 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 33.9 p -64.36 -37.69 88.38 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.477 -0.764 . . . . 0.0 110.585 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 79.8 t -65.9 -35.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -62.75 -51.37 67.41 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.418 -0.801 . . . . 0.0 110.815 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.96 79.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.424 -0.798 . . . . 0.0 109.811 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.9 tt -62.18 -39.06 91.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.968 -0.458 . . . . 0.0 111.123 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.2 m -62.65 -37.47 86.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.43 -44.18 92.0 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.905 . . . . 0.0 112.249 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.95 -45.02 91.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.061 -1.024 . . . . 0.0 111.639 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.09 -40.84 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.724 -0.61 . . . . 0.0 109.965 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 30.9 mtp -63.73 -32.58 74.11 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.575 -0.703 . . . . 0.0 110.416 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.05 -32.24 70.72 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.106 -0.996 . . . . 0.0 110.143 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -91.17 -14.68 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.432 ' ND2' ' CB ' ' A' ' 437' ' ' SER . 2.2 t-20 -67.11 -36.98 83.1 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 0.0 109.5 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -115.33 20.38 14.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 12.5 p -37.34 146.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 122.149 -0.344 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 14.1 p -72.89 72.91 1.12 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.346 -0.846 . . . . 0.0 109.976 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -111.14 133.39 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.945 0.878 . . . . 0.0 112.819 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -92.37 145.76 31.23 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.698 -0.627 . . . . 0.0 109.848 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.96 -28.95 81.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 O-C-N 123.05 1.026 . . . . 0.0 109.825 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.57 -26.54 2.27 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.766 0.793 . . . . 0.0 111.168 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 67.21 0.75 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 82.4 p -51.07 109.86 0.37 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.522 -0.737 . . . . 0.0 110.585 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 413' ' ' VAL . 19.9 m -76.68 110.45 11.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.886 -0.509 . . . . 0.0 110.558 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.92 137.95 42.91 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 N-CA-C 109.663 -0.937 . . . . 0.0 109.663 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -147.73 83.53 1.53 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 113.704 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 420' ' ' SER . 33.0 p -100.09 26.85 6.03 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.021 -1.05 . . . . 0.0 108.481 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -110.06 -31.71 7.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.319 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -57.7 -50.59 64.14 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 436' ' ' VAL . 30.0 p90 -98.96 -11.77 21.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.814 -1.403 . . . . 0.0 111.975 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 416' ' ' THR . 6.2 t -65.92 -47.4 74.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.336 -1.477 . . . . 0.0 109.197 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -77.21 -45.36 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 110.63 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.14 77.82 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.597 -0.69 . . . . 0.0 111.475 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.85 -43.15 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.717 -0.614 . . . . 0.0 112.021 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.7 p -56.73 -39.96 74.85 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.113 -0.992 . . . . 0.0 111.225 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.99 -43.84 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.784 . . . . 0.0 109.834 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.2 OUTLIER -60.55 -34.14 73.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 112.045 -178.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -37.03 77.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.348 -1.47 . . . . 0.0 108.056 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.77 -29.63 70.26 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -179.44 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.344 -1.473 . . . . 0.0 108.969 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.7 99.14 0.72 Allowed 'Trans proline' 0 N--CA 1.484 0.913 0 N-CA-C 108.938 -1.216 . . . . 0.0 108.938 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.4 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 4.3 t -87.59 101.3 13.5 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.765 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -156.82 88.95 1.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 109.989 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.99 164.97 28.63 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.894 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.57 128.54 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.879 -0.513 . . . . 0.0 109.714 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.43 HG12 ' CG ' ' A' ' 419' ' ' TYR . 75.6 t -124.37 140.88 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.759 -0.588 . . . . 0.0 109.755 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.432 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 4.8 m -126.65 132.61 51.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 110.908 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.92 169.82 23.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -141.75 32.0 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.944 . . . . 0.0 109.626 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 138.08 168.73 11.4 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.84 92.55 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.85 88.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.906 . . . . 0.0 110.418 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.71 96.22 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.278 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.11 75.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.47 -38.82 81.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.981 . . . . 0.0 110.472 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 449' ' ' VAL . 90.3 mmt-85 -64.26 -40.22 95.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.368 -0.833 . . . . 0.0 110.138 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -70.81 -30.13 66.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.7 -46.68 78.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.372 -0.83 . . . . 0.0 111.575 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 446' ' ' ARG . 7.5 p -60.56 -32.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.774 -1.203 . . . . 0.0 108.974 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.82 -28.37 69.96 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.691 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.61 -37.58 82.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.08 -37.0 85.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 67.8 t -59.27 -26.66 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.679 -0.638 . . . . 0.0 109.314 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 17.0 mmt -67.66 -36.49 80.84 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 459' ' ' GLN . 14.8 tmm? -59.45 -29.05 67.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.834 -0.541 . . . . 0.0 110.233 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.04 -21.13 37.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.476 -0.765 . . . . 0.0 109.929 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -72.68 -25.33 61.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.651 -0.656 . . . . 0.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 455' ' ' MET . 96.9 mm-40 -77.27 2.41 15.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.338 -0.851 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.83 82.85 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 120.936 -1.103 . . . . 0.0 111.705 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -138.06 144.53 41.01 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 118.821 1.31 . . . . 0.0 111.428 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -89.44 175.3 7.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 16.6 m -138.74 162.38 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.855 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.78 115.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.2 120.55 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.788 -1.195 . . . . 0.0 112.116 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 94.9 mt -107.66 172.95 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.795 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -129.41 156.6 43.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.29 -159.75 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.673 -0.642 . . . . 0.0 109.424 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -46.84 -15.98 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.904 -1.122 . . . . 0.0 112.849 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -88.05 4.93 43.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.879 -1.138 . . . . 0.0 111.985 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -58.57 -37.61 76.14 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.066 -1.021 . . . . 0.0 111.14 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 53.5 m -56.11 -47.18 78.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.447 -0.783 . . . . 0.0 111.1 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -65.97 -37.71 86.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -0.829 . . . . 0.0 109.101 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -34.45 71.84 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.748 -0.595 . . . . 0.0 110.192 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -61.39 -39.84 92.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.0 109.593 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 59.6 ttp -62.01 -41.61 98.25 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -111.01 -150.1 0.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 109.052 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 48.26 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.021 -1.05 . . . . 0.0 112.302 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -132.91 21.48 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.605 . . . . 0.0 110.463 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 480' ' ' GLU . 47.7 tp10 -110.15 3.67 20.37 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.397 -0.814 . . . . 0.0 111.408 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.17 -24.31 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.905 -1.122 . . . . 0.0 112.421 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.21 69.64 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.106 -0.997 . . . . 0.0 110.81 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 24.7 t -90.38 51.15 1.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.58 16.82 23.37 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.081 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -126.16 59.9 1.32 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.177 -1.19 . . . . 0.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 84.7 mt -64.18 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.069 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 488' ' ' THR . 14.4 mm -155.15 -82.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.16 -0.962 . . . . 0.0 109.736 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.523 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.0 t -98.99 12.25 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.784 -0.572 . . . . 0.0 110.761 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -97.05 79.93 0.69 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.54 -67.99 0.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 495' ' ' GLU . 95.7 mtt-85 -96.75 -26.72 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.802 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -67.52 -44.34 78.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.933 -1.104 . . . . 0.0 110.524 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.46 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 2.6 mt -70.59 -37.84 73.96 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 -39.98 6.45 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 491' ' ' ARG . 89.7 mt-10 -102.14 -9.47 20.48 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.815 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 84.31 -9.18 64.9 Favored Glycine 0 N--CA 1.5 2.949 0 O-C-N 120.523 -1.36 . . . . 0.0 111.111 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 99.4 mtp -68.17 179.25 1.6 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.248 . . . . 0.0 112.11 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.55 153.77 25.77 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.523 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.4 155.04 25.95 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.191 0.996 . . . . 0.0 112.036 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 7.3 t -44.6 132.33 4.89 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.642 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.409 ' HB3' ' CA ' ' A' ' 528' ' ' HIS . 56.3 Cg_endo -85.51 112.94 1.35 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.596 1.314 . . . . 0.0 109.51 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.11 26.05 0.07 OUTLIER Glycine 0 N--CA 1.504 3.194 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.987 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.418 ' CB ' HG21 ' A' ' 487' ' ' ILE . 74.7 m -92.8 173.87 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -1.207 . . . . 0.0 111.022 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 91.6 m -115.66 127.71 55.37 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 531' ' ' GLN . 13.2 t -118.46 130.51 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.867 0.842 . . . . 0.0 111.125 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.6 123.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 534' ' ' ILE . 14.5 p -113.73 115.18 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.647 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 36.7 m-20 -84.34 108.48 17.2 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.894 -1.129 . . . . 0.0 108.418 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 0.5 OUTLIER -99.73 175.36 5.83 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 122.376 1.084 . . . . 0.0 112.969 -176.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.81 -55.85 0.05 OUTLIER Glycine 0 N--CA 1.503 3.102 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.19 -155.05 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.51 -17.86 2.54 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.046 -1.033 . . . . 0.0 111.019 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 57.5 tp -72.43 -25.05 61.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.278 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 75.2 m -65.58 -44.31 87.05 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 110.492 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 11.0 tp -64.46 -46.31 83.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.829 -0.544 . . . . 0.0 111.938 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.55 -43.81 79.8 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 0.0 112.084 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -62.5 -51.13 68.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.112 -0.992 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -59.81 -43.07 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.832 -0.542 . . . . 0.0 110.459 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -41.36 90.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.747 -0.596 . . . . 0.0 111.464 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 39.1 p -64.47 -33.27 75.49 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.053 -1.03 . . . . 0.0 109.832 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 60.8 tp -68.3 -40.44 81.75 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.694 0.759 . . . . 0.0 109.83 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -22.22 62.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -47.46 -60.17 2.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.393 -0.817 . . . . 0.0 111.895 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.88 -51.13 56.06 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -55.15 -29.83 58.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.684 -0.891 . . . . 0.0 110.414 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -47.96 -37.67 15.01 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -66.58 -42.51 86.89 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.409 ' CA ' ' HB3' ' A' ' 501' ' ' PRO . 32.2 m80 -94.62 -94.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.31 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -83.69 144.17 29.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.963 -1.085 . . . . 0.0 110.074 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 4.2 p -171.81 146.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.392 -1.323 . . . . 0.0 113.836 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.8 OUTLIER 171.86 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 76.5 t -110.44 104.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 120.742 -1.223 . . . . 0.0 113.258 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.26 116.17 31.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.435 ' CG2' HG13 ' A' ' 507' ' ' VAL . 5.7 pt -127.91 155.19 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.475 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 61.4 p -128.87 -172.69 2.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -149.4 156.04 41.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 110.563 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 85.3 p -145.32 23.26 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.663 . . . . 0.0 110.654 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -163.63 -41.6 0.02 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.63 0.4 38.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.979 . . . . 0.0 110.939 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -40.58 -39.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.583 -0.698 . . . . 0.0 112.23 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 40.5 p -63.86 -91.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -70.25 79.53 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.4 t -87.06 -18.72 29.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.953 . . . . 0.0 111.611 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.22 -38.97 93.97 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 18.9 m -69.17 -24.93 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.515 -0.991 . . . . 0.0 109.792 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.53 77.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.76 -0.587 . . . . 0.0 109.865 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.298 -0.876 . . . . 0.0 108.877 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 56.8 ttm -64.55 -31.91 73.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.93 -50.39 61.23 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 90.0 mtp -58.43 -44.27 89.05 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.838 . . . . 0.0 110.339 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.44 -32.07 73.4 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.459 -0.776 . . . . 0.0 111.474 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.67 -15.86 62.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.66 3.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.266 -0.896 . . . . 0.0 112.725 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 147.65 -13.08 1.35 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.364 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 62.9 t -85.77 103.23 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.015 -1.285 . . . . 0.0 110.708 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -151.6 114.09 4.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.784 . . . . 0.0 110.245 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 6.1 p -86.79 127.1 34.99 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.424 0.631 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -88.25 -87.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -153.48 -69.63 0.14 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.023 -1.048 . . . . 0.0 109.6 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -79.5 -20.16 47.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.686 -0.634 . . . . 0.0 110.031 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -137.98 119.65 15.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -150.59 -44.7 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -84.6 65.68 4.03 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -96.11 -24.54 16.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -1.003 . . . . 0.0 110.645 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -65.37 -37.53 87.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.783 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.37 119.86 45.7 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.71 -1.65 11.81 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 O-C-N 123.161 1.085 . . . . 0.0 110.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.53 76.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.616 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.115 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.471 0.653 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 19.3 m -59.78 -34.09 72.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.618 -0.677 . . . . 0.0 110.271 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 126.18 74.02 0.21 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 10.3 tp -141.85 55.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.957 . . . . 0.0 110.591 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -146.54 137.11 23.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.588 -0.695 . . . . 0.0 109.959 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.54 130.02 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.669 . . . . 0.0 109.593 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 53.1 tp -108.88 -1.76 18.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.189 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -61.22 147.56 43.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.95 -1.094 . . . . 0.0 109.883 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -48.33 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.528 -0.733 . . . . 0.0 111.677 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -40.53 89.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 77.8 p -66.11 -41.44 90.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.442 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 89.0 t -68.31 -33.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.679 -0.638 . . . . 0.0 110.451 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -58.37 -48.99 78.83 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.421 -0.799 . . . . 0.0 111.402 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.68 -32.17 71.79 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.949 0.88 . . . . 0.0 109.856 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.409 ' CD2' HD13 ' A' ' 399' ' ' ILE . 2.2 tm? -61.8 -41.53 97.87 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.758 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.5 p -71.86 -34.68 69.43 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.193 -0.942 . . . . 0.0 112.641 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.0 -50.22 71.6 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.996 -1.065 . . . . 0.0 112.435 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.06 -43.14 71.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.263 -0.898 . . . . 0.0 112.014 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 399' ' ' ILE . 94.1 mt -61.41 -44.79 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.112 -0.992 . . . . 0.0 110.009 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 5.9 ttm -61.42 -31.55 71.49 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.617 -0.677 . . . . 0.0 110.758 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.26 -25.21 67.7 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.539 -0.726 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 419' ' ' TYR . 65.5 tp60 -99.79 -20.65 16.11 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.272 -0.893 . . . . 0.0 109.21 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 98.0 m-20 -82.7 -7.01 59.68 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -94.67 -56.47 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 402' ' ' GLN . 6.4 p -27.88 124.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.1 m -60.13 95.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 122.159 0.98 . . . . 0.0 109.979 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.415 ' CG2' ' CZ ' ' A' ' 415' ' ' ARG . 13.9 t -65.27 137.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.132 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.2 130.68 29.1 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.684 -0.635 . . . . 0.0 110.267 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.47 -20.79 41.27 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.117 1.061 . . . . 0.0 111.07 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.35 -32.6 71.78 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.787 0.803 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 69.88 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.0 m -49.69 142.3 8.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.791 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.86 143.88 27.17 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.38 136.63 56.1 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 N-CA-C 108.794 -1.272 . . . . 0.0 108.794 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.415 ' CZ ' ' CG2' ' A' ' 407' ' ' VAL . 98.1 mtt180 -123.18 -15.53 7.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.391 -0.818 . . . . 0.0 112.881 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.9 p -102.74 6.45 39.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.025 . . . . 0.0 109.014 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -78.51 -79.92 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.05 -1.031 . . . . 0.0 111.745 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -74.12 -4.75 68.95 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.623 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 402' ' ' GLN . 81.7 m-85 -107.07 -1.94 21.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.616 -1.52 . . . . 0.0 110.207 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -84.88 -33.71 22.74 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -72.63 -37.68 67.95 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.11 85.72 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.099 0.952 . . . . 0.0 110.301 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.71 -40.98 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.253 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -69.45 -36.61 76.79 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.028 -1.045 . . . . 0.0 111.71 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.27 -42.46 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.381 -0.825 . . . . 0.0 112.008 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.51 -31.08 71.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.25 69.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.955 . . . . 0.0 109.424 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.15 -32.53 74.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -61.24 -86.49 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.475 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -172.18 -57.46 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.773 -1.205 . . . . 0.0 109.529 177.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 55.2 Cg_endo -71.07 103.44 1.38 Allowed 'Trans proline' 0 N--CA 1.488 1.198 0 N-CA-C 109.688 -0.928 . . . . 0.0 109.688 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 t -85.34 98.72 10.71 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.963 0.887 . . . . 0.0 110.712 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.731 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.2 tp -146.51 136.61 23.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -169.96 163.21 9.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.823 -1.173 . . . . 0.0 110.923 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 22.1 mt -123.49 121.52 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.793 -0.567 . . . . 0.0 110.409 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 57.3 t -127.27 137.14 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.917 . . . . 0.0 109.137 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 4.1 p -131.83 139.24 48.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.98 -1.075 . . . . 0.0 111.536 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -148.88 168.06 29.37 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.67 70.01 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 110.48 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 133.24 148.97 6.02 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.68 32.31 81.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.68 -9.16 58.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.698 -0.884 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.07 94.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.136 -0.978 . . . . 0.0 110.834 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -79.21 -28.01 54.34 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.94 -41.01 90.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.539 -0.977 . . . . 0.0 109.55 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 467' ' ' ALA . 8.4 mmm180 -64.89 -40.15 94.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.876 -0.515 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -70.27 -31.63 69.09 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.074 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.99 -50.49 64.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.52 -0.738 . . . . 0.0 112.051 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.5 -33.57 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.272 . . . . 0.0 109.174 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.89 -27.3 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -61.33 -33.95 74.45 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 455' ' ' MET . 1.5 tp -63.56 -38.43 91.08 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 91.8 t -58.88 -25.85 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 90.0 mtp -66.2 -39.77 89.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.45 -0.781 . . . . 0.0 109.221 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.3 OUTLIER -60.06 -23.44 63.76 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.874 0.845 . . . . 0.0 109.089 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 455' ' ' MET . . . -83.77 -23.65 31.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.463 0.649 . . . . 0.0 109.878 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 23.9 tpt85 -67.0 -42.96 84.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -71.42 -27.9 63.61 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.726 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -74.89 0.02 17.02 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.617 -0.677 . . . . 0.0 111.725 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.36 76.43 Favored Glycine 0 N--CA 1.496 2.679 0 O-C-N 120.837 -1.164 . . . . 0.0 110.718 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 461' ' ' ARG . 16.8 ptp180 -129.87 136.27 49.34 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.215 -1.168 . . . . 0.0 110.953 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 99.2 mt-10 -91.84 161.53 14.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.222 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 29.1 m -136.77 153.22 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 111.271 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.447 ' O ' HG11 ' A' ' 505' ' ' VAL . 53.4 tt0 -100.72 116.41 32.56 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 465' ' ' ILE . 1.1 pt -130.29 135.11 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.065 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 87.5 mt -126.22 122.12 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.118 -0.989 . . . . 0.0 111.86 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.413 ' CB ' ' NE ' ' A' ' 446' ' ' ARG . . . -66.03 155.88 35.4 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.452 -0.78 . . . . 0.0 109.128 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.99 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.406 -0.809 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 511' ' ' GLU . 5.0 t0 -46.11 -22.68 0.24 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.23 -0.919 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -70.32 -4.65 23.11 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.446 -0.784 . . . . 0.0 110.892 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -53.77 -34.18 58.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.118 -0.989 . . . . 0.0 112.929 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 75.5 m -59.41 -45.23 92.08 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.137 -0.977 . . . . 0.0 110.074 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 476' ' ' MET . 51.4 tt0 -66.84 -39.35 87.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.7 -0.625 . . . . 0.0 109.932 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 15.8 mmt -60.39 -34.52 74.02 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -61.77 -36.23 80.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.28 -0.888 . . . . 0.0 108.621 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 473' ' ' GLN . 7.3 tpp -59.45 -41.94 90.82 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.568 0.699 . . . . 0.0 109.124 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -118.16 -146.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 46.06 88.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.216 -0.927 . . . . 0.0 111.627 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -131.79 22.55 4.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.735 -0.603 . . . . 0.0 110.139 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -115.77 -15.49 11.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.695 -0.628 . . . . 0.0 110.735 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -118.15 -7.0 10.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 113.175 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -171.54 54.45 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 120.751 -1.218 . . . . 0.0 112.296 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.0 p -64.67 -21.63 66.78 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.926 -1.109 . . . . 0.0 110.576 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 149.67 48.17 0.02 OUTLIER Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.93 59.17 1.74 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.788 -0.83 . . . . 0.0 109.774 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 464' ' ' GLN . 24.9 mt -80.17 -80.29 0.14 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER 177.27 -41.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 174.131 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.9 p -103.85 9.53 36.84 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.503 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -103.14 60.78 0.48 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 499' ' ' PHE . 54.7 ttm-85 -144.12 -50.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.956 . . . . 0.0 108.835 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 98.0 mtt180 -122.97 -29.86 3.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.976 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 497' ' ' MET . 9.8 mt-30 -65.2 -41.19 94.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -0.921 . . . . 0.0 110.534 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.58 -31.48 21.17 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.503 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.93 -43.57 5.49 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -100.13 -9.65 22.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.535 -1.353 . . . . 0.0 113.904 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.22 -18.83 46.57 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.676 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.411 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 98.3 mtp -66.36 -178.47 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -1.151 . . . . 0.0 109.935 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.23 145.7 41.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.734 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -114.35 149.32 36.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.664 -0.648 . . . . 0.0 110.645 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 94.6 m -50.54 103.71 0.38 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 0.0 109.811 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.498 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 44.3 Cg_endo -72.37 113.04 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.559 1.294 . . . . 0.0 108.928 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 529' ' ' ASN . . . 171.05 34.33 0.03 OUTLIER Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.431 ' HB3' HD12 ' A' ' 487' ' ' ILE . 22.8 p -92.91 179.04 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -1.061 . . . . 0.0 110.654 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.428 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 97.8 m -111.17 121.6 45.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.45 HG13 ' CD2' ' A' ' 522' ' ' LEU . 63.4 t -123.02 134.89 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.205 -0.934 . . . . 0.0 113.227 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 4.2 pt -131.99 120.29 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 507' ' ' VAL . 9.8 p -106.1 114.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.537 -1.352 . . . . 0.0 111.478 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 468' ' ' ALA . 12.0 m-20 -82.27 108.5 15.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.9 tm0? -106.83 175.15 5.6 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.349 1.071 . . . . 0.0 113.305 -175.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -170.58 -51.91 0.04 OUTLIER Glycine 0 N--CA 1.503 3.145 0 N-CA-C 103.401 -3.88 . . . . 0.0 103.401 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 469' ' ' ASP . 32.0 tp10 -82.17 162.94 22.26 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 173.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.69 -12.32 20.11 Favored 'General case' 0 C--N 1.274 -2.712 0 O-C-N 121.636 -0.665 . . . . 0.0 110.658 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 513' ' ' LEU . 4.5 mm? -67.44 -27.16 66.81 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.2 m -91.43 -13.06 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 111.225 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 20.5 tp -78.34 -46.84 19.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -80.61 -38.52 29.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.467 -0.77 . . . . 0.0 111.512 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.64 -44.39 96.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.9 -1.125 . . . . 0.0 109.702 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 85.8 m -62.2 -41.96 98.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 519' ' ' LEU . 0.8 OUTLIER -60.2 -31.76 70.45 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.762 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 21.4 m -64.65 -53.98 39.03 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.855 -1.153 . . . . 0.0 110.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.27 93.57 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.133 -0.979 . . . . 0.0 109.888 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.45 ' CD2' HG13 ' A' ' 505' ' ' VAL . 3.2 mt -65.34 -31.98 73.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.459 -0.776 . . . . 0.0 112.181 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.06 -45.9 68.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.017 -1.052 . . . . 0.0 110.325 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.33 62.13 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.52 82.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.508 -0.995 . . . . 0.0 112.375 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.433 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -26.38 68.22 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.956 -1.09 . . . . 0.0 110.872 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -53.72 -25.8 20.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.485 -0.759 . . . . 0.0 109.243 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.498 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.7 m80 -109.98 -130.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.423 ' HB2' ' CA ' ' A' ' 502' ' ' GLY . 98.1 m-20 -89.91 70.65 7.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.532 -1.355 . . . . 0.0 113.234 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -133.28 158.0 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -148.77 154.59 39.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.759 -0.588 . . . . 0.0 109.608 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 35.4 t -107.14 106.55 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.35 -0.844 . . . . 0.0 113.12 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 506' ' ' ILE . 5.2 tp -106.72 113.66 27.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.413 HG21 HG12 ' A' ' 532' ' ' VAL . 12.1 pt -125.56 130.4 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.028 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.486 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 62.5 p -96.8 179.03 5.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -154.82 161.0 41.64 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.589 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.59 14.58 2.74 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.464 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -146.95 20.19 1.6 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 56.4 tt0 -93.83 -0.95 55.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.301 -1.117 . . . . 0.0 111.038 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -55.86 -42.75 76.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.834 -1.166 . . . . 0.0 111.25 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.1 m -102.75 -58.25 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 111.169 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -90.98 85.83 1.31 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.424 ' HA ' ' HG3' ' A' ' 539' ' ' GLN . 14.9 t -98.56 -40.78 8.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.561 -0.964 . . . . 0.0 111.608 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.09 -41.39 97.13 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 4.5 t -68.54 -23.31 64.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.522 -0.987 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.52 94.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 108.642 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -65.36 -42.11 93.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.743 -0.598 . . . . 0.0 109.958 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.21 -29.67 68.88 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.657 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.71 79.93 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 24.9 ttm -56.78 -53.02 62.65 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.598 -0.689 . . . . 0.0 110.282 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.39 -31.88 69.64 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.639 -0.663 . . . . 0.0 110.986 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -61.48 -20.04 62.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.415 -0.803 . . . . 0.0 109.776 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -72.37 -1.17 14.54 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.191 -0.943 . . . . 0.0 111.868 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.04 -8.81 9.76 Favored Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.872 -1.143 . . . . 0.0 110.992 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 58.5 t -85.85 101.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -1.221 . . . . 0.0 108.505 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -171.11 137.82 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.217 -0.927 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 8.7 p -83.9 123.22 29.71 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -86.4 -77.41 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -150.34 -72.88 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.39 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -87.36 -20.81 26.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -116.34 -179.8 3.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.178 -0.952 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 125.77 31.32 0.83 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 79.32 7.14 88.68 Favored Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.281 -1.129 . . . . 0.0 111.275 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -96.72 -15.36 21.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.79 -1.418 . . . . 0.0 111.098 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -92.0 -10.21 40.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.233 -0.917 . . . . 0.0 111.061 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.31 52.06 0.23 Allowed Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.194 -0.941 . . . . 0.0 111.446 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.79 -15.25 21.4 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.089 1.047 . . . . 0.0 110.767 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -92.1 -0.82 57.44 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.342 -0.849 . . . . 0.0 112.075 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.502 2.158 0 O-C-N 120.838 -1.164 . . . . 0.0 111.312 -179.402 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.0 m -70.57 149.47 47.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.68 . . . . 0.0 109.816 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -70.45 90.26 0.37 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.87 127.29 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.574 -0.956 . . . . 0.0 109.826 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -73.9 135.36 43.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.536 -0.728 . . . . 0.0 109.748 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 11.0 p -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.467 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.29 145.26 56.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.679 -0.638 . . . . 0.0 109.579 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.53 73.46 1.03 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 110.733 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.22 -11.13 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.584 -0.697 . . . . 0.0 110.713 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.58 -30.11 70.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.358 -0.839 . . . . 0.0 110.724 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.6 m -60.98 -44.71 96.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.22 -33.77 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.437 -0.789 . . . . 0.0 109.949 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -59.39 -47.79 84.1 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.179 -0.95 . . . . 0.0 110.559 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.64 78.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' A' ' 434' ' ' ALA . 0.6 OUTLIER -62.14 -39.38 92.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.025 -0.422 . . . . 0.0 111.195 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.0 p -64.69 -34.49 78.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 110.748 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -65.15 -43.73 90.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.96 -44.77 75.98 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.328 -0.858 . . . . 0.0 112.235 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 399' ' ' ILE . 62.2 mt -64.27 -43.77 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 6.9 tpp -61.36 -29.28 69.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.315 0.578 . . . . 0.0 109.484 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.06 -29.17 70.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.449 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 6.4 mm-40 -90.9 -15.5 29.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.081 . . . . 0.0 109.419 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.5 -37.98 86.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.648 -0.657 . . . . 0.0 110.079 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -116.86 18.9 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.047 -1.033 . . . . 0.0 110.441 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.1 p -58.76 120.92 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.397 -0.814 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 3.8 t -56.94 104.22 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.645 0.736 . . . . 0.0 110.525 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.0 p -112.71 135.33 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 138.31 25.6 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.96 -27.94 36.1 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.12 1.063 . . . . 0.0 110.758 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -62.53 -31.36 72.12 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.91 0.862 . . . . 0.0 109.996 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.61 59.32 0.69 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 30.7 t -61.34 126.99 29.33 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.751 0.786 . . . . 0.0 111.313 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.18 146.14 84.13 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.01 121.24 8.24 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -95.05 14.17 22.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.462 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 419' ' ' TYR . 14.6 p -92.07 20.9 5.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.878 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.23 -29.18 9.48 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.0 -49.63 76.5 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.456 ' CD1' HG11 ' A' ' 436' ' ' VAL . 21.0 p90 -99.29 -11.91 20.83 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.055 1.428 . . . . 0.0 112.943 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.3 m -70.88 -42.14 70.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.264 -1.523 . . . . 0.0 108.203 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 425' ' ' VAL . 33.6 t70 -78.94 -44.58 22.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.907 -0.496 . . . . 0.0 110.758 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -64.74 -48.04 76.05 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.773 -0.579 . . . . 0.0 112.409 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.42 -42.33 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.319 -0.863 . . . . 0.0 111.469 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 81.2 p -60.68 -42.84 97.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.182 -0.949 . . . . 0.0 111.343 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 421' ' ' ASP . 32.8 m -68.7 -29.32 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.33 -0.856 . . . . 0.0 111.949 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.34 -33.18 64.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.283 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.27 -32.71 73.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.026 -1.046 . . . . 0.0 108.594 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.17 -33.98 77.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.38 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.44 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -177.06 -56.11 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.556 -1.34 . . . . 0.0 110.001 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.4 Cg_endo -68.59 107.93 1.74 Allowed 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 109.291 -1.08 . . . . 0.0 109.291 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 531' ' ' GLN . 1.5 m -100.41 109.21 21.36 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.89 0.852 . . . . 0.0 110.898 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -174.8 95.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' A' ' 395' ' ' LEU . . . -136.86 167.01 22.29 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.929 0.871 . . . . 0.0 112.372 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 435' ' ' ILE . 40.0 pt -116.3 127.66 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.467 0.651 . . . . 0.0 109.541 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 54.0 t -125.04 137.35 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.369 -0.832 . . . . 0.0 109.327 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 28.1 m -119.61 123.45 43.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.359 -0.838 . . . . 0.0 110.951 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.96 155.66 19.63 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.17 75.55 0.25 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.737 -0.861 . . . . 0.0 109.368 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 113.65 145.49 9.2 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.27 38.96 95.39 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.25 -30.0 69.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.6 -0.941 . . . . 0.0 110.737 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.29 93.88 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.416 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.55 -28.05 68.26 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.37 -46.5 88.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.49 -1.006 . . . . 0.0 110.757 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 13.0 mtm-85 -64.81 -40.76 95.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.557 -0.714 . . . . 0.0 111.189 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -69.22 -29.97 68.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.127 -0.983 . . . . 0.0 110.37 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -61.67 -51.5 68.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.329 -0.857 . . . . 0.0 110.449 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 2.4 p -58.0 -31.74 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.095 -1.003 . . . . 0.0 108.765 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.02 -27.34 69.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.24 -34.28 76.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.106 -0.996 . . . . 0.0 108.756 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.87 -34.41 77.88 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 85.7 t -59.3 -30.12 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.633 -0.667 . . . . 0.0 109.742 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 60.3 mtt -66.34 -39.28 89.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.001 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.4 ttp -58.86 -25.21 63.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.652 -0.655 . . . . 0.0 110.176 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.36 -22.68 32.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 110.058 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -64.52 -45.39 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.573 -0.704 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.05 -29.86 65.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -75.82 3.8 9.26 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 111.357 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.67 23.92 75.45 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -128.37 145.64 51.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.445 -1.032 . . . . 0.0 110.344 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.432 ' CB ' HD13 ' A' ' 487' ' ' ILE . 51.0 mp0 -99.09 169.79 9.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 35.5 m -141.27 150.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.086 -1.009 . . . . 0.0 111.212 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.402 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 41.4 tt0 -101.2 123.62 45.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.49 146.78 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.225 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 95.5 mt -132.99 124.61 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.437 -0.789 . . . . 0.0 110.674 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.8 161.94 28.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.16 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.534 -0.729 . . . . 0.0 109.863 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -49.42 -19.16 0.49 Allowed 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.665 -1.272 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -76.17 -5.67 47.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.213 -0.929 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -56.97 -23.44 45.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.033 -1.042 . . . . 0.0 111.027 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 11.6 t -60.6 -48.57 81.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.11 -46.36 84.57 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 30.1 tpp -53.57 -35.03 60.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.897 -0.502 . . . . 0.0 110.904 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -60.72 -38.7 85.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.439 -0.788 . . . . 0.0 109.962 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 10.6 tpt -61.79 -37.67 85.22 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.602 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -113.12 -144.47 0.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 55.54 50.73 13.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.829 -1.169 . . . . 0.0 111.398 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -100.6 23.57 10.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.27 -10.21 39.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 112.265 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . 0.417 ' N ' ' CD ' ' A' ' 481' ' ' ARG . 0.0 OUTLIER -173.2 24.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.944 -1.098 . . . . 0.0 112.746 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 3.8 pp -171.62 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.4 p -61.13 -21.44 63.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.112 -0.992 . . . . 0.0 110.804 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 164.0 53.24 0.02 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.6 66.14 0.75 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.661 -0.905 . . . . 0.0 109.77 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 486' ' ' LEU . 75.4 mt -77.2 -82.1 0.09 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.427 -0.795 . . . . 0.0 109.21 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 503' ' ' SER . 35.8 mm -152.64 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 109.255 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 499' ' ' PHE . 3.9 t -100.74 10.67 40.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.572 -0.705 . . . . 0.0 111.077 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.426 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -91.92 72.63 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.461 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 51.0 ttm-85 -142.92 -73.96 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -90.37 -26.81 19.74 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.255 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -62.67 -48.06 80.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 110.512 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.426 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 4.8 mt -71.64 -41.82 68.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.513 -0.742 . . . . 0.0 111.457 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 45.9 tp -102.66 -45.4 5.04 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -87.02 -5.02 59.21 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.076 -1.015 . . . . 0.0 112.492 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 62.41 47.22 91.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.02 -177.17 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.923 . . . . 0.0 109.411 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.87 48.62 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 109.12 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.461 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.3 OUTLIER -113.92 148.74 36.28 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.076 0.941 . . . . 0.0 111.453 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 8.2 t -48.68 121.43 9.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.586 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.84 114.36 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.384 1.202 . . . . 0.0 110.676 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -170.69 33.36 0.16 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.441 ' HB2' ' CG2' ' A' ' 487' ' ' ILE . 36.7 t -80.75 143.22 33.08 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 48.1 m -115.25 108.48 16.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 464' ' ' GLN . 41.4 t -113.09 141.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 506' ' ' ILE . 15.9 pt -136.46 103.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 175.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 507' ' ' VAL . 8.6 p -103.49 107.02 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.739 -1.225 . . . . 0.0 112.263 -176.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.18 107.95 17.49 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 6.5 tp-100 -131.0 115.18 16.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . 0.484 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -73.33 -64.73 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.85 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.85 -12.87 1.96 Allowed 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.629 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.74 -34.56 78.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.342 -0.849 . . . . 0.0 109.438 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 22.9 t -90.4 -14.52 32.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.697 -0.627 . . . . 0.0 111.236 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.45 -48.92 71.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.038 -1.039 . . . . 0.0 108.922 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.86 -41.7 74.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.968 -0.457 . . . . 0.0 110.865 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.92 -47.05 81.52 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 78.9 m -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.367 -0.833 . . . . 0.0 110.239 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -39.58 77.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.849 -0.532 . . . . 0.0 110.674 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 11.5 m -61.97 -39.63 92.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.384 -0.823 . . . . 0.0 110.301 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.34 -41.68 96.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.873 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.82 -22.4 65.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.748 -0.595 . . . . 0.0 110.458 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -47.24 -63.69 0.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.07 -51.71 50.85 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.708 -1.245 . . . . 0.0 110.46 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -29.34 65.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.908 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.475 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -59.99 -25.1 64.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.513 -0.742 . . . . 0.0 112.481 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -41.94 -27.74 0.13 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.542 -0.724 . . . . 0.0 111.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -108.22 -126.94 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.73 . . . . 0.0 111.047 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -89.86 96.87 10.88 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.622 -1.299 . . . . 0.0 114.49 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -113.17 131.08 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 O-C-N 120.893 -1.129 . . . . 0.0 111.462 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 432' ' ' SER . 86.8 mt-30 -120.27 126.85 51.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.08 123.51 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 122.581 1.181 . . . . 0.0 113.091 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 9.2 mp -119.57 119.3 33.4 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 534' ' ' ILE . 0.8 OUTLIER -132.78 129.01 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.658 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.544 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 30.2 p -101.58 -166.69 1.33 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 4.3 t0 -159.07 169.12 24.96 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' SER . . . . . 0.484 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -140.73 17.85 2.34 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.719 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.99 2.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 536' ' ' ASP . 83.9 mt-30 -96.75 1.19 50.58 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.507 -0.996 . . . . 0.0 111.947 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -53.45 -40.66 65.41 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.985 -1.072 . . . . 0.0 111.388 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.0 m -104.18 -45.18 4.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.162 -0.961 . . . . 0.0 111.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.85 67.27 0.34 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.0 t -65.39 -42.81 92.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.523 -0.987 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.71 -39.83 97.96 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 57.3 m -60.56 -33.94 73.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.589 -0.948 . . . . 0.0 109.997 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.2 82.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.14 -42.16 98.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.57 -0.706 . . . . 0.0 109.637 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 99.1 mtp -65.44 -31.84 73.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.705 -0.622 . . . . 0.0 109.832 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.44 -54.05 48.66 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.513 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.22 -44.14 95.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.306 -0.871 . . . . 0.0 110.519 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.68 -31.57 72.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.359 -0.838 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -67.72 -15.59 63.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.089 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.59 6.73 4.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 112.098 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 151.15 -16.68 0.9 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.209 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.61 101.08 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.072 -1.252 . . . . 0.0 109.858 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -154.06 116.19 4.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 110.268 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 18.3 m -63.16 135.7 57.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.563 -0.71 . . . . 0.0 110.056 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.55 -90.72 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 0.0 110.89 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 36.0 mmm-85 -147.87 -80.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.014 -1.053 . . . . 0.0 110.62 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -93.58 -22.6 18.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 0.0 110.889 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -131.09 140.72 50.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.482 -0.761 . . . . 0.0 110.17 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 147.71 -104.67 0.29 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -94.98 -18.75 33.23 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -70.03 -33.91 72.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -1.075 . . . . 0.0 110.081 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -82.73 -13.14 56.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.541 -0.725 . . . . 0.0 110.661 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 116.95 0.35 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 0.0 110.081 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.84 -28.33 36.45 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 N-CA-C 109.491 -1.004 . . . . 0.0 109.491 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -168.51 -61.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.68 -0.638 . . . . 0.0 109.516 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.507 2.411 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.456 179.581 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 61.9 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.7 m -72.42 148.77 44.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.71 -0.618 . . . . 0.0 110.158 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 106.62 -23.94 26.89 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 18.7 tt -108.53 106.56 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.35 -1.088 . . . . 0.0 110.11 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -78.77 -36.78 42.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.238 -0.914 . . . . 0.0 110.47 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.465 -0.772 . . . . 0.0 109.615 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.06 139.13 39.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.636 -0.665 . . . . 0.0 109.997 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -106.06 38.83 1.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 110.254 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -103.93 34.91 2.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.608 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.1 -46.62 86.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.518 -0.739 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.6 t -62.74 -44.03 97.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.787 -0.571 . . . . 0.0 110.303 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.16 -34.64 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.177 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.0 -42.07 98.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.526 -0.734 . . . . 0.0 111.658 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.33 59.6 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.002 -1.061 . . . . 0.0 112.388 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 399' ' ' ILE . 1.1 pp -69.62 -33.92 73.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.996 . . . . 0.0 111.057 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 70.3 m -55.55 -43.07 75.48 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.589 -0.694 . . . . 0.0 111.226 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -68.09 -41.19 82.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -0.817 . . . . 0.0 111.518 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -65.51 -40.41 92.97 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.187 -0.946 . . . . 0.0 112.59 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 395' ' ' LEU . 0.0 OUTLIER -66.66 -39.24 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 121.147 -0.971 . . . . 0.0 109.882 -178.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' MET . . . . . 0.417 ' CG ' HD11 ' A' ' 435' ' ' ILE . 8.7 mtp -64.42 -39.73 94.41 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.153 -0.967 . . . . 0.0 109.174 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.74 -29.83 70.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 419' ' ' TYR . 59.8 tp60 -90.47 -11.15 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.473 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.54 -38.91 77.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.806 -0.559 . . . . 0.0 110.291 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -117.8 19.26 13.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.066 . . . . 0.0 109.872 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.15 148.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 CA-C-O 121.176 0.513 . . . . 0.0 110.859 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.6 m -77.06 81.38 3.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.4 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.402 ' CG1' ' CB ' ' A' ' 412' ' ' SER . 48.4 t -105.58 130.26 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.944 0.878 . . . . 0.0 111.702 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -96.79 144.38 27.76 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.66 -23.44 56.54 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.143 1.075 . . . . 0.0 110.767 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.398 -0.814 . . . . 0.0 110.69 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 56.76 0.5 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' SER . . . . . 0.402 ' CB ' ' CG1' ' A' ' 407' ' ' VAL . 11.7 p -69.53 137.43 52.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.443 -0.786 . . . . 0.0 111.334 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.9 p -88.99 146.25 36.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.52 135.48 28.73 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.09 1.047 . . . . 0.0 111.276 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 417' ' ' ALA . 99.8 mtt180 -96.81 -87.84 0.3 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.714 -0.616 . . . . 0.0 109.515 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.0 t -29.8 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 415' ' ' ARG . . . -50.83 -69.99 0.1 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.302 -0.873 . . . . 0.0 111.46 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -77.36 -1.57 76.14 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.708 -1.245 . . . . 0.0 111.29 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 402' ' ' GLN . 76.6 m-85 -108.25 0.32 21.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.791 -1.417 . . . . 0.0 110.28 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.0 p -92.6 -33.72 14.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -73.74 -37.2 65.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.83 82.73 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.43 0.633 . . . . 0.0 110.038 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.442 ' HA ' ' CD2' ' A' ' 426' ' ' LEU . 77.0 t -67.74 -42.66 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.624 -0.672 . . . . 0.0 111.758 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.6 m -59.82 -43.29 94.61 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.975 -1.078 . . . . 0.0 112.352 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.91 -50.58 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.013 -1.055 . . . . 0.0 109.747 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -47.75 -31.57 4.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.641 -0.662 . . . . 0.0 111.688 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.74 -35.46 74.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 109.292 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.32 -31.03 72.07 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.549 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.35 -74.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.545 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER 178.89 -53.91 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.18 -0.95 . . . . 0.0 110.108 178.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.5 Cg_endo -79.84 116.23 3.43 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 1.8 m -105.67 100.39 9.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.355 -0.938 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.4 137.72 20.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -173.45 160.72 3.95 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 120.511 -1.368 . . . . 0.0 112.762 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 400' ' ' MET . 3.3 pt -122.32 117.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.4 ' CG2' ' CG2' ' A' ' 423' ' ' VAL . 70.4 t -122.11 137.77 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 110.749 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.9 t -121.74 129.83 52.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.017 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.75 147.9 18.76 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -146.11 80.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.587 -0.949 . . . . 0.0 109.645 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 121.83 110.48 2.11 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.09 85.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.03 -19.72 25.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.587 -0.949 . . . . 0.0 110.613 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.93 92.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 110.914 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.9 -30.58 70.13 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -62.6 -40.19 96.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.611 -0.935 . . . . 0.0 110.44 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.411 ' O ' HG11 ' A' ' 449' ' ' VAL . 8.4 mpt_? -64.37 -38.1 89.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -71.28 -30.15 65.92 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.3 -0.875 . . . . 0.0 109.996 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -64.81 -44.7 89.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.548 -0.72 . . . . 0.0 111.646 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 450' ' ' ALA . 10.5 p -64.72 -32.44 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -64.42 -31.07 72.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.21 -38.02 75.95 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.051 -1.03 . . . . 0.0 108.445 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.4 -31.09 72.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.14 -32.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 58.2 mtt -66.13 -40.13 90.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 56.4 ttp -58.99 -21.07 58.21 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.241 0.543 . . . . 0.0 110.101 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 463' ' ' VAL . . . -84.54 -22.64 30.05 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 177.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.37 -27.4 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -78.26 9.17 4.03 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.312 -0.868 . . . . 0.0 112.274 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.09 26.4 72.41 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.88 145.32 36.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 111.405 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -99.43 163.23 12.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 456' ' ' ALA . 33.7 m -132.21 158.77 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 118.924 -1.11 . . . . 0.0 112.268 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.99 107.13 17.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.429 HD13 ' CG2' ' A' ' 449' ' ' VAL . 0.5 OUTLIER -118.2 124.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.706 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.468 ' HB ' HG22 ' A' ' 507' ' ' VAL . 85.6 mt -122.03 115.37 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.862 -0.524 . . . . 0.0 110.916 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 508' ' ' ASP . . . -66.17 165.63 13.35 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.471 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.01 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -51.41 -19.07 1.21 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.956 -1.09 . . . . 0.0 111.129 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -78.98 -8.19 58.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -0.787 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . 0.403 ' HD2' ' CG2' ' A' ' 466' ' ' ILE . 79.8 ttt-85 -52.36 -24.85 8.35 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.99 -1.069 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -58.12 -42.88 86.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.806 . . . . 0.0 109.358 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -65.09 -38.83 91.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' MET . . . . . 0.416 ' CE ' ' HG2' ' A' ' 478' ' ' GLN . 28.2 ttt -62.0 -32.28 72.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.783 -0.573 . . . . 0.0 110.29 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -61.69 -40.04 93.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 110.083 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 73.4 mtm -62.51 -35.54 79.73 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 62.8 pttt -121.47 -148.06 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . 0.416 ' HG2' ' CE ' ' A' ' 474' ' ' MET . 1.0 OUTLIER 53.6 70.09 0.63 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.161 -0.962 . . . . 0.0 111.192 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -112.98 23.8 13.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.68 3.21 26.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.854 . . . . 0.0 111.06 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.13 -29.8 0.53 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.19 -0.944 . . . . 0.0 111.664 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.41 72.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.803 -1.186 . . . . 0.0 110.791 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.4 m -72.36 -18.42 61.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.464 -0.772 . . . . 0.0 110.121 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.43 46.68 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 485' ' ' GLU . 13.6 pt-20 -149.01 103.74 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.926 . . . . 0.0 110.572 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.531 ' O ' HG13 ' A' ' 487' ' ' ILE . 96.4 mt -98.46 -84.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.602 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 486' ' ' LEU . 3.3 mp -157.35 -65.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.08 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.469 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.6 t -99.9 11.12 40.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.45 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -92.91 77.22 1.17 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 54.5 ttt85 -145.17 -63.72 0.34 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 495' ' ' GLU . 92.7 mtt-85 -97.98 -31.32 12.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.421 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -64.53 -43.95 92.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.45 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 2.2 mt -69.09 -38.53 79.01 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.318 0.58 . . . . 0.0 110.822 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.87 -48.4 3.64 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 491' ' ' ARG . 94.8 mt-10 -90.0 -10.3 45.45 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.666 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 491' ' ' ARG . . . 83.0 -13.16 45.81 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.641 -1.287 . . . . 0.0 111.017 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 70.6 mmm -67.86 -179.67 1.23 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.095 -1.238 . . . . 0.0 111.01 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.96 153.62 28.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.64 -0.663 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.469 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.52 151.03 32.08 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.773 0.797 . . . . 0.0 110.354 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -55.72 150.42 26.86 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.83 -0.544 . . . . 0.0 111.839 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.66 115.74 4.35 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.653 1.344 . . . . 0.0 109.599 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -177.12 39.34 0.09 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.496 ' HA ' HG12 ' A' ' 487' ' ' ILE . 29.0 t -99.96 109.99 22.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.909 -0.76 . . . . 0.0 112.806 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.413 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 55.5 m -95.48 107.06 19.19 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 43.4 t -109.58 126.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.414 -174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 533' ' ' LEU . 38.6 pt -122.59 109.99 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 466' ' ' ILE . 13.9 p -108.03 112.95 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 43.6 t0 -84.04 110.39 18.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.6 tm0? -97.39 175.2 6.33 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.356 1.074 . . . . 0.0 113.757 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -169.69 -44.05 0.03 OUTLIER Glycine 0 N--CA 1.508 3.46 0 N-CA-C 105.91 -2.876 . . . . 0.0 105.91 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -99.54 -162.56 0.96 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -120.27 -1.67 10.22 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 111.222 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 513' ' ' LEU . 4.6 mm? -74.84 -27.4 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.751 . . . . 0.0 109.454 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 52.9 m -87.15 -17.09 33.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.66 -0.65 . . . . 0.0 112.008 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 31.7 tp -81.51 -52.59 7.07 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.847 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -71.43 -43.47 66.68 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.599 -0.688 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -40.0 95.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.027 -1.046 . . . . 0.0 111.143 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 70.6 m -61.26 -48.32 81.97 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.264 -0.975 . . . . 0.0 108.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 519' ' ' LEU . 0.1 OUTLIER -58.15 -32.34 68.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.301 0.572 . . . . 0.0 109.654 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.6 m -61.79 -41.58 97.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.826 -0.546 . . . . 0.0 109.876 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.55 -42.27 74.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 109.682 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 2.0 mt -59.6 -22.25 61.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.625 -0.672 . . . . 0.0 111.225 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.8 -57.4 4.92 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.672 -0.643 . . . . 0.0 112.235 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.59 50.03 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.009 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.36 64.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.882 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -56.48 -23.62 40.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.408 -0.808 . . . . 0.0 111.863 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.73 -36.61 37.28 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.125 -0.984 . . . . 0.0 110.919 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -132.88 -69.79 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.374 -0.829 . . . . 0.0 111.13 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.402 ' C ' ' CG2' ' A' ' 530' ' ' VAL . 31.0 m-80 -83.56 154.92 23.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.31 -0.868 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -179.59 153.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 CA-C-O 121.401 0.62 . . . . 0.0 109.939 177.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.45 ' CG ' ' HB2' ' A' ' 432' ' ' SER . 0.1 OUTLIER -174.75 95.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 41.7 t -104.69 107.16 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.41 ' HB2' ' CG2' ' A' ' 506' ' ' ILE . 7.4 mp -108.31 114.1 27.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . . . . . . . . . 8.2 pt -123.85 136.29 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.571 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 53.4 p -112.99 -169.63 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -157.87 166.14 33.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.032 -1.042 . . . . 0.0 110.85 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 2.9 p -146.83 21.94 1.26 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.81 -0.556 . . . . 0.0 109.912 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.39 -30.71 0.04 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -78.76 -0.13 29.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.086 -1.243 . . . . 0.0 111.142 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -38.88 -29.88 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -102.93 -29.44 11.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.43 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -120.22 59.08 0.55 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.5 t -64.57 -37.26 86.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.625 -0.927 . . . . 0.0 110.717 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -57.16 -43.8 93.35 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 93.9 p -63.56 -29.57 70.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.414 -1.051 . . . . 0.0 109.676 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.39 80.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.732 -0.605 . . . . 0.0 109.882 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.9 mp -61.99 -41.14 97.72 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.5 mmm -64.74 -33.63 76.41 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -57.14 -53.57 56.58 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.105 0.479 . . . . 0.0 109.92 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 33.4 ttm -55.11 -47.19 75.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.427 -0.795 . . . . 0.0 110.332 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.606 -0.684 . . . . 0.0 111.401 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -66.38 -17.8 64.98 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 4.48 5.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.354 -0.841 . . . . 0.0 112.384 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 154.66 -17.54 0.57 Allowed Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.533 -1.318 . . . . 0.0 111.524 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.44 108.75 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.042 -1.269 . . . . 0.0 110.327 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -166.71 117.84 0.95 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.424 -0.798 . . . . 0.0 110.246 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 87.5 m -86.71 123.51 31.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.543 -0.723 . . . . 0.0 109.169 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -73.7 -95.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.412 -0.805 . . . . 0.0 108.971 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -132.53 -90.42 0.41 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.83 -1.169 . . . . 0.0 109.015 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -114.21 -23.71 9.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.053 -1.029 . . . . 0.0 110.692 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -98.83 143.79 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 110.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 90.61 111.62 1.55 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 81.82 -62.8 4.47 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -80.2 -2.09 43.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.404 -1.056 . . . . 0.0 111.737 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.23 -44.1 75.14 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.147 -0.971 . . . . 0.0 109.085 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.16 90.28 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.91 -8.0 19.76 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.645 1.339 . . . . 0.0 110.517 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -91.09 98.32 11.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.659 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.022 0.439 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 47.0 t -61.41 -43.35 99.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.503 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -100.67 -138.57 10.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 384' ' ' ILE . 87.3 mt -93.3 124.9 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.769 -0.842 . . . . 0.0 110.656 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -109.96 124.23 51.03 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.408 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 p -107.73 135.6 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.25 129.25 46.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.202 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -108.8 179.87 4.06 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.23 -18.48 37.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.809 -0.557 . . . . 0.0 111.092 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 38.5 tp -59.4 -29.34 67.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 71.3 m -60.83 -44.99 96.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.571 -0.706 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.15 -34.18 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.704 . . . . 0.0 110.605 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -58.16 -52.5 65.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.421 -0.8 . . . . 0.0 111.576 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.54 78.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.386 -0.821 . . . . 0.0 109.954 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.409 ' CD2' HD13 ' A' ' 399' ' ' ILE . 3.2 tt -62.17 -38.52 89.39 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.588 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.1 m -71.55 -34.18 69.79 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.984 -1.072 . . . . 0.0 112.137 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.71 -45.23 87.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.104 -0.997 . . . . 0.0 112.335 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -70.39 -41.62 72.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.122 -0.986 . . . . 0.0 111.999 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.497 ' HA ' ' CD1' ' A' ' 419' ' ' TYR . 50.0 mt -63.73 -40.72 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.358 -0.839 . . . . 0.0 108.936 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 ttm -58.62 -34.88 71.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.705 -0.622 . . . . 0.0 109.486 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.41 -20.08 62.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.055 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.495 ' HG2' ' CD2' ' A' ' 419' ' ' TYR . 6.2 tp-100 -91.58 -20.26 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.938 -1.101 . . . . 0.0 108.995 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.66 -32.67 73.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -116.36 19.75 14.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.088 -1.008 . . . . 0.0 110.286 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 5.9 p -59.06 117.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.557 -0.714 . . . . 0.0 109.852 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.8 p -52.71 102.92 0.06 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.477 -0.764 . . . . 0.0 110.748 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.59 132.86 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.553 -0.717 . . . . 0.0 110.233 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -93.94 139.77 22.74 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.532 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.75 -25.28 53.77 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.219 1.115 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.15 -29.15 69.39 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.522 0.677 . . . . 0.0 111.133 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 58.65 0.57 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 80.4 p -50.31 111.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.667 0.746 . . . . 0.0 111.941 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.03 150.49 91.81 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.48 147.86 92.95 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.313 1.165 . . . . 0.0 110.567 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.42 ' HD3' ' HB3' ' A' ' 439' ' ' GLN . 82.2 mtp180 -128.49 -15.35 4.55 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.625 -0.672 . . . . 0.0 112.604 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 t -103.88 18.32 22.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 108.391 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -86.21 -76.46 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.703 -0.623 . . . . 0.0 112.208 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -75.73 -4.01 74.85 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.972 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.497 ' CD1' ' HA ' ' A' ' 399' ' ' ILE . 96.8 m-85 -107.8 -13.88 14.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.293 1.546 . . . . 0.0 109.647 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -41.33 74.85 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -68.73 -36.69 78.74 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.01 81.27 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 122.038 0.923 . . . . 0.0 109.807 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.412 ' HA ' HD21 ' A' ' 426' ' ' LEU . 79.4 t -69.07 -44.06 81.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -60.69 -38.92 86.57 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.879 -1.138 . . . . 0.0 111.287 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.19 -44.14 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -55.61 -32.61 63.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.651 -0.656 . . . . 0.0 111.74 -178.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.37 77.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.618 -1.301 . . . . 0.0 108.631 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.54 -30.1 71.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.78 -89.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -179.9 -58.58 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.506 -1.372 . . . . 0.0 109.017 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.61 99.78 0.65 Allowed 'Trans proline' 0 N--CA 1.485 1.004 0 N-CA-C 108.661 -1.323 . . . . 0.0 108.661 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.473 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 67.7 m -94.98 110.36 22.27 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.864 0.84 . . . . 0.0 111.872 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 1.3 tp -166.56 90.22 0.4 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -135.49 169.77 16.99 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.93 0.871 . . . . 0.0 112.439 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 435' ' ' ILE . 33.0 pt -127.22 130.21 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.425 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.66 97.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.864 -1.147 . . . . 0.0 110.311 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 37.3 m -76.01 129.5 36.96 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.382 -0.824 . . . . 0.0 111.145 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -107.19 170.93 16.13 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . 0.42 ' HB3' ' HD3' ' A' ' 415' ' ' ARG . 67.6 tp60 -170.03 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.522 -0.987 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -64.12 -49.7 65.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -156.32 141.95 8.38 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -111.85 -26.09 9.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.972 . . . . 0.0 110.639 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.57 88.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.394 -0.816 . . . . 0.0 110.617 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.39 -29.36 64.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.51 -39.01 91.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.62 -0.929 . . . . 0.0 109.477 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -61.97 -46.52 88.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 111.391 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.11 -32.85 65.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.047 -1.033 . . . . 0.0 111.199 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 57.9 ttm-85 -61.8 -47.37 85.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 452' ' ' LEU . 3.7 p -57.44 -30.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.747 -1.221 . . . . 0.0 108.565 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.3 -26.42 68.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 80.8 mm-40 -63.87 -33.25 75.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.942 -1.099 . . . . 0.0 108.618 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 452' ' ' LEU . 4.0 mm? -63.17 -33.97 76.62 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 90.1 t -59.75 -30.56 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.617 . . . . 0.0 109.586 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.22 -35.25 79.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -60.72 -28.75 68.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 109.597 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.7 31.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.512 -0.742 . . . . 0.0 109.72 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -63.61 -43.82 95.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.12 -30.61 69.81 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -76.28 5.48 6.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.564 -0.71 . . . . 0.0 111.757 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.4 75.19 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -138.44 120.32 15.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.485 -1.009 . . . . 0.0 110.802 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.06 171.12 14.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 109.246 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' A' ' 504' ' ' THR . 30.0 m -140.14 155.14 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 111.433 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.418 ' HA ' ' CD2' ' A' ' 486' ' ' LEU . 51.7 tt0 -101.52 117.65 35.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 465' ' ' ILE . 2.5 pt -128.38 136.15 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.809 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 466' ' ' ILE . 4.7 mp -125.42 117.38 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.092 -1.005 . . . . 0.0 111.279 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -65.79 161.17 21.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.734 -1.229 . . . . 0.0 109.016 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.74 -158.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 511' ' ' GLU . 28.8 p-10 -44.81 -21.58 0.06 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.818 -1.176 . . . . 0.0 112.411 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.2 -2.79 23.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.321 -0.862 . . . . 0.0 111.577 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.03 -41.33 82.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.94 -1.1 . . . . 0.0 111.735 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.1 m -55.82 -45.36 78.35 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.966 -1.084 . . . . 0.0 110.469 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.29 -37.16 86.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.491 -0.755 . . . . 0.0 108.972 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.2 ttp -60.52 -33.8 73.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.761 -0.587 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.83 -37.7 85.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.78 -40.85 94.12 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.248 -0.908 . . . . 0.0 109.722 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -121.93 -141.94 0.33 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 109.453 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 51.23 88.86 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.706 -1.246 . . . . 0.0 110.936 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -136.74 34.96 2.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.728 . . . . 0.0 109.157 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -128.52 -3.69 5.41 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.879 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -132.36 -13.28 3.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.97 -1.081 . . . . 0.0 112.443 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.59 71.83 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.893 -1.129 . . . . 0.0 111.169 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.7 p -92.41 50.04 1.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.43 36.16 7.11 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -122.27 47.25 1.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.622 -0.928 . . . . 0.0 110.104 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 464' ' ' GLN . 20.7 mt -75.44 -79.87 0.09 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.433 HG22 ' CG2' ' A' ' 488' ' ' THR . 0.1 OUTLIER 179.31 -42.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 110.342 174.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.433 ' CG2' HG22 ' A' ' 487' ' ' ILE . 3.2 p -103.85 8.94 37.05 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.564 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -97.95 60.29 0.99 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.376 -1.889 . . . . 0.0 108.376 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.412 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 67.6 ttt180 -142.42 -70.9 0.33 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -108.87 -21.0 12.86 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.872 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -65.42 -46.79 78.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.633 -0.667 . . . . 0.0 111.898 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.96 -56.72 2.98 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.0 111.075 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.17 -42.21 93.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.471 -0.768 . . . . 0.0 112.808 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -99.99 -3.32 32.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.944 -1.098 . . . . 0.0 113.142 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 65.05 47.82 77.81 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 44.3 mtt -119.75 -174.05 2.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.788 -0.831 . . . . 0.0 109.655 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.23 131.94 55.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.32 -0.863 . . . . 0.0 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.43 ' O ' ' HD3' ' A' ' 501' ' ' PRO . 0.3 OUTLIER -115.19 140.32 49.19 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 2.2 t -44.7 99.96 0.22 Allowed Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 122.212 -0.305 . . . . 0.0 111.597 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 499' ' ' PHE . 41.9 Cg_endo -67.92 113.95 3.19 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 107.996 -1.579 . . . . 0.0 107.996 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 179.52 32.25 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 40.0 t -93.13 176.29 6.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.066 . . . . 0.0 111.591 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.442 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 79.2 m -116.61 124.23 49.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.406 ' CG2' HD12 ' A' ' 522' ' ' LEU . 57.6 t -121.92 136.82 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 112.872 -175.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 2.0 pp -130.07 110.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.455 HG13 ' CG2' ' A' ' 534' ' ' ILE . 12.4 p -99.16 108.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.147 -1.596 . . . . 0.0 110.344 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 73.0 m-20 -82.78 108.25 16.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -97.8 174.66 6.49 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 122.743 1.259 . . . . 0.0 113.194 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.56 -64.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.822 0 N-CA-C 103.943 -3.663 . . . . 0.0 103.943 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 469' ' ' ASP . 32.3 tt0 -70.98 -142.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.02 -19.04 1.16 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.727 -1.233 . . . . 0.0 111.442 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.24 -21.92 62.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 77.3 p -72.05 -41.09 67.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.503 -0.748 . . . . 0.0 110.953 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 10.8 tp -65.39 -52.47 53.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.0 111.283 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . 0.412 ' HG3' ' CB ' ' A' ' 553' ' ' ALA . 25.9 ttmt -67.36 -46.88 72.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.501 -0.75 . . . . 0.0 111.571 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.39 -49.01 79.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.272 -0.892 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 81.7 m -58.54 -42.67 88.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.475 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -40.41 93.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.326 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 37.8 p -64.88 -39.94 94.33 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.056 -1.027 . . . . 0.0 111.195 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -41.77 87.21 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.202 1.001 . . . . 0.0 108.588 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.406 HD12 ' CG2' ' A' ' 505' ' ' VAL . 0.8 OUTLIER -65.36 -22.01 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.721 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -47.29 -62.82 1.25 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.318 -0.864 . . . . 0.0 112.992 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.79 61.71 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.313 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -61.68 -31.43 71.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.657 -0.908 . . . . 0.0 111.805 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.455 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -72.19 -22.57 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 112.382 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -40.57 -27.47 0.05 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.428 -0.795 . . . . 0.0 112.385 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' A' ' 501' ' ' PRO . 49.7 t60 -114.23 -117.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 111.5 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.5 90.01 8.1 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.513 -1.367 . . . . 0.0 114.551 -177.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.455 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 7.6 p -127.79 149.52 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 109.967 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 86.5 mt-30 -126.04 132.31 52.0 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.994 -0.441 . . . . 0.0 110.07 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 87.3 t -109.33 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.49 1.138 . . . . 0.0 111.576 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.3 OUTLIER -117.14 119.77 36.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.455 ' CG2' HG13 ' A' ' 507' ' ' VAL . 4.5 pt -129.1 140.43 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.464 -1.294 . . . . 0.0 111.902 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.5 p -110.23 -174.23 2.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -154.98 161.51 41.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.027 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 68.2 p -140.36 18.11 2.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.012 -0.43 . . . . 0.0 109.907 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.07 0.23 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -98.62 0.91 45.74 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.393 -1.063 . . . . 0.0 110.764 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -40.21 54.96 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.117 -0.99 . . . . 0.0 112.271 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 8.6 p -96.39 -63.76 1.11 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.256 -0.903 . . . . 0.0 110.764 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -89.12 95.2 2.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 15.4 t -98.51 -41.39 7.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.687 -0.89 . . . . 0.0 110.191 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.46 93.86 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 46.5 t -63.91 -38.65 91.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.621 -0.929 . . . . 0.0 111.07 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.08 87.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.515 -0.74 . . . . 0.0 110.663 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.46 -40.66 97.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.487 -0.758 . . . . 0.0 109.867 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.01 -32.25 73.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.675 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.49 -53.03 61.45 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.925 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 36.6 ttm -58.06 -48.35 80.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.381 -0.824 . . . . 0.0 110.768 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.82 -31.53 68.55 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.329 -0.857 . . . . 0.0 111.286 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.84 -21.71 66.01 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.3 -0.875 . . . . 0.0 110.382 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.412 ' CB ' ' HG3' ' A' ' 516' ' ' LYS . . . -72.26 0.28 10.31 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.263 -0.898 . . . . 0.0 112.532 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 125.48 -14.97 7.23 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.83 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 67.2 t -83.72 105.46 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.239 . . . . 0.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -172.09 147.2 2.05 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.548 -0.72 . . . . 0.0 110.714 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 9.9 t -108.83 138.59 44.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -76.73 -88.94 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.029 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -140.2 -77.47 0.32 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.012 -1.055 . . . . 0.0 111.115 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -72.16 -21.66 61.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.524 -0.735 . . . . 0.0 110.916 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -145.07 153.16 41.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.473 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -92.18 40.1 2.93 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.49 68.87 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -94.54 -2.07 52.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.184 -1.186 . . . . 0.0 111.409 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -87.02 -5.86 58.93 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.722 -1.236 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -134.11 51.73 6.87 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.08 -1.013 . . . . 0.0 111.08 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 566' ' ' ARG . 41.4 Cg_endo -72.68 -17.73 25.87 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.157 1.082 . . . . 0.0 110.574 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -169.42 112.7 0.51 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.261 -0.899 . . . . 0.0 109.655 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.551 -179.23 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 70.8 m -62.99 -42.29 99.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.483 -0.761 . . . . 0.0 109.98 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 139.5 82.77 0.09 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 17.2 tt -110.77 131.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.943 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -139.31 102.09 4.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.786 . . . . 0.0 110.126 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 67.3 t -108.51 100.6 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.537 -0.727 . . . . 0.0 110.082 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.18 -44.1 66.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.515 -0.741 . . . . 0.0 111.291 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -92.65 173.37 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.608 0.718 . . . . 0.0 111.875 -178.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.76 84.52 2.22 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.765 0.793 . . . . 0.0 110.677 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 67.6 tp -63.41 -40.67 97.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.622 -0.674 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.6 m -60.87 -44.79 96.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.557 -0.714 . . . . 0.0 110.625 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.75 -35.03 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.654 -0.653 . . . . 0.0 111.043 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -60.4 -49.13 78.8 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.992 -1.067 . . . . 0.0 111.272 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.19 80.15 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.134 -0.979 . . . . 0.0 109.613 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 434' ' ' ALA . 0.7 OUTLIER -59.39 -40.27 86.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.444 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 400' ' ' MET . 47.3 t -63.34 -42.5 98.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -59.22 -45.8 90.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.257 -0.902 . . . . 0.0 111.917 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -65.88 -41.34 91.7 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.152 -0.968 . . . . 0.0 111.089 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 435' ' ' ILE . 92.9 mt -62.31 -41.02 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 396' ' ' SER . 32.4 mmm -63.42 -34.97 78.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.487 -0.758 . . . . 0.0 110.845 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.19 -28.28 67.83 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.828 -1.17 . . . . 0.0 110.221 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -90.79 -20.03 22.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.805 -1.185 . . . . 0.0 108.498 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . 0.405 ' OD1' ' CB ' ' A' ' 437' ' ' SER . 39.6 t30 -64.46 -31.57 72.83 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -114.42 18.81 16.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 9.9 p -40.9 149.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 121.535 0.683 . . . . 0.0 112.149 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 23.3 p -87.43 72.86 9.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -91.61 131.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.363 -0.836 . . . . 0.0 112.219 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -96.89 144.1 27.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.635 . . . . 0.0 109.747 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.31 -20.82 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.405 1.213 . . . . 0.0 110.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -57.31 -40.87 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.85 0.833 . . . . 0.0 110.031 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 67.98 0.96 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 27.0 t -54.5 119.8 5.75 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 122.066 0.936 . . . . 0.0 112.048 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.428 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 7.3 p -71.06 147.65 93.84 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 35.3 Cg_endo -59.42 135.15 63.1 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.058 1.031 . . . . 0.0 110.765 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.459 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 90.8 mtm-85 -103.51 -6.29 21.92 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.272 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 6.0 p -99.49 18.9 16.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.674 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.26 -35.01 6.93 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.67 94.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.459 ' CE2' ' O ' ' A' ' 415' ' ' ARG . 4.0 m-85 -93.86 -9.9 35.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.762 -1.434 . . . . 0.0 110.399 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -43.98 61.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.867 -1.145 . . . . 0.0 109.004 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.78 -45.72 57.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.727 -0.608 . . . . 0.0 110.307 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.48 -49.04 78.39 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.75 -0.594 . . . . 0.0 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 90.3 t -69.57 -43.43 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 0.0 112.575 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 79.5 p -62.26 -39.54 93.22 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.925 -1.109 . . . . 0.0 111.421 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 426' ' ' LEU . 12.1 p -67.69 -28.13 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.321 -0.862 . . . . 0.0 111.821 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.433 ' N ' HG11 ' A' ' 425' ' ' VAL . 0.4 OUTLIER -75.02 -31.22 61.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 111.151 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.14 74.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.963 . . . . 0.0 109.203 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.21 -29.88 70.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.97 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.556 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.36 -52.3 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.713 -1.242 . . . . 0.0 111.671 177.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.5 Cg_endo -77.7 112.7 3.36 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 O-C-N 122.568 0.773 . . . . 0.0 110.775 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 0.3 OUTLIER -87.12 99.66 12.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.631 -0.668 . . . . 0.0 109.245 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.5 tp -162.67 92.56 0.79 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.171 -0.956 . . . . 0.0 111.063 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 395' ' ' LEU . . . -139.83 170.56 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.542 0.687 . . . . 0.0 111.832 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.493 HD11 HG23 ' A' ' 435' ' ' ILE . 45.3 pt -121.84 141.52 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 109.414 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.427 HG12 ' CG ' ' A' ' 419' ' ' TYR . 57.3 t -141.92 148.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -0.805 . . . . 0.0 109.806 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' OD1' ' A' ' 403' ' ' ASN . 44.5 t -127.38 133.64 50.01 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.439 -0.788 . . . . 0.0 110.272 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -115.17 129.51 8.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -130.61 34.19 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.616 -0.932 . . . . 0.0 109.818 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -148.73 -137.45 2.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -67.29 120.87 14.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.68 -9.13 23.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.883 . . . . 0.0 111.734 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.72 90.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.49 -28.2 73.34 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.33 -38.36 87.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.755 -0.85 . . . . 0.0 110.199 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.416 ' CD ' ' CB ' ' A' ' 467' ' ' ALA . 0.1 OUTLIER -59.86 -50.15 74.9 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.438 -0.789 . . . . 0.0 110.281 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.36 -29.28 67.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -61.04 -54.97 38.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.772 -0.58 . . . . 0.0 112.01 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.68 -35.65 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.909 -1.119 . . . . 0.0 109.394 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.53 -26.89 68.91 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.444 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.41 -34.78 79.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.037 -1.04 . . . . 0.0 108.828 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.97 -35.57 81.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 88.6 t -58.42 -27.31 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.846 -0.534 . . . . 0.0 109.714 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.4 mtt -71.09 -34.92 71.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.29 -32.78 72.63 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.55 0.691 . . . . 0.0 109.604 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.63 -22.69 32.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.772 -0.58 . . . . 0.0 110.231 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -65.65 -42.74 91.06 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.259 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.59 -29.44 63.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.326 -0.859 . . . . 0.0 110.512 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.71 8.22 4.74 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 111.07 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.94 75.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.65 124.31 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -1.007 . . . . 0.0 110.527 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.96 166.53 18.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.186 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.411 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 33.4 m -141.11 156.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -102.6 120.05 39.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.09 128.51 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.192 -0.943 . . . . 0.0 111.104 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.5 121.2 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.416 ' CB ' ' CD ' ' A' ' 446' ' ' ARG . . . -81.25 165.04 21.82 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.277 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.66 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.423 0.63 . . . . 0.0 109.612 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -51.22 -12.63 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.736 -1.228 . . . . 0.0 112.639 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -81.99 -2.94 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.773 -1.204 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.945 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 35.4 t -63.38 -44.24 95.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -62.85 -41.61 99.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.659 -0.65 . . . . 0.0 110.139 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.0 mmt -67.76 -29.08 68.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.625 . . . . 0.0 110.706 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -59.99 -42.13 93.57 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.655 -1.278 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 mtm -67.19 -39.22 86.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 109.629 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -131.6 128.86 40.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.802 . . . . 0.0 110.632 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 55.32 92.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.189 -0.944 . . . . 0.0 112.255 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . 0.429 ' O ' ' HG ' ' A' ' 482' ' ' LEU . 75.7 m-20 -81.84 26.27 0.51 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.4 ' CB ' HD21 ' A' ' 482' ' ' LEU . 4.7 mp0 50.83 42.48 27.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.561 -1.337 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 57.09 21.92 6.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 479' ' ' ASP . 0.3 OUTLIER -124.42 20.03 8.81 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.54 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.0 p -47.21 -22.25 0.36 Allowed 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 168.98 78.92 0.04 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -175.01 41.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.711 -0.876 . . . . 0.0 109.677 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 487' ' ' ILE . 78.2 mt -75.3 -82.76 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.463 ' CD1' ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -162.15 -70.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.658 -1.276 . . . . 0.0 109.751 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 3.1 t -100.08 8.75 43.71 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.153 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.476 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -82.92 61.27 4.8 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.556 -2.217 . . . . 0.0 107.556 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -143.77 -68.51 0.33 Allowed 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.609 -0.936 . . . . 0.0 109.252 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -100.73 -31.06 11.38 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.487 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -62.02 -43.99 97.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.509 -0.744 . . . . 0.0 110.826 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.476 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 6.0 mt -72.42 -39.05 68.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.553 -0.717 . . . . 0.0 111.8 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 43.1 tp -106.11 -42.26 5.14 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -89.72 -4.06 57.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.892 -1.13 . . . . 0.0 113.254 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 66.13 47.16 75.04 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.3 mmm -120.01 177.29 5.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.944 -0.739 . . . . 0.0 111.128 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.38 134.51 54.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -114.75 149.32 37.07 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.871 0.843 . . . . 0.0 111.486 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -50.82 105.69 0.55 Allowed Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.48 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.402 ' HB2' ' CB ' ' A' ' 528' ' ' HIS . 53.3 Cg_endo -78.47 112.75 3.23 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.283 1.149 . . . . 0.0 109.21 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.23 0.19 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.463 ' CB ' ' CD1' ' A' ' 487' ' ' ILE . 92.0 p -95.8 175.47 6.5 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.451 1.119 . . . . 0.0 113.713 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 23.2 m -125.92 106.99 10.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 175.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.36 136.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.375 -0.828 . . . . 0.0 111.524 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 506' ' ' ILE . 3.9 pt -141.0 110.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 507' ' ' VAL . 7.1 p -112.21 114.65 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.388 -1.445 . . . . 0.0 113.152 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -84.58 131.39 34.62 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.6 tp-100 -156.95 114.89 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.721 -1.592 . . . . 0.0 115.011 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . 0.429 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -76.93 -66.54 1.8 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 31.1 tt0 -58.65 172.12 0.55 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.26 -13.75 11.71 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.196 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.66 -36.78 83.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.236 -0.915 . . . . 0.0 109.632 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 4.7 m -83.09 -13.8 54.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.776 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 509' ' ' GLN . 33.0 tp -69.15 -44.62 71.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 108.812 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.9 -36.01 77.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.851 -0.531 . . . . 0.0 111.401 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -57.28 -50.27 73.43 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.807 -1.183 . . . . 0.0 110.465 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 522' ' ' LEU . 68.3 m -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.599 -0.688 . . . . 0.0 110.502 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -39.5 76.15 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.73 -0.606 . . . . 0.0 111.106 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.7 m -61.86 -39.65 92.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.389 -0.819 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -44.61 84.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.575 -0.703 . . . . 0.0 109.561 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 518' ' ' THR . 0.4 OUTLIER -61.11 -22.8 64.99 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.464 -0.772 . . . . 0.0 111.808 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -46.0 -60.84 2.03 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.233 -0.917 . . . . 0.0 112.174 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -74.02 -50.79 9.92 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.508 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.75 83.67 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.326 -1.103 . . . . 0.0 113.432 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.458 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -65.67 -23.82 66.87 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -44.67 -25.87 0.32 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.381 -0.825 . . . . 0.0 111.514 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.402 ' CB ' ' HB2' ' A' ' 501' ' ' PRO . 1.8 t-80 -98.06 -140.06 0.3 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.226 -0.921 . . . . 0.0 111.224 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.08 85.8 0.73 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.822 -1.174 . . . . 0.0 111.815 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.458 ' CB ' ' HA ' ' A' ' 526' ' ' ALA . 71.6 t -146.2 168.13 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.097 -1.002 . . . . 0.0 111.494 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 432' ' ' SER . 8.5 tp60 -162.31 164.53 27.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 3.6 t -115.45 115.39 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.435 -0.791 . . . . 0.0 112.163 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.9 tp -110.78 120.53 42.69 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.406 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 2.4 pt -139.95 146.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.079 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 65.1 p -105.48 -169.5 1.6 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -158.75 167.95 28.14 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.321 -0.862 . . . . 0.0 109.923 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' SER . . . . . 0.429 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.8 OUTLIER -133.03 -6.64 3.07 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.677 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -129.09 28.42 4.1 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . 0.424 ' CG ' ' HA ' ' A' ' 543' ' ' THR . 44.5 tt0 -98.67 -1.49 40.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.757 -0.849 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -56.32 -43.95 79.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.206 -0.934 . . . . 0.0 112.173 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 26.2 m -102.6 -56.89 2.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.913 -1.117 . . . . 0.0 110.94 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -88.51 59.0 4.1 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 539' ' ' GLN . 11.7 t -65.58 -44.38 86.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.983 . . . . 0.0 111.572 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -61.27 -40.26 98.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.5 m -62.9 -37.36 86.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.947 . . . . 0.0 111.53 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.6 72.07 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.088 -1.008 . . . . 0.0 109.73 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.85 -41.26 97.85 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.907 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.37 -30.12 70.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.188 -0.945 . . . . 0.0 109.017 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -57.53 -54.92 41.33 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.298 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 57.8 ttm -55.65 -46.82 77.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . 0.419 ' HA ' ' CG1' ' A' ' 555' ' ' VAL . 86.4 mttt -61.17 -31.78 71.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.576 -0.703 . . . . 0.0 112.183 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.71 -16.58 62.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.353 -0.842 . . . . 0.0 111.226 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 5.49 4.24 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.171 -0.956 . . . . 0.0 113.059 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 118.35 -16.58 11.62 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 120.805 -1.184 . . . . 0.0 111.037 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 551' ' ' LYS . 10.3 p -85.99 119.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.199 -1.177 . . . . 0.0 110.764 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -167.03 136.2 2.81 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 68.1 p -97.97 153.0 18.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -73.55 -81.04 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.583 -0.698 . . . . 0.0 110.731 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -170.02 -67.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.512 -0.742 . . . . 0.0 109.93 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -94.22 -22.84 18.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.459 -0.775 . . . . 0.0 110.306 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -149.51 110.0 4.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.119 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -78.36 144.88 28.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.63 72.18 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.98 -4.85 49.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.347 -1.09 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -93.05 0.18 57.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.936 . . . . 0.0 110.981 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . 0.509 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -152.19 59.88 3.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 109.517 -178.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 37.9 Cg_endo -91.92 -5.54 3.67 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.513 1.27 . . . . 0.0 110.988 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -113.83 -19.47 11.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.774 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.083 179.539 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 120.872 0.368 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 78.5 p -63.06 -37.04 85.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.527 -0.733 . . . . 0.0 109.828 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 134.04 88.95 0.34 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.67 127.18 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -118.61 169.02 10.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.406 -0.808 . . . . 0.0 109.985 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.88 132.75 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.749 -0.594 . . . . 0.0 110.615 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 387' ' ' LEU . 4.5 mm? -86.57 147.2 26.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.466 -0.771 . . . . 0.0 110.705 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -138.1 -153.63 0.49 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.689 -0.632 . . . . 0.0 109.848 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.45 -17.1 58.63 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.339 -0.85 . . . . 0.0 111.122 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.74 -36.64 81.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.261 -0.899 . . . . 0.0 110.617 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.1 t -62.79 -43.15 99.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.435 -0.791 . . . . 0.0 109.487 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 81.0 t -66.31 -36.08 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.982 -0.449 . . . . 0.0 110.76 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -60.75 -50.51 73.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.19 -0.944 . . . . 0.0 110.232 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.37 -33.02 72.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 7.6 tt -59.7 -39.7 85.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.81 -0.556 . . . . 0.0 110.621 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.1 p -68.6 -32.49 72.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.409 -0.807 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -64.34 -43.06 95.79 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.557 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -69.03 -40.31 78.7 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.0 112.719 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.07 -43.37 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 27.2 mtp -61.86 -22.66 65.71 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.26 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -63.26 -30.54 71.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.104 -0.997 . . . . 0.0 108.984 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -90.04 -14.21 34.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.192 -0.942 . . . . 0.0 109.457 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -66.39 -39.3 88.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.77 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -116.92 18.45 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.752 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 6.3 p -59.43 114.93 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.385 -0.822 . . . . 0.0 109.793 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.0 p -52.12 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.171 -0.956 . . . . 0.0 110.95 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.661 -0.65 . . . . 0.0 110.179 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.24 137.35 24.89 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 0.0 110.204 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.44 -29.3 45.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.165 1.087 . . . . 0.0 111.279 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.55 -25.59 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.119 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 60.54 0.5 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 m -58.91 115.79 3.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.495 0.664 . . . . 0.0 111.52 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.44 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 6.9 p -64.15 150.09 92.91 Favored Pre-proline 0 N--CA 1.501 2.095 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 36.6 Cg_endo -59.91 139.14 86.62 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 122.789 0.889 . . . . 0.0 110.228 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -116.38 -1.39 12.3 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.465 ' HA ' ' CE2' ' A' ' 419' ' ' TYR . 34.9 p -97.34 22.09 9.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.766 -1.209 . . . . 0.0 109.489 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -108.68 -31.58 7.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.37 -44.16 98.04 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 416' ' ' THR . 27.0 p90 -103.04 -10.81 18.61 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.418 . . . . 0.0 111.875 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.0 t -67.22 -43.03 83.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 108.083 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -79.36 -44.32 21.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.933 -0.479 . . . . 0.0 111.304 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -65.38 -46.33 80.54 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.629 -0.67 . . . . 0.0 112.417 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 88.8 t -70.37 -43.31 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.444 -0.785 . . . . 0.0 111.99 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -43.17 99.48 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.918 -1.114 . . . . 0.0 111.813 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.47 -29.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.204 -0.935 . . . . 0.0 111.495 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -71.57 -33.99 69.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 111.737 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.57 -33.26 70.91 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.59 -30.76 71.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -64.21 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.443 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.2 OUTLIER -177.32 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 110.399 177.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -72.48 101.5 1.27 Allowed 'Trans proline' 0 N--CA 1.485 0.99 0 N-CA-C 109.455 -1.017 . . . . 0.0 109.455 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 26.4 t -87.72 101.2 13.45 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.559 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.98 89.33 0.79 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 426' ' ' LEU . . . -131.68 164.84 25.05 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.882 0.848 . . . . 0.0 112.481 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.77 128.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 58.4 t -122.3 138.33 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.2 m -119.58 126.46 51.25 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 111.494 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -129.45 160.39 22.64 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -120.71 -30.63 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.896 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.1 173.45 31.27 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.17 29.73 70.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.89 -20.5 65.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 111.188 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.27 89.16 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.134 -0.979 . . . . 0.0 110.904 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.73 -37.12 57.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -62.17 -35.8 79.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.784 -0.833 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.416 ' O ' HG11 ' A' ' 449' ' ' VAL . 0.0 OUTLIER -61.52 -44.45 97.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.675 0.75 . . . . 0.0 109.724 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -68.84 -31.56 70.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.973 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -64.63 -45.04 88.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 111.713 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 450' ' ' ALA . 10.0 p -58.15 -31.21 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.613 -1.305 . . . . 0.0 108.9 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.97 -27.05 68.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -64.51 -36.02 82.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.873 -1.142 . . . . 0.0 108.503 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.38 -34.33 78.07 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 450' ' ' ALA . 98.1 t -60.53 -30.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.3 mmm -68.33 -37.01 80.14 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.547 -0.72 . . . . 0.0 109.417 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -58.31 -28.82 65.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.767 -0.583 . . . . 0.0 109.976 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -85.03 -22.98 28.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -66.95 -44.6 80.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 110.413 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -74.42 -29.33 61.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.327 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.49 14.75 5.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.592 -0.692 . . . . 0.0 112.193 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.98 26.67 71.48 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.477 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -124.05 126.16 45.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.216 -1.167 . . . . 0.0 110.337 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -92.56 158.56 15.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.456 -0.777 . . . . 0.0 110.28 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.03 163.33 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.768 0.794 . . . . 0.0 111.516 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -113.75 121.56 44.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.03 123.47 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.26 1.028 . . . . 0.0 111.829 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 467' ' ' ALA . 4.5 mp -101.11 169.06 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 471' ' ' ARG . . . -130.83 156.47 44.96 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.84 -159.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.448 -0.783 . . . . 0.0 110.019 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -48.66 -15.25 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.991 -1.068 . . . . 0.0 111.823 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -87.54 5.47 39.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.003 -1.061 . . . . 0.0 111.007 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 467' ' ' ALA . 13.8 tpt180 -58.95 -36.94 75.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.298 -0.876 . . . . 0.0 111.447 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 21.9 t -59.7 -45.42 92.19 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.405 -0.809 . . . . 0.0 110.2 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.09 -41.0 95.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.361 -0.837 . . . . 0.0 110.396 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 18.5 ttm -62.84 -35.17 79.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 0.0 111.19 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -60.13 -39.26 85.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.346 -0.846 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.3 -40.23 93.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 63.1 pttt -109.18 -148.81 0.43 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.556 -0.715 . . . . 0.0 109.865 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 477' ' ' LYS . 23.7 tt0 50.46 80.6 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.195 -0.941 . . . . 0.0 110.957 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -123.73 34.75 5.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -125.9 4.81 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.494 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.22 -34.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 112.503 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.47 71.73 1.29 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.987 -1.071 . . . . 0.0 112.108 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 35.0 t -92.28 48.81 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.7 33.1 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -119.64 54.91 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.53 -0.982 . . . . 0.0 110.392 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.59 -84.22 0.45 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.488 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.97 -88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.257 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . 0.251 26.4 p -102.7 22.48 13.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 111.511 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -62.41 89.25 0.05 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -111.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -106.32 -21.97 12.95 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.616 -1.302 . . . . 0.0 109.416 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -47.96 -23.5 0.8 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.876 . . . . 0.0 111.629 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.51 -60.37 3.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 112.068 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 5.96 28.01 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.299 -1.501 . . . . 0.0 111.885 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -83.41 -6.07 59.35 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.035 -1.041 . . . . 0.0 112.702 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.84 -7.6 80.64 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.085 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.64 -176.23 0.61 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.176 -1.19 . . . . 0.0 109.493 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.56 167.52 10.53 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.01 150.91 29.94 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 9.4 t -82.5 138.99 44.29 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 139.05 52.85 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.283 1.149 . . . . 0.0 110.357 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.9 -9.09 0.98 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 10.9 t -77.41 139.03 39.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -1.154 . . . . 0.0 113.164 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 531' ' ' GLN . 80.6 m -111.13 124.28 51.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 532' ' ' VAL . 50.4 t -116.34 125.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.61 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 533' ' ' LEU . 22.6 pt -121.57 120.27 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 534' ' ' ILE . 9.6 p -120.21 108.86 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.145 -0.972 . . . . 0.0 111.622 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -85.11 121.63 28.15 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.888 -1.132 . . . . 0.0 108.343 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.0 tp-100 -148.59 105.25 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . 0.488 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -69.42 -38.79 80.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 4.9 tt0 -79.43 -155.44 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 -7.01 0.56 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.625 -0.672 . . . . 0.0 110.974 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.28 -34.42 74.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.357 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' SER . . . . . 0.414 ' HB2' ' NE2' ' A' ' 509' ' ' GLN . 1.6 m -87.71 -22.19 24.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.333 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.4 tp -68.74 -46.33 69.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.15 -0.969 . . . . 0.0 109.606 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 553' ' ' ALA . 32.8 ttpt -69.09 -44.18 73.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.664 -0.648 . . . . 0.0 112.296 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -39.99 94.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.498 -1.376 . . . . 0.0 110.452 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 77.5 m -60.42 -44.2 95.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.113 -0.992 . . . . 0.0 109.347 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.404 ' CD1' ' HG3' ' A' ' 550' ' ' MET . 0.1 OUTLIER -55.85 -35.54 66.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.944 -0.473 . . . . 0.0 109.998 -179.226 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.5 m -59.05 -39.15 81.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.1 -40.86 78.1 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.492 0.663 . . . . 0.0 109.971 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.77 -22.79 67.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.456 -0.777 . . . . 0.0 111.146 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -47.93 -57.42 5.73 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.446 -0.784 . . . . 0.0 111.774 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.32 -50.84 61.08 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.18 -29.88 34.21 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.482 -1.011 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -57.96 -23.51 54.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.776 -0.577 . . . . 0.0 111.255 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -41.39 -43.89 2.67 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.598 -0.689 . . . . 0.0 112.319 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 -62.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.416 ' C ' ' CG2' ' A' ' 530' ' ' VAL . 4.3 t30 -80.77 156.09 26.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.392 -0.817 . . . . 0.0 110.468 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.416 ' CG2' ' C ' ' A' ' 529' ' ' ASN . 0.1 OUTLIER -174.34 151.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.988 0.899 . . . . 0.0 110.791 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.4 ' CB ' HG22 ' A' ' 504' ' ' THR . 0.0 OUTLIER -177.39 91.71 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 54.2 t -99.36 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.011 0.91 . . . . 0.0 111.3 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.77 113.41 26.63 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 176.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.502 ' CG2' HG13 ' A' ' 507' ' ' VAL . 0.6 OUTLIER -131.28 144.77 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.837 -177.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.539 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 69.9 p -105.6 -177.11 3.27 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -160.03 168.11 26.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.013 -1.055 . . . . 0.0 110.83 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' SER . . . . . 0.488 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -142.94 -4.89 0.91 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.328 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -103.98 5.64 46.58 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 543' ' ' THR . 97.0 mt-30 -82.42 -1.43 50.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -1.192 . . . . 0.0 111.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.59 -43.21 75.79 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 0.0 110.494 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 24.6 m -106.98 -45.02 4.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.56 70.41 0.3 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 539' ' ' GLN . 11.9 t -64.76 -43.97 91.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.58 -0.953 . . . . 0.0 111.402 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -64.16 -29.64 75.52 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.099 -1.001 . . . . 0.0 110.637 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t -65.16 -36.07 83.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.301 -1.117 . . . . 0.0 110.797 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.39 90.9 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.796 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 10.8 mp -62.63 -42.22 99.47 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.838 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.5 ttp -63.14 -35.76 81.36 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.275 -0.891 . . . . 0.0 108.705 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -51.98 -50.44 61.28 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' MET . . . . . 0.404 ' HG3' ' CD1' ' A' ' 519' ' ' LEU . 58.0 ttm -55.33 -49.15 72.93 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.795 -0.566 . . . . 0.0 110.395 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.58 -31.75 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.683 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.87 -17.09 64.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.843 . . . . 0.0 109.92 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 516' ' ' LYS . . . -68.88 1.05 3.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.343 -0.848 . . . . 0.0 113.122 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 137.04 -11.2 3.89 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.224 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.81 106.67 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.257 -1.143 . . . . 0.0 110.25 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -158.74 116.11 2.82 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 24.0 p -77.25 162.33 27.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -101.08 -83.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 111.307 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -142.54 -75.74 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 110.865 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -93.28 -22.17 19.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.496 -0.752 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -131.5 155.11 47.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.388 -0.82 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -73.46 -120.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -67.66 83.38 0.15 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.35 -16.79 22.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.42 -1.047 . . . . 0.0 110.91 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -98.76 -4.37 33.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.108 -0.995 . . . . 0.0 110.943 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 56.59 1.3 Allowed Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.003 -1.061 . . . . 0.0 109.894 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.58 -12.81 27.17 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.213 1.112 . . . . 0.0 111.724 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -155.13 86.96 1.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.665 -179.429 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.187 0.517 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 21.4 t -63.81 -44.25 93.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 140.82 75.63 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 51.1 pt -100.87 8.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.451 -1.029 . . . . 0.0 110.872 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -72.51 -33.8 67.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.197 -0.94 . . . . 0.0 111.019 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 34.5 m -99.28 121.23 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.345 -0.847 . . . . 0.0 110.795 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -122.76 -69.0 0.85 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.257 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -87.0 172.05 10.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 110.352 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -89.84 78.5 6.83 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.34 -40.16 96.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.71 -0.619 . . . . 0.0 111.135 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.4 m -61.25 -46.42 90.45 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.699 -0.626 . . . . 0.0 111.561 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 67.7 t -66.29 -33.06 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 110.147 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -60.39 -48.75 80.4 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.937 -1.102 . . . . 0.0 109.848 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.824 . . . . 0.0 108.841 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.54 -41.11 93.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.513 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -36.38 82.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.25 -0.906 . . . . 0.0 110.453 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -66.07 -45.25 81.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.382 -0.823 . . . . 0.0 112.194 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.87 -43.5 75.24 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.109 -0.994 . . . . 0.0 111.879 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.4 mt -63.69 -41.38 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.442 -0.786 . . . . 0.0 110.528 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 mtt -59.62 -33.22 71.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.736 -0.603 . . . . 0.0 110.445 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.31 -36.8 78.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.748 -0.595 . . . . 0.0 110.495 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 63.3 tp60 -92.75 -13.9 28.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.638 -1.289 . . . . 0.0 110.02 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.28 -32.31 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -115.3 18.6 16.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.371 -0.831 . . . . 0.0 109.72 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.8 p -41.87 149.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.257 0.551 . . . . 0.0 112.095 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 47.5 p -82.65 72.97 9.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.49 131.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.393 -0.817 . . . . 0.0 111.313 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -94.91 145.0 28.77 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.08 -23.41 60.82 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.093 1.049 . . . . 0.0 110.272 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -55.87 -24.43 37.0 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.617 0.722 . . . . 0.0 110.861 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.99 63.1 0.46 Allowed 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 59.5 p -50.25 107.12 0.14 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.25 -0.906 . . . . 0.0 111.177 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.65 153.62 77.51 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.58 122.17 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.254 -1.095 . . . . 0.0 109.254 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -96.62 -5.96 37.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 420' ' ' SER . 13.4 p -93.3 22.79 4.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.767 -1.208 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -105.0 -37.3 7.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.767 . . . . 0.0 109.044 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.48 -49.0 77.82 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.45 ' CD1' HG13 ' A' ' 436' ' ' VAL . 43.1 p90 -100.89 -8.89 22.11 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.503 1.652 . . . . 0.0 112.982 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 416' ' ' THR . 80.9 p -69.71 -36.59 76.05 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.574 -1.65 . . . . 0.0 107.05 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -78.64 -48.14 15.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.959 -0.463 . . . . 0.0 111.173 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.57 -48.7 78.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.429 -0.795 . . . . 0.0 111.251 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 426' ' ' LEU . 77.1 t -65.28 -46.05 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.611 . . . . 0.0 111.803 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.6 t -61.19 -45.9 92.71 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.976 -1.077 . . . . 0.0 112.64 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.53 -46.95 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.116 -0.99 . . . . 0.0 110.715 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 0.4 OUTLIER -53.33 -33.97 55.62 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 111.821 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.54 75.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.872 -1.142 . . . . 0.0 109.045 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -60.83 -29.15 69.32 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -66.84 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.6 -55.76 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.589 -1.319 . . . . 0.0 109.839 178.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.0 Cg_endo -71.99 106.21 1.97 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 N-CA-C 106.744 -2.06 . . . . 0.0 106.744 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.494 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 0.2 OUTLIER -90.52 99.92 12.86 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.107 -177.298 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 2.9 mt -141.99 140.39 32.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -169.5 150.89 4.26 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.559 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 20.7 pt -119.43 120.97 65.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 419' ' ' TYR . 82.1 t -125.36 139.98 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.1 t -117.05 122.43 44.14 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 155.35 20.57 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -136.12 -36.21 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.574 -0.957 . . . . 0.0 111.439 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.13 155.51 26.18 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.15 62.23 4.85 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -86.54 -21.35 26.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.997 . . . . 0.0 110.537 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.83 84.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.393 -0.817 . . . . 0.0 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 -36.4 77.22 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.73 -35.77 75.23 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 109.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.447 ' HD3' ' CB ' ' A' ' 467' ' ' ALA . 16.0 tpt85 -62.97 -49.79 73.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.63 -0.669 . . . . 0.0 112.243 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -74.5 -31.13 62.07 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.963 -1.086 . . . . 0.0 111.108 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.73 -48.4 81.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.372 -0.83 . . . . 0.0 110.275 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.46 -31.34 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.737 -1.227 . . . . 0.0 108.655 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.14 -29.53 70.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.4 -32.38 73.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.112 -0.993 . . . . 0.0 108.358 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.35 -35.09 76.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.429 ' CG1' ' CG2' ' A' ' 463' ' ' VAL . 52.0 t -61.1 -26.5 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.6 tpp -66.66 -40.16 88.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.358 -0.839 . . . . 0.0 108.748 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -56.49 -27.09 56.21 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.95 -23.4 31.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.78 -34.24 71.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -82.22 10.21 7.28 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.608 -0.683 . . . . 0.0 112.077 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.44 29.83 71.49 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 19.8 tpp85 -126.02 126.98 45.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.95 . . . . 0.0 110.546 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 48.7 tp10 -95.94 160.22 14.57 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.429 ' CG2' ' CG1' ' A' ' 453' ' ' VAL . 19.1 m -142.27 161.36 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.777 -1.202 . . . . 0.0 112.493 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 58.7 tt0 -107.54 122.82 47.44 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 465' ' ' ILE . 0.2 OUTLIER -128.09 128.55 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.505 -0.747 . . . . 0.0 110.782 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 78.6 mt -126.89 122.16 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.607 -0.683 . . . . 0.0 110.016 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . 0.447 ' CB ' ' HD3' ' A' ' 446' ' ' ARG . . . -86.69 169.02 13.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.045 -1.035 . . . . 0.0 108.776 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 467' ' ' ALA . . . -57.28 -160.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.64 -15.95 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.661 -1.274 . . . . 0.0 113.412 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -76.35 -9.44 58.64 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.591 -1.318 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -57.35 -32.85 67.16 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.055 . . . . 0.0 111.093 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 26.2 t -62.16 -44.46 96.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.415 -0.803 . . . . 0.0 110.047 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.16 -41.53 94.58 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.428 -0.795 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.48 76.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.547 -0.721 . . . . 0.0 110.578 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.61 -39.13 87.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.181 -0.95 . . . . 0.0 109.376 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -39.72 95.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -100.07 -146.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.68 80.06 0.1 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.807 -1.183 . . . . 0.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.45 14.06 15.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.965 -0.459 . . . . 0.0 110.291 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -92.5 -2.32 56.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 111.686 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.66 33.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.058 -1.026 . . . . 0.0 110.823 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 1.4 tp -151.61 7.14 0.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.185 -1.006 . . . . 0.0 113.596 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.8 t -55.0 -25.22 28.44 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.474 -1.391 . . . . 0.0 110.445 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 160.46 41.65 0.02 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -130.86 30.65 4.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.663 -0.904 . . . . 0.0 109.314 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 464' ' ' GLN . 1.9 tp -60.33 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 487' ' ' ILE . 29.5 mm -153.23 -82.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 108.656 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.452 ' HA ' ' CD2' ' A' ' 499' ' ' PHE . 24.4 p -100.34 11.36 39.59 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.347 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -77.42 63.91 3.28 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -135.48 -70.96 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . 0.406 ' HD3' ' CE ' ' A' ' 497' ' ' MET . 87.2 mtt-85 -118.52 -8.23 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.848 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 499' ' ' PHE . 4.3 mp0 -73.45 -38.05 65.62 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . 0.416 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 2.8 mt -93.85 -21.44 19.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 25.8 tp -103.64 -31.3 9.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 491' ' ' ARG . 0.5 OUTLIER -131.47 -2.13 3.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.559 -1.338 . . . . 0.0 113.148 -177.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 78.77 49.26 6.62 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 118.646 -1.74 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' MET . . . . . 0.406 ' CE ' ' HD3' ' A' ' 491' ' ' ARG . 1.8 ttm -112.41 -177.38 3.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -118.82 137.34 53.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.463 ' CD1' ' NE2' ' A' ' 492' ' ' GLN . 0.1 OUTLIER -114.4 150.02 35.29 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.314 -0.866 . . . . 0.0 111.902 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 8.7 t -64.0 115.32 18.25 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.963 -0.46 . . . . 0.0 109.842 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.44 ' CG ' ' CB ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -69.3 115.71 4.16 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.217 1.114 . . . . 0.0 110.282 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -157.75 19.69 0.37 Allowed Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.431 ' HB3' HD11 ' A' ' 487' ' ' ILE . 17.3 p -97.89 174.42 6.59 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.774 1.274 . . . . 0.0 113.751 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.411 ' HB ' ' CG1' ' A' ' 463' ' ' VAL . 10.1 m -122.5 103.53 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.44 134.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -134.39 121.49 36.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 507' ' ' VAL . 7.5 p -115.94 104.18 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.537 -1.352 . . . . 0.0 111.446 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.83 99.36 10.85 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 515' ' ' LEU . 94.4 mm-40 -111.62 103.9 12.24 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -175.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.5 62.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -98.9 163.16 12.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -100.33 -9.05 22.71 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.825 -0.547 . . . . 0.0 111.125 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -41.34 97.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.298 -0.876 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -6.13 48.34 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.589 -0.695 . . . . 0.0 111.276 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 509' ' ' GLN . 0.9 OUTLIER -69.78 -56.5 6.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 178.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.2 -40.68 64.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.473 -0.767 . . . . 0.0 111.468 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.009 -1.057 . . . . 0.0 110.605 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 98.6 m -60.07 -44.41 94.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.223 -0.923 . . . . 0.0 108.789 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.8 -37.44 42.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -0.763 . . . . 0.0 110.434 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.3 m -64.77 -42.28 95.21 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.525 -0.734 . . . . 0.0 111.852 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.23 -47.16 74.71 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.226 -0.922 . . . . 0.0 111.565 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 4.3 pp -78.2 -18.11 55.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.396 -0.815 . . . . 0.0 111.9 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -47.07 -46.1 22.24 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.405 -0.81 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.31 90.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.89 89.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.787 . . . . 0.0 111.668 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.427 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -62.04 -29.38 70.25 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.063 -1.023 . . . . 0.0 111.005 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -58.15 -27.39 63.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.044 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.44 ' CB ' ' CG ' ' A' ' 501' ' ' PRO . 65.4 m80 -108.9 -117.66 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.832 -0.542 . . . . 0.0 111.094 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.4 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 10.5 m120 -91.28 65.78 5.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.405 -1.434 . . . . 0.0 113.666 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -139.71 165.18 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.551 -1.343 . . . . 0.0 110.279 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.434 ' CB ' ' CB ' ' A' ' 432' ' ' SER . 15.1 mp0 -150.5 161.02 43.33 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.729 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 18.9 t -112.3 107.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.992 -1.068 . . . . 0.0 113.075 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 7.2 tp -110.67 117.48 33.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.404 ' CG2' ' CG1' ' A' ' 507' ' ' VAL . 10.7 pt -137.36 133.71 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 117.996 -1.481 . . . . 0.0 113.148 -175.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 82.4 p -99.02 -168.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -155.54 164.67 38.36 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.28 -18.81 0.71 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.551 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -111.77 -17.05 8.77 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.69 1.74 52.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.452 -1.028 . . . . 0.0 110.265 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -32.32 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 78.3 p -101.05 115.16 29.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 69.8 59.8 5.35 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 58.7 p -68.46 -10.32 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.949 -0.736 . . . . 0.0 110.659 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.96 80.48 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 39.0 m -61.08 -29.85 69.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.974 . . . . 0.0 109.312 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.26 70.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.922 -0.486 . . . . 0.0 110.028 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.1 mp -61.8 -42.62 99.23 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 109.26 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 64.3 mtt -64.64 -34.31 77.98 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -48.92 -51.75 28.39 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 96.4 mmm -56.1 -42.57 76.98 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -57.56 -31.72 66.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.528 -0.732 . . . . 0.0 110.059 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -62.76 -30.0 71.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.34 -7.61 38.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.648 -0.658 . . . . 0.0 111.246 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.25 -5.16 38.41 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.515 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.43 118.58 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 118.942 1.371 . . . . 0.0 111.117 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -171.72 137.88 1.05 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 5.0 t -105.99 152.65 23.07 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -75.14 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.995 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -138.56 -89.92 0.22 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.756 -1.215 . . . . 0.0 111.195 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -89.87 -21.39 22.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.031 -1.043 . . . . 0.0 111.405 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -81.5 138.53 35.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.323 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -92.95 37.58 3.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 140.48 79.1 0.06 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -92.91 -14.18 27.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.524 -0.986 . . . . 0.0 110.72 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -91.11 -6.63 53.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.611 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.08 54.54 1.21 Allowed Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.333 -0.855 . . . . 0.0 109.693 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.19 -7.38 20.45 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.445 1.234 . . . . 0.0 111.566 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -153.51 101.55 2.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.502 -179.345 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.084 0.468 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 70.5 m -60.56 -43.35 97.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.077 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -143.34 135.54 6.47 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 384' ' ' ILE . 49.8 pt -86.37 133.44 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.547 -0.972 . . . . 0.0 109.87 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -137.36 164.15 29.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.0 110.292 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.48 143.89 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.537 -0.727 . . . . 0.0 110.074 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.46 176.33 8.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.687 . . . . 0.0 110.381 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -73.72 157.66 36.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.723 -0.611 . . . . 0.0 110.191 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -85.95 54.55 3.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.655 -0.653 . . . . 0.0 110.492 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -40.27 95.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.497 -0.752 . . . . 0.0 110.193 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 75.7 p -61.32 -40.79 95.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.664 -0.647 . . . . 0.0 110.946 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.8 t -71.3 -24.11 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.587 -0.696 . . . . 0.0 111.769 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.11 -52.92 52.58 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.945 -1.097 . . . . 0.0 111.178 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.94 78.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.438 -0.789 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.431 ' O ' HG13 ' A' ' 399' ' ' ILE . 8.1 tt -62.18 -41.02 97.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.743 -0.598 . . . . 0.0 111.152 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 11.1 t -62.81 -40.26 96.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 0.0 111.309 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.76 -44.34 93.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.415 -0.803 . . . . 0.0 110.861 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -65.52 -38.1 88.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.359 -0.838 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 395' ' ' LEU . 0.5 OUTLIER -64.13 -40.85 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.241 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 56.6 mtp -63.39 -28.82 70.25 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.83 -26.83 66.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.255 -0.903 . . . . 0.0 108.799 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 419' ' ' TYR . 0.6 OUTLIER -90.44 -18.45 25.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 176.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -66.04 -38.48 88.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.688 -0.633 . . . . 0.0 110.397 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -116.5 18.67 15.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 8.2 p -60.39 118.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.506 -0.746 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 t -53.11 101.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.417 0.627 . . . . 0.0 111.536 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.21 134.62 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' HIS . . . . . 0.418 ' CB ' ' HE2' ' A' ' 411' ' ' LYS . 0.1 OUTLIER -91.09 141.53 26.5 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.438 -0.789 . . . . 0.0 109.8 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.53 -27.72 32.73 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.151 1.08 . . . . 0.0 110.138 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.86 -34.12 76.08 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.761 0.791 . . . . 0.0 109.668 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 408' ' ' HIS . 0.0 OUTLIER -138.82 58.66 1.64 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.7 t -50.68 98.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.116 -0.99 . . . . 0.0 111.81 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.437 ' CG2' ' HD2' ' A' ' 414' ' ' PRO . 7.6 p -58.61 148.44 66.53 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.93 -0.482 . . . . 0.0 109.713 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 413' ' ' VAL . 38.4 Cg_endo -63.47 149.76 90.26 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.228 1.12 . . . . 0.0 109.682 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -136.3 -8.86 1.98 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.667 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 420' ' ' SER . 19.2 p -102.17 19.32 18.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -80.32 -77.01 0.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.612 -0.68 . . . . 0.0 111.854 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -84.36 -2.23 89.15 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.217 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 402' ' ' GLN . 85.3 m-85 -107.14 -20.89 13.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 120.573 2.187 . . . . 0.0 108.827 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 416' ' ' THR . 37.6 t -72.67 -40.61 66.14 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.66 -38.11 88.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.09 89.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.807 0.813 . . . . 0.0 109.297 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' A' ' 426' ' ' LEU . 63.5 t -66.39 -44.97 90.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -61.42 -35.58 77.96 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.964 -1.085 . . . . 0.0 111.257 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 93.0 t -62.27 -47.46 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.427 -0.795 . . . . 0.0 110.679 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 432' ' ' SER . 1.4 pp -57.56 -33.29 67.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.413 -0.804 . . . . 0.0 111.996 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.17 -36.96 80.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.716 -1.24 . . . . 0.0 108.333 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -31.93 71.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -65.65 -90.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 8.3 tpp85 -178.54 -57.97 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.406 -1.434 . . . . 0.0 109.097 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.33 93.54 0.41 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.447 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 5.5 t -85.96 111.48 20.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.4 OUTLIER -163.97 89.12 0.55 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -139.15 168.31 20.13 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.686 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.82 130.93 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.617 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.38 150.83 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.91 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 13.8 m -123.05 127.46 48.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.315 -0.865 . . . . 0.0 110.663 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -122.49 160.3 16.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -148.85 -47.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.911 . . . . 0.0 109.562 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -101.46 142.44 15.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 73.87 89.16 0.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.7 -44.69 4.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.945 . . . . 0.0 110.804 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.27 97.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.784 . . . . 0.0 110.775 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.11 62.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.37 -41.76 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -1.027 . . . . 0.0 110.771 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -43.85 98.13 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -67.73 -29.13 68.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.199 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -61.61 -47.66 84.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.524 -0.735 . . . . 0.0 110.864 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 450' ' ' ALA . 7.1 p -59.66 -31.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.857 -1.152 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 449' ' ' VAL . . . -64.0 -27.88 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.576 -0.849 . . . . 0.0 108.758 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.84 -34.06 77.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.149 -0.97 . . . . 0.0 108.448 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' LEU . . . . . 0.408 ' O ' ' CG ' ' A' ' 455' ' ' MET . 33.3 tp -62.62 -34.99 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.01 -25.81 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 79.9 mtp -69.81 -42.37 73.77 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.878 . . . . 0.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.0 OUTLIER -62.39 -20.8 64.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.121 -0.987 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.0 -22.69 36.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 0.0 109.745 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.26 -41.91 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.333 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.25 -26.74 63.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.486 -0.759 . . . . 0.0 109.51 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.1 2.86 16.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.0 111.707 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 83.95 4.27 88.68 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.033 -1.042 . . . . 0.0 111.878 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 132.2 33.78 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.993 1.397 . . . . 0.0 111.136 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -76.7 -174.38 2.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.61 -0.681 . . . . 0.0 110.036 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.95 144.77 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.44 114.56 27.14 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.437 HG22 HD13 ' A' ' 465' ' ' ILE 0.255 0.0 OUTLIER -127.3 129.13 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 111.431 -175.811 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 83.1 mt -124.71 120.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.834 -0.542 . . . . 0.0 110.545 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.45 24.95 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.34 -160.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.81 -0.556 . . . . 0.0 110.085 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -51.37 -17.08 0.66 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.76 -1.213 . . . . 0.0 111.082 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -73.44 -6.33 45.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.481 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -57.54 -31.62 66.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.3 m -59.08 -45.69 90.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.547 -0.721 . . . . 0.0 110.301 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.56 -40.43 95.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.494 -0.754 . . . . 0.0 109.056 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 92.7 mtp -62.37 -33.15 74.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.829 -0.544 . . . . 0.0 110.744 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -61.25 -38.98 88.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.949 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.5 ttp -59.18 -40.13 84.71 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.43 -0.794 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.417 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 62.6 pttt -119.58 -146.39 0.38 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' GLN . . . . . 0.417 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.3 mm-40 43.64 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.135 -0.978 . . . . 0.0 112.131 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -121.35 14.04 11.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.528 -0.732 . . . . 0.0 110.527 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -101.61 -10.12 20.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 111.659 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -132.15 0.41 3.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.109 -0.994 . . . . 0.0 112.939 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.32 44.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.656 -1.278 . . . . 0.0 112.873 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.7 t -89.34 48.76 1.65 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.654 -1.279 . . . . 0.0 110.47 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.06 58.24 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.8 44.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -1.15 . . . . 0.0 109.672 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' LEU . . . . . 0.404 ' O ' HG12 ' A' ' 487' ' ' ILE . 95.1 mt -59.03 -84.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.923 -1.11 . . . . 0.0 109.318 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.425 HG13 ' OG ' ' A' ' 503' ' ' SER . 22.8 mm -156.37 -82.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.83 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' THR . . . . . 0.447 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.5 t -98.37 11.57 37.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.791 -0.568 . . . . 0.0 110.472 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.96 74.65 2.29 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . 0.411 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 72.8 ttt-85 -144.83 -72.5 0.26 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -107.42 -22.73 12.46 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.565 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.02 -37.93 89.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.196 -0.94 . . . . 0.0 109.847 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 1.3 mt -89.32 -53.72 4.43 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.022 0.915 . . . . 0.0 108.647 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.39 -42.96 87.14 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.032 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -112.79 -8.81 13.72 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.16 -4.74 79.84 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.273 -1.517 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 94.6 mtp -68.52 -177.73 0.99 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.056 -1.261 . . . . 0.0 110.594 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.54 148.33 32.35 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.446 -0.784 . . . . 0.0 110.652 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.447 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.34 155.15 25.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.069 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 4.9 t -51.31 116.68 7.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.18 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 528' ' ' HIS . 48.3 Cg_endo -76.41 114.45 3.88 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.434 1.229 . . . . 0.0 110.41 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.2 28.62 0.03 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' SER . . . . . 0.425 ' OG ' HG13 ' A' ' 487' ' ' ILE . 47.1 t -92.01 169.24 10.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.363 -1.081 . . . . 0.0 111.833 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 52.6 m -110.88 117.86 34.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 531' ' ' GLN . 32.1 t -112.33 130.23 66.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.725 0.774 . . . . 0.0 110.008 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.416 ' CG1' HG12 ' A' ' 465' ' ' ILE . 14.6 pt -138.91 131.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.125 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.464 HG11 ' CG2' ' A' ' 534' ' ' ILE . 7.7 p -129.63 109.25 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.243 1.021 . . . . 0.0 111.245 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -85.47 110.16 18.98 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -126.19 106.91 9.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.61 58.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -85.97 149.15 25.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.0 -15.59 18.22 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.55 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.41 -31.41 65.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 5.0 m -83.45 -20.08 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.435 -0.791 . . . . 0.0 110.469 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.84 -43.99 86.86 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.5 -40.31 85.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.849 -0.532 . . . . 0.0 111.371 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.01 -51.72 68.12 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.065 -1.022 . . . . 0.0 110.719 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 92.2 m -59.34 -39.53 83.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 519' ' ' LEU . 0.8 OUTLIER -59.49 -38.52 81.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 122.092 -0.38 . . . . 0.0 111.279 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 69.5 p -64.11 -30.88 71.92 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.939 -1.1 . . . . 0.0 109.297 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 48.7 tp -70.02 -41.26 74.52 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.733 0.777 . . . . 0.0 109.331 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 -20.63 61.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.98 -0.45 . . . . 0.0 111.672 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -58.88 3.93 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.264 -0.897 . . . . 0.0 111.439 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.29 80.21 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.03 -30.37 66.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.877 -0.778 . . . . 0.0 110.575 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -52.24 -27.53 15.22 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.126 -0.984 . . . . 0.0 110.782 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -64.24 -36.79 85.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.633 -0.667 . . . . 0.0 109.27 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 501' ' ' PRO . 1.0 OUTLIER -132.2 -60.11 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.674 -0.641 . . . . 0.0 110.775 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -78.68 116.27 18.93 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 2.4 p -169.68 144.11 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 C-N-CA 117.262 -1.775 . . . . 0.0 115.462 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.527 ' O ' ' HB ' ' A' ' 505' ' ' VAL . 1.8 mt-30 175.9 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 80.3 t -115.0 114.73 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.501 0 O-C-N 120.525 -1.36 . . . . 0.0 113.853 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 0.3 OUTLIER -116.93 117.47 29.79 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 103.447 -2.798 . . . . 0.0 103.447 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' ILE . . . . . 0.464 ' CG2' HG11 ' A' ' 507' ' ' VAL . 6.2 pt -135.43 149.12 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.416 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 49.2 p -112.86 -168.07 1.27 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -158.69 168.14 27.66 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.733 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.32 17.68 1.71 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.214 0.53 . . . . 0.0 109.675 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -150.84 27.14 1.03 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.62 0.03 57.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.6 -0.941 . . . . 0.0 111.288 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -54.36 -43.66 71.51 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.869 -1.144 . . . . 0.0 110.048 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 73.3 p -113.88 155.38 25.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.13 43.76 83.64 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 9.8 t -63.22 -43.96 96.64 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.314 -1.11 . . . . 0.0 110.866 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.24 89.4 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 65.9 m -62.39 -36.41 82.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.9 -0.765 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.89 84.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.353 -0.842 . . . . 0.0 109.871 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 547' ' ' LEU . 11.3 mp -62.94 -41.77 99.59 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.635 0.731 . . . . 0.0 109.074 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 97.4 mtp -62.69 -28.12 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -55.82 -53.98 50.16 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' MET . . . . . . . . . . . . . 89.8 mmm -55.62 -46.15 77.43 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.28 -0.888 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.39 -30.88 71.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.708 -0.62 . . . . 0.0 111.424 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -67.19 -18.02 65.08 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.552 -0.717 . . . . 0.0 110.895 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.82 7.08 4.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.402 -0.811 . . . . 0.0 112.679 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.85 -12.69 9.29 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.094 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 93.4 t -88.31 115.33 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.057 -1.26 . . . . 0.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -170.31 133.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.602 -0.686 . . . . 0.0 110.257 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 15.9 p -76.89 162.85 27.28 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.77 -62.74 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.34 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -145.99 -102.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.64 -0.663 . . . . 0.0 109.987 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -92.95 -22.73 19.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.584 -1.323 . . . . 0.0 110.248 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -117.11 153.22 33.14 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.184 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 120.57 73.34 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 96.73 -25.33 26.96 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 568' ' ' ALA . 78.8 tt0 -94.3 -1.73 53.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -1.103 . . . . 0.0 110.927 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -81.94 -6.53 59.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.092 -1.005 . . . . 0.0 111.246 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' ARG . . . . . 0.429 ' CB ' ' CD ' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -153.45 -65.69 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 O-C-N 121.046 -1.034 . . . . 0.0 110.981 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 566' ' ' ARG . 47.2 Cg_endo -73.92 -7.0 19.44 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 122.948 0.973 . . . . 0.0 111.702 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 564' ' ' GLU . . . 54.86 21.16 3.45 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.992 -1.068 . . . . 0.0 111.392 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.029 179.838 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 389' ' ' GLU . 80.2 tt0 . . . . . 0 N--CA 1.503 2.206 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.87 -43.15 99.43 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.537 -1.352 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 70.8 m -62.78 -44.2 96.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.673 -0.642 . . . . 0.0 110.312 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 395' ' ' LEU . 69.1 t -65.84 -36.32 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.634 -0.666 . . . . 0.0 110.836 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.73 -44.2 97.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 111.568 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.0 91.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.492 -0.755 . . . . 0.0 112.124 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 399' ' ' ILE . 1.8 pp -71.88 -28.51 63.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.179 -0.951 . . . . 0.0 112.256 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.9 t -63.09 -43.9 97.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.701 -1.249 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -64.98 -42.97 94.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.731 -0.606 . . . . 0.0 111.59 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -63.28 -40.05 96.31 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.417 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.668 HG23 ' HD1' ' A' ' 419' ' ' TYR . 82.3 mt -63.52 -42.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.3 mtp -63.54 -32.0 73.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.165 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -57.87 -32.34 67.59 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 7.7 mp0 -93.09 -15.91 25.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.998 -1.064 . . . . 0.0 109.603 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -64.75 -36.35 84.03 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.24 18.43 17.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.785 . . . . 0.0 109.596 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.9 p -35.54 142.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.609 0 CA-C-O 121.354 0.597 . . . . 0.0 111.686 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 406' ' ' THR . 9.4 t -74.27 72.98 1.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.707 -0.621 . . . . 0.0 109.782 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 412' ' ' SER . 11.2 p -104.39 132.03 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.918 . . . . 0.0 111.52 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -93.33 142.05 24.76 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.46 -28.35 54.01 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.085 1.045 . . . . 0.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.22 -23.94 62.73 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.569 -0.707 . . . . 0.0 110.482 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 57.21 0.51 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' SER . . . . . 0.462 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 35.5 t -59.01 126.48 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 111.499 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.6 p -87.77 113.12 53.09 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.921 -0.487 . . . . 0.0 110.446 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 50.9 Cg_endo -69.26 142.72 50.95 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.102 1.054 . . . . 0.0 109.423 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.423 ' NH1' ' CG ' ' A' ' 402' ' ' GLN . 83.2 mtp180 -159.38 63.11 0.39 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 109.534 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 74.1 p -66.83 -35.7 80.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.938 -1.101 . . . . 0.0 108.741 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -69.56 -10.45 58.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 111.2 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.13 -44.63 97.16 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.746 ' HB3' HG13 ' A' ' 436' ' ' VAL . 9.6 m-85 -93.94 -2.42 53.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.13 -1.218 . . . . 0.0 109.805 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 7.3 t -80.61 -36.81 32.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 425' ' ' VAL . 39.6 t0 -79.06 -46.03 18.94 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.388 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.14 -49.67 76.32 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.89 0.852 . . . . 0.0 110.781 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.884 ' HA ' HD23 ' A' ' 426' ' ' LEU . 55.9 t -72.16 -40.49 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.767 -0.583 . . . . 0.0 112.297 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 66.8 p -59.39 -39.13 82.36 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.889 -1.132 . . . . 0.0 110.835 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 421' ' ' ASP . 97.3 t -61.51 -42.49 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.71 -0.619 . . . . 0.0 109.67 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -58.62 -32.73 69.3 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.444 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.72 73.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.607 -1.308 . . . . 0.0 109.32 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' A' ' 425' ' ' VAL . 82.7 mt-30 -62.62 -31.22 72.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 426' ' ' LEU . 90.2 m-20 -62.89 -90.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -171.92 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.346 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.68 105.73 1.52 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.039 1.02 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -85.15 100.93 12.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.782 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.749 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 20.9 tp -165.04 96.94 0.72 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.756 -1.215 . . . . 0.0 111.821 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -144.07 177.02 8.87 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.769 0.795 . . . . 0.0 111.89 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 44.4 pt -116.7 139.29 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.791 ' CG2' HG21 ' A' ' 423' ' ' VAL . 44.1 t -144.33 145.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.4 m -129.96 139.04 51.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.51 -0.744 . . . . 0.0 109.551 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.36 149.76 19.41 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -103.96 -49.64 3.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.751 -0.852 . . . . 0.0 109.262 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -146.75 153.86 25.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 93.09 106.62 1.76 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -46.99 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -1.009 . . . . 0.0 110.675 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.79 84.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 112.01 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.29 -29.25 64.54 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 120.729 -1.232 . . . . 0.0 110.514 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -38.89 89.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.509 -0.995 . . . . 0.0 110.804 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.526 ' CG ' ' HB1' ' A' ' 467' ' ' ALA . 6.9 mpt_? -64.91 -41.74 95.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.77 -27.79 63.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.301 -0.874 . . . . 0.0 110.498 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 41.3 ttm180 -62.89 -56.13 20.03 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.334 -0.854 . . . . 0.0 111.219 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 506' ' ' ILE . 11.8 p -57.34 -32.04 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.508 -1.37 . . . . 0.0 108.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.03 -26.34 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 49.4 tp10 -60.59 -32.7 71.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.06 -37.32 87.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.4 t -60.6 -27.05 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.78 -0.575 . . . . 0.0 109.812 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.59 -37.1 82.09 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.9 ttp -58.38 -29.46 66.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.652 0.739 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.77 31.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 0.0 109.555 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.41 -43.17 98.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -71.59 -27.43 63.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.732 -0.605 . . . . 0.0 110.478 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -82.65 6.44 17.81 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.493 -0.755 . . . . 0.0 111.282 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.63 28.42 72.24 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.867 -1.146 . . . . 0.0 110.628 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -134.6 129.07 34.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.052 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -85.26 167.54 15.55 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 23.5 m -145.31 149.25 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.86 . . . . 0.0 110.293 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.932 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.5 tt0 -97.52 126.11 42.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.895 HD13 HG21 ' A' ' 453' ' ' VAL . 1.9 pt -134.07 139.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.458 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.748 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.2 mp -129.31 126.08 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.347 -0.846 . . . . 0.0 110.688 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.526 ' HB1' ' CG ' ' A' ' 446' ' ' ARG . . . -84.28 -177.92 6.78 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.542 -0.723 . . . . 0.0 109.934 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.0 -162.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.213 0.53 . . . . 0.0 110.043 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.28 -16.86 6.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -0.969 . . . . 0.0 110.556 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -72.04 -11.07 60.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.374 -0.829 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -56.05 -34.0 65.51 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.13 -0.981 . . . . 0.0 111.903 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 39.0 t -55.66 -45.87 77.63 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.153 -0.967 . . . . 0.0 110.426 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -64.94 -37.91 89.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -32.47 70.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.92 -0.487 . . . . 0.0 110.506 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -59.65 -42.18 92.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.964 -1.085 . . . . 0.0 108.817 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.7 mtt -65.46 -35.65 81.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -102.92 -148.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 51.04 45.18 28.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.955 -1.091 . . . . 0.0 111.604 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -95.42 12.01 30.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.28 -0.887 . . . . 0.0 110.903 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -84.01 -1.68 55.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 111.131 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.841 ' HG2' HD22 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.976 -1.078 . . . . 0.0 112.796 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.841 HD22 ' HG2' ' A' ' 481' ' ' ARG . 0.2 OUTLIER -105.66 30.03 6.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.553 -1.342 . . . . 0.0 111.785 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 37.3 m -60.91 -28.21 68.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.935 -1.103 . . . . 0.0 110.251 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 161.81 46.84 0.02 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -130.54 40.82 3.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.57 -0.959 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.932 HD22 ' HA ' ' A' ' 464' ' ' GLN . 89.0 mt -67.36 -81.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.831 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.0 OUTLIER -175.63 -60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.41 -1.431 . . . . 0.0 112.547 173.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 487' ' ' ILE . 1.5 t -101.82 12.83 36.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.471 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -87.28 66.38 3.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.8 ttm180 -143.39 -63.42 0.4 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.32 -1.106 . . . . 0.0 108.885 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 37.5 mmt180 -101.86 -36.04 8.8 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -61.24 -29.96 70.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.644 -0.66 . . . . 0.0 111.492 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 5.9 mt -93.57 -29.91 15.25 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.513 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.7 OUTLIER -103.89 -38.21 7.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -6.39 12.13 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 100.47 -19.34 53.05 Favored Glycine 0 N--CA 1.504 3.204 0 CA-C-N 120.641 1.564 . . . . 0.0 112.274 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.4 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 10.9 mtp -69.29 175.1 4.13 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.982 -1.305 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.57 150.04 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.493 -0.754 . . . . 0.0 111.138 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -113.71 150.03 33.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.718 -0.614 . . . . 0.0 109.72 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 500' ' ' THR . 6.9 t -55.32 107.19 0.8 Allowed Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.474 -0.766 . . . . 0.0 110.573 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' A' ' 528' ' ' HIS . 40.0 Cg_endo -67.76 114.28 3.28 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.173 1.091 . . . . 0.0 110.316 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -166.11 26.19 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.831 ' CB ' HD13 ' A' ' 487' ' ' ILE . 22.9 t -96.0 -179.62 4.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.297 -1.119 . . . . 0.0 111.628 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.691 ' HB ' HG12 ' A' ' 463' ' ' VAL . 87.5 m -124.14 131.88 53.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 522' ' ' LEU . 62.9 t -121.5 135.78 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.901 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.813 HG22 ' HB2' ' A' ' 533' ' ' LEU . 26.0 pt -135.99 118.86 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.748 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.9 p -115.51 104.29 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 111.451 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.429 ' HA ' ' H ' ' A' ' 535' ' ' THR . 9.9 p-10 -86.73 121.39 29.16 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.47 129.2 7.76 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -77.56 -44.87 11.82 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -77.19 148.04 36.11 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -99.51 -12.19 20.38 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 121.907 -0.495 . . . . 0.0 111.645 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.7 OUTLIER -64.01 -34.98 79.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.8 m -69.68 -37.71 76.77 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.578 0.704 . . . . 0.0 110.577 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 550' ' ' MET . 57.7 tp -63.14 -42.79 99.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.736 -0.602 . . . . 0.0 111.209 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -66.37 -43.3 86.3 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 518' ' ' THR . 18.9 pt-20 -68.29 -42.13 79.93 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.858 -1.151 . . . . 0.0 110.51 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 466' ' ' ILE . 52.1 m -61.55 -40.14 93.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.659 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -61.0 -39.8 91.12 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 516' ' ' LYS . 75.6 p -60.09 -57.08 14.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.049 -1.032 . . . . 0.0 110.672 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.43 -41.12 98.47 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.149 -0.969 . . . . 0.0 110.721 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.798 HD12 HG11 ' A' ' 505' ' ' VAL . 5.1 tt -57.66 -30.39 65.39 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.627 -0.671 . . . . 0.0 110.727 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.12 -47.44 68.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.488 -0.758 . . . . 0.0 111.421 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -60.63 -50.02 72.19 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.42 -36.18 83.32 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.662 -0.905 . . . . 0.0 111.687 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.501 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.7 -25.12 66.17 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.273 -0.892 . . . . 0.0 110.964 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -53.47 -40.38 65.24 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.204 -0.935 . . . . 0.0 108.73 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 501' ' ' PRO . 1.5 t-80 -93.02 -135.35 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.417 ' HB3' ' HA2' ' A' ' 502' ' ' GLY . 16.5 t30 -88.87 78.95 7.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.602 -1.311 . . . . 0.0 112.402 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -140.21 168.68 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.114 -0.991 . . . . 0.0 108.62 178.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -164.0 162.97 23.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.602 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.6 t -113.44 110.69 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.709 0.766 . . . . 0.0 112.071 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.813 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.89 117.63 34.64 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 507' ' ' VAL . 11.7 pt -135.69 160.75 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 117.533 -1.667 . . . . 0.0 111.921 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 436' ' ' VAL . 47.0 p -125.55 -168.45 1.84 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -159.35 168.83 25.39 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.508 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.9 17.98 2.31 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.583 178.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.95 11.49 3.36 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 26.5 mt-30 -95.59 0.85 53.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.04 -1.271 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -53.69 -26.72 24.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.031 -1.043 . . . . 0.0 111.22 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 56.8 m -107.08 -36.81 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.417 -0.802 . . . . 0.0 109.89 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -134.42 107.46 0.66 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.1 t -97.74 -43.26 7.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -1.004 . . . . 0.0 111.629 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.65 -35.02 90.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 34.5 m -62.0 -32.24 72.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -1.079 . . . . 0.0 110.173 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.99 -35.06 79.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.86 -0.525 . . . . 0.0 109.923 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.1 mp -61.76 -43.72 98.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.0 -34.0 76.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 108.741 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.77 -52.5 56.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.659 ' CG ' HD11 ' A' ' 519' ' ' LEU . 32.0 ttp -58.31 -42.96 87.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.325 -0.86 . . . . 0.0 109.866 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HA ' ' CG1' ' A' ' 555' ' ' VAL . 99.0 mttt -61.6 -32.16 72.27 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.738 -0.601 . . . . 0.0 111.233 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.52 -12.72 61.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.589 -0.694 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.83 6.85 1.04 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.321 -0.862 . . . . 0.0 113.013 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.3 -15.76 42.48 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.522 -1.361 . . . . 0.0 110.933 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 555' ' ' VAL . 13.6 p . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.291 -1.123 . . . . 0.0 109.863 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.293 0.568 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.54 -38.49 89.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.69 -0.632 . . . . 0.0 110.976 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.0 m -62.51 -47.41 84.05 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.389 -0.819 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.15 -36.47 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.481 -0.762 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.36 82.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.237 -0.914 . . . . 0.0 109.655 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.55 -34.19 77.66 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.664 0.745 . . . . 0.0 108.999 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.6 OUTLIER -60.67 -39.45 88.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.98 -0.45 . . . . 0.0 110.659 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.9 m -64.6 -36.95 85.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.479 -0.763 . . . . 0.0 111.029 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -64.51 -46.63 82.09 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.288 -0.882 . . . . 0.0 111.997 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -70.06 -41.22 74.46 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.24 -0.913 . . . . 0.0 111.703 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 435' ' ' ILE . 96.5 mt -62.68 -40.6 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 109.675 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.434 ' HA ' ' CB ' ' A' ' 403' ' ' ASN . 18.3 mtp -63.01 -31.97 73.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.617 -0.677 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -60.74 -32.93 72.2 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.041 -1.037 . . . . 0.0 109.517 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 10.1 tp-100 -90.44 -14.93 31.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.797 -1.189 . . . . 0.0 109.385 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 400' ' ' MET . 44.3 t-20 -65.48 -35.94 82.38 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -115.63 18.6 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -39.07 148.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-O 121.677 0.751 . . . . 0.0 112.228 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 19.3 m -84.35 77.53 9.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 407' ' ' VAL . 14.8 p -97.21 131.48 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.343 -0.848 . . . . 0.0 112.355 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -96.62 145.04 28.89 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.89 -21.57 57.19 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.066 1.035 . . . . 0.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.62 -36.29 66.81 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.83 0.824 . . . . 0.0 110.42 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 67.61 0.51 Allowed 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 14.3 m -62.67 135.27 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.818 0.818 . . . . 0.0 111.091 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.487 HG23 ' HD2' ' A' ' 414' ' ' PRO . 8.6 p -81.51 149.19 64.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.487 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.3 Cg_endo -58.47 136.67 75.83 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.018 1.009 . . . . 0.0 110.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.403 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 80.5 mtt85 -96.3 -8.94 31.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.664 -0.648 . . . . 0.0 112.662 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.0 t -99.34 19.09 16.14 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.95 -1.094 . . . . 0.0 109.175 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -106.17 -36.97 6.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -68.82 -38.62 85.51 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.596 ' CB ' HG13 ' A' ' 436' ' ' VAL . 3.8 m-85 -94.9 -8.05 38.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.774 -1.427 . . . . 0.0 110.42 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -40.54 65.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.873 -1.142 . . . . 0.0 108.529 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 425' ' ' VAL . 66.2 t0 -76.11 -44.47 38.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.898 -0.501 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.557 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -66.96 -48.59 68.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 111.445 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 426' ' ' LEU . 72.2 t -67.87 -42.96 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.598 -0.689 . . . . 0.0 111.441 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.6 t -59.09 -42.61 90.86 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.812 -1.18 . . . . 0.0 111.309 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 421' ' ' ASP . 90.5 t -61.8 -46.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.193 -0.942 . . . . 0.0 110.886 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -56.87 -37.24 71.06 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.243 -0.91 . . . . 0.0 112.28 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.43 -36.87 79.69 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.896 -1.128 . . . . 0.0 108.937 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -59.82 -30.49 68.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.26 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.44 -55.88 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.603 -1.31 . . . . 0.0 109.416 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 49.2 Cg_endo -73.4 106.44 2.18 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 533' ' ' LEU . 6.0 m -85.17 97.82 10.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.878 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 18.1 tp -150.01 134.02 17.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.69 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -174.4 175.35 2.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.905 -1.122 . . . . 0.0 110.894 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.1 pt -134.09 121.05 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.403 0.62 . . . . 0.0 110.072 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.693 ' CG2' HG21 ' A' ' 423' ' ' VAL . 62.7 t -120.61 134.76 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.227 -0.92 . . . . 0.0 109.257 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 11.8 p -118.24 123.6 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.85 -1.156 . . . . 0.0 111.809 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 -178.14 34.18 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -171.41 39.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.991 . . . . 0.0 109.599 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -155.04 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -118.35 134.49 10.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -98.78 -16.08 19.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.689 -0.889 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.35 77.78 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.48 -0.763 . . . . 0.0 111.824 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -78.66 -35.05 33.27 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.42 -35.44 79.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.963 . . . . 0.0 109.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.772 ' O ' HG12 ' A' ' 449' ' ' VAL . 0.0 OUTLIER -60.49 -46.75 88.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.835 -0.541 . . . . 0.0 110.364 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 97.5 mt-10 -66.99 -29.37 69.19 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -62.06 -46.01 91.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.968 HG22 HD12 ' A' ' 506' ' ' ILE . 5.3 p -58.81 -30.63 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.801 -1.187 . . . . 0.0 109.03 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.93 -26.49 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.77 -35.63 76.91 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.92 -1.113 . . . . 0.0 108.412 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 452' ' ' LEU . 3.9 mm? -62.38 -37.9 87.52 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.897 . . . . 0.0 108.673 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 463' ' ' VAL . 66.8 t -57.97 -28.9 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.588 -0.695 . . . . 0.0 109.976 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 457' ' ' ARG . 65.8 mtt -65.76 -39.5 91.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.383 -0.823 . . . . 0.0 108.814 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 63.0 ttp -61.66 -21.49 64.46 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.608 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.19 32.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 0.0 109.891 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 454' ' ' MET . 82.7 mtp180 -67.08 -40.77 87.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 109.324 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.21 -34.19 75.8 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.604 0.716 . . . . 0.0 109.1 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -76.78 1.53 17.03 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.65 27.39 72.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 15.3 ttm180 -128.74 118.62 23.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -1.038 . . . . 0.0 110.402 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 0.5 OUTLIER -76.22 164.58 25.93 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.3 m -136.88 157.53 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.272 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.859 ' HA ' HD22 ' A' ' 486' ' ' LEU . 59.2 tt0 -105.7 111.81 24.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 482' ' ' LEU . 1.2 pt -122.32 129.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 466' ' ' ILE . 5.3 mp -119.36 111.99 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 112.169 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -57.43 164.12 2.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.294 -0.878 . . . . 0.0 109.806 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.449 ' HB3' HH11 ' A' ' 446' ' ' ARG . . . -58.78 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.898 -0.501 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -57.84 -12.25 2.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.117 -0.989 . . . . 0.0 111.2 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 446' ' ' ARG . 96.7 mtt-85 -88.82 6.08 40.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.145 -0.972 . . . . 0.0 111.164 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.6 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 53.6 ttp180 -57.9 -25.28 60.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.067 . . . . 0.0 111.037 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 7.7 t -59.02 -47.62 84.56 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.219 -0.925 . . . . 0.0 111.218 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.07 -35.82 82.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 33.0 ttp -66.28 -32.0 73.15 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.52 -37.3 83.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.31 -0.869 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 45.0 mtt -60.5 -36.4 78.24 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -121.08 -143.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.413 ' NE2' ' HD2' ' A' ' 481' ' ' ARG . 53.7 tp60 47.96 88.24 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.98 -1.075 . . . . 0.0 111.456 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -129.03 20.93 5.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 110.081 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -110.17 -0.72 17.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 111.377 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 482' ' ' LEU . 12.6 mtt180 -135.25 -13.36 2.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.886 -1.134 . . . . 0.0 112.723 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.722 HD22 HD11 ' A' ' 465' ' ' ILE . 0.6 OUTLIER -170.95 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.967 -1.083 . . . . 0.0 111.004 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.6 m -75.11 -18.26 60.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.64 47.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 20.1 pt-20 -139.9 74.8 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.669 -0.901 . . . . 0.0 111.051 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 464' ' ' GLN . 67.3 mt -94.85 -81.02 0.4 Allowed 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.4 OUTLIER 161.16 -34.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.75 0 C-N-CA 123.552 0.741 . . . . 0.0 110.435 173.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.541 HG21 ' CB ' ' A' ' 525' ' ' ALA . 7.0 p -102.14 12.7 36.36 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -153.36 95.78 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.433 ' N ' ' CD2' ' A' ' 493' ' ' LEU . 72.2 ttt180 -145.81 -72.21 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.455 ' CB ' ' HB2' ' A' ' 497' ' ' MET . 74.1 mtt-85 -90.13 -16.55 29.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.962 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -56.95 4.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.71 -1.244 . . . . 0.0 109.95 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 493' ' ' LEU . 1.1 pt? -58.92 -28.08 65.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.724 -0.61 . . . . 0.0 111.07 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 494' ' ' LEU . 1.0 OUTLIER -104.81 -46.37 4.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 111.938 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 495' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 491' ' ' ARG . 51.0 mt-10 -104.25 -7.93 19.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 112.5 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.87 -3.5 87.04 Favored Glycine 0 N--CA 1.508 3.438 0 O-C-N 120.581 -1.324 . . . . 0.0 110.051 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' CB ' ' A' ' 491' ' ' ARG . 93.7 mmm -64.8 -177.25 0.32 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -1.075 . . . . 0.0 112.721 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.64 169.46 8.8 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.744 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 488' ' ' THR . 1.2 p90 -142.33 150.09 40.31 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.564 -0.71 . . . . 0.0 110.443 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 30.8 m -61.77 109.25 2.06 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.48 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -84.91 113.35 1.55 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.362 1.191 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 168.85 31.83 0.02 OUTLIER Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.584 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.716 ' HB3' HG21 ' A' ' 487' ' ' ILE . 4.5 p -96.35 -175.4 3.34 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 463' ' ' VAL . 25.1 m -110.03 122.75 48.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.765 HG11 ' CD1' ' A' ' 522' ' ' LEU . 46.4 t -115.64 129.58 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.731 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.968 HD12 HG22 ' A' ' 449' ' ' VAL . 15.2 pt -124.6 119.31 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.69 ' HB ' HG21 ' A' ' 518' ' ' THR . 3.6 p -107.34 110.76 32.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.807 -1.183 . . . . 0.0 109.96 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.757 ' OD2' HG11 ' A' ' 449' ' ' VAL . 21.4 m-20 -82.71 105.7 13.95 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 9.0 tm0? -109.21 178.37 4.47 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.08 0.943 . . . . 0.0 112.714 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.437 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -167.36 -91.24 0.08 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -38.89 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.603 -0.299 . . . . 0.0 111.566 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -179.02 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.39 -1.444 . . . . 0.0 110.883 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 513' ' ' LEU . 14.2 tp -62.87 -30.77 71.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.573 -0.704 . . . . 0.0 109.935 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 6.0 p -69.17 -38.79 78.9 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.761 -0.587 . . . . 0.0 111.749 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.6 tp -64.26 -45.45 88.04 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.396 -0.815 . . . . 0.0 112.106 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 51.9 mtpt -65.11 -45.48 84.98 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.73 -42.62 95.08 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.288 -0.882 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 507' ' ' VAL . 74.4 m -58.54 -46.93 85.78 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.834 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 550' ' ' MET . 5.5 mt -62.95 -36.91 85.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.246 -0.908 . . . . 0.0 111.008 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.5 m -58.07 -41.31 83.14 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.165 -0.959 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.38 -37.84 63.32 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.59 0.71 . . . . 0.0 109.498 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.765 ' CD1' HG11 ' A' ' 505' ' ' VAL . 2.0 tp -63.65 -22.23 66.79 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -46.43 -52.78 12.37 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.5 -0.75 . . . . 0.0 112.005 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.74 -50.54 53.17 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.788 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -58.26 -44.12 88.24 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.667 -0.902 . . . . 0.0 111.858 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.35 -25.41 67.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 0.0 111.246 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -55.41 -26.2 40.3 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.091 -1.005 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.48 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.9 m80 -110.88 -130.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.607 -0.683 . . . . 0.0 109.913 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -88.49 78.05 7.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.557 -1.339 . . . . 0.0 112.614 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.788 HG21 ' HB1' ' A' ' 525' ' ' ALA . 0.9 OUTLIER -134.34 158.4 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 109.152 178.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 98.2 mm-40 -150.82 157.99 43.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.739 -0.601 . . . . 0.0 109.726 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 69.1 t -110.78 96.81 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.192 -0.943 . . . . 0.0 113.468 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.663 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.5 OUTLIER -95.9 114.19 25.88 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 174.57 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.65 HG22 ' CG1' ' A' ' 507' ' ' VAL . 4.9 pt -130.04 136.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.401 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.494 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 18.5 p -96.68 176.25 6.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 1.8 p30 -158.59 168.16 27.66 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.948 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.437 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.7 t -140.61 59.36 1.55 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -37.28 158.95 0.01 OUTLIER Glycine 0 N--CA 1.507 3.382 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.999 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.78 -87.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.166 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -108.77 -81.23 0.57 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.775 -1.203 . . . . 0.0 112.805 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 t -139.75 -30.16 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.675 0.75 . . . . 0.0 109.511 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -98.89 50.97 1.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.0 t -76.34 3.27 11.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 122.128 -0.631 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -50.2 -26.68 9.53 Favored Glycine 0 N--CA 1.502 3.088 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.0 m -70.61 -20.85 62.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.995 -1.297 . . . . 0.0 109.047 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.785 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -68.48 -34.33 75.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -63.83 -42.65 97.57 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.393 -0.817 . . . . 0.0 109.928 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.07 -34.51 75.02 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.83 -44.09 39.11 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.699 ' HB2' HD21 ' A' ' 515' ' ' LEU . 1.4 tmt? -57.49 -47.11 82.8 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.5 -33.42 71.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.677 -0.64 . . . . 0.0 111.496 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -63.96 -18.89 64.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.295 -0.878 . . . . 0.0 110.064 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.99 0.07 6.61 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.36 -0.838 . . . . 0.0 112.379 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 111.7 -12.4 27.6 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.816 -1.177 . . . . 0.0 111.52 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 519' ' ' LEU . 68.8 t . . . . . 0 N--CA 1.496 1.867 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.629 0.728 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.13 -37.3 86.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.503 -0.748 . . . . 0.0 110.882 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 49.0 m -60.02 -44.23 94.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.587 -0.696 . . . . 0.0 111.189 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 433' ' ' LEU . 77.2 t -77.21 -29.56 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 111.063 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -65.51 -47.8 74.75 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.12 . . . . 0.0 111.166 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.26 88.76 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.876 0.846 . . . . 0.0 110.331 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.574 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.3 tt -61.88 -38.83 89.75 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.207 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.2 m -61.15 -36.72 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.063 -0.398 . . . . 0.0 110.77 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -60.76 -44.07 97.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 110.734 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ASP . . . . . 0.425 ' O ' ' CE1' ' A' ' 419' ' ' TYR . 39.1 t70 -65.58 -44.39 86.81 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 0.0 111.962 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.769 HG23 ' HB3' ' A' ' 419' ' ' TYR . 0.9 OUTLIER -63.3 -42.17 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 121.106 -0.996 . . . . 0.0 108.983 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 2.9 ttt -61.96 -26.72 68.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.727 -0.608 . . . . 0.0 109.578 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -62.27 -31.13 71.67 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.653 ' O ' HG12 ' A' ' 405' ' ' VAL . 27.4 tp60 -89.75 -11.69 41.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 0.0 109.83 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.51 -39.92 88.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 -116.57 17.8 15.23 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.788 -1.195 . . . . 0.0 109.721 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.4 p -56.87 118.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.612 -0.68 . . . . 0.0 110.001 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -54.58 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.083 -1.011 . . . . 0.0 109.559 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 405' ' ' VAL . 43.0 t -96.02 130.9 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.899 -0.501 . . . . 0.0 110.132 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.12 131.78 34.1 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.475 -0.765 . . . . 0.0 109.878 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 -24.03 43.88 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.164 1.086 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.36 -37.4 80.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.941 0.877 . . . . 0.0 110.181 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 67.6 1.03 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.8 p -49.8 155.3 0.88 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.108 0.956 . . . . 0.0 112.088 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 407' ' ' VAL . 7.3 p -101.45 143.65 27.02 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 417' ' ' ALA . 38.1 Cg_endo -64.77 131.26 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 N-CA-C 109.104 -1.152 . . . . 0.0 109.104 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -109.51 -19.06 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.516 -0.74 . . . . 0.0 112.502 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 420' ' ' SER . 9.8 t -101.86 14.95 30.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 414' ' ' PRO . . . -75.55 -77.86 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.689 -0.632 . . . . 0.0 111.607 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -89.0 -0.72 80.65 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.782 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.769 ' HB3' HG23 ' A' ' 399' ' ' ILE . 80.2 m-85 -107.98 -26.39 10.71 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.775 2.288 . . . . 0.0 108.763 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 416' ' ' THR . 4.9 t -71.19 -38.78 72.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 175.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 -38.8 92.19 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -59.88 -37.22 78.74 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.748 0.785 . . . . 0.0 109.327 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 75.9 t -66.85 -44.42 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.7 p -61.02 -37.82 83.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.642 -1.286 . . . . 0.0 111.529 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.25 -46.47 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -55.3 -32.78 62.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 0.0 111.686 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.16 78.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.806 -1.184 . . . . 0.0 108.877 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.49 -30.57 65.21 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.68 -89.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.488 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -174.67 -54.33 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.617 -1.302 . . . . 0.0 108.93 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.9 Cg_endo -70.81 98.71 0.8 Allowed 'Trans proline' 0 N--CA 1.487 1.135 0 N-CA-C 109.179 -1.123 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.533 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -84.34 102.09 12.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.804 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.91 98.1 1.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.35 -0.844 . . . . 0.0 111.928 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -142.92 168.32 19.99 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.48 -0.763 . . . . 0.0 111.82 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.27 129.92 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.747 -0.596 . . . . 0.0 111.385 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.624 ' CG2' HG21 ' A' ' 423' ' ' VAL . 25.5 t -133.02 155.44 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.312 -0.868 . . . . 0.0 110.083 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.7 t -133.09 138.9 46.87 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.427 -0.796 . . . . 0.0 111.024 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -101.41 -171.34 28.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -153.18 26.15 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.732 -0.863 . . . . 0.0 109.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.9 10.33 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.56 55.35 15.22 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.42 -9.08 59.58 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -57.69 -45.96 84.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.134 -0.979 . . . . 0.0 111.723 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -83.05 -28.55 36.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.74 -40.43 88.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.952 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.783 ' O ' HG12 ' A' ' 449' ' ' VAL . 5.5 mmt85 -65.97 -39.27 90.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.51 -0.744 . . . . 0.0 109.66 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -67.66 -29.5 68.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.141 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 49.7 ttt85 -64.21 -47.0 81.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 446' ' ' ARG . 9.5 p -56.5 -30.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.554 -1.341 . . . . 0.0 109.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.498 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 95.3 mt-10 -62.76 -33.68 75.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.734 -1.229 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 452' ' ' LEU . 4.2 mm? -65.02 -34.54 78.67 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.927 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.3 t -60.47 -31.75 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 96.3 mmm -65.14 -40.1 93.95 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.3 ttp -59.63 -22.45 61.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.603 -0.686 . . . . 0.0 110.318 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 461' ' ' ARG . . . -81.93 -22.79 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -65.37 -43.09 91.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.429 -0.794 . . . . 0.0 109.655 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.19 -28.93 63.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -76.03 -2.92 33.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.699 -0.626 . . . . 0.0 111.388 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.58 19.99 72.46 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.406 ' HG3' ' HB1' ' A' ' 456' ' ' ALA . 32.2 ptt180 -136.72 151.18 48.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -1.064 . . . . 0.0 110.406 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.523 ' HB2' HD13 ' A' ' 487' ' ' ILE . 92.3 mt-10 -102.07 178.84 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.927 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.4 m -141.9 158.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.778 -1.201 . . . . 0.0 111.578 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.9 tt0 -102.1 119.33 38.62 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -126.77 130.97 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.232 -0.918 . . . . 0.0 111.081 -178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 465' ' ' ILE . 91.1 mt -129.11 123.56 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.852 -0.53 . . . . 0.0 110.277 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -75.66 165.71 24.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.424 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -58.1 -161.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.571 -0.706 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.53 -20.52 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -74.57 -2.86 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.395 -0.815 . . . . 0.0 110.752 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.444 ' CZ ' HD12 ' A' ' 482' ' ' LEU . 0.9 OUTLIER -54.19 -26.06 26.15 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.108 -0.995 . . . . 0.0 110.46 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.2 p -65.41 -46.81 78.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.392 -0.818 . . . . 0.0 109.966 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.77 -49.25 69.03 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.373 -0.829 . . . . 0.0 110.329 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 6.4 ttt -58.57 -30.61 67.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 110.403 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -58.75 -33.37 70.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 47.3 ttp -58.47 -39.08 78.95 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.315 0.579 . . . . 0.0 110.295 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -125.14 -157.36 0.78 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.835 -0.541 . . . . 0.0 109.663 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 45.82 61.44 2.65 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.443 -0.786 . . . . 0.0 112.167 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -98.05 9.03 43.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.586 -0.696 . . . . 0.0 109.795 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -93.04 -0.59 57.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.598 ' C ' HD23 ' A' ' 482' ' ' LEU . 0.2 OUTLIER -141.16 3.38 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 112.454 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.5 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.872 -1.142 . . . . 0.0 111.815 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.9 p -93.76 48.24 1.27 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.132 -0.98 . . . . 0.0 108.926 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.82 26.66 28.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -118.52 47.58 1.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.495 -1.003 . . . . 0.0 108.814 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.82 HD11 ' HA3' ' A' ' 489' ' ' GLY . 0.2 OUTLIER -96.11 -82.77 0.39 Allowed 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.644 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.894 HG21 ' OG ' ' A' ' 503' ' ' SER . 38.0 mm -142.71 -90.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.076 -1.015 . . . . 0.0 108.99 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.452 ' HB ' ' CG ' ' A' ' 499' ' ' PHE . 0.0 OUTLIER -102.09 11.85 37.73 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.653 -0.654 . . . . 0.0 110.263 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.82 ' HA3' HD11 ' A' ' 486' ' ' LEU . . . -81.78 77.62 2.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.482 ' CG ' ' H ' ' A' ' 491' ' ' ARG . 0.2 OUTLIER -144.47 -86.11 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 490' ' ' ARG . 77.9 mtt85 -112.14 -17.16 12.87 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.443 -0.785 . . . . 0.0 109.227 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 497' ' ' MET . 8.0 mp0 -49.64 -36.1 23.51 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.61 -1.306 . . . . 0.0 111.226 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 521' ' ' LEU . 60.9 mt -71.84 -66.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.16 -0.962 . . . . 0.0 108.465 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 494' ' ' LEU . 0.7 OUTLIER -54.11 -28.99 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.408 0.623 . . . . 0.0 110.377 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 495' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 80.0 mm-40 -84.51 -3.16 58.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.0 111.585 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 69.91 48.87 38.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.49 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 94.4 mtp -123.01 -177.39 3.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -1.001 . . . . 0.0 111.127 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.48 170.63 7.96 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.649 -0.657 . . . . 0.0 110.325 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.452 ' CG ' ' HB ' ' A' ' 488' ' ' THR . 4.6 m-85 -109.21 125.64 52.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.257 -0.902 . . . . 0.0 108.612 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.7 t -68.02 150.89 97.58 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.613 -0.679 . . . . 0.0 110.852 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.444 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 42.5 Cg_endo -71.6 123.7 9.67 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.611 1.322 . . . . 0.0 111.049 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 161.64 -2.06 0.07 OUTLIER Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.72 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.894 ' OG ' HG21 ' A' ' 487' ' ' ILE . 8.6 m -82.81 153.21 25.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.343 . . . . 0.0 113.502 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.866 ' HB ' HG12 ' A' ' 463' ' ' VAL . 50.7 m -118.58 91.88 3.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.665 ' CB ' HD21 ' A' ' 522' ' ' LEU . 18.3 t -87.85 135.8 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.756 HG22 ' HB2' ' A' ' 533' ' ' LEU . 18.2 pt -136.55 122.43 28.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 534' ' ' ILE . 8.5 p -123.67 111.98 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.669 -1.269 . . . . 0.0 112.787 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -86.59 123.04 31.34 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.406 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.4 pm0 -160.52 129.23 4.76 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 117.488 -1.685 . . . . 0.0 115.434 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.485 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.3 -43.02 6.76 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.61 151.54 45.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -98.83 -11.68 21.55 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.24 -40.46 90.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 13.5 t -67.71 -39.95 84.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.819 -0.551 . . . . 0.0 111.201 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' A' ' 550' ' ' MET . 64.4 tp -62.67 -44.76 95.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.595 -0.691 . . . . 0.0 111.235 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 32.2 ttpt -71.36 -46.57 60.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.294 -0.878 . . . . 0.0 112.975 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.03 -44.08 85.7 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 83.1 m -56.84 -43.4 81.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.309 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.1 OUTLIER -53.76 -34.42 58.94 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.33 0.586 . . . . 0.0 109.882 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.403 ' HA ' ' OD2' ' A' ' 523' ' ' ASP . 27.0 m -62.35 -41.48 98.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.508 -0.745 . . . . 0.0 109.513 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 493' ' ' LEU . 1.0 OUTLIER -62.66 -40.52 97.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.738 0.78 . . . . 0.0 108.928 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.33 -21.34 63.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.923 -0.485 . . . . 0.0 110.851 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 523' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 520' ' ' THR . 95.4 m-20 -46.09 -64.55 0.72 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.622 -0.673 . . . . 0.0 112.453 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.03 -52.47 49.79 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 120.577 -1.327 . . . . 0.0 110.737 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.24 68.18 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.258 -1.142 . . . . 0.0 111.006 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.87 -20.66 66.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -37.9 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 0.7 OUTLIER -145.44 -79.25 0.18 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.267 -1.521 . . . . 0.0 113.751 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.435 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 82.5 m-20 -90.65 72.63 6.76 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.712 -1.243 . . . . 0.0 114.087 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 9.6 p -130.16 150.63 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.738 -1.226 . . . . 0.0 112.572 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.507 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 87.8 mm-40 -144.02 149.86 37.34 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 5.2 t -112.33 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.761 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.756 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -103.08 116.67 32.96 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -136.0 150.7 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.747 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.3 p -118.13 -163.99 0.98 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.54 163.15 40.36 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.607 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.485 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 3.8 p -128.7 22.25 5.9 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.875 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -174.0 43.85 0.14 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.35 -0.41 56.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.881 -0.776 . . . . 0.0 111.732 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -55.68 -42.71 75.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.995 -1.066 . . . . 0.0 110.851 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 m -116.76 156.38 27.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.591 -0.693 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.53 34.38 55.22 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -62.62 -43.36 98.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.42 -1.047 . . . . 0.0 110.61 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -62.77 -33.53 87.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.9 m -63.98 -39.45 94.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.846 -0.797 . . . . 0.0 111.007 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.53 -37.09 82.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.01 -42.26 99.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.657 -0.652 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 63.8 tpp -63.59 -34.58 78.14 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.5 -0.75 . . . . 0.0 109.515 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.23 -53.89 50.26 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.737 ' HB2' HD21 ' A' ' 515' ' ' LEU . 39.0 ttp -58.57 -44.86 89.88 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.317 -0.864 . . . . 0.0 109.914 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 555' ' ' VAL . 75.8 mmtt -60.28 -32.04 70.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.643 -0.66 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.81 -16.6 63.83 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.337 -0.852 . . . . 0.0 110.607 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.38 2.85 2.65 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 138.73 -16.66 3.29 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.21 -1.472 . . . . 0.0 111.817 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 555' ' ' VAL . 35.2 m . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.996 -1.297 . . . . 0.0 110.262 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.456 HD23 ' CZ ' ' A' ' 393' ' ' ARG . 93.9 mt -71.66 -31.13 66.48 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.904 -1.123 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 17.0 p -64.63 -40.64 95.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.816 -0.552 . . . . 0.0 111.915 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.59 -35.93 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 111.961 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.456 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 77.3 mtm180 -63.81 -46.99 82.66 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.71 -1.244 . . . . 0.0 110.63 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.35 75.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.688 HD13 ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -63.34 -39.03 93.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.825 -0.547 . . . . 0.0 110.52 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 59.3 m -61.23 -37.84 84.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.424 -0.797 . . . . 0.0 110.419 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -63.3 -44.69 94.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.325 -0.859 . . . . 0.0 111.663 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -67.66 -46.06 73.48 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.149 -0.969 . . . . 0.0 111.949 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 436' ' ' VAL . 63.9 mt -65.44 -42.35 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.985 -1.072 . . . . 0.0 109.921 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 16.6 ttm -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.19 -25.66 65.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.52 -0.738 . . . . 0.0 109.381 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 0.0 OUTLIER -93.11 -15.64 25.83 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.867 -1.146 . . . . 0.0 109.025 175.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 0.4 OUTLIER -67.3 -40.3 86.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.608 -0.683 . . . . 0.0 110.263 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -115.49 18.67 15.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.969 -1.082 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 405' ' ' VAL . 7.1 p -48.7 116.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.492 -0.755 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.8 p -50.49 89.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.786 -0.571 . . . . 0.0 111.016 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 413' ' ' VAL . 14.2 p -108.74 133.7 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -96.76 141.7 23.47 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 110.85 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.93 -24.35 39.83 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.143 1.075 . . . . 0.0 110.232 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -66.76 -32.32 73.53 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.782 0.801 . . . . 0.0 110.392 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 67.21 1.14 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 18.6 t -49.56 148.74 2.69 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.55 -0.718 . . . . 0.0 110.604 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -100.93 110.06 59.9 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.637 . . . . 0.0 110.855 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.81 121.37 5.44 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.004 1.002 . . . . 0.0 111.3 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.4 ' HE ' HG22 ' A' ' 413' ' ' VAL . 13.2 ptp180 -169.4 61.7 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.825 . . . . 0.0 110.181 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.2 t -67.47 -31.36 71.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.323 -0.861 . . . . 0.0 108.799 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.64 47.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 110.735 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.7 81.24 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.519 ' CD1' HG11 ' A' ' 436' ' ' VAL . 26.0 p90 -90.27 -0.42 57.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.93 -1.336 . . . . 0.0 110.161 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.8 m -76.07 -38.81 56.59 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.801 ' O ' HG23 ' A' ' 425' ' ' VAL . 30.8 t70 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.447 0.642 . . . . 0.0 109.962 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.594 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.49 -49.51 75.08 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.971 0.891 . . . . 0.0 111.068 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 436' ' ' VAL . 97.4 t -68.41 -42.24 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.771 -0.581 . . . . 0.0 111.146 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 88.1 p -59.48 -33.05 70.83 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.007 . . . . 0.0 110.42 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 421' ' ' ASP . 76.6 t -63.11 -46.03 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.7 -0.625 . . . . 0.0 111.026 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.8 pp -64.13 -34.76 78.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.178 -0.951 . . . . 0.0 112.367 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.26 85.5 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.629 -1.294 . . . . 0.0 109.15 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -63.3 -32.3 73.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -66.33 -93.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -177.26 -53.79 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.369 -1.457 . . . . 0.0 109.433 177.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 41.1 Cg_endo -68.72 106.36 1.46 Allowed 'Trans proline' 0 N--CA 1.48 0.726 0 N-CA-C 108.204 -1.498 . . . . 0.0 108.204 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.462 ' HB3' ' N ' ' A' ' 532' ' ' VAL . 0.2 OUTLIER -92.36 103.56 15.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.6 OUTLIER -164.07 89.81 0.57 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.938 -1.102 . . . . 0.0 109.27 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -137.4 170.0 16.83 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.785 0.802 . . . . 0.0 111.414 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.35 126.73 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 423' ' ' VAL . 22.4 t -130.04 160.4 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 110.729 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.5 t -133.58 138.79 46.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.434 -0.791 . . . . 0.0 110.685 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.02 166.51 23.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -116.89 -44.59 2.81 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.283 -1.128 . . . . 0.0 109.492 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.9 165.85 38.3 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.98 36.21 64.73 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.677 ' HB3' ' NH1' ' A' ' 470' ' ' ARG . . . -59.13 -22.34 60.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.79 -0.829 . . . . 0.0 112.001 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.56 90.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.82 -29.49 59.15 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 448' ' ' ARG . 43.4 tt0 -60.17 -41.3 92.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.597 -0.943 . . . . 0.0 109.957 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.609 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.0 mtm180 -64.01 -36.12 82.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.16 -30.13 68.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.415 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 445' ' ' GLN . 89.3 mtt-85 -64.62 -49.73 69.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -57.43 -32.58 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.003 -1.061 . . . . 0.0 110.138 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.67 -27.18 68.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 454' ' ' MET . 83.4 tt0 -66.55 -36.6 83.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -62.56 -35.47 79.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.936 HG13 ' CG2' ' A' ' 463' ' ' VAL . 46.9 t -64.63 -28.2 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 95.0 mtp -68.26 -42.73 79.17 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.216 -0.928 . . . . 0.0 111.764 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 6.6 ptm -63.36 -21.58 66.36 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.51 -1.369 . . . . 0.0 109.245 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.43 48.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.456 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.16 -41.05 97.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.47 -22.53 62.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.799 -0.563 . . . . 0.0 110.497 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -75.28 -0.23 18.9 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.171 -0.956 . . . . 0.0 111.651 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 82.24 12.53 80.59 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 120.92 -1.112 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -139.54 151.84 46.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 110.653 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.74 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.8 mt-10 -92.85 179.28 5.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.587 -0.696 . . . . 0.0 109.205 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.936 ' CG2' HG13 ' A' ' 453' ' ' VAL . 14.7 m -141.85 153.23 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.779 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.681 ' HB3' HG22 ' A' ' 505' ' ' VAL . 53.8 tt0 -98.52 118.31 34.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -122.72 128.82 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.42 -0.8 . . . . 0.0 109.467 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.649 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.4 mp -121.39 115.92 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.972 -0.455 . . . . 0.0 110.224 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -71.05 161.41 31.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.46 ' HA ' ' NE2' ' A' ' 509' ' ' GLN . . . -57.36 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.121 -0.987 . . . . 0.0 110.298 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -48.43 -19.8 0.35 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.036 -1.04 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ARG . . . . . 0.677 ' NH1' ' HB3' ' A' ' 442' ' ' ALA . 99.8 mtt180 -78.22 -10.64 59.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.625 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 60.9 ttt-85 -55.11 -25.51 31.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 111.827 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 77.9 p -59.06 -41.92 89.1 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.989 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -64.95 -41.54 95.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.566 -0.709 . . . . 0.0 109.541 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 38.7 ttm -58.0 -36.6 72.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.588 -0.695 . . . . 0.0 110.536 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -60.89 -40.62 93.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -0.82 . . . . 0.0 109.869 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 52.2 mtt -62.79 -40.05 96.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.622 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.413 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 65.0 pttt -117.52 -158.3 0.7 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.165 -0.959 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.413 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 94.8 mm-40 46.15 88.83 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.452 -0.78 . . . . 0.0 112.118 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -116.75 26.28 9.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -107.7 -9.82 15.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 111.449 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -11.39 3.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 111.909 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -173.58 55.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 5.7 t -62.27 -18.48 61.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.318 -0.864 . . . . 0.0 109.921 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 486' ' ' LEU . . . 163.81 -21.08 0.15 Allowed Glycine 0 N--CA 1.501 2.986 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.51 71.31 3.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.029 -1.277 . . . . 0.0 110.014 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -86.77 -82.96 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.398 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.887 HG22 HG23 ' A' ' 488' ' ' THR . 34.5 mm -145.23 -86.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.147 . . . . 0.0 110.322 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 499' ' ' PHE . 69.7 p -96.33 47.78 1.08 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -111.65 59.84 0.35 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.478 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 79.2 ttt180 -143.98 -61.44 0.39 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.438 -1.037 . . . . 0.0 108.908 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -110.71 -31.01 7.35 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.382 0.611 . . . . 0.0 110.558 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -35.92 82.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.306 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.492 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 7.1 mt -91.95 -26.46 18.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.332 -0.855 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 41.7 tp -104.55 -41.64 5.65 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.66 -8.68 18.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.972 -1.08 . . . . 0.0 113.733 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 86.6 -16.36 46.0 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.674 -1.267 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.83 -178.52 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.197 -1.178 . . . . 0.0 109.429 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.38 156.49 22.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.177 -0.952 . . . . 0.0 110.644 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.956 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -113.66 149.06 35.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.855 -0.528 . . . . 0.0 109.726 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -47.09 104.67 0.42 Allowed Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.531 -0.731 . . . . 0.0 110.575 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 529' ' ' ASN . 55.3 Cg_endo -76.72 111.89 3.34 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.25 1.131 . . . . 0.0 110.422 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 174.42 34.64 0.04 OUTLIER Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.824 ' OG ' HD12 ' A' ' 487' ' ' ILE . 14.5 m -99.35 -177.21 3.52 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.331 1.063 . . . . 0.0 113.461 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.824 ' HB ' HG12 ' A' ' 463' ' ' VAL . 52.4 m -120.48 128.79 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 464' ' ' GLN . 37.4 t -116.45 131.79 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.911 0.863 . . . . 0.0 112.726 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 533' ' ' LEU . 39.6 mt -129.71 113.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.947 -1.096 . . . . 0.0 108.121 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 534' ' ' ILE . 10.6 p -114.93 105.21 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.883 -1.136 . . . . 0.0 111.9 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.405 ' OD2' HG11 ' A' ' 449' ' ' VAL . 83.5 m-20 -85.48 124.17 31.75 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 468' ' ' ALA . 9.3 tp-100 -160.1 125.78 4.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -91.4 -31.82 9.28 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.15 -164.08 0.83 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.02 -5.67 3.09 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.89 -39.14 79.92 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.126 -0.984 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.9 m -87.29 -17.34 32.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.559 -0.713 . . . . 0.0 111.733 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 550' ' ' MET . 59.7 tp -73.52 -41.8 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.43 -0.794 . . . . 0.0 109.871 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.2 mttt -74.54 -43.06 57.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.527 -0.733 . . . . 0.0 111.888 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.4 OUTLIER -61.05 -44.55 97.22 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.971 -1.081 . . . . 0.0 110.954 -178.298 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -60.16 -42.1 94.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 0.0 109.508 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.492 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.41 -38.35 77.21 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.797 -0.564 . . . . 0.0 109.619 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.9 m -61.42 -36.33 80.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.303 -0.873 . . . . 0.0 108.993 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 521' ' ' LEU . 0.2 OUTLIER -68.36 -38.29 81.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.8 -0.563 . . . . 0.0 109.984 178.459 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.627 HD11 HG11 ' A' ' 505' ' ' VAL . 0.5 OUTLIER -67.68 -21.29 65.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.15 -0.969 . . . . 0.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 523' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 5.7 t0 -46.44 -63.33 1.03 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.37 -0.831 . . . . 0.0 111.198 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.74 79.36 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 529' ' ' ASN . . . -53.49 -29.75 37.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.75 -0.853 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -46.42 -25.41 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 112.767 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -59.02 -42.91 91.31 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.78 -35.74 0.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.286 -0.884 . . . . 0.0 110.856 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.639 ' HB3' ' HB1' ' A' ' 525' ' ' ALA . 41.1 t-20 -79.77 103.14 9.47 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 529' ' ' ASN . 16.4 m -149.45 125.86 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.08 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.7 OUTLIER 176.23 100.2 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.462 ' N ' ' HB3' ' A' ' 432' ' ' SER . 95.5 t -107.47 109.86 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.629 1.204 . . . . 0.0 109.989 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.754 HD21 ' CG1' ' A' ' 423' ' ' VAL 0.306 4.3 tt -114.45 115.58 27.51 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 103.028 -2.952 . . . . 0.0 103.028 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 507' ' ' VAL . 0.5 OUTLIER -134.48 129.65 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.841 -177.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 68.1 p -100.87 -163.58 1.03 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.6 165.62 36.02 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.21 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 4.4 p -132.94 16.14 4.23 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.38 42.96 0.31 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -96.5 -0.04 49.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.745 -0.856 . . . . 0.0 112.182 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -46.07 -32.06 2.65 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.161 -0.962 . . . . 0.0 111.496 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 t -131.49 162.59 29.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.463 -0.773 . . . . 0.0 109.377 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.69 31.71 58.0 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -61.91 -46.53 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.964 . . . . 0.0 110.758 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.3 -38.19 94.78 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 5.6 t -63.13 -33.73 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.816 -0.814 . . . . 0.0 109.686 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.49 -37.11 80.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.598 -0.689 . . . . 0.0 110.293 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.97 -41.02 97.67 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.461 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 87.7 mmm -65.51 -32.97 74.85 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.377 -0.827 . . . . 0.0 108.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -54.11 -54.76 35.04 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.597 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.492 ' CG ' HD11 ' A' ' 519' ' ' LEU . 65.9 ttp -59.11 -43.22 91.89 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.16 -0.962 . . . . 0.0 110.439 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.26 -32.36 73.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.424 -0.798 . . . . 0.0 112.133 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.1 -13.54 61.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.375 -0.828 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.555 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -72.8 6.91 2.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 112.664 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 140.7 -17.69 2.82 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.87 -1.157 . . . . 0.0 110.967 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 81.5 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.155 -1.203 . . . . 0.0 110.303 -179.407 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 120.557 0.218 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.31 -39.71 87.95 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.6 m -64.24 -42.57 96.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.477 -0.764 . . . . 0.0 109.946 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 433' ' ' LEU . 86.5 t -67.79 -34.41 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.784 -0.572 . . . . 0.0 110.621 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -61.12 -48.09 83.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.296 -0.877 . . . . 0.0 111.349 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.89 78.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.45 -0.782 . . . . 0.0 110.458 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.743 ' CD2' HD11 ' A' ' 399' ' ' ILE . 10.0 tt -61.86 -39.15 90.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.751 -0.593 . . . . 0.0 110.507 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 60.6 m -63.17 -40.35 97.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.747 -0.596 . . . . 0.0 111.49 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.42 -41.8 97.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.333 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.3 -42.39 93.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.618 -0.676 . . . . 0.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -63.08 -39.01 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 120.906 -1.121 . . . . 0.0 108.761 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.583 ' CG ' HD11 ' A' ' 435' ' ' ILE . 42.5 mtp -65.37 -28.47 69.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.37 -29.87 70.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.742 ' O ' HG12 ' A' ' 405' ' ' VAL . 55.1 tt0 -92.8 -13.58 28.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.43 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -36.91 84.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.651 -0.656 . . . . 0.0 109.458 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -116.81 18.85 14.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.791 -1.193 . . . . 0.0 109.919 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.8 p -61.81 118.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.493 -0.754 . . . . 0.0 110.007 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.2 m -53.91 105.08 0.12 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 405' ' ' VAL . 44.8 t -106.53 132.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.612 -0.68 . . . . 0.0 109.548 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -91.95 140.68 24.83 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.552 -0.718 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.1 -23.37 33.88 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.264 1.139 . . . . 0.0 110.265 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -58.68 -43.0 89.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.322 -0.862 . . . . 0.0 109.395 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 67.38 0.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 91.4 p -52.66 117.4 2.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.241 -0.912 . . . . 0.0 111.525 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 407' ' ' VAL . 8.7 p -62.58 149.94 87.4 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -61.88 140.47 85.41 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.068 1.036 . . . . 0.0 110.095 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.438 ' NH2' ' HB2' ' A' ' 439' ' ' GLN . 42.2 mtm180 -106.44 -12.77 15.54 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.839 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 420' ' ' SER . 38.5 p -103.26 10.77 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.388 -1.445 . . . . 0.0 108.792 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.68 -87.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.47 78.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.652 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' A' ' 399' ' ' ILE . 78.7 m-85 -108.32 -25.38 11.04 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 120.756 2.278 . . . . 0.0 109.184 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 416' ' ' THR . 3.7 t -72.94 -40.75 65.14 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -64.12 -35.87 82.16 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 419' ' ' TYR . . . -60.0 -39.13 84.71 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.338 0.589 . . . . 0.0 109.877 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.892 ' HA ' HD23 ' A' ' 426' ' ' LEU . 57.3 t -66.84 -45.6 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 0.0 111.03 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 85.9 p -60.08 -41.51 92.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.142 -0.974 . . . . 0.0 111.577 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.88 -47.02 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.404 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -50.55 -32.56 18.89 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.61 -0.682 . . . . 0.0 112.0 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.18 71.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 0.0 109.278 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.08 -29.46 69.76 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -64.73 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.569 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.65 -51.12 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.503 -1.373 . . . . 0.0 111.346 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 50.1 Cg_endo -86.31 110.11 0.98 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 O-C-N 122.698 0.841 . . . . 0.0 110.03 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.568 ' HA ' HD11 ' A' ' 426' ' ' LEU . 2.8 m -91.19 99.78 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 111.089 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.825 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 7.4 tp -156.79 90.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.619 -0.676 . . . . 0.0 111.017 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -138.43 166.58 23.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.772 -0.58 . . . . 0.0 110.979 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.583 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.1 pp -122.17 125.36 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.631 -0.668 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.743 ' CG2' HG21 ' A' ' 423' ' ' VAL . 38.2 t -128.21 153.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.012 -1.055 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.9 t -132.92 139.09 47.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.21 -0.931 . . . . 0.0 111.735 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 415' ' ' ARG . . . -141.57 143.85 13.63 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLN . . . . . 0.438 ' HB2' ' NH2' ' A' ' 415' ' ' ARG . 27.1 mt-30 -143.29 55.25 1.36 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -1.066 . . . . 0.0 110.279 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 151.73 140.31 3.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.47 79.66 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.01 60.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.964 . . . . 0.0 112.014 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.35 89.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 110.883 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.79 -31.05 56.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.17 -40.39 86.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.699 -0.883 . . . . 0.0 111.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.572 ' O ' HG12 ' A' ' 449' ' ' VAL . 51.9 mtt-85 -64.14 -41.84 97.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 73.5 tt0 -72.65 -29.51 63.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -61.25 -46.13 91.66 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.394 -0.816 . . . . 0.0 110.463 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -62.78 -31.22 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.317 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -58.81 -34.19 71.22 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.93 -30.18 70.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.2 -0.938 . . . . 0.0 108.619 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.06 -37.07 83.58 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.84 ' CG2' HG21 ' A' ' 465' ' ' ILE . 37.0 t -60.59 -29.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.87 -39.43 87.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -23.97 66.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.654 -0.654 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -82.08 -21.75 36.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -67.48 -41.56 84.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.852 -0.53 . . . . 0.0 110.297 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -71.77 -34.44 69.44 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.089 -1.007 . . . . 0.0 110.374 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -77.71 6.99 6.31 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.464 -0.773 . . . . 0.0 111.702 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.85 24.12 72.81 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.558 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.7 ttm180 -124.53 129.17 50.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.609 -0.936 . . . . 0.0 110.835 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.594 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.1 mt-10 -92.54 161.41 14.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.671 ' CG2' HG13 ' A' ' 453' ' ' VAL . 17.2 m -145.31 157.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 486' ' ' LEU . 57.6 tt0 -103.13 124.68 49.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.795 -0.566 . . . . 0.0 109.726 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.84 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -129.09 132.17 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.048 . . . . 0.0 109.31 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.647 HG23 ' HD3' ' A' ' 471' ' ' ARG . 87.2 mt -125.11 121.4 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.062 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -79.75 163.0 24.82 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.69 -159.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.337 -0.852 . . . . 0.0 109.949 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.53 -16.08 0.33 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.643 -1.286 . . . . 0.0 111.021 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -72.16 -14.53 61.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.975 -1.078 . . . . 0.0 110.218 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.647 ' HD3' HG23 ' A' ' 466' ' ' ILE . 49.1 ttp180 -57.47 -30.92 65.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.161 -0.962 . . . . 0.0 110.877 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 85.1 p -55.46 -44.3 76.27 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.343 -0.848 . . . . 0.0 109.66 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -65.03 -37.99 89.41 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -36.46 77.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.715 -0.616 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -59.23 -38.1 79.15 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.195 -0.941 . . . . 0.0 109.938 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 97.8 mtp -60.22 -38.09 82.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.88 -146.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.497 -0.752 . . . . 0.0 109.772 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.58 78.51 0.08 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.036 -1.04 . . . . 0.0 111.853 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -117.75 10.26 13.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.427 ' CB ' ' HD3' ' A' ' 481' ' ' ARG . 30.1 mp0 -77.94 -4.48 47.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.971 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.688 ' C ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.4 17.63 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.224 -0.923 . . . . 0.0 113.278 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 481' ' ' ARG . 9.8 mp -125.44 4.86 7.64 Favored 'General case' 0 N--CA 1.508 2.438 0 CA-C-N 120.475 1.489 . . . . 0.0 112.279 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 10.3 m -74.55 35.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.385 -1.447 . . . . 0.0 112.512 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 109.08 9.78 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 120.669 -1.27 . . . . 0.0 110.088 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -87.82 11.7 14.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.135 -1.215 . . . . 0.0 110.385 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' A' ' 464' ' ' GLN . 3.9 mm? -53.37 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.959 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -174.65 -69.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.87 . . . . 0.0 109.118 174.247 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.0 t -103.35 10.5 37.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.0 111.496 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -79.82 66.89 3.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 499' ' ' PHE . 66.4 ttt180 -142.78 -69.64 0.34 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.456 ' HG3' ' HG2' ' A' ' 490' ' ' ARG . 74.9 mtt180 -116.1 -19.8 10.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.248 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.745 ' HG2' HD23 ' A' ' 493' ' ' LEU . 36.2 tt0 -63.1 -39.81 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 0.0 108.487 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.745 HD23 ' HG2' ' A' ' 492' ' ' GLN . 3.2 mt -92.51 -18.34 23.29 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.132 0.491 . . . . 0.0 110.966 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 52.5 tp -104.23 -46.84 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.417 -0.802 . . . . 0.0 112.548 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.47 -5.72 15.09 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.26 -0.9 . . . . 0.0 113.103 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 79.0 48.15 7.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 491' ' ' ARG . 96.1 mmm -111.68 -179.44 3.7 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 122.118 -0.637 . . . . 0.0 109.626 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.18 149.54 35.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 0.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 490' ' ' ARG . 28.2 m-85 -131.22 149.21 52.67 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.776 0.798 . . . . 0.0 111.723 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 500' ' ' THR . 2.6 t -56.07 107.29 0.84 Allowed Pre-proline 0 N--CA 1.496 1.831 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.947 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.62 114.74 4.1 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.54 1.284 . . . . 0.0 109.435 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -174.35 30.85 0.09 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.959 ' CB ' HD13 ' A' ' 487' ' ' ILE . 86.0 p -92.7 173.25 7.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 112.44 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.506 ' HB ' HG12 ' A' ' 463' ' ' VAL . 26.5 m -119.81 99.55 6.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.769 HG11 HD21 ' A' ' 522' ' ' LEU . 61.1 t -93.36 134.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.819 0.819 . . . . 0.0 112.071 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.754 HG22 ' HB3' ' A' ' 533' ' ' LEU . 18.5 pt -130.1 149.54 33.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.76 HG22 ' HG2' ' A' ' 509' ' ' GLN . 5.2 p -142.07 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.435 1.112 . . . . 0.0 110.785 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -83.91 108.94 17.21 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.76 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.6 mm-40 -133.9 114.97 13.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -73.76 -32.39 59.23 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.59 ' OE1' HD21 ' A' ' 513' ' ' LEU . 96.8 mt-10 -97.31 175.33 6.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.46 -7.76 13.42 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.81 -0.556 . . . . 0.0 111.027 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 514' ' ' SER . 4.3 pp -67.62 -37.95 83.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.212 -0.93 . . . . 0.0 111.254 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 513' ' ' LEU . 2.3 p -93.24 -14.77 26.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 0.0 111.199 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.918 ' O ' HD22 ' A' ' 519' ' ' LEU . 59.2 tp -70.08 -48.38 57.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.01 -1.056 . . . . 0.0 108.424 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.97 -42.44 89.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.001 -0.437 . . . . 0.0 111.667 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -57.9 -46.93 84.2 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.212 -0.93 . . . . 0.0 111.111 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 98.6 m -62.31 -45.94 90.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -55.3 -28.56 54.36 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.632 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 m -64.15 -28.24 69.63 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 39.3 tp -80.93 -34.03 33.61 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.523 -0.736 . . . . 0.0 109.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.769 HD21 HG11 ' A' ' 505' ' ' VAL . 4.3 mm? -58.01 -31.86 67.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.8 -63.89 0.86 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.951 -0.468 . . . . 0.0 111.62 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.5 52.04 Favored Glycine 0 N--CA 1.499 2.886 0 O-C-N 120.867 -1.146 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -63.09 -39.91 96.1 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.105 -1.232 . . . . 0.0 113.284 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.68 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -58.13 -26.2 62.37 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.083 -1.011 . . . . 0.0 112.128 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -54.89 -30.36 58.02 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -106.65 -128.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.389 -0.82 . . . . 0.0 110.439 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.412 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.7 OUTLIER -86.71 67.7 9.92 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.721 -1.237 . . . . 0.0 111.974 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 525' ' ' ALA . 2.8 t -133.86 163.83 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.66 -1.275 . . . . 0.0 110.253 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 2.9 mm-40 -163.81 165.0 23.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 33.1 t -109.95 105.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.427 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -103.75 115.07 29.81 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 507' ' ' VAL . 7.1 pt -136.0 164.97 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 117.854 -1.538 . . . . 0.0 113.912 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 436' ' ' VAL . 70.1 p -127.67 -168.3 1.87 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.97 169.08 25.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.435 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.85 17.18 2.31 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.784 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -155.27 33.55 0.65 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.563 HE22 HD13 ' A' ' 435' ' ' ILE . 57.0 tt0 -97.04 -0.29 47.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.683 -0.893 . . . . 0.0 111.66 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -51.36 -43.88 61.95 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 77.2 p -119.59 161.12 21.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 57.93 29.06 61.53 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -59.85 -45.58 91.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.291 -1.123 . . . . 0.0 110.615 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.81 -36.82 93.32 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 35.5 m -63.76 -35.72 81.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.033 -0.686 . . . . 0.0 110.788 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.601 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -58.86 -39.15 80.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.509 -0.744 . . . . 0.0 110.355 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.02 -40.19 94.84 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 48.3 ttp -63.96 -30.35 71.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.49 -53.97 31.9 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.457 ' HA ' HD23 ' A' ' 519' ' ' LEU . 12.4 ttp -57.76 -42.96 85.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -0.837 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.18 -31.68 67.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.476 -0.765 . . . . 0.0 111.669 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -68.43 -31.87 71.51 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.304 -0.873 . . . . 0.0 109.95 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.81 21.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.945 -0.472 . . . . 0.0 111.465 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 107.43 25.61 5.97 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.657 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.561 -0.964 . . . . 0.0 109.961 179.179 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.29 -41.32 98.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.115 -0.991 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 61.4 m -59.81 -43.68 94.37 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.57 -0.706 . . . . 0.0 110.206 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 69.4 t -65.76 -35.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.302 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -61.93 -46.4 89.49 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.289 -0.882 . . . . 0.0 110.59 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.19 80.14 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.696 0.76 . . . . 0.0 109.161 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -61.96 -39.39 91.98 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 400' ' ' MET . 68.3 m -61.15 -36.43 79.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.072 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -63.87 -44.48 92.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.085 -1.009 . . . . 0.0 111.46 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.84 -46.09 76.18 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.182 -0.949 . . . . 0.0 111.861 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 395' ' ' LEU . 78.6 mt -64.84 -42.74 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.812 . . . . 0.0 109.99 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 396' ' ' SER . 40.4 mmm -62.22 -31.76 72.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.874 -0.516 . . . . 0.0 109.65 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -58.53 -34.09 70.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.377 -0.827 . . . . 0.0 109.154 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.609 ' O ' HG12 ' A' ' 405' ' ' VAL . 95.6 mt-30 -90.57 -14.64 32.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.22 -39.27 89.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -116.85 18.8 14.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.945 -1.097 . . . . 0.0 110.555 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.693 HG11 ' CZ ' ' A' ' 415' ' ' ARG . 3.5 p -51.34 117.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.538 -0.726 . . . . 0.0 109.177 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 25.4 m -52.17 98.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.499 0.666 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 413' ' ' VAL . 8.4 p -109.42 133.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.755 -0.59 . . . . 0.0 109.906 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -92.19 140.28 24.43 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 111.185 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.91 -28.17 42.66 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.254 1.133 . . . . 0.0 110.22 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.9 -33.29 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.826 0.822 . . . . 0.0 109.861 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.17 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 118.53 5.24 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.746 . . . . 0.0 110.675 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.1 p -71.68 110.65 8.08 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.757 -0.589 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.03 139.18 29.46 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 O-C-N 123.066 1.035 . . . . 0.0 110.31 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.693 ' CZ ' HG11 ' A' ' 405' ' ' VAL . 23.7 ptt85 -168.85 60.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.672 -0.642 . . . . 0.0 110.738 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.7 t -65.48 -34.96 79.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -67.29 -7.05 21.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.689 -0.632 . . . . 0.0 110.953 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.75 -43.73 98.53 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.613 ' CB ' HG13 ' A' ' 436' ' ' VAL . 1.1 m-85 -91.64 -3.36 56.44 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.857 -1.378 . . . . 0.0 108.938 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 33.8 p -77.96 -39.04 43.8 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 425' ' ' VAL . 25.3 t70 -77.6 -43.55 31.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.471 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.16 -49.82 74.3 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.666 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 78.7 t -71.26 -41.42 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.922 -0.487 . . . . 0.0 111.861 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -58.92 -41.7 87.94 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.03 -1.044 . . . . 0.0 111.242 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 421' ' ' ASP . 84.4 t -64.47 -45.42 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -56.17 -35.71 67.52 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.54 -0.725 . . . . 0.0 111.993 -177.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.92 81.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.062 -1.024 . . . . 0.0 108.593 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.88 -30.59 71.6 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -63.68 -89.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.424 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.05 -60.66 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.449 -1.407 . . . . 0.0 109.565 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 45.5 Cg_endo -71.56 113.28 3.58 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 N-CA-C 108.242 -1.484 . . . . 0.0 108.242 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 15.2 m -108.96 117.28 33.79 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.897 0.856 . . . . 0.0 112.039 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.539 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -173.22 97.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.87 172.54 12.7 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.203 -0.935 . . . . 0.0 112.462 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 435' ' ' ILE . 0.2 OUTLIER -124.81 136.95 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.381 0.61 . . . . 0.0 109.703 178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 423' ' ' VAL . 60.4 t -141.58 152.9 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 109.629 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.1 p -139.81 149.81 43.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.868 . . . . 0.0 110.752 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.63 159.94 21.76 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -149.23 22.96 0.94 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.93 . . . . 0.0 110.835 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -162.5 -118.13 0.45 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.89 131.33 11.78 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -103.47 -15.02 16.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.293 -1.122 . . . . 0.0 111.291 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -71.55 -43.94 65.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.42 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.08 -28.76 71.22 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -63.84 -40.55 96.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.638 -0.919 . . . . 0.0 109.98 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 449' ' ' VAL . 83.3 mtt85 -64.31 -41.18 96.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.559 -0.713 . . . . 0.0 110.418 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 50.2 mt-10 -70.07 -29.28 66.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.087 -1.008 . . . . 0.0 110.222 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -62.92 -53.09 59.41 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.713 HG22 HD12 ' A' ' 506' ' ' ILE . 13.6 p -57.77 -30.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.051 -1.031 . . . . 0.0 108.626 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.11 -26.52 68.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.71 -35.33 80.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.866 -1.146 . . . . 0.0 108.292 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 455' ' ' MET . 96.0 mt -63.93 -31.38 72.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.495 -0.753 . . . . 0.0 109.009 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.944 HG13 ' CG2' ' A' ' 463' ' ' VAL . 58.1 t -58.48 -38.36 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.248 -0.908 . . . . 0.0 108.948 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 48.0 mtt -63.49 -35.82 81.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.495 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 452' ' ' LEU . 64.7 ttp -54.78 -26.24 33.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.366 -0.834 . . . . 0.0 109.587 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.51 -22.84 32.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.667 -0.646 . . . . 0.0 110.497 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -62.02 -46.09 90.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.373 -0.829 . . . . 0.0 108.989 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.0 -31.82 70.93 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.56 -0.84 21.8 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.41 32.03 82.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.527 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 22.8 ttt85 -130.79 122.15 26.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.969 . . . . 0.0 110.868 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 487' ' ' ILE . 95.6 mt-10 -71.71 162.78 28.93 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.944 ' CG2' HG13 ' A' ' 453' ' ' VAL . 28.4 m -138.45 168.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.999 -1.063 . . . . 0.0 111.588 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.753 ' HB2' HD11 ' A' ' 486' ' ' LEU . 59.1 tt0 -120.45 115.78 24.16 Favored 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.952 HD11 HD13 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -131.11 138.83 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.508 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.585 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.2 mt -130.91 125.39 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.716 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.4 164.76 25.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 509' ' ' GLN . . . -58.7 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.693 -0.629 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -46.55 -21.44 0.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.175 -0.953 . . . . 0.0 112.043 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -75.37 -7.62 54.51 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.406 -0.809 . . . . 0.0 112.397 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.579 ' CD ' HG23 ' A' ' 466' ' ' ILE . 77.6 ttt-85 -57.5 -25.53 59.94 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.784 -1.198 . . . . 0.0 110.904 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.1 p -59.14 -41.98 89.57 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -62.44 -41.16 98.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.79 69.66 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.87 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -58.31 -39.75 80.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.081 . . . . 0.0 109.171 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 69.1 mtm -60.92 -39.33 89.0 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.793 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -122.97 -140.7 0.32 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.354 -0.841 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 48.52 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.791 -1.193 . . . . 0.0 112.53 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -136.81 28.53 2.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.29 -0.881 . . . . 0.0 109.671 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -108.99 -9.24 15.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.609 ' HB2' HD23 ' A' ' 482' ' ' LEU . 3.0 mtt180 -133.3 -10.45 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 112.418 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.952 HD13 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -168.92 61.99 0.06 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.751 -1.218 . . . . 0.0 113.062 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 44.2 t -89.36 48.63 1.64 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.746 -1.221 . . . . 0.0 110.575 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 100.03 2.5 55.98 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.986 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -91.05 43.31 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.122 1.461 . . . . 0.0 110.273 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 464' ' ' GLN . 0.2 OUTLIER -58.73 -81.92 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.966 HG22 HG23 ' A' ' 488' ' ' THR . 0.2 OUTLIER -173.37 -73.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.092 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 70.5 p -103.31 25.47 9.52 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.82 94.81 0.53 Allowed Glycine 0 N--CA 1.496 2.639 0 O-C-N 121.549 -0.72 . . . . 0.0 111.835 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -144.35 -111.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 495' ' ' GLU . 28.4 mmt180 -103.2 -32.73 9.47 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.002 -1.061 . . . . 0.0 108.597 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -47.84 -22.45 0.56 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.04 -58.96 4.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.318 -0.864 . . . . 0.0 111.317 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.71 5.41 26.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.974 -1.079 . . . . 0.0 111.994 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 491' ' ' ARG . 59.0 mm-40 -84.66 -5.93 59.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.977 -1.077 . . . . 0.0 113.069 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 95.82 -11.95 67.65 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.715 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.44 -176.69 0.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.128 -1.219 . . . . 0.0 108.98 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.41 170.43 8.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.352 -0.842 . . . . 0.0 109.637 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -111.41 153.02 26.68 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.684 ' H ' HG21 ' A' ' 488' ' ' THR . 52.2 m -81.98 120.71 78.08 Favored Pre-proline 0 N--CA 1.484 1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 34.7 Cg_endo -61.84 138.91 77.05 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.407 1.214 . . . . 0.0 111.291 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 149.6 -7.38 0.81 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.683 ' OG ' HG21 ' A' ' 487' ' ' ILE . 48.7 m -85.25 160.25 19.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.302 . . . . 0.0 112.209 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.558 ' HB ' HG12 ' A' ' 463' ' ' VAL . 86.4 m -106.0 163.27 12.89 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.489 HG11 HD13 ' A' ' 522' ' ' LEU . 59.7 t -151.14 121.7 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.878 -1.139 . . . . 0.0 111.312 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.713 HD12 HG22 ' A' ' 449' ' ' VAL . 6.2 pt -136.2 112.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 1.016 HG12 HG22 ' A' ' 534' ' ' ILE . 7.8 p -114.48 104.33 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.6 1.191 . . . . 0.0 113.06 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.573 ' OD2' HG11 ' A' ' 449' ' ' VAL . 90.4 m-20 -83.98 124.96 31.59 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.614 ' CD ' HD13 ' A' ' 515' ' ' LEU . 1.2 pm0 -159.36 126.69 4.75 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.95 -41.86 6.97 Favored Glycine 0 N--CA 1.505 3.258 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -72.04 142.55 49.27 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.68 -12.78 20.71 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.095 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.99 -33.64 76.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 36.3 t -81.14 -23.36 38.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.847 -0.533 . . . . 0.0 111.314 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.636 HD21 ' HG2' ' A' ' 550' ' ' MET . 57.0 tp -65.85 -47.34 75.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.177 -0.952 . . . . 0.0 110.417 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.6 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 55.1 mtmt -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.673 -0.642 . . . . 0.0 111.586 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -58.81 -51.2 71.02 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.271 -0.893 . . . . 0.0 110.599 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 73.9 m -58.07 -41.07 82.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.766 HD12 HG21 ' A' ' 555' ' ' VAL . 0.3 OUTLIER -59.5 -38.09 80.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.041 -0.412 . . . . 0.0 111.853 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 47.0 p -64.71 -35.68 81.83 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.793 -1.192 . . . . 0.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.6 OUTLIER -70.35 -38.25 74.8 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.313 1.054 . . . . 0.0 108.19 177.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 530' ' ' VAL . 38.6 tp -62.98 -28.01 69.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.156 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -47.21 -63.12 1.12 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -51.4 58.76 Favored Glycine 0 N--CA 1.502 3.042 0 O-C-N 120.58 -1.325 . . . . 0.0 110.018 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -60.41 -30.22 69.47 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -1.036 . . . . 0.0 110.306 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -64.08 -20.61 66.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.757 -0.59 . . . . 0.0 112.315 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -37.76 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 2.6 m170 -147.69 -79.93 0.15 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 120.634 1.561 . . . . 0.0 114.304 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.438 ' HB2' ' N ' ' A' ' 502' ' ' GLY . 82.4 m-20 -86.26 60.59 6.32 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 522' ' ' LEU . 14.9 p -117.91 133.49 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.858 -1.151 . . . . 0.0 113.362 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.405 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 94.3 mt-30 -122.42 129.12 51.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 70.7 t -115.09 117.95 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.123 0.964 . . . . 0.0 112.049 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 423' ' ' VAL . 9.3 mp -114.33 118.43 33.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 1.016 HG22 HG12 ' A' ' 507' ' ' VAL . 9.3 pt -128.77 134.8 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 118.254 -1.378 . . . . 0.0 110.858 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.657 HG22 ' HB ' ' A' ' 436' ' ' VAL . 55.3 p -112.87 -163.46 0.85 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.41 165.24 36.27 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.646 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.501 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 6.6 p -130.17 22.17 5.27 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.876 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -168.47 35.22 0.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -95.81 -0.63 50.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' ARG . . . . . 0.915 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.6 ptt180 -47.53 -24.7 0.91 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.149 -0.969 . . . . 0.0 111.251 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.915 HG23 ' HG3' ' A' ' 540' ' ' ARG . 69.3 p -124.57 162.0 24.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 51.21 38.09 39.6 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -59.45 -45.39 91.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.665 -0.903 . . . . 0.0 110.508 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.88 -38.15 94.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 33.1 m -61.55 -32.65 72.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.745 -0.856 . . . . 0.0 109.629 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.49 -37.83 79.28 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.009 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.0 mp -62.51 -40.02 95.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.765 . . . . 0.0 109.305 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.14 -31.53 72.03 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.33 -54.2 28.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.935 -0.478 . . . . 0.0 109.828 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 519' ' ' LEU . 79.6 mmm -57.98 -43.25 86.44 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.475 -0.766 . . . . 0.0 109.619 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.18 -31.61 70.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.756 -0.59 . . . . 0.0 110.958 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.82 -25.29 67.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.145 -0.972 . . . . 0.0 109.532 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.6 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -73.94 0.44 13.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.484 -0.76 . . . . 0.0 111.723 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 109.31 -14.74 33.15 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.295 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 519' ' ' LEU . 41.2 t . . . . . 0 N--CA 1.5 2.059 0 CA-C-N 118.685 1.242 . . . . 0.0 110.13 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.479 0.657 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.57 -37.2 86.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.7 m -61.92 -41.72 98.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.473 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.681 HG11 ' HB3' ' A' ' 433' ' ' LEU . 60.5 t -70.29 -34.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.162 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.71 -42.77 89.41 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.876 -1.14 . . . . 0.0 109.815 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.49 73.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.305 -0.872 . . . . 0.0 108.737 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.8 OUTLIER -60.51 -41.55 94.61 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.45 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 40.0 t -64.88 -39.28 93.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.432 -0.793 . . . . 0.0 111.403 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.57 -43.86 92.56 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.301 -0.874 . . . . 0.0 112.461 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -75.66 -45.72 35.47 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.823 -1.173 . . . . 0.0 112.115 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.831 HG21 ' O ' ' A' ' 435' ' ' ILE . 97.7 mt -62.87 -42.27 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.88 . . . . 0.0 109.995 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 35.6 mtp -60.77 -31.84 71.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.665 -0.647 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.57 -22.5 66.93 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.3 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 72.5 tp60 -92.65 -20.63 20.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.097 . . . . 0.0 108.98 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.02 -30.95 70.3 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -114.99 19.25 15.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.211 -0.931 . . . . 0.0 109.857 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 405' ' ' VAL . 8.4 p -50.84 113.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 406' ' ' THR . 5.1 t -48.77 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.638 -0.664 . . . . 0.0 111.833 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.685 HG23 HG12 ' A' ' 413' ' ' VAL . 7.4 p -112.92 133.42 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.536 -0.728 . . . . 0.0 110.117 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -96.04 143.24 25.78 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.89 . . . . 0.0 110.044 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.85 -24.62 53.71 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.34 1.179 . . . . 0.0 110.385 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -61.28 -39.79 91.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 66.23 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 93.4 p -50.48 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.096 -1.003 . . . . 0.0 110.313 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 407' ' ' VAL . 9.3 p -63.33 110.33 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.923 -0.485 . . . . 0.0 110.616 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.5 136.35 12.35 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 O-C-N 122.939 0.968 . . . . 0.0 110.531 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -153.67 70.14 0.83 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.503 -0.748 . . . . 0.0 110.766 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 46.3 p -65.21 -39.03 92.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' A' ' 420' ' ' SER . . . -49.86 -25.2 2.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.682 -0.636 . . . . 0.0 111.383 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -50.77 -62.25 5.42 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.376 -0.827 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.532 ' CG ' HG13 ' A' ' 436' ' ' VAL . 20.0 p90 -88.22 -2.7 58.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.791 -1.417 . . . . 0.0 111.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 417' ' ' ALA . 51.6 p -72.19 -39.75 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 425' ' ' VAL . 36.7 t70 -76.86 -45.66 27.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.978 -0.451 . . . . 0.0 110.571 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.477 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.0 -48.9 79.69 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.439 -0.788 . . . . 0.0 111.099 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 436' ' ' VAL . 89.3 t -68.48 -46.19 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.1 p -64.18 -33.04 74.87 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.665 -1.272 . . . . 0.0 111.039 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 421' ' ' ASP . 52.4 t -65.65 -36.17 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.695 . . . . 0.0 111.506 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.891 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 1.6 pp -70.25 -33.89 72.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 111.586 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.56 78.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.909 -1.119 . . . . 0.0 109.647 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -65.54 -33.38 75.78 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -65.29 -95.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -169.85 -61.85 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.442 -1.411 . . . . 0.0 109.452 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.26 113.85 2.08 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 109.196 -1.117 . . . . 0.0 109.196 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.79 ' O ' HD22 ' A' ' 433' ' ' LEU . 17.3 t -96.55 103.31 15.21 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.718 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 432' ' ' SER . 0.2 OUTLIER -152.96 88.23 1.31 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.891 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -118.04 156.43 28.6 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.025 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.831 ' O ' HG21 ' A' ' 399' ' ' ILE 0.263 62.2 mt -122.61 127.3 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 423' ' ' VAL . 45.2 t -141.42 153.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.954 -1.091 . . . . 0.0 111.196 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.3 p -136.26 143.06 44.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.72 129.6 9.95 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.52 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.23 -23.69 10.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.886 -0.773 . . . . 0.0 109.841 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.14 160.28 33.56 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.43 46.47 94.29 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.37 77.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 111.029 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.63 92.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.294 -0.879 . . . . 0.0 111.157 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.85 72.15 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -59.82 -41.06 90.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -1.014 . . . . 0.0 110.277 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.563 ' CD ' ' HB1' ' A' ' 467' ' ' ALA . 54.4 mtm180 -67.48 -38.5 84.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.364 -0.835 . . . . 0.0 110.996 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 45.5 tt0 -71.64 -31.85 67.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.271 -0.893 . . . . 0.0 111.553 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.74 -53.61 44.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.067 -1.021 . . . . 0.0 110.41 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.647 ' CG2' HD12 ' A' ' 506' ' ' ILE . 11.7 p -55.24 -30.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.038 -1.039 . . . . 0.0 109.218 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.37 -27.95 68.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.15 -34.95 79.6 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.34 -36.07 79.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 95.2 t -58.28 -29.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 91.7 mtp -67.2 -39.68 86.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -55.39 -27.89 50.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.306 -0.871 . . . . 0.0 109.893 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.72 40.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.8 -43.34 88.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 109.514 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -68.59 -30.43 69.17 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.458 0.647 . . . . 0.0 109.841 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -73.68 -1.09 17.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.655 -0.653 . . . . 0.0 111.641 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 79.86 18.56 72.36 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 120.876 -1.14 . . . . 0.0 110.612 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.81 149.94 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.347 -1.09 . . . . 0.0 111.093 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -94.96 -178.51 4.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 7.3 m -148.0 170.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.926 -1.109 . . . . 0.0 110.805 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -119.35 128.37 54.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.719 HG21 ' CG2' ' A' ' 453' ' ' VAL . 11.2 pt -134.55 141.53 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.561 HG23 ' HD3' ' A' ' 471' ' ' ARG . 85.8 mt -132.7 124.71 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.595 -0.691 . . . . 0.0 109.719 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -79.84 165.9 22.25 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -60.54 -159.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -49.08 -20.86 0.61 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.61 -1.307 . . . . 0.0 111.334 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.39 -8.98 58.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.456 -0.777 . . . . 0.0 111.353 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.573 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 64.5 ttp85 -59.44 -23.11 62.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.909 -1.119 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 12.5 t -59.64 -44.13 93.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.391 -0.818 . . . . 0.0 109.527 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -60.89 -45.22 95.46 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.31 -36.0 72.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.637 -0.664 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -59.22 -40.31 85.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.157 -0.965 . . . . 0.0 111.331 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 7.5 ttm -61.59 -36.3 80.28 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.293 -0.879 . . . . 0.0 110.604 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 53.4 pttt -125.29 -146.84 0.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.797 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.438 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 87.9 mm-40 51.59 71.71 0.43 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.091 -1.006 . . . . 0.0 112.41 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -112.17 18.57 18.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.29 -10.56 40.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.429 -0.795 . . . . 0.0 111.289 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.657 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -142.8 -0.95 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.955 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.657 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.31 62.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.64 -1.288 . . . . 0.0 111.415 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 36.6 m -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.888 -1.133 . . . . 0.0 110.318 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 153.19 55.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.8 pt-20 -158.0 92.47 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.2 1.0 . . . . 0.0 110.757 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.564 ' C ' HD12 ' A' ' 487' ' ' ILE . 61.8 mt -99.16 -82.13 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.628 HD13 ' CB ' ' A' ' 503' ' ' SER . 3.1 mp -150.15 -69.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 499' ' ' PHE . 1.4 t -99.91 16.23 24.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.383 -0.823 . . . . 0.0 112.092 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.08 59.67 4.96 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 70.7 ttt180 -142.0 -54.83 0.45 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -1.142 . . . . 0.0 109.544 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 28.3 mmt180 -104.12 -36.23 7.77 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.778 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.453 ' HG3' ' HA ' ' A' ' 498' ' ' ALA . 10.1 mt-30 -61.46 -41.0 96.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 493' ' ' LEU . 1.2 mt -70.19 -42.08 72.88 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.521 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -105.89 -42.94 5.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.031 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.64 -10.63 24.73 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.921 -1.111 . . . . 0.0 113.083 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 88.3 -21.69 23.57 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 120.68 -1.262 . . . . 0.0 110.909 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.417 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 78.6 mtm -66.14 176.23 1.81 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.138 -1.213 . . . . 0.0 110.188 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 492' ' ' GLN . . . -112.27 152.03 28.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 111.056 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.1 OUTLIER -113.14 150.07 32.71 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 500' ' ' THR . 6.0 t -43.25 105.59 0.44 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.032 -0.418 . . . . 0.0 110.524 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.03 114.09 2.66 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.336 1.177 . . . . 0.0 111.572 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.66 34.91 0.18 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.628 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.1 p -93.61 167.62 11.56 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 112.827 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.438 ' HB ' HG12 ' A' ' 463' ' ' VAL . 41.2 m -119.52 159.58 24.05 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.657 HG21 ' CD1' ' A' ' 522' ' ' LEU . 73.7 t -143.57 130.78 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 118.527 -1.269 . . . . 0.0 113.026 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.647 HD12 ' CG2' ' A' ' 449' ' ' VAL . 4.7 pt -137.0 120.61 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 534' ' ' ILE . 11.5 p -119.32 99.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.691 -1.256 . . . . 0.0 111.547 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.541 ' OD1' HG23 ' A' ' 535' ' ' THR . 96.4 m-20 -83.08 98.42 9.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.763 ' CD ' HD23 ' A' ' 515' ' ' LEU . 1.7 pm0 -124.78 123.93 41.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.519 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -75.19 -53.93 5.91 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -69.61 -161.52 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.95 -10.6 2.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.947 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 517' ' ' GLU . 12.9 tp -65.4 -28.02 68.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -0.981 . . . . 0.0 108.596 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 3.6 m -83.84 -19.86 34.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.663 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.763 HD23 ' CD ' ' A' ' 509' ' ' GLN . 0.4 OUTLIER -65.8 -48.93 70.07 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.412 178.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.01 -39.87 65.66 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.0 111.824 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 513' ' ' LEU . 79.2 mm-40 -61.83 -47.22 86.07 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.586 -0.696 . . . . 0.0 111.572 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.503 HG21 ' HB ' ' A' ' 507' ' ' VAL . 97.7 m -60.96 -43.01 99.35 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.523 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -56.45 -35.65 68.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.873 -0.517 . . . . 0.0 110.717 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 97.6 m -64.35 -43.91 93.11 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 111.668 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.22 -42.01 93.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.265 -0.897 . . . . 0.0 108.944 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.657 ' CD1' HG21 ' A' ' 505' ' ' VAL . 1.8 tp -62.78 -28.47 70.01 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.531 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -46.5 -65.46 0.55 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.413 -0.804 . . . . 0.0 113.166 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -67.88 -49.4 48.74 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.129 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.12 67.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.679 -0.895 . . . . 0.0 111.332 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 522' ' ' LEU . . . -57.13 -24.19 52.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 112.619 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -41.94 -27.0 0.1 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.565 -0.709 . . . . 0.0 112.182 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -108.95 -118.99 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.208 -0.932 . . . . 0.0 112.584 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -89.23 90.25 8.27 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 120.355 -1.466 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.536 HG21 ' HB1' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -119.4 136.87 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 O-C-N 120.407 -1.433 . . . . 0.0 113.116 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 432' ' ' SER . 9.9 mp0 -126.36 133.58 51.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 40.6 t -114.99 121.66 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 122.971 1.367 . . . . 0.0 111.648 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 434' ' ' ALA . 0.8 OUTLIER -123.67 122.53 38.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 507' ' ' VAL . 9.6 pt -133.09 133.24 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.826 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.541 HG23 ' OD1' ' A' ' 508' ' ' ASP . 55.8 p -106.47 -164.32 0.99 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.79 168.73 26.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.519 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -135.38 13.71 3.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.418 178.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -152.22 27.6 0.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.509 HE22 HG22 ' A' ' 435' ' ' ILE . 10.4 tt0 -99.5 0.86 43.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -1.062 . . . . 0.0 112.272 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -59.62 -33.98 72.2 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.977 -1.077 . . . . 0.0 112.12 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 27.6 m -102.98 -58.06 1.94 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.072 -1.017 . . . . 0.0 110.819 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -100.34 94.43 1.32 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.8 t -95.31 -36.32 11.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -1.009 . . . . 0.0 110.48 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -60.26 -34.78 86.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.8 p -64.05 -34.3 77.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.942 . . . . 0.0 111.09 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.46 -37.29 83.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.425 -0.797 . . . . 0.0 109.887 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.81 -40.14 96.45 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.471 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.0 mmm -68.18 -27.52 66.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.401 -0.812 . . . . 0.0 110.319 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -59.46 -55.41 35.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.523 ' HG3' HD11 ' A' ' 519' ' ' LEU . 51.8 ttm -58.89 -48.63 80.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.478 -0.764 . . . . 0.0 110.394 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -59.48 -32.57 70.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.644 -0.66 . . . . 0.0 111.781 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -66.45 -25.07 66.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.259 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.48 -1.04 9.62 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.334 -0.854 . . . . 0.0 111.192 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 116.16 -15.22 15.84 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.897 -1.127 . . . . 0.0 111.162 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.503 2.217 0 CA-C-N 118.942 1.371 . . . . 0.0 109.713 -179.853 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.775 0.321 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.42 -42.08 98.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.193 -0.942 . . . . 0.0 109.396 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.4 m -64.89 -42.88 94.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.878 -0.514 . . . . 0.0 110.712 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 433' ' ' LEU . 99.9 t -66.45 -35.69 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.536 -0.728 . . . . 0.0 110.665 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -62.45 -45.29 93.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.277 -0.889 . . . . 0.0 109.802 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -71.56 -36.88 71.07 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.58 0.705 . . . . 0.0 110.149 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.587 ' C ' HD13 ' A' ' 395' ' ' LEU . 2.6 tm? -61.18 -38.75 87.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.964 -0.46 . . . . 0.0 110.016 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 400' ' ' MET . 42.7 t -63.72 -40.48 96.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.636 -0.665 . . . . 0.0 109.845 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.18 -42.75 99.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.543 -0.723 . . . . 0.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.79 -42.21 97.77 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.116 -0.99 . . . . 0.0 111.708 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 435' ' ' ILE . 58.9 mt -66.63 -41.21 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 0.0 110.431 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 435' ' ' ILE . 47.1 mmm -58.25 -33.91 69.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.52 -33.39 75.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.563 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -92.4 -3.83 54.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.936 -1.102 . . . . 0.0 109.778 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 9.2 m120 -89.15 -26.99 21.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.488 -0.757 . . . . 0.0 109.033 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 19.14 15.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 108.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.1 p -52.61 107.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.2 m -49.73 101.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.316 -0.865 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 405' ' ' VAL . 74.3 t -113.6 133.32 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.614 . . . . 0.0 110.113 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -92.04 140.17 24.6 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.593 -0.692 . . . . 0.0 109.871 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 -27.87 33.73 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.282 1.149 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -62.41 -29.91 70.83 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.364 -0.835 . . . . 0.0 110.0 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 59.11 0.68 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.3 t -60.03 122.28 13.94 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.934 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -74.54 120.61 82.33 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.723 -0.61 . . . . 0.0 110.378 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.474 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 47.5 Cg_endo -73.65 132.44 17.33 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 122.907 0.951 . . . . 0.0 110.008 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 414' ' ' PRO . 90.8 mtt180 -160.94 56.07 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.833 -0.542 . . . . 0.0 110.017 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 45.0 p -67.34 -34.38 77.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.73 -1.231 . . . . 0.0 108.417 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -71.12 -2.29 15.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.783 -0.573 . . . . 0.0 112.195 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.0 97.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 423' ' ' VAL . 33.6 p90 -98.15 -4.06 36.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 8.1 t -73.91 -42.07 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -71.79 -40.82 68.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.34 98.73 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.72 0.771 . . . . 0.0 110.257 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 533' ' ' LEU . 73.5 t -69.18 -42.17 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.637 -0.664 . . . . 0.0 111.641 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 90.6 p -58.84 -41.67 87.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 0.0 110.946 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.54 -43.39 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.337 -0.852 . . . . 0.0 110.899 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.8 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 0.4 OUTLIER -62.64 -35.12 78.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.193 -0.942 . . . . 0.0 111.669 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.72 77.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.734 -1.229 . . . . 0.0 109.217 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.64 -30.11 70.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.8 -88.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.96 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 120.487 -1.383 . . . . 0.0 109.999 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.44 ' HA ' ' HG2' ' A' ' 531' ' ' GLN . 45.6 Cg_endo -73.01 109.98 2.94 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 123.092 1.048 . . . . 0.0 109.724 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.583 ' CB ' HD12 ' A' ' 533' ' ' LEU . 3.4 m -83.81 98.66 9.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.35 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 10.8 tp -146.04 135.42 22.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -172.18 164.77 6.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 400' ' ' MET . 19.5 pt -133.51 118.45 30.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -126.6 150.87 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.995 -1.066 . . . . 0.0 109.863 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 9.2 p -131.73 139.95 49.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.815 -0.553 . . . . 0.0 109.723 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.48 160.9 20.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.84 -19.2 11.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.656 -0.908 . . . . 0.0 110.306 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -174.93 168.15 40.63 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 57.48 82.73 0.05 OUTLIER Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -93.32 -18.49 22.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.502 -0.999 . . . . 0.0 111.444 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.88 -44.74 84.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.973 . . . . 0.0 109.516 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.03 -28.58 70.2 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -61.22 -41.12 96.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.645 -0.914 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 57.9 mtm-85 -61.31 -42.05 98.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.92 . . . . 0.0 110.304 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -72.27 -28.76 63.33 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.387 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -62.21 -50.6 71.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.917 -1.115 . . . . 0.0 110.995 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 506' ' ' ILE . 7.6 p -62.16 -32.8 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.691 -1.255 . . . . 0.0 108.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.85 -27.53 69.4 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 454' ' ' MET . 80.4 tt0 -65.08 -33.57 76.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.43 -36.31 82.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 463' ' ' VAL . 99.1 t -60.93 -27.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 59.4 mtt -66.13 -38.94 89.4 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -22.95 65.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.719 0.771 . . . . 0.0 109.18 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.09 -24.97 30.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -69.49 -40.48 77.02 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.947 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.37 -31.59 71.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.272 -0.892 . . . . 0.0 109.422 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -81.56 10.13 6.43 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.69 36.28 93.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -138.44 123.25 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.451 -1.029 . . . . 0.0 111.819 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 46.7 mp0 -85.29 166.47 16.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.755 HG12 ' HB ' ' A' ' 504' ' ' THR . 34.0 m -138.14 157.8 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 111.99 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.794 ' HA ' HD22 ' A' ' 486' ' ' LEU . 47.0 tt0 -96.44 111.51 23.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.958 HD11 HD22 ' A' ' 482' ' ' LEU . 1.6 pp -127.23 131.9 70.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.845 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.661 ' HB ' HG23 ' A' ' 507' ' ' VAL . 3.5 mp -102.08 170.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -123.67 156.82 35.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.55 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.502 0.668 . . . . 0.0 109.964 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -54.43 -11.34 0.52 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.947 -1.096 . . . . 0.0 111.845 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -91.6 7.03 43.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.707 -1.246 . . . . 0.0 112.051 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 29.9 ttt85 -59.26 -34.45 72.27 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.856 -1.153 . . . . 0.0 111.526 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 3.7 t -57.21 -53.92 52.62 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.928 -1.108 . . . . 0.0 111.92 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 474' ' ' MET . 13.7 pt20 -66.43 -37.92 86.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.895 -1.128 . . . . 0.0 109.457 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 473' ' ' GLN . 26.8 ttt -58.68 -32.52 69.21 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.758 -0.589 . . . . 0.0 109.515 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -62.11 -37.8 86.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.766 -0.583 . . . . 0.0 109.673 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.58 -40.61 79.38 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.915 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.49 -152.71 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.588 -0.695 . . . . 0.0 109.147 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 50.34 81.33 0.06 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.863 -1.148 . . . . 0.0 111.623 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -122.03 27.47 8.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 110.09 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -113.42 -19.85 11.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.702 ' HB2' HD23 ' A' ' 482' ' ' LEU . 7.9 mtt180 -109.19 -14.44 14.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.693 -0.63 . . . . 0.0 111.795 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -171.87 62.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.081 -1.012 . . . . 0.0 111.33 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 51.4 p -90.72 48.59 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.832 -1.168 . . . . 0.0 110.169 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.84 26.03 43.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.99 54.01 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -1.06 . . . . 0.0 109.1 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.794 HD22 ' HA ' ' A' ' 464' ' ' GLN . 13.8 mt -79.21 -81.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.773 HG22 HG23 ' A' ' 488' ' ' THR . 0.0 OUTLIER 178.29 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.979 -1.076 . . . . 0.0 111.514 174.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.773 HG23 HG22 ' A' ' 487' ' ' ILE . 4.0 p -102.69 10.05 38.84 Favored 'General case' 0 C--N 1.3 -1.543 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.299 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.7 65.62 2.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.3 ttm180 -144.31 -68.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.94 -29.92 8.04 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.934 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 498' ' ' ALA . 1.2 mm-40 -62.01 -45.54 93.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.58 -0.7 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.01 -18.54 24.45 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.347 -0.846 . . . . 0.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -47.3 4.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.373 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -101.98 -8.32 21.61 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.78 -14.53 61.44 Favored Glycine 0 N--CA 1.503 3.131 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.588 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 63.1 mtt -67.97 -176.14 0.65 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.425 ' HA ' ' HG2' ' A' ' 492' ' ' GLN . . . -114.63 148.18 38.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.622 -0.674 . . . . 0.0 110.745 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.437 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.371 -0.831 . . . . 0.0 109.195 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 500' ' ' THR . 6.3 t -60.85 112.11 5.18 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.171 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 528' ' ' HIS . 43.2 Cg_endo -72.29 113.74 3.79 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.402 1.212 . . . . 0.0 109.501 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -162.33 19.74 0.17 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.723 ' CB ' HD13 ' A' ' 487' ' ' ILE . 24.2 p -93.9 175.34 6.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.254 -1.145 . . . . 0.0 111.096 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.755 ' HB ' HG12 ' A' ' 463' ' ' VAL . 54.1 m -116.73 127.72 54.65 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.849 ' CB ' HD21 ' A' ' 522' ' ' LEU . 69.1 t -113.64 129.87 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.371 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 465' ' ' ILE . 1.3 pp -126.4 164.11 27.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 534' ' ' ILE . 13.8 p -151.2 110.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.959 -1.088 . . . . 0.0 108.874 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 53.8 t0 -84.25 104.96 14.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.369 1.08 . . . . 0.0 108.138 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.477 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -98.73 174.57 6.34 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.498 1.142 . . . . 0.0 113.285 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.33 -56.31 0.05 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -75.09 -156.39 0.05 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -125.83 -19.17 4.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 110.461 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 513' ' ' LEU . 4.4 mm? -70.41 -31.07 68.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.368 -0.833 . . . . 0.0 110.679 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 57.7 p -67.77 -40.55 84.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.784 -0.572 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.4 tp -64.59 -45.94 84.79 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 111.143 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -67.62 -43.35 80.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.418 -0.801 . . . . 0.0 113.064 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 518' ' ' THR . 27.0 pt-20 -65.76 -41.81 91.63 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.765 -1.209 . . . . 0.0 110.362 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.736 HG22 HD12 ' A' ' 522' ' ' LEU . 98.0 m -62.88 -42.48 99.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.006 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.736 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -60.6 -39.42 88.05 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.691 -178.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 516' ' ' LYS . 81.3 p -65.27 -31.3 72.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.389 -0.819 . . . . 0.0 111.897 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.614 HD22 HE22 ' A' ' 464' ' ' GLN . 9.6 tt -81.9 -38.45 25.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.037 -1.04 . . . . 0.0 109.787 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.849 HD21 ' CB ' ' A' ' 505' ' ' VAL . 1.8 mt -64.11 -26.62 68.62 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.782 -0.574 . . . . 0.0 111.292 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -48.22 -51.21 26.39 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.275 -0.891 . . . . 0.0 111.586 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -71.41 -50.2 22.16 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -66.89 -38.43 86.25 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.473 -1.016 . . . . 0.0 113.001 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.9 -33.88 73.8 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.211 -0.931 . . . . 0.0 111.602 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -57.17 -28.82 63.13 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.962 -1.086 . . . . 0.0 108.11 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.461 ' CG ' ' HG3' ' A' ' 501' ' ' PRO . 80.0 m80 -93.99 -135.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.426 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 89.5 m-20 -89.77 69.69 7.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.725 -1.234 . . . . 0.0 112.893 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.69 ' CG1' HD23 ' A' ' 522' ' ' LEU . 2.5 t -141.77 168.24 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -159.54 162.75 35.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.842 -0.536 . . . . 0.0 110.843 -178.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 42.4 t -109.79 100.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.15 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 423' ' ' VAL . 0.5 OUTLIER -100.58 117.98 35.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.972 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -127.51 155.58 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.323 -176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.619 ' CB ' HG22 ' A' ' 436' ' ' VAL . 36.7 p -128.39 -178.11 4.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 61.8 m-20 -154.55 163.71 39.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.7 p -140.35 18.85 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.916 -0.49 . . . . 0.0 109.732 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.79 26.0 0.18 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.07 0.74 51.88 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.128 -1.219 . . . . 0.0 111.814 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -43.4 -42.04 4.48 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.224 -0.923 . . . . 0.0 111.366 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 65.5 p -106.19 163.48 12.77 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 50.11 36.79 28.98 Favored Glycine 0 N--CA 1.503 3.152 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -58.74 -43.66 90.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.52 -0.988 . . . . 0.0 111.107 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.6 -38.4 96.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 43.1 m -65.32 -33.02 74.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -1.0 . . . . 0.0 111.364 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.59 -37.5 87.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.731 . . . . 0.0 110.294 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.58 -42.66 99.17 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.501 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 8.4 tpp -61.85 -34.71 76.47 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -53.57 -52.1 60.86 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.174 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.736 ' CG ' HD11 ' A' ' 519' ' ' LEU . 40.1 ttp -57.32 -45.66 84.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.344 -0.848 . . . . 0.0 110.177 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.7 -31.28 72.4 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.429 -0.794 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.88 -13.02 62.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.471 -0.768 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -78.87 9.77 3.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.432 -0.792 . . . . 0.0 112.709 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 123.84 -14.75 7.99 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 -179.881 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.243 0.544 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 391' ' ' SER . 4.1 pp -64.35 -33.04 74.92 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.71 -0.619 . . . . 0.0 110.659 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' SER . . . . . 0.558 ' N ' HD12 ' A' ' 390' ' ' LEU . 50.9 m -60.79 -36.7 79.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.325 -0.859 . . . . 0.0 109.736 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.0 t -65.48 -33.82 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.287 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.52 -48.24 79.82 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.241 -0.912 . . . . 0.0 110.914 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.13 77.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -0.791 . . . . 0.0 109.435 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 422' ' ' ALA . 0.9 OUTLIER -62.17 -39.66 93.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.951 -0.468 . . . . 0.0 111.504 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 55.8 p -65.71 -37.52 86.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -0.912 . . . . 0.0 110.325 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -65.07 -44.85 87.59 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.537 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.69 -43.3 80.44 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.131 -0.981 . . . . 0.0 111.331 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 436' ' ' VAL . 96.7 mt -61.45 -42.28 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.629 ' CG ' HD11 ' A' ' 435' ' ' ILE . 19.5 mtp -62.67 -29.1 70.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.952 -0.467 . . . . 0.0 109.981 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -61.2 -29.67 69.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.85 -1.156 . . . . 0.0 109.541 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 99.3 mm-40 -89.33 -16.97 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 109.231 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 400' ' ' MET . 37.7 t30 -66.4 -38.54 87.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.526 -0.733 . . . . 0.0 110.799 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -116.32 19.0 15.05 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 405' ' ' VAL . 10.8 p -48.15 117.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.65 -0.657 . . . . 0.0 111.019 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.8 p -52.35 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.646 HG23 HG12 ' A' ' 413' ' ' VAL . 11.0 p -109.86 133.06 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.598 0.713 . . . . 0.0 110.663 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -90.8 135.1 29.3 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.33 -30.38 45.07 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.098 1.052 . . . . 0.0 110.542 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -59.65 -28.33 67.16 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.811 0.815 . . . . 0.0 109.822 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 56.2 0.76 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.9 m -54.17 117.78 3.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.67 0.748 . . . . 0.0 111.379 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.646 HG12 HG23 ' A' ' 407' ' ' VAL . 7.7 p -67.87 111.51 7.9 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.563 . . . . 0.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.31 138.13 24.39 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 122.999 1.0 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -161.25 70.68 0.37 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.829 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 57.9 p -67.75 -38.06 82.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.837 -1.165 . . . . 0.0 107.895 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 420' ' ' SER . . . -56.63 -23.95 44.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.871 -0.518 . . . . 0.0 111.177 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -47.99 -58.18 7.22 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -87.41 -1.99 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.967 -1.314 . . . . 0.0 110.847 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 10.9 t -71.03 -42.9 68.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.909 -1.12 . . . . 0.0 108.502 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -75.69 -44.63 41.19 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.811 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.78 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.71 -48.02 73.41 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.833 ' CG2' HG21 ' A' ' 436' ' ' VAL . 57.9 t -68.27 -44.41 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.334 -0.854 . . . . 0.0 111.45 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.6 m -61.73 -38.14 86.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 111.229 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.4 p -65.03 -29.5 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 112.754 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.773 ' HB3' HD13 ' A' ' 395' ' ' LEU . 2.2 pp -76.98 -32.2 57.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.398 -1.439 . . . . 0.0 110.575 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.39 84.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 108.837 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -59.27 -36.22 75.14 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -64.73 -88.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 4.6 tpp180 -175.13 -60.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.726 -1.233 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 430' ' ' ARG . 39.0 Cg_endo -64.39 102.76 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 122.886 0.94 . . . . 0.0 111.397 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.784 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.1 OUTLIER -82.51 99.99 9.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.872 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 11.0 tp -163.7 93.04 0.72 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.26 -0.9 . . . . 0.0 111.195 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.472 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -150.04 162.36 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.011 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 435' ' ' ILE . 2.5 pp -113.96 128.55 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.094 0.473 . . . . 0.0 109.897 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.833 HG21 ' CG2' ' A' ' 423' ' ' VAL . 78.3 t -132.18 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -0.877 . . . . 0.0 108.935 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 42.8 t -130.46 138.63 50.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.023 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -95.94 135.99 12.61 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.679 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -107.71 -14.27 14.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.959 -0.73 . . . . 0.0 110.255 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.57 170.6 42.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.19 44.94 97.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.92 89.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.332 -1.099 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.39 -44.7 93.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.627 -0.671 . . . . 0.0 110.55 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.87 -28.66 64.42 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.4 -41.88 98.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.909 . . . . 0.0 109.607 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.662 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.5 mtm180 -61.77 -45.01 95.75 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.375 -0.828 . . . . 0.0 110.047 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -63.45 -29.65 70.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.661 . . . . 0.0 109.42 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 53.1 ttt85 -67.52 -50.54 58.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.578 -0.701 . . . . 0.0 111.388 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.3 p -55.21 -31.74 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.528 -1.357 . . . . 0.0 110.423 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 481' ' ' ARG . . . -64.36 -26.83 68.64 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 82.0 tt0 -60.19 -35.13 74.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.94 -37.68 88.01 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.961 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.4 t -63.05 -27.06 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.013 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.6 mtp -66.28 -39.73 89.6 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.189 -0.944 . . . . 0.0 108.642 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.1 ttp -58.88 -25.8 63.67 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.64 -0.663 . . . . 0.0 109.442 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 463' ' ' VAL . . . -82.63 -22.43 34.71 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.581 -0.7 . . . . 0.0 110.405 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.88 -47.57 71.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.76 -28.47 65.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -79.5 5.2 13.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.58 -0.7 . . . . 0.0 110.756 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.45 34.45 89.97 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -130.75 127.14 38.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -1.01 . . . . 0.0 110.292 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.413 ' C ' HG13 ' A' ' 463' ' ' VAL . 30.8 tt0 -81.53 159.28 24.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.961 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.9 m -144.87 151.81 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.502 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.835 ' HG3' HD13 ' A' ' 486' ' ' LEU . 57.9 tt0 -102.98 123.33 46.39 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.543 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.772 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -141.7 146.25 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 120.825 -1.172 . . . . 0.0 108.732 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.785 HG23 ' HD3' ' A' ' 471' ' ' ARG . 83.6 mt -134.01 129.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -78.22 168.58 19.63 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.26 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.505 -0.747 . . . . 0.0 109.786 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -48.56 -22.74 0.8 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.915 -1.115 . . . . 0.0 111.903 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -73.23 -6.3 45.0 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.332 -0.855 . . . . 0.0 112.206 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 466' ' ' ILE . 34.7 ttt85 -60.16 -24.73 64.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.803 -1.186 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -61.45 -46.37 90.35 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.216 -0.928 . . . . 0.0 110.612 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -65.21 -41.3 94.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 53.2 ttm -60.39 -32.47 71.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.027 -0.421 . . . . 0.0 110.453 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -61.36 -37.69 84.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 80.5 mmm -59.76 -35.9 75.55 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.951 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 59.4 pttt -134.93 -141.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 109.801 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.501 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 89.3 mm-40 47.06 90.46 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.969 -1.082 . . . . 0.0 113.034 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -94.55 -23.46 17.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.475 ' O ' HD22 ' A' ' 482' ' ' LEU . 98.0 mt-10 -70.44 -29.53 66.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.514 -0.741 . . . . 0.0 109.059 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.64 ' HA ' ' HB1' ' A' ' 450' ' ' ALA . 9.1 mpt_? -83.52 8.48 13.91 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.997 -0.44 . . . . 0.0 111.294 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.688 ' N ' HD22 ' A' ' 482' ' ' LEU . 3.2 mm? 53.87 28.26 8.22 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.986 -1.071 . . . . 0.0 110.802 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.28 50.24 0.06 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.493 -0.755 . . . . 0.0 112.417 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 159.61 42.04 0.02 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -179.62 89.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.597 -0.943 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 464' ' ' GLN . 47.1 mt -99.09 -81.28 0.45 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 503' ' ' SER . 1.1 mp -158.98 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.487 -0.758 . . . . 0.0 109.448 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 499' ' ' PHE . 1.8 p -102.86 14.31 32.26 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.496 -0.752 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -79.55 56.92 4.48 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -143.06 -61.75 0.42 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.224 -1.162 . . . . 0.0 109.245 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -109.35 -31.29 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.298 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.08 -38.1 89.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 521' ' ' LEU . 5.4 mt -91.16 -26.82 18.89 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 111.358 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.0 OUTLIER -105.72 -44.36 4.67 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -102.4 -8.33 21.23 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.863 -1.148 . . . . 0.0 113.518 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.81 -21.49 33.11 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.732 -1.23 . . . . 0.0 111.276 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 38.0 mtm -64.09 -178.6 0.35 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -1.186 . . . . 0.0 109.348 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.04 154.16 28.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 111.347 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.434 ' HB2' ' HB ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -115.82 148.98 39.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.937 -0.477 . . . . 0.0 109.864 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 79.1 m -44.06 101.52 0.26 Allowed Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 122.089 -0.382 . . . . 0.0 110.759 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 43.4 Cg_endo -68.34 113.75 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.681 1.358 . . . . 0.0 109.239 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . 174.98 38.06 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.932 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.6 p -90.83 174.55 7.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.882 -0.776 . . . . 0.0 111.79 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 463' ' ' VAL . 13.6 m -112.74 94.36 4.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 522' ' ' LEU . 59.4 t -85.64 131.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.225 1.012 . . . . 0.0 112.656 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.829 HG23 HD22 ' A' ' 533' ' ' LEU 0.294 65.3 mt -137.77 96.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 534' ' ' ILE . 3.9 p -104.19 107.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.978 1.371 . . . . 0.0 113.574 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.44 107.58 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.0 -1.062 . . . . 0.0 109.413 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.437 HE22 HG22 ' A' ' 466' ' ' ILE . 78.2 mm-40 -126.96 116.46 20.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -72.83 -40.61 52.06 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 175.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 509' ' ' GLN . 93.0 mt-10 -86.71 147.22 25.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.11 -12.07 22.19 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.629 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.96 -38.81 92.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 109.526 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 72.1 p -86.82 -16.61 35.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.615 -0.678 . . . . 0.0 111.109 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 60.1 tp -72.06 -47.69 49.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.165 -0.959 . . . . 0.0 109.905 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.807 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 31.3 ttpt -69.85 -46.02 66.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.679 -0.638 . . . . 0.0 112.692 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.67 -41.59 98.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.965 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.578 HG21 HD12 ' A' ' 466' ' ' ILE . 29.9 m -56.86 -44.74 82.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.483 -0.76 . . . . 0.0 111.194 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 515' ' ' LEU . 43.3 mt -60.77 -28.22 68.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.7 m -61.1 -41.17 96.18 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.327 -0.858 . . . . 0.0 109.472 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 493' ' ' LEU . 50.7 tp -65.49 -41.09 93.64 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.846 ' CD1' HG11 ' A' ' 505' ' ' VAL . 1.4 tt -64.17 -22.95 67.13 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.845 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -48.06 -64.19 0.86 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.376 -0.828 . . . . 0.0 113.205 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.69 -50.54 60.84 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.771 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -62.35 -36.38 82.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.966 . . . . 0.0 111.77 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -64.99 -25.23 67.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.447 -0.783 . . . . 0.0 112.72 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -40.88 -27.82 0.06 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -107.28 -108.73 0.31 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.109 -0.994 . . . . 0.0 113.065 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.511 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.1 OUTLIER -89.51 81.47 6.53 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.553 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 531' ' ' GLN . 5.9 t -143.87 165.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.843 -1.161 . . . . 0.0 111.729 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 12.8 mm-40 -157.52 161.83 38.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 55.3 t -114.96 107.17 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.354 -0.841 . . . . 0.0 111.511 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.829 HD22 HG23 ' A' ' 506' ' ' ILE . 5.5 tt -105.49 119.22 38.55 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 507' ' ' VAL . 4.1 pt -139.94 153.08 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.296 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.509 HG22 ' HB ' ' A' ' 436' ' ' VAL . 26.6 p -143.11 114.62 8.01 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.95 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -77.08 175.56 9.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.681 1.229 . . . . 0.0 111.83 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.541 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.3 m -129.98 -10.3 4.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.105 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -122.67 34.78 3.65 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -98.29 0.84 46.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.862 -0.787 . . . . 0.0 111.999 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 541' ' ' THR . 38.4 ptt180 -49.36 -31.22 8.97 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.096 -1.003 . . . . 0.0 110.216 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 540' ' ' ARG . 46.1 p -129.78 166.54 19.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.5 34.66 55.38 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -61.7 -45.8 92.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.496 -1.002 . . . . 0.0 111.802 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.23 -34.69 90.65 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 48.0 m -64.08 -37.86 88.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.71 -0.876 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.26 -37.25 72.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 110.023 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.9 mp -63.14 -39.94 96.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.658 -0.652 . . . . 0.0 110.102 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.68 -29.11 70.41 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.487 -0.758 . . . . 0.0 109.203 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -56.29 -52.6 63.9 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 555' ' ' VAL . 56.0 ttm -55.61 -46.65 77.31 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.277 -0.889 . . . . 0.0 109.521 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 551' ' ' LYS . . . . . 0.705 ' HA ' HG23 ' A' ' 555' ' ' VAL . 97.5 mttt -57.6 -32.0 66.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.824 -0.548 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -68.46 -25.51 65.03 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.4 -0.813 . . . . 0.0 111.403 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.807 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -70.37 0.85 5.75 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.083 -1.011 . . . . 0.0 112.787 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.39 -15.25 9.28 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 120.787 -1.196 . . . . 0.0 110.832 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.705 HG23 ' HA ' ' A' ' 551' ' ' LYS . 34.2 m . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.304 -1.115 . . . . 0.0 110.034 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.638 0.256 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.51 -42.56 99.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.235 -0.916 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.3 m -60.99 -42.12 97.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.715 -0.616 . . . . 0.0 110.082 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.23 -35.27 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.691 -0.631 . . . . 0.0 111.032 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -63.27 -47.1 83.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.043 0.925 . . . . 0.0 109.448 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.5 tt -61.96 -38.86 90.1 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.719 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.8 m -68.32 -36.15 78.87 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -63.07 -45.28 92.91 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.261 -0.899 . . . . 0.0 111.129 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.13 -40.87 86.86 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.116 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 419' ' ' TYR . 96.5 mt -62.75 -42.58 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 0.9 OUTLIER -61.04 -31.57 71.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.77 -30.87 71.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.966 -1.084 . . . . 0.0 109.827 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 61.0 tp60 -89.39 -16.31 31.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 109.205 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 400' ' ' MET . 17.0 t30 -66.11 -34.31 77.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.571 -0.706 . . . . 0.0 109.672 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -114.09 17.9 17.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 109.518 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.731 HG13 HG23 ' A' ' 407' ' ' VAL . 8.3 p -40.43 148.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.559 0.695 . . . . 0.0 112.243 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.4 m -85.63 77.18 9.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.731 HG23 HG13 ' A' ' 405' ' ' VAL . 82.5 t -94.51 129.74 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 111.064 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -98.92 144.93 29.09 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.6 -19.09 42.56 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.199 1.105 . . . . 0.0 111.488 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.61 -33.22 71.21 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -158.09 64.03 0.45 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.5 m -61.3 131.28 49.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 110.979 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' A' ' 414' ' ' PRO . 7.8 p -78.68 148.66 73.33 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.468 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.5 Cg_endo -60.18 138.82 83.89 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.834 0.912 . . . . 0.0 110.622 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -101.05 -5.02 26.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 420' ' ' SER . 17.5 p -97.83 17.97 16.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.777 -1.202 . . . . 0.0 108.943 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.28 -32.56 7.73 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -69.47 -40.01 79.37 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.74 ' HD1' HG23 ' A' ' 399' ' ' ILE . 4.9 m-85 -98.93 -10.95 22.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.74 -1.447 . . . . 0.0 111.215 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 416' ' ' THR . 58.2 p -74.17 -38.13 63.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.746 -1.221 . . . . 0.0 107.841 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 425' ' ' VAL . 99.0 m-20 -75.17 -48.35 24.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.35 -48.31 73.41 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.527 -0.733 . . . . 0.0 111.727 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.932 ' HA ' HD23 ' A' ' 426' ' ' LEU . 58.0 t -66.94 -43.82 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.576 -0.703 . . . . 0.0 112.423 -177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -61.59 -42.19 98.51 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.856 -1.152 . . . . 0.0 111.147 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 421' ' ' ASP . 77.7 t -61.7 -28.65 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.3 -0.875 . . . . 0.0 110.667 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -72.89 -32.12 65.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.446 -0.784 . . . . 0.0 111.558 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.35 76.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.904 -1.123 . . . . 0.0 109.389 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -61.93 -30.14 70.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.51 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.405 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 3.4 tpp85 -172.19 -61.21 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.694 -1.254 . . . . 0.0 109.256 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 531' ' ' GLN . 44.3 Cg_endo -71.35 110.91 2.97 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 O-C-N 123.086 1.045 . . . . 0.0 110.637 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 426' ' ' LEU . 6.7 t -88.46 98.06 11.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.69 -0.631 . . . . 0.0 110.45 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.839 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 19.7 tp -164.31 97.07 0.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.663 -1.273 . . . . 0.0 112.34 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -141.34 175.63 9.5 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.104 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.475 ' O ' HG21 ' A' ' 399' ' ' ILE . 46.4 pt -118.83 130.59 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.325 0.583 . . . . 0.0 110.4 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.723 ' CG2' HG21 ' A' ' 423' ' ' VAL . 58.2 t -127.88 136.02 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.921 -1.112 . . . . 0.0 109.611 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 73.9 m -121.56 125.69 47.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.345 -0.847 . . . . 0.0 110.996 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -103.2 -176.71 26.46 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -129.41 -41.17 1.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.616 -0.932 . . . . 0.0 109.838 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -159.88 167.0 35.23 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.7 64.06 2.97 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.77 ' HB1' HH22 ' A' ' 446' ' ' ARG . . . -80.6 -21.26 41.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.59 -0.947 . . . . 0.0 110.362 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.22 97.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.462 -0.774 . . . . 0.0 111.171 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -66.1 -31.06 78.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.77 -30.41 71.41 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.603 -0.939 . . . . 0.0 109.807 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.77 HH22 ' HB1' ' A' ' 442' ' ' ALA . 2.8 mmt85 -63.97 -43.45 95.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.59 -0.694 . . . . 0.0 109.976 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.74 -33.85 64.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.335 -0.853 . . . . 0.0 110.783 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.24 -53.59 52.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.362 -0.836 . . . . 0.0 111.511 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.611 HG22 ' CD1' ' A' ' 506' ' ' ILE . 12.7 p -58.61 -33.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.757 -1.214 . . . . 0.0 108.883 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.62 68.07 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.42 -37.99 82.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.064 -1.022 . . . . 0.0 108.61 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 455' ' ' MET . 79.2 mt -63.12 -36.72 84.54 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.896 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.5 t -60.66 -27.44 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -0.825 . . . . 0.0 109.586 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 94.4 mtp -67.73 -40.95 84.17 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' MET . . . . . 0.417 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.1 OUTLIER -62.41 -20.74 64.79 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.235 -0.916 . . . . 0.0 109.93 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.23 -23.06 32.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.614 -0.679 . . . . 0.0 109.562 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -68.56 -40.19 80.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.676 . . . . 0.0 109.563 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.45 -32.21 68.06 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.408 -0.807 . . . . 0.0 109.661 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.68 3.1 12.38 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.753 -0.592 . . . . 0.0 111.725 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.44 71.8 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.424 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 61.1 ttm-85 -125.37 122.42 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 98.1 mt-10 -84.85 168.18 15.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.896 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.4 m -143.62 149.08 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 111.22 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.916 ' HA ' HD22 ' A' ' 486' ' ' LEU . 4.1 pt20 -99.08 121.66 41.28 Favored 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.729 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -123.5 129.72 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.733 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.4 mp -117.76 112.99 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -65.23 -179.44 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.813 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.514 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -61.94 -161.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.16 -14.59 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.732 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.72 -3.07 45.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.122 -0.986 . . . . 0.0 111.967 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 74.6 ttt-85 -57.04 -31.13 64.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.886 -1.133 . . . . 0.0 111.21 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.6 t -60.01 -44.44 94.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.855 . . . . 0.0 109.857 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.21 -36.01 82.86 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.1 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.864 -0.523 . . . . 0.0 109.936 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -61.47 -37.57 84.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.534 -0.729 . . . . 0.0 109.605 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 65.5 ttp -58.55 -38.11 77.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.919 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.4 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.9 pttt -124.89 -152.42 0.51 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.2 mm-40 48.3 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.909 -1.12 . . . . 0.0 111.824 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -127.65 11.47 6.75 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.562 -0.712 . . . . 0.0 110.665 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -98.24 -14.51 20.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.546 -0.721 . . . . 0.0 110.267 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -108.67 -13.96 14.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.557 -0.715 . . . . 0.0 111.84 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.451 HD22 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -175.7 56.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.953 -1.092 . . . . 0.0 110.932 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 93.2 p -60.17 -23.67 64.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.017 -1.052 . . . . 0.0 110.181 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 151.22 55.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -132.4 48.87 2.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.821 -0.811 . . . . 0.0 110.407 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.916 HD22 ' HA ' ' A' ' 464' ' ' GLN . 19.0 mt -73.61 -80.56 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.664 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER -178.96 -44.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.796 -1.19 . . . . 0.0 110.246 174.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 487' ' ' ILE . 5.0 p -102.63 8.75 39.63 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.851 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.416 ' HA2' HD12 ' A' ' 493' ' ' LEU . . . -85.85 60.09 4.68 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 66.3 ttt180 -145.77 -45.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.906 -0.761 . . . . 0.0 109.542 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 36.7 mtt85 -120.86 -46.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.429 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 498' ' ' ALA . 32.4 mt-30 -61.61 -50.32 73.04 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.092 -1.005 . . . . 0.0 111.452 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.416 HD12 ' HA2' ' A' ' 489' ' ' GLY . 7.3 mt -71.08 -37.53 72.45 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.97 -0.457 . . . . 0.0 111.603 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -104.76 -38.07 6.82 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.13 -8.18 15.19 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.773 -1.205 . . . . 0.0 114.132 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 91.54 -21.34 36.1 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 120.766 -1.209 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 52.1 mmm -67.12 178.73 1.35 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.133 -1.216 . . . . 0.0 109.851 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 492' ' ' GLN . . . -114.31 148.83 36.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 112.23 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.477 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -115.95 148.92 39.55 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.559 0.695 . . . . 0.0 110.301 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 19.1 m -52.45 107.57 0.87 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.869 -0.52 . . . . 0.0 110.117 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 41.1 Cg_endo -70.74 114.41 3.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.437 1.23 . . . . 0.0 109.556 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -171.95 27.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.743 ' O ' HG22 ' A' ' 530' ' ' VAL . 60.2 p -94.3 177.97 5.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.634 -0.921 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.805 ' HB ' HG12 ' A' ' 463' ' ' VAL . 51.5 m -125.53 125.39 43.16 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 522' ' ' LEU . 8.5 p -109.32 131.01 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.949 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.611 ' CD1' HG22 ' A' ' 449' ' ' VAL . 2.4 pt -126.0 112.32 29.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.733 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.3 p -112.68 115.5 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 111.851 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 2.0 t70 -83.12 105.63 14.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 21.8 tm0? -94.12 174.12 7.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.7 0.762 . . . . 0.0 111.199 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.46 -74.66 0.04 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 105.364 -3.094 . . . . 0.0 105.364 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -54.49 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 5.3 mttt 179.07 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.625 0 O-C-N 120.695 -1.253 . . . . 0.0 110.57 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 513' ' ' LEU . 29.6 mt -70.0 -20.89 63.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.641 -0.662 . . . . 0.0 110.493 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 17.9 m -64.43 -42.12 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.358 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 7.6 tp -65.5 -44.17 87.88 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.23 0.538 . . . . 0.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.71 -43.89 83.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.457 -0.777 . . . . 0.0 112.348 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.85 -51.21 69.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.05 -1.031 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.65 ' CG2' HD13 ' A' ' 466' ' ' ILE . 30.6 m -59.1 -41.5 88.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.726 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.55 -39.23 79.63 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.924 -0.485 . . . . 0.0 110.848 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.1 m -61.02 -37.14 81.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 0.0 110.167 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.426 HD23 ' OE1' ' A' ' 464' ' ' GLN . 61.2 tp -67.09 -40.43 86.94 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 505' ' ' VAL . 0.3 OUTLIER -64.66 -21.95 66.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.754 -0.591 . . . . 0.0 111.641 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -45.74 -62.66 1.21 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.592 -0.692 . . . . 0.0 111.951 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -84.68 -48.17 5.08 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.984 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -69.77 -41.94 74.49 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 522' ' ' LEU . . . -65.0 -25.69 67.97 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.786 -1.196 . . . . 0.0 112.325 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -42.46 -28.13 0.2 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.411 -0.806 . . . . 0.0 112.182 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.23 -137.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 111.177 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.416 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 84.5 m-20 -72.43 73.97 1.02 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.9 -1.125 . . . . 0.0 112.129 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 503' ' ' SER . 41.2 t -137.73 164.52 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.42 -0.8 . . . . 0.0 110.668 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 432' ' ' SER . 1.5 mm-40 -160.59 162.21 32.77 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.839 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 8.5 t -114.65 111.62 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 120.947 -1.096 . . . . 0.0 113.794 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.2 tp -102.2 114.86 29.38 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.657 HG22 ' CG1' ' A' ' 507' ' ' VAL . 7.9 pt -133.33 161.46 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 C-N-CA 118.677 -1.209 . . . . 0.0 112.596 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.594 HG22 ' HB ' ' A' ' 436' ' ' VAL . 68.9 p -131.16 -171.56 2.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 24.0 t70 -151.12 157.58 42.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.83 20.87 2.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.387 -0.821 . . . . 0.0 110.794 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -153.75 -42.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -78.79 0.32 27.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.503 -0.998 . . . . 0.0 111.229 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' ARG . . . . . 0.448 ' HG3' HG23 ' A' ' 541' ' ' THR . 33.6 ptt-85 -38.1 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 540' ' ' ARG . 4.0 p -102.36 -25.14 13.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.962 -1.086 . . . . 0.0 110.623 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -127.51 55.57 0.75 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 8.9 t -75.17 -15.64 60.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.783 -0.833 . . . . 0.0 111.542 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.09 93.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 87.8 p -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -1.044 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.43 -36.46 76.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 109.628 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 543' ' ' THR . 10.4 mp -61.71 -43.21 99.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.405 -0.809 . . . . 0.0 109.163 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.7 ttp -63.34 -35.14 79.39 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.0 -50.64 60.94 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.726 ' HG3' HD11 ' A' ' 519' ' ' LEU . 28.2 ttt -57.97 -46.1 85.67 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -60.9 -31.45 70.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.414 -0.804 . . . . 0.0 111.052 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.83 -20.86 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.389 -0.82 . . . . 0.0 110.071 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.82 3.3 6.8 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.426 -0.796 . . . . 0.0 112.64 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.63 -13.26 8.75 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.419 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.269 . . . . 0.0 109.911 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.439 0.638 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -40.26 96.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.979 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.9 t -60.63 -45.72 92.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.456 -0.777 . . . . 0.0 110.68 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.66 -28.48 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -64.51 -52.3 58.52 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.999 -1.063 . . . . 0.0 111.533 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.32 77.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.336 -0.853 . . . . 0.0 109.134 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.604 ' CD2' HD12 ' A' ' 399' ' ' ILE . 8.0 tt -61.27 -38.06 85.35 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 t -65.51 -43.65 89.41 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.118 -0.989 . . . . 0.0 111.781 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -64.07 -45.36 89.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.319 -0.863 . . . . 0.0 111.964 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -64.94 -44.86 88.06 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.29 -0.881 . . . . 0.0 111.283 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.791 HG23 ' HD1' ' A' ' 419' ' ' TYR . 71.4 mt -63.98 -41.83 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.34 -0.85 . . . . 0.0 110.519 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 5.6 tpp -60.62 -35.01 75.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.351 -0.843 . . . . 0.0 109.995 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.35 -31.03 70.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 405' ' ' VAL . 5.6 tp-100 -87.45 -16.59 34.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.801 -1.187 . . . . 0.0 108.78 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.33 -31.98 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.722 -0.611 . . . . 0.0 110.273 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -113.67 17.84 17.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.6 p -52.46 108.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.59 -0.694 . . . . 0.0 109.729 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 64.9 p -50.03 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.462 -0.774 . . . . 0.0 111.37 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 405' ' ' VAL . 58.6 t -107.24 133.02 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -94.32 142.21 24.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.572 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.22 -21.91 54.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.336 1.177 . . . . 0.0 110.318 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -60.46 -40.29 90.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 110.002 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 68.28 1.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.4 t -53.89 110.62 0.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.8 p -62.63 111.54 4.95 Favored Pre-proline 0 N--CA 1.492 1.653 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.813 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.8 133.32 21.66 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.096 1.051 . . . . 0.0 109.972 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.91 63.6 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.485 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 68.8 p -66.0 -33.16 75.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 108.762 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -63.59 -10.26 17.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.626 -0.671 . . . . 0.0 111.578 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.56 51.93 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.965 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.791 ' HD1' HG23 ' A' ' 399' ' ' ILE . 12.9 m-85 -93.16 -2.04 55.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.61 -1.524 . . . . 0.0 110.133 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 4.8 m -82.48 -33.0 28.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 108.781 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 425' ' ' VAL . 98.0 m-20 -78.88 -44.42 22.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.666 . . . . 0.0 110.123 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.94 -42.02 95.02 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.636 -0.665 . . . . 0.0 111.412 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.927 HG21 ' CG2' ' A' ' 436' ' ' VAL . 88.8 t -80.2 -44.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.773 -0.579 . . . . 0.0 112.258 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.1 m -60.28 -42.01 94.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.929 -1.107 . . . . 0.0 110.475 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 421' ' ' ASP . 13.5 p -64.22 -29.76 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.422 -0.799 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -68.32 -31.77 71.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.554 -0.716 . . . . 0.0 110.074 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.49 78.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.056 -1.028 . . . . 0.0 108.771 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.13 -28.87 63.09 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -67.46 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.514 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 6.0 tmm_? -173.04 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 120.726 -1.234 . . . . 0.0 110.397 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.3 Cg_endo -71.17 120.48 7.04 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 N-CA-C 110.182 -0.738 . . . . 0.0 110.182 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.467 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 2.0 t -94.91 99.96 11.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.805 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.8 tp -163.24 98.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.955 -1.091 . . . . 0.0 110.741 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -140.48 177.14 8.22 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.504 0.669 . . . . 0.0 111.047 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.459 ' O ' HG21 ' A' ' 399' ' ' ILE . 3.3 mt -117.43 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.819 -0.551 . . . . 0.0 110.146 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.927 ' CG2' HG21 ' A' ' 423' ' ' VAL . 67.1 t -133.47 140.05 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.47 -0.769 . . . . 0.0 110.473 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 19.1 m -132.25 142.87 49.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.711 -0.618 . . . . 0.0 109.586 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.01 162.95 22.08 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -120.43 -42.74 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.895 . . . . 0.0 109.308 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.83 63.82 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 173.62 86.2 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.23 -28.23 10.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.512 -0.993 . . . . 0.0 110.724 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.49 79.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.444 -0.785 . . . . 0.0 110.781 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -77.97 -30.74 50.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.12 -31.55 64.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.401 -1.058 . . . . 0.0 109.348 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.439 ' HD2' ' HB1' ' A' ' 467' ' ' ALA . 61.2 ttp180 -62.9 -43.66 98.2 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.569 0.699 . . . . 0.0 110.152 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 47.7 tt0 -80.0 -29.46 39.47 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -0.853 . . . . 0.0 110.619 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -62.62 -47.69 82.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.0 p -60.32 -31.53 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.903 -1.123 . . . . 0.0 108.227 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.2 -28.45 69.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.806 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 454' ' ' MET . 53.6 tp10 -63.14 -32.9 74.39 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.45 -33.05 74.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.6 t -59.98 -29.8 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 61.4 mtt -66.65 -36.07 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.23 -27.52 62.1 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.576 -0.702 . . . . 0.0 109.435 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.1 32.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.64 -0.663 . . . . 0.0 109.777 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -64.39 -44.64 90.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -71.46 -30.9 66.55 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.503 0.668 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -76.38 -2.16 30.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.676 -0.64 . . . . 0.0 110.981 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.44 25.68 74.83 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.78 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.1 ttm180 -133.38 120.78 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.501 -1.0 . . . . 0.0 110.552 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 92.9 mt-10 -79.85 172.1 14.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 453' ' ' VAL . 27.2 m -144.46 153.02 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.62 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.1 tt0 -97.82 120.2 37.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -131.34 135.06 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.044 -1.035 . . . . 0.0 110.321 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.758 HG23 ' HD3' ' A' ' 471' ' ' ARG . 93.2 mt -127.51 123.55 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -78.81 162.96 25.74 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -161.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.666 -0.646 . . . . 0.0 109.294 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -47.64 -19.03 0.17 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.783 -1.198 . . . . 0.0 111.69 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.31 -7.17 54.37 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.758 ' HD3' HG23 ' A' ' 466' ' ' ILE . 58.2 ttp180 -57.09 -24.9 57.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.035 -1.041 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 40.4 t -58.44 -45.36 88.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.403 -0.811 . . . . 0.0 110.181 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.95 -40.67 96.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 108.623 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 7.6 ttm -57.25 -39.5 75.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.742 -0.599 . . . . 0.0 110.446 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -57.11 -35.43 69.43 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 53.5 tpp -59.67 -36.77 77.1 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.347 0.594 . . . . 0.0 110.04 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.0 pttt -134.76 -145.87 0.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.586 . . . . 0.0 110.403 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 92.8 mm-40 51.11 40.95 26.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.749 -1.219 . . . . 0.0 111.498 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.33 10.85 18.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.0 110.313 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 480' ' ' GLU . 74.7 tt0 -82.74 -3.94 57.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 111.487 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.801 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -159.78 15.23 0.14 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.206 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.801 HD23 ' HG2' ' A' ' 481' ' ' ARG . 1.6 pp -169.45 38.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.716 -1.24 . . . . 0.0 111.888 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 90.8 p -87.78 50.4 1.99 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.32 24.77 28.01 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -125.49 57.64 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.517 -0.99 . . . . 0.0 108.982 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 464' ' ' GLN . 84.7 mt -97.49 -82.05 0.42 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.786 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 175.77 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 174.407 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.544 HG21 ' OE1' ' A' ' 464' ' ' GLN . 8.8 t -104.28 10.45 35.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.884 -0.51 . . . . 0.0 111.112 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -149.66 93.91 0.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 491' ' ' ARG . 34.9 ttm180 -139.82 -81.15 0.28 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 490' ' ' ARG . 8.7 ptm180 -134.18 -13.91 2.37 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.986 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.531 ' HB2' ' CE2' ' A' ' 499' ' ' PHE . 8.2 mt-30 -61.42 -30.69 70.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.879 -1.138 . . . . 0.0 111.252 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.456 HD23 ' HZ ' ' A' ' 499' ' ' PHE . 36.0 mt -64.88 -57.64 8.29 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 494' ' ' LEU . 2.2 tm? -63.36 -37.98 89.36 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.925 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.55 -7.63 58.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.766 -0.584 . . . . 0.0 112.541 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.34 60.19 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 96.2 mtp -122.7 -173.49 2.71 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.375 -1.074 . . . . 0.0 110.046 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -103.25 165.93 10.74 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.669 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 492' ' ' GLN . 65.2 m-85 -111.58 152.6 27.39 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.651 0.739 . . . . 0.0 112.284 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 487' ' ' ILE . 5.5 m -69.86 112.2 11.55 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.27 115.69 2.3 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.284 1.149 . . . . 0.0 111.226 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.58 27.64 0.04 OUTLIER Glycine 0 N--CA 1.505 3.29 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.294 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.786 ' HB3' HG21 ' A' ' 487' ' ' ILE . 12.5 p -96.84 -177.39 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.959 -1.318 . . . . 0.0 111.877 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.734 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.4 m -118.51 112.36 19.82 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 522' ' ' LEU . 57.1 t -106.03 137.2 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 119.661 -0.815 . . . . 0.0 112.564 -175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.0 pt -134.26 163.13 37.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 534' ' ' ILE . 10.1 p -159.95 106.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 122.873 1.32 . . . . 0.0 111.842 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.94 122.45 28.29 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 507' ' ' VAL . 86.7 mm-40 -145.17 112.54 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.67 -34.36 56.78 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.45 147.16 23.59 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.32 -10.49 22.25 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.025 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 513' ' ' LEU . 14.7 tp -64.32 -34.63 78.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.429 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 71.6 m -87.75 -17.44 31.66 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.38 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 519' ' ' LEU . 56.4 tp -67.62 -46.43 72.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 108.765 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.9 mttt -70.29 -40.46 74.27 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.76 -49.96 75.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.253 -0.905 . . . . 0.0 111.06 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.591 HG21 HD12 ' A' ' 466' ' ' ILE . 91.3 m -56.5 -39.99 74.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.34 -0.85 . . . . 0.0 109.834 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.3 OUTLIER -54.89 -38.91 68.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.593 -0.692 . . . . 0.0 110.123 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 99.4 m -62.45 -39.19 92.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.512 -0.742 . . . . 0.0 109.783 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.497 HD23 ' NE2' ' A' ' 464' ' ' GLN . 49.2 tp -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.498 -0.751 . . . . 0.0 110.391 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.822 HD11 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.26 -21.46 63.93 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.484 -0.76 . . . . 0.0 111.08 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -45.81 -65.33 0.56 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.76 -51.68 55.76 Favored Glycine 0 N--CA 1.503 3.15 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.521 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 488' ' ' THR . . . -59.03 -32.46 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.56 -0.965 . . . . 0.0 111.296 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.4 -22.47 66.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.151 -0.968 . . . . 0.0 112.437 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -39.18 -28.23 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -119.04 -110.98 0.34 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.142 -0.974 . . . . 0.0 111.828 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -90.8 93.12 9.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.381 -1.449 . . . . 0.0 113.578 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.5 t -141.19 166.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.859 -1.15 . . . . 0.0 111.498 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.467 ' HG2' ' N ' ' A' ' 432' ' ' SER . 1.1 tp-100 -164.68 163.25 21.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.805 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.9 t -114.64 107.39 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.658 ' HB3' HG22 ' A' ' 506' ' ' ILE . 1.6 tp -104.53 119.04 38.06 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 507' ' ' VAL . 14.9 pt -140.5 161.03 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 117.613 -1.635 . . . . 0.0 112.96 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 436' ' ' VAL . 81.7 p -121.74 -169.86 1.94 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -149.16 155.79 41.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.18 20.38 2.43 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.042 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.06 -46.21 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.452 ' OE1' ' HB1' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.93 2.44 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.888 . . . . 0.0 111.648 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 540' ' ' ARG . . . . . 0.642 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.1 ptt180 -36.33 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 540' ' ' ARG . 66.7 p -93.02 117.98 30.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.074 -1.016 . . . . 0.0 109.242 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 63.83 70.21 1.12 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.415 ' O ' HD13 ' A' ' 547' ' ' LEU . 74.9 p -80.13 -3.17 47.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.752 -0.852 . . . . 0.0 111.981 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.65 -35.59 81.87 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 -32.54 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.827 -0.808 . . . . 0.0 110.279 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.17 -35.19 80.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.658 . . . . 0.0 109.324 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 543' ' ' THR . 10.1 mp -62.45 -43.28 99.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.796 -0.565 . . . . 0.0 110.639 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 93.4 mtp -65.2 -37.61 87.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -50.92 -51.46 51.82 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.099 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.424 ' CG ' HD11 ' A' ' 519' ' ' LEU . 38.0 ttp -58.29 -40.47 82.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.364 -0.835 . . . . 0.0 109.561 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HG3' ' HB ' ' A' ' 555' ' ' VAL . 85.3 tttt -61.9 -32.17 72.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.0 110.368 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.4 -16.09 62.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 0.0 110.352 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -77.14 8.41 3.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.214 -0.929 . . . . 0.0 112.629 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 155.79 -16.74 0.47 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.79 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 551' ' ' LYS . 53.2 t . . . . . 0 N--CA 1.495 1.814 0 CA-C-N 118.967 1.384 . . . . 0.0 109.273 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 121.3 0.571 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.48 -42.36 98.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.729 -0.607 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 33.9 p -64.36 -37.69 88.38 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.477 -0.764 . . . . 0.0 110.585 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 79.8 t -65.9 -35.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -62.75 -51.37 67.41 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.418 -0.801 . . . . 0.0 110.815 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.96 79.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.424 -0.798 . . . . 0.0 109.811 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.9 tt -62.18 -39.06 91.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.968 -0.458 . . . . 0.0 111.123 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.2 m -62.65 -37.47 86.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.43 -44.18 92.0 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.905 . . . . 0.0 112.249 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.95 -45.02 91.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.061 -1.024 . . . . 0.0 111.639 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.09 -40.84 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.724 -0.61 . . . . 0.0 109.965 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.486 ' CG ' HD11 ' A' ' 435' ' ' ILE . 30.9 mtp -63.73 -32.58 74.11 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.575 -0.703 . . . . 0.0 110.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.05 -32.24 70.72 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.106 -0.996 . . . . 0.0 110.143 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -91.17 -14.68 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -67.11 -36.98 83.1 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 0.0 109.5 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -115.33 20.38 14.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 12.5 p -37.34 146.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 122.149 -0.344 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 14.1 p -72.89 72.91 1.12 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.346 -0.846 . . . . 0.0 109.976 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.894 HG21 HG22 ' A' ' 413' ' ' VAL . 12.3 p -111.14 133.39 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.945 0.878 . . . . 0.0 112.819 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -92.37 145.76 31.23 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.698 -0.627 . . . . 0.0 109.848 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.96 -28.95 81.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 O-C-N 123.05 1.026 . . . . 0.0 109.825 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.57 -26.54 2.27 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.766 0.793 . . . . 0.0 111.168 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 67.21 0.75 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 82.4 p -51.07 109.86 0.37 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.522 -0.737 . . . . 0.0 110.585 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.894 HG22 HG21 ' A' ' 407' ' ' VAL . 19.9 m -76.68 110.45 11.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.886 -0.509 . . . . 0.0 110.558 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.92 137.95 42.91 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 N-CA-C 109.663 -0.937 . . . . 0.0 109.663 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -147.73 83.53 1.53 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 113.704 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.532 HG22 ' OH ' ' A' ' 419' ' ' TYR . 33.0 p -100.09 26.85 6.03 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.021 -1.05 . . . . 0.0 108.481 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -110.06 -31.71 7.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.319 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -57.7 -50.59 64.14 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.603 ' CG ' HG13 ' A' ' 436' ' ' VAL . 30.0 p90 -98.96 -11.77 21.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.814 -1.403 . . . . 0.0 111.975 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 416' ' ' THR . 6.2 t -65.92 -47.4 74.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.336 -1.477 . . . . 0.0 109.197 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 425' ' ' VAL . 65.6 t0 -77.21 -45.36 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 110.63 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -57.97 -49.14 77.82 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.597 -0.69 . . . . 0.0 111.475 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.735 ' HA ' HD23 ' A' ' 426' ' ' LEU . 61.1 t -69.85 -43.15 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.717 -0.614 . . . . 0.0 112.021 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.7 p -56.73 -39.96 74.85 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.113 -0.992 . . . . 0.0 111.225 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 421' ' ' ASP . 94.4 t -65.99 -43.84 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.784 . . . . 0.0 109.834 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -60.55 -34.14 73.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 112.045 -178.317 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -37.03 77.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.348 -1.47 . . . . 0.0 108.056 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.77 -29.63 70.26 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -179.44 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.344 -1.473 . . . . 0.0 108.969 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.7 99.14 0.72 Allowed 'Trans proline' 0 N--CA 1.484 0.913 0 N-CA-C 108.938 -1.216 . . . . 0.0 108.938 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 4.3 t -87.59 101.3 13.5 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.765 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -156.82 88.95 1.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 109.989 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.99 164.97 28.63 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.894 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.2 pp -114.57 128.54 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.879 -0.513 . . . . 0.0 109.714 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 423' ' ' VAL . 75.6 t -124.37 140.88 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.759 -0.588 . . . . 0.0 109.755 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 4.8 m -126.65 132.61 51.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 110.908 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.92 169.82 23.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -141.75 32.0 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.944 . . . . 0.0 109.626 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 138.08 168.73 11.4 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.84 92.55 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.85 88.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.906 . . . . 0.0 110.418 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.71 96.22 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.278 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.11 75.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.47 -38.82 81.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.981 . . . . 0.0 110.472 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 449' ' ' VAL . 90.3 mmt-85 -64.26 -40.22 95.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.368 -0.833 . . . . 0.0 110.138 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -70.81 -30.13 66.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 95.7 mtt-85 -65.7 -46.68 78.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.372 -0.83 . . . . 0.0 111.575 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.5 p -60.56 -32.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.774 -1.203 . . . . 0.0 108.974 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.82 -28.37 69.96 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.691 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 80.0 tt0 -67.61 -37.58 82.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.08 -37.0 85.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 463' ' ' VAL . 67.8 t -59.27 -26.66 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.679 -0.638 . . . . 0.0 109.314 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 17.0 mmt -67.66 -36.49 80.84 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 459' ' ' GLN . 14.8 tmm? -59.45 -29.05 67.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.834 -0.541 . . . . 0.0 110.233 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.04 -21.13 37.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.476 -0.765 . . . . 0.0 109.929 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -72.68 -25.33 61.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.651 -0.656 . . . . 0.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 455' ' ' MET . 96.9 mm-40 -77.27 2.41 15.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.338 -0.851 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.83 82.85 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 120.936 -1.103 . . . . 0.0 111.705 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -138.06 144.53 41.01 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 118.821 1.31 . . . . 0.0 111.428 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.65 ' C ' HD11 ' A' ' 487' ' ' ILE . 98.1 mt-10 -89.44 175.3 7.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 453' ' ' VAL . 16.6 m -138.74 162.38 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.855 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.78 115.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 482' ' ' LEU . 1.2 tp -119.2 120.55 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.788 -1.195 . . . . 0.0 112.116 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 507' ' ' VAL . 94.9 mt -107.66 172.95 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.795 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 466' ' ' ILE . . . -129.41 156.6 43.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.29 -159.75 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.673 -0.642 . . . . 0.0 109.424 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -46.84 -15.98 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.904 -1.122 . . . . 0.0 112.849 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -88.05 4.93 43.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.879 -1.138 . . . . 0.0 111.985 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 14.2 tpt180 -58.57 -37.61 76.14 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.066 -1.021 . . . . 0.0 111.14 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 53.5 m -56.11 -47.18 78.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.447 -0.783 . . . . 0.0 111.1 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -65.97 -37.71 86.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -0.829 . . . . 0.0 109.101 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.445 ' HE3' ' HE2' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -58.98 -34.45 71.84 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.748 -0.595 . . . . 0.0 110.192 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -61.39 -39.84 92.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.0 109.593 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 59.6 ttp -62.01 -41.61 98.25 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.445 ' HE2' ' HE3' ' A' ' 474' ' ' MET . 22.6 pttm -111.01 -150.1 0.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 109.052 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.552 ' NE2' HD21 ' A' ' 482' ' ' LEU . 41.1 tt0 48.26 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.021 -1.05 . . . . 0.0 112.302 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -132.91 21.48 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.605 . . . . 0.0 110.463 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 480' ' ' GLU . 47.7 tp10 -110.15 3.67 20.37 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.397 -0.814 . . . . 0.0 111.408 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.631 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -137.17 -24.31 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.905 -1.122 . . . . 0.0 112.421 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.631 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -158.21 69.64 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.106 -0.997 . . . . 0.0 110.81 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 24.7 t -90.38 51.15 1.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.58 16.82 23.37 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.081 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -126.16 59.9 1.32 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.177 -1.19 . . . . 0.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 487' ' ' ILE . 84.7 mt -64.18 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.069 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.784 HD11 ' CA ' ' A' ' 463' ' ' VAL . 14.4 mm -155.15 -82.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.16 -0.962 . . . . 0.0 109.736 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.553 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.0 t -98.99 12.25 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.784 -0.572 . . . . 0.0 110.761 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -97.05 79.93 0.69 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.54 -67.99 0.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 495' ' ' GLU . 95.7 mtt-85 -96.75 -26.72 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.802 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -67.52 -44.34 78.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.933 -1.104 . . . . 0.0 110.524 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 493' ' ' LEU . 2.6 mt -70.59 -37.84 73.96 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.8 OUTLIER -103.75 -39.98 6.45 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.174 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 495' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 491' ' ' ARG . 89.7 mt-10 -102.14 -9.47 20.48 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.815 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 84.31 -9.18 64.9 Favored Glycine 0 N--CA 1.5 2.949 0 O-C-N 120.523 -1.36 . . . . 0.0 111.111 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.428 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 99.4 mtp -68.17 179.25 1.6 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.248 . . . . 0.0 112.11 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.55 153.77 25.77 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.4 155.04 25.95 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.191 0.996 . . . . 0.0 112.036 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 500' ' ' THR . 7.3 t -44.6 132.33 4.89 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.642 -177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.446 ' HB3' ' CA ' ' A' ' 528' ' ' HIS . 56.3 Cg_endo -85.51 112.94 1.35 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.596 1.314 . . . . 0.0 109.51 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.11 26.05 0.07 OUTLIER Glycine 0 N--CA 1.504 3.194 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.987 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 487' ' ' ILE . 74.7 m -92.8 173.87 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -1.207 . . . . 0.0 111.022 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.806 ' HB ' HG12 ' A' ' 463' ' ' VAL . 91.6 m -115.66 127.71 55.37 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 522' ' ' LEU . 13.2 t -118.46 130.51 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.867 0.842 . . . . 0.0 111.125 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.705 HG22 ' HB3' ' A' ' 533' ' ' LEU . 6.1 pt -135.6 123.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 0.0 109.017 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 534' ' ' ILE . 14.5 p -113.73 115.18 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.647 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 36.7 m-20 -84.34 108.48 17.2 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.894 -1.129 . . . . 0.0 108.418 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 0.5 OUTLIER -99.73 175.36 5.83 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 122.376 1.084 . . . . 0.0 112.969 -176.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.81 -55.85 0.05 OUTLIER Glycine 0 N--CA 1.503 3.102 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.19 -155.05 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.51 -17.86 2.54 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.046 -1.033 . . . . 0.0 111.019 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 57.5 tp -72.43 -25.05 61.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.278 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 75.2 m -65.58 -44.31 87.05 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 110.492 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.894 HD21 ' HG3' ' A' ' 550' ' ' MET . 11.0 tp -64.46 -46.31 83.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.829 -0.544 . . . . 0.0 111.938 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.55 -43.81 79.8 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 0.0 112.084 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -62.5 -51.13 68.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.112 -0.992 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 522' ' ' LEU . 97.4 m -59.81 -43.07 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.832 -0.542 . . . . 0.0 110.459 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -41.36 90.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.747 -0.596 . . . . 0.0 111.464 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 39.1 p -64.47 -33.27 75.49 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.053 -1.03 . . . . 0.0 109.832 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 60.8 tp -68.3 -40.44 81.75 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.694 0.759 . . . . 0.0 109.83 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 505' ' ' VAL . 0.6 OUTLIER -70.97 -22.22 62.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 523' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 48.6 t0 -47.46 -60.17 2.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.393 -0.817 . . . . 0.0 111.895 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.88 -51.13 56.06 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.555 ' HB1' ' OD1' ' A' ' 529' ' ' ASN . . . -55.15 -29.83 58.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.684 -0.891 . . . . 0.0 110.414 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -47.96 -37.67 15.01 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -66.58 -42.51 86.89 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.446 ' CA ' ' HB3' ' A' ' 501' ' ' PRO . 32.2 m80 -94.62 -94.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.31 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.555 ' OD1' ' HB1' ' A' ' 525' ' ' ALA . 15.8 p-10 -83.69 144.17 29.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.963 -1.085 . . . . 0.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 4.2 p -171.81 146.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.392 -1.323 . . . . 0.0 113.836 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.8 OUTLIER 171.86 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 76.5 t -110.44 104.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 120.742 -1.223 . . . . 0.0 113.258 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.6 OUTLIER -109.26 116.17 31.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.931 HG22 HG12 ' A' ' 507' ' ' VAL . 5.7 pt -127.91 155.19 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.475 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.705 HG22 ' HB ' ' A' ' 436' ' ' VAL . 61.4 p -128.87 -172.69 2.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -149.4 156.04 41.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 110.563 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 85.3 p -145.32 23.26 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.663 . . . . 0.0 110.654 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -163.63 -41.6 0.02 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.63 ' CD ' ' HB2' ' A' ' 546' ' ' ALA . 46.3 tt0 -81.63 0.4 38.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.979 . . . . 0.0 110.939 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 541' ' ' THR . 40.8 ptt180 -40.58 -39.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.583 -0.698 . . . . 0.0 112.23 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.416 ' N ' ' HG3' ' A' ' 540' ' ' ARG . 40.5 p -63.86 -91.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -70.25 79.53 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 543' ' ' THR . 9.4 t -87.06 -18.72 29.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.953 . . . . 0.0 111.611 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.22 -38.97 93.97 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 18.9 m -69.17 -24.93 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.515 -0.991 . . . . 0.0 109.792 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.15 -36.53 77.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.76 -0.587 . . . . 0.0 109.865 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.298 -0.876 . . . . 0.0 108.877 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 56.8 ttm -64.55 -31.91 73.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.93 -50.39 61.23 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.894 ' HG3' HD21 ' A' ' 515' ' ' LEU . 90.0 mtp -58.43 -44.27 89.05 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.838 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 551' ' ' LYS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 84.7 tttt -63.44 -32.07 73.4 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.459 -0.776 . . . . 0.0 111.474 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.67 -15.86 62.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.66 3.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.266 -0.896 . . . . 0.0 112.725 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 147.65 -13.08 1.35 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.364 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 551' ' ' LYS . 62.9 t . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.015 -1.285 . . . . 0.0 110.708 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.505 2.309 0 CA-C-O 121.498 0.665 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -40.53 89.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 77.8 p -66.11 -41.44 90.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.442 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 433' ' ' LEU . 89.0 t -68.31 -33.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.679 -0.638 . . . . 0.0 110.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -58.37 -48.99 78.83 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.421 -0.799 . . . . 0.0 111.402 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.68 -32.17 71.79 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.949 0.88 . . . . 0.0 109.856 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.606 HD13 HD12 ' A' ' 399' ' ' ILE . 2.2 tm? -61.8 -41.53 97.87 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.758 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' SER . . . . . 0.466 ' HB2' HD12 ' A' ' 435' ' ' ILE . 78.5 p -71.86 -34.68 69.43 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.193 -0.942 . . . . 0.0 112.641 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.0 -50.22 71.6 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.996 -1.065 . . . . 0.0 112.435 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.06 -43.14 71.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.263 -0.898 . . . . 0.0 112.014 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 395' ' ' LEU . 94.1 mt -61.41 -44.79 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.112 -0.992 . . . . 0.0 110.009 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.492 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 5.9 ttm -61.42 -31.55 71.49 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.617 -0.677 . . . . 0.0 110.758 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.26 -25.21 67.7 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.539 -0.726 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 405' ' ' VAL . 65.5 tp60 -99.79 -20.65 16.11 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.272 -0.893 . . . . 0.0 109.21 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.581 ' ND2' HG22 ' A' ' 399' ' ' ILE . 98.0 m-20 -82.7 -7.01 59.68 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -94.67 -56.47 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 402' ' ' GLN . 6.4 p -27.88 124.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.1 m -60.13 95.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 122.159 0.98 . . . . 0.0 109.979 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.903 HG21 ' CZ ' ' A' ' 415' ' ' ARG . 13.9 t -65.27 137.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.132 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.2 130.68 29.1 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.684 -0.635 . . . . 0.0 110.267 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.47 -20.79 41.27 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.117 1.061 . . . . 0.0 111.07 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.35 -32.6 71.78 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.787 0.803 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 69.88 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.0 m -49.69 142.3 8.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.791 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.835 HG12 HG13 ' A' ' 407' ' ' VAL . 11.4 p -98.86 143.88 27.17 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.38 136.63 56.1 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 N-CA-C 108.794 -1.272 . . . . 0.0 108.794 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.903 ' CZ ' HG21 ' A' ' 407' ' ' VAL . 98.1 mtt180 -123.18 -15.53 7.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.391 -0.818 . . . . 0.0 112.881 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.9 p -102.74 6.45 39.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.025 . . . . 0.0 109.014 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -78.51 -79.92 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.05 -1.031 . . . . 0.0 111.745 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -74.12 -4.75 68.95 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.623 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.595 ' O ' HG23 ' A' ' 423' ' ' VAL . 81.7 m-85 -107.07 -1.94 21.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.616 -1.52 . . . . 0.0 110.207 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -84.88 -33.71 22.74 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 425' ' ' VAL . 47.3 t0 -72.63 -37.68 67.95 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.11 85.72 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.099 0.952 . . . . 0.0 110.301 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 436' ' ' VAL . 98.5 t -67.71 -40.98 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.253 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -69.45 -36.61 76.79 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.028 -1.045 . . . . 0.0 111.71 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 421' ' ' ASP . 87.0 t -65.27 -42.46 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.381 -0.825 . . . . 0.0 112.008 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.748 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 2.1 pp -65.51 -31.08 71.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.109 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.25 69.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.955 . . . . 0.0 109.424 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.15 -32.53 74.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -61.24 -86.49 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.534 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -172.18 -57.46 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.773 -1.205 . . . . 0.0 109.529 177.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 55.2 Cg_endo -71.07 103.44 1.38 Allowed 'Trans proline' 0 N--CA 1.488 1.198 0 N-CA-C 109.688 -0.928 . . . . 0.0 109.688 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 3.2 t -85.34 98.72 10.71 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.963 0.887 . . . . 0.0 110.712 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.76 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.2 tp -146.51 136.61 23.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -169.96 163.21 9.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.823 -1.173 . . . . 0.0 110.923 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.597 ' O ' HG21 ' A' ' 399' ' ' ILE . 22.1 mt -123.49 121.52 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.793 -0.567 . . . . 0.0 110.409 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 423' ' ' VAL . 57.3 t -127.27 137.14 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.917 . . . . 0.0 109.137 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 539' ' ' GLN . 4.1 p -131.83 139.24 48.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.98 -1.075 . . . . 0.0 111.536 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 537' ' ' SER . . . -148.88 168.06 29.37 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.67 70.01 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 110.48 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 133.24 148.97 6.02 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.68 32.31 81.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.68 -9.16 58.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.698 -0.884 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.07 94.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.136 -0.978 . . . . 0.0 110.834 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -79.21 -28.01 54.34 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.94 -41.01 90.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.539 -0.977 . . . . 0.0 109.55 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.516 ' NE ' ' HB2' ' A' ' 467' ' ' ALA . 8.4 mmm180 -64.89 -40.15 94.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.876 -0.515 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -70.27 -31.63 69.09 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.074 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.99 -50.49 64.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.52 -0.738 . . . . 0.0 112.051 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 506' ' ' ILE . 7.2 p -58.5 -33.57 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.272 . . . . 0.0 109.174 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.89 -27.3 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -61.33 -33.95 74.45 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 455' ' ' MET . 1.5 tp -63.56 -38.43 91.08 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.847 HG13 ' CG2' ' A' ' 463' ' ' VAL . 91.8 t -58.88 -25.85 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 90.0 mtp -66.2 -39.77 89.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.45 -0.781 . . . . 0.0 109.221 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.3 OUTLIER -60.06 -23.44 63.76 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.874 0.845 . . . . 0.0 109.089 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 453' ' ' VAL . . . -83.77 -23.65 31.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.463 0.649 . . . . 0.0 109.878 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 23.9 tpt85 -67.0 -42.96 84.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -71.42 -27.9 63.61 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.726 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -74.89 0.02 17.02 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.617 -0.677 . . . . 0.0 111.725 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.36 76.43 Favored Glycine 0 N--CA 1.496 2.679 0 O-C-N 120.837 -1.164 . . . . 0.0 110.718 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 461' ' ' ARG . 16.8 ptp180 -129.87 136.27 49.34 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.215 -1.168 . . . . 0.0 110.953 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 99.2 mt-10 -91.84 161.53 14.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.222 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.926 HG12 ' HB ' ' A' ' 504' ' ' THR . 29.1 m -136.77 153.22 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 111.271 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.939 ' HA ' HD22 ' A' ' 486' ' ' LEU . 53.4 tt0 -100.72 116.41 32.56 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 506' ' ' ILE . 1.1 pt -130.29 135.11 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.065 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.598 ' HB ' HG23 ' A' ' 507' ' ' VAL . 87.5 mt -126.22 122.12 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.118 -0.989 . . . . 0.0 111.86 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.516 ' HB2' ' NE ' ' A' ' 446' ' ' ARG . . . -66.03 155.88 35.4 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.452 -0.78 . . . . 0.0 109.128 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.99 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.406 -0.809 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 511' ' ' GLU . 5.0 t0 -46.11 -22.68 0.24 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.23 -0.919 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -70.32 -4.65 23.11 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.446 -0.784 . . . . 0.0 110.892 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.478 ' HD2' ' HB3' ' A' ' 467' ' ' ALA . 6.1 tpt180 -53.77 -34.18 58.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.118 -0.989 . . . . 0.0 112.929 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 75.5 m -59.41 -45.23 92.08 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.137 -0.977 . . . . 0.0 110.074 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 476' ' ' MET . 51.4 tt0 -66.84 -39.35 87.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.7 -0.625 . . . . 0.0 109.932 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 15.8 mmt -60.39 -34.52 74.02 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -61.77 -36.23 80.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.28 -0.888 . . . . 0.0 108.621 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 473' ' ' GLN . 7.3 tpp -59.45 -41.94 90.82 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.568 0.699 . . . . 0.0 109.124 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -118.16 -146.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 46.06 88.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.216 -0.927 . . . . 0.0 111.627 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -131.79 22.55 4.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.735 -0.603 . . . . 0.0 110.139 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -115.77 -15.49 11.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.695 -0.628 . . . . 0.0 110.735 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.632 ' C ' HD23 ' A' ' 482' ' ' LEU . 22.4 mtt180 -118.15 -7.0 10.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 113.175 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -171.54 54.45 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 120.751 -1.218 . . . . 0.0 112.296 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.0 p -64.67 -21.63 66.78 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.926 -1.109 . . . . 0.0 110.576 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 149.67 48.17 0.02 OUTLIER Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.93 59.17 1.74 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.788 -0.83 . . . . 0.0 109.774 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 464' ' ' GLN . 24.9 mt -80.17 -80.29 0.14 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 177.27 -41.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 174.131 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.629 HG23 HG22 ' A' ' 487' ' ' ILE . 6.9 p -103.85 9.53 36.84 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.503 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.4 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -103.14 60.78 0.48 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 499' ' ' PHE . 54.7 ttm-85 -144.12 -50.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.956 . . . . 0.0 108.835 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 98.0 mtt180 -122.97 -29.86 3.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.976 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -65.2 -41.19 94.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -0.921 . . . . 0.0 110.534 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 493' ' ' LEU . 5.8 mt -86.58 -31.48 21.17 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.503 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -102.93 -43.57 5.49 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -100.13 -9.65 22.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.535 -1.353 . . . . 0.0 113.904 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.22 -18.83 46.57 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.676 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 98.3 mtp -66.36 -178.47 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -1.151 . . . . 0.0 109.935 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.23 145.7 41.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.734 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -114.35 149.32 36.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.664 -0.648 . . . . 0.0 110.645 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 94.6 m -50.54 103.71 0.38 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 0.0 109.811 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 44.3 Cg_endo -72.37 113.04 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.559 1.294 . . . . 0.0 108.928 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 529' ' ' ASN . . . 171.05 34.33 0.03 OUTLIER Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 487' ' ' ILE . 22.8 p -92.91 179.04 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -1.061 . . . . 0.0 110.654 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.926 ' HB ' HG12 ' A' ' 463' ' ' VAL . 97.8 m -111.17 121.6 45.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.87 ' CG1' HD21 ' A' ' 522' ' ' LEU . 63.4 t -123.02 134.89 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.205 -0.934 . . . . 0.0 113.227 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.669 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.2 pt -131.99 120.29 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 534' ' ' ILE . 9.8 p -106.1 114.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.537 -1.352 . . . . 0.0 111.478 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 12.0 m-20 -82.27 108.5 15.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.9 tm0? -106.83 175.15 5.6 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.349 1.071 . . . . 0.0 113.305 -175.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -170.58 -51.91 0.04 OUTLIER Glycine 0 N--CA 1.503 3.145 0 N-CA-C 103.401 -3.88 . . . . 0.0 103.401 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 469' ' ' ASP . 32.0 tp10 -82.17 162.94 22.26 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 173.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.69 -12.32 20.11 Favored 'General case' 0 C--N 1.274 -2.712 0 O-C-N 121.636 -0.665 . . . . 0.0 110.658 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 513' ' ' LEU . 4.5 mm? -67.44 -27.16 66.81 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.2 m -91.43 -13.06 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 111.225 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 519' ' ' LEU . 20.5 tp -78.34 -46.84 19.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 13.6 ptpt -80.61 -38.52 29.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.467 -0.77 . . . . 0.0 111.512 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.64 -44.39 96.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.9 -1.125 . . . . 0.0 109.702 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.783 HG22 HD12 ' A' ' 522' ' ' LEU . 85.8 m -62.2 -41.96 98.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.8 OUTLIER -60.2 -31.76 70.45 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.762 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 21.4 m -64.65 -53.98 39.03 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.855 -1.153 . . . . 0.0 110.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 521' ' ' LEU . 0.2 OUTLIER -62.74 -39.27 93.57 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.133 -0.979 . . . . 0.0 109.888 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.87 HD21 ' CG1' ' A' ' 505' ' ' VAL . 3.2 mt -65.34 -31.98 73.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.459 -0.776 . . . . 0.0 112.181 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.06 -45.9 68.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.017 -1.052 . . . . 0.0 110.325 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.33 62.13 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -67.13 -36.52 82.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.508 -0.995 . . . . 0.0 112.375 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -26.38 68.22 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.956 -1.09 . . . . 0.0 110.872 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -53.72 -25.8 20.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.485 -0.759 . . . . 0.0 109.243 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.514 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.7 m80 -109.98 -130.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.433 ' HB2' ' CA ' ' A' ' 502' ' ' GLY . 98.1 m-20 -89.91 70.65 7.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.532 -1.355 . . . . 0.0 113.234 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -133.28 158.0 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -148.77 154.59 39.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.759 -0.588 . . . . 0.0 109.608 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 35.4 t -107.14 106.55 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.35 -0.844 . . . . 0.0 113.12 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.669 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.2 tp -106.72 113.66 27.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.885 HG22 HG12 ' A' ' 507' ' ' VAL . 12.1 pt -125.56 130.4 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.028 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 62.5 p -96.8 179.03 5.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 8.3 t0 -154.82 161.0 41.64 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.589 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 438' ' ' GLY . 0.1 OUTLIER -138.59 14.58 2.74 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.464 178.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -146.95 20.19 1.6 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 56.4 tt0 -93.83 -0.95 55.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.301 -1.117 . . . . 0.0 111.038 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -55.86 -42.75 76.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.834 -1.166 . . . . 0.0 111.25 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.1 m -102.75 -58.25 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 111.169 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -90.98 85.83 1.31 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 539' ' ' GLN . 14.9 t -98.56 -40.78 8.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.561 -0.964 . . . . 0.0 111.608 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.09 -41.39 97.13 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 4.5 t -68.54 -23.31 64.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.522 -0.987 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.603 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.14 -39.52 94.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 108.642 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.0 mp -65.36 -42.11 93.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.743 -0.598 . . . . 0.0 109.958 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.21 -29.67 68.88 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.657 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -61.42 -48.71 79.93 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 519' ' ' LEU . 24.9 ttm -56.78 -53.02 62.65 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.598 -0.689 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.39 -31.88 69.64 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.639 -0.663 . . . . 0.0 110.986 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -61.48 -20.04 62.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.415 -0.803 . . . . 0.0 109.776 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -72.37 -1.17 14.54 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.191 -0.943 . . . . 0.0 111.868 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.04 -8.81 9.76 Favored Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.872 -1.143 . . . . 0.0 110.992 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.124 -1.221 . . . . 0.0 108.505 178.759 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.58 -30.11 70.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.358 -0.839 . . . . 0.0 110.724 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.6 m -60.98 -44.71 96.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.22 -33.77 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.437 -0.789 . . . . 0.0 109.949 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -59.39 -47.79 84.1 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.179 -0.95 . . . . 0.0 110.559 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.64 78.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 426' ' ' LEU . 0.6 OUTLIER -62.14 -39.38 92.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.025 -0.422 . . . . 0.0 111.195 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.0 p -64.69 -34.49 78.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 110.748 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -65.15 -43.73 90.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.96 -44.77 75.98 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.328 -0.858 . . . . 0.0 112.235 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 435' ' ' ILE . 62.2 mt -64.27 -43.77 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 6.9 tpp -61.36 -29.28 69.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.315 0.578 . . . . 0.0 109.484 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.06 -29.17 70.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.594 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.4 mm-40 -90.9 -15.5 29.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.081 . . . . 0.0 109.419 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.5 -37.98 86.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.648 -0.657 . . . . 0.0 110.079 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -116.86 18.9 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.047 -1.033 . . . . 0.0 110.441 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 402' ' ' GLN . 7.1 p -58.76 120.92 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.397 -0.814 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 406' ' ' THR . 3.8 t -56.94 104.22 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.645 0.736 . . . . 0.0 110.525 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 413' ' ' VAL . 6.0 p -112.71 135.33 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 138.31 25.6 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.96 -27.94 36.1 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.12 1.063 . . . . 0.0 110.758 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -62.53 -31.36 72.12 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.91 0.862 . . . . 0.0 109.996 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.61 59.32 0.69 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 30.7 t -61.34 126.99 29.33 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.751 0.786 . . . . 0.0 111.313 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 407' ' ' VAL . 7.1 p -74.18 146.14 84.13 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 413' ' ' VAL . 40.5 Cg_endo -68.01 121.24 8.24 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -95.05 14.17 22.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.462 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.888 HG22 ' OH ' ' A' ' 419' ' ' TYR . 14.6 p -92.07 20.9 5.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.878 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.23 -29.18 9.48 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.0 -49.63 76.5 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.888 ' OH ' HG22 ' A' ' 416' ' ' THR . 21.0 p90 -99.29 -11.91 20.83 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.055 1.428 . . . . 0.0 112.943 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.3 m -70.88 -42.14 70.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.264 -1.523 . . . . 0.0 108.203 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.6 t70 -78.94 -44.58 22.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.907 -0.496 . . . . 0.0 110.758 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.532 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.74 -48.04 76.05 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.773 -0.579 . . . . 0.0 112.409 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 426' ' ' LEU . 89.8 t -68.42 -42.33 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.319 -0.863 . . . . 0.0 111.469 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 81.2 p -60.68 -42.84 97.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.182 -0.949 . . . . 0.0 111.343 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 422' ' ' ALA . 32.8 m -68.7 -29.32 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.33 -0.856 . . . . 0.0 111.949 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -73.34 -33.18 64.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.283 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.27 -32.71 73.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.026 -1.046 . . . . 0.0 108.594 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.17 -33.98 77.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.38 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.478 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -177.06 -56.11 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.556 -1.34 . . . . 0.0 110.001 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.4 Cg_endo -68.59 107.93 1.74 Allowed 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 109.291 -1.08 . . . . 0.0 109.291 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 531' ' ' GLN . 1.5 m -100.41 109.21 21.36 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.89 0.852 . . . . 0.0 110.898 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -174.8 95.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -136.86 167.01 22.29 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.929 0.871 . . . . 0.0 112.372 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 399' ' ' ILE . 40.0 pt -116.3 127.66 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.467 0.651 . . . . 0.0 109.541 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.803 HG13 ' CG ' ' A' ' 419' ' ' TYR . 54.0 t -125.04 137.35 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.369 -0.832 . . . . 0.0 109.327 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 28.1 m -119.61 123.45 43.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.359 -0.838 . . . . 0.0 110.951 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.96 155.66 19.63 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.17 75.55 0.25 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.737 -0.861 . . . . 0.0 109.368 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 113.65 145.49 9.2 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.27 38.96 95.39 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.25 -30.0 69.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.6 -0.941 . . . . 0.0 110.737 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.29 93.88 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.416 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.55 -28.05 68.26 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.37 -46.5 88.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.49 -1.006 . . . . 0.0 110.757 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 449' ' ' VAL . 13.0 mtm-85 -64.81 -40.76 95.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.557 -0.714 . . . . 0.0 111.189 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 14.3 mt-10 -69.22 -29.97 68.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.127 -0.983 . . . . 0.0 110.37 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -61.67 -51.5 68.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.329 -0.857 . . . . 0.0 110.449 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 1.01 HG22 HD12 ' A' ' 506' ' ' ILE . 2.4 p -58.0 -31.74 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.095 -1.003 . . . . 0.0 108.765 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.02 -27.34 69.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.24 -34.28 76.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.106 -0.996 . . . . 0.0 108.756 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 452' ' ' LEU . 4.6 mm? -63.87 -34.41 77.88 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.7 t -59.3 -30.12 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.633 -0.667 . . . . 0.0 109.742 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 60.3 mtt -66.34 -39.28 89.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.001 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.4 ttp -58.86 -25.21 63.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.652 -0.655 . . . . 0.0 110.176 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.36 -22.68 32.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 110.058 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -64.52 -45.39 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.573 -0.704 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.05 -29.86 65.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -75.82 3.8 9.26 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 111.357 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.67 23.92 75.45 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -128.37 145.64 51.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.445 -1.032 . . . . 0.0 110.344 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 487' ' ' ILE . 51.0 mp0 -99.09 169.79 9.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 35.5 m -141.27 150.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.086 -1.009 . . . . 0.0 111.212 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.887 ' HB3' HG22 ' A' ' 505' ' ' VAL . 13.1 tt0 -101.2 123.62 45.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -137.49 146.78 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.225 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.787 ' HB ' HG23 ' A' ' 507' ' ' VAL . 95.5 mt -132.99 124.61 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.437 -0.789 . . . . 0.0 110.674 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.461 ' HB1' ' CD ' ' A' ' 446' ' ' ARG . . . -75.8 161.94 28.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.16 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.534 -0.729 . . . . 0.0 109.863 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -49.42 -19.16 0.49 Allowed 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.665 -1.272 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ARG . . . . . 0.4 ' HD2' ' NE ' ' A' ' 446' ' ' ARG . 96.2 mtt-85 -76.17 -5.67 47.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.213 -0.929 . . . . 0.0 111.031 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 466' ' ' ILE . 71.8 ttt180 -56.97 -23.44 45.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.033 -1.042 . . . . 0.0 111.027 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 11.6 t -60.6 -48.57 81.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.11 -46.36 84.57 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 30.1 tpp -53.57 -35.03 60.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.897 -0.502 . . . . 0.0 110.904 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -60.72 -38.7 85.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.439 -0.788 . . . . 0.0 109.962 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 10.6 tpt -61.79 -37.67 85.22 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.602 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -113.12 -144.47 0.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.652 ' CG ' HD21 ' A' ' 482' ' ' LEU . 35.7 tp60 55.54 50.73 13.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.829 -1.169 . . . . 0.0 111.398 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -100.6 23.57 10.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.27 -10.21 39.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 112.265 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -173.2 24.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.944 -1.098 . . . . 0.0 112.746 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 482' ' ' LEU . 3.8 pp -171.62 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.4 p -61.13 -21.44 63.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.112 -0.992 . . . . 0.0 110.804 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 164.0 53.24 0.02 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.6 66.14 0.75 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.661 -0.905 . . . . 0.0 109.77 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 464' ' ' GLN . 75.4 mt -77.2 -82.1 0.09 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.427 -0.795 . . . . 0.0 109.21 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 503' ' ' SER . 35.8 mm -152.64 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 109.255 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.471 ' CB ' ' HB3' ' A' ' 499' ' ' PHE . 3.9 t -100.74 10.67 40.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.572 -0.705 . . . . 0.0 111.077 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.449 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -91.92 72.63 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 51.0 ttm-85 -142.92 -73.96 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -90.37 -26.81 19.74 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.255 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -62.67 -48.06 80.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 110.512 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.477 ' N ' HD23 ' A' ' 493' ' ' LEU . 4.8 mt -71.64 -41.82 68.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.513 -0.742 . . . . 0.0 111.457 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 45.9 tp -102.66 -45.4 5.04 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -87.02 -5.02 59.21 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.076 -1.015 . . . . 0.0 112.492 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 62.41 47.22 91.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.02 -177.17 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.923 . . . . 0.0 109.411 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.87 48.62 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 109.12 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.471 ' HB3' ' CB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -113.92 148.74 36.28 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.076 0.941 . . . . 0.0 111.453 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 500' ' ' THR . 8.2 t -48.68 121.43 9.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.586 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 49.0 Cg_endo -78.84 114.36 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.384 1.202 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -170.69 33.36 0.16 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.827 ' HB2' HG21 ' A' ' 487' ' ' ILE . 36.7 t -80.75 143.22 33.08 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.922 ' HB ' HG12 ' A' ' 463' ' ' VAL . 48.1 m -115.25 108.48 16.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.942 HG21 HD21 ' A' ' 522' ' ' LEU . 41.4 t -113.09 141.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 1.01 HD12 HG22 ' A' ' 449' ' ' VAL . 15.9 pt -136.46 103.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 175.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.787 HG23 ' HB ' ' A' ' 466' ' ' ILE . 8.6 p -103.49 107.02 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.739 -1.225 . . . . 0.0 112.263 -176.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 3.9 t70 -85.18 107.95 17.49 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 6.5 tp-100 -131.0 115.18 16.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -73.33 -64.73 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.85 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.85 -12.87 1.96 Allowed 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.629 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.5 OUTLIER -63.74 -34.56 78.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.342 -0.849 . . . . 0.0 109.438 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 514' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 509' ' ' GLN . 22.9 t -90.4 -14.52 32.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.697 -0.627 . . . . 0.0 111.236 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 534' ' ' ILE . 42.6 tp -65.45 -48.92 71.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.038 -1.039 . . . . 0.0 108.922 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.676 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 98.8 mttt -69.86 -41.7 74.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.968 -0.457 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.92 -47.05 81.52 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 78.9 m -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.367 -0.833 . . . . 0.0 110.239 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -57.61 -39.58 77.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.849 -0.532 . . . . 0.0 110.674 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 11.5 m -61.97 -39.63 92.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.384 -0.823 . . . . 0.0 110.301 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.34 -41.68 96.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.873 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.942 HD21 HG21 ' A' ' 505' ' ' VAL . 2.6 mt -61.82 -22.4 65.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.748 -0.595 . . . . 0.0 110.458 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -47.24 -63.69 0.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.07 -51.71 50.85 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.708 -1.245 . . . . 0.0 110.46 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -29.34 65.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.908 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.469 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -59.99 -25.1 64.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.513 -0.742 . . . . 0.0 112.481 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -41.94 -27.74 0.13 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.542 -0.724 . . . . 0.0 111.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 1.9 t-80 -108.22 -126.94 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.73 . . . . 0.0 111.047 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -89.86 96.87 10.88 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.622 -1.299 . . . . 0.0 114.49 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -113.17 131.08 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 O-C-N 120.893 -1.129 . . . . 0.0 111.462 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 432' ' ' SER . 86.8 mt-30 -120.27 126.85 51.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.558 ' C ' HD12 ' A' ' 533' ' ' LEU . 49.7 t -117.08 123.51 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 122.581 1.181 . . . . 0.0 113.091 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 532' ' ' VAL . 9.2 mp -119.57 119.3 33.4 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.756 HG22 HG12 ' A' ' 507' ' ' VAL . 0.8 OUTLIER -132.78 129.01 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.658 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.66 HG22 ' HB ' ' A' ' 436' ' ' VAL . 30.2 p -101.58 -166.69 1.33 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 4.3 t0 -159.07 169.12 24.96 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.511 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -140.73 17.85 2.34 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.719 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.99 2.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 536' ' ' ASP . 83.9 mt-30 -96.75 1.19 50.58 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.507 -0.996 . . . . 0.0 111.947 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -53.45 -40.66 65.41 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.985 -1.072 . . . . 0.0 111.388 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.0 m -104.18 -45.18 4.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.162 -0.961 . . . . 0.0 111.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.85 67.27 0.34 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -65.39 -42.81 92.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.523 -0.987 . . . . 0.0 110.891 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.71 -39.83 97.96 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 57.3 m -60.56 -33.94 73.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.589 -0.948 . . . . 0.0 109.997 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.35 -37.2 82.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.14 -42.16 98.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.57 -0.706 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 99.1 mtp -65.44 -31.84 73.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.705 -0.622 . . . . 0.0 109.832 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.44 -54.05 48.66 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.513 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.434 ' CG ' HD11 ' A' ' 519' ' ' LEU . 43.2 ttp -60.22 -44.14 95.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.306 -0.871 . . . . 0.0 110.519 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.68 -31.57 72.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.359 -0.838 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -67.72 -15.59 63.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.089 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.676 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -75.59 6.73 4.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 112.098 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 151.15 -16.68 0.9 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.209 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.072 -1.252 . . . . 0.0 109.858 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.004 0.43 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.1 -46.62 86.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.518 -0.739 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.6 t -62.74 -44.03 97.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.787 -0.571 . . . . 0.0 110.303 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 433' ' ' LEU . 77.4 t -65.16 -34.64 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.0 -42.07 98.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.526 -0.734 . . . . 0.0 111.658 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.33 59.6 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.002 -1.061 . . . . 0.0 112.388 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.821 HD12 HD11 ' A' ' 399' ' ' ILE . 1.1 pp -69.62 -33.92 73.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.996 . . . . 0.0 111.057 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' SER . . . . . 0.421 ' N ' ' HG ' ' A' ' 395' ' ' LEU . 70.3 m -55.55 -43.07 75.48 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.589 -0.694 . . . . 0.0 111.226 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -68.09 -41.19 82.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -0.817 . . . . 0.0 111.518 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -65.51 -40.41 92.97 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.187 -0.946 . . . . 0.0 112.59 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 395' ' ' LEU . 0.0 OUTLIER -66.66 -39.24 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 121.147 -0.971 . . . . 0.0 109.882 -178.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.728 ' HG3' HD11 ' A' ' 435' ' ' ILE . 8.7 mtp -64.42 -39.73 94.41 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.153 -0.967 . . . . 0.0 109.174 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.74 -29.83 70.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 419' ' ' TYR . 59.8 tp60 -90.47 -11.15 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.473 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 400' ' ' MET . 40.1 t30 -69.54 -38.91 77.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.806 -0.559 . . . . 0.0 110.291 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -117.8 19.26 13.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.066 . . . . 0.0 109.872 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 407' ' ' VAL . 7.7 p -41.15 148.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 CA-C-O 121.176 0.513 . . . . 0.0 110.859 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.6 m -77.06 81.38 3.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.4 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 412' ' ' SER . 48.4 t -105.58 130.26 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.944 0.878 . . . . 0.0 111.702 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -96.79 144.38 27.76 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.66 -23.44 56.54 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.143 1.075 . . . . 0.0 110.767 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.398 -0.814 . . . . 0.0 110.69 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 56.76 0.5 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' SER . . . . . 0.787 ' HA ' HG13 ' A' ' 407' ' ' VAL . 11.7 p -69.53 137.43 52.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.443 -0.786 . . . . 0.0 111.334 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 407' ' ' VAL . 5.9 p -88.99 146.25 36.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.52 135.48 28.73 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.09 1.047 . . . . 0.0 111.276 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 417' ' ' ALA . 99.8 mtt180 -96.81 -87.84 0.3 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.714 -0.616 . . . . 0.0 109.515 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.0 t -29.8 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 415' ' ' ARG . . . -50.83 -69.99 0.1 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.302 -0.873 . . . . 0.0 111.46 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -77.36 -1.57 76.14 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.708 -1.245 . . . . 0.0 111.29 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.561 ' HD2' HG23 ' A' ' 399' ' ' ILE . 76.6 m-85 -108.25 0.32 21.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.791 -1.417 . . . . 0.0 110.28 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.42 ' HB2' ' HD3' ' A' ' 448' ' ' ARG . 70.0 p -92.6 -33.72 14.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -73.74 -37.2 65.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.83 82.73 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.43 0.633 . . . . 0.0 110.038 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.969 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.0 t -67.74 -42.66 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.624 -0.672 . . . . 0.0 111.758 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.6 m -59.82 -43.29 94.61 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.975 -1.078 . . . . 0.0 112.352 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.91 -50.58 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.013 -1.055 . . . . 0.0 109.747 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.969 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -47.75 -31.57 4.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.641 -0.662 . . . . 0.0 111.688 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.74 -35.46 74.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 109.292 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.32 -31.03 72.07 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.549 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.35 -74.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.585 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER 178.89 -53.91 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.18 -0.95 . . . . 0.0 110.108 178.225 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.5 Cg_endo -79.84 116.23 3.43 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.578 ' HA ' HD11 ' A' ' 426' ' ' LEU . 1.8 m -105.67 100.39 9.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.355 -0.938 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.469 ' HB3' HG11 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -149.4 137.72 20.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.421 ' HB1' HG22 ' A' ' 423' ' ' VAL . . . -173.45 160.72 3.95 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 120.511 -1.368 . . . . 0.0 112.762 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.728 HD11 ' HG3' ' A' ' 400' ' ' MET . 3.3 pt -122.32 117.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 423' ' ' VAL . 70.4 t -122.11 137.77 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 110.749 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.9 t -121.74 129.83 52.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.017 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.75 147.9 18.76 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -146.11 80.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.587 -0.949 . . . . 0.0 109.645 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 121.83 110.48 2.11 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.09 85.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.03 -19.72 25.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.587 -0.949 . . . . 0.0 110.613 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.93 92.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 110.914 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.9 -30.58 70.13 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -62.6 -40.19 96.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.611 -0.935 . . . . 0.0 110.44 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.684 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 8.4 mpt_? -64.37 -38.1 89.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -71.28 -30.15 65.92 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.3 -0.875 . . . . 0.0 109.996 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ARG . . . . . 0.42 ' HD3' ' HB2' ' A' ' 420' ' ' SER . 44.7 ttm-85 -64.81 -44.7 89.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.548 -0.72 . . . . 0.0 111.646 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.5 p -64.72 -32.44 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.663 ' HB1' ' HE ' ' A' ' 481' ' ' ARG . . . -64.42 -31.07 72.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.21 -38.02 75.95 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.051 -1.03 . . . . 0.0 108.445 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.4 -31.09 72.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.856 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.4 t -60.14 -32.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 58.2 mtt -66.13 -40.13 90.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 56.4 ttp -58.99 -21.07 58.21 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.241 0.543 . . . . 0.0 110.101 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.54 -22.64 30.05 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.37 -27.4 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -78.26 9.17 4.03 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.312 -0.868 . . . . 0.0 112.274 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.09 26.4 72.41 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.88 145.32 36.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 111.405 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -99.43 163.23 12.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.972 HG12 ' HB ' ' A' ' 504' ' ' THR . 33.7 m -132.21 158.77 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 118.924 -1.11 . . . . 0.0 112.268 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.847 ' HA ' HD22 ' A' ' 486' ' ' LEU . 57.1 tt0 -102.99 107.13 17.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 453' ' ' VAL . 0.5 OUTLIER -118.2 124.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.706 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.562 HG23 ' CD ' ' A' ' 471' ' ' ARG . 85.6 mt -122.03 115.37 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.862 -0.524 . . . . 0.0 110.916 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.684 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -66.17 165.63 13.35 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.471 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.607 ' HB3' ' NH2' ' A' ' 446' ' ' ARG . . . -59.01 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 511' ' ' GLU . 26.9 t0 -51.41 -19.07 1.21 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.956 -1.09 . . . . 0.0 111.129 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -78.98 -8.19 58.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -0.787 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 79.8 ttt-85 -52.36 -24.85 8.35 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.99 -1.069 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -58.12 -42.88 86.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.806 . . . . 0.0 109.358 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' GLN . . . . . 0.495 ' HA ' ' HE2' ' A' ' 476' ' ' MET . 85.0 mt-30 -65.09 -38.83 91.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.676 ' CE ' HD21 ' A' ' 482' ' ' LEU . 28.2 ttt -62.0 -32.28 72.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.783 -0.573 . . . . 0.0 110.29 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -61.69 -40.04 93.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 110.083 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 473' ' ' GLN . 73.4 mtm -62.51 -35.54 79.73 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.576 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 62.8 pttt -121.47 -148.06 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.426 ' HG2' ' CE ' ' A' ' 474' ' ' MET . 1.0 OUTLIER 53.6 70.09 0.63 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.161 -0.962 . . . . 0.0 111.192 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -112.98 23.8 13.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.68 3.21 26.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.854 . . . . 0.0 111.06 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.679 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -143.13 -29.8 0.53 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.19 -0.944 . . . . 0.0 111.664 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.679 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.5 OUTLIER -150.41 72.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.803 -1.186 . . . . 0.0 110.791 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.4 m -72.36 -18.42 61.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.464 -0.772 . . . . 0.0 110.121 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.43 46.68 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.6 pt-20 -149.01 103.74 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.926 . . . . 0.0 110.572 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.847 HD22 ' HA ' ' A' ' 464' ' ' GLN . 96.4 mt -98.46 -84.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.602 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 486' ' ' LEU . 3.3 mp -157.35 -65.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.08 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.6 t -99.9 11.12 40.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.469 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -92.91 77.22 1.17 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 54.5 ttt85 -145.17 -63.72 0.34 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 495' ' ' GLU . 92.7 mtt-85 -97.98 -31.32 12.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.421 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -64.53 -43.95 92.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 493' ' ' LEU . 2.2 mt -69.09 -38.53 79.01 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.318 0.58 . . . . 0.0 110.822 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 494' ' ' LEU . 7.4 tt -105.87 -48.4 3.64 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 491' ' ' ARG . 94.8 mt-10 -90.0 -10.3 45.45 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.666 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 496' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 491' ' ' ARG . . . 83.0 -13.16 45.81 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.641 -1.287 . . . . 0.0 111.017 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 70.6 mmm -67.86 -179.67 1.23 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.095 -1.238 . . . . 0.0 111.01 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.96 153.62 28.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.64 -0.663 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.52 151.03 32.08 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.773 0.797 . . . . 0.0 110.354 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -55.72 150.42 26.86 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.83 -0.544 . . . . 0.0 111.839 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 42.3 Cg_endo -70.66 115.74 4.35 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.653 1.344 . . . . 0.0 109.599 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -177.12 39.34 0.09 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.491 ' HA ' HG12 ' A' ' 487' ' ' ILE . 29.0 t -99.96 109.99 22.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.909 -0.76 . . . . 0.0 112.806 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.972 ' HB ' HG12 ' A' ' 463' ' ' VAL . 55.5 m -95.48 107.06 19.19 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 464' ' ' GLN . 43.4 t -109.58 126.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.414 -174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 533' ' ' LEU . 38.6 pt -122.59 109.99 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 534' ' ' ILE . 13.9 p -108.03 112.95 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 43.6 t0 -84.04 110.39 18.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.6 tm0? -97.39 175.2 6.33 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.356 1.074 . . . . 0.0 113.757 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -169.69 -44.05 0.03 OUTLIER Glycine 0 N--CA 1.508 3.46 0 N-CA-C 105.91 -2.876 . . . . 0.0 105.91 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 469' ' ' ASP . 73.1 mm-40 -99.54 -162.56 0.96 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -120.27 -1.67 10.22 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 111.222 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 513' ' ' LEU . 4.6 mm? -74.84 -27.4 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.751 . . . . 0.0 109.454 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 52.9 m -87.15 -17.09 33.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.66 -0.65 . . . . 0.0 112.008 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.435 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 31.7 tp -81.51 -52.59 7.07 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.847 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 54.5 mtmt -71.43 -43.47 66.68 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.599 -0.688 . . . . 0.0 112.207 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -40.0 95.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.027 -1.046 . . . . 0.0 111.143 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 466' ' ' ILE . 70.6 m -61.26 -48.32 81.97 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.264 -0.975 . . . . 0.0 108.744 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 519' ' ' LEU . 0.1 OUTLIER -58.15 -32.34 68.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.301 0.572 . . . . 0.0 109.654 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.6 m -61.79 -41.58 97.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.826 -0.546 . . . . 0.0 109.876 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.606 HD23 ' CD ' ' A' ' 464' ' ' GLN . 51.8 tp -69.55 -42.27 74.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 109.682 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.555 HD21 ' CG2' ' A' ' 505' ' ' VAL . 2.0 mt -59.6 -22.25 61.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.625 -0.672 . . . . 0.0 111.225 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.8 -57.4 4.92 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.672 -0.643 . . . . 0.0 112.235 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.59 50.03 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.009 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.36 64.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.882 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -56.48 -23.62 40.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.408 -0.808 . . . . 0.0 111.863 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.73 -36.61 37.28 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.125 -0.984 . . . . 0.0 110.919 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 66.6 m-70 -132.88 -69.79 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.374 -0.829 . . . . 0.0 111.13 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.58 ' C ' HG22 ' A' ' 530' ' ' VAL . 31.0 m-80 -83.56 154.92 23.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.31 -0.868 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.58 HG22 ' C ' ' A' ' 529' ' ' ASN . 0.0 OUTLIER -179.59 153.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 CA-C-O 121.401 0.62 . . . . 0.0 109.939 177.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' A' ' 432' ' ' SER . 0.1 OUTLIER -174.75 95.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 41.7 t -104.69 107.16 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.685 ' HB2' HG22 ' A' ' 506' ' ' ILE . 7.4 mp -108.31 114.1 27.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.941 HG22 HG12 ' A' ' 507' ' ' VAL . 8.2 pt -123.85 136.29 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.571 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.733 HG22 ' HB ' ' A' ' 436' ' ' VAL . 53.4 p -112.99 -169.63 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -157.87 166.14 33.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.032 -1.042 . . . . 0.0 110.85 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 2.9 p -146.83 21.94 1.26 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.81 -0.556 . . . . 0.0 109.912 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.39 -30.71 0.04 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -78.76 -0.13 29.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.086 -1.243 . . . . 0.0 111.142 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -38.88 -29.88 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -102.93 -29.44 11.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.43 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -120.22 59.08 0.55 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.5 t -64.57 -37.26 86.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.625 -0.927 . . . . 0.0 110.717 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 543' ' ' THR . . . -57.16 -43.8 93.35 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 93.9 p -63.56 -29.57 70.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.414 -1.051 . . . . 0.0 109.676 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.88 -35.39 80.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.732 -0.605 . . . . 0.0 109.882 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.9 mp -61.99 -41.14 97.72 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.5 mmm -64.74 -33.63 76.41 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.14 -53.57 56.58 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.105 0.479 . . . . 0.0 109.92 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.454 ' HG3' HD11 ' A' ' 519' ' ' LEU . 33.4 ttm -55.11 -47.19 75.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.427 -0.795 . . . . 0.0 110.332 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.606 -0.684 . . . . 0.0 111.401 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -66.38 -17.8 64.98 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -74.02 4.48 5.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.354 -0.841 . . . . 0.0 112.384 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 154.66 -17.54 0.57 Allowed Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.533 -1.318 . . . . 0.0 111.524 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.042 -1.269 . . . . 0.0 110.327 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 120.716 0.293 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 38.5 tp -59.4 -29.34 67.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 71.3 m -60.83 -44.99 96.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.571 -0.706 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.15 -34.18 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.704 . . . . 0.0 110.605 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -58.16 -52.5 65.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.421 -0.8 . . . . 0.0 111.576 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.54 78.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.386 -0.821 . . . . 0.0 109.954 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 399' ' ' ILE . 3.2 tt -62.17 -38.52 89.39 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.588 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.1 m -71.55 -34.18 69.79 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.984 -1.072 . . . . 0.0 112.137 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.71 -45.23 87.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.104 -0.997 . . . . 0.0 112.335 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -70.39 -41.62 72.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.122 -0.986 . . . . 0.0 111.999 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.501 ' HA ' ' CD1' ' A' ' 419' ' ' TYR . 50.0 mt -63.73 -40.72 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.358 -0.839 . . . . 0.0 108.936 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 ttm -58.62 -34.88 71.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.705 -0.622 . . . . 0.0 109.486 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.41 -20.08 62.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.055 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.763 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.2 tp-100 -91.58 -20.26 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.938 -1.101 . . . . 0.0 108.995 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.66 -32.67 73.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -116.36 19.75 14.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.088 -1.008 . . . . 0.0 110.286 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 407' ' ' VAL . 5.9 p -59.06 117.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.557 -0.714 . . . . 0.0 109.852 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.8 p -52.71 102.92 0.06 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.477 -0.764 . . . . 0.0 110.748 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 405' ' ' VAL . 57.8 t -107.59 132.86 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.553 -0.717 . . . . 0.0 110.233 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -93.94 139.77 22.74 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.532 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.75 -25.28 53.77 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.219 1.115 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.15 -29.15 69.39 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.522 0.677 . . . . 0.0 111.133 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 58.65 0.57 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 80.4 p -50.31 111.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.667 0.746 . . . . 0.0 111.941 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.632 HG13 ' HD2' ' A' ' 414' ' ' PRO . 32.9 t -64.03 150.49 91.81 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 413' ' ' VAL . 37.7 Cg_endo -63.48 147.86 92.95 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.313 1.165 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 407' ' ' VAL . 82.2 mtp180 -128.49 -15.35 4.55 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.625 -0.672 . . . . 0.0 112.604 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 420' ' ' SER . 10.2 t -103.88 18.32 22.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 108.391 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -86.21 -76.46 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.703 -0.623 . . . . 0.0 112.208 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -75.73 -4.01 74.85 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.972 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.503 ' CD2' ' HG2' ' A' ' 402' ' ' GLN . 96.8 m-85 -107.8 -13.88 14.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.293 1.546 . . . . 0.0 109.647 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 416' ' ' THR . 5.4 t -69.9 -41.33 74.85 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -68.73 -36.69 78.74 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.01 81.27 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 122.038 0.923 . . . . 0.0 109.807 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.884 HG21 HG22 ' A' ' 436' ' ' VAL . 79.4 t -69.07 -44.06 81.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -60.69 -38.92 86.57 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.879 -1.138 . . . . 0.0 111.287 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.19 -44.14 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -55.61 -32.61 63.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.651 -0.656 . . . . 0.0 111.74 -178.252 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.37 77.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.618 -1.301 . . . . 0.0 108.631 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.54 -30.1 71.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.78 -89.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 11.3 tpp180 -179.9 -58.58 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.506 -1.372 . . . . 0.0 109.017 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 430' ' ' ARG . 43.1 Cg_endo -68.61 99.78 0.65 Allowed 'Trans proline' 0 N--CA 1.485 1.004 0 N-CA-C 108.661 -1.323 . . . . 0.0 108.661 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.489 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 67.7 m -94.98 110.36 22.27 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.864 0.84 . . . . 0.0 111.872 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 1.3 tp -166.56 90.22 0.4 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -135.49 169.77 16.99 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.93 0.871 . . . . 0.0 112.439 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 435' ' ' ILE . 33.0 pt -127.22 130.21 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.425 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.884 HG22 HG21 ' A' ' 423' ' ' VAL . 47.6 t -125.66 97.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.864 -1.147 . . . . 0.0 110.311 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 37.3 m -76.01 129.5 36.96 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.382 -0.824 . . . . 0.0 111.145 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -107.19 170.93 16.13 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 415' ' ' ARG . 67.6 tp60 -170.03 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.522 -0.987 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -64.12 -49.7 65.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -156.32 141.95 8.38 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -111.85 -26.09 9.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.972 . . . . 0.0 110.639 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.57 88.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.394 -0.816 . . . . 0.0 110.617 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.39 -29.36 64.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.51 -39.01 91.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.62 -0.929 . . . . 0.0 109.477 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.635 ' O ' HG12 ' A' ' 449' ' ' VAL . 58.7 ttp180 -61.97 -46.52 88.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 111.391 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 2.9 tm-20 -73.11 -32.85 65.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.047 -1.033 . . . . 0.0 111.199 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -61.8 -47.37 85.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.807 HG11 ' OD2' ' A' ' 508' ' ' ASP . 3.7 p -57.44 -30.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.747 -1.221 . . . . 0.0 108.565 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.3 -26.42 68.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.87 -33.25 75.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.942 -1.099 . . . . 0.0 108.618 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm? -63.17 -33.97 76.62 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 90.1 t -59.75 -30.56 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.617 . . . . 0.0 109.586 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.22 -35.25 79.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -60.72 -28.75 68.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 109.597 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.7 31.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.512 -0.742 . . . . 0.0 109.72 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -63.61 -43.82 95.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.12 -30.61 69.81 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -76.28 5.48 6.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.564 -0.71 . . . . 0.0 111.757 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.4 75.19 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -138.44 120.32 15.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.485 -1.009 . . . . 0.0 110.802 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.06 171.12 14.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 109.246 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 30.0 m -140.14 155.14 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 111.433 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.966 ' HA ' HD22 ' A' ' 486' ' ' LEU . 51.7 tt0 -101.52 117.65 35.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.807 HD11 HD22 ' A' ' 482' ' ' LEU . 2.5 pt -128.38 136.15 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.809 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.678 ' N ' HD12 ' A' ' 466' ' ' ILE . 4.7 mp -125.42 117.38 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.092 -1.005 . . . . 0.0 111.279 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -65.79 161.17 21.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.734 -1.229 . . . . 0.0 109.016 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.74 -158.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 511' ' ' GLU . 28.8 p-10 -44.81 -21.58 0.06 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.818 -1.176 . . . . 0.0 112.411 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.2 -2.79 23.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.321 -0.862 . . . . 0.0 111.577 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.03 -41.33 82.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.94 -1.1 . . . . 0.0 111.735 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.1 m -55.82 -45.36 78.35 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.966 -1.084 . . . . 0.0 110.469 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.29 -37.16 86.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.491 -0.755 . . . . 0.0 108.972 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.2 ttp -60.52 -33.8 73.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.761 -0.587 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.83 -37.7 85.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.78 -40.85 94.12 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.248 -0.908 . . . . 0.0 109.722 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -121.93 -141.94 0.33 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 109.453 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 51.23 88.86 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.706 -1.246 . . . . 0.0 110.936 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -136.74 34.96 2.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.728 . . . . 0.0 109.157 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -128.52 -3.69 5.41 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.879 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.404 ' CB ' HD23 ' A' ' 482' ' ' LEU . 7.3 mtt180 -132.36 -13.28 3.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.97 -1.081 . . . . 0.0 112.443 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -169.59 71.83 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.893 -1.129 . . . . 0.0 111.169 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.7 p -92.41 50.04 1.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.43 36.16 7.11 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -122.27 47.25 1.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.622 -0.928 . . . . 0.0 110.104 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.966 HD22 ' HA ' ' A' ' 464' ' ' GLN . 20.7 mt -75.44 -79.87 0.09 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.68 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER 179.31 -42.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 110.342 174.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.609 HG23 HG22 ' A' ' 487' ' ' ILE . 3.2 p -103.85 8.94 37.05 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.564 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -97.95 60.29 0.99 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.376 -1.889 . . . . 0.0 108.376 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 67.6 ttt180 -142.42 -70.9 0.33 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -108.87 -21.0 12.86 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.872 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -65.42 -46.79 78.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.633 -0.667 . . . . 0.0 111.898 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.96 -56.72 2.98 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.0 111.075 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.2 tm? -65.17 -42.21 93.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.471 -0.768 . . . . 0.0 112.808 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -99.99 -3.32 32.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.944 -1.098 . . . . 0.0 113.142 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 65.05 47.82 77.81 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 44.3 mtt -119.75 -174.05 2.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.788 -0.831 . . . . 0.0 109.655 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.23 131.94 55.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.32 -0.863 . . . . 0.0 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.3 OUTLIER -115.19 140.32 49.19 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 500' ' ' THR . 2.2 t -44.7 99.96 0.22 Allowed Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 122.212 -0.305 . . . . 0.0 111.597 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 499' ' ' PHE . 41.9 Cg_endo -67.92 113.95 3.19 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 107.996 -1.579 . . . . 0.0 107.996 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 179.52 32.25 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.68 ' CB ' HD13 ' A' ' 487' ' ' ILE . 40.0 t -93.13 176.29 6.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.066 . . . . 0.0 111.591 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.916 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.2 m -116.61 124.23 49.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 464' ' ' GLN . 57.6 t -121.92 136.82 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 112.872 -175.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 533' ' ' LEU . 2.0 pp -130.07 110.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 534' ' ' ILE . 12.4 p -99.16 108.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.147 -1.596 . . . . 0.0 110.344 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.807 ' OD2' HG11 ' A' ' 449' ' ' VAL . 73.0 m-20 -82.78 108.25 16.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -97.8 174.66 6.49 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 122.743 1.259 . . . . 0.0 113.194 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.56 -64.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.822 0 N-CA-C 103.943 -3.663 . . . . 0.0 103.943 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 469' ' ' ASP . 32.3 tt0 -70.98 -142.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.02 -19.04 1.16 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.727 -1.233 . . . . 0.0 111.442 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.24 -21.92 62.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 77.3 p -72.05 -41.09 67.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.503 -0.748 . . . . 0.0 110.953 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 10.8 tp -65.39 -52.47 53.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.0 111.283 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.766 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 25.9 ttmt -67.36 -46.88 72.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.501 -0.75 . . . . 0.0 111.571 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.39 -49.01 79.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.272 -0.892 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.45 HG21 ' HB ' ' A' ' 507' ' ' VAL . 81.7 m -58.54 -42.67 88.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.475 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.2 OUTLIER -61.14 -40.41 93.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.326 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 37.8 p -64.88 -39.94 94.33 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.056 -1.027 . . . . 0.0 111.195 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.3 OUTLIER -66.76 -41.77 87.21 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.202 1.001 . . . . 0.0 108.588 178.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 505' ' ' VAL . 0.8 OUTLIER -65.36 -22.01 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.721 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -47.29 -62.82 1.25 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.318 -0.864 . . . . 0.0 112.992 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.79 61.71 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.313 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 488' ' ' THR . . . -61.68 -31.43 71.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.657 -0.908 . . . . 0.0 111.805 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.732 ' CB ' HG11 ' A' ' 530' ' ' VAL . . . -72.19 -22.57 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 112.382 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -40.57 -27.47 0.05 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.428 -0.795 . . . . 0.0 112.385 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 501' ' ' PRO . 49.7 t60 -114.23 -117.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 111.5 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.404 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 2.4 m120 -89.5 90.01 8.1 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.513 -1.367 . . . . 0.0 114.551 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.732 HG11 ' CB ' ' A' ' 526' ' ' ALA . 7.6 p -127.79 149.52 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 109.967 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 86.5 mt-30 -126.04 132.31 52.0 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.994 -0.441 . . . . 0.0 110.07 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 87.3 t -109.33 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.49 1.138 . . . . 0.0 111.576 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.3 OUTLIER -117.14 119.77 36.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 507' ' ' VAL . 4.5 pt -129.1 140.43 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.464 -1.294 . . . . 0.0 111.902 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.681 HG22 ' HB ' ' A' ' 436' ' ' VAL . 11.5 p -110.23 -174.23 2.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 28.9 m-20 -154.98 161.51 41.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.027 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 68.2 p -140.36 18.11 2.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.012 -0.43 . . . . 0.0 109.907 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.07 0.23 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -98.62 0.91 45.74 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.393 -1.063 . . . . 0.0 110.764 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -40.21 54.96 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.117 -0.99 . . . . 0.0 112.271 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 8.6 p -96.39 -63.76 1.11 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.256 -0.903 . . . . 0.0 110.764 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -89.12 95.2 2.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.4 t -98.51 -41.39 7.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.687 -0.89 . . . . 0.0 110.191 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.39 -37.46 93.86 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 46.5 t -63.91 -38.65 91.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.621 -0.929 . . . . 0.0 111.07 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.83 -39.08 87.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.515 -0.74 . . . . 0.0 110.663 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.46 -40.66 97.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.487 -0.758 . . . . 0.0 109.867 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.01 -32.25 73.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.675 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.49 -53.03 61.45 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.925 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.469 ' HB2' HD21 ' A' ' 515' ' ' LEU . 36.6 ttm -58.06 -48.35 80.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.381 -0.824 . . . . 0.0 110.768 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.82 -31.53 68.55 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.329 -0.857 . . . . 0.0 111.286 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.84 -21.71 66.01 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.3 -0.875 . . . . 0.0 110.382 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.766 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -72.26 0.28 10.31 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.263 -0.898 . . . . 0.0 112.532 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 125.48 -14.97 7.23 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.83 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.239 . . . . 0.0 109.832 -179.889 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.765 0.793 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 67.6 tp -63.41 -40.67 97.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.622 -0.674 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.6 m -60.87 -44.79 96.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.557 -0.714 . . . . 0.0 110.625 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 433' ' ' LEU . 85.8 t -66.75 -35.03 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.654 -0.653 . . . . 0.0 111.043 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -60.4 -49.13 78.8 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.992 -1.067 . . . . 0.0 111.272 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.19 80.15 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.134 -0.979 . . . . 0.0 109.613 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.7 OUTLIER -59.39 -40.27 86.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.444 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 396' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 400' ' ' MET . 47.3 t -63.34 -42.5 98.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -59.22 -45.8 90.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.257 -0.902 . . . . 0.0 111.917 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -65.88 -41.34 91.7 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.152 -0.968 . . . . 0.0 111.089 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.638 HG21 ' O ' ' A' ' 435' ' ' ILE . 92.9 mt -62.31 -41.02 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 396' ' ' SER . 32.4 mmm -63.42 -34.97 78.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.487 -0.758 . . . . 0.0 110.845 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.19 -28.28 67.83 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.828 -1.17 . . . . 0.0 110.221 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.449 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 58.8 tp60 -90.79 -20.03 22.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.805 -1.185 . . . . 0.0 108.498 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 400' ' ' MET . 39.6 t30 -64.46 -31.57 72.83 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -114.42 18.81 16.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -40.9 149.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 121.535 0.683 . . . . 0.0 112.149 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 23.3 p -87.43 72.86 9.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.709 HG23 HG12 ' A' ' 413' ' ' VAL . 12.3 p -91.61 131.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.363 -0.836 . . . . 0.0 112.219 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -96.89 144.1 27.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.635 . . . . 0.0 109.747 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.31 -20.82 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.405 1.213 . . . . 0.0 110.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -57.31 -40.87 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.85 0.833 . . . . 0.0 110.031 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -150.56 67.98 0.96 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 27.0 t -54.5 119.8 5.75 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 122.066 0.936 . . . . 0.0 112.048 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.709 HG12 HG23 ' A' ' 407' ' ' VAL . 7.3 p -71.06 147.65 93.84 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 413' ' ' VAL . 35.3 Cg_endo -59.42 135.15 63.1 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.058 1.031 . . . . 0.0 110.765 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ARG . . . . . 0.459 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 90.8 mtm-85 -103.51 -6.29 21.92 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.272 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 6.0 p -99.49 18.9 16.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.674 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.26 -35.01 6.93 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.67 94.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.778 ' CB ' HG13 ' A' ' 436' ' ' VAL . 4.0 m-85 -93.86 -9.9 35.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.762 -1.434 . . . . 0.0 110.399 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -43.98 61.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.867 -1.145 . . . . 0.0 109.004 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.78 -45.72 57.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.727 -0.608 . . . . 0.0 110.307 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 425' ' ' VAL . . . -61.48 -49.04 78.39 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.75 -0.594 . . . . 0.0 111.797 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.84 ' HA ' HD23 ' A' ' 426' ' ' LEU . 90.3 t -69.57 -43.43 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 0.0 112.575 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 79.5 p -62.26 -39.54 93.22 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.925 -1.109 . . . . 0.0 111.421 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.1 p -67.69 -28.13 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.321 -0.862 . . . . 0.0 111.821 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -75.02 -31.22 61.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 111.151 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.14 74.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.963 . . . . 0.0 109.203 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.21 -29.88 70.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.97 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.592 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.36 -52.3 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.713 -1.242 . . . . 0.0 111.671 177.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.5 Cg_endo -77.7 112.7 3.36 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 O-C-N 122.568 0.773 . . . . 0.0 110.775 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.493 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 0.3 OUTLIER -87.12 99.66 12.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.631 -0.668 . . . . 0.0 109.245 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.5 tp -162.67 92.56 0.79 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.171 -0.956 . . . . 0.0 111.063 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -139.83 170.56 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.542 0.687 . . . . 0.0 111.832 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.638 ' O ' HG21 ' A' ' 399' ' ' ILE . 45.3 pt -121.84 141.52 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 109.414 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.778 HG13 ' CB ' ' A' ' 419' ' ' TYR . 57.3 t -141.92 148.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -0.805 . . . . 0.0 109.806 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' OD1' ' A' ' 403' ' ' ASN . 44.5 t -127.38 133.64 50.01 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.439 -0.788 . . . . 0.0 110.272 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -115.17 129.51 8.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -130.61 34.19 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.616 -0.932 . . . . 0.0 109.818 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -148.73 -137.45 2.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -67.29 120.87 14.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.68 -9.13 23.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.883 . . . . 0.0 111.734 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.72 90.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.49 -28.2 73.34 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.33 -38.36 87.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.755 -0.85 . . . . 0.0 110.199 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.418 ' CD ' ' HB2' ' A' ' 467' ' ' ALA . 0.1 OUTLIER -59.86 -50.15 74.9 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.438 -0.789 . . . . 0.0 110.281 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.36 -29.28 67.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -61.04 -54.97 38.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.772 -0.58 . . . . 0.0 112.01 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.68 -35.65 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.909 -1.119 . . . . 0.0 109.394 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.476 ' HB2' ' HG2' ' A' ' 480' ' ' GLU . . . -63.53 -26.89 68.91 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.444 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.41 -34.78 79.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.037 -1.04 . . . . 0.0 108.828 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.97 -35.57 81.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 463' ' ' VAL . 88.6 t -58.42 -27.31 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.846 -0.534 . . . . 0.0 109.714 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.4 mtt -71.09 -34.92 71.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.29 -32.78 72.63 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.55 0.691 . . . . 0.0 109.604 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.63 -22.69 32.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.772 -0.58 . . . . 0.0 110.231 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -65.65 -42.74 91.06 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.259 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.59 -29.44 63.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.326 -0.859 . . . . 0.0 110.512 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.71 8.22 4.74 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 111.07 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.94 75.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.65 124.31 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -1.007 . . . . 0.0 110.527 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.618 ' C ' HD11 ' A' ' 487' ' ' ILE . 81.9 mt-10 -82.96 166.53 18.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.186 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.911 ' CG2' HG13 ' A' ' 453' ' ' VAL . 33.4 m -141.11 156.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.754 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.9 tt0 -102.6 120.05 39.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -126.09 128.51 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.192 -0.943 . . . . 0.0 111.104 -178.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.627 HG23 ' CD ' ' A' ' 471' ' ' ARG . 5.3 mp -125.5 121.2 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.418 ' HB2' ' CD ' ' A' ' 446' ' ' ARG . . . -81.25 165.04 21.82 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.277 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.66 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.423 0.63 . . . . 0.0 109.612 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -51.22 -12.63 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.736 -1.228 . . . . 0.0 112.639 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -81.99 -2.94 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.773 -1.204 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.627 ' CD ' HG23 ' A' ' 466' ' ' ILE . 70.1 ttp85 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.945 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 35.4 t -63.38 -44.24 95.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -62.85 -41.61 99.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.659 -0.65 . . . . 0.0 110.139 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.0 mmt -67.76 -29.08 68.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.625 . . . . 0.0 110.706 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -59.99 -42.13 93.57 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.655 -1.278 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 mtm -67.19 -39.22 86.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 109.629 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 477' ' ' LYS . 57.2 pttt -131.6 128.86 40.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.802 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 55.32 92.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.189 -0.944 . . . . 0.0 112.255 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 482' ' ' LEU . 75.7 m-20 -81.84 26.27 0.51 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.633 ' CB ' HD23 ' A' ' 482' ' ' LEU . 4.7 mp0 50.83 42.48 27.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.561 -1.337 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 57.09 21.92 6.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.633 HD23 ' CB ' ' A' ' 480' ' ' GLU . 0.3 OUTLIER -124.42 20.03 8.81 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.54 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.0 p -47.21 -22.25 0.36 Allowed 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 168.98 78.92 0.04 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -175.01 41.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.711 -0.876 . . . . 0.0 109.677 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 464' ' ' GLN . 78.2 mt -75.3 -82.76 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.969 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -162.15 -70.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.658 -1.276 . . . . 0.0 109.751 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.1 t -100.08 8.75 43.71 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.153 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.466 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -82.92 61.27 4.8 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.556 -2.217 . . . . 0.0 107.556 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.41 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 51.8 ttt85 -143.77 -68.51 0.33 Allowed 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.609 -0.936 . . . . 0.0 109.252 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -100.73 -31.06 11.38 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.487 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -62.02 -43.99 97.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.509 -0.744 . . . . 0.0 110.826 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 6.0 mt -72.42 -39.05 68.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.553 -0.717 . . . . 0.0 111.8 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 43.1 tp -106.11 -42.26 5.14 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -89.72 -4.06 57.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.892 -1.13 . . . . 0.0 113.254 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 66.13 47.16 75.04 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.3 mmm -120.01 177.29 5.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.944 -0.739 . . . . 0.0 111.128 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.38 134.51 54.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -114.75 149.32 37.07 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.871 0.843 . . . . 0.0 111.486 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 500' ' ' THR . 5.2 t -50.82 105.69 0.55 Allowed Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.48 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -78.47 112.75 3.23 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.283 1.149 . . . . 0.0 109.21 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -169.73 37.23 0.19 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.969 ' CB ' HD13 ' A' ' 487' ' ' ILE . 92.0 p -95.8 175.47 6.5 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.451 1.119 . . . . 0.0 113.713 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.855 ' HB ' HG12 ' A' ' 463' ' ' VAL . 23.2 m -125.92 106.99 10.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 522' ' ' LEU . 40.4 t -97.36 136.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.375 -0.828 . . . . 0.0 111.524 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 533' ' ' LEU . 3.9 pt -141.0 110.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 534' ' ' ILE . 7.1 p -112.21 114.65 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.388 -1.445 . . . . 0.0 113.152 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.44 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 98.3 m-20 -84.58 131.39 34.62 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.6 tp-100 -156.95 114.89 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.721 -1.592 . . . . 0.0 115.011 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -76.93 -66.54 1.8 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 31.1 tt0 -58.65 172.12 0.55 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.26 -13.75 11.71 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.196 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.66 -36.78 83.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.236 -0.915 . . . . 0.0 109.632 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 4.7 m -83.09 -13.8 54.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.776 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 509' ' ' GLN . 33.0 tp -69.15 -44.62 71.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 108.812 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.9 -36.01 77.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.851 -0.531 . . . . 0.0 111.401 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -57.28 -50.27 73.43 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.807 -1.183 . . . . 0.0 110.465 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.79 ' O ' HD12 ' A' ' 522' ' ' LEU . 68.3 m -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.599 -0.688 . . . . 0.0 110.502 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.75 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -57.37 -39.5 76.15 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.73 -0.606 . . . . 0.0 111.106 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.7 m -61.86 -39.65 92.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.389 -0.819 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.496 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.4 OUTLIER -65.92 -44.61 84.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.575 -0.703 . . . . 0.0 109.561 179.14 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 518' ' ' THR . 0.4 OUTLIER -61.11 -22.8 64.99 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.464 -0.772 . . . . 0.0 111.808 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -46.0 -60.84 2.03 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.233 -0.917 . . . . 0.0 112.174 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -74.02 -50.79 9.92 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.508 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.75 83.67 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.326 -1.103 . . . . 0.0 113.432 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 530' ' ' VAL . . . -65.67 -23.82 66.87 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -44.67 -25.87 0.32 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.381 -0.825 . . . . 0.0 111.514 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.06 -140.06 0.3 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.226 -0.921 . . . . 0.0 111.224 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 530' ' ' VAL . 1.9 t-20 -71.08 85.8 0.73 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.822 -1.174 . . . . 0.0 111.815 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 526' ' ' ALA . 71.6 t -146.2 168.13 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.097 -1.002 . . . . 0.0 111.494 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 432' ' ' SER . 8.5 tp60 -162.31 164.53 27.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 3.6 t -115.45 115.39 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.435 -0.791 . . . . 0.0 112.163 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.9 tp -110.78 120.53 42.69 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 507' ' ' VAL . 2.4 pt -139.95 146.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.079 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 436' ' ' VAL . 65.1 p -105.48 -169.5 1.6 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -158.75 167.95 28.14 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.321 -0.862 . . . . 0.0 109.923 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.498 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.8 OUTLIER -133.03 -6.64 3.07 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.677 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -129.09 28.42 4.1 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 44.5 tt0 -98.67 -1.49 40.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.757 -0.849 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -56.32 -43.95 79.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.206 -0.934 . . . . 0.0 112.173 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 26.2 m -102.6 -56.89 2.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.913 -1.117 . . . . 0.0 110.94 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -88.51 59.0 4.1 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.7 t -65.58 -44.38 86.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.983 . . . . 0.0 111.572 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.27 -40.26 98.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.5 m -62.9 -37.36 86.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.947 . . . . 0.0 111.53 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.64 -36.6 72.07 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.088 -1.008 . . . . 0.0 109.73 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.1 mp -63.85 -41.26 97.85 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.907 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.37 -30.12 70.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.188 -0.945 . . . . 0.0 109.017 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.53 -54.92 41.33 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.298 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.75 ' HG3' HD11 ' A' ' 519' ' ' LEU . 57.8 ttm -55.65 -46.82 77.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 551' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 555' ' ' VAL . 86.4 mttt -61.17 -31.78 71.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.576 -0.703 . . . . 0.0 112.183 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.71 -16.58 62.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.353 -0.842 . . . . 0.0 111.226 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 5.49 4.24 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.171 -0.956 . . . . 0.0 113.059 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 118.35 -16.58 11.62 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 120.805 -1.184 . . . . 0.0 111.037 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 551' ' ' LYS . 10.3 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.199 -1.177 . . . . 0.0 110.764 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 . . . . . 0 N--CA 1.503 2.175 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.74 -36.64 81.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.261 -0.899 . . . . 0.0 110.617 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.1 t -62.79 -43.15 99.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.435 -0.791 . . . . 0.0 109.487 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 81.0 t -66.31 -36.08 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.982 -0.449 . . . . 0.0 110.76 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -60.75 -50.51 73.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.19 -0.944 . . . . 0.0 110.232 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.37 -33.02 72.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 426' ' ' LEU . 7.6 tt -59.7 -39.7 85.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.81 -0.556 . . . . 0.0 110.621 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.1 p -68.6 -32.49 72.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.409 -0.807 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -64.34 -43.06 95.79 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.557 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -69.03 -40.31 78.7 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.0 112.719 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.446 HD11 HD21 ' A' ' 395' ' ' LEU . 61.9 mt -65.07 -43.37 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 27.2 mtp -61.86 -22.66 65.71 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.26 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -63.26 -30.54 71.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.104 -0.997 . . . . 0.0 108.984 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.727 ' NE2' HG11 ' A' ' 405' ' ' VAL . 1.8 mm-40 -90.04 -14.21 34.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.192 -0.942 . . . . 0.0 109.457 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 400' ' ' MET . 42.5 t-20 -66.39 -39.3 88.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.77 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -116.92 18.45 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.752 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 407' ' ' VAL . 6.3 p -59.43 114.93 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.385 -0.822 . . . . 0.0 109.793 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.0 p -52.12 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.171 -0.956 . . . . 0.0 110.95 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 405' ' ' VAL . 61.0 t -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.661 -0.65 . . . . 0.0 110.179 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.24 137.35 24.89 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 0.0 110.204 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.44 -29.3 45.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.165 1.087 . . . . 0.0 111.279 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.55 -25.59 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.119 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 60.54 0.5 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 m -58.91 115.79 3.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.495 0.664 . . . . 0.0 111.52 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 414' ' ' PRO . 6.9 p -64.15 150.09 92.91 Favored Pre-proline 0 N--CA 1.501 2.095 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -59.91 139.14 86.62 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 122.789 0.889 . . . . 0.0 110.228 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -116.38 -1.39 12.3 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.743 HG22 ' OH ' ' A' ' 419' ' ' TYR . 34.9 p -97.34 22.09 9.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.766 -1.209 . . . . 0.0 109.489 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -108.68 -31.58 7.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.37 -44.16 98.04 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.743 ' OH ' HG22 ' A' ' 416' ' ' THR . 27.0 p90 -103.04 -10.81 18.61 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.418 . . . . 0.0 111.875 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.0 t -67.22 -43.03 83.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 108.083 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.4 t0 -79.36 -44.32 21.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.933 -0.479 . . . . 0.0 111.304 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 425' ' ' VAL . . . -65.38 -46.33 80.54 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.629 -0.67 . . . . 0.0 112.417 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.837 ' HA ' HD23 ' A' ' 426' ' ' LEU . 88.8 t -70.37 -43.31 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.444 -0.785 . . . . 0.0 111.99 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -43.17 99.48 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.918 -1.114 . . . . 0.0 111.813 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 421' ' ' ASP . 33.1 m -64.47 -29.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.204 -0.935 . . . . 0.0 111.495 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -71.57 -33.99 69.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 111.737 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.57 -33.26 70.91 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.59 -30.76 71.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -64.21 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.485 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.2 OUTLIER -177.32 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 110.399 177.382 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -72.48 101.5 1.27 Allowed 'Trans proline' 0 N--CA 1.485 0.99 0 N-CA-C 109.455 -1.017 . . . . 0.0 109.455 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.477 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 26.4 t -87.72 101.2 13.45 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.559 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.98 89.33 0.79 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -131.68 164.84 25.05 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.882 0.848 . . . . 0.0 112.481 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.77 128.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 58.4 t -122.3 138.33 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.2 m -119.58 126.46 51.25 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 111.494 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -129.45 160.39 22.64 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -120.71 -30.63 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.896 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.1 173.45 31.27 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.17 29.73 70.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.706 ' HB3' ' NH2' ' A' ' 470' ' ' ARG . . . -67.89 -20.5 65.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.27 89.16 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.134 -0.979 . . . . 0.0 110.904 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.73 -37.12 57.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -62.17 -35.8 79.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.784 -0.833 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.873 ' HD3' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.52 -44.45 97.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.675 0.75 . . . . 0.0 109.724 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -68.84 -31.56 70.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.973 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -64.63 -45.04 88.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 111.713 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.0 p -58.15 -31.21 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.613 -1.305 . . . . 0.0 108.9 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.97 -27.05 68.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -64.51 -36.02 82.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.873 -1.142 . . . . 0.0 108.503 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 452' ' ' LEU . 4.5 mm? -65.38 -34.33 78.07 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.92 HG13 ' CG2' ' A' ' 463' ' ' VAL . 98.1 t -60.53 -30.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.3 mmm -68.33 -37.01 80.14 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.547 -0.72 . . . . 0.0 109.417 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -58.31 -28.82 65.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.767 -0.583 . . . . 0.0 109.976 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -85.03 -22.98 28.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -66.95 -44.6 80.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 110.413 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -74.42 -29.33 61.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.327 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.49 14.75 5.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.592 -0.692 . . . . 0.0 112.193 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.98 26.67 71.48 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.477 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 42.9 ttm180 -124.05 126.16 45.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.216 -1.167 . . . . 0.0 110.337 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 486' ' ' LEU . 53.8 mp0 -92.56 158.56 15.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.456 -0.777 . . . . 0.0 110.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.92 ' CG2' HG13 ' A' ' 453' ' ' VAL . 26.9 m -140.03 163.33 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.768 0.794 . . . . 0.0 111.516 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.709 ' OE1' HD13 ' A' ' 486' ' ' LEU . 43.4 tp60 -113.75 121.56 44.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.599 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -119.03 123.47 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.26 1.028 . . . . 0.0 111.829 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.686 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.5 mp -101.11 169.06 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.873 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -130.83 156.47 44.96 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.84 -159.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.448 -0.783 . . . . 0.0 110.019 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -48.66 -15.25 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.991 -1.068 . . . . 0.0 111.823 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ARG . . . . . 0.706 ' NH2' ' HB3' ' A' ' 442' ' ' ALA . 76.0 mtt85 -87.54 5.47 39.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.003 -1.061 . . . . 0.0 111.007 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.565 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 13.8 tpt180 -58.95 -36.94 75.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.298 -0.876 . . . . 0.0 111.447 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 21.9 t -59.7 -45.42 92.19 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.405 -0.809 . . . . 0.0 110.2 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.09 -41.0 95.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.361 -0.837 . . . . 0.0 110.396 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.445 ' SD ' ' NE2' ' A' ' 478' ' ' GLN . 18.5 ttm -62.84 -35.17 79.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 0.0 111.19 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -60.13 -39.26 85.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.346 -0.846 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.3 -40.23 93.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 63.1 pttt -109.18 -148.81 0.43 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.556 -0.715 . . . . 0.0 109.865 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.445 ' NE2' ' SD ' ' A' ' 474' ' ' MET . 44.7 tt0 50.46 80.6 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.195 -0.941 . . . . 0.0 110.957 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -123.73 34.75 5.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -125.9 4.81 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.494 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.41 ' CB ' HD23 ' A' ' 482' ' ' LEU . 0.5 OUTLIER -138.22 -34.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 112.503 -179.109 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 481' ' ' ARG . 0.4 OUTLIER -145.47 71.73 1.29 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.987 -1.071 . . . . 0.0 112.108 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 35.0 t -92.28 48.81 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.7 33.1 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -119.64 54.91 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.53 -0.982 . . . . 0.0 110.392 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.709 HD13 ' OE1' ' A' ' 464' ' ' GLN . 0.1 OUTLIER -101.59 -84.22 0.45 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.488 178.263 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 488' ' ' THR . 4.6 mp -140.97 -88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.257 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 26.4 p -102.7 22.48 13.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 111.511 -178.547 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -62.41 89.25 0.05 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -111.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 495' ' ' GLU . 94.9 mtt-85 -106.32 -21.97 12.95 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.616 -1.302 . . . . 0.0 109.416 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -47.96 -23.5 0.8 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.876 . . . . 0.0 111.629 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.51 -60.37 3.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 112.068 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 5.96 28.01 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.299 -1.501 . . . . 0.0 111.885 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 71.7 mm-40 -83.41 -6.07 59.35 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.035 -1.041 . . . . 0.0 112.702 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.84 -7.6 80.64 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.085 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.64 -176.23 0.61 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.176 -1.19 . . . . 0.0 109.493 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.56 167.52 10.53 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.01 150.91 29.94 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 488' ' ' THR . 9.4 t -82.5 138.99 44.29 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 139.05 52.85 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.283 1.149 . . . . 0.0 110.357 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 148.9 -9.09 0.98 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 10.9 t -77.41 139.03 39.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -1.154 . . . . 0.0 113.164 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.829 ' HB ' HG12 ' A' ' 463' ' ' VAL . 80.6 m -111.13 124.28 51.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 522' ' ' LEU . 50.4 t -116.34 125.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.61 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.829 HG22 ' HB3' ' A' ' 533' ' ' LEU . 22.6 pt -121.57 120.27 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 534' ' ' ILE . 9.6 p -120.21 108.86 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.145 -0.972 . . . . 0.0 111.622 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.515 ' OD2' HG11 ' A' ' 449' ' ' VAL . 95.0 m-20 -85.11 121.63 28.15 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.888 -1.132 . . . . 0.0 108.343 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.0 tp-100 -148.59 105.25 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -69.42 -38.79 80.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 4.9 tt0 -79.43 -155.44 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 -7.01 0.56 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.625 -0.672 . . . . 0.0 110.974 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.28 -34.42 74.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.357 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' SER . . . . . 0.443 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.6 m -87.71 -22.19 24.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.333 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.4 tp -68.74 -46.33 69.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.15 -0.969 . . . . 0.0 109.606 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 32.8 ttpt -69.09 -44.18 73.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.664 -0.648 . . . . 0.0 112.296 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 517' ' ' GLU . . . . . 0.443 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.5 OUTLIER -64.77 -39.99 94.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.498 -1.376 . . . . 0.0 110.452 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 77.5 m -60.42 -44.2 95.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.113 -0.992 . . . . 0.0 109.347 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.1 OUTLIER -55.85 -35.54 66.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.944 -0.473 . . . . 0.0 109.998 -179.226 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.5 m -59.05 -39.15 81.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.1 -40.86 78.1 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.492 0.663 . . . . 0.0 109.971 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.496 ' CD1' HG21 ' A' ' 505' ' ' VAL . 12.2 tp -63.77 -22.79 67.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.456 -0.777 . . . . 0.0 111.146 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 523' ' ' ASP . . . . . 0.553 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 98.6 m-20 -47.93 -57.42 5.73 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.446 -0.784 . . . . 0.0 111.774 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.32 -50.84 61.08 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.18 -29.88 34.21 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.482 -1.011 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.648 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -57.96 -23.51 54.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.776 -0.577 . . . . 0.0 111.255 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -41.39 -43.89 2.67 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.598 -0.689 . . . . 0.0 112.319 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 -62.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.577 ' C ' HG22 ' A' ' 530' ' ' VAL . 1.7 t-20 -80.77 156.09 26.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.392 -0.817 . . . . 0.0 110.468 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 526' ' ' ALA . 0.1 OUTLIER -174.34 151.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.988 0.899 . . . . 0.0 110.791 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.825 ' CB ' HG23 ' A' ' 504' ' ' THR . 0.0 OUTLIER -177.39 91.71 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 54.2 t -99.36 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.011 0.91 . . . . 0.0 111.3 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.829 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.77 113.41 26.63 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 176.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.735 HG22 HG12 ' A' ' 507' ' ' VAL . 0.6 OUTLIER -131.28 144.77 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.837 -177.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 69.9 p -105.6 -177.11 3.27 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -160.03 168.11 26.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.013 -1.055 . . . . 0.0 110.83 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.518 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -142.94 -4.89 0.91 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.328 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -103.98 5.64 46.58 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 543' ' ' THR . 97.0 mt-30 -82.42 -1.43 50.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -1.192 . . . . 0.0 111.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.59 -43.21 75.79 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 0.0 110.494 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 24.6 m -106.98 -45.02 4.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.56 70.41 0.3 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.9 t -64.76 -43.97 91.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.58 -0.953 . . . . 0.0 111.402 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 543' ' ' THR . . . -64.16 -29.64 75.52 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.099 -1.001 . . . . 0.0 110.637 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t -65.16 -36.07 83.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.301 -1.117 . . . . 0.0 110.797 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.11 -38.39 90.9 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.796 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.8 mp -62.63 -42.22 99.47 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.838 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.5 ttp -63.14 -35.76 81.36 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.275 -0.891 . . . . 0.0 108.705 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.98 -50.44 61.28 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.578 ' HG3' HD11 ' A' ' 519' ' ' LEU . 58.0 ttm -55.33 -49.15 72.93 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.795 -0.566 . . . . 0.0 110.395 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.58 -31.75 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.683 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.87 -17.09 64.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.843 . . . . 0.0 109.92 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -68.88 1.05 3.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.343 -0.848 . . . . 0.0 113.122 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 137.04 -11.2 3.89 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.224 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.257 -1.143 . . . . 0.0 110.25 -179.643 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.34 -40.16 96.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.71 -0.619 . . . . 0.0 111.135 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.4 m -61.25 -46.42 90.45 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.699 -0.626 . . . . 0.0 111.561 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 433' ' ' LEU . 67.7 t -66.29 -33.06 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 110.147 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -60.39 -48.75 80.4 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.937 -1.102 . . . . 0.0 109.848 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.824 . . . . 0.0 108.841 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.731 ' CD2' HD22 ' A' ' 426' ' ' LEU . 1.2 tp -60.54 -41.11 93.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.513 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -36.38 82.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.25 -0.906 . . . . 0.0 110.453 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -66.07 -45.25 81.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.382 -0.823 . . . . 0.0 112.194 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.87 -43.5 75.24 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.109 -0.994 . . . . 0.0 111.879 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.547 HG22 ' OD1' ' A' ' 403' ' ' ASN . 64.4 mt -63.69 -41.38 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.442 -0.786 . . . . 0.0 110.528 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.445 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 22.8 mtt -59.62 -33.22 71.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.736 -0.603 . . . . 0.0 110.445 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.31 -36.8 78.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.748 -0.595 . . . . 0.0 110.495 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 9.3 tp-100 -92.75 -13.9 28.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.638 -1.289 . . . . 0.0 110.02 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.547 ' OD1' HG22 ' A' ' 399' ' ' ILE . 13.9 m120 -69.28 -32.31 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -115.3 18.6 16.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.371 -0.831 . . . . 0.0 109.72 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.8 p -41.87 149.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.257 0.551 . . . . 0.0 112.095 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 47.5 p -82.65 72.97 9.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.435 HG23 HG13 ' A' ' 413' ' ' VAL . 8.1 p -101.49 131.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.393 -0.817 . . . . 0.0 111.313 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -94.91 145.0 28.77 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.08 -23.41 60.82 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.093 1.049 . . . . 0.0 110.272 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -55.87 -24.43 37.0 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.617 0.722 . . . . 0.0 110.861 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.99 63.1 0.46 Allowed 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 59.5 p -50.25 107.12 0.14 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.25 -0.906 . . . . 0.0 111.177 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 407' ' ' VAL . 4.3 m -62.65 153.62 77.51 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.58 122.17 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.254 -1.095 . . . . 0.0 109.254 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -96.62 -5.96 37.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 419' ' ' TYR . 13.4 p -93.3 22.79 4.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.767 -1.208 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -105.0 -37.3 7.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.767 . . . . 0.0 109.044 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 402' ' ' GLN . . . -62.48 -49.0 77.82 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 416' ' ' THR . 43.1 p90 -100.89 -8.89 22.11 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.503 1.652 . . . . 0.0 112.982 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 416' ' ' THR . 80.9 p -69.71 -36.59 76.05 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.574 -1.65 . . . . 0.0 107.05 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -78.64 -48.14 15.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.959 -0.463 . . . . 0.0 111.173 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.57 -48.7 78.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.429 -0.795 . . . . 0.0 111.251 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.878 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.1 t -65.28 -46.05 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.611 . . . . 0.0 111.803 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.6 t -61.19 -45.9 92.71 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.976 -1.077 . . . . 0.0 112.64 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.53 -46.95 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.116 -0.99 . . . . 0.0 110.715 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.878 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -53.33 -33.97 55.62 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 111.821 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.54 75.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.872 -1.142 . . . . 0.0 109.045 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -60.83 -29.15 69.32 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -66.84 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.516 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.6 -55.76 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.589 -1.319 . . . . 0.0 109.839 178.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.0 Cg_endo -71.99 106.21 1.97 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 N-CA-C 106.744 -2.06 . . . . 0.0 106.744 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.553 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 0.2 OUTLIER -90.52 99.92 12.86 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.107 -177.298 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 2.9 mt -141.99 140.39 32.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 533' ' ' LEU . . . -169.5 150.89 4.26 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.7 pt -119.43 120.97 65.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 535' ' ' THR . 82.1 t -125.36 139.98 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.1 t -117.05 122.43 44.14 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 155.35 20.57 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -136.12 -36.21 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.574 -0.957 . . . . 0.0 111.439 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.13 155.51 26.18 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.15 62.23 4.85 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -86.54 -21.35 26.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.997 . . . . 0.0 110.537 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.83 84.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.393 -0.817 . . . . 0.0 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 -36.4 77.22 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.73 -35.77 75.23 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 109.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 467' ' ' ALA . 16.0 tpt85 -62.97 -49.79 73.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.63 -0.669 . . . . 0.0 112.243 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 4.7 mt-10 -74.5 -31.13 62.07 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.963 -1.086 . . . . 0.0 111.108 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.73 -48.4 81.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.372 -0.83 . . . . 0.0 110.275 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 506' ' ' ILE . 9.6 p -61.46 -31.34 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.737 -1.227 . . . . 0.0 108.655 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.14 -29.53 70.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.4 -32.38 73.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.112 -0.993 . . . . 0.0 108.358 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.35 -35.09 76.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.934 HG13 ' CG2' ' A' ' 463' ' ' VAL . 52.0 t -61.1 -26.5 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.6 tpp -66.66 -40.16 88.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.358 -0.839 . . . . 0.0 108.748 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -56.49 -27.09 56.21 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.95 -23.4 31.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.78 -34.24 71.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -82.22 10.21 7.28 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.608 -0.683 . . . . 0.0 112.077 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.44 29.83 71.49 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' ARG . . . . . 0.622 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 19.8 tpp85 -126.02 126.98 45.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.95 . . . . 0.0 110.546 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 48.7 tp10 -95.94 160.22 14.57 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.934 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.1 m -142.27 161.36 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.777 -1.202 . . . . 0.0 112.493 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.544 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 58.7 tt0 -107.54 122.82 47.44 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -128.09 128.55 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.505 -0.747 . . . . 0.0 110.782 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.529 HD12 HG21 ' A' ' 518' ' ' THR . 78.6 mt -126.89 122.16 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.607 -0.683 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.611 ' HB2' ' HD3' ' A' ' 446' ' ' ARG . . . -86.69 169.02 13.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.045 -1.035 . . . . 0.0 108.776 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 467' ' ' ALA . . . -57.28 -160.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.64 -15.95 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.661 -1.274 . . . . 0.0 113.412 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -76.35 -9.44 58.64 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.591 -1.318 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -57.35 -32.85 67.16 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.055 . . . . 0.0 111.093 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 26.2 t -62.16 -44.46 96.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.415 -0.803 . . . . 0.0 110.047 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.16 -41.53 94.58 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.428 -0.795 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.48 76.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.547 -0.721 . . . . 0.0 110.578 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.61 -39.13 87.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.181 -0.95 . . . . 0.0 109.376 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -39.72 95.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -100.07 -146.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.68 80.06 0.1 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.807 -1.183 . . . . 0.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.45 14.06 15.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.965 -0.459 . . . . 0.0 110.291 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -92.5 -2.32 56.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 111.686 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -178.66 33.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.058 -1.026 . . . . 0.0 110.823 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 482' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 481' ' ' ARG . 1.4 tp -151.61 7.14 0.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.185 -1.006 . . . . 0.0 113.596 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.8 t -55.0 -25.22 28.44 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.474 -1.391 . . . . 0.0 110.445 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 160.46 41.65 0.02 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -130.86 30.65 4.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.663 -0.904 . . . . 0.0 109.314 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.574 HD12 HG12 ' A' ' 487' ' ' ILE . 1.9 tp -60.33 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 1.045 HG22 HG23 ' A' ' 488' ' ' THR . 29.5 mm -153.23 -82.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 108.656 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 488' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 487' ' ' ILE . 24.4 p -100.34 11.36 39.59 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.347 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -77.42 63.91 3.28 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -135.48 -70.96 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' ARG . . . . . 0.445 ' HD3' ' CE ' ' A' ' 497' ' ' MET . 87.2 mtt-85 -118.52 -8.23 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.848 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 492' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 499' ' ' PHE . 4.3 mp0 -73.45 -38.05 65.62 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 521' ' ' LEU . 2.8 mt -93.85 -21.44 19.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 25.8 tp -103.64 -31.3 9.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 491' ' ' ARG . 0.5 OUTLIER -131.47 -2.13 3.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.559 -1.338 . . . . 0.0 113.148 -177.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 78.77 49.26 6.62 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 118.646 -1.74 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' MET . . . . . 0.445 ' CE ' ' HD3' ' A' ' 491' ' ' ARG . 1.8 ttm -112.41 -177.38 3.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -118.82 137.34 53.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.679 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -114.4 150.02 35.29 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.314 -0.866 . . . . 0.0 111.902 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 500' ' ' THR . 8.7 t -64.0 115.32 18.25 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.963 -0.46 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.459 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -69.3 115.71 4.16 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.217 1.114 . . . . 0.0 110.282 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 502' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -157.75 19.69 0.37 Allowed Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 487' ' ' ILE . 17.3 p -97.89 174.42 6.59 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.774 1.274 . . . . 0.0 113.751 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.815 ' HB ' HG12 ' A' ' 463' ' ' VAL . 10.1 m -122.5 103.53 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.553 HG11 HD22 ' A' ' 522' ' ' LEU . 62.1 t -90.44 134.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 0.7 OUTLIER -134.39 121.49 36.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.534 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.918 HG22 ' HG2' ' A' ' 509' ' ' GLN . 7.5 p -115.94 104.18 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.537 -1.352 . . . . 0.0 111.446 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.83 99.36 10.85 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.918 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.4 mm-40 -111.62 103.9 12.24 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -175.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.41 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -71.63 -36.5 62.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -98.9 163.16 12.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.486 ' HD3' HD13 ' A' ' 515' ' ' LEU . 56.0 mmtt -100.33 -9.05 22.71 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.825 -0.547 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.3 OUTLIER -61.67 -41.34 97.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.298 -0.876 . . . . 0.0 109.534 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -6.13 48.34 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.589 -0.695 . . . . 0.0 111.276 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.486 HD13 ' HD3' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -69.78 -56.5 6.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 178.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.2 -40.68 64.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.473 -0.767 . . . . 0.0 111.468 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.009 -1.057 . . . . 0.0 110.605 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.529 HG21 HD12 ' A' ' 466' ' ' ILE . 98.6 m -60.07 -44.41 94.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.223 -0.923 . . . . 0.0 108.789 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.753 HD11 ' HE3' ' A' ' 550' ' ' MET . 0.4 OUTLIER -50.8 -37.44 42.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -0.763 . . . . 0.0 110.434 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.3 m -64.77 -42.28 95.21 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.525 -0.734 . . . . 0.0 111.852 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.5 OUTLIER -66.23 -47.16 74.71 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.226 -0.922 . . . . 0.0 111.565 -178.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 0.553 HD22 HG11 ' A' ' 505' ' ' VAL . 4.3 pp -78.2 -18.11 55.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.396 -0.815 . . . . 0.0 111.9 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -47.07 -46.1 22.24 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.405 -0.81 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.31 90.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.41 -37.89 89.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.787 . . . . 0.0 111.668 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -29.38 70.25 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.063 -1.023 . . . . 0.0 111.005 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -58.15 -27.39 63.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.044 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 65.4 m80 -108.9 -117.66 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.832 -0.542 . . . . 0.0 111.094 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.409 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 10.5 m120 -91.28 65.78 5.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.405 -1.434 . . . . 0.0 113.666 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 530' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -139.71 165.18 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.551 -1.343 . . . . 0.0 110.279 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 15.1 mp0 -150.5 161.02 43.33 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.729 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 18.9 t -112.3 107.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.992 -1.068 . . . . 0.0 113.075 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 434' ' ' ALA . 7.2 tp -110.67 117.48 33.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.738 HG22 HG12 ' A' ' 507' ' ' VAL . 10.7 pt -137.36 133.71 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 117.996 -1.481 . . . . 0.0 113.148 -175.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 436' ' ' VAL . 82.4 p -99.02 -168.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -155.54 164.67 38.36 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.41 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.3 OUTLIER -142.28 -18.81 0.71 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.551 178.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -111.77 -17.05 8.77 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' GLN . . . . . 0.483 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 1.0 OUTLIER -87.69 1.74 52.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.452 -1.028 . . . . 0.0 110.265 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -32.32 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 78.3 p -101.05 115.16 29.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 69.8 59.8 5.35 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 539' ' ' GLN . 58.7 p -68.46 -10.32 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.949 -0.736 . . . . 0.0 110.659 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.96 80.48 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 39.0 m -61.08 -29.85 69.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.974 . . . . 0.0 109.312 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.734 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.65 -32.26 70.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.922 -0.486 . . . . 0.0 110.028 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.1 mp -61.8 -42.62 99.23 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 109.26 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 64.3 mtt -64.64 -34.31 77.98 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.92 -51.75 28.39 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.753 ' HE3' HD11 ' A' ' 519' ' ' LEU . 96.4 mmm -56.1 -42.57 76.98 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -57.56 -31.72 66.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.528 -0.732 . . . . 0.0 110.059 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -62.76 -30.0 71.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 519' ' ' LEU . . . -69.34 -7.61 38.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.648 -0.658 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.25 -5.16 38.41 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.515 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 555' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.501 2.125 0 CA-C-N 118.942 1.371 . . . . 0.0 111.117 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.122 0.486 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -40.27 95.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.497 -0.752 . . . . 0.0 110.193 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 75.7 p -61.32 -40.79 95.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.664 -0.647 . . . . 0.0 110.946 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.8 t -71.3 -24.11 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.587 -0.696 . . . . 0.0 111.769 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.11 -52.92 52.58 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.945 -1.097 . . . . 0.0 111.178 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.94 78.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.438 -0.789 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.739 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.1 tt -62.18 -41.02 97.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.743 -0.598 . . . . 0.0 111.152 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 11.1 t -62.81 -40.26 96.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 0.0 111.309 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.76 -44.34 93.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.415 -0.803 . . . . 0.0 110.861 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -65.52 -38.1 88.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.359 -0.838 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.5 OUTLIER -64.13 -40.85 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.241 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 400' ' ' MET . . . . . 0.648 ' CG ' HD11 ' A' ' 435' ' ' ILE . 56.6 mtp -63.39 -28.82 70.25 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.83 -26.83 66.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.255 -0.903 . . . . 0.0 108.799 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.625 ' O ' HG12 ' A' ' 405' ' ' VAL . 2.0 tm0? -90.44 -18.45 25.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -66.04 -38.48 88.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.688 -0.633 . . . . 0.0 110.397 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -116.5 18.67 15.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 402' ' ' GLN . 8.2 p -60.39 118.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.506 -0.746 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 406' ' ' THR . 5.8 t -53.11 101.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.417 0.627 . . . . 0.0 111.536 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.763 HG23 HG12 ' A' ' 413' ' ' VAL . 4.0 p -114.21 134.62 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' HIS . . . . . 0.432 ' CB ' ' HE2' ' A' ' 411' ' ' LYS . 0.1 OUTLIER -91.09 141.53 26.5 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.438 -0.789 . . . . 0.0 109.8 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.53 -27.72 32.73 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.151 1.08 . . . . 0.0 110.138 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.86 -34.12 76.08 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.761 0.791 . . . . 0.0 109.668 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 408' ' ' HIS . 0.0 OUTLIER -138.82 58.66 1.64 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 412' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 13.7 t -50.68 98.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.116 -0.99 . . . . 0.0 111.81 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 407' ' ' VAL . 7.6 p -58.61 148.44 66.53 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.93 -0.482 . . . . 0.0 109.713 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' PRO . . . . . 0.545 ' HD2' HG23 ' A' ' 413' ' ' VAL . 38.4 Cg_endo -63.47 149.76 90.26 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.228 1.12 . . . . 0.0 109.682 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -136.3 -8.86 1.98 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.667 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 420' ' ' SER . 19.2 p -102.17 19.32 18.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -80.32 -77.01 0.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.612 -0.68 . . . . 0.0 111.854 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -84.36 -2.23 89.15 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.217 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 423' ' ' VAL . 85.3 m-85 -107.14 -20.89 13.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 120.573 2.187 . . . . 0.0 108.827 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 416' ' ' THR . 37.6 t -72.67 -40.61 66.14 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 425' ' ' VAL . 35.5 t0 -65.66 -38.11 88.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.4 -39.09 89.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.807 0.813 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.73 ' CG1' HD21 ' A' ' 533' ' ' LEU . 63.5 t -66.39 -44.97 90.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -61.42 -35.58 77.96 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.964 -1.085 . . . . 0.0 111.257 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 421' ' ' ASP . 93.0 t -62.27 -47.46 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.427 -0.795 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 423' ' ' VAL . 1.4 pp -57.56 -33.29 67.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.413 -0.804 . . . . 0.0 111.996 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' A' ' 533' ' ' LEU . . . -68.17 -36.96 80.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.716 -1.24 . . . . 0.0 108.333 178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -31.93 71.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -65.65 -90.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 8.3 tpp85 -178.54 -57.97 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.406 -1.434 . . . . 0.0 109.097 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -68.33 93.54 0.41 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 5.5 t -85.96 111.48 20.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -163.97 89.12 0.55 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.513 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -139.15 168.31 20.13 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.686 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.648 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.6 pp -127.82 130.93 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.617 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 423' ' ' VAL . 9.4 t -124.38 150.83 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 13.8 m -123.05 127.46 48.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.315 -0.865 . . . . 0.0 110.663 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -122.49 160.3 16.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -148.85 -47.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.911 . . . . 0.0 109.562 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -101.46 142.44 15.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 73.87 89.16 0.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.7 -44.69 4.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.945 . . . . 0.0 110.804 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.27 97.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.784 . . . . 0.0 110.775 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.11 62.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.37 -41.76 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -1.027 . . . . 0.0 110.771 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.86 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.5 -43.85 98.13 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -67.73 -29.13 68.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.199 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -61.61 -47.66 84.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.524 -0.735 . . . . 0.0 110.864 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -59.66 -31.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.857 -1.152 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.0 -27.88 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.576 -0.849 . . . . 0.0 108.758 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.84 -34.06 77.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.149 -0.97 . . . . 0.0 108.448 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' LEU . . . . . 0.408 ' O ' ' CG ' ' A' ' 455' ' ' MET . 33.3 tp -62.62 -34.99 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.78 HG13 ' HB ' ' A' ' 463' ' ' VAL . 59.9 t -63.01 -25.81 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 79.9 mtp -69.81 -42.37 73.77 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.878 . . . . 0.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.0 OUTLIER -62.39 -20.8 64.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.121 -0.987 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.0 -22.69 36.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 0.0 109.745 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.26 -41.91 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.333 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.25 -26.74 63.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.486 -0.759 . . . . 0.0 109.51 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.1 2.86 16.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.0 111.707 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 83.95 4.27 88.68 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.033 -1.042 . . . . 0.0 111.878 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 132.2 33.78 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.993 1.397 . . . . 0.0 111.136 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 487' ' ' ILE . 55.8 mp0 -76.7 -174.38 2.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.61 -0.681 . . . . 0.0 110.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.78 ' HB ' HG13 ' A' ' 453' ' ' VAL . 43.0 t -134.95 144.77 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' GLN . . . . . 0.597 ' HB3' HG22 ' A' ' 505' ' ' VAL . 50.8 tt0 -92.44 114.56 27.14 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' ILE . . . . . 0.544 HD13 ' N ' ' A' ' 466' ' ' ILE 0.255 0.0 OUTLIER -127.3 129.13 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 111.431 -175.811 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.751 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.1 mt -124.71 120.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.834 -0.542 . . . . 0.0 110.545 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -78.16 164.45 24.95 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.34 -160.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.81 -0.556 . . . . 0.0 110.085 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -51.37 -17.08 0.66 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.76 -1.213 . . . . 0.0 111.082 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -73.44 -6.33 45.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.481 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ARG . . . . . 0.703 ' HD3' HG23 ' A' ' 466' ' ' ILE . 62.2 ttp180 -57.54 -31.62 66.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.3 m -59.08 -45.69 90.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.547 -0.721 . . . . 0.0 110.301 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.56 -40.43 95.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.494 -0.754 . . . . 0.0 109.056 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 92.7 mtp -62.37 -33.15 74.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.829 -0.544 . . . . 0.0 110.744 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -61.25 -38.98 88.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.949 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.5 ttp -59.18 -40.13 84.71 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.43 -0.794 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 62.6 pttt -119.58 -146.39 0.38 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 478' ' ' GLN . . . . . 0.437 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.3 mm-40 43.64 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.135 -0.978 . . . . 0.0 112.131 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -121.35 14.04 11.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.528 -0.732 . . . . 0.0 110.527 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -101.61 -10.12 20.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 111.659 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -132.15 0.41 3.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.109 -0.994 . . . . 0.0 112.939 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.32 44.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.656 -1.278 . . . . 0.0 112.873 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.7 t -89.34 48.76 1.65 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.654 -1.279 . . . . 0.0 110.47 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.06 58.24 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.8 44.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -1.15 . . . . 0.0 109.672 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 487' ' ' ILE . 95.1 mt -59.03 -84.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.923 -1.11 . . . . 0.0 109.318 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 462' ' ' GLU . 22.8 mm -156.37 -82.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.83 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 488' ' ' THR . . . . . 0.459 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.5 t -98.37 11.57 37.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.791 -0.568 . . . . 0.0 110.472 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.96 74.65 2.29 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.421 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 72.8 ttt-85 -144.83 -72.5 0.26 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -107.42 -22.73 12.46 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.565 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.02 -37.93 89.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.196 -0.94 . . . . 0.0 109.847 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 493' ' ' LEU . 1.3 mt -89.32 -53.72 4.43 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.022 0.915 . . . . 0.0 108.647 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.39 -42.96 87.14 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.032 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -112.79 -8.81 13.72 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.16 -4.74 79.84 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.273 -1.517 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 94.6 mtp -68.52 -177.73 0.99 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.056 -1.261 . . . . 0.0 110.594 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.54 148.33 32.35 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.446 -0.784 . . . . 0.0 110.652 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.459 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.34 155.15 25.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.069 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -51.31 116.68 7.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.18 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 501' ' ' PRO . . . . . 0.538 ' HG3' ' CD2' ' A' ' 528' ' ' HIS . 48.3 Cg_endo -76.41 114.45 3.88 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.434 1.229 . . . . 0.0 110.41 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.2 28.62 0.03 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' SER . . . . . 0.595 ' CB ' HG21 ' A' ' 487' ' ' ILE . 47.1 t -92.01 169.24 10.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.363 -1.081 . . . . 0.0 111.833 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.73 ' O ' HG13 ' A' ' 463' ' ' VAL . 52.6 m -110.88 117.86 34.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 1.069 HG11 HD21 ' A' ' 522' ' ' LEU . 32.1 t -112.33 130.23 66.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.725 0.774 . . . . 0.0 110.008 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 533' ' ' LEU . 14.6 pt -138.91 131.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.125 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.751 HG23 ' HB ' ' A' ' 466' ' ' ILE . 7.7 p -129.63 109.25 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.243 1.021 . . . . 0.0 111.245 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 508' ' ' ASP . . . . . 0.508 ' OD2' HG11 ' A' ' 449' ' ' VAL . 80.4 m-20 -85.47 110.16 18.98 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.595 ' HG2' HG22 ' A' ' 507' ' ' VAL . 90.4 mm-40 -126.19 106.91 9.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 510' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -72.39 -37.61 58.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.455 ' HG2' HD21 ' A' ' 513' ' ' LEU . 30.4 tp10 -85.97 149.15 25.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.0 -15.59 18.22 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.55 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 511' ' ' GLU . 3.5 pp -72.41 -31.41 65.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 5.0 m -83.45 -20.08 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.435 -0.791 . . . . 0.0 110.469 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 519' ' ' LEU . 54.3 tp -65.84 -43.99 86.86 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.5 -40.31 85.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.849 -0.532 . . . . 0.0 111.371 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.01 -51.72 68.12 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.065 -1.022 . . . . 0.0 110.719 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.519 HG21 HD12 ' A' ' 466' ' ' ILE . 92.2 m -59.34 -39.53 83.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.846 HD11 ' CE ' ' A' ' 550' ' ' MET . 0.8 OUTLIER -59.49 -38.52 81.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 122.092 -0.38 . . . . 0.0 111.279 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 69.5 p -64.11 -30.88 71.92 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.939 -1.1 . . . . 0.0 109.297 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 48.7 tp -70.02 -41.26 74.52 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.733 0.777 . . . . 0.0 109.331 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' LEU . . . . . 1.069 HD21 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -72.83 -20.63 61.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.98 -0.45 . . . . 0.0 111.672 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 523' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -48.22 -58.88 3.93 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.264 -0.897 . . . . 0.0 111.439 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.29 80.21 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.746 ' HB1' ' HB2' ' A' ' 529' ' ' ASN . . . -58.03 -30.37 66.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.877 -0.778 . . . . 0.0 110.575 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -52.24 -27.53 15.22 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.126 -0.984 . . . . 0.0 110.782 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -64.24 -36.79 85.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.633 -0.667 . . . . 0.0 109.27 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 528' ' ' HIS . . . . . 0.538 ' CD2' ' HG3' ' A' ' 501' ' ' PRO . 0.3 OUTLIER -132.2 -60.11 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.674 -0.641 . . . . 0.0 110.775 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 529' ' ' ASN . . . . . 0.746 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . 5.7 m120 -78.68 116.27 18.93 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.678 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 2.4 p -169.68 144.11 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 C-N-CA 117.262 -1.775 . . . . 0.0 115.462 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 505' ' ' VAL . 1.8 mt-30 175.9 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 534' ' ' ILE . 80.3 t -115.0 114.73 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.501 0 O-C-N 120.525 -1.36 . . . . 0.0 113.853 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.73 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -116.93 117.47 29.79 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 103.447 -2.798 . . . . 0.0 103.447 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 534' ' ' ILE . . . . . 0.662 HG22 HG12 ' A' ' 507' ' ' VAL . 6.2 pt -135.43 149.12 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.416 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.441 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 49.2 p -112.86 -168.07 1.27 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -158.69 168.14 27.66 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.733 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' SER . . . . . 0.419 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -144.32 17.68 1.71 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.214 0.53 . . . . 0.0 109.675 178.118 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -150.84 27.14 1.03 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -92.62 0.03 57.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.6 -0.941 . . . . 0.0 111.288 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -54.36 -43.66 71.51 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.869 -1.144 . . . . 0.0 110.048 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 73.3 p -113.88 155.38 25.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.13 43.76 83.64 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -63.22 -43.96 96.64 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.314 -1.11 . . . . 0.0 110.866 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 544' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.49 -34.24 89.4 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 65.9 m -62.39 -36.41 82.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.9 -0.765 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.34 -39.89 84.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.353 -0.842 . . . . 0.0 109.871 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.3 mp -62.94 -41.77 99.59 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.635 0.731 . . . . 0.0 109.074 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 97.4 mtp -62.69 -28.12 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.82 -53.98 50.16 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 550' ' ' MET . . . . . 0.846 ' CE ' HD11 ' A' ' 519' ' ' LEU . 89.8 mmm -55.62 -46.15 77.43 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.28 -0.888 . . . . 0.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.39 -30.88 71.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.708 -0.62 . . . . 0.0 111.424 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -67.19 -18.02 65.08 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.552 -0.717 . . . . 0.0 110.895 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.82 7.08 4.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.402 -0.811 . . . . 0.0 112.679 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.85 -12.69 9.29 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.094 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.057 -1.26 . . . . 0.0 109.826 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.166 0.508 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 15.2 m -82.02 150.66 27.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.807 -0.558 . . . . 0.0 110.26 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 78.35 23.49 65.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 41.3 pt -97.57 -4.34 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.485 -1.009 . . . . 0.0 111.311 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -62.71 -44.86 95.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.916 -1.115 . . . . 0.0 109.444 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.65 132.66 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.0 110.476 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.793 HD12 HD22 ' A' ' 390' ' ' LEU . 96.5 mt -113.15 -171.4 1.86 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.962 . . . . 0.0 110.312 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -60.49 -41.05 93.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 0.0 110.999 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 389' ' ' GLU . 80.2 tt0 -142.11 3.84 1.6 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.0 -1.063 . . . . 0.0 112.379 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.793 HD22 HD12 ' A' ' 387' ' ' LEU . 54.0 tp -61.87 -43.15 99.43 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.537 -1.352 . . . . 0.0 109.614 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 70.8 m -62.78 -44.2 96.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.673 -0.642 . . . . 0.0 110.312 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 395' ' ' LEU . 69.1 t -65.84 -36.32 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.634 -0.666 . . . . 0.0 110.836 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.73 -44.2 97.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 111.568 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.0 91.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.492 -0.755 . . . . 0.0 112.124 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 399' ' ' ILE . 1.8 pp -71.88 -28.51 63.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.179 -0.951 . . . . 0.0 112.256 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.9 t -63.09 -43.9 97.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.701 -1.249 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -64.98 -42.97 94.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.731 -0.606 . . . . 0.0 111.59 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -63.28 -40.05 96.31 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.417 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.668 HG23 ' HD1' ' A' ' 419' ' ' TYR . 82.3 mt -63.52 -42.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.3 mtp -63.54 -32.0 73.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.165 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -57.87 -32.34 67.59 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 7.7 mp0 -93.09 -15.91 25.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.998 -1.064 . . . . 0.0 109.603 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -64.75 -36.35 84.03 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.24 18.43 17.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.785 . . . . 0.0 109.596 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.9 p -35.54 142.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.609 0 CA-C-O 121.354 0.597 . . . . 0.0 111.686 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 406' ' ' THR . 9.4 t -74.27 72.98 1.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.707 -0.621 . . . . 0.0 109.782 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 412' ' ' SER . 11.2 p -104.39 132.03 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.918 . . . . 0.0 111.52 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -93.33 142.05 24.76 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.46 -28.35 54.01 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.085 1.045 . . . . 0.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.22 -23.94 62.73 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.569 -0.707 . . . . 0.0 110.482 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 57.21 0.51 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' SER . . . . . 0.462 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 35.5 t -59.01 126.48 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 111.499 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.6 p -87.77 113.12 53.09 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.921 -0.487 . . . . 0.0 110.446 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 50.9 Cg_endo -69.26 142.72 50.95 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.102 1.054 . . . . 0.0 109.423 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.423 ' NH1' ' CG ' ' A' ' 402' ' ' GLN . 83.2 mtp180 -159.38 63.11 0.39 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 109.534 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 74.1 p -66.83 -35.7 80.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.938 -1.101 . . . . 0.0 108.741 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -69.56 -10.45 58.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 111.2 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.13 -44.63 97.16 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.746 ' HB3' HG13 ' A' ' 436' ' ' VAL . 9.6 m-85 -93.94 -2.42 53.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.13 -1.218 . . . . 0.0 109.805 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 7.3 t -80.61 -36.81 32.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 425' ' ' VAL . 39.6 t0 -79.06 -46.03 18.94 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.388 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.14 -49.67 76.32 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.89 0.852 . . . . 0.0 110.781 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.884 ' HA ' HD23 ' A' ' 426' ' ' LEU . 55.9 t -72.16 -40.49 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.767 -0.583 . . . . 0.0 112.297 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 66.8 p -59.39 -39.13 82.36 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.889 -1.132 . . . . 0.0 110.835 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 421' ' ' ASP . 97.3 t -61.51 -42.49 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.71 -0.619 . . . . 0.0 109.67 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -58.62 -32.73 69.3 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.444 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.72 73.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.607 -1.308 . . . . 0.0 109.32 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' A' ' 425' ' ' VAL . 82.7 mt-30 -62.62 -31.22 72.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 426' ' ' LEU . 90.2 m-20 -62.89 -90.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -171.92 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.346 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.68 105.73 1.52 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.039 1.02 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -85.15 100.93 12.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.782 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.749 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 20.9 tp -165.04 96.94 0.72 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.756 -1.215 . . . . 0.0 111.821 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -144.07 177.02 8.87 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.769 0.795 . . . . 0.0 111.89 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 44.4 pt -116.7 139.29 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.791 ' CG2' HG21 ' A' ' 423' ' ' VAL . 44.1 t -144.33 145.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.4 m -129.96 139.04 51.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.51 -0.744 . . . . 0.0 109.551 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.36 149.76 19.41 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -103.96 -49.64 3.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.751 -0.852 . . . . 0.0 109.262 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -146.75 153.86 25.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 93.09 106.62 1.76 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -46.99 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -1.009 . . . . 0.0 110.675 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.79 84.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 112.01 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.29 -29.25 64.54 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 120.729 -1.232 . . . . 0.0 110.514 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -38.89 89.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.509 -0.995 . . . . 0.0 110.804 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.526 ' CG ' ' HB1' ' A' ' 467' ' ' ALA . 6.9 mpt_? -64.91 -41.74 95.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.77 -27.79 63.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.301 -0.874 . . . . 0.0 110.498 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 41.3 ttm180 -62.89 -56.13 20.03 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.334 -0.854 . . . . 0.0 111.219 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 506' ' ' ILE . 11.8 p -57.34 -32.04 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.508 -1.37 . . . . 0.0 108.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.03 -26.34 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 49.4 tp10 -60.59 -32.7 71.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.06 -37.32 87.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.4 t -60.6 -27.05 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.78 -0.575 . . . . 0.0 109.812 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.59 -37.1 82.09 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.9 ttp -58.38 -29.46 66.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.652 0.739 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.77 31.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 0.0 109.555 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.41 -43.17 98.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -71.59 -27.43 63.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.732 -0.605 . . . . 0.0 110.478 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -82.65 6.44 17.81 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.493 -0.755 . . . . 0.0 111.282 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.63 28.42 72.24 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.867 -1.146 . . . . 0.0 110.628 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -134.6 129.07 34.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.052 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -85.26 167.54 15.55 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 23.5 m -145.31 149.25 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.86 . . . . 0.0 110.293 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.932 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.5 tt0 -97.52 126.11 42.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.895 HD13 HG21 ' A' ' 453' ' ' VAL . 1.9 pt -134.07 139.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.458 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.748 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.2 mp -129.31 126.08 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.347 -0.846 . . . . 0.0 110.688 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.526 ' HB1' ' CG ' ' A' ' 446' ' ' ARG . . . -84.28 -177.92 6.78 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.542 -0.723 . . . . 0.0 109.934 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.0 -162.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.213 0.53 . . . . 0.0 110.043 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.28 -16.86 6.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -0.969 . . . . 0.0 110.556 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -72.04 -11.07 60.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.374 -0.829 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -56.05 -34.0 65.51 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.13 -0.981 . . . . 0.0 111.903 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 39.0 t -55.66 -45.87 77.63 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.153 -0.967 . . . . 0.0 110.426 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -64.94 -37.91 89.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -32.47 70.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.92 -0.487 . . . . 0.0 110.506 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -59.65 -42.18 92.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.964 -1.085 . . . . 0.0 108.817 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.7 mtt -65.46 -35.65 81.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -102.92 -148.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 51.04 45.18 28.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.955 -1.091 . . . . 0.0 111.604 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -95.42 12.01 30.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.28 -0.887 . . . . 0.0 110.903 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -84.01 -1.68 55.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 111.131 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.841 ' HG2' HD22 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.976 -1.078 . . . . 0.0 112.796 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.841 HD22 ' HG2' ' A' ' 481' ' ' ARG . 0.2 OUTLIER -105.66 30.03 6.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.553 -1.342 . . . . 0.0 111.785 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 37.3 m -60.91 -28.21 68.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.935 -1.103 . . . . 0.0 110.251 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 161.81 46.84 0.02 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -130.54 40.82 3.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.57 -0.959 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.932 HD22 ' HA ' ' A' ' 464' ' ' GLN . 89.0 mt -67.36 -81.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.831 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.0 OUTLIER -175.63 -60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.41 -1.431 . . . . 0.0 112.547 173.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 487' ' ' ILE . 1.5 t -101.82 12.83 36.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.471 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -87.28 66.38 3.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.8 ttm180 -143.39 -63.42 0.4 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.32 -1.106 . . . . 0.0 108.885 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 37.5 mmt180 -101.86 -36.04 8.8 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -61.24 -29.96 70.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.644 -0.66 . . . . 0.0 111.492 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 5.9 mt -93.57 -29.91 15.25 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.513 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.7 OUTLIER -103.89 -38.21 7.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -6.39 12.13 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 100.47 -19.34 53.05 Favored Glycine 0 N--CA 1.504 3.204 0 CA-C-N 120.641 1.564 . . . . 0.0 112.274 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.4 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 10.9 mtp -69.29 175.1 4.13 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.982 -1.305 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.57 150.04 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.493 -0.754 . . . . 0.0 111.138 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -113.71 150.03 33.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.718 -0.614 . . . . 0.0 109.72 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 500' ' ' THR . 6.9 t -55.32 107.19 0.8 Allowed Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.474 -0.766 . . . . 0.0 110.573 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' A' ' 528' ' ' HIS . 40.0 Cg_endo -67.76 114.28 3.28 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.173 1.091 . . . . 0.0 110.316 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -166.11 26.19 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.831 ' CB ' HD13 ' A' ' 487' ' ' ILE . 22.9 t -96.0 -179.62 4.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.297 -1.119 . . . . 0.0 111.628 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.691 ' HB ' HG12 ' A' ' 463' ' ' VAL . 87.5 m -124.14 131.88 53.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 522' ' ' LEU . 62.9 t -121.5 135.78 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.901 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.813 HG22 ' HB2' ' A' ' 533' ' ' LEU . 26.0 pt -135.99 118.86 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.748 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.9 p -115.51 104.29 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 111.451 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.429 ' HA ' ' H ' ' A' ' 535' ' ' THR . 9.9 p-10 -86.73 121.39 29.16 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.47 129.2 7.76 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -77.56 -44.87 11.82 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -77.19 148.04 36.11 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -99.51 -12.19 20.38 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 121.907 -0.495 . . . . 0.0 111.645 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.7 OUTLIER -64.01 -34.98 79.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.8 m -69.68 -37.71 76.77 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.578 0.704 . . . . 0.0 110.577 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 550' ' ' MET . 57.7 tp -63.14 -42.79 99.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.736 -0.602 . . . . 0.0 111.209 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -66.37 -43.3 86.3 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 518' ' ' THR . 18.9 pt-20 -68.29 -42.13 79.93 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.858 -1.151 . . . . 0.0 110.51 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 466' ' ' ILE . 52.1 m -61.55 -40.14 93.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.659 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -61.0 -39.8 91.12 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 516' ' ' LYS . 75.6 p -60.09 -57.08 14.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.049 -1.032 . . . . 0.0 110.672 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.43 -41.12 98.47 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.149 -0.969 . . . . 0.0 110.721 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.798 HD12 HG11 ' A' ' 505' ' ' VAL . 5.1 tt -57.66 -30.39 65.39 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.627 -0.671 . . . . 0.0 110.727 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.12 -47.44 68.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.488 -0.758 . . . . 0.0 111.421 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -60.63 -50.02 72.19 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.42 -36.18 83.32 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.662 -0.905 . . . . 0.0 111.687 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.501 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.7 -25.12 66.17 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.273 -0.892 . . . . 0.0 110.964 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -53.47 -40.38 65.24 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.204 -0.935 . . . . 0.0 108.73 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 501' ' ' PRO . 1.5 t-80 -93.02 -135.35 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.417 ' HB3' ' HA2' ' A' ' 502' ' ' GLY . 16.5 t30 -88.87 78.95 7.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.602 -1.311 . . . . 0.0 112.402 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -140.21 168.68 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.114 -0.991 . . . . 0.0 108.62 178.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -164.0 162.97 23.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.602 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.6 t -113.44 110.69 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.709 0.766 . . . . 0.0 112.071 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.813 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.89 117.63 34.64 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 507' ' ' VAL . 11.7 pt -135.69 160.75 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 117.533 -1.667 . . . . 0.0 111.921 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 436' ' ' VAL . 47.0 p -125.55 -168.45 1.84 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -159.35 168.83 25.39 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.508 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.9 17.98 2.31 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.583 178.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.95 11.49 3.36 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 26.5 mt-30 -95.59 0.85 53.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.04 -1.271 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -53.69 -26.72 24.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.031 -1.043 . . . . 0.0 111.22 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 56.8 m -107.08 -36.81 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.417 -0.802 . . . . 0.0 109.89 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -134.42 107.46 0.66 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.1 t -97.74 -43.26 7.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -1.004 . . . . 0.0 111.629 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.65 -35.02 90.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 34.5 m -62.0 -32.24 72.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -1.079 . . . . 0.0 110.173 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.99 -35.06 79.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.86 -0.525 . . . . 0.0 109.923 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.1 mp -61.76 -43.72 98.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.0 -34.0 76.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 108.741 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.77 -52.5 56.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.659 ' CG ' HD11 ' A' ' 519' ' ' LEU . 32.0 ttp -58.31 -42.96 87.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.325 -0.86 . . . . 0.0 109.866 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HA ' ' CG1' ' A' ' 555' ' ' VAL . 99.0 mttt -61.6 -32.16 72.27 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.738 -0.601 . . . . 0.0 111.233 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.52 -12.72 61.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.589 -0.694 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.83 6.85 1.04 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.321 -0.862 . . . . 0.0 113.013 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.3 -15.76 42.48 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.522 -1.361 . . . . 0.0 110.933 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 555' ' ' VAL . 13.6 p -66.99 121.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.291 -1.123 . . . . 0.0 109.863 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -157.11 113.6 2.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.844 -0.535 . . . . 0.0 109.899 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 557' ' ' THR . 6.2 t -92.76 113.41 25.68 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.55 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -87.5 -81.06 0.24 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -155.49 -64.4 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.487 -0.758 . . . . 0.0 110.379 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -87.01 -22.66 25.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -149.01 151.64 34.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -93.12 -138.67 8.88 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -96.05 24.18 31.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -64.42 -33.34 75.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -1.039 . . . . 0.0 110.257 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.19 -1.14 56.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.788 -0.57 . . . . 0.0 111.292 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.715 ' HD2' HG23 ' A' ' 569' ' ' THR . 16.9 mmt85 -107.1 79.82 0.75 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.096 -1.002 . . . . 0.0 110.368 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.94 -16.46 32.58 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.272 1.143 . . . . 0.0 111.649 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -157.52 22.42 0.29 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.169 -0.957 . . . . 0.0 111.271 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' THR . . . . . 0.715 HG23 ' HD2' ' A' ' 566' ' ' ARG . 9.6 t . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.641 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 120.874 0.368 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 93.6 p -62.88 -32.96 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 109.663 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 103.29 117.08 4.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 386' ' ' VAL . 77.6 mt -95.27 117.59 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.539 -0.977 . . . . 0.0 109.666 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -68.82 -33.78 74.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.844 -0.535 . . . . 0.0 110.557 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 384' ' ' ILE . 14.5 p -106.48 141.76 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.619 -0.676 . . . . 0.0 110.916 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.28 127.14 55.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.737 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -115.64 -168.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.5 -0.75 . . . . 0.0 110.076 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.51 87.86 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.565 -0.71 . . . . 0.0 110.162 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.54 -38.49 89.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.69 -0.632 . . . . 0.0 110.976 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.0 m -62.51 -47.41 84.05 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.389 -0.819 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.15 -36.47 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.481 -0.762 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.36 82.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.237 -0.914 . . . . 0.0 109.655 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.55 -34.19 77.66 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.664 0.745 . . . . 0.0 108.999 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.6 OUTLIER -60.67 -39.45 88.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.98 -0.45 . . . . 0.0 110.659 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.9 m -64.6 -36.95 85.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.479 -0.763 . . . . 0.0 111.029 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -64.51 -46.63 82.09 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.288 -0.882 . . . . 0.0 111.997 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -70.06 -41.22 74.46 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.24 -0.913 . . . . 0.0 111.703 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 435' ' ' ILE . 96.5 mt -62.68 -40.6 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 109.675 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.434 ' HA ' ' CB ' ' A' ' 403' ' ' ASN . 18.3 mtp -63.01 -31.97 73.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.617 -0.677 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -60.74 -32.93 72.2 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.041 -1.037 . . . . 0.0 109.517 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 10.1 tp-100 -90.44 -14.93 31.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.797 -1.189 . . . . 0.0 109.385 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 400' ' ' MET . 44.3 t-20 -65.48 -35.94 82.38 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -115.63 18.6 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -39.07 148.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-O 121.677 0.751 . . . . 0.0 112.228 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 19.3 m -84.35 77.53 9.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 407' ' ' VAL . 14.8 p -97.21 131.48 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.343 -0.848 . . . . 0.0 112.355 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -96.62 145.04 28.89 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.89 -21.57 57.19 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.066 1.035 . . . . 0.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.62 -36.29 66.81 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.83 0.824 . . . . 0.0 110.42 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 67.61 0.51 Allowed 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 14.3 m -62.67 135.27 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.818 0.818 . . . . 0.0 111.091 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.487 HG23 ' HD2' ' A' ' 414' ' ' PRO . 8.6 p -81.51 149.19 64.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.487 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.3 Cg_endo -58.47 136.67 75.83 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.018 1.009 . . . . 0.0 110.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.403 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 80.5 mtt85 -96.3 -8.94 31.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.664 -0.648 . . . . 0.0 112.662 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.0 t -99.34 19.09 16.14 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.95 -1.094 . . . . 0.0 109.175 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -106.17 -36.97 6.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -68.82 -38.62 85.51 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.596 ' CB ' HG13 ' A' ' 436' ' ' VAL . 3.8 m-85 -94.9 -8.05 38.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.774 -1.427 . . . . 0.0 110.42 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -40.54 65.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.873 -1.142 . . . . 0.0 108.529 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 425' ' ' VAL . 66.2 t0 -76.11 -44.47 38.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.898 -0.501 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.557 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -66.96 -48.59 68.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 111.445 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 426' ' ' LEU . 72.2 t -67.87 -42.96 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.598 -0.689 . . . . 0.0 111.441 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.6 t -59.09 -42.61 90.86 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.812 -1.18 . . . . 0.0 111.309 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 421' ' ' ASP . 90.5 t -61.8 -46.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.193 -0.942 . . . . 0.0 110.886 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -56.87 -37.24 71.06 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.243 -0.91 . . . . 0.0 112.28 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.43 -36.87 79.69 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.896 -1.128 . . . . 0.0 108.937 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -59.82 -30.49 68.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.26 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.44 -55.88 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.603 -1.31 . . . . 0.0 109.416 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 49.2 Cg_endo -73.4 106.44 2.18 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 533' ' ' LEU . 6.0 m -85.17 97.82 10.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.878 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 18.1 tp -150.01 134.02 17.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.69 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -174.4 175.35 2.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.905 -1.122 . . . . 0.0 110.894 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.1 pt -134.09 121.05 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.403 0.62 . . . . 0.0 110.072 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.693 ' CG2' HG21 ' A' ' 423' ' ' VAL . 62.7 t -120.61 134.76 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.227 -0.92 . . . . 0.0 109.257 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 11.8 p -118.24 123.6 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.85 -1.156 . . . . 0.0 111.809 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 -178.14 34.18 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -171.41 39.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.991 . . . . 0.0 109.599 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -155.04 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -118.35 134.49 10.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -98.78 -16.08 19.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.689 -0.889 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.35 77.78 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.48 -0.763 . . . . 0.0 111.824 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -78.66 -35.05 33.27 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.42 -35.44 79.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.963 . . . . 0.0 109.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.772 ' O ' HG12 ' A' ' 449' ' ' VAL . 0.0 OUTLIER -60.49 -46.75 88.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.835 -0.541 . . . . 0.0 110.364 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 97.5 mt-10 -66.99 -29.37 69.19 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -62.06 -46.01 91.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.968 HG22 HD12 ' A' ' 506' ' ' ILE . 5.3 p -58.81 -30.63 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.801 -1.187 . . . . 0.0 109.03 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.93 -26.49 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.77 -35.63 76.91 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.92 -1.113 . . . . 0.0 108.412 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 452' ' ' LEU . 3.9 mm? -62.38 -37.9 87.52 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.897 . . . . 0.0 108.673 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 463' ' ' VAL . 66.8 t -57.97 -28.9 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.588 -0.695 . . . . 0.0 109.976 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 457' ' ' ARG . 65.8 mtt -65.76 -39.5 91.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.383 -0.823 . . . . 0.0 108.814 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 63.0 ttp -61.66 -21.49 64.46 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.608 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.19 32.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 0.0 109.891 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 454' ' ' MET . 82.7 mtp180 -67.08 -40.77 87.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 109.324 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.21 -34.19 75.8 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.604 0.716 . . . . 0.0 109.1 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -76.78 1.53 17.03 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.65 27.39 72.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 15.3 ttm180 -128.74 118.62 23.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -1.038 . . . . 0.0 110.402 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 0.5 OUTLIER -76.22 164.58 25.93 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.3 m -136.88 157.53 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.272 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.859 ' HA ' HD22 ' A' ' 486' ' ' LEU . 59.2 tt0 -105.7 111.81 24.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 482' ' ' LEU . 1.2 pt -122.32 129.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 466' ' ' ILE . 5.3 mp -119.36 111.99 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 112.169 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -57.43 164.12 2.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.294 -0.878 . . . . 0.0 109.806 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.449 ' HB3' HH11 ' A' ' 446' ' ' ARG . . . -58.78 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.898 -0.501 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -57.84 -12.25 2.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.117 -0.989 . . . . 0.0 111.2 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 446' ' ' ARG . 96.7 mtt-85 -88.82 6.08 40.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.145 -0.972 . . . . 0.0 111.164 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.6 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 53.6 ttp180 -57.9 -25.28 60.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.067 . . . . 0.0 111.037 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 7.7 t -59.02 -47.62 84.56 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.219 -0.925 . . . . 0.0 111.218 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.07 -35.82 82.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 33.0 ttp -66.28 -32.0 73.15 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.52 -37.3 83.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.31 -0.869 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 45.0 mtt -60.5 -36.4 78.24 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -121.08 -143.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.413 ' NE2' ' HD2' ' A' ' 481' ' ' ARG . 53.7 tp60 47.96 88.24 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.98 -1.075 . . . . 0.0 111.456 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -129.03 20.93 5.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 110.081 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -110.17 -0.72 17.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 111.377 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 482' ' ' LEU . 12.6 mtt180 -135.25 -13.36 2.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.886 -1.134 . . . . 0.0 112.723 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.722 HD22 HD11 ' A' ' 465' ' ' ILE . 0.6 OUTLIER -170.95 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.967 -1.083 . . . . 0.0 111.004 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.6 m -75.11 -18.26 60.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.64 47.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 20.1 pt-20 -139.9 74.8 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.669 -0.901 . . . . 0.0 111.051 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 464' ' ' GLN . 67.3 mt -94.85 -81.02 0.4 Allowed 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.4 OUTLIER 161.16 -34.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.75 0 C-N-CA 123.552 0.741 . . . . 0.0 110.435 173.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.541 HG21 ' CB ' ' A' ' 525' ' ' ALA . 7.0 p -102.14 12.7 36.36 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -153.36 95.78 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.433 ' N ' ' CD2' ' A' ' 493' ' ' LEU . 72.2 ttt180 -145.81 -72.21 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.455 ' CB ' ' HB2' ' A' ' 497' ' ' MET . 74.1 mtt-85 -90.13 -16.55 29.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.962 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -56.95 4.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.71 -1.244 . . . . 0.0 109.95 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 493' ' ' LEU . 1.1 pt? -58.92 -28.08 65.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.724 -0.61 . . . . 0.0 111.07 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 494' ' ' LEU . 1.0 OUTLIER -104.81 -46.37 4.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 111.938 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 495' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 491' ' ' ARG . 51.0 mt-10 -104.25 -7.93 19.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 112.5 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.87 -3.5 87.04 Favored Glycine 0 N--CA 1.508 3.438 0 O-C-N 120.581 -1.324 . . . . 0.0 110.051 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' CB ' ' A' ' 491' ' ' ARG . 93.7 mmm -64.8 -177.25 0.32 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -1.075 . . . . 0.0 112.721 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.64 169.46 8.8 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.744 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 488' ' ' THR . 1.2 p90 -142.33 150.09 40.31 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.564 -0.71 . . . . 0.0 110.443 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 30.8 m -61.77 109.25 2.06 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.48 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -84.91 113.35 1.55 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.362 1.191 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 168.85 31.83 0.02 OUTLIER Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.584 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.716 ' HB3' HG21 ' A' ' 487' ' ' ILE . 4.5 p -96.35 -175.4 3.34 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 463' ' ' VAL . 25.1 m -110.03 122.75 48.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.765 HG11 ' CD1' ' A' ' 522' ' ' LEU . 46.4 t -115.64 129.58 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.731 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.968 HD12 HG22 ' A' ' 449' ' ' VAL . 15.2 pt -124.6 119.31 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.69 ' HB ' HG21 ' A' ' 518' ' ' THR . 3.6 p -107.34 110.76 32.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.807 -1.183 . . . . 0.0 109.96 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.757 ' OD2' HG11 ' A' ' 449' ' ' VAL . 21.4 m-20 -82.71 105.7 13.95 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 9.0 tm0? -109.21 178.37 4.47 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.08 0.943 . . . . 0.0 112.714 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.437 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -167.36 -91.24 0.08 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -38.89 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.603 -0.299 . . . . 0.0 111.566 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -179.02 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.39 -1.444 . . . . 0.0 110.883 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 513' ' ' LEU . 14.2 tp -62.87 -30.77 71.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.573 -0.704 . . . . 0.0 109.935 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 6.0 p -69.17 -38.79 78.9 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.761 -0.587 . . . . 0.0 111.749 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.6 tp -64.26 -45.45 88.04 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.396 -0.815 . . . . 0.0 112.106 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 51.9 mtpt -65.11 -45.48 84.98 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.73 -42.62 95.08 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.288 -0.882 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 507' ' ' VAL . 74.4 m -58.54 -46.93 85.78 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.834 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 550' ' ' MET . 5.5 mt -62.95 -36.91 85.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.246 -0.908 . . . . 0.0 111.008 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.5 m -58.07 -41.31 83.14 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.165 -0.959 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.38 -37.84 63.32 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.59 0.71 . . . . 0.0 109.498 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.765 ' CD1' HG11 ' A' ' 505' ' ' VAL . 2.0 tp -63.65 -22.23 66.79 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -46.43 -52.78 12.37 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.5 -0.75 . . . . 0.0 112.005 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.74 -50.54 53.17 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.788 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -58.26 -44.12 88.24 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.667 -0.902 . . . . 0.0 111.858 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.35 -25.41 67.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 0.0 111.246 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -55.41 -26.2 40.3 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.091 -1.005 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.48 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.9 m80 -110.88 -130.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.607 -0.683 . . . . 0.0 109.913 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -88.49 78.05 7.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.557 -1.339 . . . . 0.0 112.614 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.788 HG21 ' HB1' ' A' ' 525' ' ' ALA . 0.9 OUTLIER -134.34 158.4 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 109.152 178.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 98.2 mm-40 -150.82 157.99 43.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.739 -0.601 . . . . 0.0 109.726 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 69.1 t -110.78 96.81 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.192 -0.943 . . . . 0.0 113.468 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.663 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.5 OUTLIER -95.9 114.19 25.88 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 174.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.65 HG22 ' CG1' ' A' ' 507' ' ' VAL . 4.9 pt -130.04 136.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.401 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.494 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 18.5 p -96.68 176.25 6.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 1.8 p30 -158.59 168.16 27.66 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.948 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.437 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.7 t -140.61 59.36 1.55 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -37.28 158.95 0.01 OUTLIER Glycine 0 N--CA 1.507 3.382 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.999 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.78 -87.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.166 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -108.77 -81.23 0.57 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.775 -1.203 . . . . 0.0 112.805 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 t -139.75 -30.16 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.675 0.75 . . . . 0.0 109.511 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -98.89 50.97 1.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.0 t -76.34 3.27 11.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 122.128 -0.631 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -50.2 -26.68 9.53 Favored Glycine 0 N--CA 1.502 3.088 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.0 m -70.61 -20.85 62.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.995 -1.297 . . . . 0.0 109.047 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.785 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -68.48 -34.33 75.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -63.83 -42.65 97.57 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.393 -0.817 . . . . 0.0 109.928 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.07 -34.51 75.02 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.83 -44.09 39.11 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.699 ' HB2' HD21 ' A' ' 515' ' ' LEU . 1.4 tmt? -57.49 -47.11 82.8 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.5 -33.42 71.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.677 -0.64 . . . . 0.0 111.496 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -63.96 -18.89 64.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.295 -0.878 . . . . 0.0 110.064 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.99 0.07 6.61 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.36 -0.838 . . . . 0.0 112.379 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 111.7 -12.4 27.6 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.816 -1.177 . . . . 0.0 111.52 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 519' ' ' LEU . 68.8 t -82.89 114.95 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -172.53 138.99 0.93 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.42 -0.8 . . . . 0.0 109.932 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 88.9 m -92.15 135.5 33.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -73.17 -79.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.13 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -157.81 -70.31 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.552 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -81.33 -23.14 37.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 0.0 111.113 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -158.85 148.37 19.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.332 -0.855 . . . . 0.0 110.815 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -106.79 149.12 16.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.54 90.16 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.09 -2.35 50.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.623 -0.928 . . . . 0.0 111.696 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -82.87 -0.77 49.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.083 -1.011 . . . . 0.0 110.85 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.442 HH11 HG23 ' A' ' 569' ' ' THR . 3.9 mmm180 -103.94 81.75 0.51 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.64 -21.02 52.72 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.283 1.149 . . . . 0.0 111.033 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -160.72 -51.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.444 -0.785 . . . . 0.0 110.15 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' THR . . . . . 0.442 HG23 HH11 ' A' ' 566' ' ' ARG . 7.4 t . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.077 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.944 0.402 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.8 m -104.45 31.41 4.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.741 . . . . 0.0 109.646 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 101.62 111.1 3.41 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 85.1 mt -97.61 -14.8 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.574 -0.957 . . . . 0.0 110.224 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -64.88 -42.75 94.55 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.325 -0.86 . . . . 0.0 109.337 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 387' ' ' LEU . 82.4 t -94.41 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.794 -0.566 . . . . 0.0 110.286 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.42 ' N ' HG12 ' A' ' 386' ' ' VAL . 96.4 mt -79.5 97.16 6.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.523 -0.736 . . . . 0.0 109.955 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -99.75 118.37 36.1 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.503 -0.748 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -116.23 33.14 5.7 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.629 0.728 . . . . 0.0 109.402 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.13 -37.3 86.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.503 -0.748 . . . . 0.0 110.882 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 49.0 m -60.02 -44.23 94.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.587 -0.696 . . . . 0.0 111.189 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 433' ' ' LEU . 77.2 t -77.21 -29.56 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 111.063 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -65.51 -47.8 74.75 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.12 . . . . 0.0 111.166 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.26 88.76 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.876 0.846 . . . . 0.0 110.331 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.574 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.3 tt -61.88 -38.83 89.75 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.207 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.2 m -61.15 -36.72 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.063 -0.398 . . . . 0.0 110.77 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -60.76 -44.07 97.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 110.734 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.425 ' O ' ' CE1' ' A' ' 419' ' ' TYR . 39.1 t70 -65.58 -44.39 86.81 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 0.0 111.962 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.769 HG23 ' HB3' ' A' ' 419' ' ' TYR . 0.9 OUTLIER -63.3 -42.17 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 121.106 -0.996 . . . . 0.0 108.983 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 2.9 ttt -61.96 -26.72 68.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.727 -0.608 . . . . 0.0 109.578 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -62.27 -31.13 71.67 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.653 ' O ' HG12 ' A' ' 405' ' ' VAL . 27.4 tp60 -89.75 -11.69 41.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 0.0 109.83 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.51 -39.92 88.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 -116.57 17.8 15.23 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.788 -1.195 . . . . 0.0 109.721 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.4 p -56.87 118.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.612 -0.68 . . . . 0.0 110.001 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -54.58 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.083 -1.011 . . . . 0.0 109.559 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 405' ' ' VAL . 43.0 t -96.02 130.9 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.899 -0.501 . . . . 0.0 110.132 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.12 131.78 34.1 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.475 -0.765 . . . . 0.0 109.878 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 -24.03 43.88 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.164 1.086 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.36 -37.4 80.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.941 0.877 . . . . 0.0 110.181 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 67.6 1.03 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.8 p -49.8 155.3 0.88 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.108 0.956 . . . . 0.0 112.088 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 407' ' ' VAL . 7.3 p -101.45 143.65 27.02 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 417' ' ' ALA . 38.1 Cg_endo -64.77 131.26 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 N-CA-C 109.104 -1.152 . . . . 0.0 109.104 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -109.51 -19.06 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.516 -0.74 . . . . 0.0 112.502 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 420' ' ' SER . 9.8 t -101.86 14.95 30.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 414' ' ' PRO . . . -75.55 -77.86 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.689 -0.632 . . . . 0.0 111.607 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -89.0 -0.72 80.65 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.782 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.769 ' HB3' HG23 ' A' ' 399' ' ' ILE . 80.2 m-85 -107.98 -26.39 10.71 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.775 2.288 . . . . 0.0 108.763 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 416' ' ' THR . 4.9 t -71.19 -38.78 72.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 175.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 -38.8 92.19 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -59.88 -37.22 78.74 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.748 0.785 . . . . 0.0 109.327 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 75.9 t -66.85 -44.42 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.7 p -61.02 -37.82 83.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.642 -1.286 . . . . 0.0 111.529 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.25 -46.47 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -55.3 -32.78 62.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 0.0 111.686 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.16 78.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.806 -1.184 . . . . 0.0 108.877 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.49 -30.57 65.21 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.68 -89.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.488 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -174.67 -54.33 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.617 -1.302 . . . . 0.0 108.93 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.9 Cg_endo -70.81 98.71 0.8 Allowed 'Trans proline' 0 N--CA 1.487 1.135 0 N-CA-C 109.179 -1.123 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.533 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -84.34 102.09 12.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.804 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.91 98.1 1.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.35 -0.844 . . . . 0.0 111.928 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -142.92 168.32 19.99 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.48 -0.763 . . . . 0.0 111.82 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.27 129.92 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.747 -0.596 . . . . 0.0 111.385 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.624 ' CG2' HG21 ' A' ' 423' ' ' VAL . 25.5 t -133.02 155.44 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.312 -0.868 . . . . 0.0 110.083 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.7 t -133.09 138.9 46.87 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.427 -0.796 . . . . 0.0 111.024 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -101.41 -171.34 28.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -153.18 26.15 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.732 -0.863 . . . . 0.0 109.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.9 10.33 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.56 55.35 15.22 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.42 -9.08 59.58 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -57.69 -45.96 84.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.134 -0.979 . . . . 0.0 111.723 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -83.05 -28.55 36.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.74 -40.43 88.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.952 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.783 ' O ' HG12 ' A' ' 449' ' ' VAL . 5.5 mmt85 -65.97 -39.27 90.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.51 -0.744 . . . . 0.0 109.66 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -67.66 -29.5 68.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.141 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 49.7 ttt85 -64.21 -47.0 81.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 446' ' ' ARG . 9.5 p -56.5 -30.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.554 -1.341 . . . . 0.0 109.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.498 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 95.3 mt-10 -62.76 -33.68 75.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.734 -1.229 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 452' ' ' LEU . 4.2 mm? -65.02 -34.54 78.67 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.927 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.3 t -60.47 -31.75 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 96.3 mmm -65.14 -40.1 93.95 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.3 ttp -59.63 -22.45 61.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.603 -0.686 . . . . 0.0 110.318 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 461' ' ' ARG . . . -81.93 -22.79 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -65.37 -43.09 91.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.429 -0.794 . . . . 0.0 109.655 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.19 -28.93 63.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -76.03 -2.92 33.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.699 -0.626 . . . . 0.0 111.388 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.58 19.99 72.46 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.406 ' HG3' ' HB1' ' A' ' 456' ' ' ALA . 32.2 ptt180 -136.72 151.18 48.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -1.064 . . . . 0.0 110.406 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.523 ' HB2' HD13 ' A' ' 487' ' ' ILE . 92.3 mt-10 -102.07 178.84 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.927 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.4 m -141.9 158.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.778 -1.201 . . . . 0.0 111.578 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.9 tt0 -102.1 119.33 38.62 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -126.77 130.97 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.232 -0.918 . . . . 0.0 111.081 -178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 465' ' ' ILE . 91.1 mt -129.11 123.56 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.852 -0.53 . . . . 0.0 110.277 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -75.66 165.71 24.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.424 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -58.1 -161.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.571 -0.706 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.53 -20.52 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -74.57 -2.86 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.395 -0.815 . . . . 0.0 110.752 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.444 ' CZ ' HD12 ' A' ' 482' ' ' LEU . 0.9 OUTLIER -54.19 -26.06 26.15 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.108 -0.995 . . . . 0.0 110.46 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.2 p -65.41 -46.81 78.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.392 -0.818 . . . . 0.0 109.966 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.77 -49.25 69.03 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.373 -0.829 . . . . 0.0 110.329 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 6.4 ttt -58.57 -30.61 67.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 110.403 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -58.75 -33.37 70.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 47.3 ttp -58.47 -39.08 78.95 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.315 0.579 . . . . 0.0 110.295 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -125.14 -157.36 0.78 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.835 -0.541 . . . . 0.0 109.663 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 45.82 61.44 2.65 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.443 -0.786 . . . . 0.0 112.167 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -98.05 9.03 43.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.586 -0.696 . . . . 0.0 109.795 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -93.04 -0.59 57.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.598 ' C ' HD23 ' A' ' 482' ' ' LEU . 0.2 OUTLIER -141.16 3.38 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 112.454 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.5 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.872 -1.142 . . . . 0.0 111.815 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.9 p -93.76 48.24 1.27 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.132 -0.98 . . . . 0.0 108.926 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.82 26.66 28.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -118.52 47.58 1.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.495 -1.003 . . . . 0.0 108.814 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.82 HD11 ' HA3' ' A' ' 489' ' ' GLY . 0.2 OUTLIER -96.11 -82.77 0.39 Allowed 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.644 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.894 HG21 ' OG ' ' A' ' 503' ' ' SER . 38.0 mm -142.71 -90.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.076 -1.015 . . . . 0.0 108.99 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.452 ' HB ' ' CG ' ' A' ' 499' ' ' PHE . 0.0 OUTLIER -102.09 11.85 37.73 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.653 -0.654 . . . . 0.0 110.263 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.82 ' HA3' HD11 ' A' ' 486' ' ' LEU . . . -81.78 77.62 2.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.482 ' CG ' ' H ' ' A' ' 491' ' ' ARG . 0.2 OUTLIER -144.47 -86.11 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 490' ' ' ARG . 77.9 mtt85 -112.14 -17.16 12.87 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.443 -0.785 . . . . 0.0 109.227 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 497' ' ' MET . 8.0 mp0 -49.64 -36.1 23.51 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.61 -1.306 . . . . 0.0 111.226 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 521' ' ' LEU . 60.9 mt -71.84 -66.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.16 -0.962 . . . . 0.0 108.465 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 494' ' ' LEU . 0.7 OUTLIER -54.11 -28.99 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.408 0.623 . . . . 0.0 110.377 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 495' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 80.0 mm-40 -84.51 -3.16 58.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.0 111.585 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 69.91 48.87 38.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.49 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 94.4 mtp -123.01 -177.39 3.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -1.001 . . . . 0.0 111.127 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.48 170.63 7.96 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.649 -0.657 . . . . 0.0 110.325 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.452 ' CG ' ' HB ' ' A' ' 488' ' ' THR . 4.6 m-85 -109.21 125.64 52.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.257 -0.902 . . . . 0.0 108.612 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.7 t -68.02 150.89 97.58 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.613 -0.679 . . . . 0.0 110.852 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.444 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 42.5 Cg_endo -71.6 123.7 9.67 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.611 1.322 . . . . 0.0 111.049 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 161.64 -2.06 0.07 OUTLIER Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.72 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.894 ' OG ' HG21 ' A' ' 487' ' ' ILE . 8.6 m -82.81 153.21 25.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.343 . . . . 0.0 113.502 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.866 ' HB ' HG12 ' A' ' 463' ' ' VAL . 50.7 m -118.58 91.88 3.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.665 ' CB ' HD21 ' A' ' 522' ' ' LEU . 18.3 t -87.85 135.8 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.756 HG22 ' HB2' ' A' ' 533' ' ' LEU . 18.2 pt -136.55 122.43 28.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 534' ' ' ILE . 8.5 p -123.67 111.98 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.669 -1.269 . . . . 0.0 112.787 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -86.59 123.04 31.34 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.406 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.4 pm0 -160.52 129.23 4.76 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 117.488 -1.685 . . . . 0.0 115.434 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.485 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.3 -43.02 6.76 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.61 151.54 45.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -98.83 -11.68 21.55 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.24 -40.46 90.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 13.5 t -67.71 -39.95 84.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.819 -0.551 . . . . 0.0 111.201 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' A' ' 550' ' ' MET . 64.4 tp -62.67 -44.76 95.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.595 -0.691 . . . . 0.0 111.235 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 32.2 ttpt -71.36 -46.57 60.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.294 -0.878 . . . . 0.0 112.975 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.03 -44.08 85.7 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 83.1 m -56.84 -43.4 81.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.309 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.1 OUTLIER -53.76 -34.42 58.94 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.33 0.586 . . . . 0.0 109.882 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.403 ' HA ' ' OD2' ' A' ' 523' ' ' ASP . 27.0 m -62.35 -41.48 98.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.508 -0.745 . . . . 0.0 109.513 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 493' ' ' LEU . 1.0 OUTLIER -62.66 -40.52 97.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.738 0.78 . . . . 0.0 108.928 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.33 -21.34 63.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.923 -0.485 . . . . 0.0 110.851 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 523' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 520' ' ' THR . 95.4 m-20 -46.09 -64.55 0.72 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.622 -0.673 . . . . 0.0 112.453 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.03 -52.47 49.79 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 120.577 -1.327 . . . . 0.0 110.737 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.24 68.18 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.258 -1.142 . . . . 0.0 111.006 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.87 -20.66 66.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -37.9 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 0.7 OUTLIER -145.44 -79.25 0.18 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.267 -1.521 . . . . 0.0 113.751 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.435 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 82.5 m-20 -90.65 72.63 6.76 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.712 -1.243 . . . . 0.0 114.087 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 9.6 p -130.16 150.63 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.738 -1.226 . . . . 0.0 112.572 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.507 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 87.8 mm-40 -144.02 149.86 37.34 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 5.2 t -112.33 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.761 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.756 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -103.08 116.67 32.96 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -136.0 150.7 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.747 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.3 p -118.13 -163.99 0.98 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.54 163.15 40.36 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.607 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.485 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 3.8 p -128.7 22.25 5.9 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.875 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -174.0 43.85 0.14 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.35 -0.41 56.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.881 -0.776 . . . . 0.0 111.732 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -55.68 -42.71 75.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.995 -1.066 . . . . 0.0 110.851 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 m -116.76 156.38 27.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.591 -0.693 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.53 34.38 55.22 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -62.62 -43.36 98.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.42 -1.047 . . . . 0.0 110.61 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -62.77 -33.53 87.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.9 m -63.98 -39.45 94.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.846 -0.797 . . . . 0.0 111.007 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.53 -37.09 82.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.01 -42.26 99.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.657 -0.652 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 63.8 tpp -63.59 -34.58 78.14 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.5 -0.75 . . . . 0.0 109.515 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.23 -53.89 50.26 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.737 ' HB2' HD21 ' A' ' 515' ' ' LEU . 39.0 ttp -58.57 -44.86 89.88 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.317 -0.864 . . . . 0.0 109.914 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 555' ' ' VAL . 75.8 mmtt -60.28 -32.04 70.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.643 -0.66 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.81 -16.6 63.83 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.337 -0.852 . . . . 0.0 110.607 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.38 2.85 2.65 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 138.73 -16.66 3.29 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.21 -1.472 . . . . 0.0 111.817 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 555' ' ' VAL . 35.2 m -102.01 120.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 120.996 -1.297 . . . . 0.0 110.262 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -169.71 133.29 1.25 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.757 -0.589 . . . . 0.0 109.974 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 46.4 m -98.84 126.86 44.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.41 -0.806 . . . . 0.0 109.364 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -76.92 -80.87 0.09 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.274 -0.891 . . . . 0.0 111.373 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -171.9 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.374 -0.829 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -86.27 -21.56 27.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 110.921 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -123.89 124.38 42.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -72.81 -128.32 0.11 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -70.12 96.47 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.65 -6.74 58.78 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.673 -0.898 . . . . 0.0 111.426 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -98.46 -21.77 16.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.137 -0.977 . . . . 0.0 110.688 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.426 ' HD2' ' HB ' ' A' ' 569' ' ' THR . 0.8 OUTLIER -111.46 120.36 42.89 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 110.43 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -9.69 22.41 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.22 1.116 . . . . 0.0 109.225 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -74.03 65.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.225 0 O-C-N 121.409 -0.807 . . . . 0.0 109.909 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' THR . . . . . 0.426 ' HB ' ' HD2' ' A' ' 566' ' ' ARG . 7.7 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 67.2 m -58.93 -43.8 91.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.908 . . . . 0.0 110.701 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 135.13 -9.59 4.45 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.156 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 96.5 mt -88.49 126.04 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.126 -1.22 . . . . 0.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -120.42 165.73 14.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.432 -0.793 . . . . 0.0 110.377 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.11 142.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.788 . . . . 0.0 109.817 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.9 124.54 48.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.728 . . . . 0.0 109.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 431' ' ' PRO . 62.9 t0 -68.97 -52.21 31.4 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.421 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -139.39 3.02 2.1 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.437 -0.789 . . . . 0.0 111.419 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.456 HD23 ' CZ ' ' A' ' 393' ' ' ARG . 93.9 mt -71.66 -31.13 66.48 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.904 -1.123 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 17.0 p -64.63 -40.64 95.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.816 -0.552 . . . . 0.0 111.915 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.59 -35.93 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 111.961 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.456 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 77.3 mtm180 -63.81 -46.99 82.66 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.71 -1.244 . . . . 0.0 110.63 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.35 75.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.688 HD13 ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -63.34 -39.03 93.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.825 -0.547 . . . . 0.0 110.52 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 59.3 m -61.23 -37.84 84.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.424 -0.797 . . . . 0.0 110.419 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -63.3 -44.69 94.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.325 -0.859 . . . . 0.0 111.663 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -67.66 -46.06 73.48 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.149 -0.969 . . . . 0.0 111.949 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 436' ' ' VAL . 63.9 mt -65.44 -42.35 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.985 -1.072 . . . . 0.0 109.921 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 16.6 ttm -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.19 -25.66 65.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.52 -0.738 . . . . 0.0 109.381 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 0.0 OUTLIER -93.11 -15.64 25.83 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.867 -1.146 . . . . 0.0 109.025 175.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 0.4 OUTLIER -67.3 -40.3 86.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.608 -0.683 . . . . 0.0 110.263 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -115.49 18.67 15.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.969 -1.082 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 405' ' ' VAL . 7.1 p -48.7 116.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.492 -0.755 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.8 p -50.49 89.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.786 -0.571 . . . . 0.0 111.016 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 413' ' ' VAL . 14.2 p -108.74 133.7 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -96.76 141.7 23.47 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 110.85 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.93 -24.35 39.83 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.143 1.075 . . . . 0.0 110.232 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -66.76 -32.32 73.53 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.782 0.801 . . . . 0.0 110.392 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 67.21 1.14 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 18.6 t -49.56 148.74 2.69 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.55 -0.718 . . . . 0.0 110.604 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -100.93 110.06 59.9 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.637 . . . . 0.0 110.855 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.81 121.37 5.44 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.004 1.002 . . . . 0.0 111.3 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.4 ' HE ' HG22 ' A' ' 413' ' ' VAL . 13.2 ptp180 -169.4 61.7 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.825 . . . . 0.0 110.181 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.2 t -67.47 -31.36 71.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.323 -0.861 . . . . 0.0 108.799 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.64 47.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 110.735 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.7 81.24 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.519 ' CD1' HG11 ' A' ' 436' ' ' VAL . 26.0 p90 -90.27 -0.42 57.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.93 -1.336 . . . . 0.0 110.161 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.8 m -76.07 -38.81 56.59 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.801 ' O ' HG23 ' A' ' 425' ' ' VAL . 30.8 t70 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.447 0.642 . . . . 0.0 109.962 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.594 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.49 -49.51 75.08 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.971 0.891 . . . . 0.0 111.068 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 436' ' ' VAL . 97.4 t -68.41 -42.24 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.771 -0.581 . . . . 0.0 111.146 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 88.1 p -59.48 -33.05 70.83 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.007 . . . . 0.0 110.42 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 421' ' ' ASP . 76.6 t -63.11 -46.03 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.7 -0.625 . . . . 0.0 111.026 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.8 pp -64.13 -34.76 78.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.178 -0.951 . . . . 0.0 112.367 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.26 85.5 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.629 -1.294 . . . . 0.0 109.15 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -63.3 -32.3 73.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -66.33 -93.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -177.26 -53.79 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.369 -1.457 . . . . 0.0 109.433 177.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 41.1 Cg_endo -68.72 106.36 1.46 Allowed 'Trans proline' 0 N--CA 1.48 0.726 0 N-CA-C 108.204 -1.498 . . . . 0.0 108.204 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.462 ' HB3' ' N ' ' A' ' 532' ' ' VAL . 0.2 OUTLIER -92.36 103.56 15.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.6 OUTLIER -164.07 89.81 0.57 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.938 -1.102 . . . . 0.0 109.27 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -137.4 170.0 16.83 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.785 0.802 . . . . 0.0 111.414 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.35 126.73 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 423' ' ' VAL . 22.4 t -130.04 160.4 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 110.729 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.5 t -133.58 138.79 46.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.434 -0.791 . . . . 0.0 110.685 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.02 166.51 23.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -116.89 -44.59 2.81 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.283 -1.128 . . . . 0.0 109.492 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.9 165.85 38.3 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.98 36.21 64.73 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.677 ' HB3' ' NH1' ' A' ' 470' ' ' ARG . . . -59.13 -22.34 60.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.79 -0.829 . . . . 0.0 112.001 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.56 90.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.82 -29.49 59.15 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 448' ' ' ARG . 43.4 tt0 -60.17 -41.3 92.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.597 -0.943 . . . . 0.0 109.957 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.609 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.0 mtm180 -64.01 -36.12 82.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.16 -30.13 68.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.415 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 445' ' ' GLN . 89.3 mtt-85 -64.62 -49.73 69.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -57.43 -32.58 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.003 -1.061 . . . . 0.0 110.138 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.67 -27.18 68.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 454' ' ' MET . 83.4 tt0 -66.55 -36.6 83.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -62.56 -35.47 79.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.936 HG13 ' CG2' ' A' ' 463' ' ' VAL . 46.9 t -64.63 -28.2 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 95.0 mtp -68.26 -42.73 79.17 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.216 -0.928 . . . . 0.0 111.764 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 6.6 ptm -63.36 -21.58 66.36 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.51 -1.369 . . . . 0.0 109.245 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.43 48.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.456 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.16 -41.05 97.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.47 -22.53 62.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.799 -0.563 . . . . 0.0 110.497 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -75.28 -0.23 18.9 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.171 -0.956 . . . . 0.0 111.651 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 82.24 12.53 80.59 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 120.92 -1.112 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -139.54 151.84 46.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 110.653 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.74 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.8 mt-10 -92.85 179.28 5.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.587 -0.696 . . . . 0.0 109.205 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.936 ' CG2' HG13 ' A' ' 453' ' ' VAL . 14.7 m -141.85 153.23 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.779 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.681 ' HB3' HG22 ' A' ' 505' ' ' VAL . 53.8 tt0 -98.52 118.31 34.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -122.72 128.82 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.42 -0.8 . . . . 0.0 109.467 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.649 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.4 mp -121.39 115.92 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.972 -0.455 . . . . 0.0 110.224 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -71.05 161.41 31.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.46 ' HA ' ' NE2' ' A' ' 509' ' ' GLN . . . -57.36 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.121 -0.987 . . . . 0.0 110.298 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -48.43 -19.8 0.35 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.036 -1.04 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ARG . . . . . 0.677 ' NH1' ' HB3' ' A' ' 442' ' ' ALA . 99.8 mtt180 -78.22 -10.64 59.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.625 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 60.9 ttt-85 -55.11 -25.51 31.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 111.827 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 77.9 p -59.06 -41.92 89.1 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.989 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -64.95 -41.54 95.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.566 -0.709 . . . . 0.0 109.541 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 38.7 ttm -58.0 -36.6 72.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.588 -0.695 . . . . 0.0 110.536 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -60.89 -40.62 93.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -0.82 . . . . 0.0 109.869 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 52.2 mtt -62.79 -40.05 96.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.622 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.413 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 65.0 pttt -117.52 -158.3 0.7 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.165 -0.959 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.413 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 94.8 mm-40 46.15 88.83 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.452 -0.78 . . . . 0.0 112.118 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -116.75 26.28 9.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -107.7 -9.82 15.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 111.449 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -11.39 3.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 111.909 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -173.58 55.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 5.7 t -62.27 -18.48 61.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.318 -0.864 . . . . 0.0 109.921 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 486' ' ' LEU . . . 163.81 -21.08 0.15 Allowed Glycine 0 N--CA 1.501 2.986 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.51 71.31 3.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.029 -1.277 . . . . 0.0 110.014 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -86.77 -82.96 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.398 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.887 HG22 HG23 ' A' ' 488' ' ' THR . 34.5 mm -145.23 -86.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.147 . . . . 0.0 110.322 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 499' ' ' PHE . 69.7 p -96.33 47.78 1.08 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -111.65 59.84 0.35 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.478 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 79.2 ttt180 -143.98 -61.44 0.39 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.438 -1.037 . . . . 0.0 108.908 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -110.71 -31.01 7.35 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.382 0.611 . . . . 0.0 110.558 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -35.92 82.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.306 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.492 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 7.1 mt -91.95 -26.46 18.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.332 -0.855 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 41.7 tp -104.55 -41.64 5.65 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.66 -8.68 18.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.972 -1.08 . . . . 0.0 113.733 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 86.6 -16.36 46.0 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.674 -1.267 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.83 -178.52 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.197 -1.178 . . . . 0.0 109.429 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.38 156.49 22.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.177 -0.952 . . . . 0.0 110.644 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.956 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -113.66 149.06 35.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.855 -0.528 . . . . 0.0 109.726 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -47.09 104.67 0.42 Allowed Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.531 -0.731 . . . . 0.0 110.575 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 529' ' ' ASN . 55.3 Cg_endo -76.72 111.89 3.34 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.25 1.131 . . . . 0.0 110.422 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 174.42 34.64 0.04 OUTLIER Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.824 ' OG ' HD12 ' A' ' 487' ' ' ILE . 14.5 m -99.35 -177.21 3.52 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.331 1.063 . . . . 0.0 113.461 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.824 ' HB ' HG12 ' A' ' 463' ' ' VAL . 52.4 m -120.48 128.79 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 464' ' ' GLN . 37.4 t -116.45 131.79 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.911 0.863 . . . . 0.0 112.726 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 533' ' ' LEU . 39.6 mt -129.71 113.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.947 -1.096 . . . . 0.0 108.121 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 534' ' ' ILE . 10.6 p -114.93 105.21 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.883 -1.136 . . . . 0.0 111.9 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.405 ' OD2' HG11 ' A' ' 449' ' ' VAL . 83.5 m-20 -85.48 124.17 31.75 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 468' ' ' ALA . 9.3 tp-100 -160.1 125.78 4.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -91.4 -31.82 9.28 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.15 -164.08 0.83 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.02 -5.67 3.09 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.89 -39.14 79.92 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.126 -0.984 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.9 m -87.29 -17.34 32.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.559 -0.713 . . . . 0.0 111.733 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 550' ' ' MET . 59.7 tp -73.52 -41.8 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.43 -0.794 . . . . 0.0 109.871 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.2 mttt -74.54 -43.06 57.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.527 -0.733 . . . . 0.0 111.888 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.4 OUTLIER -61.05 -44.55 97.22 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.971 -1.081 . . . . 0.0 110.954 -178.298 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -60.16 -42.1 94.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 0.0 109.508 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.492 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.41 -38.35 77.21 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.797 -0.564 . . . . 0.0 109.619 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.9 m -61.42 -36.33 80.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.303 -0.873 . . . . 0.0 108.993 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 521' ' ' LEU . 0.2 OUTLIER -68.36 -38.29 81.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.8 -0.563 . . . . 0.0 109.984 178.459 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.627 HD11 HG11 ' A' ' 505' ' ' VAL . 0.5 OUTLIER -67.68 -21.29 65.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.15 -0.969 . . . . 0.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 523' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 5.7 t0 -46.44 -63.33 1.03 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.37 -0.831 . . . . 0.0 111.198 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.74 79.36 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 529' ' ' ASN . . . -53.49 -29.75 37.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.75 -0.853 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -46.42 -25.41 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 112.767 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -59.02 -42.91 91.31 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.78 -35.74 0.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.286 -0.884 . . . . 0.0 110.856 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.639 ' HB3' ' HB1' ' A' ' 525' ' ' ALA . 41.1 t-20 -79.77 103.14 9.47 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 529' ' ' ASN . 16.4 m -149.45 125.86 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.08 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.7 OUTLIER 176.23 100.2 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.462 ' N ' ' HB3' ' A' ' 432' ' ' SER . 95.5 t -107.47 109.86 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.629 1.204 . . . . 0.0 109.989 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.754 HD21 ' CG1' ' A' ' 423' ' ' VAL 0.306 4.3 tt -114.45 115.58 27.51 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 103.028 -2.952 . . . . 0.0 103.028 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 507' ' ' VAL . 0.5 OUTLIER -134.48 129.65 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.841 -177.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 68.1 p -100.87 -163.58 1.03 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.6 165.62 36.02 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.21 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 4.4 p -132.94 16.14 4.23 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.38 42.96 0.31 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -96.5 -0.04 49.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.745 -0.856 . . . . 0.0 112.182 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -46.07 -32.06 2.65 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.161 -0.962 . . . . 0.0 111.496 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 t -131.49 162.59 29.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.463 -0.773 . . . . 0.0 109.377 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.69 31.71 58.0 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -61.91 -46.53 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.964 . . . . 0.0 110.758 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.3 -38.19 94.78 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 5.6 t -63.13 -33.73 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.816 -0.814 . . . . 0.0 109.686 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.49 -37.11 80.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.598 -0.689 . . . . 0.0 110.293 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.97 -41.02 97.67 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.461 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 87.7 mmm -65.51 -32.97 74.85 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.377 -0.827 . . . . 0.0 108.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -54.11 -54.76 35.04 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.597 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.492 ' CG ' HD11 ' A' ' 519' ' ' LEU . 65.9 ttp -59.11 -43.22 91.89 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.16 -0.962 . . . . 0.0 110.439 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.26 -32.36 73.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.424 -0.798 . . . . 0.0 112.133 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.1 -13.54 61.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.375 -0.828 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.555 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -72.8 6.91 2.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 112.664 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 140.7 -17.69 2.82 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.87 -1.157 . . . . 0.0 110.967 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 81.5 t -91.2 114.51 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.155 -1.203 . . . . 0.0 110.303 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -166.69 128.5 1.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.472 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 557' ' ' THR . 7.9 t -80.98 127.92 33.11 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.423 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.96 -91.55 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 0.0 111.06 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -158.74 -81.77 0.05 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.041 -1.037 . . . . 0.0 110.982 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -75.44 -22.61 57.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 111.064 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -132.14 158.05 42.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.289 -0.882 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 152.34 -149.96 21.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -97.35 26.22 23.83 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -95.14 -25.19 16.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.407 -1.055 . . . . 0.0 110.665 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -91.58 -5.1 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.348 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.72 71.79 2.58 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.067 -1.021 . . . . 0.0 109.875 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 567' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 568' ' ' ALA . 41.4 Cg_endo -67.95 -24.03 40.06 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.682 1.359 . . . . 0.0 111.34 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 568' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 567' ' ' PRO . . . 177.5 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.234 -0.916 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.137 -179.433 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 71.2 m -59.15 -35.58 73.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.562 -0.711 . . . . 0.0 109.799 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.21 96.94 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 384' ' ' ILE . 9.1 tp -93.41 133.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.475 -1.015 . . . . 0.0 110.613 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.94 165.4 18.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.706 -0.621 . . . . 0.0 110.392 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 70.9 t -107.21 126.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.644 -0.66 . . . . 0.0 109.311 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.76 128.43 45.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.652 -0.655 . . . . 0.0 109.813 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.31 12.83 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.076 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.57 -10.28 59.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.52 -0.738 . . . . 0.0 111.501 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.31 -39.71 87.95 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.6 m -64.24 -42.57 96.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.477 -0.764 . . . . 0.0 109.946 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 433' ' ' LEU . 86.5 t -67.79 -34.41 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.784 -0.572 . . . . 0.0 110.621 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -61.12 -48.09 83.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.296 -0.877 . . . . 0.0 111.349 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.89 78.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.45 -0.782 . . . . 0.0 110.458 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.743 ' CD2' HD11 ' A' ' 399' ' ' ILE . 10.0 tt -61.86 -39.15 90.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.751 -0.593 . . . . 0.0 110.507 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 60.6 m -63.17 -40.35 97.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.747 -0.596 . . . . 0.0 111.49 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.42 -41.8 97.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.333 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.3 -42.39 93.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.618 -0.676 . . . . 0.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -63.08 -39.01 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 120.906 -1.121 . . . . 0.0 108.761 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.583 ' CG ' HD11 ' A' ' 435' ' ' ILE . 42.5 mtp -65.37 -28.47 69.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.37 -29.87 70.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.742 ' O ' HG12 ' A' ' 405' ' ' VAL . 55.1 tt0 -92.8 -13.58 28.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.43 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -36.91 84.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.651 -0.656 . . . . 0.0 109.458 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -116.81 18.85 14.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.791 -1.193 . . . . 0.0 109.919 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.8 p -61.81 118.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.493 -0.754 . . . . 0.0 110.007 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.2 m -53.91 105.08 0.12 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 405' ' ' VAL . 44.8 t -106.53 132.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.612 -0.68 . . . . 0.0 109.548 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -91.95 140.68 24.83 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.552 -0.718 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.1 -23.37 33.88 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.264 1.139 . . . . 0.0 110.265 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -58.68 -43.0 89.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.322 -0.862 . . . . 0.0 109.395 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 67.38 0.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 91.4 p -52.66 117.4 2.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.241 -0.912 . . . . 0.0 111.525 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 407' ' ' VAL . 8.7 p -62.58 149.94 87.4 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -61.88 140.47 85.41 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.068 1.036 . . . . 0.0 110.095 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.438 ' NH2' ' HB2' ' A' ' 439' ' ' GLN . 42.2 mtm180 -106.44 -12.77 15.54 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.839 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 420' ' ' SER . 38.5 p -103.26 10.77 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.388 -1.445 . . . . 0.0 108.792 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.68 -87.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.47 78.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.652 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' A' ' 399' ' ' ILE . 78.7 m-85 -108.32 -25.38 11.04 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 120.756 2.278 . . . . 0.0 109.184 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 416' ' ' THR . 3.7 t -72.94 -40.75 65.14 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -64.12 -35.87 82.16 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 419' ' ' TYR . . . -60.0 -39.13 84.71 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.338 0.589 . . . . 0.0 109.877 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.892 ' HA ' HD23 ' A' ' 426' ' ' LEU . 57.3 t -66.84 -45.6 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 0.0 111.03 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 85.9 p -60.08 -41.51 92.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.142 -0.974 . . . . 0.0 111.577 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.88 -47.02 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.404 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -50.55 -32.56 18.89 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.61 -0.682 . . . . 0.0 112.0 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.18 71.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 0.0 109.278 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.08 -29.46 69.76 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -64.73 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.569 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.65 -51.12 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.503 -1.373 . . . . 0.0 111.346 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 50.1 Cg_endo -86.31 110.11 0.98 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 O-C-N 122.698 0.841 . . . . 0.0 110.03 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.568 ' HA ' HD11 ' A' ' 426' ' ' LEU . 2.8 m -91.19 99.78 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 111.089 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.825 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 7.4 tp -156.79 90.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.619 -0.676 . . . . 0.0 111.017 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -138.43 166.58 23.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.772 -0.58 . . . . 0.0 110.979 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.583 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.1 pp -122.17 125.36 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.631 -0.668 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.743 ' CG2' HG21 ' A' ' 423' ' ' VAL . 38.2 t -128.21 153.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.012 -1.055 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.9 t -132.92 139.09 47.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.21 -0.931 . . . . 0.0 111.735 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 415' ' ' ARG . . . -141.57 143.85 13.63 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLN . . . . . 0.438 ' HB2' ' NH2' ' A' ' 415' ' ' ARG . 27.1 mt-30 -143.29 55.25 1.36 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -1.066 . . . . 0.0 110.279 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 151.73 140.31 3.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.47 79.66 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.01 60.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.964 . . . . 0.0 112.014 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.35 89.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 110.883 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.79 -31.05 56.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.17 -40.39 86.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.699 -0.883 . . . . 0.0 111.049 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.572 ' O ' HG12 ' A' ' 449' ' ' VAL . 51.9 mtt-85 -64.14 -41.84 97.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 73.5 tt0 -72.65 -29.51 63.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -61.25 -46.13 91.66 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.394 -0.816 . . . . 0.0 110.463 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -62.78 -31.22 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.317 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -58.81 -34.19 71.22 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.93 -30.18 70.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.2 -0.938 . . . . 0.0 108.619 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.06 -37.07 83.58 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.84 ' CG2' HG21 ' A' ' 465' ' ' ILE . 37.0 t -60.59 -29.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.87 -39.43 87.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -23.97 66.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.654 -0.654 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -82.08 -21.75 36.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -67.48 -41.56 84.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.852 -0.53 . . . . 0.0 110.297 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -71.77 -34.44 69.44 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.089 -1.007 . . . . 0.0 110.374 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -77.71 6.99 6.31 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.464 -0.773 . . . . 0.0 111.702 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.85 24.12 72.81 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.558 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.7 ttm180 -124.53 129.17 50.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.609 -0.936 . . . . 0.0 110.835 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.594 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.1 mt-10 -92.54 161.41 14.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.671 ' CG2' HG13 ' A' ' 453' ' ' VAL . 17.2 m -145.31 157.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 486' ' ' LEU . 57.6 tt0 -103.13 124.68 49.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.795 -0.566 . . . . 0.0 109.726 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.84 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -129.09 132.17 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.048 . . . . 0.0 109.31 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.647 HG23 ' HD3' ' A' ' 471' ' ' ARG . 87.2 mt -125.11 121.4 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.062 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -79.75 163.0 24.82 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.69 -159.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.337 -0.852 . . . . 0.0 109.949 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.53 -16.08 0.33 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.643 -1.286 . . . . 0.0 111.021 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -72.16 -14.53 61.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.975 -1.078 . . . . 0.0 110.218 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.647 ' HD3' HG23 ' A' ' 466' ' ' ILE . 49.1 ttp180 -57.47 -30.92 65.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.161 -0.962 . . . . 0.0 110.877 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 85.1 p -55.46 -44.3 76.27 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.343 -0.848 . . . . 0.0 109.66 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -65.03 -37.99 89.41 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -36.46 77.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.715 -0.616 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -59.23 -38.1 79.15 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.195 -0.941 . . . . 0.0 109.938 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 97.8 mtp -60.22 -38.09 82.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.88 -146.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.497 -0.752 . . . . 0.0 109.772 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.58 78.51 0.08 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.036 -1.04 . . . . 0.0 111.853 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -117.75 10.26 13.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.427 ' CB ' ' HD3' ' A' ' 481' ' ' ARG . 30.1 mp0 -77.94 -4.48 47.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.971 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.688 ' C ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.4 17.63 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.224 -0.923 . . . . 0.0 113.278 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 481' ' ' ARG . 9.8 mp -125.44 4.86 7.64 Favored 'General case' 0 N--CA 1.508 2.438 0 CA-C-N 120.475 1.489 . . . . 0.0 112.279 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 10.3 m -74.55 35.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.385 -1.447 . . . . 0.0 112.512 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 109.08 9.78 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 120.669 -1.27 . . . . 0.0 110.088 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -87.82 11.7 14.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.135 -1.215 . . . . 0.0 110.385 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' A' ' 464' ' ' GLN . 3.9 mm? -53.37 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.959 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -174.65 -69.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.87 . . . . 0.0 109.118 174.247 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.0 t -103.35 10.5 37.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.0 111.496 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -79.82 66.89 3.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 499' ' ' PHE . 66.4 ttt180 -142.78 -69.64 0.34 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.456 ' HG3' ' HG2' ' A' ' 490' ' ' ARG . 74.9 mtt180 -116.1 -19.8 10.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.248 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.745 ' HG2' HD23 ' A' ' 493' ' ' LEU . 36.2 tt0 -63.1 -39.81 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 0.0 108.487 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.745 HD23 ' HG2' ' A' ' 492' ' ' GLN . 3.2 mt -92.51 -18.34 23.29 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.132 0.491 . . . . 0.0 110.966 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 52.5 tp -104.23 -46.84 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.417 -0.802 . . . . 0.0 112.548 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.47 -5.72 15.09 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.26 -0.9 . . . . 0.0 113.103 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 79.0 48.15 7.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 491' ' ' ARG . 96.1 mmm -111.68 -179.44 3.7 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 122.118 -0.637 . . . . 0.0 109.626 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.18 149.54 35.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 0.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 490' ' ' ARG . 28.2 m-85 -131.22 149.21 52.67 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.776 0.798 . . . . 0.0 111.723 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 500' ' ' THR . 2.6 t -56.07 107.29 0.84 Allowed Pre-proline 0 N--CA 1.496 1.831 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.947 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.62 114.74 4.1 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.54 1.284 . . . . 0.0 109.435 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -174.35 30.85 0.09 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.959 ' CB ' HD13 ' A' ' 487' ' ' ILE . 86.0 p -92.7 173.25 7.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 112.44 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.506 ' HB ' HG12 ' A' ' 463' ' ' VAL . 26.5 m -119.81 99.55 6.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.769 HG11 HD21 ' A' ' 522' ' ' LEU . 61.1 t -93.36 134.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.819 0.819 . . . . 0.0 112.071 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.754 HG22 ' HB3' ' A' ' 533' ' ' LEU . 18.5 pt -130.1 149.54 33.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.76 HG22 ' HG2' ' A' ' 509' ' ' GLN . 5.2 p -142.07 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.435 1.112 . . . . 0.0 110.785 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -83.91 108.94 17.21 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.76 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.6 mm-40 -133.9 114.97 13.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -73.76 -32.39 59.23 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.59 ' OE1' HD21 ' A' ' 513' ' ' LEU . 96.8 mt-10 -97.31 175.33 6.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.46 -7.76 13.42 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.81 -0.556 . . . . 0.0 111.027 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 514' ' ' SER . 4.3 pp -67.62 -37.95 83.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.212 -0.93 . . . . 0.0 111.254 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 513' ' ' LEU . 2.3 p -93.24 -14.77 26.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 0.0 111.199 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.918 ' O ' HD22 ' A' ' 519' ' ' LEU . 59.2 tp -70.08 -48.38 57.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.01 -1.056 . . . . 0.0 108.424 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.97 -42.44 89.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.001 -0.437 . . . . 0.0 111.667 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -57.9 -46.93 84.2 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.212 -0.93 . . . . 0.0 111.111 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 98.6 m -62.31 -45.94 90.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -55.3 -28.56 54.36 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.632 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 m -64.15 -28.24 69.63 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 39.3 tp -80.93 -34.03 33.61 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.523 -0.736 . . . . 0.0 109.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.769 HD21 HG11 ' A' ' 505' ' ' VAL . 4.3 mm? -58.01 -31.86 67.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.8 -63.89 0.86 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.951 -0.468 . . . . 0.0 111.62 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.5 52.04 Favored Glycine 0 N--CA 1.499 2.886 0 O-C-N 120.867 -1.146 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -63.09 -39.91 96.1 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.105 -1.232 . . . . 0.0 113.284 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.68 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -58.13 -26.2 62.37 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.083 -1.011 . . . . 0.0 112.128 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -54.89 -30.36 58.02 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -106.65 -128.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.389 -0.82 . . . . 0.0 110.439 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.412 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.7 OUTLIER -86.71 67.7 9.92 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.721 -1.237 . . . . 0.0 111.974 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 525' ' ' ALA . 2.8 t -133.86 163.83 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.66 -1.275 . . . . 0.0 110.253 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 2.9 mm-40 -163.81 165.0 23.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 33.1 t -109.95 105.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.427 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -103.75 115.07 29.81 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 507' ' ' VAL . 7.1 pt -136.0 164.97 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 117.854 -1.538 . . . . 0.0 113.912 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 436' ' ' VAL . 70.1 p -127.67 -168.3 1.87 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.97 169.08 25.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.435 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.85 17.18 2.31 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.784 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -155.27 33.55 0.65 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.563 HE22 HD13 ' A' ' 435' ' ' ILE . 57.0 tt0 -97.04 -0.29 47.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.683 -0.893 . . . . 0.0 111.66 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -51.36 -43.88 61.95 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 77.2 p -119.59 161.12 21.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 57.93 29.06 61.53 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -59.85 -45.58 91.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.291 -1.123 . . . . 0.0 110.615 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.81 -36.82 93.32 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 35.5 m -63.76 -35.72 81.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.033 -0.686 . . . . 0.0 110.788 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.601 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -58.86 -39.15 80.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.509 -0.744 . . . . 0.0 110.355 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.02 -40.19 94.84 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 48.3 ttp -63.96 -30.35 71.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.49 -53.97 31.9 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.457 ' HA ' HD23 ' A' ' 519' ' ' LEU . 12.4 ttp -57.76 -42.96 85.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -0.837 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.18 -31.68 67.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.476 -0.765 . . . . 0.0 111.669 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -68.43 -31.87 71.51 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.304 -0.873 . . . . 0.0 109.95 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.81 21.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.945 -0.472 . . . . 0.0 111.465 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 107.43 25.61 5.97 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.657 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.92 110.76 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.561 -0.964 . . . . 0.0 109.961 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -170.96 133.09 0.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.519 -0.738 . . . . 0.0 110.822 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 557' ' ' THR . 8.9 t -116.76 122.28 44.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -72.87 -80.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.276 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 559' ' ' ARG . 8.7 tpm_? -135.13 -78.67 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.589 -0.694 . . . . 0.0 109.157 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.24 -23.39 16.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.535 -0.728 . . . . 0.0 110.113 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -147.82 129.61 15.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -112.98 35.68 4.47 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 77.62 16.48 80.14 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.49 -24.62 66.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -1.127 . . . . 0.0 110.146 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -88.12 -4.7 58.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.533 -0.73 . . . . 0.0 111.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.548 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -168.3 54.88 0.27 Allowed Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.257 -0.902 . . . . 0.0 110.174 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 567' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 37.8 Cg_endo -87.71 -5.44 7.08 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 122.946 0.972 . . . . 0.0 110.636 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -94.16 -12.99 27.2 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.408 -0.808 . . . . 0.0 111.055 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.904 -1.045 . . . . 0.0 109.407 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.244 0.545 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 58.5 m -133.38 158.64 42.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.633 -0.667 . . . . 0.0 109.96 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 97.0 -21.8 44.24 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 92.8 mt -107.01 -21.81 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -1.029 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -114.18 51.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 388' ' ' ASP . 7.4 p -109.03 133.92 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.38 0.609 . . . . 0.0 109.935 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.5 mm? -98.21 4.14 48.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.451 -0.78 . . . . 0.0 111.384 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 386' ' ' VAL . 43.3 t0 -60.31 -45.32 93.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.169 -0.957 . . . . 0.0 110.891 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -130.25 -3.91 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.293 -0.879 . . . . 0.0 111.999 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.29 -41.32 98.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.115 -0.991 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 61.4 m -59.81 -43.68 94.37 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.57 -0.706 . . . . 0.0 110.206 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 69.4 t -65.76 -35.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.302 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -61.93 -46.4 89.49 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.289 -0.882 . . . . 0.0 110.59 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.19 80.14 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.696 0.76 . . . . 0.0 109.161 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -61.96 -39.39 91.98 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 400' ' ' MET . 68.3 m -61.15 -36.43 79.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.072 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -63.87 -44.48 92.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.085 -1.009 . . . . 0.0 111.46 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.84 -46.09 76.18 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.182 -0.949 . . . . 0.0 111.861 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 395' ' ' LEU . 78.6 mt -64.84 -42.74 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.812 . . . . 0.0 109.99 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 396' ' ' SER . 40.4 mmm -62.22 -31.76 72.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.874 -0.516 . . . . 0.0 109.65 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -58.53 -34.09 70.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.377 -0.827 . . . . 0.0 109.154 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.609 ' O ' HG12 ' A' ' 405' ' ' VAL . 95.6 mt-30 -90.57 -14.64 32.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.22 -39.27 89.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -116.85 18.8 14.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.945 -1.097 . . . . 0.0 110.555 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.693 HG11 ' CZ ' ' A' ' 415' ' ' ARG . 3.5 p -51.34 117.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.538 -0.726 . . . . 0.0 109.177 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 25.4 m -52.17 98.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.499 0.666 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 413' ' ' VAL . 8.4 p -109.42 133.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.755 -0.59 . . . . 0.0 109.906 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -92.19 140.28 24.43 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 111.185 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.91 -28.17 42.66 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.254 1.133 . . . . 0.0 110.22 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.9 -33.29 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.826 0.822 . . . . 0.0 109.861 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.17 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 118.53 5.24 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.746 . . . . 0.0 110.675 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.1 p -71.68 110.65 8.08 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.757 -0.589 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.03 139.18 29.46 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 O-C-N 123.066 1.035 . . . . 0.0 110.31 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.693 ' CZ ' HG11 ' A' ' 405' ' ' VAL . 23.7 ptt85 -168.85 60.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.672 -0.642 . . . . 0.0 110.738 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.7 t -65.48 -34.96 79.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -67.29 -7.05 21.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.689 -0.632 . . . . 0.0 110.953 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.75 -43.73 98.53 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.613 ' CB ' HG13 ' A' ' 436' ' ' VAL . 1.1 m-85 -91.64 -3.36 56.44 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.857 -1.378 . . . . 0.0 108.938 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 33.8 p -77.96 -39.04 43.8 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 425' ' ' VAL . 25.3 t70 -77.6 -43.55 31.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.471 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.16 -49.82 74.3 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.666 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 78.7 t -71.26 -41.42 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.922 -0.487 . . . . 0.0 111.861 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -58.92 -41.7 87.94 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.03 -1.044 . . . . 0.0 111.242 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 421' ' ' ASP . 84.4 t -64.47 -45.42 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -56.17 -35.71 67.52 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.54 -0.725 . . . . 0.0 111.993 -177.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.92 81.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.062 -1.024 . . . . 0.0 108.593 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.88 -30.59 71.6 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -63.68 -89.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.424 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.05 -60.66 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.449 -1.407 . . . . 0.0 109.565 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 45.5 Cg_endo -71.56 113.28 3.58 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 N-CA-C 108.242 -1.484 . . . . 0.0 108.242 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 15.2 m -108.96 117.28 33.79 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.897 0.856 . . . . 0.0 112.039 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.539 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -173.22 97.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.87 172.54 12.7 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.203 -0.935 . . . . 0.0 112.462 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 435' ' ' ILE . 0.2 OUTLIER -124.81 136.95 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.381 0.61 . . . . 0.0 109.703 178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 423' ' ' VAL . 60.4 t -141.58 152.9 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 109.629 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.1 p -139.81 149.81 43.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.868 . . . . 0.0 110.752 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.63 159.94 21.76 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -149.23 22.96 0.94 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.93 . . . . 0.0 110.835 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -162.5 -118.13 0.45 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.89 131.33 11.78 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -103.47 -15.02 16.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.293 -1.122 . . . . 0.0 111.291 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -71.55 -43.94 65.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.42 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.08 -28.76 71.22 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -63.84 -40.55 96.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.638 -0.919 . . . . 0.0 109.98 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 449' ' ' VAL . 83.3 mtt85 -64.31 -41.18 96.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.559 -0.713 . . . . 0.0 110.418 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 50.2 mt-10 -70.07 -29.28 66.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.087 -1.008 . . . . 0.0 110.222 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -62.92 -53.09 59.41 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.713 HG22 HD12 ' A' ' 506' ' ' ILE . 13.6 p -57.77 -30.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.051 -1.031 . . . . 0.0 108.626 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.11 -26.52 68.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.71 -35.33 80.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.866 -1.146 . . . . 0.0 108.292 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 455' ' ' MET . 96.0 mt -63.93 -31.38 72.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.495 -0.753 . . . . 0.0 109.009 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.944 HG13 ' CG2' ' A' ' 463' ' ' VAL . 58.1 t -58.48 -38.36 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.248 -0.908 . . . . 0.0 108.948 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 48.0 mtt -63.49 -35.82 81.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.495 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 452' ' ' LEU . 64.7 ttp -54.78 -26.24 33.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.366 -0.834 . . . . 0.0 109.587 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.51 -22.84 32.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.667 -0.646 . . . . 0.0 110.497 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -62.02 -46.09 90.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.373 -0.829 . . . . 0.0 108.989 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.0 -31.82 70.93 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.56 -0.84 21.8 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.41 32.03 82.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.527 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 22.8 ttt85 -130.79 122.15 26.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.969 . . . . 0.0 110.868 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 487' ' ' ILE . 95.6 mt-10 -71.71 162.78 28.93 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.944 ' CG2' HG13 ' A' ' 453' ' ' VAL . 28.4 m -138.45 168.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.999 -1.063 . . . . 0.0 111.588 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.753 ' HB2' HD11 ' A' ' 486' ' ' LEU . 59.1 tt0 -120.45 115.78 24.16 Favored 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.952 HD11 HD13 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -131.11 138.83 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.508 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.585 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.2 mt -130.91 125.39 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.716 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.4 164.76 25.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 509' ' ' GLN . . . -58.7 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.693 -0.629 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -46.55 -21.44 0.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.175 -0.953 . . . . 0.0 112.043 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -75.37 -7.62 54.51 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.406 -0.809 . . . . 0.0 112.397 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.579 ' CD ' HG23 ' A' ' 466' ' ' ILE . 77.6 ttt-85 -57.5 -25.53 59.94 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.784 -1.198 . . . . 0.0 110.904 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.1 p -59.14 -41.98 89.57 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -62.44 -41.16 98.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.79 69.66 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.87 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -58.31 -39.75 80.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.081 . . . . 0.0 109.171 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 69.1 mtm -60.92 -39.33 89.0 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.793 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -122.97 -140.7 0.32 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.354 -0.841 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 48.52 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.791 -1.193 . . . . 0.0 112.53 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -136.81 28.53 2.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.29 -0.881 . . . . 0.0 109.671 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -108.99 -9.24 15.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.609 ' HB2' HD23 ' A' ' 482' ' ' LEU . 3.0 mtt180 -133.3 -10.45 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 112.418 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.952 HD13 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -168.92 61.99 0.06 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.751 -1.218 . . . . 0.0 113.062 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 44.2 t -89.36 48.63 1.64 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.746 -1.221 . . . . 0.0 110.575 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 100.03 2.5 55.98 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.986 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -91.05 43.31 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.122 1.461 . . . . 0.0 110.273 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 464' ' ' GLN . 0.2 OUTLIER -58.73 -81.92 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.966 HG22 HG23 ' A' ' 488' ' ' THR . 0.2 OUTLIER -173.37 -73.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.092 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 70.5 p -103.31 25.47 9.52 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.82 94.81 0.53 Allowed Glycine 0 N--CA 1.496 2.639 0 O-C-N 121.549 -0.72 . . . . 0.0 111.835 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -144.35 -111.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 495' ' ' GLU . 28.4 mmt180 -103.2 -32.73 9.47 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.002 -1.061 . . . . 0.0 108.597 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -47.84 -22.45 0.56 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.04 -58.96 4.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.318 -0.864 . . . . 0.0 111.317 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.71 5.41 26.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.974 -1.079 . . . . 0.0 111.994 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 491' ' ' ARG . 59.0 mm-40 -84.66 -5.93 59.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.977 -1.077 . . . . 0.0 113.069 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 95.82 -11.95 67.65 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.715 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.44 -176.69 0.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.128 -1.219 . . . . 0.0 108.98 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.41 170.43 8.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.352 -0.842 . . . . 0.0 109.637 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -111.41 153.02 26.68 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.684 ' H ' HG21 ' A' ' 488' ' ' THR . 52.2 m -81.98 120.71 78.08 Favored Pre-proline 0 N--CA 1.484 1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 34.7 Cg_endo -61.84 138.91 77.05 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.407 1.214 . . . . 0.0 111.291 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 149.6 -7.38 0.81 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.683 ' OG ' HG21 ' A' ' 487' ' ' ILE . 48.7 m -85.25 160.25 19.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.302 . . . . 0.0 112.209 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.558 ' HB ' HG12 ' A' ' 463' ' ' VAL . 86.4 m -106.0 163.27 12.89 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.489 HG11 HD13 ' A' ' 522' ' ' LEU . 59.7 t -151.14 121.7 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.878 -1.139 . . . . 0.0 111.312 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.713 HD12 HG22 ' A' ' 449' ' ' VAL . 6.2 pt -136.2 112.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 1.016 HG12 HG22 ' A' ' 534' ' ' ILE . 7.8 p -114.48 104.33 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.6 1.191 . . . . 0.0 113.06 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.573 ' OD2' HG11 ' A' ' 449' ' ' VAL . 90.4 m-20 -83.98 124.96 31.59 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.614 ' CD ' HD13 ' A' ' 515' ' ' LEU . 1.2 pm0 -159.36 126.69 4.75 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.95 -41.86 6.97 Favored Glycine 0 N--CA 1.505 3.258 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -72.04 142.55 49.27 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.68 -12.78 20.71 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.095 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.99 -33.64 76.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 36.3 t -81.14 -23.36 38.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.847 -0.533 . . . . 0.0 111.314 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.636 HD21 ' HG2' ' A' ' 550' ' ' MET . 57.0 tp -65.85 -47.34 75.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.177 -0.952 . . . . 0.0 110.417 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.6 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 55.1 mtmt -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.673 -0.642 . . . . 0.0 111.586 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -58.81 -51.2 71.02 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.271 -0.893 . . . . 0.0 110.599 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 73.9 m -58.07 -41.07 82.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.766 HD12 HG21 ' A' ' 555' ' ' VAL . 0.3 OUTLIER -59.5 -38.09 80.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.041 -0.412 . . . . 0.0 111.853 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 47.0 p -64.71 -35.68 81.83 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.793 -1.192 . . . . 0.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.6 OUTLIER -70.35 -38.25 74.8 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.313 1.054 . . . . 0.0 108.19 177.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 530' ' ' VAL . 38.6 tp -62.98 -28.01 69.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.156 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -47.21 -63.12 1.12 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -51.4 58.76 Favored Glycine 0 N--CA 1.502 3.042 0 O-C-N 120.58 -1.325 . . . . 0.0 110.018 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -60.41 -30.22 69.47 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -1.036 . . . . 0.0 110.306 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -64.08 -20.61 66.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.757 -0.59 . . . . 0.0 112.315 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -37.76 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 2.6 m170 -147.69 -79.93 0.15 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 120.634 1.561 . . . . 0.0 114.304 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.438 ' HB2' ' N ' ' A' ' 502' ' ' GLY . 82.4 m-20 -86.26 60.59 6.32 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 522' ' ' LEU . 14.9 p -117.91 133.49 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.858 -1.151 . . . . 0.0 113.362 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.405 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 94.3 mt-30 -122.42 129.12 51.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 70.7 t -115.09 117.95 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.123 0.964 . . . . 0.0 112.049 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 423' ' ' VAL . 9.3 mp -114.33 118.43 33.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 1.016 HG22 HG12 ' A' ' 507' ' ' VAL . 9.3 pt -128.77 134.8 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 118.254 -1.378 . . . . 0.0 110.858 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.657 HG22 ' HB ' ' A' ' 436' ' ' VAL . 55.3 p -112.87 -163.46 0.85 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.41 165.24 36.27 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.646 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.501 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 6.6 p -130.17 22.17 5.27 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.876 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -168.47 35.22 0.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -95.81 -0.63 50.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' ARG . . . . . 0.915 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.6 ptt180 -47.53 -24.7 0.91 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.149 -0.969 . . . . 0.0 111.251 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.915 HG23 ' HG3' ' A' ' 540' ' ' ARG . 69.3 p -124.57 162.0 24.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 51.21 38.09 39.6 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -59.45 -45.39 91.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.665 -0.903 . . . . 0.0 110.508 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.88 -38.15 94.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 33.1 m -61.55 -32.65 72.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.745 -0.856 . . . . 0.0 109.629 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.49 -37.83 79.28 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.009 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.0 mp -62.51 -40.02 95.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.765 . . . . 0.0 109.305 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.14 -31.53 72.03 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.33 -54.2 28.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.935 -0.478 . . . . 0.0 109.828 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 519' ' ' LEU . 79.6 mmm -57.98 -43.25 86.44 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.475 -0.766 . . . . 0.0 109.619 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.18 -31.61 70.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.756 -0.59 . . . . 0.0 110.958 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.82 -25.29 67.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.145 -0.972 . . . . 0.0 109.532 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.6 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -73.94 0.44 13.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.484 -0.76 . . . . 0.0 111.723 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 109.31 -14.74 33.15 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.295 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 519' ' ' LEU . 41.2 t -65.84 115.01 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.685 1.242 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -164.39 137.13 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.803 -0.561 . . . . 0.0 110.124 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 9.9 t -98.64 143.76 28.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -74.86 -79.24 0.09 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.315 -0.866 . . . . 0.0 110.496 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -143.18 -79.97 0.21 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -91.25 -20.7 21.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -119.93 156.93 29.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.341 -0.849 . . . . 0.0 111.325 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -71.24 -128.22 0.07 OUTLIER Glycine 0 N--CA 1.485 1.949 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -96.08 44.05 2.07 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -96.15 -17.83 20.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.407 -1.054 . . . . 0.0 110.6 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -91.98 -3.92 55.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 110.685 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -119.0 83.32 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 111.327 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.16 -12.77 25.77 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.564 1.297 . . . . 0.0 109.999 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -107.36 69.85 0.77 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.287 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.105 -179.859 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.304 0.573 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 4.9 m -71.03 -14.53 62.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.702 -0.624 . . . . 0.0 110.462 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.25 11.99 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.883 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 36.1 pt -82.13 160.1 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.332 -1.099 . . . . 0.0 110.47 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -141.83 138.03 31.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.918 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.6 t -111.63 131.63 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.541 -0.724 . . . . 0.0 109.228 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.85 120.57 38.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.077 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -145.37 158.29 43.86 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 -86.37 57.19 4.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.719 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.57 -37.2 86.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.7 m -61.92 -41.72 98.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.473 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.681 HG11 ' HB3' ' A' ' 433' ' ' LEU . 60.5 t -70.29 -34.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.162 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.71 -42.77 89.41 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.876 -1.14 . . . . 0.0 109.815 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.49 73.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.305 -0.872 . . . . 0.0 108.737 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.8 OUTLIER -60.51 -41.55 94.61 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.45 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 40.0 t -64.88 -39.28 93.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.432 -0.793 . . . . 0.0 111.403 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.57 -43.86 92.56 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.301 -0.874 . . . . 0.0 112.461 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -75.66 -45.72 35.47 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.823 -1.173 . . . . 0.0 112.115 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.831 HG21 ' O ' ' A' ' 435' ' ' ILE . 97.7 mt -62.87 -42.27 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.88 . . . . 0.0 109.995 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 35.6 mtp -60.77 -31.84 71.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.665 -0.647 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.57 -22.5 66.93 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.3 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 72.5 tp60 -92.65 -20.63 20.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.097 . . . . 0.0 108.98 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.02 -30.95 70.3 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -114.99 19.25 15.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.211 -0.931 . . . . 0.0 109.857 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 405' ' ' VAL . 8.4 p -50.84 113.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 406' ' ' THR . 5.1 t -48.77 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.638 -0.664 . . . . 0.0 111.833 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.685 HG23 HG12 ' A' ' 413' ' ' VAL . 7.4 p -112.92 133.42 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.536 -0.728 . . . . 0.0 110.117 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -96.04 143.24 25.78 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.89 . . . . 0.0 110.044 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.85 -24.62 53.71 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.34 1.179 . . . . 0.0 110.385 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -61.28 -39.79 91.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 66.23 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 93.4 p -50.48 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.096 -1.003 . . . . 0.0 110.313 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 407' ' ' VAL . 9.3 p -63.33 110.33 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.923 -0.485 . . . . 0.0 110.616 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.5 136.35 12.35 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 O-C-N 122.939 0.968 . . . . 0.0 110.531 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -153.67 70.14 0.83 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.503 -0.748 . . . . 0.0 110.766 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 46.3 p -65.21 -39.03 92.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' A' ' 420' ' ' SER . . . -49.86 -25.2 2.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.682 -0.636 . . . . 0.0 111.383 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -50.77 -62.25 5.42 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.376 -0.827 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.532 ' CG ' HG13 ' A' ' 436' ' ' VAL . 20.0 p90 -88.22 -2.7 58.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.791 -1.417 . . . . 0.0 111.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 417' ' ' ALA . 51.6 p -72.19 -39.75 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 425' ' ' VAL . 36.7 t70 -76.86 -45.66 27.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.978 -0.451 . . . . 0.0 110.571 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.477 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.0 -48.9 79.69 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.439 -0.788 . . . . 0.0 111.099 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 436' ' ' VAL . 89.3 t -68.48 -46.19 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.1 p -64.18 -33.04 74.87 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.665 -1.272 . . . . 0.0 111.039 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 421' ' ' ASP . 52.4 t -65.65 -36.17 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.695 . . . . 0.0 111.506 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.891 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 1.6 pp -70.25 -33.89 72.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 111.586 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.56 78.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.909 -1.119 . . . . 0.0 109.647 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -65.54 -33.38 75.78 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -65.29 -95.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -169.85 -61.85 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.442 -1.411 . . . . 0.0 109.452 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.26 113.85 2.08 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 109.196 -1.117 . . . . 0.0 109.196 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.79 ' O ' HD22 ' A' ' 433' ' ' LEU . 17.3 t -96.55 103.31 15.21 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.718 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 432' ' ' SER . 0.2 OUTLIER -152.96 88.23 1.31 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.891 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -118.04 156.43 28.6 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.025 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.831 ' O ' HG21 ' A' ' 399' ' ' ILE 0.263 62.2 mt -122.61 127.3 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 423' ' ' VAL . 45.2 t -141.42 153.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.954 -1.091 . . . . 0.0 111.196 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.3 p -136.26 143.06 44.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.72 129.6 9.95 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.52 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.23 -23.69 10.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.886 -0.773 . . . . 0.0 109.841 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.14 160.28 33.56 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.43 46.47 94.29 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.37 77.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 111.029 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.63 92.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.294 -0.879 . . . . 0.0 111.157 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.85 72.15 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -59.82 -41.06 90.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -1.014 . . . . 0.0 110.277 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.563 ' CD ' ' HB1' ' A' ' 467' ' ' ALA . 54.4 mtm180 -67.48 -38.5 84.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.364 -0.835 . . . . 0.0 110.996 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 45.5 tt0 -71.64 -31.85 67.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.271 -0.893 . . . . 0.0 111.553 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.74 -53.61 44.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.067 -1.021 . . . . 0.0 110.41 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.647 ' CG2' HD12 ' A' ' 506' ' ' ILE . 11.7 p -55.24 -30.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.038 -1.039 . . . . 0.0 109.218 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.37 -27.95 68.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.15 -34.95 79.6 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.34 -36.07 79.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 95.2 t -58.28 -29.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 91.7 mtp -67.2 -39.68 86.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -55.39 -27.89 50.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.306 -0.871 . . . . 0.0 109.893 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.72 40.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.8 -43.34 88.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 109.514 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -68.59 -30.43 69.17 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.458 0.647 . . . . 0.0 109.841 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -73.68 -1.09 17.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.655 -0.653 . . . . 0.0 111.641 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 79.86 18.56 72.36 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 120.876 -1.14 . . . . 0.0 110.612 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.81 149.94 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.347 -1.09 . . . . 0.0 111.093 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -94.96 -178.51 4.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 7.3 m -148.0 170.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.926 -1.109 . . . . 0.0 110.805 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -119.35 128.37 54.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.719 HG21 ' CG2' ' A' ' 453' ' ' VAL . 11.2 pt -134.55 141.53 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.561 HG23 ' HD3' ' A' ' 471' ' ' ARG . 85.8 mt -132.7 124.71 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.595 -0.691 . . . . 0.0 109.719 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -79.84 165.9 22.25 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -60.54 -159.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -49.08 -20.86 0.61 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.61 -1.307 . . . . 0.0 111.334 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.39 -8.98 58.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.456 -0.777 . . . . 0.0 111.353 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.573 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 64.5 ttp85 -59.44 -23.11 62.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.909 -1.119 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 12.5 t -59.64 -44.13 93.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.391 -0.818 . . . . 0.0 109.527 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -60.89 -45.22 95.46 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.31 -36.0 72.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.637 -0.664 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -59.22 -40.31 85.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.157 -0.965 . . . . 0.0 111.331 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 7.5 ttm -61.59 -36.3 80.28 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.293 -0.879 . . . . 0.0 110.604 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 53.4 pttt -125.29 -146.84 0.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.797 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.438 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 87.9 mm-40 51.59 71.71 0.43 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.091 -1.006 . . . . 0.0 112.41 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -112.17 18.57 18.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.29 -10.56 40.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.429 -0.795 . . . . 0.0 111.289 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.657 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -142.8 -0.95 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.955 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.657 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.31 62.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.64 -1.288 . . . . 0.0 111.415 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 36.6 m -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.888 -1.133 . . . . 0.0 110.318 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 153.19 55.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.8 pt-20 -158.0 92.47 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.2 1.0 . . . . 0.0 110.757 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.564 ' C ' HD12 ' A' ' 487' ' ' ILE . 61.8 mt -99.16 -82.13 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.628 HD13 ' CB ' ' A' ' 503' ' ' SER . 3.1 mp -150.15 -69.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 499' ' ' PHE . 1.4 t -99.91 16.23 24.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.383 -0.823 . . . . 0.0 112.092 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.08 59.67 4.96 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 70.7 ttt180 -142.0 -54.83 0.45 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -1.142 . . . . 0.0 109.544 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 28.3 mmt180 -104.12 -36.23 7.77 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.778 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.453 ' HG3' ' HA ' ' A' ' 498' ' ' ALA . 10.1 mt-30 -61.46 -41.0 96.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.714 ' N ' HD23 ' A' ' 493' ' ' LEU . 1.2 mt -70.19 -42.08 72.88 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.521 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -105.89 -42.94 5.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.64 -10.63 24.73 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.921 -1.111 . . . . 0.0 113.083 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 88.3 -21.69 23.57 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 120.68 -1.262 . . . . 0.0 110.909 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.417 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 78.6 mtm -66.14 176.23 1.81 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.138 -1.213 . . . . 0.0 110.188 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 492' ' ' GLN . . . -112.27 152.03 28.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 111.056 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.1 OUTLIER -113.14 150.07 32.71 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 500' ' ' THR . 6.0 t -43.25 105.59 0.44 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.032 -0.418 . . . . 0.0 110.524 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.03 114.09 2.66 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.336 1.177 . . . . 0.0 111.572 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.66 34.91 0.18 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.628 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.1 p -93.61 167.62 11.56 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 112.827 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.438 ' HB ' HG12 ' A' ' 463' ' ' VAL . 41.2 m -119.52 159.58 24.05 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.657 HG21 ' CD1' ' A' ' 522' ' ' LEU . 73.7 t -143.57 130.78 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 118.527 -1.269 . . . . 0.0 113.026 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.647 HD12 ' CG2' ' A' ' 449' ' ' VAL . 4.7 pt -137.0 120.61 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 534' ' ' ILE . 11.5 p -119.32 99.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.691 -1.256 . . . . 0.0 111.547 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.541 ' OD1' HG23 ' A' ' 535' ' ' THR . 96.4 m-20 -83.08 98.42 9.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.763 ' CD ' HD23 ' A' ' 515' ' ' LEU . 1.7 pm0 -124.78 123.93 41.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.519 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -75.19 -53.93 5.91 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -69.61 -161.52 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.95 -10.6 2.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.947 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 517' ' ' GLU . 12.9 tp -65.4 -28.02 68.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -0.981 . . . . 0.0 108.596 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 3.6 m -83.84 -19.86 34.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.663 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.763 HD23 ' CD ' ' A' ' 509' ' ' GLN . 0.4 OUTLIER -65.8 -48.93 70.07 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.412 178.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.01 -39.87 65.66 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.0 111.824 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 513' ' ' LEU . 79.2 mm-40 -61.83 -47.22 86.07 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.586 -0.696 . . . . 0.0 111.572 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.503 HG21 ' HB ' ' A' ' 507' ' ' VAL . 97.7 m -60.96 -43.01 99.35 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.523 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -56.45 -35.65 68.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.873 -0.517 . . . . 0.0 110.717 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 97.6 m -64.35 -43.91 93.11 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 111.668 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.22 -42.01 93.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.265 -0.897 . . . . 0.0 108.944 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.657 ' CD1' HG21 ' A' ' 505' ' ' VAL . 1.8 tp -62.78 -28.47 70.01 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.531 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -46.5 -65.46 0.55 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.413 -0.804 . . . . 0.0 113.166 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -67.88 -49.4 48.74 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.129 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.12 67.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.679 -0.895 . . . . 0.0 111.332 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 522' ' ' LEU . . . -57.13 -24.19 52.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 112.619 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -41.94 -27.0 0.1 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.565 -0.709 . . . . 0.0 112.182 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -108.95 -118.99 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.208 -0.932 . . . . 0.0 112.584 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -89.23 90.25 8.27 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 120.355 -1.466 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.536 HG21 ' HB1' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -119.4 136.87 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 O-C-N 120.407 -1.433 . . . . 0.0 113.116 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 432' ' ' SER . 9.9 mp0 -126.36 133.58 51.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 40.6 t -114.99 121.66 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 122.971 1.367 . . . . 0.0 111.648 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 434' ' ' ALA . 0.8 OUTLIER -123.67 122.53 38.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 507' ' ' VAL . 9.6 pt -133.09 133.24 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.826 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.541 HG23 ' OD1' ' A' ' 508' ' ' ASP . 55.8 p -106.47 -164.32 0.99 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.79 168.73 26.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.519 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -135.38 13.71 3.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.418 178.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -152.22 27.6 0.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.509 HE22 HG22 ' A' ' 435' ' ' ILE . 10.4 tt0 -99.5 0.86 43.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -1.062 . . . . 0.0 112.272 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -59.62 -33.98 72.2 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.977 -1.077 . . . . 0.0 112.12 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 27.6 m -102.98 -58.06 1.94 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.072 -1.017 . . . . 0.0 110.819 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -100.34 94.43 1.32 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.8 t -95.31 -36.32 11.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -1.009 . . . . 0.0 110.48 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -60.26 -34.78 86.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.8 p -64.05 -34.3 77.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.942 . . . . 0.0 111.09 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.46 -37.29 83.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.425 -0.797 . . . . 0.0 109.887 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.81 -40.14 96.45 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.471 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.0 mmm -68.18 -27.52 66.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.401 -0.812 . . . . 0.0 110.319 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -59.46 -55.41 35.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.523 ' HG3' HD11 ' A' ' 519' ' ' LEU . 51.8 ttm -58.89 -48.63 80.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.478 -0.764 . . . . 0.0 110.394 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -59.48 -32.57 70.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.644 -0.66 . . . . 0.0 111.781 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -66.45 -25.07 66.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.259 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.48 -1.04 9.62 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.334 -0.854 . . . . 0.0 111.192 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 116.16 -15.22 15.84 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.897 -1.127 . . . . 0.0 111.162 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.82 102.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 118.942 1.371 . . . . 0.0 109.713 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -158.87 114.06 2.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.813 -0.555 . . . . 0.0 109.629 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 28.8 m -99.09 90.62 4.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.335 -0.853 . . . . 0.0 109.565 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -89.01 -89.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 560' ' ' TRP . 39.6 ptt180 -169.8 -48.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.966 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 560' ' ' TRP . . . . . 0.4 ' N ' ' HG3' ' A' ' 559' ' ' ARG . 42.0 p-90 -102.95 -24.25 13.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -140.16 157.38 45.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -0.814 . . . . 0.0 109.72 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 155.83 -112.81 0.54 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -86.12 -7.72 79.84 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -96.21 -10.53 27.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.304 -1.115 . . . . 0.0 110.755 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -93.06 -9.27 40.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.92 -1.112 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -105.01 89.56 3.03 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.54 -18.74 37.9 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.823 1.433 . . . . 0.0 111.206 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -166.18 113.99 0.91 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.453 -0.779 . . . . 0.0 110.326 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.01 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 36.4 t -62.92 -44.71 95.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.473 -0.767 . . . . 0.0 109.967 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 106.24 63.3 0.61 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 45.8 pt -108.61 25.59 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.622 -0.928 . . . . 0.0 110.132 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -90.84 36.09 0.9 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.36 148.88 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.708 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 387' ' ' LEU . 4.6 mm? -68.08 162.11 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.656 -0.652 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -87.71 12.64 12.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.39 17.03 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.997 . . . . 0.0 110.454 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.42 -42.08 98.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.193 -0.942 . . . . 0.0 109.396 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.4 m -64.89 -42.88 94.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.878 -0.514 . . . . 0.0 110.712 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 433' ' ' LEU . 99.9 t -66.45 -35.69 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.536 -0.728 . . . . 0.0 110.665 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -62.45 -45.29 93.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.277 -0.889 . . . . 0.0 109.802 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -71.56 -36.88 71.07 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.58 0.705 . . . . 0.0 110.149 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.587 ' C ' HD13 ' A' ' 395' ' ' LEU . 2.6 tm? -61.18 -38.75 87.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.964 -0.46 . . . . 0.0 110.016 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 400' ' ' MET . 42.7 t -63.72 -40.48 96.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.636 -0.665 . . . . 0.0 109.845 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.18 -42.75 99.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.543 -0.723 . . . . 0.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.79 -42.21 97.77 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.116 -0.99 . . . . 0.0 111.708 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 435' ' ' ILE . 58.9 mt -66.63 -41.21 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 0.0 110.431 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 435' ' ' ILE . 47.1 mmm -58.25 -33.91 69.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.52 -33.39 75.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.563 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -92.4 -3.83 54.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.936 -1.102 . . . . 0.0 109.778 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 9.2 m120 -89.15 -26.99 21.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.488 -0.757 . . . . 0.0 109.033 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 19.14 15.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 108.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.1 p -52.61 107.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.2 m -49.73 101.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.316 -0.865 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 405' ' ' VAL . 74.3 t -113.6 133.32 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.614 . . . . 0.0 110.113 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -92.04 140.17 24.6 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.593 -0.692 . . . . 0.0 109.871 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 -27.87 33.73 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.282 1.149 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -62.41 -29.91 70.83 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.364 -0.835 . . . . 0.0 110.0 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 59.11 0.68 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.3 t -60.03 122.28 13.94 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.934 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -74.54 120.61 82.33 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.723 -0.61 . . . . 0.0 110.378 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.474 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 47.5 Cg_endo -73.65 132.44 17.33 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 122.907 0.951 . . . . 0.0 110.008 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 414' ' ' PRO . 90.8 mtt180 -160.94 56.07 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.833 -0.542 . . . . 0.0 110.017 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 45.0 p -67.34 -34.38 77.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.73 -1.231 . . . . 0.0 108.417 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -71.12 -2.29 15.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.783 -0.573 . . . . 0.0 112.195 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.0 97.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 423' ' ' VAL . 33.6 p90 -98.15 -4.06 36.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 8.1 t -73.91 -42.07 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -71.79 -40.82 68.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.34 98.73 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.72 0.771 . . . . 0.0 110.257 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 533' ' ' LEU . 73.5 t -69.18 -42.17 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.637 -0.664 . . . . 0.0 111.641 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 90.6 p -58.84 -41.67 87.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 0.0 110.946 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.54 -43.39 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.337 -0.852 . . . . 0.0 110.899 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.8 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 0.4 OUTLIER -62.64 -35.12 78.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.193 -0.942 . . . . 0.0 111.669 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.72 77.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.734 -1.229 . . . . 0.0 109.217 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.64 -30.11 70.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.8 -88.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.96 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 120.487 -1.383 . . . . 0.0 109.999 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.44 ' HA ' ' HG2' ' A' ' 531' ' ' GLN . 45.6 Cg_endo -73.01 109.98 2.94 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 123.092 1.048 . . . . 0.0 109.724 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.583 ' CB ' HD12 ' A' ' 533' ' ' LEU . 3.4 m -83.81 98.66 9.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.35 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 10.8 tp -146.04 135.42 22.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -172.18 164.77 6.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 400' ' ' MET . 19.5 pt -133.51 118.45 30.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -126.6 150.87 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.995 -1.066 . . . . 0.0 109.863 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 9.2 p -131.73 139.95 49.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.815 -0.553 . . . . 0.0 109.723 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.48 160.9 20.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.84 -19.2 11.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.656 -0.908 . . . . 0.0 110.306 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -174.93 168.15 40.63 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 57.48 82.73 0.05 OUTLIER Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -93.32 -18.49 22.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.502 -0.999 . . . . 0.0 111.444 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.88 -44.74 84.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.973 . . . . 0.0 109.516 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.03 -28.58 70.2 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -61.22 -41.12 96.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.645 -0.914 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 57.9 mtm-85 -61.31 -42.05 98.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.92 . . . . 0.0 110.304 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -72.27 -28.76 63.33 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.387 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -62.21 -50.6 71.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.917 -1.115 . . . . 0.0 110.995 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 506' ' ' ILE . 7.6 p -62.16 -32.8 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.691 -1.255 . . . . 0.0 108.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.85 -27.53 69.4 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 454' ' ' MET . 80.4 tt0 -65.08 -33.57 76.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.43 -36.31 82.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 463' ' ' VAL . 99.1 t -60.93 -27.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 59.4 mtt -66.13 -38.94 89.4 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -22.95 65.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.719 0.771 . . . . 0.0 109.18 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.09 -24.97 30.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -69.49 -40.48 77.02 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.947 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.37 -31.59 71.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.272 -0.892 . . . . 0.0 109.422 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -81.56 10.13 6.43 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.69 36.28 93.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -138.44 123.25 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.451 -1.029 . . . . 0.0 111.819 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 46.7 mp0 -85.29 166.47 16.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.755 HG12 ' HB ' ' A' ' 504' ' ' THR . 34.0 m -138.14 157.8 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 111.99 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.794 ' HA ' HD22 ' A' ' 486' ' ' LEU . 47.0 tt0 -96.44 111.51 23.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.958 HD11 HD22 ' A' ' 482' ' ' LEU . 1.6 pp -127.23 131.9 70.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.845 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.661 ' HB ' HG23 ' A' ' 507' ' ' VAL . 3.5 mp -102.08 170.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -123.67 156.82 35.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.55 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.502 0.668 . . . . 0.0 109.964 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -54.43 -11.34 0.52 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.947 -1.096 . . . . 0.0 111.845 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -91.6 7.03 43.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.707 -1.246 . . . . 0.0 112.051 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 29.9 ttt85 -59.26 -34.45 72.27 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.856 -1.153 . . . . 0.0 111.526 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 3.7 t -57.21 -53.92 52.62 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.928 -1.108 . . . . 0.0 111.92 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 474' ' ' MET . 13.7 pt20 -66.43 -37.92 86.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.895 -1.128 . . . . 0.0 109.457 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 473' ' ' GLN . 26.8 ttt -58.68 -32.52 69.21 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.758 -0.589 . . . . 0.0 109.515 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -62.11 -37.8 86.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.766 -0.583 . . . . 0.0 109.673 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.58 -40.61 79.38 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.915 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.49 -152.71 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.588 -0.695 . . . . 0.0 109.147 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 50.34 81.33 0.06 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.863 -1.148 . . . . 0.0 111.623 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -122.03 27.47 8.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 110.09 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -113.42 -19.85 11.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.702 ' HB2' HD23 ' A' ' 482' ' ' LEU . 7.9 mtt180 -109.19 -14.44 14.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.693 -0.63 . . . . 0.0 111.795 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -171.87 62.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.081 -1.012 . . . . 0.0 111.33 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 51.4 p -90.72 48.59 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.832 -1.168 . . . . 0.0 110.169 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.84 26.03 43.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.99 54.01 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -1.06 . . . . 0.0 109.1 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.794 HD22 ' HA ' ' A' ' 464' ' ' GLN . 13.8 mt -79.21 -81.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.773 HG22 HG23 ' A' ' 488' ' ' THR . 0.0 OUTLIER 178.29 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.979 -1.076 . . . . 0.0 111.514 174.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.773 HG23 HG22 ' A' ' 487' ' ' ILE . 4.0 p -102.69 10.05 38.84 Favored 'General case' 0 C--N 1.3 -1.543 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.299 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.7 65.62 2.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.3 ttm180 -144.31 -68.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.94 -29.92 8.04 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.934 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 498' ' ' ALA . 1.2 mm-40 -62.01 -45.54 93.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.58 -0.7 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.01 -18.54 24.45 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.347 -0.846 . . . . 0.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -47.3 4.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.373 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -101.98 -8.32 21.61 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.78 -14.53 61.44 Favored Glycine 0 N--CA 1.503 3.131 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.588 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 63.1 mtt -67.97 -176.14 0.65 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.425 ' HA ' ' HG2' ' A' ' 492' ' ' GLN . . . -114.63 148.18 38.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.622 -0.674 . . . . 0.0 110.745 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.437 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.371 -0.831 . . . . 0.0 109.195 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 500' ' ' THR . 6.3 t -60.85 112.11 5.18 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.171 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 528' ' ' HIS . 43.2 Cg_endo -72.29 113.74 3.79 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.402 1.212 . . . . 0.0 109.501 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -162.33 19.74 0.17 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.723 ' CB ' HD13 ' A' ' 487' ' ' ILE . 24.2 p -93.9 175.34 6.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.254 -1.145 . . . . 0.0 111.096 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.755 ' HB ' HG12 ' A' ' 463' ' ' VAL . 54.1 m -116.73 127.72 54.65 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.849 ' CB ' HD21 ' A' ' 522' ' ' LEU . 69.1 t -113.64 129.87 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.371 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 465' ' ' ILE . 1.3 pp -126.4 164.11 27.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 534' ' ' ILE . 13.8 p -151.2 110.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.959 -1.088 . . . . 0.0 108.874 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 53.8 t0 -84.25 104.96 14.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.369 1.08 . . . . 0.0 108.138 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.477 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -98.73 174.57 6.34 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.498 1.142 . . . . 0.0 113.285 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.33 -56.31 0.05 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -75.09 -156.39 0.05 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -125.83 -19.17 4.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 110.461 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 513' ' ' LEU . 4.4 mm? -70.41 -31.07 68.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.368 -0.833 . . . . 0.0 110.679 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 57.7 p -67.77 -40.55 84.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.784 -0.572 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.4 tp -64.59 -45.94 84.79 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 111.143 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -67.62 -43.35 80.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.418 -0.801 . . . . 0.0 113.064 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 518' ' ' THR . 27.0 pt-20 -65.76 -41.81 91.63 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.765 -1.209 . . . . 0.0 110.362 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.736 HG22 HD12 ' A' ' 522' ' ' LEU . 98.0 m -62.88 -42.48 99.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.006 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.736 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -60.6 -39.42 88.05 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.691 -178.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 516' ' ' LYS . 81.3 p -65.27 -31.3 72.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.389 -0.819 . . . . 0.0 111.897 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.614 HD22 HE22 ' A' ' 464' ' ' GLN . 9.6 tt -81.9 -38.45 25.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.037 -1.04 . . . . 0.0 109.787 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.849 HD21 ' CB ' ' A' ' 505' ' ' VAL . 1.8 mt -64.11 -26.62 68.62 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.782 -0.574 . . . . 0.0 111.292 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -48.22 -51.21 26.39 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.275 -0.891 . . . . 0.0 111.586 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -71.41 -50.2 22.16 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -66.89 -38.43 86.25 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.473 -1.016 . . . . 0.0 113.001 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.9 -33.88 73.8 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.211 -0.931 . . . . 0.0 111.602 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -57.17 -28.82 63.13 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.962 -1.086 . . . . 0.0 108.11 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.461 ' CG ' ' HG3' ' A' ' 501' ' ' PRO . 80.0 m80 -93.99 -135.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.426 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 89.5 m-20 -89.77 69.69 7.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.725 -1.234 . . . . 0.0 112.893 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.69 ' CG1' HD23 ' A' ' 522' ' ' LEU . 2.5 t -141.77 168.24 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -159.54 162.75 35.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.842 -0.536 . . . . 0.0 110.843 -178.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 42.4 t -109.79 100.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.15 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 423' ' ' VAL . 0.5 OUTLIER -100.58 117.98 35.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.972 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -127.51 155.58 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.323 -176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.619 ' CB ' HG22 ' A' ' 436' ' ' VAL . 36.7 p -128.39 -178.11 4.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 61.8 m-20 -154.55 163.71 39.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.7 p -140.35 18.85 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.916 -0.49 . . . . 0.0 109.732 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.79 26.0 0.18 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.07 0.74 51.88 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.128 -1.219 . . . . 0.0 111.814 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -43.4 -42.04 4.48 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.224 -0.923 . . . . 0.0 111.366 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 65.5 p -106.19 163.48 12.77 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 50.11 36.79 28.98 Favored Glycine 0 N--CA 1.503 3.152 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -58.74 -43.66 90.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.52 -0.988 . . . . 0.0 111.107 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.6 -38.4 96.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 43.1 m -65.32 -33.02 74.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -1.0 . . . . 0.0 111.364 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.59 -37.5 87.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.731 . . . . 0.0 110.294 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.58 -42.66 99.17 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.501 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 8.4 tpp -61.85 -34.71 76.47 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -53.57 -52.1 60.86 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.174 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.736 ' CG ' HD11 ' A' ' 519' ' ' LEU . 40.1 ttp -57.32 -45.66 84.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.344 -0.848 . . . . 0.0 110.177 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.7 -31.28 72.4 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.429 -0.794 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.88 -13.02 62.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.471 -0.768 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -78.87 9.77 3.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.432 -0.792 . . . . 0.0 112.709 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 123.84 -14.75 7.99 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.2 t -85.19 115.41 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -169.1 127.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.696 -0.627 . . . . 0.0 109.606 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 13.0 t -97.15 133.09 42.26 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -73.15 -79.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.704 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -139.58 -81.22 0.29 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.213 -0.929 . . . . 0.0 110.781 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -91.15 -21.86 20.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 110.563 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -149.71 122.03 8.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.345 -0.847 . . . . 0.0 110.347 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -86.14 -130.53 2.65 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -101.79 33.66 6.32 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -91.79 -12.99 32.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.69 -0.888 . . . . 0.0 111.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -83.07 -1.97 54.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.34 -0.85 . . . . 0.0 112.122 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -109.34 75.3 0.72 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.062 -1.024 . . . . 0.0 110.804 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.69 -26.56 32.98 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.291 1.153 . . . . 0.0 110.17 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -176.17 34.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.352 -0.842 . . . . 0.0 110.12 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.361 -179.864 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.226 0.536 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.79 22.7 1.77 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.458 -0.776 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -98.48 -45.94 2.24 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.497 HG22 HG22 ' A' ' 386' ' ' VAL . 77.3 mt -109.11 130.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.579 -0.953 . . . . 0.0 110.22 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -129.15 59.12 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 384' ' ' ILE . 35.6 m -111.03 155.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.4 mm? -82.41 137.12 34.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.105 -0.997 . . . . 0.0 109.711 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ASP . . . . . 0.414 ' HB2' ' CD ' ' A' ' 431' ' ' PRO . 77.0 m-20 -95.79 9.43 40.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 111.196 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.98 -34.21 72.99 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.135 -0.978 . . . . 0.0 109.904 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 391' ' ' SER . 4.1 pp -64.35 -33.04 74.92 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.71 -0.619 . . . . 0.0 110.659 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' SER . . . . . 0.558 ' N ' HD12 ' A' ' 390' ' ' LEU . 50.9 m -60.79 -36.7 79.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.325 -0.859 . . . . 0.0 109.736 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.0 t -65.48 -33.82 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.287 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.52 -48.24 79.82 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.241 -0.912 . . . . 0.0 110.914 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.13 77.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -0.791 . . . . 0.0 109.435 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 422' ' ' ALA . 0.9 OUTLIER -62.17 -39.66 93.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.951 -0.468 . . . . 0.0 111.504 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 55.8 p -65.71 -37.52 86.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -0.912 . . . . 0.0 110.325 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -65.07 -44.85 87.59 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.537 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.69 -43.3 80.44 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.131 -0.981 . . . . 0.0 111.331 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 436' ' ' VAL . 96.7 mt -61.45 -42.28 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.629 ' CG ' HD11 ' A' ' 435' ' ' ILE . 19.5 mtp -62.67 -29.1 70.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.952 -0.467 . . . . 0.0 109.981 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -61.2 -29.67 69.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.85 -1.156 . . . . 0.0 109.541 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 99.3 mm-40 -89.33 -16.97 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 109.231 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 400' ' ' MET . 37.7 t30 -66.4 -38.54 87.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.526 -0.733 . . . . 0.0 110.799 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -116.32 19.0 15.05 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 405' ' ' VAL . 10.8 p -48.15 117.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.65 -0.657 . . . . 0.0 111.019 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.8 p -52.35 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.646 HG23 HG12 ' A' ' 413' ' ' VAL . 11.0 p -109.86 133.06 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.598 0.713 . . . . 0.0 110.663 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -90.8 135.1 29.3 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.33 -30.38 45.07 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.098 1.052 . . . . 0.0 110.542 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -59.65 -28.33 67.16 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.811 0.815 . . . . 0.0 109.822 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 56.2 0.76 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.9 m -54.17 117.78 3.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.67 0.748 . . . . 0.0 111.379 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.646 HG12 HG23 ' A' ' 407' ' ' VAL . 7.7 p -67.87 111.51 7.9 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.563 . . . . 0.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.31 138.13 24.39 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 122.999 1.0 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -161.25 70.68 0.37 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.829 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 57.9 p -67.75 -38.06 82.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.837 -1.165 . . . . 0.0 107.895 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 420' ' ' SER . . . -56.63 -23.95 44.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.871 -0.518 . . . . 0.0 111.177 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -47.99 -58.18 7.22 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -87.41 -1.99 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.967 -1.314 . . . . 0.0 110.847 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 10.9 t -71.03 -42.9 68.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.909 -1.12 . . . . 0.0 108.502 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -75.69 -44.63 41.19 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.811 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.78 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.71 -48.02 73.41 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.833 ' CG2' HG21 ' A' ' 436' ' ' VAL . 57.9 t -68.27 -44.41 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.334 -0.854 . . . . 0.0 111.45 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.6 m -61.73 -38.14 86.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 111.229 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.4 p -65.03 -29.5 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 112.754 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.773 ' HB3' HD13 ' A' ' 395' ' ' LEU . 2.2 pp -76.98 -32.2 57.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.398 -1.439 . . . . 0.0 110.575 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.39 84.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 108.837 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -59.27 -36.22 75.14 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -64.73 -88.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 4.6 tpp180 -175.13 -60.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.726 -1.233 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 388' ' ' ASP . 39.0 Cg_endo -64.39 102.76 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 122.886 0.94 . . . . 0.0 111.397 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.784 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.1 OUTLIER -82.51 99.99 9.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.872 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 11.0 tp -163.7 93.04 0.72 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.26 -0.9 . . . . 0.0 111.195 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.472 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -150.04 162.36 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.011 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 435' ' ' ILE . 2.5 pp -113.96 128.55 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.094 0.473 . . . . 0.0 109.897 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.833 HG21 ' CG2' ' A' ' 423' ' ' VAL . 78.3 t -132.18 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -0.877 . . . . 0.0 108.935 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 42.8 t -130.46 138.63 50.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.023 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -95.94 135.99 12.61 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.679 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -107.71 -14.27 14.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.959 -0.73 . . . . 0.0 110.255 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.57 170.6 42.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.19 44.94 97.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.92 89.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.332 -1.099 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.39 -44.7 93.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.627 -0.671 . . . . 0.0 110.55 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.87 -28.66 64.42 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.4 -41.88 98.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.909 . . . . 0.0 109.607 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.662 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.5 mtm180 -61.77 -45.01 95.75 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.375 -0.828 . . . . 0.0 110.047 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -63.45 -29.65 70.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.661 . . . . 0.0 109.42 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 53.1 ttt85 -67.52 -50.54 58.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.578 -0.701 . . . . 0.0 111.388 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.3 p -55.21 -31.74 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.528 -1.357 . . . . 0.0 110.423 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 481' ' ' ARG . . . -64.36 -26.83 68.64 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 82.0 tt0 -60.19 -35.13 74.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.94 -37.68 88.01 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.961 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.4 t -63.05 -27.06 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.013 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.6 mtp -66.28 -39.73 89.6 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.189 -0.944 . . . . 0.0 108.642 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.1 ttp -58.88 -25.8 63.67 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.64 -0.663 . . . . 0.0 109.442 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 463' ' ' VAL . . . -82.63 -22.43 34.71 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.581 -0.7 . . . . 0.0 110.405 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.88 -47.57 71.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.76 -28.47 65.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -79.5 5.2 13.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.58 -0.7 . . . . 0.0 110.756 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.45 34.45 89.97 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -130.75 127.14 38.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -1.01 . . . . 0.0 110.292 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.413 ' C ' HG13 ' A' ' 463' ' ' VAL . 30.8 tt0 -81.53 159.28 24.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.961 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.9 m -144.87 151.81 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.502 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.835 ' HG3' HD13 ' A' ' 486' ' ' LEU . 57.9 tt0 -102.98 123.33 46.39 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.543 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.772 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -141.7 146.25 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 120.825 -1.172 . . . . 0.0 108.732 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.785 HG23 ' HD3' ' A' ' 471' ' ' ARG . 83.6 mt -134.01 129.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -78.22 168.58 19.63 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.26 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.505 -0.747 . . . . 0.0 109.786 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -48.56 -22.74 0.8 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.915 -1.115 . . . . 0.0 111.903 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -73.23 -6.3 45.0 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.332 -0.855 . . . . 0.0 112.206 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 466' ' ' ILE . 34.7 ttt85 -60.16 -24.73 64.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.803 -1.186 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -61.45 -46.37 90.35 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.216 -0.928 . . . . 0.0 110.612 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -65.21 -41.3 94.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 53.2 ttm -60.39 -32.47 71.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.027 -0.421 . . . . 0.0 110.453 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -61.36 -37.69 84.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 80.5 mmm -59.76 -35.9 75.55 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.951 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 59.4 pttt -134.93 -141.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 109.801 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.501 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 89.3 mm-40 47.06 90.46 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.969 -1.082 . . . . 0.0 113.034 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -94.55 -23.46 17.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.475 ' O ' HD22 ' A' ' 482' ' ' LEU . 98.0 mt-10 -70.44 -29.53 66.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.514 -0.741 . . . . 0.0 109.059 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.64 ' HA ' ' HB1' ' A' ' 450' ' ' ALA . 9.1 mpt_? -83.52 8.48 13.91 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.997 -0.44 . . . . 0.0 111.294 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.688 ' N ' HD22 ' A' ' 482' ' ' LEU . 3.2 mm? 53.87 28.26 8.22 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.986 -1.071 . . . . 0.0 110.802 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.28 50.24 0.06 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.493 -0.755 . . . . 0.0 112.417 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 159.61 42.04 0.02 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -179.62 89.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.597 -0.943 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 464' ' ' GLN . 47.1 mt -99.09 -81.28 0.45 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 503' ' ' SER . 1.1 mp -158.98 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.487 -0.758 . . . . 0.0 109.448 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 499' ' ' PHE . 1.8 p -102.86 14.31 32.26 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.496 -0.752 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -79.55 56.92 4.48 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -143.06 -61.75 0.42 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.224 -1.162 . . . . 0.0 109.245 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -109.35 -31.29 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.298 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -64.08 -38.1 89.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 521' ' ' LEU . 5.4 mt -91.16 -26.82 18.89 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 111.358 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.0 OUTLIER -105.72 -44.36 4.67 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -102.4 -8.33 21.23 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.863 -1.148 . . . . 0.0 113.518 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.81 -21.49 33.11 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.732 -1.23 . . . . 0.0 111.276 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 38.0 mtm -64.09 -178.6 0.35 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -1.186 . . . . 0.0 109.348 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.04 154.16 28.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 111.347 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.434 ' HB2' ' HB ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -115.82 148.98 39.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.937 -0.477 . . . . 0.0 109.864 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 79.1 m -44.06 101.52 0.26 Allowed Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 122.089 -0.382 . . . . 0.0 110.759 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 43.4 Cg_endo -68.34 113.75 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.681 1.358 . . . . 0.0 109.239 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . 174.98 38.06 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.932 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.6 p -90.83 174.55 7.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.882 -0.776 . . . . 0.0 111.79 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 463' ' ' VAL . 13.6 m -112.74 94.36 4.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 522' ' ' LEU . 59.4 t -85.64 131.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.225 1.012 . . . . 0.0 112.656 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.829 HG23 HD22 ' A' ' 533' ' ' LEU 0.294 65.3 mt -137.77 96.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 534' ' ' ILE . 3.9 p -104.19 107.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.978 1.371 . . . . 0.0 113.574 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.44 107.58 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.0 -1.062 . . . . 0.0 109.413 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.437 HE22 HG22 ' A' ' 466' ' ' ILE . 78.2 mm-40 -126.96 116.46 20.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -72.83 -40.61 52.06 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 175.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 509' ' ' GLN . 93.0 mt-10 -86.71 147.22 25.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.11 -12.07 22.19 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.629 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.96 -38.81 92.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 109.526 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 72.1 p -86.82 -16.61 35.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.615 -0.678 . . . . 0.0 111.109 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 60.1 tp -72.06 -47.69 49.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.165 -0.959 . . . . 0.0 109.905 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.807 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 31.3 ttpt -69.85 -46.02 66.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.679 -0.638 . . . . 0.0 112.692 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.67 -41.59 98.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.965 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.578 HG21 HD12 ' A' ' 466' ' ' ILE . 29.9 m -56.86 -44.74 82.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.483 -0.76 . . . . 0.0 111.194 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 515' ' ' LEU . 43.3 mt -60.77 -28.22 68.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.7 m -61.1 -41.17 96.18 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.327 -0.858 . . . . 0.0 109.472 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 493' ' ' LEU . 50.7 tp -65.49 -41.09 93.64 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.846 ' CD1' HG11 ' A' ' 505' ' ' VAL . 1.4 tt -64.17 -22.95 67.13 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.845 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -48.06 -64.19 0.86 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.376 -0.828 . . . . 0.0 113.205 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.69 -50.54 60.84 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.771 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -62.35 -36.38 82.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.966 . . . . 0.0 111.77 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -64.99 -25.23 67.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.447 -0.783 . . . . 0.0 112.72 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -40.88 -27.82 0.06 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -107.28 -108.73 0.31 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.109 -0.994 . . . . 0.0 113.065 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.511 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.1 OUTLIER -89.51 81.47 6.53 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.553 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 531' ' ' GLN . 5.9 t -143.87 165.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.843 -1.161 . . . . 0.0 111.729 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 12.8 mm-40 -157.52 161.83 38.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 55.3 t -114.96 107.17 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.354 -0.841 . . . . 0.0 111.511 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.829 HD22 HG23 ' A' ' 506' ' ' ILE . 5.5 tt -105.49 119.22 38.55 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 507' ' ' VAL . 4.1 pt -139.94 153.08 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.296 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.509 HG22 ' HB ' ' A' ' 436' ' ' VAL . 26.6 p -143.11 114.62 8.01 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.95 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -77.08 175.56 9.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.681 1.229 . . . . 0.0 111.83 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.541 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.3 m -129.98 -10.3 4.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.105 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -122.67 34.78 3.65 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -98.29 0.84 46.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.862 -0.787 . . . . 0.0 111.999 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 541' ' ' THR . 38.4 ptt180 -49.36 -31.22 8.97 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.096 -1.003 . . . . 0.0 110.216 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 540' ' ' ARG . 46.1 p -129.78 166.54 19.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.5 34.66 55.38 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -61.7 -45.8 92.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.496 -1.002 . . . . 0.0 111.802 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.23 -34.69 90.65 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 48.0 m -64.08 -37.86 88.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.71 -0.876 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.26 -37.25 72.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 110.023 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.9 mp -63.14 -39.94 96.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.658 -0.652 . . . . 0.0 110.102 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.68 -29.11 70.41 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.487 -0.758 . . . . 0.0 109.203 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -56.29 -52.6 63.9 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 555' ' ' VAL . 56.0 ttm -55.61 -46.65 77.31 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.277 -0.889 . . . . 0.0 109.521 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 551' ' ' LYS . . . . . 0.705 ' HA ' HG23 ' A' ' 555' ' ' VAL . 97.5 mttt -57.6 -32.0 66.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.824 -0.548 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -68.46 -25.51 65.03 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.4 -0.813 . . . . 0.0 111.403 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.807 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -70.37 0.85 5.75 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.083 -1.011 . . . . 0.0 112.787 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.39 -15.25 9.28 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 120.787 -1.196 . . . . 0.0 110.832 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.705 HG23 ' HA ' ' A' ' 551' ' ' LYS . 34.2 m -86.83 109.72 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.304 -1.115 . . . . 0.0 110.034 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -171.05 140.63 1.56 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.244 -0.91 . . . . 0.0 110.002 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 57.4 m -95.54 134.71 38.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.413 -0.804 . . . . 0.0 109.168 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.14 -79.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 110.576 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -130.83 -78.88 0.53 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.411 -0.806 . . . . 0.0 111.281 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -93.1 -21.84 19.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.043 -1.035 . . . . 0.0 111.308 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 564' ' ' GLU . 14.9 pt20 -137.22 148.65 46.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -129.56 115.49 1.92 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 75.75 11.26 84.67 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 561' ' ' GLN . 76.2 tt0 -95.35 -11.69 27.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.186 -1.184 . . . . 0.0 111.121 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -82.18 -8.12 59.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.214 -0.928 . . . . 0.0 110.437 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.19 99.68 18.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 110.517 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.04 -17.59 36.2 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.281 1.148 . . . . 0.0 111.159 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -170.81 131.17 0.84 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.623 179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.277 0.561 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 1.5 m 52.73 -172.61 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.508 -0.745 . . . . 0.0 110.159 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.52 85.01 0.38 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.804 HD11 HD23 ' A' ' 387' ' ' LEU . 47.4 pt -74.62 135.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.959 . . . . 0.0 110.304 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.83 -39.65 83.87 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.728 . . . . 0.0 110.697 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.23 124.43 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.332 -0.855 . . . . 0.0 110.384 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.804 HD23 HD11 ' A' ' 384' ' ' ILE . 64.8 mt -104.5 2.06 30.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.692 -0.63 . . . . 0.0 111.623 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.04 -69.5 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.015 -1.053 . . . . 0.0 110.728 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.05 14.1 1.31 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.277 -0.889 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.51 -42.56 99.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.235 -0.916 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.3 m -60.99 -42.12 97.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.715 -0.616 . . . . 0.0 110.082 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.23 -35.27 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.691 -0.631 . . . . 0.0 111.032 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -63.27 -47.1 83.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.043 0.925 . . . . 0.0 109.448 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.5 tt -61.96 -38.86 90.1 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.719 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.8 m -68.32 -36.15 78.87 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -63.07 -45.28 92.91 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.261 -0.899 . . . . 0.0 111.129 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.13 -40.87 86.86 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.116 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 419' ' ' TYR . 96.5 mt -62.75 -42.58 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 0.9 OUTLIER -61.04 -31.57 71.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.77 -30.87 71.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.966 -1.084 . . . . 0.0 109.827 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 61.0 tp60 -89.39 -16.31 31.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 109.205 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 400' ' ' MET . 17.0 t30 -66.11 -34.31 77.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.571 -0.706 . . . . 0.0 109.672 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -114.09 17.9 17.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 109.518 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.731 HG13 HG23 ' A' ' 407' ' ' VAL . 8.3 p -40.43 148.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.559 0.695 . . . . 0.0 112.243 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.4 m -85.63 77.18 9.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.731 HG23 HG13 ' A' ' 405' ' ' VAL . 82.5 t -94.51 129.74 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 111.064 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -98.92 144.93 29.09 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.6 -19.09 42.56 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.199 1.105 . . . . 0.0 111.488 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.61 -33.22 71.21 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -158.09 64.03 0.45 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.5 m -61.3 131.28 49.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 110.979 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' A' ' 414' ' ' PRO . 7.8 p -78.68 148.66 73.33 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.468 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.5 Cg_endo -60.18 138.82 83.89 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.834 0.912 . . . . 0.0 110.622 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -101.05 -5.02 26.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 420' ' ' SER . 17.5 p -97.83 17.97 16.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.777 -1.202 . . . . 0.0 108.943 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.28 -32.56 7.73 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -69.47 -40.01 79.37 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.74 ' HD1' HG23 ' A' ' 399' ' ' ILE . 4.9 m-85 -98.93 -10.95 22.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.74 -1.447 . . . . 0.0 111.215 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 416' ' ' THR . 58.2 p -74.17 -38.13 63.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.746 -1.221 . . . . 0.0 107.841 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 425' ' ' VAL . 99.0 m-20 -75.17 -48.35 24.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.35 -48.31 73.41 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.527 -0.733 . . . . 0.0 111.727 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.932 ' HA ' HD23 ' A' ' 426' ' ' LEU . 58.0 t -66.94 -43.82 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.576 -0.703 . . . . 0.0 112.423 -177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -61.59 -42.19 98.51 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.856 -1.152 . . . . 0.0 111.147 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 421' ' ' ASP . 77.7 t -61.7 -28.65 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.3 -0.875 . . . . 0.0 110.667 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -72.89 -32.12 65.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.446 -0.784 . . . . 0.0 111.558 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.35 76.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.904 -1.123 . . . . 0.0 109.389 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -61.93 -30.14 70.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.51 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.405 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 3.4 tpp85 -172.19 -61.21 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.694 -1.254 . . . . 0.0 109.256 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 531' ' ' GLN . 44.3 Cg_endo -71.35 110.91 2.97 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 O-C-N 123.086 1.045 . . . . 0.0 110.637 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 426' ' ' LEU . 6.7 t -88.46 98.06 11.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.69 -0.631 . . . . 0.0 110.45 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.839 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 19.7 tp -164.31 97.07 0.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.663 -1.273 . . . . 0.0 112.34 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -141.34 175.63 9.5 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.104 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.475 ' O ' HG21 ' A' ' 399' ' ' ILE . 46.4 pt -118.83 130.59 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.325 0.583 . . . . 0.0 110.4 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.723 ' CG2' HG21 ' A' ' 423' ' ' VAL . 58.2 t -127.88 136.02 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.921 -1.112 . . . . 0.0 109.611 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 73.9 m -121.56 125.69 47.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.345 -0.847 . . . . 0.0 110.996 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -103.2 -176.71 26.46 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -129.41 -41.17 1.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.616 -0.932 . . . . 0.0 109.838 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -159.88 167.0 35.23 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.7 64.06 2.97 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.77 ' HB1' HH22 ' A' ' 446' ' ' ARG . . . -80.6 -21.26 41.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.59 -0.947 . . . . 0.0 110.362 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.22 97.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.462 -0.774 . . . . 0.0 111.171 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -66.1 -31.06 78.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.77 -30.41 71.41 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.603 -0.939 . . . . 0.0 109.807 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.77 HH22 ' HB1' ' A' ' 442' ' ' ALA . 2.8 mmt85 -63.97 -43.45 95.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.59 -0.694 . . . . 0.0 109.976 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.74 -33.85 64.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.335 -0.853 . . . . 0.0 110.783 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.24 -53.59 52.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.362 -0.836 . . . . 0.0 111.511 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.611 HG22 ' CD1' ' A' ' 506' ' ' ILE . 12.7 p -58.61 -33.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.757 -1.214 . . . . 0.0 108.883 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.62 68.07 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.42 -37.99 82.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.064 -1.022 . . . . 0.0 108.61 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 455' ' ' MET . 79.2 mt -63.12 -36.72 84.54 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.896 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.5 t -60.66 -27.44 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -0.825 . . . . 0.0 109.586 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 94.4 mtp -67.73 -40.95 84.17 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' MET . . . . . 0.417 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.1 OUTLIER -62.41 -20.74 64.79 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.235 -0.916 . . . . 0.0 109.93 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.23 -23.06 32.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.614 -0.679 . . . . 0.0 109.562 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -68.56 -40.19 80.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.676 . . . . 0.0 109.563 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.45 -32.21 68.06 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.408 -0.807 . . . . 0.0 109.661 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.68 3.1 12.38 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.753 -0.592 . . . . 0.0 111.725 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.44 71.8 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.424 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 61.1 ttm-85 -125.37 122.42 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 98.1 mt-10 -84.85 168.18 15.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.896 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.4 m -143.62 149.08 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 111.22 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.916 ' HA ' HD22 ' A' ' 486' ' ' LEU . 4.1 pt20 -99.08 121.66 41.28 Favored 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.729 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -123.5 129.72 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.733 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.4 mp -117.76 112.99 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -65.23 -179.44 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.813 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.514 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -61.94 -161.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.16 -14.59 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.732 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.72 -3.07 45.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.122 -0.986 . . . . 0.0 111.967 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 74.6 ttt-85 -57.04 -31.13 64.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.886 -1.133 . . . . 0.0 111.21 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.6 t -60.01 -44.44 94.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.855 . . . . 0.0 109.857 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.21 -36.01 82.86 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.1 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.864 -0.523 . . . . 0.0 109.936 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -61.47 -37.57 84.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.534 -0.729 . . . . 0.0 109.605 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 65.5 ttp -58.55 -38.11 77.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.919 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.4 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.9 pttt -124.89 -152.42 0.51 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.2 mm-40 48.3 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.909 -1.12 . . . . 0.0 111.824 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -127.65 11.47 6.75 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.562 -0.712 . . . . 0.0 110.665 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -98.24 -14.51 20.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.546 -0.721 . . . . 0.0 110.267 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -108.67 -13.96 14.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.557 -0.715 . . . . 0.0 111.84 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.451 HD22 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -175.7 56.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.953 -1.092 . . . . 0.0 110.932 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 93.2 p -60.17 -23.67 64.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.017 -1.052 . . . . 0.0 110.181 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 151.22 55.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -132.4 48.87 2.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.821 -0.811 . . . . 0.0 110.407 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.916 HD22 ' HA ' ' A' ' 464' ' ' GLN . 19.0 mt -73.61 -80.56 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.664 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER -178.96 -44.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.796 -1.19 . . . . 0.0 110.246 174.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 487' ' ' ILE . 5.0 p -102.63 8.75 39.63 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.851 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.416 ' HA2' HD12 ' A' ' 493' ' ' LEU . . . -85.85 60.09 4.68 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 66.3 ttt180 -145.77 -45.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.906 -0.761 . . . . 0.0 109.542 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 36.7 mtt85 -120.86 -46.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.429 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 498' ' ' ALA . 32.4 mt-30 -61.61 -50.32 73.04 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.092 -1.005 . . . . 0.0 111.452 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.416 HD12 ' HA2' ' A' ' 489' ' ' GLY . 7.3 mt -71.08 -37.53 72.45 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.97 -0.457 . . . . 0.0 111.603 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -104.76 -38.07 6.82 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.13 -8.18 15.19 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.773 -1.205 . . . . 0.0 114.132 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 91.54 -21.34 36.1 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 120.766 -1.209 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 52.1 mmm -67.12 178.73 1.35 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.133 -1.216 . . . . 0.0 109.851 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 492' ' ' GLN . . . -114.31 148.83 36.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 112.23 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.477 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -115.95 148.92 39.55 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.559 0.695 . . . . 0.0 110.301 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 19.1 m -52.45 107.57 0.87 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.869 -0.52 . . . . 0.0 110.117 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 41.1 Cg_endo -70.74 114.41 3.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.437 1.23 . . . . 0.0 109.556 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -171.95 27.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.743 ' O ' HG22 ' A' ' 530' ' ' VAL . 60.2 p -94.3 177.97 5.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.634 -0.921 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.805 ' HB ' HG12 ' A' ' 463' ' ' VAL . 51.5 m -125.53 125.39 43.16 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 522' ' ' LEU . 8.5 p -109.32 131.01 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.949 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.611 ' CD1' HG22 ' A' ' 449' ' ' VAL . 2.4 pt -126.0 112.32 29.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.733 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.3 p -112.68 115.5 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 111.851 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 2.0 t70 -83.12 105.63 14.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 21.8 tm0? -94.12 174.12 7.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.7 0.762 . . . . 0.0 111.199 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.46 -74.66 0.04 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 105.364 -3.094 . . . . 0.0 105.364 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -54.49 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 5.3 mttt 179.07 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.625 0 O-C-N 120.695 -1.253 . . . . 0.0 110.57 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 513' ' ' LEU . 29.6 mt -70.0 -20.89 63.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.641 -0.662 . . . . 0.0 110.493 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 17.9 m -64.43 -42.12 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.358 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 7.6 tp -65.5 -44.17 87.88 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.23 0.538 . . . . 0.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.71 -43.89 83.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.457 -0.777 . . . . 0.0 112.348 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.85 -51.21 69.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.05 -1.031 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.65 ' CG2' HD13 ' A' ' 466' ' ' ILE . 30.6 m -59.1 -41.5 88.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.726 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.55 -39.23 79.63 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.924 -0.485 . . . . 0.0 110.848 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.1 m -61.02 -37.14 81.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 0.0 110.167 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.426 HD23 ' OE1' ' A' ' 464' ' ' GLN . 61.2 tp -67.09 -40.43 86.94 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 505' ' ' VAL . 0.3 OUTLIER -64.66 -21.95 66.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.754 -0.591 . . . . 0.0 111.641 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -45.74 -62.66 1.21 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.592 -0.692 . . . . 0.0 111.951 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -84.68 -48.17 5.08 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.984 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -69.77 -41.94 74.49 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 522' ' ' LEU . . . -65.0 -25.69 67.97 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.786 -1.196 . . . . 0.0 112.325 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -42.46 -28.13 0.2 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.411 -0.806 . . . . 0.0 112.182 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.23 -137.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 111.177 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.416 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 84.5 m-20 -72.43 73.97 1.02 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.9 -1.125 . . . . 0.0 112.129 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 503' ' ' SER . 41.2 t -137.73 164.52 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.42 -0.8 . . . . 0.0 110.668 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 432' ' ' SER . 1.5 mm-40 -160.59 162.21 32.77 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.839 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 8.5 t -114.65 111.62 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 120.947 -1.096 . . . . 0.0 113.794 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.2 tp -102.2 114.86 29.38 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.657 HG22 ' CG1' ' A' ' 507' ' ' VAL . 7.9 pt -133.33 161.46 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 C-N-CA 118.677 -1.209 . . . . 0.0 112.596 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.594 HG22 ' HB ' ' A' ' 436' ' ' VAL . 68.9 p -131.16 -171.56 2.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 24.0 t70 -151.12 157.58 42.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.83 20.87 2.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.387 -0.821 . . . . 0.0 110.794 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -153.75 -42.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -78.79 0.32 27.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.503 -0.998 . . . . 0.0 111.229 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' ARG . . . . . 0.448 ' HG3' HG23 ' A' ' 541' ' ' THR . 33.6 ptt-85 -38.1 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 540' ' ' ARG . 4.0 p -102.36 -25.14 13.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.962 -1.086 . . . . 0.0 110.623 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -127.51 55.57 0.75 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 8.9 t -75.17 -15.64 60.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.783 -0.833 . . . . 0.0 111.542 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.09 93.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 87.8 p -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -1.044 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.43 -36.46 76.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 109.628 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 543' ' ' THR . 10.4 mp -61.71 -43.21 99.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.405 -0.809 . . . . 0.0 109.163 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.7 ttp -63.34 -35.14 79.39 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.0 -50.64 60.94 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.726 ' HG3' HD11 ' A' ' 519' ' ' LEU . 28.2 ttt -57.97 -46.1 85.67 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -60.9 -31.45 70.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.414 -0.804 . . . . 0.0 111.052 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.83 -20.86 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.389 -0.82 . . . . 0.0 110.071 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.82 3.3 6.8 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.426 -0.796 . . . . 0.0 112.64 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.63 -13.26 8.75 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.419 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.04 109.9 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.269 . . . . 0.0 109.911 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -170.89 147.81 2.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.566 -0.709 . . . . 0.0 110.268 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' THR . . . . . 0.604 HG23 ' HA3' ' A' ' 562' ' ' GLY . 94.2 m -92.6 120.76 33.36 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -89.56 -78.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.043 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -137.62 -78.63 0.38 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.339 -0.85 . . . . 0.0 110.126 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.35 -17.56 34.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.805 . . . . 0.0 110.842 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -116.24 141.69 47.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.069 -1.019 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' GLY . . . . . 0.604 ' HA3' HG23 ' A' ' 557' ' ' THR . . . 141.88 50.37 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 76.01 12.9 83.67 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.519 -0.989 . . . . 0.0 110.681 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -94.61 -8.78 37.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.229 -1.16 . . . . 0.0 110.72 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -92.59 -5.73 50.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -162.42 50.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.221 -0.924 . . . . 0.0 110.561 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 567' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 566' ' ' ARG . 47.4 Cg_endo -71.69 -15.85 30.18 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.372 1.196 . . . . 0.0 111.431 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -114.44 -23.64 9.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 110.983 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.425 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.103 0.478 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 78.2 p -61.27 -38.64 87.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.365 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 154.88 69.79 0.01 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 384' ' ' ILE . 49.5 mm -101.3 11.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.617 -0.931 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -91.42 -4.14 55.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 0.0 111.248 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 14.8 p -107.41 129.55 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 0.0 109.872 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.45 146.61 46.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -78.92 91.1 4.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.363 -0.836 . . . . 0.0 110.744 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.88 54.76 1.82 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.74 . . . . 0.0 109.96 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -40.26 96.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.979 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.9 t -60.63 -45.72 92.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.456 -0.777 . . . . 0.0 110.68 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.66 -28.48 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -64.51 -52.3 58.52 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.999 -1.063 . . . . 0.0 111.533 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.32 77.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.336 -0.853 . . . . 0.0 109.134 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.604 ' CD2' HD12 ' A' ' 399' ' ' ILE . 8.0 tt -61.27 -38.06 85.35 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 t -65.51 -43.65 89.41 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.118 -0.989 . . . . 0.0 111.781 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -64.07 -45.36 89.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.319 -0.863 . . . . 0.0 111.964 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -64.94 -44.86 88.06 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.29 -0.881 . . . . 0.0 111.283 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.791 HG23 ' HD1' ' A' ' 419' ' ' TYR . 71.4 mt -63.98 -41.83 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.34 -0.85 . . . . 0.0 110.519 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 5.6 tpp -60.62 -35.01 75.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.351 -0.843 . . . . 0.0 109.995 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.35 -31.03 70.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 405' ' ' VAL . 5.6 tp-100 -87.45 -16.59 34.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.801 -1.187 . . . . 0.0 108.78 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.33 -31.98 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.722 -0.611 . . . . 0.0 110.273 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -113.67 17.84 17.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.6 p -52.46 108.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.59 -0.694 . . . . 0.0 109.729 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 64.9 p -50.03 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.462 -0.774 . . . . 0.0 111.37 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 405' ' ' VAL . 58.6 t -107.24 133.02 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -94.32 142.21 24.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.572 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.22 -21.91 54.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.336 1.177 . . . . 0.0 110.318 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -60.46 -40.29 90.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 110.002 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 68.28 1.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.4 t -53.89 110.62 0.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.8 p -62.63 111.54 4.95 Favored Pre-proline 0 N--CA 1.492 1.653 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.813 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.8 133.32 21.66 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.096 1.051 . . . . 0.0 109.972 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.91 63.6 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.485 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 68.8 p -66.0 -33.16 75.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 108.762 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -63.59 -10.26 17.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.626 -0.671 . . . . 0.0 111.578 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.56 51.93 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.965 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.791 ' HD1' HG23 ' A' ' 399' ' ' ILE . 12.9 m-85 -93.16 -2.04 55.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.61 -1.524 . . . . 0.0 110.133 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 4.8 m -82.48 -33.0 28.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 108.781 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 425' ' ' VAL . 98.0 m-20 -78.88 -44.42 22.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.666 . . . . 0.0 110.123 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.94 -42.02 95.02 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.636 -0.665 . . . . 0.0 111.412 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.927 HG21 ' CG2' ' A' ' 436' ' ' VAL . 88.8 t -80.2 -44.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.773 -0.579 . . . . 0.0 112.258 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.1 m -60.28 -42.01 94.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.929 -1.107 . . . . 0.0 110.475 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 421' ' ' ASP . 13.5 p -64.22 -29.76 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.422 -0.799 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -68.32 -31.77 71.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.554 -0.716 . . . . 0.0 110.074 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.49 78.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.056 -1.028 . . . . 0.0 108.771 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.13 -28.87 63.09 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -67.46 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.514 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 6.0 tmm_? -173.04 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 120.726 -1.234 . . . . 0.0 110.397 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.3 Cg_endo -71.17 120.48 7.04 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 N-CA-C 110.182 -0.738 . . . . 0.0 110.182 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.467 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 2.0 t -94.91 99.96 11.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.805 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.8 tp -163.24 98.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.955 -1.091 . . . . 0.0 110.741 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -140.48 177.14 8.22 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.504 0.669 . . . . 0.0 111.047 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.459 ' O ' HG21 ' A' ' 399' ' ' ILE . 3.3 mt -117.43 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.819 -0.551 . . . . 0.0 110.146 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.927 ' CG2' HG21 ' A' ' 423' ' ' VAL . 67.1 t -133.47 140.05 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.47 -0.769 . . . . 0.0 110.473 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 19.1 m -132.25 142.87 49.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.711 -0.618 . . . . 0.0 109.586 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.01 162.95 22.08 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -120.43 -42.74 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.895 . . . . 0.0 109.308 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.83 63.82 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 173.62 86.2 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.23 -28.23 10.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.512 -0.993 . . . . 0.0 110.724 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.49 79.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.444 -0.785 . . . . 0.0 110.781 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -77.97 -30.74 50.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.12 -31.55 64.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.401 -1.058 . . . . 0.0 109.348 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.439 ' HD2' ' HB1' ' A' ' 467' ' ' ALA . 61.2 ttp180 -62.9 -43.66 98.2 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.569 0.699 . . . . 0.0 110.152 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 47.7 tt0 -80.0 -29.46 39.47 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -0.853 . . . . 0.0 110.619 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -62.62 -47.69 82.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.0 p -60.32 -31.53 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.903 -1.123 . . . . 0.0 108.227 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.2 -28.45 69.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.806 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 454' ' ' MET . 53.6 tp10 -63.14 -32.9 74.39 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.45 -33.05 74.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.6 t -59.98 -29.8 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 61.4 mtt -66.65 -36.07 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.23 -27.52 62.1 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.576 -0.702 . . . . 0.0 109.435 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.1 32.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.64 -0.663 . . . . 0.0 109.777 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -64.39 -44.64 90.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -71.46 -30.9 66.55 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.503 0.668 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -76.38 -2.16 30.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.676 -0.64 . . . . 0.0 110.981 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.44 25.68 74.83 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.78 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.1 ttm180 -133.38 120.78 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.501 -1.0 . . . . 0.0 110.552 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 92.9 mt-10 -79.85 172.1 14.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 453' ' ' VAL . 27.2 m -144.46 153.02 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.62 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.1 tt0 -97.82 120.2 37.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -131.34 135.06 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.044 -1.035 . . . . 0.0 110.321 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.758 HG23 ' HD3' ' A' ' 471' ' ' ARG . 93.2 mt -127.51 123.55 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -78.81 162.96 25.74 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -161.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.666 -0.646 . . . . 0.0 109.294 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -47.64 -19.03 0.17 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.783 -1.198 . . . . 0.0 111.69 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.31 -7.17 54.37 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.758 ' HD3' HG23 ' A' ' 466' ' ' ILE . 58.2 ttp180 -57.09 -24.9 57.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.035 -1.041 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 40.4 t -58.44 -45.36 88.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.403 -0.811 . . . . 0.0 110.181 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.95 -40.67 96.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 108.623 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 7.6 ttm -57.25 -39.5 75.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.742 -0.599 . . . . 0.0 110.446 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -57.11 -35.43 69.43 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 53.5 tpp -59.67 -36.77 77.1 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.347 0.594 . . . . 0.0 110.04 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.0 pttt -134.76 -145.87 0.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.586 . . . . 0.0 110.403 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 92.8 mm-40 51.11 40.95 26.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.749 -1.219 . . . . 0.0 111.498 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.33 10.85 18.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.0 110.313 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 480' ' ' GLU . 74.7 tt0 -82.74 -3.94 57.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 111.487 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.801 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -159.78 15.23 0.14 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.206 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.801 HD23 ' HG2' ' A' ' 481' ' ' ARG . 1.6 pp -169.45 38.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.716 -1.24 . . . . 0.0 111.888 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 90.8 p -87.78 50.4 1.99 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.32 24.77 28.01 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -125.49 57.64 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.517 -0.99 . . . . 0.0 108.982 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 464' ' ' GLN . 84.7 mt -97.49 -82.05 0.42 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.786 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 175.77 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 174.407 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.544 HG21 ' OE1' ' A' ' 464' ' ' GLN . 8.8 t -104.28 10.45 35.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.884 -0.51 . . . . 0.0 111.112 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -149.66 93.91 0.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 491' ' ' ARG . 34.9 ttm180 -139.82 -81.15 0.28 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 490' ' ' ARG . 8.7 ptm180 -134.18 -13.91 2.37 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.986 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.531 ' HB2' ' CE2' ' A' ' 499' ' ' PHE . 8.2 mt-30 -61.42 -30.69 70.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.879 -1.138 . . . . 0.0 111.252 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.456 HD23 ' HZ ' ' A' ' 499' ' ' PHE . 36.0 mt -64.88 -57.64 8.29 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 494' ' ' LEU . 2.2 tm? -63.36 -37.98 89.36 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.925 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.55 -7.63 58.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.766 -0.584 . . . . 0.0 112.541 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.34 60.19 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 96.2 mtp -122.7 -173.49 2.71 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.375 -1.074 . . . . 0.0 110.046 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -103.25 165.93 10.74 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.669 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 492' ' ' GLN . 65.2 m-85 -111.58 152.6 27.39 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.651 0.739 . . . . 0.0 112.284 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 487' ' ' ILE . 5.5 m -69.86 112.2 11.55 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.27 115.69 2.3 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.284 1.149 . . . . 0.0 111.226 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.58 27.64 0.04 OUTLIER Glycine 0 N--CA 1.505 3.29 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.294 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.786 ' HB3' HG21 ' A' ' 487' ' ' ILE . 12.5 p -96.84 -177.39 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.959 -1.318 . . . . 0.0 111.877 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.734 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.4 m -118.51 112.36 19.82 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 522' ' ' LEU . 57.1 t -106.03 137.2 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 119.661 -0.815 . . . . 0.0 112.564 -175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.0 pt -134.26 163.13 37.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 534' ' ' ILE . 10.1 p -159.95 106.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 122.873 1.32 . . . . 0.0 111.842 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.94 122.45 28.29 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 507' ' ' VAL . 86.7 mm-40 -145.17 112.54 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.67 -34.36 56.78 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.45 147.16 23.59 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.32 -10.49 22.25 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.025 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 513' ' ' LEU . 14.7 tp -64.32 -34.63 78.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.429 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 71.6 m -87.75 -17.44 31.66 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.38 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 519' ' ' LEU . 56.4 tp -67.62 -46.43 72.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 108.765 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.9 mttt -70.29 -40.46 74.27 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.76 -49.96 75.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.253 -0.905 . . . . 0.0 111.06 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.591 HG21 HD12 ' A' ' 466' ' ' ILE . 91.3 m -56.5 -39.99 74.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.34 -0.85 . . . . 0.0 109.834 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.3 OUTLIER -54.89 -38.91 68.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.593 -0.692 . . . . 0.0 110.123 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 99.4 m -62.45 -39.19 92.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.512 -0.742 . . . . 0.0 109.783 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.497 HD23 ' NE2' ' A' ' 464' ' ' GLN . 49.2 tp -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.498 -0.751 . . . . 0.0 110.391 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.822 HD11 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.26 -21.46 63.93 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.484 -0.76 . . . . 0.0 111.08 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -45.81 -65.33 0.56 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.76 -51.68 55.76 Favored Glycine 0 N--CA 1.503 3.15 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.521 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 488' ' ' THR . . . -59.03 -32.46 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.56 -0.965 . . . . 0.0 111.296 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.4 -22.47 66.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.151 -0.968 . . . . 0.0 112.437 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -39.18 -28.23 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -119.04 -110.98 0.34 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.142 -0.974 . . . . 0.0 111.828 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -90.8 93.12 9.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.381 -1.449 . . . . 0.0 113.578 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.5 t -141.19 166.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.859 -1.15 . . . . 0.0 111.498 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.467 ' HG2' ' N ' ' A' ' 432' ' ' SER . 1.1 tp-100 -164.68 163.25 21.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.805 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.9 t -114.64 107.39 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.658 ' HB3' HG22 ' A' ' 506' ' ' ILE . 1.6 tp -104.53 119.04 38.06 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 507' ' ' VAL . 14.9 pt -140.5 161.03 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 117.613 -1.635 . . . . 0.0 112.96 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 436' ' ' VAL . 81.7 p -121.74 -169.86 1.94 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -149.16 155.79 41.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.18 20.38 2.43 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.042 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.06 -46.21 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.452 ' OE1' ' HB1' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.93 2.44 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.888 . . . . 0.0 111.648 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 540' ' ' ARG . . . . . 0.642 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.1 ptt180 -36.33 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 540' ' ' ARG . 66.7 p -93.02 117.98 30.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.074 -1.016 . . . . 0.0 109.242 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 63.83 70.21 1.12 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.415 ' O ' HD13 ' A' ' 547' ' ' LEU . 74.9 p -80.13 -3.17 47.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.752 -0.852 . . . . 0.0 111.981 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.65 -35.59 81.87 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 -32.54 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.827 -0.808 . . . . 0.0 110.279 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.17 -35.19 80.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.658 . . . . 0.0 109.324 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 543' ' ' THR . 10.1 mp -62.45 -43.28 99.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.796 -0.565 . . . . 0.0 110.639 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 93.4 mtp -65.2 -37.61 87.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -50.92 -51.46 51.82 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.099 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.424 ' CG ' HD11 ' A' ' 519' ' ' LEU . 38.0 ttp -58.29 -40.47 82.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.364 -0.835 . . . . 0.0 109.561 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HG3' ' HB ' ' A' ' 555' ' ' VAL . 85.3 tttt -61.9 -32.17 72.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.0 110.368 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.4 -16.09 62.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 0.0 110.352 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -77.14 8.41 3.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.214 -0.929 . . . . 0.0 112.629 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 155.79 -16.74 0.47 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.79 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 551' ' ' LYS . 53.2 t -86.96 97.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 118.967 1.384 . . . . 0.0 109.273 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -154.86 129.94 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.897 -0.502 . . . . 0.0 109.873 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 75.3 m -103.27 122.39 44.68 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -73.92 -80.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.814 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -175.8 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.206 -0.934 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -88.39 -21.98 24.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.478 -0.764 . . . . 0.0 111.28 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -130.02 147.27 51.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 111.333 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -107.51 122.42 6.82 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 59.1 64.19 4.5 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.19 -5.23 55.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -1.012 . . . . 0.0 111.291 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -89.1 -1.19 57.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.55 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -152.72 51.72 0.77 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.466 -0.771 . . . . 0.0 111.299 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 567' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 38.8 Cg_endo -85.49 -39.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 122.869 0.931 . . . . 0.0 111.098 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -165.43 30.05 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.253 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.065 179.879 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 120.922 0.392 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 6.1 t -60.07 -43.95 95.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.439 -0.788 . . . . 0.0 110.238 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -155.7 132.24 3.32 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 89.8 mt -102.97 -25.07 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.984 . . . . 0.0 110.787 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -89.59 11.99 18.01 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.213 -0.929 . . . . 0.0 111.208 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 11.0 p -111.14 132.0 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.364 -0.835 . . . . 0.0 110.763 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.4 mm? -76.28 145.24 39.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.611 -0.68 . . . . 0.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -141.75 117.77 10.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.502 -0.749 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -111.1 30.78 6.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.609 -0.682 . . . . 0.0 109.836 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.48 -42.36 98.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.729 -0.607 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 33.9 p -64.36 -37.69 88.38 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.477 -0.764 . . . . 0.0 110.585 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 79.8 t -65.9 -35.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -62.75 -51.37 67.41 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.418 -0.801 . . . . 0.0 110.815 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.96 79.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.424 -0.798 . . . . 0.0 109.811 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.9 tt -62.18 -39.06 91.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.968 -0.458 . . . . 0.0 111.123 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.2 m -62.65 -37.47 86.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.43 -44.18 92.0 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.905 . . . . 0.0 112.249 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.95 -45.02 91.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.061 -1.024 . . . . 0.0 111.639 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.09 -40.84 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.724 -0.61 . . . . 0.0 109.965 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.486 ' CG ' HD11 ' A' ' 435' ' ' ILE . 30.9 mtp -63.73 -32.58 74.11 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.575 -0.703 . . . . 0.0 110.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.05 -32.24 70.72 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.106 -0.996 . . . . 0.0 110.143 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -91.17 -14.68 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -67.11 -36.98 83.1 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 0.0 109.5 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -115.33 20.38 14.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 12.5 p -37.34 146.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 122.149 -0.344 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 14.1 p -72.89 72.91 1.12 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.346 -0.846 . . . . 0.0 109.976 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.894 HG21 HG22 ' A' ' 413' ' ' VAL . 12.3 p -111.14 133.39 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.945 0.878 . . . . 0.0 112.819 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -92.37 145.76 31.23 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.698 -0.627 . . . . 0.0 109.848 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.96 -28.95 81.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 O-C-N 123.05 1.026 . . . . 0.0 109.825 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.57 -26.54 2.27 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.766 0.793 . . . . 0.0 111.168 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 67.21 0.75 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 82.4 p -51.07 109.86 0.37 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.522 -0.737 . . . . 0.0 110.585 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.894 HG22 HG21 ' A' ' 407' ' ' VAL . 19.9 m -76.68 110.45 11.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.886 -0.509 . . . . 0.0 110.558 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.92 137.95 42.91 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 N-CA-C 109.663 -0.937 . . . . 0.0 109.663 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -147.73 83.53 1.53 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 113.704 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.532 HG22 ' OH ' ' A' ' 419' ' ' TYR . 33.0 p -100.09 26.85 6.03 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.021 -1.05 . . . . 0.0 108.481 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -110.06 -31.71 7.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.319 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -57.7 -50.59 64.14 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.603 ' CG ' HG13 ' A' ' 436' ' ' VAL . 30.0 p90 -98.96 -11.77 21.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.814 -1.403 . . . . 0.0 111.975 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 416' ' ' THR . 6.2 t -65.92 -47.4 74.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.336 -1.477 . . . . 0.0 109.197 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 425' ' ' VAL . 65.6 t0 -77.21 -45.36 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 110.63 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -57.97 -49.14 77.82 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.597 -0.69 . . . . 0.0 111.475 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.735 ' HA ' HD23 ' A' ' 426' ' ' LEU . 61.1 t -69.85 -43.15 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.717 -0.614 . . . . 0.0 112.021 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.7 p -56.73 -39.96 74.85 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.113 -0.992 . . . . 0.0 111.225 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 421' ' ' ASP . 94.4 t -65.99 -43.84 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.784 . . . . 0.0 109.834 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -60.55 -34.14 73.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 112.045 -178.317 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -37.03 77.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.348 -1.47 . . . . 0.0 108.056 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.77 -29.63 70.26 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -179.44 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.344 -1.473 . . . . 0.0 108.969 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.7 99.14 0.72 Allowed 'Trans proline' 0 N--CA 1.484 0.913 0 N-CA-C 108.938 -1.216 . . . . 0.0 108.938 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 4.3 t -87.59 101.3 13.5 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.765 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -156.82 88.95 1.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 109.989 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.99 164.97 28.63 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.894 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.2 pp -114.57 128.54 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.879 -0.513 . . . . 0.0 109.714 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 423' ' ' VAL . 75.6 t -124.37 140.88 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.759 -0.588 . . . . 0.0 109.755 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 4.8 m -126.65 132.61 51.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 110.908 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.92 169.82 23.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -141.75 32.0 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.944 . . . . 0.0 109.626 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 138.08 168.73 11.4 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.84 92.55 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.85 88.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.906 . . . . 0.0 110.418 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.71 96.22 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.278 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.11 75.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.47 -38.82 81.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.981 . . . . 0.0 110.472 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 449' ' ' VAL . 90.3 mmt-85 -64.26 -40.22 95.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.368 -0.833 . . . . 0.0 110.138 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -70.81 -30.13 66.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 95.7 mtt-85 -65.7 -46.68 78.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.372 -0.83 . . . . 0.0 111.575 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.5 p -60.56 -32.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.774 -1.203 . . . . 0.0 108.974 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.82 -28.37 69.96 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.691 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 80.0 tt0 -67.61 -37.58 82.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.08 -37.0 85.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 463' ' ' VAL . 67.8 t -59.27 -26.66 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.679 -0.638 . . . . 0.0 109.314 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 17.0 mmt -67.66 -36.49 80.84 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 459' ' ' GLN . 14.8 tmm? -59.45 -29.05 67.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.834 -0.541 . . . . 0.0 110.233 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.04 -21.13 37.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.476 -0.765 . . . . 0.0 109.929 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -72.68 -25.33 61.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.651 -0.656 . . . . 0.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 455' ' ' MET . 96.9 mm-40 -77.27 2.41 15.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.338 -0.851 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.83 82.85 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 120.936 -1.103 . . . . 0.0 111.705 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -138.06 144.53 41.01 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 118.821 1.31 . . . . 0.0 111.428 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.65 ' C ' HD11 ' A' ' 487' ' ' ILE . 98.1 mt-10 -89.44 175.3 7.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 453' ' ' VAL . 16.6 m -138.74 162.38 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.855 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.78 115.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 482' ' ' LEU . 1.2 tp -119.2 120.55 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.788 -1.195 . . . . 0.0 112.116 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 507' ' ' VAL . 94.9 mt -107.66 172.95 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.795 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 466' ' ' ILE . . . -129.41 156.6 43.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.29 -159.75 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.673 -0.642 . . . . 0.0 109.424 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -46.84 -15.98 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.904 -1.122 . . . . 0.0 112.849 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -88.05 4.93 43.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.879 -1.138 . . . . 0.0 111.985 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 14.2 tpt180 -58.57 -37.61 76.14 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.066 -1.021 . . . . 0.0 111.14 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 53.5 m -56.11 -47.18 78.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.447 -0.783 . . . . 0.0 111.1 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -65.97 -37.71 86.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -0.829 . . . . 0.0 109.101 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.445 ' HE3' ' HE2' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -58.98 -34.45 71.84 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.748 -0.595 . . . . 0.0 110.192 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -61.39 -39.84 92.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.0 109.593 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 59.6 ttp -62.01 -41.61 98.25 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.445 ' HE2' ' HE3' ' A' ' 474' ' ' MET . 22.6 pttm -111.01 -150.1 0.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 109.052 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.552 ' NE2' HD21 ' A' ' 482' ' ' LEU . 41.1 tt0 48.26 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.021 -1.05 . . . . 0.0 112.302 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -132.91 21.48 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.605 . . . . 0.0 110.463 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 480' ' ' GLU . 47.7 tp10 -110.15 3.67 20.37 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.397 -0.814 . . . . 0.0 111.408 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.631 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -137.17 -24.31 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.905 -1.122 . . . . 0.0 112.421 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.631 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -158.21 69.64 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.106 -0.997 . . . . 0.0 110.81 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 24.7 t -90.38 51.15 1.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.58 16.82 23.37 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.081 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -126.16 59.9 1.32 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.177 -1.19 . . . . 0.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 487' ' ' ILE . 84.7 mt -64.18 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.069 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.784 HD11 ' CA ' ' A' ' 463' ' ' VAL . 14.4 mm -155.15 -82.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.16 -0.962 . . . . 0.0 109.736 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.553 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.0 t -98.99 12.25 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.784 -0.572 . . . . 0.0 110.761 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -97.05 79.93 0.69 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.54 -67.99 0.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 495' ' ' GLU . 95.7 mtt-85 -96.75 -26.72 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.802 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -67.52 -44.34 78.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.933 -1.104 . . . . 0.0 110.524 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 493' ' ' LEU . 2.6 mt -70.59 -37.84 73.96 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.8 OUTLIER -103.75 -39.98 6.45 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 495' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 491' ' ' ARG . 89.7 mt-10 -102.14 -9.47 20.48 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.815 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 84.31 -9.18 64.9 Favored Glycine 0 N--CA 1.5 2.949 0 O-C-N 120.523 -1.36 . . . . 0.0 111.111 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.428 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 99.4 mtp -68.17 179.25 1.6 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.248 . . . . 0.0 112.11 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.55 153.77 25.77 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.4 155.04 25.95 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.191 0.996 . . . . 0.0 112.036 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 500' ' ' THR . 7.3 t -44.6 132.33 4.89 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.642 -177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.446 ' HB3' ' CA ' ' A' ' 528' ' ' HIS . 56.3 Cg_endo -85.51 112.94 1.35 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.596 1.314 . . . . 0.0 109.51 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.11 26.05 0.07 OUTLIER Glycine 0 N--CA 1.504 3.194 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.987 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 487' ' ' ILE . 74.7 m -92.8 173.87 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -1.207 . . . . 0.0 111.022 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.806 ' HB ' HG12 ' A' ' 463' ' ' VAL . 91.6 m -115.66 127.71 55.37 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 522' ' ' LEU . 13.2 t -118.46 130.51 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.867 0.842 . . . . 0.0 111.125 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.705 HG22 ' HB3' ' A' ' 533' ' ' LEU . 6.1 pt -135.6 123.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 0.0 109.017 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 534' ' ' ILE . 14.5 p -113.73 115.18 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.647 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 36.7 m-20 -84.34 108.48 17.2 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.894 -1.129 . . . . 0.0 108.418 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 0.5 OUTLIER -99.73 175.36 5.83 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 122.376 1.084 . . . . 0.0 112.969 -176.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.81 -55.85 0.05 OUTLIER Glycine 0 N--CA 1.503 3.102 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.19 -155.05 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.51 -17.86 2.54 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.046 -1.033 . . . . 0.0 111.019 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 57.5 tp -72.43 -25.05 61.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.278 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 75.2 m -65.58 -44.31 87.05 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 110.492 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.894 HD21 ' HG3' ' A' ' 550' ' ' MET . 11.0 tp -64.46 -46.31 83.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.829 -0.544 . . . . 0.0 111.938 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.55 -43.81 79.8 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 0.0 112.084 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -62.5 -51.13 68.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.112 -0.992 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 522' ' ' LEU . 97.4 m -59.81 -43.07 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.832 -0.542 . . . . 0.0 110.459 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -41.36 90.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.747 -0.596 . . . . 0.0 111.464 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 39.1 p -64.47 -33.27 75.49 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.053 -1.03 . . . . 0.0 109.832 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 60.8 tp -68.3 -40.44 81.75 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.694 0.759 . . . . 0.0 109.83 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 505' ' ' VAL . 0.6 OUTLIER -70.97 -22.22 62.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 523' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 48.6 t0 -47.46 -60.17 2.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.393 -0.817 . . . . 0.0 111.895 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.88 -51.13 56.06 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.555 ' HB1' ' OD1' ' A' ' 529' ' ' ASN . . . -55.15 -29.83 58.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.684 -0.891 . . . . 0.0 110.414 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -47.96 -37.67 15.01 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -66.58 -42.51 86.89 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.446 ' CA ' ' HB3' ' A' ' 501' ' ' PRO . 32.2 m80 -94.62 -94.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.31 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.555 ' OD1' ' HB1' ' A' ' 525' ' ' ALA . 15.8 p-10 -83.69 144.17 29.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.963 -1.085 . . . . 0.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 4.2 p -171.81 146.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.392 -1.323 . . . . 0.0 113.836 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.8 OUTLIER 171.86 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 76.5 t -110.44 104.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 120.742 -1.223 . . . . 0.0 113.258 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.6 OUTLIER -109.26 116.17 31.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.931 HG22 HG12 ' A' ' 507' ' ' VAL . 5.7 pt -127.91 155.19 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.475 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.705 HG22 ' HB ' ' A' ' 436' ' ' VAL . 61.4 p -128.87 -172.69 2.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -149.4 156.04 41.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 110.563 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 85.3 p -145.32 23.26 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.663 . . . . 0.0 110.654 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -163.63 -41.6 0.02 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.63 ' CD ' ' HB2' ' A' ' 546' ' ' ALA . 46.3 tt0 -81.63 0.4 38.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.979 . . . . 0.0 110.939 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 541' ' ' THR . 40.8 ptt180 -40.58 -39.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.583 -0.698 . . . . 0.0 112.23 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.416 ' N ' ' HG3' ' A' ' 540' ' ' ARG . 40.5 p -63.86 -91.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -70.25 79.53 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 543' ' ' THR . 9.4 t -87.06 -18.72 29.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.953 . . . . 0.0 111.611 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.22 -38.97 93.97 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 18.9 m -69.17 -24.93 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.515 -0.991 . . . . 0.0 109.792 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.15 -36.53 77.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.76 -0.587 . . . . 0.0 109.865 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.298 -0.876 . . . . 0.0 108.877 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 56.8 ttm -64.55 -31.91 73.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.93 -50.39 61.23 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.894 ' HG3' HD21 ' A' ' 515' ' ' LEU . 90.0 mtp -58.43 -44.27 89.05 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.838 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 551' ' ' LYS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 84.7 tttt -63.44 -32.07 73.4 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.459 -0.776 . . . . 0.0 111.474 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.67 -15.86 62.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.66 3.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.266 -0.896 . . . . 0.0 112.725 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 147.65 -13.08 1.35 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.364 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 551' ' ' LYS . 62.9 t -85.77 103.23 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.015 -1.285 . . . . 0.0 110.708 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -151.6 114.09 4.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.784 . . . . 0.0 110.245 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 6.1 p -86.79 127.1 34.99 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.424 0.631 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -88.25 -87.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -153.48 -69.63 0.14 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.023 -1.048 . . . . 0.0 109.6 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -79.5 -20.16 47.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.686 -0.634 . . . . 0.0 110.031 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -137.98 119.65 15.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -150.59 -44.7 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -84.6 65.68 4.03 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -96.11 -24.54 16.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -1.003 . . . . 0.0 110.645 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -65.37 -37.53 87.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.783 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.37 119.86 45.7 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.71 -1.65 11.81 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 O-C-N 123.161 1.085 . . . . 0.0 110.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.53 76.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.616 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.115 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.471 0.653 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 19.3 m -59.78 -34.09 72.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.618 -0.677 . . . . 0.0 110.271 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 126.18 74.02 0.21 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 384' ' ' ILE . 10.3 tp -141.85 55.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.957 . . . . 0.0 110.591 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -146.54 137.11 23.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.588 -0.695 . . . . 0.0 109.959 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.54 130.02 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.669 . . . . 0.0 109.593 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 387' ' ' LEU . 53.1 tp -108.88 -1.76 18.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.189 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -61.22 147.56 43.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.95 -1.094 . . . . 0.0 109.883 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -48.33 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.528 -0.733 . . . . 0.0 111.677 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -40.53 89.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 77.8 p -66.11 -41.44 90.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.442 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 433' ' ' LEU . 89.0 t -68.31 -33.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.679 -0.638 . . . . 0.0 110.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -58.37 -48.99 78.83 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.421 -0.799 . . . . 0.0 111.402 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.68 -32.17 71.79 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.949 0.88 . . . . 0.0 109.856 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.606 HD13 HD12 ' A' ' 399' ' ' ILE . 2.2 tm? -61.8 -41.53 97.87 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.758 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' SER . . . . . 0.466 ' HB2' HD12 ' A' ' 435' ' ' ILE . 78.5 p -71.86 -34.68 69.43 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.193 -0.942 . . . . 0.0 112.641 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.0 -50.22 71.6 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.996 -1.065 . . . . 0.0 112.435 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.06 -43.14 71.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.263 -0.898 . . . . 0.0 112.014 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 395' ' ' LEU . 94.1 mt -61.41 -44.79 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.112 -0.992 . . . . 0.0 110.009 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.492 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 5.9 ttm -61.42 -31.55 71.49 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.617 -0.677 . . . . 0.0 110.758 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.26 -25.21 67.7 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.539 -0.726 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 405' ' ' VAL . 65.5 tp60 -99.79 -20.65 16.11 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.272 -0.893 . . . . 0.0 109.21 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.581 ' ND2' HG22 ' A' ' 399' ' ' ILE . 98.0 m-20 -82.7 -7.01 59.68 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -94.67 -56.47 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 402' ' ' GLN . 6.4 p -27.88 124.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.1 m -60.13 95.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 122.159 0.98 . . . . 0.0 109.979 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.903 HG21 ' CZ ' ' A' ' 415' ' ' ARG . 13.9 t -65.27 137.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.132 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.2 130.68 29.1 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.684 -0.635 . . . . 0.0 110.267 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.47 -20.79 41.27 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.117 1.061 . . . . 0.0 111.07 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.35 -32.6 71.78 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.787 0.803 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 69.88 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.0 m -49.69 142.3 8.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.791 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.835 HG12 HG13 ' A' ' 407' ' ' VAL . 11.4 p -98.86 143.88 27.17 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.38 136.63 56.1 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 N-CA-C 108.794 -1.272 . . . . 0.0 108.794 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.903 ' CZ ' HG21 ' A' ' 407' ' ' VAL . 98.1 mtt180 -123.18 -15.53 7.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.391 -0.818 . . . . 0.0 112.881 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.9 p -102.74 6.45 39.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.025 . . . . 0.0 109.014 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -78.51 -79.92 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.05 -1.031 . . . . 0.0 111.745 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -74.12 -4.75 68.95 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.623 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.595 ' O ' HG23 ' A' ' 423' ' ' VAL . 81.7 m-85 -107.07 -1.94 21.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.616 -1.52 . . . . 0.0 110.207 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -84.88 -33.71 22.74 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 425' ' ' VAL . 47.3 t0 -72.63 -37.68 67.95 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.11 85.72 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.099 0.952 . . . . 0.0 110.301 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 436' ' ' VAL . 98.5 t -67.71 -40.98 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.253 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -69.45 -36.61 76.79 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.028 -1.045 . . . . 0.0 111.71 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 421' ' ' ASP . 87.0 t -65.27 -42.46 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.381 -0.825 . . . . 0.0 112.008 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.748 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 2.1 pp -65.51 -31.08 71.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.109 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.25 69.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.955 . . . . 0.0 109.424 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.15 -32.53 74.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -61.24 -86.49 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.534 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -172.18 -57.46 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.773 -1.205 . . . . 0.0 109.529 177.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 55.2 Cg_endo -71.07 103.44 1.38 Allowed 'Trans proline' 0 N--CA 1.488 1.198 0 N-CA-C 109.688 -0.928 . . . . 0.0 109.688 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 3.2 t -85.34 98.72 10.71 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.963 0.887 . . . . 0.0 110.712 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.76 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.2 tp -146.51 136.61 23.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -169.96 163.21 9.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.823 -1.173 . . . . 0.0 110.923 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.597 ' O ' HG21 ' A' ' 399' ' ' ILE . 22.1 mt -123.49 121.52 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.793 -0.567 . . . . 0.0 110.409 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 423' ' ' VAL . 57.3 t -127.27 137.14 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.917 . . . . 0.0 109.137 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 539' ' ' GLN . 4.1 p -131.83 139.24 48.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.98 -1.075 . . . . 0.0 111.536 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 537' ' ' SER . . . -148.88 168.06 29.37 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.67 70.01 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 110.48 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 133.24 148.97 6.02 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.68 32.31 81.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.68 -9.16 58.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.698 -0.884 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.07 94.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.136 -0.978 . . . . 0.0 110.834 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -79.21 -28.01 54.34 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.94 -41.01 90.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.539 -0.977 . . . . 0.0 109.55 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.516 ' NE ' ' HB2' ' A' ' 467' ' ' ALA . 8.4 mmm180 -64.89 -40.15 94.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.876 -0.515 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -70.27 -31.63 69.09 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.074 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.99 -50.49 64.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.52 -0.738 . . . . 0.0 112.051 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 506' ' ' ILE . 7.2 p -58.5 -33.57 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.272 . . . . 0.0 109.174 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.89 -27.3 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -61.33 -33.95 74.45 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 455' ' ' MET . 1.5 tp -63.56 -38.43 91.08 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.847 HG13 ' CG2' ' A' ' 463' ' ' VAL . 91.8 t -58.88 -25.85 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 90.0 mtp -66.2 -39.77 89.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.45 -0.781 . . . . 0.0 109.221 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.3 OUTLIER -60.06 -23.44 63.76 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.874 0.845 . . . . 0.0 109.089 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 453' ' ' VAL . . . -83.77 -23.65 31.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.463 0.649 . . . . 0.0 109.878 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 23.9 tpt85 -67.0 -42.96 84.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -71.42 -27.9 63.61 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.726 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -74.89 0.02 17.02 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.617 -0.677 . . . . 0.0 111.725 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.36 76.43 Favored Glycine 0 N--CA 1.496 2.679 0 O-C-N 120.837 -1.164 . . . . 0.0 110.718 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 461' ' ' ARG . 16.8 ptp180 -129.87 136.27 49.34 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.215 -1.168 . . . . 0.0 110.953 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 99.2 mt-10 -91.84 161.53 14.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.222 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.926 HG12 ' HB ' ' A' ' 504' ' ' THR . 29.1 m -136.77 153.22 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 111.271 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.939 ' HA ' HD22 ' A' ' 486' ' ' LEU . 53.4 tt0 -100.72 116.41 32.56 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 506' ' ' ILE . 1.1 pt -130.29 135.11 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.065 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.598 ' HB ' HG23 ' A' ' 507' ' ' VAL . 87.5 mt -126.22 122.12 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.118 -0.989 . . . . 0.0 111.86 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.516 ' HB2' ' NE ' ' A' ' 446' ' ' ARG . . . -66.03 155.88 35.4 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.452 -0.78 . . . . 0.0 109.128 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.99 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.406 -0.809 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 511' ' ' GLU . 5.0 t0 -46.11 -22.68 0.24 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.23 -0.919 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -70.32 -4.65 23.11 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.446 -0.784 . . . . 0.0 110.892 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.478 ' HD2' ' HB3' ' A' ' 467' ' ' ALA . 6.1 tpt180 -53.77 -34.18 58.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.118 -0.989 . . . . 0.0 112.929 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 75.5 m -59.41 -45.23 92.08 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.137 -0.977 . . . . 0.0 110.074 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 476' ' ' MET . 51.4 tt0 -66.84 -39.35 87.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.7 -0.625 . . . . 0.0 109.932 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 15.8 mmt -60.39 -34.52 74.02 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -61.77 -36.23 80.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.28 -0.888 . . . . 0.0 108.621 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 473' ' ' GLN . 7.3 tpp -59.45 -41.94 90.82 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.568 0.699 . . . . 0.0 109.124 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -118.16 -146.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 46.06 88.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.216 -0.927 . . . . 0.0 111.627 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -131.79 22.55 4.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.735 -0.603 . . . . 0.0 110.139 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -115.77 -15.49 11.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.695 -0.628 . . . . 0.0 110.735 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.632 ' C ' HD23 ' A' ' 482' ' ' LEU . 22.4 mtt180 -118.15 -7.0 10.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 113.175 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -171.54 54.45 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 120.751 -1.218 . . . . 0.0 112.296 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.0 p -64.67 -21.63 66.78 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.926 -1.109 . . . . 0.0 110.576 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 149.67 48.17 0.02 OUTLIER Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.93 59.17 1.74 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.788 -0.83 . . . . 0.0 109.774 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 464' ' ' GLN . 24.9 mt -80.17 -80.29 0.14 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 177.27 -41.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 174.131 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.629 HG23 HG22 ' A' ' 487' ' ' ILE . 6.9 p -103.85 9.53 36.84 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.503 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.4 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -103.14 60.78 0.48 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 499' ' ' PHE . 54.7 ttm-85 -144.12 -50.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.956 . . . . 0.0 108.835 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 98.0 mtt180 -122.97 -29.86 3.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.976 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -65.2 -41.19 94.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -0.921 . . . . 0.0 110.534 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 493' ' ' LEU . 5.8 mt -86.58 -31.48 21.17 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.503 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -102.93 -43.57 5.49 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -100.13 -9.65 22.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.535 -1.353 . . . . 0.0 113.904 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.22 -18.83 46.57 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.676 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 98.3 mtp -66.36 -178.47 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -1.151 . . . . 0.0 109.935 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.23 145.7 41.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.734 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -114.35 149.32 36.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.664 -0.648 . . . . 0.0 110.645 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 94.6 m -50.54 103.71 0.38 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 0.0 109.811 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 44.3 Cg_endo -72.37 113.04 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.559 1.294 . . . . 0.0 108.928 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 529' ' ' ASN . . . 171.05 34.33 0.03 OUTLIER Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 487' ' ' ILE . 22.8 p -92.91 179.04 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -1.061 . . . . 0.0 110.654 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.926 ' HB ' HG12 ' A' ' 463' ' ' VAL . 97.8 m -111.17 121.6 45.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.87 ' CG1' HD21 ' A' ' 522' ' ' LEU . 63.4 t -123.02 134.89 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.205 -0.934 . . . . 0.0 113.227 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.669 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.2 pt -131.99 120.29 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 534' ' ' ILE . 9.8 p -106.1 114.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.537 -1.352 . . . . 0.0 111.478 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 12.0 m-20 -82.27 108.5 15.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.9 tm0? -106.83 175.15 5.6 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.349 1.071 . . . . 0.0 113.305 -175.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -170.58 -51.91 0.04 OUTLIER Glycine 0 N--CA 1.503 3.145 0 N-CA-C 103.401 -3.88 . . . . 0.0 103.401 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 469' ' ' ASP . 32.0 tp10 -82.17 162.94 22.26 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 173.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.69 -12.32 20.11 Favored 'General case' 0 C--N 1.274 -2.712 0 O-C-N 121.636 -0.665 . . . . 0.0 110.658 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 513' ' ' LEU . 4.5 mm? -67.44 -27.16 66.81 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.2 m -91.43 -13.06 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 111.225 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 519' ' ' LEU . 20.5 tp -78.34 -46.84 19.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 13.6 ptpt -80.61 -38.52 29.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.467 -0.77 . . . . 0.0 111.512 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.64 -44.39 96.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.9 -1.125 . . . . 0.0 109.702 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.783 HG22 HD12 ' A' ' 522' ' ' LEU . 85.8 m -62.2 -41.96 98.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.8 OUTLIER -60.2 -31.76 70.45 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.762 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 21.4 m -64.65 -53.98 39.03 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.855 -1.153 . . . . 0.0 110.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 521' ' ' LEU . 0.2 OUTLIER -62.74 -39.27 93.57 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.133 -0.979 . . . . 0.0 109.888 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.87 HD21 ' CG1' ' A' ' 505' ' ' VAL . 3.2 mt -65.34 -31.98 73.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.459 -0.776 . . . . 0.0 112.181 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.06 -45.9 68.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.017 -1.052 . . . . 0.0 110.325 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.33 62.13 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -67.13 -36.52 82.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.508 -0.995 . . . . 0.0 112.375 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -26.38 68.22 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.956 -1.09 . . . . 0.0 110.872 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -53.72 -25.8 20.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.485 -0.759 . . . . 0.0 109.243 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.514 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.7 m80 -109.98 -130.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.433 ' HB2' ' CA ' ' A' ' 502' ' ' GLY . 98.1 m-20 -89.91 70.65 7.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.532 -1.355 . . . . 0.0 113.234 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -133.28 158.0 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -148.77 154.59 39.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.759 -0.588 . . . . 0.0 109.608 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 35.4 t -107.14 106.55 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.35 -0.844 . . . . 0.0 113.12 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.669 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.2 tp -106.72 113.66 27.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.885 HG22 HG12 ' A' ' 507' ' ' VAL . 12.1 pt -125.56 130.4 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.028 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 62.5 p -96.8 179.03 5.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 8.3 t0 -154.82 161.0 41.64 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.589 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 438' ' ' GLY . 0.1 OUTLIER -138.59 14.58 2.74 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.464 178.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -146.95 20.19 1.6 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 56.4 tt0 -93.83 -0.95 55.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.301 -1.117 . . . . 0.0 111.038 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -55.86 -42.75 76.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.834 -1.166 . . . . 0.0 111.25 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.1 m -102.75 -58.25 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 111.169 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -90.98 85.83 1.31 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 539' ' ' GLN . 14.9 t -98.56 -40.78 8.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.561 -0.964 . . . . 0.0 111.608 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.09 -41.39 97.13 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 4.5 t -68.54 -23.31 64.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.522 -0.987 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.603 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.14 -39.52 94.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 108.642 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.0 mp -65.36 -42.11 93.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.743 -0.598 . . . . 0.0 109.958 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.21 -29.67 68.88 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.657 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -61.42 -48.71 79.93 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 519' ' ' LEU . 24.9 ttm -56.78 -53.02 62.65 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.598 -0.689 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.39 -31.88 69.64 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.639 -0.663 . . . . 0.0 110.986 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -61.48 -20.04 62.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.415 -0.803 . . . . 0.0 109.776 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -72.37 -1.17 14.54 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.191 -0.943 . . . . 0.0 111.868 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.04 -8.81 9.76 Favored Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.872 -1.143 . . . . 0.0 110.992 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 58.5 t -85.85 101.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -1.221 . . . . 0.0 108.505 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -171.11 137.82 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.217 -0.927 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 8.7 p -83.9 123.22 29.71 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -86.4 -77.41 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -150.34 -72.88 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.39 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -87.36 -20.81 26.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -116.34 -179.8 3.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.178 -0.952 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 125.77 31.32 0.83 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 79.32 7.14 88.68 Favored Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.281 -1.129 . . . . 0.0 111.275 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -96.72 -15.36 21.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.79 -1.418 . . . . 0.0 111.098 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -92.0 -10.21 40.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.233 -0.917 . . . . 0.0 111.061 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.31 52.06 0.23 Allowed Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.194 -0.941 . . . . 0.0 111.446 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.79 -15.25 21.4 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.089 1.047 . . . . 0.0 110.767 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -92.1 -0.82 57.44 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.342 -0.849 . . . . 0.0 112.075 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.502 2.158 0 O-C-N 120.838 -1.164 . . . . 0.0 111.312 -179.402 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.0 m -70.57 149.47 47.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.68 . . . . 0.0 109.816 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -70.45 90.26 0.37 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.87 127.29 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.574 -0.956 . . . . 0.0 109.826 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -73.9 135.36 43.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.536 -0.728 . . . . 0.0 109.748 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 11.0 p -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.467 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.29 145.26 56.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.679 -0.638 . . . . 0.0 109.579 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.53 73.46 1.03 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 110.733 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.22 -11.13 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.584 -0.697 . . . . 0.0 110.713 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.58 -30.11 70.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.358 -0.839 . . . . 0.0 110.724 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.6 m -60.98 -44.71 96.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.22 -33.77 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.437 -0.789 . . . . 0.0 109.949 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -59.39 -47.79 84.1 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.179 -0.95 . . . . 0.0 110.559 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.64 78.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 426' ' ' LEU . 0.6 OUTLIER -62.14 -39.38 92.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.025 -0.422 . . . . 0.0 111.195 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.0 p -64.69 -34.49 78.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 110.748 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -65.15 -43.73 90.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.96 -44.77 75.98 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.328 -0.858 . . . . 0.0 112.235 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 435' ' ' ILE . 62.2 mt -64.27 -43.77 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 6.9 tpp -61.36 -29.28 69.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.315 0.578 . . . . 0.0 109.484 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.06 -29.17 70.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.594 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.4 mm-40 -90.9 -15.5 29.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.081 . . . . 0.0 109.419 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.5 -37.98 86.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.648 -0.657 . . . . 0.0 110.079 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -116.86 18.9 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.047 -1.033 . . . . 0.0 110.441 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 402' ' ' GLN . 7.1 p -58.76 120.92 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.397 -0.814 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 406' ' ' THR . 3.8 t -56.94 104.22 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.645 0.736 . . . . 0.0 110.525 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 413' ' ' VAL . 6.0 p -112.71 135.33 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 138.31 25.6 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.96 -27.94 36.1 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.12 1.063 . . . . 0.0 110.758 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -62.53 -31.36 72.12 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.91 0.862 . . . . 0.0 109.996 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.61 59.32 0.69 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 30.7 t -61.34 126.99 29.33 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.751 0.786 . . . . 0.0 111.313 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 407' ' ' VAL . 7.1 p -74.18 146.14 84.13 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 413' ' ' VAL . 40.5 Cg_endo -68.01 121.24 8.24 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -95.05 14.17 22.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.462 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.888 HG22 ' OH ' ' A' ' 419' ' ' TYR . 14.6 p -92.07 20.9 5.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.878 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.23 -29.18 9.48 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.0 -49.63 76.5 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.888 ' OH ' HG22 ' A' ' 416' ' ' THR . 21.0 p90 -99.29 -11.91 20.83 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.055 1.428 . . . . 0.0 112.943 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.3 m -70.88 -42.14 70.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.264 -1.523 . . . . 0.0 108.203 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.6 t70 -78.94 -44.58 22.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.907 -0.496 . . . . 0.0 110.758 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.532 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.74 -48.04 76.05 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.773 -0.579 . . . . 0.0 112.409 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 426' ' ' LEU . 89.8 t -68.42 -42.33 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.319 -0.863 . . . . 0.0 111.469 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 81.2 p -60.68 -42.84 97.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.182 -0.949 . . . . 0.0 111.343 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 422' ' ' ALA . 32.8 m -68.7 -29.32 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.33 -0.856 . . . . 0.0 111.949 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -73.34 -33.18 64.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.283 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.27 -32.71 73.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.026 -1.046 . . . . 0.0 108.594 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.17 -33.98 77.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.38 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.478 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -177.06 -56.11 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.556 -1.34 . . . . 0.0 110.001 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.4 Cg_endo -68.59 107.93 1.74 Allowed 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 109.291 -1.08 . . . . 0.0 109.291 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 531' ' ' GLN . 1.5 m -100.41 109.21 21.36 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.89 0.852 . . . . 0.0 110.898 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -174.8 95.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -136.86 167.01 22.29 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.929 0.871 . . . . 0.0 112.372 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 399' ' ' ILE . 40.0 pt -116.3 127.66 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.467 0.651 . . . . 0.0 109.541 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.803 HG13 ' CG ' ' A' ' 419' ' ' TYR . 54.0 t -125.04 137.35 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.369 -0.832 . . . . 0.0 109.327 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 28.1 m -119.61 123.45 43.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.359 -0.838 . . . . 0.0 110.951 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.96 155.66 19.63 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.17 75.55 0.25 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.737 -0.861 . . . . 0.0 109.368 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 113.65 145.49 9.2 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.27 38.96 95.39 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.25 -30.0 69.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.6 -0.941 . . . . 0.0 110.737 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.29 93.88 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.416 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.55 -28.05 68.26 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.37 -46.5 88.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.49 -1.006 . . . . 0.0 110.757 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 449' ' ' VAL . 13.0 mtm-85 -64.81 -40.76 95.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.557 -0.714 . . . . 0.0 111.189 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 14.3 mt-10 -69.22 -29.97 68.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.127 -0.983 . . . . 0.0 110.37 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -61.67 -51.5 68.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.329 -0.857 . . . . 0.0 110.449 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 1.01 HG22 HD12 ' A' ' 506' ' ' ILE . 2.4 p -58.0 -31.74 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.095 -1.003 . . . . 0.0 108.765 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.02 -27.34 69.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.24 -34.28 76.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.106 -0.996 . . . . 0.0 108.756 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 452' ' ' LEU . 4.6 mm? -63.87 -34.41 77.88 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.7 t -59.3 -30.12 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.633 -0.667 . . . . 0.0 109.742 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 60.3 mtt -66.34 -39.28 89.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.001 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.4 ttp -58.86 -25.21 63.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.652 -0.655 . . . . 0.0 110.176 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.36 -22.68 32.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 110.058 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -64.52 -45.39 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.573 -0.704 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.05 -29.86 65.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -75.82 3.8 9.26 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 111.357 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.67 23.92 75.45 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -128.37 145.64 51.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.445 -1.032 . . . . 0.0 110.344 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 487' ' ' ILE . 51.0 mp0 -99.09 169.79 9.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 35.5 m -141.27 150.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.086 -1.009 . . . . 0.0 111.212 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.887 ' HB3' HG22 ' A' ' 505' ' ' VAL . 13.1 tt0 -101.2 123.62 45.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -137.49 146.78 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.225 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.787 ' HB ' HG23 ' A' ' 507' ' ' VAL . 95.5 mt -132.99 124.61 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.437 -0.789 . . . . 0.0 110.674 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.461 ' HB1' ' CD ' ' A' ' 446' ' ' ARG . . . -75.8 161.94 28.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.16 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.534 -0.729 . . . . 0.0 109.863 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -49.42 -19.16 0.49 Allowed 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.665 -1.272 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ARG . . . . . 0.4 ' HD2' ' NE ' ' A' ' 446' ' ' ARG . 96.2 mtt-85 -76.17 -5.67 47.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.213 -0.929 . . . . 0.0 111.031 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 466' ' ' ILE . 71.8 ttt180 -56.97 -23.44 45.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.033 -1.042 . . . . 0.0 111.027 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 11.6 t -60.6 -48.57 81.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.11 -46.36 84.57 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 30.1 tpp -53.57 -35.03 60.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.897 -0.502 . . . . 0.0 110.904 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -60.72 -38.7 85.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.439 -0.788 . . . . 0.0 109.962 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 10.6 tpt -61.79 -37.67 85.22 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.602 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -113.12 -144.47 0.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.652 ' CG ' HD21 ' A' ' 482' ' ' LEU . 35.7 tp60 55.54 50.73 13.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.829 -1.169 . . . . 0.0 111.398 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -100.6 23.57 10.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.27 -10.21 39.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 112.265 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -173.2 24.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.944 -1.098 . . . . 0.0 112.746 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 482' ' ' LEU . 3.8 pp -171.62 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.4 p -61.13 -21.44 63.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.112 -0.992 . . . . 0.0 110.804 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 164.0 53.24 0.02 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.6 66.14 0.75 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.661 -0.905 . . . . 0.0 109.77 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 464' ' ' GLN . 75.4 mt -77.2 -82.1 0.09 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.427 -0.795 . . . . 0.0 109.21 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 503' ' ' SER . 35.8 mm -152.64 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 109.255 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.471 ' CB ' ' HB3' ' A' ' 499' ' ' PHE . 3.9 t -100.74 10.67 40.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.572 -0.705 . . . . 0.0 111.077 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.449 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -91.92 72.63 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 51.0 ttm-85 -142.92 -73.96 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -90.37 -26.81 19.74 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.255 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -62.67 -48.06 80.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 110.512 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.477 ' N ' HD23 ' A' ' 493' ' ' LEU . 4.8 mt -71.64 -41.82 68.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.513 -0.742 . . . . 0.0 111.457 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 45.9 tp -102.66 -45.4 5.04 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -87.02 -5.02 59.21 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.076 -1.015 . . . . 0.0 112.492 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 62.41 47.22 91.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.02 -177.17 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.923 . . . . 0.0 109.411 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.87 48.62 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 109.12 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.471 ' HB3' ' CB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -113.92 148.74 36.28 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.076 0.941 . . . . 0.0 111.453 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 500' ' ' THR . 8.2 t -48.68 121.43 9.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.586 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 49.0 Cg_endo -78.84 114.36 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.384 1.202 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -170.69 33.36 0.16 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.827 ' HB2' HG21 ' A' ' 487' ' ' ILE . 36.7 t -80.75 143.22 33.08 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.922 ' HB ' HG12 ' A' ' 463' ' ' VAL . 48.1 m -115.25 108.48 16.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.942 HG21 HD21 ' A' ' 522' ' ' LEU . 41.4 t -113.09 141.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 1.01 HD12 HG22 ' A' ' 449' ' ' VAL . 15.9 pt -136.46 103.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 175.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.787 HG23 ' HB ' ' A' ' 466' ' ' ILE . 8.6 p -103.49 107.02 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.739 -1.225 . . . . 0.0 112.263 -176.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 3.9 t70 -85.18 107.95 17.49 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 6.5 tp-100 -131.0 115.18 16.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -73.33 -64.73 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.85 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.85 -12.87 1.96 Allowed 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.629 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.5 OUTLIER -63.74 -34.56 78.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.342 -0.849 . . . . 0.0 109.438 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 514' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 509' ' ' GLN . 22.9 t -90.4 -14.52 32.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.697 -0.627 . . . . 0.0 111.236 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 534' ' ' ILE . 42.6 tp -65.45 -48.92 71.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.038 -1.039 . . . . 0.0 108.922 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.676 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 98.8 mttt -69.86 -41.7 74.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.968 -0.457 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.92 -47.05 81.52 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 78.9 m -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.367 -0.833 . . . . 0.0 110.239 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -57.61 -39.58 77.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.849 -0.532 . . . . 0.0 110.674 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 11.5 m -61.97 -39.63 92.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.384 -0.823 . . . . 0.0 110.301 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.34 -41.68 96.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.873 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.942 HD21 HG21 ' A' ' 505' ' ' VAL . 2.6 mt -61.82 -22.4 65.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.748 -0.595 . . . . 0.0 110.458 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -47.24 -63.69 0.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.07 -51.71 50.85 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.708 -1.245 . . . . 0.0 110.46 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -29.34 65.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.908 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.469 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -59.99 -25.1 64.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.513 -0.742 . . . . 0.0 112.481 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -41.94 -27.74 0.13 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.542 -0.724 . . . . 0.0 111.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 1.9 t-80 -108.22 -126.94 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.73 . . . . 0.0 111.047 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -89.86 96.87 10.88 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.622 -1.299 . . . . 0.0 114.49 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -113.17 131.08 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 O-C-N 120.893 -1.129 . . . . 0.0 111.462 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 432' ' ' SER . 86.8 mt-30 -120.27 126.85 51.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.558 ' C ' HD12 ' A' ' 533' ' ' LEU . 49.7 t -117.08 123.51 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 122.581 1.181 . . . . 0.0 113.091 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 532' ' ' VAL . 9.2 mp -119.57 119.3 33.4 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.756 HG22 HG12 ' A' ' 507' ' ' VAL . 0.8 OUTLIER -132.78 129.01 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.658 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.66 HG22 ' HB ' ' A' ' 436' ' ' VAL . 30.2 p -101.58 -166.69 1.33 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 4.3 t0 -159.07 169.12 24.96 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.511 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -140.73 17.85 2.34 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.719 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.99 2.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 536' ' ' ASP . 83.9 mt-30 -96.75 1.19 50.58 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.507 -0.996 . . . . 0.0 111.947 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -53.45 -40.66 65.41 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.985 -1.072 . . . . 0.0 111.388 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.0 m -104.18 -45.18 4.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.162 -0.961 . . . . 0.0 111.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.85 67.27 0.34 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -65.39 -42.81 92.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.523 -0.987 . . . . 0.0 110.891 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.71 -39.83 97.96 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 57.3 m -60.56 -33.94 73.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.589 -0.948 . . . . 0.0 109.997 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.35 -37.2 82.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.14 -42.16 98.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.57 -0.706 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 99.1 mtp -65.44 -31.84 73.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.705 -0.622 . . . . 0.0 109.832 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.44 -54.05 48.66 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.513 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.434 ' CG ' HD11 ' A' ' 519' ' ' LEU . 43.2 ttp -60.22 -44.14 95.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.306 -0.871 . . . . 0.0 110.519 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.68 -31.57 72.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.359 -0.838 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -67.72 -15.59 63.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.089 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.676 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -75.59 6.73 4.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 112.098 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 151.15 -16.68 0.9 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.209 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.61 101.08 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.072 -1.252 . . . . 0.0 109.858 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -154.06 116.19 4.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 110.268 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 18.3 m -63.16 135.7 57.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.563 -0.71 . . . . 0.0 110.056 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.55 -90.72 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 0.0 110.89 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 36.0 mmm-85 -147.87 -80.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.014 -1.053 . . . . 0.0 110.62 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -93.58 -22.6 18.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 0.0 110.889 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -131.09 140.72 50.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.482 -0.761 . . . . 0.0 110.17 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 147.71 -104.67 0.29 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -94.98 -18.75 33.23 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -70.03 -33.91 72.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -1.075 . . . . 0.0 110.081 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -82.73 -13.14 56.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.541 -0.725 . . . . 0.0 110.661 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 116.95 0.35 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 0.0 110.081 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.84 -28.33 36.45 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 N-CA-C 109.491 -1.004 . . . . 0.0 109.491 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -168.51 -61.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.68 -0.638 . . . . 0.0 109.516 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.507 2.411 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.456 179.581 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 381' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 384' ' ' ILE . 61.9 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.7 m -72.42 148.77 44.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.71 -0.618 . . . . 0.0 110.158 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 106.62 -23.94 26.89 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 384' ' ' ILE . 18.7 tt -108.53 106.56 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.35 -1.088 . . . . 0.0 110.11 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -78.77 -36.78 42.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.238 -0.914 . . . . 0.0 110.47 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.465 -0.772 . . . . 0.0 109.615 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.06 139.13 39.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.636 -0.665 . . . . 0.0 109.997 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -106.06 38.83 1.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 110.254 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -103.93 34.91 2.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.608 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.1 -46.62 86.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.518 -0.739 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.6 t -62.74 -44.03 97.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.787 -0.571 . . . . 0.0 110.303 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 433' ' ' LEU . 77.4 t -65.16 -34.64 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.0 -42.07 98.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.526 -0.734 . . . . 0.0 111.658 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.33 59.6 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.002 -1.061 . . . . 0.0 112.388 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.821 HD12 HD11 ' A' ' 399' ' ' ILE . 1.1 pp -69.62 -33.92 73.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.996 . . . . 0.0 111.057 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' SER . . . . . 0.421 ' N ' ' HG ' ' A' ' 395' ' ' LEU . 70.3 m -55.55 -43.07 75.48 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.589 -0.694 . . . . 0.0 111.226 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -68.09 -41.19 82.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -0.817 . . . . 0.0 111.518 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -65.51 -40.41 92.97 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.187 -0.946 . . . . 0.0 112.59 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 395' ' ' LEU . 0.0 OUTLIER -66.66 -39.24 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 121.147 -0.971 . . . . 0.0 109.882 -178.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.728 ' HG3' HD11 ' A' ' 435' ' ' ILE . 8.7 mtp -64.42 -39.73 94.41 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.153 -0.967 . . . . 0.0 109.174 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.74 -29.83 70.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 419' ' ' TYR . 59.8 tp60 -90.47 -11.15 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.473 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 400' ' ' MET . 40.1 t30 -69.54 -38.91 77.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.806 -0.559 . . . . 0.0 110.291 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -117.8 19.26 13.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.066 . . . . 0.0 109.872 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 407' ' ' VAL . 7.7 p -41.15 148.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 CA-C-O 121.176 0.513 . . . . 0.0 110.859 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.6 m -77.06 81.38 3.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.4 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 412' ' ' SER . 48.4 t -105.58 130.26 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.944 0.878 . . . . 0.0 111.702 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -96.79 144.38 27.76 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.66 -23.44 56.54 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.143 1.075 . . . . 0.0 110.767 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.398 -0.814 . . . . 0.0 110.69 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 56.76 0.5 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' SER . . . . . 0.787 ' HA ' HG13 ' A' ' 407' ' ' VAL . 11.7 p -69.53 137.43 52.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.443 -0.786 . . . . 0.0 111.334 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 407' ' ' VAL . 5.9 p -88.99 146.25 36.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.52 135.48 28.73 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.09 1.047 . . . . 0.0 111.276 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 417' ' ' ALA . 99.8 mtt180 -96.81 -87.84 0.3 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.714 -0.616 . . . . 0.0 109.515 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.0 t -29.8 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 415' ' ' ARG . . . -50.83 -69.99 0.1 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.302 -0.873 . . . . 0.0 111.46 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -77.36 -1.57 76.14 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.708 -1.245 . . . . 0.0 111.29 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.561 ' HD2' HG23 ' A' ' 399' ' ' ILE . 76.6 m-85 -108.25 0.32 21.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.791 -1.417 . . . . 0.0 110.28 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.42 ' HB2' ' HD3' ' A' ' 448' ' ' ARG . 70.0 p -92.6 -33.72 14.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -73.74 -37.2 65.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.83 82.73 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.43 0.633 . . . . 0.0 110.038 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.969 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.0 t -67.74 -42.66 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.624 -0.672 . . . . 0.0 111.758 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.6 m -59.82 -43.29 94.61 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.975 -1.078 . . . . 0.0 112.352 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.91 -50.58 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.013 -1.055 . . . . 0.0 109.747 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.969 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -47.75 -31.57 4.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.641 -0.662 . . . . 0.0 111.688 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.74 -35.46 74.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 109.292 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.32 -31.03 72.07 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.549 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.35 -74.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.585 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER 178.89 -53.91 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.18 -0.95 . . . . 0.0 110.108 178.225 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.5 Cg_endo -79.84 116.23 3.43 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.578 ' HA ' HD11 ' A' ' 426' ' ' LEU . 1.8 m -105.67 100.39 9.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.355 -0.938 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.469 ' HB3' HG11 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -149.4 137.72 20.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.421 ' HB1' HG22 ' A' ' 423' ' ' VAL . . . -173.45 160.72 3.95 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 120.511 -1.368 . . . . 0.0 112.762 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.728 HD11 ' HG3' ' A' ' 400' ' ' MET . 3.3 pt -122.32 117.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 423' ' ' VAL . 70.4 t -122.11 137.77 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 110.749 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.9 t -121.74 129.83 52.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.017 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.75 147.9 18.76 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -146.11 80.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.587 -0.949 . . . . 0.0 109.645 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 121.83 110.48 2.11 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.09 85.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.03 -19.72 25.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.587 -0.949 . . . . 0.0 110.613 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.93 92.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 110.914 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.9 -30.58 70.13 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -62.6 -40.19 96.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.611 -0.935 . . . . 0.0 110.44 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.684 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 8.4 mpt_? -64.37 -38.1 89.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -71.28 -30.15 65.92 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.3 -0.875 . . . . 0.0 109.996 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ARG . . . . . 0.42 ' HD3' ' HB2' ' A' ' 420' ' ' SER . 44.7 ttm-85 -64.81 -44.7 89.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.548 -0.72 . . . . 0.0 111.646 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.5 p -64.72 -32.44 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.663 ' HB1' ' HE ' ' A' ' 481' ' ' ARG . . . -64.42 -31.07 72.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.21 -38.02 75.95 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.051 -1.03 . . . . 0.0 108.445 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.4 -31.09 72.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.856 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.4 t -60.14 -32.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 58.2 mtt -66.13 -40.13 90.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 56.4 ttp -58.99 -21.07 58.21 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.241 0.543 . . . . 0.0 110.101 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.54 -22.64 30.05 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.37 -27.4 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -78.26 9.17 4.03 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.312 -0.868 . . . . 0.0 112.274 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.09 26.4 72.41 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.88 145.32 36.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 111.405 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -99.43 163.23 12.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.972 HG12 ' HB ' ' A' ' 504' ' ' THR . 33.7 m -132.21 158.77 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 118.924 -1.11 . . . . 0.0 112.268 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.847 ' HA ' HD22 ' A' ' 486' ' ' LEU . 57.1 tt0 -102.99 107.13 17.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 453' ' ' VAL . 0.5 OUTLIER -118.2 124.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.706 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.562 HG23 ' CD ' ' A' ' 471' ' ' ARG . 85.6 mt -122.03 115.37 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.862 -0.524 . . . . 0.0 110.916 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.684 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -66.17 165.63 13.35 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.471 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.607 ' HB3' ' NH2' ' A' ' 446' ' ' ARG . . . -59.01 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 511' ' ' GLU . 26.9 t0 -51.41 -19.07 1.21 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.956 -1.09 . . . . 0.0 111.129 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -78.98 -8.19 58.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -0.787 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 79.8 ttt-85 -52.36 -24.85 8.35 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.99 -1.069 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -58.12 -42.88 86.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.806 . . . . 0.0 109.358 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' GLN . . . . . 0.495 ' HA ' ' HE2' ' A' ' 476' ' ' MET . 85.0 mt-30 -65.09 -38.83 91.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.676 ' CE ' HD21 ' A' ' 482' ' ' LEU . 28.2 ttt -62.0 -32.28 72.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.783 -0.573 . . . . 0.0 110.29 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -61.69 -40.04 93.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 110.083 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 473' ' ' GLN . 73.4 mtm -62.51 -35.54 79.73 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.576 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 62.8 pttt -121.47 -148.06 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.426 ' HG2' ' CE ' ' A' ' 474' ' ' MET . 1.0 OUTLIER 53.6 70.09 0.63 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.161 -0.962 . . . . 0.0 111.192 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -112.98 23.8 13.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.68 3.21 26.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.854 . . . . 0.0 111.06 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.679 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -143.13 -29.8 0.53 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.19 -0.944 . . . . 0.0 111.664 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.679 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.5 OUTLIER -150.41 72.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.803 -1.186 . . . . 0.0 110.791 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.4 m -72.36 -18.42 61.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.464 -0.772 . . . . 0.0 110.121 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.43 46.68 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.6 pt-20 -149.01 103.74 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.926 . . . . 0.0 110.572 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.847 HD22 ' HA ' ' A' ' 464' ' ' GLN . 96.4 mt -98.46 -84.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.602 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 486' ' ' LEU . 3.3 mp -157.35 -65.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.08 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.6 t -99.9 11.12 40.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.469 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -92.91 77.22 1.17 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 54.5 ttt85 -145.17 -63.72 0.34 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 495' ' ' GLU . 92.7 mtt-85 -97.98 -31.32 12.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.421 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -64.53 -43.95 92.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 493' ' ' LEU . 2.2 mt -69.09 -38.53 79.01 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.318 0.58 . . . . 0.0 110.822 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 494' ' ' LEU . 7.4 tt -105.87 -48.4 3.64 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 491' ' ' ARG . 94.8 mt-10 -90.0 -10.3 45.45 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.666 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 491' ' ' ARG . . . 83.0 -13.16 45.81 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.641 -1.287 . . . . 0.0 111.017 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 70.6 mmm -67.86 -179.67 1.23 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.095 -1.238 . . . . 0.0 111.01 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.96 153.62 28.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.64 -0.663 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.52 151.03 32.08 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.773 0.797 . . . . 0.0 110.354 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -55.72 150.42 26.86 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.83 -0.544 . . . . 0.0 111.839 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 42.3 Cg_endo -70.66 115.74 4.35 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.653 1.344 . . . . 0.0 109.599 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -177.12 39.34 0.09 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.491 ' HA ' HG12 ' A' ' 487' ' ' ILE . 29.0 t -99.96 109.99 22.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.909 -0.76 . . . . 0.0 112.806 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.972 ' HB ' HG12 ' A' ' 463' ' ' VAL . 55.5 m -95.48 107.06 19.19 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 464' ' ' GLN . 43.4 t -109.58 126.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.414 -174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 533' ' ' LEU . 38.6 pt -122.59 109.99 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 534' ' ' ILE . 13.9 p -108.03 112.95 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 43.6 t0 -84.04 110.39 18.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.6 tm0? -97.39 175.2 6.33 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.356 1.074 . . . . 0.0 113.757 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -169.69 -44.05 0.03 OUTLIER Glycine 0 N--CA 1.508 3.46 0 N-CA-C 105.91 -2.876 . . . . 0.0 105.91 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 469' ' ' ASP . 73.1 mm-40 -99.54 -162.56 0.96 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -120.27 -1.67 10.22 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 111.222 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 513' ' ' LEU . 4.6 mm? -74.84 -27.4 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.751 . . . . 0.0 109.454 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 52.9 m -87.15 -17.09 33.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.66 -0.65 . . . . 0.0 112.008 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.435 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 31.7 tp -81.51 -52.59 7.07 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.847 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 54.5 mtmt -71.43 -43.47 66.68 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.599 -0.688 . . . . 0.0 112.207 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -40.0 95.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.027 -1.046 . . . . 0.0 111.143 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 466' ' ' ILE . 70.6 m -61.26 -48.32 81.97 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.264 -0.975 . . . . 0.0 108.744 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 519' ' ' LEU . 0.1 OUTLIER -58.15 -32.34 68.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.301 0.572 . . . . 0.0 109.654 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.6 m -61.79 -41.58 97.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.826 -0.546 . . . . 0.0 109.876 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.606 HD23 ' CD ' ' A' ' 464' ' ' GLN . 51.8 tp -69.55 -42.27 74.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 109.682 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.555 HD21 ' CG2' ' A' ' 505' ' ' VAL . 2.0 mt -59.6 -22.25 61.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.625 -0.672 . . . . 0.0 111.225 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.8 -57.4 4.92 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.672 -0.643 . . . . 0.0 112.235 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.59 50.03 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.009 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.36 64.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.882 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -56.48 -23.62 40.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.408 -0.808 . . . . 0.0 111.863 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.73 -36.61 37.28 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.125 -0.984 . . . . 0.0 110.919 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 66.6 m-70 -132.88 -69.79 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.374 -0.829 . . . . 0.0 111.13 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.58 ' C ' HG22 ' A' ' 530' ' ' VAL . 31.0 m-80 -83.56 154.92 23.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.31 -0.868 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.58 HG22 ' C ' ' A' ' 529' ' ' ASN . 0.0 OUTLIER -179.59 153.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 CA-C-O 121.401 0.62 . . . . 0.0 109.939 177.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' A' ' 432' ' ' SER . 0.1 OUTLIER -174.75 95.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 41.7 t -104.69 107.16 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.685 ' HB2' HG22 ' A' ' 506' ' ' ILE . 7.4 mp -108.31 114.1 27.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.941 HG22 HG12 ' A' ' 507' ' ' VAL . 8.2 pt -123.85 136.29 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.571 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.733 HG22 ' HB ' ' A' ' 436' ' ' VAL . 53.4 p -112.99 -169.63 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -157.87 166.14 33.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.032 -1.042 . . . . 0.0 110.85 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 2.9 p -146.83 21.94 1.26 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.81 -0.556 . . . . 0.0 109.912 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.39 -30.71 0.04 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -78.76 -0.13 29.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.086 -1.243 . . . . 0.0 111.142 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -38.88 -29.88 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -102.93 -29.44 11.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.43 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -120.22 59.08 0.55 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.5 t -64.57 -37.26 86.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.625 -0.927 . . . . 0.0 110.717 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 543' ' ' THR . . . -57.16 -43.8 93.35 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 93.9 p -63.56 -29.57 70.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.414 -1.051 . . . . 0.0 109.676 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.88 -35.39 80.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.732 -0.605 . . . . 0.0 109.882 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.9 mp -61.99 -41.14 97.72 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.5 mmm -64.74 -33.63 76.41 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.14 -53.57 56.58 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.105 0.479 . . . . 0.0 109.92 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.454 ' HG3' HD11 ' A' ' 519' ' ' LEU . 33.4 ttm -55.11 -47.19 75.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.427 -0.795 . . . . 0.0 110.332 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.606 -0.684 . . . . 0.0 111.401 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -66.38 -17.8 64.98 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -74.02 4.48 5.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.354 -0.841 . . . . 0.0 112.384 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 154.66 -17.54 0.57 Allowed Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.533 -1.318 . . . . 0.0 111.524 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.44 108.75 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.042 -1.269 . . . . 0.0 110.327 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -166.71 117.84 0.95 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.424 -0.798 . . . . 0.0 110.246 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 87.5 m -86.71 123.51 31.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.543 -0.723 . . . . 0.0 109.169 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -73.7 -95.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.412 -0.805 . . . . 0.0 108.971 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -132.53 -90.42 0.41 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.83 -1.169 . . . . 0.0 109.015 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -114.21 -23.71 9.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.053 -1.029 . . . . 0.0 110.692 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -98.83 143.79 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 110.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 90.61 111.62 1.55 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 81.82 -62.8 4.47 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -80.2 -2.09 43.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.404 -1.056 . . . . 0.0 111.737 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.23 -44.1 75.14 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.147 -0.971 . . . . 0.0 109.085 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.16 90.28 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.91 -8.0 19.76 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.645 1.339 . . . . 0.0 110.517 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -91.09 98.32 11.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.659 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 381' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 381' ' ' THR . 36.2 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.022 0.439 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 47.0 t -61.41 -43.35 99.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.503 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -100.67 -138.57 10.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.3 124.9 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.769 -0.842 . . . . 0.0 110.656 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -109.96 124.23 51.03 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.408 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 p -107.73 135.6 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.25 129.25 46.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.202 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -108.8 179.87 4.06 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.23 -18.48 37.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.809 -0.557 . . . . 0.0 111.092 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 38.5 tp -59.4 -29.34 67.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 71.3 m -60.83 -44.99 96.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.571 -0.706 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.15 -34.18 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.704 . . . . 0.0 110.605 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -58.16 -52.5 65.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.421 -0.8 . . . . 0.0 111.576 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.54 78.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.386 -0.821 . . . . 0.0 109.954 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 399' ' ' ILE . 3.2 tt -62.17 -38.52 89.39 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.588 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.1 m -71.55 -34.18 69.79 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.984 -1.072 . . . . 0.0 112.137 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.71 -45.23 87.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.104 -0.997 . . . . 0.0 112.335 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -70.39 -41.62 72.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.122 -0.986 . . . . 0.0 111.999 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.501 ' HA ' ' CD1' ' A' ' 419' ' ' TYR . 50.0 mt -63.73 -40.72 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.358 -0.839 . . . . 0.0 108.936 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 ttm -58.62 -34.88 71.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.705 -0.622 . . . . 0.0 109.486 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.41 -20.08 62.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.055 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.763 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.2 tp-100 -91.58 -20.26 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.938 -1.101 . . . . 0.0 108.995 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.66 -32.67 73.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -116.36 19.75 14.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.088 -1.008 . . . . 0.0 110.286 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 407' ' ' VAL . 5.9 p -59.06 117.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.557 -0.714 . . . . 0.0 109.852 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.8 p -52.71 102.92 0.06 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.477 -0.764 . . . . 0.0 110.748 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 405' ' ' VAL . 57.8 t -107.59 132.86 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.553 -0.717 . . . . 0.0 110.233 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -93.94 139.77 22.74 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.532 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.75 -25.28 53.77 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.219 1.115 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.15 -29.15 69.39 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.522 0.677 . . . . 0.0 111.133 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 58.65 0.57 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 80.4 p -50.31 111.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.667 0.746 . . . . 0.0 111.941 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.632 HG13 ' HD2' ' A' ' 414' ' ' PRO . 32.9 t -64.03 150.49 91.81 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 413' ' ' VAL . 37.7 Cg_endo -63.48 147.86 92.95 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.313 1.165 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 407' ' ' VAL . 82.2 mtp180 -128.49 -15.35 4.55 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.625 -0.672 . . . . 0.0 112.604 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 420' ' ' SER . 10.2 t -103.88 18.32 22.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 108.391 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -86.21 -76.46 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.703 -0.623 . . . . 0.0 112.208 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -75.73 -4.01 74.85 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.972 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.503 ' CD2' ' HG2' ' A' ' 402' ' ' GLN . 96.8 m-85 -107.8 -13.88 14.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.293 1.546 . . . . 0.0 109.647 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 416' ' ' THR . 5.4 t -69.9 -41.33 74.85 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -68.73 -36.69 78.74 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.01 81.27 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 122.038 0.923 . . . . 0.0 109.807 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.884 HG21 HG22 ' A' ' 436' ' ' VAL . 79.4 t -69.07 -44.06 81.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -60.69 -38.92 86.57 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.879 -1.138 . . . . 0.0 111.287 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.19 -44.14 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -55.61 -32.61 63.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.651 -0.656 . . . . 0.0 111.74 -178.252 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.37 77.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.618 -1.301 . . . . 0.0 108.631 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.54 -30.1 71.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.78 -89.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 11.3 tpp180 -179.9 -58.58 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.506 -1.372 . . . . 0.0 109.017 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 430' ' ' ARG . 43.1 Cg_endo -68.61 99.78 0.65 Allowed 'Trans proline' 0 N--CA 1.485 1.004 0 N-CA-C 108.661 -1.323 . . . . 0.0 108.661 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.489 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 67.7 m -94.98 110.36 22.27 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.864 0.84 . . . . 0.0 111.872 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 1.3 tp -166.56 90.22 0.4 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -135.49 169.77 16.99 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.93 0.871 . . . . 0.0 112.439 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 435' ' ' ILE . 33.0 pt -127.22 130.21 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.425 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.884 HG22 HG21 ' A' ' 423' ' ' VAL . 47.6 t -125.66 97.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.864 -1.147 . . . . 0.0 110.311 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 37.3 m -76.01 129.5 36.96 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.382 -0.824 . . . . 0.0 111.145 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -107.19 170.93 16.13 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 415' ' ' ARG . 67.6 tp60 -170.03 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.522 -0.987 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -64.12 -49.7 65.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -156.32 141.95 8.38 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -111.85 -26.09 9.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.972 . . . . 0.0 110.639 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.57 88.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.394 -0.816 . . . . 0.0 110.617 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.39 -29.36 64.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.51 -39.01 91.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.62 -0.929 . . . . 0.0 109.477 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.635 ' O ' HG12 ' A' ' 449' ' ' VAL . 58.7 ttp180 -61.97 -46.52 88.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 111.391 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 2.9 tm-20 -73.11 -32.85 65.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.047 -1.033 . . . . 0.0 111.199 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -61.8 -47.37 85.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.807 HG11 ' OD2' ' A' ' 508' ' ' ASP . 3.7 p -57.44 -30.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.747 -1.221 . . . . 0.0 108.565 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.3 -26.42 68.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.87 -33.25 75.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.942 -1.099 . . . . 0.0 108.618 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm? -63.17 -33.97 76.62 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 90.1 t -59.75 -30.56 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.617 . . . . 0.0 109.586 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.22 -35.25 79.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -60.72 -28.75 68.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 109.597 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.7 31.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.512 -0.742 . . . . 0.0 109.72 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -63.61 -43.82 95.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.12 -30.61 69.81 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -76.28 5.48 6.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.564 -0.71 . . . . 0.0 111.757 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.4 75.19 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -138.44 120.32 15.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.485 -1.009 . . . . 0.0 110.802 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.06 171.12 14.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 109.246 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 30.0 m -140.14 155.14 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 111.433 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.966 ' HA ' HD22 ' A' ' 486' ' ' LEU . 51.7 tt0 -101.52 117.65 35.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.807 HD11 HD22 ' A' ' 482' ' ' LEU . 2.5 pt -128.38 136.15 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.809 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.678 ' N ' HD12 ' A' ' 466' ' ' ILE . 4.7 mp -125.42 117.38 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.092 -1.005 . . . . 0.0 111.279 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -65.79 161.17 21.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.734 -1.229 . . . . 0.0 109.016 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.74 -158.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 511' ' ' GLU . 28.8 p-10 -44.81 -21.58 0.06 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.818 -1.176 . . . . 0.0 112.411 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.2 -2.79 23.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.321 -0.862 . . . . 0.0 111.577 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.03 -41.33 82.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.94 -1.1 . . . . 0.0 111.735 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.1 m -55.82 -45.36 78.35 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.966 -1.084 . . . . 0.0 110.469 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.29 -37.16 86.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.491 -0.755 . . . . 0.0 108.972 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.2 ttp -60.52 -33.8 73.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.761 -0.587 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.83 -37.7 85.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.78 -40.85 94.12 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.248 -0.908 . . . . 0.0 109.722 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -121.93 -141.94 0.33 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 109.453 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 51.23 88.86 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.706 -1.246 . . . . 0.0 110.936 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -136.74 34.96 2.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.728 . . . . 0.0 109.157 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -128.52 -3.69 5.41 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.879 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.404 ' CB ' HD23 ' A' ' 482' ' ' LEU . 7.3 mtt180 -132.36 -13.28 3.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.97 -1.081 . . . . 0.0 112.443 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -169.59 71.83 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.893 -1.129 . . . . 0.0 111.169 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.7 p -92.41 50.04 1.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.43 36.16 7.11 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -122.27 47.25 1.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.622 -0.928 . . . . 0.0 110.104 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.966 HD22 ' HA ' ' A' ' 464' ' ' GLN . 20.7 mt -75.44 -79.87 0.09 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.68 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER 179.31 -42.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 110.342 174.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.609 HG23 HG22 ' A' ' 487' ' ' ILE . 3.2 p -103.85 8.94 37.05 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.564 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -97.95 60.29 0.99 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.376 -1.889 . . . . 0.0 108.376 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 67.6 ttt180 -142.42 -70.9 0.33 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -108.87 -21.0 12.86 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.872 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -65.42 -46.79 78.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.633 -0.667 . . . . 0.0 111.898 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.96 -56.72 2.98 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.0 111.075 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.2 tm? -65.17 -42.21 93.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.471 -0.768 . . . . 0.0 112.808 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -99.99 -3.32 32.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.944 -1.098 . . . . 0.0 113.142 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 65.05 47.82 77.81 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 44.3 mtt -119.75 -174.05 2.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.788 -0.831 . . . . 0.0 109.655 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.23 131.94 55.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.32 -0.863 . . . . 0.0 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.3 OUTLIER -115.19 140.32 49.19 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 500' ' ' THR . 2.2 t -44.7 99.96 0.22 Allowed Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 122.212 -0.305 . . . . 0.0 111.597 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 499' ' ' PHE . 41.9 Cg_endo -67.92 113.95 3.19 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 107.996 -1.579 . . . . 0.0 107.996 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 179.52 32.25 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.68 ' CB ' HD13 ' A' ' 487' ' ' ILE . 40.0 t -93.13 176.29 6.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.066 . . . . 0.0 111.591 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.916 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.2 m -116.61 124.23 49.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 464' ' ' GLN . 57.6 t -121.92 136.82 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 112.872 -175.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 533' ' ' LEU . 2.0 pp -130.07 110.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 534' ' ' ILE . 12.4 p -99.16 108.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.147 -1.596 . . . . 0.0 110.344 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.807 ' OD2' HG11 ' A' ' 449' ' ' VAL . 73.0 m-20 -82.78 108.25 16.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -97.8 174.66 6.49 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 122.743 1.259 . . . . 0.0 113.194 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.56 -64.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.822 0 N-CA-C 103.943 -3.663 . . . . 0.0 103.943 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 469' ' ' ASP . 32.3 tt0 -70.98 -142.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.02 -19.04 1.16 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.727 -1.233 . . . . 0.0 111.442 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.24 -21.92 62.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 77.3 p -72.05 -41.09 67.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.503 -0.748 . . . . 0.0 110.953 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 10.8 tp -65.39 -52.47 53.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.0 111.283 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.766 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 25.9 ttmt -67.36 -46.88 72.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.501 -0.75 . . . . 0.0 111.571 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.39 -49.01 79.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.272 -0.892 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.45 HG21 ' HB ' ' A' ' 507' ' ' VAL . 81.7 m -58.54 -42.67 88.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.475 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.2 OUTLIER -61.14 -40.41 93.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.326 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 37.8 p -64.88 -39.94 94.33 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.056 -1.027 . . . . 0.0 111.195 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.3 OUTLIER -66.76 -41.77 87.21 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.202 1.001 . . . . 0.0 108.588 178.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 505' ' ' VAL . 0.8 OUTLIER -65.36 -22.01 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.721 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -47.29 -62.82 1.25 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.318 -0.864 . . . . 0.0 112.992 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.79 61.71 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.313 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 488' ' ' THR . . . -61.68 -31.43 71.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.657 -0.908 . . . . 0.0 111.805 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.732 ' CB ' HG11 ' A' ' 530' ' ' VAL . . . -72.19 -22.57 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 112.382 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -40.57 -27.47 0.05 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.428 -0.795 . . . . 0.0 112.385 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 501' ' ' PRO . 49.7 t60 -114.23 -117.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 111.5 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.404 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 2.4 m120 -89.5 90.01 8.1 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.513 -1.367 . . . . 0.0 114.551 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.732 HG11 ' CB ' ' A' ' 526' ' ' ALA . 7.6 p -127.79 149.52 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 109.967 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 86.5 mt-30 -126.04 132.31 52.0 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.994 -0.441 . . . . 0.0 110.07 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 87.3 t -109.33 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.49 1.138 . . . . 0.0 111.576 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.3 OUTLIER -117.14 119.77 36.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 507' ' ' VAL . 4.5 pt -129.1 140.43 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.464 -1.294 . . . . 0.0 111.902 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.681 HG22 ' HB ' ' A' ' 436' ' ' VAL . 11.5 p -110.23 -174.23 2.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 28.9 m-20 -154.98 161.51 41.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.027 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 68.2 p -140.36 18.11 2.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.012 -0.43 . . . . 0.0 109.907 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.07 0.23 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -98.62 0.91 45.74 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.393 -1.063 . . . . 0.0 110.764 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -40.21 54.96 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.117 -0.99 . . . . 0.0 112.271 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 8.6 p -96.39 -63.76 1.11 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.256 -0.903 . . . . 0.0 110.764 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -89.12 95.2 2.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.4 t -98.51 -41.39 7.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.687 -0.89 . . . . 0.0 110.191 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.39 -37.46 93.86 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 46.5 t -63.91 -38.65 91.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.621 -0.929 . . . . 0.0 111.07 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.83 -39.08 87.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.515 -0.74 . . . . 0.0 110.663 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.46 -40.66 97.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.487 -0.758 . . . . 0.0 109.867 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.01 -32.25 73.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.675 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.49 -53.03 61.45 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.925 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.469 ' HB2' HD21 ' A' ' 515' ' ' LEU . 36.6 ttm -58.06 -48.35 80.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.381 -0.824 . . . . 0.0 110.768 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.82 -31.53 68.55 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.329 -0.857 . . . . 0.0 111.286 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.84 -21.71 66.01 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.3 -0.875 . . . . 0.0 110.382 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.766 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -72.26 0.28 10.31 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.263 -0.898 . . . . 0.0 112.532 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 125.48 -14.97 7.23 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.83 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 67.2 t -83.72 105.46 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.239 . . . . 0.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -172.09 147.2 2.05 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.548 -0.72 . . . . 0.0 110.714 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 9.9 t -108.83 138.59 44.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -76.73 -88.94 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.029 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -140.2 -77.47 0.32 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.012 -1.055 . . . . 0.0 111.115 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -72.16 -21.66 61.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.524 -0.735 . . . . 0.0 110.916 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -145.07 153.16 41.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.473 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -92.18 40.1 2.93 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.49 68.87 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -94.54 -2.07 52.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.184 -1.186 . . . . 0.0 111.409 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -87.02 -5.86 58.93 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.722 -1.236 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -134.11 51.73 6.87 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.08 -1.013 . . . . 0.0 111.08 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 567' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 566' ' ' ARG . 41.4 Cg_endo -72.68 -17.73 25.87 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.157 1.082 . . . . 0.0 110.574 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -169.42 112.7 0.51 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.261 -0.899 . . . . 0.0 109.655 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.551 -179.23 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 70.8 m -62.99 -42.29 99.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.483 -0.761 . . . . 0.0 109.98 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 139.5 82.77 0.09 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 17.2 tt -110.77 131.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.943 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -139.31 102.09 4.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.786 . . . . 0.0 110.126 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 388' ' ' ASP . 67.3 t -108.51 100.6 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.537 -0.727 . . . . 0.0 110.082 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.18 -44.1 66.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.515 -0.741 . . . . 0.0 111.291 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 386' ' ' VAL . 93.7 m-20 -92.65 173.37 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.608 0.718 . . . . 0.0 111.875 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.76 84.52 2.22 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.765 0.793 . . . . 0.0 110.677 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 67.6 tp -63.41 -40.67 97.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.622 -0.674 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.6 m -60.87 -44.79 96.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.557 -0.714 . . . . 0.0 110.625 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 433' ' ' LEU . 85.8 t -66.75 -35.03 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.654 -0.653 . . . . 0.0 111.043 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -60.4 -49.13 78.8 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.992 -1.067 . . . . 0.0 111.272 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.19 80.15 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.134 -0.979 . . . . 0.0 109.613 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.7 OUTLIER -59.39 -40.27 86.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.444 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 396' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 400' ' ' MET . 47.3 t -63.34 -42.5 98.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -59.22 -45.8 90.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.257 -0.902 . . . . 0.0 111.917 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -65.88 -41.34 91.7 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.152 -0.968 . . . . 0.0 111.089 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.638 HG21 ' O ' ' A' ' 435' ' ' ILE . 92.9 mt -62.31 -41.02 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 396' ' ' SER . 32.4 mmm -63.42 -34.97 78.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.487 -0.758 . . . . 0.0 110.845 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.19 -28.28 67.83 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.828 -1.17 . . . . 0.0 110.221 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.449 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 58.8 tp60 -90.79 -20.03 22.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.805 -1.185 . . . . 0.0 108.498 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 400' ' ' MET . 39.6 t30 -64.46 -31.57 72.83 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -114.42 18.81 16.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -40.9 149.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 121.535 0.683 . . . . 0.0 112.149 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 23.3 p -87.43 72.86 9.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.709 HG23 HG12 ' A' ' 413' ' ' VAL . 12.3 p -91.61 131.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.363 -0.836 . . . . 0.0 112.219 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -96.89 144.1 27.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.635 . . . . 0.0 109.747 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.31 -20.82 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.405 1.213 . . . . 0.0 110.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -57.31 -40.87 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.85 0.833 . . . . 0.0 110.031 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -150.56 67.98 0.96 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 27.0 t -54.5 119.8 5.75 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 122.066 0.936 . . . . 0.0 112.048 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.709 HG12 HG23 ' A' ' 407' ' ' VAL . 7.3 p -71.06 147.65 93.84 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 413' ' ' VAL . 35.3 Cg_endo -59.42 135.15 63.1 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.058 1.031 . . . . 0.0 110.765 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.459 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 90.8 mtm-85 -103.51 -6.29 21.92 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.272 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 6.0 p -99.49 18.9 16.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.674 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.26 -35.01 6.93 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.67 94.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.778 ' CB ' HG13 ' A' ' 436' ' ' VAL . 4.0 m-85 -93.86 -9.9 35.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.762 -1.434 . . . . 0.0 110.399 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -43.98 61.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.867 -1.145 . . . . 0.0 109.004 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.78 -45.72 57.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.727 -0.608 . . . . 0.0 110.307 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 425' ' ' VAL . . . -61.48 -49.04 78.39 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.75 -0.594 . . . . 0.0 111.797 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.84 ' HA ' HD23 ' A' ' 426' ' ' LEU . 90.3 t -69.57 -43.43 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 0.0 112.575 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 79.5 p -62.26 -39.54 93.22 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.925 -1.109 . . . . 0.0 111.421 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.1 p -67.69 -28.13 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.321 -0.862 . . . . 0.0 111.821 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -75.02 -31.22 61.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 111.151 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.14 74.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.963 . . . . 0.0 109.203 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.21 -29.88 70.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.97 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.592 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.36 -52.3 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.713 -1.242 . . . . 0.0 111.671 177.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.5 Cg_endo -77.7 112.7 3.36 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 O-C-N 122.568 0.773 . . . . 0.0 110.775 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.493 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 0.3 OUTLIER -87.12 99.66 12.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.631 -0.668 . . . . 0.0 109.245 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.5 tp -162.67 92.56 0.79 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.171 -0.956 . . . . 0.0 111.063 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -139.83 170.56 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.542 0.687 . . . . 0.0 111.832 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.638 ' O ' HG21 ' A' ' 399' ' ' ILE . 45.3 pt -121.84 141.52 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 109.414 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.778 HG13 ' CB ' ' A' ' 419' ' ' TYR . 57.3 t -141.92 148.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -0.805 . . . . 0.0 109.806 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' OD1' ' A' ' 403' ' ' ASN . 44.5 t -127.38 133.64 50.01 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.439 -0.788 . . . . 0.0 110.272 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -115.17 129.51 8.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -130.61 34.19 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.616 -0.932 . . . . 0.0 109.818 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -148.73 -137.45 2.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -67.29 120.87 14.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.68 -9.13 23.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.883 . . . . 0.0 111.734 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.72 90.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.49 -28.2 73.34 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.33 -38.36 87.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.755 -0.85 . . . . 0.0 110.199 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.418 ' CD ' ' HB2' ' A' ' 467' ' ' ALA . 0.1 OUTLIER -59.86 -50.15 74.9 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.438 -0.789 . . . . 0.0 110.281 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.36 -29.28 67.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -61.04 -54.97 38.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.772 -0.58 . . . . 0.0 112.01 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.68 -35.65 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.909 -1.119 . . . . 0.0 109.394 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.476 ' HB2' ' HG2' ' A' ' 480' ' ' GLU . . . -63.53 -26.89 68.91 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.444 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.41 -34.78 79.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.037 -1.04 . . . . 0.0 108.828 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.97 -35.57 81.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 463' ' ' VAL . 88.6 t -58.42 -27.31 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.846 -0.534 . . . . 0.0 109.714 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.4 mtt -71.09 -34.92 71.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.29 -32.78 72.63 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.55 0.691 . . . . 0.0 109.604 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.63 -22.69 32.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.772 -0.58 . . . . 0.0 110.231 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -65.65 -42.74 91.06 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.259 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.59 -29.44 63.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.326 -0.859 . . . . 0.0 110.512 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.71 8.22 4.74 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 111.07 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.94 75.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.65 124.31 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -1.007 . . . . 0.0 110.527 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.618 ' C ' HD11 ' A' ' 487' ' ' ILE . 81.9 mt-10 -82.96 166.53 18.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.186 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.911 ' CG2' HG13 ' A' ' 453' ' ' VAL . 33.4 m -141.11 156.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.754 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.9 tt0 -102.6 120.05 39.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -126.09 128.51 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.192 -0.943 . . . . 0.0 111.104 -178.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.627 HG23 ' CD ' ' A' ' 471' ' ' ARG . 5.3 mp -125.5 121.2 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.418 ' HB2' ' CD ' ' A' ' 446' ' ' ARG . . . -81.25 165.04 21.82 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.277 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.66 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.423 0.63 . . . . 0.0 109.612 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -51.22 -12.63 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.736 -1.228 . . . . 0.0 112.639 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -81.99 -2.94 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.773 -1.204 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.627 ' CD ' HG23 ' A' ' 466' ' ' ILE . 70.1 ttp85 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.945 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 35.4 t -63.38 -44.24 95.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -62.85 -41.61 99.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.659 -0.65 . . . . 0.0 110.139 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.0 mmt -67.76 -29.08 68.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.625 . . . . 0.0 110.706 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -59.99 -42.13 93.57 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.655 -1.278 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 mtm -67.19 -39.22 86.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 109.629 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 477' ' ' LYS . 57.2 pttt -131.6 128.86 40.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.802 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 55.32 92.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.189 -0.944 . . . . 0.0 112.255 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 482' ' ' LEU . 75.7 m-20 -81.84 26.27 0.51 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.633 ' CB ' HD23 ' A' ' 482' ' ' LEU . 4.7 mp0 50.83 42.48 27.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.561 -1.337 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 57.09 21.92 6.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.633 HD23 ' CB ' ' A' ' 480' ' ' GLU . 0.3 OUTLIER -124.42 20.03 8.81 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.54 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.0 p -47.21 -22.25 0.36 Allowed 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 168.98 78.92 0.04 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -175.01 41.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.711 -0.876 . . . . 0.0 109.677 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 464' ' ' GLN . 78.2 mt -75.3 -82.76 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.969 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -162.15 -70.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.658 -1.276 . . . . 0.0 109.751 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.1 t -100.08 8.75 43.71 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.153 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.466 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -82.92 61.27 4.8 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.556 -2.217 . . . . 0.0 107.556 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.41 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 51.8 ttt85 -143.77 -68.51 0.33 Allowed 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.609 -0.936 . . . . 0.0 109.252 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -100.73 -31.06 11.38 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.487 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -62.02 -43.99 97.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.509 -0.744 . . . . 0.0 110.826 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 6.0 mt -72.42 -39.05 68.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.553 -0.717 . . . . 0.0 111.8 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 43.1 tp -106.11 -42.26 5.14 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -89.72 -4.06 57.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.892 -1.13 . . . . 0.0 113.254 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 66.13 47.16 75.04 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.3 mmm -120.01 177.29 5.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.944 -0.739 . . . . 0.0 111.128 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.38 134.51 54.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -114.75 149.32 37.07 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.871 0.843 . . . . 0.0 111.486 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 500' ' ' THR . 5.2 t -50.82 105.69 0.55 Allowed Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.48 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -78.47 112.75 3.23 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.283 1.149 . . . . 0.0 109.21 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -169.73 37.23 0.19 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.969 ' CB ' HD13 ' A' ' 487' ' ' ILE . 92.0 p -95.8 175.47 6.5 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.451 1.119 . . . . 0.0 113.713 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.855 ' HB ' HG12 ' A' ' 463' ' ' VAL . 23.2 m -125.92 106.99 10.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 522' ' ' LEU . 40.4 t -97.36 136.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.375 -0.828 . . . . 0.0 111.524 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 533' ' ' LEU . 3.9 pt -141.0 110.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 534' ' ' ILE . 7.1 p -112.21 114.65 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.388 -1.445 . . . . 0.0 113.152 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.44 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 98.3 m-20 -84.58 131.39 34.62 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.6 tp-100 -156.95 114.89 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.721 -1.592 . . . . 0.0 115.011 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -76.93 -66.54 1.8 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 31.1 tt0 -58.65 172.12 0.55 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.26 -13.75 11.71 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.196 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.66 -36.78 83.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.236 -0.915 . . . . 0.0 109.632 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 4.7 m -83.09 -13.8 54.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.776 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 509' ' ' GLN . 33.0 tp -69.15 -44.62 71.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 108.812 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.9 -36.01 77.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.851 -0.531 . . . . 0.0 111.401 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -57.28 -50.27 73.43 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.807 -1.183 . . . . 0.0 110.465 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.79 ' O ' HD12 ' A' ' 522' ' ' LEU . 68.3 m -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.599 -0.688 . . . . 0.0 110.502 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.75 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -57.37 -39.5 76.15 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.73 -0.606 . . . . 0.0 111.106 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.7 m -61.86 -39.65 92.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.389 -0.819 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.496 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.4 OUTLIER -65.92 -44.61 84.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.575 -0.703 . . . . 0.0 109.561 179.14 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 518' ' ' THR . 0.4 OUTLIER -61.11 -22.8 64.99 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.464 -0.772 . . . . 0.0 111.808 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -46.0 -60.84 2.03 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.233 -0.917 . . . . 0.0 112.174 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -74.02 -50.79 9.92 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.508 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.75 83.67 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.326 -1.103 . . . . 0.0 113.432 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 530' ' ' VAL . . . -65.67 -23.82 66.87 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -44.67 -25.87 0.32 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.381 -0.825 . . . . 0.0 111.514 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.06 -140.06 0.3 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.226 -0.921 . . . . 0.0 111.224 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 530' ' ' VAL . 1.9 t-20 -71.08 85.8 0.73 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.822 -1.174 . . . . 0.0 111.815 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 526' ' ' ALA . 71.6 t -146.2 168.13 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.097 -1.002 . . . . 0.0 111.494 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 432' ' ' SER . 8.5 tp60 -162.31 164.53 27.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 3.6 t -115.45 115.39 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.435 -0.791 . . . . 0.0 112.163 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.9 tp -110.78 120.53 42.69 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 507' ' ' VAL . 2.4 pt -139.95 146.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.079 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 436' ' ' VAL . 65.1 p -105.48 -169.5 1.6 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -158.75 167.95 28.14 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.321 -0.862 . . . . 0.0 109.923 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.498 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.8 OUTLIER -133.03 -6.64 3.07 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.677 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -129.09 28.42 4.1 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 44.5 tt0 -98.67 -1.49 40.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.757 -0.849 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -56.32 -43.95 79.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.206 -0.934 . . . . 0.0 112.173 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 26.2 m -102.6 -56.89 2.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.913 -1.117 . . . . 0.0 110.94 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -88.51 59.0 4.1 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.7 t -65.58 -44.38 86.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.983 . . . . 0.0 111.572 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.27 -40.26 98.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.5 m -62.9 -37.36 86.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.947 . . . . 0.0 111.53 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.64 -36.6 72.07 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.088 -1.008 . . . . 0.0 109.73 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.1 mp -63.85 -41.26 97.85 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.907 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.37 -30.12 70.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.188 -0.945 . . . . 0.0 109.017 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.53 -54.92 41.33 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.298 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.75 ' HG3' HD11 ' A' ' 519' ' ' LEU . 57.8 ttm -55.65 -46.82 77.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 551' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 555' ' ' VAL . 86.4 mttt -61.17 -31.78 71.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.576 -0.703 . . . . 0.0 112.183 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.71 -16.58 62.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.353 -0.842 . . . . 0.0 111.226 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 5.49 4.24 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.171 -0.956 . . . . 0.0 113.059 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 118.35 -16.58 11.62 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 120.805 -1.184 . . . . 0.0 111.037 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 551' ' ' LYS . 10.3 p -85.99 119.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.199 -1.177 . . . . 0.0 110.764 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -167.03 136.2 2.81 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 68.1 p -97.97 153.0 18.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -73.55 -81.04 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.583 -0.698 . . . . 0.0 110.731 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -170.02 -67.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.512 -0.742 . . . . 0.0 109.93 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -94.22 -22.84 18.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.459 -0.775 . . . . 0.0 110.306 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -149.51 110.0 4.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.119 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -78.36 144.88 28.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.63 72.18 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.98 -4.85 49.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.347 -1.09 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -93.05 0.18 57.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.936 . . . . 0.0 110.981 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.511 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -152.19 59.88 3.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 109.517 -178.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 567' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 37.9 Cg_endo -91.92 -5.54 3.67 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.513 1.27 . . . . 0.0 110.988 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -113.83 -19.47 11.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.774 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.083 179.539 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 120.872 0.368 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 78.5 p -63.06 -37.04 85.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.527 -0.733 . . . . 0.0 109.828 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 134.04 88.95 0.34 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.67 127.18 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -118.61 169.02 10.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.406 -0.808 . . . . 0.0 109.985 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.88 132.75 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.749 -0.594 . . . . 0.0 110.615 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.5 mm? -86.57 147.2 26.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.466 -0.771 . . . . 0.0 110.705 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -138.1 -153.63 0.49 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.689 -0.632 . . . . 0.0 109.848 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.45 -17.1 58.63 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.339 -0.85 . . . . 0.0 111.122 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.74 -36.64 81.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.261 -0.899 . . . . 0.0 110.617 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.1 t -62.79 -43.15 99.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.435 -0.791 . . . . 0.0 109.487 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 81.0 t -66.31 -36.08 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.982 -0.449 . . . . 0.0 110.76 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -60.75 -50.51 73.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.19 -0.944 . . . . 0.0 110.232 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.37 -33.02 72.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 426' ' ' LEU . 7.6 tt -59.7 -39.7 85.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.81 -0.556 . . . . 0.0 110.621 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.1 p -68.6 -32.49 72.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.409 -0.807 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -64.34 -43.06 95.79 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.557 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -69.03 -40.31 78.7 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.0 112.719 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.446 HD11 HD21 ' A' ' 395' ' ' LEU . 61.9 mt -65.07 -43.37 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 27.2 mtp -61.86 -22.66 65.71 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.26 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -63.26 -30.54 71.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.104 -0.997 . . . . 0.0 108.984 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.727 ' NE2' HG11 ' A' ' 405' ' ' VAL . 1.8 mm-40 -90.04 -14.21 34.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.192 -0.942 . . . . 0.0 109.457 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 400' ' ' MET . 42.5 t-20 -66.39 -39.3 88.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.77 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -116.92 18.45 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.752 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 407' ' ' VAL . 6.3 p -59.43 114.93 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.385 -0.822 . . . . 0.0 109.793 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.0 p -52.12 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.171 -0.956 . . . . 0.0 110.95 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 405' ' ' VAL . 61.0 t -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.661 -0.65 . . . . 0.0 110.179 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.24 137.35 24.89 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 0.0 110.204 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.44 -29.3 45.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.165 1.087 . . . . 0.0 111.279 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.55 -25.59 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.119 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 60.54 0.5 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 m -58.91 115.79 3.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.495 0.664 . . . . 0.0 111.52 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 414' ' ' PRO . 6.9 p -64.15 150.09 92.91 Favored Pre-proline 0 N--CA 1.501 2.095 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -59.91 139.14 86.62 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 122.789 0.889 . . . . 0.0 110.228 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -116.38 -1.39 12.3 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.743 HG22 ' OH ' ' A' ' 419' ' ' TYR . 34.9 p -97.34 22.09 9.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.766 -1.209 . . . . 0.0 109.489 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -108.68 -31.58 7.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.37 -44.16 98.04 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.743 ' OH ' HG22 ' A' ' 416' ' ' THR . 27.0 p90 -103.04 -10.81 18.61 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.418 . . . . 0.0 111.875 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.0 t -67.22 -43.03 83.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 108.083 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.4 t0 -79.36 -44.32 21.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.933 -0.479 . . . . 0.0 111.304 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 425' ' ' VAL . . . -65.38 -46.33 80.54 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.629 -0.67 . . . . 0.0 112.417 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.837 ' HA ' HD23 ' A' ' 426' ' ' LEU . 88.8 t -70.37 -43.31 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.444 -0.785 . . . . 0.0 111.99 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -43.17 99.48 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.918 -1.114 . . . . 0.0 111.813 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 421' ' ' ASP . 33.1 m -64.47 -29.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.204 -0.935 . . . . 0.0 111.495 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -71.57 -33.99 69.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 111.737 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.57 -33.26 70.91 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.59 -30.76 71.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -64.21 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.485 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.2 OUTLIER -177.32 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 110.399 177.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -72.48 101.5 1.27 Allowed 'Trans proline' 0 N--CA 1.485 0.99 0 N-CA-C 109.455 -1.017 . . . . 0.0 109.455 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.477 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 26.4 t -87.72 101.2 13.45 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.559 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.98 89.33 0.79 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -131.68 164.84 25.05 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.882 0.848 . . . . 0.0 112.481 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.77 128.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 58.4 t -122.3 138.33 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.2 m -119.58 126.46 51.25 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 111.494 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -129.45 160.39 22.64 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -120.71 -30.63 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.896 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.1 173.45 31.27 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.17 29.73 70.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.706 ' HB3' ' NH2' ' A' ' 470' ' ' ARG . . . -67.89 -20.5 65.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.27 89.16 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.134 -0.979 . . . . 0.0 110.904 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.73 -37.12 57.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -62.17 -35.8 79.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.784 -0.833 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.873 ' HD3' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.52 -44.45 97.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.675 0.75 . . . . 0.0 109.724 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -68.84 -31.56 70.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.973 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -64.63 -45.04 88.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 111.713 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.0 p -58.15 -31.21 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.613 -1.305 . . . . 0.0 108.9 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.97 -27.05 68.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -64.51 -36.02 82.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.873 -1.142 . . . . 0.0 108.503 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 452' ' ' LEU . 4.5 mm? -65.38 -34.33 78.07 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.92 HG13 ' CG2' ' A' ' 463' ' ' VAL . 98.1 t -60.53 -30.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.3 mmm -68.33 -37.01 80.14 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.547 -0.72 . . . . 0.0 109.417 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -58.31 -28.82 65.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.767 -0.583 . . . . 0.0 109.976 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -85.03 -22.98 28.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -66.95 -44.6 80.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 110.413 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -74.42 -29.33 61.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.327 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.49 14.75 5.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.592 -0.692 . . . . 0.0 112.193 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.98 26.67 71.48 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.477 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 42.9 ttm180 -124.05 126.16 45.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.216 -1.167 . . . . 0.0 110.337 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 486' ' ' LEU . 53.8 mp0 -92.56 158.56 15.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.456 -0.777 . . . . 0.0 110.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.92 ' CG2' HG13 ' A' ' 453' ' ' VAL . 26.9 m -140.03 163.33 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.768 0.794 . . . . 0.0 111.516 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.709 ' OE1' HD13 ' A' ' 486' ' ' LEU . 43.4 tp60 -113.75 121.56 44.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.599 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -119.03 123.47 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.26 1.028 . . . . 0.0 111.829 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.686 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.5 mp -101.11 169.06 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.873 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -130.83 156.47 44.96 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.84 -159.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.448 -0.783 . . . . 0.0 110.019 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -48.66 -15.25 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.991 -1.068 . . . . 0.0 111.823 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ARG . . . . . 0.706 ' NH2' ' HB3' ' A' ' 442' ' ' ALA . 76.0 mtt85 -87.54 5.47 39.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.003 -1.061 . . . . 0.0 111.007 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.565 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 13.8 tpt180 -58.95 -36.94 75.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.298 -0.876 . . . . 0.0 111.447 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 21.9 t -59.7 -45.42 92.19 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.405 -0.809 . . . . 0.0 110.2 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.09 -41.0 95.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.361 -0.837 . . . . 0.0 110.396 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.445 ' SD ' ' NE2' ' A' ' 478' ' ' GLN . 18.5 ttm -62.84 -35.17 79.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 0.0 111.19 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -60.13 -39.26 85.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.346 -0.846 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.3 -40.23 93.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 63.1 pttt -109.18 -148.81 0.43 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.556 -0.715 . . . . 0.0 109.865 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.445 ' NE2' ' SD ' ' A' ' 474' ' ' MET . 44.7 tt0 50.46 80.6 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.195 -0.941 . . . . 0.0 110.957 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -123.73 34.75 5.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -125.9 4.81 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.494 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.41 ' CB ' HD23 ' A' ' 482' ' ' LEU . 0.5 OUTLIER -138.22 -34.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 112.503 -179.109 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 481' ' ' ARG . 0.4 OUTLIER -145.47 71.73 1.29 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.987 -1.071 . . . . 0.0 112.108 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 35.0 t -92.28 48.81 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.7 33.1 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -119.64 54.91 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.53 -0.982 . . . . 0.0 110.392 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.709 HD13 ' OE1' ' A' ' 464' ' ' GLN . 0.1 OUTLIER -101.59 -84.22 0.45 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.488 178.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 488' ' ' THR . 4.6 mp -140.97 -88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.257 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 26.4 p -102.7 22.48 13.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 111.511 -178.547 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -62.41 89.25 0.05 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -111.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 495' ' ' GLU . 94.9 mtt-85 -106.32 -21.97 12.95 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.616 -1.302 . . . . 0.0 109.416 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -47.96 -23.5 0.8 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.876 . . . . 0.0 111.629 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.51 -60.37 3.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 112.068 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 5.96 28.01 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.299 -1.501 . . . . 0.0 111.885 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 71.7 mm-40 -83.41 -6.07 59.35 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.035 -1.041 . . . . 0.0 112.702 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.84 -7.6 80.64 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.085 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.64 -176.23 0.61 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.176 -1.19 . . . . 0.0 109.493 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.56 167.52 10.53 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.01 150.91 29.94 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 488' ' ' THR . 9.4 t -82.5 138.99 44.29 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 139.05 52.85 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.283 1.149 . . . . 0.0 110.357 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 148.9 -9.09 0.98 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 10.9 t -77.41 139.03 39.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -1.154 . . . . 0.0 113.164 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.829 ' HB ' HG12 ' A' ' 463' ' ' VAL . 80.6 m -111.13 124.28 51.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 522' ' ' LEU . 50.4 t -116.34 125.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.61 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.829 HG22 ' HB3' ' A' ' 533' ' ' LEU . 22.6 pt -121.57 120.27 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 534' ' ' ILE . 9.6 p -120.21 108.86 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.145 -0.972 . . . . 0.0 111.622 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.515 ' OD2' HG11 ' A' ' 449' ' ' VAL . 95.0 m-20 -85.11 121.63 28.15 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.888 -1.132 . . . . 0.0 108.343 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.0 tp-100 -148.59 105.25 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -69.42 -38.79 80.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 4.9 tt0 -79.43 -155.44 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 -7.01 0.56 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.625 -0.672 . . . . 0.0 110.974 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.28 -34.42 74.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.357 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' SER . . . . . 0.443 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.6 m -87.71 -22.19 24.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.333 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.4 tp -68.74 -46.33 69.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.15 -0.969 . . . . 0.0 109.606 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 32.8 ttpt -69.09 -44.18 73.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.664 -0.648 . . . . 0.0 112.296 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' GLU . . . . . 0.443 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.5 OUTLIER -64.77 -39.99 94.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.498 -1.376 . . . . 0.0 110.452 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 77.5 m -60.42 -44.2 95.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.113 -0.992 . . . . 0.0 109.347 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.1 OUTLIER -55.85 -35.54 66.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.944 -0.473 . . . . 0.0 109.998 -179.226 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.5 m -59.05 -39.15 81.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.1 -40.86 78.1 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.492 0.663 . . . . 0.0 109.971 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.496 ' CD1' HG21 ' A' ' 505' ' ' VAL . 12.2 tp -63.77 -22.79 67.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.456 -0.777 . . . . 0.0 111.146 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' ASP . . . . . 0.553 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 98.6 m-20 -47.93 -57.42 5.73 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.446 -0.784 . . . . 0.0 111.774 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.32 -50.84 61.08 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.18 -29.88 34.21 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.482 -1.011 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.648 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -57.96 -23.51 54.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.776 -0.577 . . . . 0.0 111.255 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -41.39 -43.89 2.67 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.598 -0.689 . . . . 0.0 112.319 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 -62.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.577 ' C ' HG22 ' A' ' 530' ' ' VAL . 1.7 t-20 -80.77 156.09 26.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.392 -0.817 . . . . 0.0 110.468 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 526' ' ' ALA . 0.1 OUTLIER -174.34 151.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.988 0.899 . . . . 0.0 110.791 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.825 ' CB ' HG23 ' A' ' 504' ' ' THR . 0.0 OUTLIER -177.39 91.71 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 54.2 t -99.36 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.011 0.91 . . . . 0.0 111.3 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.829 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.77 113.41 26.63 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 176.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.735 HG22 HG12 ' A' ' 507' ' ' VAL . 0.6 OUTLIER -131.28 144.77 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.837 -177.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 69.9 p -105.6 -177.11 3.27 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -160.03 168.11 26.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.013 -1.055 . . . . 0.0 110.83 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.518 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -142.94 -4.89 0.91 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.328 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -103.98 5.64 46.58 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 543' ' ' THR . 97.0 mt-30 -82.42 -1.43 50.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -1.192 . . . . 0.0 111.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.59 -43.21 75.79 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 0.0 110.494 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 24.6 m -106.98 -45.02 4.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.56 70.41 0.3 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.9 t -64.76 -43.97 91.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.58 -0.953 . . . . 0.0 111.402 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 543' ' ' THR . . . -64.16 -29.64 75.52 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.099 -1.001 . . . . 0.0 110.637 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t -65.16 -36.07 83.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.301 -1.117 . . . . 0.0 110.797 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.11 -38.39 90.9 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.796 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 547' ' ' LEU . 10.8 mp -62.63 -42.22 99.47 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.838 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.5 ttp -63.14 -35.76 81.36 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.275 -0.891 . . . . 0.0 108.705 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.98 -50.44 61.28 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.578 ' HG3' HD11 ' A' ' 519' ' ' LEU . 58.0 ttm -55.33 -49.15 72.93 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.795 -0.566 . . . . 0.0 110.395 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.58 -31.75 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.683 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.87 -17.09 64.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.843 . . . . 0.0 109.92 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -68.88 1.05 3.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.343 -0.848 . . . . 0.0 113.122 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 137.04 -11.2 3.89 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.224 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.81 106.67 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.257 -1.143 . . . . 0.0 110.25 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -158.74 116.11 2.82 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 24.0 p -77.25 162.33 27.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -101.08 -83.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 111.307 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -142.54 -75.74 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 110.865 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -93.28 -22.17 19.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.496 -0.752 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -131.5 155.11 47.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.388 -0.82 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -73.46 -120.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -67.66 83.38 0.15 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.35 -16.79 22.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.42 -1.047 . . . . 0.0 110.91 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -98.76 -4.37 33.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.108 -0.995 . . . . 0.0 110.943 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 56.59 1.3 Allowed Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.003 -1.061 . . . . 0.0 109.894 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.58 -12.81 27.17 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.213 1.112 . . . . 0.0 111.724 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -155.13 86.96 1.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.665 -179.429 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.187 0.517 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 21.4 t -63.81 -44.25 93.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 140.82 75.63 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 51.1 pt -100.87 8.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.451 -1.029 . . . . 0.0 110.872 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -72.51 -33.8 67.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.197 -0.94 . . . . 0.0 111.019 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 386' ' ' VAL . 34.5 m -99.28 121.23 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.345 -0.847 . . . . 0.0 110.795 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -122.76 -69.0 0.85 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.257 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -87.0 172.05 10.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 110.352 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -89.84 78.5 6.83 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.34 -40.16 96.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.71 -0.619 . . . . 0.0 111.135 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.4 m -61.25 -46.42 90.45 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.699 -0.626 . . . . 0.0 111.561 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 433' ' ' LEU . 67.7 t -66.29 -33.06 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 110.147 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -60.39 -48.75 80.4 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.937 -1.102 . . . . 0.0 109.848 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.824 . . . . 0.0 108.841 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.731 ' CD2' HD22 ' A' ' 426' ' ' LEU . 1.2 tp -60.54 -41.11 93.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.513 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -36.38 82.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.25 -0.906 . . . . 0.0 110.453 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -66.07 -45.25 81.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.382 -0.823 . . . . 0.0 112.194 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.87 -43.5 75.24 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.109 -0.994 . . . . 0.0 111.879 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.547 HG22 ' OD1' ' A' ' 403' ' ' ASN . 64.4 mt -63.69 -41.38 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.442 -0.786 . . . . 0.0 110.528 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.445 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 22.8 mtt -59.62 -33.22 71.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.736 -0.603 . . . . 0.0 110.445 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.31 -36.8 78.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.748 -0.595 . . . . 0.0 110.495 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 9.3 tp-100 -92.75 -13.9 28.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.638 -1.289 . . . . 0.0 110.02 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.547 ' OD1' HG22 ' A' ' 399' ' ' ILE . 13.9 m120 -69.28 -32.31 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -115.3 18.6 16.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.371 -0.831 . . . . 0.0 109.72 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.8 p -41.87 149.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.257 0.551 . . . . 0.0 112.095 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 47.5 p -82.65 72.97 9.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.435 HG23 HG13 ' A' ' 413' ' ' VAL . 8.1 p -101.49 131.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.393 -0.817 . . . . 0.0 111.313 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -94.91 145.0 28.77 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.08 -23.41 60.82 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.093 1.049 . . . . 0.0 110.272 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -55.87 -24.43 37.0 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.617 0.722 . . . . 0.0 110.861 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.99 63.1 0.46 Allowed 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 59.5 p -50.25 107.12 0.14 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.25 -0.906 . . . . 0.0 111.177 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 407' ' ' VAL . 4.3 m -62.65 153.62 77.51 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.58 122.17 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.254 -1.095 . . . . 0.0 109.254 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -96.62 -5.96 37.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 419' ' ' TYR . 13.4 p -93.3 22.79 4.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.767 -1.208 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -105.0 -37.3 7.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.767 . . . . 0.0 109.044 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 402' ' ' GLN . . . -62.48 -49.0 77.82 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 416' ' ' THR . 43.1 p90 -100.89 -8.89 22.11 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.503 1.652 . . . . 0.0 112.982 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 416' ' ' THR . 80.9 p -69.71 -36.59 76.05 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.574 -1.65 . . . . 0.0 107.05 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -78.64 -48.14 15.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.959 -0.463 . . . . 0.0 111.173 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.57 -48.7 78.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.429 -0.795 . . . . 0.0 111.251 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.878 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.1 t -65.28 -46.05 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.611 . . . . 0.0 111.803 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.6 t -61.19 -45.9 92.71 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.976 -1.077 . . . . 0.0 112.64 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.53 -46.95 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.116 -0.99 . . . . 0.0 110.715 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.878 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -53.33 -33.97 55.62 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 111.821 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.54 75.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.872 -1.142 . . . . 0.0 109.045 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -60.83 -29.15 69.32 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -66.84 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.516 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.6 -55.76 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.589 -1.319 . . . . 0.0 109.839 178.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.0 Cg_endo -71.99 106.21 1.97 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 N-CA-C 106.744 -2.06 . . . . 0.0 106.744 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.553 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 0.2 OUTLIER -90.52 99.92 12.86 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.107 -177.298 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 2.9 mt -141.99 140.39 32.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 533' ' ' LEU . . . -169.5 150.89 4.26 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.7 pt -119.43 120.97 65.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 535' ' ' THR . 82.1 t -125.36 139.98 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.1 t -117.05 122.43 44.14 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 155.35 20.57 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -136.12 -36.21 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.574 -0.957 . . . . 0.0 111.439 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.13 155.51 26.18 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.15 62.23 4.85 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -86.54 -21.35 26.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.997 . . . . 0.0 110.537 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.83 84.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.393 -0.817 . . . . 0.0 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 -36.4 77.22 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.73 -35.77 75.23 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 109.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 467' ' ' ALA . 16.0 tpt85 -62.97 -49.79 73.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.63 -0.669 . . . . 0.0 112.243 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 4.7 mt-10 -74.5 -31.13 62.07 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.963 -1.086 . . . . 0.0 111.108 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.73 -48.4 81.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.372 -0.83 . . . . 0.0 110.275 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 506' ' ' ILE . 9.6 p -61.46 -31.34 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.737 -1.227 . . . . 0.0 108.655 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.14 -29.53 70.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.4 -32.38 73.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.112 -0.993 . . . . 0.0 108.358 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.35 -35.09 76.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.934 HG13 ' CG2' ' A' ' 463' ' ' VAL . 52.0 t -61.1 -26.5 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.6 tpp -66.66 -40.16 88.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.358 -0.839 . . . . 0.0 108.748 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -56.49 -27.09 56.21 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.95 -23.4 31.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.78 -34.24 71.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -82.22 10.21 7.28 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.608 -0.683 . . . . 0.0 112.077 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.44 29.83 71.49 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' ARG . . . . . 0.622 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 19.8 tpp85 -126.02 126.98 45.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.95 . . . . 0.0 110.546 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 48.7 tp10 -95.94 160.22 14.57 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.934 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.1 m -142.27 161.36 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.777 -1.202 . . . . 0.0 112.493 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.544 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 58.7 tt0 -107.54 122.82 47.44 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -128.09 128.55 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.505 -0.747 . . . . 0.0 110.782 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.529 HD12 HG21 ' A' ' 518' ' ' THR . 78.6 mt -126.89 122.16 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.607 -0.683 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.611 ' HB2' ' HD3' ' A' ' 446' ' ' ARG . . . -86.69 169.02 13.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.045 -1.035 . . . . 0.0 108.776 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 467' ' ' ALA . . . -57.28 -160.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.64 -15.95 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.661 -1.274 . . . . 0.0 113.412 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -76.35 -9.44 58.64 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.591 -1.318 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -57.35 -32.85 67.16 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.055 . . . . 0.0 111.093 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 26.2 t -62.16 -44.46 96.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.415 -0.803 . . . . 0.0 110.047 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.16 -41.53 94.58 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.428 -0.795 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.48 76.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.547 -0.721 . . . . 0.0 110.578 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.61 -39.13 87.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.181 -0.95 . . . . 0.0 109.376 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -39.72 95.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -100.07 -146.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.68 80.06 0.1 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.807 -1.183 . . . . 0.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.45 14.06 15.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.965 -0.459 . . . . 0.0 110.291 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -92.5 -2.32 56.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 111.686 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -178.66 33.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.058 -1.026 . . . . 0.0 110.823 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 482' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 481' ' ' ARG . 1.4 tp -151.61 7.14 0.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.185 -1.006 . . . . 0.0 113.596 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.8 t -55.0 -25.22 28.44 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.474 -1.391 . . . . 0.0 110.445 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 160.46 41.65 0.02 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -130.86 30.65 4.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.663 -0.904 . . . . 0.0 109.314 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.574 HD12 HG12 ' A' ' 487' ' ' ILE . 1.9 tp -60.33 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 1.045 HG22 HG23 ' A' ' 488' ' ' THR . 29.5 mm -153.23 -82.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 108.656 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 488' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 487' ' ' ILE . 24.4 p -100.34 11.36 39.59 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.347 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -77.42 63.91 3.28 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -135.48 -70.96 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' ARG . . . . . 0.445 ' HD3' ' CE ' ' A' ' 497' ' ' MET . 87.2 mtt-85 -118.52 -8.23 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.848 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 499' ' ' PHE . 4.3 mp0 -73.45 -38.05 65.62 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 521' ' ' LEU . 2.8 mt -93.85 -21.44 19.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 25.8 tp -103.64 -31.3 9.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 491' ' ' ARG . 0.5 OUTLIER -131.47 -2.13 3.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.559 -1.338 . . . . 0.0 113.148 -177.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 78.77 49.26 6.62 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 118.646 -1.74 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' MET . . . . . 0.445 ' CE ' ' HD3' ' A' ' 491' ' ' ARG . 1.8 ttm -112.41 -177.38 3.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -118.82 137.34 53.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.679 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -114.4 150.02 35.29 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.314 -0.866 . . . . 0.0 111.902 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 500' ' ' THR . 8.7 t -64.0 115.32 18.25 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.963 -0.46 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.459 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -69.3 115.71 4.16 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.217 1.114 . . . . 0.0 110.282 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -157.75 19.69 0.37 Allowed Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 487' ' ' ILE . 17.3 p -97.89 174.42 6.59 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.774 1.274 . . . . 0.0 113.751 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.815 ' HB ' HG12 ' A' ' 463' ' ' VAL . 10.1 m -122.5 103.53 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.553 HG11 HD22 ' A' ' 522' ' ' LEU . 62.1 t -90.44 134.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 0.7 OUTLIER -134.39 121.49 36.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.918 HG22 ' HG2' ' A' ' 509' ' ' GLN . 7.5 p -115.94 104.18 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.537 -1.352 . . . . 0.0 111.446 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.83 99.36 10.85 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.918 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.4 mm-40 -111.62 103.9 12.24 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -175.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.41 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -71.63 -36.5 62.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -98.9 163.16 12.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.486 ' HD3' HD13 ' A' ' 515' ' ' LEU . 56.0 mmtt -100.33 -9.05 22.71 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.825 -0.547 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.3 OUTLIER -61.67 -41.34 97.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.298 -0.876 . . . . 0.0 109.534 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -6.13 48.34 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.589 -0.695 . . . . 0.0 111.276 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.486 HD13 ' HD3' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -69.78 -56.5 6.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 178.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.2 -40.68 64.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.473 -0.767 . . . . 0.0 111.468 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.009 -1.057 . . . . 0.0 110.605 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.529 HG21 HD12 ' A' ' 466' ' ' ILE . 98.6 m -60.07 -44.41 94.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.223 -0.923 . . . . 0.0 108.789 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.753 HD11 ' HE3' ' A' ' 550' ' ' MET . 0.4 OUTLIER -50.8 -37.44 42.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -0.763 . . . . 0.0 110.434 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.3 m -64.77 -42.28 95.21 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.525 -0.734 . . . . 0.0 111.852 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.5 OUTLIER -66.23 -47.16 74.71 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.226 -0.922 . . . . 0.0 111.565 -178.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 0.553 HD22 HG11 ' A' ' 505' ' ' VAL . 4.3 pp -78.2 -18.11 55.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.396 -0.815 . . . . 0.0 111.9 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -47.07 -46.1 22.24 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.405 -0.81 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.31 90.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.41 -37.89 89.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.787 . . . . 0.0 111.668 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -29.38 70.25 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.063 -1.023 . . . . 0.0 111.005 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -58.15 -27.39 63.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.044 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 65.4 m80 -108.9 -117.66 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.832 -0.542 . . . . 0.0 111.094 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.409 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 10.5 m120 -91.28 65.78 5.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.405 -1.434 . . . . 0.0 113.666 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 530' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -139.71 165.18 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.551 -1.343 . . . . 0.0 110.279 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 15.1 mp0 -150.5 161.02 43.33 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.729 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 18.9 t -112.3 107.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.992 -1.068 . . . . 0.0 113.075 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 434' ' ' ALA . 7.2 tp -110.67 117.48 33.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.738 HG22 HG12 ' A' ' 507' ' ' VAL . 10.7 pt -137.36 133.71 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 117.996 -1.481 . . . . 0.0 113.148 -175.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 436' ' ' VAL . 82.4 p -99.02 -168.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -155.54 164.67 38.36 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.41 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.3 OUTLIER -142.28 -18.81 0.71 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.551 178.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -111.77 -17.05 8.77 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' GLN . . . . . 0.483 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 1.0 OUTLIER -87.69 1.74 52.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.452 -1.028 . . . . 0.0 110.265 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -32.32 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 78.3 p -101.05 115.16 29.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 69.8 59.8 5.35 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 539' ' ' GLN . 58.7 p -68.46 -10.32 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.949 -0.736 . . . . 0.0 110.659 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.96 80.48 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 39.0 m -61.08 -29.85 69.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.974 . . . . 0.0 109.312 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.734 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.65 -32.26 70.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.922 -0.486 . . . . 0.0 110.028 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.1 mp -61.8 -42.62 99.23 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 109.26 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 64.3 mtt -64.64 -34.31 77.98 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.92 -51.75 28.39 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.753 ' HE3' HD11 ' A' ' 519' ' ' LEU . 96.4 mmm -56.1 -42.57 76.98 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -57.56 -31.72 66.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.528 -0.732 . . . . 0.0 110.059 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -62.76 -30.0 71.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 519' ' ' LEU . . . -69.34 -7.61 38.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.648 -0.658 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.25 -5.16 38.41 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.515 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 555' ' ' VAL . 33.4 m -75.43 118.58 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 118.942 1.371 . . . . 0.0 111.117 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -171.72 137.88 1.05 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 5.0 t -105.99 152.65 23.07 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -75.14 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.995 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -138.56 -89.92 0.22 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.756 -1.215 . . . . 0.0 111.195 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -89.87 -21.39 22.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.031 -1.043 . . . . 0.0 111.405 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -81.5 138.53 35.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.323 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -92.95 37.58 3.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 140.48 79.1 0.06 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -92.91 -14.18 27.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.524 -0.986 . . . . 0.0 110.72 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -91.11 -6.63 53.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.611 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.08 54.54 1.21 Allowed Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.333 -0.855 . . . . 0.0 109.693 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.19 -7.38 20.45 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.445 1.234 . . . . 0.0 111.566 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -153.51 101.55 2.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.502 -179.345 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.084 0.468 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 70.5 m -60.56 -43.35 97.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.077 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -143.34 135.54 6.47 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 49.8 pt -86.37 133.44 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.547 -0.972 . . . . 0.0 109.87 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -137.36 164.15 29.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.0 110.292 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.48 143.89 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.537 -0.727 . . . . 0.0 110.074 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.46 176.33 8.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.687 . . . . 0.0 110.381 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -73.72 157.66 36.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.723 -0.611 . . . . 0.0 110.191 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -85.95 54.55 3.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.655 -0.653 . . . . 0.0 110.492 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -40.27 95.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.497 -0.752 . . . . 0.0 110.193 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 75.7 p -61.32 -40.79 95.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.664 -0.647 . . . . 0.0 110.946 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.8 t -71.3 -24.11 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.587 -0.696 . . . . 0.0 111.769 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.11 -52.92 52.58 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.945 -1.097 . . . . 0.0 111.178 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.94 78.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.438 -0.789 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.739 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.1 tt -62.18 -41.02 97.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.743 -0.598 . . . . 0.0 111.152 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 11.1 t -62.81 -40.26 96.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 0.0 111.309 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.76 -44.34 93.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.415 -0.803 . . . . 0.0 110.861 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -65.52 -38.1 88.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.359 -0.838 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.5 OUTLIER -64.13 -40.85 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.241 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.648 ' CG ' HD11 ' A' ' 435' ' ' ILE . 56.6 mtp -63.39 -28.82 70.25 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.83 -26.83 66.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.255 -0.903 . . . . 0.0 108.799 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.625 ' O ' HG12 ' A' ' 405' ' ' VAL . 2.0 tm0? -90.44 -18.45 25.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -66.04 -38.48 88.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.688 -0.633 . . . . 0.0 110.397 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -116.5 18.67 15.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 402' ' ' GLN . 8.2 p -60.39 118.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.506 -0.746 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 406' ' ' THR . 5.8 t -53.11 101.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.417 0.627 . . . . 0.0 111.536 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.763 HG23 HG12 ' A' ' 413' ' ' VAL . 4.0 p -114.21 134.62 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' HIS . . . . . 0.432 ' CB ' ' HE2' ' A' ' 411' ' ' LYS . 0.1 OUTLIER -91.09 141.53 26.5 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.438 -0.789 . . . . 0.0 109.8 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.53 -27.72 32.73 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.151 1.08 . . . . 0.0 110.138 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.86 -34.12 76.08 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.761 0.791 . . . . 0.0 109.668 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 408' ' ' HIS . 0.0 OUTLIER -138.82 58.66 1.64 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 412' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 13.7 t -50.68 98.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.116 -0.99 . . . . 0.0 111.81 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 407' ' ' VAL . 7.6 p -58.61 148.44 66.53 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.93 -0.482 . . . . 0.0 109.713 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.545 ' HD2' HG23 ' A' ' 413' ' ' VAL . 38.4 Cg_endo -63.47 149.76 90.26 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.228 1.12 . . . . 0.0 109.682 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -136.3 -8.86 1.98 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.667 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 420' ' ' SER . 19.2 p -102.17 19.32 18.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -80.32 -77.01 0.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.612 -0.68 . . . . 0.0 111.854 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -84.36 -2.23 89.15 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.217 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 423' ' ' VAL . 85.3 m-85 -107.14 -20.89 13.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 120.573 2.187 . . . . 0.0 108.827 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 416' ' ' THR . 37.6 t -72.67 -40.61 66.14 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 425' ' ' VAL . 35.5 t0 -65.66 -38.11 88.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.4 -39.09 89.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.807 0.813 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.73 ' CG1' HD21 ' A' ' 533' ' ' LEU . 63.5 t -66.39 -44.97 90.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -61.42 -35.58 77.96 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.964 -1.085 . . . . 0.0 111.257 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 421' ' ' ASP . 93.0 t -62.27 -47.46 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.427 -0.795 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 423' ' ' VAL . 1.4 pp -57.56 -33.29 67.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.413 -0.804 . . . . 0.0 111.996 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' A' ' 533' ' ' LEU . . . -68.17 -36.96 80.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.716 -1.24 . . . . 0.0 108.333 178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -31.93 71.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -65.65 -90.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 8.3 tpp85 -178.54 -57.97 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.406 -1.434 . . . . 0.0 109.097 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -68.33 93.54 0.41 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 5.5 t -85.96 111.48 20.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -163.97 89.12 0.55 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.513 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -139.15 168.31 20.13 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.686 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.648 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.6 pp -127.82 130.93 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.617 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 423' ' ' VAL . 9.4 t -124.38 150.83 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 13.8 m -123.05 127.46 48.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.315 -0.865 . . . . 0.0 110.663 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -122.49 160.3 16.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -148.85 -47.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.911 . . . . 0.0 109.562 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -101.46 142.44 15.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 73.87 89.16 0.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.7 -44.69 4.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.945 . . . . 0.0 110.804 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.27 97.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.784 . . . . 0.0 110.775 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.11 62.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.37 -41.76 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -1.027 . . . . 0.0 110.771 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.86 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.5 -43.85 98.13 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -67.73 -29.13 68.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.199 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -61.61 -47.66 84.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.524 -0.735 . . . . 0.0 110.864 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -59.66 -31.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.857 -1.152 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.0 -27.88 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.576 -0.849 . . . . 0.0 108.758 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.84 -34.06 77.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.149 -0.97 . . . . 0.0 108.448 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' LEU . . . . . 0.408 ' O ' ' CG ' ' A' ' 455' ' ' MET . 33.3 tp -62.62 -34.99 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.78 HG13 ' HB ' ' A' ' 463' ' ' VAL . 59.9 t -63.01 -25.81 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 79.9 mtp -69.81 -42.37 73.77 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.878 . . . . 0.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.0 OUTLIER -62.39 -20.8 64.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.121 -0.987 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.0 -22.69 36.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 0.0 109.745 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.26 -41.91 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.333 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.25 -26.74 63.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.486 -0.759 . . . . 0.0 109.51 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.1 2.86 16.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.0 111.707 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 83.95 4.27 88.68 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.033 -1.042 . . . . 0.0 111.878 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 132.2 33.78 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.993 1.397 . . . . 0.0 111.136 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 487' ' ' ILE . 55.8 mp0 -76.7 -174.38 2.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.61 -0.681 . . . . 0.0 110.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.78 ' HB ' HG13 ' A' ' 453' ' ' VAL . 43.0 t -134.95 144.77 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' GLN . . . . . 0.597 ' HB3' HG22 ' A' ' 505' ' ' VAL . 50.8 tt0 -92.44 114.56 27.14 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' ILE . . . . . 0.544 HD13 ' N ' ' A' ' 466' ' ' ILE 0.255 0.0 OUTLIER -127.3 129.13 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 111.431 -175.811 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.751 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.1 mt -124.71 120.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.834 -0.542 . . . . 0.0 110.545 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -78.16 164.45 24.95 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.34 -160.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.81 -0.556 . . . . 0.0 110.085 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -51.37 -17.08 0.66 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.76 -1.213 . . . . 0.0 111.082 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -73.44 -6.33 45.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.481 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ARG . . . . . 0.703 ' HD3' HG23 ' A' ' 466' ' ' ILE . 62.2 ttp180 -57.54 -31.62 66.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.3 m -59.08 -45.69 90.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.547 -0.721 . . . . 0.0 110.301 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.56 -40.43 95.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.494 -0.754 . . . . 0.0 109.056 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 92.7 mtp -62.37 -33.15 74.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.829 -0.544 . . . . 0.0 110.744 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -61.25 -38.98 88.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.949 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.5 ttp -59.18 -40.13 84.71 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.43 -0.794 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 62.6 pttt -119.58 -146.39 0.38 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' GLN . . . . . 0.437 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.3 mm-40 43.64 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.135 -0.978 . . . . 0.0 112.131 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -121.35 14.04 11.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.528 -0.732 . . . . 0.0 110.527 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -101.61 -10.12 20.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 111.659 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -132.15 0.41 3.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.109 -0.994 . . . . 0.0 112.939 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.32 44.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.656 -1.278 . . . . 0.0 112.873 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.7 t -89.34 48.76 1.65 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.654 -1.279 . . . . 0.0 110.47 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.06 58.24 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.8 44.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -1.15 . . . . 0.0 109.672 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 487' ' ' ILE . 95.1 mt -59.03 -84.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.923 -1.11 . . . . 0.0 109.318 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 462' ' ' GLU . 22.8 mm -156.37 -82.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.83 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 488' ' ' THR . . . . . 0.459 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.5 t -98.37 11.57 37.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.791 -0.568 . . . . 0.0 110.472 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.96 74.65 2.29 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.421 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 72.8 ttt-85 -144.83 -72.5 0.26 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -107.42 -22.73 12.46 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.565 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.02 -37.93 89.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.196 -0.94 . . . . 0.0 109.847 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 493' ' ' LEU . 1.3 mt -89.32 -53.72 4.43 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.022 0.915 . . . . 0.0 108.647 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.39 -42.96 87.14 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.032 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -112.79 -8.81 13.72 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.16 -4.74 79.84 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.273 -1.517 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 94.6 mtp -68.52 -177.73 0.99 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.056 -1.261 . . . . 0.0 110.594 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.54 148.33 32.35 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.446 -0.784 . . . . 0.0 110.652 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.459 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.34 155.15 25.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.069 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -51.31 116.68 7.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.18 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 501' ' ' PRO . . . . . 0.538 ' HG3' ' CD2' ' A' ' 528' ' ' HIS . 48.3 Cg_endo -76.41 114.45 3.88 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.434 1.229 . . . . 0.0 110.41 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.2 28.62 0.03 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' SER . . . . . 0.595 ' CB ' HG21 ' A' ' 487' ' ' ILE . 47.1 t -92.01 169.24 10.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.363 -1.081 . . . . 0.0 111.833 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.73 ' O ' HG13 ' A' ' 463' ' ' VAL . 52.6 m -110.88 117.86 34.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 1.069 HG11 HD21 ' A' ' 522' ' ' LEU . 32.1 t -112.33 130.23 66.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.725 0.774 . . . . 0.0 110.008 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 533' ' ' LEU . 14.6 pt -138.91 131.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.125 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.751 HG23 ' HB ' ' A' ' 466' ' ' ILE . 7.7 p -129.63 109.25 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.243 1.021 . . . . 0.0 111.245 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' ASP . . . . . 0.508 ' OD2' HG11 ' A' ' 449' ' ' VAL . 80.4 m-20 -85.47 110.16 18.98 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.595 ' HG2' HG22 ' A' ' 507' ' ' VAL . 90.4 mm-40 -126.19 106.91 9.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 510' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -72.39 -37.61 58.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.455 ' HG2' HD21 ' A' ' 513' ' ' LEU . 30.4 tp10 -85.97 149.15 25.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.0 -15.59 18.22 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.55 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 511' ' ' GLU . 3.5 pp -72.41 -31.41 65.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 5.0 m -83.45 -20.08 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.435 -0.791 . . . . 0.0 110.469 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 519' ' ' LEU . 54.3 tp -65.84 -43.99 86.86 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.5 -40.31 85.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.849 -0.532 . . . . 0.0 111.371 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.01 -51.72 68.12 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.065 -1.022 . . . . 0.0 110.719 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.519 HG21 HD12 ' A' ' 466' ' ' ILE . 92.2 m -59.34 -39.53 83.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.846 HD11 ' CE ' ' A' ' 550' ' ' MET . 0.8 OUTLIER -59.49 -38.52 81.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 122.092 -0.38 . . . . 0.0 111.279 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 69.5 p -64.11 -30.88 71.92 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.939 -1.1 . . . . 0.0 109.297 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 48.7 tp -70.02 -41.26 74.52 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.733 0.777 . . . . 0.0 109.331 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' LEU . . . . . 1.069 HD21 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -72.83 -20.63 61.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.98 -0.45 . . . . 0.0 111.672 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 523' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -48.22 -58.88 3.93 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.264 -0.897 . . . . 0.0 111.439 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.29 80.21 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.746 ' HB1' ' HB2' ' A' ' 529' ' ' ASN . . . -58.03 -30.37 66.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.877 -0.778 . . . . 0.0 110.575 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -52.24 -27.53 15.22 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.126 -0.984 . . . . 0.0 110.782 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -64.24 -36.79 85.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.633 -0.667 . . . . 0.0 109.27 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.538 ' CD2' ' HG3' ' A' ' 501' ' ' PRO . 0.3 OUTLIER -132.2 -60.11 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.674 -0.641 . . . . 0.0 110.775 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 529' ' ' ASN . . . . . 0.746 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . 5.7 m120 -78.68 116.27 18.93 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.678 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 2.4 p -169.68 144.11 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 C-N-CA 117.262 -1.775 . . . . 0.0 115.462 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 505' ' ' VAL . 1.8 mt-30 175.9 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 534' ' ' ILE . 80.3 t -115.0 114.73 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.501 0 O-C-N 120.525 -1.36 . . . . 0.0 113.853 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.73 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -116.93 117.47 29.79 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 103.447 -2.798 . . . . 0.0 103.447 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 534' ' ' ILE . . . . . 0.662 HG22 HG12 ' A' ' 507' ' ' VAL . 6.2 pt -135.43 149.12 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.416 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.441 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 49.2 p -112.86 -168.07 1.27 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -158.69 168.14 27.66 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.733 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' SER . . . . . 0.419 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -144.32 17.68 1.71 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.214 0.53 . . . . 0.0 109.675 178.118 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -150.84 27.14 1.03 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -92.62 0.03 57.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.6 -0.941 . . . . 0.0 111.288 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -54.36 -43.66 71.51 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.869 -1.144 . . . . 0.0 110.048 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 73.3 p -113.88 155.38 25.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.13 43.76 83.64 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -63.22 -43.96 96.64 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.314 -1.11 . . . . 0.0 110.866 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.49 -34.24 89.4 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 65.9 m -62.39 -36.41 82.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.9 -0.765 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.34 -39.89 84.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.353 -0.842 . . . . 0.0 109.871 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.3 mp -62.94 -41.77 99.59 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.635 0.731 . . . . 0.0 109.074 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 97.4 mtp -62.69 -28.12 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.82 -53.98 50.16 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 550' ' ' MET . . . . . 0.846 ' CE ' HD11 ' A' ' 519' ' ' LEU . 89.8 mmm -55.62 -46.15 77.43 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.28 -0.888 . . . . 0.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.39 -30.88 71.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.708 -0.62 . . . . 0.0 111.424 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -67.19 -18.02 65.08 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.552 -0.717 . . . . 0.0 110.895 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.82 7.08 4.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.402 -0.811 . . . . 0.0 112.679 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.85 -12.69 9.29 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.094 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 93.4 t -88.31 115.33 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.057 -1.26 . . . . 0.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -170.31 133.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.602 -0.686 . . . . 0.0 110.257 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 562' ' ' GLY . 15.9 p -76.89 162.85 27.28 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.77 -62.74 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.34 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -145.99 -102.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.64 -0.663 . . . . 0.0 109.987 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -92.95 -22.73 19.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.584 -1.323 . . . . 0.0 110.248 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -117.11 153.22 33.14 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.184 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 557' ' ' THR . . . 120.57 73.34 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 563' ' ' GLY . . . . . 0.438 ' O ' HG22 ' A' ' 569' ' ' THR . . . 96.73 -25.33 26.96 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 568' ' ' ALA . 78.8 tt0 -94.3 -1.73 53.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -1.103 . . . . 0.0 110.927 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -81.94 -6.53 59.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.092 -1.005 . . . . 0.0 111.246 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' ARG . . . . . 0.439 ' CG ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -153.45 -65.69 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 O-C-N 121.046 -1.034 . . . . 0.0 110.981 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 567' ' ' PRO . . . . . 0.439 ' HD3' ' CG ' ' A' ' 566' ' ' ARG . 47.2 Cg_endo -73.92 -7.0 19.44 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 122.948 0.973 . . . . 0.0 111.702 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 568' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 564' ' ' GLU . . . 54.86 21.16 3.45 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.992 -1.068 . . . . 0.0 111.392 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 569' ' ' THR . . . . . 0.547 HG23 ' OXT' ' A' ' 569' ' ' THR . 8.4 t . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.029 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 389' ' ' GLU . 80.2 tt0 . . . . . 0 N--CA 1.503 2.206 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.87 -43.15 99.43 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.537 -1.352 . . . . 0.0 109.614 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 70.8 m -62.78 -44.2 96.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.673 -0.642 . . . . 0.0 110.312 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 395' ' ' LEU . 69.1 t -65.84 -36.32 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.634 -0.666 . . . . 0.0 110.836 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.73 -44.2 97.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 111.568 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.0 91.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.492 -0.755 . . . . 0.0 112.124 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 399' ' ' ILE . 1.8 pp -71.88 -28.51 63.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.179 -0.951 . . . . 0.0 112.256 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.9 t -63.09 -43.9 97.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.701 -1.249 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -64.98 -42.97 94.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.731 -0.606 . . . . 0.0 111.59 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -63.28 -40.05 96.31 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.417 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.668 HG23 ' HD1' ' A' ' 419' ' ' TYR . 82.3 mt -63.52 -42.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.3 mtp -63.54 -32.0 73.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.165 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -57.87 -32.34 67.59 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 7.7 mp0 -93.09 -15.91 25.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.998 -1.064 . . . . 0.0 109.603 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -64.75 -36.35 84.03 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.24 18.43 17.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.785 . . . . 0.0 109.596 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.9 p -35.54 142.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.609 0 CA-C-O 121.354 0.597 . . . . 0.0 111.686 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 406' ' ' THR . 9.4 t -74.27 72.98 1.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.707 -0.621 . . . . 0.0 109.782 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 412' ' ' SER . 11.2 p -104.39 132.03 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.918 . . . . 0.0 111.52 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -93.33 142.05 24.76 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.46 -28.35 54.01 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.085 1.045 . . . . 0.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.22 -23.94 62.73 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.569 -0.707 . . . . 0.0 110.482 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 57.21 0.51 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . 0.462 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 35.5 t -59.01 126.48 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 111.499 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.6 p -87.77 113.12 53.09 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.921 -0.487 . . . . 0.0 110.446 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 50.9 Cg_endo -69.26 142.72 50.95 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.102 1.054 . . . . 0.0 109.423 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.423 ' NH1' ' CG ' ' A' ' 402' ' ' GLN . 83.2 mtp180 -159.38 63.11 0.39 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 109.534 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 74.1 p -66.83 -35.7 80.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.938 -1.101 . . . . 0.0 108.741 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -69.56 -10.45 58.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 111.2 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.13 -44.63 97.16 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.746 ' HB3' HG13 ' A' ' 436' ' ' VAL . 9.6 m-85 -93.94 -2.42 53.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.13 -1.218 . . . . 0.0 109.805 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 7.3 t -80.61 -36.81 32.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 425' ' ' VAL . 39.6 t0 -79.06 -46.03 18.94 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.388 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.14 -49.67 76.32 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.89 0.852 . . . . 0.0 110.781 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.884 ' HA ' HD23 ' A' ' 426' ' ' LEU . 55.9 t -72.16 -40.49 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.767 -0.583 . . . . 0.0 112.297 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 66.8 p -59.39 -39.13 82.36 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.889 -1.132 . . . . 0.0 110.835 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 421' ' ' ASP . 97.3 t -61.51 -42.49 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.71 -0.619 . . . . 0.0 109.67 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -58.62 -32.73 69.3 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.444 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.72 73.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.607 -1.308 . . . . 0.0 109.32 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' A' ' 425' ' ' VAL . 82.7 mt-30 -62.62 -31.22 72.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 426' ' ' LEU . 90.2 m-20 -62.89 -90.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -171.92 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.346 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.68 105.73 1.52 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.039 1.02 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -85.15 100.93 12.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.782 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.749 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 20.9 tp -165.04 96.94 0.72 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.756 -1.215 . . . . 0.0 111.821 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -144.07 177.02 8.87 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.769 0.795 . . . . 0.0 111.89 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 44.4 pt -116.7 139.29 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.791 ' CG2' HG21 ' A' ' 423' ' ' VAL . 44.1 t -144.33 145.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.4 m -129.96 139.04 51.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.51 -0.744 . . . . 0.0 109.551 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.36 149.76 19.41 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -103.96 -49.64 3.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.751 -0.852 . . . . 0.0 109.262 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -146.75 153.86 25.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 93.09 106.62 1.76 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -46.99 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -1.009 . . . . 0.0 110.675 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.79 84.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 112.01 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.29 -29.25 64.54 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 120.729 -1.232 . . . . 0.0 110.514 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -38.89 89.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.509 -0.995 . . . . 0.0 110.804 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.526 ' CG ' ' HB1' ' A' ' 467' ' ' ALA . 6.9 mpt_? -64.91 -41.74 95.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.77 -27.79 63.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.301 -0.874 . . . . 0.0 110.498 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 41.3 ttm180 -62.89 -56.13 20.03 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.334 -0.854 . . . . 0.0 111.219 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 506' ' ' ILE . 11.8 p -57.34 -32.04 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.508 -1.37 . . . . 0.0 108.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.03 -26.34 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 49.4 tp10 -60.59 -32.7 71.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.06 -37.32 87.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.4 t -60.6 -27.05 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.78 -0.575 . . . . 0.0 109.812 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.59 -37.1 82.09 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.9 ttp -58.38 -29.46 66.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.652 0.739 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.77 31.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 0.0 109.555 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.41 -43.17 98.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -71.59 -27.43 63.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.732 -0.605 . . . . 0.0 110.478 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -82.65 6.44 17.81 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.493 -0.755 . . . . 0.0 111.282 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.63 28.42 72.24 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.867 -1.146 . . . . 0.0 110.628 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -134.6 129.07 34.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.052 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -85.26 167.54 15.55 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 23.5 m -145.31 149.25 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.86 . . . . 0.0 110.293 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.932 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.5 tt0 -97.52 126.11 42.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.895 HD13 HG21 ' A' ' 453' ' ' VAL . 1.9 pt -134.07 139.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.458 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.748 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.2 mp -129.31 126.08 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.347 -0.846 . . . . 0.0 110.688 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.526 ' HB1' ' CG ' ' A' ' 446' ' ' ARG . . . -84.28 -177.92 6.78 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.542 -0.723 . . . . 0.0 109.934 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.0 -162.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.213 0.53 . . . . 0.0 110.043 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.28 -16.86 6.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -0.969 . . . . 0.0 110.556 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -72.04 -11.07 60.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.374 -0.829 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -56.05 -34.0 65.51 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.13 -0.981 . . . . 0.0 111.903 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 39.0 t -55.66 -45.87 77.63 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.153 -0.967 . . . . 0.0 110.426 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -64.94 -37.91 89.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -32.47 70.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.92 -0.487 . . . . 0.0 110.506 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -59.65 -42.18 92.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.964 -1.085 . . . . 0.0 108.817 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.7 mtt -65.46 -35.65 81.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -102.92 -148.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 51.04 45.18 28.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.955 -1.091 . . . . 0.0 111.604 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -95.42 12.01 30.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.28 -0.887 . . . . 0.0 110.903 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -84.01 -1.68 55.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 111.131 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.841 ' HG2' HD22 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.976 -1.078 . . . . 0.0 112.796 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.841 HD22 ' HG2' ' A' ' 481' ' ' ARG . 0.2 OUTLIER -105.66 30.03 6.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.553 -1.342 . . . . 0.0 111.785 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 37.3 m -60.91 -28.21 68.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.935 -1.103 . . . . 0.0 110.251 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 161.81 46.84 0.02 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -130.54 40.82 3.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.57 -0.959 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.932 HD22 ' HA ' ' A' ' 464' ' ' GLN . 89.0 mt -67.36 -81.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.831 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.0 OUTLIER -175.63 -60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.41 -1.431 . . . . 0.0 112.547 173.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 487' ' ' ILE . 1.5 t -101.82 12.83 36.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.471 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -87.28 66.38 3.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.8 ttm180 -143.39 -63.42 0.4 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.32 -1.106 . . . . 0.0 108.885 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 37.5 mmt180 -101.86 -36.04 8.8 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -61.24 -29.96 70.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.644 -0.66 . . . . 0.0 111.492 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 5.9 mt -93.57 -29.91 15.25 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.513 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.7 OUTLIER -103.89 -38.21 7.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -6.39 12.13 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 100.47 -19.34 53.05 Favored Glycine 0 N--CA 1.504 3.204 0 CA-C-N 120.641 1.564 . . . . 0.0 112.274 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.4 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 10.9 mtp -69.29 175.1 4.13 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.982 -1.305 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.57 150.04 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.493 -0.754 . . . . 0.0 111.138 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -113.71 150.03 33.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.718 -0.614 . . . . 0.0 109.72 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 500' ' ' THR . 6.9 t -55.32 107.19 0.8 Allowed Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.474 -0.766 . . . . 0.0 110.573 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' A' ' 528' ' ' HIS . 40.0 Cg_endo -67.76 114.28 3.28 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.173 1.091 . . . . 0.0 110.316 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -166.11 26.19 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.831 ' CB ' HD13 ' A' ' 487' ' ' ILE . 22.9 t -96.0 -179.62 4.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.297 -1.119 . . . . 0.0 111.628 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.691 ' HB ' HG12 ' A' ' 463' ' ' VAL . 87.5 m -124.14 131.88 53.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 522' ' ' LEU . 62.9 t -121.5 135.78 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.901 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.813 HG22 ' HB2' ' A' ' 533' ' ' LEU . 26.0 pt -135.99 118.86 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.748 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.9 p -115.51 104.29 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 111.451 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.429 ' HA ' ' H ' ' A' ' 535' ' ' THR . 9.9 p-10 -86.73 121.39 29.16 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.47 129.2 7.76 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -77.56 -44.87 11.82 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -77.19 148.04 36.11 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -99.51 -12.19 20.38 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 121.907 -0.495 . . . . 0.0 111.645 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.7 OUTLIER -64.01 -34.98 79.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.8 m -69.68 -37.71 76.77 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.578 0.704 . . . . 0.0 110.577 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 550' ' ' MET . 57.7 tp -63.14 -42.79 99.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.736 -0.602 . . . . 0.0 111.209 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -66.37 -43.3 86.3 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 518' ' ' THR . 18.9 pt-20 -68.29 -42.13 79.93 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.858 -1.151 . . . . 0.0 110.51 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 466' ' ' ILE . 52.1 m -61.55 -40.14 93.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.659 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -61.0 -39.8 91.12 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 516' ' ' LYS . 75.6 p -60.09 -57.08 14.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.049 -1.032 . . . . 0.0 110.672 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.43 -41.12 98.47 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.149 -0.969 . . . . 0.0 110.721 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.798 HD12 HG11 ' A' ' 505' ' ' VAL . 5.1 tt -57.66 -30.39 65.39 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.627 -0.671 . . . . 0.0 110.727 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.12 -47.44 68.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.488 -0.758 . . . . 0.0 111.421 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -60.63 -50.02 72.19 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.42 -36.18 83.32 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.662 -0.905 . . . . 0.0 111.687 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.501 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.7 -25.12 66.17 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.273 -0.892 . . . . 0.0 110.964 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -53.47 -40.38 65.24 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.204 -0.935 . . . . 0.0 108.73 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 501' ' ' PRO . 1.5 t-80 -93.02 -135.35 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.417 ' HB3' ' HA2' ' A' ' 502' ' ' GLY . 16.5 t30 -88.87 78.95 7.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.602 -1.311 . . . . 0.0 112.402 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -140.21 168.68 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.114 -0.991 . . . . 0.0 108.62 178.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -164.0 162.97 23.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.602 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.6 t -113.44 110.69 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.709 0.766 . . . . 0.0 112.071 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.813 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.89 117.63 34.64 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 507' ' ' VAL . 11.7 pt -135.69 160.75 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 117.533 -1.667 . . . . 0.0 111.921 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 436' ' ' VAL . 47.0 p -125.55 -168.45 1.84 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -159.35 168.83 25.39 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.508 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.9 17.98 2.31 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.583 178.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.95 11.49 3.36 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 26.5 mt-30 -95.59 0.85 53.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.04 -1.271 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -53.69 -26.72 24.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.031 -1.043 . . . . 0.0 111.22 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 56.8 m -107.08 -36.81 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.417 -0.802 . . . . 0.0 109.89 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -134.42 107.46 0.66 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.1 t -97.74 -43.26 7.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -1.004 . . . . 0.0 111.629 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.65 -35.02 90.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 34.5 m -62.0 -32.24 72.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -1.079 . . . . 0.0 110.173 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.99 -35.06 79.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.86 -0.525 . . . . 0.0 109.923 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.1 mp -61.76 -43.72 98.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.0 -34.0 76.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 108.741 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.77 -52.5 56.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.659 ' CG ' HD11 ' A' ' 519' ' ' LEU . 32.0 ttp -58.31 -42.96 87.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.325 -0.86 . . . . 0.0 109.866 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HA ' ' CG1' ' A' ' 555' ' ' VAL . 99.0 mttt -61.6 -32.16 72.27 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.738 -0.601 . . . . 0.0 111.233 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.52 -12.72 61.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.589 -0.694 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.83 6.85 1.04 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.321 -0.862 . . . . 0.0 113.013 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.3 -15.76 42.48 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.522 -1.361 . . . . 0.0 110.933 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 555' ' ' VAL . 13.6 p . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.291 -1.123 . . . . 0.0 109.863 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.293 0.568 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.54 -38.49 89.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.69 -0.632 . . . . 0.0 110.976 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.0 m -62.51 -47.41 84.05 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.389 -0.819 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.15 -36.47 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.481 -0.762 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.36 82.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.237 -0.914 . . . . 0.0 109.655 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.55 -34.19 77.66 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.664 0.745 . . . . 0.0 108.999 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.6 OUTLIER -60.67 -39.45 88.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.98 -0.45 . . . . 0.0 110.659 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.9 m -64.6 -36.95 85.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.479 -0.763 . . . . 0.0 111.029 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -64.51 -46.63 82.09 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.288 -0.882 . . . . 0.0 111.997 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -70.06 -41.22 74.46 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.24 -0.913 . . . . 0.0 111.703 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 435' ' ' ILE . 96.5 mt -62.68 -40.6 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 109.675 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.434 ' HA ' ' CB ' ' A' ' 403' ' ' ASN . 18.3 mtp -63.01 -31.97 73.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.617 -0.677 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -60.74 -32.93 72.2 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.041 -1.037 . . . . 0.0 109.517 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 69.9 tp60 -90.44 -14.93 31.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.797 -1.189 . . . . 0.0 109.385 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 400' ' ' MET . 44.3 t-20 -65.48 -35.94 82.38 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -115.63 18.6 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -39.07 148.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-O 121.677 0.751 . . . . 0.0 112.228 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 19.3 m -84.35 77.53 9.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 407' ' ' VAL . 14.8 p -97.21 131.48 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.343 -0.848 . . . . 0.0 112.355 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -96.62 145.04 28.89 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.89 -21.57 57.19 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.066 1.035 . . . . 0.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.62 -36.29 66.81 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.83 0.824 . . . . 0.0 110.42 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 67.61 0.51 Allowed 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 14.3 m -62.67 135.27 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.818 0.818 . . . . 0.0 111.091 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.487 HG23 ' HD2' ' A' ' 414' ' ' PRO . 8.6 p -81.51 149.19 64.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.487 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.3 Cg_endo -58.47 136.67 75.83 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.018 1.009 . . . . 0.0 110.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.403 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 80.5 mtt85 -96.3 -8.94 31.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.664 -0.648 . . . . 0.0 112.662 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.0 t -99.34 19.09 16.14 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.95 -1.094 . . . . 0.0 109.175 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -106.17 -36.97 6.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -68.82 -38.62 85.51 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.596 ' CB ' HG13 ' A' ' 436' ' ' VAL . 3.8 m-85 -94.9 -8.05 38.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.774 -1.427 . . . . 0.0 110.42 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -40.54 65.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.873 -1.142 . . . . 0.0 108.529 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 425' ' ' VAL . 66.2 t0 -76.11 -44.47 38.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.898 -0.501 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.557 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -66.96 -48.59 68.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 111.445 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 426' ' ' LEU . 72.2 t -67.87 -42.96 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.598 -0.689 . . . . 0.0 111.441 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.6 t -59.09 -42.61 90.86 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.812 -1.18 . . . . 0.0 111.309 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 421' ' ' ASP . 90.5 t -61.8 -46.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.193 -0.942 . . . . 0.0 110.886 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -56.87 -37.24 71.06 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.243 -0.91 . . . . 0.0 112.28 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.43 -36.87 79.69 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.896 -1.128 . . . . 0.0 108.937 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -59.82 -30.49 68.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.26 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.44 -55.88 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.603 -1.31 . . . . 0.0 109.416 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 49.2 Cg_endo -73.4 106.44 2.18 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 533' ' ' LEU . 6.0 m -85.17 97.82 10.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.878 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 18.1 tp -150.01 134.02 17.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.69 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -174.4 175.35 2.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.905 -1.122 . . . . 0.0 110.894 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.1 pt -134.09 121.05 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.403 0.62 . . . . 0.0 110.072 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.693 ' CG2' HG21 ' A' ' 423' ' ' VAL . 62.7 t -120.61 134.76 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.227 -0.92 . . . . 0.0 109.257 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 11.8 p -118.24 123.6 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.85 -1.156 . . . . 0.0 111.809 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 -178.14 34.18 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -171.41 39.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.991 . . . . 0.0 109.599 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -155.04 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -118.35 134.49 10.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -98.78 -16.08 19.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.689 -0.889 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.35 77.78 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.48 -0.763 . . . . 0.0 111.824 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -78.66 -35.05 33.27 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.42 -35.44 79.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.963 . . . . 0.0 109.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.772 ' O ' HG12 ' A' ' 449' ' ' VAL . 0.0 OUTLIER -60.49 -46.75 88.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.835 -0.541 . . . . 0.0 110.364 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 97.5 mt-10 -66.99 -29.37 69.19 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -62.06 -46.01 91.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.968 HG22 HD12 ' A' ' 506' ' ' ILE . 5.3 p -58.81 -30.63 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.801 -1.187 . . . . 0.0 109.03 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.93 -26.49 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.77 -35.63 76.91 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.92 -1.113 . . . . 0.0 108.412 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 452' ' ' LEU . 3.9 mm? -62.38 -37.9 87.52 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.897 . . . . 0.0 108.673 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 463' ' ' VAL . 66.8 t -57.97 -28.9 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.588 -0.695 . . . . 0.0 109.976 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 457' ' ' ARG . 65.8 mtt -65.76 -39.5 91.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.383 -0.823 . . . . 0.0 108.814 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 63.0 ttp -61.66 -21.49 64.46 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.608 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.19 32.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 0.0 109.891 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 454' ' ' MET . 82.7 mtp180 -67.08 -40.77 87.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 109.324 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.21 -34.19 75.8 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.604 0.716 . . . . 0.0 109.1 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -76.78 1.53 17.03 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.65 27.39 72.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 15.3 ttm180 -128.74 118.62 23.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -1.038 . . . . 0.0 110.402 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 0.5 OUTLIER -76.22 164.58 25.93 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.3 m -136.88 157.53 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.272 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.859 ' HA ' HD22 ' A' ' 486' ' ' LEU . 59.2 tt0 -105.7 111.81 24.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 482' ' ' LEU . 1.2 pt -122.32 129.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 466' ' ' ILE . 5.3 mp -119.36 111.99 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 112.169 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -57.43 164.12 2.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.294 -0.878 . . . . 0.0 109.806 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.449 ' HB3' HH11 ' A' ' 446' ' ' ARG . . . -58.78 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.898 -0.501 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -57.84 -12.25 2.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.117 -0.989 . . . . 0.0 111.2 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 446' ' ' ARG . 96.7 mtt-85 -88.82 6.08 40.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.145 -0.972 . . . . 0.0 111.164 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.6 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 53.6 ttp180 -57.9 -25.28 60.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.067 . . . . 0.0 111.037 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 7.7 t -59.02 -47.62 84.56 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.219 -0.925 . . . . 0.0 111.218 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.07 -35.82 82.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 33.0 ttp -66.28 -32.0 73.15 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.52 -37.3 83.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.31 -0.869 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 45.0 mtt -60.5 -36.4 78.24 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -121.08 -143.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.413 ' NE2' ' HD2' ' A' ' 481' ' ' ARG . 53.7 tp60 47.96 88.24 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.98 -1.075 . . . . 0.0 111.456 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -129.03 20.93 5.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 110.081 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -110.17 -0.72 17.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 111.377 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 482' ' ' LEU . 12.6 mtt180 -135.25 -13.36 2.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.886 -1.134 . . . . 0.0 112.723 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.722 HD22 HD11 ' A' ' 465' ' ' ILE . 0.6 OUTLIER -170.95 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.967 -1.083 . . . . 0.0 111.004 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.6 m -75.11 -18.26 60.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.64 47.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 20.1 pt-20 -139.9 74.8 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.669 -0.901 . . . . 0.0 111.051 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 464' ' ' GLN . 67.3 mt -94.85 -81.02 0.4 Allowed 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.4 OUTLIER 161.16 -34.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.75 0 C-N-CA 123.552 0.741 . . . . 0.0 110.435 173.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.541 HG21 ' CB ' ' A' ' 525' ' ' ALA . 7.0 p -102.14 12.7 36.36 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -153.36 95.78 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.433 ' N ' ' CD2' ' A' ' 493' ' ' LEU . 72.2 ttt180 -145.81 -72.21 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.455 ' CB ' ' HB2' ' A' ' 497' ' ' MET . 74.1 mtt-85 -90.13 -16.55 29.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.962 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -56.95 4.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.71 -1.244 . . . . 0.0 109.95 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 493' ' ' LEU . 1.1 pt? -58.92 -28.08 65.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.724 -0.61 . . . . 0.0 111.07 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.547 ' O ' HD23 ' A' ' 494' ' ' LEU . 1.0 OUTLIER -104.81 -46.37 4.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 111.938 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 491' ' ' ARG . 51.0 mt-10 -104.25 -7.93 19.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 112.5 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.87 -3.5 87.04 Favored Glycine 0 N--CA 1.508 3.438 0 O-C-N 120.581 -1.324 . . . . 0.0 110.051 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' CB ' ' A' ' 491' ' ' ARG . 93.7 mmm -64.8 -177.25 0.32 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -1.075 . . . . 0.0 112.721 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.64 169.46 8.8 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.744 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 488' ' ' THR . 1.2 p90 -142.33 150.09 40.31 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.564 -0.71 . . . . 0.0 110.443 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 30.8 m -61.77 109.25 2.06 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.48 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -84.91 113.35 1.55 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.362 1.191 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 168.85 31.83 0.02 OUTLIER Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.584 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.716 ' HB3' HG21 ' A' ' 487' ' ' ILE . 4.5 p -96.35 -175.4 3.34 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 463' ' ' VAL . 25.1 m -110.03 122.75 48.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.765 HG11 ' CD1' ' A' ' 522' ' ' LEU . 46.4 t -115.64 129.58 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.731 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.968 HD12 HG22 ' A' ' 449' ' ' VAL . 15.2 pt -124.6 119.31 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.69 ' HB ' HG21 ' A' ' 518' ' ' THR . 3.6 p -107.34 110.76 32.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.807 -1.183 . . . . 0.0 109.96 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.757 ' OD2' HG11 ' A' ' 449' ' ' VAL . 21.4 m-20 -82.71 105.7 13.95 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 0.4 OUTLIER -109.21 178.37 4.47 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.08 0.943 . . . . 0.0 112.714 -175.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.437 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -167.36 -91.24 0.08 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -38.89 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.603 -0.299 . . . . 0.0 111.566 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -179.02 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.39 -1.444 . . . . 0.0 110.883 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 513' ' ' LEU . 14.2 tp -62.87 -30.77 71.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.573 -0.704 . . . . 0.0 109.935 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 6.0 p -69.17 -38.79 78.9 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.761 -0.587 . . . . 0.0 111.749 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.6 tp -64.26 -45.45 88.04 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.396 -0.815 . . . . 0.0 112.106 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 51.9 mtpt -65.11 -45.48 84.98 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.73 -42.62 95.08 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.288 -0.882 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 507' ' ' VAL . 74.4 m -58.54 -46.93 85.78 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.834 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 550' ' ' MET . 5.5 mt -62.95 -36.91 85.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.246 -0.908 . . . . 0.0 111.008 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.5 m -58.07 -41.31 83.14 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.165 -0.959 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.38 -37.84 63.32 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.59 0.71 . . . . 0.0 109.498 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.765 ' CD1' HG11 ' A' ' 505' ' ' VAL . 2.0 tp -63.65 -22.23 66.79 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -46.43 -52.78 12.37 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.5 -0.75 . . . . 0.0 112.005 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.74 -50.54 53.17 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.788 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -58.26 -44.12 88.24 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.667 -0.902 . . . . 0.0 111.858 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.35 -25.41 67.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 0.0 111.246 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -55.41 -26.2 40.3 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.091 -1.005 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.48 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.9 m80 -110.88 -130.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.607 -0.683 . . . . 0.0 109.913 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -88.49 78.05 7.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.557 -1.339 . . . . 0.0 112.614 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.788 HG21 ' HB1' ' A' ' 525' ' ' ALA . 0.9 OUTLIER -134.34 158.4 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 109.152 178.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 98.2 mm-40 -150.82 157.99 43.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.739 -0.601 . . . . 0.0 109.726 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 69.1 t -110.78 96.81 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.192 -0.943 . . . . 0.0 113.468 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.663 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.5 OUTLIER -95.9 114.19 25.88 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 174.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.65 HG22 ' CG1' ' A' ' 507' ' ' VAL . 4.9 pt -130.04 136.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.401 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.494 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 18.5 p -96.68 176.25 6.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 1.8 p30 -158.59 168.16 27.66 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.948 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.437 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.7 t -140.61 59.36 1.55 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -37.28 158.95 0.01 OUTLIER Glycine 0 N--CA 1.507 3.382 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.999 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.78 -87.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.166 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -108.77 -81.23 0.57 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.775 -1.203 . . . . 0.0 112.805 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 t -139.75 -30.16 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.675 0.75 . . . . 0.0 109.511 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -98.89 50.97 1.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.0 t -76.34 3.27 11.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 122.128 -0.631 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -50.2 -26.68 9.53 Favored Glycine 0 N--CA 1.502 3.088 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.0 m -70.61 -20.85 62.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.995 -1.297 . . . . 0.0 109.047 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.785 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -68.48 -34.33 75.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -63.83 -42.65 97.57 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.393 -0.817 . . . . 0.0 109.928 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.07 -34.51 75.02 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.83 -44.09 39.11 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.699 ' HB2' HD21 ' A' ' 515' ' ' LEU . 1.4 tmt? -57.49 -47.11 82.8 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.5 -33.42 71.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.677 -0.64 . . . . 0.0 111.496 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -63.96 -18.89 64.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.295 -0.878 . . . . 0.0 110.064 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.99 0.07 6.61 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.36 -0.838 . . . . 0.0 112.379 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 111.7 -12.4 27.6 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.816 -1.177 . . . . 0.0 111.52 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 519' ' ' LEU . 68.8 t . . . . . 0 N--CA 1.496 1.867 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.629 0.728 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.13 -37.3 86.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.503 -0.748 . . . . 0.0 110.882 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 49.0 m -60.02 -44.23 94.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.587 -0.696 . . . . 0.0 111.189 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 433' ' ' LEU . 77.2 t -77.21 -29.56 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 111.063 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -65.51 -47.8 74.75 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.12 . . . . 0.0 111.166 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.26 88.76 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.876 0.846 . . . . 0.0 110.331 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.574 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.3 tt -61.88 -38.83 89.75 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.207 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.2 m -61.15 -36.72 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.063 -0.398 . . . . 0.0 110.77 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -60.76 -44.07 97.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 110.734 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . 0.425 ' O ' ' CE1' ' A' ' 419' ' ' TYR . 39.1 t70 -65.58 -44.39 86.81 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 0.0 111.962 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.769 HG23 ' HB3' ' A' ' 419' ' ' TYR . 0.9 OUTLIER -63.3 -42.17 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 121.106 -0.996 . . . . 0.0 108.983 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 2.9 ttt -61.96 -26.72 68.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.727 -0.608 . . . . 0.0 109.578 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -62.27 -31.13 71.67 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.653 ' O ' HG12 ' A' ' 405' ' ' VAL . 27.4 tp60 -89.75 -11.69 41.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 0.0 109.83 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.51 -39.92 88.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 -116.57 17.8 15.23 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.788 -1.195 . . . . 0.0 109.721 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.4 p -56.87 118.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.612 -0.68 . . . . 0.0 110.001 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -54.58 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.083 -1.011 . . . . 0.0 109.559 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 405' ' ' VAL . 43.0 t -96.02 130.9 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.899 -0.501 . . . . 0.0 110.132 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.12 131.78 34.1 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.475 -0.765 . . . . 0.0 109.878 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 -24.03 43.88 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.164 1.086 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.36 -37.4 80.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.941 0.877 . . . . 0.0 110.181 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 67.6 1.03 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.8 p -49.8 155.3 0.88 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.108 0.956 . . . . 0.0 112.088 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 407' ' ' VAL . 7.3 p -101.45 143.65 27.02 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 417' ' ' ALA . 38.1 Cg_endo -64.77 131.26 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 N-CA-C 109.104 -1.152 . . . . 0.0 109.104 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -109.51 -19.06 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.516 -0.74 . . . . 0.0 112.502 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 420' ' ' SER . 9.8 t -101.86 14.95 30.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 414' ' ' PRO . . . -75.55 -77.86 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.689 -0.632 . . . . 0.0 111.607 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -89.0 -0.72 80.65 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.782 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.769 ' HB3' HG23 ' A' ' 399' ' ' ILE . 80.2 m-85 -107.98 -26.39 10.71 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.775 2.288 . . . . 0.0 108.763 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 416' ' ' THR . 4.9 t -71.19 -38.78 72.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 175.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 -38.8 92.19 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -59.88 -37.22 78.74 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.748 0.785 . . . . 0.0 109.327 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 75.9 t -66.85 -44.42 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.7 p -61.02 -37.82 83.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.642 -1.286 . . . . 0.0 111.529 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.25 -46.47 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -55.3 -32.78 62.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 0.0 111.686 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.16 78.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.806 -1.184 . . . . 0.0 108.877 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.49 -30.57 65.21 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.68 -89.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.488 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -174.67 -54.33 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.617 -1.302 . . . . 0.0 108.93 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.9 Cg_endo -70.81 98.71 0.8 Allowed 'Trans proline' 0 N--CA 1.487 1.135 0 N-CA-C 109.179 -1.123 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.533 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -84.34 102.09 12.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.804 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.91 98.1 1.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.35 -0.844 . . . . 0.0 111.928 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -142.92 168.32 19.99 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.48 -0.763 . . . . 0.0 111.82 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.27 129.92 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.747 -0.596 . . . . 0.0 111.385 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.624 ' CG2' HG21 ' A' ' 423' ' ' VAL . 25.5 t -133.02 155.44 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.312 -0.868 . . . . 0.0 110.083 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.7 t -133.09 138.9 46.87 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.427 -0.796 . . . . 0.0 111.024 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -101.41 -171.34 28.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -153.18 26.15 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.732 -0.863 . . . . 0.0 109.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.9 10.33 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.56 55.35 15.22 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.42 -9.08 59.58 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -57.69 -45.96 84.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.134 -0.979 . . . . 0.0 111.723 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -83.05 -28.55 36.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.74 -40.43 88.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.952 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.783 ' O ' HG12 ' A' ' 449' ' ' VAL . 5.5 mmt85 -65.97 -39.27 90.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.51 -0.744 . . . . 0.0 109.66 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -67.66 -29.5 68.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.141 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 49.7 ttt85 -64.21 -47.0 81.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 446' ' ' ARG . 9.5 p -56.5 -30.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.554 -1.341 . . . . 0.0 109.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.498 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 95.3 mt-10 -62.76 -33.68 75.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.734 -1.229 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 452' ' ' LEU . 4.2 mm? -65.02 -34.54 78.67 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.927 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.3 t -60.47 -31.75 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 96.3 mmm -65.14 -40.1 93.95 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.3 ttp -59.63 -22.45 61.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.603 -0.686 . . . . 0.0 110.318 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 461' ' ' ARG . . . -81.93 -22.79 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -65.37 -43.09 91.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.429 -0.794 . . . . 0.0 109.655 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.19 -28.93 63.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -76.03 -2.92 33.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.699 -0.626 . . . . 0.0 111.388 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.58 19.99 72.46 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.406 ' HG3' ' HB1' ' A' ' 456' ' ' ALA . 32.2 ptt180 -136.72 151.18 48.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -1.064 . . . . 0.0 110.406 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.523 ' HB2' HD13 ' A' ' 487' ' ' ILE . 92.3 mt-10 -102.07 178.84 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.927 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.4 m -141.9 158.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.778 -1.201 . . . . 0.0 111.578 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.9 tt0 -102.1 119.33 38.62 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -126.77 130.97 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.232 -0.918 . . . . 0.0 111.081 -178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 465' ' ' ILE . 91.1 mt -129.11 123.56 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.852 -0.53 . . . . 0.0 110.277 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -75.66 165.71 24.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.424 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -58.1 -161.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.571 -0.706 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.53 -20.52 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -74.57 -2.86 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.395 -0.815 . . . . 0.0 110.752 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.444 ' CZ ' HD12 ' A' ' 482' ' ' LEU . 0.9 OUTLIER -54.19 -26.06 26.15 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.108 -0.995 . . . . 0.0 110.46 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.2 p -65.41 -46.81 78.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.392 -0.818 . . . . 0.0 109.966 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.77 -49.25 69.03 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.373 -0.829 . . . . 0.0 110.329 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 6.4 ttt -58.57 -30.61 67.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 110.403 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -58.75 -33.37 70.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 47.3 ttp -58.47 -39.08 78.95 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.315 0.579 . . . . 0.0 110.295 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -125.14 -157.36 0.78 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.835 -0.541 . . . . 0.0 109.663 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 45.82 61.44 2.65 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.443 -0.786 . . . . 0.0 112.167 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -98.05 9.03 43.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.586 -0.696 . . . . 0.0 109.795 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -93.04 -0.59 57.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.598 ' C ' HD23 ' A' ' 482' ' ' LEU . 0.2 OUTLIER -141.16 3.38 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 112.454 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.5 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.872 -1.142 . . . . 0.0 111.815 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.9 p -93.76 48.24 1.27 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.132 -0.98 . . . . 0.0 108.926 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.82 26.66 28.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -118.52 47.58 1.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.495 -1.003 . . . . 0.0 108.814 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.82 HD11 ' HA3' ' A' ' 489' ' ' GLY . 0.2 OUTLIER -96.11 -82.77 0.39 Allowed 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.644 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.894 HG21 ' OG ' ' A' ' 503' ' ' SER . 38.0 mm -142.71 -90.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.076 -1.015 . . . . 0.0 108.99 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.452 ' HB ' ' CG ' ' A' ' 499' ' ' PHE . 0.0 OUTLIER -102.09 11.85 37.73 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.653 -0.654 . . . . 0.0 110.263 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.82 ' HA3' HD11 ' A' ' 486' ' ' LEU . . . -81.78 77.62 2.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.482 ' CG ' ' H ' ' A' ' 491' ' ' ARG . 0.2 OUTLIER -144.47 -86.11 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 490' ' ' ARG . 77.9 mtt85 -112.14 -17.16 12.87 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.443 -0.785 . . . . 0.0 109.227 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 497' ' ' MET . 8.0 mp0 -49.64 -36.1 23.51 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.61 -1.306 . . . . 0.0 111.226 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 521' ' ' LEU . 60.9 mt -71.84 -66.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.16 -0.962 . . . . 0.0 108.465 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -54.11 -28.99 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.408 0.623 . . . . 0.0 110.377 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 80.0 mm-40 -84.51 -3.16 58.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.0 111.585 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 69.91 48.87 38.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.49 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 94.4 mtp -123.01 -177.39 3.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -1.001 . . . . 0.0 111.127 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.48 170.63 7.96 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.649 -0.657 . . . . 0.0 110.325 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.452 ' CG ' ' HB ' ' A' ' 488' ' ' THR . 4.6 m-85 -109.21 125.64 52.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.257 -0.902 . . . . 0.0 108.612 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.7 t -68.02 150.89 97.58 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.613 -0.679 . . . . 0.0 110.852 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.444 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 42.5 Cg_endo -71.6 123.7 9.67 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.611 1.322 . . . . 0.0 111.049 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 161.64 -2.06 0.07 OUTLIER Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.72 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.894 ' OG ' HG21 ' A' ' 487' ' ' ILE . 8.6 m -82.81 153.21 25.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.343 . . . . 0.0 113.502 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.866 ' HB ' HG12 ' A' ' 463' ' ' VAL . 50.7 m -118.58 91.88 3.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.665 ' CB ' HD21 ' A' ' 522' ' ' LEU . 18.3 t -87.85 135.8 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.756 HG22 ' HB2' ' A' ' 533' ' ' LEU . 18.2 pt -136.55 122.43 28.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 534' ' ' ILE . 8.5 p -123.67 111.98 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.669 -1.269 . . . . 0.0 112.787 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -86.59 123.04 31.34 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.406 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.4 pm0 -160.52 129.23 4.76 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 117.488 -1.685 . . . . 0.0 115.434 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.485 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.3 -43.02 6.76 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.61 151.54 45.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -98.83 -11.68 21.55 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.24 -40.46 90.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 13.5 t -67.71 -39.95 84.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.819 -0.551 . . . . 0.0 111.201 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' A' ' 550' ' ' MET . 64.4 tp -62.67 -44.76 95.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.595 -0.691 . . . . 0.0 111.235 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 32.2 ttpt -71.36 -46.57 60.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.294 -0.878 . . . . 0.0 112.975 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.03 -44.08 85.7 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 83.1 m -56.84 -43.4 81.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.309 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.1 OUTLIER -53.76 -34.42 58.94 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.33 0.586 . . . . 0.0 109.882 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.403 ' HA ' ' OD2' ' A' ' 523' ' ' ASP . 27.0 m -62.35 -41.48 98.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.508 -0.745 . . . . 0.0 109.513 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 493' ' ' LEU . 1.0 OUTLIER -62.66 -40.52 97.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.738 0.78 . . . . 0.0 108.928 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.33 -21.34 63.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.923 -0.485 . . . . 0.0 110.851 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 520' ' ' THR . 95.4 m-20 -46.09 -64.55 0.72 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.622 -0.673 . . . . 0.0 112.453 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.03 -52.47 49.79 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 120.577 -1.327 . . . . 0.0 110.737 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.24 68.18 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.258 -1.142 . . . . 0.0 111.006 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.87 -20.66 66.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -37.9 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 0.7 OUTLIER -145.44 -79.25 0.18 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.267 -1.521 . . . . 0.0 113.751 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.435 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 82.5 m-20 -90.65 72.63 6.76 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.712 -1.243 . . . . 0.0 114.087 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 9.6 p -130.16 150.63 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.738 -1.226 . . . . 0.0 112.572 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.507 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 87.8 mm-40 -144.02 149.86 37.34 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 5.2 t -112.33 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.761 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.756 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -103.08 116.67 32.96 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -136.0 150.7 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.747 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.3 p -118.13 -163.99 0.98 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.54 163.15 40.36 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.607 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.485 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 3.8 p -128.7 22.25 5.9 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.875 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -174.0 43.85 0.14 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.35 -0.41 56.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.881 -0.776 . . . . 0.0 111.732 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -55.68 -42.71 75.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.995 -1.066 . . . . 0.0 110.851 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 m -116.76 156.38 27.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.591 -0.693 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.53 34.38 55.22 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -62.62 -43.36 98.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.42 -1.047 . . . . 0.0 110.61 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -62.77 -33.53 87.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.9 m -63.98 -39.45 94.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.846 -0.797 . . . . 0.0 111.007 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.53 -37.09 82.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.01 -42.26 99.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.657 -0.652 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 63.8 tpp -63.59 -34.58 78.14 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.5 -0.75 . . . . 0.0 109.515 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.23 -53.89 50.26 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.737 ' HB2' HD21 ' A' ' 515' ' ' LEU . 39.0 ttp -58.57 -44.86 89.88 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.317 -0.864 . . . . 0.0 109.914 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 555' ' ' VAL . 75.8 mmtt -60.28 -32.04 70.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.643 -0.66 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.81 -16.6 63.83 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.337 -0.852 . . . . 0.0 110.607 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.38 2.85 2.65 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 138.73 -16.66 3.29 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.21 -1.472 . . . . 0.0 111.817 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 555' ' ' VAL . 35.2 m . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.996 -1.297 . . . . 0.0 110.262 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.456 HD23 ' CZ ' ' A' ' 393' ' ' ARG . 93.9 mt -71.66 -31.13 66.48 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.904 -1.123 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 17.0 p -64.63 -40.64 95.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.816 -0.552 . . . . 0.0 111.915 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.59 -35.93 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 111.961 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.456 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 77.3 mtm180 -63.81 -46.99 82.66 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.71 -1.244 . . . . 0.0 110.63 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.35 75.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.688 HD13 ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -63.34 -39.03 93.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.825 -0.547 . . . . 0.0 110.52 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 59.3 m -61.23 -37.84 84.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.424 -0.797 . . . . 0.0 110.419 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -63.3 -44.69 94.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.325 -0.859 . . . . 0.0 111.663 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -67.66 -46.06 73.48 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.149 -0.969 . . . . 0.0 111.949 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 436' ' ' VAL . 63.9 mt -65.44 -42.35 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.985 -1.072 . . . . 0.0 109.921 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 16.6 ttm -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.19 -25.66 65.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.52 -0.738 . . . . 0.0 109.381 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 0.0 OUTLIER -93.11 -15.64 25.83 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.867 -1.146 . . . . 0.0 109.025 175.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 0.4 OUTLIER -67.3 -40.3 86.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.608 -0.683 . . . . 0.0 110.263 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -115.49 18.67 15.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.969 -1.082 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 405' ' ' VAL . 7.1 p -48.7 116.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.492 -0.755 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.8 p -50.49 89.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.786 -0.571 . . . . 0.0 111.016 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 413' ' ' VAL . 14.2 p -108.74 133.7 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -96.76 141.7 23.47 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 110.85 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.93 -24.35 39.83 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.143 1.075 . . . . 0.0 110.232 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -66.76 -32.32 73.53 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.782 0.801 . . . . 0.0 110.392 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 67.21 1.14 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 18.6 t -49.56 148.74 2.69 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.55 -0.718 . . . . 0.0 110.604 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -100.93 110.06 59.9 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.637 . . . . 0.0 110.855 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.81 121.37 5.44 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.004 1.002 . . . . 0.0 111.3 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.4 ' HE ' HG22 ' A' ' 413' ' ' VAL . 13.2 ptp180 -169.4 61.7 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.825 . . . . 0.0 110.181 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.2 t -67.47 -31.36 71.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.323 -0.861 . . . . 0.0 108.799 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.64 47.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 110.735 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.7 81.24 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.519 ' CD1' HG11 ' A' ' 436' ' ' VAL . 26.0 p90 -90.27 -0.42 57.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.93 -1.336 . . . . 0.0 110.161 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.8 m -76.07 -38.81 56.59 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.801 ' O ' HG23 ' A' ' 425' ' ' VAL . 30.8 t70 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.447 0.642 . . . . 0.0 109.962 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.594 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.49 -49.51 75.08 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.971 0.891 . . . . 0.0 111.068 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 436' ' ' VAL . 97.4 t -68.41 -42.24 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.771 -0.581 . . . . 0.0 111.146 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 88.1 p -59.48 -33.05 70.83 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.007 . . . . 0.0 110.42 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 421' ' ' ASP . 76.6 t -63.11 -46.03 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.7 -0.625 . . . . 0.0 111.026 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.8 pp -64.13 -34.76 78.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.178 -0.951 . . . . 0.0 112.367 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.26 85.5 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.629 -1.294 . . . . 0.0 109.15 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -63.3 -32.3 73.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -66.33 -93.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -177.26 -53.79 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.369 -1.457 . . . . 0.0 109.433 177.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 41.1 Cg_endo -68.72 106.36 1.46 Allowed 'Trans proline' 0 N--CA 1.48 0.726 0 N-CA-C 108.204 -1.498 . . . . 0.0 108.204 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.462 ' HB3' ' N ' ' A' ' 532' ' ' VAL . 0.2 OUTLIER -92.36 103.56 15.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.6 OUTLIER -164.07 89.81 0.57 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.938 -1.102 . . . . 0.0 109.27 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -137.4 170.0 16.83 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.785 0.802 . . . . 0.0 111.414 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.35 126.73 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 423' ' ' VAL . 22.4 t -130.04 160.4 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 110.729 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.5 t -133.58 138.79 46.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.434 -0.791 . . . . 0.0 110.685 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.02 166.51 23.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -116.89 -44.59 2.81 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.283 -1.128 . . . . 0.0 109.492 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.9 165.85 38.3 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.98 36.21 64.73 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.677 ' HB3' ' NH1' ' A' ' 470' ' ' ARG . . . -59.13 -22.34 60.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.79 -0.829 . . . . 0.0 112.001 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.56 90.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.82 -29.49 59.15 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 448' ' ' ARG . 43.4 tt0 -60.17 -41.3 92.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.597 -0.943 . . . . 0.0 109.957 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.609 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.0 mtm180 -64.01 -36.12 82.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.16 -30.13 68.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.415 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 445' ' ' GLN . 89.3 mtt-85 -64.62 -49.73 69.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -57.43 -32.58 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.003 -1.061 . . . . 0.0 110.138 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.67 -27.18 68.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 454' ' ' MET . 83.4 tt0 -66.55 -36.6 83.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -62.56 -35.47 79.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.936 HG13 ' CG2' ' A' ' 463' ' ' VAL . 46.9 t -64.63 -28.2 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 95.0 mtp -68.26 -42.73 79.17 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.216 -0.928 . . . . 0.0 111.764 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 6.6 ptm -63.36 -21.58 66.36 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.51 -1.369 . . . . 0.0 109.245 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.43 48.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.456 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.16 -41.05 97.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.47 -22.53 62.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.799 -0.563 . . . . 0.0 110.497 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -75.28 -0.23 18.9 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.171 -0.956 . . . . 0.0 111.651 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 82.24 12.53 80.59 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 120.92 -1.112 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -139.54 151.84 46.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 110.653 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.74 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.8 mt-10 -92.85 179.28 5.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.587 -0.696 . . . . 0.0 109.205 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.936 ' CG2' HG13 ' A' ' 453' ' ' VAL . 14.7 m -141.85 153.23 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.779 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.681 ' HB3' HG22 ' A' ' 505' ' ' VAL . 53.8 tt0 -98.52 118.31 34.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -122.72 128.82 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.42 -0.8 . . . . 0.0 109.467 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.649 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.4 mp -121.39 115.92 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.972 -0.455 . . . . 0.0 110.224 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -71.05 161.41 31.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.46 ' HA ' ' NE2' ' A' ' 509' ' ' GLN . . . -57.36 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.121 -0.987 . . . . 0.0 110.298 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -48.43 -19.8 0.35 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.036 -1.04 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . 0.677 ' NH1' ' HB3' ' A' ' 442' ' ' ALA . 99.8 mtt180 -78.22 -10.64 59.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.625 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 60.9 ttt-85 -55.11 -25.51 31.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 111.827 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 77.9 p -59.06 -41.92 89.1 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.989 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -64.95 -41.54 95.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.566 -0.709 . . . . 0.0 109.541 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 38.7 ttm -58.0 -36.6 72.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.588 -0.695 . . . . 0.0 110.536 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -60.89 -40.62 93.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -0.82 . . . . 0.0 109.869 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 52.2 mtt -62.79 -40.05 96.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.622 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.413 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 65.0 pttt -117.52 -158.3 0.7 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.165 -0.959 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.413 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 94.8 mm-40 46.15 88.83 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.452 -0.78 . . . . 0.0 112.118 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -116.75 26.28 9.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -107.7 -9.82 15.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 111.449 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -11.39 3.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 111.909 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -173.58 55.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 5.7 t -62.27 -18.48 61.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.318 -0.864 . . . . 0.0 109.921 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 486' ' ' LEU . . . 163.81 -21.08 0.15 Allowed Glycine 0 N--CA 1.501 2.986 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.51 71.31 3.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.029 -1.277 . . . . 0.0 110.014 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -86.77 -82.96 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.398 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.887 HG22 HG23 ' A' ' 488' ' ' THR . 34.5 mm -145.23 -86.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.147 . . . . 0.0 110.322 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 499' ' ' PHE . 69.7 p -96.33 47.78 1.08 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -111.65 59.84 0.35 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.478 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 79.2 ttt180 -143.98 -61.44 0.39 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.438 -1.037 . . . . 0.0 108.908 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -110.71 -31.01 7.35 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.382 0.611 . . . . 0.0 110.558 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -35.92 82.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.306 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.492 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 7.1 mt -91.95 -26.46 18.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.332 -0.855 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 41.7 tp -104.55 -41.64 5.65 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.66 -8.68 18.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.972 -1.08 . . . . 0.0 113.733 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 86.6 -16.36 46.0 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.674 -1.267 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.83 -178.52 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.197 -1.178 . . . . 0.0 109.429 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.38 156.49 22.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.177 -0.952 . . . . 0.0 110.644 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.956 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -113.66 149.06 35.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.855 -0.528 . . . . 0.0 109.726 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -47.09 104.67 0.42 Allowed Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.531 -0.731 . . . . 0.0 110.575 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 529' ' ' ASN . 55.3 Cg_endo -76.72 111.89 3.34 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.25 1.131 . . . . 0.0 110.422 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 174.42 34.64 0.04 OUTLIER Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.824 ' OG ' HD12 ' A' ' 487' ' ' ILE . 14.5 m -99.35 -177.21 3.52 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.331 1.063 . . . . 0.0 113.461 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.824 ' HB ' HG12 ' A' ' 463' ' ' VAL . 52.4 m -120.48 128.79 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 464' ' ' GLN . 37.4 t -116.45 131.79 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.911 0.863 . . . . 0.0 112.726 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 533' ' ' LEU . 39.6 mt -129.71 113.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.947 -1.096 . . . . 0.0 108.121 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 534' ' ' ILE . 10.6 p -114.93 105.21 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.883 -1.136 . . . . 0.0 111.9 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.405 ' OD2' HG11 ' A' ' 449' ' ' VAL . 83.5 m-20 -85.48 124.17 31.75 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 468' ' ' ALA . 9.3 tp-100 -160.1 125.78 4.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -91.4 -31.82 9.28 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.15 -164.08 0.83 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.02 -5.67 3.09 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.89 -39.14 79.92 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.126 -0.984 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.9 m -87.29 -17.34 32.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.559 -0.713 . . . . 0.0 111.733 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 550' ' ' MET . 59.7 tp -73.52 -41.8 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.43 -0.794 . . . . 0.0 109.871 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.2 mttt -74.54 -43.06 57.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.527 -0.733 . . . . 0.0 111.888 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.4 OUTLIER -61.05 -44.55 97.22 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.971 -1.081 . . . . 0.0 110.954 -178.298 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -60.16 -42.1 94.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 0.0 109.508 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.492 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.41 -38.35 77.21 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.797 -0.564 . . . . 0.0 109.619 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.9 m -61.42 -36.33 80.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.303 -0.873 . . . . 0.0 108.993 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 521' ' ' LEU . 0.2 OUTLIER -68.36 -38.29 81.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.8 -0.563 . . . . 0.0 109.984 178.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.627 HD11 HG11 ' A' ' 505' ' ' VAL . 0.5 OUTLIER -67.68 -21.29 65.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.15 -0.969 . . . . 0.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 5.7 t0 -46.44 -63.33 1.03 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.37 -0.831 . . . . 0.0 111.198 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.74 79.36 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 529' ' ' ASN . . . -53.49 -29.75 37.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.75 -0.853 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -46.42 -25.41 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 112.767 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -59.02 -42.91 91.31 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.78 -35.74 0.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.286 -0.884 . . . . 0.0 110.856 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.639 ' HB3' ' HB1' ' A' ' 525' ' ' ALA . 41.1 t-20 -79.77 103.14 9.47 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 529' ' ' ASN . 16.4 m -149.45 125.86 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.08 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.7 OUTLIER 176.23 100.2 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.462 ' N ' ' HB3' ' A' ' 432' ' ' SER . 95.5 t -107.47 109.86 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.629 1.204 . . . . 0.0 109.989 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.754 HD21 ' CG1' ' A' ' 423' ' ' VAL 0.306 4.3 tt -114.45 115.58 27.51 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 103.028 -2.952 . . . . 0.0 103.028 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 507' ' ' VAL . 0.5 OUTLIER -134.48 129.65 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.841 -177.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 68.1 p -100.87 -163.58 1.03 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.6 165.62 36.02 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.21 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 4.4 p -132.94 16.14 4.23 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.38 42.96 0.31 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -96.5 -0.04 49.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.745 -0.856 . . . . 0.0 112.182 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -46.07 -32.06 2.65 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.161 -0.962 . . . . 0.0 111.496 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 t -131.49 162.59 29.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.463 -0.773 . . . . 0.0 109.377 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.69 31.71 58.0 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -61.91 -46.53 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.964 . . . . 0.0 110.758 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.3 -38.19 94.78 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 5.6 t -63.13 -33.73 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.816 -0.814 . . . . 0.0 109.686 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.49 -37.11 80.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.598 -0.689 . . . . 0.0 110.293 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.97 -41.02 97.67 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.461 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 87.7 mmm -65.51 -32.97 74.85 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.377 -0.827 . . . . 0.0 108.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -54.11 -54.76 35.04 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.597 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.492 ' CG ' HD11 ' A' ' 519' ' ' LEU . 65.9 ttp -59.11 -43.22 91.89 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.16 -0.962 . . . . 0.0 110.439 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.26 -32.36 73.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.424 -0.798 . . . . 0.0 112.133 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.1 -13.54 61.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.375 -0.828 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.555 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -72.8 6.91 2.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 112.664 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 140.7 -17.69 2.82 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.87 -1.157 . . . . 0.0 110.967 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 81.5 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.155 -1.203 . . . . 0.0 110.303 -179.407 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 120.557 0.218 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.31 -39.71 87.95 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.6 m -64.24 -42.57 96.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.477 -0.764 . . . . 0.0 109.946 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 433' ' ' LEU . 86.5 t -67.79 -34.41 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.784 -0.572 . . . . 0.0 110.621 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -61.12 -48.09 83.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.296 -0.877 . . . . 0.0 111.349 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.89 78.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.45 -0.782 . . . . 0.0 110.458 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.743 ' CD2' HD11 ' A' ' 399' ' ' ILE . 10.0 tt -61.86 -39.15 90.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.751 -0.593 . . . . 0.0 110.507 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 60.6 m -63.17 -40.35 97.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.747 -0.596 . . . . 0.0 111.49 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.42 -41.8 97.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.333 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.3 -42.39 93.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.618 -0.676 . . . . 0.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -63.08 -39.01 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 120.906 -1.121 . . . . 0.0 108.761 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.583 ' CG ' HD11 ' A' ' 435' ' ' ILE . 42.5 mtp -65.37 -28.47 69.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.37 -29.87 70.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.742 ' O ' HG12 ' A' ' 405' ' ' VAL . 55.1 tt0 -92.8 -13.58 28.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.43 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -66.18 -36.91 84.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.651 -0.656 . . . . 0.0 109.458 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -116.81 18.85 14.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.791 -1.193 . . . . 0.0 109.919 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.8 p -61.81 118.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.493 -0.754 . . . . 0.0 110.007 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.2 m -53.91 105.08 0.12 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 405' ' ' VAL . 44.8 t -106.53 132.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.612 -0.68 . . . . 0.0 109.548 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -91.95 140.68 24.83 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.552 -0.718 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.1 -23.37 33.88 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.264 1.139 . . . . 0.0 110.265 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -58.68 -43.0 89.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.322 -0.862 . . . . 0.0 109.395 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 67.38 0.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 91.4 p -52.66 117.4 2.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.241 -0.912 . . . . 0.0 111.525 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 407' ' ' VAL . 8.7 p -62.58 149.94 87.4 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -61.88 140.47 85.41 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.068 1.036 . . . . 0.0 110.095 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.438 ' NH2' ' HB2' ' A' ' 439' ' ' GLN . 42.2 mtm180 -106.44 -12.77 15.54 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.839 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 420' ' ' SER . 38.5 p -103.26 10.77 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.388 -1.445 . . . . 0.0 108.792 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.68 -87.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.47 78.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.652 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' A' ' 399' ' ' ILE . 78.7 m-85 -108.32 -25.38 11.04 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 120.756 2.278 . . . . 0.0 109.184 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 416' ' ' THR . 3.7 t -72.94 -40.75 65.14 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -64.12 -35.87 82.16 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 419' ' ' TYR . . . -60.0 -39.13 84.71 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.338 0.589 . . . . 0.0 109.877 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.892 ' HA ' HD23 ' A' ' 426' ' ' LEU . 57.3 t -66.84 -45.6 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 0.0 111.03 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 85.9 p -60.08 -41.51 92.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.142 -0.974 . . . . 0.0 111.577 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.88 -47.02 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.404 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -50.55 -32.56 18.89 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.61 -0.682 . . . . 0.0 112.0 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.18 71.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 0.0 109.278 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.08 -29.46 69.76 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -64.73 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.569 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.65 -51.12 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.503 -1.373 . . . . 0.0 111.346 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 50.1 Cg_endo -86.31 110.11 0.98 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 O-C-N 122.698 0.841 . . . . 0.0 110.03 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.568 ' HA ' HD11 ' A' ' 426' ' ' LEU . 2.8 m -91.19 99.78 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 111.089 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.825 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 7.4 tp -156.79 90.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.619 -0.676 . . . . 0.0 111.017 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -138.43 166.58 23.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.772 -0.58 . . . . 0.0 110.979 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.583 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.1 pp -122.17 125.36 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.631 -0.668 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.743 ' CG2' HG21 ' A' ' 423' ' ' VAL . 38.2 t -128.21 153.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.012 -1.055 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.9 t -132.92 139.09 47.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.21 -0.931 . . . . 0.0 111.735 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 415' ' ' ARG . . . -141.57 143.85 13.63 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . 0.438 ' HB2' ' NH2' ' A' ' 415' ' ' ARG . 27.1 mt-30 -143.29 55.25 1.36 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -1.066 . . . . 0.0 110.279 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 151.73 140.31 3.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.47 79.66 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.01 60.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.964 . . . . 0.0 112.014 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.35 89.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 110.883 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.79 -31.05 56.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . 0.412 ' NE2' HG21 ' A' ' 416' ' ' THR . 51.0 tt0 -67.17 -40.39 86.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.699 -0.883 . . . . 0.0 111.049 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.572 ' O ' HG12 ' A' ' 449' ' ' VAL . 51.9 mtt-85 -64.14 -41.84 97.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 73.5 tt0 -72.65 -29.51 63.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -61.25 -46.13 91.66 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.394 -0.816 . . . . 0.0 110.463 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -62.78 -31.22 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.317 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -58.81 -34.19 71.22 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.93 -30.18 70.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.2 -0.938 . . . . 0.0 108.619 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.06 -37.07 83.58 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.84 ' CG2' HG21 ' A' ' 465' ' ' ILE . 37.0 t -60.59 -29.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.87 -39.43 87.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -23.97 66.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.654 -0.654 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -82.08 -21.75 36.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -67.48 -41.56 84.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.852 -0.53 . . . . 0.0 110.297 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -71.77 -34.44 69.44 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.089 -1.007 . . . . 0.0 110.374 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -77.71 6.99 6.31 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.464 -0.773 . . . . 0.0 111.702 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.85 24.12 72.81 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.558 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.7 ttm180 -124.53 129.17 50.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.609 -0.936 . . . . 0.0 110.835 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.594 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.1 mt-10 -92.54 161.41 14.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.671 ' CG2' HG13 ' A' ' 453' ' ' VAL . 17.2 m -145.31 157.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 486' ' ' LEU . 57.6 tt0 -103.13 124.68 49.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.795 -0.566 . . . . 0.0 109.726 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.84 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -129.09 132.17 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.048 . . . . 0.0 109.31 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.647 HG23 ' HD3' ' A' ' 471' ' ' ARG . 87.2 mt -125.11 121.4 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.062 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -79.75 163.0 24.82 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.69 -159.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.337 -0.852 . . . . 0.0 109.949 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.53 -16.08 0.33 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.643 -1.286 . . . . 0.0 111.021 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -72.16 -14.53 61.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.975 -1.078 . . . . 0.0 110.218 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.647 ' HD3' HG23 ' A' ' 466' ' ' ILE . 49.1 ttp180 -57.47 -30.92 65.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.161 -0.962 . . . . 0.0 110.877 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 85.1 p -55.46 -44.3 76.27 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.343 -0.848 . . . . 0.0 109.66 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -65.03 -37.99 89.41 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -36.46 77.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.715 -0.616 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -59.23 -38.1 79.15 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.195 -0.941 . . . . 0.0 109.938 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 97.8 mtp -60.22 -38.09 82.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.88 -146.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.497 -0.752 . . . . 0.0 109.772 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 47.58 78.51 0.08 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.036 -1.04 . . . . 0.0 111.853 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -117.75 10.26 13.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.427 ' CB ' ' HD3' ' A' ' 481' ' ' ARG . 30.1 mp0 -77.94 -4.48 47.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.971 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.688 ' C ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.4 17.63 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.224 -0.923 . . . . 0.0 113.278 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 481' ' ' ARG . 9.8 mp -125.44 4.86 7.64 Favored 'General case' 0 N--CA 1.508 2.438 0 CA-C-N 120.475 1.489 . . . . 0.0 112.279 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 10.3 m -74.55 35.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.385 -1.447 . . . . 0.0 112.512 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 109.08 9.78 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 120.669 -1.27 . . . . 0.0 110.088 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -87.82 11.7 14.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.135 -1.215 . . . . 0.0 110.385 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' A' ' 464' ' ' GLN . 3.9 mm? -53.37 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.959 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -174.65 -69.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.87 . . . . 0.0 109.118 174.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.0 t -103.35 10.5 37.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.0 111.496 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -79.82 66.89 3.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 499' ' ' PHE . 66.4 ttt180 -142.78 -69.64 0.34 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.456 ' HG3' ' HG2' ' A' ' 490' ' ' ARG . 74.9 mtt180 -116.1 -19.8 10.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.248 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.745 ' HG2' HD23 ' A' ' 493' ' ' LEU . 36.2 tt0 -63.1 -39.81 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 0.0 108.487 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.745 HD23 ' HG2' ' A' ' 492' ' ' GLN . 3.2 mt -92.51 -18.34 23.29 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.132 0.491 . . . . 0.0 110.966 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 52.5 tp -104.23 -46.84 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.417 -0.802 . . . . 0.0 112.548 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.47 -5.72 15.09 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.26 -0.9 . . . . 0.0 113.103 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 79.0 48.15 7.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 491' ' ' ARG . 96.1 mmm -111.68 -179.44 3.7 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 122.118 -0.637 . . . . 0.0 109.626 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.18 149.54 35.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 0.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 490' ' ' ARG . 28.2 m-85 -131.22 149.21 52.67 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.776 0.798 . . . . 0.0 111.723 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 500' ' ' THR . 2.6 t -56.07 107.29 0.84 Allowed Pre-proline 0 N--CA 1.496 1.831 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.947 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 528' ' ' HIS . 52.5 Cg_endo -74.62 114.74 4.1 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.54 1.284 . . . . 0.0 109.435 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -174.35 30.85 0.09 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.959 ' CB ' HD13 ' A' ' 487' ' ' ILE . 86.0 p -92.7 173.25 7.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 112.44 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.506 ' HB ' HG12 ' A' ' 463' ' ' VAL . 26.5 m -119.81 99.55 6.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.769 HG11 HD21 ' A' ' 522' ' ' LEU . 61.1 t -93.36 134.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.819 0.819 . . . . 0.0 112.071 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.754 HG22 ' HB3' ' A' ' 533' ' ' LEU . 18.5 pt -130.1 149.54 33.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.76 HG22 ' HG2' ' A' ' 509' ' ' GLN . 5.2 p -142.07 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.435 1.112 . . . . 0.0 110.785 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -83.91 108.94 17.21 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.76 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.6 mm-40 -133.9 114.97 13.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -73.76 -32.39 59.23 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.59 ' OE1' HD21 ' A' ' 513' ' ' LEU . 96.8 mt-10 -97.31 175.33 6.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.46 -7.76 13.42 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.81 -0.556 . . . . 0.0 111.027 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 514' ' ' SER . 4.3 pp -67.62 -37.95 83.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.212 -0.93 . . . . 0.0 111.254 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 513' ' ' LEU . 2.3 p -93.24 -14.77 26.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 0.0 111.199 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.918 ' O ' HD22 ' A' ' 519' ' ' LEU . 59.2 tp -70.08 -48.38 57.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.01 -1.056 . . . . 0.0 108.424 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.97 -42.44 89.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.001 -0.437 . . . . 0.0 111.667 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -57.9 -46.93 84.2 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.212 -0.93 . . . . 0.0 111.111 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 98.6 m -62.31 -45.94 90.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -55.3 -28.56 54.36 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.632 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 m -64.15 -28.24 69.63 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 39.3 tp -80.93 -34.03 33.61 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.523 -0.736 . . . . 0.0 109.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.769 HD21 HG11 ' A' ' 505' ' ' VAL . 4.3 mm? -58.01 -31.86 67.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.8 -63.89 0.86 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.951 -0.468 . . . . 0.0 111.62 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.5 52.04 Favored Glycine 0 N--CA 1.499 2.886 0 O-C-N 120.867 -1.146 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -63.09 -39.91 96.1 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.105 -1.232 . . . . 0.0 113.284 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.68 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -58.13 -26.2 62.37 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.083 -1.011 . . . . 0.0 112.128 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -54.89 -30.36 58.02 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 501' ' ' PRO . 7.0 t60 -106.65 -128.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.389 -0.82 . . . . 0.0 110.439 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.412 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.7 OUTLIER -86.71 67.7 9.92 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.721 -1.237 . . . . 0.0 111.974 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 525' ' ' ALA . 2.8 t -133.86 163.83 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.66 -1.275 . . . . 0.0 110.253 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 2.9 mm-40 -163.81 165.0 23.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 33.1 t -109.95 105.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.427 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -103.75 115.07 29.81 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 507' ' ' VAL . 7.1 pt -136.0 164.97 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 117.854 -1.538 . . . . 0.0 113.912 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 436' ' ' VAL . 70.1 p -127.67 -168.3 1.87 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.97 169.08 25.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.435 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.85 17.18 2.31 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.784 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -155.27 33.55 0.65 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.563 HE22 HD13 ' A' ' 435' ' ' ILE . 57.0 tt0 -97.04 -0.29 47.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.683 -0.893 . . . . 0.0 111.66 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -51.36 -43.88 61.95 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 77.2 p -119.59 161.12 21.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 57.93 29.06 61.53 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -59.85 -45.58 91.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.291 -1.123 . . . . 0.0 110.615 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.81 -36.82 93.32 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 35.5 m -63.76 -35.72 81.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.033 -0.686 . . . . 0.0 110.788 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.601 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -58.86 -39.15 80.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.509 -0.744 . . . . 0.0 110.355 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.02 -40.19 94.84 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 48.3 ttp -63.96 -30.35 71.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.49 -53.97 31.9 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.457 ' HA ' HD23 ' A' ' 519' ' ' LEU . 12.4 ttp -57.76 -42.96 85.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -0.837 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.18 -31.68 67.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.476 -0.765 . . . . 0.0 111.669 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -68.43 -31.87 71.51 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.304 -0.873 . . . . 0.0 109.95 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.81 21.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.945 -0.472 . . . . 0.0 111.465 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 107.43 25.61 5.97 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.657 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.561 -0.964 . . . . 0.0 109.961 179.179 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.29 -41.32 98.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.115 -0.991 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 61.4 m -59.81 -43.68 94.37 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.57 -0.706 . . . . 0.0 110.206 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 69.4 t -65.76 -35.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.302 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -61.93 -46.4 89.49 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.289 -0.882 . . . . 0.0 110.59 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.19 80.14 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.696 0.76 . . . . 0.0 109.161 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -61.96 -39.39 91.98 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 400' ' ' MET . 68.3 m -61.15 -36.43 79.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.072 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -63.87 -44.48 92.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.085 -1.009 . . . . 0.0 111.46 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.84 -46.09 76.18 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.182 -0.949 . . . . 0.0 111.861 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 395' ' ' LEU . 78.6 mt -64.84 -42.74 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.812 . . . . 0.0 109.99 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 396' ' ' SER . 40.4 mmm -62.22 -31.76 72.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.874 -0.516 . . . . 0.0 109.65 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -58.53 -34.09 70.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.377 -0.827 . . . . 0.0 109.154 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.609 ' O ' HG12 ' A' ' 405' ' ' VAL . 95.6 mt-30 -90.57 -14.64 32.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.22 -39.27 89.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -116.85 18.8 14.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.945 -1.097 . . . . 0.0 110.555 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.693 HG11 ' CZ ' ' A' ' 415' ' ' ARG . 3.5 p -51.34 117.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.538 -0.726 . . . . 0.0 109.177 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 25.4 m -52.17 98.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.499 0.666 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 413' ' ' VAL . 8.4 p -109.42 133.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.755 -0.59 . . . . 0.0 109.906 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -92.19 140.28 24.43 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 111.185 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.91 -28.17 42.66 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.254 1.133 . . . . 0.0 110.22 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.9 -33.29 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.826 0.822 . . . . 0.0 109.861 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.17 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 118.53 5.24 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.746 . . . . 0.0 110.675 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.1 p -71.68 110.65 8.08 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.757 -0.589 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.03 139.18 29.46 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 O-C-N 123.066 1.035 . . . . 0.0 110.31 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.693 ' CZ ' HG11 ' A' ' 405' ' ' VAL . 23.7 ptt85 -168.85 60.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.672 -0.642 . . . . 0.0 110.738 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.7 t -65.48 -34.96 79.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -67.29 -7.05 21.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.689 -0.632 . . . . 0.0 110.953 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.75 -43.73 98.53 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.613 ' CB ' HG13 ' A' ' 436' ' ' VAL . 1.1 m-85 -91.64 -3.36 56.44 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.857 -1.378 . . . . 0.0 108.938 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 33.8 p -77.96 -39.04 43.8 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 425' ' ' VAL . 25.3 t70 -77.6 -43.55 31.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.471 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.16 -49.82 74.3 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.666 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 78.7 t -71.26 -41.42 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.922 -0.487 . . . . 0.0 111.861 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -58.92 -41.7 87.94 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.03 -1.044 . . . . 0.0 111.242 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 421' ' ' ASP . 84.4 t -64.47 -45.42 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -56.17 -35.71 67.52 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.54 -0.725 . . . . 0.0 111.993 -177.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.92 81.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.062 -1.024 . . . . 0.0 108.593 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.88 -30.59 71.6 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -63.68 -89.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.424 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.05 -60.66 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.449 -1.407 . . . . 0.0 109.565 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 45.5 Cg_endo -71.56 113.28 3.58 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 N-CA-C 108.242 -1.484 . . . . 0.0 108.242 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 15.2 m -108.96 117.28 33.79 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.897 0.856 . . . . 0.0 112.039 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.539 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -173.22 97.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.87 172.54 12.7 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.203 -0.935 . . . . 0.0 112.462 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 435' ' ' ILE . 0.2 OUTLIER -124.81 136.95 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.381 0.61 . . . . 0.0 109.703 178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 423' ' ' VAL . 60.4 t -141.58 152.9 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 109.629 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.1 p -139.81 149.81 43.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.868 . . . . 0.0 110.752 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.63 159.94 21.76 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -149.23 22.96 0.94 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.93 . . . . 0.0 110.835 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -162.5 -118.13 0.45 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.89 131.33 11.78 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -103.47 -15.02 16.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.293 -1.122 . . . . 0.0 111.291 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -71.55 -43.94 65.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.42 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.08 -28.76 71.22 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -63.84 -40.55 96.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.638 -0.919 . . . . 0.0 109.98 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 449' ' ' VAL . 83.3 mtt85 -64.31 -41.18 96.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.559 -0.713 . . . . 0.0 110.418 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 50.2 mt-10 -70.07 -29.28 66.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.087 -1.008 . . . . 0.0 110.222 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -62.92 -53.09 59.41 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.713 HG22 HD12 ' A' ' 506' ' ' ILE . 13.6 p -57.77 -30.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.051 -1.031 . . . . 0.0 108.626 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.11 -26.52 68.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.71 -35.33 80.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.866 -1.146 . . . . 0.0 108.292 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 455' ' ' MET . 96.0 mt -63.93 -31.38 72.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.495 -0.753 . . . . 0.0 109.009 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.944 HG13 ' CG2' ' A' ' 463' ' ' VAL . 58.1 t -58.48 -38.36 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.248 -0.908 . . . . 0.0 108.948 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 48.0 mtt -63.49 -35.82 81.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.495 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 452' ' ' LEU . 64.7 ttp -54.78 -26.24 33.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.366 -0.834 . . . . 0.0 109.587 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.51 -22.84 32.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.667 -0.646 . . . . 0.0 110.497 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -62.02 -46.09 90.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.373 -0.829 . . . . 0.0 108.989 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.0 -31.82 70.93 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.56 -0.84 21.8 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.41 32.03 82.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.527 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 22.8 ttt85 -130.79 122.15 26.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.969 . . . . 0.0 110.868 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 487' ' ' ILE . 95.6 mt-10 -71.71 162.78 28.93 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.944 ' CG2' HG13 ' A' ' 453' ' ' VAL . 28.4 m -138.45 168.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.999 -1.063 . . . . 0.0 111.588 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.753 ' HB2' HD11 ' A' ' 486' ' ' LEU . 59.1 tt0 -120.45 115.78 24.16 Favored 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.952 HD11 HD13 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -131.11 138.83 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.508 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.585 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.2 mt -130.91 125.39 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.716 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.4 164.76 25.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 509' ' ' GLN . . . -58.7 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.693 -0.629 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -46.55 -21.44 0.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.175 -0.953 . . . . 0.0 112.043 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -75.37 -7.62 54.51 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.406 -0.809 . . . . 0.0 112.397 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.579 ' CD ' HG23 ' A' ' 466' ' ' ILE . 77.6 ttt-85 -57.5 -25.53 59.94 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.784 -1.198 . . . . 0.0 110.904 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.1 p -59.14 -41.98 89.57 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -62.44 -41.16 98.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.79 69.66 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.87 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -58.31 -39.75 80.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.081 . . . . 0.0 109.171 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 69.1 mtm -60.92 -39.33 89.0 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.793 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -122.97 -140.7 0.32 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.354 -0.841 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 48.52 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.791 -1.193 . . . . 0.0 112.53 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -136.81 28.53 2.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.29 -0.881 . . . . 0.0 109.671 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -108.99 -9.24 15.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.609 ' HB2' HD23 ' A' ' 482' ' ' LEU . 3.0 mtt180 -133.3 -10.45 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 112.418 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.952 HD13 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -168.92 61.99 0.06 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.751 -1.218 . . . . 0.0 113.062 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 44.2 t -89.36 48.63 1.64 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.746 -1.221 . . . . 0.0 110.575 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 100.03 2.5 55.98 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.986 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -91.05 43.31 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.122 1.461 . . . . 0.0 110.273 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 464' ' ' GLN . 0.2 OUTLIER -58.73 -81.92 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.966 HG22 HG23 ' A' ' 488' ' ' THR . 0.2 OUTLIER -173.37 -73.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 70.5 p -103.31 25.47 9.52 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.82 94.81 0.53 Allowed Glycine 0 N--CA 1.496 2.639 0 O-C-N 121.549 -0.72 . . . . 0.0 111.835 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -144.35 -111.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 495' ' ' GLU . 28.4 mmt180 -103.2 -32.73 9.47 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.002 -1.061 . . . . 0.0 108.597 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -47.84 -22.45 0.56 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.04 -58.96 4.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.318 -0.864 . . . . 0.0 111.317 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.71 5.41 26.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.974 -1.079 . . . . 0.0 111.994 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 491' ' ' ARG . 59.0 mm-40 -84.66 -5.93 59.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.977 -1.077 . . . . 0.0 113.069 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 95.82 -11.95 67.65 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.715 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.44 -176.69 0.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.128 -1.219 . . . . 0.0 108.98 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.41 170.43 8.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.352 -0.842 . . . . 0.0 109.637 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -111.41 153.02 26.68 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.684 ' H ' HG21 ' A' ' 488' ' ' THR . 52.2 m -81.98 120.71 78.08 Favored Pre-proline 0 N--CA 1.484 1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 34.7 Cg_endo -61.84 138.91 77.05 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.407 1.214 . . . . 0.0 111.291 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 149.6 -7.38 0.81 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.683 ' OG ' HG21 ' A' ' 487' ' ' ILE . 48.7 m -85.25 160.25 19.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.302 . . . . 0.0 112.209 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.558 ' HB ' HG12 ' A' ' 463' ' ' VAL . 86.4 m -106.0 163.27 12.89 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.489 HG11 HD13 ' A' ' 522' ' ' LEU . 59.7 t -151.14 121.7 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.878 -1.139 . . . . 0.0 111.312 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.713 HD12 HG22 ' A' ' 449' ' ' VAL . 6.2 pt -136.2 112.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 1.016 HG12 HG22 ' A' ' 534' ' ' ILE . 7.8 p -114.48 104.33 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.6 1.191 . . . . 0.0 113.06 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.573 ' OD2' HG11 ' A' ' 449' ' ' VAL . 90.4 m-20 -83.98 124.96 31.59 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.614 ' CD ' HD13 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -159.36 126.69 4.75 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -176.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.95 -41.86 6.97 Favored Glycine 0 N--CA 1.505 3.258 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -72.04 142.55 49.27 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.68 -12.78 20.71 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.095 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.99 -33.64 76.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 36.3 t -81.14 -23.36 38.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.847 -0.533 . . . . 0.0 111.314 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.636 HD21 ' HG2' ' A' ' 550' ' ' MET . 57.0 tp -65.85 -47.34 75.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.177 -0.952 . . . . 0.0 110.417 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.6 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 55.1 mtmt -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.673 -0.642 . . . . 0.0 111.586 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -58.81 -51.2 71.02 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.271 -0.893 . . . . 0.0 110.599 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 73.9 m -58.07 -41.07 82.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.766 HD12 HG21 ' A' ' 555' ' ' VAL . 0.3 OUTLIER -59.5 -38.09 80.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.041 -0.412 . . . . 0.0 111.853 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 47.0 p -64.71 -35.68 81.83 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.793 -1.192 . . . . 0.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.6 OUTLIER -70.35 -38.25 74.8 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.313 1.054 . . . . 0.0 108.19 177.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 530' ' ' VAL . 38.6 tp -62.98 -28.01 69.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.156 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -47.21 -63.12 1.12 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -51.4 58.76 Favored Glycine 0 N--CA 1.502 3.042 0 O-C-N 120.58 -1.325 . . . . 0.0 110.018 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -60.41 -30.22 69.47 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -1.036 . . . . 0.0 110.306 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -64.08 -20.61 66.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.757 -0.59 . . . . 0.0 112.315 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -37.76 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 2.6 m170 -147.69 -79.93 0.15 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 120.634 1.561 . . . . 0.0 114.304 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.438 ' HB2' ' N ' ' A' ' 502' ' ' GLY . 82.4 m-20 -86.26 60.59 6.32 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 522' ' ' LEU . 14.9 p -117.91 133.49 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.858 -1.151 . . . . 0.0 113.362 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.405 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 94.3 mt-30 -122.42 129.12 51.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 70.7 t -115.09 117.95 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.123 0.964 . . . . 0.0 112.049 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 423' ' ' VAL . 9.3 mp -114.33 118.43 33.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 1.016 HG22 HG12 ' A' ' 507' ' ' VAL . 9.3 pt -128.77 134.8 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 118.254 -1.378 . . . . 0.0 110.858 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.657 HG22 ' HB ' ' A' ' 436' ' ' VAL . 55.3 p -112.87 -163.46 0.85 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.41 165.24 36.27 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.646 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.501 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 6.6 p -130.17 22.17 5.27 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.876 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -168.47 35.22 0.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -95.81 -0.63 50.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . 0.915 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.6 ptt180 -47.53 -24.7 0.91 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.149 -0.969 . . . . 0.0 111.251 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.915 HG23 ' HG3' ' A' ' 540' ' ' ARG . 69.3 p -124.57 162.0 24.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 51.21 38.09 39.6 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -59.45 -45.39 91.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.665 -0.903 . . . . 0.0 110.508 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.88 -38.15 94.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 33.1 m -61.55 -32.65 72.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.745 -0.856 . . . . 0.0 109.629 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.49 -37.83 79.28 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.009 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -62.51 -40.02 95.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.765 . . . . 0.0 109.305 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.14 -31.53 72.03 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.33 -54.2 28.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.935 -0.478 . . . . 0.0 109.828 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 519' ' ' LEU . 79.6 mmm -57.98 -43.25 86.44 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.475 -0.766 . . . . 0.0 109.619 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.18 -31.61 70.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.756 -0.59 . . . . 0.0 110.958 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.82 -25.29 67.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.145 -0.972 . . . . 0.0 109.532 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.6 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -73.94 0.44 13.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.484 -0.76 . . . . 0.0 111.723 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 109.31 -14.74 33.15 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.295 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 519' ' ' LEU . 41.2 t . . . . . 0 N--CA 1.5 2.059 0 CA-C-N 118.685 1.242 . . . . 0.0 110.13 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.479 0.657 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.57 -37.2 86.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.7 m -61.92 -41.72 98.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.473 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.681 HG11 ' HB3' ' A' ' 433' ' ' LEU . 60.5 t -70.29 -34.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.162 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.71 -42.77 89.41 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.876 -1.14 . . . . 0.0 109.815 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.49 73.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.305 -0.872 . . . . 0.0 108.737 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.8 OUTLIER -60.51 -41.55 94.61 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.45 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 40.0 t -64.88 -39.28 93.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.432 -0.793 . . . . 0.0 111.403 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.57 -43.86 92.56 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.301 -0.874 . . . . 0.0 112.461 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -75.66 -45.72 35.47 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.823 -1.173 . . . . 0.0 112.115 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.831 HG21 ' O ' ' A' ' 435' ' ' ILE . 97.7 mt -62.87 -42.27 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.88 . . . . 0.0 109.995 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 35.6 mtp -60.77 -31.84 71.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.665 -0.647 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.57 -22.5 66.93 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.3 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 72.5 tp60 -92.65 -20.63 20.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.097 . . . . 0.0 108.98 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.02 -30.95 70.3 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -114.99 19.25 15.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.211 -0.931 . . . . 0.0 109.857 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 405' ' ' VAL . 8.4 p -50.84 113.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 406' ' ' THR . 5.1 t -48.77 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.638 -0.664 . . . . 0.0 111.833 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.685 HG23 HG12 ' A' ' 413' ' ' VAL . 7.4 p -112.92 133.42 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.536 -0.728 . . . . 0.0 110.117 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -96.04 143.24 25.78 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.89 . . . . 0.0 110.044 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.85 -24.62 53.71 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.34 1.179 . . . . 0.0 110.385 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -61.28 -39.79 91.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 66.23 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 93.4 p -50.48 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.096 -1.003 . . . . 0.0 110.313 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 407' ' ' VAL . 9.3 p -63.33 110.33 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.923 -0.485 . . . . 0.0 110.616 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.5 136.35 12.35 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 O-C-N 122.939 0.968 . . . . 0.0 110.531 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -153.67 70.14 0.83 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.503 -0.748 . . . . 0.0 110.766 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 46.3 p -65.21 -39.03 92.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' A' ' 420' ' ' SER . . . -49.86 -25.2 2.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.682 -0.636 . . . . 0.0 111.383 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -50.77 -62.25 5.42 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.376 -0.827 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.532 ' CG ' HG13 ' A' ' 436' ' ' VAL . 20.0 p90 -88.22 -2.7 58.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.791 -1.417 . . . . 0.0 111.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 417' ' ' ALA . 51.6 p -72.19 -39.75 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 425' ' ' VAL . 36.7 t70 -76.86 -45.66 27.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.978 -0.451 . . . . 0.0 110.571 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.477 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.0 -48.9 79.69 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.439 -0.788 . . . . 0.0 111.099 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 436' ' ' VAL . 89.3 t -68.48 -46.19 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.1 p -64.18 -33.04 74.87 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.665 -1.272 . . . . 0.0 111.039 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 421' ' ' ASP . 52.4 t -65.65 -36.17 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.695 . . . . 0.0 111.506 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.891 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 1.6 pp -70.25 -33.89 72.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 111.586 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.56 78.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.909 -1.119 . . . . 0.0 109.647 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -65.54 -33.38 75.78 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -65.29 -95.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -169.85 -61.85 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.442 -1.411 . . . . 0.0 109.452 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.26 113.85 2.08 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 109.196 -1.117 . . . . 0.0 109.196 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.79 ' O ' HD22 ' A' ' 433' ' ' LEU . 17.3 t -96.55 103.31 15.21 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.718 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 432' ' ' SER . 0.2 OUTLIER -152.96 88.23 1.31 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.891 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -118.04 156.43 28.6 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.025 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.831 ' O ' HG21 ' A' ' 399' ' ' ILE 0.263 62.2 mt -122.61 127.3 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 423' ' ' VAL . 45.2 t -141.42 153.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.954 -1.091 . . . . 0.0 111.196 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.3 p -136.26 143.06 44.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.72 129.6 9.95 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.52 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.23 -23.69 10.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.886 -0.773 . . . . 0.0 109.841 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.14 160.28 33.56 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.43 46.47 94.29 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.37 77.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 111.029 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.63 92.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.294 -0.879 . . . . 0.0 111.157 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.85 72.15 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.82 -41.06 90.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -1.014 . . . . 0.0 110.277 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.563 ' CD ' ' HB1' ' A' ' 467' ' ' ALA . 54.4 mtm180 -67.48 -38.5 84.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.364 -0.835 . . . . 0.0 110.996 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 45.5 tt0 -71.64 -31.85 67.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.271 -0.893 . . . . 0.0 111.553 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.74 -53.61 44.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.067 -1.021 . . . . 0.0 110.41 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.647 ' CG2' HD12 ' A' ' 506' ' ' ILE . 11.7 p -55.24 -30.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.038 -1.039 . . . . 0.0 109.218 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.37 -27.95 68.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.15 -34.95 79.6 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.34 -36.07 79.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 95.2 t -58.28 -29.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 91.7 mtp -67.2 -39.68 86.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -55.39 -27.89 50.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.306 -0.871 . . . . 0.0 109.893 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.72 40.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.8 -43.34 88.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 109.514 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -68.59 -30.43 69.17 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.458 0.647 . . . . 0.0 109.841 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -73.68 -1.09 17.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.655 -0.653 . . . . 0.0 111.641 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 79.86 18.56 72.36 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 120.876 -1.14 . . . . 0.0 110.612 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.81 149.94 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.347 -1.09 . . . . 0.0 111.093 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -94.96 -178.51 4.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 7.3 m -148.0 170.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.926 -1.109 . . . . 0.0 110.805 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -119.35 128.37 54.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.719 HG21 ' CG2' ' A' ' 453' ' ' VAL . 11.2 pt -134.55 141.53 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.561 HG23 ' HD3' ' A' ' 471' ' ' ARG . 85.8 mt -132.7 124.71 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.595 -0.691 . . . . 0.0 109.719 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -79.84 165.9 22.25 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -60.54 -159.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -49.08 -20.86 0.61 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.61 -1.307 . . . . 0.0 111.334 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.39 -8.98 58.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.456 -0.777 . . . . 0.0 111.353 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.573 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 64.5 ttp85 -59.44 -23.11 62.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.909 -1.119 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 12.5 t -59.64 -44.13 93.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.391 -0.818 . . . . 0.0 109.527 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -60.89 -45.22 95.46 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.31 -36.0 72.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.637 -0.664 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -59.22 -40.31 85.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.157 -0.965 . . . . 0.0 111.331 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 7.5 ttm -61.59 -36.3 80.28 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.293 -0.879 . . . . 0.0 110.604 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 53.4 pttt -125.29 -146.84 0.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.797 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.438 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 87.9 mm-40 51.59 71.71 0.43 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.091 -1.006 . . . . 0.0 112.41 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -112.17 18.57 18.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.29 -10.56 40.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.429 -0.795 . . . . 0.0 111.289 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.657 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -142.8 -0.95 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.955 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.657 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.31 62.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.64 -1.288 . . . . 0.0 111.415 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 36.6 m -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.888 -1.133 . . . . 0.0 110.318 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 153.19 55.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.8 pt-20 -158.0 92.47 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.2 1.0 . . . . 0.0 110.757 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.564 ' C ' HD12 ' A' ' 487' ' ' ILE . 61.8 mt -99.16 -82.13 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.628 HD13 ' CB ' ' A' ' 503' ' ' SER . 3.1 mp -150.15 -69.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 499' ' ' PHE . 1.4 t -99.91 16.23 24.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.383 -0.823 . . . . 0.0 112.092 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.08 59.67 4.96 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 70.7 ttt180 -142.0 -54.83 0.45 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -1.142 . . . . 0.0 109.544 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.417 ' HD2' ' CE ' ' A' ' 497' ' ' MET . 28.3 mmt180 -104.12 -36.23 7.77 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.778 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.453 ' HG3' ' HA ' ' A' ' 498' ' ' ALA . 10.1 mt-30 -61.46 -41.0 96.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 493' ' ' LEU . 1.2 mt -70.19 -42.08 72.88 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.521 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -105.89 -42.94 5.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.64 -10.63 24.73 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.921 -1.111 . . . . 0.0 113.083 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 88.3 -21.69 23.57 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 120.68 -1.262 . . . . 0.0 110.909 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.417 ' CE ' ' HD2' ' A' ' 491' ' ' ARG . 78.6 mtm -66.14 176.23 1.81 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.138 -1.213 . . . . 0.0 110.188 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 492' ' ' GLN . . . -112.27 152.03 28.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 111.056 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.1 OUTLIER -113.14 150.07 32.71 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 500' ' ' THR . 6.0 t -43.25 105.59 0.44 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.032 -0.418 . . . . 0.0 110.524 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.03 114.09 2.66 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.336 1.177 . . . . 0.0 111.572 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.66 34.91 0.18 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.628 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.1 p -93.61 167.62 11.56 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 112.827 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.438 ' HB ' HG12 ' A' ' 463' ' ' VAL . 41.2 m -119.52 159.58 24.05 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.657 HG21 ' CD1' ' A' ' 522' ' ' LEU . 73.7 t -143.57 130.78 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 118.527 -1.269 . . . . 0.0 113.026 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.647 HD12 ' CG2' ' A' ' 449' ' ' VAL . 4.7 pt -137.0 120.61 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 534' ' ' ILE . 11.5 p -119.32 99.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.691 -1.256 . . . . 0.0 111.547 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.541 ' OD1' HG23 ' A' ' 535' ' ' THR . 96.4 m-20 -83.08 98.42 9.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.763 ' CD ' HD23 ' A' ' 515' ' ' LEU . 1.7 pm0 -124.78 123.93 41.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.519 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -75.19 -53.93 5.91 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -69.61 -161.52 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.95 -10.6 2.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.947 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 517' ' ' GLU . 12.9 tp -65.4 -28.02 68.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -0.981 . . . . 0.0 108.596 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 3.6 m -83.84 -19.86 34.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.663 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.763 HD23 ' CD ' ' A' ' 509' ' ' GLN . 0.4 OUTLIER -65.8 -48.93 70.07 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.412 178.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.01 -39.87 65.66 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.0 111.824 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 513' ' ' LEU . 79.2 mm-40 -61.83 -47.22 86.07 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.586 -0.696 . . . . 0.0 111.572 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.503 HG21 ' HB ' ' A' ' 507' ' ' VAL . 97.7 m -60.96 -43.01 99.35 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.523 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -56.45 -35.65 68.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.873 -0.517 . . . . 0.0 110.717 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 97.6 m -64.35 -43.91 93.11 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 111.668 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.22 -42.01 93.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.265 -0.897 . . . . 0.0 108.944 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.657 ' CD1' HG21 ' A' ' 505' ' ' VAL . 1.8 tp -62.78 -28.47 70.01 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.531 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -46.5 -65.46 0.55 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.413 -0.804 . . . . 0.0 113.166 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -67.88 -49.4 48.74 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.129 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.12 67.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.679 -0.895 . . . . 0.0 111.332 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 522' ' ' LEU . . . -57.13 -24.19 52.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 112.619 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -41.94 -27.0 0.1 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.565 -0.709 . . . . 0.0 112.182 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -108.95 -118.99 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.208 -0.932 . . . . 0.0 112.584 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -89.23 90.25 8.27 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 120.355 -1.466 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.536 HG21 ' HB1' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -119.4 136.87 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 O-C-N 120.407 -1.433 . . . . 0.0 113.116 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 432' ' ' SER . 9.9 mp0 -126.36 133.58 51.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 40.6 t -114.99 121.66 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 122.971 1.367 . . . . 0.0 111.648 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 434' ' ' ALA . 0.8 OUTLIER -123.67 122.53 38.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 507' ' ' VAL . 9.6 pt -133.09 133.24 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.826 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.541 HG23 ' OD1' ' A' ' 508' ' ' ASP . 55.8 p -106.47 -164.32 0.99 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.79 168.73 26.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.519 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -135.38 13.71 3.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.418 178.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -152.22 27.6 0.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.583 HE22 HG23 ' A' ' 435' ' ' ILE . 34.4 tt0 -99.5 0.86 43.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -1.062 . . . . 0.0 112.272 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -59.62 -33.98 72.2 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.977 -1.077 . . . . 0.0 112.12 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 27.6 m -102.98 -58.06 1.94 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.072 -1.017 . . . . 0.0 110.819 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -100.34 94.43 1.32 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.8 t -95.31 -36.32 11.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -1.009 . . . . 0.0 110.48 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -60.26 -34.78 86.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.8 p -64.05 -34.3 77.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.942 . . . . 0.0 111.09 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.46 -37.29 83.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.425 -0.797 . . . . 0.0 109.887 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.81 -40.14 96.45 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.471 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.0 mmm -68.18 -27.52 66.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.401 -0.812 . . . . 0.0 110.319 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -59.46 -55.41 35.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.523 ' HG3' HD11 ' A' ' 519' ' ' LEU . 51.8 ttm -58.89 -48.63 80.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.478 -0.764 . . . . 0.0 110.394 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -59.48 -32.57 70.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.644 -0.66 . . . . 0.0 111.781 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -66.45 -25.07 66.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.259 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.48 -1.04 9.62 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.334 -0.854 . . . . 0.0 111.192 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 116.16 -15.22 15.84 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.897 -1.127 . . . . 0.0 111.162 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.503 2.217 0 CA-C-N 118.942 1.371 . . . . 0.0 109.713 -179.853 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.775 0.321 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.42 -42.08 98.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.193 -0.942 . . . . 0.0 109.396 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.4 m -64.89 -42.88 94.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.878 -0.514 . . . . 0.0 110.712 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 433' ' ' LEU . 99.9 t -66.45 -35.69 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.536 -0.728 . . . . 0.0 110.665 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -62.45 -45.29 93.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.277 -0.889 . . . . 0.0 109.802 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -71.56 -36.88 71.07 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.58 0.705 . . . . 0.0 110.149 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 395' ' ' LEU . 2.6 tm? -61.18 -38.75 87.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.964 -0.46 . . . . 0.0 110.016 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 400' ' ' MET . 42.7 t -63.72 -40.48 96.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.636 -0.665 . . . . 0.0 109.845 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.18 -42.75 99.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.543 -0.723 . . . . 0.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.79 -42.21 97.77 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.116 -0.99 . . . . 0.0 111.708 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 435' ' ' ILE . 58.9 mt -66.63 -41.21 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 0.0 110.431 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 435' ' ' ILE . 47.1 mmm -58.25 -33.91 69.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.52 -33.39 75.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.563 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -92.4 -3.83 54.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.936 -1.102 . . . . 0.0 109.778 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 9.2 m120 -89.15 -26.99 21.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.488 -0.757 . . . . 0.0 109.033 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 19.14 15.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 108.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.1 p -52.61 107.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.2 m -49.73 101.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.316 -0.865 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 405' ' ' VAL . 74.3 t -113.6 133.32 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.614 . . . . 0.0 110.113 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -92.04 140.17 24.6 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.593 -0.692 . . . . 0.0 109.871 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 -27.87 33.73 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.282 1.149 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -62.41 -29.91 70.83 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.364 -0.835 . . . . 0.0 110.0 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 59.11 0.68 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.3 t -60.03 122.28 13.94 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.934 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -74.54 120.61 82.33 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.723 -0.61 . . . . 0.0 110.378 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.474 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 47.5 Cg_endo -73.65 132.44 17.33 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 122.907 0.951 . . . . 0.0 110.008 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 414' ' ' PRO . 90.8 mtt180 -160.94 56.07 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.833 -0.542 . . . . 0.0 110.017 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 45.0 p -67.34 -34.38 77.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.73 -1.231 . . . . 0.0 108.417 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -71.12 -2.29 15.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.783 -0.573 . . . . 0.0 112.195 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.0 97.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 423' ' ' VAL . 33.6 p90 -98.15 -4.06 36.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 8.1 t -73.91 -42.07 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -71.79 -40.82 68.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.34 98.73 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.72 0.771 . . . . 0.0 110.257 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 533' ' ' LEU . 73.5 t -69.18 -42.17 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.637 -0.664 . . . . 0.0 111.641 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 90.6 p -58.84 -41.67 87.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 0.0 110.946 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.54 -43.39 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.337 -0.852 . . . . 0.0 110.899 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.8 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 0.4 OUTLIER -62.64 -35.12 78.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.193 -0.942 . . . . 0.0 111.669 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.72 77.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.734 -1.229 . . . . 0.0 109.217 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.64 -30.11 70.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.8 -88.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.96 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 120.487 -1.383 . . . . 0.0 109.999 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.44 ' HA ' ' HG2' ' A' ' 531' ' ' GLN . 45.6 Cg_endo -73.01 109.98 2.94 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 123.092 1.048 . . . . 0.0 109.724 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.583 ' CB ' HD12 ' A' ' 533' ' ' LEU . 3.4 m -83.81 98.66 9.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.35 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 10.8 tp -146.04 135.42 22.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -172.18 164.77 6.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 400' ' ' MET . 19.5 pt -133.51 118.45 30.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -126.6 150.87 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.995 -1.066 . . . . 0.0 109.863 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 9.2 p -131.73 139.95 49.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.815 -0.553 . . . . 0.0 109.723 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.48 160.9 20.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.84 -19.2 11.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.656 -0.908 . . . . 0.0 110.306 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -174.93 168.15 40.63 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 57.48 82.73 0.05 OUTLIER Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -93.32 -18.49 22.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.502 -0.999 . . . . 0.0 111.444 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.88 -44.74 84.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.973 . . . . 0.0 109.516 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.03 -28.58 70.2 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -61.22 -41.12 96.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.645 -0.914 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 57.9 mtm-85 -61.31 -42.05 98.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.92 . . . . 0.0 110.304 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -72.27 -28.76 63.33 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.387 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -62.21 -50.6 71.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.917 -1.115 . . . . 0.0 110.995 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 506' ' ' ILE . 7.6 p -62.16 -32.8 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.691 -1.255 . . . . 0.0 108.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.85 -27.53 69.4 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 454' ' ' MET . 80.4 tt0 -65.08 -33.57 76.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.43 -36.31 82.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 463' ' ' VAL . 99.1 t -60.93 -27.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 59.4 mtt -66.13 -38.94 89.4 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -22.95 65.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.719 0.771 . . . . 0.0 109.18 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.09 -24.97 30.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -69.49 -40.48 77.02 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.947 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.37 -31.59 71.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.272 -0.892 . . . . 0.0 109.422 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -81.56 10.13 6.43 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.69 36.28 93.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -138.44 123.25 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.451 -1.029 . . . . 0.0 111.819 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 46.7 mp0 -85.29 166.47 16.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.755 HG12 ' HB ' ' A' ' 504' ' ' THR . 34.0 m -138.14 157.8 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 111.99 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.794 ' HA ' HD22 ' A' ' 486' ' ' LEU . 47.0 tt0 -96.44 111.51 23.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.958 HD11 HD22 ' A' ' 482' ' ' LEU . 1.6 pp -127.23 131.9 70.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.845 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.661 ' HB ' HG23 ' A' ' 507' ' ' VAL . 3.5 mp -102.08 170.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -123.67 156.82 35.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.55 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.502 0.668 . . . . 0.0 109.964 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -54.43 -11.34 0.52 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.947 -1.096 . . . . 0.0 111.845 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -91.6 7.03 43.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.707 -1.246 . . . . 0.0 112.051 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 29.9 ttt85 -59.26 -34.45 72.27 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.856 -1.153 . . . . 0.0 111.526 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 3.7 t -57.21 -53.92 52.62 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.928 -1.108 . . . . 0.0 111.92 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 474' ' ' MET . 13.7 pt20 -66.43 -37.92 86.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.895 -1.128 . . . . 0.0 109.457 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 473' ' ' GLN . 26.8 ttt -58.68 -32.52 69.21 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.758 -0.589 . . . . 0.0 109.515 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -62.11 -37.8 86.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.766 -0.583 . . . . 0.0 109.673 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.58 -40.61 79.38 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.915 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.49 -152.71 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.588 -0.695 . . . . 0.0 109.147 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 50.34 81.33 0.06 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.863 -1.148 . . . . 0.0 111.623 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -122.03 27.47 8.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 110.09 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -113.42 -19.85 11.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.702 ' HB2' HD23 ' A' ' 482' ' ' LEU . 7.9 mtt180 -109.19 -14.44 14.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.693 -0.63 . . . . 0.0 111.795 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -171.87 62.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.081 -1.012 . . . . 0.0 111.33 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 51.4 p -90.72 48.59 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.832 -1.168 . . . . 0.0 110.169 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.84 26.03 43.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.99 54.01 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -1.06 . . . . 0.0 109.1 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.794 HD22 ' HA ' ' A' ' 464' ' ' GLN . 13.8 mt -79.21 -81.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.773 HG22 HG23 ' A' ' 488' ' ' THR . 0.0 OUTLIER 178.29 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.979 -1.076 . . . . 0.0 111.514 174.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.773 HG23 HG22 ' A' ' 487' ' ' ILE . 4.0 p -102.69 10.05 38.84 Favored 'General case' 0 C--N 1.3 -1.543 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.299 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.7 65.62 2.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.3 ttm180 -144.31 -68.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.94 -29.92 8.04 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.934 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 498' ' ' ALA . 0.0 OUTLIER -62.01 -45.54 93.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.58 -0.7 . . . . 0.0 111.285 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.01 -18.54 24.45 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.347 -0.846 . . . . 0.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -47.3 4.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.373 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -101.98 -8.32 21.61 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.78 -14.53 61.44 Favored Glycine 0 N--CA 1.503 3.131 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.588 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 63.1 mtt -67.97 -176.14 0.65 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.425 ' HA ' ' HG2' ' A' ' 492' ' ' GLN . . . -114.63 148.18 38.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.622 -0.674 . . . . 0.0 110.745 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.437 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.371 -0.831 . . . . 0.0 109.195 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 500' ' ' THR . 6.3 t -60.85 112.11 5.18 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.171 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 528' ' ' HIS . 43.2 Cg_endo -72.29 113.74 3.79 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.402 1.212 . . . . 0.0 109.501 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -162.33 19.74 0.17 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.723 ' CB ' HD13 ' A' ' 487' ' ' ILE . 24.2 p -93.9 175.34 6.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.254 -1.145 . . . . 0.0 111.096 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.755 ' HB ' HG12 ' A' ' 463' ' ' VAL . 54.1 m -116.73 127.72 54.65 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.849 ' CB ' HD21 ' A' ' 522' ' ' LEU . 69.1 t -113.64 129.87 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.371 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 465' ' ' ILE . 1.3 pp -126.4 164.11 27.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 534' ' ' ILE . 13.8 p -151.2 110.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.959 -1.088 . . . . 0.0 108.874 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 53.8 t0 -84.25 104.96 14.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.369 1.08 . . . . 0.0 108.138 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.477 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -98.73 174.57 6.34 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.498 1.142 . . . . 0.0 113.285 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.33 -56.31 0.05 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -75.09 -156.39 0.05 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -125.83 -19.17 4.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 110.461 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 513' ' ' LEU . 4.4 mm? -70.41 -31.07 68.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.368 -0.833 . . . . 0.0 110.679 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 57.7 p -67.77 -40.55 84.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.784 -0.572 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.4 tp -64.59 -45.94 84.79 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 111.143 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -67.62 -43.35 80.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.418 -0.801 . . . . 0.0 113.064 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 518' ' ' THR . 27.0 pt-20 -65.76 -41.81 91.63 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.765 -1.209 . . . . 0.0 110.362 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.736 HG22 HD12 ' A' ' 522' ' ' LEU . 98.0 m -62.88 -42.48 99.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.006 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.736 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -60.6 -39.42 88.05 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.691 -178.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 516' ' ' LYS . 81.3 p -65.27 -31.3 72.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.389 -0.819 . . . . 0.0 111.897 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.614 HD22 HE22 ' A' ' 464' ' ' GLN . 9.6 tt -81.9 -38.45 25.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.037 -1.04 . . . . 0.0 109.787 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.849 HD21 ' CB ' ' A' ' 505' ' ' VAL . 1.8 mt -64.11 -26.62 68.62 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.782 -0.574 . . . . 0.0 111.292 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -48.22 -51.21 26.39 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.275 -0.891 . . . . 0.0 111.586 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -71.41 -50.2 22.16 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -66.89 -38.43 86.25 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.473 -1.016 . . . . 0.0 113.001 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.9 -33.88 73.8 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.211 -0.931 . . . . 0.0 111.602 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -57.17 -28.82 63.13 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.962 -1.086 . . . . 0.0 108.11 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.461 ' CG ' ' HG3' ' A' ' 501' ' ' PRO . 80.0 m80 -93.99 -135.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.426 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 89.5 m-20 -89.77 69.69 7.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.725 -1.234 . . . . 0.0 112.893 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.69 ' CG1' HD23 ' A' ' 522' ' ' LEU . 2.5 t -141.77 168.24 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -159.54 162.75 35.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.842 -0.536 . . . . 0.0 110.843 -178.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 42.4 t -109.79 100.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.15 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 423' ' ' VAL . 0.5 OUTLIER -100.58 117.98 35.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.972 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -127.51 155.58 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.323 -176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.619 ' CB ' HG22 ' A' ' 436' ' ' VAL . 36.7 p -128.39 -178.11 4.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 61.8 m-20 -154.55 163.71 39.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.7 p -140.35 18.85 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.916 -0.49 . . . . 0.0 109.732 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.79 26.0 0.18 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.07 0.74 51.88 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.128 -1.219 . . . . 0.0 111.814 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -43.4 -42.04 4.48 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.224 -0.923 . . . . 0.0 111.366 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 65.5 p -106.19 163.48 12.77 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 50.11 36.79 28.98 Favored Glycine 0 N--CA 1.503 3.152 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -58.74 -43.66 90.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.52 -0.988 . . . . 0.0 111.107 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.6 -38.4 96.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 43.1 m -65.32 -33.02 74.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -1.0 . . . . 0.0 111.364 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.59 -37.5 87.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.731 . . . . 0.0 110.294 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.58 -42.66 99.17 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.501 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 8.4 tpp -61.85 -34.71 76.47 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -53.57 -52.1 60.86 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.174 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.736 ' CG ' HD11 ' A' ' 519' ' ' LEU . 40.1 ttp -57.32 -45.66 84.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.344 -0.848 . . . . 0.0 110.177 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.7 -31.28 72.4 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.429 -0.794 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.88 -13.02 62.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.471 -0.768 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -78.87 9.77 3.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.432 -0.792 . . . . 0.0 112.709 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 123.84 -14.75 7.99 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 -179.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.243 0.544 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 391' ' ' SER . 4.1 pp -64.35 -33.04 74.92 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.71 -0.619 . . . . 0.0 110.659 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . 0.558 ' N ' HD12 ' A' ' 390' ' ' LEU . 50.9 m -60.79 -36.7 79.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.325 -0.859 . . . . 0.0 109.736 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.0 t -65.48 -33.82 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.287 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.52 -48.24 79.82 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.241 -0.912 . . . . 0.0 110.914 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.13 77.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -0.791 . . . . 0.0 109.435 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 422' ' ' ALA . 0.9 OUTLIER -62.17 -39.66 93.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.951 -0.468 . . . . 0.0 111.504 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 55.8 p -65.71 -37.52 86.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -0.912 . . . . 0.0 110.325 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -65.07 -44.85 87.59 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.537 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.69 -43.3 80.44 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.131 -0.981 . . . . 0.0 111.331 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 436' ' ' VAL . 96.7 mt -61.45 -42.28 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.629 ' CG ' HD11 ' A' ' 435' ' ' ILE . 19.5 mtp -62.67 -29.1 70.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.952 -0.467 . . . . 0.0 109.981 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -61.2 -29.67 69.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.85 -1.156 . . . . 0.0 109.541 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 99.3 mm-40 -89.33 -16.97 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 109.231 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 400' ' ' MET . 2.7 t-20 -66.4 -38.54 87.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.526 -0.733 . . . . 0.0 110.799 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -116.32 19.0 15.05 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 405' ' ' VAL . 10.8 p -48.15 117.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.65 -0.657 . . . . 0.0 111.019 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.8 p -52.35 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.646 HG23 HG12 ' A' ' 413' ' ' VAL . 11.0 p -109.86 133.06 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.598 0.713 . . . . 0.0 110.663 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -90.8 135.1 29.3 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.33 -30.38 45.07 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.098 1.052 . . . . 0.0 110.542 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -59.65 -28.33 67.16 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.811 0.815 . . . . 0.0 109.822 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 56.2 0.76 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.9 m -54.17 117.78 3.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.67 0.748 . . . . 0.0 111.379 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.646 HG12 HG23 ' A' ' 407' ' ' VAL . 7.7 p -67.87 111.51 7.9 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.563 . . . . 0.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.31 138.13 24.39 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 122.999 1.0 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -161.25 70.68 0.37 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.829 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 57.9 p -67.75 -38.06 82.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.837 -1.165 . . . . 0.0 107.895 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 420' ' ' SER . . . -56.63 -23.95 44.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.871 -0.518 . . . . 0.0 111.177 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -47.99 -58.18 7.22 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -87.41 -1.99 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.967 -1.314 . . . . 0.0 110.847 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 10.9 t -71.03 -42.9 68.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.909 -1.12 . . . . 0.0 108.502 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -75.69 -44.63 41.19 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.811 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.78 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.71 -48.02 73.41 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.833 ' CG2' HG21 ' A' ' 436' ' ' VAL . 57.9 t -68.27 -44.41 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.334 -0.854 . . . . 0.0 111.45 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.6 m -61.73 -38.14 86.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 111.229 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.4 p -65.03 -29.5 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 112.754 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.773 ' HB3' HD13 ' A' ' 395' ' ' LEU . 2.2 pp -76.98 -32.2 57.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.398 -1.439 . . . . 0.0 110.575 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.39 84.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 108.837 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -59.27 -36.22 75.14 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -64.73 -88.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 4.6 tpp180 -175.13 -60.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.726 -1.233 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 430' ' ' ARG . 39.0 Cg_endo -64.39 102.76 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 122.886 0.94 . . . . 0.0 111.397 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.784 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.1 OUTLIER -82.51 99.99 9.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.872 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 11.0 tp -163.7 93.04 0.72 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.26 -0.9 . . . . 0.0 111.195 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.472 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -150.04 162.36 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.011 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 435' ' ' ILE . 2.5 pp -113.96 128.55 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.094 0.473 . . . . 0.0 109.897 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.833 HG21 ' CG2' ' A' ' 423' ' ' VAL . 78.3 t -132.18 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -0.877 . . . . 0.0 108.935 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 42.8 t -130.46 138.63 50.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.023 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -95.94 135.99 12.61 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.679 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -107.71 -14.27 14.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.959 -0.73 . . . . 0.0 110.255 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.57 170.6 42.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.19 44.94 97.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.92 89.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.332 -1.099 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.39 -44.7 93.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.627 -0.671 . . . . 0.0 110.55 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.87 -28.66 64.42 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.4 -41.88 98.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.909 . . . . 0.0 109.607 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.662 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.5 mtm180 -61.77 -45.01 95.75 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.375 -0.828 . . . . 0.0 110.047 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -63.45 -29.65 70.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.661 . . . . 0.0 109.42 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 53.1 ttt85 -67.52 -50.54 58.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.578 -0.701 . . . . 0.0 111.388 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.3 p -55.21 -31.74 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.528 -1.357 . . . . 0.0 110.423 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 481' ' ' ARG . . . -64.36 -26.83 68.64 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 82.0 tt0 -60.19 -35.13 74.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.94 -37.68 88.01 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.961 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.4 t -63.05 -27.06 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.013 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.6 mtp -66.28 -39.73 89.6 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.189 -0.944 . . . . 0.0 108.642 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.1 ttp -58.88 -25.8 63.67 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.64 -0.663 . . . . 0.0 109.442 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 463' ' ' VAL . . . -82.63 -22.43 34.71 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.581 -0.7 . . . . 0.0 110.405 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.88 -47.57 71.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.76 -28.47 65.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -79.5 5.2 13.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.58 -0.7 . . . . 0.0 110.756 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.45 34.45 89.97 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -130.75 127.14 38.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -1.01 . . . . 0.0 110.292 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.413 ' C ' HG13 ' A' ' 463' ' ' VAL . 30.8 tt0 -81.53 159.28 24.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.961 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.9 m -144.87 151.81 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.502 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.835 ' HG3' HD13 ' A' ' 486' ' ' LEU . 57.9 tt0 -102.98 123.33 46.39 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.543 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.772 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -141.7 146.25 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 120.825 -1.172 . . . . 0.0 108.732 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.785 HG23 ' HD3' ' A' ' 471' ' ' ARG . 83.6 mt -134.01 129.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -78.22 168.58 19.63 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.26 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.505 -0.747 . . . . 0.0 109.786 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -48.56 -22.74 0.8 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.915 -1.115 . . . . 0.0 111.903 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -73.23 -6.3 45.0 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.332 -0.855 . . . . 0.0 112.206 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 466' ' ' ILE . 34.7 ttt85 -60.16 -24.73 64.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.803 -1.186 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -61.45 -46.37 90.35 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.216 -0.928 . . . . 0.0 110.612 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -65.21 -41.3 94.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 53.2 ttm -60.39 -32.47 71.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.027 -0.421 . . . . 0.0 110.453 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -61.36 -37.69 84.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 80.5 mmm -59.76 -35.9 75.55 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.951 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 59.4 pttt -134.93 -141.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 109.801 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.501 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 89.3 mm-40 47.06 90.46 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.969 -1.082 . . . . 0.0 113.034 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -94.55 -23.46 17.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.475 ' O ' HD22 ' A' ' 482' ' ' LEU . 98.0 mt-10 -70.44 -29.53 66.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.514 -0.741 . . . . 0.0 109.059 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.64 ' HA ' ' HB1' ' A' ' 450' ' ' ALA . 9.1 mpt_? -83.52 8.48 13.91 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.997 -0.44 . . . . 0.0 111.294 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.688 HD22 ' N ' ' A' ' 482' ' ' LEU . 3.2 mm? 53.87 28.26 8.22 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.986 -1.071 . . . . 0.0 110.802 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.28 50.24 0.06 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.493 -0.755 . . . . 0.0 112.417 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 159.61 42.04 0.02 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -179.62 89.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.597 -0.943 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 464' ' ' GLN . 47.1 mt -99.09 -81.28 0.45 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 503' ' ' SER . 1.1 mp -158.98 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.487 -0.758 . . . . 0.0 109.448 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 499' ' ' PHE . 1.8 p -102.86 14.31 32.26 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.496 -0.752 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -79.55 56.92 4.48 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -143.06 -61.75 0.42 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.224 -1.162 . . . . 0.0 109.245 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -109.35 -31.29 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.298 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.439 HE22 ' HB2' ' A' ' 525' ' ' ALA . 3.2 mt-30 -64.08 -38.1 89.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 521' ' ' LEU . 5.4 mt -91.16 -26.82 18.89 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 111.358 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.0 OUTLIER -105.72 -44.36 4.67 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -102.4 -8.33 21.23 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.863 -1.148 . . . . 0.0 113.518 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.81 -21.49 33.11 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.732 -1.23 . . . . 0.0 111.276 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 38.0 mtm -64.09 -178.6 0.35 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -1.186 . . . . 0.0 109.348 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.04 154.16 28.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 111.347 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.434 ' HB2' ' HB ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -115.82 148.98 39.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.937 -0.477 . . . . 0.0 109.864 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 79.1 m -44.06 101.52 0.26 Allowed Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 122.089 -0.382 . . . . 0.0 110.759 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 43.4 Cg_endo -68.34 113.75 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.681 1.358 . . . . 0.0 109.239 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . 174.98 38.06 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.932 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.6 p -90.83 174.55 7.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.882 -0.776 . . . . 0.0 111.79 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 463' ' ' VAL . 13.6 m -112.74 94.36 4.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 522' ' ' LEU . 59.4 t -85.64 131.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.225 1.012 . . . . 0.0 112.656 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.829 HG23 HD22 ' A' ' 533' ' ' LEU 0.294 65.3 mt -137.77 96.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 534' ' ' ILE . 3.9 p -104.19 107.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.978 1.371 . . . . 0.0 113.574 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.44 107.58 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.0 -1.062 . . . . 0.0 109.413 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 511' ' ' GLU . 19.1 mm100 -126.96 116.46 20.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -72.83 -40.61 52.06 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 175.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 509' ' ' GLN . 93.0 mt-10 -86.71 147.22 25.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.11 -12.07 22.19 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.629 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.96 -38.81 92.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 109.526 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 72.1 p -86.82 -16.61 35.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.615 -0.678 . . . . 0.0 111.109 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 60.1 tp -72.06 -47.69 49.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.165 -0.959 . . . . 0.0 109.905 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.807 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 31.3 ttpt -69.85 -46.02 66.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.679 -0.638 . . . . 0.0 112.692 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.67 -41.59 98.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.965 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.578 HG21 HD12 ' A' ' 466' ' ' ILE . 29.9 m -56.86 -44.74 82.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.483 -0.76 . . . . 0.0 111.194 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 515' ' ' LEU . 43.3 mt -60.77 -28.22 68.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.7 m -61.1 -41.17 96.18 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.327 -0.858 . . . . 0.0 109.472 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 493' ' ' LEU . 50.7 tp -65.49 -41.09 93.64 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.846 ' CD1' HG11 ' A' ' 505' ' ' VAL . 1.4 tt -64.17 -22.95 67.13 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.845 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -48.06 -64.19 0.86 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.376 -0.828 . . . . 0.0 113.205 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.69 -50.54 60.84 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.771 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -62.35 -36.38 82.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.966 . . . . 0.0 111.77 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -64.99 -25.23 67.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.447 -0.783 . . . . 0.0 112.72 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -40.88 -27.82 0.06 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -107.28 -108.73 0.31 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.109 -0.994 . . . . 0.0 113.065 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.511 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.1 OUTLIER -89.51 81.47 6.53 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.553 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 531' ' ' GLN . 5.9 t -143.87 165.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.843 -1.161 . . . . 0.0 111.729 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 12.8 mm-40 -157.52 161.83 38.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 55.3 t -114.96 107.17 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.354 -0.841 . . . . 0.0 111.511 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.829 HD22 HG23 ' A' ' 506' ' ' ILE . 5.5 tt -105.49 119.22 38.55 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 507' ' ' VAL . 4.1 pt -139.94 153.08 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.296 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.509 HG22 ' HB ' ' A' ' 436' ' ' VAL . 26.6 p -143.11 114.62 8.01 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.95 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -77.08 175.56 9.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.681 1.229 . . . . 0.0 111.83 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.541 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.3 m -129.98 -10.3 4.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.105 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -122.67 34.78 3.65 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -98.29 0.84 46.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.862 -0.787 . . . . 0.0 111.999 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 541' ' ' THR . 38.4 ptt180 -49.36 -31.22 8.97 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.096 -1.003 . . . . 0.0 110.216 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 540' ' ' ARG . 46.1 p -129.78 166.54 19.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.5 34.66 55.38 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -61.7 -45.8 92.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.496 -1.002 . . . . 0.0 111.802 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.23 -34.69 90.65 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 48.0 m -64.08 -37.86 88.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.71 -0.876 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.26 -37.25 72.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 110.023 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 547' ' ' LEU . 10.9 mp -63.14 -39.94 96.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.658 -0.652 . . . . 0.0 110.102 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.68 -29.11 70.41 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.487 -0.758 . . . . 0.0 109.203 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -56.29 -52.6 63.9 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 555' ' ' VAL . 56.0 ttm -55.61 -46.65 77.31 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.277 -0.889 . . . . 0.0 109.521 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . 0.705 ' HA ' HG23 ' A' ' 555' ' ' VAL . 97.5 mttt -57.6 -32.0 66.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.824 -0.548 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -68.46 -25.51 65.03 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.4 -0.813 . . . . 0.0 111.403 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.807 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -70.37 0.85 5.75 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.083 -1.011 . . . . 0.0 112.787 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.39 -15.25 9.28 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 120.787 -1.196 . . . . 0.0 110.832 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.705 HG23 ' HA ' ' A' ' 551' ' ' LYS . 34.2 m . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.304 -1.115 . . . . 0.0 110.034 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.638 0.256 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.51 -42.56 99.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.235 -0.916 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.3 m -60.99 -42.12 97.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.715 -0.616 . . . . 0.0 110.082 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.23 -35.27 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.691 -0.631 . . . . 0.0 111.032 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -63.27 -47.1 83.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.043 0.925 . . . . 0.0 109.448 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.5 tt -61.96 -38.86 90.1 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.719 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.8 m -68.32 -36.15 78.87 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -63.07 -45.28 92.91 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.261 -0.899 . . . . 0.0 111.129 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.13 -40.87 86.86 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.116 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 419' ' ' TYR . 96.5 mt -62.75 -42.58 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 0.9 OUTLIER -61.04 -31.57 71.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.77 -30.87 71.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.966 -1.084 . . . . 0.0 109.827 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 61.0 tp60 -89.39 -16.31 31.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 109.205 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 400' ' ' MET . 2.6 t-20 -66.11 -34.31 77.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.571 -0.706 . . . . 0.0 109.672 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -114.09 17.9 17.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 109.518 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.731 HG13 HG23 ' A' ' 407' ' ' VAL . 8.3 p -40.43 148.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.559 0.695 . . . . 0.0 112.243 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.4 m -85.63 77.18 9.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.731 HG23 HG13 ' A' ' 405' ' ' VAL . 82.5 t -94.51 129.74 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 111.064 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -98.92 144.93 29.09 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.6 -19.09 42.56 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.199 1.105 . . . . 0.0 111.488 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.61 -33.22 71.21 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -158.09 64.03 0.45 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.5 m -61.3 131.28 49.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 110.979 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' A' ' 414' ' ' PRO . 7.8 p -78.68 148.66 73.33 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.468 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.5 Cg_endo -60.18 138.82 83.89 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.834 0.912 . . . . 0.0 110.622 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -101.05 -5.02 26.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 420' ' ' SER . 17.5 p -97.83 17.97 16.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.777 -1.202 . . . . 0.0 108.943 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.28 -32.56 7.73 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -69.47 -40.01 79.37 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.74 ' HD1' HG23 ' A' ' 399' ' ' ILE . 4.9 m-85 -98.93 -10.95 22.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.74 -1.447 . . . . 0.0 111.215 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 416' ' ' THR . 58.2 p -74.17 -38.13 63.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.746 -1.221 . . . . 0.0 107.841 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 425' ' ' VAL . 99.0 m-20 -75.17 -48.35 24.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.35 -48.31 73.41 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.527 -0.733 . . . . 0.0 111.727 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.932 ' HA ' HD23 ' A' ' 426' ' ' LEU . 58.0 t -66.94 -43.82 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.576 -0.703 . . . . 0.0 112.423 -177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -61.59 -42.19 98.51 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.856 -1.152 . . . . 0.0 111.147 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 421' ' ' ASP . 77.7 t -61.7 -28.65 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.3 -0.875 . . . . 0.0 110.667 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -72.89 -32.12 65.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.446 -0.784 . . . . 0.0 111.558 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.35 76.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.904 -1.123 . . . . 0.0 109.389 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -61.93 -30.14 70.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.51 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.405 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 3.4 tpp85 -172.19 -61.21 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.694 -1.254 . . . . 0.0 109.256 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 531' ' ' GLN . 44.3 Cg_endo -71.35 110.91 2.97 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 O-C-N 123.086 1.045 . . . . 0.0 110.637 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 426' ' ' LEU . 6.7 t -88.46 98.06 11.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.69 -0.631 . . . . 0.0 110.45 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.839 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 19.7 tp -164.31 97.07 0.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.663 -1.273 . . . . 0.0 112.34 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -141.34 175.63 9.5 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.104 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.475 ' O ' HG21 ' A' ' 399' ' ' ILE . 46.4 pt -118.83 130.59 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.325 0.583 . . . . 0.0 110.4 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.723 ' CG2' HG21 ' A' ' 423' ' ' VAL . 58.2 t -127.88 136.02 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.921 -1.112 . . . . 0.0 109.611 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.411 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 73.9 m -121.56 125.69 47.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.345 -0.847 . . . . 0.0 110.996 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -103.2 -176.71 26.46 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -129.41 -41.17 1.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.616 -0.932 . . . . 0.0 109.838 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -159.88 167.0 35.23 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.7 64.06 2.97 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.77 ' HB1' HH22 ' A' ' 446' ' ' ARG . . . -80.6 -21.26 41.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.59 -0.947 . . . . 0.0 110.362 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.22 97.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.462 -0.774 . . . . 0.0 111.171 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -66.1 -31.06 78.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.77 -30.41 71.41 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.603 -0.939 . . . . 0.0 109.807 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.77 HH22 ' HB1' ' A' ' 442' ' ' ALA . 2.8 mmt85 -63.97 -43.45 95.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.59 -0.694 . . . . 0.0 109.976 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.74 -33.85 64.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.335 -0.853 . . . . 0.0 110.783 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.24 -53.59 52.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.362 -0.836 . . . . 0.0 111.511 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.611 HG22 ' CD1' ' A' ' 506' ' ' ILE . 12.7 p -58.61 -33.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.757 -1.214 . . . . 0.0 108.883 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.62 68.07 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.42 -37.99 82.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.064 -1.022 . . . . 0.0 108.61 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 455' ' ' MET . 79.2 mt -63.12 -36.72 84.54 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.896 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.5 t -60.66 -27.44 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -0.825 . . . . 0.0 109.586 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 94.4 mtp -67.73 -40.95 84.17 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . 0.417 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.1 OUTLIER -62.41 -20.74 64.79 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.235 -0.916 . . . . 0.0 109.93 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.23 -23.06 32.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.614 -0.679 . . . . 0.0 109.562 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -68.56 -40.19 80.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.676 . . . . 0.0 109.563 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.45 -32.21 68.06 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.408 -0.807 . . . . 0.0 109.661 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.68 3.1 12.38 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.753 -0.592 . . . . 0.0 111.725 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.44 71.8 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.424 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 61.1 ttm-85 -125.37 122.42 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 98.1 mt-10 -84.85 168.18 15.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.896 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.4 m -143.62 149.08 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 111.22 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.916 ' HA ' HD22 ' A' ' 486' ' ' LEU . 1.4 pt20 -99.08 121.66 41.28 Favored 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.729 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -123.5 129.72 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.733 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.4 mp -117.76 112.99 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -65.23 -179.44 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.813 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.514 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -61.94 -161.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.16 -14.59 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.732 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.72 -3.07 45.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.122 -0.986 . . . . 0.0 111.967 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 74.6 ttt-85 -57.04 -31.13 64.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.886 -1.133 . . . . 0.0 111.21 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.6 t -60.01 -44.44 94.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.855 . . . . 0.0 109.857 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.21 -36.01 82.86 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.1 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.864 -0.523 . . . . 0.0 109.936 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -61.47 -37.57 84.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.534 -0.729 . . . . 0.0 109.605 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 65.5 ttp -58.55 -38.11 77.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.919 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.4 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.9 pttt -124.89 -152.42 0.51 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.2 mm-40 48.3 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.909 -1.12 . . . . 0.0 111.824 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -127.65 11.47 6.75 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.562 -0.712 . . . . 0.0 110.665 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -98.24 -14.51 20.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.546 -0.721 . . . . 0.0 110.267 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -108.67 -13.96 14.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.557 -0.715 . . . . 0.0 111.84 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.451 HD22 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -175.7 56.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.953 -1.092 . . . . 0.0 110.932 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 93.2 p -60.17 -23.67 64.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.017 -1.052 . . . . 0.0 110.181 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 151.22 55.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -132.4 48.87 2.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.821 -0.811 . . . . 0.0 110.407 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.916 HD22 ' HA ' ' A' ' 464' ' ' GLN . 19.0 mt -73.61 -80.56 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.664 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER -178.96 -44.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.796 -1.19 . . . . 0.0 110.246 174.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 487' ' ' ILE . 5.0 p -102.63 8.75 39.63 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.851 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.416 ' HA2' HD12 ' A' ' 493' ' ' LEU . . . -85.85 60.09 4.68 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 66.3 ttt180 -145.77 -45.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.906 -0.761 . . . . 0.0 109.542 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 36.7 mtt85 -120.86 -46.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.429 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 498' ' ' ALA . 32.4 mt-30 -61.61 -50.32 73.04 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.092 -1.005 . . . . 0.0 111.452 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.416 HD12 ' HA2' ' A' ' 489' ' ' GLY . 7.3 mt -71.08 -37.53 72.45 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.97 -0.457 . . . . 0.0 111.603 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -104.76 -38.07 6.82 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.13 -8.18 15.19 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.773 -1.205 . . . . 0.0 114.132 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 91.54 -21.34 36.1 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 120.766 -1.209 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 52.1 mmm -67.12 178.73 1.35 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.133 -1.216 . . . . 0.0 109.851 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 492' ' ' GLN . . . -114.31 148.83 36.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 112.23 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.477 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -115.95 148.92 39.55 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.559 0.695 . . . . 0.0 110.301 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 19.1 m -52.45 107.57 0.87 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.869 -0.52 . . . . 0.0 110.117 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 41.1 Cg_endo -70.74 114.41 3.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.437 1.23 . . . . 0.0 109.556 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -171.95 27.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.743 ' O ' HG22 ' A' ' 530' ' ' VAL . 60.2 p -94.3 177.97 5.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.634 -0.921 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.805 ' HB ' HG12 ' A' ' 463' ' ' VAL . 51.5 m -125.53 125.39 43.16 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 522' ' ' LEU . 8.5 p -109.32 131.01 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.949 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.611 ' CD1' HG22 ' A' ' 449' ' ' VAL . 2.4 pt -126.0 112.32 29.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.733 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.3 p -112.68 115.5 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 111.851 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 2.0 t70 -83.12 105.63 14.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 21.8 tm0? -94.12 174.12 7.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.7 0.762 . . . . 0.0 111.199 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.46 -74.66 0.04 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 105.364 -3.094 . . . . 0.0 105.364 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -54.49 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 5.3 mttt 179.07 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.625 0 O-C-N 120.695 -1.253 . . . . 0.0 110.57 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 513' ' ' LEU . 29.6 mt -70.0 -20.89 63.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.641 -0.662 . . . . 0.0 110.493 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 17.9 m -64.43 -42.12 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.358 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 7.6 tp -65.5 -44.17 87.88 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.23 0.538 . . . . 0.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.71 -43.89 83.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.457 -0.777 . . . . 0.0 112.348 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.85 -51.21 69.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.05 -1.031 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.65 ' CG2' HD13 ' A' ' 466' ' ' ILE . 30.6 m -59.1 -41.5 88.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.726 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.55 -39.23 79.63 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.924 -0.485 . . . . 0.0 110.848 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.1 m -61.02 -37.14 81.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 0.0 110.167 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.575 HD23 HE22 ' A' ' 464' ' ' GLN . 61.2 tp -67.09 -40.43 86.94 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 505' ' ' VAL . 0.3 OUTLIER -64.66 -21.95 66.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.754 -0.591 . . . . 0.0 111.641 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -45.74 -62.66 1.21 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.592 -0.692 . . . . 0.0 111.951 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -84.68 -48.17 5.08 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.984 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -69.77 -41.94 74.49 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 522' ' ' LEU . . . -65.0 -25.69 67.97 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.786 -1.196 . . . . 0.0 112.325 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -42.46 -28.13 0.2 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.411 -0.806 . . . . 0.0 112.182 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.23 -137.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 111.177 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.416 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 84.5 m-20 -72.43 73.97 1.02 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.9 -1.125 . . . . 0.0 112.129 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 503' ' ' SER . 41.2 t -137.73 164.52 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.42 -0.8 . . . . 0.0 110.668 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 432' ' ' SER . 1.5 mm-40 -160.59 162.21 32.77 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.839 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 8.5 t -114.65 111.62 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 120.947 -1.096 . . . . 0.0 113.794 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.2 tp -102.2 114.86 29.38 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.657 HG22 ' CG1' ' A' ' 507' ' ' VAL . 7.9 pt -133.33 161.46 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 C-N-CA 118.677 -1.209 . . . . 0.0 112.596 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.594 HG22 ' HB ' ' A' ' 436' ' ' VAL . 68.9 p -131.16 -171.56 2.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 24.0 t70 -151.12 157.58 42.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.83 20.87 2.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.387 -0.821 . . . . 0.0 110.794 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -153.75 -42.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -78.79 0.32 27.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.503 -0.998 . . . . 0.0 111.229 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . 0.448 ' HG3' HG23 ' A' ' 541' ' ' THR . 33.6 ptt-85 -38.1 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 540' ' ' ARG . 4.0 p -102.36 -25.14 13.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.962 -1.086 . . . . 0.0 110.623 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -127.51 55.57 0.75 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 8.9 t -75.17 -15.64 60.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.783 -0.833 . . . . 0.0 111.542 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.09 93.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 87.8 p -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -1.044 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.43 -36.46 76.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 109.628 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 543' ' ' THR . 10.4 mp -61.71 -43.21 99.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.405 -0.809 . . . . 0.0 109.163 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.7 ttp -63.34 -35.14 79.39 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.0 -50.64 60.94 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.726 ' HG3' HD11 ' A' ' 519' ' ' LEU . 28.2 ttt -57.97 -46.1 85.67 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -60.9 -31.45 70.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.414 -0.804 . . . . 0.0 111.052 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.83 -20.86 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.389 -0.82 . . . . 0.0 110.071 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.82 3.3 6.8 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.426 -0.796 . . . . 0.0 112.64 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.63 -13.26 8.75 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.419 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.269 . . . . 0.0 109.911 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.439 0.638 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -40.26 96.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.979 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.9 t -60.63 -45.72 92.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.456 -0.777 . . . . 0.0 110.68 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.66 -28.48 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -64.51 -52.3 58.52 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.999 -1.063 . . . . 0.0 111.533 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.32 77.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.336 -0.853 . . . . 0.0 109.134 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.604 ' CD2' HD12 ' A' ' 399' ' ' ILE . 8.0 tt -61.27 -38.06 85.35 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 t -65.51 -43.65 89.41 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.118 -0.989 . . . . 0.0 111.781 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -64.07 -45.36 89.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.319 -0.863 . . . . 0.0 111.964 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -64.94 -44.86 88.06 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.29 -0.881 . . . . 0.0 111.283 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.791 HG23 ' HD1' ' A' ' 419' ' ' TYR . 71.4 mt -63.98 -41.83 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.34 -0.85 . . . . 0.0 110.519 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 5.6 tpp -60.62 -35.01 75.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.351 -0.843 . . . . 0.0 109.995 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.35 -31.03 70.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 405' ' ' VAL . 5.6 tp-100 -87.45 -16.59 34.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.801 -1.187 . . . . 0.0 108.78 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.33 -31.98 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.722 -0.611 . . . . 0.0 110.273 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -113.67 17.84 17.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.6 p -52.46 108.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.59 -0.694 . . . . 0.0 109.729 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 64.9 p -50.03 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.462 -0.774 . . . . 0.0 111.37 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 405' ' ' VAL . 58.6 t -107.24 133.02 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -94.32 142.21 24.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.572 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.22 -21.91 54.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.336 1.177 . . . . 0.0 110.318 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -60.46 -40.29 90.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 110.002 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 68.28 1.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.4 t -53.89 110.62 0.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.8 p -62.63 111.54 4.95 Favored Pre-proline 0 N--CA 1.492 1.653 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.813 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.8 133.32 21.66 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.096 1.051 . . . . 0.0 109.972 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.91 63.6 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.485 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 68.8 p -66.0 -33.16 75.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 108.762 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -63.59 -10.26 17.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.626 -0.671 . . . . 0.0 111.578 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.56 51.93 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.965 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.791 ' HD1' HG23 ' A' ' 399' ' ' ILE . 12.9 m-85 -93.16 -2.04 55.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.61 -1.524 . . . . 0.0 110.133 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 4.8 m -82.48 -33.0 28.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 108.781 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 425' ' ' VAL . 98.0 m-20 -78.88 -44.42 22.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.666 . . . . 0.0 110.123 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.94 -42.02 95.02 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.636 -0.665 . . . . 0.0 111.412 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.927 HG21 ' CG2' ' A' ' 436' ' ' VAL . 88.8 t -80.2 -44.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.773 -0.579 . . . . 0.0 112.258 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.1 m -60.28 -42.01 94.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.929 -1.107 . . . . 0.0 110.475 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 421' ' ' ASP . 13.5 p -64.22 -29.76 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.422 -0.799 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -68.32 -31.77 71.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.554 -0.716 . . . . 0.0 110.074 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.49 78.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.056 -1.028 . . . . 0.0 108.771 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.13 -28.87 63.09 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -67.46 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.514 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 6.0 tmm_? -173.04 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 120.726 -1.234 . . . . 0.0 110.397 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.3 Cg_endo -71.17 120.48 7.04 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 N-CA-C 110.182 -0.738 . . . . 0.0 110.182 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.467 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 2.0 t -94.91 99.96 11.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.805 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.8 tp -163.24 98.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.955 -1.091 . . . . 0.0 110.741 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -140.48 177.14 8.22 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.504 0.669 . . . . 0.0 111.047 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.459 ' O ' HG21 ' A' ' 399' ' ' ILE . 3.3 mt -117.43 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.819 -0.551 . . . . 0.0 110.146 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.927 ' CG2' HG21 ' A' ' 423' ' ' VAL . 67.1 t -133.47 140.05 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.47 -0.769 . . . . 0.0 110.473 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 19.1 m -132.25 142.87 49.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.711 -0.618 . . . . 0.0 109.586 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.01 162.95 22.08 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -120.43 -42.74 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.895 . . . . 0.0 109.308 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.83 63.82 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 173.62 86.2 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.23 -28.23 10.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.512 -0.993 . . . . 0.0 110.724 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.49 79.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.444 -0.785 . . . . 0.0 110.781 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -77.97 -30.74 50.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.12 -31.55 64.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.401 -1.058 . . . . 0.0 109.348 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.439 ' HD2' ' HB1' ' A' ' 467' ' ' ALA . 61.2 ttp180 -62.9 -43.66 98.2 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.569 0.699 . . . . 0.0 110.152 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 47.7 tt0 -80.0 -29.46 39.47 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -0.853 . . . . 0.0 110.619 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -62.62 -47.69 82.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.0 p -60.32 -31.53 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.903 -1.123 . . . . 0.0 108.227 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.2 -28.45 69.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.806 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 454' ' ' MET . 53.6 tp10 -63.14 -32.9 74.39 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.45 -33.05 74.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.6 t -59.98 -29.8 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 61.4 mtt -66.65 -36.07 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.23 -27.52 62.1 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.576 -0.702 . . . . 0.0 109.435 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.1 32.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.64 -0.663 . . . . 0.0 109.777 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -64.39 -44.64 90.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -71.46 -30.9 66.55 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.503 0.668 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -76.38 -2.16 30.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.676 -0.64 . . . . 0.0 110.981 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.44 25.68 74.83 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.78 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.1 ttm180 -133.38 120.78 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.501 -1.0 . . . . 0.0 110.552 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 92.9 mt-10 -79.85 172.1 14.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 453' ' ' VAL . 27.2 m -144.46 153.02 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.62 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.1 tt0 -97.82 120.2 37.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -131.34 135.06 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.044 -1.035 . . . . 0.0 110.321 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.758 HG23 ' HD3' ' A' ' 471' ' ' ARG . 93.2 mt -127.51 123.55 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -78.81 162.96 25.74 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -161.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.666 -0.646 . . . . 0.0 109.294 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -47.64 -19.03 0.17 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.783 -1.198 . . . . 0.0 111.69 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.31 -7.17 54.37 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.758 ' HD3' HG23 ' A' ' 466' ' ' ILE . 58.2 ttp180 -57.09 -24.9 57.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.035 -1.041 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 40.4 t -58.44 -45.36 88.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.403 -0.811 . . . . 0.0 110.181 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.95 -40.67 96.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 108.623 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 7.6 ttm -57.25 -39.5 75.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.742 -0.599 . . . . 0.0 110.446 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -57.11 -35.43 69.43 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 53.5 tpp -59.67 -36.77 77.1 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.347 0.594 . . . . 0.0 110.04 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.0 pttt -134.76 -145.87 0.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.586 . . . . 0.0 110.403 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 92.8 mm-40 51.11 40.95 26.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.749 -1.219 . . . . 0.0 111.498 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.33 10.85 18.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.0 110.313 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 480' ' ' GLU . 74.7 tt0 -82.74 -3.94 57.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 111.487 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.801 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -159.78 15.23 0.14 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.206 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.801 HD23 ' HG2' ' A' ' 481' ' ' ARG . 1.6 pp -169.45 38.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.716 -1.24 . . . . 0.0 111.888 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 90.8 p -87.78 50.4 1.99 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.32 24.77 28.01 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -125.49 57.64 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.517 -0.99 . . . . 0.0 108.982 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 464' ' ' GLN . 84.7 mt -97.49 -82.05 0.42 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.786 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 175.77 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 174.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.544 HG21 ' OE1' ' A' ' 464' ' ' GLN . 8.8 t -104.28 10.45 35.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.884 -0.51 . . . . 0.0 111.112 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -149.66 93.91 0.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 491' ' ' ARG . 34.9 ttm180 -139.82 -81.15 0.28 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 490' ' ' ARG . 8.7 ptm180 -134.18 -13.91 2.37 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.986 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.531 ' HB2' ' CE2' ' A' ' 499' ' ' PHE . 8.2 mt-30 -61.42 -30.69 70.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.879 -1.138 . . . . 0.0 111.252 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.456 HD23 ' HZ ' ' A' ' 499' ' ' PHE . 36.0 mt -64.88 -57.64 8.29 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 494' ' ' LEU . 2.2 tm? -63.36 -37.98 89.36 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.925 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.55 -7.63 58.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.766 -0.584 . . . . 0.0 112.541 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.34 60.19 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 96.2 mtp -122.7 -173.49 2.71 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.375 -1.074 . . . . 0.0 110.046 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -103.25 165.93 10.74 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.669 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 492' ' ' GLN . 65.2 m-85 -111.58 152.6 27.39 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.651 0.739 . . . . 0.0 112.284 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 487' ' ' ILE . 5.5 m -69.86 112.2 11.55 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.27 115.69 2.3 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.284 1.149 . . . . 0.0 111.226 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.58 27.64 0.04 OUTLIER Glycine 0 N--CA 1.505 3.29 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.294 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.786 ' HB3' HG21 ' A' ' 487' ' ' ILE . 12.5 p -96.84 -177.39 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.959 -1.318 . . . . 0.0 111.877 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.734 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.4 m -118.51 112.36 19.82 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 522' ' ' LEU . 57.1 t -106.03 137.2 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 119.661 -0.815 . . . . 0.0 112.564 -175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.0 pt -134.26 163.13 37.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 534' ' ' ILE . 10.1 p -159.95 106.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 122.873 1.32 . . . . 0.0 111.842 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.94 122.45 28.29 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 507' ' ' VAL . 86.7 mm-40 -145.17 112.54 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.67 -34.36 56.78 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.45 147.16 23.59 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.32 -10.49 22.25 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.025 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 513' ' ' LEU . 14.7 tp -64.32 -34.63 78.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.429 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 71.6 m -87.75 -17.44 31.66 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.38 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 519' ' ' LEU . 56.4 tp -67.62 -46.43 72.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 108.765 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.9 mttt -70.29 -40.46 74.27 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.76 -49.96 75.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.253 -0.905 . . . . 0.0 111.06 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.591 HG21 HD12 ' A' ' 466' ' ' ILE . 91.3 m -56.5 -39.99 74.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.34 -0.85 . . . . 0.0 109.834 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.3 OUTLIER -54.89 -38.91 68.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.593 -0.692 . . . . 0.0 110.123 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 99.4 m -62.45 -39.19 92.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.512 -0.742 . . . . 0.0 109.783 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.497 HD23 ' NE2' ' A' ' 464' ' ' GLN . 49.2 tp -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.498 -0.751 . . . . 0.0 110.391 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.822 HD11 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.26 -21.46 63.93 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.484 -0.76 . . . . 0.0 111.08 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -45.81 -65.33 0.56 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.76 -51.68 55.76 Favored Glycine 0 N--CA 1.503 3.15 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.521 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 488' ' ' THR . . . -59.03 -32.46 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.56 -0.965 . . . . 0.0 111.296 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.4 -22.47 66.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.151 -0.968 . . . . 0.0 112.437 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -39.18 -28.23 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -119.04 -110.98 0.34 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.142 -0.974 . . . . 0.0 111.828 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -90.8 93.12 9.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.381 -1.449 . . . . 0.0 113.578 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.5 t -141.19 166.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.859 -1.15 . . . . 0.0 111.498 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.467 ' HG2' ' N ' ' A' ' 432' ' ' SER . 1.1 tp-100 -164.68 163.25 21.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.805 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.9 t -114.64 107.39 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.658 ' HB3' HG22 ' A' ' 506' ' ' ILE . 1.6 tp -104.53 119.04 38.06 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 507' ' ' VAL . 14.9 pt -140.5 161.03 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 117.613 -1.635 . . . . 0.0 112.96 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 436' ' ' VAL . 81.7 p -121.74 -169.86 1.94 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -149.16 155.79 41.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.18 20.38 2.43 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.042 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.06 -46.21 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.452 ' OE1' ' HB1' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.93 2.44 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.888 . . . . 0.0 111.648 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . 0.642 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.1 ptt180 -36.33 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 540' ' ' ARG . 66.7 p -93.02 117.98 30.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.074 -1.016 . . . . 0.0 109.242 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 63.83 70.21 1.12 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.415 ' O ' HD13 ' A' ' 547' ' ' LEU . 74.9 p -80.13 -3.17 47.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.752 -0.852 . . . . 0.0 111.981 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.65 -35.59 81.87 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 -32.54 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.827 -0.808 . . . . 0.0 110.279 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.17 -35.19 80.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.658 . . . . 0.0 109.324 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 543' ' ' THR . 10.1 mp -62.45 -43.28 99.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.796 -0.565 . . . . 0.0 110.639 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 93.4 mtp -65.2 -37.61 87.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -50.92 -51.46 51.82 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.099 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.424 ' CG ' HD11 ' A' ' 519' ' ' LEU . 38.0 ttp -58.29 -40.47 82.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.364 -0.835 . . . . 0.0 109.561 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HG3' ' HB ' ' A' ' 555' ' ' VAL . 85.3 tttt -61.9 -32.17 72.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.0 110.368 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.4 -16.09 62.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 0.0 110.352 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -77.14 8.41 3.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.214 -0.929 . . . . 0.0 112.629 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 155.79 -16.74 0.47 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.79 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 551' ' ' LYS . 53.2 t . . . . . 0 N--CA 1.495 1.814 0 CA-C-N 118.967 1.384 . . . . 0.0 109.273 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 121.3 0.571 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.48 -42.36 98.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.729 -0.607 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 33.9 p -64.36 -37.69 88.38 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.477 -0.764 . . . . 0.0 110.585 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 79.8 t -65.9 -35.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -62.75 -51.37 67.41 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.418 -0.801 . . . . 0.0 110.815 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.96 79.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.424 -0.798 . . . . 0.0 109.811 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.9 tt -62.18 -39.06 91.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.968 -0.458 . . . . 0.0 111.123 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.2 m -62.65 -37.47 86.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.43 -44.18 92.0 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.905 . . . . 0.0 112.249 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.95 -45.02 91.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.061 -1.024 . . . . 0.0 111.639 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.09 -40.84 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.724 -0.61 . . . . 0.0 109.965 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.486 ' CG ' HD11 ' A' ' 435' ' ' ILE . 30.9 mtp -63.73 -32.58 74.11 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.575 -0.703 . . . . 0.0 110.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.05 -32.24 70.72 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.106 -0.996 . . . . 0.0 110.143 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -91.17 -14.68 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.432 ' ND2' ' CB ' ' A' ' 437' ' ' SER . 2.2 t-20 -67.11 -36.98 83.1 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 0.0 109.5 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -115.33 20.38 14.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 12.5 p -37.34 146.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 122.149 -0.344 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 14.1 p -72.89 72.91 1.12 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.346 -0.846 . . . . 0.0 109.976 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.894 HG21 HG22 ' A' ' 413' ' ' VAL . 12.3 p -111.14 133.39 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.945 0.878 . . . . 0.0 112.819 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -92.37 145.76 31.23 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.698 -0.627 . . . . 0.0 109.848 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.96 -28.95 81.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 O-C-N 123.05 1.026 . . . . 0.0 109.825 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.57 -26.54 2.27 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.766 0.793 . . . . 0.0 111.168 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 67.21 0.75 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 82.4 p -51.07 109.86 0.37 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.522 -0.737 . . . . 0.0 110.585 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.894 HG22 HG21 ' A' ' 407' ' ' VAL . 19.9 m -76.68 110.45 11.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.886 -0.509 . . . . 0.0 110.558 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.92 137.95 42.91 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 N-CA-C 109.663 -0.937 . . . . 0.0 109.663 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -147.73 83.53 1.53 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 113.704 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.532 HG22 ' OH ' ' A' ' 419' ' ' TYR . 33.0 p -100.09 26.85 6.03 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.021 -1.05 . . . . 0.0 108.481 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -110.06 -31.71 7.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.319 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -57.7 -50.59 64.14 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.603 ' CG ' HG13 ' A' ' 436' ' ' VAL . 30.0 p90 -98.96 -11.77 21.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.814 -1.403 . . . . 0.0 111.975 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 416' ' ' THR . 6.2 t -65.92 -47.4 74.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.336 -1.477 . . . . 0.0 109.197 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 425' ' ' VAL . 65.6 t0 -77.21 -45.36 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 110.63 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -57.97 -49.14 77.82 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.597 -0.69 . . . . 0.0 111.475 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.735 ' HA ' HD23 ' A' ' 426' ' ' LEU . 61.1 t -69.85 -43.15 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.717 -0.614 . . . . 0.0 112.021 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.7 p -56.73 -39.96 74.85 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.113 -0.992 . . . . 0.0 111.225 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 421' ' ' ASP . 94.4 t -65.99 -43.84 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.784 . . . . 0.0 109.834 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -60.55 -34.14 73.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 112.045 -178.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -37.03 77.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.348 -1.47 . . . . 0.0 108.056 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.77 -29.63 70.26 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -179.44 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.344 -1.473 . . . . 0.0 108.969 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.7 99.14 0.72 Allowed 'Trans proline' 0 N--CA 1.484 0.913 0 N-CA-C 108.938 -1.216 . . . . 0.0 108.938 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 4.3 t -87.59 101.3 13.5 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.765 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -156.82 88.95 1.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 109.989 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.99 164.97 28.63 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.894 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.2 pp -114.57 128.54 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.879 -0.513 . . . . 0.0 109.714 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 423' ' ' VAL . 75.6 t -124.37 140.88 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.759 -0.588 . . . . 0.0 109.755 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.432 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 4.8 m -126.65 132.61 51.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 110.908 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.92 169.82 23.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -141.75 32.0 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.944 . . . . 0.0 109.626 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 138.08 168.73 11.4 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.84 92.55 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.85 88.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.906 . . . . 0.0 110.418 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.71 96.22 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.278 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.11 75.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.47 -38.82 81.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.981 . . . . 0.0 110.472 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 449' ' ' VAL . 90.3 mmt-85 -64.26 -40.22 95.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.368 -0.833 . . . . 0.0 110.138 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -70.81 -30.13 66.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 95.7 mtt-85 -65.7 -46.68 78.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.372 -0.83 . . . . 0.0 111.575 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.5 p -60.56 -32.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.774 -1.203 . . . . 0.0 108.974 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.82 -28.37 69.96 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.691 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 80.0 tt0 -67.61 -37.58 82.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.08 -37.0 85.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 463' ' ' VAL . 67.8 t -59.27 -26.66 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.679 -0.638 . . . . 0.0 109.314 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 17.0 mmt -67.66 -36.49 80.84 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 459' ' ' GLN . 14.8 tmm? -59.45 -29.05 67.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.834 -0.541 . . . . 0.0 110.233 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.04 -21.13 37.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.476 -0.765 . . . . 0.0 109.929 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -72.68 -25.33 61.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.651 -0.656 . . . . 0.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 455' ' ' MET . 96.9 mm-40 -77.27 2.41 15.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.338 -0.851 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.83 82.85 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 120.936 -1.103 . . . . 0.0 111.705 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -138.06 144.53 41.01 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 118.821 1.31 . . . . 0.0 111.428 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.65 ' C ' HD11 ' A' ' 487' ' ' ILE . 98.1 mt-10 -89.44 175.3 7.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 453' ' ' VAL . 16.6 m -138.74 162.38 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.855 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.78 115.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 482' ' ' LEU . 1.2 tp -119.2 120.55 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.788 -1.195 . . . . 0.0 112.116 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 507' ' ' VAL . 94.9 mt -107.66 172.95 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.795 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 466' ' ' ILE . . . -129.41 156.6 43.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.29 -159.75 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.673 -0.642 . . . . 0.0 109.424 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -46.84 -15.98 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.904 -1.122 . . . . 0.0 112.849 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -88.05 4.93 43.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.879 -1.138 . . . . 0.0 111.985 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 14.2 tpt180 -58.57 -37.61 76.14 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.066 -1.021 . . . . 0.0 111.14 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 53.5 m -56.11 -47.18 78.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.447 -0.783 . . . . 0.0 111.1 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -65.97 -37.71 86.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -0.829 . . . . 0.0 109.101 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.445 ' HE3' ' HE2' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -58.98 -34.45 71.84 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.748 -0.595 . . . . 0.0 110.192 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -61.39 -39.84 92.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.0 109.593 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 59.6 ttp -62.01 -41.61 98.25 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.445 ' HE2' ' HE3' ' A' ' 474' ' ' MET . 22.6 pttm -111.01 -150.1 0.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 109.052 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.552 ' NE2' HD21 ' A' ' 482' ' ' LEU . 41.1 tt0 48.26 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.021 -1.05 . . . . 0.0 112.302 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -132.91 21.48 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.605 . . . . 0.0 110.463 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 480' ' ' GLU . 47.7 tp10 -110.15 3.67 20.37 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.397 -0.814 . . . . 0.0 111.408 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.631 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -137.17 -24.31 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.905 -1.122 . . . . 0.0 112.421 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.631 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -158.21 69.64 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.106 -0.997 . . . . 0.0 110.81 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 24.7 t -90.38 51.15 1.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.58 16.82 23.37 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.081 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -126.16 59.9 1.32 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.177 -1.19 . . . . 0.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 487' ' ' ILE . 84.7 mt -64.18 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.069 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.784 HD11 ' CA ' ' A' ' 463' ' ' VAL . 14.4 mm -155.15 -82.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.16 -0.962 . . . . 0.0 109.736 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.553 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.0 t -98.99 12.25 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.784 -0.572 . . . . 0.0 110.761 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -97.05 79.93 0.69 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.54 -67.99 0.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 495' ' ' GLU . 95.7 mtt-85 -96.75 -26.72 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.802 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -67.52 -44.34 78.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.933 -1.104 . . . . 0.0 110.524 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 493' ' ' LEU . 2.6 mt -70.59 -37.84 73.96 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.8 OUTLIER -103.75 -39.98 6.45 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 491' ' ' ARG . 89.7 mt-10 -102.14 -9.47 20.48 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.815 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 84.31 -9.18 64.9 Favored Glycine 0 N--CA 1.5 2.949 0 O-C-N 120.523 -1.36 . . . . 0.0 111.111 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.428 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 99.4 mtp -68.17 179.25 1.6 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.248 . . . . 0.0 112.11 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.55 153.77 25.77 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.4 155.04 25.95 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.191 0.996 . . . . 0.0 112.036 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 500' ' ' THR . 7.3 t -44.6 132.33 4.89 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.642 -177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.446 ' HB3' ' CA ' ' A' ' 528' ' ' HIS . 56.3 Cg_endo -85.51 112.94 1.35 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.596 1.314 . . . . 0.0 109.51 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.11 26.05 0.07 OUTLIER Glycine 0 N--CA 1.504 3.194 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.987 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 487' ' ' ILE . 74.7 m -92.8 173.87 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -1.207 . . . . 0.0 111.022 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.806 ' HB ' HG12 ' A' ' 463' ' ' VAL . 91.6 m -115.66 127.71 55.37 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 522' ' ' LEU . 13.2 t -118.46 130.51 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.867 0.842 . . . . 0.0 111.125 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.705 HG22 ' HB3' ' A' ' 533' ' ' LEU . 6.1 pt -135.6 123.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 0.0 109.017 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 534' ' ' ILE . 14.5 p -113.73 115.18 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.647 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 36.7 m-20 -84.34 108.48 17.2 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.894 -1.129 . . . . 0.0 108.418 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 0.5 OUTLIER -99.73 175.36 5.83 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 122.376 1.084 . . . . 0.0 112.969 -176.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.81 -55.85 0.05 OUTLIER Glycine 0 N--CA 1.503 3.102 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.19 -155.05 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.51 -17.86 2.54 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.046 -1.033 . . . . 0.0 111.019 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 57.5 tp -72.43 -25.05 61.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.278 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 75.2 m -65.58 -44.31 87.05 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 110.492 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.894 HD21 ' HG3' ' A' ' 550' ' ' MET . 11.0 tp -64.46 -46.31 83.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.829 -0.544 . . . . 0.0 111.938 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.55 -43.81 79.8 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 0.0 112.084 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -62.5 -51.13 68.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.112 -0.992 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 522' ' ' LEU . 97.4 m -59.81 -43.07 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.832 -0.542 . . . . 0.0 110.459 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -41.36 90.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.747 -0.596 . . . . 0.0 111.464 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 39.1 p -64.47 -33.27 75.49 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.053 -1.03 . . . . 0.0 109.832 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 60.8 tp -68.3 -40.44 81.75 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.694 0.759 . . . . 0.0 109.83 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 505' ' ' VAL . 0.6 OUTLIER -70.97 -22.22 62.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 48.6 t0 -47.46 -60.17 2.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.393 -0.817 . . . . 0.0 111.895 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.88 -51.13 56.06 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.555 ' HB1' ' OD1' ' A' ' 529' ' ' ASN . . . -55.15 -29.83 58.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.684 -0.891 . . . . 0.0 110.414 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -47.96 -37.67 15.01 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -66.58 -42.51 86.89 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.446 ' CA ' ' HB3' ' A' ' 501' ' ' PRO . 32.2 m80 -94.62 -94.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.31 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.555 ' OD1' ' HB1' ' A' ' 525' ' ' ALA . 15.8 p-10 -83.69 144.17 29.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.963 -1.085 . . . . 0.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 4.2 p -171.81 146.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.392 -1.323 . . . . 0.0 113.836 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.8 OUTLIER 171.86 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 76.5 t -110.44 104.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 120.742 -1.223 . . . . 0.0 113.258 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.6 OUTLIER -109.26 116.17 31.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.931 HG22 HG12 ' A' ' 507' ' ' VAL . 5.7 pt -127.91 155.19 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.475 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.705 HG22 ' HB ' ' A' ' 436' ' ' VAL . 61.4 p -128.87 -172.69 2.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -149.4 156.04 41.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 110.563 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 85.3 p -145.32 23.26 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.663 . . . . 0.0 110.654 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -163.63 -41.6 0.02 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.63 ' CD ' ' HB2' ' A' ' 546' ' ' ALA . 46.3 tt0 -81.63 0.4 38.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.979 . . . . 0.0 110.939 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 541' ' ' THR . 40.8 ptt180 -40.58 -39.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.583 -0.698 . . . . 0.0 112.23 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.416 ' N ' ' HG3' ' A' ' 540' ' ' ARG . 40.5 p -63.86 -91.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -70.25 79.53 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 543' ' ' THR . 9.4 t -87.06 -18.72 29.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.953 . . . . 0.0 111.611 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.22 -38.97 93.97 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 18.9 m -69.17 -24.93 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.515 -0.991 . . . . 0.0 109.792 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.15 -36.53 77.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.76 -0.587 . . . . 0.0 109.865 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.298 -0.876 . . . . 0.0 108.877 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 56.8 ttm -64.55 -31.91 73.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.93 -50.39 61.23 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.894 ' HG3' HD21 ' A' ' 515' ' ' LEU . 90.0 mtp -58.43 -44.27 89.05 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.838 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 84.7 tttt -63.44 -32.07 73.4 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.459 -0.776 . . . . 0.0 111.474 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.67 -15.86 62.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.66 3.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.266 -0.896 . . . . 0.0 112.725 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 147.65 -13.08 1.35 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.364 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 551' ' ' LYS . 62.9 t . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.015 -1.285 . . . . 0.0 110.708 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 N--CA 1.505 2.309 0 CA-C-O 121.498 0.665 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -40.53 89.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 77.8 p -66.11 -41.44 90.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.442 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 433' ' ' LEU . 89.0 t -68.31 -33.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.679 -0.638 . . . . 0.0 110.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -58.37 -48.99 78.83 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.421 -0.799 . . . . 0.0 111.402 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.68 -32.17 71.79 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.949 0.88 . . . . 0.0 109.856 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.606 HD13 HD12 ' A' ' 399' ' ' ILE . 2.2 tm? -61.8 -41.53 97.87 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.758 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . 0.466 ' HB2' HD12 ' A' ' 435' ' ' ILE . 78.5 p -71.86 -34.68 69.43 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.193 -0.942 . . . . 0.0 112.641 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.0 -50.22 71.6 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.996 -1.065 . . . . 0.0 112.435 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.06 -43.14 71.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.263 -0.898 . . . . 0.0 112.014 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 395' ' ' LEU . 94.1 mt -61.41 -44.79 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.112 -0.992 . . . . 0.0 110.009 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.492 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 5.9 ttm -61.42 -31.55 71.49 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.617 -0.677 . . . . 0.0 110.758 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.26 -25.21 67.7 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.539 -0.726 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 405' ' ' VAL . 65.5 tp60 -99.79 -20.65 16.11 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.272 -0.893 . . . . 0.0 109.21 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.581 ' ND2' HG22 ' A' ' 399' ' ' ILE . 98.0 m-20 -82.7 -7.01 59.68 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -94.67 -56.47 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 402' ' ' GLN . 6.4 p -27.88 124.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.1 m -60.13 95.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 122.159 0.98 . . . . 0.0 109.979 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.903 HG21 ' CZ ' ' A' ' 415' ' ' ARG . 13.9 t -65.27 137.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.132 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.2 130.68 29.1 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.684 -0.635 . . . . 0.0 110.267 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.47 -20.79 41.27 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.117 1.061 . . . . 0.0 111.07 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.35 -32.6 71.78 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.787 0.803 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 69.88 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.0 m -49.69 142.3 8.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.791 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.835 HG12 HG13 ' A' ' 407' ' ' VAL . 11.4 p -98.86 143.88 27.17 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.38 136.63 56.1 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 N-CA-C 108.794 -1.272 . . . . 0.0 108.794 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.903 ' CZ ' HG21 ' A' ' 407' ' ' VAL . 98.1 mtt180 -123.18 -15.53 7.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.391 -0.818 . . . . 0.0 112.881 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.9 p -102.74 6.45 39.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.025 . . . . 0.0 109.014 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -78.51 -79.92 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.05 -1.031 . . . . 0.0 111.745 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -74.12 -4.75 68.95 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.623 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.595 ' O ' HG23 ' A' ' 423' ' ' VAL . 81.7 m-85 -107.07 -1.94 21.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.616 -1.52 . . . . 0.0 110.207 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -84.88 -33.71 22.74 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 425' ' ' VAL . 47.3 t0 -72.63 -37.68 67.95 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.11 85.72 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.099 0.952 . . . . 0.0 110.301 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 436' ' ' VAL . 98.5 t -67.71 -40.98 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.253 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -69.45 -36.61 76.79 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.028 -1.045 . . . . 0.0 111.71 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 421' ' ' ASP . 87.0 t -65.27 -42.46 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.381 -0.825 . . . . 0.0 112.008 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.748 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 2.1 pp -65.51 -31.08 71.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.109 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.25 69.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.955 . . . . 0.0 109.424 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.15 -32.53 74.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -61.24 -86.49 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.534 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -172.18 -57.46 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.773 -1.205 . . . . 0.0 109.529 177.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 55.2 Cg_endo -71.07 103.44 1.38 Allowed 'Trans proline' 0 N--CA 1.488 1.198 0 N-CA-C 109.688 -0.928 . . . . 0.0 109.688 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 3.2 t -85.34 98.72 10.71 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.963 0.887 . . . . 0.0 110.712 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.76 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.2 tp -146.51 136.61 23.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -169.96 163.21 9.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.823 -1.173 . . . . 0.0 110.923 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.597 ' O ' HG21 ' A' ' 399' ' ' ILE . 22.1 mt -123.49 121.52 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.793 -0.567 . . . . 0.0 110.409 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 423' ' ' VAL . 57.3 t -127.27 137.14 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.917 . . . . 0.0 109.137 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 539' ' ' GLN . 4.1 p -131.83 139.24 48.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.98 -1.075 . . . . 0.0 111.536 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 537' ' ' SER . . . -148.88 168.06 29.37 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.67 70.01 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 110.48 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 133.24 148.97 6.02 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.68 32.31 81.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.68 -9.16 58.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.698 -0.884 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.07 94.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.136 -0.978 . . . . 0.0 110.834 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -79.21 -28.01 54.34 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.94 -41.01 90.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.539 -0.977 . . . . 0.0 109.55 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.516 ' NE ' ' HB2' ' A' ' 467' ' ' ALA . 8.4 mmm180 -64.89 -40.15 94.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.876 -0.515 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -70.27 -31.63 69.09 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.074 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.99 -50.49 64.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.52 -0.738 . . . . 0.0 112.051 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 506' ' ' ILE . 7.2 p -58.5 -33.57 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.272 . . . . 0.0 109.174 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.89 -27.3 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -61.33 -33.95 74.45 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 455' ' ' MET . 1.5 tp -63.56 -38.43 91.08 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.847 HG13 ' CG2' ' A' ' 463' ' ' VAL . 91.8 t -58.88 -25.85 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 90.0 mtp -66.2 -39.77 89.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.45 -0.781 . . . . 0.0 109.221 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.3 OUTLIER -60.06 -23.44 63.76 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.874 0.845 . . . . 0.0 109.089 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 453' ' ' VAL . . . -83.77 -23.65 31.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.463 0.649 . . . . 0.0 109.878 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 23.9 tpt85 -67.0 -42.96 84.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -71.42 -27.9 63.61 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.726 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -74.89 0.02 17.02 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.617 -0.677 . . . . 0.0 111.725 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.36 76.43 Favored Glycine 0 N--CA 1.496 2.679 0 O-C-N 120.837 -1.164 . . . . 0.0 110.718 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 461' ' ' ARG . 16.8 ptp180 -129.87 136.27 49.34 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.215 -1.168 . . . . 0.0 110.953 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 99.2 mt-10 -91.84 161.53 14.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.222 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.926 HG12 ' HB ' ' A' ' 504' ' ' THR . 29.1 m -136.77 153.22 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 111.271 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.939 ' HA ' HD22 ' A' ' 486' ' ' LEU . 53.4 tt0 -100.72 116.41 32.56 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 506' ' ' ILE . 1.1 pt -130.29 135.11 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.065 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.598 ' HB ' HG23 ' A' ' 507' ' ' VAL . 87.5 mt -126.22 122.12 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.118 -0.989 . . . . 0.0 111.86 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.516 ' HB2' ' NE ' ' A' ' 446' ' ' ARG . . . -66.03 155.88 35.4 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.452 -0.78 . . . . 0.0 109.128 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.99 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.406 -0.809 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 511' ' ' GLU . 5.0 t0 -46.11 -22.68 0.24 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.23 -0.919 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -70.32 -4.65 23.11 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.446 -0.784 . . . . 0.0 110.892 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.478 ' HD2' ' HB3' ' A' ' 467' ' ' ALA . 6.1 tpt180 -53.77 -34.18 58.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.118 -0.989 . . . . 0.0 112.929 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 75.5 m -59.41 -45.23 92.08 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.137 -0.977 . . . . 0.0 110.074 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 476' ' ' MET . 51.4 tt0 -66.84 -39.35 87.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.7 -0.625 . . . . 0.0 109.932 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 15.8 mmt -60.39 -34.52 74.02 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -61.77 -36.23 80.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.28 -0.888 . . . . 0.0 108.621 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 473' ' ' GLN . 7.3 tpp -59.45 -41.94 90.82 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.568 0.699 . . . . 0.0 109.124 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -118.16 -146.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 46.06 88.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.216 -0.927 . . . . 0.0 111.627 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -131.79 22.55 4.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.735 -0.603 . . . . 0.0 110.139 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -115.77 -15.49 11.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.695 -0.628 . . . . 0.0 110.735 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.632 ' C ' HD23 ' A' ' 482' ' ' LEU . 22.4 mtt180 -118.15 -7.0 10.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 113.175 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -171.54 54.45 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 120.751 -1.218 . . . . 0.0 112.296 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.0 p -64.67 -21.63 66.78 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.926 -1.109 . . . . 0.0 110.576 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 149.67 48.17 0.02 OUTLIER Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.93 59.17 1.74 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.788 -0.83 . . . . 0.0 109.774 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 464' ' ' GLN . 24.9 mt -80.17 -80.29 0.14 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 177.27 -41.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 174.131 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.629 HG23 HG22 ' A' ' 487' ' ' ILE . 6.9 p -103.85 9.53 36.84 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.503 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.4 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -103.14 60.78 0.48 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 499' ' ' PHE . 54.7 ttm-85 -144.12 -50.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.956 . . . . 0.0 108.835 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 98.0 mtt180 -122.97 -29.86 3.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.976 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -65.2 -41.19 94.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -0.921 . . . . 0.0 110.534 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 493' ' ' LEU . 5.8 mt -86.58 -31.48 21.17 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.503 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -102.93 -43.57 5.49 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -100.13 -9.65 22.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.535 -1.353 . . . . 0.0 113.904 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.22 -18.83 46.57 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.676 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 98.3 mtp -66.36 -178.47 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -1.151 . . . . 0.0 109.935 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.23 145.7 41.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.734 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -114.35 149.32 36.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.664 -0.648 . . . . 0.0 110.645 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 94.6 m -50.54 103.71 0.38 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 0.0 109.811 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 44.3 Cg_endo -72.37 113.04 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.559 1.294 . . . . 0.0 108.928 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 529' ' ' ASN . . . 171.05 34.33 0.03 OUTLIER Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 487' ' ' ILE . 22.8 p -92.91 179.04 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -1.061 . . . . 0.0 110.654 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.926 ' HB ' HG12 ' A' ' 463' ' ' VAL . 97.8 m -111.17 121.6 45.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.87 ' CG1' HD21 ' A' ' 522' ' ' LEU . 63.4 t -123.02 134.89 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.205 -0.934 . . . . 0.0 113.227 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.669 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.2 pt -131.99 120.29 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 534' ' ' ILE . 9.8 p -106.1 114.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.537 -1.352 . . . . 0.0 111.478 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 12.0 m-20 -82.27 108.5 15.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.9 tm0? -106.83 175.15 5.6 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.349 1.071 . . . . 0.0 113.305 -175.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -170.58 -51.91 0.04 OUTLIER Glycine 0 N--CA 1.503 3.145 0 N-CA-C 103.401 -3.88 . . . . 0.0 103.401 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 469' ' ' ASP . 32.0 tp10 -82.17 162.94 22.26 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 173.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.69 -12.32 20.11 Favored 'General case' 0 C--N 1.274 -2.712 0 O-C-N 121.636 -0.665 . . . . 0.0 110.658 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 513' ' ' LEU . 4.5 mm? -67.44 -27.16 66.81 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.2 m -91.43 -13.06 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 111.225 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 519' ' ' LEU . 20.5 tp -78.34 -46.84 19.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 13.6 ptpt -80.61 -38.52 29.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.467 -0.77 . . . . 0.0 111.512 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.64 -44.39 96.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.9 -1.125 . . . . 0.0 109.702 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.783 HG22 HD12 ' A' ' 522' ' ' LEU . 85.8 m -62.2 -41.96 98.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.8 OUTLIER -60.2 -31.76 70.45 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.762 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 21.4 m -64.65 -53.98 39.03 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.855 -1.153 . . . . 0.0 110.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 521' ' ' LEU . 0.2 OUTLIER -62.74 -39.27 93.57 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.133 -0.979 . . . . 0.0 109.888 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.87 HD21 ' CG1' ' A' ' 505' ' ' VAL . 3.2 mt -65.34 -31.98 73.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.459 -0.776 . . . . 0.0 112.181 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.06 -45.9 68.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.017 -1.052 . . . . 0.0 110.325 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.33 62.13 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -67.13 -36.52 82.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.508 -0.995 . . . . 0.0 112.375 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -26.38 68.22 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.956 -1.09 . . . . 0.0 110.872 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -53.72 -25.8 20.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.485 -0.759 . . . . 0.0 109.243 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.514 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.7 m80 -109.98 -130.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.433 ' HB2' ' CA ' ' A' ' 502' ' ' GLY . 98.1 m-20 -89.91 70.65 7.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.532 -1.355 . . . . 0.0 113.234 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -133.28 158.0 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -148.77 154.59 39.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.759 -0.588 . . . . 0.0 109.608 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 35.4 t -107.14 106.55 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.35 -0.844 . . . . 0.0 113.12 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.669 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.2 tp -106.72 113.66 27.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.885 HG22 HG12 ' A' ' 507' ' ' VAL . 12.1 pt -125.56 130.4 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.028 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 62.5 p -96.8 179.03 5.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 8.3 t0 -154.82 161.0 41.64 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.589 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 438' ' ' GLY . 0.1 OUTLIER -138.59 14.58 2.74 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.464 178.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -146.95 20.19 1.6 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 56.4 tt0 -93.83 -0.95 55.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.301 -1.117 . . . . 0.0 111.038 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -55.86 -42.75 76.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.834 -1.166 . . . . 0.0 111.25 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.1 m -102.75 -58.25 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 111.169 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -90.98 85.83 1.31 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 539' ' ' GLN . 14.9 t -98.56 -40.78 8.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.561 -0.964 . . . . 0.0 111.608 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.09 -41.39 97.13 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 4.5 t -68.54 -23.31 64.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.522 -0.987 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.603 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.14 -39.52 94.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 108.642 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -65.36 -42.11 93.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.743 -0.598 . . . . 0.0 109.958 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.21 -29.67 68.88 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.657 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -61.42 -48.71 79.93 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 519' ' ' LEU . 24.9 ttm -56.78 -53.02 62.65 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.598 -0.689 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.39 -31.88 69.64 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.639 -0.663 . . . . 0.0 110.986 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -61.48 -20.04 62.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.415 -0.803 . . . . 0.0 109.776 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -72.37 -1.17 14.54 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.191 -0.943 . . . . 0.0 111.868 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.04 -8.81 9.76 Favored Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.872 -1.143 . . . . 0.0 110.992 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.124 -1.221 . . . . 0.0 108.505 178.759 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.06 0.457 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.58 -30.11 70.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.358 -0.839 . . . . 0.0 110.724 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.6 m -60.98 -44.71 96.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.22 -33.77 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.437 -0.789 . . . . 0.0 109.949 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -59.39 -47.79 84.1 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.179 -0.95 . . . . 0.0 110.559 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.64 78.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 426' ' ' LEU . 0.6 OUTLIER -62.14 -39.38 92.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.025 -0.422 . . . . 0.0 111.195 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.0 p -64.69 -34.49 78.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 110.748 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -65.15 -43.73 90.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.96 -44.77 75.98 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.328 -0.858 . . . . 0.0 112.235 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 435' ' ' ILE . 62.2 mt -64.27 -43.77 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 6.9 tpp -61.36 -29.28 69.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.315 0.578 . . . . 0.0 109.484 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.06 -29.17 70.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.594 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.4 mm-40 -90.9 -15.5 29.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.081 . . . . 0.0 109.419 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.5 -37.98 86.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.648 -0.657 . . . . 0.0 110.079 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -116.86 18.9 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.047 -1.033 . . . . 0.0 110.441 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 402' ' ' GLN . 7.1 p -58.76 120.92 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.397 -0.814 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 406' ' ' THR . 3.8 t -56.94 104.22 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.645 0.736 . . . . 0.0 110.525 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 413' ' ' VAL . 6.0 p -112.71 135.33 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 138.31 25.6 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.96 -27.94 36.1 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.12 1.063 . . . . 0.0 110.758 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -62.53 -31.36 72.12 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.91 0.862 . . . . 0.0 109.996 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.61 59.32 0.69 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 30.7 t -61.34 126.99 29.33 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.751 0.786 . . . . 0.0 111.313 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 407' ' ' VAL . 7.1 p -74.18 146.14 84.13 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 413' ' ' VAL . 40.5 Cg_endo -68.01 121.24 8.24 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -95.05 14.17 22.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.462 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.888 HG22 ' OH ' ' A' ' 419' ' ' TYR . 14.6 p -92.07 20.9 5.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.878 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.23 -29.18 9.48 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.0 -49.63 76.5 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.888 ' OH ' HG22 ' A' ' 416' ' ' THR . 21.0 p90 -99.29 -11.91 20.83 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.055 1.428 . . . . 0.0 112.943 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.3 m -70.88 -42.14 70.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.264 -1.523 . . . . 0.0 108.203 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.6 t70 -78.94 -44.58 22.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.907 -0.496 . . . . 0.0 110.758 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.532 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.74 -48.04 76.05 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.773 -0.579 . . . . 0.0 112.409 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 426' ' ' LEU . 89.8 t -68.42 -42.33 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.319 -0.863 . . . . 0.0 111.469 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 81.2 p -60.68 -42.84 97.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.182 -0.949 . . . . 0.0 111.343 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 422' ' ' ALA . 32.8 m -68.7 -29.32 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.33 -0.856 . . . . 0.0 111.949 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -73.34 -33.18 64.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.283 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.27 -32.71 73.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.026 -1.046 . . . . 0.0 108.594 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.17 -33.98 77.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.38 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.478 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -177.06 -56.11 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.556 -1.34 . . . . 0.0 110.001 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.4 Cg_endo -68.59 107.93 1.74 Allowed 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 109.291 -1.08 . . . . 0.0 109.291 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 531' ' ' GLN . 1.5 m -100.41 109.21 21.36 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.89 0.852 . . . . 0.0 110.898 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -174.8 95.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -136.86 167.01 22.29 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.929 0.871 . . . . 0.0 112.372 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 399' ' ' ILE . 40.0 pt -116.3 127.66 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.467 0.651 . . . . 0.0 109.541 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.803 HG13 ' CG ' ' A' ' 419' ' ' TYR . 54.0 t -125.04 137.35 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.369 -0.832 . . . . 0.0 109.327 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 28.1 m -119.61 123.45 43.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.359 -0.838 . . . . 0.0 110.951 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.96 155.66 19.63 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.17 75.55 0.25 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.737 -0.861 . . . . 0.0 109.368 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 113.65 145.49 9.2 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.27 38.96 95.39 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.25 -30.0 69.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.6 -0.941 . . . . 0.0 110.737 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.29 93.88 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.416 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.55 -28.05 68.26 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.37 -46.5 88.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.49 -1.006 . . . . 0.0 110.757 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 449' ' ' VAL . 13.0 mtm-85 -64.81 -40.76 95.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.557 -0.714 . . . . 0.0 111.189 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 14.3 mt-10 -69.22 -29.97 68.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.127 -0.983 . . . . 0.0 110.37 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -61.67 -51.5 68.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.329 -0.857 . . . . 0.0 110.449 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 1.01 HG22 HD12 ' A' ' 506' ' ' ILE . 2.4 p -58.0 -31.74 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.095 -1.003 . . . . 0.0 108.765 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.02 -27.34 69.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.24 -34.28 76.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.106 -0.996 . . . . 0.0 108.756 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 452' ' ' LEU . 4.6 mm? -63.87 -34.41 77.88 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.7 t -59.3 -30.12 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.633 -0.667 . . . . 0.0 109.742 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 60.3 mtt -66.34 -39.28 89.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.001 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.4 ttp -58.86 -25.21 63.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.652 -0.655 . . . . 0.0 110.176 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.36 -22.68 32.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 110.058 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -64.52 -45.39 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.573 -0.704 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.05 -29.86 65.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -75.82 3.8 9.26 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 111.357 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.67 23.92 75.45 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -128.37 145.64 51.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.445 -1.032 . . . . 0.0 110.344 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 487' ' ' ILE . 51.0 mp0 -99.09 169.79 9.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 35.5 m -141.27 150.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.086 -1.009 . . . . 0.0 111.212 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.887 ' HB3' HG22 ' A' ' 505' ' ' VAL . 41.4 tt0 -101.2 123.62 45.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -137.49 146.78 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.225 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.787 ' HB ' HG23 ' A' ' 507' ' ' VAL . 95.5 mt -132.99 124.61 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.437 -0.789 . . . . 0.0 110.674 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.461 ' HB1' ' CD ' ' A' ' 446' ' ' ARG . . . -75.8 161.94 28.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.16 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.534 -0.729 . . . . 0.0 109.863 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -49.42 -19.16 0.49 Allowed 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.665 -1.272 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . 0.4 ' HD2' ' NE ' ' A' ' 446' ' ' ARG . 96.2 mtt-85 -76.17 -5.67 47.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.213 -0.929 . . . . 0.0 111.031 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 466' ' ' ILE . 71.8 ttt180 -56.97 -23.44 45.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.033 -1.042 . . . . 0.0 111.027 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 11.6 t -60.6 -48.57 81.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.11 -46.36 84.57 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 30.1 tpp -53.57 -35.03 60.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.897 -0.502 . . . . 0.0 110.904 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -60.72 -38.7 85.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.439 -0.788 . . . . 0.0 109.962 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 10.6 tpt -61.79 -37.67 85.22 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.602 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -113.12 -144.47 0.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.652 ' CG ' HD21 ' A' ' 482' ' ' LEU . 35.7 tp60 55.54 50.73 13.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.829 -1.169 . . . . 0.0 111.398 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -100.6 23.57 10.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.27 -10.21 39.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 112.265 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -173.2 24.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.944 -1.098 . . . . 0.0 112.746 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 482' ' ' LEU . 3.8 pp -171.62 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.4 p -61.13 -21.44 63.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.112 -0.992 . . . . 0.0 110.804 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 164.0 53.24 0.02 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.6 66.14 0.75 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.661 -0.905 . . . . 0.0 109.77 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 464' ' ' GLN . 75.4 mt -77.2 -82.1 0.09 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.427 -0.795 . . . . 0.0 109.21 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 503' ' ' SER . 35.8 mm -152.64 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 109.255 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.471 ' CB ' ' HB3' ' A' ' 499' ' ' PHE . 3.9 t -100.74 10.67 40.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.572 -0.705 . . . . 0.0 111.077 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.449 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -91.92 72.63 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 51.0 ttm-85 -142.92 -73.96 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -90.37 -26.81 19.74 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.255 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -62.67 -48.06 80.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 110.512 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 493' ' ' LEU . 4.8 mt -71.64 -41.82 68.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.513 -0.742 . . . . 0.0 111.457 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 45.9 tp -102.66 -45.4 5.04 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -87.02 -5.02 59.21 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.076 -1.015 . . . . 0.0 112.492 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 62.41 47.22 91.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.02 -177.17 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.923 . . . . 0.0 109.411 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.87 48.62 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 109.12 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.471 ' HB3' ' CB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -113.92 148.74 36.28 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.076 0.941 . . . . 0.0 111.453 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 500' ' ' THR . 8.2 t -48.68 121.43 9.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.586 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 49.0 Cg_endo -78.84 114.36 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.384 1.202 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -170.69 33.36 0.16 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.827 ' HB2' HG21 ' A' ' 487' ' ' ILE . 36.7 t -80.75 143.22 33.08 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.922 ' HB ' HG12 ' A' ' 463' ' ' VAL . 48.1 m -115.25 108.48 16.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.942 HG21 HD21 ' A' ' 522' ' ' LEU . 41.4 t -113.09 141.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 1.01 HD12 HG22 ' A' ' 449' ' ' VAL . 15.9 pt -136.46 103.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 175.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.787 HG23 ' HB ' ' A' ' 466' ' ' ILE . 8.6 p -103.49 107.02 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.739 -1.225 . . . . 0.0 112.263 -176.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 3.9 t70 -85.18 107.95 17.49 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 6.5 tp-100 -131.0 115.18 16.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -73.33 -64.73 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.85 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.85 -12.87 1.96 Allowed 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.629 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.5 OUTLIER -63.74 -34.56 78.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.342 -0.849 . . . . 0.0 109.438 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 509' ' ' GLN . 22.9 t -90.4 -14.52 32.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.697 -0.627 . . . . 0.0 111.236 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 534' ' ' ILE . 42.6 tp -65.45 -48.92 71.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.038 -1.039 . . . . 0.0 108.922 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.676 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 98.8 mttt -69.86 -41.7 74.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.968 -0.457 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.92 -47.05 81.52 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 78.9 m -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.367 -0.833 . . . . 0.0 110.239 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -57.61 -39.58 77.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.849 -0.532 . . . . 0.0 110.674 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 11.5 m -61.97 -39.63 92.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.384 -0.823 . . . . 0.0 110.301 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.34 -41.68 96.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.873 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.942 HD21 HG21 ' A' ' 505' ' ' VAL . 2.6 mt -61.82 -22.4 65.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.748 -0.595 . . . . 0.0 110.458 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -47.24 -63.69 0.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.07 -51.71 50.85 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.708 -1.245 . . . . 0.0 110.46 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -29.34 65.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.908 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.469 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -59.99 -25.1 64.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.513 -0.742 . . . . 0.0 112.481 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -41.94 -27.74 0.13 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.542 -0.724 . . . . 0.0 111.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 1.9 t-80 -108.22 -126.94 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.73 . . . . 0.0 111.047 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -89.86 96.87 10.88 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.622 -1.299 . . . . 0.0 114.49 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -113.17 131.08 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 O-C-N 120.893 -1.129 . . . . 0.0 111.462 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 432' ' ' SER . 86.8 mt-30 -120.27 126.85 51.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.558 ' C ' HD12 ' A' ' 533' ' ' LEU . 49.7 t -117.08 123.51 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 122.581 1.181 . . . . 0.0 113.091 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 532' ' ' VAL . 9.2 mp -119.57 119.3 33.4 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.756 HG22 HG12 ' A' ' 507' ' ' VAL . 0.8 OUTLIER -132.78 129.01 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.658 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.66 HG22 ' HB ' ' A' ' 436' ' ' VAL . 30.2 p -101.58 -166.69 1.33 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 4.3 t0 -159.07 169.12 24.96 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.511 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -140.73 17.85 2.34 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.719 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.99 2.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 536' ' ' ASP . 83.9 mt-30 -96.75 1.19 50.58 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.507 -0.996 . . . . 0.0 111.947 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -53.45 -40.66 65.41 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.985 -1.072 . . . . 0.0 111.388 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.0 m -104.18 -45.18 4.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.162 -0.961 . . . . 0.0 111.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.85 67.27 0.34 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -65.39 -42.81 92.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.523 -0.987 . . . . 0.0 110.891 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.71 -39.83 97.96 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 57.3 m -60.56 -33.94 73.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.589 -0.948 . . . . 0.0 109.997 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.35 -37.2 82.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.14 -42.16 98.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.57 -0.706 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 99.1 mtp -65.44 -31.84 73.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.705 -0.622 . . . . 0.0 109.832 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.44 -54.05 48.66 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.513 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.434 ' CG ' HD11 ' A' ' 519' ' ' LEU . 43.2 ttp -60.22 -44.14 95.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.306 -0.871 . . . . 0.0 110.519 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.68 -31.57 72.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.359 -0.838 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -67.72 -15.59 63.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.089 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.676 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -75.59 6.73 4.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 112.098 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 151.15 -16.68 0.9 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.209 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.501 2.095 0 O-C-N 121.072 -1.252 . . . . 0.0 109.858 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.004 0.43 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.1 -46.62 86.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.518 -0.739 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.6 t -62.74 -44.03 97.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.787 -0.571 . . . . 0.0 110.303 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 433' ' ' LEU . 77.4 t -65.16 -34.64 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.0 -42.07 98.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.526 -0.734 . . . . 0.0 111.658 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.33 59.6 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.002 -1.061 . . . . 0.0 112.388 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.821 HD12 HD11 ' A' ' 399' ' ' ILE . 1.1 pp -69.62 -33.92 73.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.996 . . . . 0.0 111.057 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . 0.421 ' N ' ' HG ' ' A' ' 395' ' ' LEU . 70.3 m -55.55 -43.07 75.48 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.589 -0.694 . . . . 0.0 111.226 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -68.09 -41.19 82.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -0.817 . . . . 0.0 111.518 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -65.51 -40.41 92.97 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.187 -0.946 . . . . 0.0 112.59 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 395' ' ' LEU . 0.0 OUTLIER -66.66 -39.24 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 121.147 -0.971 . . . . 0.0 109.882 -178.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.728 ' HG3' HD11 ' A' ' 435' ' ' ILE . 8.7 mtp -64.42 -39.73 94.41 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.153 -0.967 . . . . 0.0 109.174 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.74 -29.83 70.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 419' ' ' TYR . 59.8 tp60 -90.47 -11.15 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.473 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 400' ' ' MET . 40.1 t30 -69.54 -38.91 77.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.806 -0.559 . . . . 0.0 110.291 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -117.8 19.26 13.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.066 . . . . 0.0 109.872 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 407' ' ' VAL . 7.7 p -41.15 148.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 CA-C-O 121.176 0.513 . . . . 0.0 110.859 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.6 m -77.06 81.38 3.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.4 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 412' ' ' SER . 48.4 t -105.58 130.26 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.944 0.878 . . . . 0.0 111.702 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -96.79 144.38 27.76 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.66 -23.44 56.54 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.143 1.075 . . . . 0.0 110.767 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.398 -0.814 . . . . 0.0 110.69 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 56.76 0.5 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . 0.787 ' HA ' HG13 ' A' ' 407' ' ' VAL . 11.7 p -69.53 137.43 52.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.443 -0.786 . . . . 0.0 111.334 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 407' ' ' VAL . 5.9 p -88.99 146.25 36.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.52 135.48 28.73 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.09 1.047 . . . . 0.0 111.276 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 417' ' ' ALA . 99.8 mtt180 -96.81 -87.84 0.3 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.714 -0.616 . . . . 0.0 109.515 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.0 t -29.8 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 415' ' ' ARG . . . -50.83 -69.99 0.1 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.302 -0.873 . . . . 0.0 111.46 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -77.36 -1.57 76.14 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.708 -1.245 . . . . 0.0 111.29 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.561 ' HD2' HG23 ' A' ' 399' ' ' ILE . 76.6 m-85 -108.25 0.32 21.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.791 -1.417 . . . . 0.0 110.28 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.42 ' HB2' ' HD3' ' A' ' 448' ' ' ARG . 70.0 p -92.6 -33.72 14.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -73.74 -37.2 65.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.83 82.73 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.43 0.633 . . . . 0.0 110.038 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.969 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.0 t -67.74 -42.66 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.624 -0.672 . . . . 0.0 111.758 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.6 m -59.82 -43.29 94.61 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.975 -1.078 . . . . 0.0 112.352 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.91 -50.58 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.013 -1.055 . . . . 0.0 109.747 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.969 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -47.75 -31.57 4.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.641 -0.662 . . . . 0.0 111.688 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.74 -35.46 74.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 109.292 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.32 -31.03 72.07 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.549 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.35 -74.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.585 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER 178.89 -53.91 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.18 -0.95 . . . . 0.0 110.108 178.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.5 Cg_endo -79.84 116.23 3.43 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.578 ' HA ' HD11 ' A' ' 426' ' ' LEU . 1.8 m -105.67 100.39 9.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.355 -0.938 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.469 ' HB3' HG11 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -149.4 137.72 20.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.421 ' HB1' HG22 ' A' ' 423' ' ' VAL . . . -173.45 160.72 3.95 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 120.511 -1.368 . . . . 0.0 112.762 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.728 HD11 ' HG3' ' A' ' 400' ' ' MET . 3.3 pt -122.32 117.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 423' ' ' VAL . 70.4 t -122.11 137.77 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 110.749 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.9 t -121.74 129.83 52.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.017 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.75 147.9 18.76 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -146.11 80.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.587 -0.949 . . . . 0.0 109.645 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 121.83 110.48 2.11 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.09 85.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.03 -19.72 25.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.587 -0.949 . . . . 0.0 110.613 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.93 92.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 110.914 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.9 -30.58 70.13 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -62.6 -40.19 96.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.611 -0.935 . . . . 0.0 110.44 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.684 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 8.4 mpt_? -64.37 -38.1 89.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -71.28 -30.15 65.92 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.3 -0.875 . . . . 0.0 109.996 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . 0.42 ' HD3' ' HB2' ' A' ' 420' ' ' SER . 44.7 ttm-85 -64.81 -44.7 89.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.548 -0.72 . . . . 0.0 111.646 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.5 p -64.72 -32.44 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.663 ' HB1' ' HE ' ' A' ' 481' ' ' ARG . . . -64.42 -31.07 72.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.21 -38.02 75.95 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.051 -1.03 . . . . 0.0 108.445 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.4 -31.09 72.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.856 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.4 t -60.14 -32.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 58.2 mtt -66.13 -40.13 90.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 56.4 ttp -58.99 -21.07 58.21 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.241 0.543 . . . . 0.0 110.101 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.54 -22.64 30.05 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.37 -27.4 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -78.26 9.17 4.03 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.312 -0.868 . . . . 0.0 112.274 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.09 26.4 72.41 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.88 145.32 36.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 111.405 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -99.43 163.23 12.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.972 HG12 ' HB ' ' A' ' 504' ' ' THR . 33.7 m -132.21 158.77 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 118.924 -1.11 . . . . 0.0 112.268 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.847 ' HA ' HD22 ' A' ' 486' ' ' LEU . 57.1 tt0 -102.99 107.13 17.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 453' ' ' VAL . 0.5 OUTLIER -118.2 124.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.706 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.562 HG23 ' CD ' ' A' ' 471' ' ' ARG . 85.6 mt -122.03 115.37 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.862 -0.524 . . . . 0.0 110.916 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.684 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -66.17 165.63 13.35 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.471 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.607 ' HB3' ' NH2' ' A' ' 446' ' ' ARG . . . -59.01 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 511' ' ' GLU . 26.9 t0 -51.41 -19.07 1.21 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.956 -1.09 . . . . 0.0 111.129 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -78.98 -8.19 58.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -0.787 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 79.8 ttt-85 -52.36 -24.85 8.35 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.99 -1.069 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -58.12 -42.88 86.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.806 . . . . 0.0 109.358 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . 0.495 ' HA ' ' HE2' ' A' ' 476' ' ' MET . 85.0 mt-30 -65.09 -38.83 91.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.676 ' CE ' HD21 ' A' ' 482' ' ' LEU . 28.2 ttt -62.0 -32.28 72.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.783 -0.573 . . . . 0.0 110.29 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -61.69 -40.04 93.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 110.083 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 473' ' ' GLN . 73.4 mtm -62.51 -35.54 79.73 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.576 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 62.8 pttt -121.47 -148.06 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.426 ' HG2' ' CE ' ' A' ' 474' ' ' MET . 1.0 OUTLIER 53.6 70.09 0.63 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.161 -0.962 . . . . 0.0 111.192 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -112.98 23.8 13.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.68 3.21 26.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.854 . . . . 0.0 111.06 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.679 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -143.13 -29.8 0.53 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.19 -0.944 . . . . 0.0 111.664 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.679 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.5 OUTLIER -150.41 72.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.803 -1.186 . . . . 0.0 110.791 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.4 m -72.36 -18.42 61.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.464 -0.772 . . . . 0.0 110.121 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.43 46.68 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.6 pt-20 -149.01 103.74 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.926 . . . . 0.0 110.572 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.847 HD22 ' HA ' ' A' ' 464' ' ' GLN . 96.4 mt -98.46 -84.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.602 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 486' ' ' LEU . 3.3 mp -157.35 -65.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.08 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.6 t -99.9 11.12 40.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.469 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -92.91 77.22 1.17 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 54.5 ttt85 -145.17 -63.72 0.34 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 495' ' ' GLU . 92.7 mtt-85 -97.98 -31.32 12.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.421 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -64.53 -43.95 92.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 493' ' ' LEU . 2.2 mt -69.09 -38.53 79.01 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.318 0.58 . . . . 0.0 110.822 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 494' ' ' LEU . 7.4 tt -105.87 -48.4 3.64 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 491' ' ' ARG . 94.8 mt-10 -90.0 -10.3 45.45 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.666 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 491' ' ' ARG . . . 83.0 -13.16 45.81 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.641 -1.287 . . . . 0.0 111.017 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 70.6 mmm -67.86 -179.67 1.23 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.095 -1.238 . . . . 0.0 111.01 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.96 153.62 28.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.64 -0.663 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.52 151.03 32.08 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.773 0.797 . . . . 0.0 110.354 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -55.72 150.42 26.86 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.83 -0.544 . . . . 0.0 111.839 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 42.3 Cg_endo -70.66 115.74 4.35 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.653 1.344 . . . . 0.0 109.599 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -177.12 39.34 0.09 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.491 ' HA ' HG12 ' A' ' 487' ' ' ILE . 29.0 t -99.96 109.99 22.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.909 -0.76 . . . . 0.0 112.806 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.972 ' HB ' HG12 ' A' ' 463' ' ' VAL . 55.5 m -95.48 107.06 19.19 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 464' ' ' GLN . 43.4 t -109.58 126.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.414 -174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 533' ' ' LEU . 38.6 pt -122.59 109.99 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 534' ' ' ILE . 13.9 p -108.03 112.95 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 43.6 t0 -84.04 110.39 18.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.6 tm0? -97.39 175.2 6.33 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.356 1.074 . . . . 0.0 113.757 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -169.69 -44.05 0.03 OUTLIER Glycine 0 N--CA 1.508 3.46 0 N-CA-C 105.91 -2.876 . . . . 0.0 105.91 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 469' ' ' ASP . 73.1 mm-40 -99.54 -162.56 0.96 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -120.27 -1.67 10.22 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 111.222 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 513' ' ' LEU . 4.6 mm? -74.84 -27.4 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.751 . . . . 0.0 109.454 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 52.9 m -87.15 -17.09 33.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.66 -0.65 . . . . 0.0 112.008 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.435 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 31.7 tp -81.51 -52.59 7.07 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.847 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 54.5 mtmt -71.43 -43.47 66.68 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.599 -0.688 . . . . 0.0 112.207 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -40.0 95.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.027 -1.046 . . . . 0.0 111.143 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 466' ' ' ILE . 70.6 m -61.26 -48.32 81.97 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.264 -0.975 . . . . 0.0 108.744 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 519' ' ' LEU . 0.1 OUTLIER -58.15 -32.34 68.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.301 0.572 . . . . 0.0 109.654 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.6 m -61.79 -41.58 97.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.826 -0.546 . . . . 0.0 109.876 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.606 HD23 ' CD ' ' A' ' 464' ' ' GLN . 51.8 tp -69.55 -42.27 74.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 109.682 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.555 HD21 ' CG2' ' A' ' 505' ' ' VAL . 2.0 mt -59.6 -22.25 61.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.625 -0.672 . . . . 0.0 111.225 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.8 -57.4 4.92 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.672 -0.643 . . . . 0.0 112.235 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.59 50.03 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.009 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.36 64.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.882 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -56.48 -23.62 40.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.408 -0.808 . . . . 0.0 111.863 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.73 -36.61 37.28 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.125 -0.984 . . . . 0.0 110.919 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 66.6 m-70 -132.88 -69.79 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.374 -0.829 . . . . 0.0 111.13 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.58 ' C ' HG22 ' A' ' 530' ' ' VAL . 31.0 m-80 -83.56 154.92 23.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.31 -0.868 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.58 HG22 ' C ' ' A' ' 529' ' ' ASN . 0.0 OUTLIER -179.59 153.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 CA-C-O 121.401 0.62 . . . . 0.0 109.939 177.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' A' ' 432' ' ' SER . 0.1 OUTLIER -174.75 95.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 41.7 t -104.69 107.16 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.685 ' HB2' HG22 ' A' ' 506' ' ' ILE . 7.4 mp -108.31 114.1 27.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.941 HG22 HG12 ' A' ' 507' ' ' VAL . 8.2 pt -123.85 136.29 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.571 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.733 HG22 ' HB ' ' A' ' 436' ' ' VAL . 53.4 p -112.99 -169.63 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -157.87 166.14 33.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.032 -1.042 . . . . 0.0 110.85 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 2.9 p -146.83 21.94 1.26 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.81 -0.556 . . . . 0.0 109.912 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.39 -30.71 0.04 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -78.76 -0.13 29.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.086 -1.243 . . . . 0.0 111.142 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -38.88 -29.88 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -102.93 -29.44 11.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.43 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -120.22 59.08 0.55 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.5 t -64.57 -37.26 86.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.625 -0.927 . . . . 0.0 110.717 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 543' ' ' THR . . . -57.16 -43.8 93.35 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 93.9 p -63.56 -29.57 70.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.414 -1.051 . . . . 0.0 109.676 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.88 -35.39 80.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.732 -0.605 . . . . 0.0 109.882 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 547' ' ' LEU . 10.9 mp -61.99 -41.14 97.72 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.5 mmm -64.74 -33.63 76.41 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.14 -53.57 56.58 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.105 0.479 . . . . 0.0 109.92 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.454 ' HG3' HD11 ' A' ' 519' ' ' LEU . 33.4 ttm -55.11 -47.19 75.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.427 -0.795 . . . . 0.0 110.332 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.606 -0.684 . . . . 0.0 111.401 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -66.38 -17.8 64.98 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -74.02 4.48 5.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.354 -0.841 . . . . 0.0 112.384 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 154.66 -17.54 0.57 Allowed Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.533 -1.318 . . . . 0.0 111.524 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.042 -1.269 . . . . 0.0 110.327 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 120.716 0.293 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 38.5 tp -59.4 -29.34 67.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 71.3 m -60.83 -44.99 96.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.571 -0.706 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.15 -34.18 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.704 . . . . 0.0 110.605 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -58.16 -52.5 65.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.421 -0.8 . . . . 0.0 111.576 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.54 78.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.386 -0.821 . . . . 0.0 109.954 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 399' ' ' ILE . 3.2 tt -62.17 -38.52 89.39 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.588 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.1 m -71.55 -34.18 69.79 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.984 -1.072 . . . . 0.0 112.137 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.71 -45.23 87.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.104 -0.997 . . . . 0.0 112.335 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -70.39 -41.62 72.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.122 -0.986 . . . . 0.0 111.999 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.501 ' HA ' ' CD1' ' A' ' 419' ' ' TYR . 50.0 mt -63.73 -40.72 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.358 -0.839 . . . . 0.0 108.936 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 ttm -58.62 -34.88 71.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.705 -0.622 . . . . 0.0 109.486 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.41 -20.08 62.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.055 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.763 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.2 tp-100 -91.58 -20.26 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.938 -1.101 . . . . 0.0 108.995 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.66 -32.67 73.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -116.36 19.75 14.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.088 -1.008 . . . . 0.0 110.286 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 407' ' ' VAL . 5.9 p -59.06 117.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.557 -0.714 . . . . 0.0 109.852 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.8 p -52.71 102.92 0.06 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.477 -0.764 . . . . 0.0 110.748 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 405' ' ' VAL . 57.8 t -107.59 132.86 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.553 -0.717 . . . . 0.0 110.233 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -93.94 139.77 22.74 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.532 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.75 -25.28 53.77 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.219 1.115 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.15 -29.15 69.39 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.522 0.677 . . . . 0.0 111.133 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 58.65 0.57 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 80.4 p -50.31 111.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.667 0.746 . . . . 0.0 111.941 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.632 HG13 ' HD2' ' A' ' 414' ' ' PRO . 32.9 t -64.03 150.49 91.81 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 413' ' ' VAL . 37.7 Cg_endo -63.48 147.86 92.95 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.313 1.165 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 407' ' ' VAL . 82.2 mtp180 -128.49 -15.35 4.55 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.625 -0.672 . . . . 0.0 112.604 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 420' ' ' SER . 10.2 t -103.88 18.32 22.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 108.391 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -86.21 -76.46 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.703 -0.623 . . . . 0.0 112.208 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -75.73 -4.01 74.85 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.972 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.503 ' CD2' ' HG2' ' A' ' 402' ' ' GLN . 96.8 m-85 -107.8 -13.88 14.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.293 1.546 . . . . 0.0 109.647 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 416' ' ' THR . 5.4 t -69.9 -41.33 74.85 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -68.73 -36.69 78.74 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.01 81.27 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 122.038 0.923 . . . . 0.0 109.807 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.884 HG21 HG22 ' A' ' 436' ' ' VAL . 79.4 t -69.07 -44.06 81.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -60.69 -38.92 86.57 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.879 -1.138 . . . . 0.0 111.287 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.19 -44.14 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -55.61 -32.61 63.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.651 -0.656 . . . . 0.0 111.74 -178.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.37 77.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.618 -1.301 . . . . 0.0 108.631 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.54 -30.1 71.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.78 -89.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 11.3 tpp180 -179.9 -58.58 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.506 -1.372 . . . . 0.0 109.017 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 430' ' ' ARG . 43.1 Cg_endo -68.61 99.78 0.65 Allowed 'Trans proline' 0 N--CA 1.485 1.004 0 N-CA-C 108.661 -1.323 . . . . 0.0 108.661 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.489 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 67.7 m -94.98 110.36 22.27 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.864 0.84 . . . . 0.0 111.872 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 1.3 tp -166.56 90.22 0.4 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -135.49 169.77 16.99 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.93 0.871 . . . . 0.0 112.439 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 435' ' ' ILE . 33.0 pt -127.22 130.21 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.425 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.884 HG22 HG21 ' A' ' 423' ' ' VAL . 47.6 t -125.66 97.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.864 -1.147 . . . . 0.0 110.311 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 37.3 m -76.01 129.5 36.96 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.382 -0.824 . . . . 0.0 111.145 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -107.19 170.93 16.13 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 415' ' ' ARG . 67.6 tp60 -170.03 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.522 -0.987 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -64.12 -49.7 65.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -156.32 141.95 8.38 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -111.85 -26.09 9.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.972 . . . . 0.0 110.639 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.57 88.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.394 -0.816 . . . . 0.0 110.617 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.39 -29.36 64.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.51 -39.01 91.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.62 -0.929 . . . . 0.0 109.477 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.635 ' O ' HG12 ' A' ' 449' ' ' VAL . 58.7 ttp180 -61.97 -46.52 88.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 111.391 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 2.9 tm-20 -73.11 -32.85 65.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.047 -1.033 . . . . 0.0 111.199 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -61.8 -47.37 85.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.807 HG11 ' OD2' ' A' ' 508' ' ' ASP . 3.7 p -57.44 -30.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.747 -1.221 . . . . 0.0 108.565 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.3 -26.42 68.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.87 -33.25 75.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.942 -1.099 . . . . 0.0 108.618 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm? -63.17 -33.97 76.62 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 90.1 t -59.75 -30.56 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.617 . . . . 0.0 109.586 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.22 -35.25 79.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -60.72 -28.75 68.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 109.597 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.7 31.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.512 -0.742 . . . . 0.0 109.72 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -63.61 -43.82 95.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.12 -30.61 69.81 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -76.28 5.48 6.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.564 -0.71 . . . . 0.0 111.757 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.4 75.19 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -138.44 120.32 15.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.485 -1.009 . . . . 0.0 110.802 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.06 171.12 14.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 109.246 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 30.0 m -140.14 155.14 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 111.433 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.966 ' HA ' HD22 ' A' ' 486' ' ' LEU . 51.7 tt0 -101.52 117.65 35.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.807 HD11 HD22 ' A' ' 482' ' ' LEU . 2.5 pt -128.38 136.15 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.809 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 466' ' ' ILE . 4.7 mp -125.42 117.38 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.092 -1.005 . . . . 0.0 111.279 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -65.79 161.17 21.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.734 -1.229 . . . . 0.0 109.016 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.74 -158.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 511' ' ' GLU . 28.8 p-10 -44.81 -21.58 0.06 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.818 -1.176 . . . . 0.0 112.411 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.2 -2.79 23.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.321 -0.862 . . . . 0.0 111.577 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.03 -41.33 82.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.94 -1.1 . . . . 0.0 111.735 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.1 m -55.82 -45.36 78.35 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.966 -1.084 . . . . 0.0 110.469 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.29 -37.16 86.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.491 -0.755 . . . . 0.0 108.972 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.2 ttp -60.52 -33.8 73.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.761 -0.587 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.83 -37.7 85.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.78 -40.85 94.12 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.248 -0.908 . . . . 0.0 109.722 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -121.93 -141.94 0.33 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 109.453 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 51.23 88.86 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.706 -1.246 . . . . 0.0 110.936 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -136.74 34.96 2.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.728 . . . . 0.0 109.157 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -128.52 -3.69 5.41 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.879 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.404 ' CB ' HD23 ' A' ' 482' ' ' LEU . 7.3 mtt180 -132.36 -13.28 3.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.97 -1.081 . . . . 0.0 112.443 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -169.59 71.83 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.893 -1.129 . . . . 0.0 111.169 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.7 p -92.41 50.04 1.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.43 36.16 7.11 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -122.27 47.25 1.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.622 -0.928 . . . . 0.0 110.104 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.966 HD22 ' HA ' ' A' ' 464' ' ' GLN . 20.7 mt -75.44 -79.87 0.09 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.68 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER 179.31 -42.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 110.342 174.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.609 HG23 HG22 ' A' ' 487' ' ' ILE . 3.2 p -103.85 8.94 37.05 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.564 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -97.95 60.29 0.99 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.376 -1.889 . . . . 0.0 108.376 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 67.6 ttt180 -142.42 -70.9 0.33 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -108.87 -21.0 12.86 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.872 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -65.42 -46.79 78.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.633 -0.667 . . . . 0.0 111.898 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.96 -56.72 2.98 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.0 111.075 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.2 tm? -65.17 -42.21 93.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.471 -0.768 . . . . 0.0 112.808 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -99.99 -3.32 32.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.944 -1.098 . . . . 0.0 113.142 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 65.05 47.82 77.81 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 44.3 mtt -119.75 -174.05 2.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.788 -0.831 . . . . 0.0 109.655 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.23 131.94 55.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.32 -0.863 . . . . 0.0 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.3 OUTLIER -115.19 140.32 49.19 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 500' ' ' THR . 2.2 t -44.7 99.96 0.22 Allowed Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 122.212 -0.305 . . . . 0.0 111.597 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 499' ' ' PHE . 41.9 Cg_endo -67.92 113.95 3.19 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 107.996 -1.579 . . . . 0.0 107.996 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 179.52 32.25 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.68 ' CB ' HD13 ' A' ' 487' ' ' ILE . 40.0 t -93.13 176.29 6.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.066 . . . . 0.0 111.591 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.916 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.2 m -116.61 124.23 49.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 464' ' ' GLN . 57.6 t -121.92 136.82 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 112.872 -175.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 533' ' ' LEU . 2.0 pp -130.07 110.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 534' ' ' ILE . 12.4 p -99.16 108.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.147 -1.596 . . . . 0.0 110.344 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.807 ' OD2' HG11 ' A' ' 449' ' ' VAL . 73.0 m-20 -82.78 108.25 16.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -97.8 174.66 6.49 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 122.743 1.259 . . . . 0.0 113.194 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.56 -64.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.822 0 N-CA-C 103.943 -3.663 . . . . 0.0 103.943 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 469' ' ' ASP . 32.3 tt0 -70.98 -142.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.02 -19.04 1.16 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.727 -1.233 . . . . 0.0 111.442 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.24 -21.92 62.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 77.3 p -72.05 -41.09 67.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.503 -0.748 . . . . 0.0 110.953 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 10.8 tp -65.39 -52.47 53.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.0 111.283 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.766 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 25.9 ttmt -67.36 -46.88 72.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.501 -0.75 . . . . 0.0 111.571 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.39 -49.01 79.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.272 -0.892 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.45 HG21 ' HB ' ' A' ' 507' ' ' VAL . 81.7 m -58.54 -42.67 88.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.475 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.2 OUTLIER -61.14 -40.41 93.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.326 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 37.8 p -64.88 -39.94 94.33 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.056 -1.027 . . . . 0.0 111.195 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.3 OUTLIER -66.76 -41.77 87.21 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.202 1.001 . . . . 0.0 108.588 178.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 505' ' ' VAL . 0.8 OUTLIER -65.36 -22.01 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.721 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -47.29 -62.82 1.25 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.318 -0.864 . . . . 0.0 112.992 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.79 61.71 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.313 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 488' ' ' THR . . . -61.68 -31.43 71.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.657 -0.908 . . . . 0.0 111.805 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.732 ' CB ' HG11 ' A' ' 530' ' ' VAL . . . -72.19 -22.57 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 112.382 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -40.57 -27.47 0.05 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.428 -0.795 . . . . 0.0 112.385 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 501' ' ' PRO . 49.7 t60 -114.23 -117.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 111.5 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.404 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 2.4 m120 -89.5 90.01 8.1 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.513 -1.367 . . . . 0.0 114.551 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.732 HG11 ' CB ' ' A' ' 526' ' ' ALA . 7.6 p -127.79 149.52 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 109.967 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 86.5 mt-30 -126.04 132.31 52.0 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.994 -0.441 . . . . 0.0 110.07 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 87.3 t -109.33 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.49 1.138 . . . . 0.0 111.576 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.3 OUTLIER -117.14 119.77 36.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 507' ' ' VAL . 4.5 pt -129.1 140.43 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.464 -1.294 . . . . 0.0 111.902 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.681 HG22 ' HB ' ' A' ' 436' ' ' VAL . 11.5 p -110.23 -174.23 2.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 28.9 m-20 -154.98 161.51 41.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.027 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 68.2 p -140.36 18.11 2.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.012 -0.43 . . . . 0.0 109.907 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.07 0.23 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -98.62 0.91 45.74 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.393 -1.063 . . . . 0.0 110.764 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -40.21 54.96 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.117 -0.99 . . . . 0.0 112.271 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 8.6 p -96.39 -63.76 1.11 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.256 -0.903 . . . . 0.0 110.764 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -89.12 95.2 2.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.4 t -98.51 -41.39 7.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.687 -0.89 . . . . 0.0 110.191 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.39 -37.46 93.86 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 46.5 t -63.91 -38.65 91.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.621 -0.929 . . . . 0.0 111.07 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.83 -39.08 87.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.515 -0.74 . . . . 0.0 110.663 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.46 -40.66 97.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.487 -0.758 . . . . 0.0 109.867 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.01 -32.25 73.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.675 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.49 -53.03 61.45 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.925 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.469 ' HB2' HD21 ' A' ' 515' ' ' LEU . 36.6 ttm -58.06 -48.35 80.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.381 -0.824 . . . . 0.0 110.768 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.82 -31.53 68.55 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.329 -0.857 . . . . 0.0 111.286 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.84 -21.71 66.01 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.3 -0.875 . . . . 0.0 110.382 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.766 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -72.26 0.28 10.31 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.263 -0.898 . . . . 0.0 112.532 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 125.48 -14.97 7.23 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.83 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.239 . . . . 0.0 109.832 -179.889 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.765 0.793 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 67.6 tp -63.41 -40.67 97.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.622 -0.674 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.6 m -60.87 -44.79 96.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.557 -0.714 . . . . 0.0 110.625 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 433' ' ' LEU . 85.8 t -66.75 -35.03 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.654 -0.653 . . . . 0.0 111.043 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -60.4 -49.13 78.8 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.992 -1.067 . . . . 0.0 111.272 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.19 80.15 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.134 -0.979 . . . . 0.0 109.613 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.7 OUTLIER -59.39 -40.27 86.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.444 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 400' ' ' MET . 47.3 t -63.34 -42.5 98.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -59.22 -45.8 90.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.257 -0.902 . . . . 0.0 111.917 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -65.88 -41.34 91.7 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.152 -0.968 . . . . 0.0 111.089 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.638 HG21 ' O ' ' A' ' 435' ' ' ILE . 92.9 mt -62.31 -41.02 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 396' ' ' SER . 32.4 mmm -63.42 -34.97 78.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.487 -0.758 . . . . 0.0 110.845 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.19 -28.28 67.83 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.828 -1.17 . . . . 0.0 110.221 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.449 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 58.8 tp60 -90.79 -20.03 22.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.805 -1.185 . . . . 0.0 108.498 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 400' ' ' MET . 39.6 t30 -64.46 -31.57 72.83 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -114.42 18.81 16.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -40.9 149.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 121.535 0.683 . . . . 0.0 112.149 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 23.3 p -87.43 72.86 9.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.709 HG23 HG12 ' A' ' 413' ' ' VAL . 12.3 p -91.61 131.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.363 -0.836 . . . . 0.0 112.219 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -96.89 144.1 27.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.635 . . . . 0.0 109.747 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.31 -20.82 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.405 1.213 . . . . 0.0 110.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -57.31 -40.87 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.85 0.833 . . . . 0.0 110.031 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -150.56 67.98 0.96 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 27.0 t -54.5 119.8 5.75 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 122.066 0.936 . . . . 0.0 112.048 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.709 HG12 HG23 ' A' ' 407' ' ' VAL . 7.3 p -71.06 147.65 93.84 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 413' ' ' VAL . 35.3 Cg_endo -59.42 135.15 63.1 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.058 1.031 . . . . 0.0 110.765 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . 0.459 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 90.8 mtm-85 -103.51 -6.29 21.92 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.272 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 6.0 p -99.49 18.9 16.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.674 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.26 -35.01 6.93 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.67 94.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.778 ' CB ' HG13 ' A' ' 436' ' ' VAL . 4.0 m-85 -93.86 -9.9 35.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.762 -1.434 . . . . 0.0 110.399 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -43.98 61.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.867 -1.145 . . . . 0.0 109.004 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.78 -45.72 57.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.727 -0.608 . . . . 0.0 110.307 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 425' ' ' VAL . . . -61.48 -49.04 78.39 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.75 -0.594 . . . . 0.0 111.797 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.84 ' HA ' HD23 ' A' ' 426' ' ' LEU . 90.3 t -69.57 -43.43 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 0.0 112.575 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 79.5 p -62.26 -39.54 93.22 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.925 -1.109 . . . . 0.0 111.421 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.1 p -67.69 -28.13 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.321 -0.862 . . . . 0.0 111.821 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -75.02 -31.22 61.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 111.151 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.14 74.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.963 . . . . 0.0 109.203 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.21 -29.88 70.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.97 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.592 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.36 -52.3 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.713 -1.242 . . . . 0.0 111.671 177.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.5 Cg_endo -77.7 112.7 3.36 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 O-C-N 122.568 0.773 . . . . 0.0 110.775 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.493 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 0.3 OUTLIER -87.12 99.66 12.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.631 -0.668 . . . . 0.0 109.245 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.5 tp -162.67 92.56 0.79 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.171 -0.956 . . . . 0.0 111.063 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -139.83 170.56 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.542 0.687 . . . . 0.0 111.832 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.638 ' O ' HG21 ' A' ' 399' ' ' ILE . 45.3 pt -121.84 141.52 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 109.414 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.778 HG13 ' CB ' ' A' ' 419' ' ' TYR . 57.3 t -141.92 148.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -0.805 . . . . 0.0 109.806 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' OD1' ' A' ' 403' ' ' ASN . 44.5 t -127.38 133.64 50.01 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.439 -0.788 . . . . 0.0 110.272 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -115.17 129.51 8.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -130.61 34.19 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.616 -0.932 . . . . 0.0 109.818 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -148.73 -137.45 2.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -67.29 120.87 14.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.68 -9.13 23.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.883 . . . . 0.0 111.734 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.72 90.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.49 -28.2 73.34 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.33 -38.36 87.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.755 -0.85 . . . . 0.0 110.199 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.418 ' CD ' ' HB2' ' A' ' 467' ' ' ALA . 0.1 OUTLIER -59.86 -50.15 74.9 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.438 -0.789 . . . . 0.0 110.281 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.36 -29.28 67.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -61.04 -54.97 38.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.772 -0.58 . . . . 0.0 112.01 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.68 -35.65 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.909 -1.119 . . . . 0.0 109.394 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.476 ' HB2' ' HG2' ' A' ' 480' ' ' GLU . . . -63.53 -26.89 68.91 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.444 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.41 -34.78 79.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.037 -1.04 . . . . 0.0 108.828 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.97 -35.57 81.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 463' ' ' VAL . 88.6 t -58.42 -27.31 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.846 -0.534 . . . . 0.0 109.714 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.4 mtt -71.09 -34.92 71.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.29 -32.78 72.63 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.55 0.691 . . . . 0.0 109.604 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.63 -22.69 32.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.772 -0.58 . . . . 0.0 110.231 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -65.65 -42.74 91.06 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.259 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.59 -29.44 63.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.326 -0.859 . . . . 0.0 110.512 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.71 8.22 4.74 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 111.07 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.94 75.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.65 124.31 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -1.007 . . . . 0.0 110.527 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.618 ' C ' HD11 ' A' ' 487' ' ' ILE . 81.9 mt-10 -82.96 166.53 18.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.186 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.911 ' CG2' HG13 ' A' ' 453' ' ' VAL . 33.4 m -141.11 156.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.754 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.9 tt0 -102.6 120.05 39.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -126.09 128.51 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.192 -0.943 . . . . 0.0 111.104 -178.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.627 HG23 ' CD ' ' A' ' 471' ' ' ARG . 5.3 mp -125.5 121.2 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.418 ' HB2' ' CD ' ' A' ' 446' ' ' ARG . . . -81.25 165.04 21.82 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.277 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.66 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.423 0.63 . . . . 0.0 109.612 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -51.22 -12.63 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.736 -1.228 . . . . 0.0 112.639 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -81.99 -2.94 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.773 -1.204 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.627 ' CD ' HG23 ' A' ' 466' ' ' ILE . 70.1 ttp85 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.945 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 35.4 t -63.38 -44.24 95.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -62.85 -41.61 99.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.659 -0.65 . . . . 0.0 110.139 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.0 mmt -67.76 -29.08 68.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.625 . . . . 0.0 110.706 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -59.99 -42.13 93.57 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.655 -1.278 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 mtm -67.19 -39.22 86.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 109.629 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 477' ' ' LYS . 57.2 pttt -131.6 128.86 40.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.802 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 55.32 92.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.189 -0.944 . . . . 0.0 112.255 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 482' ' ' LEU . 75.7 m-20 -81.84 26.27 0.51 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.633 ' CB ' HD23 ' A' ' 482' ' ' LEU . 4.7 mp0 50.83 42.48 27.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.561 -1.337 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 57.09 21.92 6.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.633 HD23 ' CB ' ' A' ' 480' ' ' GLU . 0.3 OUTLIER -124.42 20.03 8.81 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.54 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.0 p -47.21 -22.25 0.36 Allowed 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 168.98 78.92 0.04 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -175.01 41.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.711 -0.876 . . . . 0.0 109.677 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 464' ' ' GLN . 78.2 mt -75.3 -82.76 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.969 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -162.15 -70.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.658 -1.276 . . . . 0.0 109.751 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.1 t -100.08 8.75 43.71 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.153 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.466 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -82.92 61.27 4.8 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.556 -2.217 . . . . 0.0 107.556 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.41 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 51.8 ttt85 -143.77 -68.51 0.33 Allowed 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.609 -0.936 . . . . 0.0 109.252 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -100.73 -31.06 11.38 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.487 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -62.02 -43.99 97.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.509 -0.744 . . . . 0.0 110.826 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 6.0 mt -72.42 -39.05 68.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.553 -0.717 . . . . 0.0 111.8 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 43.1 tp -106.11 -42.26 5.14 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -89.72 -4.06 57.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.892 -1.13 . . . . 0.0 113.254 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 66.13 47.16 75.04 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.3 mmm -120.01 177.29 5.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.944 -0.739 . . . . 0.0 111.128 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.38 134.51 54.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -114.75 149.32 37.07 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.871 0.843 . . . . 0.0 111.486 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 500' ' ' THR . 5.2 t -50.82 105.69 0.55 Allowed Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.48 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -78.47 112.75 3.23 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.283 1.149 . . . . 0.0 109.21 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -169.73 37.23 0.19 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.969 ' CB ' HD13 ' A' ' 487' ' ' ILE . 92.0 p -95.8 175.47 6.5 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.451 1.119 . . . . 0.0 113.713 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.855 ' HB ' HG12 ' A' ' 463' ' ' VAL . 23.2 m -125.92 106.99 10.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 522' ' ' LEU . 40.4 t -97.36 136.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.375 -0.828 . . . . 0.0 111.524 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 533' ' ' LEU . 3.9 pt -141.0 110.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 534' ' ' ILE . 7.1 p -112.21 114.65 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.388 -1.445 . . . . 0.0 113.152 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.44 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 98.3 m-20 -84.58 131.39 34.62 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.6 tp-100 -156.95 114.89 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.721 -1.592 . . . . 0.0 115.011 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -76.93 -66.54 1.8 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 31.1 tt0 -58.65 172.12 0.55 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.26 -13.75 11.71 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.196 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.66 -36.78 83.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.236 -0.915 . . . . 0.0 109.632 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 4.7 m -83.09 -13.8 54.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.776 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 509' ' ' GLN . 33.0 tp -69.15 -44.62 71.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 108.812 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.9 -36.01 77.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.851 -0.531 . . . . 0.0 111.401 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -57.28 -50.27 73.43 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.807 -1.183 . . . . 0.0 110.465 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.79 ' O ' HD12 ' A' ' 522' ' ' LEU . 68.3 m -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.599 -0.688 . . . . 0.0 110.502 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.75 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -57.37 -39.5 76.15 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.73 -0.606 . . . . 0.0 111.106 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.7 m -61.86 -39.65 92.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.389 -0.819 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.496 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.4 OUTLIER -65.92 -44.61 84.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.575 -0.703 . . . . 0.0 109.561 179.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 518' ' ' THR . 0.4 OUTLIER -61.11 -22.8 64.99 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.464 -0.772 . . . . 0.0 111.808 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -46.0 -60.84 2.03 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.233 -0.917 . . . . 0.0 112.174 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -74.02 -50.79 9.92 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.508 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.75 83.67 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.326 -1.103 . . . . 0.0 113.432 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 530' ' ' VAL . . . -65.67 -23.82 66.87 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -44.67 -25.87 0.32 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.381 -0.825 . . . . 0.0 111.514 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.06 -140.06 0.3 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.226 -0.921 . . . . 0.0 111.224 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 530' ' ' VAL . 1.9 t-20 -71.08 85.8 0.73 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.822 -1.174 . . . . 0.0 111.815 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 526' ' ' ALA . 71.6 t -146.2 168.13 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.097 -1.002 . . . . 0.0 111.494 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 432' ' ' SER . 8.5 tp60 -162.31 164.53 27.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 3.6 t -115.45 115.39 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.435 -0.791 . . . . 0.0 112.163 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.9 tp -110.78 120.53 42.69 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 507' ' ' VAL . 2.4 pt -139.95 146.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.079 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 436' ' ' VAL . 65.1 p -105.48 -169.5 1.6 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -158.75 167.95 28.14 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.321 -0.862 . . . . 0.0 109.923 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.498 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.8 OUTLIER -133.03 -6.64 3.07 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.677 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -129.09 28.42 4.1 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 44.5 tt0 -98.67 -1.49 40.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.757 -0.849 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -56.32 -43.95 79.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.206 -0.934 . . . . 0.0 112.173 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 26.2 m -102.6 -56.89 2.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.913 -1.117 . . . . 0.0 110.94 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -88.51 59.0 4.1 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.7 t -65.58 -44.38 86.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.983 . . . . 0.0 111.572 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.27 -40.26 98.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.5 m -62.9 -37.36 86.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.947 . . . . 0.0 111.53 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.64 -36.6 72.07 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.088 -1.008 . . . . 0.0 109.73 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.1 mp -63.85 -41.26 97.85 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.907 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.37 -30.12 70.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.188 -0.945 . . . . 0.0 109.017 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.53 -54.92 41.33 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.298 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.75 ' HG3' HD11 ' A' ' 519' ' ' LEU . 57.8 ttm -55.65 -46.82 77.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 555' ' ' VAL . 86.4 mttt -61.17 -31.78 71.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.576 -0.703 . . . . 0.0 112.183 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.71 -16.58 62.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.353 -0.842 . . . . 0.0 111.226 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 5.49 4.24 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.171 -0.956 . . . . 0.0 113.059 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 118.35 -16.58 11.62 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 120.805 -1.184 . . . . 0.0 111.037 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 551' ' ' LYS . 10.3 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.199 -1.177 . . . . 0.0 110.764 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 . . . . . 0 N--CA 1.503 2.175 0 CA-C-O 120.701 0.286 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.74 -36.64 81.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.261 -0.899 . . . . 0.0 110.617 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.1 t -62.79 -43.15 99.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.435 -0.791 . . . . 0.0 109.487 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 81.0 t -66.31 -36.08 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.982 -0.449 . . . . 0.0 110.76 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -60.75 -50.51 73.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.19 -0.944 . . . . 0.0 110.232 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.37 -33.02 72.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 426' ' ' LEU . 7.6 tt -59.7 -39.7 85.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.81 -0.556 . . . . 0.0 110.621 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.1 p -68.6 -32.49 72.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.409 -0.807 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -64.34 -43.06 95.79 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.557 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -69.03 -40.31 78.7 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.0 112.719 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.446 HD11 HD21 ' A' ' 395' ' ' LEU . 61.9 mt -65.07 -43.37 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 27.2 mtp -61.86 -22.66 65.71 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.26 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -63.26 -30.54 71.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.104 -0.997 . . . . 0.0 108.984 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.727 ' NE2' HG11 ' A' ' 405' ' ' VAL . 1.8 mm-40 -90.04 -14.21 34.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.192 -0.942 . . . . 0.0 109.457 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 400' ' ' MET . 42.5 t-20 -66.39 -39.3 88.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.77 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -116.92 18.45 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.752 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 407' ' ' VAL . 6.3 p -59.43 114.93 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.385 -0.822 . . . . 0.0 109.793 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.0 p -52.12 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.171 -0.956 . . . . 0.0 110.95 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 405' ' ' VAL . 61.0 t -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.661 -0.65 . . . . 0.0 110.179 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.24 137.35 24.89 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 0.0 110.204 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.44 -29.3 45.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.165 1.087 . . . . 0.0 111.279 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.55 -25.59 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.119 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 60.54 0.5 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 m -58.91 115.79 3.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.495 0.664 . . . . 0.0 111.52 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 414' ' ' PRO . 6.9 p -64.15 150.09 92.91 Favored Pre-proline 0 N--CA 1.501 2.095 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -59.91 139.14 86.62 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 122.789 0.889 . . . . 0.0 110.228 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -116.38 -1.39 12.3 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.743 HG22 ' OH ' ' A' ' 419' ' ' TYR . 34.9 p -97.34 22.09 9.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.766 -1.209 . . . . 0.0 109.489 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -108.68 -31.58 7.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.37 -44.16 98.04 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.743 ' OH ' HG22 ' A' ' 416' ' ' THR . 27.0 p90 -103.04 -10.81 18.61 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.418 . . . . 0.0 111.875 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.0 t -67.22 -43.03 83.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 108.083 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.4 t0 -79.36 -44.32 21.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.933 -0.479 . . . . 0.0 111.304 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 425' ' ' VAL . . . -65.38 -46.33 80.54 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.629 -0.67 . . . . 0.0 112.417 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.837 ' HA ' HD23 ' A' ' 426' ' ' LEU . 88.8 t -70.37 -43.31 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.444 -0.785 . . . . 0.0 111.99 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -43.17 99.48 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.918 -1.114 . . . . 0.0 111.813 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 421' ' ' ASP . 33.1 m -64.47 -29.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.204 -0.935 . . . . 0.0 111.495 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -71.57 -33.99 69.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 111.737 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.57 -33.26 70.91 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.59 -30.76 71.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -64.21 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.485 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.2 OUTLIER -177.32 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 110.399 177.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -72.48 101.5 1.27 Allowed 'Trans proline' 0 N--CA 1.485 0.99 0 N-CA-C 109.455 -1.017 . . . . 0.0 109.455 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.477 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 26.4 t -87.72 101.2 13.45 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.559 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.98 89.33 0.79 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -131.68 164.84 25.05 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.882 0.848 . . . . 0.0 112.481 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.77 128.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 58.4 t -122.3 138.33 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.2 m -119.58 126.46 51.25 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 111.494 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -129.45 160.39 22.64 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -120.71 -30.63 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.896 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.1 173.45 31.27 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.17 29.73 70.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.706 ' HB3' ' NH2' ' A' ' 470' ' ' ARG . . . -67.89 -20.5 65.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.27 89.16 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.134 -0.979 . . . . 0.0 110.904 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.73 -37.12 57.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -62.17 -35.8 79.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.784 -0.833 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.873 ' HD3' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.52 -44.45 97.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.675 0.75 . . . . 0.0 109.724 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -68.84 -31.56 70.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.973 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -64.63 -45.04 88.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 111.713 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.0 p -58.15 -31.21 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.613 -1.305 . . . . 0.0 108.9 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.97 -27.05 68.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -64.51 -36.02 82.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.873 -1.142 . . . . 0.0 108.503 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 452' ' ' LEU . 4.5 mm? -65.38 -34.33 78.07 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.92 HG13 ' CG2' ' A' ' 463' ' ' VAL . 98.1 t -60.53 -30.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.3 mmm -68.33 -37.01 80.14 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.547 -0.72 . . . . 0.0 109.417 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -58.31 -28.82 65.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.767 -0.583 . . . . 0.0 109.976 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -85.03 -22.98 28.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -66.95 -44.6 80.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 110.413 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -74.42 -29.33 61.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.327 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.49 14.75 5.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.592 -0.692 . . . . 0.0 112.193 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.98 26.67 71.48 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.477 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 42.9 ttm180 -124.05 126.16 45.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.216 -1.167 . . . . 0.0 110.337 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 486' ' ' LEU . 53.8 mp0 -92.56 158.56 15.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.456 -0.777 . . . . 0.0 110.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.92 ' CG2' HG13 ' A' ' 453' ' ' VAL . 26.9 m -140.03 163.33 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.768 0.794 . . . . 0.0 111.516 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.709 ' OE1' HD13 ' A' ' 486' ' ' LEU . 43.4 tp60 -113.75 121.56 44.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.599 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -119.03 123.47 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.26 1.028 . . . . 0.0 111.829 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.686 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.5 mp -101.11 169.06 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.873 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -130.83 156.47 44.96 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.84 -159.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.448 -0.783 . . . . 0.0 110.019 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -48.66 -15.25 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.991 -1.068 . . . . 0.0 111.823 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . 0.706 ' NH2' ' HB3' ' A' ' 442' ' ' ALA . 76.0 mtt85 -87.54 5.47 39.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.003 -1.061 . . . . 0.0 111.007 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.565 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 13.8 tpt180 -58.95 -36.94 75.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.298 -0.876 . . . . 0.0 111.447 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 21.9 t -59.7 -45.42 92.19 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.405 -0.809 . . . . 0.0 110.2 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.09 -41.0 95.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.361 -0.837 . . . . 0.0 110.396 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 18.5 ttm -62.84 -35.17 79.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 0.0 111.19 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -60.13 -39.26 85.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.346 -0.846 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.3 -40.23 93.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 63.1 pttt -109.18 -148.81 0.43 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.556 -0.715 . . . . 0.0 109.865 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 477' ' ' LYS . 23.7 tt0 50.46 80.6 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.195 -0.941 . . . . 0.0 110.957 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -123.73 34.75 5.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -125.9 4.81 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.494 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.41 ' CB ' HD23 ' A' ' 482' ' ' LEU . 0.5 OUTLIER -138.22 -34.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 112.503 -179.109 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 481' ' ' ARG . 0.4 OUTLIER -145.47 71.73 1.29 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.987 -1.071 . . . . 0.0 112.108 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 35.0 t -92.28 48.81 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.7 33.1 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -119.64 54.91 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.53 -0.982 . . . . 0.0 110.392 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.709 HD13 ' OE1' ' A' ' 464' ' ' GLN . 0.1 OUTLIER -101.59 -84.22 0.45 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.488 178.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 488' ' ' THR . 4.6 mp -140.97 -88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.257 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 26.4 p -102.7 22.48 13.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 111.511 -178.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -62.41 89.25 0.05 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -111.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 495' ' ' GLU . 94.9 mtt-85 -106.32 -21.97 12.95 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.616 -1.302 . . . . 0.0 109.416 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -47.96 -23.5 0.8 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.876 . . . . 0.0 111.629 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.51 -60.37 3.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 112.068 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 5.96 28.01 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.299 -1.501 . . . . 0.0 111.885 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 71.7 mm-40 -83.41 -6.07 59.35 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.035 -1.041 . . . . 0.0 112.702 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.84 -7.6 80.64 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.085 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.64 -176.23 0.61 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.176 -1.19 . . . . 0.0 109.493 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.56 167.52 10.53 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.01 150.91 29.94 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 488' ' ' THR . 9.4 t -82.5 138.99 44.29 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 139.05 52.85 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.283 1.149 . . . . 0.0 110.357 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 148.9 -9.09 0.98 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 10.9 t -77.41 139.03 39.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -1.154 . . . . 0.0 113.164 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.829 ' HB ' HG12 ' A' ' 463' ' ' VAL . 80.6 m -111.13 124.28 51.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 522' ' ' LEU . 50.4 t -116.34 125.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.61 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.829 HG22 ' HB3' ' A' ' 533' ' ' LEU . 22.6 pt -121.57 120.27 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 534' ' ' ILE . 9.6 p -120.21 108.86 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.145 -0.972 . . . . 0.0 111.622 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.515 ' OD2' HG11 ' A' ' 449' ' ' VAL . 95.0 m-20 -85.11 121.63 28.15 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.888 -1.132 . . . . 0.0 108.343 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.0 tp-100 -148.59 105.25 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -69.42 -38.79 80.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 4.9 tt0 -79.43 -155.44 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 -7.01 0.56 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.625 -0.672 . . . . 0.0 110.974 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.28 -34.42 74.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.357 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . 0.443 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.6 m -87.71 -22.19 24.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.333 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.4 tp -68.74 -46.33 69.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.15 -0.969 . . . . 0.0 109.606 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 32.8 ttpt -69.09 -44.18 73.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.664 -0.648 . . . . 0.0 112.296 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . 0.443 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.5 OUTLIER -64.77 -39.99 94.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.498 -1.376 . . . . 0.0 110.452 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 77.5 m -60.42 -44.2 95.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.113 -0.992 . . . . 0.0 109.347 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.1 OUTLIER -55.85 -35.54 66.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.944 -0.473 . . . . 0.0 109.998 -179.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.5 m -59.05 -39.15 81.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.1 -40.86 78.1 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.492 0.663 . . . . 0.0 109.971 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.496 ' CD1' HG21 ' A' ' 505' ' ' VAL . 12.2 tp -63.77 -22.79 67.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.456 -0.777 . . . . 0.0 111.146 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . 0.553 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 98.6 m-20 -47.93 -57.42 5.73 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.446 -0.784 . . . . 0.0 111.774 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.32 -50.84 61.08 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.18 -29.88 34.21 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.482 -1.011 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.648 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -57.96 -23.51 54.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.776 -0.577 . . . . 0.0 111.255 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -41.39 -43.89 2.67 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.598 -0.689 . . . . 0.0 112.319 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 -62.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.577 ' C ' HG22 ' A' ' 530' ' ' VAL . 4.3 t30 -80.77 156.09 26.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.392 -0.817 . . . . 0.0 110.468 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 526' ' ' ALA . 0.1 OUTLIER -174.34 151.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.988 0.899 . . . . 0.0 110.791 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.825 ' CB ' HG23 ' A' ' 504' ' ' THR . 0.0 OUTLIER -177.39 91.71 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 54.2 t -99.36 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.011 0.91 . . . . 0.0 111.3 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.829 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.77 113.41 26.63 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 176.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.735 HG22 HG12 ' A' ' 507' ' ' VAL . 0.6 OUTLIER -131.28 144.77 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.837 -177.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 69.9 p -105.6 -177.11 3.27 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -160.03 168.11 26.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.013 -1.055 . . . . 0.0 110.83 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.518 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -142.94 -4.89 0.91 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.328 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -103.98 5.64 46.58 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 543' ' ' THR . 97.0 mt-30 -82.42 -1.43 50.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -1.192 . . . . 0.0 111.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.59 -43.21 75.79 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 0.0 110.494 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 24.6 m -106.98 -45.02 4.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.56 70.41 0.3 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.9 t -64.76 -43.97 91.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.58 -0.953 . . . . 0.0 111.402 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 543' ' ' THR . . . -64.16 -29.64 75.52 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.099 -1.001 . . . . 0.0 110.637 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t -65.16 -36.07 83.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.301 -1.117 . . . . 0.0 110.797 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.11 -38.39 90.9 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.796 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 547' ' ' LEU . 10.8 mp -62.63 -42.22 99.47 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.838 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.5 ttp -63.14 -35.76 81.36 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.275 -0.891 . . . . 0.0 108.705 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.98 -50.44 61.28 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.578 ' HG3' HD11 ' A' ' 519' ' ' LEU . 58.0 ttm -55.33 -49.15 72.93 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.795 -0.566 . . . . 0.0 110.395 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.58 -31.75 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.683 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.87 -17.09 64.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.843 . . . . 0.0 109.92 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -68.88 1.05 3.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.343 -0.848 . . . . 0.0 113.122 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 137.04 -11.2 3.89 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.224 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.257 -1.143 . . . . 0.0 110.25 -179.643 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.34 -40.16 96.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.71 -0.619 . . . . 0.0 111.135 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.4 m -61.25 -46.42 90.45 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.699 -0.626 . . . . 0.0 111.561 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 433' ' ' LEU . 67.7 t -66.29 -33.06 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 110.147 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -60.39 -48.75 80.4 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.937 -1.102 . . . . 0.0 109.848 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.824 . . . . 0.0 108.841 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.731 ' CD2' HD22 ' A' ' 426' ' ' LEU . 1.2 tp -60.54 -41.11 93.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.513 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -36.38 82.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.25 -0.906 . . . . 0.0 110.453 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -66.07 -45.25 81.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.382 -0.823 . . . . 0.0 112.194 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.87 -43.5 75.24 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.109 -0.994 . . . . 0.0 111.879 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.547 HG22 ' OD1' ' A' ' 403' ' ' ASN . 64.4 mt -63.69 -41.38 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.442 -0.786 . . . . 0.0 110.528 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.445 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 22.8 mtt -59.62 -33.22 71.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.736 -0.603 . . . . 0.0 110.445 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.31 -36.8 78.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.748 -0.595 . . . . 0.0 110.495 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.641 HE22 HG21 ' A' ' 405' ' ' VAL . 63.3 tp60 -92.75 -13.9 28.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.638 -1.289 . . . . 0.0 110.02 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.547 ' OD1' HG22 ' A' ' 399' ' ' ILE . 13.9 m120 -69.28 -32.31 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -115.3 18.6 16.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.371 -0.831 . . . . 0.0 109.72 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.641 HG21 HE22 ' A' ' 402' ' ' GLN . 9.8 p -41.87 149.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.257 0.551 . . . . 0.0 112.095 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 47.5 p -82.65 72.97 9.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.435 HG23 HG13 ' A' ' 413' ' ' VAL . 8.1 p -101.49 131.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.393 -0.817 . . . . 0.0 111.313 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -94.91 145.0 28.77 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.08 -23.41 60.82 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.093 1.049 . . . . 0.0 110.272 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -55.87 -24.43 37.0 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.617 0.722 . . . . 0.0 110.861 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.99 63.1 0.46 Allowed 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 59.5 p -50.25 107.12 0.14 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.25 -0.906 . . . . 0.0 111.177 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 407' ' ' VAL . 4.3 m -62.65 153.62 77.51 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.58 122.17 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.254 -1.095 . . . . 0.0 109.254 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -96.62 -5.96 37.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 419' ' ' TYR . 13.4 p -93.3 22.79 4.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.767 -1.208 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -105.0 -37.3 7.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.767 . . . . 0.0 109.044 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 402' ' ' GLN . . . -62.48 -49.0 77.82 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 416' ' ' THR . 43.1 p90 -100.89 -8.89 22.11 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.503 1.652 . . . . 0.0 112.982 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 416' ' ' THR . 80.9 p -69.71 -36.59 76.05 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.574 -1.65 . . . . 0.0 107.05 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -78.64 -48.14 15.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.959 -0.463 . . . . 0.0 111.173 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.57 -48.7 78.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.429 -0.795 . . . . 0.0 111.251 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.878 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.1 t -65.28 -46.05 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.611 . . . . 0.0 111.803 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.6 t -61.19 -45.9 92.71 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.976 -1.077 . . . . 0.0 112.64 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.53 -46.95 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.116 -0.99 . . . . 0.0 110.715 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.878 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -53.33 -33.97 55.62 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 111.821 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.54 75.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.872 -1.142 . . . . 0.0 109.045 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -60.83 -29.15 69.32 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -66.84 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.516 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.6 -55.76 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.589 -1.319 . . . . 0.0 109.839 178.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.0 Cg_endo -71.99 106.21 1.97 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 N-CA-C 106.744 -2.06 . . . . 0.0 106.744 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.553 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 0.2 OUTLIER -90.52 99.92 12.86 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.107 -177.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 2.9 mt -141.99 140.39 32.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 533' ' ' LEU . . . -169.5 150.89 4.26 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.7 pt -119.43 120.97 65.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 535' ' ' THR . 82.1 t -125.36 139.98 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.1 t -117.05 122.43 44.14 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 155.35 20.57 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -136.12 -36.21 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.574 -0.957 . . . . 0.0 111.439 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.13 155.51 26.18 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.15 62.23 4.85 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -86.54 -21.35 26.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.997 . . . . 0.0 110.537 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.83 84.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.393 -0.817 . . . . 0.0 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 -36.4 77.22 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.73 -35.77 75.23 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 109.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 467' ' ' ALA . 16.0 tpt85 -62.97 -49.79 73.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.63 -0.669 . . . . 0.0 112.243 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 4.7 mt-10 -74.5 -31.13 62.07 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.963 -1.086 . . . . 0.0 111.108 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.73 -48.4 81.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.372 -0.83 . . . . 0.0 110.275 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 506' ' ' ILE . 9.6 p -61.46 -31.34 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.737 -1.227 . . . . 0.0 108.655 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.14 -29.53 70.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.4 -32.38 73.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.112 -0.993 . . . . 0.0 108.358 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.35 -35.09 76.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.934 HG13 ' CG2' ' A' ' 463' ' ' VAL . 52.0 t -61.1 -26.5 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.6 tpp -66.66 -40.16 88.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.358 -0.839 . . . . 0.0 108.748 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -56.49 -27.09 56.21 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.95 -23.4 31.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.78 -34.24 71.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -82.22 10.21 7.28 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.608 -0.683 . . . . 0.0 112.077 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.44 29.83 71.49 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . 0.622 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 19.8 tpp85 -126.02 126.98 45.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.95 . . . . 0.0 110.546 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 48.7 tp10 -95.94 160.22 14.57 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.934 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.1 m -142.27 161.36 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.777 -1.202 . . . . 0.0 112.493 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.544 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 58.7 tt0 -107.54 122.82 47.44 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -128.09 128.55 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.505 -0.747 . . . . 0.0 110.782 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.529 HD12 HG21 ' A' ' 518' ' ' THR . 78.6 mt -126.89 122.16 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.607 -0.683 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.611 ' HB2' ' HD3' ' A' ' 446' ' ' ARG . . . -86.69 169.02 13.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.045 -1.035 . . . . 0.0 108.776 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 467' ' ' ALA . . . -57.28 -160.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.64 -15.95 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.661 -1.274 . . . . 0.0 113.412 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -76.35 -9.44 58.64 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.591 -1.318 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -57.35 -32.85 67.16 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.055 . . . . 0.0 111.093 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 26.2 t -62.16 -44.46 96.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.415 -0.803 . . . . 0.0 110.047 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.16 -41.53 94.58 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.428 -0.795 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.48 76.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.547 -0.721 . . . . 0.0 110.578 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.61 -39.13 87.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.181 -0.95 . . . . 0.0 109.376 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -39.72 95.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -100.07 -146.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.68 80.06 0.1 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.807 -1.183 . . . . 0.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.45 14.06 15.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.965 -0.459 . . . . 0.0 110.291 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -92.5 -2.32 56.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 111.686 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -178.66 33.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.058 -1.026 . . . . 0.0 110.823 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 481' ' ' ARG . 1.4 tp -151.61 7.14 0.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.185 -1.006 . . . . 0.0 113.596 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.8 t -55.0 -25.22 28.44 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.474 -1.391 . . . . 0.0 110.445 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 160.46 41.65 0.02 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -130.86 30.65 4.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.663 -0.904 . . . . 0.0 109.314 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.574 HD12 HG12 ' A' ' 487' ' ' ILE . 1.9 tp -60.33 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 1.045 HG22 HG23 ' A' ' 488' ' ' THR . 29.5 mm -153.23 -82.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 108.656 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 487' ' ' ILE . 24.4 p -100.34 11.36 39.59 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.347 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -77.42 63.91 3.28 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -135.48 -70.96 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . 0.445 ' HD3' ' CE ' ' A' ' 497' ' ' MET . 87.2 mtt-85 -118.52 -8.23 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.848 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 499' ' ' PHE . 4.3 mp0 -73.45 -38.05 65.62 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 521' ' ' LEU . 2.8 mt -93.85 -21.44 19.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 25.8 tp -103.64 -31.3 9.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 491' ' ' ARG . 0.5 OUTLIER -131.47 -2.13 3.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.559 -1.338 . . . . 0.0 113.148 -177.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 78.77 49.26 6.62 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 118.646 -1.74 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . 0.445 ' CE ' ' HD3' ' A' ' 491' ' ' ARG . 1.8 ttm -112.41 -177.38 3.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -118.82 137.34 53.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.679 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -114.4 150.02 35.29 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.314 -0.866 . . . . 0.0 111.902 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 500' ' ' THR . 8.7 t -64.0 115.32 18.25 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.963 -0.46 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.459 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -69.3 115.71 4.16 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.217 1.114 . . . . 0.0 110.282 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -157.75 19.69 0.37 Allowed Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 487' ' ' ILE . 17.3 p -97.89 174.42 6.59 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.774 1.274 . . . . 0.0 113.751 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.815 ' HB ' HG12 ' A' ' 463' ' ' VAL . 10.1 m -122.5 103.53 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.553 HG11 HD22 ' A' ' 522' ' ' LEU . 62.1 t -90.44 134.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 0.7 OUTLIER -134.39 121.49 36.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.918 HG22 ' HG2' ' A' ' 509' ' ' GLN . 7.5 p -115.94 104.18 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.537 -1.352 . . . . 0.0 111.446 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.83 99.36 10.85 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.918 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.4 mm-40 -111.62 103.9 12.24 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -175.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.41 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -71.63 -36.5 62.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -98.9 163.16 12.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.486 ' HD3' HD13 ' A' ' 515' ' ' LEU . 56.0 mmtt -100.33 -9.05 22.71 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.825 -0.547 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.3 OUTLIER -61.67 -41.34 97.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.298 -0.876 . . . . 0.0 109.534 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -6.13 48.34 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.589 -0.695 . . . . 0.0 111.276 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.486 HD13 ' HD3' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -69.78 -56.5 6.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 178.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.2 -40.68 64.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.473 -0.767 . . . . 0.0 111.468 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.009 -1.057 . . . . 0.0 110.605 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.529 HG21 HD12 ' A' ' 466' ' ' ILE . 98.6 m -60.07 -44.41 94.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.223 -0.923 . . . . 0.0 108.789 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.753 HD11 ' HE3' ' A' ' 550' ' ' MET . 0.4 OUTLIER -50.8 -37.44 42.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -0.763 . . . . 0.0 110.434 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.3 m -64.77 -42.28 95.21 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.525 -0.734 . . . . 0.0 111.852 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.5 OUTLIER -66.23 -47.16 74.71 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.226 -0.922 . . . . 0.0 111.565 -178.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 0.553 HD22 HG11 ' A' ' 505' ' ' VAL . 4.3 pp -78.2 -18.11 55.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.396 -0.815 . . . . 0.0 111.9 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -47.07 -46.1 22.24 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.405 -0.81 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.31 90.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.41 -37.89 89.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.787 . . . . 0.0 111.668 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -29.38 70.25 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.063 -1.023 . . . . 0.0 111.005 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -58.15 -27.39 63.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.044 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 65.4 m80 -108.9 -117.66 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.832 -0.542 . . . . 0.0 111.094 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.409 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 10.5 m120 -91.28 65.78 5.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.405 -1.434 . . . . 0.0 113.666 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -139.71 165.18 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.551 -1.343 . . . . 0.0 110.279 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 15.1 mp0 -150.5 161.02 43.33 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.729 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 18.9 t -112.3 107.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.992 -1.068 . . . . 0.0 113.075 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 434' ' ' ALA . 7.2 tp -110.67 117.48 33.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.738 HG22 HG12 ' A' ' 507' ' ' VAL . 10.7 pt -137.36 133.71 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 117.996 -1.481 . . . . 0.0 113.148 -175.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 436' ' ' VAL . 82.4 p -99.02 -168.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -155.54 164.67 38.36 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.41 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.3 OUTLIER -142.28 -18.81 0.71 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.551 178.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -111.77 -17.05 8.77 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.483 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 1.0 OUTLIER -87.69 1.74 52.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.452 -1.028 . . . . 0.0 110.265 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -32.32 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 78.3 p -101.05 115.16 29.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 69.8 59.8 5.35 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 539' ' ' GLN . 58.7 p -68.46 -10.32 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.949 -0.736 . . . . 0.0 110.659 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.96 80.48 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 39.0 m -61.08 -29.85 69.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.974 . . . . 0.0 109.312 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.734 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.65 -32.26 70.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.922 -0.486 . . . . 0.0 110.028 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.1 mp -61.8 -42.62 99.23 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 109.26 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 64.3 mtt -64.64 -34.31 77.98 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.92 -51.75 28.39 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.753 ' HE3' HD11 ' A' ' 519' ' ' LEU . 96.4 mmm -56.1 -42.57 76.98 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -57.56 -31.72 66.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.528 -0.732 . . . . 0.0 110.059 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -62.76 -30.0 71.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 519' ' ' LEU . . . -69.34 -7.61 38.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.648 -0.658 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.25 -5.16 38.41 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.515 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 555' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.501 2.125 0 CA-C-N 118.942 1.371 . . . . 0.0 111.117 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.122 0.486 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -40.27 95.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.497 -0.752 . . . . 0.0 110.193 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 75.7 p -61.32 -40.79 95.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.664 -0.647 . . . . 0.0 110.946 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.8 t -71.3 -24.11 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.587 -0.696 . . . . 0.0 111.769 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.11 -52.92 52.58 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.945 -1.097 . . . . 0.0 111.178 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.94 78.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.438 -0.789 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.739 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.1 tt -62.18 -41.02 97.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.743 -0.598 . . . . 0.0 111.152 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 11.1 t -62.81 -40.26 96.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 0.0 111.309 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.76 -44.34 93.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.415 -0.803 . . . . 0.0 110.861 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -65.52 -38.1 88.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.359 -0.838 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.5 OUTLIER -64.13 -40.85 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.241 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' MET . . . . . 0.648 ' CG ' HD11 ' A' ' 435' ' ' ILE . 56.6 mtp -63.39 -28.82 70.25 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.83 -26.83 66.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.255 -0.903 . . . . 0.0 108.799 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.625 ' O ' HG12 ' A' ' 405' ' ' VAL . 0.6 OUTLIER -90.44 -18.45 25.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 176.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -66.04 -38.48 88.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.688 -0.633 . . . . 0.0 110.397 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -116.5 18.67 15.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 402' ' ' GLN . 8.2 p -60.39 118.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.506 -0.746 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 406' ' ' THR . 5.8 t -53.11 101.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.417 0.627 . . . . 0.0 111.536 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.763 HG23 HG12 ' A' ' 413' ' ' VAL . 4.0 p -114.21 134.62 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' HIS . . . . . 0.432 ' CB ' ' HE2' ' A' ' 411' ' ' LYS . 0.1 OUTLIER -91.09 141.53 26.5 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.438 -0.789 . . . . 0.0 109.8 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.53 -27.72 32.73 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.151 1.08 . . . . 0.0 110.138 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.86 -34.12 76.08 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.761 0.791 . . . . 0.0 109.668 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 408' ' ' HIS . 0.0 OUTLIER -138.82 58.66 1.64 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 13.7 t -50.68 98.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.116 -0.99 . . . . 0.0 111.81 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 407' ' ' VAL . 7.6 p -58.61 148.44 66.53 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.93 -0.482 . . . . 0.0 109.713 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' PRO . . . . . 0.545 ' HD2' HG23 ' A' ' 413' ' ' VAL . 38.4 Cg_endo -63.47 149.76 90.26 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.228 1.12 . . . . 0.0 109.682 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -136.3 -8.86 1.98 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.667 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 420' ' ' SER . 19.2 p -102.17 19.32 18.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -80.32 -77.01 0.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.612 -0.68 . . . . 0.0 111.854 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -84.36 -2.23 89.15 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.217 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 423' ' ' VAL . 85.3 m-85 -107.14 -20.89 13.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 120.573 2.187 . . . . 0.0 108.827 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 416' ' ' THR . 37.6 t -72.67 -40.61 66.14 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 425' ' ' VAL . 35.5 t0 -65.66 -38.11 88.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.4 -39.09 89.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.807 0.813 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.73 ' CG1' HD21 ' A' ' 533' ' ' LEU . 63.5 t -66.39 -44.97 90.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -61.42 -35.58 77.96 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.964 -1.085 . . . . 0.0 111.257 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 421' ' ' ASP . 93.0 t -62.27 -47.46 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.427 -0.795 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 423' ' ' VAL . 1.4 pp -57.56 -33.29 67.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.413 -0.804 . . . . 0.0 111.996 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' A' ' 533' ' ' LEU . . . -68.17 -36.96 80.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.716 -1.24 . . . . 0.0 108.333 178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -31.93 71.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -65.65 -90.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 8.3 tpp85 -178.54 -57.97 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.406 -1.434 . . . . 0.0 109.097 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -68.33 93.54 0.41 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 5.5 t -85.96 111.48 20.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -163.97 89.12 0.55 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.513 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -139.15 168.31 20.13 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.686 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.648 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.6 pp -127.82 130.93 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.617 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 423' ' ' VAL . 9.4 t -124.38 150.83 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 13.8 m -123.05 127.46 48.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.315 -0.865 . . . . 0.0 110.663 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -122.49 160.3 16.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -148.85 -47.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.911 . . . . 0.0 109.562 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -101.46 142.44 15.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 73.87 89.16 0.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.7 -44.69 4.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.945 . . . . 0.0 110.804 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.27 97.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.784 . . . . 0.0 110.775 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.11 62.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.37 -41.76 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -1.027 . . . . 0.0 110.771 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.86 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.5 -43.85 98.13 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -67.73 -29.13 68.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.199 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -61.61 -47.66 84.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.524 -0.735 . . . . 0.0 110.864 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -59.66 -31.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.857 -1.152 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.0 -27.88 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.576 -0.849 . . . . 0.0 108.758 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.84 -34.06 77.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.149 -0.97 . . . . 0.0 108.448 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' LEU . . . . . 0.408 ' O ' ' CG ' ' A' ' 455' ' ' MET . 33.3 tp -62.62 -34.99 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.78 HG13 ' HB ' ' A' ' 463' ' ' VAL . 59.9 t -63.01 -25.81 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 79.9 mtp -69.81 -42.37 73.77 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.878 . . . . 0.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.0 OUTLIER -62.39 -20.8 64.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.121 -0.987 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.0 -22.69 36.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 0.0 109.745 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.26 -41.91 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.333 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.25 -26.74 63.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.486 -0.759 . . . . 0.0 109.51 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.1 2.86 16.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.0 111.707 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 83.95 4.27 88.68 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.033 -1.042 . . . . 0.0 111.878 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 132.2 33.78 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.993 1.397 . . . . 0.0 111.136 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 487' ' ' ILE . 55.8 mp0 -76.7 -174.38 2.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.61 -0.681 . . . . 0.0 110.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.78 ' HB ' HG13 ' A' ' 453' ' ' VAL . 43.0 t -134.95 144.77 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' GLN . . . . . 0.597 ' HB3' HG22 ' A' ' 505' ' ' VAL . 50.8 tt0 -92.44 114.56 27.14 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . 0.544 HD13 ' N ' ' A' ' 466' ' ' ILE 0.255 0.0 OUTLIER -127.3 129.13 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 111.431 -175.811 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.751 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.1 mt -124.71 120.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.834 -0.542 . . . . 0.0 110.545 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -78.16 164.45 24.95 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.34 -160.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.81 -0.556 . . . . 0.0 110.085 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -51.37 -17.08 0.66 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.76 -1.213 . . . . 0.0 111.082 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -73.44 -6.33 45.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.481 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . 0.703 ' HD3' HG23 ' A' ' 466' ' ' ILE . 62.2 ttp180 -57.54 -31.62 66.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.3 m -59.08 -45.69 90.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.547 -0.721 . . . . 0.0 110.301 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.56 -40.43 95.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.494 -0.754 . . . . 0.0 109.056 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 92.7 mtp -62.37 -33.15 74.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.829 -0.544 . . . . 0.0 110.744 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -61.25 -38.98 88.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.949 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.5 ttp -59.18 -40.13 84.71 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.43 -0.794 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 62.6 pttt -119.58 -146.39 0.38 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' GLN . . . . . 0.437 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.3 mm-40 43.64 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.135 -0.978 . . . . 0.0 112.131 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -121.35 14.04 11.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.528 -0.732 . . . . 0.0 110.527 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -101.61 -10.12 20.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 111.659 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -132.15 0.41 3.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.109 -0.994 . . . . 0.0 112.939 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.32 44.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.656 -1.278 . . . . 0.0 112.873 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.7 t -89.34 48.76 1.65 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.654 -1.279 . . . . 0.0 110.47 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.06 58.24 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.8 44.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -1.15 . . . . 0.0 109.672 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 487' ' ' ILE . 95.1 mt -59.03 -84.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.923 -1.11 . . . . 0.0 109.318 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 462' ' ' GLU . 22.8 mm -156.37 -82.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.83 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . 0.459 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.5 t -98.37 11.57 37.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.791 -0.568 . . . . 0.0 110.472 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.96 74.65 2.29 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.421 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 72.8 ttt-85 -144.83 -72.5 0.26 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -107.42 -22.73 12.46 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.565 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.02 -37.93 89.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.196 -0.94 . . . . 0.0 109.847 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 493' ' ' LEU . 1.3 mt -89.32 -53.72 4.43 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.022 0.915 . . . . 0.0 108.647 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.39 -42.96 87.14 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.032 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -112.79 -8.81 13.72 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.16 -4.74 79.84 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.273 -1.517 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 94.6 mtp -68.52 -177.73 0.99 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.056 -1.261 . . . . 0.0 110.594 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.54 148.33 32.35 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.446 -0.784 . . . . 0.0 110.652 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.459 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.34 155.15 25.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.069 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -51.31 116.68 7.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.18 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 528' ' ' HIS . 48.3 Cg_endo -76.41 114.45 3.88 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.434 1.229 . . . . 0.0 110.41 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.2 28.62 0.03 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' SER . . . . . 0.595 ' CB ' HG21 ' A' ' 487' ' ' ILE . 47.1 t -92.01 169.24 10.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.363 -1.081 . . . . 0.0 111.833 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.73 ' O ' HG13 ' A' ' 463' ' ' VAL . 52.6 m -110.88 117.86 34.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 1.069 HG11 HD21 ' A' ' 522' ' ' LEU . 32.1 t -112.33 130.23 66.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.725 0.774 . . . . 0.0 110.008 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 533' ' ' LEU . 14.6 pt -138.91 131.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.125 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.751 HG23 ' HB ' ' A' ' 466' ' ' ILE . 7.7 p -129.63 109.25 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.243 1.021 . . . . 0.0 111.245 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' ASP . . . . . 0.508 ' OD2' HG11 ' A' ' 449' ' ' VAL . 80.4 m-20 -85.47 110.16 18.98 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.595 ' HG2' HG22 ' A' ' 507' ' ' VAL . 90.4 mm-40 -126.19 106.91 9.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -72.39 -37.61 58.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.455 ' HG2' HD21 ' A' ' 513' ' ' LEU . 30.4 tp10 -85.97 149.15 25.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.0 -15.59 18.22 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.55 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 511' ' ' GLU . 3.5 pp -72.41 -31.41 65.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 5.0 m -83.45 -20.08 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.435 -0.791 . . . . 0.0 110.469 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 519' ' ' LEU . 54.3 tp -65.84 -43.99 86.86 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.5 -40.31 85.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.849 -0.532 . . . . 0.0 111.371 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.01 -51.72 68.12 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.065 -1.022 . . . . 0.0 110.719 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.519 HG21 HD12 ' A' ' 466' ' ' ILE . 92.2 m -59.34 -39.53 83.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.846 HD11 ' CE ' ' A' ' 550' ' ' MET . 0.8 OUTLIER -59.49 -38.52 81.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 122.092 -0.38 . . . . 0.0 111.279 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 69.5 p -64.11 -30.88 71.92 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.939 -1.1 . . . . 0.0 109.297 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 48.7 tp -70.02 -41.26 74.52 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.733 0.777 . . . . 0.0 109.331 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' LEU . . . . . 1.069 HD21 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -72.83 -20.63 61.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.98 -0.45 . . . . 0.0 111.672 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -48.22 -58.88 3.93 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.264 -0.897 . . . . 0.0 111.439 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.29 80.21 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.746 ' HB1' ' HB2' ' A' ' 529' ' ' ASN . . . -58.03 -30.37 66.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.877 -0.778 . . . . 0.0 110.575 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -52.24 -27.53 15.22 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.126 -0.984 . . . . 0.0 110.782 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -64.24 -36.79 85.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.633 -0.667 . . . . 0.0 109.27 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 501' ' ' PRO . 1.0 OUTLIER -132.2 -60.11 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.674 -0.641 . . . . 0.0 110.775 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.746 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . 5.7 m120 -78.68 116.27 18.93 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.678 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 2.4 p -169.68 144.11 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 C-N-CA 117.262 -1.775 . . . . 0.0 115.462 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 505' ' ' VAL . 1.8 mt-30 175.9 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 534' ' ' ILE . 80.3 t -115.0 114.73 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.501 0 O-C-N 120.525 -1.36 . . . . 0.0 113.853 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.73 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -116.93 117.47 29.79 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 103.447 -2.798 . . . . 0.0 103.447 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' ILE . . . . . 0.662 HG22 HG12 ' A' ' 507' ' ' VAL . 6.2 pt -135.43 149.12 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.416 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.441 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 49.2 p -112.86 -168.07 1.27 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -158.69 168.14 27.66 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.733 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' SER . . . . . 0.419 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -144.32 17.68 1.71 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.214 0.53 . . . . 0.0 109.675 178.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -150.84 27.14 1.03 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' GLN . . . . . 0.52 HE22 HD13 ' A' ' 435' ' ' ILE . 55.6 tt0 -92.62 0.03 57.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.6 -0.941 . . . . 0.0 111.288 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -54.36 -43.66 71.51 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.869 -1.144 . . . . 0.0 110.048 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 73.3 p -113.88 155.38 25.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.13 43.76 83.64 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -63.22 -43.96 96.64 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.314 -1.11 . . . . 0.0 110.866 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.49 -34.24 89.4 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 65.9 m -62.39 -36.41 82.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.9 -0.765 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.34 -39.89 84.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.353 -0.842 . . . . 0.0 109.871 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.3 mp -62.94 -41.77 99.59 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.635 0.731 . . . . 0.0 109.074 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 97.4 mtp -62.69 -28.12 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.82 -53.98 50.16 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' MET . . . . . 0.846 ' CE ' HD11 ' A' ' 519' ' ' LEU . 89.8 mmm -55.62 -46.15 77.43 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.28 -0.888 . . . . 0.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.39 -30.88 71.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.708 -0.62 . . . . 0.0 111.424 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -67.19 -18.02 65.08 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.552 -0.717 . . . . 0.0 110.895 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.82 7.08 4.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.402 -0.811 . . . . 0.0 112.679 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.85 -12.69 9.29 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.094 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.057 -1.26 . . . . 0.0 109.826 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.166 0.508 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 15.2 m -82.02 150.66 27.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.807 -0.558 . . . . 0.0 110.26 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 78.35 23.49 65.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 41.3 pt -97.57 -4.34 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.485 -1.009 . . . . 0.0 111.311 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -62.71 -44.86 95.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.916 -1.115 . . . . 0.0 109.444 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.65 132.66 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.0 110.476 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.793 HD12 HD22 ' A' ' 390' ' ' LEU . 96.5 mt -113.15 -171.4 1.86 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.962 . . . . 0.0 110.312 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -60.49 -41.05 93.48 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 0.0 110.999 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 389' ' ' GLU . 80.2 tt0 -142.11 3.84 1.6 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.0 -1.063 . . . . 0.0 112.379 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.793 HD22 HD12 ' A' ' 387' ' ' LEU . 54.0 tp -61.87 -43.15 99.43 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.537 -1.352 . . . . 0.0 109.614 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 70.8 m -62.78 -44.2 96.79 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.673 -0.642 . . . . 0.0 110.312 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 395' ' ' LEU . 69.1 t -65.84 -36.32 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.634 -0.666 . . . . 0.0 110.836 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.73 -44.2 97.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.72 . . . . 0.0 111.568 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.0 91.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.492 -0.755 . . . . 0.0 112.124 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 399' ' ' ILE . 1.8 pp -71.88 -28.51 63.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.179 -0.951 . . . . 0.0 112.256 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.9 t -63.09 -43.9 97.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.701 -1.249 . . . . 0.0 110.276 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -64.98 -42.97 94.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.731 -0.606 . . . . 0.0 111.59 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -63.28 -40.05 96.31 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.417 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.668 HG23 ' HD1' ' A' ' 419' ' ' TYR . 82.3 mt -63.52 -42.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 42.3 mtp -63.54 -32.0 73.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.165 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -57.87 -32.34 67.59 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 109.538 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.492 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 7.7 mp0 -93.09 -15.91 25.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.998 -1.064 . . . . 0.0 109.603 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -64.75 -36.35 84.03 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.24 18.43 17.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.445 -0.785 . . . . 0.0 109.596 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 7.9 p -35.54 142.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.609 0 CA-C-O 121.354 0.597 . . . . 0.0 111.686 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 406' ' ' THR . 9.4 t -74.27 72.98 1.8 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.707 -0.621 . . . . 0.0 109.782 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 412' ' ' SER . 11.2 p -104.39 132.03 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.918 . . . . 0.0 111.52 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -93.33 142.05 24.76 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.46 -28.35 54.01 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 O-C-N 123.085 1.045 . . . . 0.0 109.802 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.22 -23.94 62.73 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.569 -0.707 . . . . 0.0 110.482 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 57.21 0.51 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . 0.462 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 35.5 t -59.01 126.48 27.89 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 111.499 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.6 p -87.77 113.12 53.09 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.921 -0.487 . . . . 0.0 110.446 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 50.9 Cg_endo -69.26 142.72 50.95 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.102 1.054 . . . . 0.0 109.423 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.423 ' NH1' ' CG ' ' A' ' 402' ' ' GLN . 83.2 mtp180 -159.38 63.11 0.39 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.424 -0.798 . . . . 0.0 109.534 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 74.1 p -66.83 -35.7 80.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.938 -1.101 . . . . 0.0 108.741 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -69.56 -10.45 58.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 111.2 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.13 -44.63 97.16 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.746 ' HB3' HG13 ' A' ' 436' ' ' VAL . 9.6 m-85 -93.94 -2.42 53.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.13 -1.218 . . . . 0.0 109.805 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 7.3 t -80.61 -36.81 32.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 425' ' ' VAL . 39.6 t0 -79.06 -46.03 18.94 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.388 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -61.14 -49.67 76.32 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.89 0.852 . . . . 0.0 110.781 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.884 ' HA ' HD23 ' A' ' 426' ' ' LEU . 55.9 t -72.16 -40.49 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.767 -0.583 . . . . 0.0 112.297 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 66.8 p -59.39 -39.13 82.36 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.889 -1.132 . . . . 0.0 110.835 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 421' ' ' ASP . 97.3 t -61.51 -42.49 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.71 -0.619 . . . . 0.0 109.67 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -58.62 -32.73 69.3 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.444 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.72 73.13 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.607 -1.308 . . . . 0.0 109.32 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' A' ' 425' ' ' VAL . 82.7 mt-30 -62.62 -31.22 72.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 426' ' ' LEU . 90.2 m-20 -62.89 -90.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -171.92 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.684 -1.26 . . . . 0.0 109.346 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.68 105.73 1.52 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.039 1.02 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.592 ' CB ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -85.15 100.93 12.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.465 -0.772 . . . . 0.0 109.782 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.749 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 20.9 tp -165.04 96.94 0.72 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.756 -1.215 . . . . 0.0 111.821 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.63 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -144.07 177.02 8.87 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.769 0.795 . . . . 0.0 111.89 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 44.4 pt -116.7 139.29 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.791 ' CG2' HG21 ' A' ' 423' ' ' VAL . 44.1 t -144.33 145.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.4 m -129.96 139.04 51.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.51 -0.744 . . . . 0.0 109.551 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.36 149.76 19.41 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -103.96 -49.64 3.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.751 -0.852 . . . . 0.0 109.262 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -146.75 153.86 25.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 93.09 106.62 1.76 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -46.99 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.484 -1.009 . . . . 0.0 110.675 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.79 84.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 112.01 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.29 -29.25 64.54 Favored Glycine 0 N--CA 1.492 2.414 0 O-C-N 120.729 -1.232 . . . . 0.0 110.514 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -38.89 89.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.509 -0.995 . . . . 0.0 110.804 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.526 ' CG ' ' HB1' ' A' ' 467' ' ' ALA . 6.9 mpt_? -64.91 -41.74 95.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.997 -1.064 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.77 -27.79 63.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.301 -0.874 . . . . 0.0 110.498 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 41.3 ttm180 -62.89 -56.13 20.03 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.334 -0.854 . . . . 0.0 111.219 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 506' ' ' ILE . 11.8 p -57.34 -32.04 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.508 -1.37 . . . . 0.0 108.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.03 -26.34 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 49.4 tp10 -60.59 -32.7 71.8 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.06 -37.32 87.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.4 t -60.6 -27.05 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.78 -0.575 . . . . 0.0 109.812 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 99.3 mtp -67.59 -37.1 82.09 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.9 ttp -58.38 -29.46 66.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.652 0.739 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.77 31.44 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 0.0 109.555 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.41 -43.17 98.28 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -71.59 -27.43 63.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.732 -0.605 . . . . 0.0 110.478 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -82.65 6.44 17.81 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.493 -0.755 . . . . 0.0 111.282 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.63 28.42 72.24 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.867 -1.146 . . . . 0.0 110.628 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -134.6 129.07 34.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.052 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -85.26 167.54 15.55 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 23.5 m -145.31 149.25 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.86 . . . . 0.0 110.293 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.932 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.5 tt0 -97.52 126.11 42.61 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.895 HD13 HG21 ' A' ' 453' ' ' VAL . 1.9 pt -134.07 139.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.458 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.748 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.2 mp -129.31 126.08 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.347 -0.846 . . . . 0.0 110.688 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.526 ' HB1' ' CG ' ' A' ' 446' ' ' ARG . . . -84.28 -177.92 6.78 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.542 -0.723 . . . . 0.0 109.934 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.0 -162.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.213 0.53 . . . . 0.0 110.043 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -56.28 -16.86 6.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.149 -0.969 . . . . 0.0 110.556 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -72.04 -11.07 60.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.374 -0.829 . . . . 0.0 111.094 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -56.05 -34.0 65.51 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.13 -0.981 . . . . 0.0 111.903 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 39.0 t -55.66 -45.87 77.63 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.153 -0.967 . . . . 0.0 110.426 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -64.94 -37.91 89.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -32.47 70.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.92 -0.487 . . . . 0.0 110.506 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -59.65 -42.18 92.22 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.964 -1.085 . . . . 0.0 108.817 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.7 mtt -65.46 -35.65 81.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -102.92 -148.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 51.04 45.18 28.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.955 -1.091 . . . . 0.0 111.604 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -95.42 12.01 30.81 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.28 -0.887 . . . . 0.0 110.903 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -84.01 -1.68 55.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 111.131 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.841 ' HG2' HD22 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.976 -1.078 . . . . 0.0 112.796 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.841 HD22 ' HG2' ' A' ' 481' ' ' ARG . 0.2 OUTLIER -105.66 30.03 6.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.553 -1.342 . . . . 0.0 111.785 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 37.3 m -60.91 -28.21 68.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.935 -1.103 . . . . 0.0 110.251 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 161.81 46.84 0.02 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -130.54 40.82 3.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.57 -0.959 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.932 HD22 ' HA ' ' A' ' 464' ' ' GLN . 89.0 mt -67.36 -81.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.831 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.0 OUTLIER -175.63 -60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.41 -1.431 . . . . 0.0 112.547 173.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 487' ' ' ILE . 1.5 t -101.82 12.83 36.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.471 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -87.28 66.38 3.5 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.8 ttm180 -143.39 -63.42 0.4 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.32 -1.106 . . . . 0.0 108.885 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 37.5 mmt180 -101.86 -36.04 8.8 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.979 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -61.24 -29.96 70.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.644 -0.66 . . . . 0.0 111.492 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 5.9 mt -93.57 -29.91 15.25 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.513 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.7 OUTLIER -103.89 -38.21 7.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -6.39 12.13 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 100.47 -19.34 53.05 Favored Glycine 0 N--CA 1.504 3.204 0 CA-C-N 120.641 1.564 . . . . 0.0 112.274 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.4 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 10.9 mtp -69.29 175.1 4.13 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.982 -1.305 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.57 150.04 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.493 -0.754 . . . . 0.0 111.138 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -113.71 150.03 33.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.718 -0.614 . . . . 0.0 109.72 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 500' ' ' THR . 6.9 t -55.32 107.19 0.8 Allowed Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.474 -0.766 . . . . 0.0 110.573 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.419 ' HG2' ' CB ' ' A' ' 528' ' ' HIS . 40.0 Cg_endo -67.76 114.28 3.28 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.173 1.091 . . . . 0.0 110.316 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -166.11 26.19 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.831 ' CB ' HD13 ' A' ' 487' ' ' ILE . 22.9 t -96.0 -179.62 4.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.297 -1.119 . . . . 0.0 111.628 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.691 ' HB ' HG12 ' A' ' 463' ' ' VAL . 87.5 m -124.14 131.88 53.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 522' ' ' LEU . 62.9 t -121.5 135.78 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.901 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.813 HG22 ' HB2' ' A' ' 533' ' ' LEU . 26.0 pt -135.99 118.86 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.748 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.9 p -115.51 104.29 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 111.451 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.429 ' HA ' ' H ' ' A' ' 535' ' ' THR . 9.9 p-10 -86.73 121.39 29.16 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.47 129.2 7.76 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -77.56 -44.87 11.82 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -77.19 148.04 36.11 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -99.51 -12.19 20.38 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 121.907 -0.495 . . . . 0.0 111.645 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.7 OUTLIER -64.01 -34.98 79.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.8 m -69.68 -37.71 76.77 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.578 0.704 . . . . 0.0 110.577 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 550' ' ' MET . 57.7 tp -63.14 -42.79 99.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.736 -0.602 . . . . 0.0 111.209 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -66.37 -43.3 86.3 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 518' ' ' THR . 18.9 pt-20 -68.29 -42.13 79.93 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.858 -1.151 . . . . 0.0 110.51 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 466' ' ' ILE . 52.1 m -61.55 -40.14 93.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.659 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -61.0 -39.8 91.12 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 516' ' ' LYS . 75.6 p -60.09 -57.08 14.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.049 -1.032 . . . . 0.0 110.672 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.43 -41.12 98.47 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.149 -0.969 . . . . 0.0 110.721 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.798 HD12 HG11 ' A' ' 505' ' ' VAL . 5.1 tt -57.66 -30.39 65.39 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.627 -0.671 . . . . 0.0 110.727 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.12 -47.44 68.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.488 -0.758 . . . . 0.0 111.421 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -60.63 -50.02 72.19 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.42 -36.18 83.32 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.662 -0.905 . . . . 0.0 111.687 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.501 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.7 -25.12 66.17 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.273 -0.892 . . . . 0.0 110.964 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -53.47 -40.38 65.24 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.204 -0.935 . . . . 0.0 108.73 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 501' ' ' PRO . 1.5 t-80 -93.02 -135.35 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.417 ' HB3' ' HA2' ' A' ' 502' ' ' GLY . 16.5 t30 -88.87 78.95 7.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.602 -1.311 . . . . 0.0 112.402 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -140.21 168.68 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.114 -0.991 . . . . 0.0 108.62 178.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -164.0 162.97 23.52 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.602 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.749 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.6 t -113.44 110.69 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.709 0.766 . . . . 0.0 112.071 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.813 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.89 117.63 34.64 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 507' ' ' VAL . 11.7 pt -135.69 160.75 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 117.533 -1.667 . . . . 0.0 111.921 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 436' ' ' VAL . 47.0 p -125.55 -168.45 1.84 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -159.35 168.83 25.39 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.508 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.9 17.98 2.31 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.583 178.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.95 11.49 3.36 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 26.5 mt-30 -95.59 0.85 53.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.04 -1.271 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -53.69 -26.72 24.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.031 -1.043 . . . . 0.0 111.22 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 56.8 m -107.08 -36.81 6.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.417 -0.802 . . . . 0.0 109.89 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -134.42 107.46 0.66 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.1 t -97.74 -43.26 7.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.494 -1.004 . . . . 0.0 111.629 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.65 -35.02 90.56 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 34.5 m -62.0 -32.24 72.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -1.079 . . . . 0.0 110.173 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.99 -35.06 79.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.86 -0.525 . . . . 0.0 109.923 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.1 mp -61.76 -43.72 98.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 88.0 mtp -67.0 -34.0 76.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 108.741 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.77 -52.5 56.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.659 ' CG ' HD11 ' A' ' 519' ' ' LEU . 32.0 ttp -58.31 -42.96 87.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.325 -0.86 . . . . 0.0 109.866 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HA ' ' CG1' ' A' ' 555' ' ' VAL . 99.0 mttt -61.6 -32.16 72.27 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.738 -0.601 . . . . 0.0 111.233 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.52 -12.72 61.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.589 -0.694 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -69.83 6.85 1.04 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.321 -0.862 . . . . 0.0 113.013 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.3 -15.76 42.48 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.522 -1.361 . . . . 0.0 110.933 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 555' ' ' VAL . 13.6 p -66.99 121.9 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.291 -1.123 . . . . 0.0 109.863 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -157.11 113.6 2.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.844 -0.535 . . . . 0.0 109.899 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 557' ' ' THR . 6.2 t -92.76 113.41 25.68 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.55 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -87.5 -81.06 0.24 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -155.49 -64.4 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.487 -0.758 . . . . 0.0 110.379 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -87.01 -22.66 25.36 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -149.01 151.64 34.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -93.12 -138.67 8.88 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -96.05 24.18 31.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -64.42 -33.34 75.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -1.039 . . . . 0.0 110.257 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.19 -1.14 56.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.788 -0.57 . . . . 0.0 111.292 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.715 ' HD2' HG23 ' A' ' 569' ' ' THR . 16.9 mmt85 -107.1 79.82 0.75 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.096 -1.002 . . . . 0.0 110.368 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.94 -16.46 32.58 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 123.272 1.143 . . . . 0.0 111.649 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -157.52 22.42 0.29 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.169 -0.957 . . . . 0.0 111.271 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . 0.715 HG23 ' HD2' ' A' ' 566' ' ' ARG . 9.6 t . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.641 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 120.874 0.368 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 93.6 p -62.88 -32.96 74.33 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.38 -0.825 . . . . 0.0 109.663 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 103.29 117.08 4.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 386' ' ' VAL . 77.6 mt -95.27 117.59 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.539 -0.977 . . . . 0.0 109.666 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -68.82 -33.78 74.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.844 -0.535 . . . . 0.0 110.557 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 384' ' ' ILE . 14.5 p -106.48 141.76 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.619 -0.676 . . . . 0.0 110.916 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.28 127.14 55.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.737 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -115.64 -168.69 1.45 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.5 -0.75 . . . . 0.0 110.076 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.51 87.86 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.565 -0.71 . . . . 0.0 110.162 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.54 -38.49 89.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.69 -0.632 . . . . 0.0 110.976 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.0 m -62.51 -47.41 84.05 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.389 -0.819 . . . . 0.0 110.816 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.15 -36.47 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.481 -0.762 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -47.36 82.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.237 -0.914 . . . . 0.0 109.655 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.55 -34.19 77.66 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.664 0.745 . . . . 0.0 108.999 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.6 OUTLIER -60.67 -39.45 88.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.98 -0.45 . . . . 0.0 110.659 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.9 m -64.6 -36.95 85.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.479 -0.763 . . . . 0.0 111.029 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -64.51 -46.63 82.09 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.288 -0.882 . . . . 0.0 111.997 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -70.06 -41.22 74.46 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.24 -0.913 . . . . 0.0 111.703 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 435' ' ' ILE . 96.5 mt -62.68 -40.6 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 109.675 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.434 ' HA ' ' CB ' ' A' ' 403' ' ' ASN . 18.3 mtp -63.01 -31.97 73.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.617 -0.677 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -60.74 -32.93 72.2 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.041 -1.037 . . . . 0.0 109.517 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 69.9 tp60 -90.44 -14.93 31.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.797 -1.189 . . . . 0.0 109.385 176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 400' ' ' MET . 44.3 t-20 -65.48 -35.94 82.38 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -115.63 18.6 15.76 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -39.07 148.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-O 121.677 0.751 . . . . 0.0 112.228 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 19.3 m -84.35 77.53 9.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 407' ' ' VAL . 14.8 p -97.21 131.48 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.343 -0.848 . . . . 0.0 112.355 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -96.62 145.04 28.89 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.89 -21.57 57.19 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.066 1.035 . . . . 0.0 111.199 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.62 -36.29 66.81 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.83 0.824 . . . . 0.0 110.42 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.5 67.61 0.51 Allowed 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 14.3 m -62.67 135.27 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.818 0.818 . . . . 0.0 111.091 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.487 HG23 ' HD2' ' A' ' 414' ' ' PRO . 8.6 p -81.51 149.19 64.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.487 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.3 Cg_endo -58.47 136.67 75.83 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.018 1.009 . . . . 0.0 110.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.403 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 80.5 mtt85 -96.3 -8.94 31.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.664 -0.648 . . . . 0.0 112.662 -177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.0 t -99.34 19.09 16.14 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.95 -1.094 . . . . 0.0 109.175 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -106.17 -36.97 6.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -68.82 -38.62 85.51 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.596 ' CB ' HG13 ' A' ' 436' ' ' VAL . 3.8 m-85 -94.9 -8.05 38.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.774 -1.427 . . . . 0.0 110.42 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.87 -40.54 65.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.873 -1.142 . . . . 0.0 108.529 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 425' ' ' VAL . 66.2 t0 -76.11 -44.47 38.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.898 -0.501 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.557 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -66.96 -48.59 68.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 111.445 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.76 ' HA ' HD23 ' A' ' 426' ' ' LEU . 72.2 t -67.87 -42.96 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.598 -0.689 . . . . 0.0 111.441 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.6 t -59.09 -42.61 90.86 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.812 -1.18 . . . . 0.0 111.309 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 421' ' ' ASP . 90.5 t -61.8 -46.6 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.193 -0.942 . . . . 0.0 110.886 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.76 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -56.87 -37.24 71.06 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.243 -0.91 . . . . 0.0 112.28 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.43 -36.87 79.69 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.896 -1.128 . . . . 0.0 108.937 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -59.82 -30.49 68.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.26 -85.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.44 -55.88 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.603 -1.31 . . . . 0.0 109.416 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 49.2 Cg_endo -73.4 106.44 2.18 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 533' ' ' LEU . 6.0 m -85.17 97.82 10.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.878 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 18.1 tp -150.01 134.02 17.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.69 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -174.4 175.35 2.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.905 -1.122 . . . . 0.0 110.894 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.1 pt -134.09 121.05 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.403 0.62 . . . . 0.0 110.072 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.693 ' CG2' HG21 ' A' ' 423' ' ' VAL . 62.7 t -120.61 134.76 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.227 -0.92 . . . . 0.0 109.257 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 11.8 p -118.24 123.6 45.84 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.85 -1.156 . . . . 0.0 111.809 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 -178.14 34.18 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -171.41 39.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.991 . . . . 0.0 109.599 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -155.04 -88.55 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -118.35 134.49 10.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -98.78 -16.08 19.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.689 -0.889 . . . . 0.0 110.971 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.35 77.78 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.48 -0.763 . . . . 0.0 111.824 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -78.66 -35.05 33.27 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.42 -35.44 79.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.963 . . . . 0.0 109.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.772 ' O ' HG12 ' A' ' 449' ' ' VAL . 0.0 OUTLIER -60.49 -46.75 88.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.835 -0.541 . . . . 0.0 110.364 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 97.5 mt-10 -66.99 -29.37 69.19 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -62.06 -46.01 91.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.968 HG22 HD12 ' A' ' 506' ' ' ILE . 5.3 p -58.81 -30.63 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.801 -1.187 . . . . 0.0 109.03 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.93 -26.49 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.77 -35.63 76.91 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.92 -1.113 . . . . 0.0 108.412 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 452' ' ' LEU . 3.9 mm? -62.38 -37.9 87.52 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.266 -0.897 . . . . 0.0 108.673 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 463' ' ' VAL . 66.8 t -57.97 -28.9 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.588 -0.695 . . . . 0.0 109.976 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 457' ' ' ARG . 65.8 mtt -65.76 -39.5 91.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.383 -0.823 . . . . 0.0 108.814 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 63.0 ttp -61.66 -21.49 64.46 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.608 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.19 32.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.331 -0.856 . . . . 0.0 109.891 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 454' ' ' MET . 82.7 mtp180 -67.08 -40.77 87.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 109.324 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.21 -34.19 75.8 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.604 0.716 . . . . 0.0 109.1 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -76.78 1.53 17.03 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.65 27.39 72.59 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 15.3 ttm180 -128.74 118.62 23.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -1.038 . . . . 0.0 110.402 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 0.5 OUTLIER -76.22 164.58 25.93 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.3 m -136.88 157.53 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.272 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.859 ' HA ' HD22 ' A' ' 486' ' ' LEU . 59.2 tt0 -105.7 111.81 24.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 482' ' ' LEU . 1.2 pt -122.32 129.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 466' ' ' ILE . 5.3 mp -119.36 111.99 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 112.169 -177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.6 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -57.43 164.12 2.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.294 -0.878 . . . . 0.0 109.806 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.449 ' HB3' HH11 ' A' ' 446' ' ' ARG . . . -58.78 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.898 -0.501 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -57.84 -12.25 2.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.117 -0.989 . . . . 0.0 111.2 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 446' ' ' ARG . 96.7 mtt-85 -88.82 6.08 40.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.145 -0.972 . . . . 0.0 111.164 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.6 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 53.6 ttp180 -57.9 -25.28 60.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.067 . . . . 0.0 111.037 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 7.7 t -59.02 -47.62 84.56 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.219 -0.925 . . . . 0.0 111.218 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.07 -35.82 82.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 33.0 ttp -66.28 -32.0 73.15 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.52 -37.3 83.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.31 -0.869 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 45.0 mtt -60.5 -36.4 78.24 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -121.08 -143.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.413 ' NE2' ' HD2' ' A' ' 481' ' ' ARG . 53.7 tp60 47.96 88.24 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.98 -1.075 . . . . 0.0 111.456 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -129.03 20.93 5.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 110.081 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -110.17 -0.72 17.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 111.377 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 482' ' ' LEU . 12.6 mtt180 -135.25 -13.36 2.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.886 -1.134 . . . . 0.0 112.723 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.722 HD22 HD11 ' A' ' 465' ' ' ILE . 0.6 OUTLIER -170.95 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.967 -1.083 . . . . 0.0 111.004 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 6.6 m -75.11 -18.26 60.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.64 47.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 20.1 pt-20 -139.9 74.8 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.669 -0.901 . . . . 0.0 111.051 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 464' ' ' GLN . 67.3 mt -94.85 -81.02 0.4 Allowed 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.4 OUTLIER 161.16 -34.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.75 0 C-N-CA 123.552 0.741 . . . . 0.0 110.435 173.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.541 HG21 ' CB ' ' A' ' 525' ' ' ALA . 7.0 p -102.14 12.7 36.36 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -153.36 95.78 0.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.433 ' N ' ' CD2' ' A' ' 493' ' ' LEU . 72.2 ttt180 -145.81 -72.21 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.455 ' CB ' ' HB2' ' A' ' 497' ' ' MET . 74.1 mtt-85 -90.13 -16.55 29.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.962 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -56.95 4.65 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.71 -1.244 . . . . 0.0 109.95 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 493' ' ' LEU . 1.1 pt? -58.92 -28.08 65.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.724 -0.61 . . . . 0.0 111.07 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.547 ' O ' HD23 ' A' ' 494' ' ' LEU . 1.0 OUTLIER -104.81 -46.37 4.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 111.938 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 491' ' ' ARG . 51.0 mt-10 -104.25 -7.93 19.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 112.5 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.87 -3.5 87.04 Favored Glycine 0 N--CA 1.508 3.438 0 O-C-N 120.581 -1.324 . . . . 0.0 110.051 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' CB ' ' A' ' 491' ' ' ARG . 93.7 mmm -64.8 -177.25 0.32 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -1.075 . . . . 0.0 112.721 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.64 169.46 8.8 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.744 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 488' ' ' THR . 1.2 p90 -142.33 150.09 40.31 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.564 -0.71 . . . . 0.0 110.443 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 30.8 m -61.77 109.25 2.06 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.48 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -84.91 113.35 1.55 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.362 1.191 . . . . 0.0 109.388 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 168.85 31.83 0.02 OUTLIER Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.584 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.716 ' HB3' HG21 ' A' ' 487' ' ' ILE . 4.5 p -96.35 -175.4 3.34 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 463' ' ' VAL . 25.1 m -110.03 122.75 48.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.765 HG11 ' CD1' ' A' ' 522' ' ' LEU . 46.4 t -115.64 129.58 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.731 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.968 HD12 HG22 ' A' ' 449' ' ' VAL . 15.2 pt -124.6 119.31 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.69 ' HB ' HG21 ' A' ' 518' ' ' THR . 3.6 p -107.34 110.76 32.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 120.807 -1.183 . . . . 0.0 109.96 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.757 ' OD2' HG11 ' A' ' 449' ' ' VAL . 21.4 m-20 -82.71 105.7 13.95 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 0.4 OUTLIER -109.21 178.37 4.47 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.08 0.943 . . . . 0.0 112.714 -175.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.437 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -167.36 -91.24 0.08 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -38.89 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.603 -0.299 . . . . 0.0 111.566 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -179.02 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.39 -1.444 . . . . 0.0 110.883 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 513' ' ' LEU . 14.2 tp -62.87 -30.77 71.77 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.573 -0.704 . . . . 0.0 109.935 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 6.0 p -69.17 -38.79 78.9 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.761 -0.587 . . . . 0.0 111.749 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.699 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.6 tp -64.26 -45.45 88.04 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.396 -0.815 . . . . 0.0 112.106 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 51.9 mtpt -65.11 -45.48 84.98 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.73 -42.62 95.08 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.288 -0.882 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 507' ' ' VAL . 74.4 m -58.54 -46.93 85.78 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.834 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 550' ' ' MET . 5.5 mt -62.95 -36.91 85.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.246 -0.908 . . . . 0.0 111.008 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.5 m -58.07 -41.31 83.14 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.165 -0.959 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.38 -37.84 63.32 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.59 0.71 . . . . 0.0 109.498 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.765 ' CD1' HG11 ' A' ' 505' ' ' VAL . 2.0 tp -63.65 -22.23 66.79 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 111.418 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -46.43 -52.78 12.37 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.5 -0.75 . . . . 0.0 112.005 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.74 -50.54 53.17 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.788 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -58.26 -44.12 88.24 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.667 -0.902 . . . . 0.0 111.858 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.35 -25.41 67.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.459 -0.776 . . . . 0.0 111.246 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -55.41 -26.2 40.3 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.091 -1.005 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.48 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.9 m80 -110.88 -130.47 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.607 -0.683 . . . . 0.0 109.913 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -88.49 78.05 7.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.557 -1.339 . . . . 0.0 112.614 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.788 HG21 ' HB1' ' A' ' 525' ' ' ALA . 0.9 OUTLIER -134.34 158.4 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 109.152 178.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 98.2 mm-40 -150.82 157.99 43.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.739 -0.601 . . . . 0.0 109.726 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 69.1 t -110.78 96.81 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.192 -0.943 . . . . 0.0 113.468 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.663 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.5 OUTLIER -95.9 114.19 25.88 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 174.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.65 HG22 ' CG1' ' A' ' 507' ' ' VAL . 4.9 pt -130.04 136.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.401 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.494 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 18.5 p -96.68 176.25 6.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 1.8 p30 -158.59 168.16 27.66 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.948 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.437 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.7 t -140.61 59.36 1.55 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -37.28 158.95 0.01 OUTLIER Glycine 0 N--CA 1.507 3.382 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.999 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -53.78 -87.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.166 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -108.77 -81.23 0.57 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.775 -1.203 . . . . 0.0 112.805 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 t -139.75 -30.16 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.675 0.75 . . . . 0.0 109.511 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -98.89 50.97 1.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.0 t -76.34 3.27 11.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 122.128 -0.631 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -50.2 -26.68 9.53 Favored Glycine 0 N--CA 1.502 3.088 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.0 m -70.61 -20.85 62.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.995 -1.297 . . . . 0.0 109.047 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.785 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -68.48 -34.33 75.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -63.83 -42.65 97.57 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.393 -0.817 . . . . 0.0 109.928 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.07 -34.51 75.02 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.83 -44.09 39.11 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.699 ' HB2' HD21 ' A' ' 515' ' ' LEU . 1.4 tmt? -57.49 -47.11 82.8 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -59.5 -33.42 71.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.677 -0.64 . . . . 0.0 111.496 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -63.96 -18.89 64.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.295 -0.878 . . . . 0.0 110.064 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.99 0.07 6.61 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.36 -0.838 . . . . 0.0 112.379 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 111.7 -12.4 27.6 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.816 -1.177 . . . . 0.0 111.52 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 519' ' ' LEU . 68.8 t -82.89 114.95 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -172.53 138.99 0.93 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.42 -0.8 . . . . 0.0 109.932 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 88.9 m -92.15 135.5 33.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -73.17 -79.61 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.13 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -157.81 -70.31 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.552 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -81.33 -23.14 37.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 0.0 111.113 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -158.85 148.37 19.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.332 -0.855 . . . . 0.0 110.815 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -106.79 149.12 16.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.54 90.16 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.09 -2.35 50.25 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.623 -0.928 . . . . 0.0 111.696 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -82.87 -0.77 49.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.083 -1.011 . . . . 0.0 110.85 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.442 HH11 HG23 ' A' ' 569' ' ' THR . 3.9 mmm180 -103.94 81.75 0.51 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.64 -21.02 52.72 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.283 1.149 . . . . 0.0 111.033 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -160.72 -51.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.444 -0.785 . . . . 0.0 110.15 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . 0.442 HG23 HH11 ' A' ' 566' ' ' ARG . 7.4 t . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.077 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.944 0.402 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.8 m -104.45 31.41 4.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.515 -0.741 . . . . 0.0 109.646 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 101.62 111.1 3.41 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 85.1 mt -97.61 -14.8 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.574 -0.957 . . . . 0.0 110.224 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -64.88 -42.75 94.55 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.325 -0.86 . . . . 0.0 109.337 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 387' ' ' LEU . 82.4 t -94.41 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.794 -0.566 . . . . 0.0 110.286 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.42 ' N ' HG12 ' A' ' 386' ' ' VAL . 96.4 mt -79.5 97.16 6.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.523 -0.736 . . . . 0.0 109.955 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -99.75 118.37 36.1 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.503 -0.748 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -116.23 33.14 5.7 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.629 0.728 . . . . 0.0 109.402 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.13 -37.3 86.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.503 -0.748 . . . . 0.0 110.882 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 49.0 m -60.02 -44.23 94.75 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.587 -0.696 . . . . 0.0 111.189 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 433' ' ' LEU . 77.2 t -77.21 -29.56 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 111.063 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -65.51 -47.8 74.75 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.12 . . . . 0.0 111.166 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.45 -39.26 88.76 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.876 0.846 . . . . 0.0 110.331 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.574 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.3 tt -61.88 -38.83 89.75 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.207 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 23.2 m -61.15 -36.72 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.063 -0.398 . . . . 0.0 110.77 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -60.76 -44.07 97.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 110.734 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.425 ' O ' ' CE1' ' A' ' 419' ' ' TYR . 39.1 t70 -65.58 -44.39 86.81 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 0.0 111.962 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.769 HG23 ' HB3' ' A' ' 419' ' ' TYR . 0.9 OUTLIER -63.3 -42.17 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.81 0 O-C-N 121.106 -0.996 . . . . 0.0 108.983 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 2.9 ttt -61.96 -26.72 68.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.727 -0.608 . . . . 0.0 109.578 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -62.27 -31.13 71.67 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.653 ' O ' HG12 ' A' ' 405' ' ' VAL . 27.4 tp60 -89.75 -11.69 41.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 0.0 109.83 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.51 -39.92 88.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.654 . . . . 0.0 110.883 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 -116.57 17.8 15.23 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.788 -1.195 . . . . 0.0 109.721 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.4 p -56.87 118.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.612 -0.68 . . . . 0.0 110.001 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -54.58 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.083 -1.011 . . . . 0.0 109.559 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 405' ' ' VAL . 43.0 t -96.02 130.9 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.899 -0.501 . . . . 0.0 110.132 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -92.12 131.78 34.1 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.475 -0.765 . . . . 0.0 109.878 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 -24.03 43.88 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.164 1.086 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.36 -37.4 80.42 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.941 0.877 . . . . 0.0 110.181 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 67.6 1.03 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 19.8 p -49.8 155.3 0.88 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.108 0.956 . . . . 0.0 112.088 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 407' ' ' VAL . 7.3 p -101.45 143.65 27.02 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 417' ' ' ALA . 38.1 Cg_endo -64.77 131.26 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 N-CA-C 109.104 -1.152 . . . . 0.0 109.104 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -109.51 -19.06 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.516 -0.74 . . . . 0.0 112.502 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 420' ' ' SER . 9.8 t -101.86 14.95 30.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.036 -1.04 . . . . 0.0 108.325 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 414' ' ' PRO . . . -75.55 -77.86 0.12 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.689 -0.632 . . . . 0.0 111.607 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -89.0 -0.72 80.65 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.782 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.769 ' HB3' HG23 ' A' ' 399' ' ' ILE . 80.2 m-85 -107.98 -26.39 10.71 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.775 2.288 . . . . 0.0 108.763 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 416' ' ' THR . 4.9 t -71.19 -38.78 72.09 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 175.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 -38.8 92.19 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -59.88 -37.22 78.74 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.748 0.785 . . . . 0.0 109.327 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 75.9 t -66.85 -44.42 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.7 p -61.02 -37.82 83.91 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.642 -1.286 . . . . 0.0 111.529 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.25 -46.47 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -55.3 -32.78 62.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 0.0 111.686 -178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.16 78.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.806 -1.184 . . . . 0.0 108.877 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -57.49 -30.57 65.21 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -65.68 -89.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.488 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -174.67 -54.33 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.617 -1.302 . . . . 0.0 108.93 177.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.9 Cg_endo -70.81 98.71 0.8 Allowed 'Trans proline' 0 N--CA 1.487 1.135 0 N-CA-C 109.179 -1.123 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.533 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.4 OUTLIER -84.34 102.09 12.46 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.804 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.91 98.1 1.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.35 -0.844 . . . . 0.0 111.928 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -142.92 168.32 19.99 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.48 -0.763 . . . . 0.0 111.82 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.27 129.92 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.747 -0.596 . . . . 0.0 111.385 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.624 ' CG2' HG21 ' A' ' 423' ' ' VAL . 25.5 t -133.02 155.44 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.312 -0.868 . . . . 0.0 110.083 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.7 t -133.09 138.9 46.87 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.427 -0.796 . . . . 0.0 111.024 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -101.41 -171.34 28.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -153.18 26.15 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.732 -0.863 . . . . 0.0 109.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.9 10.33 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 67.56 55.35 15.22 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -82.42 -9.08 59.58 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.791 -0.829 . . . . 0.0 110.724 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -57.69 -45.96 84.96 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.134 -0.979 . . . . 0.0 111.723 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -83.05 -28.55 36.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.74 -40.43 88.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.582 -0.952 . . . . 0.0 109.912 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.783 ' O ' HG12 ' A' ' 449' ' ' VAL . 5.5 mmt85 -65.97 -39.27 90.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.51 -0.744 . . . . 0.0 109.66 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -67.66 -29.5 68.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.141 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 451' ' ' GLU . 49.7 ttt85 -64.21 -47.0 81.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.699 -0.626 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 446' ' ' ARG . 9.5 p -56.5 -30.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.554 -1.341 . . . . 0.0 109.473 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.498 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 448' ' ' ARG . 95.3 mt-10 -62.76 -33.68 75.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.734 -1.229 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 452' ' ' LEU . 4.2 mm? -65.02 -34.54 78.67 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.927 HG13 ' CG2' ' A' ' 463' ' ' VAL . 59.3 t -60.47 -31.75 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 96.3 mmm -65.14 -40.1 93.95 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.3 ttp -59.63 -22.45 61.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.603 -0.686 . . . . 0.0 110.318 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 461' ' ' ARG . . . -81.93 -22.79 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -65.37 -43.09 91.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.429 -0.794 . . . . 0.0 109.655 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.19 -28.93 63.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.308 -0.87 . . . . 0.0 109.78 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -76.03 -2.92 33.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.699 -0.626 . . . . 0.0 111.388 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.58 19.99 72.46 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.406 ' HG3' ' HB1' ' A' ' 456' ' ' ALA . 32.2 ptt180 -136.72 151.18 48.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -1.064 . . . . 0.0 110.406 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.523 ' HB2' HD13 ' A' ' 487' ' ' ILE . 92.3 mt-10 -102.07 178.84 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.927 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.4 m -141.9 158.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.778 -1.201 . . . . 0.0 111.578 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.625 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.9 tt0 -102.1 119.33 38.62 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -126.77 130.97 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.232 -0.918 . . . . 0.0 111.081 -178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 465' ' ' ILE . 91.1 mt -129.11 123.56 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.852 -0.53 . . . . 0.0 110.277 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -75.66 165.71 24.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.424 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -58.1 -161.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.571 -0.706 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.53 -20.52 1.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -74.57 -2.86 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.395 -0.815 . . . . 0.0 110.752 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.444 ' CZ ' HD12 ' A' ' 482' ' ' LEU . 0.9 OUTLIER -54.19 -26.06 26.15 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.108 -0.995 . . . . 0.0 110.46 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.2 p -65.41 -46.81 78.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.392 -0.818 . . . . 0.0 109.966 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.77 -49.25 69.03 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.373 -0.829 . . . . 0.0 110.329 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 6.4 ttt -58.57 -30.61 67.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 110.403 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -58.75 -33.37 70.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 109.523 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 47.3 ttp -58.47 -39.08 78.95 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.315 0.579 . . . . 0.0 110.295 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -125.14 -157.36 0.78 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.835 -0.541 . . . . 0.0 109.663 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 45.82 61.44 2.65 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.443 -0.786 . . . . 0.0 112.167 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -98.05 9.03 43.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.586 -0.696 . . . . 0.0 109.795 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -93.04 -0.59 57.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.598 ' C ' HD23 ' A' ' 482' ' ' LEU . 0.2 OUTLIER -141.16 3.38 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 112.454 -178.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.5 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.872 -1.142 . . . . 0.0 111.815 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.9 p -93.76 48.24 1.27 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.132 -0.98 . . . . 0.0 108.926 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.82 26.66 28.77 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -118.52 47.58 1.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.495 -1.003 . . . . 0.0 108.814 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.82 HD11 ' HA3' ' A' ' 489' ' ' GLY . 0.2 OUTLIER -96.11 -82.77 0.39 Allowed 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.644 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.894 HG21 ' OG ' ' A' ' 503' ' ' SER . 38.0 mm -142.71 -90.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.076 -1.015 . . . . 0.0 108.99 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.452 ' HB ' ' CG ' ' A' ' 499' ' ' PHE . 0.0 OUTLIER -102.09 11.85 37.73 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.653 -0.654 . . . . 0.0 110.263 178.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.82 ' HA3' HD11 ' A' ' 486' ' ' LEU . . . -81.78 77.62 2.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.482 ' CG ' ' H ' ' A' ' 491' ' ' ARG . 0.2 OUTLIER -144.47 -86.11 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 490' ' ' ARG . 77.9 mtt85 -112.14 -17.16 12.87 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.443 -0.785 . . . . 0.0 109.227 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 497' ' ' MET . 8.0 mp0 -49.64 -36.1 23.51 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.61 -1.306 . . . . 0.0 111.226 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 521' ' ' LEU . 60.9 mt -71.84 -66.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.16 -0.962 . . . . 0.0 108.465 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -54.11 -28.99 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.408 0.623 . . . . 0.0 110.377 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 80.0 mm-40 -84.51 -3.16 58.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.0 111.585 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 69.91 48.87 38.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.49 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 94.4 mtp -123.01 -177.39 3.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.499 -1.001 . . . . 0.0 111.127 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.48 170.63 7.96 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.649 -0.657 . . . . 0.0 110.325 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.452 ' CG ' ' HB ' ' A' ' 488' ' ' THR . 4.6 m-85 -109.21 125.64 52.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.257 -0.902 . . . . 0.0 108.612 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 6.7 t -68.02 150.89 97.58 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.613 -0.679 . . . . 0.0 110.852 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.444 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 42.5 Cg_endo -71.6 123.7 9.67 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.611 1.322 . . . . 0.0 111.049 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 161.64 -2.06 0.07 OUTLIER Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.72 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.894 ' OG ' HG21 ' A' ' 487' ' ' ILE . 8.6 m -82.81 153.21 25.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.343 . . . . 0.0 113.502 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.866 ' HB ' HG12 ' A' ' 463' ' ' VAL . 50.7 m -118.58 91.88 3.67 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.665 ' CB ' HD21 ' A' ' 522' ' ' LEU . 18.3 t -87.85 135.8 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.756 HG22 ' HB2' ' A' ' 533' ' ' LEU . 18.2 pt -136.55 122.43 28.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 534' ' ' ILE . 8.5 p -123.67 111.98 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.669 -1.269 . . . . 0.0 112.787 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -86.59 123.04 31.34 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.406 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.4 pm0 -160.52 129.23 4.76 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 117.488 -1.685 . . . . 0.0 115.434 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.485 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.3 -43.02 6.76 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -69.61 151.54 45.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -98.83 -11.68 21.55 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.24 -40.46 90.23 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 13.5 t -67.71 -39.95 84.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.819 -0.551 . . . . 0.0 111.201 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.737 HD21 ' HB2' ' A' ' 550' ' ' MET . 64.4 tp -62.67 -44.76 95.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.595 -0.691 . . . . 0.0 111.235 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 32.2 ttpt -71.36 -46.57 60.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.294 -0.878 . . . . 0.0 112.975 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.03 -44.08 85.7 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 83.1 m -56.84 -43.4 81.07 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 109.309 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.1 OUTLIER -53.76 -34.42 58.94 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.33 0.586 . . . . 0.0 109.882 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.403 ' HA ' ' OD2' ' A' ' 523' ' ' ASP . 27.0 m -62.35 -41.48 98.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.508 -0.745 . . . . 0.0 109.513 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.656 HD21 HD21 ' A' ' 493' ' ' LEU . 1.0 OUTLIER -62.66 -40.52 97.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.738 0.78 . . . . 0.0 108.928 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.665 HD21 ' CB ' ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.33 -21.34 63.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.923 -0.485 . . . . 0.0 110.851 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 520' ' ' THR . 95.4 m-20 -46.09 -64.55 0.72 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.622 -0.673 . . . . 0.0 112.453 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.03 -52.47 49.79 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 120.577 -1.327 . . . . 0.0 110.737 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.24 68.18 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.258 -1.142 . . . . 0.0 111.006 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.87 -20.66 66.31 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -37.9 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 0.7 OUTLIER -145.44 -79.25 0.18 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.267 -1.521 . . . . 0.0 113.751 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.435 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 82.5 m-20 -90.65 72.63 6.76 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.712 -1.243 . . . . 0.0 114.087 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 9.6 p -130.16 150.63 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.738 -1.226 . . . . 0.0 112.572 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.507 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 87.8 mm-40 -144.02 149.86 37.34 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 5.2 t -112.33 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.761 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.756 ' HB2' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -103.08 116.67 32.96 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -136.0 150.7 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.747 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.3 p -118.13 -163.99 0.98 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.54 163.15 40.36 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.607 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.485 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 3.8 p -128.7 22.25 5.9 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.875 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -174.0 43.85 0.14 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.35 -0.41 56.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.881 -0.776 . . . . 0.0 111.732 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -55.68 -42.71 75.56 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.995 -1.066 . . . . 0.0 110.851 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 m -116.76 156.38 27.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.591 -0.693 . . . . 0.0 109.386 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.53 34.38 55.22 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -62.62 -43.36 98.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.42 -1.047 . . . . 0.0 110.61 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -62.77 -33.53 87.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.9 m -63.98 -39.45 94.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.846 -0.797 . . . . 0.0 111.007 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.53 -37.09 82.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.01 -42.26 99.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.657 -0.652 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 63.8 tpp -63.59 -34.58 78.14 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.5 -0.75 . . . . 0.0 109.515 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.23 -53.89 50.26 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.349 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.737 ' HB2' HD21 ' A' ' 515' ' ' LEU . 39.0 ttp -58.57 -44.86 89.88 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.317 -0.864 . . . . 0.0 109.914 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . 0.471 ' HA ' ' CG2' ' A' ' 555' ' ' VAL . 75.8 mmtt -60.28 -32.04 70.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.643 -0.66 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.81 -16.6 63.83 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.337 -0.852 . . . . 0.0 110.607 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -69.38 2.85 2.65 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 138.73 -16.66 3.29 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.21 -1.472 . . . . 0.0 111.817 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 555' ' ' VAL . 35.2 m -102.01 120.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 120.996 -1.297 . . . . 0.0 110.262 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -169.71 133.29 1.25 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.757 -0.589 . . . . 0.0 109.974 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 46.4 m -98.84 126.86 44.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.41 -0.806 . . . . 0.0 109.364 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -76.92 -80.87 0.09 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.274 -0.891 . . . . 0.0 111.373 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -171.9 -64.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.374 -0.829 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -86.27 -21.56 27.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 110.921 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -123.89 124.38 42.51 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -72.81 -128.32 0.11 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -70.12 96.47 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.65 -6.74 58.78 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.673 -0.898 . . . . 0.0 111.426 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -98.46 -21.77 16.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.137 -0.977 . . . . 0.0 110.688 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.426 ' HD2' ' HB ' ' A' ' 569' ' ' THR . 0.8 OUTLIER -111.46 120.36 42.89 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.616 -0.677 . . . . 0.0 110.43 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -9.69 22.41 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.22 1.116 . . . . 0.0 109.225 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -74.03 65.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.225 0 O-C-N 121.409 -0.807 . . . . 0.0 109.909 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . 0.426 ' HB ' ' HD2' ' A' ' 566' ' ' ARG . 7.7 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 67.2 m -58.93 -43.8 91.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.248 -0.908 . . . . 0.0 110.701 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 135.13 -9.59 4.45 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.156 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 96.5 mt -88.49 126.04 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.126 -1.22 . . . . 0.0 109.309 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -120.42 165.73 14.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.432 -0.793 . . . . 0.0 110.377 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.11 142.64 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.788 . . . . 0.0 109.817 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -102.9 124.54 48.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.728 . . . . 0.0 109.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 431' ' ' PRO . 62.9 t0 -68.97 -52.21 31.4 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.421 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -139.39 3.02 2.1 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.437 -0.789 . . . . 0.0 111.419 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.456 HD23 ' CZ ' ' A' ' 393' ' ' ARG . 93.9 mt -71.66 -31.13 66.48 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.904 -1.123 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 17.0 p -64.63 -40.64 95.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.816 -0.552 . . . . 0.0 111.915 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.59 -35.93 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.529 -0.732 . . . . 0.0 111.961 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.456 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 77.3 mtm180 -63.81 -46.99 82.66 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.71 -1.244 . . . . 0.0 110.63 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.35 75.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.688 HD13 ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -63.34 -39.03 93.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.825 -0.547 . . . . 0.0 110.52 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 59.3 m -61.23 -37.84 84.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.424 -0.797 . . . . 0.0 110.419 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -63.3 -44.69 94.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.325 -0.859 . . . . 0.0 111.663 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -67.66 -46.06 73.48 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.149 -0.969 . . . . 0.0 111.949 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 436' ' ' VAL . 63.9 mt -65.44 -42.35 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.985 -1.072 . . . . 0.0 109.921 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 16.6 ttm -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.19 -25.66 65.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.52 -0.738 . . . . 0.0 109.381 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 0.0 OUTLIER -93.11 -15.64 25.83 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.867 -1.146 . . . . 0.0 109.025 175.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 0.4 OUTLIER -67.3 -40.3 86.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.608 -0.683 . . . . 0.0 110.263 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -115.49 18.67 15.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.969 -1.082 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 405' ' ' VAL . 7.1 p -48.7 116.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.492 -0.755 . . . . 0.0 110.751 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.8 p -50.49 89.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.786 -0.571 . . . . 0.0 111.016 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 413' ' ' VAL . 14.2 p -108.74 133.7 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -96.76 141.7 23.47 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 110.85 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.93 -24.35 39.83 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.143 1.075 . . . . 0.0 110.232 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -66.76 -32.32 73.53 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.782 0.801 . . . . 0.0 110.392 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 67.21 1.14 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 18.6 t -49.56 148.74 2.69 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.55 -0.718 . . . . 0.0 110.604 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -100.93 110.06 59.9 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.682 -0.637 . . . . 0.0 110.855 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.81 121.37 5.44 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.004 1.002 . . . . 0.0 111.3 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.4 ' HE ' HG22 ' A' ' 413' ' ' VAL . 13.2 ptp180 -169.4 61.7 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.381 -0.825 . . . . 0.0 110.181 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.2 t -67.47 -31.36 71.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.323 -0.861 . . . . 0.0 108.799 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.64 47.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 110.735 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.7 81.24 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.519 ' CD1' HG11 ' A' ' 436' ' ' VAL . 26.0 p90 -90.27 -0.42 57.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.93 -1.336 . . . . 0.0 110.161 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.8 m -76.07 -38.81 56.59 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.801 ' O ' HG23 ' A' ' 425' ' ' VAL . 30.8 t70 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.447 0.642 . . . . 0.0 109.962 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.594 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.49 -49.51 75.08 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.971 0.891 . . . . 0.0 111.068 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 436' ' ' VAL . 97.4 t -68.41 -42.24 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.771 -0.581 . . . . 0.0 111.146 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 88.1 p -59.48 -33.05 70.83 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.007 . . . . 0.0 110.42 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 421' ' ' ASP . 76.6 t -63.11 -46.03 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.7 -0.625 . . . . 0.0 111.026 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.8 pp -64.13 -34.76 78.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.178 -0.951 . . . . 0.0 112.367 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.26 85.5 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.629 -1.294 . . . . 0.0 109.15 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -63.3 -32.3 73.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -66.33 -93.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -177.26 -53.79 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.369 -1.457 . . . . 0.0 109.433 177.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 41.1 Cg_endo -68.72 106.36 1.46 Allowed 'Trans proline' 0 N--CA 1.48 0.726 0 N-CA-C 108.204 -1.498 . . . . 0.0 108.204 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.462 ' HB3' ' N ' ' A' ' 532' ' ' VAL . 0.2 OUTLIER -92.36 103.56 15.99 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.6 OUTLIER -164.07 89.81 0.57 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.938 -1.102 . . . . 0.0 109.27 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -137.4 170.0 16.83 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.785 0.802 . . . . 0.0 111.414 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.35 126.73 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.497 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.815 HG21 HG21 ' A' ' 423' ' ' VAL . 22.4 t -130.04 160.4 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 110.729 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.5 t -133.58 138.79 46.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.434 -0.791 . . . . 0.0 110.685 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.02 166.51 23.48 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -116.89 -44.59 2.81 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.283 -1.128 . . . . 0.0 109.492 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.9 165.85 38.3 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.98 36.21 64.73 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.677 ' HB3' ' NH1' ' A' ' 470' ' ' ARG . . . -59.13 -22.34 60.73 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.79 -0.829 . . . . 0.0 112.001 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.56 90.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.82 -29.49 59.15 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 448' ' ' ARG . 43.4 tt0 -60.17 -41.3 92.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.597 -0.943 . . . . 0.0 109.957 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.609 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.0 mtm180 -64.01 -36.12 82.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -69.16 -30.13 68.3 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.415 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.404 ' HD2' ' HA ' ' A' ' 445' ' ' GLN . 89.3 mtt-85 -64.62 -49.73 69.93 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.504 -0.748 . . . . 0.0 111.124 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -57.43 -32.58 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.003 -1.061 . . . . 0.0 110.138 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.67 -27.18 68.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 454' ' ' MET . 83.4 tt0 -66.55 -36.6 83.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -62.56 -35.47 79.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.936 HG13 ' CG2' ' A' ' 463' ' ' VAL . 46.9 t -64.63 -28.2 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 95.0 mtp -68.26 -42.73 79.17 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.216 -0.928 . . . . 0.0 111.764 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 6.6 ptm -63.36 -21.58 66.36 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.51 -1.369 . . . . 0.0 109.245 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.43 48.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.456 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.16 -41.05 97.31 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.47 -22.53 62.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.799 -0.563 . . . . 0.0 110.497 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -75.28 -0.23 18.9 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.171 -0.956 . . . . 0.0 111.651 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 82.24 12.53 80.59 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 120.92 -1.112 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -139.54 151.84 46.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 110.653 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.74 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.8 mt-10 -92.85 179.28 5.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.587 -0.696 . . . . 0.0 109.205 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.936 ' CG2' HG13 ' A' ' 453' ' ' VAL . 14.7 m -141.85 153.23 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.779 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.681 ' HB3' HG22 ' A' ' 505' ' ' VAL . 53.8 tt0 -98.52 118.31 34.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -122.72 128.82 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.42 -0.8 . . . . 0.0 109.467 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.649 ' HB ' HG23 ' A' ' 507' ' ' VAL . 5.4 mp -121.39 115.92 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.972 -0.455 . . . . 0.0 110.224 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -71.05 161.41 31.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.46 ' HA ' ' NE2' ' A' ' 509' ' ' GLN . . . -57.36 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.121 -0.987 . . . . 0.0 110.298 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -48.43 -19.8 0.35 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.036 -1.04 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . 0.677 ' NH1' ' HB3' ' A' ' 442' ' ' ALA . 99.8 mtt180 -78.22 -10.64 59.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.625 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 60.9 ttt-85 -55.11 -25.51 31.99 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 111.827 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 77.9 p -59.06 -41.92 89.1 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.989 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -64.95 -41.54 95.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.566 -0.709 . . . . 0.0 109.541 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 38.7 ttm -58.0 -36.6 72.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.588 -0.695 . . . . 0.0 110.536 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -60.89 -40.62 93.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -0.82 . . . . 0.0 109.869 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 52.2 mtt -62.79 -40.05 96.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.622 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.413 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 65.0 pttt -117.52 -158.3 0.7 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.165 -0.959 . . . . 0.0 110.995 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.413 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 94.8 mm-40 46.15 88.83 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.452 -0.78 . . . . 0.0 112.118 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -116.75 26.28 9.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -107.7 -9.82 15.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 111.449 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -11.39 3.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 111.909 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -173.58 55.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 5.7 t -62.27 -18.48 61.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.318 -0.864 . . . . 0.0 109.921 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 486' ' ' LEU . . . 163.81 -21.08 0.15 Allowed Glycine 0 N--CA 1.501 2.986 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.51 71.31 3.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.029 -1.277 . . . . 0.0 110.014 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 484' ' ' GLY . 0.1 OUTLIER -86.77 -82.96 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.398 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.887 HG22 HG23 ' A' ' 488' ' ' THR . 34.5 mm -145.23 -86.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.147 . . . . 0.0 110.322 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 499' ' ' PHE . 69.7 p -96.33 47.78 1.08 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -111.65 59.84 0.35 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.478 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 79.2 ttt180 -143.98 -61.44 0.39 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.438 -1.037 . . . . 0.0 108.908 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -110.71 -31.01 7.35 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.382 0.611 . . . . 0.0 110.558 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -35.92 82.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.306 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.492 ' CD1' ' HA2' ' A' ' 489' ' ' GLY . 7.1 mt -91.95 -26.46 18.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.332 -0.855 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 41.7 tp -104.55 -41.64 5.65 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.66 -8.68 18.74 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.972 -1.08 . . . . 0.0 113.733 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 86.6 -16.36 46.0 Favored Glycine 0 N--CA 1.503 3.103 0 O-C-N 120.674 -1.267 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 66.5 mtt -65.83 -178.52 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.197 -1.178 . . . . 0.0 109.429 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.38 156.49 22.41 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.177 -0.952 . . . . 0.0 110.644 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.956 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -113.66 149.06 35.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.855 -0.528 . . . . 0.0 109.726 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -47.09 104.67 0.42 Allowed Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 121.531 -0.731 . . . . 0.0 110.575 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 529' ' ' ASN . 55.3 Cg_endo -76.72 111.89 3.34 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.25 1.131 . . . . 0.0 110.422 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 174.42 34.64 0.04 OUTLIER Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.824 ' OG ' HD12 ' A' ' 487' ' ' ILE . 14.5 m -99.35 -177.21 3.52 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.331 1.063 . . . . 0.0 113.461 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.824 ' HB ' HG12 ' A' ' 463' ' ' VAL . 52.4 m -120.48 128.79 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 464' ' ' GLN . 37.4 t -116.45 131.79 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.911 0.863 . . . . 0.0 112.726 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 533' ' ' LEU . 39.6 mt -129.71 113.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.947 -1.096 . . . . 0.0 108.121 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 534' ' ' ILE . 10.6 p -114.93 105.21 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.883 -1.136 . . . . 0.0 111.9 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.405 ' OD2' HG11 ' A' ' 449' ' ' VAL . 83.5 m-20 -85.48 124.17 31.75 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 468' ' ' ALA . 9.3 tp-100 -160.1 125.78 4.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -91.4 -31.82 9.28 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -83.15 -164.08 0.83 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.02 -5.67 3.09 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.279 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.89 -39.14 79.92 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.126 -0.984 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.9 m -87.29 -17.34 32.71 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.559 -0.713 . . . . 0.0 111.733 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 550' ' ' MET . 59.7 tp -73.52 -41.8 62.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.43 -0.794 . . . . 0.0 109.871 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.2 mttt -74.54 -43.06 57.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.527 -0.733 . . . . 0.0 111.888 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.4 OUTLIER -61.05 -44.55 97.22 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.971 -1.081 . . . . 0.0 110.954 -178.298 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 97.4 m -60.16 -42.1 94.22 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.983 -1.073 . . . . 0.0 109.508 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.492 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.41 -38.35 77.21 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.797 -0.564 . . . . 0.0 109.619 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.9 m -61.42 -36.33 80.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.303 -0.873 . . . . 0.0 108.993 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 521' ' ' LEU . 0.2 OUTLIER -68.36 -38.29 81.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.8 -0.563 . . . . 0.0 109.984 178.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.627 HD11 HG11 ' A' ' 505' ' ' VAL . 0.5 OUTLIER -67.68 -21.29 65.35 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.15 -0.969 . . . . 0.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 5.7 t0 -46.44 -63.33 1.03 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.37 -0.831 . . . . 0.0 111.198 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.6 -48.74 79.36 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 529' ' ' ASN . . . -53.49 -29.75 37.66 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.75 -0.853 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -46.42 -25.41 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.625 -0.672 . . . . 0.0 112.767 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -59.02 -42.91 91.31 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.78 -35.74 0.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.286 -0.884 . . . . 0.0 110.856 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.639 ' HB3' ' HB1' ' A' ' 525' ' ' ALA . 41.1 t-20 -79.77 103.14 9.47 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 529' ' ' ASN . 16.4 m -149.45 125.86 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.71 -1.196 . . . . 0.0 113.08 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.508 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.7 OUTLIER 176.23 100.2 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.462 ' N ' ' HB3' ' A' ' 432' ' ' SER . 95.5 t -107.47 109.86 29.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.629 1.204 . . . . 0.0 109.989 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.754 HD21 ' CG1' ' A' ' 423' ' ' VAL 0.306 4.3 tt -114.45 115.58 27.51 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 103.028 -2.952 . . . . 0.0 103.028 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 507' ' ' VAL . 0.5 OUTLIER -134.48 129.65 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 117.995 -1.482 . . . . 0.0 111.841 -177.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 68.1 p -100.87 -163.58 1.03 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -155.6 165.62 36.02 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.21 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 4.4 p -132.94 16.14 4.23 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.38 42.96 0.31 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -96.5 -0.04 49.53 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.745 -0.856 . . . . 0.0 112.182 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -46.07 -32.06 2.65 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.161 -0.962 . . . . 0.0 111.496 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 t -131.49 162.59 29.89 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.463 -0.773 . . . . 0.0 109.377 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.69 31.71 58.0 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -61.91 -46.53 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.561 -0.964 . . . . 0.0 110.758 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.3 -38.19 94.78 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 5.6 t -63.13 -33.73 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.816 -0.814 . . . . 0.0 109.686 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.49 -37.11 80.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.598 -0.689 . . . . 0.0 110.293 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.97 -41.02 97.67 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.461 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 87.7 mmm -65.51 -32.97 74.85 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.377 -0.827 . . . . 0.0 108.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -54.11 -54.76 35.04 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.597 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.492 ' CG ' HD11 ' A' ' 519' ' ' LEU . 65.9 ttp -59.11 -43.22 91.89 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.16 -0.962 . . . . 0.0 110.439 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -62.26 -32.36 73.06 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.424 -0.798 . . . . 0.0 112.133 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.1 -13.54 61.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.375 -0.828 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.555 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -72.8 6.91 2.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 112.664 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 140.7 -17.69 2.82 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.87 -1.157 . . . . 0.0 110.967 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 81.5 t -91.2 114.51 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.155 -1.203 . . . . 0.0 110.303 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -166.69 128.5 1.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.472 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 557' ' ' THR . 7.9 t -80.98 127.92 33.11 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.423 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.96 -91.55 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 0.0 111.06 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -158.74 -81.77 0.05 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.041 -1.037 . . . . 0.0 110.982 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -75.44 -22.61 57.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 111.064 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -132.14 158.05 42.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.289 -0.882 . . . . 0.0 110.267 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 152.34 -149.96 21.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -97.35 26.22 23.83 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -95.14 -25.19 16.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.407 -1.055 . . . . 0.0 110.665 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -91.58 -5.1 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.348 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.72 71.79 2.58 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.067 -1.021 . . . . 0.0 109.875 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 568' ' ' ALA . 41.4 Cg_endo -67.95 -24.03 40.06 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.682 1.359 . . . . 0.0 111.34 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 567' ' ' PRO . . . 177.5 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.234 -0.916 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.137 -179.433 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 71.2 m -59.15 -35.58 73.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.562 -0.711 . . . . 0.0 109.799 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.21 96.94 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 384' ' ' ILE . 9.1 tp -93.41 133.9 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.475 -1.015 . . . . 0.0 110.613 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.94 165.4 18.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.706 -0.621 . . . . 0.0 110.392 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 70.9 t -107.21 126.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.644 -0.66 . . . . 0.0 109.311 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.76 128.43 45.86 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.652 -0.655 . . . . 0.0 109.813 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -94.31 12.83 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.076 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -72.57 -10.28 59.6 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.52 -0.738 . . . . 0.0 111.501 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.31 -39.71 87.95 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.6 m -64.24 -42.57 96.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.477 -0.764 . . . . 0.0 109.946 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 433' ' ' LEU . 86.5 t -67.79 -34.41 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.784 -0.572 . . . . 0.0 110.621 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -61.12 -48.09 83.24 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.296 -0.877 . . . . 0.0 111.349 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.21 -38.89 78.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.45 -0.782 . . . . 0.0 110.458 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.743 ' CD2' HD11 ' A' ' 399' ' ' ILE . 10.0 tt -61.86 -39.15 90.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.751 -0.593 . . . . 0.0 110.507 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 60.6 m -63.17 -40.35 97.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.747 -0.596 . . . . 0.0 111.49 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.42 -41.8 97.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.333 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.3 -42.39 93.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.618 -0.676 . . . . 0.0 111.536 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.4 OUTLIER -63.08 -39.01 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 120.906 -1.121 . . . . 0.0 108.761 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.583 ' CG ' HD11 ' A' ' 435' ' ' ILE . 42.5 mtp -65.37 -28.47 69.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.674 -0.641 . . . . 0.0 110.057 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.37 -29.87 70.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.742 ' O ' HG12 ' A' ' 405' ' ' VAL . 55.1 tt0 -92.8 -13.58 28.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 0.0 109.43 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -66.18 -36.91 84.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.651 -0.656 . . . . 0.0 109.458 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -116.81 18.85 14.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.791 -1.193 . . . . 0.0 109.919 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.8 p -61.81 118.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.493 -0.754 . . . . 0.0 110.007 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.2 m -53.91 105.08 0.12 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 405' ' ' VAL . 44.8 t -106.53 132.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.612 -0.68 . . . . 0.0 109.548 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -91.95 140.68 24.83 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.552 -0.718 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.1 -23.37 33.88 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.264 1.139 . . . . 0.0 110.265 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -58.68 -43.0 89.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.322 -0.862 . . . . 0.0 109.395 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 67.38 0.99 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 91.4 p -52.66 117.4 2.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.241 -0.912 . . . . 0.0 111.525 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 407' ' ' VAL . 8.7 p -62.58 149.94 87.4 Favored Pre-proline 0 N--CA 1.495 1.823 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -61.88 140.47 85.41 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.068 1.036 . . . . 0.0 110.095 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.438 ' NH2' ' HB2' ' A' ' 439' ' ' GLN . 42.2 mtm180 -106.44 -12.77 15.54 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.839 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 420' ' ' SER . 38.5 p -103.26 10.77 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.388 -1.445 . . . . 0.0 108.792 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -62.68 -87.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.47 78.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.652 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' A' ' 399' ' ' ILE . 78.7 m-85 -108.32 -25.38 11.04 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 120.756 2.278 . . . . 0.0 109.184 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 416' ' ' THR . 3.7 t -72.94 -40.75 65.14 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -64.12 -35.87 82.16 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 419' ' ' TYR . . . -60.0 -39.13 84.71 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.338 0.589 . . . . 0.0 109.877 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.892 ' HA ' HD23 ' A' ' 426' ' ' LEU . 57.3 t -66.84 -45.6 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 0.0 111.03 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 85.9 p -60.08 -41.51 92.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.142 -0.974 . . . . 0.0 111.577 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.88 -47.02 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.404 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -50.55 -32.56 18.89 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.61 -0.682 . . . . 0.0 112.0 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.18 71.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 0.0 109.278 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -61.08 -29.46 69.76 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -64.73 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.569 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -173.65 -51.12 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.503 -1.373 . . . . 0.0 111.346 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 50.1 Cg_endo -86.31 110.11 0.98 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 O-C-N 122.698 0.841 . . . . 0.0 110.03 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.568 ' HA ' HD11 ' A' ' 426' ' ' LEU . 2.8 m -91.19 99.78 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 111.089 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.825 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 7.4 tp -156.79 90.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.619 -0.676 . . . . 0.0 111.017 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -138.43 166.58 23.9 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.772 -0.58 . . . . 0.0 110.979 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.583 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.1 pp -122.17 125.36 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.631 -0.668 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.743 ' CG2' HG21 ' A' ' 423' ' ' VAL . 38.2 t -128.21 153.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.012 -1.055 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 30.9 t -132.92 139.09 47.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.21 -0.931 . . . . 0.0 111.735 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 415' ' ' ARG . . . -141.57 143.85 13.63 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . 0.438 ' HB2' ' NH2' ' A' ' 415' ' ' ARG . 27.1 mt-30 -143.29 55.25 1.36 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.387 -1.066 . . . . 0.0 110.279 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 151.73 140.31 3.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.47 79.66 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.21 -14.01 60.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.964 . . . . 0.0 112.014 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.35 89.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.02 -1.05 . . . . 0.0 110.883 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -75.79 -31.05 56.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . 0.412 ' NE2' HG21 ' A' ' 416' ' ' THR . 51.0 tt0 -67.17 -40.39 86.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.699 -0.883 . . . . 0.0 111.049 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.572 ' O ' HG12 ' A' ' 449' ' ' VAL . 51.9 mtt-85 -64.14 -41.84 97.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 73.5 tt0 -72.65 -29.51 63.5 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -61.25 -46.13 91.66 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.394 -0.816 . . . . 0.0 110.463 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -62.78 -31.22 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.317 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -58.81 -34.19 71.22 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.93 -30.18 70.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.2 -0.938 . . . . 0.0 108.619 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.06 -37.07 83.58 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.84 ' CG2' HG21 ' A' ' 465' ' ' ILE . 37.0 t -60.59 -29.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.87 -39.43 87.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -23.97 66.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.654 -0.654 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -82.08 -21.75 36.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -67.48 -41.56 84.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.852 -0.53 . . . . 0.0 110.297 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -71.77 -34.44 69.44 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.089 -1.007 . . . . 0.0 110.374 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -77.71 6.99 6.31 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.464 -0.773 . . . . 0.0 111.702 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.85 24.12 72.81 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.558 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.7 ttm180 -124.53 129.17 50.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.609 -0.936 . . . . 0.0 110.835 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.594 ' C ' HD11 ' A' ' 487' ' ' ILE . 94.1 mt-10 -92.54 161.41 14.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.671 ' CG2' HG13 ' A' ' 453' ' ' VAL . 17.2 m -145.31 157.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 486' ' ' LEU . 57.6 tt0 -103.13 124.68 49.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.795 -0.566 . . . . 0.0 109.726 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.84 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -129.09 132.17 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.048 . . . . 0.0 109.31 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.647 HG23 ' HD3' ' A' ' 471' ' ' ARG . 87.2 mt -125.11 121.4 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.062 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -79.75 163.0 24.82 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.69 -159.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.337 -0.852 . . . . 0.0 109.949 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.53 -16.08 0.33 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.643 -1.286 . . . . 0.0 111.021 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -72.16 -14.53 61.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.975 -1.078 . . . . 0.0 110.218 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.647 ' HD3' HG23 ' A' ' 466' ' ' ILE . 49.1 ttp180 -57.47 -30.92 65.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.161 -0.962 . . . . 0.0 110.877 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 85.1 p -55.46 -44.3 76.27 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.343 -0.848 . . . . 0.0 109.66 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -65.03 -37.99 89.41 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -36.46 77.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.715 -0.616 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -59.23 -38.1 79.15 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.195 -0.941 . . . . 0.0 109.938 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 97.8 mtp -60.22 -38.09 82.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.88 -146.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.497 -0.752 . . . . 0.0 109.772 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 47.58 78.51 0.08 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.036 -1.04 . . . . 0.0 111.853 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -117.75 10.26 13.25 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.427 ' CB ' ' HD3' ' A' ' 481' ' ' ARG . 30.1 mp0 -77.94 -4.48 47.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.971 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.688 ' C ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -175.4 17.63 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.224 -0.923 . . . . 0.0 113.278 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 481' ' ' ARG . 9.8 mp -125.44 4.86 7.64 Favored 'General case' 0 N--CA 1.508 2.438 0 CA-C-N 120.475 1.489 . . . . 0.0 112.279 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 10.3 m -74.55 35.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.385 -1.447 . . . . 0.0 112.512 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 109.08 9.78 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 O-C-N 120.669 -1.27 . . . . 0.0 110.088 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -87.82 11.7 14.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.135 -1.215 . . . . 0.0 110.385 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' A' ' 464' ' ' GLN . 3.9 mm? -53.37 -84.08 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.959 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -174.65 -69.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.87 . . . . 0.0 109.118 174.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.561 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.0 t -103.35 10.5 37.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.0 111.496 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -79.82 66.89 3.49 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 499' ' ' PHE . 66.4 ttt180 -142.78 -69.64 0.34 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.456 ' HG3' ' HG2' ' A' ' 490' ' ' ARG . 74.9 mtt180 -116.1 -19.8 10.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.248 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.745 ' HG2' HD23 ' A' ' 493' ' ' LEU . 36.2 tt0 -63.1 -39.81 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.199 -0.938 . . . . 0.0 108.487 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.745 HD23 ' HG2' ' A' ' 492' ' ' GLN . 3.2 mt -92.51 -18.34 23.29 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.132 0.491 . . . . 0.0 110.966 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 52.5 tp -104.23 -46.84 4.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.417 -0.802 . . . . 0.0 112.548 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.47 -5.72 15.09 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.26 -0.9 . . . . 0.0 113.103 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 79.0 48.15 7.16 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 491' ' ' ARG . 96.1 mmm -111.68 -179.44 3.7 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 122.118 -0.637 . . . . 0.0 109.626 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.18 149.54 35.57 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 0.0 111.28 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 490' ' ' ARG . 28.2 m-85 -131.22 149.21 52.67 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.776 0.798 . . . . 0.0 111.723 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 500' ' ' THR . 2.6 t -56.07 107.29 0.84 Allowed Pre-proline 0 N--CA 1.496 1.831 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.947 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 528' ' ' HIS . 52.5 Cg_endo -74.62 114.74 4.1 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.54 1.284 . . . . 0.0 109.435 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -174.35 30.85 0.09 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.959 ' CB ' HD13 ' A' ' 487' ' ' ILE . 86.0 p -92.7 173.25 7.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -1.089 . . . . 0.0 112.44 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.506 ' HB ' HG12 ' A' ' 463' ' ' VAL . 26.5 m -119.81 99.55 6.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.769 HG11 HD21 ' A' ' 522' ' ' LEU . 61.1 t -93.36 134.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.819 0.819 . . . . 0.0 112.071 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.754 HG22 ' HB3' ' A' ' 533' ' ' LEU . 18.5 pt -130.1 149.54 33.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.76 HG22 ' HG2' ' A' ' 509' ' ' GLN . 5.2 p -142.07 98.81 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.435 1.112 . . . . 0.0 110.785 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -83.91 108.94 17.21 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.76 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.6 mm-40 -133.9 114.97 13.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -73.76 -32.39 59.23 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.59 ' OE1' HD21 ' A' ' 513' ' ' LEU . 96.8 mt-10 -97.31 175.33 6.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.46 -7.76 13.42 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.81 -0.556 . . . . 0.0 111.027 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 514' ' ' SER . 4.3 pp -67.62 -37.95 83.24 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.212 -0.93 . . . . 0.0 111.254 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 513' ' ' LEU . 2.3 p -93.24 -14.77 26.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 0.0 111.199 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.918 ' O ' HD22 ' A' ' 519' ' ' LEU . 59.2 tp -70.08 -48.38 57.98 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.01 -1.056 . . . . 0.0 108.424 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.97 -42.44 89.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.001 -0.437 . . . . 0.0 111.667 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -57.9 -46.93 84.2 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.212 -0.93 . . . . 0.0 111.111 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 98.6 m -62.31 -45.94 90.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.301 -0.874 . . . . 0.0 109.421 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -55.3 -28.56 54.36 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.632 -178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 14.8 m -64.15 -28.24 69.63 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 39.3 tp -80.93 -34.03 33.61 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.523 -0.736 . . . . 0.0 109.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.769 HD21 HG11 ' A' ' 505' ' ' VAL . 4.3 mm? -58.01 -31.86 67.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.8 -63.89 0.86 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.951 -0.468 . . . . 0.0 111.62 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.5 52.04 Favored Glycine 0 N--CA 1.499 2.886 0 O-C-N 120.867 -1.146 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -63.09 -39.91 96.1 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.105 -1.232 . . . . 0.0 113.284 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.68 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -58.13 -26.2 62.37 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.083 -1.011 . . . . 0.0 112.128 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -54.89 -30.36 58.02 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 501' ' ' PRO . 7.0 t60 -106.65 -128.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.389 -0.82 . . . . 0.0 110.439 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.412 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.7 OUTLIER -86.71 67.7 9.92 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.721 -1.237 . . . . 0.0 111.974 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 525' ' ' ALA . 2.8 t -133.86 163.83 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.66 -1.275 . . . . 0.0 110.253 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 431' ' ' PRO . 2.9 mm-40 -163.81 165.0 23.41 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 33.1 t -109.95 105.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.427 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.4 OUTLIER -103.75 115.07 29.81 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 507' ' ' VAL . 7.1 pt -136.0 164.97 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 117.854 -1.538 . . . . 0.0 113.912 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 436' ' ' VAL . 70.1 p -127.67 -168.3 1.87 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.97 169.08 25.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.435 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -140.85 17.18 2.31 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.784 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -155.27 33.55 0.65 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.563 HE22 HD13 ' A' ' 435' ' ' ILE . 57.0 tt0 -97.04 -0.29 47.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.683 -0.893 . . . . 0.0 111.66 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -51.36 -43.88 61.95 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.719 -1.238 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 77.2 p -119.59 161.12 21.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 57.93 29.06 61.53 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.461 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -59.85 -45.58 91.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.291 -1.123 . . . . 0.0 110.615 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.81 -36.82 93.32 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 35.5 m -63.76 -35.72 81.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.033 -0.686 . . . . 0.0 110.788 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.601 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -58.86 -39.15 80.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.509 -0.744 . . . . 0.0 110.355 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.02 -40.19 94.84 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 48.3 ttp -63.96 -30.35 71.43 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.49 -53.97 31.9 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.457 ' HA ' HD23 ' A' ' 519' ' ' LEU . 12.4 ttp -57.76 -42.96 85.05 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -0.837 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.18 -31.68 67.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.476 -0.765 . . . . 0.0 111.669 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -68.43 -31.87 71.51 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.304 -0.873 . . . . 0.0 109.95 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.81 21.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.945 -0.472 . . . . 0.0 111.465 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 107.43 25.61 5.97 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.657 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.92 110.76 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.561 -0.964 . . . . 0.0 109.961 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -170.96 133.09 0.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.519 -0.738 . . . . 0.0 110.822 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 557' ' ' THR . 8.9 t -116.76 122.28 44.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -72.87 -80.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.276 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 559' ' ' ARG . 8.7 tpm_? -135.13 -78.67 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.589 -0.694 . . . . 0.0 109.157 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -97.24 -23.39 16.19 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.535 -0.728 . . . . 0.0 110.113 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -147.82 129.61 15.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -112.98 35.68 4.47 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 77.62 16.48 80.14 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.49 -24.62 66.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -1.127 . . . . 0.0 110.146 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -88.12 -4.7 58.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.533 -0.73 . . . . 0.0 111.627 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.548 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -168.3 54.88 0.27 Allowed Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.257 -0.902 . . . . 0.0 110.174 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 37.8 Cg_endo -87.71 -5.44 7.08 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 122.946 0.972 . . . . 0.0 110.636 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -94.16 -12.99 27.2 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.408 -0.808 . . . . 0.0 111.055 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.904 -1.045 . . . . 0.0 109.407 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.244 0.545 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 58.5 m -133.38 158.64 42.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.633 -0.667 . . . . 0.0 109.96 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 97.0 -21.8 44.24 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 92.8 mt -107.01 -21.81 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -1.029 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -114.18 51.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.175 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 388' ' ' ASP . 7.4 p -109.03 133.92 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.38 0.609 . . . . 0.0 109.935 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.5 mm? -98.21 4.14 48.91 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.451 -0.78 . . . . 0.0 111.384 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 386' ' ' VAL . 43.3 t0 -60.31 -45.32 93.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.169 -0.957 . . . . 0.0 110.891 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -130.25 -3.91 4.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.293 -0.879 . . . . 0.0 111.999 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.29 -41.32 98.4 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.115 -0.991 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 61.4 m -59.81 -43.68 94.37 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.57 -0.706 . . . . 0.0 110.206 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 69.4 t -65.76 -35.53 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.302 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -61.93 -46.4 89.49 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.289 -0.882 . . . . 0.0 110.59 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.19 80.14 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.696 0.76 . . . . 0.0 109.161 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 1.3 tt -61.96 -39.39 91.98 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 400' ' ' MET . 68.3 m -61.15 -36.43 79.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.072 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -63.87 -44.48 92.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.085 -1.009 . . . . 0.0 111.46 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.84 -46.09 76.18 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.182 -0.949 . . . . 0.0 111.861 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 395' ' ' LEU . 78.6 mt -64.84 -42.74 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.812 . . . . 0.0 109.99 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 396' ' ' SER . 40.4 mmm -62.22 -31.76 72.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.874 -0.516 . . . . 0.0 109.65 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -58.53 -34.09 70.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.377 -0.827 . . . . 0.0 109.154 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.609 ' O ' HG12 ' A' ' 405' ' ' VAL . 95.6 mt-30 -90.57 -14.64 32.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.22 -39.27 89.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -116.85 18.8 14.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.945 -1.097 . . . . 0.0 110.555 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.693 HG11 ' CZ ' ' A' ' 415' ' ' ARG . 3.5 p -51.34 117.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.538 -0.726 . . . . 0.0 109.177 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 25.4 m -52.17 98.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.499 0.666 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 413' ' ' VAL . 8.4 p -109.42 133.77 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.755 -0.59 . . . . 0.0 109.906 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -92.19 140.28 24.43 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 111.185 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.91 -28.17 42.66 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.254 1.133 . . . . 0.0 110.22 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.9 -33.29 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.826 0.822 . . . . 0.0 109.861 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.17 0.9 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 2.4 m -57.39 118.53 5.24 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.507 -0.746 . . . . 0.0 110.675 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.1 p -71.68 110.65 8.08 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.757 -0.589 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.03 139.18 29.46 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 O-C-N 123.066 1.035 . . . . 0.0 110.31 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.693 ' CZ ' HG11 ' A' ' 405' ' ' VAL . 23.7 ptt85 -168.85 60.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.672 -0.642 . . . . 0.0 110.738 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 9.7 t -65.48 -34.96 79.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -67.29 -7.05 21.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.689 -0.632 . . . . 0.0 110.953 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.75 -43.73 98.53 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.613 ' CB ' HG13 ' A' ' 436' ' ' VAL . 1.1 m-85 -91.64 -3.36 56.44 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.857 -1.378 . . . . 0.0 108.938 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.422 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 33.8 p -77.96 -39.04 43.8 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 425' ' ' VAL . 25.3 t70 -77.6 -43.55 31.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.471 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -62.16 -49.82 74.3 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.666 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.866 ' HA ' HD23 ' A' ' 426' ' ' LEU . 78.7 t -71.26 -41.42 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.922 -0.487 . . . . 0.0 111.861 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -58.92 -41.7 87.94 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.03 -1.044 . . . . 0.0 111.242 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 421' ' ' ASP . 84.4 t -64.47 -45.42 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.336 -0.852 . . . . 0.0 110.189 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.866 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -56.17 -35.71 67.52 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.54 -0.725 . . . . 0.0 111.993 -177.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.92 81.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.062 -1.024 . . . . 0.0 108.593 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.88 -30.59 71.6 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -63.68 -89.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.424 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.05 -60.66 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.449 -1.407 . . . . 0.0 109.565 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 45.5 Cg_endo -71.56 113.28 3.58 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 N-CA-C 108.242 -1.484 . . . . 0.0 108.242 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.511 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 15.2 m -108.96 117.28 33.79 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.897 0.856 . . . . 0.0 112.039 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.539 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -173.22 97.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -138.87 172.54 12.7 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.203 -0.935 . . . . 0.0 112.462 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 435' ' ' ILE . 0.2 OUTLIER -124.81 136.95 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.381 0.61 . . . . 0.0 109.703 178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 423' ' ' VAL . 60.4 t -141.58 152.9 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 109.629 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.1 p -139.81 149.81 43.95 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.868 . . . . 0.0 110.752 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -96.63 159.94 21.76 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -149.23 22.96 0.94 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.618 -0.93 . . . . 0.0 110.835 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -162.5 -118.13 0.45 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -75.89 131.33 11.78 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -103.47 -15.02 16.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.293 -1.122 . . . . 0.0 111.291 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -71.55 -43.94 65.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.42 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.08 -28.76 71.22 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -63.84 -40.55 96.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.638 -0.919 . . . . 0.0 109.98 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.558 ' O ' HG12 ' A' ' 449' ' ' VAL . 83.3 mtt85 -64.31 -41.18 96.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.559 -0.713 . . . . 0.0 110.418 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 50.2 mt-10 -70.07 -29.28 66.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.087 -1.008 . . . . 0.0 110.222 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -62.92 -53.09 59.41 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.713 HG22 HD12 ' A' ' 506' ' ' ILE . 13.6 p -57.77 -30.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.051 -1.031 . . . . 0.0 108.626 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.11 -26.52 68.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.71 -35.33 80.2 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.866 -1.146 . . . . 0.0 108.292 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 455' ' ' MET . 96.0 mt -63.93 -31.38 72.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.495 -0.753 . . . . 0.0 109.009 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.944 HG13 ' CG2' ' A' ' 463' ' ' VAL . 58.1 t -58.48 -38.36 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.248 -0.908 . . . . 0.0 108.948 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 48.0 mtt -63.49 -35.82 81.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.495 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 452' ' ' LEU . 64.7 ttp -54.78 -26.24 33.25 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.366 -0.834 . . . . 0.0 109.587 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.51 -22.84 32.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.667 -0.646 . . . . 0.0 110.497 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -62.02 -46.09 90.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.373 -0.829 . . . . 0.0 108.989 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.0 -31.82 70.93 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.56 -0.84 21.8 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.41 32.03 82.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.527 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 22.8 ttt85 -130.79 122.15 26.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.553 -0.969 . . . . 0.0 110.868 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 487' ' ' ILE . 95.6 mt-10 -71.71 162.78 28.93 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.944 ' CG2' HG13 ' A' ' 453' ' ' VAL . 28.4 m -138.45 168.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.999 -1.063 . . . . 0.0 111.588 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.753 ' HB2' HD11 ' A' ' 486' ' ' LEU . 59.1 tt0 -120.45 115.78 24.16 Favored 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.952 HD11 HD13 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -131.11 138.83 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.508 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.585 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.2 mt -130.91 125.39 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.0 109.716 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.4 164.76 25.19 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 509' ' ' GLN . . . -58.7 -161.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.693 -0.629 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -46.55 -21.44 0.18 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.175 -0.953 . . . . 0.0 112.043 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -75.37 -7.62 54.51 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.406 -0.809 . . . . 0.0 112.397 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.579 ' CD ' HG23 ' A' ' 466' ' ' ILE . 77.6 ttt-85 -57.5 -25.53 59.94 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.784 -1.198 . . . . 0.0 110.904 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.1 p -59.14 -41.98 89.57 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -62.44 -41.16 98.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.79 69.66 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.87 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -58.31 -39.75 80.22 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.081 . . . . 0.0 109.171 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 69.1 mtm -60.92 -39.33 89.0 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.793 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -122.97 -140.7 0.32 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.354 -0.841 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 48.52 88.41 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.791 -1.193 . . . . 0.0 112.53 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -136.81 28.53 2.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.29 -0.881 . . . . 0.0 109.671 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -108.99 -9.24 15.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.609 ' HB2' HD23 ' A' ' 482' ' ' LEU . 3.0 mtt180 -133.3 -10.45 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 112.418 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.952 HD13 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -168.92 61.99 0.06 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.751 -1.218 . . . . 0.0 113.062 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 44.2 t -89.36 48.63 1.64 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.746 -1.221 . . . . 0.0 110.575 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 100.03 2.5 55.98 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.986 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -91.05 43.31 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.122 1.461 . . . . 0.0 110.273 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.753 HD11 ' HB2' ' A' ' 464' ' ' GLN . 0.2 OUTLIER -58.73 -81.92 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.966 HG22 HG23 ' A' ' 488' ' ' THR . 0.2 OUTLIER -173.37 -73.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.966 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 70.5 p -103.31 25.47 9.52 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.82 94.81 0.53 Allowed Glycine 0 N--CA 1.496 2.639 0 O-C-N 121.549 -0.72 . . . . 0.0 111.835 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -144.35 -111.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 495' ' ' GLU . 28.4 mmt180 -103.2 -32.73 9.47 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 121.002 -1.061 . . . . 0.0 108.597 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -47.84 -22.45 0.56 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.528 -0.733 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.04 -58.96 4.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.318 -0.864 . . . . 0.0 111.317 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.71 5.41 26.72 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.974 -1.079 . . . . 0.0 111.994 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 491' ' ' ARG . 59.0 mm-40 -84.66 -5.93 59.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.977 -1.077 . . . . 0.0 113.069 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 95.82 -11.95 67.65 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.715 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.44 -176.69 0.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.128 -1.219 . . . . 0.0 108.98 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -112.41 170.43 8.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.352 -0.842 . . . . 0.0 109.637 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -111.41 153.02 26.68 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.684 ' H ' HG21 ' A' ' 488' ' ' THR . 52.2 m -81.98 120.71 78.08 Favored Pre-proline 0 N--CA 1.484 1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 34.7 Cg_endo -61.84 138.91 77.05 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.407 1.214 . . . . 0.0 111.291 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 149.6 -7.38 0.81 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.683 ' OG ' HG21 ' A' ' 487' ' ' ILE . 48.7 m -85.25 160.25 19.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.302 . . . . 0.0 112.209 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.558 ' HB ' HG12 ' A' ' 463' ' ' VAL . 86.4 m -106.0 163.27 12.89 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.489 HG11 HD13 ' A' ' 522' ' ' LEU . 59.7 t -151.14 121.7 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.878 -1.139 . . . . 0.0 111.312 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.713 HD12 HG22 ' A' ' 449' ' ' VAL . 6.2 pt -136.2 112.11 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 1.016 HG12 HG22 ' A' ' 534' ' ' ILE . 7.8 p -114.48 104.33 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 122.6 1.191 . . . . 0.0 113.06 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.573 ' OD2' HG11 ' A' ' 449' ' ' VAL . 90.4 m-20 -83.98 124.96 31.59 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.614 ' CD ' HD13 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -159.36 126.69 4.75 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -176.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -85.95 -41.86 6.97 Favored Glycine 0 N--CA 1.505 3.258 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -72.04 142.55 49.27 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.68 -12.78 20.71 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.095 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.99 -33.64 76.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 36.3 t -81.14 -23.36 38.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.847 -0.533 . . . . 0.0 111.314 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.636 HD21 ' HG2' ' A' ' 550' ' ' MET . 57.0 tp -65.85 -47.34 75.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.177 -0.952 . . . . 0.0 110.417 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.6 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 55.1 mtmt -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.673 -0.642 . . . . 0.0 111.586 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -58.81 -51.2 71.02 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.271 -0.893 . . . . 0.0 110.599 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 73.9 m -58.07 -41.07 82.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.766 HD12 HG21 ' A' ' 555' ' ' VAL . 0.3 OUTLIER -59.5 -38.09 80.0 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.041 -0.412 . . . . 0.0 111.853 -178.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 47.0 p -64.71 -35.68 81.83 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.793 -1.192 . . . . 0.0 110.651 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.6 OUTLIER -70.35 -38.25 74.8 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.313 1.054 . . . . 0.0 108.19 177.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 530' ' ' VAL . 38.6 tp -62.98 -28.01 69.8 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.156 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -47.21 -63.12 1.12 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -51.4 58.76 Favored Glycine 0 N--CA 1.502 3.042 0 O-C-N 120.58 -1.325 . . . . 0.0 110.018 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -60.41 -30.22 69.47 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -1.036 . . . . 0.0 110.306 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -64.08 -20.61 66.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.757 -0.59 . . . . 0.0 112.315 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -37.76 -26.34 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 2.6 m170 -147.69 -79.93 0.15 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 120.634 1.561 . . . . 0.0 114.304 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.438 ' HB2' ' N ' ' A' ' 502' ' ' GLY . 82.4 m-20 -86.26 60.59 6.32 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 522' ' ' LEU . 14.9 p -117.91 133.49 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.858 -1.151 . . . . 0.0 113.362 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.405 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 94.3 mt-30 -122.42 129.12 51.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 70.7 t -115.09 117.95 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.123 0.964 . . . . 0.0 112.049 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 423' ' ' VAL . 9.3 mp -114.33 118.43 33.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 1.016 HG22 HG12 ' A' ' 507' ' ' VAL . 9.3 pt -128.77 134.8 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 118.254 -1.378 . . . . 0.0 110.858 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.657 HG22 ' HB ' ' A' ' 436' ' ' VAL . 55.3 p -112.87 -163.46 0.85 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.41 165.24 36.27 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.646 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.501 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 6.6 p -130.17 22.17 5.27 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.876 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -168.47 35.22 0.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -95.81 -0.63 50.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . 0.915 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.6 ptt180 -47.53 -24.7 0.91 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.149 -0.969 . . . . 0.0 111.251 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.915 HG23 ' HG3' ' A' ' 540' ' ' ARG . 69.3 p -124.57 162.0 24.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 51.21 38.09 39.6 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.8 t -59.45 -45.39 91.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.665 -0.903 . . . . 0.0 110.508 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.88 -38.15 94.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 33.1 m -61.55 -32.65 72.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.745 -0.856 . . . . 0.0 109.629 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.49 -37.83 79.28 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.009 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -62.51 -40.02 95.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.765 . . . . 0.0 109.305 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.14 -31.53 72.03 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.33 -54.2 28.58 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.935 -0.478 . . . . 0.0 109.828 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 519' ' ' LEU . 79.6 mmm -57.98 -43.25 86.44 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.475 -0.766 . . . . 0.0 109.619 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.18 -31.61 70.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.756 -0.59 . . . . 0.0 110.958 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -65.82 -25.29 67.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.145 -0.972 . . . . 0.0 109.532 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.6 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -73.94 0.44 13.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.484 -0.76 . . . . 0.0 111.723 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 109.31 -14.74 33.15 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.295 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 519' ' ' LEU . 41.2 t -65.84 115.01 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.685 1.242 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -164.39 137.13 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.803 -0.561 . . . . 0.0 110.124 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 9.9 t -98.64 143.76 28.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -74.86 -79.24 0.09 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.315 -0.866 . . . . 0.0 110.496 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -143.18 -79.97 0.21 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -91.25 -20.7 21.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -119.93 156.93 29.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.341 -0.849 . . . . 0.0 111.325 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -71.24 -128.22 0.07 OUTLIER Glycine 0 N--CA 1.485 1.949 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -96.08 44.05 2.07 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -96.15 -17.83 20.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.407 -1.054 . . . . 0.0 110.6 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -91.98 -3.92 55.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 110.685 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -119.0 83.32 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 111.327 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.16 -12.77 25.77 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.564 1.297 . . . . 0.0 109.999 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -107.36 69.85 0.77 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.287 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.105 -179.859 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.304 0.573 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 4.9 m -71.03 -14.53 62.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.702 -0.624 . . . . 0.0 110.462 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 96.72 25.25 11.99 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.883 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 36.1 pt -82.13 160.1 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.332 -1.099 . . . . 0.0 110.47 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -141.83 138.03 31.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.918 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.6 t -111.63 131.63 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.541 -0.724 . . . . 0.0 109.228 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.85 120.57 38.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.077 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -145.37 158.29 43.86 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 -86.37 57.19 4.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.329 -0.857 . . . . 0.0 109.719 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.57 -37.2 86.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.731 -0.606 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.7 m -61.92 -41.72 98.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.403 -0.811 . . . . 0.0 110.473 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.681 HG11 ' HB3' ' A' ' 433' ' ' LEU . 60.5 t -70.29 -34.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.65 -0.656 . . . . 0.0 111.162 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.71 -42.77 89.41 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.876 -1.14 . . . . 0.0 109.815 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.49 73.98 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.305 -0.872 . . . . 0.0 108.737 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 426' ' ' LEU . 0.8 OUTLIER -60.51 -41.55 94.61 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.45 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 40.0 t -64.88 -39.28 93.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.432 -0.793 . . . . 0.0 111.403 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.57 -43.86 92.56 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.301 -0.874 . . . . 0.0 112.461 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -75.66 -45.72 35.47 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.823 -1.173 . . . . 0.0 112.115 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.831 HG21 ' O ' ' A' ' 435' ' ' ILE . 97.7 mt -62.87 -42.27 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.291 -0.88 . . . . 0.0 109.995 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 35.6 mtp -60.77 -31.84 71.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.665 -0.647 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.57 -22.5 66.93 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.3 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.489 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 72.5 tp60 -92.65 -20.63 20.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.097 . . . . 0.0 108.98 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.02 -30.95 70.3 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -114.99 19.25 15.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.211 -0.931 . . . . 0.0 109.857 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 405' ' ' VAL . 8.4 p -50.84 113.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.524 -0.735 . . . . 0.0 110.499 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 406' ' ' THR . 5.1 t -48.77 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.638 -0.664 . . . . 0.0 111.833 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.685 HG23 HG12 ' A' ' 413' ' ' VAL . 7.4 p -112.92 133.42 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.536 -0.728 . . . . 0.0 110.117 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -96.04 143.24 25.78 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.89 . . . . 0.0 110.044 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.85 -24.62 53.71 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 O-C-N 123.34 1.179 . . . . 0.0 110.385 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -61.28 -39.79 91.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.591 -0.693 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 66.23 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 93.4 p -50.48 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.096 -1.003 . . . . 0.0 110.313 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 407' ' ' VAL . 9.3 p -63.33 110.33 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.923 -0.485 . . . . 0.0 110.616 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.5 136.35 12.35 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 O-C-N 122.939 0.968 . . . . 0.0 110.531 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -153.67 70.14 0.83 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.503 -0.748 . . . . 0.0 110.766 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 46.3 p -65.21 -39.03 92.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' A' ' 420' ' ' SER . . . -49.86 -25.2 2.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.682 -0.636 . . . . 0.0 111.383 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -50.77 -62.25 5.42 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 121.376 -0.827 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.532 ' CG ' HG13 ' A' ' 436' ' ' VAL . 20.0 p90 -88.22 -2.7 58.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.791 -1.417 . . . . 0.0 111.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 417' ' ' ALA . 51.6 p -72.19 -39.75 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 425' ' ' VAL . 36.7 t70 -76.86 -45.66 27.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.978 -0.451 . . . . 0.0 110.571 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.477 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.0 -48.9 79.69 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.439 -0.788 . . . . 0.0 111.099 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 436' ' ' VAL . 89.3 t -68.48 -46.19 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.1 p -64.18 -33.04 74.87 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.665 -1.272 . . . . 0.0 111.039 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 421' ' ' ASP . 52.4 t -65.65 -36.17 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.695 . . . . 0.0 111.506 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.891 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 1.6 pp -70.25 -33.89 72.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 111.586 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.56 78.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.909 -1.119 . . . . 0.0 109.647 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -65.54 -33.38 75.78 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -65.29 -95.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -169.85 -61.85 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.442 -1.411 . . . . 0.0 109.452 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.26 113.85 2.08 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 109.196 -1.117 . . . . 0.0 109.196 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.79 ' O ' HD22 ' A' ' 433' ' ' LEU . 17.3 t -96.55 103.31 15.21 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.169 0.509 . . . . 0.0 111.718 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 432' ' ' SER . 0.2 OUTLIER -152.96 88.23 1.31 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.891 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -118.04 156.43 28.6 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.025 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.831 ' O ' HG21 ' A' ' 399' ' ' ILE 0.263 62.2 mt -122.61 127.3 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.706 HG21 HG21 ' A' ' 423' ' ' VAL . 45.2 t -141.42 153.79 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.954 -1.091 . . . . 0.0 111.196 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.3 p -136.26 143.06 44.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.72 129.6 9.95 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.52 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.23 -23.69 10.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.886 -0.773 . . . . 0.0 109.841 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -165.14 160.28 33.56 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.43 46.47 94.29 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -61.78 -35.37 77.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 111.029 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.58 -45.63 92.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.294 -0.879 . . . . 0.0 111.157 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.35 -27.85 72.15 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -59.82 -41.06 90.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -1.014 . . . . 0.0 110.277 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.563 ' CD ' ' HB1' ' A' ' 467' ' ' ALA . 54.4 mtm180 -67.48 -38.5 84.48 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.364 -0.835 . . . . 0.0 110.996 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 45.5 tt0 -71.64 -31.85 67.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.271 -0.893 . . . . 0.0 111.553 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.74 -53.61 44.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.067 -1.021 . . . . 0.0 110.41 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.647 ' CG2' HD12 ' A' ' 506' ' ' ILE . 11.7 p -55.24 -30.42 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.038 -1.039 . . . . 0.0 109.218 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.37 -27.95 68.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.15 -34.95 79.6 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.34 -36.07 79.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.945 HG13 ' CG2' ' A' ' 463' ' ' VAL . 95.2 t -58.28 -29.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 91.7 mtp -67.2 -39.68 86.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -55.39 -27.89 50.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.306 -0.871 . . . . 0.0 109.893 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.72 40.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.571 -0.706 . . . . 0.0 110.84 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.8 -43.34 88.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.438 -0.789 . . . . 0.0 109.514 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -68.59 -30.43 69.17 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.458 0.647 . . . . 0.0 109.841 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -73.68 -1.09 17.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.655 -0.653 . . . . 0.0 111.641 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 79.86 18.56 72.36 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 120.876 -1.14 . . . . 0.0 110.612 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.81 149.94 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.347 -1.09 . . . . 0.0 111.093 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -94.96 -178.51 4.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.945 ' CG2' HG13 ' A' ' 453' ' ' VAL . 7.3 m -148.0 170.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.926 -1.109 . . . . 0.0 110.805 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -119.35 128.37 54.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.719 HG21 ' CG2' ' A' ' 453' ' ' VAL . 11.2 pt -134.55 141.53 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.251 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.561 HG23 ' HD3' ' A' ' 471' ' ' ARG . 85.8 mt -132.7 124.71 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.595 -0.691 . . . . 0.0 109.719 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' A' ' 471' ' ' ARG . . . -79.84 165.9 22.25 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 509' ' ' GLN . . . -60.54 -159.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -49.08 -20.86 0.61 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.61 -1.307 . . . . 0.0 111.334 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.39 -8.98 58.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.456 -0.777 . . . . 0.0 111.353 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.573 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 64.5 ttp85 -59.44 -23.11 62.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.909 -1.119 . . . . 0.0 110.452 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 12.5 t -59.64 -44.13 93.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.391 -0.818 . . . . 0.0 109.527 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -60.89 -45.22 95.46 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 34.0 ttm -58.31 -36.0 72.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.637 -0.664 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -59.22 -40.31 85.45 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.157 -0.965 . . . . 0.0 111.331 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 7.5 ttm -61.59 -36.3 80.28 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.293 -0.879 . . . . 0.0 110.604 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 53.4 pttt -125.29 -146.84 0.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.797 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.438 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 87.9 mm-40 51.59 71.71 0.43 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.091 -1.006 . . . . 0.0 112.41 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -112.17 18.57 18.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -91.29 -10.56 40.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.429 -0.795 . . . . 0.0 111.289 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.657 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -142.8 -0.95 1.14 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.955 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.657 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -175.31 62.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.64 -1.288 . . . . 0.0 111.415 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 36.6 m -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.888 -1.133 . . . . 0.0 110.318 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 153.19 55.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.8 pt-20 -158.0 92.47 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.2 1.0 . . . . 0.0 110.757 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.564 ' C ' HD12 ' A' ' 487' ' ' ILE . 61.8 mt -99.16 -82.13 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.628 HD13 ' CB ' ' A' ' 503' ' ' SER . 3.1 mp -150.15 -69.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 499' ' ' PHE . 1.4 t -99.91 16.23 24.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.383 -0.823 . . . . 0.0 112.092 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.08 59.67 4.96 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 70.7 ttt180 -142.0 -54.83 0.45 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.258 -1.142 . . . . 0.0 109.544 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.417 ' HD2' ' CE ' ' A' ' 497' ' ' MET . 28.3 mmt180 -104.12 -36.23 7.77 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.778 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.453 ' HG3' ' HA ' ' A' ' 498' ' ' ALA . 10.1 mt-30 -61.46 -41.0 96.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 493' ' ' LEU . 1.2 mt -70.19 -42.08 72.88 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.521 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.682 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -105.89 -42.94 5.0 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -97.64 -10.63 24.73 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.921 -1.111 . . . . 0.0 113.083 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 88.3 -21.69 23.57 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 120.68 -1.262 . . . . 0.0 110.909 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.417 ' CE ' ' HD2' ' A' ' 491' ' ' ARG . 78.6 mtm -66.14 176.23 1.81 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.138 -1.213 . . . . 0.0 110.188 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 492' ' ' GLN . . . -112.27 152.03 28.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 111.056 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.1 OUTLIER -113.14 150.07 32.71 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 500' ' ' THR . 6.0 t -43.25 105.59 0.44 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.032 -0.418 . . . . 0.0 110.524 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.03 114.09 2.66 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.336 1.177 . . . . 0.0 111.572 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -169.66 34.91 0.18 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.628 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.1 p -93.61 167.62 11.56 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 112.827 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.438 ' HB ' HG12 ' A' ' 463' ' ' VAL . 41.2 m -119.52 159.58 24.05 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.657 HG21 ' CD1' ' A' ' 522' ' ' LEU . 73.7 t -143.57 130.78 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 118.527 -1.269 . . . . 0.0 113.026 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.647 HD12 ' CG2' ' A' ' 449' ' ' VAL . 4.7 pt -137.0 120.61 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 534' ' ' ILE . 11.5 p -119.32 99.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.691 -1.256 . . . . 0.0 111.547 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.541 ' OD1' HG23 ' A' ' 535' ' ' THR . 96.4 m-20 -83.08 98.42 9.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.763 ' CD ' HD23 ' A' ' 515' ' ' LEU . 1.7 pm0 -124.78 123.93 41.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.519 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -75.19 -53.93 5.91 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -69.61 -161.52 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.95 -10.6 2.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.947 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 517' ' ' GLU . 12.9 tp -65.4 -28.02 68.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -0.981 . . . . 0.0 108.596 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 3.6 m -83.84 -19.86 34.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.663 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.763 HD23 ' CD ' ' A' ' 509' ' ' GLN . 0.4 OUTLIER -65.8 -48.93 70.07 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.412 178.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.01 -39.87 65.66 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.388 -0.82 . . . . 0.0 111.824 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 513' ' ' LEU . 79.2 mm-40 -61.83 -47.22 86.07 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.586 -0.696 . . . . 0.0 111.572 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.503 HG21 ' HB ' ' A' ' 507' ' ' VAL . 97.7 m -60.96 -43.01 99.35 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.523 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -56.45 -35.65 68.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.873 -0.517 . . . . 0.0 110.717 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 97.6 m -64.35 -43.91 93.11 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 111.668 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.22 -42.01 93.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.265 -0.897 . . . . 0.0 108.944 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.657 ' CD1' HG21 ' A' ' 505' ' ' VAL . 1.8 tp -62.78 -28.47 70.01 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.531 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -46.5 -65.46 0.55 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.413 -0.804 . . . . 0.0 113.166 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -67.88 -49.4 48.74 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.129 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.12 67.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.679 -0.895 . . . . 0.0 111.332 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 522' ' ' LEU . . . -57.13 -24.19 52.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 112.619 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -41.94 -27.0 0.1 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.565 -0.709 . . . . 0.0 112.182 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -108.95 -118.99 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.208 -0.932 . . . . 0.0 112.584 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -89.23 90.25 8.27 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 120.355 -1.466 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.536 HG21 ' HB1' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -119.4 136.87 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.837 0 O-C-N 120.407 -1.433 . . . . 0.0 113.116 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 432' ' ' SER . 9.9 mp0 -126.36 133.58 51.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 40.6 t -114.99 121.66 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 122.971 1.367 . . . . 0.0 111.648 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 434' ' ' ALA . 0.8 OUTLIER -123.67 122.53 38.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 507' ' ' VAL . 9.6 pt -133.09 133.24 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.826 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.541 HG23 ' OD1' ' A' ' 508' ' ' ASP . 55.8 p -106.47 -164.32 0.99 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.79 168.73 26.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.519 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -135.38 13.71 3.5 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.418 178.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -152.22 27.6 0.89 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.583 HE22 HG23 ' A' ' 435' ' ' ILE . 34.4 tt0 -99.5 0.86 43.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -1.062 . . . . 0.0 112.272 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -59.62 -33.98 72.2 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.977 -1.077 . . . . 0.0 112.12 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 27.6 m -102.98 -58.06 1.94 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.072 -1.017 . . . . 0.0 110.819 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -100.34 94.43 1.32 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 11.8 t -95.31 -36.32 11.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -1.009 . . . . 0.0 110.48 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -60.26 -34.78 86.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.8 p -64.05 -34.3 77.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.598 -0.942 . . . . 0.0 111.09 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.46 -37.29 83.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.425 -0.797 . . . . 0.0 109.887 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.81 -40.14 96.45 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.471 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.0 mmm -68.18 -27.52 66.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.401 -0.812 . . . . 0.0 110.319 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -59.46 -55.41 35.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.523 ' HG3' HD11 ' A' ' 519' ' ' LEU . 51.8 ttm -58.89 -48.63 80.73 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.478 -0.764 . . . . 0.0 110.394 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -59.48 -32.57 70.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.644 -0.66 . . . . 0.0 111.781 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -66.45 -25.07 66.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.259 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -70.48 -1.04 9.62 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.334 -0.854 . . . . 0.0 111.192 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 116.16 -15.22 15.84 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.897 -1.127 . . . . 0.0 111.162 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.82 102.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 118.942 1.371 . . . . 0.0 109.713 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -158.87 114.06 2.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.813 -0.555 . . . . 0.0 109.629 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 28.8 m -99.09 90.62 4.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.335 -0.853 . . . . 0.0 109.565 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -89.01 -89.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 560' ' ' TRP . 39.6 ptt180 -169.8 -48.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.966 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . 0.4 ' N ' ' HG3' ' A' ' 559' ' ' ARG . 42.0 p-90 -102.95 -24.25 13.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -140.16 157.38 45.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -0.814 . . . . 0.0 109.72 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 155.83 -112.81 0.54 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -86.12 -7.72 79.84 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -96.21 -10.53 27.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.304 -1.115 . . . . 0.0 110.755 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -93.06 -9.27 40.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.92 -1.112 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -105.01 89.56 3.03 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.54 -18.74 37.9 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.823 1.433 . . . . 0.0 111.206 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -166.18 113.99 0.91 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.453 -0.779 . . . . 0.0 110.326 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.01 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 36.4 t -62.92 -44.71 95.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.473 -0.767 . . . . 0.0 109.967 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 106.24 63.3 0.61 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 45.8 pt -108.61 25.59 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.622 -0.928 . . . . 0.0 110.132 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -90.84 36.09 0.9 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.476 -0.765 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.36 148.88 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.708 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 387' ' ' LEU . 4.6 mm? -68.08 162.11 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.656 -0.652 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -87.71 12.64 12.25 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.556 -0.715 . . . . 0.0 111.656 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.39 17.03 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.104 -0.997 . . . . 0.0 110.454 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 90.6 mt -61.42 -42.08 98.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.193 -0.942 . . . . 0.0 109.396 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.4 m -64.89 -42.88 94.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.878 -0.514 . . . . 0.0 110.712 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 433' ' ' LEU . 99.9 t -66.45 -35.69 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.536 -0.728 . . . . 0.0 110.665 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -62.45 -45.29 93.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.277 -0.889 . . . . 0.0 109.802 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -71.56 -36.88 71.07 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.58 0.705 . . . . 0.0 110.149 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 395' ' ' LEU . 2.6 tm? -61.18 -38.75 87.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.964 -0.46 . . . . 0.0 110.016 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 400' ' ' MET . 42.7 t -63.72 -40.48 96.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.636 -0.665 . . . . 0.0 109.845 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.18 -42.75 99.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.543 -0.723 . . . . 0.0 111.506 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -63.79 -42.21 97.77 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.116 -0.99 . . . . 0.0 111.708 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 435' ' ' ILE . 58.9 mt -66.63 -41.21 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.278 -0.889 . . . . 0.0 110.431 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 435' ' ' ILE . 47.1 mmm -58.25 -33.91 69.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.52 -33.39 75.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.472 -0.767 . . . . 0.0 109.563 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -92.4 -3.83 54.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.936 -1.102 . . . . 0.0 109.778 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 400' ' ' MET . 9.2 m120 -89.15 -26.99 21.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.488 -0.757 . . . . 0.0 109.033 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.19 19.14 15.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 108.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.1 p -52.61 107.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.2 m -49.73 101.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.316 -0.865 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 405' ' ' VAL . 74.3 t -113.6 133.32 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.614 . . . . 0.0 110.113 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -92.04 140.17 24.6 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.593 -0.692 . . . . 0.0 109.871 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 -27.87 33.73 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.282 1.149 . . . . 0.0 110.851 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -62.41 -29.91 70.83 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.364 -0.835 . . . . 0.0 110.0 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 59.11 0.68 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.3 t -60.03 122.28 13.94 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.934 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.9 p -74.54 120.61 82.33 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.723 -0.61 . . . . 0.0 110.378 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.474 ' O ' ' HG3' ' A' ' 415' ' ' ARG . 47.5 Cg_endo -73.65 132.44 17.33 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 122.907 0.951 . . . . 0.0 110.008 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 414' ' ' PRO . 90.8 mtt180 -160.94 56.07 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.833 -0.542 . . . . 0.0 110.017 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 45.0 p -67.34 -34.38 77.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.73 -1.231 . . . . 0.0 108.417 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' A' ' 420' ' ' SER . . . -71.12 -2.29 15.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.783 -0.573 . . . . 0.0 112.195 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.0 97.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 423' ' ' VAL . 33.6 p90 -98.15 -4.06 36.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 417' ' ' ALA . 8.1 t -73.91 -42.07 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -71.79 -40.82 68.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.34 98.73 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.72 0.771 . . . . 0.0 110.257 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.907 HG13 HD21 ' A' ' 533' ' ' LEU . 73.5 t -69.18 -42.17 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.637 -0.664 . . . . 0.0 111.641 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 90.6 p -58.84 -41.67 87.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 0.0 110.946 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.54 -43.39 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.337 -0.852 . . . . 0.0 110.899 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.8 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 0.4 OUTLIER -62.64 -35.12 78.61 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.193 -0.942 . . . . 0.0 111.669 -179.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.72 77.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.734 -1.229 . . . . 0.0 109.217 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.64 -30.11 70.5 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.8 -88.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.96 -61.61 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 120.487 -1.383 . . . . 0.0 109.999 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.44 ' HA ' ' HG2' ' A' ' 531' ' ' GLN . 45.6 Cg_endo -73.01 109.98 2.94 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 123.092 1.048 . . . . 0.0 109.724 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.583 ' CB ' HD12 ' A' ' 533' ' ' LEU . 3.4 m -83.81 98.66 9.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.35 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 10.8 tp -146.04 135.42 22.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.8 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -172.18 164.77 6.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 400' ' ' MET . 19.5 pt -133.51 118.45 30.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -126.6 150.87 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.995 -1.066 . . . . 0.0 109.863 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 9.2 p -131.73 139.95 49.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.815 -0.553 . . . . 0.0 109.723 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.48 160.9 20.48 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.84 -19.2 11.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.656 -0.908 . . . . 0.0 110.306 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -174.93 168.15 40.63 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 57.48 82.73 0.05 OUTLIER Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -93.32 -18.49 22.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.502 -0.999 . . . . 0.0 111.444 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -65.88 -44.74 84.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.973 . . . . 0.0 109.516 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.03 -28.58 70.2 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -61.22 -41.12 96.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.645 -0.914 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 57.9 mtm-85 -61.31 -42.05 98.02 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.92 . . . . 0.0 110.304 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -72.27 -28.76 63.33 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.387 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -62.21 -50.6 71.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.917 -1.115 . . . . 0.0 110.995 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 506' ' ' ILE . 7.6 p -62.16 -32.8 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.691 -1.255 . . . . 0.0 108.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.85 -27.53 69.4 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 454' ' ' MET . 80.4 tt0 -65.08 -33.57 76.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.43 -36.31 82.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 463' ' ' VAL . 99.1 t -60.93 -27.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 59.4 mtt -66.13 -38.94 89.4 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -22.95 65.89 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.719 0.771 . . . . 0.0 109.18 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.09 -24.97 30.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -69.49 -40.48 77.02 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.947 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.37 -31.59 71.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.272 -0.892 . . . . 0.0 109.422 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -81.56 10.13 6.43 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.207 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.69 36.28 93.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -138.44 123.25 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.451 -1.029 . . . . 0.0 111.819 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 46.7 mp0 -85.29 166.47 16.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.755 HG12 ' HB ' ' A' ' 504' ' ' THR . 34.0 m -138.14 157.8 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 111.99 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.794 ' HA ' HD22 ' A' ' 486' ' ' LEU . 47.0 tt0 -96.44 111.51 23.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.958 HD11 HD22 ' A' ' 482' ' ' LEU . 1.6 pp -127.23 131.9 70.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.845 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.661 ' HB ' HG23 ' A' ' 507' ' ' VAL . 3.5 mp -102.08 170.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -123.67 156.82 35.19 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.55 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.502 0.668 . . . . 0.0 109.964 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -54.43 -11.34 0.52 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.947 -1.096 . . . . 0.0 111.845 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -91.6 7.03 43.39 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.707 -1.246 . . . . 0.0 112.051 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.746 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 29.9 ttt85 -59.26 -34.45 72.27 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.856 -1.153 . . . . 0.0 111.526 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 3.7 t -57.21 -53.92 52.62 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.928 -1.108 . . . . 0.0 111.92 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 474' ' ' MET . 13.7 pt20 -66.43 -37.92 86.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.895 -1.128 . . . . 0.0 109.457 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 473' ' ' GLN . 26.8 ttt -58.68 -32.52 69.21 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.758 -0.589 . . . . 0.0 109.515 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -62.11 -37.8 86.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.766 -0.583 . . . . 0.0 109.673 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.58 -40.61 79.38 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.915 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.49 -152.71 0.51 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.588 -0.695 . . . . 0.0 109.147 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 50.34 81.33 0.06 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.863 -1.148 . . . . 0.0 111.623 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -122.03 27.47 8.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 110.09 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -113.42 -19.85 11.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.648 -0.658 . . . . 0.0 110.731 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.702 ' HB2' HD23 ' A' ' 482' ' ' LEU . 7.9 mtt180 -109.19 -14.44 14.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.693 -0.63 . . . . 0.0 111.795 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -171.87 62.59 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.081 -1.012 . . . . 0.0 111.33 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 51.4 p -90.72 48.59 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.832 -1.168 . . . . 0.0 110.169 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.84 26.03 43.31 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.99 54.01 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -1.06 . . . . 0.0 109.1 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.794 HD22 ' HA ' ' A' ' 464' ' ' GLN . 13.8 mt -79.21 -81.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.773 HG22 HG23 ' A' ' 488' ' ' THR . 0.0 OUTLIER 178.29 -42.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.979 -1.076 . . . . 0.0 111.514 174.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.773 HG23 HG22 ' A' ' 487' ' ' ILE . 4.0 p -102.69 10.05 38.84 Favored 'General case' 0 C--N 1.3 -1.543 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.299 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.7 65.62 2.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 41.3 ttm180 -144.31 -68.4 0.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -109.94 -29.92 8.04 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.934 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 498' ' ' ALA . 0.0 OUTLIER -62.01 -45.54 93.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.58 -0.7 . . . . 0.0 111.285 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.01 -18.54 24.45 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.347 -0.846 . . . . 0.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -47.3 4.25 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.373 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -101.98 -8.32 21.61 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.78 -14.53 61.44 Favored Glycine 0 N--CA 1.503 3.131 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.588 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 63.1 mtt -67.97 -176.14 0.65 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.425 ' HA ' ' HG2' ' A' ' 492' ' ' GLN . . . -114.63 148.18 38.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.622 -0.674 . . . . 0.0 110.745 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.437 ' CZ ' ' HD2' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -114.15 149.61 35.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.371 -0.831 . . . . 0.0 109.195 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 500' ' ' THR . 6.3 t -60.85 112.11 5.18 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.171 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 528' ' ' HIS . 43.2 Cg_endo -72.29 113.74 3.79 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.402 1.212 . . . . 0.0 109.501 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -162.33 19.74 0.17 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.723 ' CB ' HD13 ' A' ' 487' ' ' ILE . 24.2 p -93.9 175.34 6.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.254 -1.145 . . . . 0.0 111.096 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.755 ' HB ' HG12 ' A' ' 463' ' ' VAL . 54.1 m -116.73 127.72 54.65 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.849 ' CB ' HD21 ' A' ' 522' ' ' LEU . 69.1 t -113.64 129.87 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.371 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.646 ' CG1' HG22 ' A' ' 465' ' ' ILE . 1.3 pp -126.4 164.11 27.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 534' ' ' ILE . 13.8 p -151.2 110.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.959 -1.088 . . . . 0.0 108.874 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 53.8 t0 -84.25 104.96 14.73 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.369 1.08 . . . . 0.0 108.138 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.477 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -98.73 174.57 6.34 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.498 1.142 . . . . 0.0 113.285 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.33 -56.31 0.05 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -75.09 -156.39 0.05 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -125.83 -19.17 4.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 110.461 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 513' ' ' LEU . 4.4 mm? -70.41 -31.07 68.12 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.368 -0.833 . . . . 0.0 110.679 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 57.7 p -67.77 -40.55 84.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.784 -0.572 . . . . 0.0 111.22 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 550' ' ' MET . 13.4 tp -64.59 -45.94 84.79 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.442 -0.786 . . . . 0.0 111.143 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 520' ' ' THR . 99.1 mttt -67.62 -43.35 80.63 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.418 -0.801 . . . . 0.0 113.064 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 518' ' ' THR . 27.0 pt-20 -65.76 -41.81 91.63 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.765 -1.209 . . . . 0.0 110.362 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.736 HG22 HD12 ' A' ' 522' ' ' LEU . 98.0 m -62.88 -42.48 99.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.006 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.736 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -60.6 -39.42 88.05 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.691 -178.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 516' ' ' LYS . 81.3 p -65.27 -31.3 72.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.389 -0.819 . . . . 0.0 111.897 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.614 HD22 HE22 ' A' ' 464' ' ' GLN . 9.6 tt -81.9 -38.45 25.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.037 -1.04 . . . . 0.0 109.787 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.849 HD21 ' CB ' ' A' ' 505' ' ' VAL . 1.8 mt -64.11 -26.62 68.62 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.782 -0.574 . . . . 0.0 111.292 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -48.22 -51.21 26.39 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.275 -0.891 . . . . 0.0 111.586 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -71.41 -50.2 22.16 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -66.89 -38.43 86.25 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.473 -1.016 . . . . 0.0 113.001 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -60.9 -33.88 73.8 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.211 -0.931 . . . . 0.0 111.602 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -57.17 -28.82 63.13 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.962 -1.086 . . . . 0.0 108.11 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.461 ' CG ' ' HG3' ' A' ' 501' ' ' PRO . 80.0 m80 -93.99 -135.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.426 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 89.5 m-20 -89.77 69.69 7.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.725 -1.234 . . . . 0.0 112.893 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.69 ' CG1' HD23 ' A' ' 522' ' ' LEU . 2.5 t -141.77 168.24 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 431' ' ' PRO . 1.0 OUTLIER -159.54 162.75 35.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.842 -0.536 . . . . 0.0 110.843 -178.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 42.4 t -109.79 100.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.524 -0.735 . . . . 0.0 112.15 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 423' ' ' VAL . 0.5 OUTLIER -100.58 117.98 35.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.972 HG22 HG12 ' A' ' 507' ' ' VAL . 9.8 pt -127.51 155.58 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.323 -176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.619 ' CB ' HG22 ' A' ' 436' ' ' VAL . 36.7 p -128.39 -178.11 4.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 61.8 m-20 -154.55 163.71 39.79 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 3.7 p -140.35 18.85 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.916 -0.49 . . . . 0.0 109.732 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.79 26.0 0.18 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.07 0.74 51.88 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.128 -1.219 . . . . 0.0 111.814 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -43.4 -42.04 4.48 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.224 -0.923 . . . . 0.0 111.366 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 65.5 p -106.19 163.48 12.77 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 50.11 36.79 28.98 Favored Glycine 0 N--CA 1.503 3.152 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.465 HG23 ' N ' ' A' ' 544' ' ' GLY . 8.9 t -58.74 -43.66 90.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.52 -0.988 . . . . 0.0 111.107 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.6 -38.4 96.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 43.1 m -65.32 -33.02 74.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -1.0 . . . . 0.0 111.364 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.59 -37.5 87.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.731 . . . . 0.0 110.294 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.58 -42.66 99.17 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.501 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 8.4 tpp -61.85 -34.71 76.47 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -53.57 -52.1 60.86 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.174 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.736 ' CG ' HD11 ' A' ' 519' ' ' LEU . 40.1 ttp -57.32 -45.66 84.02 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.344 -0.848 . . . . 0.0 110.177 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.7 -31.28 72.4 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.429 -0.794 . . . . 0.0 110.974 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.88 -13.02 62.17 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.471 -0.768 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -78.87 9.77 3.96 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.432 -0.792 . . . . 0.0 112.709 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 123.84 -14.75 7.99 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.706 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.2 t -85.19 115.41 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -169.1 127.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.696 -0.627 . . . . 0.0 109.606 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 13.0 t -97.15 133.09 42.26 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -73.15 -79.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.704 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -139.58 -81.22 0.29 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.213 -0.929 . . . . 0.0 110.781 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -91.15 -21.86 20.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 110.563 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -149.71 122.03 8.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.345 -0.847 . . . . 0.0 110.347 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -86.14 -130.53 2.65 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -101.79 33.66 6.32 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -91.79 -12.99 32.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.69 -0.888 . . . . 0.0 111.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -83.07 -1.97 54.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.34 -0.85 . . . . 0.0 112.122 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -109.34 75.3 0.72 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.062 -1.024 . . . . 0.0 110.804 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.69 -26.56 32.98 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 O-C-N 123.291 1.153 . . . . 0.0 110.17 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -176.17 34.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.352 -0.842 . . . . 0.0 110.12 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.361 -179.864 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.226 0.536 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.79 22.7 1.77 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.458 -0.776 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -98.48 -45.94 2.24 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.497 HG22 HG22 ' A' ' 386' ' ' VAL . 77.3 mt -109.11 130.0 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.579 -0.953 . . . . 0.0 110.22 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -129.15 59.12 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 384' ' ' ILE . 35.6 m -111.03 155.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.4 mm? -82.41 137.12 34.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.105 -0.997 . . . . 0.0 109.711 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . 0.414 ' HB2' ' CD ' ' A' ' 431' ' ' PRO . 77.0 m-20 -95.79 9.43 40.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 111.196 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.98 -34.21 72.99 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.135 -0.978 . . . . 0.0 109.904 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 391' ' ' SER . 4.1 pp -64.35 -33.04 74.92 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.71 -0.619 . . . . 0.0 110.659 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . 0.558 ' N ' HD12 ' A' ' 390' ' ' LEU . 50.9 m -60.79 -36.7 79.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.325 -0.859 . . . . 0.0 109.736 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.0 t -65.48 -33.82 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.287 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.52 -48.24 79.82 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.241 -0.912 . . . . 0.0 110.914 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.13 77.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.435 -0.791 . . . . 0.0 109.435 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 422' ' ' ALA . 0.9 OUTLIER -62.17 -39.66 93.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.951 -0.468 . . . . 0.0 111.504 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 55.8 p -65.71 -37.52 86.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -0.912 . . . . 0.0 110.325 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -65.07 -44.85 87.59 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.537 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.69 -43.3 80.44 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.131 -0.981 . . . . 0.0 111.331 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 436' ' ' VAL . 96.7 mt -61.45 -42.28 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.629 ' CG ' HD11 ' A' ' 435' ' ' ILE . 19.5 mtp -62.67 -29.1 70.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.952 -0.467 . . . . 0.0 109.981 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -61.2 -29.67 69.96 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.85 -1.156 . . . . 0.0 109.541 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.54 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 99.3 mm-40 -89.33 -16.97 29.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 109.231 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 400' ' ' MET . 2.7 t-20 -66.4 -38.54 87.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.526 -0.733 . . . . 0.0 110.799 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -116.32 19.0 15.05 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 405' ' ' VAL . 10.8 p -48.15 117.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.65 -0.657 . . . . 0.0 111.019 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.8 p -52.35 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.646 HG23 HG12 ' A' ' 413' ' ' VAL . 11.0 p -109.86 133.06 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.598 0.713 . . . . 0.0 110.663 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -90.8 135.1 29.3 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.33 -30.38 45.07 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.098 1.052 . . . . 0.0 110.542 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -59.65 -28.33 67.16 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.811 0.815 . . . . 0.0 109.822 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 56.2 0.76 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.9 m -54.17 117.78 3.53 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.67 0.748 . . . . 0.0 111.379 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.646 HG12 HG23 ' A' ' 407' ' ' VAL . 7.7 p -67.87 111.51 7.9 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.563 . . . . 0.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -74.31 138.13 24.39 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 122.999 1.0 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -161.25 70.68 0.37 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.829 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 57.9 p -67.75 -38.06 82.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.837 -1.165 . . . . 0.0 107.895 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 420' ' ' SER . . . -56.63 -23.95 44.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.871 -0.518 . . . . 0.0 111.177 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -47.99 -58.18 7.22 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -87.41 -1.99 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.967 -1.314 . . . . 0.0 110.847 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 10.9 t -71.03 -42.9 68.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.909 -1.12 . . . . 0.0 108.502 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -75.69 -44.63 41.19 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.811 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.78 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.71 -48.02 73.41 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.455 -0.778 . . . . 0.0 111.751 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.833 ' CG2' HG21 ' A' ' 436' ' ' VAL . 57.9 t -68.27 -44.41 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.334 -0.854 . . . . 0.0 111.45 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.6 m -61.73 -38.14 86.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 111.229 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.4 p -65.03 -29.5 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 112.754 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.773 ' HB3' HD13 ' A' ' 395' ' ' LEU . 2.2 pp -76.98 -32.2 57.07 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.398 -1.439 . . . . 0.0 110.575 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.39 84.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.002 -1.061 . . . . 0.0 108.837 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -59.27 -36.22 75.14 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -64.73 -88.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 4.6 tpp180 -175.13 -60.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 120.726 -1.233 . . . . 0.0 109.635 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 388' ' ' ASP . 39.0 Cg_endo -64.39 102.76 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 122.886 0.94 . . . . 0.0 111.397 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.784 ' OG ' HD12 ' A' ' 533' ' ' LEU . 0.1 OUTLIER -82.51 99.99 9.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.872 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 11.0 tp -163.7 93.04 0.72 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.26 -0.9 . . . . 0.0 111.195 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.472 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -150.04 162.36 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.011 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 435' ' ' ILE . 2.5 pp -113.96 128.55 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.094 0.473 . . . . 0.0 109.897 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.833 HG21 ' CG2' ' A' ' 423' ' ' VAL . 78.3 t -132.18 158.38 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -0.877 . . . . 0.0 108.935 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 42.8 t -130.46 138.63 50.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.023 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -95.94 135.99 12.61 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.679 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -107.71 -14.27 14.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.959 -0.73 . . . . 0.0 110.255 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -179.57 170.6 42.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.19 44.94 97.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.92 89.12 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.332 -1.099 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.39 -44.7 93.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.627 -0.671 . . . . 0.0 110.55 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.87 -28.66 64.42 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.4 -41.88 98.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.655 -0.909 . . . . 0.0 109.607 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.662 ' O ' HG12 ' A' ' 449' ' ' VAL . 52.5 mtm180 -61.77 -45.01 95.75 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.375 -0.828 . . . . 0.0 110.047 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -63.45 -29.65 70.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.642 -0.661 . . . . 0.0 109.42 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 53.1 ttt85 -67.52 -50.54 58.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.578 -0.701 . . . . 0.0 111.388 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.3 p -55.21 -31.74 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.528 -1.357 . . . . 0.0 110.423 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' A' ' 481' ' ' ARG . . . -64.36 -26.83 68.64 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 82.0 tt0 -60.19 -35.13 74.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.94 -37.68 88.01 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.961 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.4 t -63.05 -27.06 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.013 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.6 mtp -66.28 -39.73 89.6 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.189 -0.944 . . . . 0.0 108.642 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.1 ttp -58.88 -25.8 63.67 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.64 -0.663 . . . . 0.0 109.442 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 463' ' ' VAL . . . -82.63 -22.43 34.71 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.581 -0.7 . . . . 0.0 110.405 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.88 -47.57 71.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.76 -28.47 65.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -79.5 5.2 13.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.58 -0.7 . . . . 0.0 110.756 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.45 34.45 89.97 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -130.75 127.14 38.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -1.01 . . . . 0.0 110.292 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.413 ' C ' HG13 ' A' ' 463' ' ' VAL . 30.8 tt0 -81.53 159.28 24.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.961 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.9 m -144.87 151.81 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.482 -1.287 . . . . 0.0 112.502 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.835 ' HG3' HD13 ' A' ' 486' ' ' LEU . 57.9 tt0 -102.98 123.33 46.39 Favored 'General case' 0 C--O 1.194 -1.845 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.543 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.772 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -141.7 146.25 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 120.825 -1.172 . . . . 0.0 108.732 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.785 HG23 ' HD3' ' A' ' 471' ' ' ARG . 83.6 mt -134.01 129.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.888 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 471' ' ' ARG . . . -78.22 168.58 19.63 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.26 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.505 -0.747 . . . . 0.0 109.786 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -48.56 -22.74 0.8 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.915 -1.115 . . . . 0.0 111.903 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -73.23 -6.3 45.0 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.332 -0.855 . . . . 0.0 112.206 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 466' ' ' ILE . 34.7 ttt85 -60.16 -24.73 64.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.803 -1.186 . . . . 0.0 110.668 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -61.45 -46.37 90.35 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.216 -0.928 . . . . 0.0 110.612 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -65.21 -41.3 94.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 53.2 ttm -60.39 -32.47 71.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.027 -0.421 . . . . 0.0 110.453 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -61.36 -37.69 84.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 80.5 mmm -59.76 -35.9 75.55 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.951 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 59.4 pttt -134.93 -141.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 109.801 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.501 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 89.3 mm-40 47.06 90.46 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.969 -1.082 . . . . 0.0 113.034 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -94.55 -23.46 17.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.475 ' O ' HD22 ' A' ' 482' ' ' LEU . 98.0 mt-10 -70.44 -29.53 66.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.514 -0.741 . . . . 0.0 109.059 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.64 ' HA ' ' HB1' ' A' ' 450' ' ' ALA . 9.1 mpt_? -83.52 8.48 13.91 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.997 -0.44 . . . . 0.0 111.294 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.688 HD22 ' N ' ' A' ' 482' ' ' LEU . 3.2 mm? 53.87 28.26 8.22 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.986 -1.071 . . . . 0.0 110.802 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.28 50.24 0.06 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.493 -0.755 . . . . 0.0 112.417 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 159.61 42.04 0.02 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -179.62 89.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.597 -0.943 . . . . 0.0 109.867 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.835 HD13 ' HG3' ' A' ' 464' ' ' GLN . 47.1 mt -99.09 -81.28 0.45 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.932 HD13 ' CB ' ' A' ' 503' ' ' SER . 1.1 mp -158.98 -46.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.487 -0.758 . . . . 0.0 109.448 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 499' ' ' PHE . 1.8 p -102.86 14.31 32.26 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.496 -0.752 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -79.55 56.92 4.48 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -143.06 -61.75 0.42 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.224 -1.162 . . . . 0.0 109.245 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -109.35 -31.29 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.298 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.439 HE22 ' HB2' ' A' ' 525' ' ' ALA . 3.2 mt-30 -64.08 -38.1 89.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 521' ' ' LEU . 5.4 mt -91.16 -26.82 18.89 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 111.358 -178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.0 OUTLIER -105.72 -44.36 4.67 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -102.4 -8.33 21.23 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.863 -1.148 . . . . 0.0 113.518 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.81 -21.49 33.11 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.732 -1.23 . . . . 0.0 111.276 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 38.0 mtm -64.09 -178.6 0.35 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -1.186 . . . . 0.0 109.348 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.04 154.16 28.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 111.347 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.434 ' HB2' ' HB ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -115.82 148.98 39.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.937 -0.477 . . . . 0.0 109.864 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 79.1 m -44.06 101.52 0.26 Allowed Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 122.089 -0.382 . . . . 0.0 110.759 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 43.4 Cg_endo -68.34 113.75 3.21 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.681 1.358 . . . . 0.0 109.239 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . 174.98 38.06 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.932 ' CB ' HD13 ' A' ' 487' ' ' ILE . 13.6 p -90.83 174.55 7.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.882 -0.776 . . . . 0.0 111.79 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.511 ' HB ' HG12 ' A' ' 463' ' ' VAL . 13.6 m -112.74 94.36 4.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 522' ' ' LEU . 59.4 t -85.64 131.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 122.225 1.012 . . . . 0.0 112.656 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.829 HG23 HD22 ' A' ' 533' ' ' LEU 0.294 65.3 mt -137.77 96.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 534' ' ' ILE . 3.9 p -104.19 107.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 122.978 1.371 . . . . 0.0 113.574 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.44 107.58 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.0 -1.062 . . . . 0.0 109.413 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 511' ' ' GLU . 19.1 mm100 -126.96 116.46 20.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -72.83 -40.61 52.06 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 175.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 509' ' ' GLN . 93.0 mt-10 -86.71 147.22 25.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.11 -12.07 22.19 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.629 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.96 -38.81 92.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 109.526 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 72.1 p -86.82 -16.61 35.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.615 -0.678 . . . . 0.0 111.109 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 60.1 tp -72.06 -47.69 49.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.165 -0.959 . . . . 0.0 109.905 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.807 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 31.3 ttpt -69.85 -46.02 66.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.679 -0.638 . . . . 0.0 112.692 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.67 -41.59 98.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.965 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.578 HG21 HD12 ' A' ' 466' ' ' ILE . 29.9 m -56.86 -44.74 82.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.483 -0.76 . . . . 0.0 111.194 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 515' ' ' LEU . 43.3 mt -60.77 -28.22 68.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.7 m -61.1 -41.17 96.18 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.327 -0.858 . . . . 0.0 109.472 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 493' ' ' LEU . 50.7 tp -65.49 -41.09 93.64 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.846 ' CD1' HG11 ' A' ' 505' ' ' VAL . 1.4 tt -64.17 -22.95 67.13 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.845 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -48.06 -64.19 0.86 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.376 -0.828 . . . . 0.0 113.205 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.69 -50.54 60.84 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.771 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -62.35 -36.38 82.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.558 -0.966 . . . . 0.0 111.77 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.453 ' HA ' ' CB ' ' A' ' 530' ' ' VAL . . . -64.99 -25.23 67.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.447 -0.783 . . . . 0.0 112.72 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -40.88 -27.82 0.06 Allowed 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -107.28 -108.73 0.31 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.109 -0.994 . . . . 0.0 113.065 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.511 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 0.1 OUTLIER -89.51 81.47 6.53 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.553 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 531' ' ' GLN . 5.9 t -143.87 165.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.843 -1.161 . . . . 0.0 111.729 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 530' ' ' VAL . 12.8 mm-40 -157.52 161.83 38.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 55.3 t -114.96 107.17 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.354 -0.841 . . . . 0.0 111.511 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.829 HD22 HG23 ' A' ' 506' ' ' ILE . 5.5 tt -105.49 119.22 38.55 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 507' ' ' VAL . 4.1 pt -139.94 153.08 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 117.833 -1.547 . . . . 0.0 111.296 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.509 HG22 ' HB ' ' A' ' 436' ' ' VAL . 26.6 p -143.11 114.62 8.01 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.95 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -77.08 175.56 9.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.681 1.229 . . . . 0.0 111.83 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.541 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 1.3 m -129.98 -10.3 4.33 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.105 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -122.67 34.78 3.65 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -98.29 0.84 46.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.862 -0.787 . . . . 0.0 111.999 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 541' ' ' THR . 38.4 ptt180 -49.36 -31.22 8.97 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.096 -1.003 . . . . 0.0 110.216 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 540' ' ' ARG . 46.1 p -129.78 166.54 19.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 54.5 34.66 55.38 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -61.7 -45.8 92.41 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.496 -1.002 . . . . 0.0 111.802 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.23 -34.69 90.65 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 48.0 m -64.08 -37.86 88.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.71 -0.876 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.26 -37.25 72.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 110.023 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 547' ' ' LEU . 10.9 mp -63.14 -39.94 96.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.658 -0.652 . . . . 0.0 110.102 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 5.7 ttt -62.68 -29.11 70.41 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.487 -0.758 . . . . 0.0 109.203 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -56.29 -52.6 63.9 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 555' ' ' VAL . 56.0 ttm -55.61 -46.65 77.31 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.277 -0.889 . . . . 0.0 109.521 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . 0.705 ' HA ' HG23 ' A' ' 555' ' ' VAL . 97.5 mttt -57.6 -32.0 66.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.824 -0.548 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -68.46 -25.51 65.03 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.4 -0.813 . . . . 0.0 111.403 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.807 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -70.37 0.85 5.75 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.083 -1.011 . . . . 0.0 112.787 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.39 -15.25 9.28 Favored Glycine 0 N--CA 1.496 2.67 0 O-C-N 120.787 -1.196 . . . . 0.0 110.832 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.705 HG23 ' HA ' ' A' ' 551' ' ' LYS . 34.2 m -86.83 109.72 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.304 -1.115 . . . . 0.0 110.034 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -171.05 140.63 1.56 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.244 -0.91 . . . . 0.0 110.002 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 57.4 m -95.54 134.71 38.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.413 -0.804 . . . . 0.0 109.168 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -75.14 -79.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.483 -0.761 . . . . 0.0 110.576 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -130.83 -78.88 0.53 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.411 -0.806 . . . . 0.0 111.281 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -93.1 -21.84 19.46 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.043 -1.035 . . . . 0.0 111.308 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 564' ' ' GLU . 14.9 pt20 -137.22 148.65 46.65 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -129.56 115.49 1.92 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 75.75 11.26 84.67 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 561' ' ' GLN . 76.2 tt0 -95.35 -11.69 27.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.186 -1.184 . . . . 0.0 111.121 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -82.18 -8.12 59.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.214 -0.928 . . . . 0.0 110.437 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.19 99.68 18.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 110.517 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.04 -17.59 36.2 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.281 1.148 . . . . 0.0 111.159 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -170.81 131.17 0.84 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.868 . . . . 0.0 110.204 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.623 179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.277 0.561 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 1.5 m 52.73 -172.61 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.508 -0.745 . . . . 0.0 110.159 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.52 85.01 0.38 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.804 HD11 HD23 ' A' ' 387' ' ' LEU . 47.4 pt -74.62 135.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.959 . . . . 0.0 110.304 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.83 -39.65 83.87 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.536 -0.728 . . . . 0.0 110.697 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.23 124.43 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.332 -0.855 . . . . 0.0 110.384 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.804 HD23 HD11 ' A' ' 384' ' ' ILE . 64.8 mt -104.5 2.06 30.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.692 -0.63 . . . . 0.0 111.623 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.04 -69.5 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.015 -1.053 . . . . 0.0 110.728 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.05 14.1 1.31 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.277 -0.889 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.51 -42.56 99.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.235 -0.916 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.3 m -60.99 -42.12 97.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.715 -0.616 . . . . 0.0 110.082 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.23 -35.27 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.691 -0.631 . . . . 0.0 111.032 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -63.27 -47.1 83.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.043 0.925 . . . . 0.0 109.448 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.5 tt -61.96 -38.86 90.1 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.719 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.8 m -68.32 -36.15 78.87 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -63.07 -45.28 92.91 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.261 -0.899 . . . . 0.0 111.129 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.13 -40.87 86.86 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.116 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.74 HG23 ' HD1' ' A' ' 419' ' ' TYR . 96.5 mt -62.75 -42.58 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.491 -0.756 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 0.9 OUTLIER -61.04 -31.57 71.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.82 . . . . 0.0 110.114 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -61.77 -30.87 71.08 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.966 -1.084 . . . . 0.0 109.827 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 61.0 tp60 -89.39 -16.31 31.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 109.205 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 400' ' ' MET . 2.6 t-20 -66.11 -34.31 77.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.571 -0.706 . . . . 0.0 109.672 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -114.09 17.9 17.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.993 -1.067 . . . . 0.0 109.518 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.731 HG13 HG23 ' A' ' 407' ' ' VAL . 8.3 p -40.43 148.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 121.559 0.695 . . . . 0.0 112.243 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.4 m -85.63 77.18 9.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.731 HG23 HG13 ' A' ' 405' ' ' VAL . 82.5 t -94.51 129.74 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 111.064 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -98.92 144.93 29.09 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.6 -19.09 42.56 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.199 1.105 . . . . 0.0 111.488 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -59.61 -33.22 71.21 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -158.09 64.03 0.45 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.5 m -61.3 131.28 49.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.0 110.979 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' A' ' 414' ' ' PRO . 7.8 p -78.68 148.66 73.33 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.468 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.5 Cg_endo -60.18 138.82 83.89 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 122.834 0.912 . . . . 0.0 110.622 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -101.05 -5.02 26.33 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 420' ' ' SER . 17.5 p -97.83 17.97 16.86 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.777 -1.202 . . . . 0.0 108.943 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.28 -32.56 7.73 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -69.47 -40.01 79.37 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.74 ' HD1' HG23 ' A' ' 399' ' ' ILE . 4.9 m-85 -98.93 -10.95 22.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.74 -1.447 . . . . 0.0 111.215 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 416' ' ' THR . 58.2 p -74.17 -38.13 63.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.746 -1.221 . . . . 0.0 107.841 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 425' ' ' VAL . 99.0 m-20 -75.17 -48.35 24.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -65.35 -48.31 73.41 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.527 -0.733 . . . . 0.0 111.727 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.932 ' HA ' HD23 ' A' ' 426' ' ' LEU . 58.0 t -66.94 -43.82 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.576 -0.703 . . . . 0.0 112.423 -177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -61.59 -42.19 98.51 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.856 -1.152 . . . . 0.0 111.147 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 421' ' ' ASP . 77.7 t -61.7 -28.65 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.3 -0.875 . . . . 0.0 110.667 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -72.89 -32.12 65.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.446 -0.784 . . . . 0.0 111.558 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.57 -36.35 76.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.904 -1.123 . . . . 0.0 109.389 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -61.93 -30.14 70.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.51 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.405 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 3.4 tpp85 -172.19 -61.21 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.694 -1.254 . . . . 0.0 109.256 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 531' ' ' GLN . 44.3 Cg_endo -71.35 110.91 2.97 Favored 'Trans proline' 0 N--CA 1.483 0.903 0 O-C-N 123.086 1.045 . . . . 0.0 110.637 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 426' ' ' LEU . 6.7 t -88.46 98.06 11.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.69 -0.631 . . . . 0.0 110.45 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.839 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 19.7 tp -164.31 97.07 0.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.663 -1.273 . . . . 0.0 112.34 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.691 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -141.34 175.63 9.5 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.104 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.475 ' O ' HG21 ' A' ' 399' ' ' ILE . 46.4 pt -118.83 130.59 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.325 0.583 . . . . 0.0 110.4 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.723 ' CG2' HG21 ' A' ' 423' ' ' VAL . 58.2 t -127.88 136.02 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.921 -1.112 . . . . 0.0 109.611 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.411 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 73.9 m -121.56 125.69 47.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.345 -0.847 . . . . 0.0 110.996 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -103.2 -176.71 26.46 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -129.41 -41.17 1.39 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.616 -0.932 . . . . 0.0 109.838 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -159.88 167.0 35.23 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.7 64.06 2.97 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.77 ' HB1' HH22 ' A' ' 446' ' ' ARG . . . -80.6 -21.26 41.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.59 -0.947 . . . . 0.0 110.362 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.07 -44.22 97.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.462 -0.774 . . . . 0.0 111.171 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -66.1 -31.06 78.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.77 -30.41 71.41 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.603 -0.939 . . . . 0.0 109.807 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.77 HH22 ' HB1' ' A' ' 442' ' ' ALA . 2.8 mmt85 -63.97 -43.45 95.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.59 -0.694 . . . . 0.0 109.976 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.74 -33.85 64.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.335 -0.853 . . . . 0.0 110.783 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.24 -53.59 52.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.362 -0.836 . . . . 0.0 111.511 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.611 HG22 ' CD1' ' A' ' 506' ' ' ILE . 12.7 p -58.61 -33.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.757 -1.214 . . . . 0.0 108.883 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.62 68.07 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.42 -37.99 82.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.064 -1.022 . . . . 0.0 108.61 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 455' ' ' MET . 79.2 mt -63.12 -36.72 84.54 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.896 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.5 t -60.66 -27.44 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -0.825 . . . . 0.0 109.586 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 94.4 mtp -67.73 -40.95 84.17 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . 0.417 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.1 OUTLIER -62.41 -20.74 64.79 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.235 -0.916 . . . . 0.0 109.93 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.23 -23.06 32.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.614 -0.679 . . . . 0.0 109.562 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -68.56 -40.19 80.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.676 . . . . 0.0 109.563 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.45 -32.21 68.06 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.408 -0.807 . . . . 0.0 109.661 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -76.68 3.1 12.38 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.753 -0.592 . . . . 0.0 111.725 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.44 71.8 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.424 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 61.1 ttm-85 -125.37 122.42 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 98.1 mt-10 -84.85 168.18 15.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.896 ' CG2' HG13 ' A' ' 453' ' ' VAL . 34.4 m -143.62 149.08 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 111.22 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.916 ' HA ' HD22 ' A' ' 486' ' ' LEU . 1.4 pt20 -99.08 121.66 41.28 Favored 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.729 HG21 ' CG2' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -123.5 129.72 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -178.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.733 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.4 mp -117.76 112.99 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.573 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -65.23 -179.44 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.813 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.514 ' HB3' ' NH1' ' A' ' 446' ' ' ARG . . . -61.94 -161.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.16 -14.59 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.732 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -79.72 -3.07 45.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.122 -0.986 . . . . 0.0 111.967 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' A' ' 467' ' ' ALA . 74.6 ttt-85 -57.04 -31.13 64.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.886 -1.133 . . . . 0.0 111.21 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.6 t -60.01 -44.44 94.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.855 . . . . 0.0 109.857 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.21 -36.01 82.86 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.1 -30.78 71.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.864 -0.523 . . . . 0.0 109.936 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -61.47 -37.57 84.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.534 -0.729 . . . . 0.0 109.605 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 65.5 ttp -58.55 -38.11 77.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.919 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.4 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.9 pttt -124.89 -152.42 0.51 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.393 -0.817 . . . . 0.0 109.293 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.2 mm-40 48.3 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 120.909 -1.12 . . . . 0.0 111.824 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -127.65 11.47 6.75 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.562 -0.712 . . . . 0.0 110.665 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -98.24 -14.51 20.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.546 -0.721 . . . . 0.0 110.267 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -108.67 -13.96 14.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.557 -0.715 . . . . 0.0 111.84 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.451 HD22 HD11 ' A' ' 465' ' ' ILE . 0.7 OUTLIER -175.7 56.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.953 -1.092 . . . . 0.0 110.932 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 93.2 p -60.17 -23.67 64.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.017 -1.052 . . . . 0.0 110.181 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 151.22 55.85 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -132.4 48.87 2.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.821 -0.811 . . . . 0.0 110.407 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.916 HD22 ' HA ' ' A' ' 464' ' ' GLN . 19.0 mt -73.61 -80.56 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.664 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER -178.96 -44.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.796 -1.19 . . . . 0.0 110.246 174.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 487' ' ' ILE . 5.0 p -102.63 8.75 39.63 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.851 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.416 ' HA2' HD12 ' A' ' 493' ' ' LEU . . . -85.85 60.09 4.68 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 66.3 ttt180 -145.77 -45.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.906 -0.761 . . . . 0.0 109.542 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 36.7 mtt85 -120.86 -46.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.429 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 498' ' ' ALA . 32.4 mt-30 -61.61 -50.32 73.04 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.092 -1.005 . . . . 0.0 111.452 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.416 HD12 ' HA2' ' A' ' 489' ' ' GLY . 7.3 mt -71.08 -37.53 72.45 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.97 -0.457 . . . . 0.0 111.603 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -104.76 -38.07 6.82 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.13 -8.18 15.19 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.773 -1.205 . . . . 0.0 114.132 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 91.54 -21.34 36.1 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 120.766 -1.209 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.537 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 52.1 mmm -67.12 178.73 1.35 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.133 -1.216 . . . . 0.0 109.851 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 492' ' ' GLN . . . -114.31 148.83 36.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 112.23 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.477 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.2 OUTLIER -115.95 148.92 39.55 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.559 0.695 . . . . 0.0 110.301 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 19.1 m -52.45 107.57 0.87 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.869 -0.52 . . . . 0.0 110.117 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 525' ' ' ALA . 41.1 Cg_endo -70.74 114.41 3.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.437 1.23 . . . . 0.0 109.556 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . -171.95 27.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.743 ' O ' HG22 ' A' ' 530' ' ' VAL . 60.2 p -94.3 177.97 5.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.634 -0.921 . . . . 0.0 111.002 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.805 ' HB ' HG12 ' A' ' 463' ' ' VAL . 51.5 m -125.53 125.39 43.16 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 522' ' ' LEU . 8.5 p -109.32 131.01 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.949 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.611 ' CD1' HG22 ' A' ' 449' ' ' VAL . 2.4 pt -126.0 112.32 29.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.733 HG23 ' HB ' ' A' ' 466' ' ' ILE . 4.3 p -112.68 115.5 50.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 111.851 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 2.0 t70 -83.12 105.63 14.25 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 21.8 tm0? -94.12 174.12 7.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.7 0.762 . . . . 0.0 111.199 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.46 -74.66 0.04 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 105.364 -3.094 . . . . 0.0 105.364 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -54.49 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 5.3 mttt 179.07 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.625 0 O-C-N 120.695 -1.253 . . . . 0.0 110.57 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 513' ' ' LEU . 29.6 mt -70.0 -20.89 63.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.641 -0.662 . . . . 0.0 110.493 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 17.9 m -64.43 -42.12 96.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.391 -0.818 . . . . 0.0 109.358 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 7.6 tp -65.5 -44.17 87.88 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.23 0.538 . . . . 0.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.71 -43.89 83.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.457 -0.777 . . . . 0.0 112.348 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.85 -51.21 69.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.05 -1.031 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.65 ' CG2' HD13 ' A' ' 466' ' ' ILE . 30.6 m -59.1 -41.5 88.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.726 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.2 OUTLIER -58.55 -39.23 79.63 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.924 -0.485 . . . . 0.0 110.848 -177.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.1 m -61.02 -37.14 81.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 0.0 110.167 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.575 HD23 HE22 ' A' ' 464' ' ' GLN . 61.2 tp -67.09 -40.43 86.94 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 505' ' ' VAL . 0.3 OUTLIER -64.66 -21.95 66.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.754 -0.591 . . . . 0.0 111.641 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -45.74 -62.66 1.21 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.592 -0.692 . . . . 0.0 111.951 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -84.68 -48.17 5.08 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.984 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 501' ' ' PRO . . . -69.77 -41.94 74.49 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 522' ' ' LEU . . . -65.0 -25.69 67.97 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.786 -1.196 . . . . 0.0 112.325 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -42.46 -28.13 0.2 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.411 -0.806 . . . . 0.0 112.182 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.23 -137.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 111.177 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.416 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 84.5 m-20 -72.43 73.97 1.02 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.9 -1.125 . . . . 0.0 112.129 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 503' ' ' SER . 41.2 t -137.73 164.52 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.42 -0.8 . . . . 0.0 110.668 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 432' ' ' SER . 1.5 mm-40 -160.59 162.21 32.77 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.839 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 8.5 t -114.65 111.62 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 120.947 -1.096 . . . . 0.0 113.794 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 506' ' ' ILE . 5.2 tp -102.2 114.86 29.38 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.657 HG22 ' CG1' ' A' ' 507' ' ' VAL . 7.9 pt -133.33 161.46 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 C-N-CA 118.677 -1.209 . . . . 0.0 112.596 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.594 HG22 ' HB ' ' A' ' 436' ' ' VAL . 68.9 p -131.16 -171.56 2.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 24.0 t70 -151.12 157.58 42.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.83 20.87 2.15 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.387 -0.821 . . . . 0.0 110.794 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -153.75 -42.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -78.79 0.32 27.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.503 -0.998 . . . . 0.0 111.229 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . 0.448 ' HG3' HG23 ' A' ' 541' ' ' THR . 33.6 ptt-85 -38.1 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 540' ' ' ARG . 4.0 p -102.36 -25.14 13.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.962 -1.086 . . . . 0.0 110.623 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -127.51 55.57 0.75 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 8.9 t -75.17 -15.64 60.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.783 -0.833 . . . . 0.0 111.542 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.09 93.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 87.8 p -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -1.044 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.43 -36.46 76.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 109.628 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 543' ' ' THR . 10.4 mp -61.71 -43.21 99.28 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.405 -0.809 . . . . 0.0 109.163 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.7 ttp -63.34 -35.14 79.39 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -52.0 -50.64 60.94 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.726 ' HG3' HD11 ' A' ' 519' ' ' LEU . 28.2 ttt -57.97 -46.1 85.67 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -60.9 -31.45 70.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.414 -0.804 . . . . 0.0 111.052 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.83 -20.86 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.389 -0.82 . . . . 0.0 110.071 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -73.82 3.3 6.8 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.426 -0.796 . . . . 0.0 112.64 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.63 -13.26 8.75 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.419 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.04 109.9 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.269 . . . . 0.0 109.911 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -170.89 147.81 2.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.566 -0.709 . . . . 0.0 110.268 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . 0.604 HG23 ' HA3' ' A' ' 562' ' ' GLY . 94.2 m -92.6 120.76 33.36 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -89.56 -78.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.043 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -137.62 -78.63 0.38 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.339 -0.85 . . . . 0.0 110.126 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.35 -17.56 34.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.805 . . . . 0.0 110.842 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -116.24 141.69 47.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.069 -1.019 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . 0.604 ' HA3' HG23 ' A' ' 557' ' ' THR . . . 141.88 50.37 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 76.01 12.9 83.67 Favored Glycine 0 N--CA 1.495 2.604 0 O-C-N 121.519 -0.989 . . . . 0.0 110.681 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -94.61 -8.78 37.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.229 -1.16 . . . . 0.0 110.72 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -92.59 -5.73 50.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 0.0 110.81 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -162.42 50.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.221 -0.924 . . . . 0.0 110.561 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 566' ' ' ARG . 47.4 Cg_endo -71.69 -15.85 30.18 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.372 1.196 . . . . 0.0 111.431 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -114.44 -23.64 9.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 110.983 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.425 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.103 0.478 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 78.2 p -61.27 -38.64 87.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.365 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 154.88 69.79 0.01 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.588 ' O ' HG22 ' A' ' 384' ' ' ILE . 49.5 mm -101.3 11.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.617 -0.931 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -91.42 -4.14 55.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 0.0 111.248 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 14.8 p -107.41 129.55 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 0.0 109.872 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.45 146.61 46.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -78.92 91.1 4.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.363 -0.836 . . . . 0.0 110.744 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.88 54.76 1.82 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.74 . . . . 0.0 109.96 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 35.2 tp -62.59 -40.26 96.34 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.979 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 3.9 t -60.63 -45.72 92.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.456 -0.777 . . . . 0.0 110.68 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.66 -28.48 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.266 -0.896 . . . . 0.0 110.942 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -64.51 -52.3 58.52 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.999 -1.063 . . . . 0.0 111.533 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.32 77.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.336 -0.853 . . . . 0.0 109.134 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.604 ' CD2' HD12 ' A' ' 399' ' ' ILE . 8.0 tt -61.27 -38.06 85.35 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.6 t -65.51 -43.65 89.41 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.118 -0.989 . . . . 0.0 111.781 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -64.07 -45.36 89.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.319 -0.863 . . . . 0.0 111.964 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -64.94 -44.86 88.06 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.29 -0.881 . . . . 0.0 111.283 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.791 HG23 ' HD1' ' A' ' 419' ' ' TYR . 71.4 mt -63.98 -41.83 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.34 -0.85 . . . . 0.0 110.519 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 5.6 tpp -60.62 -35.01 75.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.351 -0.843 . . . . 0.0 109.995 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.35 -31.03 70.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.566 ' O ' HG12 ' A' ' 405' ' ' VAL . 5.6 tp-100 -87.45 -16.59 34.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.801 -1.187 . . . . 0.0 108.78 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.33 -31.98 70.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.722 -0.611 . . . . 0.0 110.273 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -113.67 17.84 17.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.713 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 407' ' ' VAL . 7.6 p -52.46 108.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.59 -0.694 . . . . 0.0 109.729 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 64.9 p -50.03 98.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.462 -0.774 . . . . 0.0 111.37 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 405' ' ' VAL . 58.6 t -107.24 133.02 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -94.32 142.21 24.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.572 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.22 -21.91 54.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.336 1.177 . . . . 0.0 110.318 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -60.46 -40.29 90.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 110.002 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 68.28 1.23 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 33.4 t -53.89 110.62 0.61 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.299 -0.876 . . . . 0.0 110.185 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 413' ' ' VAL . 7.8 p -62.63 111.54 4.95 Favored Pre-proline 0 N--CA 1.492 1.653 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.813 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.8 133.32 21.66 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.096 1.051 . . . . 0.0 109.972 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.91 63.6 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.485 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 68.8 p -66.0 -33.16 75.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 108.762 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -63.59 -10.26 17.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.626 -0.671 . . . . 0.0 111.578 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.56 51.93 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.965 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.791 ' HD1' HG23 ' A' ' 399' ' ' ILE . 12.9 m-85 -93.16 -2.04 55.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.61 -1.524 . . . . 0.0 110.133 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 4.8 m -82.48 -33.0 28.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 108.781 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 425' ' ' VAL . 98.0 m-20 -78.88 -44.42 22.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.635 -0.666 . . . . 0.0 110.123 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.94 -42.02 95.02 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.636 -0.665 . . . . 0.0 111.412 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.927 HG21 ' CG2' ' A' ' 436' ' ' VAL . 88.8 t -80.2 -44.13 22.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.773 -0.579 . . . . 0.0 112.258 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.1 m -60.28 -42.01 94.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.929 -1.107 . . . . 0.0 110.475 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 421' ' ' ASP . 13.5 p -64.22 -29.76 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.422 -0.799 . . . . 0.0 109.465 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -68.32 -31.77 71.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.554 -0.716 . . . . 0.0 110.074 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.5 -36.49 78.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.056 -1.028 . . . . 0.0 108.771 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.13 -28.87 63.09 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -67.46 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.514 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 6.0 tmm_? -173.04 -58.15 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 120.726 -1.234 . . . . 0.0 110.397 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.3 Cg_endo -71.17 120.48 7.04 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 N-CA-C 110.182 -0.738 . . . . 0.0 110.182 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.467 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 2.0 t -94.91 99.96 11.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.465 -0.772 . . . . 0.0 110.108 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.805 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.8 tp -163.24 98.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.955 -1.091 . . . . 0.0 110.741 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -140.48 177.14 8.22 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.504 0.669 . . . . 0.0 111.047 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.459 ' O ' HG21 ' A' ' 399' ' ' ILE . 3.3 mt -117.43 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.819 -0.551 . . . . 0.0 110.146 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.927 ' CG2' HG21 ' A' ' 423' ' ' VAL . 67.1 t -133.47 140.05 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.47 -0.769 . . . . 0.0 110.473 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 19.1 m -132.25 142.87 49.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.711 -0.618 . . . . 0.0 109.586 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.01 162.95 22.08 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -120.43 -42.74 2.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.679 -0.895 . . . . 0.0 109.308 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -163.83 63.82 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 173.62 86.2 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -106.23 -28.23 10.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.512 -0.993 . . . . 0.0 110.724 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.49 79.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.444 -0.785 . . . . 0.0 110.781 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -77.97 -30.74 50.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.12 -31.55 64.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.401 -1.058 . . . . 0.0 109.348 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.439 ' HD2' ' HB1' ' A' ' 467' ' ' ALA . 61.2 ttp180 -62.9 -43.66 98.2 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.569 0.699 . . . . 0.0 110.152 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 47.7 tt0 -80.0 -29.46 39.47 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -0.853 . . . . 0.0 110.619 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -62.62 -47.69 82.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 446' ' ' ARG . 12.0 p -60.32 -31.53 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.903 -1.123 . . . . 0.0 108.227 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -61.2 -28.45 69.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.806 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 454' ' ' MET . 53.6 tp10 -63.14 -32.9 74.39 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.45 -33.05 74.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.884 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.6 t -59.98 -29.8 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 451' ' ' GLU . 61.4 mtt -66.65 -36.07 81.68 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 66.3 ttp -57.23 -27.52 62.1 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.576 -0.702 . . . . 0.0 109.435 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.27 -23.1 32.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.64 -0.663 . . . . 0.0 109.777 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -64.39 -44.64 90.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -71.46 -30.9 66.55 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.503 0.668 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -76.38 -2.16 30.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.676 -0.64 . . . . 0.0 110.981 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.44 25.68 74.83 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.78 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 41.1 ttm180 -133.38 120.78 21.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.501 -1.0 . . . . 0.0 110.552 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 92.9 mt-10 -79.85 172.1 14.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.884 ' CG2' HG13 ' A' ' 453' ' ' VAL . 27.2 m -144.46 153.02 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.62 ' HB3' HG22 ' A' ' 505' ' ' VAL . 54.1 tt0 -97.82 120.2 37.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.713 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -131.34 135.06 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.044 -1.035 . . . . 0.0 110.321 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.758 HG23 ' HD3' ' A' ' 471' ' ' ARG . 93.2 mt -127.51 123.55 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 446' ' ' ARG . . . -78.81 162.96 25.74 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -161.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.666 -0.646 . . . . 0.0 109.294 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -47.64 -19.03 0.17 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.783 -1.198 . . . . 0.0 111.69 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.31 -7.17 54.37 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.092 -1.005 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.758 ' HD3' HG23 ' A' ' 466' ' ' ILE . 58.2 ttp180 -57.09 -24.9 57.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.035 -1.041 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 40.4 t -58.44 -45.36 88.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.403 -0.811 . . . . 0.0 110.181 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.95 -40.67 96.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 108.623 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 7.6 ttm -57.25 -39.5 75.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.742 -0.599 . . . . 0.0 110.446 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -57.11 -35.43 69.43 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 53.5 tpp -59.67 -36.77 77.1 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.347 0.594 . . . . 0.0 110.04 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 61.0 pttt -134.76 -145.87 0.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.586 . . . . 0.0 110.403 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 92.8 mm-40 51.11 40.95 26.96 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.749 -1.219 . . . . 0.0 111.498 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.33 10.85 18.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.463 -0.773 . . . . 0.0 110.313 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 480' ' ' GLU . 74.7 tt0 -82.74 -3.94 57.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 111.487 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.801 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.1 OUTLIER -159.78 15.23 0.14 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.698 -1.201 . . . . 0.0 113.206 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.801 HD23 ' HG2' ' A' ' 481' ' ' ARG . 1.6 pp -169.45 38.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.716 -1.24 . . . . 0.0 111.888 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 90.8 p -87.78 50.4 1.99 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.215 -0.928 . . . . 0.0 110.401 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.32 24.77 28.01 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -125.49 57.64 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.517 -0.99 . . . . 0.0 108.982 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 464' ' ' GLN . 84.7 mt -97.49 -82.05 0.42 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.786 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 175.77 -35.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 174.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.544 HG21 ' OE1' ' A' ' 464' ' ' GLN . 8.8 t -104.28 10.45 35.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.884 -0.51 . . . . 0.0 111.112 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -149.66 93.91 0.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 491' ' ' ARG . 34.9 ttm180 -139.82 -81.15 0.28 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 490' ' ' ARG . 8.7 ptm180 -134.18 -13.91 2.37 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.986 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.531 ' HB2' ' CE2' ' A' ' 499' ' ' PHE . 8.2 mt-30 -61.42 -30.69 70.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.879 -1.138 . . . . 0.0 111.252 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.456 HD23 ' HZ ' ' A' ' 499' ' ' PHE . 36.0 mt -64.88 -57.64 8.29 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 494' ' ' LEU . 2.2 tm? -63.36 -37.98 89.36 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.925 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.55 -7.63 58.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.766 -0.584 . . . . 0.0 112.541 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.34 60.19 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 492' ' ' GLN . 96.2 mtp -122.7 -173.49 2.71 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.375 -1.074 . . . . 0.0 110.046 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -103.25 165.93 10.74 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.669 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 492' ' ' GLN . 65.2 m-85 -111.58 152.6 27.39 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.651 0.739 . . . . 0.0 112.284 -174.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 487' ' ' ILE . 5.5 m -69.86 112.2 11.55 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.27 115.69 2.3 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.284 1.149 . . . . 0.0 111.226 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.58 27.64 0.04 OUTLIER Glycine 0 N--CA 1.505 3.29 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.294 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.786 ' HB3' HG21 ' A' ' 487' ' ' ILE . 12.5 p -96.84 -177.39 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.959 -1.318 . . . . 0.0 111.877 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.734 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.4 m -118.51 112.36 19.82 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.822 HG11 HD11 ' A' ' 522' ' ' LEU . 57.1 t -106.03 137.2 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 119.661 -0.815 . . . . 0.0 112.564 -175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.0 pt -134.26 163.13 37.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 534' ' ' ILE . 10.1 p -159.95 106.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 122.873 1.32 . . . . 0.0 111.842 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.94 122.45 28.29 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.584 ' HG2' HG22 ' A' ' 507' ' ' VAL . 86.7 mm-40 -145.17 112.54 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -176.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -73.67 -34.36 56.78 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -90.45 147.16 23.59 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.32 -10.49 22.25 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.025 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 513' ' ' LEU . 14.7 tp -64.32 -34.63 78.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.17 -0.956 . . . . 0.0 108.429 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 71.6 m -87.75 -17.44 31.66 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.38 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 519' ' ' LEU . 56.4 tp -67.62 -46.43 72.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 108.765 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 99.9 mttt -70.29 -40.46 74.27 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.76 -49.96 75.38 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.253 -0.905 . . . . 0.0 111.06 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.591 HG21 HD12 ' A' ' 466' ' ' ILE . 91.3 m -56.5 -39.99 74.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.34 -0.85 . . . . 0.0 109.834 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.3 OUTLIER -54.89 -38.91 68.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.593 -0.692 . . . . 0.0 110.123 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 99.4 m -62.45 -39.19 92.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.512 -0.742 . . . . 0.0 109.783 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.497 HD23 ' NE2' ' A' ' 464' ' ' GLN . 49.2 tp -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.498 -0.751 . . . . 0.0 110.391 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.822 HD11 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -61.26 -21.46 63.93 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.484 -0.76 . . . . 0.0 111.08 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -45.81 -65.33 0.56 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.76 -51.68 55.76 Favored Glycine 0 N--CA 1.503 3.15 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.521 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' A' ' 488' ' ' THR . . . -59.03 -32.46 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.56 -0.965 . . . . 0.0 111.296 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -65.4 -22.47 66.79 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.151 -0.968 . . . . 0.0 112.437 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -39.18 -28.23 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -119.04 -110.98 0.34 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.142 -0.974 . . . . 0.0 111.828 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -90.8 93.12 9.09 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.381 -1.449 . . . . 0.0 113.578 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 14.5 t -141.19 166.17 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.859 -1.15 . . . . 0.0 111.498 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.467 ' HG2' ' N ' ' A' ' 432' ' ' SER . 1.1 tp-100 -164.68 163.25 21.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.805 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 12.9 t -114.64 107.39 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.658 ' HB3' HG22 ' A' ' 506' ' ' ILE . 1.6 tp -104.53 119.04 38.06 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.83 HG22 HG12 ' A' ' 507' ' ' VAL . 14.9 pt -140.5 161.03 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 117.613 -1.635 . . . . 0.0 112.96 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.703 HG22 ' HB ' ' A' ' 436' ' ' VAL . 81.7 p -121.74 -169.86 1.94 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -149.16 155.79 41.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.804 . . . . 0.0 110.001 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.18 20.38 2.43 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.042 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.06 -46.21 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.452 ' OE1' ' HB1' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.93 2.44 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.888 . . . . 0.0 111.648 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . 0.642 ' HG3' HG23 ' A' ' 541' ' ' THR . 40.1 ptt180 -36.33 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.7 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 540' ' ' ARG . 66.7 p -93.02 117.98 30.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.074 -1.016 . . . . 0.0 109.242 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 63.83 70.21 1.12 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.415 ' O ' HD13 ' A' ' 547' ' ' LEU . 74.9 p -80.13 -3.17 47.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.752 -0.852 . . . . 0.0 111.981 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -58.65 -35.59 81.87 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 -32.54 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.827 -0.808 . . . . 0.0 110.279 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -65.17 -35.19 80.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.648 -0.658 . . . . 0.0 109.324 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 543' ' ' THR . 10.1 mp -62.45 -43.28 99.2 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.796 -0.565 . . . . 0.0 110.639 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 93.4 mtp -65.2 -37.61 87.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -50.92 -51.46 51.82 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.099 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.424 ' CG ' HD11 ' A' ' 519' ' ' LEU . 38.0 ttp -58.29 -40.47 82.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.364 -0.835 . . . . 0.0 109.561 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . 0.412 ' HG3' ' HB ' ' A' ' 555' ' ' VAL . 85.3 tttt -61.9 -32.17 72.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.0 110.368 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.4 -16.09 62.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 0.0 110.352 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -77.14 8.41 3.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.214 -0.929 . . . . 0.0 112.629 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 155.79 -16.74 0.47 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.255 -1.45 . . . . 0.0 111.79 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 551' ' ' LYS . 53.2 t -86.96 97.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 118.967 1.384 . . . . 0.0 109.273 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -154.86 129.94 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.897 -0.502 . . . . 0.0 109.873 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 75.3 m -103.27 122.39 44.68 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -73.92 -80.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.814 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -175.8 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.206 -0.934 . . . . 0.0 110.589 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -88.39 -21.98 24.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.478 -0.764 . . . . 0.0 111.28 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -130.02 147.27 51.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 111.333 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -107.51 122.42 6.82 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 59.1 64.19 4.5 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.19 -5.23 55.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -1.012 . . . . 0.0 111.291 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -89.1 -1.19 57.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.55 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -152.72 51.72 0.77 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.466 -0.771 . . . . 0.0 111.299 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 38.8 Cg_endo -85.49 -39.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 122.869 0.931 . . . . 0.0 111.098 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -165.43 30.05 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.253 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.065 179.879 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 120.922 0.392 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 6.1 t -60.07 -43.95 95.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.439 -0.788 . . . . 0.0 110.238 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -155.7 132.24 3.32 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 89.8 mt -102.97 -25.07 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.984 . . . . 0.0 110.787 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -89.59 11.99 18.01 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.213 -0.929 . . . . 0.0 111.208 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 11.0 p -111.14 132.0 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.364 -0.835 . . . . 0.0 110.763 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.4 mm? -76.28 145.24 39.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.611 -0.68 . . . . 0.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -141.75 117.77 10.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.502 -0.749 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -111.1 30.78 6.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.609 -0.682 . . . . 0.0 109.836 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.48 -42.36 98.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.729 -0.607 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 33.9 p -64.36 -37.69 88.38 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.477 -0.764 . . . . 0.0 110.585 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 79.8 t -65.9 -35.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -62.75 -51.37 67.41 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.418 -0.801 . . . . 0.0 110.815 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -64.63 -34.96 79.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.424 -0.798 . . . . 0.0 109.811 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 422' ' ' ALA . 2.9 tt -62.18 -39.06 91.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.968 -0.458 . . . . 0.0 111.123 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.2 m -62.65 -37.47 86.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.43 -44.18 92.0 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.905 . . . . 0.0 112.249 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -63.95 -45.02 91.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.061 -1.024 . . . . 0.0 111.639 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.09 -40.84 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.724 -0.61 . . . . 0.0 109.965 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.486 ' CG ' HD11 ' A' ' 435' ' ' ILE . 30.9 mtp -63.73 -32.58 74.11 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.575 -0.703 . . . . 0.0 110.416 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.05 -32.24 70.72 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.106 -0.996 . . . . 0.0 110.143 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -91.17 -14.68 30.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.432 ' ND2' ' CB ' ' A' ' 437' ' ' SER . 2.2 t-20 -67.11 -36.98 83.1 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.482 -0.761 . . . . 0.0 109.5 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -115.33 20.38 14.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 12.5 p -37.34 146.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 122.149 -0.344 . . . . 0.0 110.692 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 14.1 p -72.89 72.91 1.12 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.346 -0.846 . . . . 0.0 109.976 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.894 HG21 HG22 ' A' ' 413' ' ' VAL . 12.3 p -111.14 133.39 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.945 0.878 . . . . 0.0 112.819 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -92.37 145.76 31.23 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.698 -0.627 . . . . 0.0 109.848 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.96 -28.95 81.33 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 O-C-N 123.05 1.026 . . . . 0.0 109.825 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.57 -26.54 2.27 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-O 121.766 0.793 . . . . 0.0 111.168 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 67.21 0.75 Allowed 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 82.4 p -51.07 109.86 0.37 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.522 -0.737 . . . . 0.0 110.585 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.894 HG22 HG21 ' A' ' 407' ' ' VAL . 19.9 m -76.68 110.45 11.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.886 -0.509 . . . . 0.0 110.558 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.92 137.95 42.91 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 N-CA-C 109.663 -0.937 . . . . 0.0 109.663 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -147.73 83.53 1.53 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 113.704 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.532 HG22 ' OH ' ' A' ' 419' ' ' TYR . 33.0 p -100.09 26.85 6.03 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.021 -1.05 . . . . 0.0 108.481 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -110.06 -31.71 7.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.319 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -57.7 -50.59 64.14 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.603 ' CG ' HG13 ' A' ' 436' ' ' VAL . 30.0 p90 -98.96 -11.77 21.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.814 -1.403 . . . . 0.0 111.975 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 416' ' ' THR . 6.2 t -65.92 -47.4 74.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.336 -1.477 . . . . 0.0 109.197 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 425' ' ' VAL . 65.6 t0 -77.21 -45.36 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 110.63 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -57.97 -49.14 77.82 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.597 -0.69 . . . . 0.0 111.475 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.735 ' HA ' HD23 ' A' ' 426' ' ' LEU . 61.1 t -69.85 -43.15 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.717 -0.614 . . . . 0.0 112.021 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.7 p -56.73 -39.96 74.85 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.113 -0.992 . . . . 0.0 111.225 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 421' ' ' ASP . 94.4 t -65.99 -43.84 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.784 . . . . 0.0 109.834 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.2 OUTLIER -60.55 -34.14 73.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 112.045 -178.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -37.03 77.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.348 -1.47 . . . . 0.0 108.056 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.77 -29.63 70.26 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . . . . . . . . . 5.3 tpp85 -179.44 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.344 -1.473 . . . . 0.0 108.969 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.7 99.14 0.72 Allowed 'Trans proline' 0 N--CA 1.484 0.913 0 N-CA-C 108.938 -1.216 . . . . 0.0 108.938 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 4.3 t -87.59 101.3 13.5 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.765 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 0.6 OUTLIER -156.82 88.95 1.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 109.989 179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -142.99 164.97 28.63 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.894 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.486 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.2 pp -114.57 128.54 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.879 -0.513 . . . . 0.0 109.714 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 423' ' ' VAL . 75.6 t -124.37 140.88 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.759 -0.588 . . . . 0.0 109.755 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.432 ' CB ' ' ND2' ' A' ' 403' ' ' ASN . 4.8 m -126.65 132.61 51.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 110.908 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -98.92 169.82 23.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -141.75 32.0 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.944 . . . . 0.0 109.626 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 138.08 168.73 11.4 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.84 92.55 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.85 88.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.906 . . . . 0.0 110.418 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.71 96.22 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.278 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.11 75.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.47 -38.82 81.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.981 . . . . 0.0 110.472 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 449' ' ' VAL . 90.3 mmt-85 -64.26 -40.22 95.54 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.368 -0.833 . . . . 0.0 110.138 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -70.81 -30.13 66.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 451' ' ' GLU . 95.7 mtt-85 -65.7 -46.68 78.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.372 -0.83 . . . . 0.0 111.575 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.5 p -60.56 -32.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.774 -1.203 . . . . 0.0 108.974 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -62.82 -28.37 69.96 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.466 -0.893 . . . . 0.0 108.691 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 448' ' ' ARG . 80.0 tt0 -67.61 -37.58 82.74 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 4.5 tt -63.08 -37.0 85.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 463' ' ' VAL . 67.8 t -59.27 -26.66 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.679 -0.638 . . . . 0.0 109.314 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 17.0 mmt -67.66 -36.49 80.84 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 459' ' ' GLN . 14.8 tmm? -59.45 -29.05 67.51 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.834 -0.541 . . . . 0.0 110.233 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.04 -21.13 37.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.476 -0.765 . . . . 0.0 109.929 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.97 -44.16 96.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -72.68 -25.33 61.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.651 -0.656 . . . . 0.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 455' ' ' MET . 96.9 mm-40 -77.27 2.41 15.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.338 -0.851 . . . . 0.0 111.268 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.83 82.85 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 120.936 -1.103 . . . . 0.0 111.705 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.0 ptt-85 -138.06 144.53 41.01 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 118.821 1.31 . . . . 0.0 111.428 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.65 ' C ' HD11 ' A' ' 487' ' ' ILE . 98.1 mt-10 -89.44 175.3 7.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 453' ' ' VAL . 16.6 m -138.74 162.38 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.855 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.78 115.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.584 HG23 HD22 ' A' ' 482' ' ' LEU . 1.2 tp -119.2 120.55 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.788 -1.195 . . . . 0.0 112.116 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 507' ' ' VAL . 94.9 mt -107.66 172.95 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.795 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 466' ' ' ILE . . . -129.41 156.6 43.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.29 -159.75 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.673 -0.642 . . . . 0.0 109.424 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -46.84 -15.98 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.904 -1.122 . . . . 0.0 112.849 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -88.05 4.93 43.4 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.879 -1.138 . . . . 0.0 111.985 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 14.2 tpt180 -58.57 -37.61 76.14 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.066 -1.021 . . . . 0.0 111.14 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 53.5 m -56.11 -47.18 78.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.447 -0.783 . . . . 0.0 111.1 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -65.97 -37.71 86.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.373 -0.829 . . . . 0.0 109.101 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.445 ' HE3' ' HE2' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -58.98 -34.45 71.84 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.748 -0.595 . . . . 0.0 110.192 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -61.39 -39.84 92.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.603 . . . . 0.0 109.593 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 59.6 ttp -62.01 -41.61 98.25 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.445 ' HE2' ' HE3' ' A' ' 474' ' ' MET . 22.6 pttm -111.01 -150.1 0.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 109.052 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.552 ' NE2' HD21 ' A' ' 482' ' ' LEU . 41.1 tt0 48.26 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.021 -1.05 . . . . 0.0 112.302 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -132.91 21.48 4.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.605 . . . . 0.0 110.463 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 480' ' ' GLU . 47.7 tp10 -110.15 3.67 20.37 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.397 -0.814 . . . . 0.0 111.408 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.631 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -137.17 -24.31 1.1 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.905 -1.122 . . . . 0.0 112.421 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.631 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -158.21 69.64 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.106 -0.997 . . . . 0.0 110.81 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 24.7 t -90.38 51.15 1.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.598 -0.689 . . . . 0.0 110.69 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.58 16.82 23.37 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.081 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -126.16 59.9 1.32 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.177 -1.19 . . . . 0.0 109.332 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 487' ' ' ILE . 84.7 mt -64.18 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.069 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.784 HD11 ' CA ' ' A' ' 463' ' ' VAL . 14.4 mm -155.15 -82.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.16 -0.962 . . . . 0.0 109.736 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.553 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.0 t -98.99 12.25 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.784 -0.572 . . . . 0.0 110.761 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -97.05 79.93 0.69 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.529 -1.828 . . . . 0.0 108.529 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -145.54 -67.99 0.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 495' ' ' GLU . 95.7 mtt-85 -96.75 -26.72 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.802 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -67.52 -44.34 78.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.933 -1.104 . . . . 0.0 110.524 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 493' ' ' LEU . 2.6 mt -70.59 -37.84 73.96 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.557 0.694 . . . . 0.0 110.94 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.8 OUTLIER -103.75 -39.98 6.45 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 491' ' ' ARG . 89.7 mt-10 -102.14 -9.47 20.48 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.097 -1.041 . . . . 0.0 112.815 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 84.31 -9.18 64.9 Favored Glycine 0 N--CA 1.5 2.949 0 O-C-N 120.523 -1.36 . . . . 0.0 111.111 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.428 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 99.4 mtp -68.17 179.25 1.6 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.079 -1.248 . . . . 0.0 112.11 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -111.55 153.77 25.77 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.4 155.04 25.95 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.191 0.996 . . . . 0.0 112.036 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 500' ' ' THR . 7.3 t -44.6 132.33 4.89 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.642 -177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.446 ' HB3' ' CA ' ' A' ' 528' ' ' HIS . 56.3 Cg_endo -85.51 112.94 1.35 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.596 1.314 . . . . 0.0 109.51 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.11 26.05 0.07 OUTLIER Glycine 0 N--CA 1.504 3.194 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.987 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 487' ' ' ILE . 74.7 m -92.8 173.87 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -1.207 . . . . 0.0 111.022 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.806 ' HB ' HG12 ' A' ' 463' ' ' VAL . 91.6 m -115.66 127.71 55.37 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.968 HG11 HD21 ' A' ' 522' ' ' LEU . 13.2 t -118.46 130.51 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.867 0.842 . . . . 0.0 111.125 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.705 HG22 ' HB3' ' A' ' 533' ' ' LEU . 6.1 pt -135.6 123.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 0.0 109.017 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 534' ' ' ILE . 14.5 p -113.73 115.18 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.023 -1.048 . . . . 0.0 110.647 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 36.7 m-20 -84.34 108.48 17.2 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.894 -1.129 . . . . 0.0 108.418 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 0.5 OUTLIER -99.73 175.36 5.83 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 122.376 1.084 . . . . 0.0 112.969 -176.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -173.81 -55.85 0.05 OUTLIER Glycine 0 N--CA 1.503 3.102 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.19 -155.05 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.51 -17.86 2.54 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.046 -1.033 . . . . 0.0 111.019 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 57.5 tp -72.43 -25.05 61.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.278 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 75.2 m -65.58 -44.31 87.05 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 110.492 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.894 HD21 ' HG3' ' A' ' 550' ' ' MET . 11.0 tp -64.46 -46.31 83.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.829 -0.544 . . . . 0.0 111.938 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -67.55 -43.81 79.8 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 0.0 112.084 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -62.5 -51.13 68.65 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.112 -0.992 . . . . 0.0 110.727 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 522' ' ' LEU . 97.4 m -59.81 -43.07 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.832 -0.542 . . . . 0.0 110.459 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -41.36 90.68 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.747 -0.596 . . . . 0.0 111.464 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 39.1 p -64.47 -33.27 75.49 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.053 -1.03 . . . . 0.0 109.832 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 60.8 tp -68.3 -40.44 81.75 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.694 0.759 . . . . 0.0 109.83 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.968 HD21 HG11 ' A' ' 505' ' ' VAL . 0.6 OUTLIER -70.97 -22.22 62.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.961 -0.462 . . . . 0.0 111.39 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 48.6 t0 -47.46 -60.17 2.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.393 -0.817 . . . . 0.0 111.895 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -63.88 -51.13 56.06 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.555 ' HB1' ' OD1' ' A' ' 529' ' ' ASN . . . -55.15 -29.83 58.58 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.684 -0.891 . . . . 0.0 110.414 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -47.96 -37.67 15.01 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -66.58 -42.51 86.89 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.446 ' CA ' ' HB3' ' A' ' 501' ' ' PRO . 32.2 m80 -94.62 -94.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.31 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.555 ' OD1' ' HB1' ' A' ' 525' ' ' ALA . 15.8 p-10 -83.69 144.17 29.56 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.963 -1.085 . . . . 0.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 4.2 p -171.81 146.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.392 -1.323 . . . . 0.0 113.836 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 505' ' ' VAL . 0.8 OUTLIER 171.86 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 76.5 t -110.44 104.95 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 O-C-N 120.742 -1.223 . . . . 0.0 113.258 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.705 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.6 OUTLIER -109.26 116.17 31.38 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.931 HG22 HG12 ' A' ' 507' ' ' VAL . 5.7 pt -127.91 155.19 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.475 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.705 HG22 ' HB ' ' A' ' 436' ' ' VAL . 61.4 p -128.87 -172.69 2.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -149.4 156.04 41.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 110.563 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 85.3 p -145.32 23.26 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.639 -0.663 . . . . 0.0 110.654 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -163.63 -41.6 0.02 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.63 ' CD ' ' HB2' ' A' ' 546' ' ' ALA . 46.3 tt0 -81.63 0.4 38.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.536 -0.979 . . . . 0.0 110.939 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 541' ' ' THR . 40.8 ptt180 -40.58 -39.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.583 -0.698 . . . . 0.0 112.23 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.416 ' N ' ' HG3' ' A' ' 540' ' ' ARG . 40.5 p -63.86 -91.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -70.25 79.53 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 543' ' ' THR . 9.4 t -87.06 -18.72 29.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.953 . . . . 0.0 111.611 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.22 -38.97 93.97 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 18.9 m -69.17 -24.93 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.515 -0.991 . . . . 0.0 109.792 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.15 -36.53 77.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.76 -0.587 . . . . 0.0 109.865 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 547' ' ' LEU . 11.2 mp -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.298 -0.876 . . . . 0.0 108.877 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 56.8 ttm -64.55 -31.91 73.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.93 -50.39 61.23 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.894 ' HG3' HD21 ' A' ' 515' ' ' LEU . 90.0 mtp -58.43 -44.27 89.05 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.838 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 84.7 tttt -63.44 -32.07 73.4 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.459 -0.776 . . . . 0.0 111.474 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.67 -15.86 62.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.5 -0.75 . . . . 0.0 111.256 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.66 3.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.266 -0.896 . . . . 0.0 112.725 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 147.65 -13.08 1.35 Allowed Glycine 0 N--CA 1.499 2.849 0 C-N-CA 119.568 -1.301 . . . . 0.0 111.364 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 551' ' ' LYS . 62.9 t -85.77 103.23 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.015 -1.285 . . . . 0.0 110.708 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -151.6 114.09 4.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.784 . . . . 0.0 110.245 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 6.1 p -86.79 127.1 34.99 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.424 0.631 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -88.25 -87.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -153.48 -69.63 0.14 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.023 -1.048 . . . . 0.0 109.6 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -79.5 -20.16 47.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.686 -0.634 . . . . 0.0 110.031 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -137.98 119.65 15.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -150.59 -44.7 0.02 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -84.6 65.68 4.03 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -96.11 -24.54 16.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -1.003 . . . . 0.0 110.645 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -65.37 -37.53 87.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.783 . . . . 0.0 109.587 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.37 119.86 45.7 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.671 -0.643 . . . . 0.0 110.489 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.71 -1.65 11.81 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 O-C-N 123.161 1.085 . . . . 0.0 110.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.53 76.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.616 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.115 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.471 0.653 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 19.3 m -59.78 -34.09 72.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.618 -0.677 . . . . 0.0 110.271 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 126.18 74.02 0.21 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 384' ' ' ILE . 10.3 tp -141.85 55.09 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.957 . . . . 0.0 110.591 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -146.54 137.11 23.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.588 -0.695 . . . . 0.0 109.959 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.54 130.02 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.669 . . . . 0.0 109.593 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 387' ' ' LEU . 53.1 tp -108.88 -1.76 18.9 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.189 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -61.22 147.56 43.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.95 -1.094 . . . . 0.0 109.883 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -48.33 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.528 -0.733 . . . . 0.0 111.677 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -40.53 89.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 77.8 p -66.11 -41.44 90.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.386 -0.821 . . . . 0.0 110.442 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 433' ' ' LEU . 89.0 t -68.31 -33.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.679 -0.638 . . . . 0.0 110.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -58.37 -48.99 78.83 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.421 -0.799 . . . . 0.0 111.402 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.68 -32.17 71.79 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.949 0.88 . . . . 0.0 109.856 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.606 HD13 HD12 ' A' ' 399' ' ' ILE . 2.2 tm? -61.8 -41.53 97.87 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.758 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . 0.466 ' HB2' HD12 ' A' ' 435' ' ' ILE . 78.5 p -71.86 -34.68 69.43 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.193 -0.942 . . . . 0.0 112.641 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.0 -50.22 71.6 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.996 -1.065 . . . . 0.0 112.435 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.06 -43.14 71.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.263 -0.898 . . . . 0.0 112.014 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 395' ' ' LEU . 94.1 mt -61.41 -44.79 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.112 -0.992 . . . . 0.0 110.009 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.492 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 5.9 ttm -61.42 -31.55 71.49 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.617 -0.677 . . . . 0.0 110.758 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -62.26 -25.21 67.7 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.539 -0.726 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.628 ' O ' HG12 ' A' ' 405' ' ' VAL . 65.5 tp60 -99.79 -20.65 16.11 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.272 -0.893 . . . . 0.0 109.21 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.581 ' ND2' HG22 ' A' ' 399' ' ' ILE . 98.0 m-20 -82.7 -7.01 59.68 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -94.67 -56.47 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 402' ' ' GLN . 6.4 p -27.88 124.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.1 m -60.13 95.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 122.159 0.98 . . . . 0.0 109.979 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.903 HG21 ' CZ ' ' A' ' 415' ' ' ARG . 13.9 t -65.27 137.4 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.132 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.2 130.68 29.1 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.684 -0.635 . . . . 0.0 110.267 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.47 -20.79 41.27 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.117 1.061 . . . . 0.0 111.07 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.35 -32.6 71.78 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.787 0.803 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 69.88 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 13.0 m -49.69 142.3 8.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.524 -0.735 . . . . 0.0 110.791 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.835 HG12 HG13 ' A' ' 407' ' ' VAL . 11.4 p -98.86 143.88 27.17 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.38 136.63 56.1 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 N-CA-C 108.794 -1.272 . . . . 0.0 108.794 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.903 ' CZ ' HG21 ' A' ' 407' ' ' VAL . 98.1 mtt180 -123.18 -15.53 7.23 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.391 -0.818 . . . . 0.0 112.881 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.9 p -102.74 6.45 39.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.025 . . . . 0.0 109.014 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -78.51 -79.92 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.05 -1.031 . . . . 0.0 111.745 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -74.12 -4.75 68.95 Favored Glycine 0 N--CA 1.481 1.676 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.623 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.595 ' O ' HG23 ' A' ' 423' ' ' VAL . 81.7 m-85 -107.07 -1.94 21.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.616 -1.52 . . . . 0.0 110.207 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -84.88 -33.71 22.74 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 425' ' ' VAL . 47.3 t0 -72.63 -37.68 67.95 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.11 85.72 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.099 0.952 . . . . 0.0 110.301 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 436' ' ' VAL . 98.5 t -67.71 -40.98 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.253 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 13.4 t -69.45 -36.61 76.79 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.028 -1.045 . . . . 0.0 111.71 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 421' ' ' ASP . 87.0 t -65.27 -42.46 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.381 -0.825 . . . . 0.0 112.008 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.748 ' CD2' ' HB2' ' A' ' 434' ' ' ALA . 2.1 pp -65.51 -31.08 71.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.109 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.25 69.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.955 . . . . 0.0 109.424 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.15 -32.53 74.27 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -61.24 -86.49 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.534 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -172.18 -57.46 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 120.773 -1.205 . . . . 0.0 109.529 177.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 55.2 Cg_endo -71.07 103.44 1.38 Allowed 'Trans proline' 0 N--CA 1.488 1.198 0 N-CA-C 109.688 -0.928 . . . . 0.0 109.688 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 3.2 t -85.34 98.72 10.71 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.963 0.887 . . . . 0.0 110.712 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.76 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.2 tp -146.51 136.61 23.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -169.96 163.21 9.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.823 -1.173 . . . . 0.0 110.923 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.597 ' O ' HG21 ' A' ' 399' ' ' ILE . 22.1 mt -123.49 121.52 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.793 -0.567 . . . . 0.0 110.409 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 423' ' ' VAL . 57.3 t -127.27 137.14 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.917 . . . . 0.0 109.137 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 539' ' ' GLN . 4.1 p -131.83 139.24 48.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.98 -1.075 . . . . 0.0 111.536 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 537' ' ' SER . . . -148.88 168.06 29.37 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -148.67 70.01 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 110.48 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 133.24 148.97 6.02 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 61.68 32.31 81.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.68 -9.16 58.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.698 -0.884 . . . . 0.0 111.261 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.07 94.8 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.136 -0.978 . . . . 0.0 110.834 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -79.21 -28.01 54.34 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.94 -41.01 90.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.539 -0.977 . . . . 0.0 109.55 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.516 ' NE ' ' HB2' ' A' ' 467' ' ' ALA . 8.4 mmm180 -64.89 -40.15 94.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.876 -0.515 . . . . 0.0 111.173 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -70.27 -31.63 69.09 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.074 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.99 -50.49 64.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.52 -0.738 . . . . 0.0 112.051 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 506' ' ' ILE . 7.2 p -58.5 -33.57 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.665 -1.272 . . . . 0.0 109.174 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -61.89 -27.3 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -61.33 -33.95 74.45 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 455' ' ' MET . 1.5 tp -63.56 -38.43 91.08 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.847 HG13 ' CG2' ' A' ' 463' ' ' VAL . 91.8 t -58.88 -25.85 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 90.0 mtp -66.2 -39.77 89.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.45 -0.781 . . . . 0.0 109.221 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.3 OUTLIER -60.06 -23.44 63.76 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.874 0.845 . . . . 0.0 109.089 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 453' ' ' VAL . . . -83.77 -23.65 31.42 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.463 0.649 . . . . 0.0 109.878 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 23.9 tpt85 -67.0 -42.96 84.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -71.42 -27.9 63.61 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.726 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -74.89 0.02 17.02 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.617 -0.677 . . . . 0.0 111.725 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.41 24.36 76.43 Favored Glycine 0 N--CA 1.496 2.679 0 O-C-N 120.837 -1.164 . . . . 0.0 110.718 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 461' ' ' ARG . 16.8 ptp180 -129.87 136.27 49.34 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.215 -1.168 . . . . 0.0 110.953 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 487' ' ' ILE . 99.2 mt-10 -91.84 161.53 14.81 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 109.222 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.926 HG12 ' HB ' ' A' ' 504' ' ' THR . 29.1 m -136.77 153.22 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 111.271 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.939 ' HA ' HD22 ' A' ' 486' ' ' LEU . 53.4 tt0 -100.72 116.41 32.56 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 506' ' ' ILE . 1.1 pt -130.29 135.11 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.065 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.598 ' HB ' HG23 ' A' ' 507' ' ' VAL . 87.5 mt -126.22 122.12 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.118 -0.989 . . . . 0.0 111.86 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.516 ' HB2' ' NE ' ' A' ' 446' ' ' ARG . . . -66.03 155.88 35.4 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.452 -0.78 . . . . 0.0 109.128 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 508' ' ' ASP . . . -58.99 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.406 -0.809 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 511' ' ' GLU . 5.0 t0 -46.11 -22.68 0.24 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.23 -0.919 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -70.32 -4.65 23.11 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.446 -0.784 . . . . 0.0 110.892 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.478 ' HD2' ' HB3' ' A' ' 467' ' ' ALA . 6.1 tpt180 -53.77 -34.18 58.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.118 -0.989 . . . . 0.0 112.929 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 75.5 m -59.41 -45.23 92.08 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.137 -0.977 . . . . 0.0 110.074 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 476' ' ' MET . 51.4 tt0 -66.84 -39.35 87.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.7 -0.625 . . . . 0.0 109.932 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 15.8 mmt -60.39 -34.52 74.02 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -61.77 -36.23 80.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.28 -0.888 . . . . 0.0 108.621 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 473' ' ' GLN . 7.3 tpp -59.45 -41.94 90.82 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.568 0.699 . . . . 0.0 109.124 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -118.16 -146.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 46.06 88.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.216 -0.927 . . . . 0.0 111.627 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -131.79 22.55 4.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.735 -0.603 . . . . 0.0 110.139 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -115.77 -15.49 11.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.695 -0.628 . . . . 0.0 110.735 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.632 ' C ' HD23 ' A' ' 482' ' ' LEU . 22.4 mtt180 -118.15 -7.0 10.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 113.175 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 481' ' ' ARG . 0.6 OUTLIER -171.54 54.45 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 120.751 -1.218 . . . . 0.0 112.296 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.0 p -64.67 -21.63 66.78 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.926 -1.109 . . . . 0.0 110.576 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 149.67 48.17 0.02 OUTLIER Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.93 59.17 1.74 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.788 -0.83 . . . . 0.0 109.774 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.939 HD22 ' HA ' ' A' ' 464' ' ' GLN . 24.9 mt -80.17 -80.29 0.14 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' A' ' 503' ' ' SER . 0.1 OUTLIER 177.27 -41.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 174.131 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.629 HG23 HG22 ' A' ' 487' ' ' ILE . 6.9 p -103.85 9.53 36.84 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.503 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.4 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -103.14 60.78 0.48 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 499' ' ' PHE . 54.7 ttm-85 -144.12 -50.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.576 -0.956 . . . . 0.0 108.835 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 497' ' ' MET . 98.0 mtt180 -122.97 -29.86 3.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.976 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -65.2 -41.19 94.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -0.921 . . . . 0.0 110.534 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 493' ' ' LEU . 5.8 mt -86.58 -31.48 21.17 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.503 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 494' ' ' LEU . 0.9 OUTLIER -102.93 -43.57 5.49 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -100.13 -9.65 22.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.535 -1.353 . . . . 0.0 113.904 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 90.22 -18.83 46.57 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.676 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 98.3 mtp -66.36 -178.47 0.67 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -1.151 . . . . 0.0 109.935 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -114.23 145.7 41.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.0 110.734 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 487' ' ' ILE . 0.2 OUTLIER -114.35 149.32 36.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.664 -0.648 . . . . 0.0 110.645 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 94.6 m -50.54 103.71 0.38 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 0.0 109.811 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 528' ' ' HIS . 44.3 Cg_endo -72.37 113.04 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.559 1.294 . . . . 0.0 108.928 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 529' ' ' ASN . . . 171.05 34.33 0.03 OUTLIER Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 487' ' ' ILE . 22.8 p -92.91 179.04 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -1.061 . . . . 0.0 110.654 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.926 ' HB ' HG12 ' A' ' 463' ' ' VAL . 97.8 m -111.17 121.6 45.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.87 ' CG1' HD21 ' A' ' 522' ' ' LEU . 63.4 t -123.02 134.89 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.205 -0.934 . . . . 0.0 113.227 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.669 HG22 ' HB3' ' A' ' 533' ' ' LEU . 4.2 pt -131.99 120.29 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 534' ' ' ILE . 9.8 p -106.1 114.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.537 -1.352 . . . . 0.0 111.478 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 467' ' ' ALA . 12.0 m-20 -82.27 108.5 15.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.9 tm0? -106.83 175.15 5.6 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.349 1.071 . . . . 0.0 113.305 -175.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -170.58 -51.91 0.04 OUTLIER Glycine 0 N--CA 1.503 3.145 0 N-CA-C 103.401 -3.88 . . . . 0.0 103.401 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 469' ' ' ASP . 32.0 tp10 -82.17 162.94 22.26 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 173.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -99.69 -12.32 20.11 Favored 'General case' 0 C--N 1.274 -2.712 0 O-C-N 121.636 -0.665 . . . . 0.0 110.658 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 513' ' ' LEU . 4.5 mm? -67.44 -27.16 66.81 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 16.2 m -91.43 -13.06 32.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 111.225 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 519' ' ' LEU . 20.5 tp -78.34 -46.84 19.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.05 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 553' ' ' ALA . 13.6 ptpt -80.61 -38.52 29.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.467 -0.77 . . . . 0.0 111.512 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.64 -44.39 96.39 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.9 -1.125 . . . . 0.0 109.702 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.783 HG22 HD12 ' A' ' 522' ' ' LEU . 85.8 m -62.2 -41.96 98.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.8 OUTLIER -60.2 -31.76 70.45 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.762 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 21.4 m -64.65 -53.98 39.03 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.855 -1.153 . . . . 0.0 110.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 521' ' ' LEU . 0.2 OUTLIER -62.74 -39.27 93.57 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.133 -0.979 . . . . 0.0 109.888 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.87 HD21 ' CG1' ' A' ' 505' ' ' VAL . 3.2 mt -65.34 -31.98 73.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.459 -0.776 . . . . 0.0 112.181 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -53.06 -45.9 68.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.017 -1.052 . . . . 0.0 110.325 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -65.25 -49.33 62.13 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -67.13 -36.52 82.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.508 -0.995 . . . . 0.0 112.375 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -26.38 68.22 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.956 -1.09 . . . . 0.0 110.872 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -53.72 -25.8 20.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.485 -0.759 . . . . 0.0 109.243 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.514 ' CG ' ' HG2' ' A' ' 501' ' ' PRO . 75.7 m80 -109.98 -130.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.433 ' HB2' ' CA ' ' A' ' 502' ' ' GLY . 98.1 m-20 -89.91 70.65 7.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.532 -1.355 . . . . 0.0 113.234 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -133.28 158.0 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -148.77 154.59 39.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.759 -0.588 . . . . 0.0 109.608 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 35.4 t -107.14 106.55 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.35 -0.844 . . . . 0.0 113.12 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.669 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.2 tp -106.72 113.66 27.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.885 HG22 HG12 ' A' ' 507' ' ' VAL . 12.1 pt -125.56 130.4 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 118.423 -1.311 . . . . 0.0 112.028 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 62.5 p -96.8 179.03 5.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 8.3 t0 -154.82 161.0 41.64 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.589 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 438' ' ' GLY . 0.1 OUTLIER -138.59 14.58 2.74 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.464 178.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -146.95 20.19 1.6 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.421 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 56.4 tt0 -93.83 -0.95 55.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.301 -1.117 . . . . 0.0 111.038 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -55.86 -42.75 76.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.834 -1.166 . . . . 0.0 111.25 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.1 m -102.75 -58.25 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 111.169 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -90.98 85.83 1.31 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 539' ' ' GLN . 14.9 t -98.56 -40.78 8.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.561 -0.964 . . . . 0.0 111.608 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -65.09 -41.39 97.13 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 4.5 t -68.54 -23.31 64.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.522 -0.987 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.603 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.14 -39.52 94.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 108.642 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.0 mp -65.36 -42.11 93.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.743 -0.598 . . . . 0.0 109.958 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.21 -29.67 68.88 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.657 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -61.42 -48.71 79.93 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 519' ' ' LEU . 24.9 ttm -56.78 -53.02 62.65 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.598 -0.689 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.39 -31.88 69.64 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.639 -0.663 . . . . 0.0 110.986 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -61.48 -20.04 62.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.415 -0.803 . . . . 0.0 109.776 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 516' ' ' LYS . . . -72.37 -1.17 14.54 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.191 -0.943 . . . . 0.0 111.868 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 122.04 -8.81 9.76 Favored Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.872 -1.143 . . . . 0.0 110.992 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 58.5 t -85.85 101.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -1.221 . . . . 0.0 108.505 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -171.11 137.82 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.217 -0.927 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 8.7 p -83.9 123.22 29.71 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -86.4 -77.41 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -150.34 -72.88 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.39 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -87.36 -20.81 26.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -116.34 -179.8 3.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.178 -0.952 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 125.77 31.32 0.83 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 79.32 7.14 88.68 Favored Glycine 0 N--CA 1.492 2.419 0 O-C-N 121.281 -1.129 . . . . 0.0 111.275 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -96.72 -15.36 21.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.79 -1.418 . . . . 0.0 111.098 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -92.0 -10.21 40.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.233 -0.917 . . . . 0.0 111.061 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.31 52.06 0.23 Allowed Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.194 -0.941 . . . . 0.0 111.446 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.79 -15.25 21.4 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.089 1.047 . . . . 0.0 110.767 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -92.1 -0.82 57.44 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.342 -0.849 . . . . 0.0 112.075 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.502 2.158 0 O-C-N 120.838 -1.164 . . . . 0.0 111.312 -179.402 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.0 m -70.57 149.47 47.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.611 -0.68 . . . . 0.0 109.816 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -70.45 90.26 0.37 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.87 127.29 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.574 -0.956 . . . . 0.0 109.826 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -73.9 135.36 43.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.536 -0.728 . . . . 0.0 109.748 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 11.0 p -102.9 147.22 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.467 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.29 145.26 56.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.679 -0.638 . . . . 0.0 109.579 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.53 73.46 1.03 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.503 -0.748 . . . . 0.0 110.733 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.22 -11.13 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.584 -0.697 . . . . 0.0 110.713 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.58 -30.11 70.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.358 -0.839 . . . . 0.0 110.724 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 67.6 m -60.98 -44.71 96.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 110.413 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.22 -33.77 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.437 -0.789 . . . . 0.0 109.949 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -59.39 -47.79 84.1 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.179 -0.95 . . . . 0.0 110.559 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.64 78.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 426' ' ' LEU . 0.6 OUTLIER -62.14 -39.38 92.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.025 -0.422 . . . . 0.0 111.195 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 90.0 p -64.69 -34.49 78.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 110.748 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -65.15 -43.73 90.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.96 -44.77 75.98 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.328 -0.858 . . . . 0.0 112.235 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 435' ' ' ILE . 62.2 mt -64.27 -43.77 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 6.9 tpp -61.36 -29.28 69.81 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.315 0.578 . . . . 0.0 109.484 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.06 -29.17 70.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.594 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.4 mm-40 -90.9 -15.5 29.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.081 . . . . 0.0 109.419 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -66.5 -37.98 86.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.648 -0.657 . . . . 0.0 110.079 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -116.86 18.9 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.047 -1.033 . . . . 0.0 110.441 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 402' ' ' GLN . 7.1 p -58.76 120.92 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.397 -0.814 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 406' ' ' THR . 3.8 t -56.94 104.22 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.645 0.736 . . . . 0.0 110.525 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 413' ' ' VAL . 6.0 p -112.71 135.33 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 138.31 25.6 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 110.637 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.96 -27.94 36.1 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.12 1.063 . . . . 0.0 110.758 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -62.53 -31.36 72.12 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.91 0.862 . . . . 0.0 109.996 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.61 59.32 0.69 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 30.7 t -61.34 126.99 29.33 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.751 0.786 . . . . 0.0 111.313 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 407' ' ' VAL . 7.1 p -74.18 146.14 84.13 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 413' ' ' VAL . 40.5 Cg_endo -68.01 121.24 8.24 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -95.05 14.17 22.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.462 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.888 HG22 ' OH ' ' A' ' 419' ' ' TYR . 14.6 p -92.07 20.9 5.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.878 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.23 -29.18 9.48 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -60.0 -49.63 76.5 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.888 ' OH ' HG22 ' A' ' 416' ' ' THR . 21.0 p90 -99.29 -11.91 20.83 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.055 1.428 . . . . 0.0 112.943 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 5.3 m -70.88 -42.14 70.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.264 -1.523 . . . . 0.0 108.203 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.6 t70 -78.94 -44.58 22.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.907 -0.496 . . . . 0.0 110.758 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.532 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -64.74 -48.04 76.05 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.773 -0.579 . . . . 0.0 112.409 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 426' ' ' LEU . 89.8 t -68.42 -42.33 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.319 -0.863 . . . . 0.0 111.469 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 81.2 p -60.68 -42.84 97.92 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.182 -0.949 . . . . 0.0 111.343 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 422' ' ' ALA . 32.8 m -68.7 -29.32 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.33 -0.856 . . . . 0.0 111.949 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -73.34 -33.18 64.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.283 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -68.27 -32.71 73.06 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.026 -1.046 . . . . 0.0 108.594 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.17 -33.98 77.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.38 -88.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.478 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.1 OUTLIER -177.06 -56.11 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 120.556 -1.34 . . . . 0.0 110.001 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.4 Cg_endo -68.59 107.93 1.74 Allowed 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 109.291 -1.08 . . . . 0.0 109.291 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 531' ' ' GLN . 1.5 m -100.41 109.21 21.36 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.89 0.852 . . . . 0.0 110.898 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -174.8 95.38 0.08 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -136.86 167.01 22.29 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.929 0.871 . . . . 0.0 112.372 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 399' ' ' ILE . 40.0 pt -116.3 127.66 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.467 0.651 . . . . 0.0 109.541 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.803 HG13 ' CG ' ' A' ' 419' ' ' TYR . 54.0 t -125.04 137.35 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.369 -0.832 . . . . 0.0 109.327 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 28.1 m -119.61 123.45 43.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.359 -0.838 . . . . 0.0 110.951 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -99.96 155.66 19.63 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.17 75.55 0.25 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.737 -0.861 . . . . 0.0 109.368 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 113.65 145.49 9.2 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 60.27 38.96 95.39 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -60.25 -30.0 69.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.6 -0.941 . . . . 0.0 110.737 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.29 93.88 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.416 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.55 -28.05 68.26 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.37 -46.5 88.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.49 -1.006 . . . . 0.0 110.757 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 449' ' ' VAL . 13.0 mtm-85 -64.81 -40.76 95.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.557 -0.714 . . . . 0.0 111.189 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 14.3 mt-10 -69.22 -29.97 68.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.127 -0.983 . . . . 0.0 110.37 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -61.67 -51.5 68.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.329 -0.857 . . . . 0.0 110.449 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 1.01 HG22 HD12 ' A' ' 506' ' ' ILE . 2.4 p -58.0 -31.74 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.095 -1.003 . . . . 0.0 108.765 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -64.02 -27.34 69.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.24 -34.28 76.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.106 -0.996 . . . . 0.0 108.756 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 452' ' ' LEU . 4.6 mm? -63.87 -34.41 77.88 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 85.7 t -59.3 -30.12 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.633 -0.667 . . . . 0.0 109.742 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 60.3 mtt -66.34 -39.28 89.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.424 -0.797 . . . . 0.0 109.001 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.4 ttp -58.86 -25.21 63.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.652 -0.655 . . . . 0.0 110.176 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.36 -22.68 32.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 110.058 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -64.52 -45.39 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.573 -0.704 . . . . 0.0 110.127 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -71.05 -29.86 65.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -75.82 3.8 9.26 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 111.357 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.67 23.92 75.45 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -128.37 145.64 51.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.445 -1.032 . . . . 0.0 110.344 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 487' ' ' ILE . 51.0 mp0 -99.09 169.79 9.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 35.5 m -141.27 150.48 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.086 -1.009 . . . . 0.0 111.212 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.887 ' HB3' HG22 ' A' ' 505' ' ' VAL . 41.4 tt0 -101.2 123.62 45.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -137.49 146.78 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 118.714 -1.194 . . . . 0.0 110.225 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.787 ' HB ' HG23 ' A' ' 507' ' ' VAL . 95.5 mt -132.99 124.61 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.437 -0.789 . . . . 0.0 110.674 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.461 ' HB1' ' CD ' ' A' ' 446' ' ' ARG . . . -75.8 161.94 28.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.16 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.534 -0.729 . . . . 0.0 109.863 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -49.42 -19.16 0.49 Allowed 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.665 -1.272 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . 0.4 ' HD2' ' NE ' ' A' ' 446' ' ' ARG . 96.2 mtt-85 -76.17 -5.67 47.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.213 -0.929 . . . . 0.0 111.031 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 466' ' ' ILE . 71.8 ttt180 -56.97 -23.44 45.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.033 -1.042 . . . . 0.0 111.027 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 11.6 t -60.6 -48.57 81.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.11 -46.36 84.57 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 30.1 tpp -53.57 -35.03 60.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.897 -0.502 . . . . 0.0 110.904 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -60.72 -38.7 85.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.439 -0.788 . . . . 0.0 109.962 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 10.6 tpt -61.79 -37.67 85.22 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.602 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -113.12 -144.47 0.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.652 ' CG ' HD21 ' A' ' 482' ' ' LEU . 35.7 tp60 55.54 50.73 13.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.829 -1.169 . . . . 0.0 111.398 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -100.6 23.57 10.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.27 -10.21 39.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.475 -0.765 . . . . 0.0 112.265 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -173.2 24.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.944 -1.098 . . . . 0.0 112.746 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 482' ' ' LEU . 3.8 pp -171.62 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.4 p -61.13 -21.44 63.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.112 -0.992 . . . . 0.0 110.804 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 164.0 53.24 0.02 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.6 66.14 0.75 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.661 -0.905 . . . . 0.0 109.77 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 464' ' ' GLN . 75.4 mt -77.2 -82.1 0.09 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.427 -0.795 . . . . 0.0 109.21 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 503' ' ' SER . 35.8 mm -152.64 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 109.255 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.471 ' CB ' ' HB3' ' A' ' 499' ' ' PHE . 3.9 t -100.74 10.67 40.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.572 -0.705 . . . . 0.0 111.077 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.449 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -91.92 72.63 1.62 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 51.0 ttm-85 -142.92 -73.96 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -90.37 -26.81 19.74 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.255 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -62.67 -48.06 80.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 110.512 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 493' ' ' LEU . 4.8 mt -71.64 -41.82 68.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.513 -0.742 . . . . 0.0 111.457 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 45.9 tp -102.66 -45.4 5.04 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -87.02 -5.02 59.21 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.076 -1.015 . . . . 0.0 112.492 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 62.41 47.22 91.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.02 -177.17 3.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.631 -0.923 . . . . 0.0 109.411 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.53 139.87 48.62 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.041 -1.037 . . . . 0.0 109.12 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.471 ' HB3' ' CB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -113.92 148.74 36.28 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.076 0.941 . . . . 0.0 111.453 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 500' ' ' THR . 8.2 t -48.68 121.43 9.92 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.586 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 49.0 Cg_endo -78.84 114.36 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.384 1.202 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -170.69 33.36 0.16 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.827 ' HB2' HG21 ' A' ' 487' ' ' ILE . 36.7 t -80.75 143.22 33.08 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.922 ' HB ' HG12 ' A' ' 463' ' ' VAL . 48.1 m -115.25 108.48 16.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 104.384 -2.451 . . . . 0.0 104.384 173.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.942 HG21 HD21 ' A' ' 522' ' ' LEU . 41.4 t -113.09 141.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -174.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 1.01 HD12 HG22 ' A' ' 449' ' ' VAL . 15.9 pt -136.46 103.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 175.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.787 HG23 ' HB ' ' A' ' 466' ' ' ILE . 8.6 p -103.49 107.02 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.739 -1.225 . . . . 0.0 112.263 -176.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 3.9 t70 -85.18 107.95 17.49 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 536' ' ' ASP . 6.5 tp-100 -131.0 115.18 16.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -73.33 -64.73 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -61.85 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.85 -12.87 1.96 Allowed 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.629 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.5 OUTLIER -63.74 -34.56 78.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.342 -0.849 . . . . 0.0 109.438 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 509' ' ' GLN . 22.9 t -90.4 -14.52 32.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.697 -0.627 . . . . 0.0 111.236 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 534' ' ' ILE . 42.6 tp -65.45 -48.92 71.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.038 -1.039 . . . . 0.0 108.922 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.676 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 98.8 mttt -69.86 -41.7 74.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.968 -0.457 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -56.92 -47.05 81.52 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 78.9 m -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.367 -0.833 . . . . 0.0 110.239 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' A' ' 550' ' ' MET . 0.2 OUTLIER -57.61 -39.58 77.22 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.849 -0.532 . . . . 0.0 110.674 -177.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 11.5 m -61.97 -39.63 92.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.384 -0.823 . . . . 0.0 110.301 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.34 -41.68 96.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.873 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.942 HD21 HG21 ' A' ' 505' ' ' VAL . 2.6 mt -61.82 -22.4 65.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.748 -0.595 . . . . 0.0 110.458 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -47.24 -63.69 0.98 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.07 -51.71 50.85 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.708 -1.245 . . . . 0.0 110.46 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -58.25 -29.34 65.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.657 -0.908 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.469 ' HA ' ' CG1' ' A' ' 530' ' ' VAL . . . -59.99 -25.1 64.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.513 -0.742 . . . . 0.0 112.481 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -41.94 -27.74 0.13 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.542 -0.724 . . . . 0.0 111.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 1.9 t-80 -108.22 -126.94 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.533 -0.73 . . . . 0.0 111.047 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -89.86 96.87 10.88 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.622 -1.299 . . . . 0.0 114.49 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -113.17 131.08 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 O-C-N 120.893 -1.129 . . . . 0.0 111.462 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.518 ' HA ' ' HB2' ' A' ' 432' ' ' SER . 86.8 mt-30 -120.27 126.85 51.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.558 ' C ' HD12 ' A' ' 533' ' ' LEU . 49.7 t -117.08 123.51 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 122.581 1.181 . . . . 0.0 113.091 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 532' ' ' VAL . 9.2 mp -119.57 119.3 33.4 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 174.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.756 HG22 HG12 ' A' ' 507' ' ' VAL . 0.8 OUTLIER -132.78 129.01 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.658 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.66 HG22 ' HB ' ' A' ' 436' ' ' VAL . 30.2 p -101.58 -166.69 1.33 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 4.3 t0 -159.07 169.12 24.96 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.511 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -140.73 17.85 2.34 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.719 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -138.98 24.99 2.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 536' ' ' ASP . 83.9 mt-30 -96.75 1.19 50.58 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.507 -0.996 . . . . 0.0 111.947 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -53.45 -40.66 65.41 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.985 -1.072 . . . . 0.0 111.388 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.0 m -104.18 -45.18 4.78 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.162 -0.961 . . . . 0.0 111.452 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.85 67.27 0.34 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.0 t -65.39 -42.81 92.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.523 -0.987 . . . . 0.0 110.891 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.71 -39.83 97.96 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 57.3 m -60.56 -33.94 73.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.589 -0.948 . . . . 0.0 109.997 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -61.35 -37.2 82.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.641 -0.662 . . . . 0.0 110.377 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.2 mp -62.14 -42.16 98.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.57 -0.706 . . . . 0.0 109.637 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 99.1 mtp -65.44 -31.84 73.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.705 -0.622 . . . . 0.0 109.832 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.44 -54.05 48.66 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.513 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.434 ' CG ' HD11 ' A' ' 519' ' ' LEU . 43.2 ttp -60.22 -44.14 95.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.306 -0.871 . . . . 0.0 110.519 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.68 -31.57 72.49 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.359 -0.838 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -67.72 -15.59 63.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.089 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.676 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -75.59 6.73 4.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 112.098 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 151.15 -16.68 0.9 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.209 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.61 101.08 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.072 -1.252 . . . . 0.0 109.858 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -154.06 116.19 4.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 110.268 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 18.3 m -63.16 135.7 57.32 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.563 -0.71 . . . . 0.0 110.056 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.55 -90.72 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 0.0 110.89 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 36.0 mmm-85 -147.87 -80.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.014 -1.053 . . . . 0.0 110.62 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -93.58 -22.6 18.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 0.0 110.889 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -131.09 140.72 50.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.482 -0.761 . . . . 0.0 110.17 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 147.71 -104.67 0.29 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -94.98 -18.75 33.23 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -70.03 -33.91 72.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -1.075 . . . . 0.0 110.081 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -82.73 -13.14 56.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.541 -0.725 . . . . 0.0 110.661 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 116.95 0.35 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 0.0 110.081 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.84 -28.33 36.45 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 N-CA-C 109.491 -1.004 . . . . 0.0 109.491 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -168.51 -61.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.68 -0.638 . . . . 0.0 109.516 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.507 2.411 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.456 179.581 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 384' ' ' ILE . 61.9 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 10.7 m -72.42 148.77 44.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.71 -0.618 . . . . 0.0 110.158 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 106.62 -23.94 26.89 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 384' ' ' ILE . 18.7 tt -108.53 106.56 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.35 -1.088 . . . . 0.0 110.11 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -78.77 -36.78 42.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.238 -0.914 . . . . 0.0 110.47 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.31 129.19 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.465 -0.772 . . . . 0.0 109.615 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.06 139.13 39.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.636 -0.665 . . . . 0.0 109.997 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -106.06 38.83 1.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 110.254 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -103.93 34.91 2.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.608 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.1 -46.62 86.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.518 -0.739 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.6 t -62.74 -44.03 97.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.787 -0.571 . . . . 0.0 110.303 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 433' ' ' LEU . 77.4 t -65.16 -34.64 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.771 -0.581 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.0 -42.07 98.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.526 -0.734 . . . . 0.0 111.658 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -58.8 -53.33 59.6 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.002 -1.061 . . . . 0.0 112.388 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.821 HD12 HD11 ' A' ' 399' ' ' ILE . 1.1 pp -69.62 -33.92 73.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.996 . . . . 0.0 111.057 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . 0.421 ' N ' ' HG ' ' A' ' 395' ' ' LEU . 70.3 m -55.55 -43.07 75.48 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.589 -0.694 . . . . 0.0 111.226 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -68.09 -41.19 82.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -0.817 . . . . 0.0 111.518 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -65.51 -40.41 92.97 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.187 -0.946 . . . . 0.0 112.59 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 395' ' ' LEU . 0.0 OUTLIER -66.66 -39.24 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 121.147 -0.971 . . . . 0.0 109.882 -178.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.728 ' HG3' HD11 ' A' ' 435' ' ' ILE . 8.7 mtp -64.42 -39.73 94.41 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.153 -0.967 . . . . 0.0 109.174 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.74 -29.83 70.82 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 419' ' ' TYR . 59.8 tp60 -90.47 -11.15 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.473 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 400' ' ' MET . 40.1 t30 -69.54 -38.91 77.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.806 -0.559 . . . . 0.0 110.291 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -117.8 19.26 13.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.066 . . . . 0.0 109.872 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 407' ' ' VAL . 7.7 p -41.15 148.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 CA-C-O 121.176 0.513 . . . . 0.0 110.859 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.6 m -77.06 81.38 3.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.74 -0.6 . . . . 0.0 109.4 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 412' ' ' SER . 48.4 t -105.58 130.26 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.944 0.878 . . . . 0.0 111.702 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -96.79 144.38 27.76 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.66 -23.44 56.54 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.143 1.075 . . . . 0.0 110.767 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -67.27 -27.88 67.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.398 -0.814 . . . . 0.0 110.69 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.49 56.76 0.5 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . 0.787 ' HA ' HG13 ' A' ' 407' ' ' VAL . 11.7 p -69.53 137.43 52.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.443 -0.786 . . . . 0.0 111.334 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 407' ' ' VAL . 5.9 p -88.99 146.25 36.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.52 135.48 28.73 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.09 1.047 . . . . 0.0 111.276 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 417' ' ' ALA . 99.8 mtt180 -96.81 -87.84 0.3 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.714 -0.616 . . . . 0.0 109.515 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.0 t -29.8 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 415' ' ' ARG . . . -50.83 -69.99 0.1 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.302 -0.873 . . . . 0.0 111.46 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -77.36 -1.57 76.14 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.708 -1.245 . . . . 0.0 111.29 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.561 ' HD2' HG23 ' A' ' 399' ' ' ILE . 76.6 m-85 -108.25 0.32 21.3 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.791 -1.417 . . . . 0.0 110.28 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.42 ' HB2' ' HD3' ' A' ' 448' ' ' ARG . 70.0 p -92.6 -33.72 14.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -73.74 -37.2 65.16 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.83 82.73 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.43 0.633 . . . . 0.0 110.038 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.969 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.0 t -67.74 -42.66 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.624 -0.672 . . . . 0.0 111.758 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.6 m -59.82 -43.29 94.61 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.975 -1.078 . . . . 0.0 112.352 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.91 -50.58 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.013 -1.055 . . . . 0.0 109.747 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.969 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -47.75 -31.57 4.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.641 -0.662 . . . . 0.0 111.688 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.74 -35.46 74.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 109.292 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.32 -31.03 72.07 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.549 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.35 -74.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.585 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER 178.89 -53.91 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.18 -0.95 . . . . 0.0 110.108 178.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 47.5 Cg_endo -79.84 116.23 3.43 Favored 'Trans proline' 0 N--CA 1.483 0.856 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.578 ' HA ' HD11 ' A' ' 426' ' ' LEU . 1.8 m -105.67 100.39 9.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.355 -0.938 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.469 ' HB3' HG11 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -149.4 137.72 20.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.421 ' HB1' HG22 ' A' ' 423' ' ' VAL . . . -173.45 160.72 3.95 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 120.511 -1.368 . . . . 0.0 112.762 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.728 HD11 ' HG3' ' A' ' 400' ' ' MET . 3.3 pt -122.32 117.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 423' ' ' VAL . 70.4 t -122.11 137.77 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 110.749 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 44.9 t -121.74 129.83 52.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.017 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.75 147.9 18.76 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -146.11 80.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.587 -0.949 . . . . 0.0 109.645 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 121.83 110.48 2.11 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 71.09 85.27 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.03 -19.72 25.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.587 -0.949 . . . . 0.0 110.613 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.37 -43.93 92.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 110.914 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.9 -30.58 70.13 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -62.6 -40.19 96.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.611 -0.935 . . . . 0.0 110.44 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.684 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 8.4 mpt_? -64.37 -38.1 89.84 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -71.28 -30.15 65.92 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.3 -0.875 . . . . 0.0 109.996 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . 0.42 ' HD3' ' HB2' ' A' ' 420' ' ' SER . 44.7 ttm-85 -64.81 -44.7 89.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.548 -0.72 . . . . 0.0 111.646 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.5 p -64.72 -32.44 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.663 ' HB1' ' HE ' ' A' ' 481' ' ' ARG . . . -64.42 -31.07 72.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -58.21 -38.02 75.95 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.051 -1.03 . . . . 0.0 108.445 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.4 -31.09 72.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.856 HG13 ' CG2' ' A' ' 463' ' ' VAL . 60.4 t -60.14 -32.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 58.2 mtt -66.13 -40.13 90.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 56.4 ttp -58.99 -21.07 58.21 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.241 0.543 . . . . 0.0 110.101 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -84.54 -22.64 30.05 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.37 -27.4 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -78.26 9.17 4.03 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.312 -0.868 . . . . 0.0 112.274 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.09 26.4 72.41 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.88 145.32 36.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 111.405 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -99.43 163.23 12.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.972 HG12 ' HB ' ' A' ' 504' ' ' THR . 33.7 m -132.21 158.77 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 118.924 -1.11 . . . . 0.0 112.268 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.847 ' HA ' HD22 ' A' ' 486' ' ' LEU . 57.1 tt0 -102.99 107.13 17.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 453' ' ' VAL . 0.5 OUTLIER -118.2 124.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.706 -178.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.562 HG23 ' CD ' ' A' ' 471' ' ' ARG . 85.6 mt -122.03 115.37 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.862 -0.524 . . . . 0.0 110.916 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.684 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -66.17 165.63 13.35 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.471 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.607 ' HB3' ' NH2' ' A' ' 446' ' ' ARG . . . -59.01 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' A' ' 511' ' ' GLU . 26.9 t0 -51.41 -19.07 1.21 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.956 -1.09 . . . . 0.0 111.129 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -78.98 -8.19 58.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.44 -0.787 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 467' ' ' ALA . 79.8 ttt-85 -52.36 -24.85 8.35 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.99 -1.069 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 68.5 m -58.12 -42.88 86.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.806 . . . . 0.0 109.358 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . 0.495 ' HA ' ' HE2' ' A' ' 476' ' ' MET . 85.0 mt-30 -65.09 -38.83 91.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.676 ' CE ' HD21 ' A' ' 482' ' ' LEU . 28.2 ttt -62.0 -32.28 72.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.783 -0.573 . . . . 0.0 110.29 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -61.69 -40.04 93.57 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 110.083 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 473' ' ' GLN . 73.4 mtm -62.51 -35.54 79.73 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.576 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 62.8 pttt -121.47 -148.06 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.426 ' HG2' ' CE ' ' A' ' 474' ' ' MET . 1.0 OUTLIER 53.6 70.09 0.63 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.161 -0.962 . . . . 0.0 111.192 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -112.98 23.8 13.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.68 3.21 26.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.854 . . . . 0.0 111.06 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.679 ' CG ' HD23 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -143.13 -29.8 0.53 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.19 -0.944 . . . . 0.0 111.664 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.679 HD23 ' CG ' ' A' ' 481' ' ' ARG . 0.5 OUTLIER -150.41 72.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.803 -1.186 . . . . 0.0 110.791 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.4 m -72.36 -18.42 61.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.464 -0.772 . . . . 0.0 110.121 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 156.43 46.68 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 485' ' ' GLU . 13.6 pt-20 -149.01 103.74 3.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.926 . . . . 0.0 110.572 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.847 HD22 ' HA ' ' A' ' 464' ' ' GLN . 96.4 mt -98.46 -84.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.285 -0.966 . . . . 0.0 108.602 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 486' ' ' LEU . 3.3 mp -157.35 -65.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-N 119.304 0.956 . . . . 0.0 109.08 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 499' ' ' PHE . 1.6 t -99.9 11.12 40.08 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.469 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -92.91 77.22 1.17 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 54.5 ttt85 -145.17 -63.72 0.34 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 495' ' ' GLU . 92.7 mtt-85 -97.98 -31.32 12.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.421 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -64.53 -43.95 92.38 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 493' ' ' LEU . 2.2 mt -69.09 -38.53 79.01 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.318 0.58 . . . . 0.0 110.822 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 494' ' ' LEU . 7.4 tt -105.87 -48.4 3.64 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 491' ' ' ARG . 94.8 mt-10 -90.0 -10.3 45.45 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.666 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 491' ' ' ARG . . . 83.0 -13.16 45.81 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.641 -1.287 . . . . 0.0 111.017 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 491' ' ' ARG . 70.6 mmm -67.86 -179.67 1.23 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.095 -1.238 . . . . 0.0 111.01 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.96 153.62 28.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.64 -0.663 . . . . 0.0 110.345 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.486 ' CB ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.52 151.03 32.08 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.773 0.797 . . . . 0.0 110.354 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 5.2 t -55.72 150.42 26.86 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.83 -0.544 . . . . 0.0 111.839 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 528' ' ' HIS . 42.3 Cg_endo -70.66 115.74 4.35 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.653 1.344 . . . . 0.0 109.599 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -177.12 39.34 0.09 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.491 ' HA ' HG12 ' A' ' 487' ' ' ILE . 29.0 t -99.96 109.99 22.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.909 -0.76 . . . . 0.0 112.806 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.972 ' HB ' HG12 ' A' ' 463' ' ' VAL . 55.5 m -95.48 107.06 19.19 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 175.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 464' ' ' GLN . 43.4 t -109.58 126.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.414 -174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 533' ' ' LEU . 38.6 pt -122.59 109.99 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 534' ' ' ILE . 13.9 p -108.03 112.95 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 467' ' ' ALA . 43.6 t0 -84.04 110.39 18.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.6 tm0? -97.39 175.2 6.33 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.356 1.074 . . . . 0.0 113.757 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -169.69 -44.05 0.03 OUTLIER Glycine 0 N--CA 1.508 3.46 0 N-CA-C 105.91 -2.876 . . . . 0.0 105.91 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 469' ' ' ASP . 73.1 mm-40 -99.54 -162.56 0.96 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -120.27 -1.67 10.22 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 111.222 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 513' ' ' LEU . 4.6 mm? -74.84 -27.4 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.751 . . . . 0.0 109.454 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 52.9 m -87.15 -17.09 33.57 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.66 -0.65 . . . . 0.0 112.008 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.435 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 31.7 tp -81.51 -52.59 7.07 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.847 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 553' ' ' ALA . 54.5 mtmt -71.43 -43.47 66.68 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.599 -0.688 . . . . 0.0 112.207 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -40.0 95.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.027 -1.046 . . . . 0.0 111.143 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 466' ' ' ILE . 70.6 m -61.26 -48.32 81.97 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.264 -0.975 . . . . 0.0 108.744 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 519' ' ' LEU . 0.1 OUTLIER -58.15 -32.34 68.09 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.301 0.572 . . . . 0.0 109.654 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.6 m -61.79 -41.58 97.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.826 -0.546 . . . . 0.0 109.876 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.606 HD23 ' CD ' ' A' ' 464' ' ' GLN . 51.8 tp -69.55 -42.27 74.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.328 -0.857 . . . . 0.0 109.682 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.555 HD21 ' CG2' ' A' ' 505' ' ' VAL . 2.0 mt -59.6 -22.25 61.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.625 -0.672 . . . . 0.0 111.225 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.8 -57.4 4.92 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.672 -0.643 . . . . 0.0 112.235 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.59 50.03 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.009 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.36 64.13 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.882 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -56.48 -23.62 40.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.408 -0.808 . . . . 0.0 111.863 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -50.73 -36.61 37.28 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.125 -0.984 . . . . 0.0 110.919 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 501' ' ' PRO . 66.6 m-70 -132.88 -69.79 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.374 -0.829 . . . . 0.0 111.13 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.58 ' C ' HG22 ' A' ' 530' ' ' VAL . 31.0 m-80 -83.56 154.92 23.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.31 -0.868 . . . . 0.0 111.066 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.58 HG22 ' C ' ' A' ' 529' ' ' ASN . 0.0 OUTLIER -179.59 153.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 CA-C-O 121.401 0.62 . . . . 0.0 109.939 177.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' A' ' 432' ' ' SER . 0.1 OUTLIER -174.75 95.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 505' ' ' VAL . 41.7 t -104.69 107.16 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.685 ' HB2' HG22 ' A' ' 506' ' ' ILE . 7.4 mp -108.31 114.1 27.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.941 HG22 HG12 ' A' ' 507' ' ' VAL . 8.2 pt -123.85 136.29 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.571 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.733 HG22 ' HB ' ' A' ' 436' ' ' VAL . 53.4 p -112.99 -169.63 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -157.87 166.14 33.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.032 -1.042 . . . . 0.0 110.85 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 2.9 p -146.83 21.94 1.26 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.81 -0.556 . . . . 0.0 109.912 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -151.39 -30.71 0.04 OUTLIER Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -78.76 -0.13 29.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.086 -1.243 . . . . 0.0 111.142 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -38.88 -29.88 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -102.93 -29.44 11.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.43 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -120.22 59.08 0.55 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 546' ' ' ALA . 9.5 t -64.57 -37.26 86.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.625 -0.927 . . . . 0.0 110.717 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 543' ' ' THR . . . -57.16 -43.8 93.35 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 93.9 p -63.56 -29.57 70.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.414 -1.051 . . . . 0.0 109.676 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.88 -35.39 80.99 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.732 -0.605 . . . . 0.0 109.882 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 547' ' ' LEU . 10.9 mp -61.99 -41.14 97.72 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 98.5 mmm -64.74 -33.63 76.41 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.14 -53.57 56.58 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.105 0.479 . . . . 0.0 109.92 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.454 ' HG3' HD11 ' A' ' 519' ' ' LEU . 33.4 ttm -55.11 -47.19 75.35 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.427 -0.795 . . . . 0.0 110.332 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.52 -29.18 70.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.606 -0.684 . . . . 0.0 111.401 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -66.38 -17.8 64.98 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 516' ' ' LYS . . . -74.02 4.48 5.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.354 -0.841 . . . . 0.0 112.384 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 154.66 -17.54 0.57 Allowed Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.533 -1.318 . . . . 0.0 111.524 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.44 108.75 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.042 -1.269 . . . . 0.0 110.327 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -166.71 117.84 0.95 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.424 -0.798 . . . . 0.0 110.246 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 87.5 m -86.71 123.51 31.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.543 -0.723 . . . . 0.0 109.169 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -73.7 -95.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.412 -0.805 . . . . 0.0 108.971 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -132.53 -90.42 0.41 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.83 -1.169 . . . . 0.0 109.015 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -114.21 -23.71 9.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.053 -1.029 . . . . 0.0 110.692 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -98.83 143.79 28.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 110.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . 90.61 111.62 1.55 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 81.82 -62.8 4.47 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -80.2 -2.09 43.34 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.404 -1.056 . . . . 0.0 111.737 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.23 -44.1 75.14 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.147 -0.971 . . . . 0.0 109.085 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.16 90.28 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.304 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.91 -8.0 19.76 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.645 1.339 . . . . 0.0 110.517 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -91.09 98.32 11.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 0.0 110.125 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.659 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 381' ' ' THR . 36.2 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.022 0.439 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 47.0 t -61.41 -43.35 99.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.503 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -100.67 -138.57 10.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.3 124.9 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.769 -0.842 . . . . 0.0 110.656 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -109.96 124.23 51.03 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.408 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 p -107.73 135.6 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 109.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.25 129.25 46.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.812 . . . . 0.0 110.202 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -108.8 179.87 4.06 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.23 -18.48 37.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.809 -0.557 . . . . 0.0 111.092 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 38.5 tp -59.4 -29.34 67.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 71.3 m -60.83 -44.99 96.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.571 -0.706 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.15 -34.18 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.704 . . . . 0.0 110.605 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -58.16 -52.5 65.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.421 -0.8 . . . . 0.0 111.576 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.54 78.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.386 -0.821 . . . . 0.0 109.954 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 399' ' ' ILE . 3.2 tt -62.17 -38.52 89.39 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.588 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 14.1 m -71.55 -34.18 69.79 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.984 -1.072 . . . . 0.0 112.137 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.71 -45.23 87.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.104 -0.997 . . . . 0.0 112.335 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -70.39 -41.62 72.77 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.122 -0.986 . . . . 0.0 111.999 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.501 ' HA ' ' CD1' ' A' ' 419' ' ' TYR . 50.0 mt -63.73 -40.72 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.358 -0.839 . . . . 0.0 108.936 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.8 ttm -58.62 -34.88 71.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.705 -0.622 . . . . 0.0 109.486 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.41 -20.08 62.66 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.227 -0.921 . . . . 0.0 109.055 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.763 ' O ' HG12 ' A' ' 405' ' ' VAL . 6.2 tp-100 -91.58 -20.26 21.85 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.938 -1.101 . . . . 0.0 108.995 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -67.66 -32.67 73.51 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -116.36 19.75 14.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.088 -1.008 . . . . 0.0 110.286 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 407' ' ' VAL . 5.9 p -59.06 117.47 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.557 -0.714 . . . . 0.0 109.852 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.8 p -52.71 102.92 0.06 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.477 -0.764 . . . . 0.0 110.748 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 405' ' ' VAL . 57.8 t -107.59 132.86 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.553 -0.717 . . . . 0.0 110.233 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -93.94 139.77 22.74 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 109.532 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.75 -25.28 53.77 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.219 1.115 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.15 -29.15 69.39 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.522 0.677 . . . . 0.0 111.133 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.37 58.65 0.57 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 80.4 p -50.31 111.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.667 0.746 . . . . 0.0 111.941 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.632 HG13 ' HD2' ' A' ' 414' ' ' PRO . 32.9 t -64.03 150.49 91.81 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 413' ' ' VAL . 37.7 Cg_endo -63.48 147.86 92.95 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.313 1.165 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 407' ' ' VAL . 82.2 mtp180 -128.49 -15.35 4.55 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.625 -0.672 . . . . 0.0 112.604 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 420' ' ' SER . 10.2 t -103.88 18.32 22.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.965 -1.084 . . . . 0.0 108.391 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -86.21 -76.46 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.703 -0.623 . . . . 0.0 112.208 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -75.73 -4.01 74.85 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.972 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.503 ' CD2' ' HG2' ' A' ' 402' ' ' GLN . 96.8 m-85 -107.8 -13.88 14.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.293 1.546 . . . . 0.0 109.647 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 416' ' ' THR . 5.4 t -69.9 -41.33 74.85 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 174.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -68.73 -36.69 78.74 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.01 81.27 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 122.038 0.923 . . . . 0.0 109.807 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.884 HG21 HG22 ' A' ' 436' ' ' VAL . 79.4 t -69.07 -44.06 81.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -60.69 -38.92 86.57 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.879 -1.138 . . . . 0.0 111.287 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.19 -44.14 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -55.61 -32.61 63.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.651 -0.656 . . . . 0.0 111.74 -178.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.37 77.0 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.618 -1.301 . . . . 0.0 108.631 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.54 -30.1 71.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.78 -89.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 431' ' ' PRO . 11.3 tpp180 -179.9 -58.58 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.506 -1.372 . . . . 0.0 109.017 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 430' ' ' ARG . 43.1 Cg_endo -68.61 99.78 0.65 Allowed 'Trans proline' 0 N--CA 1.485 1.004 0 N-CA-C 108.661 -1.323 . . . . 0.0 108.661 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.489 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 67.7 m -94.98 110.36 22.27 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.864 0.84 . . . . 0.0 111.872 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 1.3 tp -166.56 90.22 0.4 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -135.49 169.77 16.99 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.93 0.871 . . . . 0.0 112.439 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 435' ' ' ILE . 33.0 pt -127.22 130.21 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.425 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.884 HG22 HG21 ' A' ' 423' ' ' VAL . 47.6 t -125.66 97.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 120.864 -1.147 . . . . 0.0 110.311 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 37.3 m -76.01 129.5 36.96 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.382 -0.824 . . . . 0.0 111.145 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -107.19 170.93 16.13 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 415' ' ' ARG . 67.6 tp60 -170.03 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.522 -0.987 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -64.12 -49.7 65.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -156.32 141.95 8.38 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -111.85 -26.09 9.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.548 -0.972 . . . . 0.0 110.639 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.57 88.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.394 -0.816 . . . . 0.0 110.617 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -73.39 -29.36 64.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.51 -39.01 91.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.62 -0.929 . . . . 0.0 109.477 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.635 ' O ' HG12 ' A' ' 449' ' ' VAL . 58.7 ttp180 -61.97 -46.52 88.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 111.391 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 2.9 tm-20 -73.11 -32.85 65.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.047 -1.033 . . . . 0.0 111.199 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -61.8 -47.37 85.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.807 HG11 ' OD2' ' A' ' 508' ' ' ASP . 3.7 p -57.44 -30.59 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.747 -1.221 . . . . 0.0 108.565 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.3 -26.42 68.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.87 -33.25 75.27 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.942 -1.099 . . . . 0.0 108.618 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm? -63.17 -33.97 76.62 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.939 HG13 ' CG2' ' A' ' 463' ' ' VAL . 90.1 t -59.75 -30.56 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.617 . . . . 0.0 109.586 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.22 -35.25 79.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -60.72 -28.75 68.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 109.597 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.7 31.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.512 -0.742 . . . . 0.0 109.72 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -63.61 -43.82 95.76 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -68.12 -30.61 69.81 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -76.28 5.48 6.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.564 -0.71 . . . . 0.0 111.757 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.3 29.4 75.19 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -138.44 120.32 15.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.485 -1.009 . . . . 0.0 110.802 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.06 171.12 14.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.584 -0.698 . . . . 0.0 109.246 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.939 ' CG2' HG13 ' A' ' 453' ' ' VAL . 30.0 m -140.14 155.14 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 111.433 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.966 ' HA ' HD22 ' A' ' 486' ' ' LEU . 51.7 tt0 -101.52 117.65 35.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.807 HD11 HD22 ' A' ' 482' ' ' LEU . 2.5 pt -128.38 136.15 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.809 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 466' ' ' ILE . 4.7 mp -125.42 117.38 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.092 -1.005 . . . . 0.0 111.279 -178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 508' ' ' ASP . . . -65.79 161.17 21.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.734 -1.229 . . . . 0.0 109.016 177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.74 -158.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 511' ' ' GLU . 28.8 p-10 -44.81 -21.58 0.06 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.818 -1.176 . . . . 0.0 112.411 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.2 -2.79 23.12 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.321 -0.862 . . . . 0.0 111.577 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.03 -41.33 82.98 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.94 -1.1 . . . . 0.0 111.735 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.1 m -55.82 -45.36 78.35 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.966 -1.084 . . . . 0.0 110.469 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.29 -37.16 86.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.491 -0.755 . . . . 0.0 108.972 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.2 ttp -60.52 -33.8 73.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.761 -0.587 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -61.83 -37.7 85.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.78 -40.85 94.12 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.248 -0.908 . . . . 0.0 109.722 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -121.93 -141.94 0.33 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 109.453 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 51.23 88.86 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.706 -1.246 . . . . 0.0 110.936 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -136.74 34.96 2.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.728 . . . . 0.0 109.157 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -128.52 -3.69 5.41 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.879 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.404 ' CB ' HD23 ' A' ' 482' ' ' LEU . 7.3 mtt180 -132.36 -13.28 3.06 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.97 -1.081 . . . . 0.0 112.443 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 465' ' ' ILE . 0.5 OUTLIER -169.59 71.83 0.07 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.893 -1.129 . . . . 0.0 111.169 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 97.7 p -92.41 50.04 1.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 90.43 36.16 7.11 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -122.27 47.25 1.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.622 -0.928 . . . . 0.0 110.104 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.966 HD22 ' HA ' ' A' ' 464' ' ' GLN . 20.7 mt -75.44 -79.87 0.09 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.68 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.1 OUTLIER 179.31 -42.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 110.342 174.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.609 HG23 HG22 ' A' ' 487' ' ' ILE . 3.2 p -103.85 8.94 37.05 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.564 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -97.95 60.29 0.99 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.376 -1.889 . . . . 0.0 108.376 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 67.6 ttt180 -142.42 -70.9 0.33 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -108.87 -21.0 12.86 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.872 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 497' ' ' MET . 0.0 OUTLIER -65.42 -46.79 78.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.633 -0.667 . . . . 0.0 111.898 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 13.6 mt -91.96 -56.72 2.98 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.0 111.075 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 494' ' ' LEU . 1.2 tm? -65.17 -42.21 93.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.471 -0.768 . . . . 0.0 112.808 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -99.99 -3.32 32.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.944 -1.098 . . . . 0.0 113.142 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 65.05 47.82 77.81 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 492' ' ' GLN . 44.3 mtt -119.75 -174.05 2.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.788 -0.831 . . . . 0.0 109.655 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.23 131.94 55.71 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.32 -0.863 . . . . 0.0 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 490' ' ' ARG . 0.3 OUTLIER -115.19 140.32 49.19 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 500' ' ' THR . 2.2 t -44.7 99.96 0.22 Allowed Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 122.212 -0.305 . . . . 0.0 111.597 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 499' ' ' PHE . 41.9 Cg_endo -67.92 113.95 3.19 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 107.996 -1.579 . . . . 0.0 107.996 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 529' ' ' ASN . . . 179.52 32.25 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.68 ' CB ' HD13 ' A' ' 487' ' ' ILE . 40.0 t -93.13 176.29 6.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.066 . . . . 0.0 111.591 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.916 ' HB ' HG12 ' A' ' 463' ' ' VAL . 79.2 m -116.61 124.23 49.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 464' ' ' GLN . 57.6 t -121.92 136.82 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 112.872 -175.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 533' ' ' LEU . 2.0 pp -130.07 110.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 534' ' ' ILE . 12.4 p -99.16 108.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.147 -1.596 . . . . 0.0 110.344 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.807 ' OD2' HG11 ' A' ' 449' ' ' VAL . 73.0 m-20 -82.78 108.25 16.0 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 515' ' ' LEU . 1.5 tm0? -97.8 174.66 6.49 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 122.743 1.259 . . . . 0.0 113.194 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . . . . . . . . . . . -168.56 -64.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.822 0 N-CA-C 103.943 -3.663 . . . . 0.0 103.943 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 469' ' ' ASP . 32.3 tt0 -70.98 -142.99 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.02 -19.04 1.16 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.727 -1.233 . . . . 0.0 111.442 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.24 -21.92 62.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 77.3 p -72.05 -41.09 67.85 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.503 -0.748 . . . . 0.0 110.953 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.492 ' HB2' ' HG3' ' A' ' 509' ' ' GLN . 10.8 tp -65.39 -52.47 53.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.0 111.283 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.766 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 25.9 ttmt -67.36 -46.88 72.06 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.501 -0.75 . . . . 0.0 111.571 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -60.39 -49.01 79.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.272 -0.892 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.45 HG21 ' HB ' ' A' ' 507' ' ' VAL . 81.7 m -58.54 -42.67 88.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.475 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 515' ' ' LEU . 0.2 OUTLIER -61.14 -40.41 93.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.326 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 37.8 p -64.88 -39.94 94.33 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.056 -1.027 . . . . 0.0 111.195 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.3 OUTLIER -66.76 -41.77 87.21 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.202 1.001 . . . . 0.0 108.588 178.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 505' ' ' VAL . 0.8 OUTLIER -65.36 -22.01 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.721 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -47.29 -62.82 1.25 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.318 -0.864 . . . . 0.0 112.992 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.79 61.71 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.313 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 488' ' ' THR . . . -61.68 -31.43 71.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.657 -0.908 . . . . 0.0 111.805 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.732 ' CB ' HG11 ' A' ' 530' ' ' VAL . . . -72.19 -22.57 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 112.382 -178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -40.57 -27.47 0.05 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.428 -0.795 . . . . 0.0 112.385 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 501' ' ' PRO . 49.7 t60 -114.23 -117.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 0.0 111.5 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.404 ' HB2' ' HA2' ' A' ' 502' ' ' GLY . 2.4 m120 -89.5 90.01 8.1 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.513 -1.367 . . . . 0.0 114.551 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.732 HG11 ' CB ' ' A' ' 526' ' ' ALA . 7.6 p -127.79 149.52 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 109.967 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 86.5 mt-30 -126.04 132.31 52.0 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.994 -0.441 . . . . 0.0 110.07 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 87.3 t -109.33 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.49 1.138 . . . . 0.0 111.576 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.791 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.3 OUTLIER -117.14 119.77 36.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.873 HG22 HG12 ' A' ' 507' ' ' VAL . 4.5 pt -129.1 140.43 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 118.464 -1.294 . . . . 0.0 111.902 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.681 HG22 ' HB ' ' A' ' 436' ' ' VAL . 11.5 p -110.23 -174.23 2.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 509' ' ' GLN . 28.9 m-20 -154.98 161.51 41.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.027 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . . . . . . . . . 68.2 p -140.36 18.11 2.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.012 -0.43 . . . . 0.0 109.907 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.07 0.23 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -98.62 0.91 45.74 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.393 -1.063 . . . . 0.0 110.764 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -40.21 54.96 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.117 -0.99 . . . . 0.0 112.271 -178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 8.6 p -96.39 -63.76 1.11 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.256 -0.903 . . . . 0.0 110.764 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -89.12 95.2 2.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 544' ' ' GLY . 15.4 t -98.51 -41.39 7.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.687 -0.89 . . . . 0.0 110.191 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 543' ' ' THR . . . -65.39 -37.46 93.86 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 46.5 t -63.91 -38.65 91.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.621 -0.929 . . . . 0.0 111.07 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -60.83 -39.08 87.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.515 -0.74 . . . . 0.0 110.663 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 8.9 mp -62.46 -40.66 97.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.487 -0.758 . . . . 0.0 109.867 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 55.7 ttm -64.01 -32.25 73.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.675 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.49 -53.03 61.45 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.925 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.469 ' HB2' HD21 ' A' ' 515' ' ' LEU . 36.6 ttm -58.06 -48.35 80.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.381 -0.824 . . . . 0.0 110.768 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.82 -31.53 68.55 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.329 -0.857 . . . . 0.0 111.286 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.84 -21.71 66.01 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.3 -0.875 . . . . 0.0 110.382 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.766 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -72.26 0.28 10.31 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.263 -0.898 . . . . 0.0 112.532 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 125.48 -14.97 7.23 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.83 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 67.2 t -83.72 105.46 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.239 . . . . 0.0 109.832 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -172.09 147.2 2.05 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.548 -0.72 . . . . 0.0 110.714 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 9.9 t -108.83 138.59 44.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -76.73 -88.94 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.029 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -140.2 -77.47 0.32 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.012 -1.055 . . . . 0.0 111.115 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -72.16 -21.66 61.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.524 -0.735 . . . . 0.0 110.916 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -145.07 153.16 41.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.473 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -92.18 40.1 2.93 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.49 68.87 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -94.54 -2.07 52.25 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.184 -1.186 . . . . 0.0 111.409 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -87.02 -5.86 58.93 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.722 -1.236 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -134.11 51.73 6.87 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.08 -1.013 . . . . 0.0 111.08 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 566' ' ' ARG . 41.4 Cg_endo -72.68 -17.73 25.87 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.157 1.082 . . . . 0.0 110.574 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -169.42 112.7 0.51 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.261 -0.899 . . . . 0.0 109.655 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.551 -179.23 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 70.8 m -62.99 -42.29 99.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.483 -0.761 . . . . 0.0 109.98 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 139.5 82.77 0.09 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 17.2 tt -110.77 131.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.943 . . . . 0.0 110.058 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -139.31 102.09 4.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.786 . . . . 0.0 110.126 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 388' ' ' ASP . 67.3 t -108.51 100.6 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.537 -0.727 . . . . 0.0 110.082 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.18 -44.1 66.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.515 -0.741 . . . . 0.0 111.291 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 386' ' ' VAL . 93.7 m-20 -92.65 173.37 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.608 0.718 . . . . 0.0 111.875 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.76 84.52 2.22 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.765 0.793 . . . . 0.0 110.677 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 67.6 tp -63.41 -40.67 97.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.622 -0.674 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 73.6 m -60.87 -44.79 96.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.557 -0.714 . . . . 0.0 110.625 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 433' ' ' LEU . 85.8 t -66.75 -35.03 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.654 -0.653 . . . . 0.0 111.043 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -60.4 -49.13 78.8 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.992 -1.067 . . . . 0.0 111.272 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.19 80.15 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.134 -0.979 . . . . 0.0 109.613 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 426' ' ' LEU . 0.7 OUTLIER -59.39 -40.27 86.02 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.444 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 400' ' ' MET . 47.3 t -63.34 -42.5 98.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -59.22 -45.8 90.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.257 -0.902 . . . . 0.0 111.917 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -65.88 -41.34 91.7 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.152 -0.968 . . . . 0.0 111.089 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.638 HG21 ' O ' ' A' ' 435' ' ' ILE . 92.9 mt -62.31 -41.02 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.623 -0.673 . . . . 0.0 110.027 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 396' ' ' SER . 32.4 mmm -63.42 -34.97 78.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.487 -0.758 . . . . 0.0 110.845 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.19 -28.28 67.83 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.828 -1.17 . . . . 0.0 110.221 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.449 ' HA ' ' HB ' ' A' ' 405' ' ' VAL . 58.8 tp60 -90.79 -20.03 22.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.805 -1.185 . . . . 0.0 108.498 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 400' ' ' MET . 39.6 t30 -64.46 -31.57 72.83 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -114.42 18.81 16.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 402' ' ' GLN . 9.9 p -40.9 149.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 121.535 0.683 . . . . 0.0 112.149 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 23.3 p -87.43 72.86 9.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.709 HG23 HG12 ' A' ' 413' ' ' VAL . 12.3 p -91.61 131.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.363 -0.836 . . . . 0.0 112.219 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -96.89 144.1 27.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.635 . . . . 0.0 109.747 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.31 -20.82 42.21 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 123.405 1.213 . . . . 0.0 110.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -57.31 -40.87 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.85 0.833 . . . . 0.0 110.031 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 411' ' ' LYS . 0.0 OUTLIER -150.56 67.98 0.96 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 27.0 t -54.5 119.8 5.75 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 122.066 0.936 . . . . 0.0 112.048 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.709 HG12 HG23 ' A' ' 407' ' ' VAL . 7.3 p -71.06 147.65 93.84 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 413' ' ' VAL . 35.3 Cg_endo -59.42 135.15 63.1 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.058 1.031 . . . . 0.0 110.765 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.459 ' O ' ' CE2' ' A' ' 419' ' ' TYR . 90.8 mtm-85 -103.51 -6.29 21.92 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.272 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 6.0 p -99.49 18.9 16.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.674 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.26 -35.01 6.93 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.67 94.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.778 ' CB ' HG13 ' A' ' 436' ' ' VAL . 4.0 m-85 -93.86 -9.9 35.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.762 -1.434 . . . . 0.0 110.399 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.98 -43.98 61.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.867 -1.145 . . . . 0.0 109.004 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.78 -45.72 57.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.727 -0.608 . . . . 0.0 110.307 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 425' ' ' VAL . . . -61.48 -49.04 78.39 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.75 -0.594 . . . . 0.0 111.797 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.84 ' HA ' HD23 ' A' ' 426' ' ' LEU . 90.3 t -69.57 -43.43 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.423 -0.798 . . . . 0.0 112.575 -178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 79.5 p -62.26 -39.54 93.22 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.925 -1.109 . . . . 0.0 111.421 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 422' ' ' ALA . 12.1 p -67.69 -28.13 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.321 -0.862 . . . . 0.0 111.821 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -75.02 -31.22 61.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 111.151 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.14 74.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.963 . . . . 0.0 109.203 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.21 -29.88 70.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.97 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.592 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -171.36 -52.3 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 120.713 -1.242 . . . . 0.0 111.671 177.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 44.5 Cg_endo -77.7 112.7 3.36 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 O-C-N 122.568 0.773 . . . . 0.0 110.775 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.493 ' N ' ' HG2' ' A' ' 531' ' ' GLN . 0.3 OUTLIER -87.12 99.66 12.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.631 -0.668 . . . . 0.0 109.245 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.5 tp -162.67 92.56 0.79 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.171 -0.956 . . . . 0.0 111.063 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 426' ' ' LEU . . . -139.83 170.56 15.65 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.542 0.687 . . . . 0.0 111.832 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.638 ' O ' HG21 ' A' ' 399' ' ' ILE . 45.3 pt -121.84 141.52 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.736 -0.603 . . . . 0.0 109.414 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.778 HG13 ' CB ' ' A' ' 419' ' ' TYR . 57.3 t -141.92 148.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -0.805 . . . . 0.0 109.806 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.405 ' CB ' ' OD1' ' A' ' 403' ' ' ASN . 44.5 t -127.38 133.64 50.01 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.439 -0.788 . . . . 0.0 110.272 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -115.17 129.51 8.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -130.61 34.19 4.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.616 -0.932 . . . . 0.0 109.818 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -148.73 -137.45 2.84 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -67.29 120.87 14.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -99.68 -9.13 23.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.883 . . . . 0.0 111.734 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.72 90.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.49 -28.2 73.34 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -66.33 -38.36 87.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.755 -0.85 . . . . 0.0 110.199 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.418 ' CD ' ' HB2' ' A' ' 467' ' ' ALA . 0.1 OUTLIER -59.86 -50.15 74.9 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.438 -0.789 . . . . 0.0 110.281 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.36 -29.28 67.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -61.04 -54.97 38.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.772 -0.58 . . . . 0.0 112.01 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.68 -35.65 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.909 -1.119 . . . . 0.0 109.394 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.476 ' HB2' ' HG2' ' A' ' 480' ' ' GLU . . . -63.53 -26.89 68.91 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.444 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.41 -34.78 79.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.037 -1.04 . . . . 0.0 108.828 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.97 -35.57 81.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 463' ' ' VAL . 88.6 t -58.42 -27.31 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.846 -0.534 . . . . 0.0 109.714 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 67.4 mtt -71.09 -34.92 71.59 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.29 -32.78 72.63 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.55 0.691 . . . . 0.0 109.604 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -83.63 -22.69 32.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.772 -0.58 . . . . 0.0 110.231 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -65.65 -42.74 91.06 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.259 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -72.59 -29.44 63.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.326 -0.859 . . . . 0.0 110.512 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.71 8.22 4.74 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 111.07 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.94 75.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.65 124.31 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.488 -1.007 . . . . 0.0 110.527 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.618 ' C ' HD11 ' A' ' 487' ' ' ILE . 81.9 mt-10 -82.96 166.53 18.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.186 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.911 ' CG2' HG13 ' A' ' 453' ' ' VAL . 33.4 m -141.11 156.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.931 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.754 ' HA ' HD22 ' A' ' 486' ' ' LEU . 58.9 tt0 -102.6 120.05 39.88 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 466' ' ' ILE . 0.8 OUTLIER -126.09 128.51 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.192 -0.943 . . . . 0.0 111.104 -178.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.627 HG23 ' CD ' ' A' ' 471' ' ' ARG . 5.3 mp -125.5 121.2 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.418 ' HB2' ' CD ' ' A' ' 446' ' ' ARG . . . -81.25 165.04 21.82 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.277 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.66 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.423 0.63 . . . . 0.0 109.612 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -51.22 -12.63 0.14 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.736 -1.228 . . . . 0.0 112.639 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -81.99 -2.94 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.773 -1.204 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.627 ' CD ' HG23 ' A' ' 466' ' ' ILE . 70.1 ttp85 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.945 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 35.4 t -63.38 -44.24 95.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -62.85 -41.61 99.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.659 -0.65 . . . . 0.0 110.139 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.0 mmt -67.76 -29.08 68.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.701 -0.625 . . . . 0.0 110.706 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -59.99 -42.13 93.57 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 120.655 -1.278 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.3 mtm -67.19 -39.22 86.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 109.629 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 477' ' ' LYS . 57.2 pttt -131.6 128.86 40.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.802 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 55.32 92.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.189 -0.944 . . . . 0.0 112.255 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 482' ' ' LEU . 75.7 m-20 -81.84 26.27 0.51 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.633 ' CB ' HD23 ' A' ' 482' ' ' LEU . 4.7 mp0 50.83 42.48 27.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.561 -1.337 . . . . 0.0 110.511 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 57.09 21.92 6.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.633 HD23 ' CB ' ' A' ' 480' ' ' GLU . 0.3 OUTLIER -124.42 20.03 8.81 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.54 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.0 p -47.21 -22.25 0.36 Allowed 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 168.98 78.92 0.04 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -175.01 41.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.711 -0.876 . . . . 0.0 109.677 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 464' ' ' GLN . 78.2 mt -75.3 -82.76 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.969 HD13 ' CB ' ' A' ' 503' ' ' SER . 0.2 OUTLIER -162.15 -70.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.658 -1.276 . . . . 0.0 109.751 175.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 487' ' ' ILE . 3.1 t -100.08 8.75 43.71 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.153 177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.466 ' HA2' ' HG ' ' A' ' 493' ' ' LEU . . . -82.92 61.27 4.8 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.556 -2.217 . . . . 0.0 107.556 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.41 ' HD3' ' CZ ' ' A' ' 499' ' ' PHE . 51.8 ttt85 -143.77 -68.51 0.33 Allowed 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.609 -0.936 . . . . 0.0 109.252 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -100.73 -31.06 11.38 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.487 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -62.02 -43.99 97.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.509 -0.744 . . . . 0.0 110.826 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' A' ' 489' ' ' GLY . 6.0 mt -72.42 -39.05 68.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.553 -0.717 . . . . 0.0 111.8 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 43.1 tp -106.11 -42.26 5.14 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -89.72 -4.06 57.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.892 -1.13 . . . . 0.0 113.254 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 66.13 47.16 75.04 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.3 mmm -120.01 177.29 5.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.944 -0.739 . . . . 0.0 111.128 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.38 134.51 54.6 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 488' ' ' THR . 0.3 OUTLIER -114.75 149.32 37.07 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.871 0.843 . . . . 0.0 111.486 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 500' ' ' THR . 5.2 t -50.82 105.69 0.55 Allowed Pre-proline 0 N--CA 1.496 1.842 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.48 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -78.47 112.75 3.23 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.283 1.149 . . . . 0.0 109.21 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 529' ' ' ASN . . . -169.73 37.23 0.19 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.969 ' CB ' HD13 ' A' ' 487' ' ' ILE . 92.0 p -95.8 175.47 6.5 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.451 1.119 . . . . 0.0 113.713 -177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.855 ' HB ' HG12 ' A' ' 463' ' ' VAL . 23.2 m -125.92 106.99 10.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 104.818 -2.289 . . . . 0.0 104.818 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 522' ' ' LEU . 40.4 t -97.36 136.83 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.375 -0.828 . . . . 0.0 111.524 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 533' ' ' LEU . 3.9 pt -141.0 110.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.745 HG12 HG22 ' A' ' 534' ' ' ILE . 7.1 p -112.21 114.65 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.388 -1.445 . . . . 0.0 113.152 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.44 ' HA ' ' OG1' ' A' ' 535' ' ' THR . 98.3 m-20 -84.58 131.39 34.62 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.6 tp-100 -156.95 114.89 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.721 -1.592 . . . . 0.0 115.011 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 537' ' ' SER . . . -76.93 -66.54 1.8 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 31.1 tt0 -58.65 172.12 0.55 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.26 -13.75 11.71 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.837 -0.745 . . . . 0.0 112.196 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.66 -36.78 83.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.236 -0.915 . . . . 0.0 109.632 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 4.7 m -83.09 -13.8 54.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 110.776 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 509' ' ' GLN . 33.0 tp -69.15 -44.62 71.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 108.812 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -68.9 -36.01 77.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.851 -0.531 . . . . 0.0 111.401 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -57.28 -50.27 73.43 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.807 -1.183 . . . . 0.0 110.465 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.79 ' O ' HD12 ' A' ' 522' ' ' LEU . 68.3 m -60.06 -44.13 94.93 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.599 -0.688 . . . . 0.0 110.502 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.75 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.3 OUTLIER -57.37 -39.5 76.15 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.73 -0.606 . . . . 0.0 111.106 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 9.7 m -61.86 -39.65 92.62 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.389 -0.819 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.496 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.4 OUTLIER -65.92 -44.61 84.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.575 -0.703 . . . . 0.0 109.561 179.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 518' ' ' THR . 0.4 OUTLIER -61.11 -22.8 64.99 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.464 -0.772 . . . . 0.0 111.808 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -46.0 -60.84 2.03 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.233 -0.917 . . . . 0.0 112.174 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -74.02 -50.79 9.92 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.508 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -66.36 -36.75 83.67 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.326 -1.103 . . . . 0.0 113.432 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 530' ' ' VAL . . . -65.67 -23.82 66.87 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -44.67 -25.87 0.32 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.381 -0.825 . . . . 0.0 111.514 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.06 -140.06 0.3 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.226 -0.921 . . . . 0.0 111.224 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 530' ' ' VAL . 1.9 t-20 -71.08 85.8 0.73 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.822 -1.174 . . . . 0.0 111.815 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 526' ' ' ALA . 71.6 t -146.2 168.13 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.097 -1.002 . . . . 0.0 111.494 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 432' ' ' SER . 8.5 tp60 -162.31 164.53 27.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 3.6 t -115.45 115.39 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.435 -0.791 . . . . 0.0 112.163 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 506' ' ' ILE . 5.9 tp -110.78 120.53 42.69 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 507' ' ' VAL . 2.4 pt -139.95 146.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.079 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 436' ' ' VAL . 65.1 p -105.48 -169.5 1.6 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -158.75 167.95 28.14 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.321 -0.862 . . . . 0.0 109.923 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.498 ' H ' ' HA2' ' A' ' 510' ' ' GLY . 0.8 OUTLIER -133.03 -6.64 3.07 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.677 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -129.09 28.42 4.1 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.436 ' HG3' ' HA ' ' A' ' 543' ' ' THR . 44.5 tt0 -98.67 -1.49 40.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.757 -0.849 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -56.32 -43.95 79.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.206 -0.934 . . . . 0.0 112.173 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 26.2 m -102.6 -56.89 2.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.913 -1.117 . . . . 0.0 110.94 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -88.51 59.0 4.1 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.7 t -65.58 -44.38 86.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.983 . . . . 0.0 111.572 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 543' ' ' THR . . . -61.27 -40.26 98.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.5 m -62.9 -37.36 86.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.59 -0.947 . . . . 0.0 111.53 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -57.64 -36.6 72.07 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.088 -1.008 . . . . 0.0 109.73 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.1 mp -63.85 -41.26 97.85 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.907 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 36.6 ttm -61.37 -30.12 70.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.188 -0.945 . . . . 0.0 109.017 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -57.53 -54.92 41.33 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.298 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.75 ' HG3' HD11 ' A' ' 519' ' ' LEU . 57.8 ttm -55.65 -46.82 77.41 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . 0.625 ' HA ' HG13 ' A' ' 555' ' ' VAL . 86.4 mttt -61.17 -31.78 71.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.576 -0.703 . . . . 0.0 112.183 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.71 -16.58 62.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.353 -0.842 . . . . 0.0 111.226 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -74.02 5.49 4.24 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.171 -0.956 . . . . 0.0 113.059 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 118.35 -16.58 11.62 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 120.805 -1.184 . . . . 0.0 111.037 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 551' ' ' LYS . 10.3 p -85.99 119.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.199 -1.177 . . . . 0.0 110.764 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -167.03 136.2 2.81 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 68.1 p -97.97 153.0 18.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -73.55 -81.04 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.583 -0.698 . . . . 0.0 110.731 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -170.02 -67.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.512 -0.742 . . . . 0.0 109.93 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -94.22 -22.84 18.16 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.459 -0.775 . . . . 0.0 110.306 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -149.51 110.0 4.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.119 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -78.36 144.88 28.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.63 72.18 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.98 -4.85 49.08 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.347 -1.09 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -93.05 0.18 57.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.936 . . . . 0.0 110.981 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.511 ' N ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -152.19 59.88 3.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 109.517 -178.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 566' ' ' ARG . 37.9 Cg_endo -91.92 -5.54 3.67 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.513 1.27 . . . . 0.0 110.988 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -113.83 -19.47 11.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.774 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.083 179.539 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 120.872 0.368 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 78.5 p -63.06 -37.04 85.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.527 -0.733 . . . . 0.0 109.828 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 134.04 88.95 0.34 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 79.0 mt -105.67 127.18 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -118.61 169.02 10.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.406 -0.808 . . . . 0.0 109.985 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.88 132.75 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.749 -0.594 . . . . 0.0 110.615 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 387' ' ' LEU . 4.5 mm? -86.57 147.2 26.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.466 -0.771 . . . . 0.0 110.705 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -138.1 -153.63 0.49 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.689 -0.632 . . . . 0.0 109.848 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.45 -17.1 58.63 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.339 -0.85 . . . . 0.0 111.122 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.74 -36.64 81.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.261 -0.899 . . . . 0.0 110.617 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 5.1 t -62.79 -43.15 99.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.435 -0.791 . . . . 0.0 109.487 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 81.0 t -66.31 -36.08 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.982 -0.449 . . . . 0.0 110.76 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -60.75 -50.51 73.17 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.19 -0.944 . . . . 0.0 110.232 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.37 -33.02 72.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.229 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 426' ' ' LEU . 7.6 tt -59.7 -39.7 85.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.81 -0.556 . . . . 0.0 110.621 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 78.1 p -68.6 -32.49 72.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.409 -0.807 . . . . 0.0 111.153 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -64.34 -43.06 95.79 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.557 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -69.03 -40.31 78.7 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.0 112.719 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.446 HD11 HD21 ' A' ' 395' ' ' LEU . 61.9 mt -65.07 -43.37 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 403' ' ' ASN . 27.2 mtp -61.86 -22.66 65.71 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.26 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -63.26 -30.54 71.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.104 -0.997 . . . . 0.0 108.984 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.727 ' NE2' HG11 ' A' ' 405' ' ' VAL . 1.8 mm-40 -90.04 -14.21 34.34 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.192 -0.942 . . . . 0.0 109.457 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 400' ' ' MET . 42.5 t-20 -66.39 -39.3 88.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.77 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -116.92 18.45 14.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 110.752 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 407' ' ' VAL . 6.3 p -59.43 114.93 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.385 -0.822 . . . . 0.0 109.793 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 63.0 p -52.12 99.68 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.171 -0.956 . . . . 0.0 110.95 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 405' ' ' VAL . 61.0 t -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.661 -0.65 . . . . 0.0 110.179 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.24 137.35 24.89 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 0.0 110.204 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.44 -29.3 45.35 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.165 1.087 . . . . 0.0 111.279 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -63.55 -25.59 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.507 -0.746 . . . . 0.0 110.119 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 60.54 0.5 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 m -58.91 115.79 3.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.495 0.664 . . . . 0.0 111.52 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 414' ' ' PRO . 6.9 p -64.15 150.09 92.91 Favored Pre-proline 0 N--CA 1.501 2.095 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 413' ' ' VAL . 36.6 Cg_endo -59.91 139.14 86.62 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 122.789 0.889 . . . . 0.0 110.228 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -116.38 -1.39 12.3 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.743 HG22 ' OH ' ' A' ' 419' ' ' TYR . 34.9 p -97.34 22.09 9.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.766 -1.209 . . . . 0.0 109.489 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -108.68 -31.58 7.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -62.37 -44.16 98.04 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.743 ' OH ' HG22 ' A' ' 416' ' ' THR . 27.0 p90 -103.04 -10.81 18.61 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.79 -1.418 . . . . 0.0 111.875 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 7.0 t -67.22 -43.03 83.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.374 -1.454 . . . . 0.0 108.083 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 425' ' ' VAL . 33.4 t0 -79.36 -44.32 21.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.933 -0.479 . . . . 0.0 111.304 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 425' ' ' VAL . . . -65.38 -46.33 80.54 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.629 -0.67 . . . . 0.0 112.417 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.837 ' HA ' HD23 ' A' ' 426' ' ' LEU . 88.8 t -70.37 -43.31 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.444 -0.785 . . . . 0.0 111.99 -178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -43.17 99.48 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.918 -1.114 . . . . 0.0 111.813 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 421' ' ' ASP . 33.1 m -64.47 -29.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.204 -0.935 . . . . 0.0 111.495 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -71.57 -33.99 69.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 111.737 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -70.57 -33.26 70.91 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.59 -30.76 71.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -64.21 -86.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.485 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.2 OUTLIER -177.32 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 110.399 177.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -72.48 101.5 1.27 Allowed 'Trans proline' 0 N--CA 1.485 0.99 0 N-CA-C 109.455 -1.017 . . . . 0.0 109.455 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.477 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 26.4 t -87.72 101.2 13.45 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.559 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 6.4 tp -160.98 89.33 0.79 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -131.68 164.84 25.05 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.882 0.848 . . . . 0.0 112.481 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.77 128.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 535' ' ' THR . 58.4 t -122.3 138.33 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.359 -0.838 . . . . 0.0 110.07 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.2 m -119.58 126.46 51.25 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 111.494 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -129.45 160.39 22.64 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -120.71 -30.63 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.676 -0.896 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.1 173.45 31.27 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 70.17 29.73 70.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.706 ' HB3' ' NH2' ' A' ' 470' ' ' ARG . . . -67.89 -20.5 65.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.27 89.16 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.134 -0.979 . . . . 0.0 110.904 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.73 -37.12 57.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -62.17 -35.8 79.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.784 -0.833 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.873 ' HD3' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.52 -44.45 97.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.675 0.75 . . . . 0.0 109.724 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -68.84 -31.56 70.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.973 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -64.63 -45.04 88.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 111.713 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 446' ' ' ARG . 10.0 p -58.15 -31.21 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.613 -1.305 . . . . 0.0 108.9 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -63.97 -27.05 68.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -64.51 -36.02 82.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.873 -1.142 . . . . 0.0 108.503 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 452' ' ' LEU . 4.5 mm? -65.38 -34.33 78.07 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.92 HG13 ' CG2' ' A' ' 463' ' ' VAL . 98.1 t -60.53 -30.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 97.3 mmm -68.33 -37.01 80.14 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.547 -0.72 . . . . 0.0 109.417 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -58.31 -28.82 65.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.767 -0.583 . . . . 0.0 109.976 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -85.03 -22.98 28.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.796 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -66.95 -44.6 80.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 110.413 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -74.42 -29.33 61.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.327 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.49 14.75 5.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.592 -0.692 . . . . 0.0 112.193 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.98 26.67 71.48 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.477 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 42.9 ttm180 -124.05 126.16 45.77 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.216 -1.167 . . . . 0.0 110.337 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 486' ' ' LEU . 53.8 mp0 -92.56 158.56 15.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.456 -0.777 . . . . 0.0 110.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.92 ' CG2' HG13 ' A' ' 453' ' ' VAL . 26.9 m -140.03 163.33 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 121.768 0.794 . . . . 0.0 111.516 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.709 ' OE1' HD13 ' A' ' 486' ' ' LEU . 43.4 tp60 -113.75 121.56 44.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.599 HD13 HG13 ' A' ' 506' ' ' ILE . 0.7 OUTLIER -119.03 123.47 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.26 1.028 . . . . 0.0 111.829 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.686 ' HB ' HG23 ' A' ' 507' ' ' VAL . 4.5 mp -101.11 169.06 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.873 ' HB1' ' HD3' ' A' ' 446' ' ' ARG . . . -130.83 156.47 44.96 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.84 -159.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.448 -0.783 . . . . 0.0 110.019 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -48.66 -15.25 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.991 -1.068 . . . . 0.0 111.823 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . 0.706 ' NH2' ' HB3' ' A' ' 442' ' ' ALA . 76.0 mtt85 -87.54 5.47 39.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.003 -1.061 . . . . 0.0 111.007 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.565 ' HA ' ' HB3' ' A' ' 467' ' ' ALA . 13.8 tpt180 -58.95 -36.94 75.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.298 -0.876 . . . . 0.0 111.447 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 21.9 t -59.7 -45.42 92.19 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.405 -0.809 . . . . 0.0 110.2 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.09 -41.0 95.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.361 -0.837 . . . . 0.0 110.396 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 18.5 ttm -62.84 -35.17 79.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 0.0 111.19 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -60.13 -39.26 85.66 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.346 -0.846 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.3 -40.23 93.4 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 478' ' ' GLN . 63.1 pttt -109.18 -148.81 0.43 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.556 -0.715 . . . . 0.0 109.865 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 477' ' ' LYS . 23.7 tt0 50.46 80.6 0.07 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.195 -0.941 . . . . 0.0 110.957 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -123.73 34.75 5.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -125.9 4.81 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.494 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.41 ' CB ' HD23 ' A' ' 482' ' ' LEU . 0.5 OUTLIER -138.22 -34.08 0.66 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 112.503 -179.109 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 481' ' ' ARG . 0.4 OUTLIER -145.47 71.73 1.29 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.987 -1.071 . . . . 0.0 112.108 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 35.0 t -92.28 48.81 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 0.0 109.808 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.7 33.1 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -119.64 54.91 0.99 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.53 -0.982 . . . . 0.0 110.392 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.709 HD13 ' OE1' ' A' ' 464' ' ' GLN . 0.1 OUTLIER -101.59 -84.22 0.45 Allowed 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.488 178.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.945 HG22 HG23 ' A' ' 488' ' ' THR . 4.6 mp -140.97 -88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.257 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 487' ' ' ILE 0.251 26.4 p -102.7 22.48 13.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.398 -0.814 . . . . 0.0 111.511 -178.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -62.41 89.25 0.05 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -111.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 495' ' ' GLU . 94.9 mtt-85 -106.32 -21.97 12.95 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 120.616 -1.302 . . . . 0.0 109.416 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -47.96 -23.5 0.8 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.299 -0.876 . . . . 0.0 111.629 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.51 -60.37 3.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 112.068 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 5.96 28.01 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.299 -1.501 . . . . 0.0 111.885 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 491' ' ' ARG . 71.7 mm-40 -83.41 -6.07 59.35 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.035 -1.041 . . . . 0.0 112.702 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.84 -7.6 80.64 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.085 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.64 -176.23 0.61 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.176 -1.19 . . . . 0.0 109.493 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -113.56 167.52 10.53 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.01 150.91 29.94 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 488' ' ' THR . 9.4 t -82.5 138.99 44.29 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.4 139.05 52.85 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.283 1.149 . . . . 0.0 110.357 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 529' ' ' ASN . . . 148.9 -9.09 0.98 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . . . . . . . . . 10.9 t -77.41 139.03 39.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -1.154 . . . . 0.0 113.164 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.829 ' HB ' HG12 ' A' ' 463' ' ' VAL . 80.6 m -111.13 124.28 51.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.496 HG21 ' CD1' ' A' ' 522' ' ' LEU . 50.4 t -116.34 125.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.61 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.829 HG22 ' HB3' ' A' ' 533' ' ' LEU . 22.6 pt -121.57 120.27 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 534' ' ' ILE . 9.6 p -120.21 108.86 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.145 -0.972 . . . . 0.0 111.622 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.515 ' OD2' HG11 ' A' ' 449' ' ' VAL . 95.0 m-20 -85.11 121.63 28.15 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.888 -1.132 . . . . 0.0 108.343 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 511' ' ' GLU . 7.0 tp-100 -148.59 105.25 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -69.42 -38.79 80.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 4.9 tt0 -79.43 -155.44 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.07 -7.01 0.56 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.625 -0.672 . . . . 0.0 110.974 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.28 -34.42 74.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.357 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . 0.443 ' HA ' ' CG ' ' A' ' 517' ' ' GLU . 1.6 m -87.71 -22.19 24.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.333 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 54.4 tp -68.74 -46.33 69.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.15 -0.969 . . . . 0.0 109.606 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 553' ' ' ALA . 32.8 ttpt -69.09 -44.18 73.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.664 -0.648 . . . . 0.0 112.296 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . 0.443 ' CG ' ' HA ' ' A' ' 514' ' ' SER . 0.5 OUTLIER -64.77 -39.99 94.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.498 -1.376 . . . . 0.0 110.452 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 77.5 m -60.42 -44.2 95.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.113 -0.992 . . . . 0.0 109.347 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 550' ' ' MET . 0.1 OUTLIER -55.85 -35.54 66.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.944 -0.473 . . . . 0.0 109.998 -179.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 18.5 m -59.05 -39.15 81.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.1 -40.86 78.1 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.492 0.663 . . . . 0.0 109.971 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.496 ' CD1' HG21 ' A' ' 505' ' ' VAL . 12.2 tp -63.77 -22.79 67.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.456 -0.777 . . . . 0.0 111.146 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . 0.553 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 98.6 m-20 -47.93 -57.42 5.73 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.446 -0.784 . . . . 0.0 111.774 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -62.32 -50.84 61.08 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -53.18 -29.88 34.21 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.482 -1.011 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.648 ' HA ' HG13 ' A' ' 530' ' ' VAL . . . -57.96 -23.51 54.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.776 -0.577 . . . . 0.0 111.255 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -41.39 -43.89 2.67 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.598 -0.689 . . . . 0.0 112.319 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 -62.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.577 ' C ' HG22 ' A' ' 530' ' ' VAL . 4.3 t30 -80.77 156.09 26.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.392 -0.817 . . . . 0.0 110.468 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 526' ' ' ALA . 0.1 OUTLIER -174.34 151.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.988 0.899 . . . . 0.0 110.791 178.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.825 ' CB ' HG23 ' A' ' 504' ' ' THR . 0.0 OUTLIER -177.39 91.71 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 54.2 t -99.36 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.011 0.91 . . . . 0.0 111.3 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.829 ' HB3' HG22 ' A' ' 506' ' ' ILE . 0.2 OUTLIER -107.77 113.41 26.63 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 176.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.735 HG22 HG12 ' A' ' 507' ' ' VAL . 0.6 OUTLIER -131.28 144.77 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.837 -177.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 69.9 p -105.6 -177.11 3.27 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -160.03 168.11 26.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.013 -1.055 . . . . 0.0 110.83 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.518 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 1.1 p -142.94 -4.89 0.91 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.328 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -103.98 5.64 46.58 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 543' ' ' THR . 97.0 mt-30 -82.42 -1.43 50.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -1.192 . . . . 0.0 111.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.59 -43.21 75.79 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 0.0 110.494 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 24.6 m -106.98 -45.02 4.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -117.56 70.41 0.3 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 544' ' ' GLY . 11.9 t -64.76 -43.97 91.56 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.58 -0.953 . . . . 0.0 111.402 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 543' ' ' THR . . . -64.16 -29.64 75.52 Favored Glycine 0 N--CA 1.496 2.645 0 O-C-N 121.099 -1.001 . . . . 0.0 110.637 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t -65.16 -36.07 83.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.301 -1.117 . . . . 0.0 110.797 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -64.11 -38.39 90.9 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.796 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 547' ' ' LEU . 10.8 mp -62.63 -42.22 99.47 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.838 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 67.5 ttp -63.14 -35.76 81.36 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.275 -0.891 . . . . 0.0 108.705 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -51.98 -50.44 61.28 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.578 ' HG3' HD11 ' A' ' 519' ' ' LEU . 58.0 ttm -55.33 -49.15 72.93 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.795 -0.566 . . . . 0.0 110.395 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.58 -31.75 69.74 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.526 -0.734 . . . . 0.0 111.683 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.87 -17.09 64.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.843 . . . . 0.0 109.92 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 516' ' ' LYS . . . -68.88 1.05 3.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.343 -0.848 . . . . 0.0 113.122 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 137.04 -11.2 3.89 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.224 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.5 t -87.81 106.67 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.257 -1.143 . . . . 0.0 110.25 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -158.74 116.11 2.82 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 24.0 p -77.25 162.33 27.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -101.08 -83.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 111.307 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -142.54 -75.74 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 110.865 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -93.28 -22.17 19.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.496 -0.752 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -131.5 155.11 47.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.388 -0.82 . . . . 0.0 111.002 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -73.46 -120.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . -67.66 83.38 0.15 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.35 -16.79 22.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.42 -1.047 . . . . 0.0 110.91 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -98.76 -4.37 33.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.108 -0.995 . . . . 0.0 110.943 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.14 56.59 1.3 Allowed Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.003 -1.061 . . . . 0.0 109.894 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.58 -12.81 27.17 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.213 1.112 . . . . 0.0 111.724 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -155.13 86.96 1.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.665 -179.429 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.187 0.517 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 21.4 t -63.81 -44.25 93.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 140.82 75.63 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 51.1 pt -100.87 8.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.451 -1.029 . . . . 0.0 110.872 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -72.51 -33.8 67.16 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.197 -0.94 . . . . 0.0 111.019 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 386' ' ' VAL . 34.5 m -99.28 121.23 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.345 -0.847 . . . . 0.0 110.795 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 61.2 tp -122.76 -69.0 0.85 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.257 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -87.0 172.05 10.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 110.352 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -89.84 78.5 6.83 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.34 -40.16 96.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.71 -0.619 . . . . 0.0 111.135 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 74.4 m -61.25 -46.42 90.45 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.699 -0.626 . . . . 0.0 111.561 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 433' ' ' LEU . 67.7 t -66.29 -33.06 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.348 -0.845 . . . . 0.0 110.147 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -60.39 -48.75 80.4 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.937 -1.102 . . . . 0.0 109.848 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.824 . . . . 0.0 108.841 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.731 ' CD2' HD22 ' A' ' 426' ' ' LEU . 1.2 tp -60.54 -41.11 93.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.88 -0.513 . . . . 0.0 110.964 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -36.38 82.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.25 -0.906 . . . . 0.0 110.453 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -66.07 -45.25 81.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.382 -0.823 . . . . 0.0 112.194 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.87 -43.5 75.24 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.109 -0.994 . . . . 0.0 111.879 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.547 HG22 ' OD1' ' A' ' 403' ' ' ASN . 64.4 mt -63.69 -41.38 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.442 -0.786 . . . . 0.0 110.528 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.445 ' HA ' ' HB2' ' A' ' 403' ' ' ASN . 22.8 mtt -59.62 -33.22 71.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.736 -0.603 . . . . 0.0 110.445 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.31 -36.8 78.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.748 -0.595 . . . . 0.0 110.495 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.641 HE22 HG21 ' A' ' 405' ' ' VAL . 63.3 tp60 -92.75 -13.9 28.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.638 -1.289 . . . . 0.0 110.02 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.547 ' OD1' HG22 ' A' ' 399' ' ' ILE . 13.9 m120 -69.28 -32.31 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -115.3 18.6 16.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.371 -0.831 . . . . 0.0 109.72 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.641 HG21 HE22 ' A' ' 402' ' ' GLN . 9.8 p -41.87 149.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.257 0.551 . . . . 0.0 112.095 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 47.5 p -82.65 72.97 9.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.435 HG23 HG13 ' A' ' 413' ' ' VAL . 8.1 p -101.49 131.89 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.393 -0.817 . . . . 0.0 111.313 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -94.91 145.0 28.77 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.08 -23.41 60.82 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.093 1.049 . . . . 0.0 110.272 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -55.87 -24.43 37.0 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.617 0.722 . . . . 0.0 110.861 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.99 63.1 0.46 Allowed 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 59.5 p -50.25 107.12 0.14 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.25 -0.906 . . . . 0.0 111.177 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 407' ' ' VAL . 4.3 m -62.65 153.62 77.51 Favored Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.58 122.17 11.05 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.254 -1.095 . . . . 0.0 109.254 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -96.62 -5.96 37.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 419' ' ' TYR . 13.4 p -93.3 22.79 4.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.767 -1.208 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -105.0 -37.3 7.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.767 . . . . 0.0 109.044 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 402' ' ' GLN . . . -62.48 -49.0 77.82 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 416' ' ' THR . 43.1 p90 -100.89 -8.89 22.11 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.503 1.652 . . . . 0.0 112.982 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 416' ' ' THR . 80.9 p -69.71 -36.59 76.05 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.574 -1.65 . . . . 0.0 107.05 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -78.64 -48.14 15.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.959 -0.463 . . . . 0.0 111.173 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -62.57 -48.7 78.29 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.429 -0.795 . . . . 0.0 111.251 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.878 ' HA ' HD23 ' A' ' 426' ' ' LEU . 77.1 t -65.28 -46.05 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.611 . . . . 0.0 111.803 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.6 t -61.19 -45.9 92.71 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.976 -1.077 . . . . 0.0 112.64 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.53 -46.95 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.116 -0.99 . . . . 0.0 110.715 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.878 HD23 ' HA ' ' A' ' 423' ' ' VAL . 0.4 OUTLIER -53.33 -33.97 55.62 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.458 -0.776 . . . . 0.0 111.821 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.54 75.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.872 -1.142 . . . . 0.0 109.045 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -60.83 -29.15 69.32 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -66.84 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.516 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 0.0 OUTLIER -175.6 -55.76 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.589 -1.319 . . . . 0.0 109.839 178.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 52.0 Cg_endo -71.99 106.21 1.97 Allowed 'Trans proline' 0 N--CA 1.483 0.899 0 N-CA-C 106.744 -2.06 . . . . 0.0 106.744 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.553 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 0.2 OUTLIER -90.52 99.92 12.86 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.107 -177.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 532' ' ' VAL . 2.9 mt -141.99 140.39 32.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 533' ' ' LEU . . . -169.5 150.89 4.26 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 399' ' ' ILE . 20.7 pt -119.43 120.97 65.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 535' ' ' THR . 82.1 t -125.36 139.98 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.1 t -117.05 122.43 44.14 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.364 -0.835 . . . . 0.0 110.293 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -97.41 155.35 20.57 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -136.12 -36.21 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.574 -0.957 . . . . 0.0 111.439 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -152.13 155.51 26.18 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 66.15 62.23 4.85 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -86.54 -21.35 26.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.997 . . . . 0.0 110.537 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -64.97 -45.83 84.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.393 -0.817 . . . . 0.0 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 -36.4 77.22 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.73 -35.77 75.23 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 109.904 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 467' ' ' ALA . 16.0 tpt85 -62.97 -49.79 73.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.63 -0.669 . . . . 0.0 112.243 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 4.7 mt-10 -74.5 -31.13 62.07 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.963 -1.086 . . . . 0.0 111.108 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.73 -48.4 81.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.372 -0.83 . . . . 0.0 110.275 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 506' ' ' ILE . 9.6 p -61.46 -31.34 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.737 -1.227 . . . . 0.0 108.655 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 447' ' ' GLU . . . -62.14 -29.53 70.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.4 -32.38 73.98 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.112 -0.993 . . . . 0.0 108.358 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.35 -35.09 76.47 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.934 HG13 ' CG2' ' A' ' 463' ' ' VAL . 52.0 t -61.1 -26.5 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.6 tpp -66.66 -40.16 88.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.358 -0.839 . . . . 0.0 108.748 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . . . . . . . . . 64.7 ttp -56.49 -27.09 56.21 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.575 -0.703 . . . . 0.0 109.575 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 461' ' ' ARG . . . -83.95 -23.4 31.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 0.0 110.039 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.78 -34.24 71.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -82.22 10.21 7.28 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.608 -0.683 . . . . 0.0 112.077 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.44 29.83 71.49 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . 0.622 ' O ' ' HB1' ' A' ' 456' ' ' ALA . 19.8 tpp85 -126.02 126.98 45.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.95 . . . . 0.0 110.546 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 487' ' ' ILE . 48.7 tp10 -95.94 160.22 14.57 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.934 ' CG2' HG13 ' A' ' 453' ' ' VAL . 19.1 m -142.27 161.36 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.777 -1.202 . . . . 0.0 112.493 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.544 ' HA ' ' CD1' ' A' ' 486' ' ' LEU . 58.7 tt0 -107.54 122.82 47.44 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 465' ' ' ILE . 0.2 OUTLIER -128.09 128.55 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.505 -0.747 . . . . 0.0 110.782 -177.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.529 HD12 HG21 ' A' ' 518' ' ' THR . 78.6 mt -126.89 122.16 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.607 -0.683 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.611 ' HB2' ' HD3' ' A' ' 446' ' ' ARG . . . -86.69 169.02 13.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.045 -1.035 . . . . 0.0 108.776 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 467' ' ' ALA . . . -57.28 -160.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.64 -15.95 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.661 -1.274 . . . . 0.0 113.412 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -76.35 -9.44 58.64 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.591 -1.318 . . . . 0.0 111.086 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -57.35 -32.85 67.16 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.055 . . . . 0.0 111.093 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 26.2 t -62.16 -44.46 96.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.415 -0.803 . . . . 0.0 110.047 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.16 -41.53 94.58 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.428 -0.795 . . . . 0.0 110.243 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.48 76.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.547 -0.721 . . . . 0.0 110.578 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.61 -39.13 87.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.181 -0.95 . . . . 0.0 109.376 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -39.72 95.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -100.07 -146.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 52.68 80.06 0.1 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.807 -1.183 . . . . 0.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -116.45 14.06 15.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.965 -0.459 . . . . 0.0 110.291 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -92.5 -2.32 56.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 111.686 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 482' ' ' LEU . 0.0 OUTLIER -178.66 33.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.058 -1.026 . . . . 0.0 110.823 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 481' ' ' ARG . 1.4 tp -151.61 7.14 0.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.185 -1.006 . . . . 0.0 113.596 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.8 t -55.0 -25.22 28.44 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.474 -1.391 . . . . 0.0 110.445 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 160.46 41.65 0.02 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -130.86 30.65 4.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.663 -0.904 . . . . 0.0 109.314 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.574 HD12 HG12 ' A' ' 487' ' ' ILE . 1.9 tp -60.33 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 1.045 HG22 HG23 ' A' ' 488' ' ' THR . 29.5 mm -153.23 -82.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 108.656 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 487' ' ' ILE . 24.4 p -100.34 11.36 39.59 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.347 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 493' ' ' LEU . . . -77.42 63.91 3.28 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -135.48 -70.96 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . 0.445 ' HD3' ' CE ' ' A' ' 497' ' ' MET . 87.2 mtt-85 -118.52 -8.23 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.848 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . 0.463 ' NE2' ' CD1' ' A' ' 499' ' ' PHE . 4.3 mp0 -73.45 -38.05 65.62 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 521' ' ' LEU . 2.8 mt -93.85 -21.44 19.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.675 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 25.8 tp -103.64 -31.3 9.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 491' ' ' ARG . 0.5 OUTLIER -131.47 -2.13 3.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.559 -1.338 . . . . 0.0 113.148 -177.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 78.77 49.26 6.62 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 118.646 -1.74 . . . . 0.0 109.178 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . 0.445 ' CE ' ' HD3' ' A' ' 491' ' ' ARG . 1.8 ttm -112.41 -177.38 3.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -118.82 137.34 53.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.424 -0.797 . . . . 0.0 109.801 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.679 ' HB3' HG22 ' A' ' 488' ' ' THR . 0.1 OUTLIER -114.4 150.02 35.29 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.314 -0.866 . . . . 0.0 111.902 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 500' ' ' THR . 8.7 t -64.0 115.32 18.25 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.963 -0.46 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.459 ' CB ' ' HB2' ' A' ' 528' ' ' HIS . 41.2 Cg_endo -69.3 115.71 4.16 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.217 1.114 . . . . 0.0 110.282 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 529' ' ' ASN . . . -157.75 19.69 0.37 Allowed Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 487' ' ' ILE . 17.3 p -97.89 174.42 6.59 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.774 1.274 . . . . 0.0 113.751 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.815 ' HB ' HG12 ' A' ' 463' ' ' VAL . 10.1 m -122.5 103.53 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.553 HG11 HD22 ' A' ' 522' ' ' LEU . 62.1 t -90.44 134.55 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 533' ' ' LEU . 0.7 OUTLIER -134.39 121.49 36.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.918 HG22 ' HG2' ' A' ' 509' ' ' GLN . 7.5 p -115.94 104.18 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.537 -1.352 . . . . 0.0 111.446 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.83 99.36 10.85 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.918 ' HG2' HG22 ' A' ' 507' ' ' VAL . 94.4 mm-40 -111.62 103.9 12.24 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -175.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.41 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -71.63 -36.5 62.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -98.9 163.16 12.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.486 ' HD3' HD13 ' A' ' 515' ' ' LEU . 56.0 mmtt -100.33 -9.05 22.71 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.825 -0.547 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 513' ' ' LEU . 0.3 OUTLIER -61.67 -41.34 97.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.298 -0.876 . . . . 0.0 109.534 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -6.13 48.34 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.589 -0.695 . . . . 0.0 111.276 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.486 HD13 ' HD3' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -69.78 -56.5 6.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 178.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -73.2 -40.68 64.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.473 -0.767 . . . . 0.0 111.468 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.009 -1.057 . . . . 0.0 110.605 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.529 HG21 HD12 ' A' ' 466' ' ' ILE . 98.6 m -60.07 -44.41 94.78 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.223 -0.923 . . . . 0.0 108.789 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.753 HD11 ' HE3' ' A' ' 550' ' ' MET . 0.4 OUTLIER -50.8 -37.44 42.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -0.763 . . . . 0.0 110.434 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 19.3 m -64.77 -42.28 95.21 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.525 -0.734 . . . . 0.0 111.852 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 521' ' ' LEU . 0.5 OUTLIER -66.23 -47.16 74.71 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.226 -0.922 . . . . 0.0 111.565 -178.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 0.553 HD22 HG11 ' A' ' 505' ' ' VAL . 4.3 pp -78.2 -18.11 55.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.396 -0.815 . . . . 0.0 111.9 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -47.07 -46.1 22.24 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.405 -0.81 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -64.48 -46.31 90.7 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 530' ' ' VAL . . . -64.41 -37.89 89.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.787 . . . . 0.0 111.668 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 530' ' ' VAL . . . -62.04 -29.38 70.25 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.063 -1.023 . . . . 0.0 111.005 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -58.15 -27.39 63.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.044 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 501' ' ' PRO . 65.4 m80 -108.9 -117.66 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.832 -0.542 . . . . 0.0 111.094 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.409 ' CB ' ' HA2' ' A' ' 502' ' ' GLY . 10.5 m120 -91.28 65.78 5.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.405 -1.434 . . . . 0.0 113.666 -177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 526' ' ' ALA . 1.0 OUTLIER -139.71 165.18 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.551 -1.343 . . . . 0.0 110.279 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 432' ' ' SER . 15.1 mp0 -150.5 161.02 43.33 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.729 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 433' ' ' LEU . 18.9 t -112.3 107.86 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.992 -1.068 . . . . 0.0 113.075 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 434' ' ' ALA . 7.2 tp -110.67 117.48 33.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.738 HG22 HG12 ' A' ' 507' ' ' VAL . 10.7 pt -137.36 133.71 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 117.996 -1.481 . . . . 0.0 113.148 -175.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 436' ' ' VAL . 82.4 p -99.02 -168.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -155.54 164.67 38.36 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.41 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.3 OUTLIER -142.28 -18.81 0.71 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.551 178.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -111.77 -17.05 8.77 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.483 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 1.0 OUTLIER -87.69 1.74 52.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.452 -1.028 . . . . 0.0 110.265 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -32.32 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 78.3 p -101.05 115.16 29.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.506 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 69.8 59.8 5.35 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 539' ' ' GLN . 58.7 p -68.46 -10.32 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.949 -0.736 . . . . 0.0 110.659 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.96 80.48 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 39.0 m -61.08 -29.85 69.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.974 . . . . 0.0 109.312 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.734 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -69.65 -32.26 70.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.922 -0.486 . . . . 0.0 110.028 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.1 mp -61.8 -42.62 99.23 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 109.26 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 64.3 mtt -64.64 -34.31 77.98 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -48.92 -51.75 28.39 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.753 ' HE3' HD11 ' A' ' 519' ' ' LEU . 96.4 mmm -56.1 -42.57 76.98 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -57.56 -31.72 66.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.528 -0.732 . . . . 0.0 110.059 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -62.76 -30.0 71.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 519' ' ' LEU . . . -69.34 -7.61 38.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.648 -0.658 . . . . 0.0 111.246 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 106.25 -5.16 38.41 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.515 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 555' ' ' VAL . 33.4 m -75.43 118.58 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 118.942 1.371 . . . . 0.0 111.117 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -171.72 137.88 1.05 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.312 -0.867 . . . . 0.0 110.956 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . . . . . . . . . 5.0 t -105.99 152.65 23.07 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -75.14 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.995 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -138.56 -89.92 0.22 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.756 -1.215 . . . . 0.0 111.195 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -89.87 -21.39 22.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.031 -1.043 . . . . 0.0 111.405 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -81.5 138.53 35.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.323 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . . . . . . . . . . . -92.95 37.58 3.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . . . . . . . . . . . 140.48 79.1 0.06 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -92.91 -14.18 27.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.524 -0.986 . . . . 0.0 110.72 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -91.11 -6.63 53.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.611 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.08 54.54 1.21 Allowed Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.333 -0.855 . . . . 0.0 109.693 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.19 -7.38 20.45 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.445 1.234 . . . . 0.0 111.566 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . . . . . . . . . . . -153.51 101.55 2.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.502 -179.345 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.084 0.468 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . . 70.5 m -60.56 -43.35 97.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.077 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -143.34 135.54 6.47 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 49.8 pt -86.37 133.44 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.547 -0.972 . . . . 0.0 109.87 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -137.36 164.15 29.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.0 110.292 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 32.9 m -71.48 143.89 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.537 -0.727 . . . . 0.0 110.074 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.46 176.33 8.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.687 . . . . 0.0 110.381 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -73.72 157.66 36.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.723 -0.611 . . . . 0.0 110.191 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -85.95 54.55 3.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.655 -0.653 . . . . 0.0 110.492 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -40.27 95.73 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.497 -0.752 . . . . 0.0 110.193 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 75.7 p -61.32 -40.79 95.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.664 -0.647 . . . . 0.0 110.946 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 433' ' ' LEU . 91.8 t -71.3 -24.11 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.587 -0.696 . . . . 0.0 111.769 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.11 -52.92 52.58 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.945 -1.097 . . . . 0.0 111.178 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.94 78.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.438 -0.789 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.739 ' CD2' HD11 ' A' ' 399' ' ' ILE . 8.1 tt -62.18 -41.02 97.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.743 -0.598 . . . . 0.0 111.152 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 11.1 t -62.81 -40.26 96.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 0.0 111.309 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.76 -44.34 93.89 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.415 -0.803 . . . . 0.0 110.861 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -65.52 -38.1 88.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.359 -0.838 . . . . 0.0 111.997 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 395' ' ' LEU . 0.5 OUTLIER -64.13 -40.85 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.241 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.648 ' CG ' HD11 ' A' ' 435' ' ' ILE . 56.6 mtp -63.39 -28.82 70.25 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.83 -26.83 66.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.255 -0.903 . . . . 0.0 108.799 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.625 ' O ' HG12 ' A' ' 405' ' ' VAL . 0.6 OUTLIER -90.44 -18.45 25.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 109.461 176.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -66.04 -38.48 88.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.688 -0.633 . . . . 0.0 110.397 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -116.5 18.67 15.01 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 402' ' ' GLN . 8.2 p -60.39 118.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.506 -0.746 . . . . 0.0 110.354 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 406' ' ' THR . 5.8 t -53.11 101.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.417 0.627 . . . . 0.0 111.536 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.763 HG23 HG12 ' A' ' 413' ' ' VAL . 4.0 p -114.21 134.62 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' HIS . . . . . 0.432 ' CB ' ' HE2' ' A' ' 411' ' ' LYS . 0.1 OUTLIER -91.09 141.53 26.5 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.438 -0.789 . . . . 0.0 109.8 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.53 -27.72 32.73 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.151 1.08 . . . . 0.0 110.138 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.86 -34.12 76.08 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.761 0.791 . . . . 0.0 109.668 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 408' ' ' HIS . 0.0 OUTLIER -138.82 58.66 1.64 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 13.7 t -50.68 98.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.116 -0.99 . . . . 0.0 111.81 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.763 HG12 HG23 ' A' ' 407' ' ' VAL . 7.6 p -58.61 148.44 66.53 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.93 -0.482 . . . . 0.0 109.713 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.545 ' HD2' HG23 ' A' ' 413' ' ' VAL . 38.4 Cg_endo -63.47 149.76 90.26 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.228 1.12 . . . . 0.0 109.682 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -136.3 -8.86 1.98 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.667 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 420' ' ' SER . 19.2 p -102.17 19.32 18.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -80.32 -77.01 0.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.612 -0.68 . . . . 0.0 111.854 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . -84.36 -2.23 89.15 Favored Glycine 0 N--CA 1.484 1.872 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.217 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 423' ' ' VAL . 85.3 m-85 -107.14 -20.89 13.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 120.573 2.187 . . . . 0.0 108.827 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 416' ' ' THR . 37.6 t -72.67 -40.61 66.14 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 425' ' ' VAL . 35.5 t0 -65.66 -38.11 88.4 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 395' ' ' LEU . . . -61.4 -39.09 89.46 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.807 0.813 . . . . 0.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.73 ' CG1' HD21 ' A' ' 533' ' ' LEU . 63.5 t -66.39 -44.97 90.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.037 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -61.42 -35.58 77.96 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.964 -1.085 . . . . 0.0 111.257 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 421' ' ' ASP . 93.0 t -62.27 -47.46 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.427 -0.795 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 423' ' ' VAL . 1.4 pp -57.56 -33.29 67.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.413 -0.804 . . . . 0.0 111.996 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' A' ' 533' ' ' LEU . . . -68.17 -36.96 80.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.716 -1.24 . . . . 0.0 108.333 178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.62 -31.93 71.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -65.65 -90.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ARG . . . . . 0.413 ' HB3' ' HD3' ' A' ' 431' ' ' PRO . 8.3 tpp85 -178.54 -57.97 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.406 -1.434 . . . . 0.0 109.097 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 430' ' ' ARG . 43.3 Cg_endo -68.33 93.54 0.41 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.554 -1.364 . . . . 0.0 108.554 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 426' ' ' LEU . 5.5 t -85.96 111.48 20.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -163.97 89.12 0.55 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.513 ' HB2' HD22 ' A' ' 426' ' ' LEU . . . -139.15 168.31 20.13 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.686 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.648 HD11 ' CG ' ' A' ' 400' ' ' MET . 2.6 pp -127.82 130.93 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.617 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 423' ' ' VAL . 9.4 t -124.38 150.83 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.493 -0.754 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 13.8 m -123.05 127.46 48.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.315 -0.865 . . . . 0.0 110.663 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -122.49 160.3 16.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -148.85 -47.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.911 . . . . 0.0 109.562 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . -101.46 142.44 15.71 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . 73.87 89.16 0.18 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.7 -44.69 4.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.593 -0.945 . . . . 0.0 110.804 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.27 97.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.784 . . . . 0.0 110.775 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.43 -29.11 62.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.37 -41.76 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -1.027 . . . . 0.0 110.771 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.86 ' HG2' ' HB1' ' A' ' 467' ' ' ALA . 0.0 OUTLIER -61.5 -43.85 98.13 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.244 -0.91 . . . . 0.0 109.754 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -67.73 -29.13 68.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.199 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -61.61 -47.66 84.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.524 -0.735 . . . . 0.0 110.864 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 446' ' ' ARG . 7.1 p -59.66 -31.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.857 -1.152 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 453' ' ' VAL . . . -64.0 -27.88 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.576 -0.849 . . . . 0.0 108.758 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.84 -34.06 77.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.149 -0.97 . . . . 0.0 108.448 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' LEU . . . . . 0.408 ' O ' ' CG ' ' A' ' 455' ' ' MET . 33.3 tp -62.62 -34.99 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.78 HG13 ' HB ' ' A' ' 463' ' ' VAL . 59.9 t -63.01 -25.81 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 79.9 mtp -69.81 -42.37 73.77 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.878 . . . . 0.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 452' ' ' LEU . 0.0 OUTLIER -62.39 -20.8 64.82 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.121 -0.987 . . . . 0.0 109.894 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -82.0 -22.69 36.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 0.0 109.745 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.26 -41.91 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.333 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.25 -26.74 63.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.486 -0.759 . . . . 0.0 109.51 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.1 2.86 16.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.0 111.707 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 83.95 4.27 88.68 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.033 -1.042 . . . . 0.0 111.878 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.09 132.2 33.78 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.993 1.397 . . . . 0.0 111.136 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 487' ' ' ILE . 55.8 mp0 -76.7 -174.38 2.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.61 -0.681 . . . . 0.0 110.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.78 ' HB ' HG13 ' A' ' 453' ' ' VAL . 43.0 t -134.95 144.77 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.766 -0.584 . . . . 0.0 110.472 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' GLN . . . . . 0.597 ' HB3' HG22 ' A' ' 505' ' ' VAL . 50.8 tt0 -92.44 114.56 27.14 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . 0.544 HD13 ' N ' ' A' ' 466' ' ' ILE 0.255 0.0 OUTLIER -127.3 129.13 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 111.431 -175.811 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.751 ' HB ' HG23 ' A' ' 507' ' ' VAL . 83.1 mt -124.71 120.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.834 -0.542 . . . . 0.0 110.545 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 446' ' ' ARG . . . -78.16 164.45 24.95 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.34 -160.47 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.81 -0.556 . . . . 0.0 110.085 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -51.37 -17.08 0.66 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.76 -1.213 . . . . 0.0 111.082 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -73.44 -6.33 45.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.481 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . 0.703 ' HD3' HG23 ' A' ' 466' ' ' ILE . 62.2 ttp180 -57.54 -31.62 66.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.3 m -59.08 -45.69 90.19 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.547 -0.721 . . . . 0.0 110.301 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.56 -40.43 95.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.494 -0.754 . . . . 0.0 109.056 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 92.7 mtp -62.37 -33.15 74.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.829 -0.544 . . . . 0.0 110.744 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -61.25 -38.98 88.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.949 . . . . 0.0 110.208 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 66.5 ttp -59.18 -40.13 84.71 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.43 -0.794 . . . . 0.0 109.622 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 478' ' ' GLN . 62.6 pttt -119.58 -146.39 0.38 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' GLN . . . . . 0.437 ' HG2' ' HG3' ' A' ' 477' ' ' LYS . 96.3 mm-40 43.64 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.135 -0.978 . . . . 0.0 112.131 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -121.35 14.04 11.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.528 -0.732 . . . . 0.0 110.527 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -101.61 -10.12 20.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 111.659 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -132.15 0.41 3.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.109 -0.994 . . . . 0.0 112.939 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.32 44.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.656 -1.278 . . . . 0.0 112.873 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.7 t -89.34 48.76 1.65 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.654 -1.279 . . . . 0.0 110.47 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.06 58.24 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.8 44.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -1.15 . . . . 0.0 109.672 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 487' ' ' ILE . 95.1 mt -59.03 -84.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.923 -1.11 . . . . 0.0 109.318 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 462' ' ' GLU . 22.8 mm -156.37 -82.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.83 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . 0.459 ' HA ' ' CG ' ' A' ' 499' ' ' PHE . 2.5 t -98.37 11.57 37.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.791 -0.568 . . . . 0.0 110.472 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.96 74.65 2.29 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.421 ' HB3' ' CE1' ' A' ' 499' ' ' PHE . 72.8 ttt-85 -144.83 -72.5 0.26 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -107.42 -22.73 12.46 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.565 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.02 -37.93 89.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.196 -0.94 . . . . 0.0 109.847 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 493' ' ' LEU . 1.3 mt -89.32 -53.72 4.43 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.022 0.915 . . . . 0.0 108.647 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 35.2 tp -66.39 -42.96 87.14 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.032 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -112.79 -8.81 13.72 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.16 -4.74 79.84 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.273 -1.517 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' MET . . . . . . . . . . . . . 94.6 mtp -68.52 -177.73 0.99 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.056 -1.261 . . . . 0.0 110.594 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -110.54 148.33 32.35 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.446 -0.784 . . . . 0.0 110.652 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.459 ' CG ' ' HA ' ' A' ' 488' ' ' THR . 0.2 OUTLIER -113.34 155.15 25.7 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.963 0.887 . . . . 0.0 111.069 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 500' ' ' THR . 4.9 t -51.31 116.68 7.91 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.18 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 528' ' ' HIS . 48.3 Cg_endo -76.41 114.45 3.88 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.434 1.229 . . . . 0.0 110.41 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.2 28.62 0.03 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' SER . . . . . 0.595 ' CB ' HG21 ' A' ' 487' ' ' ILE . 47.1 t -92.01 169.24 10.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.363 -1.081 . . . . 0.0 111.833 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.73 ' O ' HG13 ' A' ' 463' ' ' VAL . 52.6 m -110.88 117.86 34.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 1.069 HG11 HD21 ' A' ' 522' ' ' LEU . 32.1 t -112.33 130.23 66.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.725 0.774 . . . . 0.0 110.008 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 533' ' ' LEU . 14.6 pt -138.91 131.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.371 -0.831 . . . . 0.0 109.125 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.751 HG23 ' HB ' ' A' ' 466' ' ' ILE . 7.7 p -129.63 109.25 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.243 1.021 . . . . 0.0 111.245 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . 0.508 ' OD2' HG11 ' A' ' 449' ' ' VAL . 80.4 m-20 -85.47 110.16 18.98 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.595 ' HG2' HG22 ' A' ' 507' ' ' VAL . 90.4 mm-40 -126.19 106.91 9.89 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 537' ' ' SER . . . -72.39 -37.61 58.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.455 ' HG2' HD21 ' A' ' 513' ' ' LEU . 30.4 tp10 -85.97 149.15 25.39 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.0 -15.59 18.22 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.55 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 511' ' ' GLU . 3.5 pp -72.41 -31.41 65.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' SER . . . . . . . . . . . . . 5.0 m -83.45 -20.08 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.435 -0.791 . . . . 0.0 110.469 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 519' ' ' LEU . 54.3 tp -65.84 -43.99 86.86 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.5 -40.31 85.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.849 -0.532 . . . . 0.0 111.371 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -57.01 -51.72 68.12 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.065 -1.022 . . . . 0.0 110.719 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.519 HG21 HD12 ' A' ' 466' ' ' ILE . 92.2 m -59.34 -39.53 83.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.846 HD11 ' CE ' ' A' ' 550' ' ' MET . 0.8 OUTLIER -59.49 -38.52 81.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 122.092 -0.38 . . . . 0.0 111.279 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . . . . . . . . . 69.5 p -64.11 -30.88 71.92 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.939 -1.1 . . . . 0.0 109.297 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 48.7 tp -70.02 -41.26 74.52 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.733 0.777 . . . . 0.0 109.331 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' LEU . . . . . 1.069 HD21 HG11 ' A' ' 505' ' ' VAL . 0.4 OUTLIER -72.83 -20.63 61.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.98 -0.45 . . . . 0.0 111.672 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -48.22 -58.88 3.93 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.264 -0.897 . . . . 0.0 111.439 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.29 80.21 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.746 ' HB1' ' HB2' ' A' ' 529' ' ' ASN . . . -58.03 -30.37 66.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.877 -0.778 . . . . 0.0 110.575 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 523' ' ' ASP . . . -52.24 -27.53 15.22 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.126 -0.984 . . . . 0.0 110.782 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -64.24 -36.79 85.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.633 -0.667 . . . . 0.0 109.27 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 501' ' ' PRO . 1.0 OUTLIER -132.2 -60.11 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.674 -0.641 . . . . 0.0 110.775 -179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.746 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . 5.7 m120 -78.68 116.27 18.93 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.678 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' VAL . . . . . . . . . . . . . 2.4 p -169.68 144.11 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 C-N-CA 117.262 -1.775 . . . . 0.0 115.462 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 505' ' ' VAL . 1.8 mt-30 175.9 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.464 HG12 HG23 ' A' ' 534' ' ' ILE . 80.3 t -115.0 114.73 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.501 0 O-C-N 120.525 -1.36 . . . . 0.0 113.853 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.73 HD21 ' CG1' ' A' ' 423' ' ' VAL . 0.3 OUTLIER -116.93 117.47 29.79 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 103.447 -2.798 . . . . 0.0 103.447 175.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' ILE . . . . . 0.662 HG22 HG12 ' A' ' 507' ' ' VAL . 6.2 pt -135.43 149.12 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.416 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.441 ' HA ' ' HB ' ' A' ' 436' ' ' VAL . 49.2 p -112.86 -168.07 1.27 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -158.69 168.14 27.66 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.733 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' SER . . . . . 0.419 ' N ' ' HA2' ' A' ' 510' ' ' GLY . 0.0 OUTLIER -144.32 17.68 1.71 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.214 0.53 . . . . 0.0 109.675 178.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -150.84 27.14 1.03 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' GLN . . . . . 0.52 HE22 HD13 ' A' ' 435' ' ' ILE . 55.6 tt0 -92.62 0.03 57.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.6 -0.941 . . . . 0.0 111.288 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -54.36 -43.66 71.51 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.869 -1.144 . . . . 0.0 110.048 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 73.3 p -113.88 155.38 25.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 55.13 43.76 83.64 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 544' ' ' GLY . 9.8 t -63.22 -43.96 96.64 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.314 -1.11 . . . . 0.0 110.866 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 543' ' ' THR . . . -63.49 -34.24 89.4 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 65.9 m -62.39 -36.41 82.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.9 -0.765 . . . . 0.0 110.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 549' ' ' ALA . . . -59.34 -39.89 84.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.353 -0.842 . . . . 0.0 109.871 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 547' ' ' LEU . 11.3 mp -62.94 -41.77 99.59 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.635 0.731 . . . . 0.0 109.074 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 97.4 mtp -62.69 -28.12 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 546' ' ' ALA . . . -55.82 -53.98 50.16 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' MET . . . . . 0.846 ' CE ' HD11 ' A' ' 519' ' ' LEU . 89.8 mmm -55.62 -46.15 77.43 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.28 -0.888 . . . . 0.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.39 -30.88 71.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.708 -0.62 . . . . 0.0 111.424 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -67.19 -18.02 65.08 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.552 -0.717 . . . . 0.0 110.895 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -75.82 7.08 4.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.402 -0.811 . . . . 0.0 112.679 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLY . . . . . . . . . . . . . . . 121.85 -12.69 9.29 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.094 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 93.4 t -88.31 115.33 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.057 -1.26 . . . . 0.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -170.31 133.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.602 -0.686 . . . . 0.0 110.257 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 562' ' ' GLY . 15.9 p -76.89 162.85 27.28 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.77 -62.74 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.34 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -145.99 -102.1 0.1 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.64 -0.663 . . . . 0.0 109.987 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -92.95 -22.73 19.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.584 -1.323 . . . . 0.0 110.248 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -117.11 153.22 33.14 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 0.0 110.184 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 557' ' ' THR . . . 120.57 73.34 0.35 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' GLY . . . . . 0.438 ' O ' HG22 ' A' ' 569' ' ' THR . . . 96.73 -25.33 26.96 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 568' ' ' ALA . 78.8 tt0 -94.3 -1.73 53.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -1.103 . . . . 0.0 110.927 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -81.94 -6.53 59.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.092 -1.005 . . . . 0.0 111.246 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' ARG . . . . . 0.439 ' CG ' ' HD3' ' A' ' 567' ' ' PRO . 0.0 OUTLIER -153.45 -65.69 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 O-C-N 121.046 -1.034 . . . . 0.0 110.981 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . 0.439 ' HD3' ' CG ' ' A' ' 566' ' ' ARG . 47.2 Cg_endo -73.92 -7.0 19.44 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 122.948 0.973 . . . . 0.0 111.702 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 564' ' ' GLU . . . 54.86 21.16 3.45 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.992 -1.068 . . . . 0.0 111.392 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' THR . . . . . 0.547 HG23 ' OXT' ' A' ' 569' ' ' THR . 8.4 t . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.029 179.838 . . . . . . . . 1 1 . 1 stop_ save_